PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Han, KJ; Foster, DG; Zhang, NY; Kanisha, K; Dzieciatkowska, M; Sclafani, RA; Hansen, KC; Peng, JM; Liu, CW				Han, Ke-Jun; Foster, Daniel G.; Zhang, Nan-Yan; Kanisha, Kavdia; Dzieciatkowska, Monika; Sclafani, Robert A.; Hansen, Kirk C.; Peng, Junmin; Liu, Chang-Wei			Ubiquitin-specific Protease 9x Deubiquitinates and Stabilizes the Spinal Muscular Atrophy Protein-Survival Motor Neuron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE GENE-PRODUCT; COILED BODIES; SMN PROTEIN; MASS-SPECTROMETRY; SNRNP BIOGENESIS; DEGRADATION; COMPLEX; SEVERITY; DEFECTS; ENZYME	Spinal muscular atrophy (SMA), the leading genetic disorder of infant mortality, is caused by low levels of survival motor neuron (SMN) protein. Currently it is not clear how the SMN protein levels are regulated at the post-transcriptional level. In this report, we find that Usp9x, a deubiquitinating enzyme, stably associates with the SMN complex via directly interacting with SMN. Usp9x deubiquitinates SMN that is mostly mono-and di-ubiquitinated. Knockdown of Usp9x promotes SMN degradation and reduces the protein levels of SMN and the SMN complex in cultured mammalian cells. Interestingly, Usp9x does not deubiquitinate nuclear SMN Delta 7, the main protein product of the SMN2 gene, which is polyubiquitinated and rapidly degraded by the proteasome. Together, our results indicate that SMN and SMN Delta 7 are differently ubiquitinated; Usp9x plays an important role in stabilizing SMN and the SMN complex, likely via antagonizing Ub-dependent SMN degradation.	[Han, Ke-Jun; Foster, Daniel G.; Zhang, Nan-Yan; Dzieciatkowska, Monika; Sclafani, Robert A.; Hansen, Kirk C.; Liu, Chang-Wei] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Kanisha, Kavdia; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, Struct Biol & Dev Neurobiol, Memphis, TN 38105 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; St Jude Children's Research Hospital	Liu, CW (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	changwei.liu@ucdenver.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Sclafani, Robert/0000-0002-1100-6489	National Institutes of Health [5RO1NS72397]; American-Syrian-Lebanese Associated Charities; Cancer League of Colorado; NIH/NCRR Colorado CTSI Grant [UL1 RR025780]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American-Syrian-Lebanese Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Cancer League of Colorado; NIH/NCRR Colorado CTSI Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1NS72397 (to C. W. L.) and grants from the American-Syrian-Lebanese Associated Charities (to J. P.) and the Cancer League of Colorado (to K. J. H.).; We are grateful to D. R. Alessi for providing the Usp9x and Usp9x(C1566A) plasmids, L. G. Xu for providing a 293T cDNA library, and B. Chong for initial Usp9x purification. We thank the members of the Liu lab for insightful discussion and reading of the manuscript. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core supported in part by NIH/NCRR Colorado CTSI Grant UL1 RR025780.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Carvalho T, 1999, J CELL BIOL, V147, P715, DOI 10.1083/jcb.147.4.715; Carvallo L, 2010, J BIOL CHEM, V285, P29546, DOI 10.1074/jbc.M110.155812; Chang HC, 2004, NEUROCHEM INT, V45, P1107, DOI 10.1016/j.neuint.2004.04.005; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; Dimova NV, 2012, NAT CELL BIOL, V14, P168, DOI 10.1038/ncb2425; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Han KJ, 2010, J BIOL CHEM, V285, P12543, DOI 10.1074/jbc.M109.072231; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; HIRAKATA M, 1993, J IMMUNOL, V150, P3592; HOVLAND P, 1989, GENE, V83, P57, DOI 10.1016/0378-1119(89)90403-4; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Marx C, 2010, CANCER RES, V70, P3709, DOI 10.1158/0008-5472.CAN-09-3768; Matera AG, 1998, AM J HUM GENET, V63, P317, DOI 10.1086/301992; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Praveen K, 2012, CELL REPORTS, V1, P624, DOI 10.1016/j.celrep.2012.05.014; Raasi Shahri, 2005, V301, P47; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Rossoll W, 2009, RESULTS PROBL CELL D, V48, P289, DOI 10.1007/400_2009_4; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taya S, 1998, J CELL BIOL, V142, P1053, DOI 10.1083/jcb.142.4.1053; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Yin H, 2010, J BIOL CHEM, V285, P13580, DOI 10.1074/jbc.M109.046359; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2001, EXP CELL RES, V265, P252, DOI 10.1006/excr.2001.5186; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhu X, 2007, PROTEINS, V69, P1, DOI 10.1002/prot.21546	77	42	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43741	43752		10.1074/jbc.M112.372318	http://dx.doi.org/10.1074/jbc.M112.372318			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23112048	Green Published, hybrid			2022-12-25	WOS:000312940800053
J	Funderud, I; Lindgren, M; Lovstad, M; Endestad, T; Voytek, B; Knight, RT; Solbakk, AK				Funderud, Ingrid; Lindgren, Magnus; Lovstad, Marianne; Endestad, Tor; Voytek, Bradley; Knight, Robert T.; Solbakk, Anne-Kristin			Differential Go/NoGo Activity in Both Contingent Negative Variation and Spectral Power	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; HIGH-RESOLUTION EEG; VISUAL WORKING-MEMORY; SELF-PACED MOVEMENT; PREFRONTAL CORTEX; ALPHA-BAND; ELECTROPHYSIOLOGICAL CORRELATE; ANTICIPATORY ATTENTION; NEURONAL OSCILLATIONS; GAMMA-SYNCHRONIZATION	We investigated whether both the contingent negative variation (CNV), an event-related potential index of preparatory brain activity, and event-related oscillatory EEG activity differentiated Go and NoGo trials in a delayed response task. CNV and spectral power (4-100 Hz) were calculated from EEG activity in the preparatory interval in 16 healthy adult participants. As previously reported, CNV amplitudes were higher in Go compared to NoGo trials. In addition, event-related spectral power of the Go condition was reduced in the theta to low gamma range compared to the NoGo condition, confirming that preparing to respond is associated with modulation of event-related spectral activity as well as the CNV. Altogether, the impact of the experimental manipulation on both slow event-related potentials and oscillatory EEG activity may reflect coordinated dynamic changes in the excitability of distributed neural networks involved in preparation.	[Funderud, Ingrid; Lindgren, Magnus; Endestad, Tor; Solbakk, Anne-Kristin] Univ Oslo, Rikshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci,Dept Neuropsychiat & Psy, N-0027 Oslo, Norway; [Lindgren, Magnus] Lund Univ, Dept Psychol, Lund, Sweden; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Nesodden, Norway; [Endestad, Tor] Univ Oslo, Dept Psychol, Oslo, Norway; [Voytek, Bradley] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Voytek, Bradley; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of Oslo; National Hospital Norway; Lund University; University of Oslo; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Funderud, I (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Div Surg & Clin Neurosci,Dept Neuropsychiat & Psy, N-0027 Oslo, Norway.	ingridfunderud@hotmail.com	Voytek, Bradley/K-3305-2016	Voytek, Bradley/0000-0003-1640-2525; Funderud, Ingrid/0000-0002-4481-7237; Endestad, Tor/0000-0002-4403-6887	South-Eastern Norway Regional Health Authority [SUN-001-SS, 2008047]; Research Council of Norway [186504/V50]; National Institute of Neurological Disorders [NS21135, PO40813]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135, R56NS021135, R37NS021135] Funding Source: NIH RePORTER	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); National Institute of Neurological Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research is supported by the South-Eastern Norway Regional Health Authority, http://www.helse-sorost.no (grants SUN-001-SS and 2008047), the Research Council of Norway, http://www.forskningsradet.no (grant 186504/V50), and the National Institute of Neurological Disorders, http://www.ninds.nih.gov (NS21135 and PO40813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2004, EXP BRAIN RES, V159, P14, DOI 10.1007/s00221-004-1928-8; Babiloni C, 1999, NEUROIMAGE, V10, P658, DOI 10.1006/nimg.1999.0504; Babiloni C, 2004, NEUROPSYCHOLOGY, V18, P719, DOI 10.1037/0894-4105.18.4.719; Babiloni C, 2003, EUR J NEUROSCI, V18, P1692, DOI 10.1046/j.1460-9568.2003.02851.x; Babiloni C, 2006, CEREB CORTEX, V16, P1690, DOI 10.1093/cercor/bhj104; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bastiaansen MC, 1999, CLIN NEUROPHYSIOL, V110, P250, DOI 10.1016/S0013-4694(98)00122-9; Bastiaansen MCM, 2001, INT J PSYCHOPHYSIOL, V43, P91, DOI 10.1016/S0167-8760(01)00181-7; Bastiaansen MCM, 2001, CLIN NEUROPHYSIOL, V112, P393, DOI 10.1016/S1388-2457(00)00537-X; Bender S, 2005, NEUROIMAGE, V27, P737, DOI 10.1016/j.neuroimage.2005.05.020; Bender S, 2004, CLIN NEUROPHYSIOL, V115, P1836, DOI 10.1016/j.clinph.2004.03.023; Bidet-Caulet A, 2012, EUR J NEUROSCI, V36, P2996, DOI 10.1111/j.1460-9568.2012.08223.x; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; BRUNIA CHM, 1988, BIOL PSYCHOL, V26, P165, DOI 10.1016/0301-0511(88)90018-X; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chen R, 1999, EXP BRAIN RES, V129, P77, DOI 10.1007/s002210050938; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Doesburg SM, 2012, BRAIN RES, V1431, P77, DOI 10.1016/j.brainres.2011.11.005; Doesburg SM, 2009, BRAIN RES, V1303, P97, DOI 10.1016/j.brainres.2009.09.069; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Ergenoglu T, 2004, COGNITIVE BRAIN RES, V20, P376, DOI 10.1016/j.cogbrainres.2004.03.009; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Filipovic SR, 2001, CLIN NEUROPHYSIOL, V112, P1307, DOI 10.1016/S1388-2457(01)00558-2; Gomez CM, 2004, ACTA NEUROBIOL EXP, V64, P143; Gomez CM, 2001, BRAIN TOPOGR, V13, P149, DOI 10.1023/A:1007816201345; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Jia X., 2011, PLOS BIOL, V9, P1; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; LOVELESS NE, 1974, J GERONTOL, V29, P52, DOI 10.1093/geronj/29.1.52; Magnani G, 1998, MOVEMENT DISORD, V13, P653, DOI 10.1002/mds.870130408; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Manning JR, 2009, J NEUROSCI, V29, P13613, DOI 10.1523/JNEUROSCI.2041-09.2009; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Mazaheri A, 2008, J NEUROSCI, V28, P7781, DOI 10.1523/JNEUROSCI.1631-08.2008; MCCARTHY G, 1978, NEUROPSYCHOLOGIA, V16, P571, DOI 10.1016/0028-3932(78)90085-4; Molnar M, 2008, PSYCHOPHYSIOLOGY, V45, P412, DOI 10.1111/j.1469-8986.2008.00648.x; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; PFURTSCHELLER G, 1975, ELECTROEN CLIN NEURO, V38, P93, DOI 10.1016/0013-4694(75)90215-1; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; PFURTSCHELLER G, 1992, NEUROREPORT, V3, P1057, DOI 10.1097/00001756-199212000-00006; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Rockstroh B, 1992, SLOW BRAIN POTENTIAL; ROHRBAUGH JW, 1976, SCIENCE, V191, P1055, DOI 10.1126/science.1251217; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; Salari N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038090; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; TECCE JJ, 1972, PSYCHOL BULL, V77, P73, DOI 10.1037/h0032177; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; van Dijk H, 2010, P NATL ACAD SCI USA, V107, P900, DOI 10.1073/pnas.0908821107; VIJN PCM, 1991, BRAIN RES, V550, P49, DOI 10.1016/0006-8993(91)90403-I; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; Voytek B, 2010, P NATL ACAD SCI USA, V107, P18167, DOI 10.1073/pnas.1007277107; Voytek B, 2010, J COGNITIVE NEUROSCI, V22, P2491, DOI 10.1162/jocn.2009.21384; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Weerts T C, 1973, Biol Psychol, V1, P1, DOI 10.1016/0301-0511(73)90010-0; Whitham EM, 2008, CLIN NEUROPHYSIOL, V119, P1166, DOI 10.1016/j.clinph.2008.01.024; Worden MS, 2000, J NEUROSCI, V20	70	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48504	10.1371/journal.pone.0048504	http://dx.doi.org/10.1371/journal.pone.0048504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119040	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500153
J	Wu, HM; Kuan, YC; Chu, CH; Hsu, WH; Wang, WC				Wu, Hsin-Mao; Kuan, Yi-Chia; Chu, Chia-Han; Hsu, Wen-Hwei; Wang, Wen-Ching			Crystal Structures of Lysine-Preferred Racemases, the Non-Antibiotic Selectable Markers for Transgenic Plants	PLOS ONE			English	Article							AMINO-ACID RACEMASE; ALANINE RACEMASE; ESCHERICHIA-COLI; BACILLUS-STEAROTHERMOPHILUS; PSEUDOMONAS-PUTIDA; SCORING FUNCTION; PROTEIN MODELS; SPECIFICITY; SITE; PEPTIDOGLYCAN	Lysine racemase, a pyridoxal 5'-phosphate (PLP)-dependent amino acid racemase that catalyzes the interconversion of lysine enantiomers, is valuable to serve as a novel non-antibiotic selectable marker in the generation of transgenic plants. Here, we have determined the first crystal structure of a lysine racemase (Lyr) from Proteus mirabilis BCRC10725, which shows the highest activity toward lysine and weaker activity towards arginine. In addition, we establish the first broad-specificity amino acid racemase (Bar) structure from Pseudomonas putida DSM84, which presents not only the highest activity toward lysine but also remarkably broad substrate specificity. A complex structure of Bar-lysine is also established here. These structures demonstrate the similar fold of alanine racemase, which is a head-to-tail homodimer with each protomer containing an N-terminal (alpha/beta)(8) barrel and a C-terminal beta-stranded domain. The active-site residues are located at the protomer interface that is a funnel-like cavity with two catalytic bases, one from each protomer, and the PLP binding site is at the bottom of this cavity. Structural comparisons, site-directed mutagenesis, kinetic, and modeling studies identify a conserved arginine and an adjacent conserved asparagine that fix the orientation of the PLP O3 atom in both structures and assist in the enzyme activity. Furthermore, side chains of two residues in alpha-helix 10 have been discovered to point toward the cavity and define the substrate specificity. Our results provide a structural foundation for the design of racemases with pre-determined substrate specificity and for the development of the non-antibiotic selection system in transgenic plants.	[Wu, Hsin-Mao; Wang, Wen-Ching] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Wu, Hsin-Mao; Wang, Wen-Ching] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Kuan, Yi-Chia; Hsu, Wen-Hwei] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Chu, Chia-Han; Wang, Wen-Ching] Natl Tsing Hua Univ, Biomed Sci & Engn Ctr, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Chung Hsing University; National Tsing Hua University	Wang, WC (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	wcwang@mx.nthu.edu.tw	Wang, Wen-Ching/ABI-2253-2020; Chu, Chu/T-6038-2019		National Science Council [NSC-100-2325-B-007-001, NSC99-2811-B-007-006, NSC98-2313-B-007-005-MY3, NSC98-3112-B-007-004, NSC101-2321-B-007-004]; National Research Program for Biopharmaceuticals, Taiwan [NRPB 100ID1012]; Toward Word-Class University Project from National Tsing Hua University, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Research Program for Biopharmaceuticals, Taiwan; Toward Word-Class University Project from National Tsing Hua University, Taiwan	This work was supported by grants from National Science Council (NSC-100-2325-B-007-001, NSC99-2811-B-007-006, NSC98-2313-B-007-005-MY3, NSC98-3112-B-007-004, NSC101-2321-B-007-004) and National Research Program for Biopharmaceuticals (NRPB 100ID1012), Taiwan. This work was also partially supported by Toward Word-Class University Project from National Tsing Hua University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Au K, 2008, ACTA CRYSTALLOGR F, V64, P327, DOI 10.1107/S1744309108007252; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CAPARROS M, 1992, J BACTERIOL, V174, P5549; CHANG YF, 1974, J BACTERIOL, V117, P753, DOI 10.1128/JB.117.2.753-764.1974; Chen IC, 2010, PLANT MOL BIOL, V72, P153, DOI 10.1007/s11103-009-9558-y; Chen IC, 2009, APPL ENVIRON MICROB, V75, P5161, DOI 10.1128/AEM.00074-09; Chiu WC, 2006, J MOL BIOL, V359, P741, DOI 10.1016/j.jmb.2006.03.063; CHOI SY, 1994, P NATL ACAD SCI USA, V91, P10144, DOI 10.1073/pnas.91.21.10144; Chu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013361; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESAKI N, 1986, BIOCHEMISTRY-US, V25, P3261, DOI 10.1021/bi00359a027; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; HUANG HT, 1958, J AM CHEM SOC, V80, P1006, DOI 10.1021/ja01537a071; HUANG HT, 1958, J BACTERIOL, V76, P495, DOI 10.1128/JB.76.5.495-498.1958; Im H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-116; Inagaki K, 1984, Prog Clin Biol Res, V144A, P355; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kino K, 2007, APPL MICROBIOL BIOT, V73, P1299, DOI 10.1007/s00253-006-0600-6; Krammer A, 2005, J MOL GRAPH MODEL, V23, P395, DOI 10.1016/j.jmgm.2004.11.007; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; Kuan YC, 2011, PROCESS BIOCHEM, V46, P1914, DOI 10.1016/j.procbio.2011.06.019; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeMagueres P, 2005, BIOCHEMISTRY-US, V44, P1471, DOI 10.1021/bi0486583; LeMagueres P, 2003, BIOCHEMISTRY-US, V42, P14752, DOI 10.1021/bi030165v; LILLEY PE, 1993, GENE, V129, P9; LIM YH, 1993, J BACTERIOL, V175, P4213, DOI 10.1128/JB.175.13.4213-4217.1993; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Morollo AA, 1999, BIOCHEMISTRY-US, V38, P3293, DOI 10.1021/bi9822729; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noda M, 2004, J BIOL CHEM, V279, P46153, DOI 10.1074/jbc.M404605200; Oikawa T, 2006, J BIOTECHNOL, V125, P503, DOI 10.1016/j.jbiotec.2006.04.002; Ono K, 2006, PHYTOCHEMISTRY, V67, P856, DOI 10.1016/j.phytochem.2006.02.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patrick DSS, 2011, CRYST GROWTH DES; Patrick WM, 2002, CHEMBIOCHEM, V3, P789, DOI 10.1002/1439-7633(20020802)3:8<789::AID-CBIC789>3.0.CO;2-D; Raghuraman A, 2006, J MED CHEM, V49, P3553, DOI 10.1021/jm060092o; SCHLEIFER KH, 1975, Z IMMUNITATSFORSCH, V149, P104; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c; Spassov VZ, 2007, PROTEIN SCI, V16, P494, DOI 10.1110/ps.062447107; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Sun SX, 1999, BIOCHEMISTRY-US, V38, P4058, DOI 10.1021/bi982924t; Uo T, 2001, J BACTERIOL, V183, P2226, DOI 10.1128/JB.183.7.2226-2233.2001; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Watababe A, 1999, J BIOL CHEM, V274, P4189, DOI 10.1074/jbc.274.7.4189; Watanabe A, 1999, J BIOCHEM-TOKYO, V126, P781, DOI 10.1093/oxfordjournals.jbchem.a022517; Watanabe A, 2002, J BIOL CHEM, V277, P19166, DOI 10.1074/jbc.M201615200; Wu DL, 2008, PROTEIN SCI, V17, P1066, DOI 10.1110/ps.083495908; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306	56	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48301	10.1371/journal.pone.0048301	http://dx.doi.org/10.1371/journal.pone.0048301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118975	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500095
J	Zintzen, V; Anderson, MJ; Roberts, CD; Harvey, ES; Stewart, AL; Struthers, CD				Zintzen, Vincent; Anderson, Marti J.; Roberts, Clive D.; Harvey, Euan S.; Stewart, Andrew L.; Struthers, Carl D.			Diversity and Composition of Demersal Fishes along a Depth Gradient Assessed by Baited Remote Underwater Stereo-Video	PLOS ONE			English	Article							SPECIES-RICHNESS; COMMUNITY STRUCTURE; CONTINENTAL-SLOPE; NORTH-ATLANTIC; NEW-ZEALAND; GROUNDFISH ASSEMBLAGES; PORCUPINE SEABIGHT; BODY-SIZE; BIODIVERSITY; PATTERNS	Background: Continental slopes are among the steepest environmental gradients on earth. However, they still lack finer quantification and characterisation of their faunal diversity patterns for many parts of the world. Methodology/Principal Findings: Changes in fish community structure and diversity along a depth gradient from 50 to 1200 m were studied from replicated stereo baited remote underwater video deployments within each of seven depth zones at three locations in north-eastern New Zealand. Strong, but gradual turnover in the identities of species and community structure was observed with increasing depth. Species richness peaked in shallow depths, followed by a decrease beyond 100 m to a stable average value from 700 to 1200 m. Evenness increased to 700 m depth, followed by a decrease to 1200 m. Average taxonomic distinctness Delta(+) response was unimodal with a peak at 300 m. The variation in taxonomic distinctness A(+) first decreased sharply from 50 to 300 m, then increased beyond 500 m depth, indicating that species from deep samples belonged to more distant taxonomic groups than those from shallow samples. Fishes with northern distributions progressively decreased in their proportional representation with depth whereas those with widespread distributions increased. Conclusions/Significance: This study provides the first characterization of diversity patterns for bait-attracted fish species on continental slopes in New Zealand and is an imperative primary step towards development of explanatory and predictive ecological models, as well as being fundamental for the implementation of efficient management and conservation strategies for fishery resources.	[Zintzen, Vincent; Roberts, Clive D.; Stewart, Andrew L.; Struthers, Carl D.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand; [Anderson, Marti J.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Harvey, Euan S.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Harvey, Euan S.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia	Massey University; University of Western Australia; University of Western Australia	Zintzen, V (corresponding author), Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand.	vincentz@tepapa.govt.nz	Harvey, Euan/B-2896-2011; Stewart, Andrew/HGC-0709-2022; Anderson, Marti J./AAQ-9038-2021	Harvey, Euan/0000-0002-9069-4581; Anderson, Marti J./0000-0002-4018-4049; Struthers, Carl David/0000-0002-8224-0336	Royal Society of New Zealand Marsden grant [MAU0713]; Te Papa Collection Development Programme [AP3126]; Foundation for Research, Science and Technology/National Institute of Water and Atmospheric Research Marine Biodiversity and Biosecurity OBI [COIX0502]	Royal Society of New Zealand Marsden grant(Royal Society of New ZealandMarsden Fund (NZ)); Te Papa Collection Development Programme; Foundation for Research, Science and Technology/National Institute of Water and Atmospheric Research Marine Biodiversity and Biosecurity OBI	This work was supported by a Royal Society of New Zealand Marsden grant (MAU0713), Te Papa Collection Development Programme (AP3126) and Foundation for Research, Science and Technology/National Institute of Water and Atmospheric Research Marine Biodiversity and Biosecurity OBI (contract COIX0502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson TJ, 2007, FISH B-NOAA, V105, P168; [Anonymous], 1975, COMMUNITIES ECOSYSTE; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P185, DOI 10.1016/j.dsr2.2007.09.005; Blanco M, 2006, TRENDS FOOD SCI TECH, V18, P29, DOI 10.1016/j.tifs.2006.07.015; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2006, AUSTR SOC FISH BIOL, VVol. 1, P101, DOI DOI 10.1007/978-1-62703-724-2_1; Cappo M., 2003, AQUATIC PROTECTED AR, P455; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Clark MR, 2010, MAR ECOL-EVOL PERSP, V31, P39, DOI 10.1111/j.1439-0485.2010.00384.x; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Collins MA, 2005, P ROY SOC B-BIOL SCI, V272, P2051, DOI 10.1098/rspb.2005.3189; Douglas RH, 1998, PROG RETIN EYE RES, V17, P597, DOI 10.1016/S1350-9462(98)00002-0; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; ESCHMEYER WN, 2008, CATALOG FISHES; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; FRANCIS M, 2001, COASTAL FISHES NZ; Francis MP, 2002, ENVIRON BIOL FISH, V65, P215, DOI 10.1023/A:1020046713411; Freedman D., 1983, J BUS ECON STAT, V1, P292, DOI [10.2307/1391660, DOI 10.2307/1391660]; Gage J. D., 1991, DEEP SEA BIOL NATURA; GORDON JDM, 1992, J MAR BIOL ASSOC UK, V72, P213, DOI 10.1017/S002531540004889X; Gray JS, 2001, SCI MAR, V65, P41, DOI 10.3989/scimar.2001.65s241; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; HAEDRICH RL, 1988, J NAT HIST, V22, P1325, DOI 10.1080/00222938800770811; Harvey E, 2002, MAR TECHNOL SOC J, V36, P38, DOI 10.4031/002533202787914106; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2010, MAR TECHNOL SOC J, V44, P75, DOI 10.4031/MTSJ.44.1.3; Helfman G., 2009, DIVERSITY FISH BIOL; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jaccard P, 1900, B SOC VAUD SCI NAT, V36, P87; Jacob W, 1998, DEEP-SEA RES PT I, V45, P2119, DOI 10.1016/S0967-0637(98)00051-X; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Jones EG, 2003, MAR ECOL PROG SER, V251, P75, DOI 10.3354/meps251075; Kallianiotis A, 2000, PROG OCEANOGR, V46, P429, DOI 10.1016/S0079-6611(00)00028-8; KOSLOW JA, 1994, DEEP-SEA RES PT I, V41, P113; KOSLOW JA, 1993, PROG OCEANOGR, V31, P321; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Last PR., 2009, SHARK RAYS AUSTR, V2; Leathwick JR, 2006, MAR ECOL PROG SER, V321, P267, DOI 10.3354/meps321267; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Lorance P, 2002, AQUAT LIVING RESOUR, V15, P263, DOI 10.1016/S0990-7440(02)01189-0; Magnussen E, 2002, MAR ECOL PROG SER, V238, P211, DOI 10.3354/meps238211; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marshall N. B., 1960, Discovery Reports, V31, P1; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; Merigot B, 2007, FISH RES, V88, P120, DOI 10.1016/j.fishres.2007.08.003; MERRETT NR, 1991, J MAR BIOL ASSOC UK, V71, P329, DOI 10.1017/S0025315400051638; Moranta J, 1998, MAR ECOL PROG SER, V171, P247, DOI 10.3354/meps171247; MULLINS HT, 1985, GEOLOGY, V13, P491, DOI 10.1130/0091-7613(1985)13<491:OZEEEF>2.0.CO;2; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nelson JS, 1984, FISHES WORLD; Paugy D., 1992, ROCKPOOL FISHES NZ T, V2, P569; Paulin C.D., 1985, National Museum of New Zealand Miscellaneous Series, P1; Paulin C. D., 1993, P 2 INT TEMP REEF S, P191; Pelletier D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030536; Powell Shawna M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P19; PRIEDE IG, 1994, J MAR BIOL ASSOC UK, V74, P481, DOI 10.1017/S0025315400047615; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; REID JL, 1986, PROG OCEANOGR, V16, P1, DOI 10.1016/0079-6611(86)90036-4; Rex M.A., 1983, SEA, P453; Rex M. A, 2010, DEEP SEA BIODIVERSIT; Ross SW, 2007, DEEP-SEA RES PT I, V54, P975, DOI 10.1016/j.dsr.2007.03.010; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Smith KF, 2002, GLOBAL ECOL BIOGEOGR, V11, P313, DOI 10.1046/j.1466-822X.2002.00286.x; Sousa P, 2006, AQUAT LIVING RESOUR, V19, P93, DOI 10.1051/alr:2006009; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Tolimieri N, 2007, ENVIRON BIOL FISH, V78, P241, DOI 10.1007/s10641-006-9093-5; Tolimieri N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010653; Trenkel VM, 2004, MAR ECOL PROG SER, V284, P293, DOI 10.3354/meps284293; Trenkel VM, 2004, ICES J MAR SCI, V61, P1050, DOI 10.1016/j.icesjms.2004.06.002; Wei CL, 2010, MAR ECOL PROG SER, V399, P1, DOI 10.3354/meps08388; Williams A, 2001, MAR ECOL PROG SER, V212, P247, DOI 10.3354/meps212247; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zintzen V, 2011, ECOGRAPHY, V34, P306, DOI 10.1111/j.1600-0587.2010.06546.x	89	60	63	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48522	10.1371/journal.pone.0048522	http://dx.doi.org/10.1371/journal.pone.0048522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119045	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500158
J	Beck, EJ; Mandalia, S; Sangha, R; Youle, M; Brettle, R; Gompels, M; Johnson, M; Pozniak, A; Schwenk, A; Taylor, S; Walsh, J; Wilkins, E; Williams, I; Gazzard, B				Beck, Eduard J.; Mandalia, Sundhiya; Sangha, Roshni; Youle, Mike; Brettle, Ray; Gompels, Mark; Johnson, Margaret; Pozniak, Anton; Schwenk, Achim; Taylor, Stephen; Walsh, John; Wilkins, Ed; Williams, Ian; Gazzard, Brian		NPMS-HHC Steering Grp	Lower Healthcare Costs Associated with the Use of a Single-Pill ARV Regimen in the UK, 2004-2008	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; TABLET REGIMEN; ADHERENCE; SIMPLIFICATION; AIDS	Aim: Investigate the cost and effects of a single-pill versus two- or three pill first-line antiretroviral combinations in reducing viral load, increasing CD4 counts, and first-line failure rate associated with respective regimens at 6 and 12 months. Methods: Patients on first-line TDF+3TC+EFV, TDF+FTC+EFV, Truvada (R)+EFV or Atripla (R) between 1996-2008 were identified and viral load and CD4 counts measured at baseline, six and twelve months respectively. Factors that independently predicted treatment failure at six and twelve months were derived using multivariate Cox's proportional hazard regression analyses. Use and cost of hospital services were calculated at six and twelve months respectively. Results: All regimens reduced viral load to below the limit of detection and CD4 counts increased to similar levels at six and twelve months for all treatment regimens. No statistically significant differences were observed for rate of treatment failure at six and twelve months. People on Atripla (R) generated lower healthcare costs for non-AIDS patients at 5,340 pound (5,254 pound to 5,426) pound per patient-semester and 9,821 pound (9,719 pound to 9,924) pound per patient-year that was 1,344 pound (95%CI 1,222 pound to 1,465) pound less per patient-semester and 1,954 pound (95%CI 1,801 pound to 2,107) pound less per patient-year compared with Truvada (R)+EFV; healthcare costs for AIDS patients were similar across all regimens. Conclusion: The single pill regimen is as effective as the two- and three-pill regimens of the same drugs, but if started as first-line induction therapy there would be a 20% savings on healthcare costs at six and 17% of costs at twelve months compared with Truvada (R)+EFV, that generated the next lowest costs.	[Beck, Eduard J.; Mandalia, Sundhiya; Sangha, Roshni; Youle, Mike; Gazzard, Brian] NPMS HHC CIC, Coordinating & Analyt Ctr, London, England; [Beck, Eduard J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Mandalia, Sundhiya; Gazzard, Brian] Univ London Imperial Coll Sci Technol & Med, London, England; [Youle, Mike; Johnson, Margaret] Royal Free Hosp, London NW3 2QG, England; [Brettle, Ray] Edinburgh Gen Hosp, Edinburgh, Midlothian, Scotland; [Gompels, Mark] Southmead Hosp, Bristol, Avon, England; [Beck, Eduard J.; Mandalia, Sundhiya; Pozniak, Anton; Gazzard, Brian] Chelsea & Westminster Hosp, London, England; [Schwenk, Achim] N Middlesex Hosp, London N18 1QX, England; [Taylor, Stephen] Birmingham Heartland Hosp, Birmingham, W Midlands, England; [Walsh, John] St Marys Hosp, London, England; [Wilkins, Ed] N Manchester Grp Hosp, Manchester, Lancs, England; [Williams, Ian] Mortimer Market Ctr, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Southmead Hospital; Imperial College London; Heart of England NHS Foundation Trust; Imperial College London	Beck, EJ (corresponding author), NPMS HHC CIC, Coordinating & Analyt Ctr, London, England.	becke@unaids.org			Gilead	Gilead(Gilead Sciences)	This study was financially supported through a non-restrictive grant from Gilead, with no influence on the independence of the Steering Group and its editorial policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was financially supported through a non-restrictive grant from Gilead. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Beck E.J., 2001, EFFECTIVE MANAGEMENT, P113; Beck EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027830; Beck EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020200; Beck Eduard J., 2006, HIV PANDEMIC LOCAL G; Beck EJ, 2004, AIDS, V18, P2411; Beck EJ, 2012, PHARMACOECONOMICS, V30, P1; Beck EJ, 2003, BRIT J SEX MED, V27, P21; BECK EJ, 2010, USE COST HIV SERVICE; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Cohen C, 2011, 13 EUR AIDS C EACS O; Colombo GL, 2011, CLINICOECONOMIC OUTC, V3, P197, DOI 10.2147/CEOR.S24130; DeJesus E, 2009, JAIDS-J ACQ IMM DEF, V51, P163, DOI 10.1097/QAI.0b013e3181a572cf; Duse AG, 2008, S AFR J HIV MED, P53; Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816; Hodder SL, 2010, AIDS PATIENT CARE ST, V24, P87, DOI 10.1089/apc.2009.0259; Maggiolo F, 2008, J INT AIDS SOC S1, V11, pP167; Mandalia S, 2002, HIV Med, V3, P254, DOI 10.1046/j.1468-1293.2002.00110.x; Mandalia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015677; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Postma MJ, 1997, HEALTH POLICY, V41, P157, DOI 10.1016/S0168-8510(97)00019-5; Rossi V, 2012, WHOS 2010 RECOMMENDA; Rubin DB, 2004, MULTIPLE IMPUTATION; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Scourfield A, 2012, 17 INT AIDS C MEX CI, V26, P1399; Thakkar B, 1998, 23 SUGI; TOLLEY K, 1993, HEALTH POLICY, V24, P55, DOI 10.1016/0168-8510(93)90088-7; Tolley K, 1995, EC SOCIAL IMPACT AID, P54; UNAIDS/PEPFAR, 2007, INT GUID PROT CONF S; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008; World Health Organization, 2003, M HELD 16 18 DEC 200; World Health Organization, 2011, TREATM 2 0 FRAM ACT; World Health Organization, 2010, UN ACC SCAL PRIOR HI	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47376	10.1371/journal.pone.0047376	http://dx.doi.org/10.1371/journal.pone.0047376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	032HJ	23118869	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705600011
J	Brandt, T; Townsley, FM; Teufel, DP; Freund, SMV; Veprintsev, DB				Brandt, Tobias; Townsley, Fiona M.; Teufel, Daniel P.; Freund, Stefan M. V.; Veprintsev, Dmitry B.			Molecular Basis for Modulation of the p53 Target Selectivity by KLF4	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; INTERACTING PROTEIN KINASE-2; DNA-BINDING SPECIFICITY; C-TERMINAL DOMAIN; TRANSACTIVATION SUBDOMAINS; CORE DOMAIN; COMPLEX; PHOSPHORYLATION; ACTIVATION; RADIATION	The tumour suppressor p53 controls transcription of various genes involved in apoptosis, cell-cycle arrest, DNA repair and metabolism. However, its DNA-recognition specificity is not nearly sufficient to explain binding to specific locations in vivo. Here, we present evidence that KLF4 increases the DNA-binding affinity of p53 through the formation of a loosely arranged ternary complex on DNA. This effect depends on the distance between the response elements of KLF4 and p53. Using nuclear magnetic resonance and fluorescence techniques, we found that the amino-terminal domain of p53 interacts with the KLF4 zinc fingers and mapped the interaction site. The strength of this interaction was increased by phosphorylation of the p53 N-terminus, particularly on residues associated with regulation of cell-cycle arrest genes. Taken together, the cooperative binding of KLF4 and p53 to DNA exemplifies a regulatory mechanism that contributes to p53 target selectivity.	[Brandt, Tobias; Townsley, Fiona M.; Teufel, Daniel P.; Freund, Stefan M. V.; Veprintsev, Dmitry B.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Brandt, Tobias] Max Planck Inst Biophys, D-6000 Frankfurt, Germany; [Veprintsev, Dmitry B.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Veprintsev, Dmitry B.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland	MRC Laboratory Molecular Biology; Max Planck Society; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Veprintsev, DB (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	dmitry.veprintsev@psi.ch	Veprintsev, Dmitry B/H-2228-2012	Veprintsev, Dmitry B/0000-0002-3583-5409; Teufel, Daniel/0000-0002-6527-2117	Medical Research Council (MRC); Cambridge European Trust; MRC	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge European Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TB was supported by the Medical Research Council (MRC) and the Cambridge European Trust. This research was supported by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2001, NAT STRUCT BIOL, V8, P730, DOI 10.1038/nsb0901-730; Arbely E, 2011, P NATL ACAD SCI USA, V108, P8251, DOI 10.1073/pnas.1105028108; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Boehme KA, 2009, CRIT REV BIOCHEM MOL, V44, P367, DOI 10.3109/10409230903401507; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Goddard T.D., SPARKY 3; Hamroun D, 2006, HUM MUTAT, V27, P14, DOI 10.1002/humu.20269; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Melero R, 2011, P NATL ACAD SCI USA, V108, P557, DOI [10.1073/pnas.1015520107, 10.1073/pnas.101S520107]; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MIYASHITA T, 1995, CELL, V80, P293; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Petty TJ, 2011, EMBO J, V30, P2167, DOI 10.1038/emboj.2011.127; Rajagopalan S, 2010, P NATL ACAD SCI USA, V107, P8587, DOI 10.1073/pnas.1003689107; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Weinberg RL, 2004, J MOL BIOL, V342, P801, DOI 10.1016/j.jmb.2004.07.042; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Yeh PY, 2004, ONCOGENE, V23, P3580, DOI 10.1038/sj.onc.1207426; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345	55	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48252	10.1371/journal.pone.0048252	http://dx.doi.org/10.1371/journal.pone.0048252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118962	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705600034
J	Harris, LW; Pietsch, S; Cheng, TMK; Schwarz, E; Guest, PC; Bahn, S				Harris, Laura W.; Pietsch, Sandra; Cheng, Tammy M. K.; Schwarz, Emanuel; Guest, Paul C.; Bahn, Sabine			Comparison of Peripheral and Central Schizophrenia Biomarker Profiles	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CELL-ADHESION MOLECULE-1; EXPRESSION; NEURONS; INSULIN	We have recently shown that a molecular biomarker signature comprised of inflammatory, hormonal and growth factors occurs in the blood serum from first onset schizophrenia patients. Here, we use the same platform to investigate post mortem brain tissue (Brodmann area 10) from schizophrenia patients who were mainly chronically ill and drug treated. Twenty-one analytes are differentially expressed in post-mortem brain tissue. Comparison with our previous mRNA profiling studies of the same patient samples in another frontal cortical area showed that 9 of these molecules were also altered at the transcriptional level. Furthermore, 9 of the molecules were also altered in serum from living first onset schizophrenia patients compared to controls. We propose a model in which the brain and periphery are coordinated through hormones and other regulatory molecules released into the blood via the diffuse neuroendocrine system. These findings provide further evidence for the systemic nature of schizophrenia and give added validity to the concept that schizophrenia can be investigated through studies of blood-based biomarkers.	[Harris, Laura W.; Pietsch, Sandra; Cheng, Tammy M. K.; Schwarz, Emanuel; Guest, Paul C.; Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Bahn, Sabine] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands	University of Cambridge; Erasmus University Rotterdam; Erasmus MC	Bahn, S (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	sb209@cam.ac.uk		Harris, Laura/0000-0003-4312-7223; guest, paul/0000-0002-5030-7137	Stanley Medical Research Institute (SMRI); European Union FP7 SchizDX research programme [223427]	Stanley Medical Research Institute (SMRI); European Union FP7 SchizDX research programme	This research was supported by the Stanley Medical Research Institute (SMRI), www.stanleyresearch.org, and the European Union FP7 SchizDX research programme (grant reference 223427), http://schizdx.pera.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh T, 2004, NEUROREPORT, V15, P2029, DOI 10.1097/00001756-200409150-00007; Avgustin B, 2005, CROAT MED J, V46, P268; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carrizo E, 2008, SCHIZOPHR RES, V103, P83, DOI 10.1016/j.schres.2008.03.004; Chen ZS, 2009, AM J PATHOL, V174, P1139, DOI 10.2353/ajpath.2009.080879; Curtis CE, 1999, BIOL PSYCHIAT, V46, P102, DOI 10.1016/S0006-3223(98)00363-1; Dantz D, 2002, J CLIN ENDOCR METAB, V87, P835, DOI 10.1210/jc.87.2.835; Dickerson F, 2007, SCHIZOPHR RES, V93, P261, DOI 10.1016/j.schres.2007.03.022; Fan XD, 2007, PSYCHIAT RES, V149, P267, DOI 10.1016/j.psychres.2006.07.011; Fitzgerald Peter, 2008, J Psychopharmacol, V22, P12, DOI 10.1177/0269216307087148; Fleisig H, 2004, NEUROSCIENCE, V127, P91, DOI 10.1016/j.neuroscience.2004.04.060; Forster C, 2005, J PHYSIOL-LONDON, V565, P475, DOI 10.1113/jphysiol.2005.084038; Fulzele S, 2009, SCHIZOPHR RES, V115, P372, DOI 10.1016/j.schres.2009.06.005; Ghigo E, 2001, ENDOCRINE, V14, P87, DOI 10.1385/ENDO:14:1:087; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guest PC, 2011, PSYCHONEUROENDOCRINO, V36, P1092, DOI 10.1016/j.psyneuen.2010.12.018; Hafner H, 2006, WORLD PSYCHIATRY, V5, P130; Harris LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003964; Hawkins BT, 2007, DIABETOLOGIA, V50, P202, DOI 10.1007/s00125-006-0485-z; Huang Chiung-Chun, 2010, Chang Gung Med J, V33, P115; Kariagina A, 2004, ENDOCRINOLOGY, V145, P104, DOI 10.1210/en.2003-0669; Knapp M, 2004, SCHIZOPHRENIA BULL, V30, P279, DOI 10.1093/oxfordjournals.schbul.a007078; Koga M, 1998, DIABETIC MED, V15, P661, DOI 10.1002/(SICI)1096-9136(199808)15:8<661::AID-DIA645>3.0.CO;2-G; Krishnamurthy D, 2011, PROTEOMICS, V11, P495, DOI 10.1002/pmic.201000496; Leake A, 2000, NEUROSCI LETT, V291, P201, DOI 10.1016/S0304-3940(00)01418-X; McIntyre RS, 2008, CNS DRUGS, V22, P443, DOI 10.2165/00023210-200822060-00001; McIntyre RS, 2007, MED HYPOTHESES, V69, P773, DOI 10.1016/j.mehy.2007.01.078; Messamore E, 2003, SCHIZOPHR RES, V62, P251, DOI 10.1016/S0920-9964(02)00311-0; Mielke JG, 2011, PROG MOL BIOL TRANSL, V98, P133, DOI 10.1016/B978-0-12-385506-0.00004-1; Peter K, 1997, ARTERIOSCL THROM VAS, V17, P505, DOI 10.1161/01.ATV.17.3.505; PHELPS CJ, 1994, P SOC EXP BIOL MED, V206, P6, DOI 10.3181/00379727-206-43719; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; RAMCHAND R, 1994, LIFE SCI, V54, P1579, DOI 10.1016/0024-3205(94)90029-9; Rothermundt M, 2000, NEUROREPORT, V11, P3385, DOI 10.1097/00001756-200010200-00024; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; Schiffman J, 2002, AM J PSYCHIAT, V159, P238, DOI 10.1176/appi.ajp.159.2.238; Schmitt Andrea, 2005, Neuropsychiatr Dis Treat, V1, P171, DOI 10.2147/nedt.1.2.171.61048; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Schwarz E, 2010, BIOMARK INSIGHTS, V5, P39; Soderlund J, 2009, MOL PSYCHIATR, V14, P1069, DOI 10.1038/mp.2009.52; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X	41	64	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e46368	10.1371/journal.pone.0046368	http://dx.doi.org/10.1371/journal.pone.0046368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118852	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600004
J	Jia, Y; Tang, RJ; Wang, L; Zhang, X; Wang, Y; Jia, XM; Jiang, YY				Jia, Yu; Tang, Ren-Jie; Wang, Lin; Zhang, Xiang; Wang, Ying; Jia, Xin-Ming; Jiang, Yuan-Ying			Calcium-Activated-Calcineurin Reduces the In Vitro and In Vivo Sensitivity of Fluconazole to Candida albicans via Rta2p	PLOS ONE			English	Article							PLASMA-MEMBRANE ATPASE; CERAMIDE BIOSYNTHESIS; AZOLE RESISTANCE; DRUG-RESISTANCE; SERUM; GENE; SUSCEPTIBILITY; EPIDEMIOLOGY; INFECTION; SPHINGOLIPIDS	Due to the emergence of drug-resistance, first-line therapy with fluconazole (FLC) increasingly resulted in clinical failure for the treatment of candidemia. Our previous studies found that in vitro RTA2 was involved in the calcineurin-mediated resistance to FLC in C. albicans. In this study, we found that calcium-activated-calcineurin significantly reduced the in vitro sensitivity of C. albicans to FLC by blocking the impairment of FLC to the plasma membrane via Rta2p. Furthermore, we found that RTA2 itself was not involved in C. albicans virulence, but the disruption of RTA2 dramatically increased the therapeutic efficacy of FLC in a murine model of systemic candidiasis. Conversely, both re-introduction of one RTA2 allele and ectopic expression of RTA2 significantly reduced FLC efficacy in a mammalian host. Finally, we found that calcium-activated-calcineurin, through its target Rta2p, dramatically reduced the efficacy of FLC against candidemia. Given the critical roles of Rta2p in controlling the efficacy of FLC, Rta2p can be a potential drug target for antifungal therapies.	[Jia, Yu; Jia, Xin-Ming] Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China; [Jia, Yu; Tang, Ren-Jie; Wang, Lin; Jiang, Yuan-Ying] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Zhang, Xiang] Tongji Univ, Sch Med, Peoples Hosp 10, Dept Neurosurg, Shanghai 200092, Peoples R China; [Wang, Ying] Second Mil Med Univ, Changhai Hosp, Dept Dermatol, Shanghai, Peoples R China	Tongji University; Naval Medical University; Tongji University; Naval Medical University	Jia, XM (corresponding author), Tongji Univ, Sch Med, Dept Immunol, Shanghai 200092, Peoples R China.	jiaxm@tongji.edu.cn; jiangyy@smmu.edu.cn	jiang, anyi/GPT-0379-2022		National Science Foundation of China [30900055, 30825041, 90913008]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (30900055, 30825041 and 90913008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cortes JA, 2011, REV IBEROAM MICOL, V28, P74, DOI 10.1016/j.riam.2010.12.002; Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Bader T, 2003, INFECT IMMUN, V71, P5344, DOI 10.1128/IAI.71.9.5344-5354.2003; Bassetti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024198; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; Chapman Stanley W, 2008, Trans Am Clin Climatol Assoc, V119, P197; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cowen LE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000471; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Epp E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000753; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; FONZI WA, 1993, GENETICS, V134, P717; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Galgiani JM, 1997, REFERENCE METHOD BRO; Gamarra S, 2010, ANTIMICROB AGENTS CH, V54, P1753, DOI 10.1128/AAC.01728-09; Hameed S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018684; Hassan I, 2009, J INFECTION, V59, P360, DOI 10.1016/j.jinf.2009.08.020; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Jia X, 2009, CELL MOL LIFE SCI, V66, P122, DOI 10.1007/s00018-008-8409-3; Jia XM, 2008, BIOCHEM BIOPH RES CO, V373, P631, DOI 10.1016/j.bbrc.2008.06.093; Jutiamornlerd Noppawan, 2011, Journal of the Medical Association of Thailand, V94, P927; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kawaai H, 2009, BURNS, V35, P397, DOI 10.1016/j.burns.2008.08.010; Lee MCS, 2002, J BIOL CHEM, V277, P22395, DOI 10.1074/jbc.M200450200; Marchetti O, 2000, ANTIMICROB AGENTS CH, V44, P2932, DOI 10.1128/AAC.44.11.2932-2938.2000; MOORE E W, 1970, Journal of Clinical Investigation, V49, P318, DOI 10.1172/JCI106241; Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200; Nakayama H, 2007, J ANTIMICROB CHEMOTH, V60, P1264, DOI 10.1093/jac/dkm321; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Odabasi Z, 2007, ANTIMICROB AGENTS CH, V51, P4214, DOI 10.1128/AAC.01589-06; Onyewu C, 2006, ANTIMICROB AGENTS CH, V50, P3963, DOI 10.1128/AAC.00393-06; Ortega M, 2011, J HOSP INFECT, V77, P157, DOI 10.1016/j.jhin.2010.09.026; Paderu P, 2007, ANTIMICROB AGENTS CH, V51, P2253, DOI 10.1128/AAC.01536-06; Pagano L, 2010, BLOOD REV, V24, P51, DOI 10.1016/j.blre.2009.11.003; Pfaller MA, 2005, J CLIN MICROBIOL, V43, P5848, DOI 10.1128/JCM.43.12.5848-5859.2005; Rex JH, 1997, CLIN INFECT DIS, V24, P235, DOI 10.1093/clinids/24.2.235; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Schelenz S, 2011, J ORAL PATHOL MED, V40, P83, DOI 10.1111/j.1600-0714.2010.00937.x; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Sionov E, 2012, ANTIMICROB AGENTS CH, V56, P1162, DOI 10.1128/AAC.05502-11; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Sun S, 2008, ANTIMICROB AGENTS CH, V52, P409, DOI 10.1128/AAC.01070-07; Traeder C, 2008, MYCOSES, V51, P58, DOI 10.1111/j.1439-0507.2008.01574.x; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037768; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; Withee JL, 1997, MOL BIOL CELL, V8, P263, DOI 10.1091/mbc.8.2.263; Yang YL, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-22; Zaoutis T, 2010, CURR MED RES OPIN, V26, P1761, DOI 10.1185/03007995.2010.487796; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939	57	10	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48369	10.1371/journal.pone.0048369	http://dx.doi.org/10.1371/journal.pone.0048369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118995	Green Submitted, gold, Green Published			2022-12-25	WOS:000310705600041
J	Peng, Q; Yeh, HD; Wei, LL; Enjyoj, K; Machaidze, Z; Csizmad, E; Schuetz, C; Lee, KM; Deng, SP; Robson, SC; Markmann, J; Buhler, L				Peng, Qiang; Yeh, Heidi; Wei, Lingling; Enjyoj, Keiichi; Machaidze, Zurab; Csizmad, Eva; Schuetz, Christian; Lee, Kang Mi; Deng, Shaoping; Robson, Simon C.; Markmann, James; Buhler, Leo			Mechanisms of Xenogeneic Baboon Platelet Aggregation and Phagocytosis by Porcine Liver Sinusoidal Endothelial Cells	PLOS ONE			English	Article							PIG; CLEARANCE; XENOTRANSPLANTATION; SURVIVAL	Background: Baboons receiving xenogeneic livers from wild type and transgenic pigs survive less than 10 days. One of the major issues is the early development of profound thrombocytopenia that results in fatal hemorrhage. Histological examination of xenotransplanted livers has shown baboon platelet activation, phagocytosis and sequestration within the sinusoids. In order to study the mechanisms of platelet consumption in liver xenotransplantation, we have developed an in vitro system to examine the interaction between pig endothelial cells with baboon platelets and to thereby identify molecular mechanisms and therapies. Methods: Fresh pig hepatocytes, liver sinusoidal and aortic endothelial cells were isolated by collagenase digestion of livers and processing of aortae from GTKO and Gal+ MGH-miniature swine. These primary cell cultures were then tested for the differential ability to induce baboon or pig platelet aggregation. Phagocytosis was evaluated by direct observation of CFSE labeled-platelets, which are incubated with endothelial cells under confocal light microscopy. Aurintricarboxylic acid (GpIb antagonist blocking interactions with von Willebrand factor/vWF), eptifibatide (Gp IIb/IIIa antagonist), and anti-Mac-1 Ab (anti-alpha(M)beta(2) integrin Ab) were tested for the ability to inhibit phagocytosis. Results: None of the pig cells induced aggregation or phagocytosis of porcine platelets. However, pig hepatocytes, liver sinusoidal and aortic endothelial cells (GTKO and Gal+) all induced moderate aggregation of baboon platelets. Importantly, pig liver sinusoidal endothelial cells efficiently phagocytosed baboon platelets, while pig aortic endothelial cells and hepatocytes had minimal effects on platelet numbers. Anti-MAC-1 Ab, aurintricarboxylic acid or eptifibatide, significantly decreased baboon platelet phagocytosis by pig liver endothelial cells (P<0.01). Conclusions: Although pig hepatocytes and aortic endothelial cells directly caused aggregation of baboon platelets, only pig liver endothelial cells efficiently phagocytosed baboon platelets. Blocking vWF and integrin adhesion pathways prevented both aggregation and phagocytosis.	[Peng, Qiang; Yeh, Heidi; Wei, Lingling; Machaidze, Zurab; Schuetz, Christian; Lee, Kang Mi; Deng, Shaoping; Markmann, James; Buhler, Leo] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Transplant Surg, Boston, MA 02115 USA; [Enjyoj, Keiichi; Csizmad, Eva; Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Gastroenterol, Ctr Liver, Boston, MA 02215 USA; [Buhler, Leo] Univ Hosp Geneva, Dept Surg, Surg Res Unit, Geneva, Switzerland	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; University of Geneva	Buhler, L (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Transplant Surg, Boston, MA 02115 USA.	Leo.Buhler@hcuge.ch	Schuetz, Christian/K-5234-2013; Robson, Simon C./AAA-8537-2021	Schuetz, Christian/0000-0002-6828-4543; Buhler, Leo/0000-0002-9461-8498	Department of Transplant Surgery, Massachusetts General Hospital; Department of Gastroenterology, Liver Center, Beth Israel Deaconess Medical Center (Harvard Medical School, Boston); foundation Insuleman (Switzerland); foundation Louis-Jeantet (Switzerland); National Institutes of Health [P01 AI045897-11A1 DHS/SCR]; Transplantation Biology Research Center, Massachusetts General Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045897] Funding Source: NIH RePORTER	Department of Transplant Surgery, Massachusetts General Hospital; Department of Gastroenterology, Liver Center, Beth Israel Deaconess Medical Center (Harvard Medical School, Boston); foundation Insuleman (Switzerland); foundation Louis-Jeantet (Switzerland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transplantation Biology Research Center, Massachusetts General Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Department of Transplant Surgery, Massachusetts General Hospital and the Department of Gastroenterology, Liver Center, Beth Israel Deaconess Medical Center (Harvard Medical School, Boston), by the foundations Insuleman and Louis-Jeantet (Switzerland) and National Institutes of Health (P01 AI045897-11A1 DHS/SCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues at the Department of Transplant Surgery, Massachusetts General Hospital and the Transplantation Biology Research Center, Massachusetts General Hospital for their support. In particular, we thank David K. C. Cooper for his advice and support.	Alwayn IPJ, 2000, XENOTRANSPLANTATION, V7, P247, DOI 10.1034/j.1399-3089.2000.00965.x; Babic AM, 2007, TRANSFUSION, V47, P442, DOI 10.1111/j.1537-2995.2007.01134.x; Badlou BA, 2006, TRANSFUSION, V46, P2090, DOI 10.1111/j.1537-2995.2006.01034.x; Burlak C, 2010, XENOTRANSPLANTATION, V17, P350, DOI 10.1111/j.1399-3089.2010.00605.x; Cooper DKC, 2007, TRANSPLANTATION, V84, P1, DOI 10.1097/01.tp.0000260427.75804.f2; Cozzi E, 2000, TRANSPLANTATION, V70, P15; Ekser B, 2010, AM J TRANSPLANT, V10, P273, DOI 10.1111/j.1600-6143.2009.02945.x; Esch JSA, 2005, XENOTRANSPLANTATION, V12, P30, DOI 10.1111/j.1399-3089.2004.00187.x; Hara H, 2008, TRANSPL INT, V21, P1163, DOI 10.1111/j.1432-2277.2008.00736.x; Kim D, 2005, CELL BIOL INT, V29, P638, DOI 10.1016/j.cellbi.2005.03.016; Loveland BE, 2004, XENOTRANSPLANTATION, V11, P171, DOI 10.1046/j.1399-3089.2003.00103.x; Manfredi AA, 2010, CURR OPIN HEMATOL, V17, P3, DOI 10.1097/MOH.0b013e3283324f97; Markovic N, 2009, AM J PHYSIOL-GASTR L, V297, pG1066, DOI 10.1152/ajpgi.00278.2009; McGregor CGA, 2005, J THORAC CARDIOV SUR, V130, P844, DOI 10.1016/j.jtcvs.2005.04.017; Nedredal Geir I, 2003, Comp Hepatol, V2, P1, DOI 10.1186/1476-5926-2-1; Paris LL, 2012, XENOTRANSPLANTATION, V19, P31, DOI 10.1111/j.1399-3089.2011.00685.x; Paris LL, 2011, XENOTRANSPLANTATION, V18, P245, DOI 10.1111/j.1399-3089.2011.00639.x; PRAANINGVANDALEN DP, 1981, GASTROENTEROLOGY, V81, P1036; Rumjantseva V, 2010, TRANSFUS APHER SCI, V42, P63, DOI 10.1016/j.transci.2009.10.008; Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030; Wang TY, 2011, CIRCULATION, V123, P722, DOI 10.1161/CIRCULATIONAHA.110.958041	21	23	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47273	10.1371/journal.pone.0047273	http://dx.doi.org/10.1371/journal.pone.0047273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118867	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600010
J	Stuardo, V; Agusti, C; Godinez, JM; Montoliu, A; Torne, A; Tarrats, A; Alcalde, C; Martin, D; Fernandez-Montoli, E; Vanrell, C; Sole, J; Canet, Y; Marqueta, JM; Mohamed, J; Cuenca, I; Lonca, M; Sirera, G; Ferrer, E; Domingo, P; Lloveras, B; Miro, JM; De Sanjose, S; Casabona, J				Stuardo, Valeria; Agusti, Cristina; Godinez, Jose Manuel; Montoliu, Alexandra; Torne, Aureli; Tarrats, Antoni; Alcalde, Carmen; Martin, Dolores; Fernandez-Montoli, Eulalia; Vanrell, Cristina; Sole, Josefa; Canet, Yolanda; Marqueta, Jose Manuel; Mohamed, Jadiyettu; Cuenca, Isabel; Lonca, Montserrat; Sirera, Guillem; Ferrer, Elena; Domingo, Pere; Lloveras, Belen; Miro, Josep Maria; De Sanjose, Silvia; Casabona, Jordi			Human Papillomavirus Infection in HIV-1 Infected Women in Catalonia (Spain): Implications for Prevention of Cervical Cancer	PLOS ONE			English	Article							GENOTYPE DISTRIBUTION; HPV INFECTIONS; YOUNG-WOMEN; HIV; NEOPLASIA; LESIONS; PREVALENCE; HISTORY	Background: High-risk human Papillomavirus infection is a necessary factor for cervical squamous intraepithelial lesions and invasive cervical cancer. In HIV-1-infected women, HPV infection is more prevalent and a higher risk of cervical cancer has been identified. We aimed to calculate the prevalence of infection by HR-HPV, determine the factors associated with this infection and abnormal cytology findings and to describe the history of cervical cancer screening in HIV-1-infected women. Methods: We enrolled 479 HIV-1-infected women from the PISCIS cohort. Each patient underwent a gynecological checkup, PAP smear, HPV AND Hybrid capture, HPV genotyping, and colposcopy and biopsy, if necessary. We applied questionnaires to obtain information on sociodemographic, behavioral, clinical, and cervical screening variables. We present a cross-sectional analysis. Results: Median age was 42 years. The prevalence of HR-HPV infection was 33.2% and that of high-grade squamous intraepithelial lesions (HSIL) was 3.8%. The most common genotypes were 16(23%), 53(20.3%), and 52(16.2%). The factor associated with HR-HPV infection was age < 30 years (odds ratio[OR], 2.5; 95% confidence interval[CI], 1.1-5.6). The factors associated with the presence of HSIL or low-grade squamous intraepithelial lesions (LSIL) were CD4T-lymphocyte count < 200cells/mm(3) versus > 500cells/mm(3) (OR, 8.4; 95% CI, 3.7-19.2), HIV-1 viral load > 10,000copies/mL versus < 400copies/mL (OR, 2.1; 95% CI, 1.0-4.4), and use of oral contraceptives (OR, 2.0; 95% CI, 1.0-3.9). Sixty percent of HIV-1-infected women had had one Pap smear within the last 2 years. Conclusions: The high prevalence of HPV infection and cervical lesions in the HIV-1-infected population in Catalonia, as well as the low coverage and frequency of screening in this group, means that better preventive efforts are necessary and should include vaccination against HPV, better accessibility to screening programs, training of health care professionals, and specific health education for HIV-1-infected women.	[Stuardo, Valeria; Agusti, Cristina; Montoliu, Alexandra; Casabona, Jordi] ASPC, ICO, CEEISCAT, Badalona, Spain; [Casabona, Jordi] UAB, Dept Pediat Obstet Ginecol Med, Fac Med, Bellaterra, Spain; [Godinez, Jose Manuel; Lloveras, Belen; De Sanjose, Silvia] IDIBELL, Catalan Inst Oncol ICO, Unit Infect & Canc, Barcelona, Spain; [Torne, Aureli; Lonca, Montserrat; Miro, Josep Maria] Hosp Clin, IDIBAPS, Mataro, Spain; [Tarrats, Antoni; Sirera, Guillem] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Martin, Dolores; Fernandez-Montoli, Eulalia] Hosp Univ Bellvitge, Bellvitge, Spain; [Sole, Josefa] Hosp Mataro, Mataro, Spain; [Canet, Yolanda] Corp Sanitaria Parc Tauli, Sabadell, Spain; [Marqueta, Jose Manuel] Hosp Palamo, Palamos, Spain; [Cuenca, Isabel] Hosp Comarcal Alt Penedes, Vilafranca Del Penede s, Spain; [Domingo, Pere] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Lloveras, Belen] Hosp Mar, Barcelona, Spain; [De Sanjose, Silvia] Ctr Invest Biomed Red CIBER Epidemiol & Salud Pub, Barcelona, Spain; [Godinez, Jose Manuel] RTICC, Barcelona, Spain; [Stuardo, Valeria] Univ Chile, Fac Med, ESP, Santiago, Chile	Autonomous University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Germans Trias i Pujol; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital of Santa Creu i Sant Pau; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Chile	Stuardo, V (corresponding author), ASPC, ICO, CEEISCAT, Badalona, Spain.	vstuardo@med.uchile.cl	Avila, Valeria Stuardo/H-4761-2018; Godínez, Jose M./N-2209-2018; de Sanjosé Llongueras, Silvia/H-6339-2014; Domingo, Pere/AAP-7571-2021; Fernández-Montolí, Maria-Eulalia/AAR-6572-2020; Domingo, Pere/CAF-3577-2022	Avila, Valeria Stuardo/0000-0001-9861-0285; Godínez, Jose M./0000-0003-2555-7596; Domingo, Pere/0000-0003-1138-5770; Fernández-Montolí, Maria-Eulalia/0000-0002-1792-7545; Casabona-Barbara, Jordi/0000-0003-4816-5536; Montoliu, Alexandra/0000-0002-4251-7062; Torne, Aureli/0000-0003-4700-9507	Foundation for AIDS Research and Prevention in Spain (FIPSE); Ministry of Work and Social Affairs of Spain (MTAS); Agencia Salut Publica de Catalunya (ASPC); Generalitat de Catalunya, Badalona, Spain	Foundation for AIDS Research and Prevention in Spain (FIPSE); Ministry of Work and Social Affairs of Spain (MTAS); Agencia Salut Publica de Catalunya (ASPC); Generalitat de Catalunya, Badalona, Spain	Sources of support: Foundation for AIDS Research and Prevention in Spain (FIPSE), Ministry of Work and Social Affairs of Spain (MTAS) and Agencia Salut Publica de Catalunya (ASPC), Generalitat de Catalunya, Badalona, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahdieh L, 2000, AM J EPIDEMIOL, V151, P1148, DOI 10.1093/oxfordjournals.aje.a010165; [Anonymous], SIST INT VIG EP SIDA; [Anonymous], GLOBOCAN 2008 INT AG; Berrebi A, 2008, GYNECOL OBSTET FERTI, V36, P521, DOI 10.1016/j.gyobfe.2008.02.007; Bosch FX, 2002, VIRUS RES, V89, P183, DOI 10.1016/S0168-1702(02)00187-9; Broker T R, 2001, Dev Biol (Basel), V106, P443; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castellsague X, 2012, J MED VIROL, V84, P947, DOI 10.1002/jmv.23282; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Darwich L, 2011, INT J GYNECOL CANCER, V21, P1486, DOI 10.1097/IGC.0b013e31822a0195; de Sanjose S, 2002, VIRUS RES, V89, P201, DOI 10.1016/S0168-1702(02)00189-2; de Sanjose S, 2008, EUR J OBSTET GYN R B, V140, P234, DOI 10.1016/j.ejogrb.2008.04.005; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Galceran J, 2007, EUR J CANCER, V43, P1085, DOI 10.1016/j.ejca.2007.01.028; Grinsztejn B, 2009, INT J INFECT DIS, V13, P72, DOI 10.1016/j.ijid.2008.03.031; Heard I, 2002, AIDS, V16, P1799, DOI 10.1097/00002030-200209060-00013; Heard I, 2009, CURR OPIN HIV AIDS, V4, P68, DOI 10.1097/COH.0b013e328319bcbe; Jaen A, 2005, MED CLIN-BARCELONA, V124, P525, DOI 10.1157/13073938; Mayans MV, 1999, SEX TRANSM DIS, V26, P500, DOI 10.1097/00007435-199910000-00003; Minkoff H, 2010, J INFECT DIS, V201, P681, DOI 10.1086/650467; ONUSIDA. America Latina. Situacion de la epidemia de SIDA, 2007, PROGR CONJ NAC UN VI; Palefsky J, 2006, Adv Dent Res, V19, P99; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; Temmerman M, 1999, INT J GYNECOL OBSTET, V65, P171, DOI 10.1016/S0020-7292(99)00043-0; Videla S, 2009, JAIDS-J ACQ IMM DEF, V50, P168, DOI 10.1097/QAI.0b013e3181938e63; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	32	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47755	10.1371/journal.pone.0047755	http://dx.doi.org/10.1371/journal.pone.0047755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118894	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600017
J	Dunn, SR; Thomas, MC; Nette, GW; Dove, SG				Dunn, Simon R.; Thomas, Michael C.; Nette, Geoffrey W.; Dove, Sophie G.			A Lipidomic Approach to Understanding Free Fatty Acid Lipogenesis Derived from Dissolved Inorganic Carbon within Cnidarian-Dinoflagellate Symbiosis	PLOS ONE			English	Article							MICROALGA PORPHYRIDIUM-CRUENTUM; CORAL MONTIPORA-DIGITATA; EICOSAPENTAENOIC ACID; SCLERACTINIAN CORALS; LIGHT-INTENSITY; REEF CORALS; WAX ESTERS; ZOOXANTHELLAE; BIOSYNTHESIS; ASSIMILATION	The cnidarian-dinoflagellate symbiosis is arguably one of the most important within the marine environment in that it is integral to the formation of coral reefs. However, the regulatory processes that perpetuate this symbiosis remain unresolved. It is essential to understand these processes, if we are to elucidate the mechanisms that support growth and resource accumulation by coral host, and conversely, recently observed reduction and/or mortality of corals in response to rapid environmental change. This study specifically focused on one area of metabolic activity within the symbiosis, that of free fatty acid synthesis within both the dinoflagellate symbionts and cnidarian host. The main model system used was Aiptasia pulchella and Symbiodinium sp. in combination with aposymbiotic A. pulchella, the symbiotic coral Acropora millepora system and dinoflagellate culture. Fatty acids (FAs) were selected because of their multiple essential roles inclusive of energy storage (resource accumulation), membrane structure fluidity and cell signaling. The study addressed free FA lipogenesis by using a new method of enriched stable isotopic (C-13) incorporation from dissolved inorganic carbon ((DIC)-C-13) combined with HPLC-MS. FAs derived from (DIC)-C-13 aligned with a mixture of known lipogenesis pathways with the addition of some unusual FAs. After 120 hr, C-13-enriched FA synthesis rates were attributed to only a complex integration of both n- and n-6 lipogenesis pathways within the dinoflagellate symbionts. Furthermore, there was no detectible evidence of symbiont derived enriched isotope fatty acids, catabolized C-13 derivatives or (DIC)-C-13 being directly utilized, in host late n-6 pathway long-chain FA lipogenesis. These findings do not align with a popular mutualistic translocation model with respect to the use of translocated symbiont photoassimilates in host long-chain FA lipogenesis, which has important connotations for linking nutrient sources with metabolite production and the dynamic regulation of this symbiosis.	[Dunn, Simon R.; Dove, Sophie G.] Univ Queensland, Global Change Inst, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia; [Thomas, Michael C.; Nette, Geoffrey W.] Moreton Bay Res Stn, Dunwich, Qld, Australia	University of Queensland	Dunn, SR (corresponding author), Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia.	s.dunn2@uq.edu.au	Dove, Sophie/I-7873-2013	Dove, Sophie/0000-0003-1823-8634	Australian Research Council [COE 561435, LP110100566]	Australian Research Council(Australian Research Council)	This study was supported by the Australian Research Council through the COE 561435 and LP110100566 grant funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOGHRABI S, 1995, J COMP PHYSIOL B, V165, P183; Bell MV, 1990, NUTR WILD DOMESTIC A, P11; Bertucci A, 2011, MAR BIOTECHNOL, V13, P992, DOI 10.1007/s10126-011-9363-x; Bigogno C, 2002, LIPIDS, V37, P209, DOI 10.1007/s11745-002-0882-6; BISHOP DG, 1980, LIPIDS, V15, P799, DOI 10.1007/BF02534368; BLANQUET RS, 1979, MAR BIOL, V54, P185, DOI 10.1007/BF00386597; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; Douglas A.E., 2010, SYMBIOTIC HABIT; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furla P, 2005, INTEGR COMP BIOL, V45, P595, DOI 10.1093/icb/45.4.595; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; HARLAND AD, 1993, MAR BIOL, V117, P113, DOI 10.1007/BF00346432; HARLAND AD, 1991, MAR BIOL, V110, P13, DOI 10.1007/BF01313087; HARRISON PJ, 1980, J PHYCOL, V16, P28, DOI 10.1111/j.1529-8817.1980.tb02994.x; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Hughes AD, 2010, MAR ECOL PROG SER, V420, P91, DOI 10.3354/meps08866; JOHNSTON M, 1995, P ROY SOC B-BIOL SCI, V260, P293, DOI 10.1098/rspb.1995.0094; Khozin I, 1997, PLANT PHYSIOL, V114, P223, DOI 10.1104/pp.114.1.223; LATYSHEV NA, 1991, MAR ECOL PROG SER, V76, P295, DOI 10.3354/meps076295; Loram JE, 2007, MOL ECOL, V16, P4849, DOI 10.1111/j.1365-294X.2007.03491.x; Mansour MP, 2005, J APPL PHYCOL, V17, P287, DOI 10.1007/s10811-005-6625-x; Mortillaro JM, 2009, J EXP MAR BIOL ECOL, V378, P22, DOI 10.1016/j.jembe.2009.07.003; MUSCATINE L, 1994, LIMNOL OCEANOGR, V39, P925; MUSCATINE L, 1989, MAR BIOL, V100, P185, DOI 10.1007/BF00391957; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Muscatine L, 1983, INT C END, P649; Oku H, 2003, FISHERIES SCI, V69, P625, DOI 10.1046/j.1444-2906.2003.00665.x; Papina M, 2003, COMP BIOCHEM PHYS B, V135, P533, DOI 10.1016/S1096-4959(03)00118-0; PATTON JS, 1977, MAR BIOL, V44, P235, DOI 10.1007/BF00387705; PATTON JS, 1983, MAR BIOL, V75, P121, DOI 10.1007/BF00405994; Pitt KA, 2009, HYDROBIOLOGIA, V616, P119, DOI 10.1007/s10750-008-9581-z; Raven JA, 1997, ADV BOT RES, V27, P85; RAVEN JA, 1993, GLOBAL PLANET CHANGE, V8, P1, DOI 10.1016/0921-8181(93)90058-V; Rosic NN, 2010, J APPL PHYCOL, V22, P139, DOI 10.1007/s10811-009-9433-x; Santos SR, 2002, MOL PHYLOGENET EVOL, V23, P97, DOI 10.1016/S1055-7903(02)00010-6; Shiran D, 1996, LIPIDS, V31, P1277, DOI 10.1007/BF02587913; Teece MA, 2011, LIMNOL OCEANOGR, V56, P1285, DOI 10.4319/lo.2011.56.4.1285; Tolosa I, 2011, CORAL REEFS, V30, P763, DOI 10.1007/s00338-011-0753-3; Wallis JG, 2002, TRENDS BIOCHEM SCI, V27, P467, DOI 10.1016/S0968-0004(02)02168-0; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Whitehead LF, 2003, J EXP BIOL, V206, P3149, DOI 10.1242/jeb.00539; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x; Zhukova NV, 2006, BOT MAR, V49, P339, DOI 10.1515/BOT.2006.041	47	38	39	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e46801	10.1371/journal.pone.0046801	http://dx.doi.org/10.1371/journal.pone.0046801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115631	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200019
J	Wei, J; Bhatt, S; Chang, LM; Sampson, HA; Masilamani, M				Wei, John; Bhatt, Shiven; Chang, Lisa M.; Sampson, Hugh A.; Masilamani, Madhan			Isoflavones, Genistein and Daidzein, Regulate Mucosal Immune Response by Suppressing Dendritic Cell Function	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ALLERGEN-SPECIFIC TH1; TOLL-LIKE RECEPTORS; AIRWAY INFLAMMATION; SOY ISOFLAVONE; INFANT FORMULA; MURINE MODEL; MOUSE MODEL; IFN-GAMMA; NK CELLS	Lipopolysaccharide (LPS), a component of gram-negative bacterial cell walls, has been shown to have a strong adjuvant effect towards inhaled antigens contributing to airway inflammation. Isoflavones are anti-inflammatory molecules present in abundant quantities in soybeans. We investigated the effect of isoflavones on human dendritic cell (DC) activation via LPS stimulation and subsequent DC-mediated effector cell function both in vitro and in a mouse model of upper airway inflammation. Human monocyte-derived DCs (MDDC) were matured with LPS (or TNF-alpha) +/- isoflavones (genistein or daidzein). The surface expression levels of DC activation markers were analyzed by flow cytometry. Mature DCs +/- isoflavones were washed and cultured with freshly-isolated allogenic naive CD4(+) T cells for 5 days or with autologous natural killer (NK) cells for 2 hours. The percentages of proliferating IFN-gamma(+) CD4(+) T cells and cytokine levels in culture supernatants were assessed. NK cell degranulation and DC cytotoxicity were measured by flow cytometry. Isoflavones significantly suppressed the activation-induced expression of DC maturation markers (CD83, CD80, CD86) and MHC class I but not MHC class II molecules in vitro. Isoflavone treatment inhibited the ability of LPS-DCs to induce IFN-gamma in CD4(+) T cells. NK cell degranulation and the percentage of dead DCs were significantly increased in isoflavone-treated DC-NK co-culture experiments. Dietary isoflavones suppressed the mucosal immune response to intra-nasal sensitization of mice to ovalbumin. Similar results were obtained when isoflavones were co-administered during sensitization. These results demonstrate that soybean isoflavones suppress immune sensitization by suppressing DC-maturation and its subsequent DC-mediated effector cell functions.	[Wei, John; Bhatt, Shiven; Chang, Lisa M.; Sampson, Hugh A.; Masilamani, Madhan] Mt Sinai Sch Med, Jaffe Food Allergy Inst, Dept Pediat, Div Allergy & Immunol, New York, NY USA; [Sampson, Hugh A.; Masilamani, Madhan] Mt Sinai Sch Med, Inst Immunol, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Masilamani, M (corresponding author), Mt Sinai Sch Med, Jaffe Food Allergy Inst, Dept Pediat, Div Allergy & Immunol, New York, NY USA.	madhan.masilamani@mssm.edu	Masilamani, Madhan/H-3691-2019	Bhatt, Shiven/0000-0001-5030-2347; Masilamani, Madhan/0000-0001-8181-8848	Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York	Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York	This study was funded by the Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Badger TM, 2009, AM J CLIN NUTR, V89, pS1668, DOI 10.3945/ajcn.2009.26736U; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bao ZS, 2011, INT IMMUNOPHARMACOL, V11, P899, DOI 10.1016/j.intimp.2011.02.001; Barnes S, 2010, LYMPHAT RES BIOL, V8, P89, DOI 10.1089/lrb.2009.0030; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Beavers KM, 2010, APPL PHYSIOL NUTR ME, V35, P261, DOI 10.1139/H10-015; Beck VB, 2005, J STEROID BIOCHEM, V94, P499, DOI 10.1016/j.jsbmb.2004.12.038; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Cui JQ, 2005, J ALLERGY CLIN IMMUN, V115, P309, DOI 10.1016/j.jaci.2004.10.046; DEBOER M, 1986, J IMMUNOL, V136, P3447; Dehzad N, 2011, J IMMUNOL, V186, P2238, DOI 10.4049/jimmunol.1002027; Dharajiya N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008172; Dijsselbloem N, 2004, BIOCHEM PHARMACOL, V68, P1171, DOI 10.1016/j.bcp.2004.05.036; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Ferlazzo G, 2009, J CLIN IMMUNOL; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kalhan R, 2008, CLIN EXP ALLERGY, V38, P103, DOI 10.1111/j.1365-2222.2007.02862.x; Kaufman P B, 1997, J Altern Complement Med, V3, P7, DOI 10.1089/acm.1997.3.7; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; MARSHALL T, 1988, J ALLERGY CLIN IMMUN, V82, P550, DOI 10.1016/0091-6749(88)90964-5; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Masilamani M, 2012, IMMUNOL RES; Masilamani M, 2011, J ALLERGY CLIN IMMUN, V128, P1242, DOI 10.1016/j.jaci.2011.05.009; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Merritt RJ, 2004, J NUTR, V134, p1220S, DOI 10.1093/jn/134.5.1220S; Miyake Y, 2005, J ALLERGY CLIN IMMUN, V115, P1176, DOI 10.1016/j.jaci.2005.02.016; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; OGAWARA H, 1986, J ANTIBIOT, V39, P606, DOI 10.7164/antibiotics.39.606; Orgaard A, 2008, EXP BIOL MED, V233, P1066, DOI 10.3181/0712-MR-347; Pende D, 2006, BLOOD, V107, P2030, DOI 10.1182/blood-2005-07-2696; Randolph DA, 1999, J IMMUNOL, V162, P2375; Regal JF, 2000, P SOC EXP BIOL MED, V223, P372, DOI 10.1046/j.1525-1373.2000.22353.x; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; SCHWARTZ LB, 1980, J INVEST DERMATOL, V74, P349, DOI 10.1111/1523-1747.ep12543620; Setchell KDR, 1997, LANCET, V350, P23, DOI 10.1016/S0140-6736(96)09480-9; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Shen H, 2008, J IMMUNOL, V181, P1849, DOI 10.4049/jimmunol.181.3.1849; Smith LJ, 2004, J ASTHMA, V41, P833, DOI 10.1081/JAS-200038447; Spaggiari GM, 2001, EUR J IMMUNOL, V31, P1656, DOI 10.1002/1521-4141(200106)31:6<1656::AID-IMMU1656>3.0.CO;2-V; Steinman RM, 2007, EUR J IMMUNOL, V37, pS53, DOI 10.1002/eji.200737400; Strom BL, 2001, JAMA-J AM MED ASSOC, V286, P807, DOI 10.1001/jama.286.7.807; Takaoka A, 2001, J IMMUNOL, V167, P2349, DOI 10.4049/jimmunol.167.4.2349; Truyen E, 2006, THORAX, V61, P202, DOI 10.1136/thx.2005.052399; Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044; Valsecchi AE, 2011, EUR J PHARMACOL, V650, P694, DOI 10.1016/j.ejphar.2010.10.060; Verdrengh M, 2003, INFLAMM RES, V52, P341, DOI 10.1007/s00011-003-1182-8; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Weighardt H, 2004, EUR J IMMUNOL, V34, P558, DOI 10.1002/eji.200324714; Yamasaki M, 2007, CANCER SCI, V98, P1740, DOI 10.1111/j.1349-7006.2007.00595.x; Yellayi S, 2003, J ENDOCRINOL, V176, P267, DOI 10.1677/joe.0.1760267; Yum MK, 2011, TOXICOL APPL PHARM, V257, P174, DOI 10.1016/j.taap.2011.09.002; Zhang Y, 1999, J NUTR, V129, P399, DOI 10.1093/jn/129.2.399	61	57	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47979	10.1371/journal.pone.0047979	http://dx.doi.org/10.1371/journal.pone.0047979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110148	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400028
J	Yoshihisa, Y; Hassan, MA; Furusawa, Y; Tabuchi, Y; Kondo, T; Shimizu, T				Yoshihisa, Yoko; Hassan, Mariame Ali; Furusawa, Yukihiro; Tabuchi, Yoshiaki; Kondo, Takashi; Shimizu, Tadamichi			Alkannin, HSP70 Inducer, Protects against UVB-Induced Apoptosis in Human Keratinocytes	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; INDUCED CELL-DEATH; STRESS-PROTEINS; IN-VITRO; EXPRESSION; INDUCTION; SHIKONIN; SKIN; INHIBITION; CHAPERONES	Alkannin is an active constituent from the root extract of Alkanna tinctoria of the Boraginaceae family and it may have utility as a heat shock protein 70 (HSP70) inducer in living organisms. Here, the effects of alkannin-induced HSP70 on ultraviolet (UV) B (40 mJ/cm(2))-induced apoptosis were investigated in human keratinocyte HaCaT cells. Pretreatment of cells with alkannin (1 mu M) caused significant inhibition of UVB-induced apoptosis and caspase-3 cleavage. On the other hand, the addition of KNK437 (HSP70 inhibitor) reversed the action of alkannin increasing UVB-induced apoptosis in a dose-dependent manner. In addition, differences in gene expression associated with the suppression of UVB-induced apoptosis in the presence of alkannin were investigated using Gene Chip assay. Our results indicate that alkannin suppresses UVB-induced apoptosis through the induction of HSP70 in human keratinocytes, and therefore, we suggest the usefulness of using alkannin as an antiaging agent.	[Yoshihisa, Yoko; Shimizu, Tadamichi] Toyama Univ, Dept Dermatol, Life Sci Res Ctr, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Hassan, Mariame Ali; Furusawa, Yukihiro; Kondo, Takashi] Toyama Univ, Dept Radiol Sci, Life Sci Res Ctr, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Tabuchi, Yoshiaki] Toyama Univ, Div Mol Genet Res, Life Sci Res Ctr, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Hassan, Mariame Ali] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt	University of Toyama; University of Toyama; University of Toyama; Egyptian Knowledge Bank (EKB); Cairo University	Shimizu, T (corresponding author), Toyama Univ, Dept Dermatol, Life Sci Res Ctr, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	shimizut@med.u-toyama.ac.jp		Shimizu, Tadamichi/0000-0002-3231-0279; Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [20591337, 22390229]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant-in-Aid for Scientific Research (C) (20591337) and (B) (22390229) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed K, 2012, INT J HYPERTHER, V28, P1, DOI 10.3109/02656736.2011.627408; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cui ZG, 2004, FREE RADICAL RES, V38, P363, DOI 10.1080/1071576042000191754; EDWARDS MJ, 1991, J INVEST DERMATOL, V96, P392, DOI 10.1111/1523-1747.ep12466250; FENG GE, 2003, TRAD HERBAL DRUGS, V9, P6; Gray CC, 1999, INT J BIOCHEM CELL B, V31, P559, DOI 10.1016/S1357-2725(99)00004-7; Grone A, 2002, VET IMMUNOL IMMUNOP, V88, P1, DOI 10.1016/S0165-2427(02)00136-8; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Gutsmann-Conrad A, 1998, EXP CELL RES, V241, P404, DOI 10.1006/excr.1998.4069; Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749; Hirano H, 2005, APOPTOSIS, V10, P331, DOI 10.1007/s10495-005-0807-5; Hisa T, 1998, ANTICANCER RES, V18, P783; HOLLAND DB, 1993, J INVEST DERMATOL, V101, P196, DOI 10.1111/1523-1747.ep12363791; KANE KS, 1995, J INVEST DERMATOL, V104, P62, DOI 10.1111/1523-1747.ep12613497; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Kwon SB, 2002, J DERMATOL SCI, V28, P144, DOI 10.1016/S0923-1811(01)00156-6; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Lim ES, 2007, ANN NY ACAD SCI, V1095, P7, DOI 10.1196/annals.1397.002; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lu Q, 2002, BIOORG MED CHEM LETT, V12, P1375, DOI 10.1016/S0960-894X(02)00158-0; Mack Judith A., 2005, Birth Defects Research, V75, P314, DOI 10.1002/bdrc.20055; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MAYTIN EV, 1992, J BIOL CHEM, V267, P23189; MAYTIN EV, 1994, J INVEST DERMATOL, V103, P547, DOI 10.1111/1523-1747.ep12396274; Merwald H, 2006, CELL STRESS CHAPERON, V11, P81, DOI 10.1379/CSC-89R.1; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; MURAMATSU T, 1992, J INVEST DERMATOL, V98, P786, DOI 10.1111/1523-1747.ep12499953; Schmidt-Rose T, 1999, J PHOTOCH PHOTOBIO B, V53, P144, DOI 10.1016/S1011-1344(99)00141-4; SELLINS KS, 1987, J IMMUNOL, V139, P3199; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Soti C, 2003, EXP GERONTOL, V38, P1037, DOI 10.1016/S0531-5565(03)00185-2; Souil E, 2001, BRIT J DERMATOL, V144, P260, DOI 10.1046/j.1365-2133.2001.04010.x; TAYLOR CR, 1990, J AM ACAD DERMATOL, V22, P1, DOI 10.1016/0190-9622(90)70001-X; TRAUTINGER F, 1993, J INVEST DERMATOL, V101, P334, DOI 10.1111/1523-1747.ep12365491; Trautinger F, 1996, J INVEST DERMATOL, V107, P442, DOI 10.1111/1523-1747.ep12365498; TRAUTINGER F, 1995, J INVEST DERMATOL, V105, P160, DOI 10.1111/1523-1747.ep12317003; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Tsuruma T, 1996, TRANSPLANT P, V28, P2629; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; Yang F, 2006, INT J CANCER, V119, P1184, DOI 10.1002/ijc.21943; Yenari MA, 1999, MOL MED TODAY, V5, P525, DOI 10.1016/S1357-4310(99)01599-3; YOUNG AR, 1987, PHOTODERMATOLOGY, V4, P127; Zhou XW, 1998, J INVEST DERMATOL, V111, P194, DOI 10.1046/j.1523-1747.1998.00266.x	44	17	19	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e479030	10.1371/journal.pone.0047903	http://dx.doi.org/10.1371/journal.pone.0047903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110127	Green Submitted, gold, Green Published			2022-12-25	WOS:000310193400023
J	Ramaswamy, S; Cooper, D; Poddar, N; MacLean, DM; Rambhadran, A; Taylor, JN; Uhm, H; Landes, CF; Jayaraman, V				Ramaswamy, Swarna; Cooper, David; Poddar, Nitesh; MacLean, David M.; Rambhadran, Anu; Taylor, J. Nick; Uhm, Heui; Landes, Christy F.; Jayaraman, Vasanthi			Role of Conformational Dynamics in alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid (AMPA) Receptor Partial Agonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; IONOTROPIC GLUTAMATE-RECEPTOR; RESONANCE ENERGY-TRANSFER; SINGLE-MOLECULE; PROTEIN INTERACTIONS; SYNAPTIC PLASTICITY; NMR-SPECTROSCOPY; GLUR2; ACTIVATION; MECHANISM	We have investigated the range of cleft closure conformational states that the agonist-binding domains of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors occupy when bound to a series of willardiine derivatives using single-molecule FRET. These studies show that the agonist-binding domain exhibits varying degrees of dynamics when bound to the different willardiines with differing efficacies. The chlorowillardiine- and nitrowillardiine-bound form of the agonist-binding domain probes a narrower range of cleft closure states relative to the iodowillardiine bound form of the protein, with the antagonist (alpha S)-alpha-amino-3-[(4-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinepropanoic acid (UBP-282)-bound form exhibiting the widest range of cleft closure states. Additionally, the average cleft closure follows the order UBP-282 > iodowillardiine > chlorowillardiine > nitrowillardiine-bound forms of agonist-binding domain. These single-molecule FRET data, along with our previously reported data for the glutamate-bound forms of wild type and T686S mutant proteins, show that the mean currents under nondesensitizing conditions can be directly correlated to the fraction of the agonist-binding domains in the "closed" cleft conformation. These results indicate that channel opening in the AMPA receptors is controlled by both the ability of the agonist to induce cleft closure and the dynamics of the agonist-binding domain when bound to the agonist.	[Cooper, David; Poddar, Nitesh; Taylor, J. Nick; Uhm, Heui; Landes, Christy F.] Rice Univ, Dept Chem, Houston, TX 77251 USA; [Ramaswamy, Swarna; MacLean, David M.; Rambhadran, Anu; Jayaraman, Vasanthi] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Ctr Membrane Biol,Dept Biochem & Mol Biol, Houston, TX 77030 USA	Rice University; University of Texas System; University of Texas Health Science Center Houston	Landes, CF (corresponding author), Rice Univ, Dept Chem, MS 60, Houston, TX 77251 USA.	cflandes@rice.edu; vasanthi.jayaraman@uth.tmc.edu	Landes, Christy/I-5501-2014; poddar, nitesh/AAD-9130-2022	MacLean, David/0000-0001-8294-6075; PODDAR, NITESH/0000-0002-2162-9110	National Institutes of Health [GM094246]; Gulf Coast Consortia Grant/Welch Foundation [H-E-0035/R-11-0055]; American Heart Association [11GRNT7890004]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gulf Coast Consortia Grant/Welch Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094246. This work was also supported by Gulf Coast Consortia Grant/Welch Foundation Grant H-E-0035/R-11-0055 and American Heart Association Grant 11GRNT7890004.	Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Birdsey-Benson A, 2010, J NEUROSCI, V30, P1463, DOI 10.1523/JNEUROSCI.4558-09.2010; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Darugar Q, 2008, J VIROL, V82, P12164, DOI 10.1128/JVI.01158-08; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Jayaraman V, 2000, BIOCHEMISTRY-US, V39, P8693, DOI 10.1021/bi000892f; Jayaraman V, 2004, METHOD ENZYMOL, V380, P170; Jayaraman V, 2000, FEBS LETT, V475, P278, DOI 10.1016/S0014-5793(00)01690-2; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JOHNSON KR, 2009, NATL GEOGR, V215, P8; Karam P, 2010, P NATL ACAD SCI USA, V107, P17480, DOI 10.1073/pnas.1008068107; Keifer J, 2010, EUR J NEUROSCI, V32, P269, DOI 10.1111/j.1460-9568.2010.07339.x; Kwak S, 2005, J MOL MED, V83, P110, DOI 10.1007/s00109-004-0599-z; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; MacLean DM, 2011, J NEUROSCI, V31, P2136, DOI 10.1523/JNEUROSCI.4314-10.2011; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Madden DR, 2001, J BIOL CHEM, V276, P37821; MADSEN U, 1994, BIOMED PHARMACOTHER, V48, P305, DOI 10.1016/0753-3322(94)90176-7; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Maltsev AS, 2010, J BIOL CHEM, V285, P10154, DOI 10.1074/jbc.M109.088641; Mankiewicz KA, 2007, BRAZ J MED BIOL RES, V40, P1419, DOI 10.1590/S0100-879X2007001100001; Mankiewicz KA, 2008, BIOCHEMISTRY-US, V47, P398, DOI 10.1021/bi702004b; McFeeters RL, 2004, FASEB J, V18, P428, DOI 10.1096/fj.03-0873rev; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; O'Neill MJ, 2007, CURR DRUG TARGETS, V8, P603, DOI 10.2174/138945007780618517; Oswald RE, 2007, CURR DRUG TARGETS, V8, P573, DOI 10.2174/138945007780618526; Poon K, 2011, MOL PHARMACOL, V80, P49, DOI 10.1124/mol.111.071688; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1992, TRENDS PHARMACOL SCI, V13, P291, DOI 10.1016/0165-6147(92)90088-N; Taylor JN, 2008, BIOCHEM BIOPH RES CO, V373, P213, DOI 10.1016/j.bbrc.2008.05.191; Taylor JN, 2011, J PHYS CHEM B, V115, P1105, DOI 10.1021/jp1050707; Taylor JN, 2010, BIOPHYS J, V98, P164, DOI 10.1016/j.bpj.2009.09.047; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valentine ER, 2005, BIOCHEMISTRY-US, V44, P3410, DOI 10.1021/bi047984f; Vogelsang J, 2007, ANAL CHEM, V79, P7367, DOI 10.1021/ac071176n; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	53	35	35	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43557	43564		10.1074/jbc.M112.371815	http://dx.doi.org/10.1074/jbc.M112.371815			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115239	Green Published, hybrid			2022-12-25	WOS:000312940800036
J	Hardy, RY; Resh, MD				Hardy, Rayshonda Y.; Resh, Marilyn D.			Identification of N-terminal Residues of Sonic Hedgehog Important for Palmitoylation by Hedgehog Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL MODIFICATION; ANIMAL DEVELOPMENT; PROTEIN; RANGE; GENE; FORM; MUTATIONS; CANCER	Sonic Hedgehog (Shh) is a secreted morphogen that regulates embryonic development. After removal of the signal peptide, Shh is processed to the mature, active form through autocleavage and a series of lipid modifications, including the attachment of palmitate. Covalent attachment of palmitate to the N-terminal cysteine of Shh is catalyzed by Hedgehog acyltransferase (Hhat) and is critical for proper signaling. The sequences within Shh that are responsible for palmitoylation by Hhat are not known. Here we show that the first six amino acids of mature Shh (CGPGRG) are sufficient for Hhat-mediated palmitoylation. Alanine scanning mutagenesis was used to determine the role of each amino acid and the positional sequence requirement in a cell-based Shh palmitoylation assay. Mutation of residues in the GPGR sequence to Ala had no effect on palmitoylation, provided that a positively charged residue was present within the first seven residues. The N-terminal position exhibited a strong but not exclusive requirement for Cys. Constructs with an N-terminal Ala were not palmitoylated. However, an N-terminal Ser served as a substrate for Hhat, but not the Drosophila melanogaster ortholog Rasp, highlighting a critical difference between the mammalian and fly enzymes. These findings define residues and regions within Shh that are necessary for its recognition as a substrate for Hhat-mediated palmitoylation. Finally, we report the results of a bioinformatics screen to identify other potential Hhat substrates encoded in the human genome.	[Resh, Marilyn D.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; Cornell Univ, Weill Grad Sch Med Sci, Grad Program Biochem Cell & Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Resh, MD (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave,Box 143, New York, NY 10065 USA.	m-resh@ski.mskcc.org		Resh, Marilyn/0000-0001-6118-9466	National Institutes of Health [GM57966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57966.	ALLAND L, 1994, J BIOL CHEM, V269, P16701; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Hehr U, 2004, EUR J PEDIATR, V163, P347, DOI 10.1007/s00431-004-1459-0; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Odent S, 1999, HUM MOL GENET, V8, P1683, DOI 10.1093/hmg/8.9.1683; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PESECKIS SM, 1993, J BIOL CHEM, V268, P5107; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 2009, HUM MUTAT, V30, pE921, DOI 10.1002/humu.21090; Singh S, 2009, HUM GENET, V125, P95, DOI 10.1007/s00439-008-0599-0; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	35	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42881	42889		10.1074/jbc.M112.426833	http://dx.doi.org/10.1074/jbc.M112.426833			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23112049	Green Published, hybrid			2022-12-25	WOS:000312501600046
J	Vitashenkova, N; Moeller, JB; Leth-Larsen, R; Schlosser, A; Lund, KP; Tornoe, I; Vitved, L; Hansen, S; Willis, A; Kharazova, AD; Skjodt, K; Sorensen, GL; Holmskov, U				Vitashenkova, Nina; Moeller, Jesper Bonnet; Leth-Larsen, Rikke; Schlosser, Anders; Lund, Kit Peiter; Tornoe, Ida; Vitved, Lars; Hansen, Soren; Willis, Anthony; Kharazova, Alexandra D.; Skjodt, Karsten; Sorensen, Grith Lykke; Holmskov, Uffe			Identification and Characterization of a Chitin-binding Protein Purified from Coelomic Fluid of the Lugworm Arenicola marina Defining a Novel Protein Sequence Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; POLYANDROCARPA-MISAKIENSIS; ANTIMICROBIAL PEPTIDE; INNATE IMMUNITY; CDNA CLONING; PURIFICATION; INVERTEBRATE; SPECIFICITY; DIVERSITY; MOLECULES	We have isolated a novel type of lectin named Arenicola marina lectin-1 (AML-1) from the lugworm A. marina. The lectin was purified from the coelomic fluid by affinity chromatography on a GlcNAc-derivatized column and eluted with GlcNAc. On SDS-PAGE, AML-1 showed an apparent molecular mass of 27 and 31 kDa in the reduced state. The N-terminal amino acid sequences were identical in these two bands. In the unreduced state, a complex band pattern was observed with bands from 35 kDa to more than 200 kDa. Two different full-length clones encoding polypeptides of 241 and 243 amino acids, respectively, were isolated from a coelomocyte cDNA library. The two clones, designated AML-1a and AML-1b, were 92% identical at the protein level and represent a novel type of protein sequence family. Purified AML-1 induced agglutination of rabbit erythrocytes, which could be inhibited by N-acetylated saccharides. Recombinant AML-1b showed the same band pattern as the native protein, whereas recombinant AML-1a in the reduced state lacked a 27 kDa band. AML-1b bound GlcNAc-derivatized columns and chitin, whereas AML-1a did not bind to these matrices. Immunohistochemical analysis revealed that AML-1 is expressed by coelomocytes in the nephridium and in round cells in the epidermis and in eggs. Moreover, AML-1 expression was up-regulated in response to a parasitic infection. We conclude that AML-1 purified from coelomic fluid is encoded by AML-1b and represents a novel type of protein family that binds acetylated components.	[Vitashenkova, Nina; Moeller, Jesper Bonnet; Schlosser, Anders; Lund, Kit Peiter; Tornoe, Ida; Sorensen, Grith Lykke; Holmskov, Uffe] Univ So Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, DK-5000 Odense C, Denmark; [Leth-Larsen, Rikke; Vitved, Lars; Hansen, Soren; Skjodt, Karsten] Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat, DK-5000 Odense C, Denmark; [Willis, Anthony] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; [Vitashenkova, Nina; Kharazova, Alexandra D.] St Petersburg State Univ, Fac Biol, Dept Cytol & Histol, St Petersburg 199034, Russia	University of Southern Denmark; University of Southern Denmark; University of Oxford; Saint Petersburg State University	Holmskov, U (corresponding author), Univ So Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, JP Winsloews Vej 25-3, DK-5000 Odense C, Denmark.	uholmskov@health.sdu.dk	Kharazova, Alexandra/I-6876-2015; Holmskov, Uffe/AAA-3056-2022; Moeller, Jesper B/E-6377-2015	Kharazova, Alexandra/0000-0001-9149-9633; Holmskov, Uffe/0000-0002-2391-9445; Moeller, Jesper B/0000-0001-8786-8037; Sorensen, Grith Lykke/0000-0002-5273-1097; Leth-Larsen, Rikke/0000-0002-1612-4089; Skjodt, Karsten/0000-0002-9161-8185; Hansen, Soren/0000-0002-8186-4630	Benzon Foundation	Benzon Foundation	This research work was supported by the Benzon Foundation.	Abe Y, 1999, EUR J BIOCHEM, V261, P33, DOI 10.1046/j.1432-1327.1999.00238.x; Adema CM, 1999, PARASITOLOGY, V119, P395, DOI 10.1017/S0031182099004850; Adema CM, 1997, P NATL ACAD SCI USA, V94, P8691, DOI 10.1073/pnas.94.16.8691; Andra J, 2008, BIOCHEM J, V410, P113, DOI 10.1042/BJ20071051; Azumi Kaoru, 1996, P43; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cooper DNW, 1997, J BIOL CHEM, V272, P1514, DOI 10.1074/jbc.272.3.1514; COOPER EL, 1985, DEV COMP IMMUNOL, V9, P577, DOI 10.1016/0145-305X(85)90021-7; DALES RP, 1982, COMP BIOCHEM PHYS A, V73, P663, DOI 10.1016/0300-9629(82)90272-9; DAM TK, 1994, BIOCHEM BIOPH RES CO, V203, P36, DOI 10.1006/bbrc.1994.2145; Davidson CR, 2008, DEV COMP IMMUNOL, V32, P608, DOI 10.1016/j.dci.2007.11.004; DRICKAMER K, 1995, CURR OPIN STRUC BIOL, V5, P612, DOI 10.1016/0959-440X(95)80052-2; FITZGERALD SW, 1989, J EXP ZOOL, V249, P293, DOI 10.1002/jez.1402490308; FITZGERALD SW, 1982, DEV COMP IMMUNOL, V6, P23, DOI 10.1016/0145-305X(82)90004-0; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; GARTE SJ, 1976, BIOCHIM BIOPHYS ACTA, V439, P368, DOI 10.1016/0005-2795(76)90073-8; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Hirabayashi J, 1998, J BIOL CHEM, V273, P14450, DOI 10.1074/jbc.273.23.14450; HIRABAYASHI J, 1992, J BIOL CHEM, V267, P15485; Hirabayashi J, 1996, J BIOL CHEM, V271, P2497, DOI 10.1074/jbc.271.5.2497; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; HIRABAYASHI J, 1992, J BIOCHEM-TOKYO, V111, P553, DOI 10.1093/oxfordjournals.jbchem.a123794; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Loker ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00025; Loker ES, 2010, ADV EXP MED BIOL, V708, P17; Lu JH, 1998, IMMUNOBIOLOGY, V199, P190, DOI 10.1016/S0171-2985(98)80026-0; Messier-Solek C, 2010, SEMIN IMMUNOL, V22, P39, DOI 10.1016/j.smim.2009.11.007; Nair SV, 2000, COMP BIOCHEM PHYS B, V125, P279, DOI 10.1016/S0305-0491(99)00180-7; Ovchinnikova TV, 2004, FEBS LETT, V577, P209, DOI 10.1016/j.febslet.2004.10.012; Ozeki Y, 1997, COMP BIOCHEM PHYS B, V118, P1, DOI 10.1016/S0305-0491(97)00014-X; Poget SF, 1999, J MOL BIOL, V290, P867, DOI 10.1006/jmbi.1999.2910; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Saito T, 1997, J BIOL CHEM, V272, P30703, DOI 10.1074/jbc.272.49.30703; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Schlosser A, 2006, SCAND J IMMUNOL, V64, P104, DOI 10.1111/j.1365-3083.2006.01778.x; Schlosser A, 2009, J IMMUNOL, V183, P3800, DOI 10.4049/jimmunol.0901526; Soderhall K, 2010, ADV EXP MED BIOL, V708, P1, DOI 10.1007/978-1-4419-8059-5; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Thomsen T, 2010, J BIOL CHEM, V285, P1229, DOI 10.1074/jbc.M109.061523; TSUJI T, 1986, CARBOHYD RES, V151, P391, DOI 10.1016/S0008-6215(00)90358-6; Tunkijjanukij S, 1998, DEV COMP IMMUNOL, V22, P139, DOI 10.1016/S0145-305X(98)00017-2; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; VASTA GR, 1994, ANN NY ACAD SCI, V712, P55, DOI 10.1111/j.1749-6632.1994.tb33562.x; Vetvicka V., 1994, IMMUNOLOGY ANNELIDS; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x	49	3	3	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42846	42855		10.1074/jbc.M112.420976	http://dx.doi.org/10.1074/jbc.M112.420976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23115230	Green Published, hybrid			2022-12-25	WOS:000312501600043
J	Bhattacharya, A; Baker, NE				Bhattacharya, Abhishek; Baker, Nicholas E.			The Role of the bHLH Protein Hairy in Morphogenetic Furrow Progression in the Developing Drosophila Eye	PLOS ONE			English	Article							RETINAL DETERMINATION GENES; HELIX-LOOP-HELIX; CELL FATES; EXTRACELLULAR SIGNALS; PRONEURAL GENE; EXTRAMACROCHAETAE; HEDGEHOG; NETWORK; TRANSCRIPTION; DAUGHTERLESS	In Drosophila eye development, a wave of differentiation follows a morphogenetic furrow progressing across the eye imaginal disc. This is subject to negative regulation attributed to the HLH repressor proteins Hairy and Extramacrochaete. Recent studies identify negative feedback on the bHLH gene daughterless as one of the main functions of extramacrochaete. Here the role of hairy was assessed in relation to daughterless and other HLH genes. Hairy was not found to regulate the expression of Daughterless, Extramacrochaete or Atonal, and Hairy expression was largely unregulated by these other genes. Null alleles of hairy did not alter the rate or pattern of differentiation, either alone or in the absence of Extramacrochaete. These findings question whether hairy is an important regulator of the progression of retinal differentiation in Drosophila, alone or redundantly with extramacrochaete.	[Bhattacharya, Abhishek; Baker, Nicholas E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	nbaker@einstein.yu.edu		Bhattacharya, Abhishek/0000-0002-4456-054X	National Institutes of Health [GM047892]; Research to Prevent Blindness; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant from the National Institutes of Health (GM047892) and by an unrestricted grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifragis P, 1997, P NATL ACAD SCI USA, V94, P13099, DOI 10.1073/pnas.94.24.13099; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Baker NE, 1998, MECH DEVELOP, V74, P3, DOI 10.1016/S0925-4773(98)00054-9; Baker NE, 2011, BIOESSAYS, V33, P538, DOI 10.1002/bies.201000131; Baonza A, 2001, DEVELOPMENT, V128, P3889; Baonza A, 2000, DEVELOPMENT, V127, P2383; Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; Bhattacharya A, 2011, CELL, V147, P881, DOI 10.1016/j.cell.2011.08.055; Bhattacharya A, 2009, DEV BIOL, V327, P288, DOI 10.1016/j.ydbio.2008.11.037; BROWN NL, 1995, CELL, V80, P879, DOI 10.1016/0092-8674(95)90291-0; Brown NL, 1996, DEV BIOL, V179, P65, DOI 10.1006/dbio.1996.0241; BROWN NL, 1991, DEVELOPMENT, V113, P1245; Campuzano S, 2001, ONCOGENE, V20, P8299, DOI 10.1038/sj.onc.1205162; Corrigall D, 2007, DEV CELL, V13, P730, DOI 10.1016/j.devcel.2007.09.015; CRONMILLER C, 1993, MECH DEVELOP, V42, P159, DOI 10.1016/0925-4773(93)90005-I; Escudero LM, 2007, DEV CELL, V13, P717, DOI 10.1016/j.devcel.2007.09.002; Firth LC, 2005, DEV CELL, V8, P541, DOI 10.1016/j.devcel.2005.01.017; Firth LC, 2009, DEV BIOL, V327, P366, DOI 10.1016/j.ydbio.2008.12.021; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Fu WM, 2003, DEVELOPMENT, V130, P5229, DOI 10.1242/dev.00764; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Greenwood S, 1999, DEVELOPMENT, V126, P5795; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Roignant JY, 2009, INT J DEV BIOL, V53, P795, DOI 10.1387/ijdb.072483jr; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; WAINWRIGHT SM, 1992, MOL CELL BIOL, V12, P2475, DOI 10.1128/MCB.12.6.2475; Wolff Tanya, 1993, P1277; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47503	10.1371/journal.pone.0047503	http://dx.doi.org/10.1371/journal.pone.0047503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118874	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500019
J	Boxma, PY; van den Berg, E; Geleijnse, JM; Laverman, GD; Schurgers, LJ; Vermeer, C; Kema, IP; Muskiet, FA; Navis, G; Bakker, SJL; de Borst, MH				Boxma, Paul Y.; van den Berg, Else; Geleijnse, Johanna M.; Laverman, Gozewijn D.; Schurgers, Leon J.; Vermeer, Cees; Kema, Ido P.; Muskiet, Frits A.; Navis, Gerjan; Bakker, Stephan J. L.; de Borst, Martin H.			Vitamin K Intake and Plasma Desphospho-Uncarboxylated Matrix Gla-Protein Levels in Kidney Transplant Recipients	PLOS ONE			English	Article							CORONARY-ARTERY CALCIUM; VASCULAR CALCIFICATION; HEMODIALYSIS-PATIENTS; DEFICIENCY; MENAQUINONES; DISEASE; RISK	Vitamin K is essential for activation of gamma-carboxyglutamate (Gla)-proteins including the vascular calcification inhibitor matrix Gla-protein (MGP). Insufficient vitamin K intake leads to production of uncarboxylated, mostly inactive proteins and contributes to an increased cardiovascular risk. In kidney transplant recipients, cardiovascular risk is high but vitamin K intake and status have not been defined. We investigated dietary vitamin K intake, vascular vitamin K status and its determinants in kidney transplant recipients. We estimated vitamin K intake in a cohort of kidney transplant recipients (n = 60) with stable renal function (creatinine clearance 61 [42-77] (median [interquartile range]) ml/min), who were 75 [35-188] months after transplantation, using three-day food records and food frequency questionnaires. Vascular vitamin K status was assessed by measuring plasma desphospho-uncarboxylated MGP (dp-ucMGP). Total vitamin K intake was below the recommended level in 50% of patients. Lower vitamin K intake was associated with less consumption of green vegetables (33 vs 40 g/d, p = 0.06) and increased dp-ucMGP levels (621 vs 852 pmol/L, p<0.05). Accordingly, dp-ucMGP levels were elevated (>500 pmol/L) in 80% of patients. Multivariate regression identified creatinine clearance, coumarin use, body mass index, high sensitivity-CRP and sodium excretion as independent determinants of dp-ucMGP levels. In a considerable part of the kidney transplant population, vitamin K intake is too low for maximal carboxylation of vascular MGP. The high dp-ucMGP levels may result in an increased risk for arterial calcification. Whether increasing vitamin K intake may have health benefits for kidney transplant recipients should be addressed by future studies.	[Boxma, Paul Y.; van den Berg, Else; Navis, Gerjan; Bakker, Stephan J. L.; de Borst, Martin H.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, NL-9713 AV Groningen, Netherlands; [Boxma, Paul Y.; van den Berg, Else; Kema, Ido P.; Muskiet, Frits A.; Navis, Gerjan; Bakker, Stephan J. L.; de Borst, Martin H.] Univ Groningen, Groningen, Netherlands; [van den Berg, Else; Bakker, Stephan J. L.] Top Inst Food & Nutr, Wageningen, Netherlands; [Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Laverman, Gozewijn D.] ZGT Hosp Almelo, Div Nephrol, Dept Internal Med, Almelo, Netherlands; [Schurgers, Leon J.] Maastricht Univ, Dept Biochem, Maastricht, Netherlands; [Vermeer, Cees] Maastricht Univ, VitaK, Maastricht, Netherlands; [Kema, Ido P.; Muskiet, Frits A.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; Top Institute Food & Nutrition; Wageningen University & Research; Maastricht University; Maastricht University; University of Groningen	de Borst, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, NL-9713 AV Groningen, Netherlands.	m.h.de.borst@umcg.nl	Geleijnse, Johanna Marianna M/B-5749-2012; Schurgers, Leon/AAT-7100-2021; Bakker, Stephan J. L./J-4023-2015	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Bakker, Stephan J. L./0000-0003-3356-6791; Vermeer, Cees/0000-0002-2300-8561; Schurgers, Leon/0000-0001-7867-6957; De Borst, Martin/0000-0002-4127-8733	Dutch Kidney foundation [KJPB.08.07]; University Medical Center Groningen (Mandema stipend); European Union (FP7, Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment Project consortium (SysKid)) [241544]; Dutch Kidney Foundation (NIGRAM consortium) [CP10.11]	Dutch Kidney foundation; University Medical Center Groningen (Mandema stipend); European Union (FP7, Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment Project consortium (SysKid)); Dutch Kidney Foundation (NIGRAM consortium)	Dr. de Borst is supported by personal development grants from the Dutch Kidney foundation (KJPB.08.07, www.nierstichting.nl) and the University Medical Center Groningen (Mandema stipend), and by the European Union (FP7, Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment Project consortium (SysKid, www.syskid.eu), project number 241544)). This work is supported by a consortium grant from the Dutch Kidney Foundation (NIGRAM consortium, grant no CP10.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, DUTCH FOOD COMP TABL; Beulens JWJ, 2009, ATHEROSCLEROSIS, V203, P489, DOI 10.1016/j.atherosclerosis.2008.07.010; Cranenburg ECM, 2012, KIDNEY INT, V82, P605, DOI 10.1038/ki.2012.191; Cranenburg ECM, 2010, THROMB HAEMOSTASIS, V104, P811, DOI 10.1160/TH09-11-0786; Geleijnse JM, 2004, J NUTR, V134, P3100, DOI 10.1093/jn/134.11.3100; Gungor O, 2011, CLIN NEPHROL, V75, P491, DOI 10.5414/CNP75491; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Lambers Heerspink HJ, 2012, KIDNEY INT, V82, P330, DOI 10.1038/ki.2012.74; Margreiter R, 2002, LANCET, V359, P741, DOI 10.1016/S0140-6736(02)07875-3; Mazzaferro S, 2007, AM J NEPHROL, V27, P75, DOI 10.1159/000099095; Moe SM, 2005, KIDNEY INT, V67, P2295, DOI 10.1111/j.1523-1755.2005.00333.x; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; National Academy of Sciences, 2001, DIET REF INT VIT A V; Ohsaki Y, 2006, BIOSCI BIOTECH BIOCH, V70, P926, DOI 10.1271/bbb.70.926; Oterdoom LH, 2009, TRANSPLANTATION, V87, P1562, DOI 10.1097/TP.0b013e3181a4bb80; Prasad GVR, 1999, AM J KIDNEY DIS, V33, P963, DOI 10.1016/S0272-6386(99)70433-6; PRICE PA, 1985, J BIOL CHEM, V260, P4971; RAMOTAR K, 1984, J INFECT DIS, V150, P213, DOI 10.1093/infdis/150.2.213; REDDI K, 1995, CYTOKINE, V7, P287, DOI 10.1006/cyto.1995.0034; Rennenberg RJMW, 2010, EUR J CLIN INVEST, V40, P344, DOI 10.1111/j.1365-2362.2010.02275.x; SALYERS AA, 1978, AM J CLIN NUTR, V31, pS128, DOI 10.1093/ajcn/31.10.S128; Schlieper G, 2011, J AM SOC NEPHROL, V22, P387, DOI 10.1681/ASN.2010040339; Schurgers LJ, 2010, CLIN J AM SOC NEPHRO, V5, P568, DOI 10.2215/CJN.07081009; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Schurgers LJ, 2002, BBA-GEN SUBJECTS, V1570, P27, DOI 10.1016/S0304-4165(02)00147-2; Schurgers LJ, 2000, HAEMOSTASIS, V30, P298; Shea MK, 2008, AM J EPIDEMIOL, V167, P313, DOI 10.1093/aje/kwm306; Shea MK, 2011, J NUTR, V141, P1529, DOI 10.3945/jn.111.139634; Shearer MJ, 1996, J NUTR, V126, pS1181, DOI 10.1093/jn/126.suppl_4.1181S; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; van den Berg E, 2012, NEPHROL DIAL TRANSPL, V27, P3352, DOI 10.1093/ndt/gfs069; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Weijs B, 2011, EUR HEART J, V32, P2555, DOI 10.1093/eurheartj/ehr226; Westenfeld R, 2012, AM J KIDNEY DIS, V59, P186, DOI 10.1053/j.ajkd.2011.10.041	34	71	71	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47991	10.1371/journal.pone.0047991	http://dx.doi.org/10.1371/journal.pone.0047991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118917	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500053
J	Eaton, CJ; Cabrera, IE; Servin, JA; Wright, SJ; Cox, MP; Borkovich, KA				Eaton, Carla J.; Cabrera, Ilva E.; Servin, Jacqueline A.; Wright, Sara J.; Cox, Murray P.; Borkovich, Katherine A.			The Guanine Nucleotide Exchange Factor RIC8 Regulates Conidial Germination through G alpha Proteins in Neurospora crassa	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; ADENYLYL-CYCLASE; ASPERGILLUS-NIDULANS; SUBUNIT; PATHWAYS; GROWTH; DIFFERENTIATION; DYNAMICS; HOMOLOG; ROLES	Heterotrimeric G protein signaling is essential for normal hyphal growth in the filamentous fungus Neurospora crassa. We have previously demonstrated that the non-receptor guanine nucleotide exchange factor RIC8 acts upstream of the G alpha proteins GNA-1 and GNA-3 to regulate hyphal extension. Here we demonstrate that regulation of hyphal extension results at least in part, from an important role in control of asexual spore (conidia) germination. Loss of GNA-3 leads to a drastic reduction in conidial germination, which is exacerbated in the absence of GNA-1. Mutation of RIC8 leads to a reduction in germination similar to that in the Delta gna-1, Delta gna-3 double mutant, suggesting that RIC8 regulates conidial germination through both GNA-1 and GNA-3. Support for a more significant role for GNA-3 is indicated by the observation that expression of a GTPase-deficient, constitutively active gna-3 allele in the Delta ric8 mutant leads to a significant increase in conidial germination. Localization of the three G alpha proteins during conidial germination was probed through analysis of cells expressing fluorescently tagged proteins. Functional TagRFP fusions of each of the three G alpha subunits were constructed through insertion of TagRFP in a conserved loop region of the G alpha subunits. The results demonstrated that GNA-1 localizes to the plasma membrane and vacuoles, and also to septa throughout conidial germination. GNA-2 and GNA-3 localize to both the plasma membrane and vacuoles during early germination, but are then found in intracellular vacuoles later during hyphal outgrowth.	[Eaton, Carla J.; Cabrera, Ilva E.; Servin, Jacqueline A.; Wright, Sara J.; Borkovich, Katherine A.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Eaton, Carla J.; Cabrera, Ilva E.; Servin, Jacqueline A.; Wright, Sara J.; Borkovich, Katherine A.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Cox, Murray P.] Massey Univ, Bioprotect Res Ctr, Inst Mol BioSci, Palmerston North, New Zealand; [Cox, Murray P.] Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	University of California System; University of California Riverside; University of California System; University of California Riverside; Massey University; Massey University	Borkovich, KA (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	Katherine.Borkovich@ucr.edu	Eaton, Carla/J-3108-2013; Cox, Murray/A-1459-2012	Cox, Murray/0000-0003-1936-0236; Eaton, Carla/0000-0002-0633-1535	National Institutes of Health [GM086565]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health grant GM086565 to KAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Baasiri RA, 1997, GENETICS, V147, P137; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bowman BJ, 2009, EUKARYOT CELL, V8, P1845, DOI 10.1128/EC.00174-09; Chang MH, 2004, GENETICS, V167, P1305, DOI 10.1534/genetics.103.025379; Chermette R, 2008, MYCOPATHOLOGIA, V166, P385, DOI 10.1007/s11046-008-9102-7; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; DiCaudo DJ, 2006, J AM ACAD DERMATOL, V55, P929, DOI 10.1016/j.jaad.2006.04.039; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Garcia-Rico RO, 2009, INT MICROBIOL, V12, P123, DOI 10.2436/20.1501.01.89; Garcia-Rico RO, 2011, FUNGAL GENET BIOL, V48, P641, DOI 10.1016/j.fgb.2010.11.013; GRIFFIN DH, 1994, FUNGAL PHYSL; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Ivey FD, 1999, FUNGAL GENET BIOL, V26, P48, DOI 10.1006/fgbi.1998.1101; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Ivey FD, 1996, MOL BIOL CELL, V7, P1283, DOI 10.1091/mbc.7.8.1283; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Kays AM, 2004, GENETICS, V166, P1229, DOI 10.1534/genetics.166.3.1229; Kays AM, 2000, MOL CELL BIOL, V20, P7693, DOI 10.1128/MCB.20.20.7693-7705.2000; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Krystofova S, 2005, EUKARYOT CELL, V4, P365, DOI 10.1128/EC.4.2.365-378.2005; Krystofova S, 2006, EUKARYOT CELL, V5, P1503, DOI 10.1128/EC.00124-06; Lafon A, 2005, GENETICS, V171, P71, DOI 10.1534/genetics.105.040584; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Li LD, 2006, EUKARYOT CELL, V5, P1287, DOI 10.1128/EC.00109-06; Li Y, 2010, MOL PLANT MICROBE IN, V23, P317, DOI 10.1094/MPMI-23-3-0317; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; R Development Core Team, 2012, R LANG ENV STAT COMP; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Truesdell GM, 2000, PHYSIOL MOL PLANT P, V56, P131, DOI 10.1006/pmpp.2000.0256; TURNER GE, 1993, J BIOL CHEM, V268, P14805; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; Wright SJ, 2011, GENETICS, V189, P165, DOI 10.1534/genetics.111.129270; Yang Q, 2002, EUKARYOT CELL, V1, P378, DOI 10.1128/EC.1.3.378-390.2002; Yatzkan E, 1999, MOL MICROBIOL, V31, P197, DOI 10.1046/j.1365-2958.1999.01161.x; Zuber S, 2003, GENETICS, V164, P487; [No title captured]	43	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48026	10.1371/journal.pone.0048026	http://dx.doi.org/10.1371/journal.pone.0048026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118921	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500057
J	Lirng, JF; Wang, PS; Chen, HC; Soong, BW; Guo, WY; Wu, HM; Chang, CY				Lirng, Jiing-Feng; Wang, Po-Shan; Chen, Hung-Chieh; Soong, Bing-Wen; Guo, Wan Yuo; Wu, Hsiu-Mei; Chang, Cheng-Yen			Differences between Spinocerebellar Ataxias and Multiple System Atrophy-Cerebellar Type on Proton Magnetic Resonance Spectroscopy	PLOS ONE			English	Article							CEREBRAL METABOLISM; STROKE; SCA2; DIAGNOSIS; PATTERNS; FAMILY; BRAIN	Purpose: A broad spectrum of diseases can manifest cerebellar ataxia. In this study, we investigated whether proton magnetic resonance spectroscopy (MRS) may help differentiate spinocerebellar ataxias (SCA) from multiple systemic atrophy-cerebellar type (MSA-C). Material and Methods: This prospective study recruited 156 patients with ataxia, including spinocerebellar ataxia (SCA) types 1, 2, 3, 6 and 17 (N = 94) and MSA-C (N = 62), and 44 healthy controls. Single voxel proton MRS in the cerebellar hemispheres and vermis were measured. The differences were evaluated using nonparametric statistic tests. Results: When compared with healthy controls, the cerebellar and vermis NAA/Cr and NAA/Cho were lower in all patients(p < 0.002). The Cho/Cr was lower in SCA2 and MSA-C (p < 0.0005). The NAA/Cr and Cho/Cr were lower in MSA-C or SCA2 comparing with SCA3 or SCA6. The MRS features of SCA1 were in between (p < 0.018). The cerebellar NAA/Cho was lower in SCA2 than SCA1, SCA3 or SCA6 (p < 0.04). The cerebellar NAA/Cho in MSA-C was lower than SCA3 (p < 0.0005). In the early stages of diseases (SARA score < 10), significant lower NAA/Cr and NAA/Cho in SCA2, SCA3, SCA6 or MSA-C were observed comparing with healthy controls (p < 0.017). The Cho/Cr was lower in MSA-C or SCA2 (p < 0.0005). Patients with MSA-C and SCA2 had lower NAA/Cr and Cho/Cr than SCA3 or SCA6 (p < 0.016). Conclusion: By using MRS, significantly lower NAA/Cr, Cho/Cr and NAA/Cho in the cerebellar hemispheres and vermis were found in patients with ataxia (SCAs and MSA-C). Rapid neuronal degeneration and impairment of membrane activities were observed more often in patients with MSA-C than those with SCA, even in early stages. MRS could also help distinguish between SCA2 and other subtypes of SCAs. MRS ratios may be of use as biomarkers in early stages of disease and should be further assessed in a longitudinal study.	[Lirng, Jiing-Feng; Wang, Po-Shan; Soong, Bing-Wen] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Lirng, Jiing-Feng; Chen, Hung-Chieh; Guo, Wan Yuo; Wu, Hsiu-Mei; Chang, Cheng-Yen] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Wang, Po-Shan] Municipal Gandau Hosp, Dept Med, Taipei, Taiwan; [Soong, Bing-Wen] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lirng, JF (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan.	jflirng@vghtpe.gov.tw; hungchiehchen@gmail.com; bwsoong@gmail.com	Chen, hung-chieh/AAH-6591-2019	Chen, hung-chieh/0000-0003-3544-5045	Hsu Tsung Pei Medical Research Fund; Taipei Veterans General Hospital [V101-C1-045, V99C1-155, V100C-129, VGHUST100-G7-3-2, VGHUST101-G4-2-4]; National Science Council, Taiwan, ROC [NSC99-2314-B-010-013-MY3, NSC 101-2325-B-010 - 014, NSC99-2221-E-075-003, NSC99-2221-E-010-012, NSC100-2221-E-010-009, NSC 101-2221-E-010-004-MY2, NSC101-2314-B-733-001-MY2]; NSC [NSC 100-2911-I-008-001]; Brain Research Center, National Yang-Ming University and the Ministry of Education, Aim for the Top University Plan, Taiwan [V101-E7-005]	Hsu Tsung Pei Medical Research Fund; Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); Brain Research Center, National Yang-Ming University and the Ministry of Education, Aim for the Top University Plan, Taiwan	This work was supported by funds from Hsu Tsung Pei Medical Research Fund and research grants from Taipei Veterans General Hospital (V101-C1-045, V99C1-155, V100C-129, VGHUST100-G7-3-2, VGHUST101-G4-2-4), the National Science Council, Taiwan, ROC (NSC99-2314-B-010-013-MY3, NSC 101-2325-B-010 - 014, NSC99-2221-E-075-003, NSC99-2221-E-010-012, NSC100-2221-E-010-009, NSC 101-2221-E-010-004-MY2, NSC101-2314-B-733-001-MY2), NSC supported for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 100-2911-I-008-001) and Brain Research Center, National Yang-Ming University and the Ministry of Education, Aim for the Top University Plan (V101-E7-005), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Boesch SM, 2001, J MAGN RESON IMAGING, V13, P553, DOI 10.1002/jmri.1078; Boesch SM, 2007, J MAGN RESON IMAGING, V25, P564, DOI 10.1002/jmri.20846; BRUHN H, 1989, MAGNET RESON MED, V9, P126, DOI 10.1002/mrm.1910090115; Brusse E, 2007, CLIN GENET, V71, P12, DOI 10.1111/j.1399-0004.2006.00722.x; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; Estrada R, 1999, ACTA NEUROPATHOL, V97, P306, DOI 10.1007/s004010050989; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Hadjivassiliou M, 2011, ACTA NEUROL SCAND, V126, P138; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Koeppen AH, 1999, J NEUROPATH EXP NEUR, V58, P748, DOI 10.1097/00005072-199907000-00009; KUGEL H, 1992, RADIOLOGY, V183, P701, DOI 10.1148/radiology.183.3.1584924; Lee EA, 2004, PARKINSONISM RELAT D, V10, P363, DOI 10.1016/j.parkreldis.2004.04.008; Lee YC, 2011, MOVEMENT DISORD, V26, P2081, DOI 10.1002/mds.23809; Mascalchi M, 1998, ANN NEUROL, V43, P244, DOI 10.1002/ana.410430215; MEYERHOFF DJ, 1994, ANN NEUROL, V36, P40; MILLER BL, 1991, NMR BIOMED, V4, P47, DOI 10.1002/nbm.1940040203; NG TC, 1994, RADIOLOGY, V193, P465, DOI 10.1148/radiology.193.2.7972764; Oz G, 2011, CEREBELLUM, V10, P208, DOI 10.1007/s12311-010-0213-6; OPPENHEIMER SM, 1995, MAGN RESON MED, V33, P61, DOI 10.1002/mrm.1910330109; Oz G, 2010, MOVEMENT DISORD, V25, P1253, DOI 10.1002/mds.23067; PETROFF OAC, 1992, NEUROLOGY, V42, P1349, DOI 10.1212/WNL.42.7.1349; Ross AJ, 2005, NEUROBIOL AGING, V26, P873, DOI 10.1016/j.neurobiolaging.2004.07.008; Ross B, 1999, MAGNETIC RESONANCE S, P12; Ross BM, 2000, MOVEMENT DISORD, V15, P294, DOI 10.1002/1531-8257(200003)15:2<294::AID-MDS1013>3.0.CO;2-D; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Takahashi H, 1998, ACTA NEUROPATHOL, V95, P333, DOI 10.1007/s004010050807; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; VANDERGROND J, 1995, STROKE, V26, P822, DOI 10.1161/01.STR.26.5.822; Wang PS, 2007, J NEUROL, V254, P838, DOI 10.1007/s00415-006-0383-9	32	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47925	10.1371/journal.pone.0047925	http://dx.doi.org/10.1371/journal.pone.0047925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118909	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500047
J	Wang, L; Dai, WJ; Su, YA; Wang, G; Tan, YL; Jin, Z; Zeng, YW; Yu, X; Chen, W; Wang, XD; Si, TM				Wang, Li; Dai, Wenji; Su, Yunai; Wang, Gang; Tan, Yunlong; Jin, Zhen; Zeng, Yawei; Yu, Xin; Chen, Wei; Wang, Xiaodong; Si, Tianmei			Amplitude of Low-Frequency Oscillations in First-Episode, Treatment-Naive Patients with Major Depressive Disorder: A Resting-State Functional MRI Study	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DEFAULT MODE NETWORK; REGIONAL HOMOGENEITY; TREATMENT-RESISTANT; COGNITIVE MODEL; NEURAL ACTIVITY; BRAIN ACTIVITY; DRUG-NAIVE; CONNECTIVITY; CORTEX	Background: Resting-state fMRI is a novel approach to measure spontaneous brain activity in patients with major depressive disorder (MDD). Although most resting-state fMRI studies have focused on the examination of temporal correlations between low-frequency oscillations (LFOs), few studies have explored the amplitude of these LFOs in MDD. In this study, we applied the approaches of amplitude of low-frequency fluctuation (ALFF) and fractional ALFF to examine the amplitude of LFOs in MDD. Methodology/Principal Findings: A total of 36 subjects, 18 first-episode, treatment-naive patients with MDD matched with 18 healthy controls (HCs) completed the fMRI scans. Compared with HCs, MDD patients showed increased ALFF in the right fusiform gyrus and the right anterior and posterior lobes of the cerebellum but decreased ALFF in the left inferior temporal gyrus, bilateral inferior parietal lobule, and right lingual gyrus. The fALFF in patients was significantly increased in the right precentral gyrus, right inferior temporal gyrus, bilateral fusiform gyrus, and bilateral anterior and posterior lobes of the cerebellum but was decreased in the left dorsolateral prefrontal cortex, bilateral medial orbitofrontal cortex, bilateral middle temporal gyrus, left inferior temporal gyrus, and right inferior parietal lobule. After taking gray matter (GM) volume as a covariate, the results still remained. Conclusions/Significance: These findings indicate that MDD patients have altered LFO amplitude in a number of regions distributed over the frontal, temporal, parietal, and occipital cortices and the cerebellum. These aberrant regions may be related to the disturbances of multiple emotion-and cognition-related networks observed in MDD and the apparent heterogeneity in depressive symptom domains. Such brain functional alteration of MDD may contribute to further understanding of MDD-related network imbalances demonstrated in previous fMRI studies.	[Wang, Li; Dai, Wenji; Su, Yunai; Yu, Xin; Si, Tianmei] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Wang, Li; Dai, Wenji; Su, Yunai; Yu, Xin; Si, Tianmei] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Wang, Gang] Capital Med Univ, Beijing Anding Hosp, Mood Disorders Ctr, Beijing, Peoples R China; [Tan, Yunlong] Beijing Huilongguan Hosp, Ctr Psychiat Res, Beijing, Peoples R China; [Jin, Zhen; Zeng, Yawei] Peoples Liberat Army, Hosp 306, Dept Radiol, Beijing, Peoples R China; [Chen, Wei] Chinese Minist Hlth, Key Lab Med Neurobiol, Hangzhou, Zhejiang, Peoples R China; [Wang, Xiaodong] Max Planck Inst Psychiat, D-80804 Munich, Germany	Peking University; Capital Medical University; Max Planck Society	Si, TM (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	si.tian-mei@163.com	Wang, Xiao-Dong/A-9610-2010	Wang, Xiao-Dong/0000-0001-7730-3710; SU, YUNAI/0000-0001-8445-9633	Capital Foundation of Medicine Research and Development [2009-2026]	Capital Foundation of Medicine Research and Development	This work was supported partly by grants from Capital Foundation of Medicine Research and Development (No. 2009-2026, http://www.bjhbkj.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alexopoulos GS, 2012, J AFFECT DISORDERS, V139, P56, DOI 10.1016/j.jad.2011.12.002; American Psychiatric Association, 1994, DIAGN STAT MAN PSYCH; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Bellani M, 2011, PROG NEURO-PSYCHOPH, V35, P1544, DOI 10.1016/j.pnpbp.2010.11.040; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BIVER F, 1994, BIOL PSYCHIAT, V36, P381, DOI 10.1016/0006-3223(94)91213-0; Brody AL, 1999, PSYCHIAT RES-NEUROIM, V91, P127, DOI 10.1016/S0925-4927(99)00034-7; Canbeyli R, 2010, BEHAV BRAIN RES, V207, P249, DOI 10.1016/j.bbr.2009.11.002; Cao X, 2012, J AFFECT DI IN PRESS; Chantiluke K, 2012, BIOL PSYCHIAT, V71, P59, DOI 10.1016/j.biopsych.2011.09.005; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P59, DOI 10.1093/scan/nsn037; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Goulden N, 2012, BIOL PSYCHI IN PRESS; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Kim J, 2000, FOOD SCI, V97, P271; Klumpp H, 2010, INT J PSYCHOPHYSIOL, V75, P77, DOI 10.1016/j.ijpsycho.2009.10.003; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lai CH, 2012, J AFFECT DISORDERS, V136, P453, DOI 10.1016/j.jad.2011.11.004; Little JT, 2005, BIOL PSYCHIAT, V57, P220, DOI 10.1016/j.biopsych.2004.10.033; Liu F, 2012, PROG NEUROP IN PRESS; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Ma N, 2007, AM J PSYCHIAT, V164, P823, DOI 10.1176/appi.ajp.164.5.823; MAIER W, 1988, J AFFECT DISORDERS, V14, P61, DOI 10.1016/0165-0327(88)90072-9; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Mayberg HS, 2003, NEUROIMAG CLIN N AM, V13, P805, DOI 10.1016/S1052-5149(03)00104-7; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Schaefer HS, 2006, BIOL PSYCHIAT, V60, P974, DOI 10.1016/j.biopsych.2006.03.024; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Steele JD, 2007, J AFFECT DISORDERS, V101, P1, DOI 10.1016/j.jad.2006.11.009; Suslow T, 2010, BIOL PSYCHIAT, V67, P155, DOI 10.1016/j.biopsych.2009.07.023; Tao H, 2011, MOL PSYCHIA IN PRESS; Thomas Emma J, 2009, Front Hum Neurosci, V3, P30, DOI 10.3389/neuro.09.030.2009; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yan CG, 2010, FRONTIERS SYSTEMS NE, V14, P13, DOI [10.3389/fnsys.2010.00013, DOI 10.3389/FNSYS.2010.00013]; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	63	47	60	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48658	10.1371/journal.pone.0048658	http://dx.doi.org/10.1371/journal.pone.0048658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119084	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500192
J	Bueno, LS; Lopes-Aguiar, C; Ruggiero, RN; Romcy-Pereira, RN; Leite, JP				Bueno-Junior, Lezio Soares; Lopes-Aguiar, Cleiton; Ruggiero, Rafael Naime; Romcy-Pereira, Rodrigo Neves; Leite, Joao Pereira			Muscarinic and Nicotinic Modulation of Thalamo-Prefrontal Cortex Synaptic Pasticity In Vivo	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; MEDIODORSAL THALAMIC NUCLEUS; CHOLINERGIC MODULATION; MIDLINE THALAMUS; GABAERGIC INHIBITION; GLUTAMATE RELEASE; BASAL FOREBRAIN; RAT; ACETYLCHOLINE	The mediodorsal nucleus of the thalamus (MD) is a rich source of afferents to the medial prefrontal cortex (mPFC). Dysfunctions in the thalamo-prefrontal connections can impair networks implicated in working memory, some of which are affected in Alzheimer disease and schizophrenia. Considering the importance of the cholinergic system to cortical functioning, our study aimed to investigate the effects of global cholinergic activation of the brain on MD-mPFC synaptic plasticity by measuring the dynamics of long-term potentiation (LTP) and depression (LTD) in vivo. Therefore, rats received intraventricular injections either of the muscarinic agonist pilocarpine (PILO; 40 nmol/mu L), the nicotinic agonist nicotine (NIC; 320 nmol/mu L), or vehicle. The injections were administered prior to either thalamic high-frequency (HFS) or low-frequency stimulation (LFS). Test pulses were applied to MD for 30 min during baseline and 240 min after HFS or LFS, while field postsynaptic potentials were recorded in the mPFC. The transient oscillatory effects of PILO and NIC were monitored through recording of thalamic and cortical local field potentials. Our results show that HFS did not affect mPFC responses in vehicle-injected rats, but induced a delayed-onset LTP with distinct effects when applied following PILO or NIC. Conversely, LFS induced a stable LTD in control subjects, but was unable to induce LTD when applied after PILO or NIC. Taken together, our findings show distinct modulatory effects of each cholinergic brain activation on MD-mPFC plasticity following HFS and LFS. The LTP-inducing action and long-lasting suppression of cortical LTD induced by PILO and NIC might implicate differential modulation of thalamo-prefrontal functions under low and high input drive.	[Bueno-Junior, Lezio Soares; Lopes-Aguiar, Cleiton; Ruggiero, Rafael Naime; Romcy-Pereira, Rodrigo Neves; Leite, Joao Pereira] Univ Sao Paulo, Dept Neurosci & Behav Sci, Ribeirao Preto Sch Med, Sao Paulo, Brazil; [Romcy-Pereira, Rodrigo Neves] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte	Romcy-Pereira, RN (corresponding author), Univ Sao Paulo, Dept Neurosci & Behav Sci, Ribeirao Preto Sch Med, Sao Paulo, Brazil.	rnrpereira@neuro.ufrn.br	Lopes Aguiar, Cleiton/B-3776-2018; Bueno-Junior, Lezio/D-5571-2012; Aguiar, Cleiton L/E-7716-2017; Ruggiero, Rafael N/V-8283-2017; Ruggiero, Rafael/AAK-4996-2021; Leite, Joao/B-9070-2012	Lopes Aguiar, Cleiton/0000-0001-9310-6338; Bueno-Junior, Lezio/0000-0002-8530-8105; Aguiar, Cleiton L/0000-0001-9310-6338; Ruggiero, Rafael N/0000-0002-4712-6853; Ruggiero, Rafael/0000-0002-4712-6853; Leite, Joao/0000-0003-0558-3519; Romcy-Pereira, Rodrigo/0000-0003-1042-9196	FAPESP [2008/57413-7]; FAPESP-CInAPCe [2005/56447-7]; CNPq [502726/2009-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP-CInAPCe(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from FAPESP (#2008/57413-7), FAPESP-CInAPCe (#2005/56447-7) and CNPq (#502726/2009-1). Respectively, these are the funder's websites: http://www.fapesp.br/en/, http://www.fcm.unicamp.br/cinapce/, http://www.cnpq.br/english/cnpq/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar CL, 2008, NEUROSCIENCE, V153, P1309, DOI 10.1016/j.neuroscience.2008.02.040; Antoniadis EA, 2006, NEUROBIOL LEARN MEM, V85, P71, DOI 10.1016/j.nlm.2005.08.011; Bailey KR, 2005, BEHAV NEUROSCI, V119, P410, DOI 10.1037/0735-7044.119.2.410; Balatoni B, 2003, BRAIN RES, V959, P304, DOI 10.1016/S0006-8993(02)03768-X; Bertram EH, 2008, EPILEPSIA, V49, P256, DOI 10.1111/j.1528-1167.2007.01408.x; Broicher T, 2008, PFLUG ARCH EUR J PHY, V456, P1049, DOI 10.1007/s00424-008-0473-x; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Buzsaki G, 1989, EXS, V57, P159; Carr DB, 2007, J NEUROPHYSIOL, V97, P3432, DOI 10.1152/jn.00828.2006; Castro-Alamancos MA, 2002, J NEUROSCI, V22, P9651; CAVALHEIRO EA, 1995, ITAL J NEUROL SCI, V16, P33, DOI 10.1007/BF02229072; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Clarke PBS, 2004, PROG BRAIN RES, V145, P253, DOI 10.1016/S0079-6123(03)45017-6; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Del Arco A, 2009, J NEURAL TRANSM, V116, P941, DOI 10.1007/s00702-009-0243-8; Detari L, 1997, EUR J NEUROSCI, V9, P1153, DOI 10.1111/j.1460-9568.1997.tb01469.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dringenberg HC, 2007, CEREB CORTEX, V17, P839, DOI 10.1093/cercor/bhk038; Dringenberg HC, 2004, EUR J NEUROSCI, V20, P557, DOI 10.1111/j.1460-9568.2004.03515.x; Dringenberg HC, 2003, NEUROSCIENCE, V119, P839, DOI 10.1016/S0306-4522(03)00197-0; Eckert U, 2012, HUM BRAIN MAPP, V33, P2627, DOI 10.1002/hbm.21389; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; FERRON A, 1984, BRAIN RES, V302, P257, DOI 10.1016/0006-8993(84)90238-5; Floresco SB, 2003, J NEUROSCI, V23, P3930; Friedman A, 2007, EPILEPSIA, V48, P126, DOI 10.1111/j.1528-1167.2007.01300.x; GIGG J, 1994, HIPPOCAMPUS, V4, P189, DOI 10.1002/hipo.450040209; Gioanni Y, 1999, EUR J NEUROSCI, V11, P18, DOI 10.1046/j.1460-9568.1999.00403.x; Giocomo LM, 2007, MOL NEUROBIOL, V36, P184, DOI 10.1007/s12035-007-0032-z; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Groenewegen HJ, 1997, J PSYCHOPHARMACOL, V11, P99, DOI 10.1177/026988119701100202; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; Herholz K, 2008, NEUROPSYCHOLOGIA, V46, P1642, DOI 10.1016/j.neuropsychologia.2007.11.024; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 1999, J NEUROPHYSIOL, V82, P2827, DOI 10.1152/jn.1999.82.5.2827; Hirata A, 2010, J NEUROPHYSIOL, V103, P1147, DOI 10.1152/jn.00955.2009; Hogsden JL, 2009, BRAIN RES, V1283, P25, DOI 10.1016/j.brainres.2009.06.001; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Horner RL, 1999, NEUROSCIENCE, V93, P215, DOI 10.1016/S0306-4522(99)00126-8; HOSS W, 1990, BRAIN RES, V533, P232, DOI 10.1016/0006-8993(90)91344-G; Hsieh CY, 2000, BRAIN RES, V880, P51, DOI 10.1016/S0006-8993(00)02766-9; Izquierdo A, 2010, J NEUROSCI, V30, P661, DOI 10.1523/JNEUROSCI.3795-09.2010; Kawai H, 2007, NAT NEUROSCI, V10, P1168, DOI 10.1038/nn1956; Kito S, 2009, EUR PSYCHIAT, V24, P269, DOI 10.1016/j.eurpsy.2008.12.012; Klein JC, 2010, NEUROIMAGE, V51, P555, DOI 10.1016/j.neuroimage.2010.02.062; Kuo MC, 2009, NEUROSCIENCE, V163, P430, DOI 10.1016/j.neuroscience.2009.06.026; Kuroda M, 1998, PROG NEUROBIOL, V54, P417, DOI 10.1016/S0301-0082(97)00070-1; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Lopes-Aguiar C, 2013, NEUROPHARMACOLOGY, V65, P143, DOI 10.1016/j.neuropharm.2012.09.013; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Mansvelder HD, 2009, SEMIN CELL DEV BIOL, V20, P432, DOI 10.1016/j.semcdb.2009.01.007; MANTZ J, 1988, NEUROSCIENCE, V27, P517, DOI 10.1016/0306-4522(88)90285-0; MANTZ J, 1990, BRAIN RES, V524, P22, DOI 10.1016/0006-8993(90)90487-V; MCCORMICK DA, 1989, TRENDS NEUROSCI, V12, P215, DOI 10.1016/0166-2236(89)90125-2; MCCORMICK DA, 1986, J PHYSIOL-LONDON, V375, P169, DOI 10.1113/jphysiol.1986.sp016112; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Mckay BE, 2007, BIOCHEM PHARMACOL, V74, P1120, DOI 10.1016/j.bcp.2007.07.001; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; Metherate R, 2011, NEUROSCI BIOBEHAV R, V35, P2058, DOI 10.1016/j.neubiorev.2010.11.010; Metzger CD, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00138; Mitelman SA, 2006, NEUROSCI LETT, V392, P16, DOI 10.1016/j.neulet.2005.08.056; Negyessy L, 2005, EXP BRAIN RES, V164, P148, DOI 10.1007/s00221-005-2237-6; Otani S, 2003, J PHYSIOL-PARIS, V97, P423, DOI 10.1016/j.jphysparis.2004.01.002; Padilla-Coreano N, 2012, NEUROPHARMACOLOGY, V62, P457, DOI 10.1016/j.neuropharm.2011.08.037; Pakkenberg B, 2009, ACTA PSYCHIAT SCAND, V120, P345, DOI 10.1111/j.1600-0447.2009.01447.x; Parent M, 2008, J COMP NEUROL, V511, P678, DOI 10.1002/cne.21868; Parikh V, 2008, ANN NY ACAD SCI, V1129, P225, DOI 10.1196/annals.1417.021; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PIROT S, 1994, EUR J NEUROSCI, V6, P1225, DOI 10.1111/j.1460-9568.1994.tb00621.x; PIROT S, 1995, EUR J PHARMACOL, V285, P45, DOI 10.1016/0014-2999(95)00377-W; Puig MV, 2003, CEREB CORTEX, V13, P870, DOI 10.1093/cercor/13.8.870; Raedler TJ, 2007, MOL PSYCHIATR, V12, P232, DOI 10.1038/sj.mp.4001924; Raggenbass M, 2002, J NEUROBIOL, V53, P580, DOI 10.1002/neu.10152; Rasmusson DD, 2000, BEHAV BRAIN RES, V115, P205, DOI 10.1016/S0166-4328(00)00259-X; Ribeiro S, 2004, LEARN MEMORY, V11, P686, DOI 10.1101/lm.75604; Robbins TW, 2007, CEREB CORTEX, V17, pI151, DOI 10.1093/cercor/bhm066; Romcy-Pereira R, 2004, EUR J NEUROSCI, V20, P3453, DOI 10.1111/j.1460-9568.2004.03808.x; Romcy-Pereira RN, 2009, PHYSIOL BEHAV, V98, P44, DOI 10.1016/j.physbeh.2009.04.010; Scarr E, 2009, EXPERT REV NEUROTHER, V9, P73, DOI 10.1586/14737175.9.1.73; Sloan DM, 2011, NEUROBIOL DIS, V43, P435, DOI 10.1016/j.nbd.2011.04.017; Sloan DM, 2011, EPILEPSIA, V52, P523, DOI 10.1111/j.1528-1167.2010.02919.x; Sloan DM, 2009, EPILEPSIA, V50, P556, DOI 10.1111/j.1528-1167.2008.01790.x; Stenberg D, 2007, CELL MOL LIFE SCI, V64, P1187, DOI 10.1007/s00018-007-6530-3; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Toth A, 2012, BRAIN RES BULL, V87, P117, DOI 10.1016/j.brainresbull.2011.10.005; Usrey WM, 2002, CURR OPIN NEUROBIOL, V12, P411, DOI 10.1016/S0959-4388(02)00339-2; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Volk DW, 2010, CURR TOP BEHAV NEURO, V4, P485, DOI 10.1007/7854_2010_44; Watanabe Y, 2012, NEUROSCI BIOBEHAV R, V36, P134, DOI 10.1016/j.neubiorev.2011.05.003	96	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47484	10.1371/journal.pone.0047484	http://dx.doi.org/10.1371/journal.pone.0047484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118873	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600012
J	Mueller, AK; Behrends, J; Hagens, K; Mahlo, J; Schaible, UE; Schneider, BE				Mueller, Ann-Kristin; Behrends, Jochen; Hagens, Kristine; Mahlo, Jacqueline; Schaible, Ulrich E.; Schneider, Bianca E.			Natural Transmission of Plasmodium berghei Exacerbates Chronic Tuberculosis in an Experimental Co-Infection Model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RESPIRATORY-DISTRESS-SYNDROME; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; TNF-ALPHA; PULMONARY TUBERCULOSIS; PROTECTIVE IMMUNITY; CEREBRAL MALARIA; RODENT MALARIA; C57BL/6 MICE	Human populations are rarely exposed to one pathogen alone. Particularly in high incidence regions such as sub-Saharan Africa, concurrent infections with more than one pathogen represent a widely underappreciated public health problem. Two of the world's most notorious killers, malaria and tuberculosis, are co-endemic in impoverished populations in the tropics. However, interactions between both infections in a co-infected individual have not been studied in detail. Both pathogens have a major impact on the lung as the prime target organ for aerogenic Mycobacterium tuberculosis and the site for one of the main complications in severe malaria, malaria-associated acute respiratory distress syndrome (MA-ARDS). In order to study the ramifications caused by both infections within the same host we established an experimental mouse model of co-infection between Mycobacterium tuberculosis and Plasmodium berghei NK65, a recently described model for MA-ARDS. Our study provides evidence that malaria-induced immune responses impair host resistance to Mycobacterium tuberculosis. Using the natural routes of infection, we observed that co-infection exacerbated chronic tuberculosis while rendering mice less refractory to Plasmodium. Co-infected animals presented with enhanced inflammatory immune responses as reflected by exacerbated leukocyte infiltrates, tissue pathology and hypercytokinemia accompanied by altered T-cell responses. Our results - demonstrating striking changes in the immune regulation by co-infection with Plasmodium and Mycobacterium - are highly relevant for the medical management of both infections in humans.	[Behrends, Jochen; Hagens, Kristine; Mahlo, Jacqueline; Schaible, Ulrich E.; Schneider, Bianca E.] Res Ctr Borstel, Dept Mol Infect Biol, Borstel, Germany; [Mueller, Ann-Kristin] Univ Heidelberg Hosp, Dept Infect Dis, Parasitol Unit, Heidelberg, Germany	Forschungszentrum Borstel; Ruprecht Karls University Heidelberg	Schneider, BE (corresponding author), Res Ctr Borstel, Dept Mol Infect Biol, Borstel, Germany.	bschneider@fz-borstel.de			Research Center Borstel; MRC [G0700163] Funding Source: UKRI; Medical Research Council [G0700163] Funding Source: researchfish	Research Center Borstel; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by in-house funding from the Research Center Borstel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Arcila ML, 2007, CELL IMMUNOL, V249, P80, DOI 10.1016/j.cellimm.2007.11.006; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; BARNES PF, 1988, J INFECT DIS, V158, P366, DOI 10.1093/infdis/158.2.366; Barrios-Payan Jorge, 2006, Gac Med Mex, V142, P273; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Bingisser P, 1996, AM J RESP CELL MOL, V15, P64, DOI 10.1165/ajrcmb.15.1.8679223; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Colombatti R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-57; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Corleis B, 2012, CELL MICROBIOL; Couper KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000004; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Favre N, 1999, MICROBES INFECT, V1, P961, DOI 10.1016/S1286-4579(99)80513-9; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; FLESCH IEA, 1994, INT IMMUNOL, V6, P693, DOI 10.1093/intimm/6.5.693; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Fulton SA, 2002, INFECT IMMUN, V70, P5322, DOI 10.1128/IAI.70.9.5322-5327.2002; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Hawkes M, 2010, MICROBES INFECT, V12, P864, DOI 10.1016/j.micinf.2010.05.013; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Jamil B, 2007, TUBERCULOSIS, V87, P279, DOI 10.1016/j.tube.2007.03.004; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Langhorne J, 2004, IMMUNOL REV, V201, P35, DOI 10.1111/j.0105-2896.2004.00182.x; Lin PL, 2007, J INVEST DERM SYMP P, V12, P22, DOI 10.1038/sj.jidsymp.5650027; Lovegrove FE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000068; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; MURPHY JR, 1981, INFECT IMMUN, V33, P199, DOI 10.1128/IAI.33.1.199-211.1981; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray PJ, 1999, INFECT IMMUN, V67, P3087, DOI 10.1128/IAI.67.6.3087-3095.1999; Murray PJ, 1997, J IMMUNOL, V158, P315; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Osuchowski MF, 2006, J IMMUNOL, V177, P1967, DOI 10.4049/jimmunol.177.3.1967; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Page KR, 2005, INFECT IMMUN, V73, P8369, DOI 10.1128/IAI.73.12.8369-8380.2005; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Petrofsky M, 1999, CLIN IMMUNOL, V91, P354, DOI 10.1006/clim.1999.4709; Ray JCJ, 2009, J IMMUNOL, V182, P3706, DOI 10.4049/jimmunol.0802297; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rojas M, 1999, J IMMUNOL, V162, P6122; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schreiber T, 2009, J IMMUNOL, V183, P1301, DOI 10.4049/jimmunol.0803567; Scott CP, 2004, AM J TROP MED HYG, V70, P144, DOI 10.4269/ajtmh.2004.70.144; SMRKOVSKI LL, 1978, J IMMUNOL, V121, P1257; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Sugawara I, 2004, INFECT IMMUN, V72, P1804, DOI 10.1128/IAI.72.3.1804-1806.2004; Turner J, 2002, J IMMUNOL, V169, P6343, DOI 10.4049/jimmunol.169.11.6343; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; vanderPoll T, 1997, J INFECT DIS, V175, P118, DOI 10.1093/infdis/175.1.118; Vaughan JA, 1999, INFECT IMMUN, V67, P4285, DOI 10.1128/IAI.67.8.4285-4289.1999; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	73	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48110	10.1371/journal.pone.0048110	http://dx.doi.org/10.1371/journal.pone.0048110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110184	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500036
J	Armstrong, SM; Wang, CS; Tigdi, J; Si, XE; Dumpit, C; Charles, S; Gamage, A; Moraes, TJ; Lee, WL				Armstrong, Susan M.; Wang, Changsen; Tigdi, Jayesh; Si, Xiaoe; Dumpit, Carlo; Charles, Steffany; Gamage, Asela; Moraes, Theo J.; Lee, Warren L.			Influenza Infects Lung Microvascular Endothelium Leading to Microvascular Leak: Role of Apoptosis and Claudin-5	PLOS ONE			English	Article							TIGHT JUNCTION STRANDS; BLOOD-BRAIN-BARRIER; CELLS; VIRUS; INJURY; EXPRESSION; HOSPITALIZATION; PERMEABILITY; DYSFUNCTION; MECHANISMS	Severe influenza infections are complicated by acute lung injury, a syndrome of pulmonary microvascular leak. The pathogenesis of this complication is unclear. We hypothesized that human influenza could directly infect the lung microvascular endothelium, leading to loss of endothelial barrier function. We infected human lung microvascular endothelium with both clinical and laboratory strains of human influenza. Permeability of endothelial monolayers was assessed by spectrofluorimetry and by measurement of the transendothelial electrical resistance. We determined the molecular mechanisms of flu-induced endothelial permeability and developed a mouse model of severe influenza. We found that both clinical and laboratory strains of human influenza can infect and replicate in human pulmonary microvascular endothelium, leading to a marked increase in permeability. This was caused by apoptosis of the lung endothelium, since inhibition of caspases greatly attenuated influenza-induced endothelial leak. Remarkably, replication-deficient virus also caused a significant degree of endothelial permeability, despite displaying no cytotoxic effects to the endothelium. Instead, replication-deficient virus induced degradation of the tight junction protein claudin-5; the adherens junction protein VE-cadherin and the actin cytoskeleton were unaffected. Over-expression of claudin-5 was sufficient to prevent replication-deficient virus-induced permeability. The barrier-protective agent formoterol was able to markedly attenuate flu-induced leak in association with dose-dependent induction of claudin-5. Finally, mice infected with human influenza developed pulmonary edema that was abrogated by parenteral treatment with formoterol. Thus, we describe two distinct mechanisms by which human influenza can induce pulmonary microvascular leak. Our findings have implications for the pathogenesis and treatment of acute lung injury from severe influenza.	[Armstrong, Susan M.; Gamage, Asela; Moraes, Theo J.; Lee, Warren L.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Wang, Changsen; Tigdi, Jayesh; Dumpit, Carlo; Charles, Steffany; Lee, Warren L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Si, Xiaoe; Moraes, Theo J.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Lee, Warren L.] Univ Toronto, Fac Med, Div Respirol, Toronto, ON, Canada; [Lee, Warren L.] Univ Toronto, Fac Med, Interdept Div Crit Care Med, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Lee, WL (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.	warren.lee@utoronto.ca	Moraes, Theo/CAJ-3254-2022	Moraes, Theo/0000-0001-9968-6601; Lee, Warren/0000-0002-1788-6587	Canadian Institutes of Health Research; Ontario Thoracic Society; Physician Services Incorporated Foundation; Government of Ontario; CIHR; McLaughlin Centre	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Thoracic Society; Physician Services Incorporated Foundation; Government of Ontario; CIHR(Canadian Institutes of Health Research (CIHR)); McLaughlin Centre	WLL is supported by the Canadian Institutes of Health Research, the Ontario Thoracic Society, the Physician Services Incorporated Foundation and an Early Researcher Award from the Government of Ontario. SMA is supported by a MD/PhD Studentship award from the CIHR and an MD/PhD Studentship award from the McLaughlin Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1999, J IMMUNOL, V163, P2867; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Armstrong SM, 2012, AM J PATHOL, V180, P1308, DOI 10.1016/j.ajpath.2011.12.002; Beese M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-68; COLDENSTANFIELD M, 1993, J IMMUNOL, V151, P310; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; CRAWFORD DH, 1983, J GEN VIROL, V64, P697, DOI 10.1099/0022-1317-64-3-697; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Feldmann A, 2000, J VIROL, V74, P8018, DOI 10.1128/JVI.74.17.8018-8027.2000; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gillrie MR, 2007, BLOOD, V110, P3426, DOI 10.1182/blood-2007-04-084582; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Goto H, 2010, AM J RESP CRIT CARE, V181, P1336, DOI 10.1164/rccm.200907-1002OC; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kawasaki M, 2000, AM J PATHOL, V157, P597, DOI 10.1016/S0002-9440(10)64570-1; Klenk HD, 2005, THROMB HAEMOSTASIS, V94, P262, DOI 10.1160/TH05-04-0264; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuster SP, 2010, EUR J CLIN MICROBIOL, V29, P835, DOI 10.1007/s10096-010-0935-x; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Mandel I, 2012, J CELL BIOCHEM, V113, P2415, DOI 10.1002/jcb.24118; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183; Sayner SL, 2011, AM J PHYSIOL-LUNG C, V300, pL667, DOI 10.1152/ajplung.00433.2010; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith FG, 2012, LANCET, V379, P229, DOI 10.1016/S0140-6736(11)61623-1; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Visseren FLJ, 1999, J LAB CLIN MED, V134, P623, DOI 10.1016/S0022-2143(99)90103-8; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; WojtowiczPraga SM, 1997, INVEST NEW DRUG, V15, P61, DOI 10.1023/A:1005722729132; Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com; Yuan L, 2012, J BIOL CHEM	49	81	86	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47323	10.1371/journal.pone.0047323	http://dx.doi.org/10.1371/journal.pone.0047323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115643	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200034
J	Aydemir, TB; Chang, SM; Guthrie, GJ; Maki, AB; Ryu, MS; Karabiyik, A; Cousins, RJ				Aydemir, Tolunay Beker; Chang, Shou-Mei; Guthrie, Gregory J.; Maki, Alyssa B.; Ryu, Moon-Suhn; Karabiyik, Afife; Cousins, Robert J.			Zinc Transporter ZIP14 Functions in Hepatic Zinc, Iron and Glucose Homeostasis during the Innate Immune Response (Endotoxemia)	PLOS ONE			English	Article							TRANSFERRIN-BOUND IRON; ACUTE-PHASE; ACRODERMATITIS-ENTEROPATHICA; LIVER-REGENERATION; PARENTERAL ZINC; NITRIC-OXIDE; METALLOTHIONEIN; METABOLISM; EXPRESSION; SLC39A14	ZIP14 (slc39A14) is a zinc transporter induced in response to pro-inflammatory stimuli. ZIP14 induction accompanies the reduction in serum zinc (hypozincemia) of acute inflammation. ZIP14 can transport Zn2+ and non-transferrin-bound Fe2+ in vitro. Using a Zip14(-/-) mouse model we demonstrated that ZIP14 was essential for control of phosphatase PTP1B activity and phosphorylation of c-Met during liver regeneration. In the current studies, a global screening of ZIP transporter gene expression in response to LPS- induced endotoxemia was conducted. Following LPS, Zip14 was the most highly upregulated Zip transcript in liver, but also in white adipose tissue and muscle. Using ZIP14(-/-) mice we show that ZIP14 contributes to zinc absorption from the gastrointestinal tract directly or indirectly as zinc absorption was decreased in the KOs. In contrast, Zip14(-/-) mice absorbed more iron. The Zip14 KO mice did not exhibit hypozincemia following LPS, but do have hypoferremia. Livers of Zip14-/- mice had increased transcript abundance for hepcidin, divalent metal transporter-1, ferritin and transferrin receptor-1 and greater accumulation of iron. The Zip14(-/-) phenotype included greater body fat, hypoglycemia and higher insulin levels, as well as increased liver glucose and greater phosphorylation of the insulin receptor and increased GLUT2, SREBP-1c and FASN expression. The Zip14 KO mice exhibited decreased circulating IL-6 with increased hepatic SOCS-3 following LPS, suggesting SOCS-3 inhibited insulin signaling which produced the hypoglycemia in this genotype. The results are consistent with ZIP14 ablation yielding abnormal labile zinc pools which lead to increased SOCS-3 production through G-coupled receptor activation and increased cAMP production as well as signaled by increased pSTAT3 via the IL-6 receptor, which inhibits IRS1/2 phosphorylation. Our data show the role of ZIP14 in the hepatocyte is multi-functional since zinc and iron trafficking are altered in the Zip14(-/-) mice and their phenotype shows defects in glucose homeostasis.	[Aydemir, Tolunay Beker; Chang, Shou-Mei; Guthrie, Gregory J.; Maki, Alyssa B.; Ryu, Moon-Suhn; Karabiyik, Afife; Cousins, Robert J.] Univ Florida, Dept Food Sci & Human Nutr, Coll Agr & Life Sci, Gainesville, FL 32611 USA; [Aydemir, Tolunay Beker; Chang, Shou-Mei; Guthrie, Gregory J.; Maki, Alyssa B.; Ryu, Moon-Suhn; Karabiyik, Afife; Cousins, Robert J.] Univ Florida, Coll Agr & Life Sci, Ctr Nutr Sci, Gainesville, FL 32611 USA; [Aydemir, Tolunay Beker; Cousins, Robert J.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cousins, RJ (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Coll Agr & Life Sci, Gainesville, FL 32611 USA.	cousins@ufl.edu	Guthrie, Gregory/ABI-4949-2022	Guthrie, Gregory/0000-0001-7644-9582; Ryu, Moon-Suhn/0000-0002-9533-9263	United States National Institutes of Health [DK31127, DK 94244]; CALS Alumni Fellowships; Boston Family Endowment Funds of the University of Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK031127, R37DK031127, R01DK094244, R01DK031127] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CALS Alumni Fellowships; Boston Family Endowment Funds of the University of Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research described in this report was funded by United States National Institutes of Health Grants DK31127 and DK 94244 (R.J.C.), CALS Alumni Fellowships (A.B.M. and M.-S.R.) and limited support from Boston Family Endowment Funds of the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Aydemir TB, 2012, GASTROENTEROLOGY, V142, P1536, DOI 10.1053/j.gastro.2012.02.046; Brand IA, 1996, J BIOL CHEM, V271, P1941, DOI 10.1074/jbc.271.4.1941; Braunschweig CL, 1997, J NUTR, V127, P70, DOI 10.1093/jn/127.1.70; CHESTERS JK, 1981, BRIT J NUTR, V46, P119, DOI 10.1079/BJN19810015; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Citiulo F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002777; Collins JF, PHYSL GASTROINTESTIN, P1921; Corbett D, 2012, INFECT IMMUN, V80, P14, DOI 10.1128/IAI.05904-11; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; COUSINS RJ, 1985, PHYSIOL REV, V65, P238, DOI 10.1152/physrev.1985.65.2.238; Cousins RJ, 2011, ZINC HUMAN HLTH; COWEN LA, 1986, BIOCHEM BIOPH RES CO, V134, P944, DOI 10.1016/S0006-291X(86)80511-3; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Davis SR, 1998, J NUTR, V128, P825, DOI 10.1093/jn/128.5.825; DISILVESTRO RA, 1984, AM J PHYSIOL, V247, pE436, DOI 10.1152/ajpendo.1984.247.4.E436; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; ETZEL KR, 1983, J NUTR, V113, P1657, DOI 10.1093/jn/113.8.1657; ETZEL KR, 1981, P SOC EXP BIOL MED, V167, P233; Fausto N, 2005, J HEPATO-BILIARY-PAN, V12, P181, DOI 10.1007/s00534-005-0979-y; Fernandez-Real JM, 2002, DIABETES, V51, P2348, DOI 10.2337/diabetes.51.8.2348; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Gielda LM, 2012, MBIO, V3, DOI 10.1128/mBio.00171-12; Gifford CA, 2012, J ANIM SCI, V90, P1438, DOI 10.2527/jas.2011-4846; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Haase H, 2011, ZINC HUMAN HLTH; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Harrison-Findik DD, 2010, WORLD J HEPATOL, V2, P302, DOI 10.4254/wjh.v2.i8.302; Hogstrand C, 2009, TRMOME, V535, P1; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Im SS, 2011, CELL METAB, V13, P540, DOI 10.1016/j.cmet.2011.04.001; Jansen J, 2009, J NUTR BIOCHEM, V20, P399, DOI 10.1016/j.jnutbio.2009.01.009; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; King J., 2006, MODERN NUTR HLTH DIS, P271; Krones CJ, 2004, J INVEST SURG, V17, P249, DOI 10.1080/08941930490502817; Lichten LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021526; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lichten LA, 2009, AM J PHYSIOL-GASTR L, V296, pG860, DOI 10.1152/ajpgi.90676.2008; LINDER MC, 1973, BIOCHIM BIOPHYS ACTA, V297, P70, DOI 10.1016/0304-4165(73)90050-0; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; Niles BJ, 2008, J BIOL CHEM, V283, P5168, DOI 10.1074/jbc.M709043200; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; PEDROSA FO, 1977, P NATL ACAD SCI USA, V74, P2742, DOI 10.1073/pnas.74.7.2742; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; QUARTERMAN J, 1966, BIOCHEM BIOPH RES CO, V25, P354, DOI 10.1016/0006-291X(66)90785-6; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Rofe AM, 1996, BIOCHEM J, V314, P793, DOI 10.1042/bj3140793; Rofe AM, 2000, BIOL TRACE ELEM RES, V75, P87, DOI 10.1385/BTER:75:1-3:87; Ryu MS, 2008, J NUTR, V138, P2076, DOI 10.3945/jn.108.093575; Slucca M, 2010, DIABETES, V59, P128, DOI 10.2337/db09-1098; Smidt K, 2007, MOL CELL ENDOCRINOL, V264, P68, DOI 10.1016/j.mce.2006.10.010; THYRESSON N, 1974, ACTA DERM-VENEREOL, V54, P383; Tominaga K, 2005, FEBS J, V272, P1590, DOI 10.1111/j.1742-4658.2005.04580.x; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; WEINBERG ED, 1984, PHYSIOL REV, V64, P65, DOI 10.1152/physrev.1984.64.1.65; Wood RJ, 2006, MODERN NUTR HLTH DIS, P248; Yeagley D, 2010, INT J INTERFERON CYT, V2010, P9, DOI [10.2147/ IJICMR.S6690, DOI 10.2147/IJICMR.S6690]; Zangger K, 2001, FASEB J, V15, P1303, DOI 10.1096/fj.00-0641fje; Zhang JJ, 2009, BRIT J PHARMACOL, V158, P475, DOI 10.1111/j.1476-5381.2009.00246.x; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	71	112	116	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48679	10.1371/journal.pone.0048679	http://dx.doi.org/10.1371/journal.pone.0048679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110240	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200169
J	Bacon, SJ; Bacher, S; Aebi, A				Bacon, Steven James; Bacher, Sven; Aebi, Alexandre			Gaps in Border Controls Are Related to Quarantine Alien Insect Invasions in Europe	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; PATHWAYS; TRADE; RISK; INTERCEPTIONS; DISPERSAL; TRANSPORT; ENTRY; PLANT	Alien insects are increasingly being dispersed around the world through international trade, causing a multitude of negative environmental impacts and billions of dollars in economic losses annually. Border controls form the last line of defense against invasions, whereby inspectors aim to intercept and stop consignments that are contaminated with harmful alien insects. In Europe, member states depend on one another to prevent insect introductions by operating a first point of entry rule - controlling goods only when they initially enter the continent. However, ensuring consistency between border control points is difficult because there exists no optimal inspection strategy. For the first time, we developed a method to quantify the volume of agricultural trade that should be inspected for quarantine insects at border control points in Europe, based on global agricultural trade of over 100 million distinct origin-commodity-species-destination pathways. This metric was then used to evaluate the performance of existing border controls, as measured by border interception results in Europe between 2003 and 2007. Alarmingly, we found significant gaps between the trade pathways that should be inspected and actual number of interceptions. Moreover, many of the most likely introduction pathways yielded none or very few insect interceptions, because regular interceptions are only made on only a narrow range of pathways. European countries with gaps in border controls have been invaded by higher numbers of quarantine alien insect species, indicating the importance of proper inspections to prevent insect invasions. Equipped with an optimal inspection strategy based on the underlying risks of trade, authorities globally will be able to implement more effective and consistent border controls.	[Bacon, Steven James; Aebi, Alexandre] ART, Biodivers & Environm Management, Zurich, Switzerland; [Bacher, Sven] Univ Fribourg, CH-1700 Fribourg, Switzerland	University of Fribourg	Bacon, SJ (corresponding author), ART, Biodivers & Environm Management, Zurich, Switzerland.	sj_bacon@hotmail.com	Aebi, Alexandre/B-7482-2013; Bacher, Sven/F-5431-2010	Bacher, Sven/0000-0001-5147-7165	Swiss Federal Office for the Environment	Swiss Federal Office for the Environment	This work was supported by the Swiss Federal Office for the Environment to AA and SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AUSTR QUAR SHAR RESP; [Anonymous], REQ DIAGN REP ORG IN; Baker R. H. A., 2009, Bulletin OEPP, V39, P87, DOI 10.1111/j.1365-2338.2009.02246.x; Bogich TL, 2008, J APPL ECOL, V45, P1134, DOI 10.1111/j.1365-2664.2008.01494.x; Campbell FT, 2001, BIOSCIENCE, V51, P148, DOI 10.1641/0006-3568(2001)051[0148:TSORAF]2.0.CO;2; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Dobbs TT, 2004, FLA ENTOMOL, V87, P65, DOI 10.1653/0015-4040(2004)087[0065:CAAAPF]2.0.CO;2; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Drake JA, 1989, BIOL INVASIONS GLOBA; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Everett RA, 2000, TRENDS ECOL EVOL, V15, P177, DOI 10.1016/S0169-5347(00)01835-8; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Liebhold Andrew M., 2006, American Entomologist, V52, P48; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; National Research Council of the United States, 2002, PRED INV NON PLANTS; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Roques A., 2006, Bulletin OEPP, V36, P490; Roques A, 2010, ALIEN TERRESTRIAL AR; Roques Alain, 2010, New Zealand Journal of Forestry Science, V40, pS77; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Skarpaas O, 2009, J APPL ECOL, V46, P55, DOI 10.1111/j.1365-2664.2008.01561.x; Tatem AJ, 2009, ECOGRAPHY, V32, P94, DOI 10.1111/j.1600-0587.2008.05588.x; van Kooten O, 2007, AGR EC, V38, P363; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; Yemshanov D, 2012, BIOL INVASIONS, V14, P797, DOI 10.1007/s10530-011-0117-5; Zuur Alain F., 2009, P1	40	83	87	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47689	10.1371/journal.pone.0047689	http://dx.doi.org/10.1371/journal.pone.0047689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112835	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200068
J	Chow, J; Kovacic, F; Antonia, YD; Krauss, U; Fersini, F; Schmeisser, C; Lauinger, B; Bongen, P; Pietruszka, J; Schmidt, M; Menyes, I; Bornscheuer, UT; Eckstein, M; Thum, O; Liese, A; Mueller-Dieckmann, J; Jaeger, KE; Streit, WR				Chow, Jennifer; Kovacic, Filip; Antonia, Yuliya Dall; Krauss, Ulrich; Fersini, Francesco; Schmeisser, Christel; Lauinger, Benjamin; Bongen, Patrick; Pietruszka, Joerg; Schmidt, Marlen; Menyes, Ina; Bornscheuer, Uwe T.; Eckstein, Marrit; Thum, Oliver; Liese, Andreas; Mueller-Dieckmann, Jochen; Jaeger, Karl-Erich; Streit, Wolfgang R.			The Metagenome-Derived Enzymes LipS and LipT Increase the Diversity of Known Lipases	PLOS ONE			English	Article							ALPHA/BETA-HYDROLASE FOLD; THERMUS-SCOTODUCTUS SA-01; HORMONE-SENSITIVE LIPASE; PIG-LIVER ESTERASE; CRYSTAL-STRUCTURE; CANDIDA-ANTARCTICA; SYMBIOBACTERIUM-THERMOPHILUM; THERMOSTABLE ENZYMES; KINETIC RESOLUTIONS; PHYLOGENETIC TREES	Triacylglycerol lipases (EC 3.1.1.3) catalyze both hydrolysis and synthesis reactions with a broad spectrum of substrates rendering them especially suitable for many biotechnological applications. Most lipases used today originate from mesophilic organisms and are susceptible to thermal denaturation whereas only few possess high thermotolerance. Here, we report on the identification and characterization of two novel thermostable bacterial lipases identified by functional metagenomic screenings. Metagenomic libraries were constructed from enrichment cultures maintained at 65 to 75 degrees C and screened resulting in the identification of initially 10 clones with lipolytic activities. Subsequently, two ORFs were identified encoding lipases, LipS and LipT. Comparative sequence analyses suggested that both enzymes are members of novel lipase families. LipS is a 30.2 kDa protein and revealed a half-life of 48 h at 70 degrees C. The lipT gene encoded for a multimeric enzyme with a half-life of 3 h at 70 degrees C. LipS had an optimum temperature at 70 degrees C and LipT at 75 degrees C. Both enzymes catalyzed hydrolysis of long-chain (C-12 and C-14) fatty acid esters and additionally hydrolyzed a number of industry-relevant substrates. LipS was highly specific for (R)-ibuprofen-phenyl ester with an enantiomeric excess (ee) of 99%. Furthermore, LipS was able to synthesize 1-propyl laurate and 1-tetradecyl myristate at 70 degrees C with rates similar to those of the lipase CalB from Candida antarctica. LipS represents the first example of a thermostable metagenome-derived lipase with significant synthesis activities. Its X-ray structure was solved with a resolution of 1.99 angstrom revealing an unusually compact lid structure.	[Chow, Jennifer; Schmeisser, Christel; Streit, Wolfgang R.] Univ Hamburg, Dept Microbiol & Biotechnol, Bioctr Klein Flottbek, Hamburg, Germany; [Kovacic, Filip; Krauss, Ulrich; Jaeger, Karl-Erich] Univ Dusseldorf, Res Ctr Juelich, Inst Mol Enzyme Technol, Julich, Germany; [Antonia, Yuliya Dall; Fersini, Francesco; Mueller-Dieckmann, Jochen] Deutsch Elektronen Synchrotron DESY, EMBL Hamburg Outstn, Hamburg, Germany; [Lauinger, Benjamin; Bongen, Patrick; Pietruszka, Joerg] Univ Dusseldorf, Res Ctr Juelich, Inst Bioorgan Chem, Julich, Germany; [Eckstein, Marrit; Thum, Oliver] Evonik Ind AG, Bioproc Dev Consumer Specialties & Biocatalysis B, Essen, Germany; [Schmidt, Marlen; Menyes, Ina; Bornscheuer, Uwe T.] Ernst Moritz Arndt Univ Greifswald, Dept Biotechnol & Enzyme Catalysis, Inst Biochem, Greifswald, Germany; [Liese, Andreas] Hamburg Univ Technol, Inst Tech Biocatalysis, Hamburg, Germany	University of Hamburg; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Evonik Industries; Ernst Moritz Arndt Universitat Greifswald; Hamburg University of Technology	Streit, WR (corresponding author), Univ Hamburg, Dept Microbiol & Biotechnol, Bioctr Klein Flottbek, Hamburg, Germany.	wolfgang.streit@uni-hamburg.de	Filip, Kovacic/GRJ-3538-2022; Bornscheuer, Uwe T/C-4612-2012; Streit, Wolfgang/S-3049-2019; Streit, Wolfgang R/K-1366-2012; Kovacic, Filip/ABG-7585-2020; Pietruszka, Jörg/G-5731-2013; Thum, Oliver/F-2201-2010; jaeger, karl/ABB-1955-2020; Liese, Andreas/H-5669-2018	Filip, Kovacic/0000-0002-0313-427X; Bornscheuer, Uwe T/0000-0003-0685-2696; Streit, Wolfgang/0000-0001-7617-7396; Pietruszka, Jörg/0000-0002-9819-889X; Thum, Oliver/0000-0002-2568-1450; Krauss, Ulrich/0000-0003-2219-7388; Chow, Jennifer/0000-0002-7499-5325; Liese, Andreas/0000-0002-4867-9935	German Federal Ministry of Education and Research (BMBF); European Community's Seventh Framework Programme (FP7) [227764]; "Deutsche Forschungsgemeinschaft'' (DFG) in frame of the research training group "Biocatalysis in non-conventional media:'' (BioNoCo) [GK1166]; "ExpresSys:'' in the framework of the funding measure GenoMik	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Community's Seventh Framework Programme (FP7); "Deutsche Forschungsgemeinschaft'' (DFG) in frame of the research training group "Biocatalysis in non-conventional media:'' (BioNoCo); "ExpresSys:'' in the framework of the funding measure GenoMik	This work was kindly funded by the German Federal Ministry of Education and Research (BMBF) cluster Biokatalyse2021 (http://www.biokatalyse2021.de). The research leading to the crystallization results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 227764 (P-CUBE; www.p-cube.eu/). K.-E. Jaeger and U. Krauss acknowledge support by the "Deutsche Forschungsgemeinschaft'' (DFG) in frame of the research training group GK1166 "Biocatalysis in non-conventional media:'' (BioNoCo; www.bionoco.rwth-aachen.de). J. Pietruszka thanks the BMBF for funding the project "ExpresSys:'' in the framework of the funding measure GenoMik (http://genomik-transfer.de/en/index_en.php?section = home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Balkwill DL, 2004, EXTREMOPHILES, V8, P37, DOI 10.1007/s00792-003-0357-0; Belhaj-Ben Romdhane I, 2012, GENE, V494, P112, DOI 10.1016/j.gene.2011.11.059; Beloqui A, 2010, APPL ENVIRON MICROB, V76, P5934, DOI 10.1128/AEM.00902-10; Bennett MD, IN PRESS; Bordes F, 2011, J BIOTECHNOL, V156, P117, DOI 10.1016/j.jbiotec.2011.06.035; BROCK TD, 1969, J BACTERIOL, V98, P289, DOI 10.1128/JB.98.1.289-297.1969; BROCK TD, 1973, APPL MICROBIOL, V25, P72, DOI 10.1128/AEM.25.1.72-76.1973; Bruins ME, 2001, APPL BIOCHEM BIOTECH, V90, P155, DOI 10.1385/ABAB:90:2:155; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; CASTENHOLZ RW, 1969, BACTERIOL REV, V33, P476, DOI 10.1128/MMBR.33.4.476-504.1969; Cava F, 2009, EXTREMOPHILES, V13, P213, DOI 10.1007/s00792-009-0226-6; CHEN CS, 1982, J AM CHEM SOC, V104, P7294, DOI 10.1021/ja00389a064; Leow TC, 2007, EXTREMOPHILES, V11, P527, DOI 10.1007/s00792-007-0069-y; Chow J, 2011, HDB MOL MICROBIAL EC, P499; Dalhus B, 2002, J MOL BIOL, V318, P707, DOI 10.1016/S0022-2836(02)00050-5; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dominguez A, 2004, BIOTECHNOL LETT, V26, P705, DOI 10.1023/B:BILE.0000024092.27943.75; du Plessis EM, 2010, CURR MICROBIOL, V60, P248, DOI 10.1007/s00284-009-9533-5; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Ebrahimi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023146; El Gihani MT, 1999, CURR OPIN CHEM BIOL, V3, P11, DOI 10.1016/S1367-5931(99)80003-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Estrada Gutarra Melissa Limoeiro, 2009, Biotechnology Journal, V4, P1450, DOI 10.1002/biot.200800298; Fersini F, 2012, ACTA CRYSTALLOGR F, V68, P923, DOI 10.1107/S1744309112025651; Franken BJ, 2009, HDB MICROBIOLOGY HYD, P2860; Fu J, 2012, APPL MICROBIOL BIOTE; Fucinos P, 2005, BIOTECHNOL PROGR, V21, P1198, DOI 10.1021/bp050080g; Fucinos P, 2011, PROTEIN EXPRES PURIF, V78, P120, DOI 10.1016/j.pep.2011.04.002; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Gounder K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-577; Hamzic M, 2011, CHIRALITY, V23, pE110, DOI 10.1002/chir.21025; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Henne A, 2000, APPL ENVIRON MICROB, V66, P3113, DOI 10.1128/AEM.66.7.3113-3116.2000; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Hough DW, 1999, CURR OPIN CHEM BIOL, V3, P39, DOI 10.1016/S1367-5931(99)80008-8; HUTT AJ, 1984, CLIN PHARMACOKINET, V9, P371, DOI 10.2165/00003088-198409040-00007; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Joo JC, 2012, BIOTECHNOL BIOENG; Kakugawa S, 2007, APPL MICROBIOL BIOT, V74, P585, DOI 10.1007/s00253-006-0687-9; Kazlauskas RJ, 2006, ENZYME ASSAYS HIGH T, P16; Kieft TL, 1999, APPL ENVIRON MICROB, V65, P1214; Kim HK, 1998, BIOSCI BIOTECH BIOCH, V62, P66, DOI 10.1271/bbb.62.66; Kim S, 2007, ACTA CRYSTALLOGR F, V63, P579, DOI 10.1107/S1744309107026152; Kjeldsen KU, 2007, FEMS MICROBIOL ECOL, V61, P384, DOI 10.1111/j.1574-6941.2006.00255.x; Kjellerup BV, 2005, BIOFOULING, V21, P19, DOI 10.1080/08927010500070992; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KRISTJANSSON JK, 1994, SYST APPL MICROBIOL, V17, P44, DOI 10.1016/S0723-2020(11)80030-5; Kroutil W, 1997, TETRAHEDRON-ASYMMETR, V8, P3263, DOI 10.1016/S0957-4166(97)00429-1; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Lai KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023269; LAWRENCE RC, 1967, NATURE, V213, P1264, DOI 10.1038/2131264a0; Li HB, 2005, PROTEIN EXPRES PURIF, V42, P153, DOI 10.1016/j.pep.2005.03.011; Li WF, 2005, BIOTECHNOL ADV, V23, P271, DOI 10.1016/j.biotechadv.2005.01.002; Liese A., 2006, IND BIOTRANSFORMATIO; Liles MR, 2009, COLD SPRING HARBOR P; Liu P, 2004, J MOL BIOL, V342, P551, DOI 10.1016/j.jmb.2004.06.069; Lopez-Lopez O, 2010, J BIOTECHNOL, V145, P226, DOI 10.1016/j.jbiotec.2009.11.017; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meilleur C, 2009, J IND MICROBIOL BIOT, V36, P853, DOI 10.1007/s10295-009-0562-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musidlowska A, 2001, ANGEW CHEM INT EDIT, V40, P2851, DOI 10.1002/1521-3773(20010803)40:15<2851::AID-ANIE2851>3.0.CO;2-V; Musidlowska-Persson A, 2002, J MOL CATAL B-ENZYM, V19, P129, DOI 10.1016/S1381-1177(02)00159-5; Nam KH, 2009, BIOCHEM BIOPH RES CO, V389, P247, DOI 10.1016/j.bbrc.2009.08.123; Nam KH, 2009, PROTEINS, V74, P1036, DOI 10.1002/prot.22313; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishida H., 2011, INT J EVOL BIOL, V2011; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohno M, 2000, INT J SYST EVOL MICR, V50, P1829, DOI 10.1099/00207713-50-5-1829; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Perner M, 2011, HDB MOL MICROBIAL EC, P481; Pietruszka J, 2009, EUR J ORG CHEM, V2009, P6217, DOI 10.1002/ejoc.200901025; Reetz MT, 2010, J AM CHEM SOC, V132, P9144, DOI 10.1021/ja1030479; Reetz MT, 2000, CHIRALITY, V12, P479, DOI 10.1002/(SICI)1520-636X(2000)12:5/6<479::AID-CHIR32>3.0.CO;2-#; Reetz MT, 2002, CURR OPIN CHEM BIOL, V6, P145, DOI 10.1016/S1367-5931(02)00297-1; Reetz MT, 1997, ANGEW CHEM INT EDIT, V36, P2830, DOI 10.1002/anie.199728301; Reymond J.-L., 2006, ENZYME ASSAYS HIGH T, DOI 10.1002/3527607846; Royter M, 2009, EXTREMOPHILES, V13, P769, DOI 10.1007/s00792-009-0265-z; Sako Y, 1996, INT J SYST BACTERIOL, V46, P1099, DOI 10.1099/00207713-46-4-1099; Salameh MA, 2007, APPL ENVIRON MICROB, V73, P7725, DOI 10.1128/AEM.01509-07; SALVADORI P, 1991, CHIRALITY, V3, P376, DOI 10.1002/chir.530030424; Sambrook J, 2001, MOL CLONING LAB MANU; Sandstrom AG, 2012, P NATL ACAD SCI USA, V109, P78, DOI 10.1073/pnas.1111537108; Schalk-Hihi C, 2011, PROTEIN SCI, V20, P670, DOI 10.1002/pro.596; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P515, DOI 10.1016/S0167-7799(02)02073-5; Schmeisser C, 2007, APPL MICROBIOL BIOT, V75, P955, DOI 10.1007/s00253-007-0945-5; Schmidt O, 2010, APPL ENVIRON MICROB, V76, P2027, DOI 10.1128/AEM.02895-09; Siddiqui KS, 2005, EXTREMOPHILES, V9, P471, DOI 10.1007/s00792-005-0464-1; Skirnisdottir S, 2001, EXTREMOPHILES, V5, P45, DOI 10.1007/s007920000172; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Trooskens G, 2005, BIOINFORMATICS, V21, P3801, DOI 10.1093/bioinformatics/bti590; Tufvesson P, 2007, BIOTECHNOL BIOENG, V97, P447, DOI 10.1002/bit.21258; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Ueda K, 2004, NUCLEIC ACIDS RES, V32, P4937, DOI 10.1093/nar/gkh830; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vieille C, 1996, Biotechnol Annu Rev, V2, P1, DOI 10.1016/S1387-2656(08)70006-1; Voget S, 2003, APPL ENVIRON MICROB, V69, P6235, DOI 10.1128/AEM.69.10.6235-6242.2003; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	107	56	58	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47665	10.1371/journal.pone.0047665	http://dx.doi.org/10.1371/journal.pone.0047665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112831	Green Published, gold			2022-12-25	WOS:000310310200064
J	Nam, YJ; Tran, LSP; Kojima, M; Sakakibara, H; Nishiyama, R; Shin, R				Nam, Youn-Jeong; Lam-Son Phan Tran; Kojima, Mikiko; Sakakibara, Hitoshi; Nishiyama, Rie; Shin, Ryoung			Regulatory Roles of Cytokinins and Cytokinin Signaling in Response to Potassium Deficiency in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID RESPONSES; PHOSPHATE-STARVATION; GENES; GROWTH; AUXIN; BIOSYNTHESIS; METABOLISM; EXPRESSION; DEPRIVATION; PHOSPHORUS	Potassium (K) is an important plant macronutrient that has various functions throughout the whole plant over its entire life span. Cytokinins (CKs) are known to regulate macronutrient homeostasis by controlling the expression of nitrate, phosphate and sulfate transporters. Although several studies have described how CKs signal deficiencies for some macronutrients, the roles of CKs in K signaling are poorly understood. CK content has been shown to decrease under K-starved conditions. Specifically, a CK-deficient mutant was more tolerant to low K than wild-type; however, a plant with an overaccumulation of CKs was more sensitive to low K. These results suggest that K deprivation alters CK metabolism, leading to a decrease in CK content. To investigate this phenomenon further, several Arabidopsis lines, including a CK-deficient mutant and CK receptor mutants, were analyzed in low K conditions using molecular, genetic and biochemical approaches. ROS accumulation and root hair growth in low K were also influenced by CKs. CK receptor mutants lost the responsiveness to K-deficient signaling, including ROS accumulation and root hair growth, but the CK-deficient mutant accumulated more ROS and exhibited upregulated expression of HAK5, which is a high-affinity K uptake transporter gene that is rapidly induced by low K stress in ROS- and ethylene-dependent manner in response to low K. From these results, we conclude that a reduction in CK levels subsequently allows fast and effective stimulation of low K-induced ROS accumulation, root hair growth and HAK5 expression, leading to plant adaptation to low K conditions.	[Nam, Youn-Jeong; Lam-Son Phan Tran; Kojima, Mikiko; Sakakibara, Hitoshi; Nishiyama, Rie; Shin, Ryoung] RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan	RIKEN	Shin, R (corresponding author), RIKEN Plant Sci Ctr, Yokohama, Kanagawa, Japan.	rshin@psc.riken.jp	Kojima, Mikiko/D-1459-2017; Tran, Lam-Son P/A-1346-2009; Sakakibara, Hitoshi/A-6040-2010; Shin, Ryoung/N-4766-2014	Tran, Lam-Son P/0000-0001-9883-9768; Sakakibara, Hitoshi/0000-0001-5449-6492; Shin, Ryoung/0000-0003-4486-2852	RIKEN (Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan)	RIKEN (Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan)	This work was supported by RIKEN (Rikagaku Kenkyusho (Institute of Physical and Chemical Research, Japan)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amtmann John, 2006, JEMS, V31, P52; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Chow B, 2004, J EXP BOT, V55, P247, DOI 10.1093/jxb/erh032; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Franco-Zorrilla JM, 2005, PLANT PHYSIOL, V138, P847, DOI 10.1104/pp.105.060517; Galichet A, 2008, PLANT PHYSIOL, V146, P1155, DOI 10.1104/pp.107.107425; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hansen H, 2003, FUNCT PLANT BIOL, V30, P365, DOI 10.1071/FP02223; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Jung JY, 2009, PLANT CELL, V21, P607, DOI 10.1105/tpc.108.063099; Kiba T, 2005, PLANT CELL PHYSIOL, V46, P339, DOI 10.1093/pcp/pci033; Kim MJ, 2009, PLANT PHYSIOL, V151, P1433, DOI 10.1104/pp.109.144766; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; LEIGH RA, 1984, NEW PHYTOL, V97, P1, DOI 10.1111/j.1469-8137.1984.tb04103.x; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Marschner H, 1995, MINERA NUTR HIGHER P; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Maruyama-Nakashita A, 2004, PLANT J, V38, P779, DOI 10.1111/j.1365-313X.2004.02079.x; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Pospisilova J, 2005, BIOL PLANTARUM, V49, P533, DOI 10.1007/s10535-005-0047-0; Qi Z, 2008, J EXP BOT, V59, P595, DOI 10.1093/jxb/erm330; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Sakakibara H, 2006, TRENDS PLANT SCI, V11, P440, DOI 10.1016/j.tplants.2006.07.004; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Seguela M, 2008, PLANT J, V55, P289, DOI 10.1111/j.1365-313X.2008.03502.x; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Shin R, 2005, PLANT CELL PHYSIOL, V46, P1350, DOI 10.1093/pcp/pci145; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Takei K, 2004, PLANT CELL PHYSIOL, V45, P1053, DOI 10.1093/pcp/pch119; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Vicente-Agullo F, 2004, PLANT J, V40, P523, DOI 10.1111/j.1365-313X.2004.02230.x; Wang YH, 2002, PLANT PHYSIOL, V130, P1361, DOI 10.1104/pp.008854; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	41	71	74	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47797	10.1371/journal.pone.0047797	http://dx.doi.org/10.1371/journal.pone.0047797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112848	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200082
J	Wang, ZL; Liu, TT; Huang, ZY; Wu, XB; Yan, WY; Zeng, ZJ				Wang, Zi Long; Liu, Ting Ting; Huang, Zachary Y.; Wu, Xiao Bo; Yan, Wei Yu; Zeng, Zhi Jiang			Transcriptome Analysis of the Asian Honey Bee Apis cerana cerana	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; MELLIFERA L. QUEEN; CASTE DETERMINATION; WORKER LARVAE; MELIPONA-QUADRIFASCIATA; JUVENILE-HORMONE; HEXAMERIN GENES; PATHWAY GENES; PATTERNS; REVEALS	Background: The Eastern hive honey bee, Apis cerana cerana is a native and widely bred honey bee species in China. Molecular biology research about this honey bee species is scarce, and genomic information for A. c. cerana is not currently available. Transcriptome and expression profiling data for this species are therefore important resources needed to better understand the biological mechanisms of A. c. cerana. In this study, we obtained the transcriptome information of A. c. cerana by RNA-sequencing and compared gene expression differences between queens and workers of A. c. cerana by digital gene expression (DGE) analysis. Results: Using high-throughput Illumina RNA sequencing we obtained 51,581,510 clean reads corresponding to 4.64 Gb total nucleotides from a single run. These reads were assembled into 46,999 unigenes with a mean length of 676 bp. Based on a sequence similarity search against the five public databases (NR, Swissport, GO, COG, KEGG) with a cut-off E-value of 10 25 using BLASTX, a total of 24,630 unigenes were annotated with gene descriptions, gene ontology terms, or metabolic pathways. Using these transcriptome data as references we analyzed the gene expression differences between the queens and workers of A. c. cerana using a tag-based digital gene expression method. We obtained 5.96 and 5.66 million clean tags from the queen and worker samples, respectively. A total of 414 genes were differentially expressed between them, with 189 up-regulated and 225 down-regulated in queens. Conclusions: Our transcriptome data provide a comprehensive sequence resource for future A. c. cerana study, establishing an important public information platform for functional genomic studies in A. c. cerana. Furthermore, the DGE data provide comprehensive gene expression information for the queens and workers, which will facilitate our understanding of the molecular mechanisms of the different physiological aspects of the two castes.	[Wang, Zi Long; Liu, Ting Ting; Wu, Xiao Bo; Yan, Wei Yu; Zeng, Zhi Jiang] Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Huang, Zachary Y.] Michigan State Univ, Dept Ecol, Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA	Jiangxi Agricultural University; Michigan State University; Michigan State University	Zeng, ZJ (corresponding author), Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China.	bees1965@sina.com	Huang, Zachary/D-5485-2011; Wang, Zhiquan/HHS-6768-2022	Huang, Zachary/0000-0001-5354-5547; 	Earmarked Fund for China Agriculture Research System [CARS-45-KXJ12]; Special Fund for Agro-scientific Research in the Public Interest [200903006]; National Natural Science Foundation of China [31060327]; Natural Science Foundation of Jiangxi Province [20111522040297]	Earmarked Fund for China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work was supported by the Earmarked Fund for China Agriculture Research System (No. CARS-45-KXJ12), Special Fund for Agro-scientific Research in the Public Interest (No. 200903006), the National Natural Science Foundation of China (No. 31060327) and the Natural Science Foundation of Jiangxi Province (No. 20111522040297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Azevedo SV, 2011, J INSECT PHYSIOL, V57, P38, DOI 10.1016/j.jinsphys.2010.09.004; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Begna D, 2012, J PROTEOME RES, V11, P1317, DOI 10.1021/pr200974a; Begna D, 2011, J PROTEOME RES, V10, P4263, DOI 10.1021/pr200473a; Cheng S L, 2001, APICULTURAL SCI CHIN, P488; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corona M, 2005, MECH AGEING DEV, V126, P1230, DOI 10.1016/j.mad.2005.07.004; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; Evans JD, 2001, GENOME BIOL, V2; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graff J, 2007, MOL ECOL, V16, P675, DOI 10.1111/j.1365-294X.2007.03162.x; Grozinger CM, 2007, MOL ECOL, V16, P4837, DOI 10.1111/j.1365-294X.2007.03545.x; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Humann FC, 2011, INSECT BIOCHEM MOLEC, V41, P602, DOI 10.1016/j.ibmb.2011.03.013; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Judice C, 2004, INSECT SOC, V51, P352, DOI 10.1007/s00040-004-0771-z; Judice CC, 2006, INSECT MOL BIOL, V15, P33, DOI 10.1111/j.1365-2583.2005.00605.x; Li JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013455; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Markovets AA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S8; Martins JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029006; Martins JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-23; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Mutti NS, 2011, J EXP BIOL, V214, P3977, DOI 10.1242/jeb.061499; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; Pereboom JJM, 2005, P ROY SOC B-BIOL SCI, V272, P1145, DOI 10.1098/rspb.2005.3060; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; SEVERSON DW, 1989, INSECT BIOCHEM, V19, P215, DOI 10.1016/0020-1790(89)90094-2; Thompson GJ, 2007, J EXP ZOOL PART A, V307A, P600, DOI 10.1002/jez.415; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Willis LG, 1992, MOL PHYLOGENET EVOL, V1, P169, DOI 10.1016/1055-7903(92)90013-7; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zeng ZJ, 2009, APICULTURE, P36; Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103	46	32	39	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47954	10.1371/journal.pone.0047954	http://dx.doi.org/10.1371/journal.pone.0047954			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112877	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200120
J	Szpyt, J; Lorenzon, N; Perez, CF; Norris, E; Allen, PD; Beam, KG; Samso, M				Szpyt, John; Lorenzon, Nancy; Perez, Claudio F.; Norris, Ethan; Allen, Paul D.; Beam, Kurt G.; Samso, Montserrat			Three-Dimensional Localization of the alpha and beta Subunits and of the II-III Loop in the Skeletal Muscle L-type Ca2+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; DIHYDROPYRIDINE RECEPTOR; RYANODINE RECEPTOR; ELECTRON CRYOMICROSCOPY; CRYSTAL-STRUCTURE; CYTOPLASMIC LOOP; RELEASE CHANNEL; SODIUM-CHANNEL; ACTIN GENE; DOMAINS II	The L-type Ca2+ channel (dihydropyridine receptor (DHPR) in skeletal muscle acts as the voltage sensor for excitation-contraction coupling. To better resolve the spatial organization of the DHPR subunits (alpha(1s) or Ca(V)1.1, alpha(2), beta(1a), delta 1, and gamma), we created transgenic mice expressing a recombinant beta(1a) subunit with YFP and a biotin acceptor domain attached to its N- and C-termini, respectively. DHPR complexes were purified from skeletal muscle, negatively stained, imaged by electron microscopy, and subjected to single-particle image analysis. The resulting 19.1-A resolution, three-dimensional reconstruction shows a main body of 17 x 11 x 8 nm with five corners along its perimeter. Two protrusions emerge from either face of the main body: the larger one attributed to the alpha(2)-delta 1 subunit that forms a flexible hook-shaped feature and a smaller protrusion on the opposite side that corresponds to the II-III loop of Ca(V)1.1 as revealed by antibody labeling. Novel features discernible in the electron density accommodate the atomic coordinates of a voltage-gated sodium channel and of the beta subunit in a single docking possibility that defines the alpha 1-beta interaction. The beta subunit appears more closely associated to the membrane than expected, which may better account for both its role in localizing the alpha(1s) subunit to the membrane and its suggested role in excitation-contraction coupling.	[Samso, Montserrat] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Szpyt, John; Perez, Claudio F.; Allen, Paul D.; Samso, Montserrat] Brigham & Womens Hosp, Dept Anesthesia, Boston, MA 02115 USA; [Szpyt, John; Perez, Claudio F.; Allen, Paul D.; Samso, Montserrat] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lorenzon, Nancy] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Norris, Ethan; Beam, Kurt G.] Univ Colorado Denver, Dept Physiol & Biophys, Aurora, CO 80045 USA	Virginia Commonwealth University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Samso, M (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia Campus, Richmond, VA 23298 USA.	msamso@vcu.edu		Samso, Montserrat/0000-0002-2788-3283	National Institutes of Health Grant [5K01AR054818, 1R01GM081819, 2R01AR05510]; Brigham and Women's Hospital Biomedical Research Institute Fund; Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054818, R01AR055104, P01AR052354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081819] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital Biomedical Research Institute Fund; Virginia Commonwealth University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5K01AR054818 (to C. F. P.), 1R01GM081819 (to P. D. A. and M. S.), and 2R01AR05510 (to K. G. B. and P. D. A.). This work was also supported by the Brigham and Women's Hospital Biomedical Research Institute Fund to sustain Research Excellence (to M. S.) and by Virginia Commonwealth University startup funds (to M. S.).	Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Andronache Z, 2007, P NATL ACAD SCI USA, V104, P17885, DOI 10.1073/pnas.0704340104; Arikkath J, 2003, J BIOL CHEM, V278, P1212, DOI 10.1074/jbc.M208689200; Bannister RA, 2008, J BIOL CHEM, V283, P23217, DOI 10.1074/jbc.M804312200; Beurg M, 1999, BIOPHYS J, V76, P1744, DOI 10.1016/S0006-3495(99)77336-4; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Carbonneau L, 2005, BIOPHYS J, V89, P243, DOI 10.1529/biophysj.104.056218; Casarotto MG, 2006, CLIN EXP PHARMACOL P, V33, P1114, DOI 10.1111/j.1440-1681.2006.04501.x; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; CONSLER TG, 1993, P NATL ACAD SCI USA, V90, P6934, DOI 10.1073/pnas.90.15.6934; Conway JF, 2010, J MOL BIOL, V397, P575, DOI 10.1016/j.jmb.2010.01.043; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dulhunty AF, 2006, CLIN EXP PHARMACOL P, V33, P763, DOI 10.1111/j.1440-1681.2006.04441.x; Dulhunty AF, 1999, BIOPHYS J, V77, P189, DOI 10.1016/S0006-3495(99)76881-5; ELHAYEK R, 1995, J BIOL CHEM, V270, P22116, DOI 10.1074/jbc.270.38.22116; FLORIO V, 1992, METHOD ENZYMOL, V207, P529; Frank J, 2009, Q REV BIOPHYS, V42, P139, DOI 10.1017/S0033583509990059; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; GLAESER RM, 1989, ULTRAMICROSCOPY, V27, P307, DOI 10.1016/0304-3991(89)90021-1; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; HAASE H, 1991, EUR J PHARM-MOLEC PH, V207, P51, DOI 10.1016/S0922-4106(05)80037-9; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Kobrinsky E, 2004, BIOPHYS J, V87, P844, DOI 10.1529/biophysj.104.041152; Kugler G, 2004, J BIOL CHEM, V279, P4721, DOI 10.1074/jbc.M307538200; Leong P, 1998, J BIOL CHEM, V273, P7791, DOI 10.1074/jbc.273.14.7791; Leong P, 1998, J BIOL CHEM, V273, P29958, DOI 10.1074/jbc.273.45.29958; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lorenzon NM, 2007, J GEN PHYSIOL, V130, P379, DOI 10.1085/jgp.200609730; Lorenzon NM, 2004, J BIOL CHEM, V279, P44057, DOI 10.1074/jbc.M405318200; LU XY, 1995, J BIOL CHEM, V270, P18459, DOI 10.1074/jbc.270.31.18459; LU XY, 1994, J BIOL CHEM, V269, P6511; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Murata K, 2010, J ELECTRON MICROSC, V59, P215, DOI 10.1093/jmicro/dfp059; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Nakai J, 1997, P NATL ACAD SCI USA, V94, P1019, DOI 10.1073/pnas.94.3.1019; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Proenza C, 2002, J BIOL CHEM, V277, P6530, DOI 10.1074/jbc.M106471200; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Serysheva II, 2002, P NATL ACAD SCI USA, V99, P10370, DOI 10.1073/pnas.162363499; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sheridan DC, 2012, CHANNELS, V6, P26, DOI 10.4161/chan.18916; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Tae HS, 2011, J BIOL CHEM, V286, P22589, DOI 10.1074/jbc.M110.205476; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vendel AC, 2006, PROTEIN SCI, V15, P378, DOI 10.1110/ps.051894506; Walsh CP, 2009, J BIOL CHEM, V284, P22310, DOI 10.1074/jbc.M109.017152; Wang MC, 2002, J MOL BIOL, V323, P85, DOI 10.1016/S0022-2836(02)00890-2; Wolf M, 2003, J MOL BIOL, V332, P171, DOI 10.1016/S0022-2836(03)00899-4; Yang L, 2011, FASEB J, V25, P928, DOI 10.1096/fj.10-172353; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13	70	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43853	43861		10.1074/jbc.M112.419283	http://dx.doi.org/10.1074/jbc.M112.419283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118233	Green Published, hybrid			2022-12-25	WOS:000312940800062
J	Hagel, JM; Beaudoin, GAW; Fossati, E; Ekins, A; Martin, VJJ; Facchini, PJ				Hagel, Jillian M.; Beaudoin, Guillaume A. W.; Fossati, Elena; Ekins, Andrew; Martin, Vincent J. J.; Facchini, Peter J.			Characterization of a Flavoprotein Oxidase from Opium Poppy Catalyzing the Final Steps in Sanguinarine and Papaverine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BERBERINE BRIDGE ENZYME; BRANCH-POINT ENZYME; CELL-CULTURES; DIHYDROBENZOPHENANTHRIDINE OXIDASE; ALKALOID BIOSYNTHESIS; MOLECULAR-CLONING; (S)-TETRAHYDROPROTOBERBERINE OXIDASE; BENZYLISOQUINOLINE ALKALOIDS; CANNABIS-SATIVA; ACID SYNTHASE	Benzylisoquinoline alkaloids are a diverse class of plant specialized metabolites that includes the analgesic morphine, the antimicrobials sanguinarine and berberine, and the vasodilator papaverine. The two-electron oxidation of dihydrosanguinarine catalyzed by dihydrobenzophenanthridine oxidase (DBOX) is the final step in sanguinarine biosynthesis. The formation of the fully conjugated ring system in sanguinarine is similar to the four-electron oxidations of (S)-canadine to berberine and (S)-tetrahydropapaverine to papaverine. We report the isolation and functional characterization of an opium poppy (Papaver somniferum) cDNA encoding DBOX, a flavoprotein oxidase with homology to (S)-tetrahydroprotoberberine oxidase and the berberine bridge enzyme. A query of translated opium poppy stem transcriptome databases using berberine bridge enzyme yielded several candidate genes, including an (S)-tetrahydroprotoberberine oxidase-like sequence selected for heterologous expression in Pichia pastoris. The recombinant enzyme preferentially catalyzed the oxidation of dihydrosanguinarine to sanguinarine but also converted (RS)-tetrahydropapaverine to papaverine and several protoberberine alkaloids to oxidized forms, including (RS)-canadine to berberine. The Km values of 201 and 146 mu M for dihydrosanguinarine and the protoberberine alkaloid (S)-scoulerine, respectively, suggested high concentrations of these substrates in the plant. Virus-induced gene silencing to reduce DBOX transcript levels resulted in a corresponding reduction in sanguinarine, dihydrosanguinarine, and papaverine accumulation in opium poppy roots in sup-port of DBOX as a multifunctional oxidative enzyme in BIA metabolism.	[Hagel, Jillian M.; Beaudoin, Guillaume A. W.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Fossati, Elena; Ekins, Andrew; Martin, Vincent J. J.] Concordia Univ, Dept Biol, Montreal, PQ H4B 1R6, Canada	University of Calgary; Concordia University - Canada	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca		Facchini, Peter/0000-0002-7693-290X	Genome Canada; Genome Alberta; Genome Quebec; Government of Alberta; Canada Foundation for Innovation-Leaders Opportunity Fund; Natural Sciences and Engineering Research Council of Canada; Fonds Quebecois de la Recherche sur la Nature et les Technologies	Genome Canada(Genome Canada); Genome Alberta; Genome Quebec; Government of Alberta; Canada Foundation for Innovation-Leaders Opportunity Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	This work was supported by Genome Canada, Genome Alberta, Genome Quebec, the Government of Alberta, and the Canada Foundation for Innovation-Leaders Opportunity Fund.; Recipient of scholarships from the Natural Sciences and Engineering Research Council of Canada and Fonds Quebecois de la Recherche sur la Nature et les Technologies.	AMANN M, 1984, TETRAHEDRON LETT, V25, P953, DOI 10.1016/S0040-4039(01)80071-X; AMANN M, 1988, EUR J BIOCHEM, V175, P17, DOI 10.1111/j.1432-1033.1988.tb14160.x; ARAKAWA H, 1992, ARCH BIOCHEM BIOPHYS, V299, P1, DOI 10.1016/0003-9861(92)90236-P; Barken I, 2008, ANTICANCER RES, V28, P3701; BATTERSBY AR, 1977, BIOORG CHEM, V6, P43, DOI 10.1016/0045-2068(77)90006-2; Bird DA, 2001, PLANTA, V213, P888, DOI 10.1007/s004250100582; BROCHMANNHANSSEN E, 1975, J CHEM SOC PERK T 1, P1531, DOI 10.1039/p19750001531; Chavez MLD, 2011, ARCH BIOCHEM BIOPHYS, V507, P186, DOI 10.1016/j.abb.2010.11.016; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chou WM, 1998, PLANT J, V15, P289, DOI 10.1046/j.1365-313X.1998.00220.x; Custers JHHV, 2004, PLANT J, V39, P147, DOI 10.1111/j.1365-313X.2004.02117.x; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; Desgagne-Penix I, 2012, PLANT J, V72, P331, DOI 10.1111/j.1365-313X.2012.05084.x; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; Facchini PJ, 1996, PLANT PHYSIOL, V112, P1669, DOI 10.1104/pp.112.4.1669; Farrow SC, 2012, PHYTOCHEMISTRY, V77, P79, DOI 10.1016/j.phytochem.2012.02.014; Frick S, 2005, J NAT PROD, V68, P666, DOI 10.1021/np0496643; Gesell A, 2011, PLANTA, V233, P1185, DOI 10.1007/s00425-011-1357-4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hagel JM, 2008, TRENDS PLANT SCI, V13, P631, DOI 10.1016/j.tplants.2008.09.005; Han X, 2010, PHYTOCHEMISTRY, V71, P1305, DOI 10.1016/j.phytochem.2010.04.022; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Hirata K, 2004, PHYTOCHEMISTRY, V65, P1039, DOI 10.1016/j.phytochem.2004.02.015; Ignatov A, 1997, ARCH BIOCHEM BIOPHYS, V347, P208, DOI 10.1006/abbi.1997.0336; Joosten V, 2007, CURR OPIN CHEM BIOL, V11, P195, DOI 10.1016/j.cbpa.2007.01.010; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; ONeil M.J., 2006, MERCK INDEX ENCY CHE, V14th; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; SCHUMACHER HM, 1988, PLANT CELL REP, V7, P43, DOI 10.1007/BF00272975; Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Taura F, 2007, FEBS LETT, V581, P2929, DOI 10.1016/j.febslet.2007.05.043; UPRETY H, 1975, PHYTOCHEMISTRY, V14, P1535, DOI 10.1016/0031-9422(75)85346-5; Wijekoon CP, 2012, PLANT J, V69, P1052, DOI 10.1111/j.1365-313X.2011.04855.x; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Winkler A, 2009, PHYTOCHEMISTRY, V70, P1092, DOI 10.1016/j.phytochem.2009.06.005; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5	48	39	49	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42972	42983		10.1074/jbc.M112.420414	http://dx.doi.org/10.1074/jbc.M112.420414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23118227	Green Published, hybrid			2022-12-25	WOS:000312501600054
J	Yurtsever, Z; Sala-Rabanal, M; Randolph, DT; Scheaffer, SM; Roswit, WT; Alevy, YG; Patel, AC; Heier, RF; Romero, AG; Nichols, CG; Holtzman, MJ; Brett, TJ				Yurtsever, Zeynep; Sala-Rabanal, Monica; Randolph, David T.; Scheaffer, Suzanne M.; Roswit, William T.; Alevy, Yael G.; Patel, Anand C.; Heier, Richard F.; Romero, Arthur G.; Nichols, Colin G.; Holtzman, Michael J.; Brett, Tom J.			Self-cleavage of Human CLCA1 Protein by a Novel Internal Metalloprotease Domain Controls Calcium-activated Chloride Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECURRENT AIRWAY-OBSTRUCTION; CYSTIC-FIBROSIS; MEMBRANE-PROTEIN; CATALYTIC DOMAIN; FAMILY-MEMBERS; DISEASE; MCLCA3; CLONING; HCLCA2; GENE	The chloride channel calcium-activated (CLCA) family are secreted proteins that regulate both chloride transport and mucin expression, thus controlling the production of mucus in respiratory and other systems. Accordingly, human CLCA1 is a critical mediator of hypersecretory lung diseases, such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis, that manifest mucus obstruction. Despite relevance to homeostasis and disease, the mechanism of CLCA1 function remains largely undefined. We address this void by showing that CLCA proteins contain a consensus proteolytic cleavage site recognized by a novel zincin metalloprotease domain located within the N terminus of CLCA itself. CLCA1 mutations that inhibit self-cleavage prevent activation of calcium-activated chloride channel (CaCC)-mediated chloride transport. CaCC activation requires cleavage to unmask the N-terminal fragment of CLCA1, which can independently gate CaCCs. Gating of CaCCs mediated by CLCA1 does not appear to involve proteolytic cleavage of the channel because a mutant N-terminal fragment deficient in proteolytic activity is able to induce currents comparable with that of the native fragment. These data provide both a mechanistic basis for CLCA1 self-cleavage and a novel mechanism for regulation of chloride channel activity specific to the mucosal interface.	[Yurtsever, Zeynep] Washington Univ, Sch Med, Biochem Program, St Louis, MO 63110 USA; [Yurtsever, Zeynep; Randolph, David T.; Roswit, William T.; Alevy, Yael G.; Heier, Richard F.; Romero, Arthur G.; Holtzman, Michael J.; Brett, Tom J.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Nichols, Colin G.; Holtzman, Michael J.; Brett, Tom J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Alevy, Yael G.; Patel, Anand C.; Romero, Arthur G.; Holtzman, Michael J.; Brett, Tom J.] Washington Univ, Sch Med, Drug Discovery Program, St Louis, MO 63110 USA; [Patel, Anand C.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Brett, Tom J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Brett, TJ (corresponding author), Campus Box 8052,660 S Euclid, St Louis, MO 63110 USA.	tbrett@wustl.edu	Brett, Thomas/AAC-9147-2019; Sala-Rabanal, Monica/AAU-2383-2021; Nichols, Colin/D-6336-2012; Patel, Anand/B-1441-2009	Brett, Thomas/0000-0002-6871-6676; Yurtsever, Zeynep/0000-0001-6848-8602; Patel, Anand/0000-0002-6570-8582	National Institutes of Health [RO1-HL073159, P50-HL107183, RO1-HL54171]; American Heart Association [0730336N]; American Cancer Society Grant [IRG-58-010-52]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171, K08HL083095, R01HL073159, P50HL107183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society Grant(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL073159 and P50-HL107183 (to M. J. H.) and RO1-HL54171 (to C. G. N.). This work was also supported in part by funding from the American Heart Association (Grant 0730336N) and American Cancer Society Grant IRG-58-010-52 (to T. J. B).	Alevy Y. G., 2012, J CLIN INVE IN PRESS; Andrade A, 2007, EUR J NEUROSCI, V25, P1705, DOI 10.1111/j.1460-9568.2007.05454.x; Anton F, 2005, J HISTOCHEM CYTOCHEM, V53, P1011, DOI 10.1369/jhc.4A6599.2005; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bauer CS, 2010, CURR OPIN NEUROBIOL, V20, P563, DOI 10.1016/j.conb.2010.05.007; Bothe MK, 2008, J HISTOCHEM CYTOCHEM, V56, P495, DOI 10.1369/jhc.2008.950592; Bothe MK, 2012, MOL CELLS, V33, P251, DOI 10.1007/s10059-012-2217-1; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Braun J, 2010, HISTOCHEM CELL BIOL, V133, P285, DOI 10.1007/s00418-009-0667-0; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Devel L, 2010, BIOCHIMIE, V92, P1501, DOI 10.1016/j.biochi.2010.07.017; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Evans SR, 2004, J BIOL CHEM, V279, P41792, DOI 10.1074/jbc.M408354200; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Gerhardt S, 2007, J MOL BIOL, V373, P891, DOI 10.1016/j.jmb.2007.07.047; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Hamann M, 2009, J PHYSIOL-LONDON, V587, P2255, DOI 10.1113/jphysiol.2009.170159; Hegab AE, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012484; Huan CL, 2008, AM J PHYSIOL-CELL PH, V295, pC279, DOI 10.1152/ajpcell.00060.2008; Jeong SM, 2005, BIOCHEM BIOPH RES CO, V334, P569, DOI 10.1016/j.bbrc.2005.06.122; Kamada F, 2004, GENES IMMUN, V5, P540, DOI 10.1038/sj.gene.6364124; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Range F, 2007, VET PATHOL, V44, P901, DOI 10.1354/vp.44-6-901; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ritzka M, 2004, HUM GENET, V115, P483, DOI 10.1007/s00439-004-1190-y; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tortorella MD, 2009, CURR PHARM DESIGN, V15, P2359, DOI 10.2174/138161209788682433; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; van der Doef HPJ, 2010, J PEDIATR GASTR NUTR, V50, P347, DOI 10.1097/MPG.0b013e3181afce6c; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Yamamura Aya, 2011, Pulm Circ, V1, P269, DOI 10.4103/2045-8932.83447; Yamazaki J, 2005, BBA-BIOMEMBRANES, V1715, P132, DOI 10.1016/j.bbamem.2005.08.001; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007	50	50	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42138	42149		10.1074/jbc.M112.410282	http://dx.doi.org/10.1074/jbc.M112.410282			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23112050	Green Published, hybrid			2022-12-25	WOS:000312103000052
J	Leyva-Gonzalez, MA; Ibarra-Laclette, E; Cruz-Ramirez, A; Herrera-Estrella, L				Antonio Leyva-Gonzalez, Marco; Ibarra-Laclette, Enrique; Cruz-Ramirez, Alfredo; Herrera-Estrella, Luis			Functional and Transcriptome Analysis Reveals an Acclimatization Strategy for Abiotic Stress Tolerance Mediated by Arabidopsis NF-YA Family Members	PLOS ONE			English	Article							CCAAT-BINDING FACTOR; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; PROMOTER SEQUENCES; EMBRYO DEVELOPMENT; LEAFY COTYLEDON1; PLANT-RESPONSES; PHOSPHATE; GROWTH; DROUGHT	Nuclear Factor Y (NF-Y) is a heterotrimeric complex formed by NF-YA/NF-YB/NF-YC subunits that binds to the CCAAT-box in eukaryotic promoters. In contrast to other organisms, in which a single gene encodes each subunit, in plants gene families of over 10 members encode each of the subunits. Here we report that five members of the Arabidopsis thaliana NF-YA family are strongly induced by several stress conditions via transcriptional and miR169-related post-transcriptional mechanisms. Overexpression of NF-YA2, 7 and 10 resulted in dwarf late-senescent plants with enhanced tolerance to several types of abiotic stress. These phenotypes are related to alterations in sucrose/starch balance and cell elongation observed in NF-YA overexpressing plants. The use of transcriptomic analysis of transgenic plants that express miR169-resistant versions of NF-YA2, 3, 7, and 10 under an estradiol inducible system, as well as a dominant-repressor version of NF-YA2 revealed a set of genes, whose promoters are enriched in NF-Y binding sites (CCAAT-box) and that may be directly regulated by the NF-Y complex. This analysis also suggests that NF-YAs could participate in modulating gene regulation through positive and negative mechanisms. We propose a model in which the increase in NF-YA transcript levels in response to abiotic stress is part of an adaptive response to adverse environmental conditions in which a reduction in plant growth rate plays a key role.	[Antonio Leyva-Gonzalez, Marco; Ibarra-Laclette, Enrique; Cruz-Ramirez, Alfredo; Herrera-Estrella, Luis] Ctr Invest & Estudios Avanzados Irapuato, Lab Nacl Genom Biodiversidad LANGEBIO, Guanajuato, Mexico		Herrera-Estrella, L (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Utrecht, Netherlands.	lherrera@ira.cinvestav.mx	Herrera-Estrella, Luis/AAL-2472-2020; Estrella, Luis R Herrera/G-7351-2011; Ramírez, Luis Alfredo Cruz/K-2548-2019; Herrera-Estrella, Luis/ABC-7431-2020; Cruz-Ramirez, Luis Alfredo/B-7588-2009	Herrera-Estrella, Luis/0000-0001-7936-3856; Estrella, Luis R Herrera/0000-0001-7936-3856; Ramírez, Luis Alfredo Cruz/0000-0001-9973-5784; Cruz-Ramirez, Luis Alfredo/0000-0001-9973-5784; Leyva Gonzalez, Marco Antonio/0000-0002-9435-973X	Howard Hughes Medical Institute [55005946]; CONACyT (Mexico) [299/43979]; CONACyT [176135]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by grants from the Howard Hughes Medical Institute www.hhmi.org/ (Grant 55005946) and CONACyT (Mexico) www.conacyt.mx/ (299/43979) to L. H.-E. M. A. L.-G. is indebted to CONACyT for a PhD fellowship (176135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Arguello-Astorga G, 1998, ANNU REV PLANT PHYS, V49, P525, DOI 10.1146/annurev.arplant.49.1.525; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; BERRY M, 1992, NATURE, V358, P499, DOI 10.1038/358499a0; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chen XM, 2002, DEVELOPMENT, V129, P1085; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Dang VD, 1996, J BACTERIOL, V178, P1842, DOI 10.1128/jb.178.7.1842-1849.1996; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Fulton DC, 2008, PLANT CELL, V20, P1040, DOI 10.1105/tpc.107.056507; Gibson SI, 2004, J EXP BOT, V55, P253, DOI 10.1093/jxb/erh048; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ito Y, 2011, PLANT SCI, V181, P105, DOI 10.1016/j.plantsci.2011.04.009; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; Koyama T, 2007, PLANT CELL, V19, P473, DOI 10.1105/tpc.106.044792; Krapp A, 2011, PLANT PHYSIOL, V157, P1255, DOI 10.1104/pp.111.179838; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Lei MG, 2011, PLANT PHYSIOL, V156, P1116, DOI 10.1104/pp.110.171736; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Li L, 2009, PLANT J, V58, P485, DOI 10.1111/j.1365-313X.2009.03793.x; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; LI XY, 1992, J BIOL CHEM, V267, P8984; Li YJ, 2010, PLANT SCI, V178, P271, DOI 10.1016/j.plantsci.2010.01.007; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Linhart C, 2005, CELL CYCLE, V4, P1788, DOI 10.4161/cc.4.12.2173; Litzka O, 1996, EUR J BIOCHEM, V238, P675, DOI 10.1111/j.1432-1033.1996.0675w.x; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Manni I, 2008, MOL BIOL CELL, V19, P5203, DOI 10.1091/mbc.E08-03-0295; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; McNabb DS, 1997, MOL CELL BIOL, V17, P7008, DOI 10.1128/MCB.17.12.7008; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Muller R, 2007, PLANT PHYSIOL, V143, P156, DOI 10.1104/pp.106.090167; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Rodriguez-Negrete EA, 2009, J VIROL, V83, P1332, DOI 10.1128/JVI.01474-08; ROY B, 1995, MOL CELL BIOL, V15, P2263; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schroder F, 2011, PLANT PHYSIOL, V156, P1620, DOI 10.1104/pp.111.177204; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stephenson TJ, 2010, FUNCT INTEGR GENOMIC, V10, P265, DOI 10.1007/s10142-010-0158-3; Strand A, 1997, PLANT J, V12, P605, DOI 10.1046/j.1365-313X.1997.00605.x; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Thon M, 2010, NUCLEIC ACIDS RES, V38, P1098, DOI 10.1093/nar/gkp1091; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Xiao S, 2010, PLANT CELL, V22, P1463, DOI 10.1105/tpc.110.075333; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	78	113	122	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48138	10.1371/journal.pone.0048138	http://dx.doi.org/10.1371/journal.pone.0048138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118940	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500071
J	Howel, D				Howel, Denise			Waist Circumference and Abdominal Obesity among Older Adults: Patterns, Prevalence and Trends	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; WEIGHT-MANAGEMENT; HEALTH; RISK; OVERWEIGHT; INEQUALITIES; NUTRITION; DISEASE; PEOPLE	Objectives: To describe the patterns and trends in waist circumference and abdominal obesity for those aged 70-89 contrasting the standard and new age-related cut-points, and to investigate how they vary with time, age and educational level. Methods: The subjects were 7129 men and 9244 women aged 70-89 years who participated in the Health Survey for England during 1993-2010. The outcome measures were the percentiles of waist circumference and standard and new indicators of abdominal obesity based on waist circumference. Binomial and quantile regression were used to investigate the relationship with key explanatory variables. Results: The distribution of waist circumference among community-dwelling older adults in England has shifted upwards since 1993 (an increase in median of 4.5 cm in men and 5.1 cm in women). The prevalence of abdominal obesity has increased, while those in the low-risk group have decreased. Abdominal obesity was higher in those aged 70-79 compared to 80-89, and in those who left education earlier. The prevalence of abdominal obesity varies considerably with new and standard cut-points, which makes it impractical to use the new ones on a population that includes subjects across the adult age range. Conclusions: Obesity is increasing among the elderly, but more work is needed on devising age-appropriate indicators of high risk based on waist circumference.	Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Howel, D (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	denise.howel@ncl.ac.uk						Bartley M, 2000, J EPIDEMIOL COMMUN H, V54, P806, DOI 10.1136/jech.54.11.806; Brunner E, 1998, BRIT MED J, V316, P308, DOI 10.1136/bmj.316.7127.308a; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Craig R., 2010, HLTH SURVEY ENGLAND, V1; Craig R, 2010, HLTH SURVEY ENGLAND, V2; Finucane M, 2011, LANCET, V377, P577; Fone DL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-115; Ford ES, 2011, INT J OBESITY, V35, P736, DOI 10.1038/ijo.2010.186; Ford ES, 2003, OBES RES, V11, P1223, DOI 10.1038/oby.2003.168; Gomez-Cabello A, 2011, OBES REV, V12, P583, DOI 10.1111/j.1467-789X.2011.00878.x; Gutierrez-Fisac JL, 2004, OBES RES, V12, P710, DOI 10.1038/oby.2004.83; Han TS, 2011, BRIT MED BULL, V97, P169, DOI 10.1093/bmb/ldr002; Heim N, 2011, AM J EPIDEMIOL, V174, P479, DOI 10.1093/aje/kwr093; Houston DK, 2009, J AM DIET ASSOC, V109, P1886, DOI 10.1016/j.jada.2009.08.014; Howel D, 2011, OBESITY; International Diabetes Federation, 2006, IDF CONS WORLDW DEF; Jefferys M, 1996, AM J PUBLIC HEALTH, V86, P474, DOI 10.2105/AJPH.86.4.474; Khang YH, 2010, J KOREAN MED SCI, V25, P1582, DOI 10.3346/jkms.2010.25.11.1582; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Molarius A, 1998, INT J OBESITY, V22, P719, DOI 10.1038/sj.ijo.0800660; Molarius A, 2000, J AM GERIATR SOC, V48, P1638, DOI 10.1111/j.1532-5415.2000.tb03876.x; Okosun I, 2000, INT J OBESITY, V24; Okosun IS, 2004, PREV MED, V39, P197, DOI 10.1016/j.ypmed.2004.01.023; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Samper-Ternent R, 2012, REV CLIN GERONTOL, V22, P10, DOI 10.1017/S0959259811000190; Stevens J, 2010, EUR J CLIN NUTR, V64, P6, DOI 10.1038/ejcn.2009.101; Turcato E, 2000, INT J OBESITY, V24, P1005, DOI 10.1038/sj.ijo.0801352; Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228; Visscher TLS, 2001, INT J OBESITY, V25, P1730, DOI 10.1038/sj.ijo.0801787; Wardle J, 2008, INT J OBESITY, V32, P527, DOI 10.1038/sj.ijo.0803740; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305	35	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48528	10.1371/journal.pone.0048528	http://dx.doi.org/10.1371/journal.pone.0048528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119047	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500160
J	Hurt, JK; Coleman, JL; Fitzpatrick, BJ; Taylor-Blake, B; Bridges, AS; Vihko, P; Zylka, MJ				Hurt, Julie K.; Coleman, Jennifer L.; Fitzpatrick, Brendan J.; Taylor-Blake, Bonnie; Bridges, Arlene S.; Vihko, Pirkko; Zylka, Mark J.			Prostatic Acid Phosphatase Is Required for the Antinociceptive Effects of Thiamine and Benfotiamine	PLOS ONE			English	Article							DIABETIC POLYNEUROPATHY; INTESTINAL TRANSPORT; NEUROPATHIC PAIN; RATS; MICE; DERIVATIVES; TISSUES; MONOPHOSPHATE; HYPERALGESIA; NOCICEPTION	Thiamine (Vitamin B1) is an essential vitamin that must be obtained from the diet for proper neurological function. At higher doses, thiamine and benfotiamine (S-benzoylthiamine O-monophosphate, BT)-a phosphorylated derivative of thiamine-have antinociceptive effects in animals and humans, although how these compounds inhibit pain is unknown. Here, we found that Prostatic acid phosphatase (PAP, ACPP) can dephosphorylate BT in vitro, in dorsal root ganglia (DRG) neurons and in primary-afferent axon terminals in the dorsal spinal cord. The dephosphorylated product S-benzoylthiamine (S-BT) then decomposes to O-benzoylthiamine (O-BT) and to thiamine in a pH-dependent manner, independent of additional enzymes. This unique reaction mechanism reveals that BT only requires a phosphatase for conversion to thiamine. However, we found that the antinociceptive effects of BT, thiamine monophosphate (TMP) and thiamine-a compound that is not phosphorylated-were entirely dependent on PAP at the spinal level. Moreover, pharmacokinetic studies with wild-type and Pap(-/-) mice revealed that PAP is not required for the conversion of BT to thiamine in vivo. Taken together, our study highlights an obligatory role for PAP in the antinociceptive effects of thiamine and phosphorylated thiamine analogs, and suggests a novel phosphatase-independent function for PAP.	[Hurt, Julie K.; Coleman, Jennifer L.; Fitzpatrick, Brendan J.; Taylor-Blake, Bonnie; Bridges, Arlene S.; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Vihko, Pirkko] Univ Helsinki, Div Clin Chem, HUSLAB, Dept Clin Med, Helsinki, Finland	University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki	Zylka, MJ (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	zylka@med.unc.edu	BRIDGES, ARLENE/N-4534-2013		National Institute of Neurological Disorders and Stroke [R01NS067688]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067688] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (R01NS067688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyei-Owusu K, 2009, FEBS J, V276, P2905, DOI 10.1111/j.1742-4658.2009.07018.x; Ang CD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004573.pub3; Ba A, 2008, CELL MOL NEUROBIOL, V28, P923, DOI 10.1007/s10571-008-9297-7; Balakumar P, 2010, PHARMACOL RES, V61, P482, DOI 10.1016/j.phrs.2010.02.008; Batifoulier F, 2006, EUR J AGRON, V25, P163, DOI 10.1016/j.eja.2006.04.009; BETTENDORFF L, 1994, METAB BRAIN DIS, V9, P183, DOI 10.1007/BF01991194; Bettendorff L, 2007, NAT CHEM BIOL, V3, P211, DOI 10.1038/nchembio867; BUCHWALD SL, 1984, J BIOL CHEM, V259, P2208; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; ENOMOTO KI, 1985, BRAIN RES, V358, P316, DOI 10.1016/0006-8993(85)90976-X; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; Franca DS, 2001, EUR J PHARMACOL, V421, P157, DOI 10.1016/S0014-2999(01)01038-X; Frederich M, 2009, FEBS J, V276, P3256, DOI 10.1111/j.1742-4658.2009.07040.x; Ganapathy V, 2004, PFLUG ARCH EUR J PHY, V447, P641, DOI 10.1007/s00424-003-1068-1; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; Gibson GE, 2007, ANTIOXID REDOX SIGN, V9, P1605, DOI 10.1089/ars.2007.1766; Gigliobianco T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-148; Gilbert J., 2008, EFSA J, V864, P1, DOI [10.2903/j.efsa.2008.864, DOI 10.2903/J.EFSA.2008.864.10.2903/J.EFSA.2008.864]; Gomeza J, 2001, LIFE SCI, V68, P2457, DOI 10.1016/S0024-3205(01)01039-6; Greb A, 1998, INT J CLIN PHARM TH, V36, P216; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Henriquez-Sanchez P, 2009, BRIT J NUTR, V102, pS10, DOI 10.1017/S0007114509993126; KNYIHARCSILLIK E, 1986, J HISTOCHEM CYTOCHEM, V34, P363, DOI 10.1177/34.3.3005391; Lazareno S, 2004, MOL PHARMACOL, V65, P257, DOI 10.1124/mol.65.1.257; Lie MA, 2005, BIOCHEMISTRY-US, V44, P14792, DOI 10.1021/bi051134y; Loew D, 1996, INT J CLIN PHARM TH, V34, P47; Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077; Mihara Y, 2001, J BIOSCI BIOENG, V92, P50, DOI 10.1263/jbb.92.50; Mihara Y, 2000, APPL ENVIRON MICROB, V66, P2811, DOI 10.1128/AEM.66.7.2811-2816.2000; Moallem Seyed Adel, 2008, Iran Biomed J, V12, P173; Navarro D, 2008, METAB BRAIN DIS, V23, P445, DOI 10.1007/s11011-008-9105-6; Nikolic A, 2009, SRP ARK CELOK LEK, V137, P594, DOI 10.2298/SARH0912594N; Pan XL, 2010, BRAIN, V133, P1342, DOI 10.1093/brain/awq069; PETROV SA, 1992, FIZIOL ZH SSSR, V38, P79; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; RINDI G, 1995, ARCH PHYSIOL BIOCHEM, V103, P33, DOI 10.3109/13813459509007560; Rindi G, 2000, P SOC EXP BIOL MED, V224, P246, DOI 10.1046/j.1525-1373.2000.22428.x; Said HM, 2001, AM J PHYSIOL-GASTR L, V281, pG144, DOI 10.1152/ajpgi.2001.281.1.G144; Sanchez-Ramirez GM, 2006, EUR J PHARMACOL, V530, P48, DOI 10.1016/j.ejphar.2005.11.016; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Song XS, 2009, ANESTHESIOLOGY, V110, P387, DOI 10.1097/ALN.0b013e3181942f1e; Sriram K, 2012, NUTR CLIN PRACT, V27, P41, DOI 10.1177/0884533611426149; Stracke H, 2008, EXP CLIN ENDOCR DIAB, V116, P600, DOI 10.1055/s-2008-1065351; Tylicki A, 2011, POSTEPY HIGIENY MEDY, V65, P23; Volvert Marie-Laure, 2008, BMC Pharmacology, V8, P10, DOI 10.1186/1471-2210-8-10; WADA T, 1961, SCIENCE, V134, P195, DOI 10.1126/science.134.3473.195; Wang ZB, 2005, PAIN, V114, P266, DOI 10.1016/j.pain.2004.12.027; Winkler G, 1999, ARZNEIMITTEL-FORSCH, V49, P220; YAMAZAKI M, 1968, Vitamins (Kyoto), V38, P12; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	50	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48562	10.1371/journal.pone.0048562	http://dx.doi.org/10.1371/journal.pone.0048562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119057	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500170
J	Sobhakumari, A; Love-Homan, L; Fletcher, EVM; Martin, SM; Parsons, AD; Spitz, DR; Knudson, CM; Simons, AL				Sobhakumari, Arya; Love-Homan, Laurie; Fletcher, Elise V. M.; Martin, Sean M.; Parsons, Arlene D.; Spitz, Douglas R.; Knudson, C. Michael; Simons, Andrean L.			Susceptibility of Human Head and Neck Cancer Cells to Combined Inhibition of Glutathione and Thioredoxin Metabolism	PLOS ONE			English	Article							BUTHIONINE SULFOXIMINE; OXIDATIVE STRESS; PHASE-I; CARCINOMA CELLS; MESSENGER-RNA; REDUCTASE; RESISTANCE; APOPTOSIS; DEPLETION; MODULATION	Increased glutathione (GSH) and thioredoxin (Trx) metabolism are mechanisms that are widely implicated in resistance of cancer cells to chemotherapy. The current study determined if simultaneous inhibition of GSH and Trx metabolism enhanced cell killing of human head and neck squamous cell carcinoma (HNSCC) cells by a mechanism involving oxidative stress. Inhibition of GSH and Trx metabolism with buthionine sulfoximine (BSO) and auranofin (AUR), respectively, induced significant decreases in clonogenic survival compared to either drug alone in FaDu, Cal-27 and SCC-25 HNSCC cells in vitro and in vivo in Cal-27 xenografts. BSO+AUR significantly increased glutathione and thioredoxin oxidation and suppressed peroxiredoxin activity in vitro. Pre-treatment with N-acetylcysteine completely reversed BSO+AUR-induced cell killing in FaDu and Cal-27 cells, while catalase and selenium supplementation only inhibited BSO+AUR-induced cell killing in FaDu cells. BSO+AUR decreased caspase 3/7 activity in HNSCC cells and significantly reduced the viability of both Bax/Bak double knockout (DKO) and DKO-Bax reconstituted hematopoietic cells suggesting that necrosis was involved. BSO+AUR also significantly sensitized FaDu, Cal-27, SCC-25 and SQ20B cells to cell killing induced by the EGFR inhibitor Erlotinib in vitro. These results support the conclusion that simultaneous inhibition of GSH and Trx metabolism pathways induces oxidative stress and clonogenic killing in HNSCCs and this strategy may be useful in sensitizing HNSCCs to EGFR inhibitors.	[Sobhakumari, Arya; Love-Homan, Laurie; Fletcher, Elise V. M.; Martin, Sean M.; Knudson, C. Michael; Simons, Andrean L.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Sobhakumari, Arya; Fletcher, Elise V. M.; Spitz, Douglas R.; Simons, Andrean L.] Univ Iowa, Interdisciplinary Human Toxicol Program, Iowa City, IA USA; [Parsons, Arlene D.; Spitz, Douglas R.; Knudson, C. Michael; Simons, Andrean L.] Univ Iowa, Dept Radiat Oncol, Free Rad & Radiat Biol Program, Iowa City, IA USA; [Spitz, Douglas R.; Knudson, C. Michael; Simons, Andrean L.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Simons, AL (corresponding author), Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.	andrean-simons@uiowa.edu		Burnett, Andrean/0000-0002-6685-0353; Knudson, Charles Michael/0000-0003-3964-5466; Spitz, Douglas/0000-0002-1254-8765	National Institutes of Health [K01CA134941, R01CA133114, P30CA086862]; Departments of Pathology and Radiation Oncology at The University of Iowa; NATIONAL CANCER INSTITUTE [P30CA086862, K01CA134941, T32CA078586, R01CA133114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Departments of Pathology and Radiation Oncology at The University of Iowa; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants K01CA134941 (ALS), R01CA133114 and P30CA086862 (DRS), as well as the Departments of Pathology and Radiation Oncology at The University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Ang KK, 2002, CANCER RES, V62, P7350; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; BAILEY HH, 1994, J CLIN ONCOL, V12, P194, DOI 10.1200/JCO.1994.12.1.194; Bailey HH, 1997, J NATL CANCER I, V89, P1789, DOI 10.1093/jnci/89.23.1789; Bailey HH, 1998, CHEM-BIOL INTERACT, V112, P239, DOI 10.1016/S0009-2797(97)00164-6; BENN HP, 1990, J RHEUMATOL, V17, P466; BLOCKA K, 1983, AM J MED, V75, P114, DOI 10.1016/0002-9343(83)90483-7; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Brown KK, 2010, FEBS LETT, V584, P1257, DOI 10.1016/j.febslet.2010.02.042; Corti A, 2010, ANTICANCER RES, V30, P1169; Cox AG, 2008, BIOCHEM PHARMACOL, V76, P1097, DOI 10.1016/j.bcp.2008.08.021; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Fath MA, 2011, CLIN CANCER RES, V17, P6206, DOI 10.1158/1078-0432.CCR-11-0736; GALLO JM, 1995, CANCER RES, V55, P4507; GRANDIS JR, 1993, CANCER RES, V53, P3579; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kandasamy K, 2003, CANCER RES, V63, P1712; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; LAI SL, 1995, ONCOL RES, V7, P31; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mandal PK, 2010, CANCER RES, V70, P9505, DOI 10.1158/0008-5472.CAN-10-1509; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; MAVIS RD, 1968, J BIOL CHEM, V243, P809; McKeage MJ, 2002, COORDIN CHEM REV, V232, P127, DOI 10.1016/S0010-8545(02)00048-6; Mitchell J B, 1987, Br J Cancer Suppl, V8, P96; Mustacich D, 2007, BIOCHEM J, V346, P1; ODWYER PJ, 1992, J NATL CANCER I, V84, P264, DOI 10.1093/jnci/84.4.264; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Rackham O, 2011, FREE RADICAL BIO MED, V50, P689, DOI 10.1016/j.freeradbiomed.2010.12.015; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Scarbrough PM, 2012, FREE RADICAL BIO MED, V52, P436, DOI 10.1016/j.freeradbiomed.2011.10.493; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SCHNIER C, 1990, BIOL TRACE ELEM RES, V26-7, P471, DOI 10.1007/BF02992702; SHAH JP, 1995, CA-CANCER J CLIN, V45, P352, DOI 10.3322/canjclin.45.6.352; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; Siegsmund MJ, 1999, UROL RES, V27, P157, DOI 10.1007/s002400050103; Simons AL, 2009, J ONCOL, V2009, DOI 10.1155/2009/519563; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; SPITZ DR, 1990, BIOCHEM J, V267, P453, DOI 10.1042/bj2670453; SPITZ DR, 1993, J CELL PHYSIOL, V156, P72, DOI 10.1002/jcp.1041560111; SPITZ DR, 1995, J CELL PHYSIOL, V165, P600, DOI 10.1002/jcp.1041650318; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Troyano A, 2001, J BIOL CHEM, V276, P47107, DOI 10.1074/jbc.M104516200; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weber CN, 2007, CANCER BIOL THER, V6, P156, DOI 10.4161/cbt.6.2.3556; WEICHSELBAUM RR, 1986, P NATL ACAD SCI USA, V83, P2684, DOI 10.1073/pnas.83.8.2684; YAO KS, 1993, CANCER RES, V53, P3662; Zimmermann M, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-11	53	55	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48175	10.1371/journal.pone.0048175	http://dx.doi.org/10.1371/journal.pone.0048175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118946	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500077
J	Zhou, XG; Wu, FZ				Zhou, Xingang; Wu, Fengzhi			p-Coumaric Acid Influenced Cucumber Rhizosphere Soil Microbial Communities and the Growth of Fusarium oxysporum f.sp cucumerinum Owen	PLOS ONE			English	Article							PHENOLIC-ACIDS; ENZYME-ACTIVITIES; CINNAMIC ACID; PLANT; DIVERSITY; CARBON; MICROORGANISMS; POPULATIONS; INPUTS; DYNAMICS	Background: Autotoxicity of cucumber root exudates or decaying residues may be the cause of the soil sickness of cucumber. However, how autotoxins affect soil microbial communities is not yet fully understood. Methodology/Principal Findings: The aims of this study were to study the effects of an artificially applied autotoxin of cucumber, p-coumaric acid, on cucumber seedling growth, rhizosphere soil microbial communities, and Fusarium oxysporum f.sp. cucumerinum Owen (a soil-borne pathogen of cucumber) growth. Abundance, structure and composition of rhizosphere bacterial and fungal communities were analyzed with real-time PCR, PCR-denaturing gradient gel electrophoresis (DGGE) and clone library methods. Soil dehydrogenase activity and microbial biomass C (MBC) were determined to indicate the activity and size of the soil microflora. Results showed that p-coumaric acid (0.1-1.0 mu mol/g soil) decreased cucumber leaf area, and increased soil dehydrogenase activity, MBC and rhizosphere bacterial and fungal community abundances. p-Coumaric acid also changed the structure and composition of rhizosphere bacterial and fungal communities, with increases in the relative abundances of bacterial taxa Firmicutes, Betaproteobacteria, Gammaproteobacteria and fungal taxa Sordariomycete, Zygomycota, and decreases in the relative abundances of bacterial taxa Bacteroidetes, Deltaproteobacteria, Planctomycetes, Verrucomicrobia and fungal taxon Pezizomycete. In addition, p-coumaric acid increased Fusarium oxysporum population densities in soil. Conclusions/Significance: These results indicate that p-coumaric acid may play a role in the autotoxicity of cucumber via influencing soil microbial communities.	[Zhou, Xingang; Wu, Fengzhi] NE Agr Univ, Dept Hort, Harbin, Peoples R China	Northeast Agricultural University - China	Wu, FZ (corresponding author), NE Agr Univ, Dept Hort, Harbin, Peoples R China.	fzwu2006@yahoo.com.cn			National Basic Research Program of China [2009CB119004-05]; National Staple Vegetable Industrial Technology Systems of China [CARS-25-08]	National Basic Research Program of China(National Basic Research Program of China); National Staple Vegetable Industrial Technology Systems of China	This work was supported by the National Basic Research Program of China (2009CB119004-05) and National Staple Vegetable Industrial Technology Systems of China (CARS-25-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2010, SOIL SCI SOC AM J, V74, P1181, DOI 10.2136/sssaj2008.0065; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Bastos AER, 2000, ARCH MICROBIOL, V174, P346, DOI 10.1007/s002030000216; BAZIRAMAKENGA R, 1995, J CHEM ECOL, V21, P1271, DOI 10.1007/BF02027561; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bonanomi G, 2011, NEW PHYTOL, V191, P1018, DOI 10.1111/j.1469-8137.2011.03765.x; Bressan M, 2009, ISME J, V3, P1243, DOI 10.1038/ismej.2009.68; Chen LH, 2011, APPL MICROBIOL BIOT, V89, P1653, DOI 10.1007/s00253-010-2948-x; Chen Y, 2011, APPL SOIL ECOL, V51, P102, DOI 10.1016/j.apsoil.2011.09.004; DALTON BR, 1987, SOIL SCI SOC AM J, V51, P1515, DOI 10.2136/sssaj1987.03615995005100060020x; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; DWORKIN M, 1966, ANNU REV MICROBIOL, V20, P75, DOI 10.1146/annurev.mi.20.100166.000451; Ehlers BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026321; Eilers KG, 2010, SOIL BIOL BIOCHEM, V42, P896, DOI 10.1016/j.soilbio.2010.02.003; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hao WY, 2010, PLANT SOIL, V336, P485, DOI 10.1007/s11104-010-0505-0; Hery M, 2005, FEMS MICROBIOL ECOL, V51, P333, DOI 10.1016/j.femsec.2004.09.008; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Ibekwe AM, 2010, SOIL BIOL BIOCHEM, V42, P567, DOI 10.1016/j.soilbio.2009.11.033; Inderjit, 2003, PLANTA, V217, P529, DOI 10.1007/s00425-003-1054-z; Inderjit, 2005, PLANT SOIL, V274, P227, DOI 10.1007/s11104-004-0159-x; Kaur H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004700; Kong CH, 2008, SOIL BIOL BIOCHEM, V40, P1862, DOI 10.1016/j.soilbio.2008.03.009; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kyselkova M, 2009, ISME J, V3, P1127, DOI 10.1038/ismej.2009.61; LARKIN RP, 1993, PHYTOPATHOLOGY, V83, P1105, DOI 10.1094/Phyto-83-1105; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; MCCARTY GW, 1986, SOIL SCI SOC AM J, V50, P920, DOI 10.2136/sssaj1986.03615995005000040018x; MCCARTY GW, 1991, FEMS MICROBIOL ECOL, V85, P345, DOI 10.1111/j.1574-6968.1991.tb04761.x; Meier CL, 2009, J ECOL, V97, P941, DOI 10.1111/j.1365-2745.2009.01537.x; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Muscolo A, 2006, PLANT SOIL, V284, P305, DOI 10.1007/s11104-006-0040-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Qu XH, 2008, APPL SOIL ECOL, V39, P172, DOI 10.1016/j.apsoil.2007.12.007; Sanguin H, 2009, NEW PHYTOL, V184, P694, DOI 10.1111/j.1469-8137.2009.03010.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHAFER SR, 1991, J CHEM ECOL, V17, P369, DOI 10.1007/BF00994339; Shi SJ, 2011, FEMS MICROBIOL ECOL, V77, P600, DOI 10.1111/j.1574-6941.2011.01150.x; Singh HP, 1999, CRIT REV PLANT SCI, V18, P757, DOI 10.1080/07352689991309478; Souto XC, 2000, J CHEM ECOL, V26, P2025, DOI 10.1023/A:1005504029243; SPARLING GP, 1981, SOIL BIOL BIOCHEM, V13, P455, DOI 10.1016/0038-0717(81)90034-1; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang H, 2009, FEMS MICROBIOL LETT, V298, P267, DOI 10.1111/j.1574-6968.2009.01730.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang ML, 2008, ALLELOPATHY J, V22, P311; Watanabe K, 1998, APPL ENVIRON MICROB, V64, P1203; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wu FZ, 2009, EUR J SOIL BIOL, V45, P356, DOI 10.1016/j.ejsobi.2009.04.001; Yarwood SA, 2009, FEMS MICROBIOL ECOL, V70, P151, DOI 10.1111/j.1574-6941.2009.00733.x; Ye SF, 2004, PLANT SOIL, V263, P143, DOI 10.1023/B:PLSO.0000047721.78555.dc; Yu JingQuan, 2000, Plant and Soil, V223, P147; YU JQ, 1994, J CHEM ECOL, V20, P21, DOI 10.1007/BF02065988; Zhang ZY, 2010, J APPL MICROBIOL, V108, P1839, DOI 10.1111/j.1365-2672.2009.04589.x; Zhou XG, 2012, FEMS MICROBIOL ECOL, V80, P469, DOI 10.1111/j.1574-6941.2012.01312.x; Zhou XG, 2011, EUR J SOIL BIOL, V47, P279, DOI 10.1016/j.ejsobi.2011.07.001	60	106	132	7	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48288	10.1371/journal.pone.0048288	http://dx.doi.org/10.1371/journal.pone.0048288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118972	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705600039
J	Unterweger, D; Kitaoka, M; Miyata, ST; Bachmann, V; Brooks, TM; Moloney, J; Sosa, O; Silva, D; Duran-Gonzalez, J; Provenzano, D; Pukatzki, S				Unterweger, Daniel; Kitaoka, Maya; Miyata, Sarah T.; Bachmann, Verena; Brooks, Teresa M.; Moloney, Jessica; Sosa, Oscar; Silva, David; Duran-Gonzalez, Jorge; Provenzano, Daniele; Pukatzki, Stefan			Constitutive Type VI Secretion System Expression Gives Vibrio cholerae Intra- and Interspecific Competitive Advantages	PLOS ONE			English	Article							ICMF FAMILY PROTEIN; DICTYOSTELIUM; TOXIN; LIPOPOLYSACCHARIDE; IDENTIFICATION; MECHANISMS; REGULATOR; VIRULENCE; RESPONSES; REQUIRES	The type VI secretion system (T6SS) mediates protein translocation across the cell membrane of Gram-negative bacteria, including Vibrio cholerae - the causative agent of cholera. All V. cholerae strains examined to date harbor gene clusters encoding a T6SS. Structural similarity and sequence homology between components of the T6SS and the T4 bacteriophage cell-puncturing device suggest that the T6SS functions as a contractile molecular syringe to inject effector molecules into prokaryotic and eukaryotic target cells. Regulation of the T6SS is critical. A subset of V. cholerae strains, including the clinical O37 serogroup strain V52, express T6SS constitutively. In contrast, pandemic strains impose tight control that can be genetically disrupted: mutations in the quorum sensing gene luxO and the newly described regulator gene tsrA lead to constitutive T6SS expression in the El Tor strain C6706. In this report, we examined environmental V. cholerae isolates from the Rio Grande with regard to T6SS regulation. Rough V. cholerae lacking O-antigen carried a nonsense mutation in the gene encoding the global T6SS regulator VasH and did not display virulent behavior towards Escherichia coli and other environmental bacteria. In contrast, smooth V. cholerae strains engaged constitutively in type VI-mediated secretion and displayed virulence towards prokaryotes (E. coli and other environmental bacteria) and a eukaryote (the social amoeba Dictyostelium discoideum). Furthermore, smooth V. cholerae strains were able to outcompete each other in a T6SS-dependent manner. The work presented here suggests that constitutive T6SS expression provides V. cholerae with an advantage in intraspecific and interspecific competition.	[Unterweger, Daniel; Kitaoka, Maya; Miyata, Sarah T.; Bachmann, Verena; Brooks, Teresa M.; Moloney, Jessica; Pukatzki, Stefan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Sosa, Oscar; Silva, David; Duran-Gonzalez, Jorge; Provenzano, Daniele] Univ Texas Brownsville, Dept Biomed Sci, Brownsville, TX 78520 USA	University of Alberta; University of Texas System; University of Texas Rio Grande Valley	Pukatzki, S (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	spukatzki@ualberta.ca	Unterweger, Daniel/J-6867-2017; Unterweger, Daniel/AAP-6082-2021; Jorge, Duran Gonzalez/AAP-3913-2021	Unterweger, Daniel/0000-0002-3021-0960; Unterweger, Daniel/0000-0001-7459-6386; Jorge, Duran Gonzalez/0000-0002-6811-9900; Provenzano, Daniele/0000-0002-8880-0023	Canadian Institute for Health Research [MOP-84473]; Alberta Innovates-Health Solutions; Alberta Heritage Foundation for Medical Research Endowment Fund; National Institutes of Health [MD001091-01, GM068855-02]; Olegario Rana fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM068855] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD001091] Funding Source: NIH RePORTER	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Alberta Heritage Foundation for Medical Research Endowment Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Olegario Rana fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Work in S.P.'s laboratory is supported by the Canadian Institute for Health Research Operating Grant MOP-84473 and Alberta Innovates-Health Solutions (funded by the Alberta Heritage Foundation for Medical Research Endowment Fund). D.P. was supported by National Institutes of Health grants MD001091-01 and GM068855-02 and an Olegario Rana fellowship. D.U. and S.T.M. were supported by Graduate Studentships from Alberta Innovates-Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bernard CS, 2011, J BACTERIOL, V193, P2158, DOI 10.1128/JB.00029-11; BLAKE PA, 1980, NEW ENGL J MED, V302, P305, DOI 10.1056/NEJM198002073020601; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Das Soumita, 2003, In Silico Biology, V3, P287; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Fullner KJ, 2002, J EXP MED, V195, P1455, DOI 10.1084/jem.20020318; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; GUPTA RK, 1992, INFECT IMMUN, V60, P3201, DOI 10.1128/IAI.60.8.3201-3208.1992; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Jonson G, 1996, INFECT IMMUN, V64, P3778, DOI 10.1128/IAI.64.9.3778-3785.1996; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; Kitaoka M, 2011, J BACTERIOL, V193, P6471, DOI 10.1128/JB.05414-11; Lee VT, 2007, INFECT IMMUN, V75, P1089, DOI 10.1128/IAI.01184-06; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Losonsky GA, 1997, CLIN DIAGN LAB IMMUN, V4, P264, DOI 10.1128/CDLI.4.3.264-269.1997; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2012, J BIOL CHEM, V287, P15610, DOI 10.1074/jbc.M111.301630; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MILLER CE, 1972, INFECT IMMUN, V6, P739, DOI 10.1128/IAI.6.5.739-742.1972; Mitra RK, 2001, J MED MICROBIOL, V50, P268, DOI 10.1099/0022-1317-50-3-268; PIERCE NF, 1970, ANN INTERN MED, V72, P357, DOI 10.7326/0003-4819-72-3-357; Provenzano D, 2006, MICROBIOL IMMUNOL, V50, P899, DOI 10.1111/j.1348-0421.2006.tb03866.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2002, P NATL ACAD SCI USA, V99, P3159, DOI 10.1073/pnas.052704399; Qadri F, 1999, CLIN DIAGN LAB IMMUN, V6, P812, DOI 10.1128/CDLI.6.6.812-818.1999; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Vesth T, 2010, MICROB ECOL, V59, P1, DOI 10.1007/s00248-009-9596-7; Williams SG, 1996, INFECT IMMUN, V64, P283, DOI 10.1128/IAI.64.1.283-289.1996; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107	39	55	57	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48320	10.1371/journal.pone.0048320	http://dx.doi.org/10.1371/journal.pone.0048320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110230	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500060
J	Uusi-Heikkila, S; Bockenhoff, L; Wolter, C; Arlinghaus, R				Uusi-Heikkila, Silva; Boeckenhoff, Linda; Wolter, Christian; Arlinghaus, Robert			Differential Allocation by Female Zebrafish (Danio rerio) to Different-Sized Males - An Example in a Fish Species Lacking Parental Care	PLOS ONE			English	Article							MALE BODY-SIZE; MATE-CHOICE; SEXUAL SELECTION; MATING PREFERENCES; BEHAVIOR; SUCCESS; COSTS; MONOPOLIZATION; REPRODUCTION; INVESTMENT	Organisms allocate resources to reproduction in response to the costs and benefits of current and future reproductive opportunities. According to the differential allocation hypothesis, females allocate more resources to high-quality males. We tested whether a fish species lacking parental care (zebrafish, Danio rerio) expresses male size-dependent differential allocation in monogamous spawning trials. In addition, we tested whether reproductive allocation by females is affected by previous experience of different-quality males, potentially indicating plasticity in mate choice. To that end, females were conditioned to large, small or random-sized males (controls) for 14 days to manipulate females' expectations of the future mate quality. Females showed a clear preference for large males in terms of spawning probability and clutch size independent of the conditioning treatment. However, when females experienced variation in male size (random-sized conditioning treatment) they discriminated less against small males compared to females conditioned to large and small males. This might suggest that differential allocation and size-dependent sexual selection is of less relevance in nature than revealed in the present laboratory study.	[Uusi-Heikkila, Silva; Wolter, Christian; Arlinghaus, Robert] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Boeckenhoff, Linda] Univ Potsdam, Unit Evolutionary Biol Systemat Zool, Inst Biochem & Biol, Potsdam, Germany; [Arlinghaus, Robert] Humboldt Univ, Inland Fisheries Management Lab, Dept Crop & Anim Sci, Fac Agr & Hort, D-10099 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Potsdam; Humboldt University of Berlin	Uusi-Heikkila, S (corresponding author), Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland.	silva.uusi-heikkila@utu.fi	Arlinghaus, Robert/E-3340-2010; Arlinghaus, Robert/J-6171-2019; Wolter, Christian/F-6210-2014	Arlinghaus, Robert/0000-0003-2861-527X; Wolter, Christian/0000-0002-2819-2900	Adaptfish project; Gottfried-Wilhelm-Leibniz-Community; Emil Aaltosen Saatio; German Federal Ministry for Education and Research [01UU0907]	Adaptfish project; Gottfried-Wilhelm-Leibniz-Community; Emil Aaltosen Saatio; German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Funding for this study was through the Adaptfish project grant to RA and CW by the Gottfried-Wilhelm-Leibniz-Community (www.adaptfish.igb-berlin.de). The finalization of this study was financially supported by Emil Aaltosen Saatio (www.emilaaltonen.fi) and the project Besatzfisch by the German Federal Ministry for Education and Research in the Program on Social-Ecological Research (grant # 01UU0907, www.besatz-fisch.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; BAKKER TCM, 1991, BEHAV ECOL SOCIOBIOL, V29, P205, DOI 10.1007/BF00166402; Barbosa M, 2006, J FISH BIOL, V68, P1636, DOI 10.1111/j.1095-8649.2006.01133.x; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; BREDEN F, 1995, ENVIRON BIOL FISH, V42, P323, DOI 10.1007/BF00004926; Brown C, 2003, FISH FISH, V4, P280, DOI 10.1046/j.1467-2979.2003.00122.x; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Colwill RM, 2005, BEHAV PROCESS, V70, P19, DOI 10.1016/j.beproc.2005.03.001; Dahm, 2002, ZEBRAFISH PRACTICAL; Engeszer RE, 2004, CURR BIOL, V14, P881, DOI 10.1016/j.cub.2004.04.042; Evans JP, 2010, BEHAV ECOL, V21, P465, DOI 10.1093/beheco/arq006; Filby AL, 2010, PHYSIOL BEHAV, V101, P567; Fisher R.A., 1930, GENETICAL THEORY NAT; Foote CJ, 1997, CAN J FISH AQUAT SCI, V54, P1785, DOI 10.1139/cjfas-54-8-1785; Forsgren E, 1997, P ROY SOC B-BIOL SCI, V264, P1283, DOI 10.1098/rspb.1997.0177; Gomez-Laplaza LM, 2007, ETHOLOGY, V113, P1019; Gowaty PA, 2007, P NATL ACAD SCI USA, V104, P15023, DOI 10.1073/pnas.0706622104; GRANT JWA, 1992, ANIM BEHAV, V44, P101, DOI 10.1016/S0003-3472(05)80759-6; Griffiths SW, 2004, P ROY SOC B-BIOL SCI, V271, P695, DOI 10.1098/rspb.2003.2648; HALL D, 1995, J COMP PSYCHOL, V109, P76, DOI 10.1037/0735-7036.109.1.76; Hamilton IM, 2002, CAN J ZOOL, V80, P2164, DOI 10.1139/Z02-199; Harris WE, 2009, PHILOS T R SOC B, V364, P1039, DOI 10.1098/rstb.2008.0299; HEYWOOD JS, 1989, EVOLUTION, V43, P1387, DOI [10.2307/2409455, 10.1111/j.1558-5646.1989.tb02590.x]; Hisaoka KK., 1962, COPEIA, V1962, P788, DOI DOI 10.2307/1440680; HOUDE AE, 1990, SCIENCE, V248, P1405, DOI 10.1126/science.248.4961.1405; Hudman SP, 2007, BEHAVIOUR, V144, P1065, DOI 10.1163/156853907781871879; Hutter S, 2010, BEHAVIOUR, V147, P641, DOI 10.1163/000579510X12632972473944; JARVI T, 1990, ETHOLOGY, V84, P123, DOI 10.1111/j.1439-0310.1990.tb00789.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kasumovic MM, 2009, J EVOLUTION BIOL, V22, P324, DOI 10.1111/j.1420-9101.2008.01648.x; Kirkpatrick M, 1996, EVOLUTION, V50, P2125, DOI [10.2307/2410684, 10.1111/j.1558-5646.1996.tb03603.x]; Kokko H, 1997, BEHAV ECOL SOCIOBIOL, V41, P99, DOI 10.1007/s002650050369; Kolm N, 2003, J FISH BIOL, V63, P144, DOI 10.1111/j.1095-8649.2003.00205.x; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lehtonen T, 2007, THESIS U HELSINKI HE; LIGHTBODY JP, 1988, AM NAT, V132, P20, DOI 10.1086/284835; McGhee KE, 2007, BEHAV ECOL, V18, P822, DOI 10.1093/beheco/arm051; MILINSKI M, 1992, P ROY SOC B-BIOL SCI, V250, P229, DOI 10.1098/rspb.1992.0153; Moretz JA, 2007, ENVIRON BIOL FISH, V80, P91, DOI 10.1007/s10641-006-9122-4; Paull GC, 2010, ZEBRAFISH, V7, P109, DOI 10.1089/zeb.2009.0618; PRICE TD, 1984, EVOLUTION, V38, P327, DOI 10.1111/j.1558-5646.1984.tb00291.x; Pyron M, 2003, CAN J ZOOL, V81, P122, DOI 10.1139/Z02-229; R Development Core Team, 2009, R FDN STAT COMP; Reyer HU, 1999, P ROY SOC B-BIOL SCI, V266, P2101, DOI 10.1098/rspb.1999.0894; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Roff Derek A., 1992; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Skinner AMJ, 2004, THESIS U SHEFFIELD S; Skinner AMJ, 2007, BEHAV ECOL, V18, P905, DOI 10.1093/beheco/arm059; Spence R, 2005, ANIM BEHAV, V69, P1317, DOI 10.1016/j.anbehav.2004.10.010; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Spence Rowena, 2006, Front Zool, V3, P5, DOI 10.1186/1742-9994-3-5; Spence R, 2006, BEHAV ECOL, V17, P779, DOI 10.1093/beheco/arl016; Turnell ER, 2003, BIOL BULL-US, V205, P225, DOI 10.2307/1543265; Uusi-Heikkila S, 2012, ENVIRON BIOL FISH, V93, P461, DOI 10.1007/s10641-011-9937-5; Uusi-Heikkila S, 2011, P ROY SOC B-BIOL SCI, V278, P709, DOI 10.1098/rspb.2010.1507; Verzijden MN, 2007, BIOL LETTERS, V3, P134, DOI 10.1098/rsbl.2006.0601; Walling CA, 2008, ANIM BEHAV, V76, P271, DOI 10.1016/j.anbehav.2008.03.008; Watt PJ, 2011, ETHOLOGY, V117, P1003, DOI 10.1111/j.1439-0310.2011.01953.x; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Wiegmann DD, 1995, ANIM BEHAV, V50, P1543, DOI 10.1016/0003-3472(95)80010-7; Williams FE, 2002, BEHAV PROCESS, V58, P125, DOI 10.1016/S0376-6357(02)00025-6; Witte K, 2002, ANIM BEHAV, V63, P943, DOI 10.1006/anbe.2001.1982; WITTENBERGER JF, 1983, MATE CHOICE; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	65	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48317	10.1371/journal.pone.0048317	http://dx.doi.org/10.1371/journal.pone.0048317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110229	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500059
J	Degen, T; Bakalovic, N; Bergvinson, D; Turlings, TCJ				Degen, Thomas; Bakalovic, Nenad; Bergvinson, David; Turlings, Ted C. J.			Differential Performance and Parasitism of Caterpillars on Maize Inbred Lines with Distinctly Different Herbivore-Induced Volatile Emissions	PLOS ONE			English	Article							INDUCED PLANT ODORS; FALL ARMYWORM LEPIDOPTERA; BENEFICIAL INSECTS; METHYL SALICYLATE; SPODOPTERA-FRUGIPERDA; PATHOGEN RESISTANCE; INDIRECT DEFENSES; NATURAL ENEMIES; WASPS; ATTRACTION	Plant volatiles induced by insect feeding are known to attract natural enemies of the herbivores. Six maize inbred lines that showed distinctly different patterns of volatile emission in laboratory assays were planted in randomized plots in the Central Mexican Highlands to test their ability to recruit parasitic wasps under field conditions. The plants were artificially infested with neonate larvae of the fall armyworm Spodoptera frugiperda, and two of its main endoparasitoids, Campoletis sonorensis and Cotesia marginiventris, were released in the plots. Volatiles were collected from equally treated reference plants in the neighbourhood of the experimental field. The cumulative amount of 36 quantified volatile compounds determined for each line was in good accordance with findings from the laboratory; there was an almost 15-fold difference in total emission between the two extreme lines. We found significant differences among the lines with respect to the numbers of armyworms recovered from the plants, their average weight gain and parasitism rates. Average weight of the caterpillars was negatively correlated with the average total amount of volatiles released by the six inbred lines. However, neither total volatile emission nor any specific single compound within the blend could explain the differential parasitism rates among the lines, with the possible exception of (E)-2-hexenal for Campoletis sonorensis and methyl salicylate for Cotesia marginiventris. Herbivore-induced plant volatiles and/or correlates thereof contribute to reducing insect damage of maize plants through direct plant defence and enhanced attraction of parasitoids, alleged indirect defence. The potential to exploit these volatiles for pest control deserves to be further evaluated.	[Degen, Thomas; Bakalovic, Nenad; Turlings, Ted C. J.] Univ Neuchatel, Inst Biol, Lab Fundamental & Appl Res Chem Ecol, CH-2000 Neuchatel, Switzerland; [Bergvinson, David] Ctr Int Mejoramiento Maiz & Trigo CIMMYT, Texcoco, Edo De Mexico, Mexico	University of Neuchatel; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Turlings, TCJ (corresponding author), Univ Neuchatel, Inst Biol, Lab Fundamental & Appl Res Chem Ecol, CH-2000 Neuchatel, Switzerland.	ted.turlings@unine.ch	Degen, Thomas/E-8677-2012; Turlings, Ted CJ/E-8671-2012	Turlings, Ted CJ/0000-0002-8315-785X; Degen, Thomas/0000-0003-2101-2433	Swiss National Science Foundation [31-46237-95]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grant 31-46237-95 from the Swiss National Science Foundation (www.snf.ch). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Allison JD, 2009, NEW PHYTOL, V184, P768, DOI 10.1111/j.1469-8137.2009.03046.x; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; BERGVINSON DJ, 1995, J CHEM ECOL, V21, P343, DOI 10.1007/BF02036722; Bottrell DG, 1998, ANNU REV ENTOMOL, V43, P347, DOI 10.1146/annurev.ento.43.1.347; Carroll MJ, 2008, J CHEM ECOL, V34, P291, DOI 10.1007/s10886-007-9414-y; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; D'Alessandro M, 2005, CHEM SENSES, V30, P739, DOI 10.1093/chemse/bji066; D'Alessandro M, 2006, J CHEM ECOL, V32, P2733, DOI 10.1007/s10886-006-9196-7; D'Alessandro M, 2009, J CHEM ECOL, V35, P999, DOI 10.1007/s10886-009-9692-7; De Boer JG, 2004, J CHEM ECOL, V30, P255, DOI 10.1023/B:JOEC.0000017976.60630.8c; De Lange ES, 2008, THESIS UTRECHT U UTR; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Degen T, 2004, PLANT PHYSIOL, V135, P1928, DOI 10.1104/pp.104.039891; Degenhardt J, 2003, CURR OPIN BIOTECH, V14, P169, DOI 10.1016/S0958-1669(03)00025-9; Degenhardt J, 2009, P NATL ACAD SCI USA, V106, P13213, DOI 10.1073/pnas.0906365106; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Erb M, 2011, PLANT CELL ENVIRON, V34, P1088, DOI 10.1111/j.1365-3040.2011.02307.x; Faeth SH, 1994, INDUCED PLANT RESPON; Furlong MJ, 2010, ENTOMOL EXP APPL, V135, P225, DOI 10.1111/j.1570-7458.2010.00988.x; Gouinguene S, 2001, CHEMOECOLOGY, V11, P9, DOI 10.1007/PL00001832; Gouinguene S, 2005, J CHEM ECOL, V31, P1023, DOI 10.1007/s10886-005-4245-1; Gouinguene S, 2000, THESIS U NEUCHATEL N; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Hare JD, 2011, ANNU REV ENTOMOL, V56, P161, DOI 10.1146/annurev-ento-120709-144753; Heil M, 2004, J ECOL, V92, P527, DOI 10.1111/j.0022-0477.2004.00890.x; Hoballah ME, 2005, J CHEM ECOL, V31, P2003, DOI 10.1007/s10886-005-6074-7; Hoballah ME, 2004, AGR FOREST ENTOMOL, V6, P83, DOI 10.1111/j.1461-9555.2004.00207.x; Hoballah MEF, 2002, J CHEM ECOL, V28, P951, DOI 10.1023/A:1015253600083; Hoballah MEF, 2001, EVOL ECOL RES, V3, P553; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P81, DOI 10.1046/j.1461-9563.2002.00138.x; James DG, 2004, J CHEM ECOL, V30, P1613, DOI 10.1023/B:JOEC.0000042072.18151.6f; James DG, 2003, J CHEM ECOL, V29, P1601, DOI 10.1023/A:1024270713493; Karimzadeh J, 2008, ECOL ENTOMOL, V33, P45, DOI 10.1111/j.1365-2311.2007.00933.x; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Kollner TG, 2004, PHYTOCHEMISTRY, V65, P1895, DOI 10.1016/j.phytochem.2004.05.021; Kranz J, 1977, DIS PESTS WEEDS TROP; Ockroy MLB, 2001, AGR FOREST ENTOMOL, V3, P201, DOI 10.1046/j.1461-9555.2001.00107.x; Pare PW, 1997, PLANT PHYSIOL, V114, P1161, DOI 10.1104/pp.114.4.1161; Poelman EH, 2009, FUNCT ECOL, V23, P951, DOI 10.1111/j.1365-2435.2009.01570.x; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Tamo C, 2006, ANIM BIOL, V56, P205, DOI 10.1163/157075606777304177; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Turlings TCJ, 2004, PHYSIOL ENTOMOL, V29, P45, DOI 10.1111/j.1365-3032.2004.0362.x; Turlings TCJ, 1998, ECOSCIENCE, V5, P321, DOI 10.1080/11956860.1998.11682472; TURLINGS TCJ, 2004, ADV INSECT CHEM ECOL; Turlings TCJ, 2006, CURR OPIN PLANT BIOL, V9, P421, DOI 10.1016/j.pbi.2006.05.010; van der Meijden E, 2000, OIKOS, V89, P202, DOI 10.1034/j.1600-0706.2000.890123.x; von Merey G, 2011, PHYTOCHEMISTRY, V72, P1838, DOI 10.1016/j.phytochem.2011.04.022; von Merey GE, 2012, BIOL CONTROL, V60, P7, DOI 10.1016/j.biocontrol.2011.09.010; WISEMAN BR, 1980, FLA ENTOMOL, V63, P425, DOI 10.2307/3494525; YANG G, 1993, ENVIRON ENTOMOL, V22, P547, DOI 10.1093/ee/22.3.547; Yarro JG, 1985, INSECT SCI ITS APPL, V6, P171	57	35	35	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47589	10.1371/journal.pone.0047589	http://dx.doi.org/10.1371/journal.pone.0047589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112820	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200053
J	Luo, XM; Lei, MYY				Luo, Xin M.; Lei, Margarida Y. Y.			Recombination Activating Gene-2 Regulates CpG-Mediated Interferon-alpha Production in Mouse Bone Marrow-Derived Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2-2; COLONY-STIMULATING FACTOR; INFLAMED LYMPH-NODES; I INTERFERON; V(D)J RECOMBINATION; IMMATURE APCS; PROGENITORS; PRECURSORS; INDUCTION; ANTIGEN	Using mice that lack recombination activating gene-2 (Rag2), we have found that bone marrow-derived plasmacytoid dendritic cells (pDCs) as main producers of interferon-alpha (IFN alpha) require Rag2 for normal development. This is a novel function for Rag2, whose classical role is to initiate B and T cell development. Here we showed that a population of common progenitor cells in the mouse bone marrow possessed the potential to become either B cells or pDCs upon appropriate stimulations, and the lack of Rag2 hindered the development of both types of progeny cells. A closer look at pDCs revealed that Rag2(-/-) pDCs expressed a high level of Ly6C and were defective at producing IFN alpha in response to CpG, a ligand for toll-like receptor 9. This phenotype was not shared by Rag1(-/-) pDCs. The induction of CCR7, CD40 and CD86 with CpG, however, was normal in Rag2(-/-) pDCs. In addition, Rag2(-/-) pDCs retained the function to promote antibody class switching and plasma cell formation through producing IL-6. Further analysis showed that interferon regulatory factor-8, a transcription factor important for both IFNa induction and pDC development, was dysregulated in pDCs lacking Rag2. These results indicate that the generation of interferon response in pDCs requires Rag2 and suggest the lymphoid origin of bone marrow-derived pDCs.	[Luo, Xin M.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Lei, Margarida Y. Y.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Virginia Polytechnic Institute & State University; California Institute of Technology	Luo, XM (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	xinluo@vt.edu	Luo, Xin M/J-6544-2016	Luo, Xin M/0000-0002-2809-5836	California Institute of Technology	California Institute of Technology	This study was financially supported by Dr. David Baltimore at California Institute of Technology through various grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bjoerck P, 2011, J IMMUNOL, V186, P1477, DOI 10.4049/jimmunol.1000454; Blasius A, 2004, BLOOD, V103, P4201, DOI 10.1182/blood-2003-09-3108; Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711; Butchi NB, 2011, AM J PATHOL, V179, P783, DOI 10.1016/j.ajpath.2011.04.011; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chen W, 2004, BLOOD, V103, P2547, DOI 10.1182/blood-2003-09-3058; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chun J, 1999, CURR BIOL, V9, pR251, DOI 10.1016/S0960-9822(99)80156-0; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Deriano L, 2011, NATURE, V471, P119, DOI 10.1038/nature09755; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Farkas L, 2001, AM J PATHOL, V159, P237, DOI 10.1016/S0002-9440(10)61689-6; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Harman BC, 2006, BLOOD, V108, P878, DOI 10.1182/blood-2005-11-4545; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; JUTILA MA, 1988, EUR J IMMUNOL, V18, P1819, DOI 10.1002/eji.1830181125; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kreisel FH, 2006, CELL IMMUNOL, V242, P91, DOI 10.1016/j.cellimm.2006.09.009; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Osawa Y, 2006, J IMMUNOL, V177, P4841, DOI 10.4049/jimmunol.177.7.4841; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Pilbeam K, 2008, J IMMUNOL, V180, P1432, DOI 10.4049/jimmunol.180.3.1432; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; Pulendran B, 2000, J IMMUNOL, V165, P566, DOI 10.4049/jimmunol.165.1.566; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Schatz D G, 1997, Semin Immunol, V9, P149, DOI 10.1006/smim.1997.0068; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Villadangos JA, 2008, IMMUNITY, V29, P352, DOI 10.1016/j.immuni.2008.09.002; Vremec D, 2007, BLOOD, V109, P1165, DOI 10.1182/blood-2006-05-015354; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093	59	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47952	10.1371/journal.pone.0047952	http://dx.doi.org/10.1371/journal.pone.0047952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110142	Green Published, gold, Green Accepted			2022-12-25	WOS:000310310200119
J	Rodriguez, I; Longas, E; de Vega, M; Salas, M				Rodriguez, Irene; Longas, Elisa; de Vega, Miguel; Salas, Margarita			The Essential Role of the 3 ' Terminal Template Base in the First Steps of Protein-Primed DNA Replication	PLOS ONE			English	Article							IN-VITRO; NUCLEOTIDE-SEQUENCE; STRAND DISPLACEMENT; LINEAR TEMPLATE; INITIATION; POLYMERASE; ELONGATION; MECHANISM; COMPLEX; OCCURS	Bacteriophages phi 29 and Nf from Bacillus subtilis start replication of their linear genomes at both ends using a protein-primed mechanism by means of which the DNA polymerase initiates replication by adding dAMP to the terminal protein, this insertion being directed by the second and third 3' terminal thymine of the template strand, respectively. In this work, we have obtained evidences about the role of the 3' terminal base during the initiation steps of phi 29 and Nf genome replication. The results indicate that the absence of the 3' terminal base modifies the initiation position carried out by phi 29 DNA polymerase in such a way that now the third position of the template, instead of the second one, guides the incorporation of the initiating nucleotide. In the case of Nf, although the lack of the 3' terminal base has no effect on the initiation position, its absence impairs further elongation of the TP-dAMP initiation product. The results show the essential role of the 3' terminal base in guaranteeing the correct positioning of replication origins at the polymerization active site to allow accurate initiation of replication and further elongation.	[Rodriguez, Irene; Longas, Elisa; de Vega, Miguel; Salas, Margarita] Univ Autonoma Madrid, Ctr Super Invest Cient, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Salas, M (corresponding author), Univ Autonoma Madrid, Ctr Super Invest Cient, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, Madrid, Spain.	msalas@cbm.uam.es	RODRIGUEZ, IRENE/AAQ-4626-2020; de Vega, Miguel/K-2878-2014; Salas, Margarita/J-9873-2014	de Vega, Miguel/0000-0003-1285-7549; Salas, Margarita/0000-0001-5939-3441	Spanish Ministry of Science and Innovation [BFU 2008-00215, Consolider-Ingenio CSD 2007-00015]; Autonomous Community of Madrid [P-MAT-0283-0505]; Institutional grant from Fundacion Ramon Areces	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomous Community of Madrid; Institutional grant from Fundacion Ramon Areces	This work was supported by the Spanish Ministry of Science and Innovation (grants BFU 2008-00215, and Consolider-Ingenio CSD 2007-00015 to MS); and Autonomous Community of Madrid (grant P-MAT-0283-0505 to MS). Institutional grant from Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1987, J VIROL, V61, P3983, DOI 10.1128/JVI.61.12.3983-3991.1987; CALDENTEY J, 1993, NUCLEIC ACIDS RES, V21, P3725, DOI 10.1093/nar/21.16.3725; ESCARMIS C, 1982, NUCLEIC ACIDS RES, V10, P5785, DOI 10.1093/nar/10.19.5785; Gonzalez-Huici V, 2000, J BIOL CHEM, V275, P40547, DOI 10.1074/jbc.M007170200; GUTIERREZ J, 1986, VIROLOGY, V155, P474, DOI 10.1016/0042-6822(86)90209-6; Illana B, 1998, VIROLOGY, V248, P12, DOI 10.1006/viro.1998.9276; Kamtekar S, 2006, EMBO J, V25, P1335, DOI 10.1038/sj.emboj.7601027; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; KING AJ, 1994, EMBO J, V13, P5786, DOI 10.1002/j.1460-2075.1994.tb06917.x; Kornberg A., 1992, DNA REPLICATION; Lazaro JM, 1995, METHOD ENZYMOL, V262, P42; Longas E, 2006, NUCLEIC ACIDS RES, V34, P6051, DOI 10.1093/nar/gkl769; Longas E, 2008, P NATL ACAD SCI USA, V105, P18290, DOI 10.1073/pnas.0809882105; Martin AC, 1996, J MOL BIOL, V260, P369, DOI 10.1006/jmbi.1996.0407; Mencia M, 2011, P NATL ACAD SCI USA, V108, P18655, DOI 10.1073/pnas.1114397108; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; PENALVA MA, 1982, P NATL ACAD SCI-BIOL, V79, P5522, DOI 10.1073/pnas.79.18.5522; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; SALAS M, 1978, J MOL BIOL, V119, P269, DOI 10.1016/0022-2836(78)90438-2; Salas M, 1999, GENET ENG P, V21, P159; Salas M, 1996, MECH PRIMING DNA SYN, P131; YOSHIKAWA H, 1982, GENE, V17, P323; YOSHIKAWA H, 1981, P NATL ACAD SCI-BIOL, V78, P2596, DOI 10.1073/pnas.78.4.2596; YOSHIKAWA H, 1985, GENE, V37, P125, DOI 10.1016/0378-1119(85)90264-1	26	0	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48257	10.1371/journal.pone.0048257	http://dx.doi.org/10.1371/journal.pone.0048257			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110220	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200163
J	Vervoort, MTW; Vonk, JA; Mooijman, PJW; Van den Elsen, SJJ; Van Megen, HHB; Veenhuizen, P; Landeweert, R; Bakker, J; Mulder, C; Helder, J				Vervoort, Mariette T. W.; Vonk, J. Arie; Mooijman, Paul J. W.; Van den Elsen, Sven J. J.; Van Megen, Hanny H. B.; Veenhuizen, Peter; Landeweert, Renske; Bakker, Jaap; Mulder, Christian; Helder, Johannes			SSU Ribosomal DNA-Based Monitoring of Nematode Assemblages Reveals Distinct Seasonal Fluctuations within Evolutionary Heterogeneous Feeding Guilds	PLOS ONE			English	Article							REAL-TIME PCR; COMMUNITY STRUCTURE; FOOD WEBS; AGRICULTURAL SOIL; DIVERSITY; BIODIVERSITY; IDENTIFICATION; FRAMEWORK; ABUNDANCE; ECOLOGY	Soils are among the most complex, diverse and competitive habitats on Earth and soil biota are responsible for ecosystem services such as nutrient cycling, carbon sequestration and remediation of freshwater. The extreme biodiversity prohibits the making of a full inventory of soil life. Hence, an appropriate indicator group should be selected to determine the biological condition of soil systems. Due to their ubiquity and the diverse responses to abiotic and biotic changes, nematodes are suitable indicators for environmental monitoring. However, the time-consuming microscopic analysis of nematode communities has limited the scale at which this indicator group is used. In an attempt to circumvent this problem, a quantitative PCR-based tool for the detection of a consistent part of the soil nematofauna was developed based on a phylum-wide molecular framework consisting of 2,400 full-length SSU rDNA sequences. Taxon-specific primers were designed and tested for specificity. Furthermore, relationships were determined between the quantitative PCR output and numbers of target nematodes. As a first field test for this DNA sequence signature-based approach, seasonal fluctuations of nematode assemblages under open canopy (one field) and closed canopy (one forest) were monitored. Fifteen taxa from four feeding guilds (covering similar to 65% of the free-living nematode biodiversity at higher taxonomical level) were detected at two trophic levels. These four feeding guilds are composed of taxa that developed independently by parallel evolution and we detected ecologically interpretable patterns for free-living nematodes belonging to the lower trophic level of soil food webs. Our results show temporal fluctuations, which can be even opposite within taxa belonging to the same guild. This research on nematode assemblages revealed ecological information about the soil food web that had been partly overlooked.	[Vonk, J. Arie; Mulder, Christian] Natl Inst Publ Hlth & Environm RIVM, Lab Ecol Risk Assessment, Bilthoven, Netherlands; [Vervoort, Mariette T. W.; Mooijman, Paul J. W.; Van den Elsen, Sven J. J.; Van Megen, Hanny H. B.; Bakker, Jaap; Helder, Johannes] Wageningen Univ WUR, Dept Plant Sci, Nematol Lab, Wageningen, Netherlands; [Veenhuizen, Peter; Landeweert, Renske] Lab Soil & Crop Res BLGG AgroXpertus, Wageningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research	Mulder, C (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Ecol Risk Assessment, Bilthoven, Netherlands.	Mulder@rivm.nl; Hans.Helder@wur.nl	Mulder, Christian/N-4726-2015; Vonk, Jan Arie/B-1105-2009	Mulder, Christian/0000-0001-5735-6989; Vonk, Jan Arie/0000-0002-8803-1148	ERGO of Netherlands Organization for Scientific Research (NWO, The Hague) [838.06.062, 838.06.063, 838.06.064]	ERGO of Netherlands Organization for Scientific Research (NWO, The Hague)(Netherlands Organization for Scientific Research (NWO))	The research was financially supported by the ERGO grants 838.06.062, 838.06.063, and 838.06.064 of The Netherlands Organization for Scientific Research (NWO, The Hague). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aislabie J, 2011, SOIL RES, V49, P270, DOI 10.1071/SR10147; Alphei J, 1998, APPL SOIL ECOL, V9, P9, DOI 10.1016/S0929-1393(98)00047-X; [Anonymous], 1960, NEMATOLOGY; Atkins SD, 2005, FEMS MICROBIOL ECOL, V51, P257, DOI 10.1016/j.femsec.2004.09.002; Birkhofer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043292; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bongers T., 1994, IDENTIFICATION KEY N, V46; Brunborg IM, 2004, J VIROL METHODS, V122, P171, DOI 10.1016/j.jviromet.2004.08.014; BRZESKI MW, 1994, NEMATOLOGICA, V40, P313, DOI 10.1163/003525994X00229; Chabrier C, 2008, APPL SOIL ECOL, V40, P299, DOI 10.1016/j.apsoil.2008.05.004; Chen XY, 2010, EUR J SOIL BIOL, V46, P319, DOI 10.1016/j.ejsobi.2010.05.002; Christensen S, 2012, SOIL BIOL BIOCHEM, V55, P17, DOI 10.1016/j.soilbio.2012.05.018; Cunha A, 1999, NATURE, V402, P253, DOI 10.1038/46211; De Ley P, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P3, DOI 10.1079/9780851990095.0003; De Mesel I, 2006, MAR ECOL PROG SER, V321, P157, DOI 10.3354/meps321157; DECUYPER C, 1982, COMP BIOCHEM PHYS A, V73, P283, DOI 10.1016/0300-9629(82)90071-8; Derycke S, 2012, MOL ECOL RESOUR, V12, P607, DOI 10.1111/j.1755-0998.2012.03128.x; Donn S, 2012, METHODS ECOL EVOL, V3, P12, DOI 10.1111/j.2041-210X.2011.00145.x; Ettema CH, 2003, SOIL BIOL BIOCHEM, V35, P339, DOI 10.1016/S0038-0717(02)00276-6; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Fitter AH, 2005, FUNCT ECOL, V19, P369, DOI 10.1111/j.0269-8463.2005.00969.x; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Fontaine B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036881; FRECKMAN DW, 1985, ANNU REV PHYTOPATHOL, V23, P275, DOI 10.1146/annurev.py.23.090185.001423; Fujimoto T, 2009, APPL SOIL ECOL, V43, P200, DOI 10.1016/j.apsoil.2009.07.006; Gagliardi JV, 2000, APPL ENVIRON MICROB, V66, P877, DOI 10.1128/AEM.66.3.877-883.2000; Hirschmann H., 1952, Zoologische Jahrbuecher (Systematik), V81, P313; Hoss S, 2011, ENVIRON INT, V37, P940, DOI 10.1016/j.envint.2011.03.013; Holterman M, 2008, MOL ECOL RESOUR, V8, P23, DOI 10.1111/j.1471-8286.2007.01963.x; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Holtkamp R, 2008, APPL SOIL ECOL, V39, P23, DOI 10.1016/j.apsoil.2007.11.002; Hunt HW, 2002, GLOBAL CHANGE BIOL, V8, P33, DOI 10.1046/j.1365-2486.2002.00425.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jones KL, 2006, MOL ECOL NOTES, V6, P712, DOI 10.1111/j.1471-8286.2006.01319.x; Le Novere N, 2001, BIOINFORMATICS, V17, P1226, DOI 10.1093/bioinformatics/17.12.1226; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mulder C, 2005, J BIOGEOGR, V32, P1775, DOI 10.1111/j.1365-2699.2005.01321.x; Mulder C, 2005, ECOTOX ENVIRON SAFE, V62, P278, DOI 10.1016/j.ecoenv.2005.03.028; Mulder C, 2011, ECOLOGY, V92; Mulder C, 2012, ADV ECOL RES, V46, P1, DOI 10.1016/B978-0-12-396992-7.00001-0; Mulder C, 2011, ECOL EVOL, V1, P386, DOI 10.1002/ece3.36; Mulder C, 2009, GLOBAL CHANGE BIOL, V15, P2730, DOI 10.1111/j.1365-2486.2009.01899.x; Myers N, 1996, P NATL ACAD SCI USA, V93, P2764, DOI 10.1073/pnas.93.7.2764; NEHER DA, 1995, PLANT SOIL, V170, P167, DOI 10.1007/BF02183065; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Neilson R, 2009, NEMATODES AS ENVIRONMENTAL INDICATORS, P188, DOI 10.1079/9781845933852.0188; Okada H, 2008, NEMATOLOGY, V10, P689, DOI 10.1163/156854108785787280; PETERSEN H, 1982, OIKOS, V39, P287, DOI 10.2307/3544689; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Postma-Blaauw MB, 2005, OECOLOGIA, V142, P428, DOI 10.1007/s00442-004-1741-x; Reuman DC, 2009, ADV ECOL RES, V41, P45, DOI 10.1016/S0065-2504(09)00402-4; Rybarczyk-Mydlowska K, PHYTOPATHOL IN PRESS, V102; Scheu Stefan, 2002, P223, DOI 10.1017/CBO9780511542190.010; SIN WC, 1970, CHROMOSOMA, V32, P191; Sohlenius B, 2001, PEDOBIOLOGIA, V45, P408, DOI 10.1078/0031-4056-00096; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Thonar C, 2012, MOL ECOL RESOUR, V12, P219, DOI 10.1111/j.1755-0998.2011.03086.x; van Eekeren N, 2010, SOIL BIOL BIOCHEM, V42, P1491, DOI 10.1016/j.soilbio.2010.05.016; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Weeda EJ, 1996, VEGETATIE NEDERLAND, P61; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; Yeates GW, 2007, CAN J FOREST RES, V37, P216, DOI 10.1139/X06-172; Yeates GW, 1999, SOIL BIOL BIOCHEM, V31, P1721, DOI 10.1016/S0038-0717(99)00091-7	66	32	32	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47555	10.1371/journal.pone.0047555	http://dx.doi.org/10.1371/journal.pone.0047555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112818	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200051
J	Trebern-Launay, K; Foucher, Y; Giral, M; Legendre, C; Kreis, H; Kessler, M; Ladriere, M; Kamar, N; Rostaing, L; Garrigue, V; Mourad, G; Morelon, E; Soulillou, JP; Dantal, J				Trebern-Launay, Katy; Foucher, Yohann; Giral, Magali; Legendre, Christophe; Kreis, Henri; Kessler, Michele; Ladriere, Marc; Kamar, Nassim; Rostaing, Lionel; Garrigue, Valerie; Mourad, Georges; Morelon, Emmanuel; Soulillou, Jean-Paul; Dantal, Jacques			Poor Long-Term Outcome in Second Kidney Transplantation: A Delayed Event	PLOS ONE			English	Article							RISK-FACTORS; REPEAT TRANSPLANTATION; UNITED-STATES; SINGLE-CENTER; SURVIVAL; DONOR; RETRANSPLANTATION; EXPERIENCE; RECIPIENTS; FAILURE	Background: Old studies reported a worse outcome for second transplant recipient (STR) than for first transplant recipient (FTR) mainly due to non-comparable populations with numbers confounding factors. More recent analysis, based on improved methodology by using multivariate regressions, challenged this generally accepted idea: the poor prognosis for STR is still under debate. Methodology: To assess the long-term patient-and-graft survival of STR compared to FTR, we performed an observational study based on the French DIVAT prospective cohort between 1996 and 2010 (N = 3103 including 641 STR). All patients were treated with a CNI, an mTOR inhibitor or belatacept in addition to steroids and mycophenolate mofetil for maintenance therapy. Patient-and-graft survival and acute rejection episode (ARE) were analyzed using Cox models adjusted for all potential confounding factors such as pre-transplant anti-HLA immunization. Results: We showed that STR have a higher risk of graft failure than FTR (HR = 2.18, p = 0.0013) but that this excess risk was observed after few years of transplantation. There was no significant difference between STR and FTR in the occurrence of either overall ARE (HR = 1.01, p = 0.9675) or steroid-resistant ARE (HR = 1.27, p = 0.4087). Conclusions: The risk of graft failure following second transplantation remained consistently higher than that observed in first transplantation after adjusting for confounding factors. The rarely performed time-dependent statistical modeling may explain the heterogeneous conclusions of the literature concerning second transplantation outcomes. In clinical practice, physicians should not consider STR and FTR equally.	[Trebern-Launay, Katy; Foucher, Yohann; Giral, Magali; Soulillou, Jean-Paul; Dantal, Jacques] CHU Hotel Dieu, INSERM, U643, ITUN, Nantes, France; [Trebern-Launay, Katy; Foucher, Yohann] Univ Nantes, Biostat Rech Clin & Mesures Subject Sante EA4275, Nantes, France; [Legendre, Christophe; Kreis, Henri] Hop Necker Enfants Malad, APHP, Serv Transplantat Renale & Soins Intensifs, Paris, France; [Legendre, Christophe] Univ Paris Descartes & Sorbonne Paris Cite, Paris, France; [Kessler, Michele; Ladriere, Marc] CHU Brabois, Serv Transplantat Renale, Nancy, France; [Kamar, Nassim; Rostaing, Lionel] CHU Rangueil, Serv Nephrol, HTA, F-31054 Toulouse, France; [Kamar, Nassim; Rostaing, Lionel] Univ Toulouse 3, F-31062 Toulouse, France; [Garrigue, Valerie; Mourad, Georges] Hop Lapeyronie, Serv Nephrol Transplantat, Montpellier, France; [Morelon, Emmanuel] Hop Edouard Herriot, Serv Nephrol Transplantat & Immunol Clin, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Montpellier; CHU de Montpellier; CHU Lyon	Soulillou, JP (corresponding author), CHU Hotel Dieu, INSERM, U643, ITUN, Nantes, France.	jean-paul.soulillou@univ-nantes.fr	Foucher, Yohann/L-8995-2015; Foucher, Yohann/G-2714-2013; Foucher, Yohann/ABB-6362-2021; Kamar, Nassim/L-6462-2014	Foucher, Yohann/0000-0003-0330-7457; Foucher, Yohann/0000-0003-0330-7457; Kamar, Nassim/0000-0003-1930-8964; Trebern-Launay, Katy/0000-0002-8310-5419	RTRS; Fondation de Co-operation Scientifique - CENTAURE; Roche Laboratory; RTRS 'CENTAURE'; Novartis Pharma	RTRS; Fondation de Co-operation Scientifique - CENTAURE; Roche Laboratory(Roche Holding); RTRS 'CENTAURE'; Novartis Pharma	This work was partly supported by the RTRS, the 'Fondation de Co-operation Scientifique - CENTAURE' and Roche Laboratory. K. Trebern-Launay is the recipient of a grant for epidemiology and biostatistics research from the RTRS 'CENTAURE' and Novartis Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. This work was partly supported by Roche Laboratory, and K. Trebern-Launay is the recipient of a grant for epidemiology and biostatistics research from Novartis Pharma. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ABOULJOUD MS, 1995, TRANSPLANTATION, V60, P138; ALMOND PS, 1991, TRANSPLANTATION, V52, P253, DOI 10.1097/00007890-199108000-00013; [Anonymous], 2006, SURVIVAL ANAL TECHNI; Arnol M, 2008, TRANSPLANTATION, V86, P1084, DOI 10.1097/TP.0b013e318187ba5c; Coupel S, 2003, KIDNEY INT, V64, P674, DOI 10.1046/j.1523-1755.2003.00104.x; Gjertson David W, 2002, Clin Transpl, P335; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gruber SA, 2009, SURGERY, V146, P646, DOI 10.1016/j.surg.2009.05.020; Hagan C, 2003, TRANSPLANTATION, V75, P1687, DOI 10.1097/01.TP.0000062536.34333.BB; Howard RJ, 2001, AM J KIDNEY DIS, V38, P31, DOI 10.1053/ajkd.2001.25178; KERMAN RH, 1991, TRANSPLANTATION, V51, P316, DOI 10.1097/00007890-199102000-00008; Ladriere M, 2010, CLIN TRANSPL, P460; Magee JC, 2007, AM J TRANSPLANT, V7, P1424, DOI 10.1111/j.1600-6143.2007.01786.x; Miles CD, 2007, AM J TRANSPLANT, V7, P1140, DOI 10.1111/j.1600-6143.2007.01742.x; Ojo AO, 1998, TRANSPLANTATION, V66, P1651, DOI 10.1097/00007890-199812270-00014; R Core Team, 2021, R LANG ENV STAT COMP; Rao PS, 2007, AM J KIDNEY DIS, V49, P294, DOI 10.1053/j.ajkd.2006.11.022; Rao PS, 2006, TRANSPLANTATION, V82, P669, DOI 10.1097/01.tp.0000235434.13327.11; Rigden S, 1999, NEPHROL DIAL TRANSPL, V14, P566, DOI 10.1093/ndt/14.3.566; Scornik JC, 1995, CYTOMETRY, V22, P259, DOI 10.1002/cyto.990220402; Sola E, 2010, TRANSPLANTATION, V89, P714, DOI 10.1097/TP.0b013e3181c892dd; STRATTA RJ, 1988, TRANSPLANTATION, V45, P40; Therneau TM, 2000, MODELING SURVIVAL DA; Volinsky CT, 2000, BIOMETRICS, V56, P256, DOI 10.1111/j.0006-341X.2000.00256.x; Wang D, 2009, TRANSPL IMMUNOL, V20, P150, DOI 10.1016/j.trim.2008.09.010	25	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47915	10.1371/journal.pone.0047915	http://dx.doi.org/10.1371/journal.pone.0047915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110130	gold, Green Published, Green Submitted			2022-12-25	WOS:000310193600037
J	Beven, L; Duret, S; Batailler, B; Dubrana, MP; Saillard, C; Renaudin, J; Arricau-Bouvery, N				Beven, Laure; Duret, Sybille; Batailler, Brigitte; Dubrana, Marie-Pierre; Saillard, Colette; Renaudin, Joel; Arricau-Bouvery, Nathalie			The Repetitive Domain of ScARP3d Triggers Entry of Spiroplasma citri into Cultured Cells of the Vector Circulifer haematoceps	PLOS ONE			English	Article							MYCOPLASMA-HYOPNEUMONIAE; PROMOTE ADHERENCE; SURFACE-PROTEINS; STUBBORN DISEASE; IN-VITRO; LEAFHOPPER; IDENTIFICATION; SPIRALIN; ADHESION; PATHOGENICITY	Spiroplasma citri is a plant pathogenic mollicute transmitted by the leafhopper vector Circulifer haematoceps. Successful transmission requires the spiroplasmas to cross the intestinal epithelium and salivary gland barriers through endocytosis mediated by receptor-ligand interactions. To characterize these interactions we studied the adhesion and invasion capabilities of a S. citri mutant using the Ciha-1 leafhopper cell line. S. citri GII3 wild-type contains 7 plasmids, 5 of which (pSci1 to 5) encode 8 related adhesins (ScARPs). As compared to the wild-type strain GII3, the S. citri mutant G/6 lacking pSci1 to 5 was affected in its ability to adhere and enter into the Ciha-1 cells. Proteolysis analyses, Triton X-114 partitioning and agglutination assays showed that the N-terminal part of ScARP3d, consisting of repeated sequences, was exposed to the spiroplasma surface whereas the C-terminal part was anchored into the membrane. Latex beads cytadherence assays showed the ScARP3d repeat domain (Rep3d) to be involved, and internalization of the Rep3d-coated beads to be actin-dependent. These data suggested that ScARP3d, via its Rep3d domain, was implicated in adhesion of S. citri GII3 to insect cells. Inhibition tests using anti-Rep3d antibodies and competitive assays with recombinant Rep3d both resulted in a decrease of insect cells invasion by the spiroplasmas. Unexpectedly, treatment of Ciha-1 cells with the actin polymerisation inhibitor cytochalasin D increased adhesion and consequently entry of S. citri GII3. For the ScARPs-less mutant G/6, only adhesion was enhanced though to a lesser extent following cytochalasin D treatment. All together these results strongly suggest a role of ScARPs, and particularly ScARP3d, in adhesion and invasion of the leafhopper cells by S. citri.	[Beven, Laure; Duret, Sybille; Batailler, Brigitte; Dubrana, Marie-Pierre; Saillard, Colette; Renaudin, Joel; Arricau-Bouvery, Nathalie] INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Beven, Laure; Duret, Sybille; Batailler, Brigitte; Dubrana, Marie-Pierre; Saillard, Colette; Renaudin, Joel; Arricau-Bouvery, Nathalie] Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France; [Batailler, Brigitte] Univ Bordeaux, UMS3420, Bordeaux Imaging Ctr, Bordeaux, France; [Batailler, Brigitte] CNRS, Bordeaux Imaging Ctr, UMS 3420, Bordeaux, France; [Batailler, Brigitte] INSERM, Bordeaux Imaging Ctr, US 004, Bordeaux, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Arricau-Bouvery, N (corresponding author), INRA, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France.	nbouvery@bordeaux.inra.fr	Beven, Laure/Q-1096-2018	Beven, Laure/0000-0003-4407-3255; Arricau-Bouvery, Nathalie/0000-0001-9505-4834	INRA grant from the department of Plant Health and Environment [SPE 2009_1090_01]; Universite Victor Segalen Bordeaux2	INRA grant from the department of Plant Health and Environment; Universite Victor Segalen Bordeaux2	This work was funded by a INRA grant from the department of Plant Health and Environment (SPE 2009_1090_01) and the Universite Victor Segalen Bordeaux2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev D, 2012, J PROTEOME RES, V11, P224, DOI 10.1021/pr2008626; Ammar E, 2004, ARCH MICROBIOL, V181, P97, DOI 10.1007/s00203-003-0630-8; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Berg M, 2001, GENE, V275, P57, DOI 10.1016/S0378-1119(01)00655-2; Berho N, 2006, MICROBIOL-SGM, V152, P873, DOI 10.1099/mic.0.28541-0; Berho N, 2006, MICROBIOL-SGM, V152, P2703, DOI 10.1099/mic.0.29085-0; Breton M, 2008, MICROBIOL-SGM, V154, P3232, DOI 10.1099/mic.0.2008/019562-0; Breton M, 2010, APPL ENVIRON MICROB, V76, P3198, DOI 10.1128/AEM.00181-10; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Castano S, 2002, BBA-BIOMEMBRANES, V1562, P45, DOI 10.1016/S0005-2736(02)00366-8; Cote JP, 2011, INFECT IMMUN, V79, P1826, DOI 10.1128/IAI.01129-10; Davis RE, 2005, PLASMID, V53, P179, DOI 10.1016/j.plasmid.2004.09.002; Dersch P, 2000, INFECT IMMUN, V68, P2930, DOI 10.1128/IAI.68.5.2930-2938.2000; Deutscher AT, 2012, J PROTEOME RES, V11, P1924, DOI 10.1021/pr201115v; Duret S, 2010, MICROBIOL-SGM, V156, P1097, DOI 10.1099/mic.0.035063-0; Fletcher J, 1998, PHYTOPATHOLOGY, V88, P1351, DOI 10.1094/PHYTO.1998.88.12.1351; FLETCHER J, 1981, PHYTOPATHOLOGY, V71, P1073, DOI 10.1094/Phyto-71-1073; FLETCHER J, 1989, CURR MICROBIOL, V19, P383, DOI 10.1007/BF01570886; Fleury B, 2002, INFECT IMMUN, V70, P5612, DOI 10.1128/IAI.70.10.5612-5621.2002; FOS A, 1986, ANN INST PASTEUR MIC, V137A, P97, DOI 10.1016/S0769-2609(86)80009-6; Killiny N, 2006, MICROBIOL-SGM, V152, P1221, DOI 10.1099/mic.0.28602-0; Killiny N, 2005, PHYTOPATHOLOGY, V95, P541, DOI 10.1094/PHYTO-95-0541; Kwon MO, 1999, PHYTOPATHOLOGY, V89, P1144, DOI 10.1094/PHYTO.1999.89.12.1144; Labroussaa F, 2010, APPL ENVIRON MICROB, V76, P1879, DOI 10.1128/AEM.02384-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; LIU HY, 1983, PHYTOPATHOLOGY, V73, P582, DOI 10.1094/Phyto-73-582; LIU HY, 1983, PHYTOPATHOLOGY, V73, P585, DOI 10.1094/Phyto-73-585; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; McKee ML, 1996, INFECT IMMUN, V64, P2225, DOI 10.1128/IAI.64.6.2225-2233.1996; Minion FC, 2000, INFECT IMMUN, V68, P3056, DOI 10.1128/IAI.68.5.3056-3060.2000; MURAI M, 1993, MICROBIOL IMMUNOL, V37, P69, DOI 10.1111/j.1348-0421.1993.tb03181.x; Ozbek E, 2003, J INVERTEBR PATHOL, V82, P167, DOI 10.1016/S0022-2011(03)00031-4; PRAMSI S, 1993, MOL MICROBIOL, V9, P1119; RASOOLY R, 1994, PHYTOPARASITICA, V22, P209, DOI 10.1007/BF02980320; SAGLIO P, 1973, INT J SYST BACTERIOL, V23, P191, DOI 10.1099/00207713-23-3-191; SAGLIO P, 1971, CR ACAD SCI D NAT, V272, P1387; Saillard C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-195; Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; Vadia S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002356; Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005; VIGNAULT JC, 1980, CR ACAD SCI D NAT, V290, P775; Wang HB, 2009, J MOL BIOL, V392, P352, DOI 10.1016/j.jmb.2009.06.077; Wells CL, 1998, INFECT IMMUN, V66, P2410, DOI 10.1128/IAI.66.6.2410-2419.1998; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; WROBLEWSKI H, 1977, BIOCHIM BIOPHYS ACTA, V465, P275, DOI 10.1016/0005-2736(77)90079-7; Yu J, 2000, PHYTOPATHOLOGY, V90, P716, DOI 10.1094/PHYTO.2000.90.7.716; ZHANG QJ, 1995, INFECT IMMUN, V63, P1013, DOI 10.1128/IAI.63.3.1013-1019.1995	50	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48606	10.1371/journal.pone.0048606	http://dx.doi.org/10.1371/journal.pone.0048606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119070	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500179
J	Horton, BM; Hauber, ME; Maney, DL				Horton, Brent M.; Hauber, Mark E.; Maney, Donna L.			Morph Matters: Aggression Bias in a Polymorphic Sparrow	PLOS ONE			English	Article							WHITE-THROATED SPARROW; HISTORY TRADE-OFFS; ZONOTRICHIA-ALBICOLLIS; COLOR POLYMORPHISM; MATE CHOICE; SONG; TESTOSTERONE; EVOLUTION; COMPETITION; DOMINANCE	In species with discrete morphs exhibiting alternative behavioral strategies, individuals may vary their aggressive behavior in competitive encounters according to the phenotype of their opponent. Such aggression bias has been documented in multiple polymorphic species evolving under negative frequency-dependent selection, but it has not been well-studied under other selection regimes. We investigated this phenomenon in white-throated sparrows (Zonotrichia albicollis), a passerine with plumage polychromatism maintained by disassortative mating. The two distinct color morphs differ with respect to reproductive strategy in that white-striped birds invest more in territorial aggression than tan-striped birds. Whether territorial aggression in this species is biased according to the morph of an intruder is less understood. We found that during peak territorial and mating activity, both color morphs and sexes can exhibit aggression bias, but whether they do so depends on the strategy (morph) of the intruder. During simulated territorial intrusions, resident white-striped males and tan-striped females, which represent the opposite ends of a continuum from high to low territorial aggression, altered their territorial responses according to intruder morph. Tan-striped males and white-striped females, which represent the middle of the continuum, did not show a bias. We propose that because of the disassortative mating system and morph differences in reproductive strategy, the fitness risks of intrusions vary according to the morphs of the resident and the intruder, and that aggression bias is an attuned response to varying threats to fitness.	[Horton, Brent M.; Maney, Donna L.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Hauber, Mark E.] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA; [Hauber, Mark E.] CUNY, Grad Ctr, New York, NY USA	Emory University; City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Horton, BM (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.	bhorto2@emory.edu	Maney, Donna L/G-3706-2011	Maney, Donna L/0000-0002-1006-2358	NIH [R01 MH082833-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082833] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by NIH R01 MH082833-02 to D. Maney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkhead TR, 1992, SPERM COMPETITION BI; Collins CE, 1999, CONDOR, V101, P842, DOI 10.2307/1370072; Dijkstra Peter D., 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/689254; Dijkstra PD, 2010, EVOLUTION, V64, P2797, DOI 10.1111/j.1558-5646.2010.01046.x; Dijkstra PD, 2009, BEHAV ECOL, V20, P138, DOI 10.1093/beheco/arn125; Falls J. B., 2010, BIRDS N AM ONLINE, DOI [10.2173/bna.128, DOI 10.2173/BNA.128]; FALLS JB, 1988, CAN J ZOOL, V66, P206, DOI 10.1139/z88-029; FICKEN RW, 1978, Z TIERPSYCHOL, V46, P43; Formica VA, 2009, J EVOLUTION BIOL, V22, P2395, DOI 10.1111/j.1420-9101.2009.01855.x; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Horton BM, 2010, AUK, V127, P540, DOI 10.1525/auk.2010.09096; HOUTMAN AM, 1994, ANIM BEHAV, V48, P377, DOI 10.1006/anbe.1994.1251; Jones JG, 1987, THESIS U TORONTO TOR; KNAPTON RW, 1983, CAN J ZOOL, V61, P1288, DOI 10.1139/z83-173; KOPACHENA JG, 1993, BEHAVIOUR, V124, P249, DOI 10.1163/156853993X00605; KOPACHENA JG, 1993, WILSON BULL, V105, P48; Kroodsma DE, 2001, ANIM BEHAV, V61, P1029, DOI 10.1006/anbe.2000.1676; LEMON RE, 1974, CAN J ZOOL, V52, P83, DOI 10.1139/z74-013; Maney DL, 2008, GEN COMP ENDOCR, V157, P275, DOI 10.1016/j.ygcen.2008.03.023; MARLER CA, 1988, BEHAV ECOL SOCIOBIOL, V23, P21, DOI 10.1007/BF00303053; Moore IT, 2004, ANIM BEHAV, V67, P411, DOI 10.1016/j.anbehav.2003.03.021; Nowicki S, 1998, BEHAVIOUR, V135, P615, DOI 10.1163/156853998792897888; Parker KA, 2010, EVOLUTION, V64, P2431, DOI 10.1111/j.1558-5646.2010.01013.x; Pauers MJ, 2008, BIOL LETTERS, V4, P156, DOI 10.1098/rsbl.2007.0581; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Pryke SR, 2007, BEHAV ECOL, V18, P621, DOI 10.1093/beheco/arm020; Pryke SR, 2009, AM NAT, V174, P455, DOI 10.1086/605376; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Seehausen O, 2004, P ROY SOC B-BIOL SCI, V271, P1345, DOI 10.1098/rspb.2004.2737; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 1998, OIKOS, V83, P432, DOI 10.2307/3546671; THORNEYCROFT HB, 1975, EVOLUTION, V29, P611, DOI 10.1111/j.1558-5646.1975.tb00855.x; Trivers R., 1972, SEXUAL SELECTION DES, P139; Tuttle EM, 2003, BEHAV ECOL, V14, P425, DOI 10.1093/beheco/14.3.425; Tuttle EM, 1993, THESIS U NEW YORK AL; WAAS JR, 1988, CAN J ZOOL, V66, P2578, DOI 10.1139/z88-379; WASSERMAN FE, 1979, CONDOR, V81, P424, DOI 10.2307/1366974; WINGFIELD JC, 1994, ANIM BEHAV, V47, P77, DOI 10.1006/anbe.1994.1009	39	28	28	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48705	10.1371/journal.pone.0048705	http://dx.doi.org/10.1371/journal.pone.0048705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119092	Green Published, gold			2022-12-25	WOS:000310600500199
J	Kozol, R; Blanco-Bercial, L; Bucklin, A				Kozol, Robert; Blanco-Bercial, Leocadio; Bucklin, Ann			Multi-Gene Analysis Reveals a Lack of Genetic Divergence between Calanus agulhensis and C. sinicus (Copepoda; Calanoida)	PLOS ONE			English	Article							CRYPTIC SPECIATION; COMPARATIVE PHYLOGEOGRAPHY; HAPLOTYPE RECONSTRUCTION; MOLECULAR SYSTEMATICS; SPECIES BOUNDARIES; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; BALLAST WATER; RIBOSOMAL-RNA; LIFE-CYCLE	The discrimination and taxonomic identification of marine species continues to pose a challenge despite the growing number of diagnostic metrics and approaches. This study examined the genetic relationship between two sibling species of the genus Calanus (Crustacea; Copepoda; Calanidae), C. agulhensis and C. sinicus, using a multi-gene analysis. DNA sequences were determined for portions of the mitochondrial cytochrome c oxidase I (mtCOI); nuclear citrate synthase (CS), and large subunit (28S) rRNA genes for specimens collected from the Sea of Japan and North East (NE) Pacific Ocean for C. sinicus and from the Benguela Current and Agulhas Bank, off South Africa, for C. agulhensis. For mtCOI, C. sinicus and C. agulhensis showed similar levels of haplotype diversity (H-d = 0.695 and 0.660, respectively) and nucleotide diversity (pi = 0.003 and 0.002, respectively). Pairwise F-ST distances for mtCOI were significant only between C. agulhensis collected from the Agulhas and two C. sinicus populations: the Sea of Japan (F-ST = 0.152, p < 0.01) and NE Pacific (F-ST = 0.228, p < 0.005). Between the species, F-ST distances were low for both mtCOI (F-ST = 0.083, p = 0.003) and CS (F-ST = 0.050, p = 0.021). Large subunit (28S) rRNA showed no variation between the species. Our results provide evidence of the lack of genetic distinction of C. sinicus and C. agulhensis, raise questions of whether C. agulhensis warrants status as a distinct species, and indicate the clear need for more intensive and extensive ecological and genetic analysis.	[Kozol, Robert; Blanco-Bercial, Leocadio; Bucklin, Ann] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	University of Connecticut	Kozol, R (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	rkozol@my.uri.edu	Kozol, Robert/GXM-3637-2022; Blanco-Bercial, Leocadio/N-4061-2019; Blanco-Bercial, Leocadio/G-5441-2013	Blanco-Bercial, Leocadio/0000-0003-0658-7183; Blanco-Bercial, Leocadio/0000-0003-0658-7183; Bucklin, Ann/0000-0003-3750-9348; Kozol, Robert/0000-0001-5320-1453	Alfred P. Sloan Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	The authors gratefully acknowledge programmatic support from the Alfred P. Sloan Foundation. A product of the Census of Marine Zooplankton (CMarZ, see www.CMarZ.org), an ocean realm field project of the Census of Marine Life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2007, BIOL J LINN SOC, V90, P279, DOI 10.1111/j.1095-8312.2007.00723.x; Atkinson LP, 1987, J OCEAN SOC JAP, V4, P389; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blanco-Bercial L, 2011, J EXP MAR BIOL ECOL, V404, P108, DOI 10.1016/j.jembe.2011.05.011; BRADFORD JM, 1988, HYDROBIOLOGIA, V167, P73, DOI 10.1007/BF00026295; Bradford-Grieve JM, 2010, J NAT HIST, V44, P279, DOI 10.1080/00222930903359644; Braga E, 1999, MAR BIOL, V133, P79, DOI 10.1007/s002270050445; Brodsky KA, 1972, ISSLED FAUNY MOREJ, V12, P1; Brodsky KA, 1965, ISSLED FAUNY MOREI, V3, P22; Bucklin A, 1996, DEEP-SEA RES PT II, V43, P1665, DOI 10.1016/S0967-0645(96)00059-8; BUCKLIN A, 1995, MAR BIOL, V121, P655, DOI 10.1007/BF00349301; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; Bucklin A, 1998, MAR BIOL, V132, P97, DOI 10.1007/s002270050375; Bucklin Ann, 1992, Molecular Marine Biology and Biotechnology, V1, P397; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cleve PT, 1904, MARINE INVESTIGATION, V3, P177; de Decker A.H.B., 1991, Annals of the South African Museum, V101, P27; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Dong F, 2010, MOL PHYLOGENET EVOL, V57, P1268, DOI 10.1016/j.ympev.2010.09.023; Durbin A, 2008, MAR BIOL, V155, P1, DOI 10.1007/s00227-008-0996-x; Eberl R, 2007, AQUAT BIOL, V1, P33, DOI 10.3354/ab00002; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FLEMINGER A, 1987, Biological Oceanography, V5, P43; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FROST BW, 1974, MAR BIOL, V26, P77, DOI 10.1007/BF00389089; FROST BW, 1971, J FISH RES BOARD CAN, V28, P23, DOI 10.1139/f71-004; Fu YX, 1997, GENETICS, V147, P915; Goetze E, 2005, EVOLUTION, V59, P2378; Goetze E, 2003, P ROY SOC B-BIOL SCI, V270, P2321, DOI 10.1098/rspb.2003.2505; Gordon AL, 1986, J GEOPHYS RES, V91; Hall C, 2011, J MARINE SYST, V85, P1, DOI 10.1016/j.jmarsys.2010.10.003; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hill RS, 2001, MAR BIOL, V139, P279; Holsinger Kent E, 2009, Nat Rev Genet, V10, P639, DOI 10.1038/nrg2611; HUANG C, 1993, J PLANKTON RES, V15, P1229, DOI 10.1093/plankt/15.11.1229; Huggett J, 2003, MAR ECOL PROG SER, V250, P247, DOI 10.3354/meps250247; Huggett JA, 2000, ICES J MAR SCI, V57, P1834, DOI 10.1006/jmsc.2000.0977; Hulsemann Kuni, 1994, Invertebrate Taxonomy, V8, P1461, DOI 10.1071/IT9941461; Pereira TJ, 2010, MAR BIOL, V157, P1665, DOI 10.1007/s00227-010-1439-z; Kasyan VV, 2010, RUSS J MAR BIOL+, V36, P167, DOI 10.1134/S1063074010030028; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin YS, 2005, J XIAMEN U NATURAL S, P1; Lindeque PK, 1999, MAR BIOL, V133, P91, DOI 10.1007/s002270050446; Machida RJ, 2006, MAR BIOL, V148, P1071, DOI 10.1007/s00227-005-0140-0; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nuwer M, 2008, THESIS U WASHINGTON; Nuwer M, 2008, MAR BIOL, V156, P107, DOI 10.1007/s00227-008-1068-y; Ortman B. D., 2008, THESIS U CONNECTICUT; Peterson W, 1998, J MARINE SYST, V15, P313, DOI 10.1016/S0924-7963(97)00082-1; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PROBYN TA, 1994, S AFR J SCI, V90, P166; Ragionieri L, 2009, MOL PHYLOGENET EVOL, V52, P825, DOI 10.1016/j.ympev.2009.04.008; Richardson AJ, 2003, MAR ECOL PROG SER, V254, P239, DOI 10.3354/meps254239; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; Shih HT, 2011, MOL PHYLOGENET EVOL, V58, P427, DOI 10.1016/j.ympev.2010.11.013; Stamatakis A, 2007, J VLSI SIG PROC SYST, V48, P271, DOI 10.1007/s11265-007-0067-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steele JH, 2009, OCEAN CURRENTS DERIV, P125; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHASHI M, 1980, Journal of the Oceanographical Society of Japan, V36, P209, DOI 10.1007/BF02070334; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taniguchi M, 2004, J PLANKTON RES, V26, P1249, DOI 10.1093/plankt/fbh115; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; Unal E, 2006, DEEP-SEA RES PT II, V53, P1961, DOI 10.1016/j.dsr2.2006.03.017; Unal E, 2010, PROG OCEANOGR, V87, P175, DOI 10.1016/j.pocean.2010.09.017; UYE S, 1990, MAR BIOL, V104, P389, DOI 10.1007/BF01314341; Uye S, 2000, ICES J MAR SCI, V57, P1850, DOI 10.1006/jmsc.2000.0965; Uye Shin-ichi, 1997, Plankton Biology and Ecology, V44, P3; VERHEYE HM, 1994, S AFR J SCI, V90, P154; WILLIAMS RJ, 1988, ESTUAR COAST SHELF S, V26, P409, DOI 10.1016/0272-7714(88)90021-2; Yebra L, 2011, MAR ECOL PROG SER, V428, P135, DOI 10.3354/meps09056	80	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e45710	10.1371/journal.pone.0045710	http://dx.doi.org/10.1371/journal.pone.0045710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118849	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500004
J	Marasco, R; Rolli, E; Ettoumi, B; Vigani, G; Mapelli, F; Borin, S; Abou-Hadid, AF; El-Behairy, UA; Sorlini, C; Cherif, A; Zocchi, G; Daffonchio, D				Marasco, Ramona; Rolli, Eleonora; Ettoumi, Besma; Vigani, Gianpiero; Mapelli, Francesca; Borin, Sara; Abou-Hadid, Ayman F.; El-Behairy, Usama A.; Sorlini, Claudia; Cherif, Ameur; Zocchi, Graziano; Daffonchio, Daniele			A Drought Resistance-Promoting Microbiome Is Selected by Root System under Desert Farming	PLOS ONE			English	Article							PLANT-GROWTH PROMOTION; WATER-USE EFFICIENCY; BACTERIAL ENDOPHYTES; PAENIBACILLUS-POLYMYXA; ARABIDOPSIS-THALIANA; DEFICIT IRRIGATION; CONFER RESISTANCE; BACILLUS-PUMILUS; DRIP IRRIGATION; SONORAN DESERT	Background: Traditional agro-systems in arid areas are a bulwark for preserving soil stability and fertility, in the sight of "reverse desertification". Nevertheless, the impact of desert farming practices on the diversity and abundance of the plant associated microbiome is poorly characterized, including its functional role in supporting plant development under drought stress. Methodology/Principal Findings: We assessed the structure of the microbiome associated to the drought-sensitive pepper plant (Capsicum annuum L.) cultivated in a traditional Egyptian farm, focusing on microbe contribution to a crucial ecosystem service, i.e. plant growth under water deficit. The root system was dissected by sampling root/soil with a different degree of association to the plant: the endosphere, the rhizosphere and the root surrounding soil that were compared to the uncultivated soil. Bacterial community structure and diversity, determined by using Denaturing Gradient Gel Electrophoresis, differed according to the microhabitat, indicating a selective pressure determined by the plant activity. Similarly, culturable bacteria genera showed different distribution in the three root system fractions. Bacillus spp. (68% of the isolates) were mainly recovered from the endosphere, while rhizosphere and the root surrounding soil fractions were dominated by Klebsiella spp. (61% and 44% respectively). Most of the isolates (95%) presented in vitro multiple plant growth promoting (PGP) activities and stress resistance capabilities, but their distribution was different among the root system fractions analyzed, with enhanced abilities for Bacillus and the rhizobacteria strains. We show that the C. annuum rhizosphere under desert farming enriched populations of PGP bacteria capable of enhancing plant photosynthetic activity and biomass synthesis (up to 40%) under drought stress. Conclusions/Significance: Crop cultivation provides critical ecosystem services in arid lands with the plant root system acting as a "resource island" able to attract and select microbial communities endowed with multiple PGP traits that sustain plant development under water limiting conditions.	[Marasco, Ramona; Rolli, Eleonora; Mapelli, Francesca; Borin, Sara; Sorlini, Claudia; Daffonchio, Daniele] Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, Milan, Italy; [Ettoumi, Besma; Cherif, Ameur] Univ Tunis El Manar, Lab Microorganismes & Biomol Act, Tunis, Tunisia; [Ettoumi, Besma; Cherif, Ameur] Univ La Manouba, Inst Super Biotechnol, Lab Biotechnol & Valorisat Biogeo Ressources, Sidi Thabet, Ariana, Tunisia; [Vigani, Gianpiero; Zocchi, Graziano] Univ Milan, Dipartimento Sci Agr & Alimentari Prod, Milan, Italy; [Abou-Hadid, Ayman F.; El-Behairy, Usama A.] Ain Shams Univ, Dept Hort, Cairo, Egypt	University of Milan; Universite de Tunis-El-Manar; Universite de la Manouba; University of Milan; Egyptian Knowledge Bank (EKB); Ain Shams University	Daffonchio, D (corresponding author), Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, Milan, Italy.	daniele.daffonchio@unimi.it	Marasco, Ramona/ABF-3088-2021; Cherif, Ameur/AAC-6136-2021; rolshausen, philippe/F-7999-2011; Daffonchio, Daniele/AAF-4922-2019; Vigani, Gianpiero/R-5539-2019	Marasco, Ramona/0000-0003-4776-7519; Daffonchio, Daniele/0000-0003-0947-925X; /0000-0001-7310-3842; Borin, Sara/0000-0001-7479-8199; Vigani, Gianpiero/0000-0001-8852-3866; Abou Hadid, Ayman/0000-0003-0548-7447; Rolli, Eleonora/0000-0002-5814-9735; Mapelli, Francesca/0000-0002-2928-6538	FIRB of the Italian Ministry of University and Research [RBIN047MBH]; European Union (European Community) [245746]; Universita degli Studi di Milano; European Social Found; Regione Lombardia; BIOGESTECA project (Fondo per la promozione di accordi istituzionali) [15083/RCC]	FIRB of the Italian Ministry of University and Research; European Union (European Community)(European Commission); Universita degli Studi di Milano; European Social Found(European Social Fund (ESF)); Regione Lombardia(Regione Lombardia); BIOGESTECA project (Fondo per la promozione di accordi istituzionali)	This work was financially supported by the FIRB project no RBIN047MBH "Strategy to improve crop productivity under water stress" of the Italian Ministry of University and Research, the European Union in the ambit of project BIODESERT (European Community's Seventh Framework Programme CSA-SA REGPOT-2008-2 under grant agreement no 245746). ER and FM are supported by Universita degli Studi di Milano, European Social Found and Regione Lombardia (contract "Dote Ricerca"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Umberto Fascio (CIMA, Centro Interdipartimentale di Microscopia avanzata of the University of Milan) for technical support at the confocal microscope, Dr. Isabella Tamagnini for the contribution in sampling activities, Dr. Gian Attilio Sacchi and BIOGESTECA project (no 15083/RCC "Fondo per la promozione di accordi istituzionali") for helpful discussion on the biology of plant microbe interaction under water stress and Mr. Andrea Fiorentini for his availability for the recovery of soil, seeds and pots for the microcosm experiments.	Ambrosini A, 2012, PLANT SOIL, V356, P245, DOI 10.1007/s11104-011-1079-1; Aravind R, 2009, LETT APPL MICROBIOL, V48, P58, DOI 10.1111/j.1472-765X.2008.02486.x; Bachar A, 2012, MICROB ECOL, V63, P694, DOI 10.1007/s00248-011-9957-x; Balachandar D, 2006, WORLD J MICROB BIOT, V22, P707, DOI 10.1007/s11274-005-9094-0; Balloi A, 2010, AGROCHIMICA, V54, P353; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bashan Y, 2012, J ENVIRON MANAGE, V102, P26, DOI 10.1016/j.jenvman.2011.12.032; Belimov AA, 2009, NEW PHYTOL, V181, P413, DOI 10.1111/j.1469-8137.2008.02657.x; Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cappuccino J. C., 1992, MICROBIOLOGY LAB MAN, Vthird, P125, DOI DOI 10.2307/1309615; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Chanal A, 2006, ENVIRON MICROBIOL, V8, P514, DOI 10.1111/j.1462-2920.2005.00921.x; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Dalla Costa L, 2002, AUST J AGR RES, V53, P201, DOI 10.1071/AR00133; De Luca G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023784; Delfine S, 2001, J AM SOC HORTIC SCI, V126, P297, DOI 10.21273/JASHS.126.3.297; Dorji K, 2005, SCI HORTIC-AMSTERDAM, V104, P137, DOI 10.1016/j.scienta.2004.08.015; Fan B, 2012, J MICROBIOL, V50, P38, DOI 10.1007/s12275-012-1439-4; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Francis I, 2010, ENVIRON MICROBIOL, V12, P1, DOI 10.1111/j.1462-2920.2009.01989.x; Garbeva P, 2003, MICROB ECOL, V45, P302, DOI 10.1007/s00248-002-2034-8; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; Goberna M, 2007, APPL SOIL ECOL, V36, P107, DOI 10.1016/j.apsoil.2006.12.003; Gonzalez-Dugo V, 2007, SCI HORTIC-AMSTERDAM, V114, P77, DOI 10.1016/j.scienta.2007.05.014; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han JG, 2009, MICROB ECOL, V58, P363, DOI 10.1007/s00248-009-9491-2; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Joseph B, 2007, INT J PLANT PROD, V1, P141; Kang SZ, 2001, SCI HORTIC-AMSTERDAM, V89, P257, DOI 10.1016/S0304-4238(00)00245-4; Kavroulakis N, 2010, PLANT SOIL, V333, P233, DOI 10.1007/s11104-010-0338-x; Khan Z, 2009, PLANT SOIL, V322, P197, DOI 10.1007/s11104-009-9908-1; KING EO, 1954, J LAB CLIN MED, V44, P301; Kniskern JM, 2007, MOL PLANT MICROBE IN, V20, P1512, DOI 10.1094/MPMI-20-12-1512; Koberl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024452; Kokalis-Burelle N, 2002, PLANT SOIL, V238, P257, DOI 10.1023/A:1014464716261; Kumar G, 2012, MICROBIOL RES, V167, P220, DOI 10.1016/j.micres.2011.09.001; Lal S, 2009, INDIAN J MICROBIOL, V49, P2, DOI 10.1007/s12088-009-0008-y; Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377; Long HH, 2010, NEW PHYTOL, V185, P554, DOI 10.1111/j.1469-8137.2009.03079.x; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Madigan MT, 2009, BROCK BIOL MICROORGA; Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; Mehta S, 2001, CURR MICROBIOL, V43, P51, DOI 10.1007/s002840010259; Mendes R, 2007, APPL ENVIRON MICROB, V73, P7259, DOI 10.1128/AEM.01222-07; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nielsen P, 1997, FEMS MICROBIOL ECOL, V22, P183, DOI 10.1016/S0168-6496(96)00089-X; Olarewaju JD, 2007, INT J PLANT BREEDING, V1, P29, DOI DOI 10.3923/IJPBG.2007.29.33; Park MS, 2005, J MICROBIOL, V43, P219; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Rajkumar M, 2012, BIOTECHNOL ADV, V30, P1562, DOI 10.1016/j.biotechadv.2012.04.011; Rasband WS, 1997, IMAGEJ; Rasche F, 2006, CAN J MICROBIOL, V52, P1036, DOI 10.1139/W06-059; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santaella C, 2008, ENVIRON MICROBIOL, V10, P2150, DOI 10.1111/j.1462-2920.2008.01650.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sezen SM, 2006, AGR WATER MANAGE, V81, P115, DOI 10.1016/j.agwat.2005.04.002; Sgroy V, 2009, APPL MICROBIOL BIOT, V85, P371, DOI 10.1007/s00253-009-2116-3; Shankar M, 2011, J BASIC MICROB, V51, P523, DOI 10.1002/jobm.201000342; Siddikee MA, 2010, J MICROBIOL BIOTECHN, V20, P1577, DOI 10.4014/jmb.1007.07011; Sturz AV, 2000, CRIT REV PLANT SCI, V19, P1, DOI 10.1016/S0735-2689(01)80001-0; Sun L, 2008, MICROB ECOL, V55, P415, DOI 10.1007/s00248-007-9287-1; Sziderics AH, 2007, CAN J MICROBIOL, V53, P1195, DOI 10.1139/W07-082; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timmusk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017968; Trivedi P, 2011, MICROB ECOL, V62, P324, DOI 10.1007/s00248-011-9822-y	75	267	280	11	250	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48479	10.1371/journal.pone.0048479	http://dx.doi.org/10.1371/journal.pone.0048479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119032	Green Published, gold			2022-12-25	WOS:000310600500148
J	Matsui, T; Koyano, KW; Tamura, K; Osada, T; Adachi, Y; Miyamoto, K; Chikazoe, J; Kamigaki, T; Miyashita, Y				Matsui, Teppei; Koyano, Kenji W.; Tamura, Keita; Osada, Takahiro; Adachi, Yusuke; Miyamoto, Kentaro; Chikazoe, Junichi; Kamigaki, Tsukasa; Miyashita, Yasushi			fMRI Activity in the Macaque Cerebellum Evoked by Intracortical Microstimulation of the Primary Somatosensory Cortex: Evidence for Polysynaptic Propagation	PLOS ONE			English	Article							ELECTRICAL MICROSTIMULATION; FUNCTIONAL CONNECTIVITY; CEREBRAL-CORTEX; STIMULATION; MONKEYS; SIGNALS; MAPS	Simultaneous electrical microstimulation (EM) and functional magnetic resonance imaging (fMRI) is a useful tool for probing connectivity across brain areas in vivo. However, it is not clear whether intracortical EM can evoke blood-oxygenation-level-dependent (BOLD) signal in areas connected polysynaptically to the stimulated site. To test for the presence of the BOLD activity evoked by polysynaptic propagation of the EM signal, we conducted simultaneous fMRI and EM in the primary somatosensory cortex (S1) of macaque monkeys. We in fact observed BOLD activations in the contralateral cerebellum which is connected to the stimulation site (i.e. S1) only through polysynaptic pathways. Furthermore, the magnitude of cerebellar activations was dependent on the current amplitude of the EM, confirming the EM is the cause of the cerebellar activations. These results suggest the importance of considering polysynaptic signal propagation, particularly via pathways including subcortical structures, for correctly interpreting 'functional connectivity' as assessed by simultaneous EM and fMRI.	[Matsui, Teppei; Koyano, Kenji W.; Tamura, Keita; Osada, Takahiro; Adachi, Yusuke; Miyamoto, Kentaro; Chikazoe, Junichi; Kamigaki, Tsukasa; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan; [Matsui, Teppei; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Phys, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Osada, Takahiro/GLU-9088-2022; ADACHI, Yusuke/O-5316-2016; Tamura, Keita/I-2931-2012; Miyashita, Yasushi/B-7171-2019	Osada, Takahiro/0000-0002-3743-3200; ADACHI, Yusuke/0000-0001-8697-994X; Tamura, Keita/0000-0003-2697-1510; Kamigaki, Tsukasa/0000-0002-5184-708X; Koyano, Kenji/0000-0002-2160-1732; Chikazoe, Junichi/0000-0003-4155-1370; Miyashita, Yasushi/0000-0003-3496-8637; Miyamoto, Kentaro/0000-0003-1386-0045	Ministry for Education, Culture, Sports, Science and Technology (MEXT) [19002010, 24220008]; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS) [218747, 211438, 234682, 23800017]; Grants-in-Aid for Scientific Research [23800017] Funding Source: KAKEN	Ministry for Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Specially Promoted Research (19002010), a Grant-in-Aid for Scientific Research (S) (24220008) from the Ministry for Education, Culture, Sports, Science and Technology (MEXT), and by the Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency to Y. M.; Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists to T. M. (218747), K. T. (211438) and K. M. (234682); Grant-in-Aid for Research Activity Start-up to K. W. K. (23800017) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2012, CEREB CORTEX, V22, P1586, DOI 10.1093/cercor/bhr234; Bushara KO, 2001, NEUROREPORT, V12, P2483, DOI 10.1097/00001756-200108080-00039; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Field CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003928; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Koyama M, 2004, NEURON, V41, P795, DOI 10.1016/S0896-6273(04)00047-9; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Logothetis NK, 2010, NAT NEUROSCI, V13, P1283, DOI 10.1038/nn.2631; Matsui T, 2007, NAT METHODS, V4, P161, DOI 10.1038/nmeth987; Matsui T, 2011, CEREB CORTEX, V21, P2348, DOI 10.1093/cercor/bhr019; Moeller S, 2008, SCIENCE, V320, P1355, DOI 10.1126/science.1157436; Murayama Y, 2011, MAGN RESON IMAGING, V29, P1351, DOI 10.1016/j.mri.2011.08.002; Ohashi Y, 2011, MOL CELL NEUROSCI, V46, P136, DOI 10.1016/j.mcn.2010.08.013; Paxinos G., 2000, RHESUS MONKEY BRAIN; Schmahmann JD, 1996, HUM BRAIN MAPP, V4, P174, DOI 10.1002/(SICI)1097-0193(1996)4:3<174::AID-HBM3>3.0.CO;2-0; SHARP FR, 1989, J COMP NEUROL, V284, P621, DOI 10.1002/cne.902840409; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Sultan F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1912; Sutan F, 2011, MAGN RESON IMAGING, V29, P1374, DOI 10.1016/j.mri.2011.04.005; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034	22	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47515	10.1371/journal.pone.0047515	http://dx.doi.org/10.1371/journal.pone.0047515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118875	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500020
J	Schumacher, J; Pradier, JM; Simon, A; Traeger, S; Moraga, J; Collado, IG; Viaud, M; Tudzynski, B				Schumacher, Julia; Pradier, Jean-Marc; Simon, Adeline; Traeger, Stefanie; Moraga, Javier; Gonzalez Collado, Isidro; Viaud, Muriel; Tudzynski, Bettina			Natural Variation in the VELVET Gene bcvel1 Affects Virulence and Light-Dependent Differentiation in Botrytis cinerea	PLOS ONE			English	Article							ABC TRANSPORTER BCATRB; GRAY MOLD FUNGUS; ASPERGILLUS-NIDULANS; SCLEROTINIA-SCLEROTIORUM; BOTRYOTINIA-FUCKELIANA; SECONDARY METABOLISM; NECROTIZING ACTIVITY; OXALIC-ACID; VEA GENE; BIOSYNTHESIS	Botrytis cinerea is an aggressive plant pathogen causing gray mold disease on various plant species. In this study, we identified the genetic origin for significantly differing phenotypes of the two sequenced B. cinerea isolates, B05.10 and T4, with regard to light-dependent differentiation, oxalic acid (OA) formation and virulence. By conducting a map-based cloning approach we identified a single nucleotide polymorphism (SNP) in an open reading frame encoding a VELVET gene (bcvel1). The SNP in isolate T4 results in a truncated protein that is predominantly found in the cytosol in contrast to the full-length protein of isolate B05.10 that accumulates in the nuclei. Deletion of the full-length gene in B05.10 resulted in the T4 phenotype, namely light-independent conidiation, loss of sclerotial development and oxalic acid production, and reduced virulence on several host plants. These findings indicate that the identified SNP represents a loss-of-function mutation of bcvel1. In accordance, the expression of the B05.10 copy in T4 rescued the wild-type/B05.10 phenotype. BcVEL1 is crucial for full virulence as deletion mutants are significantly hampered in killing and decomposing plant tissues. However, the production of the two best known secondary metabolites, the phytotoxins botcinic acid and botrydial, are not affected by the deletion of bcvel1 indicating that other factors are responsible for reduced virulence. Genome-wide expression analyses of B05.10- and Delta bcvel1-infected plant material revealed a number of genes differentially expressed in the mutant: while several protease-encoding genes are under-expressed in Delta bcvel1 compared to the wild type, the group of over-expressed genes is enriched for genes encoding sugar, amino acid and ammonium transporters and glycoside hydrolases reflecting the response of Delta bcvel1 mutants to nutrient starvation conditions.	[Pradier, Jean-Marc; Simon, Adeline; Viaud, Muriel] INRA, BIOGER, Grignon, France; [Schumacher, Julia; Traeger, Stefanie; Tudzynski, Bettina] Univ Munster, IBBP, Munster, Germany; [Moraga, Javier; Gonzalez Collado, Isidro] Univ Cadiz, Dept Organ Chem, Cadiz, Spain	AgroParisTech; INRAE; University of Munster; Universidad de Cadiz	Viaud, M (corresponding author), INRA, BIOGER, Grignon, France.	viaud@versailles.inra.fr; Bettina.Tudzynski@uni-muenster.de	Moraga, Javier/E-6056-2015; Schumacher, Julia/B-9142-2019; Collado, Isidro G. González/G-5501-2015	Moraga, Javier/0000-0001-6383-924X; Schumacher, Julia/0000-0001-9120-9675; Collado, Isidro G. González/0000-0002-8612-0593; Simon, Adeline/0000-0002-0020-6442	MICINN [AGL2009-13359-C02-01]; Junta de Andalucia [P07-FQM-02689]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Junta de Andalucia(Junta de Andalucia)	IGC acknowledges the financial support from MICINN (AGL2009-13359-C02-01) and Junta de Andalucia (P07-FQM-02689). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Barnes B, 1930, ANN BOT-LONDON, V44, P825, DOI 10.1093/oxfordjournals.aob.a090252; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2008, FUNGAL GENET BIOL, V45, P127, DOI 10.1016/j.fgb.2007.06.001; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Beever RE, 2007, BOTRYTIS BIOL PATHOL, P29; Billon-Grand G, 2012, MOL PLANT PATHOL, V13, P568, DOI 10.1111/j.1364-3703.2011.00772.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brito N, 2006, MOL PLANT MICROBE IN, V19, P25, DOI 10.1094/MPMI-19-0025; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Chettri P, 2012, FUNGAL GENET BIOL, V49, P141, DOI 10.1016/j.fgb.2011.11.009; Choi YE, 2011, APPL ENVIRON MICROB, V77, P942, DOI 10.1128/AEM.01830-10; Choquer M, 2007, FEMS MICROBIOL LETT, V277, P1, DOI 10.1111/j.1574-6968.2007.00930.x; Coley-Smith JR, 1980, BIOL BOTRYTIS CINERE; Collado IG, 2000, CURR ORG CHEM, V4, P1261, DOI 10.2174/1385272003375815; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; COVE DJ, 1976, HEREDITY, V36, P191, DOI 10.1038/hdy.1976.24; Dalmais B, 2011, MOL PLANT PATHOL, V12, P564, DOI [10.1111/j.1364-3703.2010.00692.x, 10.1111/J.1364-3703.2010.00692.X]; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Doss RP, 2003, PHYTOCHEMISTRY, V63, P687, DOI 10.1016/S0031-9422(03)00323-6; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; Duran RM, 2007, APPL MICROBIOL BIOT, V73, P1158, DOI 10.1007/s00253-006-0581-5; Elad Y, 2007, BOTRYTIS BIOL PATHOL, P1, DOI DOI 10.1007/978-1-4020-2626-3_1; FARETRA F, 1992, RECENT ADVANCES IN BOTRYTIS RESEARCH, P7; FARETRA F, 1988, J GEN MICROBIOL, V134, P2543; Faretra F., 1987, Phytopathologia Mediterranea, V26, P29; Fillinger S, 2008, ANTIMICROB AGENTS CH, V52, P3933, DOI 10.1128/AAC.00615-08; Frias M, 2011, NEW PHYTOL, V192, P483, DOI 10.1111/j.1469-8137.2011.03802.x; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; Giraud T, 1997, MOL BIOL EVOL, V14, P1177, DOI 10.1093/oxfordjournals.molbev.a025727; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Gonzalez Collado I, 2007, NAT PROD REP, V24, P674, DOI 10.1039/b603085h; GRINDLE M, 1979, J GEN MICROBIOL, V111, P109, DOI 10.1099/00221287-111-1-109; Gronover CS, 2004, MOL PLANT MICROBE IN, V17, P537, DOI 10.1094/MPMI.2004.17.5.537; Gronover CS, 2001, MOL PLANT MICROBE IN, V14, P1293, DOI 10.1094/MPMI.2001.14.11.1293; Han Y, 2007, J BIOL CHEM, V282, P9581, DOI 10.1074/jbc.M608961200; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028291; KAFER E, 1965, GENETICS, V52, P217; KANGATHARALINGAM N, 1984, CURR MICROBIOL, V10, P99, DOI 10.1007/BF01575767; Kars I, 2005, PLANT J, V43, P213, DOI 10.1111/j.1365-313X.2005.02436.x; Kato N, 2003, EUKARYOT CELL, V2, P1178, DOI 10.1128/EC.2.6.1178-1186.2003; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Krappmann S, 2005, EUKARYOT CELL, V4, P1298, DOI 10.1128/EC.4.7.1298-1307.2005; Kretschmer M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000696; Kunz C, 2006, NEW PHYTOL, V170, P537, DOI 10.1111/j.1469-8137.2006.01682.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Laskowski-Peak MC, 2012, FUNGAL GENET BIOL, V49, P838, DOI 10.1016/j.fgb.2012.07.001; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; Liu WW, 2011, FUNGAL GENET BIOL, V48, P377, DOI 10.1016/j.fgb.2010.12.004; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Myung K, 2012, PLANT PATHOL, V61, P152, DOI 10.1111/j.1365-3059.2011.02504.x; Kieu NP, 2012, MOL PLANT PATHOL, V13, P816, DOI 10.1111/j.1364-3703.2012.00790.x; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Noda J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-38; Pinedo C, 2008, ACS CHEM BIOL, V3, P791, DOI 10.1021/cb800225v; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Quidde T, 1998, PHYSIOL MOL PLANT P, V52, P151, DOI 10.1006/pmpp.1998.0142; Reino JL, 2004, J PHYTOPATHOL, V152, P563, DOI 10.1111/j.1439-0434.2004.00896.x; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Rolland S, 2009, MICROBIOL-SGM, V155, P2097, DOI 10.1099/mic.0.025999-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schoonbeek H, 2001, MOL PLANT MICROBE IN, V14, P562, DOI 10.1094/MPMI.2001.14.4.562; Schumacher J, 2012, MORPHOGENESIS PATHOG, V22, P225, DOI DOI 10.1007/978-3-642-22916-9_11; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Simon A, 2010, BIOINFORMATICS, V26, P2468, DOI 10.1093/bioinformatics/btq410; Stefanato FL, 2008, 3 BOTR GEN WORKSH TE, P24; Stefanato FL, 2009, PLANT J, V58, P499, DOI 10.1111/j.1365-313X.2009.03794.x; Stinnett SM, 2007, MOL MICROBIOL, V63, P242, DOI 10.1111/j.1365-2958.2006.05506.x; SUZUKI Y, 1979, Annals of the Phytopathological Society of Japan, V45, P54, DOI 10.3186/jjphytopath.45.54; TAN KK, 1973, T BRIT MYCOL SOC, V61, P147; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; Thaning C, 2000, J PHYTOPATHOL, V148, P627, DOI 10.1046/j.1439-0434.2000.00546.x; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Tudzynski P., 2009, MYCOTA, P29; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI 10.1111/J.1364-3703.2007.00417.X; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2; ZEUN R, 1985, PHYTOPATHOL Z, V112, P259; Zheng Q., 2008, NUCLEIC ACIDS RES, V1, P36	96	59	61	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47840	10.1371/journal.pone.0047840	http://dx.doi.org/10.1371/journal.pone.0047840			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118899	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500039
J	Senska, G; Schroder, H; Putter, C; Dost, P				Senska, Goetz; Schroeder, Hilal; Puetter, Carolin; Dost, Philipp			Significantly Reducing Post-Tonsillectomy Haemorrhage Requiring Surgery by Suturing the Faucial Pillars: A Retrospective Analysis	PLOS ONE			English	Article								Background: The tonsillectomy is one of the most frequently performed surgical procedures. Given the comparatively frequent postsurgical bleeding associated with this procedure, particular attention has been paid to reduction of the postoperative bleeding rate. In 2006, we introduced routine suturing of the faucial pillars at our clinic to reduce postoperative haemorrhage. Methods: Two groups from the years 2003-2005 (n = 1000) and 2007-2009 (n = 1000) have been compared. We included all patients who had an elective tonsillectomy due to a benign, non-acute inflammatory tonsil illness. In the years 2007-2009, we additionally sutured the faucial pillars after completing haemostasis. For primary haemostasis we used suture ligation and bipolar diathermy. Results: The rate of bleeding requiring second surgery for haemostasis was 3.6% in 2003-2005 but only 2.0% in 2007-2009 (absolute risk reduction 1.6% (95% CI 0.22%-2.45%, p = 0.04)). The median surgery time-including adenoidectomy and paracentesis surgery-increased from 25 to 31 minutes (p < 0.01). Conclusions: We have been able to substantiate that suturing of the faucial pillars nearly halves the rate of postoperative haemorrhage. Surgery takes 8 minutes longer on average. Bleeding occurs later, mostly after 24 h. The limitations of this study relate to its retrospective character and all the potential biases related to observational studies.	[Senska, Goetz; Schroeder, Hilal; Dost, Philipp] Marienhosp Gelsenkirchen GmbH, Plast Operationen, Ohren Heilkunde, Nasen,Hals, Gelsenkirchen, Germany; [Puetter, Carolin] Univ Klinikum Essen, Inst Med Informat Biometrie & Epidemiol, Essen, Germany	St. Marien Hospital; University of Duisburg Essen	Senska, G (corresponding author), Marienhosp Gelsenkirchen GmbH, Plast Operationen, Ohren Heilkunde, Nasen,Hals, Gelsenkirchen, Germany.	goetzsenska@arcor.de						British Association of Otorhinolaryngologists - Head and Neck Surgeons website, 2005, NAT PROSP TONS AUD F; Burton M, 2007, COCHRANE DB SYST REV, V18; CARMODY D, 1982, J LARYNGOL OTOL, V96, P635, DOI 10.1017/S0022215100092926; GARDNER JF, 1968, ARCH OTOLARYNGOL, V88, P551; KING J T, 1956, Laryngoscope, V66, P1068; Klask J, 2003, GESUNDH OKON QUAL MA, V8, P238; Krishna P, 2001, LARYNGOSCOPE, V111, P1358, DOI 10.1097/00005537-200108000-00008; KRISTENSEN S, 1984, CLIN OTOLARYNGOL, V9, P347, DOI 10.1111/j.1365-2273.1984.tb01519.x; McClelland L, 2005, J LARYNGOL OTOL, V119, P753, DOI 10.1258/002221505774481336; Ramjettan S, 1996, S AFR J SURG, V34, P189; Schmidt H, 1996, LARYNGO RHINO OTOL, V75, P447, DOI 10.1055/s-2007-997613; TAMI TA, 1987, LARYNGOSCOPE, V97, P1307, DOI 10.1288/00005537-198711000-00011; van Cruijsen N, 2008, EUR ARCH OTO-RHINO-L, V265, P115, DOI 10.1007/s00405-007-0391-0; WEIGHILL JS, 1986, J LARYNGOL OTOL, V100, P307, DOI 10.1017/S0022215100099199; Windfuhr JP, 2009, EUR ARCH OTO-RHINO-L, V266, P111, DOI 10.1007/s00405-008-0720-y; Windfuhr JP, 2005, OTOLARYNG HEAD NECK, V132, P281, DOI 10.1016/j.otohns.2004.09.007; Windfuhr JP, 2001, ANAL 229 CASES HNO, V49, P706	17	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47874	10.1371/journal.pone.0047874	http://dx.doi.org/10.1371/journal.pone.0047874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118902	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500041
J	Simon, M; Fromentin, JM; Bonhommeau, S; Gaertner, D; Brodziak, J; Etienne, MP				Simon, Maximilien; Fromentin, Jean-Marc; Bonhommeau, Sylvain; Gaertner, Daniel; Brodziak, Jon; Etienne, Marie-Pierre			Effects of Stochasticity in Early Life History on Steepness and Population Growth Rate Estimates: An Illustration on Atlantic Bluefin Tuna	PLOS ONE			English	Article							MATCH MISMATCH HYPOTHESIS; FINDING CONFIDENCE-LIMITS; COD GADUS-MORHUA; THUNNUS-THYNNUS; STOCK ASSESSMENT; NATURAL MORTALITY; FERTILIZATION SUCCESS; MANAGEMENT PROCEDURES; CARRYING-CAPACITY; BAYESIAN-APPROACH	The intrinsic population growth rate (r) of the surplus production function used in the biomass dynamic model and the steepness (h) of the stock-recruitment relationship used in age-structured population dynamics models are two key parameters in fish stock assessment. There is generally insufficient information in the data to estimate these parameters that thus have to be constrained. We developed methods to directly estimate the probability distributions of r and h for the Atlantic bluefin tuna (Thunnus thynnus, Scombridae), using all available biological and ecological information. We examined the existing literature to define appropriate probability distributions of key life history parameters associated with intrinsic growth rate and steepness, paying particular attention to the natural mortality for early life history stages. The estimated probability distribution of the population intrinsic growth rate was weakly informative, with an estimated mean r = 0.77 (+/-0.53) and an interquartile range of (0.34, 1.12). The estimated distribution of h was more informative, but also strongly asymmetric with an estimated mean h = 0.89 (+/-0.20) and a median of 0.99. We note that these two key demographic parameters strongly depend on the distribution of early life history mortality rate (M-0), which is known to exhibit high year-to-year variations. This variability results in a widely spread distribution of M-0 that affects the distribution of the intrinsic population growth rate and further makes the spawning stock biomass an inadequate proxy to predict recruitment levels.	[Simon, Maximilien] AgroParistech ENGREF, Ecole Natl Genie Rural Eaux & Forets, Paris, France; [Simon, Maximilien; Fromentin, Jean-Marc; Bonhommeau, Sylvain] IFREMER, UMR EME Exploited Marine Ecosyst 212, F-34203 Sete, France; [Gaertner, Daniel] IRD Inst Rech Dev, UMR EME Exploited Marine Ecosyst 212, Sete, France; [Brodziak, Jon] Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Etienne, Marie-Pierre] INRA, UMR AgroParistech INRA 518, Paris, France	AgroParisTech; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; AgroParisTech; INRAE	Simon, M (corresponding author), AgroParistech ENGREF, Ecole Natl Genie Rural Eaux & Forets, Paris, France.	maximilien.simon@ifremer.fr	Bonhommeau, Sylvain/P-8654-2014; Gaertner, Daniel P/H-8042-2013	Bonhommeau, Sylvain/0000-0002-0882-5918; Gaertner, Daniel P/0000-0002-1194-4432; Etienne, Marie-Pierre/0000-0002-2097-2267; Fromentin, Jean-Marc/0000-0002-1496-4332	AgroParistech-ENGREF	AgroParistech-ENGREF	Financial support from AgroParistech-ENGREF (contracts to M.S.) made the report and analysis possible The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain G, 2007, FISH OCEANOGR, V16, P489, DOI 10.1111/j.1365-2419.2007.00443.x; ALVAREZBUYLLA ER, 1994, ECOLOGY, V75, P255, DOI 10.2307/1939401; [Anonymous], 1983, NOAA TECH REPORT NMF; [Anonymous], 2010, WORKSH UND QUANT MOR; [Anonymous], 1999, 1998 DET BLUEF REP I; [Anonymous], 2010, REPORT 2010 ATLANTIC; Baglin RE, 1976, ICCAT COL VOL SCI PA, V5, P279; Bakun A., 1996, OCEAN PROCESSES MARI; Bjornstad ON, 1999, P NATL ACAD SCI USA, V96, P5066, DOI 10.1073/pnas.96.9.5066; BOGSTAD B, 1994, ICES MAR SC, V198, P576; Brandon JR, 2007, ICES J MAR SCI, V64, P1085, DOI 10.1093/icesjms/fsm102; Butterworth DS, 2007, ICES J MAR SCI, V64, P613, DOI 10.1093/icesjms/fsm003; Butterworth DS, 1999, ICES J MAR SCI, V56, P985, DOI 10.1006/jmsc.1999.0532; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Carruthers T, 2010, COMPUTING PRIOR PROB; Caswell H, 2000, MATRIX POPULATION MO, V2nd; Chaloupka M, 2007, ECOL MODEL, V205, P93, DOI 10.1016/j.ecolmodel.2007.02.010; Chen KS, 2006, FISHERIES SCI, V72, P985, DOI 10.1111/j.1444-2906.2006.01247.x; Cochrane KL, 1998, REV FISH BIOL FISHER, V8, P177, DOI 10.1023/A:1008894011847; Conn PB, 2010, CAN J FISH AQUAT SCI, V67, P511, DOI 10.1139/F09-194; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Cort J. L., 1991, COL VOL SCI PAP ICCA, V35, P213; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Cotter AJR, 2004, FISH FISH, V5, P235, DOI 10.1111/j.1467-2679.2004.00157.x; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; Cushing D.H., 1974, P399; Cushing D.H., 1995, POPULATION PRODUCTIO; DAVIS TLO, 1991, MAR ECOL PROG SER, V73, P33, DOI 10.3354/meps073033; Farley JH, 2007, FISH RES, V83, P151, DOI 10.1016/j.fishres.2006.09.006; Farley JH, 1998, FISH B-NOAA, V96, P223; Forrest RE, 2010, CAN J FISH AQUAT SCI, V67, P1611, DOI 10.1139/F10-077; FORTIER L, 1995, MAR ECOL PROG SER, V120, P11, DOI 10.3354/meps120011; Fromentin J-M, 2010, ICCAT COL VOL SCI PA, V65, P1052; Fromentin JM, 2007, CAN J FISH AQUAT SCI, V64, P827, DOI 10.1139/F07-050; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Fromentin JM, 2001, ECOLOGY, V82, P567, DOI 10.1890/0012-9658(2001)082[0567:EODDAS]2.0.CO;2; Fromentin JM, 2001, FISH RES, V53, P133, DOI 10.1016/S0165-7836(00)00299-X; Fromentin JM, 2000, ICES J MAR SCI, V57, P330, DOI 10.1006/jmsc.1999.0638; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garcia A, 2006, SCI MARINA, V70; Garcia S, 1981, DOCUMENTS TECHNIQUES, P224; Gavaris S., 1988, ADAPTIVE FRAMEWORK E; Gelman A., 1992, STAT SCI, V7, P457, DOI [DOI 10.1214/SS/1177011136, 10.1214/ss/1177011136]; Gislason H, 2010, FISH FISH, V11, P149, DOI 10.1111/j.1467-2979.2009.00350.x; Goodyear C.P., 1980, P253; Gotceitas V, 1996, MAR ECOL PROG SER, V130, P29, DOI 10.3354/meps130029; Gunn J., 2001, TUNA PHYSL ECOLOGY E, P167, DOI 10.1016/S1546-5098(01)19006-0; Hammond TR, 2005, J NW ATLANTIC FISHER, V35; Hilborn R, 2007, SCI MAR, V67; Hilborn R., 1991, QUANTITATIVE FISHERI, Vfirst; Hjort J., 1926, Journal du Conseil Copenhague, V1, P5; Hjort J., 1914, RAPPORTS PROCES VERB, V20, P1; HOUDE ED, 1989, FISH B-NOAA, V87, P471; ICCAT, 1996, COLLECT VOL SCI PAP, V43, P1; Itano DG, 2000, JIMAR CONTRIBUTION; Itoh T, 2000, FISHERIES SCI, V66, P834, DOI 10.1046/j.1444-2906.2000.00135.x; JENKINS GP, 1991, CAN J FISH AQUAT SCI, V48, P1358, DOI 10.1139/f91-162; JENKINS GP, 1990, MAR ECOL PROG SER, V63, P93, DOI 10.3354/meps063093; Jusup M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021903; Kaji T, 1996, MAR FRESHWATER RES, V47, P261, DOI 10.1071/MF9960261; Kaji T, 1999, FISHERIES SCI, V65, P583, DOI 10.2331/fishsci.65.583; Kawakami Y, 2008, GEN COMP ENDOCR, V155, P597, DOI 10.1016/j.ygcen.2007.09.005; Kell LT, 2007, CAN J FISH AQUAT SCI, V64, P837, DOI 10.1139/F07-051; Kell LT, 2003, SCI MARINA BARCELONA, V2003; Kelly CJ, 2006, FISH RES, V79, P233, DOI 10.1016/j.fishres.2006.03.007; KIMURA DK, 1988, J CONSEIL, V44, P253; Knell RJ, 1998, TRENDS ECOL EVOL, V13, P186, DOI 10.1016/S0169-5347(97)01321-9; Kurota H, 2009, CAN J FISH AQUAT SCI, V66, P321, DOI 10.1139/F08-197; La Mesa M, 2005, SCI MARINA, V69; LANG KL, 1994, ENVIRON BIOL FISH, V39, P259, DOI 10.1007/BF00005128; LASKER R, 1975, FISH B-NOAA, V73, P453; Lasker R, 1981, ROLE STABLE OCEAN LA; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; LO NCH, 1995, MAR ECOL PROG SER, V127, P15, DOI 10.3354/meps127015; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Mace P.M., 1988, GEN BIOECONOMIC SIMU; Mangel M, 2010, FISH FISH, V11, P89, DOI 10.1111/j.1467-2979.2009.00345.x; Margulies D, 2007, RESUMEN INVESTIGACIO; Mather F.J., 1995, NOAA TECHNICAL MEMOR, V370, P1; May R.C., 1974, P1; McAllister MK, 2001, CAN J FISH AQUAT SCI, V58, P1871, DOI 10.1139/cjfas-58-9-1871; MCALLISTER MK, 1994, CAN J FISH AQUAT SCI, V51, P2673, DOI 10.1139/f94-267; McAllister MK, 1998, ICES J MAR SCI, V55, P1031, DOI 10.1006/jmsc.1998.0425; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; Medina A, 2002, J FISH BIOL, V60, P203, DOI [10.1111/j.1095-8649.2002.tb02398.x, 10.1006/jfbi.2001.1835]; Medina A, 2007, MAR ECOL PROG SER, V337, P221, DOI 10.3354/meps337221; Mertz G., 1994, Fisheries Oceanography, V3, P236, DOI 10.1111/j.1365-2419.1994.tb00101.x; Meyer R, 1999, CAN J FISH AQUAT SCI, V56, P1078, DOI 10.1139/cjfas-56-6-1078; Michielsens CGJ, 2008, CAN J FISH AQUAT SCI, V65, P962, DOI 10.1139/F08-015; Millar RB, 2004, BIOMETRICS, V60, P536, DOI 10.1111/j.0006-341X.2004.00201.x; Miyashita S, 2001, FISHERY B; Miyashita S, 2002, B FISHERIES LAB KINK, P171; Morgan M. Joanne, 2009, Journal of Northwest Atlantic Fishery Science, V41, P37; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1591, DOI 10.1139/f93-180; Myers RA, 1997, FISH B-NOAA, V95, P762; Paradis AR, 1996, CAN J FISH AQUAT SCI, V53, P1226, DOI 10.1139/cjfas-53-6-1226; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P1820, DOI 10.1139/f91-215; Pertierra JP, 1997, FISH RES, V30, P127, DOI 10.1016/S0165-7836(96)00546-2; PETERMAN RM, 1988, CAN J FISH AQUAT SCI, V45, P8, DOI 10.1139/f88-002; PETERSEN CW, 1992, ECOLOGY, V73, P391, DOI 10.2307/1940747; Picard N, 2009, MATH BIOSCI, V219, P23, DOI 10.1016/j.mbs.2009.02.002; Porch CE, 2003, SUSTAINABLE FISHERIE, V75; Punt AE, 1997, REV FISH BIOL FISHER, V7, P35, DOI 10.1023/A:1018419207494; Punt AE, 2001, MAR FRESHWATER RES, V52, P819, DOI 10.1071/MF00095; Punt AE, 2007, ICES J MAR SCI, V64, P603, DOI 10.1093/icesjms/fsm035; Rakitin A, 1999, CAN J FISH AQUAT SCI, V56, P2315, DOI 10.1139/cjfas-56-12-2315; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Restrepo VR, 2010, AQUAT LIVING RESOUR, V23, P335, DOI 10.1051/alr/2011004; Rivot E, 2004, ECOL MODEL, V179, P463, DOI 10.1016/j.ecolmodel.2004.05.011; Rochet MJ, 2005, ICES J MAR SCI, V62, P1647, DOI 10.1016/j.icesjms.2005.06.009; Rodriguez-Roda J, 1967, INVESTIGACION PESQUE, V31, P35; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Rose GA, 1997, REV FISH BIOL FISHER, V7, P365, DOI 10.1023/A:1018495929784; Satoh K, 2008, FISH RES, V89, P248, DOI 10.1016/j.fishres.2007.09.003; Sawada Y, 2005, AQUAC RES, V36, P413, DOI 10.1111/j.1365-2109.2005.01222.x; Schaefer Kurt M., 2005, Inter-American Tropical Tuna Commission Bulletin, V23, P3; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schaefer Kurt M., 1998, Inter-American Tropical Tuna Commission Bulletin, V21, P205; Schaefer MB., 1954, INT AM TROPICAL TUNA, V1, P23; SCOTT GP, 1993, B MAR SCI, V53, P912; Shapiro DY, 1996, BEHAV ECOL, V7, P19, DOI 10.1093/beheco/7.1.19; Sharpe FR, 1911, PHILOS MAG, V21, P5; Stobberup KA, 2006, FISH RES, V82, P194, DOI 10.1016/j.fishres.2006.06.005; Su N, 2011, FISHERIES OCEANOGRAP; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; WARE DM, 1985, CAN J FISH AQUAT SCI, V42, P577, DOI 10.1139/f85-075; Wootton R.J., 1998, ECOLOGY TELEOST FISH	130	15	15	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48583	10.1371/journal.pone.0048583	http://dx.doi.org/10.1371/journal.pone.0048583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119063	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500174
J	Greenberg, CH; Frosch, MP; Goldstein, JN; Rosand, J; Greenberg, SM				Greenberg, Charles H.; Frosch, Matthew P.; Goldstein, Joshua N.; Rosand, Jonathan; Greenberg, Steven M.			Modeling Intracerebral Hemorrhage Growth and Response to Anticoagulation	PLOS ONE			English	Article							BLOOD-PRESSURE REDUCTION; FRESH-FROZEN PLASMA; CEREBRAL-HEMORRHAGE; HEMATOMA EXPANSION; INTRACRANIAL HEMORRHAGE; WARFARIN; THERAPY; COAGULOPATHY; MICROBLEEDS	The mechanism for hemorrhage enlargement in the brain, a key determinant of patient outcome following hemorrhagic stroke, is unknown. We performed computer-based stochastic simulation of one proposed mechanism, in which hemorrhages grow in "domino" fashion via secondary shearing of neighboring vessel segments. Hemorrhages were simulated by creating an initial site of primary bleeding and an associated risk of secondary rupture at adjacent sites that decayed over time. Under particular combinations of parameters for likelihood of secondary rupture and time-dependent decay, a subset of lesions expanded, creating a bimodal distribution of microbleeds and macrobleeds. Systematic variation of the model to simulate anticoagulation yielded increases in both macrobleed occurrence (26.9%, 53.2%, and 70.0% of all hemorrhagic events under conditions simulating no, low-level, and high-level anticoagulation) and final hemorrhage size (median volumes 111, 276, and 412 under the same three conditions), consistent with data from patients with anticoagulant-related brain hemorrhages. Reversal from simulated high-level anticoagulation to normal coagulation was able to reduce final hemorrhage size only if applied relatively early in the course of hemorrhage expansion. These findings suggest that a model based on a secondary shearing mechanism can account for some of the clinically observed properties of intracerebral hemorrhage, including the bimodal distribution of volumes and the enhanced hemorrhage growth seen with anticoagulation. Future iterations of this model may be useful for elucidating the effects of hemorrhage growth of factors related to secondary shearing (such as small vessel pathology) or time-dependent decay (such as hemostatic agents).	[Rosand, Jonathan; Greenberg, Steven M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Greenberg, Charles H.] Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut, San Francisco, CA USA; [Greenberg, Charles H.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA USA; [Frosch, Matthew P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, CS Kubik Lab Neuropathol, Boston, MA USA; [Goldstein, Joshua N.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Emergency Med, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Greenberg, SM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA.	sgreenberg@partners.org	Demchuk, Andrew M/E-1103-2012; Frosch, Matthew P/ABD-7456-2021; Goldstein, Joshua N/H-8953-2016	Demchuk, Andrew M/0000-0002-4930-7789; Frosch, Matthew P/0000-0002-3940-9861; 	National Institutes of Health [R01 AG026484]; National Science Foundation Graduate Research Fellowship [DGE-1144247]; NATIONAL INSTITUTE ON AGING [R01AG026484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (R01 AG026484), the National Science Foundation Graduate Research Fellowship under grant DGE-1144247. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Biffi A, 2011, LANCET NEUROL, V10, P702, DOI 10.1016/S1474-4422(11)70148-X; Boyko MJ, 2012, STROKE, V43, pA3046; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brody DL, 2005, NEUROCRIT CARE, V2, P263, DOI 10.1385/NCC:2:3:263; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brouwers HB, 2012, STROKE J CEREBRAL CI; Cucchiara B, 2008, STROKE, V39, P2993, DOI 10.1161/STROKEAHA.108.520668; Dowlatshahi D, 2011, NEUROLOGY, V76, P1238, DOI 10.1212/WNL.0b013e3182143317; FISHER CM, 1971, J NEUROPATH EXP NEUR, V30, P536, DOI 10.1097/00005072-197107000-00015; Flaherty ML, 2008, NEUROLOGY, V71, P1084, DOI 10.1212/01.wnl.0000326895.58992.27; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Goldstein JN, 2008, NEUROCRIT CARE, V9, P277, DOI 10.1007/s12028-008-9049-z; Greenberg SM, 2009, STROKE, V40, P2382, DOI 10.1161/STROKEAHA.109.548974; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; HART RG, 1995, STROKE, V26, P1471, DOI 10.1161/01.STR.26.8.1471; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Qureshi AI, 2010, ARCH NEUROL-CHICAGO, V67, P570, DOI 10.1001/archneurol.2010.61; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Siddiq F, 2008, NEUROCRIT CARE, V8, P36, DOI 10.1007/s12028-007-9011-5; Sjoblom L, 2001, STROKE, V32, P2567, DOI 10.1161/hs1101.098523; Steiner T, 2010, STROKE, V41, P402, DOI 10.1161/STROKEAHA.109.552919; Woo D, 2002, STROKE, V33, P1190, DOI 10.1161/01.STR.0000014774.88027.22; Yamashita S, 2011, INTERNAL MED, V50, P413, DOI 10.2169/internalmedicine.50.4239	26	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48458	10.1371/journal.pone.0048458	http://dx.doi.org/10.1371/journal.pone.0048458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119028	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600045
J	Ioudinkova, ES; Barat, A; Pichugin, A; Markova, E; Sklyar, I; Pirozhkova, I; Robin, C; Lipinski, M; Ogryzko, V; Vassetzky, YS; Razin, SV				Ioudinkova, Elena S.; Barat, Ana; Pichugin, Andrey; Markova, Elena; Sklyar, Ilya; Pirozhkova, Iryna; Robin, Chloe; Lipinski, Marc; Ogryzko, Vasily; Vassetzky, Yegor S.; Razin, Sergey V.			Distinct Distribution of Ectopically Expressed Histone Variants H2A.Bbd and MacroH2A in Open and Closed Chromatin Domains	PLOS ONE			English	Article							INACTIVE X-CHROMOSOME; GENE-EXPRESSION; ALPHA-GLOBIN; REGULATORY ELEMENTS; NUCLEOSOME; PROTEIN; SPERMIOGENESIS; TRANSCRIPTION; REPLICATION; EXPLORATION	Background: It becomes increasingly evident that nuclesomes are far from being identical to each other. This nucleosome diversity is due partially to the existence of histone variants encoded by separate genes. Among the known histone variants the less characterized are H2A.Bbd and different forms of macroH2A. This is especially true in the case of H2A.Bbd as there are still no commercially available antibodies specific to H2A.Bbd that can be used for chromatin immunoprecipitation (ChIP). Methods: We have generated HeLa S3 cell lines stably expressing epitope-tagged versions of macroH2A1.1, H2A.Bbd or canonical H2A and analyzed genomic distribution of the tagged histones using ChIP-on-chip technique. Results: The presence of histone H2A variants macroH2A1.1 and H2A.Bbd has been analyzed in the chromatin of several segments of human chromosomes 11, 16 and X that have been chosen for their different gene densities and chromatin status. Chromatin immunoprecipitation (ChIP) followed by hybridization with custom NimbleGene genomic microarrays demonstrated that in open chromatin domains containing tissue-specific along with housekeeping genes, the H2A.Bbd variant was preferentially associated with the body of a subset of transcribed genes. The macroH2A1.1 variant was virtually absent from some genes and underrepresented in others. In contrast, in closed chromatin domains which contain only tissue-specific genes inactive in HeLa S3 cells, both macroH2A1.1 and H2A.Bbd histone variants were present and often colocalized. Conclusions: Genomic distribution of macro H2A and H2A.Bbd does not follow any simple rule and is drastically different in open and closed genomic domains.	[Ioudinkova, Elena S.; Barat, Ana; Pichugin, Andrey; Markova, Elena; Sklyar, Ilya; Pirozhkova, Iryna; Robin, Chloe; Lipinski, Marc; Ogryzko, Vasily; Vassetzky, Yegor S.] Univ Paris 11, CNRS, Inst Canc Gustave Roussy, UMR 8126, Villejuif, France; [Ioudinkova, Elena S.; Markova, Elena; Sklyar, Ilya; Razin, Sergey V.] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Ioudinkova, Elena S.; Pichugin, Andrey; Markova, Elena; Sklyar, Ilya; Pirozhkova, Iryna; Robin, Chloe; Lipinski, Marc; Ogryzko, Vasily; Vassetzky, Yegor S.; Razin, Sergey V.] Lab Franco Russe Rech Oncol, LIA1066, Villejuif, France; [Barat, Ana] Dublin City Univ, Sch Comp, Ctr Sci Comp & Complex Syst Modelling SCI SYM, Dublin 9, Ireland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Dublin City University	Vassetzky, YS (corresponding author), Univ Paris 11, CNRS, Inst Canc Gustave Roussy, UMR 8126, Villejuif, France.	vassetzky@igr.fr	Pichugin, Andrey Mihaylovich/Q-1759-2016; Ogryzko, Vasily/M-6665-2015; Vassetzky, Yegor S/C-6447-2008; Razin, Sergey V/M-6701-2015; Vassetzky, Yegor/M-3383-2019	Pichugin, Andrey Mihaylovich/0000-0003-3810-1977; Ogryzko, Vasily/0000-0002-8548-1389; Vassetzky, Yegor S/0000-0003-3101-7043; Razin, Sergey V/0000-0003-1976-8661; Vassetzky, Yegor/0000-0003-3101-7043; Pirozhkova, Iryna/0000-0001-8196-7069	Ministry of Science and Education of the Russian Federation [16.740.11.0353, 16.740.11.0483]; Russian Academy of Sciences; Russian Foundation for the Support of Fundamental Sciences (RFBR) [09-04-12033-ofi_m, 11-04-00361_a]; INCa; Canceropole d'Ile de France; Fondation de France; postdoctoral fellowship from the Fondation de France; IRCSET INSPIRE International Mobility Fellowship Scheme, Dublin Ireland	Ministry of Science and Education of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for the Support of Fundamental Sciences (RFBR); INCa(Institut National du Cancer (INCA) France); Canceropole d'Ile de France(Region Ile-de-France); Fondation de France(Fondation de France); postdoctoral fellowship from the Fondation de France; IRCSET INSPIRE International Mobility Fellowship Scheme, Dublin Ireland	The work of SR lab was supported by the Ministry of Science and Education of the Russian Federation (grants 16.740.11.0353, 16.740.11.0483), the presidium of the Russian Academy of Sciences (grant MCB), by Russian Foundation for the Support of Fundamental Sciences (RFBR grants 09-04-12033-ofi_m and 11-04-00361_a). The work in YV lab was supported by INCa, Canceropole d'Ile de France and the Fondation de France. AP was supported by a postdoctoral fellowship from the Fondation de France. AB was supported by IRCSET INSPIRE International Mobility Fellowship Scheme, Dublin Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; Alexander MK, 2007, J CELL BIOL, V179, P269, DOI 10.1083/jcb.200706053; Angelov D, 2004, EMBO J, V23, P3815, DOI 10.1038/sj.emboj.7600400; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Chadwick BP, 2001, NUCLEIC ACIDS RES, V29, P2699, DOI 10.1093/nar/29.13.2699; Chadwick BP, 2001, J CELL BIOL, V152, P375, DOI 10.1083/jcb.152.2.375; Changolkar LN, 2008, MOL CELL BIOL, V28, P2059, DOI 10.1128/MCB.01362-07; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Choo JH, 2006, HUM MOL GENET, V15, P717, DOI 10.1093/hmg/ddi485; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; CRADDOCK CF, 1995, EMBO J, V14, P1718, DOI 10.1002/j.1460-2075.1995.tb07161.x; Dillon N, 2000, BIOESSAYS, V22, P657, DOI 10.1002/1521-1878(200007)22:7<657::AID-BIES8>3.3.CO;2-U; Flint J, 2001, HUM MOL GENET, V10, P371, DOI 10.1093/hmg/10.4.371; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Gautier T, 2004, EMBO REP, V5, P715, DOI 10.1038/sj.embor.7400182; Gonzalez-Romero R, 2008, GENE, V413, P1, DOI 10.1016/j.gene.2008.02.003; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishibashi T, 2010, NUCLEIC ACIDS RES, V38, P1780, DOI 10.1093/nar/gkp1129; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Klochkov DB, 2009, GENOMICS, V93, P481, DOI 10.1016/j.ygeno.2009.01.001; Marques M, 2010, EPIGENETICS-US, V5, P267, DOI 10.4161/epi.5.4.11520; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; NOLL M, 1974, NATURE, V251, P249, DOI 10.1038/251249a0; OLINS AL, 1974, SCIENCE, V183, P330, DOI 10.1126/science.183.4122.330; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; Razin SV, 2003, INT REV CYTOL, V226, P63, DOI 10.1016/S0074-7696(03)01002-7; Scacheri PC, 2006, METHOD ENZYMOL, V411, P270, DOI 10.1016/S0076-6879(06)11014-9; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; Shaw ML, 2009, MOL REPROD DEV, V76, P1128, DOI 10.1002/mrd.21077; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tolstorukov MY, 2012, MOL CELL IN PRESS; Tufarelli C, 2001, GENOMICS, V71, P307, DOI 10.1006/geno.2000.6394; Viens A, 2006, MOL CELL BIOL, V26, P5325, DOI 10.1128/MCB.00584-06; Wang J, 2011, BBA-GENE REGUL MECH, V1809, P221, DOI 10.1016/j.bbagrm.2011.04.003; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	48	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47157	10.1371/journal.pone.0047157	http://dx.doi.org/10.1371/journal.pone.0047157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118866	gold, Green Submitted, Green Published			2022-12-25	WOS:000310705600009
J	Lin, DM; Lai, JS; Muller-Landau, HC; Mi, XC; Ma, KP				Lin, Dunmei; Lai, Jiangshan; Muller-Landau, Helene C.; Mi, Xiangcheng; Ma, Keping			Topographic Variation in Aboveground Biomass in a Subtropical Evergreen Broad-Leaved Forest in China	PLOS ONE			English	Article							NEOTROPICAL FOREST; SPATIAL-PATTERNS; CARBON STOCKS; HABITAT ASSOCIATIONS; AMAZONIAN FOREST; TROPICAL FOREST; CLIMATE-CHANGE; LIVE BIOMASS; TREE; SOIL	The subtropical forest biome occupies about 25% of China, with species diversity only next to tropical forests. Despite the recognized importance of subtropical forest in regional carbon storage and cycling, uncertainties remain regarding the carbon storage of subtropical forests, and few studies have quantified within-site variation of biomass, making it difficult to evaluate the role of these forests in the global and regional carbon cycles. Using data for a 24-ha census plot in east China, we quantify aboveground biomass, characterize its spatial variation among different habitats, and analyse species relative contribution to the total aboveground biomass of different habitats. The average aboveground biomass was 223.0 Mg ha(-1) (bootstrapped 95% confidence intervals [217.6, 228.5]) and varied substantially among four topographically defined habitats, from 180.6 Mg ha(-1) (bootstrapped 95% CI [167.1, 195.0]) in the upper ridge to 245.9 Mg ha 21 (bootstrapped 95% CI [238.3, 253.8]) in the lower ridge, with upper and lower valley intermediate. In consistent with our expectation, individual species contributed differently to the total aboveground biomass of different habitats, reflecting significant species habitat associations. Different species show differently in habitat preference in terms of biomass contribution. These patterns may be the consequences of ecological strategies difference among different species. Results from this study enhance our ability to evaluate the role of subtropical forests in the regional carbon cycle and provide valuable information to guide the protection and management of subtropical broad-leaved forest for carbon sequestration and carbon storage.	[Lin, Dunmei; Lai, Jiangshan; Mi, Xiangcheng; Ma, Keping] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Lin, Dunmei] Beijing Univ, Chinese Acad Sci, Beijing 100871, Peoples R China; [Muller-Landau, Helene C.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Peking University; Smithsonian Institution; Smithsonian Tropical Research Institute	Ma, KP (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	kpma@ibcas.ac.cn	Lin, Dunmei/I-6779-2012	Lin, Dunmei/0000-0001-6112-7783; Muller-Landau, Helene C./0000-0002-3526-9021	Chinese Academy of Sciences [KZCX2-YW-430]; Earthwatch Institute; HSBC Climate Partnership	Chinese Academy of Sciences(Chinese Academy of Sciences); Earthwatch Institute; HSBC Climate Partnership	This study was funded by Chinese Academy of Sciences (KZCX2-YW-430). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Ryan Chisholm for helpful suggestions in manuscript preparation and the field crew for their hard work throughout this study. We are grateful to acknowledge the support of Earthwatch Institute and the HSBC Climate Partnership.	Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baraloto C, 2011, GLOBAL CHANGE BIOL, V17, P2677, DOI 10.1111/j.1365-2486.2011.02432.x; Brown S, 2002, ENVIRON POLLUT, V116, P363, DOI 10.1016/S0269-7491(01)00212-3; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Caspersen JP, 2001, ECOL RES, V16, P895, DOI 10.1046/j.1440-1703.2001.00455.x; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Chen B, 2009, GUTIANSHAN FOREST DY; Chen Q., 1993, CHIN J PLANT ECOL, V17, P38; Chen W, 2000, J FUJIAN FORESTRY TE, V27, P31; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Du G, 1987, J ZHEJIANG FORESTRY, V7, P5; Du YJ, 2012, ACTA OECOL, V39, P87, DOI 10.1016/j.actao.2012.01.006; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fang JY, 1998, ECOL APPL, V8, P1084, DOI 10.2307/2640963; Fang JY., 1996, ACTA ECOL SIN, V16, P497, DOI DOI 10.1016/j.chnaes.2015.03.001; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hoover CM, 2012, FOREST ECOL MANAG, V266, P108, DOI 10.1016/j.foreco.2011.11.010; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; [胡正华 Hu Zhenghua], 2008, [生态环境, Ecology and Environment], V17, P1961; Hughes RF, 1999, ECOLOGY, V80, P1892; Imai N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008267; Keith H, 2010, GLOBAL CHANGE BIOL, V16, P2971, DOI 10.1111/j.1365-2486.2009.02146.x; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; KIRA T, 1991, ECOL RES, V6, P185, DOI 10.1007/BF02347161; Kohl M, 2006, TROP FOREST, P1; Kral K, 2010, FOREST ECOL MANAG, V260, P2196, DOI 10.1016/j.foreco.2010.09.020; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Liu A., 2002, NATURAL FOREST RESOU; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Lorenz K, 2010, CARBON SEQUESTRATION IN FOREST ECOSYSTEMS, P1, DOI 10.1007/978-90-481-3266-9; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Man XingXing, 2011, Biodiversity Science, V19, P197, DOI 10.3724/SP.J.1003.2011.09220; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; McEwan RW, 2011, FOREST ECOL MANAG, V262, P1817, DOI 10.1016/j.foreco.2011.07.028; Naeem S., 2009, BIODIVERSITY ECOSYST; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paoli GD, 2008, OECOLOGIA, V155, P287, DOI 10.1007/s00442-007-0906-9; Paoli GD, 2007, ECOSYSTEMS, V10, P503, DOI 10.1007/s10021-007-9042-y; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Ruiz-Jaen MC, 2011, NEW PHYTOL, V189, P978, DOI 10.1111/j.1469-8137.2010.03501.x; Ruiz-Jaen MC, 2010, BIOTROPICA, V42, P638, DOI 10.1111/j.1744-7429.2010.00631.x; Running SW, 2008, SCIENCE, V321, P652, DOI 10.1126/science.1159607; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Schulze ED, 2006, BIOGEOSCIENCES, V3, P147, DOI 10.5194/bg-3-147-2006; Shi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020778; Smithwick EAH, 2002, ECOL APPL, V12, P1303, DOI 10.1890/1051-0761(2002)012[1303:PUBOCS]2.0.CO;2; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Tateno R, 2003, ECOL RES, V18, P559, DOI 10.1046/j.1440-1703.2003.00578.x; Vance-Chalcraft HD, 2010, BIOTROPICA, V42, P290, DOI 10.1111/j.1744-7429.2009.00600.x; VANSCHAIK CP, 1985, BIOTROPICA, V17, P196, DOI 10.2307/2388217; Vittoz P, 2007, BOT HELV, V117, P109, DOI 10.1007/s00035-007-0797-8; Wang XH, 2007, FOREST ECOL MANAG, V245, P76, DOI 10.1016/j.foreco.2007.03.043; Wu, 1980, VEGETATION CHINA; Yamada T, 2007, J ECOL, V95, P332, DOI 10.1111/j.1365-2745.2006.01209.x; Yang TH, 2010, SCI CHINA LIFE SCI, V53, P811, DOI 10.1007/s11427-010-4021-5; Yu MingJian, 2001, Journal of Zhejiang University (Agriculture and Life Sciences), V27, P375; Zhang J, 2007, FOREST ECOL MANAG, V245, P64, DOI 10.1016/j.foreco.2007.03.042; Zhang L., 2010, THESIS CHINESE ACAD; Zhong Z, 1987, J SW CHINA NORMAL U, V3, P109	71	48	63	9	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48244	10.1371/journal.pone.0048244	http://dx.doi.org/10.1371/journal.pone.0048244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118961	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705600033
J	Nelson, AM; Walk, ST; Taube, S; Taniuchi, M; Houpt, ER; Wobus, CE; Young, VB				Nelson, Adam M.; Walk, Seth T.; Taube, Stefan; Taniuchi, Mami; Houpt, Eric R.; Wobus, Christiane E.; Young, Vincent B.			Disruption of the Human Gut Microbiota following Norovirus Infection	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; UNITED-STATES; ESCHERICHIA-COLI; GASTROINTESTINAL MICROBIOTA; MOLECULAR EPIDEMIOLOGY; INTESTINAL MICROBIOTA; DISEASE; GASTROENTERITIS; PROBIOTICS; DIARRHEA	The gut microbiota, the collection of all bacterial members in the intestinal tract, plays a key role in health. Disruption of the indigenous microbiota by a variety of stressors, including antibiotic therapy and intestinal infections, is associated with multiple health problems. We sought to determine if infection with Norovirus disrupts the gut microbiota. Barcoded pyrosequencing of the 16S rRNA-encoding gene was used to characterize the stool microbiota in Norovirus-infected human patients (n = 38). While the microbiota in most infected patients (n = 31) resembled that seen in uninfected healthy controls, a minority of patients (n = 7) possessed a significantly altered microbiota characterized by reduced relative numbers of Bacteriodetes and a corresponding increase in Proteobacteria. In these patients, the increase in Proteobacteria was due to a single operational taxonomic unit (OTU) of Escherichia coli. We cultured E. coli from Norovirus-infected patients and characterized them using PCR-ribotyping and virulence factor analysis. Multiple ribotypes were encountered, but none possessed typical virulence factors commonly carried by enteropathogenic E. coli strains. Microbiota disruption and elevated Proteobacteria were not significantly correlated to patient age, gender, sampling time following illness onset, or overall gut inflammation. These results demonstrate that some patients have a disrupted microbiota following Norovirus infection, and therefore may be at elevated risk for long-term health complications.	[Nelson, Adam M.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Nelson, Adam M.; Walk, Seth T.; Young, Vincent B.] Univ Michigan, Sch Med, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA; [Taube, Stefan; Wobus, Christiane E.; Young, Vincent B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Taniuchi, Mami; Houpt, Eric R.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Virginia	Nelson, AM (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	nelso222@gmail.com	Young, Vincent B/B-3179-2009; Young, Vincent Bensan/M-9916-2019	Young, Vincent B/0000-0003-3687-2364; Young, Vincent Bensan/0000-0003-3687-2364; Wobus, Christiane/0000-0001-5286-0924; Taube, Stefan/0000-0002-9159-3651	National Institute of Allergy and Infectious Diseases (NIAID) [5 U01 AI075396]; University of Michigan T32 Pulmonary training grant; Biological Sciences Scholars Program; University of Michigan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075396] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Michigan T32 Pulmonary training grant; Biological Sciences Scholars Program; University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Award Number 5 U01 AI075396 from the National Institute of Allergy and Infectious Diseases (NIAID) to V.B.Y., the University of Michigan T32 Pulmonary training grant to A.M.N., the Biological Sciences Scholars Program and start-up funds from the University of Michigan to C.E.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Carroll IM, 2012, NEUROGASTROENTEROL M; Chen CC, 2011, WORLD J GASTROENTERO, V17, P4218, DOI 10.3748/wjg.v17.i37.4218; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clarke G, 2012, ALIMENT PHARM THER, V35, P403, DOI 10.1111/j.1365-2036.2011.04965.x; FENG PCS, 1982, APPL ENVIRON MICROB, V43, P1320, DOI 10.1128/AEM.43.6.1320-1329.1982; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Green K, 2007, FIELDS VIROLOGY, P949; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; Hohne M, 2004, J MED VIROL, V72, P312, DOI 10.1002/jmv.10573; Hoveyda N, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-15; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jensen MA, 1996, APPL ENVIRON MICROB, V62, P2741, DOI 10.1128/AEM.62.8.2741-2746.1996; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; KOSTMAN JR, 1992, J CLIN MICROBIOL, V30, P2084, DOI 10.1128/JCM.30.8.2084-2087.1992; Krogius-Kurikka L, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-95; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Lyra A, 2009, WORLD J GASTROENTERO, V15, P5936, DOI 10.3748/wjg.15.5936; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Marshall JK, 2007, CLIN GASTROENTEROL H, V5, P457, DOI 10.1016/j.cgh.2006.11.025; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Pyleris E, 2012, DIG DIS SCI; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwille-Kiuntke J, 2011, NEUROGASTROENT MOTIL, V23, pE479, DOI 10.1111/j.1365-2982.2011.01779.x; Schwille-Kiuntke J, 2011, Z GASTROENTEROL, V49, P997, DOI 10.1055/s-0031-1281581; Shornikova AV, 1997, PEDIATR INFECT DIS J, V16, P1103, DOI 10.1097/00006454-199712000-00002; Si JM, 2004, WORLD J GASTROENTERO, V10, P1802; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Taniuchi M, 2012, DIAGNOSTIC IN PRESS; Thabane M, 2010, AM J GASTROENTEROL, V105, P933, DOI 10.1038/ajg.2010.74; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Varyukhina S, 2012, MICROBES INFECT, V14, P273, DOI 10.1016/j.micinf.2011.10.007; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Zanini B, 2012, AM J GASTROENTEROL; Zheng DP, 2010, J CLIN MICROBIOL, V48, P168, DOI 10.1128/JCM.01622-09	53	86	87	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48224	10.1371/journal.pone.0048224	http://dx.doi.org/10.1371/journal.pone.0048224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118957	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705600030
J	Shi, DN; Li, P; Ma, L; Zhong, DY; Chu, HY; Yan, F; Lv, Q; Qin, C; Wang, W; Wang, ML; Tong, N; Zhang, ZD; Yin, CJ				Shi, Danni; Li, Pu; Ma, Lan; Zhong, Dongyan; Chu, Haiyan; Yan, Fu; Lv, Qiang; Qin, Chao; Wang, Wei; Wang, Meilin; Tong, Na; Zhang, Zhengdong; Yin, Changjun			A Genetic Variant in pre-miR-27a Is Associated with a Reduced Renal Cell Cancer Risk in a Chinese Population	PLOS ONE			English	Article							ONCOGENIC MICRORNA-27A; CIGARETTE-SMOKING; CARCINOMA; EXPRESSION; PRECURSORS; MATURATION; SURVIVIN; TARGET; COHORT; MIRNA	Background: MicroRNAs (miRNAs) are a class of small non-coding RNAs to regulate cell differentiation, proliferation, development, and apoptosis. The single nucleotide polymorphism (SNP) rs895819 is located at the terminal loop of pre-miR-27a. Here, we aimed to investigate whether SNP rs895819 was associated with the development of renal cell cancer (RCC) in a Chinese population. Methods: In this case-control study, we recruited 594 RCC patients and 600 cancer-free controls with frequency matched by age and sex. We genotyped this polymorphism using the TaqMan assay and assessed the effect of this polymorphism on RCC survival. Logistic regression model was used to assess the genetic effects on the development of RCC and interactions between rs895819 polymorphism and risk factors. Results: Compared with AA homozygote, individuals carrying AG/GG genotypes had a statistically significant reduced susceptibility to RCC (adjusted OR = 0.71, 95% CI = 0.56-0.90). Furthermore, AG/GG genotypes were associated with reduced RCC susceptibility in localized clinical stage (adjusted OR = 0.71, 95% CI = 0.55-0.91), and similar effects were observed in well differentiated and poorly differentiated RCC (adjusted OR = 0.71, 95% CI = 0.55-0.93 for well differentiated, adjusted OR = 0.51, 95% CI = 0.28-0.93 for poorly differentiated). We also observed that rs895819 had multiplicative interactions with age and hypertension. However, the polymorphism did not influence the survival of RCC. Conclusion: Our results suggest that the pre-miR-27a rs895819 polymorphism can predict RCC risk in a Chinese population. Larger population-based prospective studies should be used to validate our findings.	[Shi, Danni; Ma, Lan; Chu, Haiyan; Zhang, Zhengdong] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Shi, Danni; Ma, Lan; Zhong, Dongyan; Chu, Haiyan; Yan, Fu; Wang, Wei; Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Mol Genet Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Shi, Danni; Zhong, Dongyan; Wang, Meilin; Tong, Na; Zhang, Zhengdong] Nanjing Med Univ, Dept Occupat Med & Environm Hlth, Jiangsu Key Lab Canc Biomarkers, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Li, Pu; Lv, Qiang; Qin, Chao; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhang, ZD (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	drzdzhang@gmail.com; drcjyin@gmail.com	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [81230068, 30972444, 81102089, 81201571]; Key Program of Natural Science Foundation of Jiangsu Province [BK2010080]; National Science Foundation of Jiangsu Province [BK2011773, BK2011775]; Qin Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Science Foundation of Jiangsu Province; Qin Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partly supported by the National Natural Science Foundation of China (81230068, 30972444, 81102089 and 81201571), the Key Program of Natural Science Foundation of Jiangsu Province (BK2010080), and National Science Foundation of Jiangsu Province (BK2011773 and BK2011775), the Qin Lan Project of Jiangsu Provincial Department of Education, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Baytekin F, 2011, UROL ONCOL-SEMIN ORI, V29, P502, DOI 10.1016/j.urolonc.2009.09.001; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Ficarra V, 2005, CANCER, V103, P68, DOI 10.1002/cncr.20749; Gao LB, 2011, BREAST CANCER RES TR, V125, P571, DOI 10.1007/s10549-010-0993-x; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hunt JD, 2005, INT J CANCER, V114, P101, DOI 10.1002/ijc.20618; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kosari F, 2005, CLIN CANCER RES, V11, P5128, DOI 10.1158/1078-0432.CCR-05-0073; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lei Y, 2010, MOL CELL BIOCHEM, V344, P23, DOI 10.1007/s11010-010-0525-3; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maitland ML, 2009, CLIN CANCER RES, V15, P6250, DOI 10.1158/1078-0432.CCR-09-0058; McLaughlin JK, 2000, SEMIN ONCOL, V27, P115; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Setiawan VW, 2007, AM J EPIDEMIOL, V166, P932, DOI 10.1093/aje/kwm170; STEFFENS J, 1992, UROL RES, V20, P111, DOI 10.1007/BF00296521; Sun QM, 2010, CANCER SCI, V101, P2241, DOI 10.1111/j.1349-7006.2010.01667.x; Yang RX, 2010, BREAST CANCER RES TR, V121, P693, DOI 10.1007/s10549-009-0633-5; Zamparese R, 2008, CANCER INVEST, V26, P929, DOI 10.1080/07357900802017553; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhu LJ, 2012, DNA CELL BIOL, V31, P349, DOI 10.1089/dna.2011.1348	39	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e46566	10.1371/journal.pone.0046566	http://dx.doi.org/10.1371/journal.pone.0046566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118855	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705600006
J	Tighe, M; Haling, RE; Flavel, RJ; Young, IM				Tighe, Matthew; Haling, Rebecca E.; Flavel, Richard J.; Young, Iain M.			Ecological Succession, Hydrology and Carbon Acquisition of Biological Soil Crusts Measured at the Micro-Scale	PLOS ONE			English	Article							WATER REPELLENCY; INFILTRATION; DISTURBANCE; ROLES	The hydrological characteristics of biological soil crusts (BSCs) are not well understood. In particular the relationship between runoff and BSC surfaces at relatively large (>1 m(2)) scales is ambiguous. Further, there is a dearth of information on small scale (mm to cm) hydrological characterization of crust types which severely limits any interpretation of trends at larger scales. Site differences and broad classifications of BSCs as one soil surface type rather than into functional form exacerbate the problem. This study examines, for the first time, some hydrological characteristics and related surface variables of a range of crust types at one site and at a small scale (sub mm to mm). X-ray tomography and fine scale hydrological measurements were made on intact BSCs, followed by C and C isotopic analyses. A 'hump' shaped relationship was found between the successional stage/sensitivity to physical disturbance classification of BSCs and their hydrophobicity, and a similar but 'inverse hump' relationship exists with hydraulic conductivity. Several bivariate relationships were found between hydrological variables. Hydraulic conductivity and hydrophobicity of BSCs were closely related but this association was confounded by crust type. The surface coverage of crust and the microporosity 0.5 mm below the crust surface were closely associated irrespective of crust type. The delta C-13 signatures of the BSCs were also related to hydraulic conductivity, suggesting that the hydrological characteristics of BSCs alter the chemical processes of their immediate surroundings via the physiological response (C acquisition) of the crust itself. These small scale results illustrate the wide range of hydrological properties associated with BSCs, and suggest associations between the ecological successional stage/functional form of BSCs and their ecohydrological role that needs further examination.	[Tighe, Matthew; Haling, Rebecca E.; Flavel, Richard J.; Young, Iain M.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of New England	Tighe, M (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	mtighe2@une.edu.au	Young, Iain McEwing/C-9210-2011; Flavel, Richard/I-6100-2016; Tighe, Matt/AAC-5369-2019	Young, Iain McEwing/0000-0002-7588-9006; Tighe, Matt/0000-0003-1027-0082; Flavel, Richard/0000-0001-7867-2104	internal University of New England staff research support grant	internal University of New England staff research support grant	This research was funded by an internal University of New England staff research support grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; Bird MI, 2008, J ARCHAEOL SCI, V35, P2698, DOI 10.1016/j.jas.2008.04.018; Chamizo S, 2012, EUR J SOIL SCI, V63, P42, DOI 10.1111/j.1365-2389.2011.01406.x; Chamizo S, 2012, ECOSYSTEMS, V15, P148, DOI 10.1007/s10021-011-9499-6; Crawford JW, 2012, J R SOC INTERFACE, V9, P1302, DOI 10.1098/rsif.2011.0679; Doerr SH, 1998, EARTH SURF PROC LAND, V23, P663, DOI 10.1002/(SICI)1096-9837(199807)23:7&lt;663::AID-ESP909&gt;3.0.CO;2-6; Doerr SH, 2000, EARTH-SCI REV, V51, P33, DOI 10.1016/S0012-8252(00)00011-8; Eldridge D., 1997, PRACTICAL GUIDE SOIL; Eldridge D.J., 2003, BIOL SOIL CRUSTS STR, V150, P315; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P389, DOI 10.1071/SR9940389; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Feeney DS, 2006, GEODERMA, V135, P72, DOI 10.1016/j.geoderma.2005.11.007; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; GREENE RSB, 1989, AUST J SOIL RES, V27, P213, DOI 10.1071/SR9890213; GREENE RSB, 1990, AUST J SOIL RES, V28, P755, DOI 10.1071/SR9900755; Hallett PD, 1999, EUR J SOIL SCI, V50, P35, DOI 10.1046/j.1365-2389.1999.00214.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Isbell R. F., 1996, The Australian soil classification.; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Menon M, 2011, J HYDROL, V397, P47, DOI 10.1016/j.jhydrol.2010.11.021; Miralles-Mellado I, 2011, SOIL SCI SOC AM J, V75, P1330, DOI 10.2136/sssaj2010.0283; Munoz-Robles C, 2011, GEODERMA, V160, P524, DOI 10.1016/j.geoderma.2010.10.024; O'Donnell AG, 2007, NAT REV MICROBIOL, V5, P689, DOI 10.1038/nrmicro1714; Philip J.R., 1954, J I ENG AUST, V26, P255; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rice SK, 1996, PLANT CELL ENVIRON, V19, P118, DOI 10.1111/j.1365-3040.1996.tb00233.x; SMILES DE, 1976, AUST J SOIL RES, V14, P103, DOI 10.1071/SR9760103; Taina IA, 2008, CAN J SOIL SCI, V88, P1, DOI 10.4141/CJSS06027; Tighe M, 2012, EARTH SURF PROC LAND, V37, P620, DOI 10.1002/esp.3191; Tighe M, 2009, AGR ECOSYST ENVIRON, V132, P212, DOI 10.1016/j.agee.2009.04.001; Warren S. D., 2001, BIOL SOIL CRUSTS STR, DOI [DOI 10.1007/978-3-642-56475-8_26, 10.1007/978-3-642-56475-8_26]; Wasley J, 2006, FUNCT PLANT BIOL, V33, P443, DOI 10.1071/FP05306; White I., 1992, Advances in measurement of soil physical properties. Bringing theory into practice. Proceedings of a symposium San Antonio, Texas 21-26 October 1990., P69; Wiesmeier M, 2009, SOIL TILL RES, V104, P299, DOI 10.1016/j.still.2009.04.005; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472	38	11	12	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48565	10.1371/journal.pone.0048565	http://dx.doi.org/10.1371/journal.pone.0048565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119058	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705600049
J	Calderaro, A; Piccolo, G; Gorrini, C; Montecchini, S; Rossi, S; Medici, MC; Chezzi, C; Snounou, G				Calderaro, Adriana; Piccolo, Giovanna; Gorrini, Chiara; Montecchini, Sara; Rossi, Sabina; Medici, Maria Cristina; Chezzi, Carlo; Snounou, Georges			A New Real-Time PCR for the Detection of Plasmodium ovale wallikeri	PLOS ONE			English	Article							MALARIA PARASITES; RIBOSOMAL-RNA; FIELD SAMPLES; VIVAX	It has been proposed that ovale malaria in humans is caused by two closely related but distinct species of malaria parasites: P. ovale curtisi and P. ovale wallikeri. We have extended and optimized a Real-time PCR assay targeting the parasite's small subunit ribosomal RNA (ssrRNA) gene to detect both these species. When the assay was applied to 31 archival blood samples from patients diagnosed with P. ovale, it was found that the infection in 20 was due to P. ovale curtisi and in the remaining 11 to P. ovale wallikeri. Thus, this assay provides a useful tool that can be applied to epidemiological investigations of the two newly recognized distinct P. ovale species, that might reveal if these species also differ in their clinical manifestation, drugs susceptibility and relapse periodicity. The results presented confirm that P. ovale wallikeri is not confined to Southeast Asia, since the majority of the patients analyzed in this study had acquired their P. ovale infection in African countries, mostly situated in West Africa.	[Calderaro, Adriana; Piccolo, Giovanna; Gorrini, Chiara; Montecchini, Sara; Rossi, Sabina; Medici, Maria Cristina; Chezzi, Carlo] Univ Parma, Microbiol Sect, Dept Pathol & Lab Med, I-43100 Parma, Italy; [Snounou, Georges] Univ Paris 06, UMR S 945, Paris, France; [Snounou, Georges] Inst Natl Sante & Rech Med, UMR S 945, Paris, France	University of Parma; University Hospital of Parma; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Calderaro, A (corresponding author), Univ Parma, Microbiol Sect, Dept Pathol & Lab Med, I-43100 Parma, Italy.	adriana.calderaro@unipr.it	ROSSI, Sabina/ABD-2601-2020; piccolo, giovanna/HHZ-8454-2022; Snounou, Georges/F-3352-2011	Snounou, Georges/0000-0002-6133-6398	Ministry of University and Scientific Research grant (Parma, Italy) [FIL 2009]; "Fondazione Cariparma'' (Italy)	Ministry of University and Scientific Research grant (Parma, Italy); "Fondazione Cariparma'' (Italy)	This work was supported by the Ministry of University and Scientific Research grant FIL 2009 (Parma, Italy) and by a grant from the "Fondazione Cariparma'' 2011-2013 (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06; Calderaro A, 2008, DIAGN MICR INFEC DIS, V61, P434, DOI 10.1016/j.diagmicrobio.2008.03.016; Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005; Craig C. F., 1914, Journal of Parasitology Urbana, V1, DOI 10.2307/3271184; JAMES S. P., 1933, PARASITOLOGY, V25, P87, DOI 10.1017/S0031182000019235; Kawamoto F, 1996, J CLIN MICROBIOL, V34, P2287, DOI 10.1128/JCM.34.9.2287-2289.1996; LYSENKO AJ, 1969, B WORLD HEALTH ORGAN, V40, P383; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Oguike MC, 2011, INT J PARASITOL, V41, P677, DOI 10.1016/j.ijpara.2011.01.004; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Snounou G, 1998, ACTA TROP, V70, P197, DOI 10.1016/S0001-706X(98)00021-7; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Stephens J. W., 1922, Annals of Tropical Medicine and Parasitology, V16, P383; Sutherland CJ, 2010, J INFECT DIS, V201, P1544, DOI 10.1086/652240; Tachibana M, 2002, MOL BIOCHEM PARASIT, V122, P223, DOI 10.1016/S0166-6851(02)00101-9; Talman AM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-140; Win TT, 2004, EMERG INFECT DIS, V10, P1235, DOI 10.3201/eid1007.030411	21	27	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48033	10.1371/journal.pone.0048033	http://dx.doi.org/10.1371/journal.pone.0048033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110165	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200140
J	Casalegno, JS; Carval, KL; Eibach, D; Valdeyron, ML; Lamblin, G; Jacquemoud, H; Mellier, G; Lina, B; Gaucherand, P; Mathevet, P; Mekki, Y				Casalegno, Jean-sebastien; Carval, Karine Le Bail; Eibach, Daniel; Valdeyron, Marie-Laure; Lamblin, Gery; Jacquemoud, Herve; Mellier, Georges; Lina, Bruno; Gaucherand, Pascal; Mathevet, Patrice; Mekki, Yahia			High Risk HPV Contamination of Endocavity Vaginal Ultrasound Probes: An Underestimated Route of Nosocomial Infection?	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; ULTRAVIOLET C; DISINFECTION; ETIOLOGY; COVERS	Background: Endocavity ultrasound is seen as a harmless procedure and has become a common gynaecological procedure. However without correct disinfection, it may result in nosocomial transmission of genito-urinary pathogens, such as high-risk Human Papillomavirus (HR-HPV). We aimed to evaluate the currently recommended disinfection procedure for covered endocavity ultrasound probes, which consists of "Low Level Disinfection" (LLD) with "quaternary ammonium compounds" containing wipes. Methods: From May to October 2011 swabs were taken from endovaginal ultrasound probes at the Gynecology Department of the Lyon University Hospital. During the first phase (May-June 2011) samples were taken after the ultrasound examination and after the LLD procedure. In a second phase (July-October 2011) swab samples were collected just before the probe was used. All samples were tested for the presence of human DNA (as a marker for a possible transmission of infectious pathogens from the genital tract) and HPV DNA with the Genomica DNA microarray (35 different HPV genotypes). Results: We collected 217 samples before and 200 samples after the ultrasound examination. The PCR was inhibited in two cases. Human DNA was detected in 36 (18%) post-examination samples and 61 (28%) pre-examination samples. After the ultrasound LLD procedure, 6 (3.0%) samples contained HR-HPV types (16, 31, 2653 and 58). Similarly, HPV was detected in 6 pre-examination samples (2.7%). Amongst these 4 (1.9%) contained HR-HPV (types 53 and 70). Conclusion: Our study reveals that a considerable number of ultrasound probes are contaminated with human and HR-HPV DNA, despite LLD disinfection and probe cover. In all hospitals, where LLD is performed, the endovaginal ultrasound procedure must therefore be considered a source for nosocomial HR-HPV infections. We recommend the stringent use of high-level disinfectants, such as glutaraldehyde or hydrogen peroxide solutions.	[Casalegno, Jean-sebastien; Eibach, Daniel; Lina, Bruno; Mekki, Yahia] Hosp Civils Lyon, Ctr Biol & Pathol Est, Virol Lab, Lyon, France; [Carval, Karine Le Bail; Lamblin, Gery; Mellier, Georges; Gaucherand, Pascal; Mathevet, Patrice] Hosp Civils Lyon, Dept Obstet Gynecol, Lyon, France; [Eibach, Daniel] European Ctr Dis Prevent & Control, European Publ Hlth Microbiol Training Programme, Stockholm, Sweden; [Valdeyron, Marie-Laure] Hosp Civils Lyon, Dept Prevent Med, Lyon, France; [Jacquemoud, Herve] Hosp Civils Lyon, Tech Support Dept, Lyon, France	CHU Lyon; CHU Lyon; European Centre for Disease Prevention & Control; CHU Lyon; CHU Lyon	Casalegno, JS (corresponding author), Hosp Civils Lyon, Ctr Biol & Pathol Est, Virol Lab, Lyon, France.	jean-sebastien.casalegno@chu-lyon.fr; yahia.mekki@chu-lyon.fr	casalegno, jean-sebastien/AAD-4467-2021; lina, bruno/N-3663-2019; LINA, bruno/M-4572-2014; Casalegno, jean-sebastien/M-4566-2014	lina, bruno/0000-0002-8959-2123; casalegno, jean-sebastien/0000-0003-3271-9856	Germitec	Germitec	This study has been funded by Germitec. Study sponsors had no involvement in the study design, the sample collection, the analysis, the interpretation of data, the writing of the manuscript and in the decision to submit the manuscript for publication. None of the authors have any participation or involvement in the Germitec society.	[Anonymous], 2007, GAIN PROT US UN DISP; Bloc S, 2011, J ULTRAS MED, V30, P785, DOI 10.7863/jum.2011.30.6.785; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Casalegno JS, 2011, INT J GYNECOL OBSTET, V114, P116, DOI 10.1016/j.ijgo.2011.01.030; Centers for Disease Control and Prevention, 2008, GUID DIS STER HEALTH; Ding DC, 2011, GYNECOL ONCOL, V121, P148, DOI 10.1016/j.ygyno.2010.11.040; FERENCZY A, 1989, OBSTET GYNECOL, V74, P950; Gage JC, 2010, CANCER EPIDEM BIOMAR, V19, P1668, DOI 10.1158/1055-9965.EPI-09-1286; HIGNETT M, 1995, J ASSIST REPROD GEN, V12, P606, DOI 10.1007/BF02212583; Kac G, 2010, INFECT CONT HOSP EP, V31, P165, DOI 10.1086/649794; Ma STC, 2012, EMERG MED J; Martinelli M, 2012, CLIN MICROBIOL INFEC, V18, pE197, DOI 10.1111/j.1469-0691.2012.03839.x; Milki AA, 1998, FERTIL STERIL, V69, P409, DOI 10.1016/S0015-0282(97)00571-2; MUNOZ N, 1994, MUTAT RES, V305, P293, DOI 10.1016/0027-5107(94)90249-6; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Roden RBS, 1997, J INFECT DIS, V176, P1076, DOI 10.1086/516515; Storment JM, 1997, SOUTHERN MED J, V90, P206, DOI 10.1097/00007611-199702000-00007; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	18	64	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48137	10.1371/journal.pone.0048137	http://dx.doi.org/10.1371/journal.pone.0048137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110191	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200151
J	Chen, AH; Afonso, B; Silver, PA; Savage, DF				Chen, Anna H.; Afonso, Bruno; Silver, Pamela A.; Savage, David F.			Spatial and Temporal Organization of Chromosome Duplication and Segregation in the Cyanobacterium Synechococcus elongatus PCC 7942	PLOS ONE			English	Article							BACTERIAL-DNA REPLICATION; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; POLAR LOCALIZATION; CELL-DIVISION; INITIATION; DYNAMICS; ORIGIN; GROWTH; CYCLE	The spatial and temporal control of chromosome duplication and segregation is crucial for proper cell division. While this process is well studied in eukaryotic and some prokaryotic organisms, relatively little is known about it in prokaryotic polyploids such as Synechococcus elongatus PCC 7942, which is known to possess one to eight copies of its single chromosome. Using a fluorescent repressor-operator system, S. elongatus chromosomes and chromosome replication forks were tagged and visualized. We found that chromosomal duplication is asynchronous and that the total number of chromosomes is correlated with cell length. Thus, replication is independent of cell cycle and coupled to cell growth. Replication events occur in a spatially random fashion. However, once assembled, replisomes move in a constrained manner. On the other hand, we found that segregation displays a striking spatial organization in some cells. Chromosomes transiently align along the major axis of the cell and timing of alignment was correlated to cell division. This mechanism likely contributes to the non-random segregation of chromosome copies to daughter cells.	[Chen, Anna H.; Afonso, Bruno; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Silver, Pamela A.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Savage, David F.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Savage, David F.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA.	pamela_silver@hms.harvard.edu			National Institutes of Health [GM080177]; Graduate Research Fellowship from the National Science Foundation; Fundacoa para a Ciencia e a Tecnologia and Graduate Program in Areas of Basic and Applied Biology (GABBA); Wyss Institute for Biologically Inspired Engineering and Department of Defense; Department of Energy Office of Science Early Career Research Program through Office of Basic Energy Sciences Grant [DE-SC0006394]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Research Fellowship from the National Science Foundation; Fundacoa para a Ciencia e a Tecnologia and Graduate Program in Areas of Basic and Applied Biology (GABBA); Wyss Institute for Biologically Inspired Engineering and Department of Defense; Department of Energy Office of Science Early Career Research Program through Office of Basic Energy Sciences Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health (Grant #GM080177) and a Graduate Research Fellowship from the National Science Foundation to AHC, by the Fundacoa para a Ciencia e a Tecnologia and Graduate Program in Areas of Basic and Applied Biology (GABBA) to BA and by the Wyss Institute for Biologically Inspired Engineering and Department of Defense to PAS, and the Department of Energy Office of Science Early Career Research Program through Office of Basic Energy Sciences Grant DE-SC0006394 to DFS. DFS was a Department of Energy Physical Biosciences Fellow of the Life Sciences Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MM, 1968, J GEN MICROBIOL, V51, P199, DOI 10.1099/00221287-51-2-199; Bates D, 2008, MOL MICROBIOL, V69, P1341, DOI 10.1111/j.1365-2958.2008.06378.x; Berlatzky IA, 2008, P NATL ACAD SCI USA, V105, P14136, DOI 10.1073/pnas.0804982105; BINDER BJ, 1990, J BACTERIOL, V172, P2313, DOI 10.1128/jb.172.5.2313-2319.1990; Chang YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027080; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Fogel MA, 2005, MOL MICROBIOL, V55, P125, DOI 10.1111/j.1365-2958.2004.04379.x; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Gitai Z, 2005, TRENDS MICROBIOL, V13, P221, DOI 10.1016/j.tim.2005.03.006; Gordon GS, 2002, MOL MICROBIOL, V44, P501, DOI 10.1046/j.1365-2958.2002.02901.x; Graumann PL, 2010, BACTERIAL CHROMATIN, P31, DOI 10.1007/978-90-481-3473-1_3; Griese M, 2011, FEMS MICROBIOL LETT, V323, P124, DOI 10.1111/j.1574-6968.2011.02368.x; Ha T, 2012, SINGLE MOL VIEWS PRO; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; Hu B, 2007, MOL MICROBIOL, V63, P1640, DOI 10.1111/j.1365-2958.2007.05618.x; Image processing with ImageJ, 2004, BIOPHOTONICS INT, V11, P36; Jain IH, 2012, P NATL ACAD SCI USA; Jensen RB, 2006, J BACTERIOL, V188, P2244, DOI 10.1128/JB.188.6.2244-2253.2006; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Jensen RB, 2001, EMBO J, V20, P4952, DOI 10.1093/emboj/20.17.4952; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Li YF, 2002, MOL MICROBIOL, V46, P985, DOI 10.1046/j.1365-2958.2002.03234.x; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; Losick R, 1999, J BACTERIOL, V181, P4143, DOI 10.1128/JB.181.14.4143-4145.1999; Mackey Shannon R, 2007, Methods Mol Biol, V362, P115; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Niki H, 2000, GENE DEV, V14, P212; Niki H, 1998, GENE DEV, V12, P1036, DOI 10.1101/gad.12.7.1036; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Phillips I., 2006, NEW BIOBRICK ASSEMBL; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Reyes-Larnothe R, 2008, TRENDS MICROBIOL, V16, P238, DOI 10.1016/j.tim.2008.02.003; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Schneider D, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-39; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; SKARSTAD K, 1988, J BACTERIOL, V170, P852, DOI 10.1128/jb.170.2.852-858.1988; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Stuurman N., 2007, MICROSC TODAY, V15, P42, DOI DOI 10.1017/S1551929500055541; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Watanabe S, 2012, MOL MICROBIOL, V83, P856, DOI 10.1111/j.1365-2958.2012.07971.x; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1	48	38	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47837	10.1371/journal.pone.0047837	http://dx.doi.org/10.1371/journal.pone.0047837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112856	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200091
J	Ethier, C; Tardif, M; Arul, L; Poirier, GG				Ethier, Chantal; Tardif, Maxime; Arul, Laura; Poirier, Guy G.			PARP-1 Modulation of mTOR Signaling in Response to a DNA Alkylating Agent	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; APOPTOSIS-INDUCING FACTOR; CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE-1; IN-VITRO; MAMMALIAN TARGET; AUTOPHAGY; PHOSPHORYLATION; RICTOR; PARTHANATOS	Poly(ADP-ribose) polymerase-1 (PARP-1) is widely involved in cell death responses. Depending on the degree of injury and on cell type, PARP activation may lead to autophagy, apoptosis or necrosis. In HEK293 cells exposed to the alkylating agent N-methyl-N'-nitro-N'-nitrosoguanine (MNNG), we show that PARP-1 activation triggers a necrotic cell death response. The massive poly(ADP-ribose) (PAR) synthesis following PARP-1 activation leads to the modulation of mTORC1 pathway. Shortly after MNNG exposure, NAD+ and ATP levels decrease, while AMP levels drastically increase. We characterized at the molecular level the consequences of these altered nucleotide levels. First, AMP-activated protein kinase (AMPK) is activated and the mTORC1 pathway is inhibited by the phosphorylation of Raptor, in an attempt to preserve cellular energy. Phosphorylation of the mTORC1 target S6 is decreased as well as the phosphorylation of the mTORC2 component Rictor on Thr1135. Finally, Akt phosphorylation on Ser473 is lost and then, cell death by necrosis occurs. Inhibition of PARP-1 with the potent PARP inhibitor AG14361 prevents all of these events. Moreover, the antioxidant N-acetyl-L-cysteine (NAC) can also abrogate all the signaling events caused by MNNG exposure suggesting that reactive oxygen species (ROS) production is involved in PARP-1 activation and modulation of mTOR signaling. In this study, we show that PARP-1 activation and PAR synthesis affect the energetic status of cells, inhibit the mTORC1 signaling pathway and possibly modulate the mTORC2 complex affecting cell fate. These results provide new evidence that cell death by necrosis is orchestrated by the balance between several signaling pathways, and that PARP-1 and PAR take part in these events.	[Ethier, Chantal; Tardif, Maxime; Arul, Laura; Poirier, Guy G.] Univ Laval, CHUQ Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Ethier, Chantal; Tardif, Maxime; Arul, Laura; Poirier, Guy G.] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University	Poirier, GG (corresponding author), Univ Laval, CHUQ Res Ctr, Quebec City, PQ G1K 7P4, Canada.	guy.poirier@crchul.ulaval.ca		Poirier, Guy/0000-0002-4869-1424	Canadian Institutes of Health Research (CIHR);  [MPO102473]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); 	This study was supported by Canadian Institutes of Health Research (CIHR). The grant number is MPO102473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar EB, 1999, BBA-GEN SUBJECTS, V1428, P137, DOI 10.1016/S0304-4165(99)00054-9; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chiu LY, 2011, BIOCHEM PHARMACOL, V81, P459, DOI 10.1016/j.bcp.2010.10.016; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Ethier C, 2007, APOPTOSIS, V12, P2037, DOI 10.1007/s10495-007-0127-z; Formentini L, 2009, J BIOL CHEM, V284, P17668, DOI 10.1074/jbc.M109.002931; Fossati S, 2007, NEUROCHEM INT, V50, P203, DOI 10.1016/j.neuint.2006.08.009; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Harhaji-Trajkovic L, 2009, J CELL MOL MED, V13, P3644, DOI 10.1111/j.1582-4934.2009.00663.x; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hassa PO, 2009, FRONT BIOSCI-LANDMRK, V14, P72, DOI 10.2741/3232; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Juvekar A, 2012, CANCER DISCOV, V2, P1048, DOI 10.1158/2159-8290.CD-11-0336; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; LAMARRE D, 1988, BIOCHIM BIOPHYS ACTA, V950, P147, DOI 10.1016/0167-4781(88)90007-3; Liu XS, 2008, CANCER BIOL THER, V7, P937; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Treins C, 2010, ONCOGENE, V29, P1003, DOI 10.1038/onc.2009.401; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	59	56	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47978	10.1371/journal.pone.0047978	http://dx.doi.org/10.1371/journal.pone.0047978			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110147	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200125
J	Hughes, AL; Becker, EA; Lauck, M; Karl, JA; Braasch, AT; O'Connor, DH; O'Connor, SL				Hughes, Austin L.; Becker, Ericka A.; Lauck, Michael; Karl, Julie A.; Braasch, Andrew T.; O'Connor, David H.; O'Connor, Shelby L.			SIV Genome-Wide Pyrosequencing Provides a Comprehensive and Unbiased View of Variation within and outside CD8 T Lymphocyte Epitopes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CLASS-I ALLELES; CYNOMOLGUS MACAQUES; ELITE CONTROLLERS; CELL RESPONSES; ESCAPE; TYPE-1; DIVERSITY; VARIANTS; COMMON	Deep sequencing technology is revolutionizing our understanding of HIV/SIV evolution. It is known that acute SIV sequence variation within CD8 T lymphocyte (CD8-TL) epitopes is similar among MHC-identical animals, but we do not know whether this persists into the chronic phase. We now determine whether chronic viral variation in MHC-identical animals infected with clonal SIV is similar throughout the entire coding sequence when using a sensitive deep sequencing approach. We pyrosequenced the entire coding sequence of the SIV genome isolated from a unique cohort of four SIVmac239-infected, MHC-identical Mauritian cynomolgus macaques (MCM) 48 weeks after infection; one MCM in the cohort became an elite controller. Among the three non-controllers, we found that genome-wide sequences were similar between animals and we detected increased sequence complexity within 64% of CD8-TL epitopes when compared to Sanger sequencing methods. When we compared sequences between the MHC-matched controller and the three non-controllers, we found the viral population in the controller was less diverse and accumulated different variants than the viral populations in the non-controllers. Importantly, we found that initial PCR amplification of viral cDNA did not significantly affect the sequences detected, suggesting that data obtained by pyrosequencing PCR-amplified viral cDNA accurately represents the diversity of sequences replicating within an animal. This demonstrates that chronic sequence diversity across the entire SIV coding sequence is similar among MHC-identical animals with comparable viral loads when infected with the same clonal virus stock. Additionally, our approach to genome-wide SIV sequencing accurately reflects the diversity of sequences present in the replicating viral population. In sum, our study suggests that genome-wide pyrosequencing of immunodeficiency viruses captures a thorough and unbiased picture of sequence diversity, and may be a useful approach to employ when evaluating which sequences to include as part of a vaccine immunogen.	[Becker, Ericka A.; Karl, Julie A.; O'Connor, David H.; O'Connor, Shelby L.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Lauck, Michael; Braasch, Andrew T.; O'Connor, David H.; O'Connor, Shelby L.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Wisconsin System; University of Wisconsin Madison	O'Connor, SL (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.	soconnor@primate.wisc.edu		o'connor, david/0000-0003-2139-470X	National Institutes of Health [R01 AI084787, R01 AI077376, R21 AI082880, R33 AI082880-03, R21 AI068488, R01 GM43940-22]; CHAVI/HVTN; Research Facilities Improvement Program [RR15459-01, RR020141-01]; National Center for Research Resources (NCRR) [P51 RR000167]; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Heath; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167, C06RR015459, C06RR020141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077376, R33AI082880, R01AI084787, R21AI068488, R21AI082880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHAVI/HVTN; Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Heath; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 AI084787, R01 AI077376, R21 AI082880, R33 AI082880-03, R21 AI068488, and R01 GM43940-22. SLO and ATB were supported by a CHAVI/HVTN Early Stage Investigator award. The research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. The authors would also like to thank members of the Wisconsin National Primate Research Center, a facility supported by grant P51 RR000167 from the National Center for Research Resources (NCRR) and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Heath. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Becker EA, 2012, GENOME BIOL EVOL, V4, P457, DOI 10.1093/gbe/evs029; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Budde ML, 2011, J VIROL, V85, P3250, DOI 10.1128/JVI.02355-10; Burwitz BJ, 2009, J VIROL, V83, P6011, DOI 10.1128/JVI.00199-09; Cale EM, 2011, J VIROL, V85, P3746, DOI 10.1128/JVI.02420-10; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Harris R. S, 2007, THESIS; Hughes AL, 2009, VIROLOGY, V393, P127, DOI 10.1016/j.virol.2009.07.016; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keele BF, 2009, CURR OPIN HIV AIDS, V4, P352, DOI 10.1097/COH.0b013e32832d9fef; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Lauck M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019056; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang BH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026745; Maness NJ, 2008, J VIROL, V82, P5245, DOI 10.1128/JVI.00292-08; Maness NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/jem.20071261; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson EK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-71; Newberg MH, 2006, J IMMUNOL, V176, P319, DOI 10.4049/jimmunol.176.1.319; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; O'Connor SL, 2012, J VIROL, V86, P605, DOI 10.1128/JVI.05511-11; O'Connor SL, 2010, SCI TRANSL MED, V2, pra18; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vanderford TH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002048; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Weinfurter JT, 2011, J VIROL, V85, P530, DOI 10.1128/JVI.01025-10; Wiseman RW, 2007, J VIROL, V81, P349, DOI 10.1128/JVI.01841-06	42	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47818	10.1371/journal.pone.0047818	http://dx.doi.org/10.1371/journal.pone.0047818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112852	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200087
J	Lanan, MC; Dornhaus, A; Jones, EI; Waser, A; Bronstein, JL				Lanan, Michele C.; Dornhaus, Anna; Jones, Emily I.; Waser, Andrew; Bronstein, Judith L.			The Trail Less Traveled: Individual Decision-Making and Its Effect on Group Behavior	PLOS ONE			English	Article							ANT LASIUS-NIGER; SELF-ORGANIZATION; SYMMETRY-BREAKING; FORAGING ACTIVITY; FOOD; HYMENOPTERA; EMERGENCE; SELECTION; MODEL; FORMICIDAE	Social insect colonies are complex systems in which the interactions of many individuals lead to colony-level collective behaviors such as foraging. However, the emergent properties of collective behaviors may not necessarily be adaptive. Here, we examine symmetry breaking, an emergent pattern exhibited by some social insects that can lead colonies to focus their foraging effort on only one of several available food patches. Symmetry breaking has been reported to occur in several ant species. However, it is not clear whether it arises as an unavoidable epiphenomenon of pheromone recruitment, or whether it is an adaptive behavior that can be controlled through modification of the individual behavior of workers. In this paper, we used a simulation model to test how symmetry breaking is affected by the degree of non-linearity of recruitment, the specific mechanism used by individuals to choose between patches, patch size, and forager number. The model shows that foraging intensity on different trails becomes increasingly asymmetric as the recruitment response of individuals varies from linear to highly non-linear, supporting the predictions of previous work. Surprisingly, we also found that the direction of the relationship between forager number (i.e., colony size) and asymmetry varied depending on the specific details of the decision rule used by individuals. Limiting the size of the resource produced a damping effect on asymmetry, but only at high forager numbers. Variation in the rule used by individual ants to choose trails is a likely mechanism that could cause variation among the foraging behaviors of species, and is a behavior upon which selection could act.	[Lanan, Michele C.] Univ Arizona, Dept Entomol, Tucson, AZ 85719 USA; [Dornhaus, Anna; Bronstein, Judith L.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Jones, Emily I.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	University of Arizona; University of Arizona; Washington State University	Lanan, MC (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85719 USA.	lanan@email.arizona.edu	Jones, Emily/B-7895-2010	Jones, Emily/0000-0002-0605-884X	Center for Insect Science at the University of Arizona, NSF [IOS 0841756, DMS 0540524]; NIH Postdoctoral Excellence in Research and Teaching (PERT) fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	Center for Insect Science at the University of Arizona, NSF; NIH Postdoctoral Excellence in Research and Teaching (PERT) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Center for Insect Science at the University of Arizona, NSF grants IOS 0841756 and DMS 0540524, http://cis.arl.arizona.edu/. It was also funded by a NIH Postdoctoral Excellence in Research and Teaching (PERT) fellowship to Michele Lanan http://cis.arl.arizona.edu/PERT/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler E, 2005, AM NAT, V166, P643, DOI 10.1086/498139; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; BECKERS R, 1992, J THEOR BIOL, V159, P397, DOI 10.1016/S0022-5193(05)80686-1; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Beekman M, 2001, P NATL ACAD SCI USA, V98, P9703, DOI 10.1073/pnas.161285298; Bonabeau E, 1998, PHILOS T R SOC B, V353, P1561, DOI 10.1098/rstb.1998.0310; Bonabeau E, 1997, ACTA BIOTHEOR, V45, P29, DOI 10.1023/A:1000259222500; Bonser R, 1998, ECOL ENTOMOL, V23, P15, DOI 10.1046/j.1365-2311.1998.00103.x; Brown MJF, 2000, BEHAV ECOL SOCIOBIOL, V47, P195, DOI 10.1007/s002650050011; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; COLEMAN S, 1973, PHYS REV D, V7, P1888, DOI 10.1103/PhysRevD.7.1888; Collignon B, 2010, P ROY SOC B-BIOL SCI, V277, P1267, DOI 10.1098/rspb.2009.1976; Couzin ID, 2003, P ROY SOC B-BIOL SCI, V270, P139, DOI 10.1098/rspb.2002.2210; de Biseau J.C., 1992, Psyche (Cambridge), V98, P323, DOI 10.1155/1991/38402; de Vries H, 2002, BEHAV ECOL SOCIOBIOL, V51, P557, DOI 10.1007/s00265-002-0454-6; DENEUBOURG JL, 1989, J INSECT BEHAV, V2, P719, DOI 10.1007/BF01065789; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; DENEUBOURG JL, 1986, PHYSICA D, V22, P176, DOI 10.1016/0167-2789(86)90239-3; Detrain C, 1997, ANIM BEHAV, V53, P537, DOI 10.1006/anbe.1996.0305; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Devigne C, 2006, INSECT SOC, V53, P46, DOI 10.1007/s00040-005-0834-9; Dornhaus A, 2011, ANN REV ENT IN PRESS; Dornhaus A, 2010, ANT ECOLOGY, P210; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Fewell JH, 1999, EVOL ECOL RES, V1, P537; Folgarait PJ, 1999, ECOL ENTOMOL, V24, P163, DOI 10.1046/j.1365-2311.1999.00180.x; FRANKS NR, 1991, J INSECT BEHAV, V4, P583, DOI 10.1007/BF01048072; GOSS S, 1990, NATO ADV SCI I G-ECO, V20, P661; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Holldobler B., 1990, pi; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Jackson D, 2004, BIOSYSTEMS, V76, P101, DOI 10.1016/j.biosystems.2004.05.028; Lanan MC, FORAGING STRAT UNPUB; Lanan MC, 2010, COLLECTIVE DECISION; Mailleux AC, 2000, ANIM BEHAV, V59, P1061, DOI 10.1006/anbe.2000.1396; Narendra A, 2007, J EXP BIOL, V210, P570, DOI 10.1242/jeb.02678; Nicolis SC, 1999, J THEOR BIOL, V198, P575, DOI 10.1006/jtbi.1999.0934; Pasteels J.M., 1987, Experientia Supplementum (Basel), V54, P155; Philpott SM, 2009, ENVIRON ENTOMOL, V38, P790, DOI 10.1603/022.038.0331; Portha S, 2002, BEHAV ECOL, V13, P776, DOI 10.1093/beheco/13.6.776; Robson SK, 1995, CHEM ECOLOGY INSECTS; Schatz B, 1999, J EXP BIOL, V202, P1897; Schilman PE, 2003, ANIM BEHAV, V66, P687, DOI 10.1006/anbe.2003.2242; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Suckling DM, 2011, J CHEM ECOL, V37, P1143, DOI 10.1007/s10886-011-0019-0; Sumpter DJT, 2003, BEHAV ECOL SOCIOBIOL, V53, P131, DOI 10.1007/s00265-002-0549-0; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; SUNDSTROM L, 1993, INSECT SOC, V40, P147, DOI 10.1007/BF01240703	50	14	14	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47976	10.1371/journal.pone.0047976	http://dx.doi.org/10.1371/journal.pone.0047976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112880	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200123
J	Marinelli, S; Vacca, V; Ricordy, R; Uggenti, C; Tata, AM; Luvisetto, S; Pavone, F				Marinelli, Sara; Vacca, Valentina; Ricordy, Ruggero; Uggenti, Carolina; Tata, Ada Maria; Luvisetto, Siro; Pavone, Flaminia			The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes	PLOS ONE			English	Article							ACIDIC PROTEIN GFAP; AXONAL-TRANSPORT; GLIAL-CELLS; SNAP-25; TOXIN; EXPRESSION; RAT; NEURONS; NEUROEXOCYTOSIS; ACTIVATION	In recent years a growing debate is about whether botulinum neurotoxins are retrogradely transported from the site of injection. Immunodetection of cleaved SNAP-25 (cl-SNAP-25), the protein of the SNARE complex targeted by botulinum neurotoxin serotype A (BoNT/A), could represent an excellent approach to investigate the mechanism of action on the nociceptive pathways at peripheral and/or central level. After peripheral administration of BoNT/A, we analyzed the expression of cl-SNAP-25, from the hindpaw's nerve endings to the spinal cord, together with the behavioral effects on neuropathic pain. We used the chronic constriction injury of the sciatic nerve in CD1 mice as animal model of neuropathic pain. We evaluated immunostaining of cl-SNAP-25 in the peripheral nerve endings, along the sciatic nerve, in dorsal root ganglia and in spinal dorsal horns after intraplantar injection of saline or BoNT/A, alone or colocalized with either glial fibrillar acidic protein, GFAP, or complement receptor 3/cluster of differentiation 11b, CD11b, or neuronal nuclei, NeuN, depending on the area investigated. Immunofluorescence analysis shows the presence of the cl-SNAP-25 in all tissues examined, from the peripheral endings to the spinal cord, suggesting a retrograde transport of BoNT/A. Moreover, we performed in vitro experiments to ascertain if BoNT/A was able to interact with the proliferative state of Schwann cells (SC). We found that BoNT/A modulates the proliferation of SC and inhibits the acetylcholine release from SC, evidencing a new biological effect of the toxin and further supporting the retrograde transport of the toxin along the nerve and its ability to influence regenerative processes. The present results strongly sustain a combinatorial action at peripheral and central neural levels and encourage the use of BoNT/A for the pathological pain conditions difficult to treat in clinical practice and dramatically impairing patients' quality of life.	[Marinelli, Sara; Vacca, Valentina; Luvisetto, Siro; Pavone, Flaminia] Ist Ricovero & Cura Carattere Sci Fdn, Cell Biol & Neurobiol Inst, Natl Res Council Italy, Rome, Italy; [Ricordy, Ruggero] Natl Res Council Italy, Inst Mol Biol & Pathol, Rome, Italy; [Uggenti, Carolina; Tata, Ada Maria] Univ Roma La Sapienza, Ctr Neurobiol Res Daniel Bovet, Dept Biol & Biotechnol Charles Darwin, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Pavone, F (corresponding author), Ist Ricovero & Cura Carattere Sci Fdn, Cell Biol & Neurobiol Inst, Natl Res Council Italy, Rome, Italy.	flaminia.pavone@cnr.it	Luvisetto, Siro/M-9557-2015; Luvisetto, Siro/AAJ-6985-2021; Uggenti, Carolina/G-9145-2017; Luvisetto, Siro/K-1844-2019; Marinelli, Sara/L-7738-2019; Vacca, Valentina/J-6643-2018	Luvisetto, Siro/0000-0003-1399-2152; Luvisetto, Siro/0000-0003-1399-2152; Uggenti, Carolina/0000-0003-2673-5120; Marinelli, Sara/0000-0001-5393-4796; Vacca, Valentina/0000-0003-2657-0450; Pavone, Flaminia/0000-0001-5189-2748	FILAS Regione Lazio Funds for "Sviluppo della Ricerca sul Cervello''; Progetti di Ricerca di Interesse Nazionale	FILAS Regione Lazio Funds for "Sviluppo della Ricerca sul Cervello''; Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This publication was made possible thanks to the cooperation with the Regione Lazio, as part of the "Distretto Tecnologico delle Bioscienze''. SM was supported by a research fellowship from FILAS Regione Lazio Funds for "Sviluppo della Ricerca sul Cervello''. This work was supported by Progetti di Ricerca di Interesse Nazionale 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonucci F, 2008, J NEUROSCI, V28, P3689, DOI 10.1523/JNEUROSCI.0375-08.2008; Aoki KR, 2011, PARKINSONISM RELAT D, V17, pS28, DOI 10.1016/j.parkreldis.2011.06.013; Bach-Rojecky L, 2010, EUR J PHARMACOL, V633, P10, DOI 10.1016/j.ejphar.2010.01.020; Bach-Rojecky L, 2009, PHARMACOL BIOCHEM BE, V94, P234, DOI 10.1016/j.pbb.2009.08.012; Barden JA, 1999, J NEUROCYTOL, V28, P469, DOI 10.1023/A:1007053004771; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; BROCKES JP, 1987, METHOD ENZYMOL, V147, P217; BROCKES JP, 1984, PROC R SOC SER B-BIO, V222, P121, DOI 10.1098/rspb.1984.0053; Caleo M, 2009, J NEUROCHEM, V109, P15, DOI 10.1111/j.1471-4159.2009.05887.x; Camprubi-Robles M, 2009, FASEB J, V23, P3722, DOI 10.1096/fj.09-134346; Cobianchi S, 2010, NEUROSCIENCE, V168, P273, DOI 10.1016/j.neuroscience.2010.03.035; Curra A, 2009, NEUROLOGY, V72, P1095, DOI 10.1212/01.wnl.0000345010.98495.fc; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; Filipovic B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029803; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; GARRISON CJ, 1991, BRAIN RES, V565, P1, DOI 10.1016/0006-8993(91)91729-K; Hashizume H, 2000, SPINE, V25, P1206, DOI 10.1097/00007632-200005150-00003; Hepp R, 1999, GLIA, V27, P181, DOI 10.1002/(SICI)1098-1136(199908)27:2<181::AID-GLIA8>3.0.CO;2-9; Jeftinija SD, 1997, BRAIN RES, V750, P41, DOI 10.1016/S0006-8993(96)00610-5; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Kitamura Y, 2009, NEUROSCIENCE, V159, P1422, DOI 10.1016/j.neuroscience.2009.01.066; Lawrence GW, 2012, BIOCHEM J, V441, P443, DOI 10.1042/BJ20111117; Loreti S, 2007, NEURON GLIA BIOL, V3, P269, DOI 10.1017/S1740925X08000045; Luvisetto S, 2007, NEUROSCIENCE, V145, P1, DOI 10.1016/j.neuroscience.2006.12.004; Luvisetto S, 2006, BRAIN RES, V1082, P124, DOI 10.1016/j.brainres.2006.01.117; Luvisetto S, 2003, TOXICON, V41, P475, DOI 10.1016/S0041-0101(02)00370-7; Maienschein V, 1999, GLIA, V26, P233, DOI 10.1002/(SICI)1098-1136(199905)26:3<233::AID-GLIA5>3.0.CO;2-2; Marinelli S, 2010, NEUROSCIENCE, V171, P316, DOI 10.1016/j.neuroscience.2010.08.067; Matak I, 2011, NEUROSCIENCE, V186, P201, DOI 10.1016/j.neuroscience.2011.04.026; Matak I, 2012, NEUROCHEM INT, V61, P236, DOI 10.1016/j.neuint.2012.05.001; Megighian A, 2010, J CELL SCI, V123, P3276, DOI 10.1242/jcs.071316; Mika J, 2011, NEUROSCIENCE, V175, P358, DOI 10.1016/j.neuroscience.2010.11.040; Milara J, 2012, THORAX, V67, P229, DOI 10.1136/thoraxjnl-2011-200376; Montecucco C, 2005, TRENDS BIOCHEM SCI, V30, P367, DOI 10.1016/j.tibs.2005.05.002; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Parpura V, 1995, FEBS LETT, V377, P489, DOI 10.1016/0014-5793(95)01401-2; Pavone F, 2011, 7 INT C BAS THER ASP; Pavone F, 2010, TOXINS, V2, P2890, DOI 10.3390/toxins2122890; Restani L, 2012, TRAFFIC, V13, P1083, DOI 10.1111/j.1600-0854.2012.01369.x; Restani L, 2011, J NEUROSCI, V31, P15650, DOI 10.1523/JNEUROSCI.2618-11.2011; Rossetto O, 2001, TOXICON, V39, P27, DOI 10.1016/S0041-0101(00)00163-X; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; SCHIAVO G, 1995, METHOD ENZYMOL, V248, P643; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schubert V, 2011, GLIA, V59, P1472, DOI 10.1002/glia.21190; Svensson CI, 2010, MOL INTERV, V10, P25, DOI 10.1124/mi.10.1.6; Syed N, 2010, J NEUROSCI, V30, P6122, DOI 10.1523/JNEUROSCI.1681-09.2010; Tao-Cheng JH, 2000, J NEUROCYTOL, V29, P67, DOI 10.1023/A:1007168231323; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Vacca V, 2012, BRAIN BEHAV IMMUN, V26, P489, DOI 10.1016/j.bbi.2012.01.002; VOLTERRA A, 2005, NEUROGLIA, P190; Welch MJ, 2000, TOXICON, V38, P245, DOI 10.1016/S0041-0101(99)00153-1; Wilhelm A, 2004, NEUROSCI RES, V48, P249, DOI 10.1016/j.neures.2003.11.002; Xiao LZ, 2011, PAIN MED, V12, P1385, DOI 10.1111/j.1526-4637.2011.01182.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	61	93	99	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47977	10.1371/journal.pone.0047977	http://dx.doi.org/10.1371/journal.pone.0047977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110146	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200124
J	Sonnleitner, E; Valentini, M; Wenner, N; Haichar, FE; Haas, D; Lapouge, K				Sonnleitner, Elisabeth; Valentini, Martina; Wenner, Nicolas; Haichar, Feth el Zahar; Haas, Dieter; Lapouge, Karine			Novel Targets of the CbrAB/Crc Carbon Catabolite Control System Revealed by Transcript Abundance in Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS SPUTUM; GLOBAL REGULATOR; REPRESSION CONTROL; AMINO-ACIDS; TRANSLATION INITIATION; BIOFILM DEVELOPMENT; RESPONSE REGULATOR; ETHANOL OXIDATION; ESCHERICHIA-COLI; SMALL RNA	The opportunistic human pathogen Pseudomonas aeruginosa is able to utilize a wide range of carbon and nitrogen compounds, allowing it to grow in vastly different environments. The uptake and catabolism of growth substrates are organized hierarchically by a mechanism termed catabolite repression control (Crc) whereby the Crc protein establishes translational repression of target mRNAs at CA (catabolite activity) motifs present in target mRNAs near ribosome binding sites. Poor carbon sources lead to activation of the CbrAB two-component system, which induces transcription of the small RNA (sRNA) CrcZ. This sRNA relieves Crc-mediated repression of target mRNAs. In this study, we have identified novel targets of the CbrAB/Crc system in P. aeruginosa using transcriptome analysis in combination with a search for CA motifs. We characterized four target genes involved in the uptake and utilization of less preferred carbon sources: estA (secreted esterase), acsA (acetyl-CoA synthetase), bkdR (regulator of branched-chain amino acid catabolism) and aroP2 (aromatic amino acid uptake protein). Evidence for regulation by CbrAB, CrcZ and Crc was obtained in vivo using appropriate reporter fusions, in which mutation of the CA motif resulted in loss of catabolite repression. CbrB and CrcZ were important for growth of P. aeruginosa in cystic fibrosis (CF) sputum medium, suggesting that the CbrAB/Crc system may act as an important regulator during chronic infection of the CF lung.	[Sonnleitner, Elisabeth] Univ Vienna, Dept Microbiol Immunobiol & Genet, Max F Perutz Labs, Vienna, Austria; [Valentini, Martina; Wenner, Nicolas; Haichar, Feth el Zahar; Haas, Dieter; Lapouge, Karine] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Lausanne	Sonnleitner, E (corresponding author), Univ Vienna, Dept Microbiol Immunobiol & Genet, Max F Perutz Labs, Dr Bohrgasse 9, Vienna, Austria.	Sonnleitner@univie.ac.at; karine.lapouge@unil.ch	Zahar, Haichar Feth el/L-3009-2019; Haichar, Feth el Zahar/H-7745-2012; Valentini, Martina/AAC-6009-2022	Zahar, Haichar Feth el/0000-0003-3687-0529; Haichar, Feth el Zahar/0000-0003-3687-0529; Valentini, Martina/0000-0002-1948-8339; Sonnleitner, Elisabeth/0000-0002-6961-9536; Lapouge, Karine/0000-0003-0620-9553	Austrian Science Fund [T448-B20]; Sandoz Family Foundation; Swiss National Foundation for Scientific Research [31003A-127587, 3100A0-100180]	Austrian Science Fund(Austrian Science Fund (FWF)); Sandoz Family Foundation; Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	Elisabeth Sonnleither was supported by the Hertha-Firnberg Research fellowship T448-B20 from the Austrian Science Fund. Karine Lapouge was supported by the Sandoz Family Foundation (Programme for academic promotion) and the Swiss National Foundation for Scientific Research (project 31003A-127587). Dieter Haas was supported by the Swiss National Foundation for Scientific Research (project 3100A0-100180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou L, 2011, J BACTERIOL, V193, P2784, DOI 10.1128/JB.00164-11; Amador CI, 2010, ENVIRON MICROBIOL, V12, P1748, DOI 10.1111/j.1462-2920.2010.02254.x; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Caille O, 2007, J BACTERIOL, V189, P4561, DOI 10.1128/JB.00095-07; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x; Drew R, 2004, PSEUDOMONAS, VOL 2: VIRULENCE AND GENE REGULATION, P425; DURHAM DR, 1982, J BACTERIOL, V149, P534, DOI 10.1128/JB.149.2.534-541.1982; Gliese N, 2004, MICROBIOL-SGM, V150, P1851, DOI 10.1099/mic.0.26882-0; Gorisch H, 2003, BBA-PROTEINS PROTEOM, V1647, P98, DOI 10.1016/S1570-9639(03)00066-9; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Hester KL, 2000, J BACTERIOL, V182, P1144, DOI 10.1128/JB.182.4.1144-1149.2000; Hester KL, 2000, J BACTERIOL, V182, P1150, DOI 10.1128/JB.182.4.1150-1153.2000; HOSHINO T, 1990, J BACTERIOL, V172, P5531, DOI 10.1128/jb.172.10.5531-5539.1990; HOSHINO T, 1980, J BACTERIOL, V141, P1055, DOI 10.1128/JB.141.3.1055-1063.1980; Huang JF, 2012, APPL ENVIRON MICROB, V78, P5016, DOI 10.1128/AEM.00026-12; Itoh Y., 2007, PSEUDOMONAS MODEL SY, V5, P371; Kaberdin VR, 2006, FEMS MICROBIOL REV, V30, P967, DOI 10.1111/j.1574-6976.2006.00043.x; Kretzschmar U, 2010, ARCH MICROBIOL, V192, P685, DOI 10.1007/s00203-010-0593-5; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Linares JF, 2010, ENVIRON MICROBIOL, V12, P3196, DOI 10.1111/j.1462-2920.2010.02292.x; MADHUSUDHAN KT, 1993, J BACTERIOL, V175, P3934, DOI 10.1128/JB.175.13.3934-3940.1993; MARTIN RR, 1973, J BACTERIOL, V115, P198, DOI 10.1128/JB.115.1.198-204.1973; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Moreno R, 2009, NUCLEIC ACIDS RES, V37, P7678, DOI 10.1093/nar/gkp825; Moreno R, 2009, PROTEOMICS, V9, P2910, DOI 10.1002/pmic.200800918; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Palmer GC, 2010, J BACTERIOL, V192, P2722, DOI 10.1128/JB.00112-10; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; STUER W, 1986, J BACTERIOL, V168, P1070, DOI 10.1128/jb.168.3.1070-1074.1986; Wilhelm S, 1999, J BACTERIOL, V181, P6977, DOI 10.1128/JB.181.22.6977-6986.1999; Wilhelm S, 2011, CHEMBIOCHEM, V12, P1476, DOI 10.1002/cbic.201100013; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10	45	45	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e44637	10.1371/journal.pone.0044637	http://dx.doi.org/10.1371/journal.pone.0044637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115619	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200006
J	Zong, ZY				Zong, Zhiyong			Discovery of bla(OXA-199), a Chromosome-Based bla(OXA-48)-Like Variant, in Shewanella xiamenensis	PLOS ONE			English	Article							D BETA-LACTAMASE; OXACILLINASE; RESISTANCE	Introduction: bla(OXA-48) is a globally emerging carbapenemase-encoding gene. The progenitor of bla(OXA-48) appears to be a Shewanella species. The presence of the bla(OXA-48)-like gene was investigated for two Shewanella xiamenensis strains. Methods: Strain WCJ25 was recovered from post-surgical abdominal drainages, while S4 was the type strain of S. xiamenensis. Species identification for WCJ25 was established by sequencing the 16S rDNA and gyrB genes. PCR was used to screen the bla(OXA-48)-like genes and to obtain their complete sequences. A phylogenetic tree of the bla(OXA-48)-like genes was constructed. The genetic context of the bla(OXA-48)-like gene in strain WCJ25 was investigated by inverse PCR using self-ligated AseI- or RsaI-restricted WCJ25 DNA fragments as template, while that in strain S4 was determined by PCR mapping using that in WCJ25 as template. Results: A new bla(OXA-48) variant, designated bla(OXA-48b), with four silent nucleotide differences from the bla(OXA-48) (designated bla(OXA-48)a) found in the Enterobacteriaceae was identified in strain S4. Strain WCJ25 had a new blaOXA-48-like variant, bla(OXA-199), with five nucleotide differences from bla(OXA-48)a and bla(OXA-48b). The OXA-199 protein has three amino acid substitutions (H37Y, V44A and D153G) compared with OXA-48. Both bla(OXA-48b) and bla(OXA-199) were found adjacent to genes encoding a peptidase (indicated as orf), a protein of unknown function (sprT), an endonuclease I (endA), and a ribosomal RNA methyl transferase (rsmE) upstream and to transcriptional regulator gene lysR and an acetyl-CoA carboxylase-encoding gene downstream. In addition, the insertion sequence ISShes2 was found inserted downstream of bla(OXA-199) but not of bla(OXA-48b). The 26 bp sequences upstream and 63 bp downstream of bla(OXA-48a), bla(OXA-48b) and bla(OXA-199) were identical. Conclusions: bla(OXA-48a), bla(OXA-48b) and bla(OXA-199) might have a common origin, suggesting that the bla(OXA-48a) gene found in the Enterobacteriaceae could have originated from the chromosome of S. xiamenensis.	[Zong, Zhiyong] Sichuan Univ, W China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China; [Zong, Zhiyong] State Key Lab Biotherapy, Div Infect Dis, Chengdu, Peoples R China	Sichuan University	Zong, ZY (corresponding author), Sichuan Univ, W China Hosp, Ctr Infect Dis, Chengdu 610064, Peoples R China.	zongzhiy@scu.edu.cn		ZONG, ZHIYONG/0000-0002-7675-260X	West China Hospital	West China Hospital	This study was funded by internal funding from West China Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert D, 2006, J BACTERIOL, V188, P6506, DOI 10.1128/JB.00375-06; Carrer A, 2010, ANTIMICROB AGENTS CH, V54, P1369, DOI 10.1128/AAC.01312-09; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Huang JX, 2010, INT J SYST EVOL MICR, V60, P1585, DOI 10.1099/ijs.0.013300-0; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P348, DOI 10.1128/AAC.48.1.348-351.2004; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P2546, DOI 10.1128/AAC.00022-11; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Zong ZY, 2011, J MED MICROBIOL, V60, P1387, DOI 10.1099/jmm.0.031625-0	11	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48280	10.1371/journal.pone.0048280	http://dx.doi.org/10.1371/journal.pone.0048280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110226	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200166
J	Leger, M; Quiedeville, A; Paizanis, E; Natkunarajah, S; Freret, T; Boulouard, M; Schumann-Bard, P				Leger, Marianne; Quiedeville, Anne; Paizanis, Eleni; Natkunarajah, Sharuja; Freret, Thomas; Boulouard, Michel; Schumann-Bard, Pascale			Environmental Enrichment Enhances Episodic-Like Memory in Association with a Modified Neuronal Activation Profile in Adult Mice	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; OBJECT RECOGNITION MEMORY; LONG-TERM-MEMORY; PERIRHINAL CORTEX; C-FOS; TRANSCRIPTION FACTORS; POSTRHINAL CORTEX; VISUAL-STIMULI; HIPPOCAMPAL; LESIONS	Although environmental enrichment is well known to improve learning and memory in rodents, the underlying neuronal networks' plasticity remains poorly described. Modifications of the brain activation pattern by enriched condition (EC), especially in the frontal cortex and the baso-lateral amygdala, have been reported during an aversive memory task in rodents. The aims of our study were to examine 1) whether EC modulates episodic-like memory in an object recognition task and 2) whether EC modulates the task-induced neuronal networks. To this end, adult male mice were housed either in standard condition (SC) or in EC for three weeks before behavioral experiments (n = 12/group). Memory performances were examined in an object recognition task performed in a Y-maze with a 2-hour or 24-hour delay between presentation and test (inter-session intervals, ISI). To characterize the mechanisms underlying the promnesiant effect of EC, the brain activation profile was assessed after either the presentation or the test sessions using immunohistochemical techniques with c-Fos as a neuronal activation marker. EC did not modulate memory performances after a 2 h-ISI, but extended object recognition memory to a 24 h-ISI. In contrast, SC mice did not discriminate the novel object at this ISI. Compared to SC mice, no activation related to the presentation session was found in selected brain regions of EC mice (in particular, no effect was found in the hippocampus and the perirhinal cortex and a reduced activation was found in the baso-lateral amygdala). On the other hand, an activation of the hippocampus and the infralimbic cortex was observed after the test session for EC, but not SC mice. These results suggest that the persistence of object recognition memory in EC could be related to a reorganization of neuronal networks occurring as early as the memory encoding.	[Leger, Marianne; Quiedeville, Anne; Paizanis, Eleni; Natkunarajah, Sharuja; Freret, Thomas; Boulouard, Michel; Schumann-Bard, Pascale] Univ Caen Basse Normandie, Grp Memoire & Plasticite Comportementale GMPc, EA 4259, Caen, France	Universite de Caen Normandie	Leger, M (corresponding author), Univ Caen Basse Normandie, Grp Memoire & Plasticite Comportementale GMPc, EA 4259, Caen, France.	marianne.leger@unicaen.fr	freret, thomas/AAA-2491-2019; freret, thomas/B-2068-2012; Michel, Boulouard/N-9028-2015	freret, thomas/0000-0002-4446-4451; freret, thomas/0000-0002-4446-4451; Quiedeville, Anne/0000-0001-8666-4083; Leger, Marianne/0000-0002-7811-8522; Michel, Boulouard/0000-0003-3825-8659	French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	Marianne Leger is supported by funding from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2002, J NEUROSCI, V22, P9626; Aggleton JP, 2005, Q J EXP PSYCHOL-B, V58, P218, DOI 10.1080/02724990444000131; Aggleton JP, 1997, BRAIN RES BULL, V43, P279, DOI 10.1016/S0361-9230(97)00007-5; Albasser MM, 2010, EUR J NEUROSCI, V31, P134, DOI 10.1111/j.1460-9568.2009.07042.x; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arque G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002575; Barbelivien A, 2006, BEHAV BRAIN RES, V169, P231, DOI 10.1016/j.bbr.2006.01.012; Barker GRI, 2008, J NEUROSCI, V28, P2837, DOI 10.1523/JNEUROSCI.4447-07.2008; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; BENNETT EL, 1969, SCIENCE, V163, P825, DOI 10.1126/science.163.3869.825; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Castilla-Ortega E, 2012, BEHAV BRAIN RES, V232, P400, DOI 10.1016/j.bbr.2012.04.018; Chambon C, 2011, BEHAV BRAIN RES, V222, P151, DOI 10.1016/j.bbr.2011.03.032; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P112, DOI 10.1006/nlme.1997.3746; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; DeVito LM, 2010, BEHAV BRAIN RES, V215, P318, DOI 10.1016/j.bbr.2009.09.014; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; Eacott MJ, 2005, LEARN MEMORY, V12, P221, DOI 10.1101/lm.92505; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Freret T, 2012, BEHAV BRAIN RES, V230, P304, DOI 10.1016/j.bbr.2012.02.012; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Gresack JE, 2007, NEUROBIOL LEARN MEM, V88, P393, DOI 10.1016/j.nlm.2007.07.015; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hattori S, 2007, BEHAV BRAIN RES, V180, P69, DOI 10.1016/j.bbr.2007.02.036; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Huang FL, 2006, J NEUROSCI, V26, P6230, DOI 10.1523/JNEUROSCI.1182-06.2006; Jobim PFC, 2012, BEHAV BRAIN RES, V228, P151, DOI 10.1016/j.bbr.2011.12.004; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Leger M, 2012, BEHAV BRAIN RES, V228, P22, DOI 10.1016/j.bbr.2011.11.022; Maren S, 1996, BEHAV NEUROSCI, V110, P718, DOI 10.1037/0735-7044.110.4.718; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Nikolaev E, 2002, BRAIN RES, V957, P91, DOI 10.1016/S0006-8993(02)03606-5; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Norman G, 2005, BEHAV NEUROSCI, V119, P557, DOI 10.1037/0735-7044.119.2.557; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rinaldi A, 2010, NEUROBIOL LEARN MEM, V94, P373, DOI 10.1016/j.nlm.2010.08.004; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Seoane A., 2012, HIPPOCAMPUS; Soule Jonathan, 2008, Neural Plasticity, V2008, P269097, DOI 10.1155/2008/269097; Sundquist SJ, 2005, J NEUROSCI METH, V141, P9, DOI 10.1016/j.jneumeth.2004.05.007; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tinsley CJ, 2011, LEARN MEMORY, V18, P484, DOI 10.1101/lm.2274911; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Viola GG, 2010, PHYSIOL BEHAV, V99, P17, DOI 10.1016/j.physbeh.2009.10.003; Wan HM, 1999, J NEUROSCI, V19, P1142; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Zhu XO, 1997, NEUROSCI LETT, V229, P141, DOI 10.1016/S0304-3940(97)00437-0; ZHU XO, 1995, NEUROSCIENCE, V69, P821, DOI 10.1016/0306-4522(95)00320-I	59	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e48043	10.1371/journal.pone.0048043	http://dx.doi.org/10.1371/journal.pone.0048043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110171	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400030
J	Randall, PA; Pardo, M; Nunes, EJ; Cruz, LL; Vemuri, VK; Makriyannis, A; Baqi, Y; Muller, CE; Correa, M; Salamone, JD				Randall, Patrick A.; Pardo, Marta; Nunes, Eric J.; Lopez Cruz, Laura; Vemuri, V. Kiran; Makriyannis, Alex; Baqi, Younis; Mueller, Christa E.; Correa, Merce; Salamone, John D.			Dopaminergic Modulation of Effort-Related Choice Behavior as Assessed by a Progressive Ratio Chow Feeding Choice Task: Pharmacological Studies and the Role of Individual Differences	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; INSTRUMENTAL RESPONSE SELECTION; CANNABINOID CB1 ANTAGONISTS; A(2A) RECEPTOR ANTAGONISM; FOOD-REINFORCED BEHAVIOR; DECISION-MAKING; ADENOSINE A(2A); DARPP-32 PHOSPHORYLATION; SEEKING BEHAVIOR; D2 ANTAGONISM	Mesolimbic dopamine (DA) is involved in behavioral activation and effort-related processes. Rats with impaired DA transmission reallocate their instrumental behavior away from food-reinforced tasks with high response requirements, and instead select less effortful food-seeking behaviors. In the present study, the effects of several drug treatments were assessed using a progressive ratio (PROG)/chow feeding concurrent choice task. With this task, rats can lever press on a PROG schedule reinforced by a preferred high-carbohydrate food pellet, or alternatively approach and consume the less-preferred but concurrently available laboratory chow. Rats pass through each ratio level 15 times, after which the ratio requirement is incremented by one additional response. The DA D-2 antagonist haloperidol (0.025-0.1 mg/kg) reduced number of lever presses and highest ratio achieved but did not reduce chow intake. In contrast, the adenosine A(2A) antagonist MSX-3 increased lever presses and highest ratio achieved, but decreased chow consumption. The cannabinoid CB1 inverse agonist and putative appetite suppressant AM251 decreased lever presses, highest ratio achieved, and chow intake; this effect was similar to that produced by pre-feeding. Furthermore, DA-related signal transduction activity (pDARPP-32(Thr34) expression) was greater in nucleus accumbens core of high responders (rats with high lever pressing output) compared to low responders. Thus, the effects of DA antagonism differed greatly from those produced by pre-feeding or reduced CB1 transmission, and it appears unlikely that haloperidol reduces PROG responding because of a general reduction in primary food motivation or the unconditioned reinforcing properties of food. Furthermore, accumbens core signal transduction activity is related to individual differences in work output.	[Randall, Patrick A.; Pardo, Marta; Nunes, Eric J.; Lopez Cruz, Laura; Correa, Merce; Salamone, John D.] Univ Connecticut, Dept Psychol, Storrs, CT USA; [Pardo, Marta; Lopez Cruz, Laura; Correa, Merce] Univ Jaume 1, Area Psicobiol, Castellon de La Plana, Spain; [Vemuri, V. Kiran; Makriyannis, Alex] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Baqi, Younis; Mueller, Christa E.] Univ Bonn, Inst Pharmazeut, Pharma Zentrum Bonn, Bonn, Germany	University of Connecticut; Universitat Jaume I; Northeastern University; University of Bonn	Salamone, JD (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT USA.	john.salamone@uconn.edu	Baqi, Younis/I-8240-2016; Lopez-Cruz, Laura/AAJ-3913-2021; Pardo Andres, Marta/AAD-6953-2022; Baqi, Younis/R-8364-2019; Salamone, John/H-8165-2015; CORREA, MERCE/G-6125-2011; Müller, Christa Elisabeth/C-7748-2014	Baqi, Younis/0000-0002-9659-8419; Pardo Andres, Marta/0000-0003-0808-1303; Baqi, Younis/0000-0002-9659-8419; Salamone, John/0000-0001-6435-9635; CORREA, MERCE/0000-0002-9868-3131; Müller, Christa Elisabeth/0000-0002-0013-6624; Lopez-Cruz, Laura/0000-0003-4735-6445	National Institute of Mental Health [MH078023]; National Institute of Drug Abuse [U01DA016194]; Fundacio Bancaixa-UJI [P1.1B2010-43, PREDOC-2007-43]; Ministerio Educacion, FPU [AP2010-3793]; NIH(NIMH); NIH(NIDA); UCB Pharma within the Biopharma collaborative project Neuroallianz; German Federal Ministry of Education and Research (BMBF); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA016194] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Fundacio Bancaixa-UJI; Ministerio Educacion, FPU(German Research Foundation (DFG)); NIH(NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); UCB Pharma within the Biopharma collaborative project Neuroallianz(UCB Pharma SA); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants to J. Salamone from the National Institute of Mental Health (MH078023) and the National Institute of Drug Abuse (U01DA016194), and M. Correa has received funding from Fundacio Bancaixa-UJI (P1.1B2010-43). M. Pardo was supported by Fundacio Bancaixa-UJI (PREDOC-2007-43), and L. Lopez-Cruz was supported by Ministerio Educacion, FPU (AP2010-3793). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J. Salamone's work was funded by the NIH(NIMH) and NIH(NIDA), and he has received compensation from Merck- Seronno, Pfizer and Roche. A. Makriyannis was supported by NIH(NIDA). C. Muller received funding by UCB Pharma within the Biopharma collaborative project Neuroallianz funded by the German Federal Ministry of Education and Research (BMBF). M. Correa received funding by Fundacio Bancaixa-UJI (P1.1B2010-43). M. Pardo was supported by Fundacio Bancaixa-UJI (PREDOC-2007-43), and L. Lopez-Cruz was supported by Ministerio Educacion, FPU (AP2010-3793). None of the other authors had financial interests to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aberman JE, 1999, NEUROSCIENCE, V92, P545, DOI 10.1016/S0306-4522(99)00004-4; Aberman JE, 1998, PHARMACOL BIOCHEM BE, V61, P341, DOI 10.1016/S0091-3057(98)00112-9; Arnold JM, 1997, PHARMACOL BIOCHEM BE, V57, P441, DOI 10.1016/S0091-3057(96)00445-5; Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Beeler JA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00049; Beeler JA, 2012, EUR J NEUROSCI, V36, P2533, DOI 10.1111/j.1460-9568.2012.08167.x; Beeler JA, 2012, EUR J NEUROSCI, V35, P146, DOI 10.1111/j.1460-9568.2011.07916.x; Cagniard B, 2006, NEUROPSYCHOPHARMACOL, V31, P1362, DOI 10.1038/sj.npp.1300966; Cocker PJ, 2012, NEUROPSYCHOPHARMACOL, V37, P1825, DOI 10.1038/npp.2012.30; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Correa M, 2002, BEHAV BRAIN RES, V137, P179, DOI 10.1016/S0166-4328(02)00292-9; Cousins MS, 1996, BEHAV BRAIN RES, V74, P189, DOI 10.1016/0166-4328(95)00151-4; COUSINS MS, 1993, PHARMACOL BIOCHEM BE, V46, P943, DOI 10.1016/0091-3057(93)90226-J; Danielli B, 2010, J NEUROCHEM, V112, P531, DOI 10.1111/j.1471-4159.2009.06483.x; Denk F, 2005, PSYCHOPHARMACOLOGY, V179, P587, DOI 10.1007/s00213-004-2059-4; Farrar AM, 2010, NEUROSCIENCE, V166, P1056, DOI 10.1016/j.neuroscience.2009.12.056; Farrar AM, 2007, PSYCHOPHARMACOLOGY, V191, P579, DOI 10.1007/s00213-006-0554-5; Ferre S, 1997, PSYCHOPHARMACOLOGY, V133, P107, DOI 10.1007/s002130050380; Ferre S, 2004, PARKINSONISM RELAT D, V10, P265, DOI 10.1016/j.parkreldis.2004.02.014; Floresco SB, 2008, NEUROPSYCHOPHARMACOL, V33, P1966, DOI 10.1038/sj.npp.1301565; Font L, 2008, PSYCHOPHARMACOLOGY, V199, P515, DOI 10.1007/s00213-008-1174-z; Fuxe K., 2003, Neurology, V61, pS19; Hamill S, 1999, PHARMACOL BIOCHEM BE, V64, P21, DOI 10.1016/S0091-3057(99)00092-1; Hillion J, 2002, J BIOL CHEM, V277, P18091, DOI 10.1074/jbc.M107731200; Keppel G, 1991, DESIGN ANAL RES HDB; Koch M, 2000, PSYCHOPHARMACOLOGY, V152, P67, DOI 10.1007/s002130000505; Kuroiwa M, 2008, J NEUROCHEM, V107, P1014, DOI 10.1111/j.1471-4159.2008.05702.x; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Mai B, 2012, COGN AFFECT BEHAV NE, V12, P74, DOI 10.3758/s13415-011-0068-4; MCCULLOUGH LD, 1992, BRAIN RES, V592, P29, DOI 10.1016/0006-8993(92)91654-W; McLaughlin PJ, 2003, BEHAV PHARMACOL, V14, P583, DOI 10.1097/00008877-200312000-00002; Mingote S, 2005, EUR J NEUROSCI, V21, P1749, DOI 10.1111/j.1460-9568.2005.03972.x; Mingote S, 2008, J NEUROSCI, V28, P9037, DOI 10.1523/JNEUROSCI.1525-08.2008; Mott AM, 2009, PSYCHOPHARMACOLOGY, V204, P103, DOI 10.1007/s00213-008-1441-z; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nowend KL, 2001, PHARMACOL BIOCHEM BE, V69, P373, DOI 10.1016/S0091-3057(01)00524-X; Nunes EJ, 2010, NEUROSCIENCE, V170, P268, DOI 10.1016/j.neuroscience.2010.05.068; Pardo M, 2012, NEUROPHARMACOLOGY, V62, P2068, DOI 10.1016/j.neuropharm.2011.12.033; PAXINOS G, 1998, RAT BRIAN STEREOTAXI; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Randall PA, 2010, PHARMACOL BIOCHEM BE, V97, P179, DOI 10.1016/j.pbb.2010.07.021; Randall PA, 2011, PSYCHOPHARMACOLOGY, V216, P173, DOI 10.1007/s00213-011-2198-3; Robbins TW, 2007, PSYCHOPHARMACOLOGY, V191, P433, DOI 10.1007/s00213-006-0528-7; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; SALAMONE JD, 1991, PSYCHOPHARMACOLOGY, V104, P515, DOI 10.1007/BF02245659; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Salamone JD, 2002, PSYCHOPHARMACOLOGY, V160, P371, DOI 10.1007/s00213-001-0994-x; SALAMONE JD, 1990, NEUROSCIENCE, V39, P17, DOI 10.1016/0306-4522(90)90218-S; Salamone JD, 1996, PSYCHOPHARMACOLOGY, V125, P105, DOI 10.1007/BF02249408; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; SALAMONE JD, 1988, PSYCHOBIOLOGY, V16, P196; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Salamone JD, 2006, CURR PSYCHIATRY REV, V2, P267, DOI 10.2174/157340006776875914; Salamone JD, 2006, ADDICT BIOL, V11, P43, DOI 10.1111/j.1369-1600.2006.00011.x; Salamone JD, 2012, J EXP ANAL BEHAV, V97, P125, DOI 10.1901/jeab.2012.97-125; Salamone JD, 2009, BEHAV BRAIN RES, V201, P216, DOI 10.1016/j.bbr.2009.02.021; SCHIFFMANN SN, 1991, J NEUROCHEM, V57, P1062, DOI 10.1111/j.1471-4159.1991.tb08257.x; Schweimer J, 2005, LEARN MEMORY, V12, P334, DOI 10.1101/lm.90605; Segovia KN, 2011, NEUROSCIENCE, V196, P178, DOI 10.1016/j.neuroscience.2011.07.078; Segovia KN, 2012, EUR J NEUROSCI, V35, P1354, DOI 10.1111/j.1460-9568.2012.08036.x; Sink KS, 2008, PSYCHOPHARMACOLOGY, V196, P565, DOI 10.1007/s00213-007-0988-4; SKJOLDAGER P, 1993, LEARN MOTIV, V24, P303, DOI 10.1006/lmot.1993.1019; Smith KS, 2011, P NATL ACAD SCI USA, V108, pE255, DOI 10.1073/pnas.1101920108; STEWART WJ, 1975, AUST J PSYCHOL, V27, P9, DOI 10.1080/00049537508255235; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; Yger M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00056	68	131	132	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47934	10.1371/journal.pone.0047934	http://dx.doi.org/10.1371/journal.pone.0047934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110135	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000310193400026
J	Tomas, J; Wrzosek, L; Bouznad, N; Bouet, S; Mayeur, C; Noordine, ML; Honvo-Houeto, E; Langella, P; Thomas, M; Cherbuy, C				Tomas, Julie; Wrzosek, Laura; Bouznad, Nassim; Bouet, Stephan; Mayeur, Camille; Noordine, Marie-Louise; Honvo-Houeto, Edith; Langella, Philippe; Thomas, Muriel; Cherbuy, Claire			Primocolonization is associated with colonic epithelial maturation during conventionalization	FASEB JOURNAL			English	Article						intestine; microbiota; proliferation; germ-free rat; transporters	MICROBIAL DIVERSITY; ESTABLISHMENT; INTESTINE; PROLIFERATION; HOMEOSTASIS; MICROFLORA; SUCCESSION; RECEPTORS; INDUCTION; MUCOSA	Interaction between the gut microbiota and the host starts immediately after birth with the progressive colonization of the sterile intestine. Our aim was to investigate the interactions taking place in the colonic epithelium after the first exposure to gut microbiota. Germ-free (GF) rats were inoculated with two different microbiotas: the first, obtained from suckling rats, was rich in primocolonizing bacteria and the second, obtained from adult rats, was representative of a mature microbiota. Once transferred into GF rats, these two microbiotas evolved such that they converged, and recapitulated the primocolonization pattern, mimicking the chronological scheme of implantation following birth. The two microbiotas induced common responses in the colonic epithelium: a transitory proliferative phase followed by a compensatory phase characterized by increases in the abundance of p21(Cip1) and p27(Kip1) and in the number of goblet cells. The effects of the two microbiotas diverged only through their effects on colonic transporters. Analyses of solute carriers and aquaporins revealed that functional maturation was more pronounced following exposure to adult microbiota than suckling microbiota. The colon matured in parallel with the evolution of the microbiota composition, and we therefore suggest a link between intestinal events regulating homeostasis of the colon and modulation of microbial composition.-Tomas, J., Wrzosek, L., Bouznad, N., Bouet, S., Mayeur, C., Noordine, M.-L., Honvo-Houeto, E., Langella, P., Thomas, M., Cherbuy, C. Primocolonization is associated with colonic epithelial maturation during conventionalization. FASEB J. 27, 645-655 (2013). www.fasebj.org	[Tomas, Julie; Wrzosek, Laura; Mayeur, Camille; Noordine, Marie-Louise; Langella, Philippe; Thomas, Muriel; Cherbuy, Claire] INRA, Commensal & Probiot Host Interact Lab, F-78350 Jouy En Josas, France; [Tomas, Julie; Wrzosek, Laura; Mayeur, Camille; Noordine, Marie-Louise; Langella, Philippe; Thomas, Muriel; Cherbuy, Claire] AgroParisTech, Unite Mixte Rech UMR 1319, Microbiol Alimentat Serv Sante MICALIS, Jouy En Josas, France; [Bouznad, Nassim] Univ Liege, Human Genet Unit, B-4000 Liege, Belgium; [Bouznad, Nassim; Bouet, Stephan] INRA, F-78350 Jouy En Josas, France; [Bouet, Stephan] AgroParisTech, UMR Anim Genet & Integrat Biol 1313, Jouy En Josas, France; [Bouet, Stephan] Commissariat Energie Atom & Energies Alternat CEA, Lab Radiobiol & Genom Studies, DSV, IRCM,SREIT, Jouy En Josas, France; [Honvo-Houeto, Edith] INRA, Genom & Physiol Lactat, F-78350 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; University of Liege; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Cherbuy, C (corresponding author), INRA, MICALIS, UMR 1319, F-78350 Jouy En Josas, France.	claire.cherbuy@jouy.inra.fr	Langella, Philippe/N-8368-2017; thomas, muriel/HDO-3887-2022; TOMAS, Julie/AAC-9819-2022; Thomas, Muriel/D-9164-2015	Langella, Philippe/0000-0001-5960-4341; Thomas, Muriel/0000-0002-7608-3274; TOMAS, Julie/0000-0001-9389-0273	Institut National de la Recherche Agronomique (Jouy-en-Josas, France); French Ministry of Education and Research	Institut National de la Recherche Agronomique (Jouy-en-Josas, France); French Ministry of Education and Research	The authors thank Christine Delorme and Sylvie Miquel for fruitful discussions and critical reading of the manuscript, the Animalerie Axenique de MICALIS (ANAXEM) platform [Microbiologie de l'Alimentation au Service de la Sante (MICALIS), Jouy-en-Josas, France] for animal facilities, and Catherine Philippe for SCFA analyses. J.T. was recipient of a Contrat Jeune Scientifique from the Institut National de la Recherche Agronomique (Jouy-en-Josas, France), and L. W. was recipient of a Ph.D. grant from the French Ministry of Education and Research. The authors declare no conflicts of interest.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Cheesman SE, 2011, P NATL ACAD SCI USA, V108, P4570, DOI 10.1073/pnas.1000072107; Cherbuy C, 2004, EUR J BIOCHEM, V271, P87, DOI 10.1046/j.1432-1033.2003.03908.x; CHERBUY C, 1995, GASTROENTEROLOGY, V109, P1890, DOI 10.1016/0016-5085(95)90756-4; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chowdhury Shankar R, 2007, BMC Genomics, V8, P215, DOI 10.1186/1471-2164-8-215; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Danielsen M, 2007, J PROTEOME RES, V6, P2596, DOI 10.1021/pr070038b; Djouzi Z, 1997, J NUTR, V127, P2260, DOI 10.1093/jn/127.11.2260; Drozdowski LA, 2010, WORLD J GASTROENTERO, V16, P787, DOI 10.3748/wjg.v16.i7.787; Duerr CU, 2012, SEMIN IMMUNOL, V24, P25, DOI 10.1016/j.smim.2011.11.002; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gillilland MG, 2012, APPL ENVIRON MICROB, V78, P2359, DOI 10.1128/AEM.05239-11; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hopkins MJ, 2005, FEMS MICROBIOL ECOL, V54, P77, DOI 10.1016/j.femsec.2005.03.001; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Joly F, 2009, AM J PHYSIOL-GASTR L, V297, pG116, DOI 10.1152/ajpgi.90657.2008; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe; Marchesi JR, 2011, ENVIRON MICROBIOL, V13, P3088, DOI 10.1111/j.1462-2920.2011.02574.x; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Preidis GA, 2012, FASEB J, V26, P1960, DOI 10.1096/fj.10-177980; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rul F, 2011, J BIOL CHEM, V286, P10288, DOI 10.1074/jbc.M110.168666; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Stockinger S, 2011, CELL MOL LIFE SCI, V68, P3699, DOI 10.1007/s00018-011-0831-2; Thiagarajah JR, 2007, GUT, V56, P1529, DOI 10.1136/gut.2006.104620; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028789	42	54	57	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					645	655		10.1096/fj.12-216861	http://dx.doi.org/10.1096/fj.12-216861			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23118025				2022-12-25	WOS:000314358000023
J	Garnier, D; Magnus, N; Lee, TH; Bentley, V; Meehan, B; Milsom, C; Montermini, L; Kislinger, T; Rak, J				Garnier, Delphine; Magnus, Nathalie; Lee, Tae Hoon; Bentley, Victoria; Meehan, Brian; Milsom, Chloe; Montermini, Laura; Kislinger, Thomas; Rak, Janusz			Cancer Cells Induced to Express Mesenchymal Phenotype Release Exosome-like Extracellular Vesicles Carrying Tissue Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-BEARING MICROPARTICLES; E-CADHERIN; TUMOR PROGRESSION; MICROVESICLES; GLIOBLASTOMA; ANGIOGENESIS; COAGULATION; THROMBOSIS; DISEASE	Aggressive epithelial cancer cells frequently adopt mesenchymal characteristics and exhibit aberrant interactions with their surroundings, including the vasculature. Whether the release/uptake of extracellular vesicles (EVs) plays a role during these processes has not been studied. EVs are heterogeneous membrane structures that originate either at the surface (microparticles), or within (exosomes) activated or transformed cells, and are involved in intercellular trafficking of bioactive molecules. Here, we show that epithelial cancer cells (A431, DLD-1) adopt mesenchymal features (epithelial-to-mesenchymal transition-like state) upon activation of epidermal growth factor receptor (EGFR) coupled with blockade of E-cadherin. This treatment leads to a coordinated loss of EGFR and tissue factor (TF) from the plasma membrane and coincides with a surge in emission of small, exosome-like EVs containing both receptors. TF (but not EGFR) is selectively up-regulated in EVs produced by mesenchymal-like cancer cells and can be transferred to cultured endothelial cells rendering them highly procoagulant. We postulate that epithelial-to-mesenchymal transition-like changes may alter cancer cell interactions with the vascular systems through altered vesiculation and TF shedding.	[Rak, Janusz] McGill Univ, Montreal Childrens Hosp, Res Inst, RI MUHC, Montreal, PQ H3Z 2Z3, Canada; [Milsom, Chloe] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Kislinger, Thomas] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Rak, J (corresponding author), McGill Univ, Montreal Childrens Hosp, Res Inst, RI MUHC, Pl Toulon,4060 Ste,PT 232, Montreal, PQ H3Z 2Z3, Canada.	janusz.rak@mcgill.ca	Kislinger, Thomas/A-5934-2008	Lee, Tae Hoon/0000-0002-4195-1174; Garnier, Delphine/0000-0002-5744-5612; Kislinger, Thomas/0000-0003-3525-5540	Canadian Institutes of Health Research [MOP-102736, MOP 111119]; Foundation of Stars/Montreal Children's Hospital Foundation (MCHF); Fonds de recherche en sante du Quebec (FRSQ); Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation of Stars/Montreal Children's Hospital Foundation (MCHF); Fonds de recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants MOP-102736 and MOP 111119 (to J.R.). Infrastructure support was provided by Fonds de recherche en sante du Quebec. Postdoctoral awards were funded by Thelma Adams Award Program from the Foundation of Stars/Montreal Children's Hospital Foundation (MCHF) and Canadian Institutes of Health Research (to D. G. and C. M., respectively).; Recipient of a doctoral studentship from Fonds de recherche en sante du Quebec (FRSQ).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bogdanov VY, 2003, NAT MED, V9, P458, DOI 10.1038/nm841; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; Dahl KDC, 2008, CANCER RES, V68, P4606, DOI 10.1158/0008-5472.CAN-07-5046; Davila M, 2008, J THROMB HAEMOST, V6, P1517, DOI 10.1111/j.1538-7836.2008.02987.x; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Falanga A, 2005, SEMIN THROMB HEMOST, V31, P104, DOI 10.1055/s-2005-863812; Hansen CB, 2001, BLOOD, V97, P1712, DOI 10.1182/blood.V97.6.1712; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Horowitz NA, 2011, BLOOD, V118, P2889, DOI 10.1182/blood-2011-03-341222; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Magnus N, 2010, BLOOD, V116, P815, DOI 10.1182/blood-2009-10-250639; Mandal SK, 2007, BLOOD, V110, P161, DOI 10.1182/blood-2006-10-050476; Mandal SK, 2006, BLOOD, V107, P4746, DOI 10.1182/blood-2005-11-4674; Milsom CC, 2008, CANCER RES, V68, P10068, DOI 10.1158/0008-5472.CAN-08-2067; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rak J., 2009, CANC GENOME TUMOR MI, P150; Rak J, 2012, BIOESSAYS, V34, P489, DOI 10.1002/bies.201100169; Rickles FR, 2006, PATHOPHYSIOL HAEMO T, V35, P103, DOI 10.1159/000093551; Rong Y, 2009, CANCER RES, V69, P2540, DOI 10.1158/0008-5472.CAN-08-1547; Ruf W, 2011, J THROMB HAEMOST, V9, P306, DOI 10.1111/j.1538-7836.2011.04318.x; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Taylor P, 2009, J PROTEOME RES, V8, P1610, DOI 10.1021/pr800986c; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Wang JG, 2012, BLOOD, V119, P5543, DOI 10.1182/blood-2012-01-402156; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yu JL, 2005, BLOOD, V105, P1734, DOI 10.1182/blood-2004-05-2042; Yu J, 2008, ARTERIOSCL THROM VAS, V28, P1975, DOI 10.1161/ATVBAHA.108.175083; Zuo JH, 2011, J CELL BIOCHEM, V112, P2508, DOI 10.1002/jcb.23175; Zwicker JI, 2011, ARTERIOSCL THROM VAS, V31, P728, DOI 10.1161/ATVBAHA.109.200964; Zwicker JI, 2010, THROMB RES, V125, pS89, DOI 10.1016/S0049-3848(10)70022-0	45	112	113	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43565	43572		10.1074/jbc.M112.401760	http://dx.doi.org/10.1074/jbc.M112.401760			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118232	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000312940800037
J	Valentine, CD; Lukacs, GL; Verkman, AS; Haggie, PM				Valentine, Cathleen D.; Lukacs, Gergely L.; Verkman, Alan S.; Haggie, Peter M.			Reduced PDZ Interactions of Rescued Delta F508CFTR Increases Its Cell Surface Mobility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; PROTEIN-QUALITY CONTROL; CYSTIC-FIBROSIS; PLASMA-MEMBRANE; CFTR; EXPRESSION; DEGRADATION; DIFFUSION; DOMAIN; RECEPTORS	Deletion of phenylalanine 508 (Delta F508) in the cystic fibrosis transmembrane conductance regulator (CFTR) plasma membrane chloride channel is the most common cause of cystic fibrosis (CF). Though several maneuvers can rescue endoplasmic reticulum-retained Delta F508CFTR and promote its trafficking to the plasma membrane, rescued Delta F508CFTR remains susceptible to quality control mechanisms that lead to accelerated endocytosis, ubiquitination, and lysosomal degradation. To investigate the role of scaffold protein interactions in rescued Delta F508CFTR surface instability, the plasma membrane mobility of Delta F508CFTR was measured in live cells by quantum dot single particle tracking. Following rescue by low temperature, chemical correctors, thapsigargin, or overexpression of GRASP55, Delta F508CFTR diffusion was more rapid than that of wild-type CFTR because of reduced interactions with PDZ domain-containing scaffold proteins. Knock-down of the plasma membrane quality control proteins CHIP and Hsc70 partially restored Delta F508CFTR-scaffold association. Quantitative comparisons of CFTR cell surface diffusion and endocytosis kinetics suggested an association between reduced scaffold binding and CFTR internalization. Our surface diffusion measurements in live cells indicate defective scaffold interactions of rescued Delta F508CFTR at the cell surface, which may contribute to its defective peripheral processing.	[Valentine, Cathleen D.; Verkman, Alan S.; Haggie, Peter M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Lukacs, Gergely L.] McGill Univ, GRASP, Montreal, PQ H3G 1Y6, Canada	University of California System; University of California San Francisco; McGill University; McGill University	Haggie, PM (corresponding author), Univ Calif San Francisco, Dept Med, 1246 HSE,513 Parnassus Ave, San Francisco, CA 94143 USA.	peter.haggie@ucsf.edu		Lukacs, Gergely/0000-0003-0900-0675	National Institutes of Health [DK081355, DK075302, EB000415]; Cystic Fibrosis Foundation; Canadian Institute of Health Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, R01DK081355, R01DK075302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported, in whole or in part, by National Institutes of Health Grants DK081355 (to P. M. H.), DK075302 (to G. L. L.), EB000415 (to A. S. V.), a Research Development Program grant from the Cystic Fibrosis Foundation (to P. M. H. and A. S. V.), and a grant from the Canadian Institute of Health Research (to G. L. L.).	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Favia M, 2010, MOL BIOL CELL, V21, P73, DOI 10.1091/mbc.E09-03-0185; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Haardt M, 1999, J BIOL CHEM, V274, P21873, DOI 10.1074/jbc.274.31.21873; Haggie PM, 2008, J BIOL CHEM, V283, P23510, DOI 10.1074/jbc.C800100200; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Jin S, 2007, BIOPHYS J, V93, P1079, DOI 10.1529/biophysj.106.102244; Kwon SH, 2007, CELL PHYSIOL BIOCHEM, V20, P763, DOI 10.1159/000110436; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Owen DM, 2009, TRAFFIC, V10, P962, DOI 10.1111/j.1600-0854.2009.00908.x; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Phuan PW, 2011, MOL PHARMACOL, V80, P683, DOI 10.1124/mol.111.073056; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sainlos M, 2011, NAT CHEM BIOL, V7, P81, DOI 10.1038/NCHEMBIO.498; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Varga K., 2008, BIOCHEM J, V15, P555; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	43	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43630	43638		10.1074/jbc.M112.421172	http://dx.doi.org/10.1074/jbc.M112.421172			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115232	Green Published, hybrid			2022-12-25	WOS:000312940800043
J	Benlahrech, A; Meiser, A; Herath, S; Papagatsias, T; Athanasopoulos, T; Li, FC; Self, S; Bachy, V; Hervouet, C; Logan, K; Klavinskis, L; Dickson, G; Patterson, S				Benlahrech, Adel; Meiser, Andrea; Herath, Shanthi; Papagatsias, Timos; Athanasopoulos, Takis; Li, Fucheng; Self, Steve; Bachy, Veronique; Hervouet, Catherine; Logan, Karen; Klavinskis, Linda; Dickson, George; Patterson, Steven			Fragmentation of SIV-gag Vaccine Induces Broader T Cell Responses	PLOS ONE			English	Article							MHC CLASS-I; IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; LYMPHOCYTE RESPONSES; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; RHESUS-MONKEYS; CTL RESPONSES; HIV-1 GAG; DEGRADATION	Background: High mutation rates of human immunodeficiency virus (HIV) allows escape from T cell recognition preventing development of effective T cell vaccines. Vaccines that induce diverse T cell immune responses would help overcome this problem. Using SIV gag as a model vaccine, we investigated two approaches to increase the breadth of the CD8 T cell response. Namely, fusion of vaccine genes to ubiquitin to target the proteasome and increase levels of MHC class I peptide complexes and gene fragmentation to overcome competition between epitopes for presentation and recognition. Methodology/Principal Findings: Three vaccines were compared: full-length unmodified SIV-mac239 gag, full-length gag fused at the N-terminus to ubiquitin and 7 gag fragments of equal size spanning the whole of gag with ubiquitin-fused to the N-terminus of each fragment. Genes were cloned into a replication defective adenovirus vector and immunogenicity assessed in an in vitro human priming system. The breadth of the CD8 T cell response, defined by the number of distinct epitopes, was assessed by IFN-gamma-ELISPOT and memory phenotype and cytokine production evaluated by flow cytometry. We observed an increase of two-to six-fold in the number of epitopes recognised in the ubiquitin-fused fragments compared to the ubiquitin-fused full-length gag. In contrast, although proteasomal targeting was achieved, there was a marked reduction in the number of epitopes recognised in the ubiquitin-fused full-length gag compared to the full-length unmodified gene, but there were no differences in the number of epitope responses induced by non-ubiquitinated full-length gag and the ubiquitin-fused mini genes. Fragmentation and ubiquitination did not affect T cell memory differentiation and polyfunctionality, though most responses were directed against the Ad5 vector. Conclusion/Significance: Fragmentation but not fusion with ubiquitin increases the breadth of the CD8 T vaccine response against SIV-mac239 gag. Thus gene fragmentation of HIV vaccines may maximise responses.	[Benlahrech, Adel; Meiser, Andrea; Herath, Shanthi; Papagatsias, Timos; Patterson, Steven] Univ London Imperial Coll Sci Technol & Med, Dept Med, Chelsea & Westminster Hosp, London, England; [Athanasopoulos, Takis; Dickson, George] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Li, Fucheng; Self, Steve] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Bachy, Veronique; Hervouet, Catherine; Klavinskis, Linda] Kings Coll London, Guys Hosp, Peter Gorer Dept Immunobiol, London WC2R 2LS, England; [Logan, Karen] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England	Imperial College London; University of London; Royal Holloway University London; Fred Hutchinson Cancer Center; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London	Patterson, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Chelsea & Westminster Hosp, London, England.	s.patterson@imperial.ac.uk		Patterson, Steven/0000-0003-0652-7797; Klavinskis, Linda S./0000-0001-5828-6978	Bill & Melinda Gates Foundation; MRC [G0100482, G0200284] Funding Source: UKRI; Medical Research Council [G0100482, G0200284] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was conducted as part of the Collaboration for AIDS Vaccine Discovery with support from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Bullock TNJ, 2003, J IMMUNOL, V170, P1822, DOI 10.4049/jimmunol.170.4.1822; Colleton BA, 2009, J VIROL, V83, P6288, DOI 10.1128/JVI.02611-08; Decaluwe H, 2010, P NATL ACAD SCI USA, V107, P9311, DOI 10.1073/pnas.0913729107; Dobano C, 2007, IMMUNOL LETT, V111, P92, DOI 10.1016/j.imlet.2007.05.007; Erickson AL, 2008, CLIN VACCINE IMMUNOL, V15, P1745, DOI 10.1128/CVI.00247-08; Ferrando-Martinez S, 2012, J VIROL, V86, P3667, DOI 10.1128/JVI.07034-11; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fluet ME, 2008, VIROLOGY, V370, P22, DOI 10.1016/j.virol.2007.08.020; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Goldwich A, 2008, J IMMUNOL, V180, P372, DOI 10.4049/jimmunol.180.1.372; GRANT EP, 1995, J IMMUNOL, V155, P3750; Huang XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012936; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Koup RA, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007252; Liu Y, 2011, VACCINE, V29, P2582, DOI 10.1016/j.vaccine.2011.01.049; Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852; Makedonas G, 2011, IMMUNOL REV, V239, P109, DOI 10.1111/j.1600-065X.2010.00968.x; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Newberg MH, 2006, J IMMUNOL, V176, P319, DOI 10.4049/jimmunol.176.1.319; Oukka M, 1996, J IMMUNOL, V157, P3039; Palmowski MJ, 2002, J IMMUNOL, V168, P4391, DOI 10.4049/jimmunol.168.9.4391; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Richmond M, 2011, J VIROL, V85, P1275, DOI 10.1128/JVI.01707-10; Rodriguez F, 1998, J VIROL, V72, P5174, DOI 10.1128/JVI.72.6.5174-5181.1998; Roy-Proulx G, 2001, EUR J IMMUNOL, V31, P2284, DOI 10.1002/1521-4141(200108)31:8<2284::AID-IMMU2284>3.0.CO;2-E; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; Singh RAK, 2004, J IMMUNOL, V173, P4387, DOI 10.4049/jimmunol.173.7.4387; Siota M, 2011, EXPERT REV VACCINES, V10, P299, DOI [10.1586/ERV.10.169, 10.1586/erv.10.169]; Stack JH, 2000, NAT BIOTECHNOL, V18, P1298, DOI 10.1038/82422; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tobery T, 1999, J IMMUNOL, V162, P639; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; Tsai V, 1998, CRIT REV IMMUNOL, V18, P65, DOI 10.1615/CritRevImmunol.v18.i1-2.80; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Wallace ME, 1999, J VIROL, V73, P7619, DOI 10.1128/JVI.73.9.7619-7626.1999; Weidt G, 1998, J IMMUNOL, V160, P2923; Wong SBJ, 2004, J IMMUNOL, V173, P3073, DOI 10.4049/jimmunol.173.5.3073; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	51	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48038	10.1371/journal.pone.0048038	http://dx.doi.org/10.1371/journal.pone.0048038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118924	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500059
J	Chow, D; Guo, L; Gai, F; Goulian, M				Chow, David; Guo, Lin; Gai, Feng; Goulian, Mark			Fluorescence Correlation Spectroscopy Measurements of the Membrane Protein TetA in Escherichia coli Suggest Rapid Diffusion at Short Length Scales	PLOS ONE			English	Article							LATERAL DIFFUSION; OUTER-MEMBRANE; SINGLE-MOLECULE; PLASMA-MEMBRANE; CELL-MEMBRANES; DYNAMICS; MOBILITY; RECEPTOR; MODEL; PHOSPHOLIPIDS	Structural inhomogeneities in biomembranes can lead to complex diffusive behavior of membrane proteins that depend on the length or time scales that are probed. This effect is well studied in eukaryotic cells, but has been explored only recently in bacteria. Here we used fluorescence recovery after photobleaching (FRAP) and fluorescence correlation spectroscopy (FCS) to study diffusion of the membrane protein TetA-YFP in E. coli. We find that the diffusion constant determined from FRAP is comparable to other reports of inner membrane protein diffusion constants in E. coli. However, FCS, which probes diffusion on shorter length scales, gives a value that is almost two orders of magnitude higher and is comparable to lipid diffusion constants. These results suggest there is a population of TetA-YFP molecules in the membrane that move rapidly over short length scales (similar to 400 nm) but move significantly more slowly over the longer length scales probed by FRAP.	[Chow, David; Goulian, Mark] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Guo, Lin; Gai, Feng] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Goulian, Mark] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Goulian, M (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	goulian@sas.upenn.edu	Guo, Lin/L-1647-2016		NSF MRSEC [DMR05M20020, DMR11M20901]; NIH [GM080279, GM065978]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065978, R01GM080279] Funding Source: NIH RePORTER	NSF MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF MRSEC awards DMR05M20020 and DMR11M20901 and NIH awards GM080279 (to M. G.) and GM065978 (to F. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababneh ZQ, 2009, MAGN RESON IMAGING, V27, P859, DOI 10.1016/j.mri.2008.11.004; Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Batchelor E, 2006, MOL MICROBIOL, V59, P1767, DOI 10.1111/j.1365-2958.2006.05048.x; Batchelor E, 2004, J BACTERIOL, V186, P7618, DOI 10.1128/JB.186.22.7618-7625.2004; Bohnert JA, 2010, ANTIMICROB AGENTS CH, V54, P3770, DOI 10.1128/AAC.00620-10; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen Y, 2006, METHODS, V39, P147, DOI 10.1016/j.ymeth.2006.05.008; Chiantia S, 2009, BBA-BIOMEMBRANES, V1788, P225, DOI 10.1016/j.bbamem.2008.08.013; Chowdhury P, 2007, J MOL BIOL, V369, P462, DOI 10.1016/j.jmb.2007.03.042; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; Edidin M, 2001, TRENDS CELL BIOL, V11, P492, DOI 10.1016/S0962-8924(01)02139-0; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Etienne E, 2006, APPL OPTICS, V45, P4497, DOI 10.1364/AO.45.004497; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gaede HC, 2003, BIOPHYS J, V85, P1734, DOI 10.1016/S0006-3495(03)74603-7; Garcia-Saez AJ, 2008, METHODS, V46, P116, DOI 10.1016/j.ymeth.2008.06.011; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Gibbs KA, 2004, MOL MICROBIOL, V53, P1771, DOI 10.1111/j.1365-2958.2004.04242.x; Guo L, 2007, J PHYS CHEM B, V111, P14244, DOI 10.1021/jp076562n; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Kumar M, 2010, BIOPHYS J, V98, P552, DOI 10.1016/j.bpj.2009.11.002; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Mika JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025664; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Oddershede L, 2002, BIOPHYS J, V83, P3152, DOI 10.1016/S0006-3495(02)75318-6; Ramadurai S, 2010, BIOPHYS J, V99, P1482, DOI 10.1016/j.bpj.2010.06.036; Ramadurai S, 2009, J AM CHEM SOC, V131, P12650, DOI 10.1021/ja902853g; Ritchie K, 2007, BIOPOLYMERS, V87, P95, DOI 10.1002/bip.20801; Rogers JMG, 2011, LANGMUIR, V27, P3815, DOI 10.1021/la200480d; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; SCANDELL.CJ, 1972, P NATL ACAD SCI USA, V69, P2056, DOI 10.1073/pnas.69.8.2056; SCHINDLER M, 1980, NATURE, V285, P261, DOI 10.1038/285261a0; Schwille P, 2000, P NATL ACAD SCI USA, V97, P151, DOI 10.1073/pnas.97.1.151; Schwille P, 1999, CYTOMETRY, V36, P176, DOI 10.1002/(SICI)1097-0320(19990701)36:3<176::AID-CYTO5>3.0.CO;2-F; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smith-Dupont KB, 2010, BIOCHEMISTRY-US, V49, P4672, DOI 10.1021/bi100426p; Spector J, 2010, BIOPHYS J, V99, P3880, DOI 10.1016/j.bpj.2010.10.029; TOCANNE JF, 1994, PROG LIPID RES, V33, P203, DOI 10.1016/0163-7827(94)90027-2; van den Wildenberg SMJL, 2011, BIOPOLYMERS, V95, P312, DOI 10.1002/bip.21585; Wang EX, 2011, J CELL BIOL, V194, P538, DOI 10.1083/jcb.201103044	54	9	9	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48600	10.1371/journal.pone.0048600	http://dx.doi.org/10.1371/journal.pone.0048600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119068	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500177
J	Dittrich, AS; Winkler, T; Wellman, T; de Prost, N; Musch, G; Harris, RS; Melo, MFV				Dittrich, A. Susanne; Winkler, Tilo; Wellman, Tyler; de Prost, Nicolas; Musch, Guido; Harris, R. Scott; Melo, Marcos F. Vidal			Modeling F-18-FDG Kinetics during Acute Lung Injury: Experimental Data and Estimation Errors	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; POSITRON-EMISSION-TOMOGRAPHY; METABOLIC-ACTIVITY; MECHANICAL VENTILATION; NEUTROPHIL KINETICS; FDG-PET; INFLAMMATION; SHEEP; PERFUSION; LAVAGE	Background: There is increasing interest in Positron Emission Tomography (PET) of 2-deoxy-2-[18F]flouro-D-glucose (F-18-FDG) to evaluate pulmonary inflammation during acute lung injury (ALI). We assessed the effect of extra-vascular lung water on estimates of F-18-FDG-kinetics parameters in experimental and simulated data using the Patlak and Sokoloff methods, and our recently proposed four-compartment model. Methodology/Principal Findings: Eleven sheep underwent unilateral lung lavage and 4 h mechanical ventilation. Five sheep received intravenous endotoxin (10 ng/kg/min). Dynamic F-18-FDG PET was performed at the end of the 4 h period. F-18-FDG net uptake rate (Ki), phosphorylation rate (k(3)), and volume of distribution (F-e) were estimated in three isogravitational regions for each method. Simulations of normal and ALI F-18-FDG-kinetics were conducted to study the dependence of estimated parameters on the transport rate constants to (k(5)) and from (k(6)) the extra-vascular extra-cellular compartment. The four-compartment model described 85.7% of the studied F-18-FDG-kinetics better than the Sokoloff model. Relative to the four-compartment model the Sokoloff model exhibited a consistent positive bias in Ki (3.32 [1.30-5.65] 10(-4)/min, p<0.001) and showed inaccurate estimates of the parameters composing Ki (k(3) and F-e), even when Ki was similar for those methods. In simulations, errors in estimates of Ki due to the extra-vascular extra-cellular compartment depended on both k(5) and k(5)/k(6), with errors for the Patlak and Sokoloff methods of 0.02 [-0.01-0.18] and 0.40 [0.18-0.60] 10(-3)/min for normal lungs and of -0.47 [-0.89-0.72] and 2.35 [0.85-3.68] 10(-3)/min in ALI. Conclusions/Significance: F-18-FDG accumulation in lung extra-vascular fluid, which is commonly increased during lung injury, can result in substantial estimation errors using the traditional Patlak and Sokoloff methods. These errors depend on the extra-vascular extra-cellular compartment volume and its transport rates with other compartments. The four-compartment model provides more accurate quantification of F-18-FDG-kinetics than those methods in the presence of increased extra-vascular fluid.	[Dittrich, A. Susanne; Winkler, Tilo; Wellman, Tyler; de Prost, Nicolas; Musch, Guido; Melo, Marcos F. Vidal] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Dittrich, A. Susanne; Winkler, Tilo; Wellman, Tyler; de Prost, Nicolas; Musch, Guido; Harris, R. Scott; Melo, Marcos F. Vidal] Harvard Univ, Sch Med, Boston, MA USA; [Harris, R. Scott] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Dittrich, A. Susanne] Univ Hosp Dresden, Dept Anesthesia & Intens Care Therapy, Dresden, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Melo, MFV (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	VidalMelo.Marcos@mgh.harvard.edu	Melo, Marcos Vidal/AAN-7219-2020; Dittrich, A. Susanne/K-8502-2019; Melo, Marcos F Vidal/C-3452-2013; Winkler, Tilo/B-5337-2009	Winkler, Tilo/0000-0002-7276-5550; de Prost, Nicolas/0000-0002-4833-4320	NHLBI (National Heart, Lung and Blood Institute) [5R01HL086827]; Family Klee Foundation (Stiftung Familie Klee); German National Academic Foundation (Studienstiftung des deutschen Volkes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086827] Funding Source: NIH RePORTER	NHLBI (National Heart, Lung and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Family Klee Foundation (Stiftung Familie Klee); German National Academic Foundation (Studienstiftung des deutschen Volkes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NHLBI (National Heart, Lung and Blood Institute) grant 5R01HL086827 to MFVM. ASF was supported in part by the Family Klee Foundation (Stiftung Familie Klee, http://www.s-fk.de/) and by the German National Academic Foundation (Studienstiftung des deutschen Volkes, http://www.studienstiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2003, CRIT CARE MED, V31, P157, DOI 10.1097/00003246-200301000-00025; Bellani G, 2009, CRIT CARE MED, V37, P2216, DOI 10.1097/CCM.0b013e3181aab31f; Chen DL, 2004, AM J PHYSIOL-LUNG C, V286, pL834, DOI 10.1152/ajplung.00339.2003; CHOI Y, 1994, J NUCL MED, V35, P818; Costa ELV, 2010, ANESTHESIOLOGY, V112, P658, DOI 10.1097/ALN.0b013e3181cbd1d4; DAVIES L, 1993, J AM STAT ASSOC, V88, P782, DOI 10.2307/2290763; de Prost N, 2011, J APPL PHYSIOL, V111, P1249, DOI 10.1152/japplphysiol.00311.2011; de Prost N, 2010, AM J ROENTGENOL, V195, P292, DOI 10.2214/AJR.10.4499; Dimitrakopoulou-Strauss A, 2009, CLIN NUCL MED, V34, P576, DOI 10.1097/RLU.0b013e3181b06bc5; Galletti GG, 2002, J APPL PHYSIOL, V93, P1104, DOI 10.1152/japplphysiol.00910.2001; Ghesani M, 2005, ECHOCARDIOGR-J CARD, V22, P165, DOI 10.1111/j.0742-2822.2005.04032.x; HEDLUND LW, 1984, INVEST RADIOL, V19, P254, DOI 10.1097/00004424-198407000-00004; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; HOGG JC, 1987, PHYSIOL REV, V67, P1249, DOI 10.1152/physrev.1987.67.4.1249; Huyer W, 1999, J GLOBAL OPTIM, V14, P331, DOI 10.1023/A:1008382309369; IDELL S, 1985, AM REV RESPIR DIS, V132, P1098; JONES HA, 1994, AM J RESP CRIT CARE, V149, P1635, DOI 10.1164/ajrccm.149.6.7516252; Jones HA, 1997, EUR RESPIR J, V10, P795; Klinzing S, 2000, RES EXP MED, V200, P27; LACHMANN B, 1980, ACTA ANAESTH SCAND, V24, P231, DOI 10.1111/j.1399-6576.1980.tb01541.x; LANDAW EM, 1984, AM J PHYSIOL, V246, pR665, DOI 10.1152/ajpregu.1984.246.5.R665; McClean MA, 2003, EUR RESPIR J, V22, P50, DOI 10.1183/09031936.03.00099802; Melo MFV, 2003, J NUCL MED, V44, P1982; Musch G, 2008, AM J RESP CRIT CARE, V177, P292, DOI 10.1164/rccm.200703-484OC; Musch G, 2007, ANESTHESIOLOGY, V106, P723, DOI 10.1097/01.anes.0000264748.86145.ac; O'Neill K, 2003, J APPL PHYSIOL, V95, P2471, DOI 10.1152/japplphysiol.00401.2003; Paik JY, 2005, J NUCL MED, V46, P365; Paquet N, 2004, J NUCL MED, V45, P784; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Prager MH, 2006, FUNCTION 4D CONTOUR; REISS M, 1978, J CLIN INVEST, V61, P480, DOI 10.1172/JCI108959; Rodrigues RS, 2008, INTENS CARE MED, V34, P2273, DOI 10.1007/s00134-008-1220-7; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schroeder T, 2008, ACAD RADIOL, V15, P763, DOI 10.1016/j.acra.2007.12.016; Schroeder T, 2007, J NUCL MED, V48, P413; Schuster DP, 2007, AM J PHYSIOL-LUNG C, V292, pL845, DOI 10.1152/ajplung.00350.2006; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Tucci M, 2010, AM J RESP CRIT CARE, V181; WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388; Zambelli V, 2012, INTENS CARE MED, V38, P694, DOI 10.1007/s00134-011-2456-1	40	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47588	10.1371/journal.pone.0047588	http://dx.doi.org/10.1371/journal.pone.0047588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118881	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500025
J	Fluri, F; Morgenthaler, NG; Mueller, B; Christ-Crain, M; Katan, M				Fluri, Felix; Morgenthaler, Nils G.; Mueller, Beat; Christ-Crain, Mirjam; Katan, Mira			Copeptin, Procalcitonin and Routine Inflammatory Markers-Predictors of Infection after Stroke	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; C-REACTIVE PROTEIN; IMMUNODEPRESSION; COMPLICATIONS; PRECURSOR; BRAIN; RISK	Background: Early predictors for the development of stroke-associated infection may identify patients at high risk and reduce post-stroke infection and mortality. Methods: In 383 prospectively enrolled acute stroke patients we assessed time point and type of post-stroke infections (i.e. pneumonia, urinary tract infection (UTI) other infection (OI)). Blood samples were collected on admission, and days 1, and 3 to assess white blood cells (WBC), monocytes, C-reactive protein (CRP), procalcitonin (PCT), and copeptin. To determine the magnitude of association with the development of infections, odds ratios (OR) were calculated for each prognostic blood marker. The discriminatory ability of different predictors was assessed, by calculating area under the receiver operating characteristic curves (AUC). Prognostic models including the three parameters with the best performance were identified. Results: Of 383 patients, 66 (17.2%) developed an infection after onset of stroke. WBC, CRP, copeptin and PCT were all independent predictors of any infection, pneumonia and UTI developed at least 24 hours after measurements. The combination of the biomarkers WBC, CRP and copeptin (AUC: 0.92) and WBC, CRP and PCT (AUC: 0.90) showed a better predictive accuracy concerning the development of pneumonia during hospitalization compared to each marker by itself (p-Wald <0.0001). Conclusion: Among ischemic stroke patients, copeptin, PCT, WBC and CRP measured on admission were predictors of infection in general, and specifically for pneumonia and UTI within 5 days after stroke. The combination of these biomarkers improved the prediction of patients who developed an infection.	[Fluri, Felix] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Fluri, Felix; Katan, Mira] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Morgenthaler, Nils G.] Charite, Inst Expt Endokrinol, Berlin, Germany; [Mueller, Beat] Cantonal Hosp Aarau, Med Univ Clin, Aarau, Switzerland; [Christ-Crain, Mirjam] Univ Basel Hosp, Dept Endocrinol, CH-4031 Basel, Switzerland; [Katan, Mira] Columbia Univ, Dept Neurol, Div Stroke, New York, NY USA	University of Basel; University of Zurich; University Zurich Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Kantonsspital Aarau AG (KSA); University of Basel; Columbia University	Fluri, F (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.	ffluri@gmx.ch	Mueller, Beat/G-2662-2012	Katan, Mira/0000-0002-9265-8066; Christ-Crain, Mirjam/0000-0002-6336-0965	Swiss National Science Foundation [PBZHP3-130982]; Fondation Leducq	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Leducq(Leducq Foundation)	This work was supported by the Swiss National Science Foundation (PBZHP3-130982, to MK) and the Fondation Leducq (career development grant, to MK). The funding institutions had no role in study design, data collection, analysis decision to publish, or preparation of the manuscript.	Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; Chamorro A, 2006, J NEUROL NEUROSUR PS, V77, P1279, DOI 10.1136/jnnp.2006.100800; Chamorro A, 2005, STROKE, V36, P1495, DOI 10.1161/01.STR.0000170644.15504.49; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2007, J NEUROL SCI, V252, P29, DOI 10.1016/j.jns.2006.10.001; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Emsley HCA, 2008, NEUROCRIT CARE, V9, P125, DOI 10.1007/s12028-007-9035-x; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Harms H, 2011, CEREBROVASC DIS, V32, P552, DOI 10.1159/000331922; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kofoed K, 2007, CRIT CARE, V11, DOI 10.1186/cc5723; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Sakr Y, 2008, INFECTION, V36, P396, DOI 10.1007/s15010-008-7374-Y; Salat D, 2011, EUR NEUROL, V65, P82, DOI 10.1159/000322903; Schuetz P, 2011, EUR RESPIR J, V37, P384, DOI 10.1183/09031936.00035610; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Vargas M, 2006, STROKE, V37, P461, DOI 10.1161/01.STR.0000199138.73365.b3; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Wartenberg KE, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/830614; Weimar C, 2002, EUR NEUROL, V48, P133, DOI 10.1159/000065512	24	63	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48309	10.1371/journal.pone.0048309	http://dx.doi.org/10.1371/journal.pone.0048309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118979	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500099
J	Kim, JH; Jang, BG; Choi, BY; Kwon, LM; Sohn, M; Song, HK; Suh, SW				Kim, Jin Hee; Jang, Bong Geom; Choi, Bo Young; Kwon, Lyo Min; Sohn, Min; Song, Hong Ki; Suh, Sang Won			Zinc Chelation Reduces Hippocampal Neurogenesis after Pilocarpine-Induced Seizure	PLOS ONE			English	Article							HYPOGLYCEMIC NEURONAL DEATH; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ADULT-RAT; DENTATE GYRUS; CELL-PROLIFERATION; CEREBRAL-ISCHEMIA; CHELATABLE ZINC; LIMBIC SEIZURES; GRANULE CELLS	Several studies have shown that epileptic seizures increase hippocampal neurogenesis in the adult. However, the mechanism underlying increased neurogenesis after seizures remains largely unknown. Neurogenesis occurs in the subgranular zone (SGZ) of the hippocampus in the adult brain, although an understanding of why it actively occurs in this region has remained elusive. A high level of vesicular zinc is localized in the presynaptic terminals of the SGZ. Previously, we demonstrated that a possible correlation may exist between synaptic zinc localization and high rates of neurogenesis in this area after hypoglycemia. Using a lithium-pilocarpine model, we tested our hypothesis that zinc plays a key role in modulating hippocampal neurogenesis after seizure. Then, we injected the zinc chelator, clioquinol (CQ, 30 mg/kg), into the intraperitoneal space to reduce brain zinc availability. Neuronal death was detected with Fluoro Jade-B and NeuN staining to determine whether CQ has neuroprotective effects after seizure. The total number of degenerating and live neurons was similar in vehicle and in CQ treated rats at 1 week after seizure. Neurogenesis was evaluated using BrdU, Ki67 and doublecortin (DCX) immunostaining 1 week after seizure. The number of BrdU, Ki67 and DCX positive cell was increased after seizure. However, the number of BrdU, Ki67 and DCX positive cells was significantly decreased by CQ treatment. Intracellular zinc chelator, N,N,N0,N-Tetrakis (2-pyridylmethyl) ethylenediamine (TPEN), also reduced seizure-induced neurogenesis in the hippocampus. The present study shows that zinc chelation does not prevent neurodegeneration but does reduce seizure-induced progenitor cell proliferation and neurogenesis. Therefore, this study suggests that zinc has an essential role for modulating hippocampal neurogenesis after seizure.	[Song, Hong Ki] Hallym Univ, Coll Med, Dept Neurol, Chunchon, South Korea; [Kim, Jin Hee; Jang, Bong Geom; Choi, Bo Young; Kwon, Lyo Min; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea	Hallym University; Hallym University; Inha University	Song, HK (corresponding author), Hallym Univ, Coll Med, Dept Neurol, Chunchon, South Korea.	hksong0@paran.com; swsuh@hallym.ac.kr	Kwon, Lyo Min/ABC-5338-2020	Choi, Bo Young/0000-0002-9579-3503; SOHN, MIN/0000-0003-4021-2051; Kwon, Lyo Min/0000-0001-5611-2480	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120202]	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120202).	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; DANSCHER G, 1985, J HISTOCHEM CYTOCHEM, V33, P706, DOI 10.1177/33.7.4008918; DVERGSTEN CL, 1983, BRAIN RES, V271, P217, DOI 10.1016/0006-8993(83)90284-6; ECKENHOFF MF, 1988, J NEUROSCI, V8, P2729; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; GOLUB MS, 1994, AM J CLIN NUTR, V60, P238, DOI 10.1093/ajcn/60.2.238; GUENEAU G, 1982, DEV NEUROSCI-BASEL, V5, P345, DOI 10.1159/000112694; HALAS ES, 1983, PHYSIOL BEHAV, V30, P371, DOI 10.1016/0031-9384(83)90140-3; HOUSER CR, 1990, J NEUROSCI, V10, P267; Jo SM, 2000, BRAIN RES, V870, P163, DOI 10.1016/S0006-8993(00)02418-5; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kuhn HG, 1996, J NEUROSCI, V16, P2027; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; MANFORD M, 1992, NEUROLOGY, V42, P1911; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; OKANO HJ, 1993, J NEUROSCI, V13, P2930; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Park MH, 2011, NEUROBIOL DIS; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; PERSINGER MA, 1988, PHYSIOL BEHAV, V44, P27, DOI 10.1016/0031-9384(88)90342-3; PRASAD AS, 1963, AM J CLIN NUTR, V12, P437, DOI 10.1093/ajcn/12.6.437; Sandstead HH, 2000, J NUTR, V130, p496S, DOI 10.1093/jn/130.2.496S; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; STEWART GR, 1984, BRAIN RES, V290, P43, DOI 10.1016/0006-8993(84)90734-0; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2005, DIABETES, V54, P500, DOI 10.2337/diabetes.54.2.500; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2003, J NEUROSCI, V23, P10681; Suh SW, 2001, NEUROREPORT, V12, P1523, DOI 10.1097/00001756-200105250-00044; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q	50	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48543	10.1371/journal.pone.0048543	http://dx.doi.org/10.1371/journal.pone.0048543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119054	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500167
J	Klein, J; Darvin, ME; Muller, KE; Lademann, J				Klein, Julia; Darvin, Maxim E.; Mueller, Kerstin E.; Lademann, Juergen			Serial Non-Invasive Measurements of Dermal Carotenoid Concentrations in Dairy Cows following Recovery from Abomasal Displacement	PLOS ONE			English	Article							RESONANCE RAMAN-SPECTROSCOPY; HUMAN SKIN; BETA-CAROTENE; OXIDATIVE STRESS; VITAMIN-E; LYCOPENE CONCENTRATIONS; RADICAL FORMATION; NITRIC-OXIDE; PLASMA; DISEASE	Maintaining the health of farm animals forms the basis for a sustainable and profitable production of food from animal origin. Recently, the effects of carotenoids on the oxidative status as well as on reproductive and immune functions in cattle have been demonstrated. The present study aimed at investigating dermal carotenoid levels in cattle recovering from abomasal displacement. For this purpose, serial in vivo measurements were undertaken using a miniaturized scanner system that relies on reflection spectroscopy (Opsolution GmbH, Kassel, Germany). In a first trial, repeated measurements of dermal carotenoid concentrations were performed on the udder skin of healthy non-lactating cattle (n = 6) for one month in weekly intervals. In a second trial, in vivo dermal carotenoid concentrations were determined in intervals in 23 cows following surgical treatment of abomasal displacement. The results show that dermal carotenoid concentrations, determined on a weekly basis over a period of one month, showed variations of up to 18% in the healthy individuals kept under constant conditions with respect to housing and nutrition. Repeated measurements during the recovery period following surgical treatment of abomasal displacement resulted in an increase in dermal carotenoid concentrations in 18 of 20 animals with a favourable outcome when compared with results obtained within 12 hours following surgery. The mean increase in dermal carotenoid concentrations in subsequent measurements was 53 +/- 44%, whereas levels decreased (mean 31 +/- 27%) in cattle with a fatal outcome. These results indicate potential applications for reflection spectroscopy for non-invasive early detection of changes in the dermal carotenoid concentrations as a reflection of the antioxidant status in an animal.	[Klein, Julia; Darvin, Maxim E.; Lademann, Juergen] Charite, Dept Dermatol Venerol & Allergol, Ctr Expt & Appl Cutaneous Physiol, Berlin, Germany; [Klein, Julia; Mueller, Kerstin E.] Free Univ Berlin, Fac Vet Med, Clin Ruminants & Swine, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Darvin, ME (corresponding author), Charite, Dept Dermatol Venerol & Allergol, Ctr Expt & Appl Cutaneous Physiol, Berlin, Germany.	maxim.darvin@charite.de	Darvin, Maxim/P-7071-2018	Darvin, Maxim/0000-0003-1075-1994; Jurgen, Lademann/0000-0003-1828-7460				BATRA TR, 1992, INT J VITAM NUTR RES, V62, P233; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Calderon F, 2007, J DAIRY SCI, V90, P5651, DOI 10.3168/jds.2007-0264; Darvin ME, 2006, LASER PHYS, V16, P833, DOI 10.1134/S1054660X06050148; Darvin ME, 2010, SKIN PHARMACOL PHYS, V23, P40, DOI 10.1159/000257262; Darvin ME, 2012, J BIOPHOTONICS, V5, P550, DOI 10.1002/jbio.201100080; Darvin ME, 2011, MOLECULES, V16, P10491, DOI 10.3390/molecules161210491; Darvin ME, 2009, EXP DERMATOL, V18, P1060, DOI 10.1111/j.1600-0625.2009.00946.x; Darvin ME, 2005, LASER PHYS, V15, P295; Darvin ME, 2005, J PHYS D APPL PHYS, V38, P2696, DOI 10.1088/0022-3727/38/15/023; Darvin ME, 2008, J BIOMEDICAL OPTICS, V13; De Spirt S, 2012, SKIN PHARMACOL PHYS, V25, P2, DOI 10.1159/000330521; Dinges G, 2004, UNTERSUCHUNGEN ZUM A, p[66, 93]; Gecit I, 2012, J CANCER RES CLIN, V138, P739, DOI 10.1007/s00432-011-1136-4; Gorber, 2009, SONOGRAPHISCHE UBERW; Haag SF, 2010, SKIN PHARMACOL PHYS, V23, P306, DOI 10.1159/000313539; Haag SF, 2011, EXP DERMATOL, V20, P483, DOI 10.1111/j.1600-0625.2010.01246.x; Heinrichs AJ, 2009, VET MICROBIOL, V134, P172, DOI 10.1016/j.vetmic.2008.09.025; Hummel M, 2005, ELEKTROMYOGRAPHISCHE; Kankofer M, 2001, REPROD DOMEST ANIM, V36, P203, DOI 10.1046/j.1439-0531.2001.d01-38.x; Klein J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.101514; Lademann J, 2011, SKIN PHARMACOL PHYS, V24, P238, DOI 10.1159/000326074; Lima XT, 2011, J EUR ACAD DERMATOL, V25, P945, DOI 10.1111/j.1468-3083.2010.03888.x; LOTTHAMMER KH, 1977, DEUT TIERARZTL WOCH, V84, P220; Ludewig T, 1996, ANAT HISTOL EMBRYOL, V25, P121, DOI 10.1111/j.1439-0264.1996.tb00069.x; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Maeda H, 1998, BIOCHEMISTRY-MOSCOW+, V63, P854; Martens H, 1998, PROC INTERNAT WORKSH, P81; Meinke M. C., 2011, FREE RADIC ANTIOXID, V1, P15, DOI [10.5530/ax.2011.2.4, DOI 10.5530/AX.2011.2.4]; Meinke MC, 2010, EUR J PHARM BIOPHARM, V76, P269, DOI 10.1016/j.ejpb.2010.06.004; Mudron P, 1999, J VET MED A, V46, P219, DOI 10.1046/j.1439-0442.1999.00206.x; Niedorf F, 2003, N-S ARCH PHARMACOL, V367, pR110; Niedorf F, 2001, ENTWICKLUNG EINES VE; Noziere P, 2006, ANIM FEED SCI TECH, V131, P418, DOI 10.1016/j.anifeedsci.2006.06.018; Noziere P, 2006, J DAIRY SCI, V89, P2634, DOI 10.3168/jds.S0022-0302(06)72340-2; Ranjan R, 2005, VET RES COMMUN, V29, P27, DOI 10.1023/B:VERC.0000046740.59694.5d; Rehage J, 1996, SCHWEIZ ARCH TIERH, V138, P361; Sattler T, 2001, UNTERSUCHUNGEN ZUM A; Scarmo S, 2012, EUR J CLIN NUTR, V66, P555, DOI 10.1038/ejcn.2012.31; Stahl W, 1998, J NUTR, V128, P903, DOI 10.1093/jn/128.5.903; Stone V, 2007, IEEE T NANOBIOSCI, V6, P331, DOI 10.1109/TNB.2007.909005; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vierck HB, 2012, EUR J APPL PHYSIOL, V112, P3361, DOI 10.1007/s00421-011-2296-2; Whitehead RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032988; Zastrow L, 2009, SKIN PHARMACOL PHYS, V22, P31, DOI 10.1159/000188083	45	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47706	10.1371/journal.pone.0047706	http://dx.doi.org/10.1371/journal.pone.0047706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118891	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500034
J	Lehe, JD; Sitoe, NE; Tobaiwa, O; Loquiha, O; Quevedo, JI; Peter, TF; Jani, IV				Lehe, Jonathan D.; Sitoe, Nadia E.; Tobaiwa, Ocean; Loquiha, Osvaldo; Quevedo, Jorge I.; Peter, Trevor F.; Jani, Ilesh V.			Evaluating Operational Specifications of Point-of-Care Diagnostic Tests: A Standardized Scorecard	PLOS ONE			English	Article							GLOBAL HEALTH; TUBERCULOSIS	The expansion of HIV antiretroviral therapy into decentralized rural settings will increasingly require simple point-of-care (POC) diagnostic tests that can be used without laboratory infrastructure and technical skills. New POC test devices are becoming available but decisions around which technologies to deploy may be biased without systematic assessment of their suitability for decentralized healthcare settings. To address this, we developed a standardized, quantitative scorecard tool to objectively evaluate the operational characteristics of POC diagnostic devices. The tool scores devices on a scale of 1-5 across 30 weighted characteristics such as ease of use, quality control, electrical requirements, shelf life, portability, cost and service, and provides a cumulative score that ranks products against a set of ideal POC characteristics. The scorecard was tested on 19 devices for POC CD4 T-lymphocyte cell counting, clinical chemistry or hematology testing. Single and multi-parameter devices were assessed in each of test categories. The scores across all devices ranged from 2.78 to 4.40 out of 5. The tool effectively ranked devices within each category (p<0.01) except the CD4 and multi-parameter hematology products. The tool also enabled comparison of different characteristics between products. Agreement across the four scorers for each product was high (intra-class correlation >0.80; p<0.001). Use of this tool enables the systematic evaluation of diagnostic tests to facilitate product selection and investment in appropriate technology. It is particularly relevant for countries and testing programs considering the adoption of new POC diagnostic tests.	[Sitoe, Nadia E.; Jani, Ilesh V.] Inst Nacl Saude, Maputo, Mozambique; [Lehe, Jonathan D.; Tobaiwa, Ocean; Quevedo, Jorge I.; Peter, Trevor F.] Clinton Hlth Access Initiat, Maputo, Mozambique; [Loquiha, Osvaldo] Univ Eduardo Mondlane, Dept Math & Informat, Maputo, Mozambique	Eduardo Mondlane University	Jani, IV (corresponding author), Inst Nacl Saude, Maputo, Mozambique.	ilesh.jani@gmail.com		Sitoe, Nadia/0000-0001-7310-8221; Jani, Ilesh/0000-0002-6880-6655	Absolute Return for Kids (ARK-CHAI Point-of-care Project); UNITAID (UNITAID-CHAI Pediatric HIV/AIDS Project) [154]	Absolute Return for Kids (ARK-CHAI Point-of-care Project); UNITAID (UNITAID-CHAI Pediatric HIV/AIDS Project)	This work was supported by grants from Absolute Return for Kids (http://www.arkonline.org/ - ARK-CHAI Point-of-care Project) and UNITAID (http://www.unitaid.eu/hivaids-projects?id = 154 - the UNITAID-CHAI Pediatric HIV/AIDS Project). The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jani IV, 2010, CLIN INFECT DIS, V51, P609, DOI 10.1086/655763; Mccoy D, 2009, HEALTH POLICY PLANN, V24, P407, DOI 10.1093/heapol/czp026; Murtagh M., 2011, UNITAID TECHNICAL RE; Pai NP, 2012, DISCOV MED, V13, P35; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Schito M, 2012, J INFECT DIS, V205, pS169, DOI 10.1093/infdis/jis044; Small PM, 2000, LANCET, V356, P1048, DOI 10.1016/S0140-6736(00)02724-0; Stevens W, 2008, NATURE REV MICROBIOL, pS36; TDR Diagnostics Evaluation Expert Panel, 2008, NATURE REV MICROBIOL, pS21; *UNAIDS, 2010, UNAIDS OUTL REP 2010; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524	14	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47459	10.1371/journal.pone.0047459	http://dx.doi.org/10.1371/journal.pone.0047459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118871	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500017
J	Renteria, JL; Gardener, MR; Panetta, FD; Atkinson, R; Crawley, MJ				Luis Renteria, Jorge; Gardener, Mark R.; Panetta, F. Dane; Atkinson, Rachel; Crawley, Mick J.			Possible Impacts of the Invasive Plant Rubus niveus on the Native Vegetation of the Scalesia Forest in the Galapagos Islands	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; ALIEN PLANTS; SOIL; CONSEQUENCES; ASSEMBLAGES; ECOSYSTEM; PATTERNS; DRIVERS	Originally from Asia, Rubus niveus has become one of the most widespread invasive plant species in the Galapagos Islands. It has invaded open vegetation, shrubland and forest alike. It forms dense thickets up to 4 m high, appearing to displace native vegetation, and threaten the integrity of several native communities. This study used correlation analysis between a R. niveus cover gradient and a number of biotic (vascular plant species richness, cover and vegetation structure) and abiotic (light and soil properties) parameters to help understand possible impacts in one of the last remaining fragments of the Scalesia forest in Santa Cruz Island, Galapagos. Higher cover of R. niveus was associated with significantly lower native species richness and cover, and a different forest structure. Results illustrated that 60% R. niveus cover could be considered a threshold for these impacts. We suggest that a maximum of 40% R. niveus cover could be a suitable management target.	[Luis Renteria, Jorge; Crawley, Mick J.] Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot, Berks, England; [Luis Renteria, Jorge; Gardener, Mark R.; Atkinson, Rachel] Charles Darwin Fdn, Puerto Ayora, Galapagos Islan, Ecuador; [Gardener, Mark R.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Panetta, F. Dane] Ecosci Precinct, Dept Employment Econ Dev & Innovat, Biosecur Queensland, Invas Plant Sci, Brisbane, Qld, Australia	Imperial College London; University of Western Australia; Queensland Department of Agriculture & Fisheries	Renteria, JL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Silwood Pk Campus, Ascot, Berks, England.	jorge.renteria@fcdarwin.org.ec		Renteria, Jorge L./0000-0002-6551-4702	Charles Darwin Foundation; Rufford Small Grants Foundation	Charles Darwin Foundation; Rufford Small Grants Foundation	This work was supported by The Charles Darwin Foundation and The Rufford Small Grants Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair RJ, 1998, IMPACT ENV WEEDS BIO; Adsersen H, 1990, BOT RES MANAGEMENT G, P149; [Anonymous], 1992, BIOL J LINN SOC, V46, P1; Atkinson R., 2012, ROLE SCI CONSERVATIO, P183; Atkinson R, 2008, CONSEQUENCES HERBIVO, P121; Bell JJ, 2003, BIOL BULL-US, V205, P144, DOI 10.2307/1543235; Caplan JS, 2006, NORTHWEST SCI, V80, P9; Carrion V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018835; Corey S., 1998, PLANT PROTECTION Q, V13, P151; Crawley M. J., 1987, COLONIZATION SUCCESS, V26, P429; CRAWLEY MJ, 1986, PHILOS T ROY SOC B, V314, P711, DOI 10.1098/rstb.1986.0082; D'Antonio C.M., 2001, J MEDITER ECOL2, V2, P233; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Ehrenfeld JG, 2001, ECOL APPL, V11, P1287, DOI 10.2307/3060920; Gaines WL, 2000, NAT AREA J, V20, P366; Garcia G, 2012, EVALUCION PROYECTOS; Gooden B, 2009, BIOL CONSERV, V142, P2631, DOI 10.1016/j.biocon.2009.06.012; Gratton C, 2005, RESTOR ECOL, V13, P358, DOI 10.1111/j.1526-100X.2005.00045.x; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; HALLE F, 2007, CHILI ADANSONIA, V29, P333; Hamann O, 2001, BIODIVERS CONSERV, V10, P223, DOI 10.1023/A:1008952319105; Hansen AJ, 1990, BIOL INVASIONS EUROP; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Innis AF, 2005, COMP ECOLOGY INVASIV; ITOW S, 1988, VEGETATIO, V77, P193, DOI 10.1007/BF00045765; Itow S., 2003, GLOBAL ENV RES, V7, P39; Itow Syuzo, 1995, Pacific Science, V49, P17; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jager H, 2009, J ECOL, V97, P1252, DOI 10.1111/j.1365-2745.2009.01578.x; Jager H, 1999, IMPACT INTRO TREE CI; Laurelle L, 1966, STUDY SOIL SCI INDEF, P87; Lawesson JE, 1990, MONOGRAPHS SYSTEMATI, V32, P201; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MACDONALD IAW, 1991, ENVIRON CONSERV, V18, P51, DOI 10.1017/S0376892900021305; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mauchamp A, 2010, INFORME GALAPAGOS 20; Morrison LW, 2003, ENVIRON ENTOMOL, V32, P548, DOI 10.1603/0046-225X-32.3.548; Neufeld E, 2007, INT J APPROX REASON, V46, P257, DOI 10.1016/j.ijar.2006.09.013; Panetta F. D., 1999, 12th Australian Weeds Conference, Papers and Proceedings, Hobart, Tasmania, Australia, 12-16 September 1999: Weed management into the 21st century: do we know where we're going?, P144; Paterson ID, 2011, BIOL CONTROL, V57, P59, DOI 10.1016/j.biocontrol.2010.12.002; Pavlik BM, 1990, REINTRODUCTION AMSIN; Preston C, 2006, TREADING PRICKLY PAT, P557; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; Randall RP, 2002, GLOBAL COMPENDIUM WE; Renteria J, 2007, ESTRATEGIAS ERRADICA; Renteria Jorge L., 2006, Galapagos Research, V64, P31; Renteria JL, 2012, INVAS PLANT SCI MANA, V5, P37, DOI 10.1614/IPSM-D-11-00043.1; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Richardson DM, 2004, S AFR J SCI, V100, P45; Rosenthal SK, 2006, CAN J FISH AQUAT SCI, V63, P1276, DOI 10.1139/F06-037; SHIMIZU Y, 1997, REGIONAL VIEWS, V11, P23; Simao MCM, 2010, OIKOS, V119, P1553, DOI 10.1111/j.1600-0706.2010.18382.x; Soria M.C., 2006, AVIAN SEED DISPERSER; Stromberg JC, 2009, RESTOR ECOL, V17, P177, DOI 10.1111/j.1526-100X.2008.00514.x; Sundaram B, 2012, BIOL INVASIONS, V14, P1127, DOI 10.1007/s10530-011-0144-2; Tassin J, 2006, REV ECOL-TERRE VIE, V61, P35; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Trueman Mandy, 2010, Galapagos Research, V67, P26; Ujvari B, 2011, AUSTRAL ECOL, V36, P126, DOI 10.1111/j.1442-9993.2010.02126.x; Vargas R, 2009, STRUCTURE REGENERATI, P13; Vila M, 2006, J BIOGEOGR, V33, P853, DOI 10.1111/j.1365-2699.2005.01430.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Vitousek PM, 1996, AM SCI, V84, P468; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wilkinson SR, 2002, MANAGEMENT ELEPHANT; Zavaleta E, 2000, AMBIO, V29, P462, DOI 10.1639/0044-7447(2000)029[0462:TEVOCA]2.0.CO;2	69	31	34	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48106	10.1371/journal.pone.0048106	http://dx.doi.org/10.1371/journal.pone.0048106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118934	Green Submitted, gold, Green Published			2022-12-25	WOS:000310600500068
J	Vehmaa, A; Brutemark, A; Engstrom-Ost, J				Vehmaa, Anu; Brutemark, Andreas; Engstrom-Ost, Jonna			Maternal Effects May Act as an Adaptation Mechanism for Copepods Facing pH and Temperature Changes	PLOS ONE			English	Article							OCEAN ACIDIFICATION; EGG-PRODUCTION; SIZE; VARIABILITY; RESPONSES; SUCCESS; GULF	Acidification of the seas, caused by increased dissolution of CO2 into surface water, and global warming challenge the adaptation mechanisms of marine organisms. In boreal coastal environments, temperature and pH vary greatly seasonally, but sometimes also rapidly within hours due to upwelling events. We studied if copepod zooplankton living in a fluctuating environment are tolerant to climate change effects predicted for 2100, i.e., a temperature increase of 3 degrees C and a pH decrease of 0.4. Egg production of the copepod Acartia sp. was followed over five consecutive days at four temperature and pH conditions (17 degrees C/ambient pH; 17 degrees C/low pH; 20 degrees C/ambient pH; 20 degrees C/low pH). Egg production was higher in treatments with warmer temperature but the increase was smaller when copepods were simultaneously exposed to warmer temperature and lowered pH. To reveal if maternal effects are important in terms of adaptation to a changing environment, we conducted an egg transplantation experiment, where the produced eggs were moved to a different environment and egg hatching was monitored for three days. When pH changed between the egg production and hatching conditions, it resulted in lower hatching success, but the effect was diminished over the course of the experiment possibly due to improved maternal provisioning. Warmer egg production temperature induced a positive maternal effect and increased the egg hatching rate. Warmer hatching temperature resulted also in earlier hatching. However, the temperature effects appear to be dependent on the ambient sea temperature. Our preliminary results indicate that maternal effects are an important mechanism in the face of environmental change.	[Vehmaa, Anu; Brutemark, Andreas; Engstrom-Ost, Jonna] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Vehmaa, Anu; Brutemark, Andreas; Engstrom-Ost, Jonna] Abo Akad Univ, Ekenas, Finland; [Brutemark, Andreas] Tvarminne Zool Stn, SF-10900 Hango, Finland	Novia University of Applied Sciences; Abo Akademi University	Vehmaa, A (corresponding author), Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland.	anu.vehmaa@novia.fi	Vehmaa, Anu/A-2671-2010; Engström-Öst, Jonna/C-7373-2008	Vehmaa, Anu/0000-0003-4912-3258; Engström-Öst, Jonna/0000-0003-1792-7702	Academy of Finland [255566]; Maj and Tor Nessling Foundation; Walter and Andree de Nottbeck foundation	Academy of Finland(Academy of Finland); Maj and Tor Nessling Foundation; Walter and Andree de Nottbeck foundation	The study was funded by Academy of Finland (project number 255566; http://www.aka.fi/eng), Maj and Tor Nessling Foundation (http://www.nessling.fi/en/) and Walter and Andree de Nottbeck foundation (http://nottbeck.org/en/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brutemark A, 2011, OCEANOL HYDROBIOL ST, V40, P91, DOI 10.2478/s13545-011-0034-3; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Diekmann ABS, 2012, MAR BIOL, V159, P2399, DOI 10.1007/s00227-012-1955-0; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Fischer B, 2011, OIKOS, V120, P258, DOI 10.1111/j.1600-0706.2010.18642.x; Fischer JM, 2001, ECOLOGY, V82, P2984, DOI 10.1890/0012-9658(2001)082[2984:EHAZCR]2.0.CO;2; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Jonasdottir SH, 2009, MAR ECOL PROG SER, V382, P139, DOI 10.3354/meps07985; Karell P, 2008, FUNCT ECOL, V22, P682, DOI 10.1111/j.1365-2435.2008.01425.x; Karlson AML, 2009, J PLANKTON RES, V31, P459, DOI 10.1093/plankt/fbn131; Katajisto T, 1998, MAR ECOL PROG SER, V163, P133, DOI 10.3354/meps163133; Katajisto T, 2004, MAR BIOL, V145, P751, DOI 10.1007/s00227-004-1361-3; Koski M, 1999, J PLANKTON RES, V21, P1779, DOI 10.1093/plankt/21.9.1779; Kurihara H, 2004, MAR POLLUT BULL, V49, P721, DOI 10.1016/j.marpolbul.2004.05.005; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Lacey EP, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P54; Liblik T, 2011, BOREAL ENVIRON RES, V16, P73; Mauchline J, 1998, BIOL CALANOID COPEPO; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Mayor DJ, 2012, J PLANKTON RES, V34, P258, DOI 10.1093/plankt/fbr107; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2009, R FDN STAT COMP; Rodriguez-Grana L, 2010, MAR ECOL PROG SER, V401, P1, DOI 10.3354/meps08459; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; VIITASALO M, 1995, MAR BIOL, V123, P241, DOI 10.1007/BF00353615; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185	36	70	71	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48538	10.1371/journal.pone.0048538	http://dx.doi.org/10.1371/journal.pone.0048538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119052	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500165
J	Cai, MY; Wei, JH; Zhang, ZL; Zhao, HW; Qiu, YQ; Fang, Y; Gao, ZL; Cao, JZ; Chen, W; Zhou, FJ; Xie, D; Luo, JH				Cai, Muyan; Wei, Jinhuan; Zhang, Zhiling; Zhao, Hongwei; Qiu, Yunqiao; Fang, Yong; Gao, Zhenli; Cao, Jiazheng; Chen, Wei; Zhou, Fangjian; Xie, Dan; Luo, Junhang			Impact of Age on the Cancer-Specific Survival of Patients with Localized Renal Cell Carcinoma: Martingale Residual and Competing Risks Analysis	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; BREAST-CANCER; PROSTATE-CANCER; OLDER WOMEN; YOUNG AGE; MANAGEMENT; DIAGNOSIS; EXPERIENCE; NOMOGRAM; MEN	Background: Age at diagnosis has been shown to be an independent prognostic factor of localized renal cell carcinoma (RCC) in several studies. We used contemporary statistical methods to reevaluate the effect of age on the cancer-specific survival (CSS) of localized RCC. Methods and Findings: 1,147 patients with localized RCC who underwent radical nephrectomy between 1993 and 2009 were identified in our four institutions. The association between age and CSS was estimated, and the potential threshold was identified by a univariate Cox model and by martingale residual analysis. Competing risks regression was used to identify the independent impact of age on CSS. The median age was 52 years (range, 19-84 years). The median follow-up was 61 months (range, 6-144 months) for survivors. A steep increasing smoothed martingale residual plot indicated an adverse prognostic effect of age on CSS. The age cut-off of 45 years was most predictive of CSS on univariate Cox analysis and martingale residual analysis (p = 0.005). Age <= 45 years was independently associated with a higher CSS rate in the multivariate Cox regression model (HR = 1.59, 95% CI = 1.05-2.40, p = 0.027) as well as in competing risks regression (HR = 3.60, 95% CI = 1.93-6.71, p = 0.001). Conclusions: Increasing age was associated with a higher incidence of cancer-specific mortality of localized RCC. Age dichotomized at 45 years would maximize the predictive value of age on CSS, and independently predict the CSS of patients with localized RCC.	[Cai, Muyan; Wei, Jinhuan; Fang, Yong; Cao, Jiazheng; Chen, Wei; Luo, Junhang] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Muyan; Xie, Dan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Zhiling; Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Hongwei; Gao, Zhenli] Qingdao Univ, Coll Med, Dept Urol, Affiliated Yantai Yuhuangding Hosp, Yantai, Peoples R China; [Qiu, Yunqiao] GuangZhou Univ Chinese Med, Dept Urol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Qingdao University; Guangzhou University of Chinese Medicine	Luo, JH (corresponding author), Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	lxied@mail.sysu.edu.cn; luojunh@mail.sysu.edu.cn			National Natural Science Foundation of China [30900539, 81172429]; Fundamental Research Funds for the Central Universities [09ykpy35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by the National Natural Science Foundation of China (30900539,81172429), and the Fundamental Research Funds for the Central Universities (09ykpy35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SURVIVAL ANAL TECHNI; Bechis SK, 2011, J CLIN ONCOL, V29, P235, DOI 10.1200/JCO.2010.30.2075; Bedke J, 2008, J UROLOGY, V180, P62, DOI 10.1016/j.juro.2008.03.026; Brandt A, 2009, ONCOLOGIST, V14, P1209, DOI 10.1634/theoncologist.2009-0132; Chung M, 1996, CANCER, V77, P97, DOI 10.1002/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.3.CO;2-T; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; Denzinger Stefan, 2007, World J Surg Oncol, V5, P16, DOI 10.1186/1477-7819-5-16; DOMERGUE J, 1988, CANCER, V61, P835, DOI 10.1002/1097-0142(19880215)61:4<835::AID-CNCR2820610432>3.0.CO;2-X; Foster JA, 2010, ONCOLOGIST, V15, P584, DOI 10.1634/theoncologist.2009-0198; Guinee VF, 2000, LANCET, V356, P1113, DOI 10.1016/S0140-6736(05)74557-8; Haymart MR, 2009, ONCOLOGIST, V14, P216, DOI 10.1634/theoncologist.2008-0194; Jeong IG, 2009, J UROLOGY, V182, P445, DOI 10.1016/j.juro.2009.04.013; Jung EJ, 2009, UROLOGY, V73, P137, DOI 10.1016/j.urology.2008.08.460; Karakiewicz PI, 2007, J CLIN ONCOL, V25, P1316, DOI 10.1200/JCO.2006.06.1218; Karakiewicz PI, 2008, CUAJ-CAN UROL ASSOC, V2, P610, DOI 10.5489/cuaj.978; Konety BR, 2008, J UROLOGY, V179, P1797, DOI 10.1016/j.juro.2008.01.044; Lam JS, 2006, J CLIN ONCOL, V24, P5565, DOI 10.1200/JCO.2006.08.1794; Leonard RC, 2010, ONCOLOGIST, V15, P657, DOI 10.1634/theoncologist.2009-0284; Mell LK, 2010, J CLIN ONCOL, V28, P15, DOI 10.1200/JCO.2008.20.9288; Muss HB, 2010, ONCOLOGIST, V15, P57, DOI 10.1634/theoncologist.2010-S5-57; Nguyen NP, 2010, ANN SURG ONCOL, V17, P2570, DOI 10.1245/s10434-010-1167-0; Pectasides D, 2007, INT J GYNECOL CANCER, V17, P1003, DOI 10.1111/j.1525-1438.2007.00912.x; Pfreundschuh M, 2008, LANCET ONCOL, V9, P435, DOI 10.1016/S1470-2045(08)70078-0; Richstone L, 2008, BJU INT, V101, P541, DOI 10.1111/j.1464-410X.2007.07410.x; Soares M, 2006, CRIT CARE MED, V34, P715, DOI 10.1097/01.CCM.0000201883.05900.3F; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Taccoen X, 2007, EUR UROL, V51, P980, DOI 10.1016/j.eururo.2006.10.025; Thoroddsen A, 2008, SCAND J UROL NEPHROL, V42, P121, DOI 10.1080/00365590701571555; Verhoest G, 2007, EUR UROL, V51, P1298, DOI 10.1016/j.eururo.2006.11.056; Vinh-Hung V, 2010, ONCOLOGIST, V15, P1050, DOI 10.1634/theoncologist.2010-0044; Voutilainen PE, 2001, THYROID, V11, P953, DOI 10.1089/105072501753211028; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056	33	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48489	10.1371/journal.pone.0048489	http://dx.doi.org/10.1371/journal.pone.0048489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119034	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600046
J	Lai, DH; He, YZ; Dai, YP; Li, X				Lai, Dehui; He, Yongzhong; Dai, Yuping; Li, Xun			Combined Minimally Invasive Percutaneous Nephrolithotomy and Retrograde Intrarenal Surgery for Staghorn Calculi in Patients with Solitary Kidney	PLOS ONE			English	Article							MANAGEMENT; EFFICACY; ACCESS; EXTRACTION; PUNCTURE; SAFETY; TRACTS	Background: To present our experience with simultaneous combined minimally invasive percutaneous nephrolithotomy (MPCNL) and retrograde intrarenal surgery (RIRS) to manage patients with staghorn calculi in solitary kidney, and evaluate the safety, efficiency and feasibility of this approach. Methodology/Principal Findings: The study included 20 patients with staghorn calculi in solitary kidney. Demographic characteristics, stone location and surface area were recorded. After informed consent, the patients underwent one stage MPCNL firstly. Combined second stage MPCNL and RIRS simultaneously were performed at postoperative 5-7 days. Operative parameters, stone-free rate (SFR), stone analyses and complications were evaluated. Serum creatinine (Scr), glomerular filtration rate (GFR) and chronic kidney disease (CKD) were measured preoperatively, postoperatively at 1 month, and each follow-up visit. All patients had staghorn stones involving multiple calyces. The mean stone burden was 1099.9 +/- 843.95 mm(2). All patients had only one percutaneous access tract. The mean whole operative duration was 154.37 +/- 32.45 min. The mean blood loss was 64 (12-140) ml. The final SFR was 90%. During the 1-month follow-up study period, four patients improved in CKD stage. Two patients who had CKD (stage 5) still needed dialysis postoperatively. Mean Scr of the rest patients preoperatively was 187.16 +/- 94.12 compared to 140.99 +/- 57.92 umol/L by the end of 1-month follow-up period (p = 0.019). The same findings were observed in GFR in that preoperatively it was 43.80 +/- 24.74 ml/min and by the end of the 1-month follow-up it was 49.55 +/- 21.18 ml/min (p = 0.05). Conclusions/Significance: Combined MPCNL and RIRS management effectively decrease the number and size of percutaneous access tracts, which is safe, feasible, and efficient for managing staghorn calculi in solitary kidney with satisfactory SFR and reducing blood loss, potential morbidity associated with multiple tracts. The approach did not adversely affect renal function at both short-term and long-term follow-up.	[He, Yongzhong; Li, Xun] Guangzhou Med Univ, Dept Urol, Affiliated Hosp 5, Guangzhou, Guangdong, Peoples R China; [Lai, Dehui; Dai, Yuping] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Guangzhou Medical University; Sun Yat Sen University	Li, X (corresponding author), Guangzhou Med Univ, Dept Urol, Affiliated Hosp 5, Guangzhou, Guangdong, Peoples R China.	157773933@qq.com						Auge Brian, 2001, Journal of Endourology, V15, pA60; Bryniarski P, 2012, J ENDOUROL, V26, P52, DOI 10.1089/end.2011.0235; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; El-Assmy A, 2008, J UROLOGY, V179, P2229, DOI 10.1016/j.juro.2008.01.095; El-Nahas AR, 2007, J UROLOGY, V177, P576, DOI 10.1016/j.juro.2006.09.048; Falahatkar S, 2008, J ENDOUROL, V22, P1447, DOI 10.1089/end.2007.0285; FERNSTROM I, 1976, SCAND J UROL NEPHROL, V10, P257, DOI 10.1080/21681805.1976.11882084; Ganpule AP, 2008, CURR OPIN UROL, V18, P220, DOI 10.1097/MOU.0b013e3282f3e6e4; Ibarluzea G, 2007, BJU INT, V100, P233, DOI 10.1111/j.1464-410X.2007.06960.x; Jackman SV, 1998, WORLD J UROL, V16, P371, DOI 10.1007/s003450050083; KOGA S, 1991, BRIT J UROL, V68, P122, DOI 10.1111/j.1464-410X.1991.tb15278.x; Lahme S, 2001, EUR UROL, V40, P619, DOI 10.1159/000049847; Landman J, 2003, J UROLOGY, V169, P64, DOI 10.1016/S0022-5347(05)64036-0; Lazarus J, 2011, J ENDOUROL, V25, P747, DOI 10.1089/end.2010.0494; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Li X, 2009, J ENDOUROL, V23, P1693, DOI 10.1089/end.2009.1537; Marguet CG, 2005, BJU INT, V96, P1097, DOI 10.1111/j.1464-410X.2005.05808.x; Michel MS, 2007, EUR UROL, V51, P899, DOI 10.1016/j.eururo.2006.10.020; Monga M, 2000, J ENDOUROL, V14, P419, DOI 10.1089/end.2000.14.419; Pietrow PK, 2003, J UROLOGY, V169, P1247, DOI 10.1097/01.ju.0000049643.18775.65; Preminger GM, 2005, J UROLOGY, V173, P1991, DOI 10.1097/01.ju.0000161171.67806.2a; Rassweiler JJ, 2000, BJU INT, V86, P919, DOI 10.1046/j.1464-410x.2000.00906.x; Singla M, 2008, UROLOGY, V71, P1039, DOI 10.1016/j.urology.2007.11.072; Soucy F, 2009, J ENDOUROL, V23, P1669, DOI 10.1089/end.2009.1534; STOLLER ML, 1994, J UROLOGY, V152, P1977, DOI 10.1016/S0022-5347(17)32283-8; STREEM SB, 1986, UROLOGY, V27, P247, DOI 10.1016/0090-4295(86)90283-9; Tiselius HG., 2008, GUIDELINES UROLITHIA; Williams SK, 2008, CURR OPIN UROL, V18, P224, DOI 10.1097/MOU.0b013e3282f517c0; Wong C, 2002, J ENDOUROL, V16, P477, DOI 10.1089/089277902760367430; Zhong W, 2008, J ENDOUROL, V22, P2147, DOI 10.1089/end.2008.0001	30	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48435	10.1371/journal.pone.0048435	http://dx.doi.org/10.1371/journal.pone.0048435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119016	gold, Green Submitted, Green Published			2022-12-25	WOS:000310705600042
J	Yang, Y; Du, LP; Sun, M; Kijlstra, A; Yang, PZ				Yang, Yan; Du, Liping; Sun, Min; Kijlstra, Aize; Yang, Peizeng			IFN-beta Inhibits the Increased Expression of IL-9 during Experimental Autoimmune Uveoretinitis	PLOS ONE			English	Article							RETINOID-BINDING-PROTEIN; T-CELLS; MULTIPLE-SCLEROSIS; T(H)17 CELLS; CYTOKINE; UVEITIS; DIFFERENTIATION; INDUCTION; ANTIGEN; DETERMINANT	Purpose: It has been shown that IL-9 plays a proinflammatory role in the pathogenesis of certain autoimmune diseases. This study was designed to investigate the possible role of IL-9 in the development of experimental autoimmune uveoretinitis (EAU) and the effect of IFN-beta on its expression. Methods: EAU was induced in B10RIII mice by immunization with interphotoreceptor retinoid-binding protein peptide 161-180 (IRBP161-180). IFN-beta was administered subcutaneously to IRBP161-180 immunized mice every other day from day one before immunization to the end of the study. Splenocytes and draining lymph node (DLN) cells from EAU mice or control mice or EAU mice treated with IFN-beta or PBS were stimulated with anti-CD3/CD28 or IRBP161-180 for 3 days. Naive T cells cultured under Th1 or Th17 polarizing conditions were incubated in the presence or absence of IFN-beta for 4 days. Effector/memory T cells were activated by anti-CD3/CD28 in the presence or absence of IFN-beta for 3 days. IFN-beta-treated monocytes were cocultured with naive T cells or effector/memory T cells for 3 days. Culture supernatants were collected and IL-9 was detected by ELISA. Results: IL-9 expression in splenocytes and DLN cells was increased in EAU mice during the inflammatory phase and returned back to lower levels during the recovery phase. IFN-beta in vivo treatment significantly inhibited EAU activity in association with a down-regulated expression of IL-9. In vitro polarized Th1 and Th17 cells both secreted IL-9 and the addition of IFN-beta suppressed production of IL-9 by both Th subsets. Beside its effect on polarized Th cells, IFN-beta also suppressed the secretion of IL-9 by effector/memory T cells. However, IFN-beta-treated monocytes had no effect on the production of IL-9 when cocultured with naive or effector/memory T cells. Conclusion: IL-9 expression is increased during EAU which could be suppressed by IFN-b.	[Yang, Yan; Du, Liping; Sun, Min; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Yang, Yan; Du, Liping; Sun, Min; Yang, Peizeng] Chongqing Eye Inst, Chongqing, Peoples R China; [Yang, Yan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands	Chongqing Medical University; Sun Yat Sen University; Maastricht University; Maastricht University Medical Centre (MUMC)	Yang, PZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China.	peizengycmu@126.com	Yang, Peizeng/C-6336-2013; Du, Liping/M-9495-2019		Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Key Project of National Natural Science Foundation of China [81130019]; National Natural Science Foundation of China [81070722]; National Natural Science Foundation Project [30973242]; Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Fund for PAR-EU Scholars Program	Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality; Fund for PAR-EU Scholars Program	This work was supported by Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003) http://www.ctin.ac.cn/View.aspx? id = 14380, Key Project of National Natural Science Foundation of China (81130019) http://159.226.244.22/portal/Proj_List.asp, National Natural Science Foundation of China (81070722) http://159.226.244.22/portal/Proj_List.asp, National Natural Science Foundation Project (30973242) http://159.226.244.22/portal/Proj_List.asp, Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality, http://cqkjdj.cstc.gov.cn/View.aspx?id = 1000, and Fund for PAR-EU Scholars Program, http://www.cqhrss.gov.cn/u/cqhrss/news_37398.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Ang M, 2012, MOL VIS, V18, P565; Byrnes AA, 2002, ANN NEUROL, V51, P165, DOI 10.1002/ana.10084; Caspi RR, 2011, INVEST OPHTH VIS SCI, V52, P1873, DOI 10.1167/iovs.10-6909; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; CASPI RR, 1988, J IMMUNOL, V140, P1490; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; DONOSO LA, 1989, J IMMUNOL, V143, P79; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Elyaman W, 2012, IMMUNITY, V36, P623, DOI 10.1016/j.immuni.2012.01.020; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; GERY I, 1986, INVEST OPHTH VIS SCI, V27, P1296; HU LH, 1989, CELL IMMUNOL, V122, P251, DOI 10.1016/0008-8749(89)90165-2; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Krakauer M, 2008, MULT SCLER J, V14, P622, DOI 10.1177/1352458507087136; Li HM, 2011, EUR J IMMUNOL, V41, P2197, DOI 10.1002/eji.201041125; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; MILO R, 1995, J NEUROIMMUNOL, V61, P185, DOI 10.1016/0165-5728(95)00085-G; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Stephens GL, 2011, EUR J IMMUNOL, V41, P952, DOI 10.1002/eji.201040879; Sun M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019870; Sun M, 2010, OCUL IMMUNOL INFLAMM, V18, P38, DOI 10.3109/09273940903414525; Sun M, 2010, INVEST OPHTH VIS SCI, V51, P383, DOI 10.1167/iovs.09-3514; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Tripathi P, 2004, EXP MOL PATHOL, V76, P122, DOI 10.1016/j.yexmp.2003.10.007; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; WACKER WB, 1977, J IMMUNOL, V119, P1949; Xu H, 1997, CELL IMMUNOL, V178, P69, DOI 10.1006/cimm.1997.1121; Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226; Zhou Y, 2011, J IMMUNOL, V186, P4415, DOI 10.4049/jimmunol.1003307	34	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48566	10.1371/journal.pone.0048566	http://dx.doi.org/10.1371/journal.pone.0048566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119059	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600050
J	Luo, W; Su, J; Zhang, XB; Yang, Z; Zhou, MQ; Jiang, ZM; Hao, PP; Liu, SD; Wen, Q; Jin, Q; Ma, L				Luo, Wei; Su, Jin; Zhang, Xiao-Bing; Yang, Zhi; Zhou, Ming-Qian; Jiang, Zhen-Min; Hao, Pei-Pei; Liu, Su-Dong; Wen, Qian; Jin, Qi; Ma, Li			Limited T Cell Receptor Repertoire Diversity in Tuberculosis Patients Correlates with Clinical Severity	PLOS ONE			English	Article							RESPONSES; EXPRESSION; INFECTION; IMMUNITY; CD4(+); INDIVIDUALS; EXPANSION; DIAGNOSIS; SEQUENCE	Background: The importance of CD4(+) and CD8(+) T cells in protection against tuberculosis (TB) is well known, however, the association between changes to the T cell repertoire and disease presentation has never been analyzed. Characterization of T-cells in TB patients in previous study only analyzed the TCR beta chain and omitted analysis of the V alpha family even though a chain also contribute to antigen recognition. Furthermore, limited information is available regarding the heterogeneity compartment and overall function of the T cells in TB patients as well as the common TCR structural features of Mtb antigen specific T cells among the vast numbers of TB patients. Methodology/Principal Findings: CDR3 spectratypes of CD4(+) and CD8(+) T cells were analyzed from 86 patients with TB exhibiting differing degrees of disease severity, and CDR3 spectratype complexity scoring system was used to characterize TCR repertoire diversity. TB patients with history of other chronic disease and other bacterial or viral infections were excluded for the study to decrease the likely contribution of TCRs specific to non-TB antigens as far as possible. Each patient was age-matched with a healthy donor group to control for age variability. Results showed that healthy controls had a normally diversified TCR repertoire while TB patients represented with restricted TCR repertoire. Patients with mild disease had the highest diversity of TCR repertoire while severely infected patients had the lowest, which suggest TCR repertoire diversity inversely correlates with disease severity. In addition, TB patients showed preferred usage of certain TCR types and have a bias in the usage of variable (V) and joining (J) gene segments and N nucleotide insertions. Conclusions/Significance: Results from this study promote a better knowledge about the public characteristics of T cells among TB patients and provides new insight into the TCR repertoire associated with clinic presentation in TB patients.	[Zhang, Xiao-Bing; Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Zhang, Xiao-Bing; Jin, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Luo, Wei; Yang, Zhi; Zhou, Ming-Qian; Jiang, Zhen-Min; Hao, Pei-Pei; Liu, Su-Dong; Wen, Qian; Ma, Li] So Med Univ, Inst Mol Immunol, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China; [Su, Jin] So Med Univ, Dept Resp Dis, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Southern Medical University - China; Southern Medical University - China	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China.	zdsys@vip.sina.com; maryhmz@126.com		Ma, Li/0000-0001-5847-2375	National Science and Technology Key Projects on Major Infectious Diseases [2012ZX10003002-007]; National Natural Science Foundation of China [81171539, 30972680]; Key Project of Guangdong Natural Science Foundation [S2011020003154]; Research Fund for the Doctoral Program of Higher Education [20114433110002]; State Key Laboratory for Molecular Virology and Genetic Engineering [2011KF03]	National Science and Technology Key Projects on Major Infectious Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Guangdong Natural Science Foundation; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); State Key Laboratory for Molecular Virology and Genetic Engineering	This work was supported by grants from National Science and Technology Key Projects on Major Infectious Diseases (2012ZX10003002-007) & National Natural Science Foundation of China (81171539, 30972680) & Key Project of Guangdong Natural Science Foundation (S2011020003154) & Research Fund for the Doctoral Program of Higher Education (20114433110002) & The State Key Laboratory for Molecular Virology and Genetic Engineering (2011KF03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2007, INFECT IMMUN, V75, P5210, DOI 10.1128/IAI.00624-07; Basile JI, 2011, J INFECT DIS, V204, P1054, DOI 10.1093/infdis/jir460; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Caccamo N, 2003, CLIN EXP IMMUNOL, V133, P260, DOI 10.1046/j.1365-2249.2003.02201.x; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Esin S, 1999, INFECT IMMUN, V67, P3800, DOI 10.1128/IAI.67.8.3800-3809.1999; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Gold MC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040039; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Junker A, 2007, BRAIN, V130, P2789, DOI 10.1093/brain/awm214; Kumar SV, 2010, EUR REV MED PHARMACO, V14, P831; Luo W, 2011, J MOL MED, V89, P903, DOI 10.1007/s00109-011-0760-4; Luo W, 2011, CANCER SCI, V102, P706, DOI 10.1111/j.1349-7006.2011.01868.x; Luo W, 2010, CANCER IMMUNOL IMMUN, V59, P247, DOI 10.1007/s00262-009-0745-0; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Mycko MP, 2004, J IMMUNOL, V173, P1689, DOI 10.4049/jimmunol.173.3.1689; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Pahwa S, 2003, AIDS RES HUM RETROV, V19, P487, DOI 10.1089/088922203766774531; Patel VB, 2010, AM J RESP CRIT CARE, V182, P569, DOI 10.1164/rccm.200912-1931OC; Roy E, 2007, CURR MOL MED, V7, P373, DOI 10.2174/156652407780831557; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Sun W, 2005, GENES IMMUN, V6, P248, DOI 10.1038/sj.gene.6364166; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Vallejo AN, 2006, IMMUNOL RES, V36, P221, DOI 10.1385/IR:36:1:221; Winslow GM, 2008, IMMUNOL REV, V225, P284, DOI 10.1111/j.1600-065X.2008.00693.x; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140	30	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48117	10.1371/journal.pone.0048117	http://dx.doi.org/10.1371/journal.pone.0048117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110186	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500038
J	Vassal-Stermann, E; Duranton, A; Black, AF; Azadiguian, G; Demaude, J; Lortat-Jacob, H; Breton, L; Vives, RR				Vassal-Stermann, Emilie; Duranton, Albert; Black, Annie F.; Azadiguian, Gayane; Demaude, Julien; Lortat-Jacob, Hugues; Breton, Lionel; Vives, Romain R.			A New C-Xyloside Induces Modifications of GAG Expression, Structure and Functional Properties	PLOS ONE			English	Article							GROWTH FACTOR/SCATTER FACTOR; PROTEIN LINKAGE REGION; BETA-D-XYLOSIDES; HEPARAN-SULFATE; GLYCOSAMINOGLYCAN BIOSYNTHESIS; PRIME GLYCOSAMINOGLYCANS; MOLECULAR DIVERSITY; CHONDROITIN SULFATE; SKIN FIBROBLASTS; UV-IRRADIATION	Proteoglycans (PGs) are critically involved in major cellular processes. Most PG activities are due to the large interactive properties of their glycosaminoglycan (GAG) polysaccharide chains, whose expression and fine structural features are tightly controlled by a complex and highly regulated biosynthesis machinery. Xylosides are known to bypass PG-associated GAG biosynthesis and prime the assembly of free polysaccharide chains. These are, therefore, attractive molecules to interfere with GAG expression and function. Recently, we have developed a new xyloside derivative, C-Xyloside, that shares classical GAG-inducing xyloside activities while exhibiting improved metabolic stability. We have previously shown that C-Xyloside had beneficial effects on skin homoeostasis/regeneration using a number of models, but its precise effects on GAG expression and fine structure remained to be addressed. In this study, we have therefore investigated this in details, using a reconstructed dermal tissue as model. Our results first confirmed that C-Xyloside strongly enhanced synthesis of GAG chains, but also induced significant changes in their structure. C-Xyloside primed GAGs were exclusively chondroitin/dermatan sulfate (CS/DS) that featured reduced chain size, increased O-sulfation, and changes in iduronate content and distribution. Surprisingly, C-Xyloside also affected PG-borne GAGs, the main difference being observed in CS/DS 4-O/6-O-sulfation ratio. Such changes were found to affect the biological properties of CS/DS, as revealed by the significant reduction in binding to Hepatocyte Growth Factor observed upon C-Xyloside treatment. Overall, this study provides new insights into the effect of C-Xyloside on GAG structure and activities, which opens up perspectives and applications of such compound in skin repair/regeneration. It also provides a new illustration about the use of xylosides as tools for modifying GAG fine structure/function relationships.	[Vassal-Stermann, Emilie; Lortat-Jacob, Hugues; Vives, Romain R.] Univ Grenoble 1, CNRS, Inst Biol Struct Jean Pierre Ebel, CEA,Unite Mixte Rech UMR 5075, Grenoble, France; [Duranton, Albert; Black, Annie F.; Azadiguian, Gayane; Demaude, Julien; Breton, Lionel] Oreal Res & Innovat, Clichy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Vives, RR (corresponding author), Univ Grenoble 1, CNRS, Inst Biol Struct Jean Pierre Ebel, CEA,Unite Mixte Rech UMR 5075, Grenoble, France.	romain.vives@ibs.fr	Vives, Romain/I-9372-2012	Stermann, Emilie/0000-0002-8486-4935; Duranton, Albert/0000-0002-4057-7176	L'Oreal research and innovation; L'Oreal	L'Oreal research and innovation; L'Oreal(L'Oreal Group)	This study was funded by L'Oreal research and innovation, and has been performed on the basis of a scientific collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by an investigator initiated grant from L'Oreal. AD, AFB, GA, JD and LB are employees of L'Oreal Recherche. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bernerd F, 1997, DEV BIOL, V183, P123, DOI 10.1006/dbio.1996.8465; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Black AF, 2005, TISSUE ENG, V11, P723, DOI 10.1089/ten.2005.11.723; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Cavezza A, 2009, BIOORG MED CHEM LETT, V19, P845, DOI 10.1016/j.bmcl.2008.12.037; Deakin JA, 2009, J BIOL CHEM, V284, P6311, DOI 10.1074/jbc.M807671200; Delehedde M., 2002, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V1, P89, DOI 10.2174/1568014023355935; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Garud DR, 2008, J BIOL CHEM, V283, P28881, DOI 10.1074/jbc.M805939200; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; HISCOCK DRR, 1995, BBA-GEN SUBJECTS, V1244, P104, DOI 10.1016/0304-4165(94)00206-D; Kuberan B, 2008, CHEMBIOCHEM, V9, P198, DOI 10.1002/cbic.200700494; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; LYON M, 1994, J BIOL CHEM, V269, P11216; LYON M, 1994, J BIOL CHEM, V269, P11208; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Mildner M, 2007, J INVEST DERMATOL, V127, P2637, DOI 10.1038/sj.jid.5700938; Muto J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025480; Passi A, 1997, FEBS LETT, V402, P286, DOI 10.1016/S0014-5793(97)00008-2; Pineau N, 2008, EUR J DERMATOL, V18, P36; Pineau N, 2011, EUR J DERMATOL, V21, P359, DOI 10.1684/ejd.2011.1340; Prydz K, 2009, GLYCOCONJUGATE J, V26, P1117, DOI 10.1007/s10719-009-9232-2; Raman K, 2011, BIOCHEM BIOPH RES CO, V404, P86, DOI 10.1016/j.bbrc.2010.11.069; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Shin JE, 2011, J KOREAN MED SCI, V26, P417, DOI 10.3346/jkms.2011.26.3.417; Sok J, 2008, EUR J DERMATOL, V18, P297, DOI 10.1684/ejd.2008.0392; Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Takamiya Masataka, 2009, Legal Medicine, V11, P186, DOI 10.1016/j.legalmed.2009.03.010; Tran VM, 2010, GLYCOCONJUGATE J, V27, P625, DOI 10.1007/s10719-010-9306-1; Ueno M, 2001, J BIOL CHEM, V276, P29134, DOI 10.1074/jbc.M102089200; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Vuillermoz B, 2005, MOL CELL BIOCHEM, V277, P63, DOI 10.1007/s11010-005-5073-x; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; Zhang LJ, 2010, PROG MOL BIOL TRANSL, V93, P1, DOI 10.1016/S1877-1173(10)93001-9; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295	46	22	23	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47933	10.1371/journal.pone.0047933	http://dx.doi.org/10.1371/journal.pone.0047933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110134	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500029
J	Chen, DM; Zhang, XX; Kang, HZ; Sun, X; Yin, S; Du, HM; Yamanaka, N; Gapare, W; Wu, HX; Liu, CJ				Chen, Dongmei; Zhang, Xianxian; Kang, Hongzhang; Sun, Xiao; Yin, Shan; Du, Hongmei; Yamanaka, Norikazu; Gapare, Washington; Wu, Harry X.; Liu, Chunjiang			Phylogeography of Quercus variabilis Based on Chloroplast DNA Sequence in East Asia: Multiple Glacial Refugia and Mainland-Migrated Island Populations	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; GENETIC-VARIATION; TEMPERATE PLANTS; WHITE OAKS; CLIMATE; MODEL; DIVERGENCE; HAPLOTYPES; DIVERSITY; GROWTH	The biogeographical relationships between far-separated populations, in particular, those in the mainland and islands, remain unclear for widespread species in eastern Asia where the current distribution of plants was greatly influenced by the Quaternary climate. Deciduous Oriental oak (Quercus variabilis) is one of the most widely distributed species in eastern Asia. In this study, leaf material of 528 Q. variabilis trees from 50 populations across the whole distribution (Mainland China, Korea Peninsular as well as Japan, Zhoushan and Taiwan Islands) was collected, and three cpDNA intergenic spacer fragments were sequenced using universal primers. A total of 26 haplotypes were detected, and it showed a weak phylogeographical structure in eastern Asia populations at species level, however, in the central-eastern region of Mainland China, the populations had more haplotypes than those in other regions, with a significant phylogeographical structure (N-ST = 0.751 > G(ST) = 0.690, P < 0.05). Q. variabilis displayed high interpopulation and low intrapopulation genetic diversity across the distribution range. Both unimodal mismatch distribution and significant negative Fu's F-S indicated a demographic expansion of Q. variabilis populations in East Asia. A fossil calibrated phylogenetic tree showed a rapid speciation during Pleistocene, with a population augment occurred in Middle Pleistocene. Both diversity patterns and ecological niche modelling indicated there could be multiple glacial refugia and possible bottleneck or founder effects occurred in the southern Japan. We dated major spatial expansion of Q. variabilis population in eastern Asia to the last glacial cycle(s), a period with sea-level fluctuations and land bridges in East China Sea as possible dispersal corridors. This study showed that geographical heterogeneity combined with climate and sea-level changes have shaped the genetic structure of this wide-ranging tree species in East Asia.	[Chen, Dongmei; Zhang, Xianxian; Kang, Hongzhang; Sun, Xiao; Yin, Shan; Du, Hongmei; Liu, Chunjiang] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Chen, Dongmei; Zhang, Xianxian; Kang, Hongzhang; Sun, Xiao; Yin, Shan; Du, Hongmei; Liu, Chunjiang] Shanghai Jiao Tong Univ, Res Ctr Low Carbon Agr, Shanghai 200030, Peoples R China; [Yin, Shan; Liu, Chunjiang] Minist Agr, Key Lab Urban Agr S, Shanghai, Peoples R China; [Yamanaka, Norikazu] Tottori Univ, Arid Land Res Ctr, Tottori 680, Japan; [Gapare, Washington; Wu, Harry X.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia; [Wu, Harry X.] Swedish Univ Agr Sci, Umea Plant Sci Ctr, S-90183 Umea, Sweden	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs; Tottori University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swedish University of Agricultural Sciences; Umea University	Liu, CJ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China.	chjliu@sjtu.edu.cn	Gapare, Washington/AAD-8335-2021; Gapare, Washington J/I-2938-2012; Norikazu, Yamanaka/D-4628-2019	Chen, Dongmei/0000-0003-0038-3411; Yamanaka, Norikazu/0000-0003-4997-4060; Kang, Hongzhang/0000-0003-4026-3588; Wu, Harry/0000-0002-7072-4704	Natural Science Foundation of China [31070532, 308001138, 30671674]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (NO. 31070532, 308001138 and 30671674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Carbone I, 2001, MOL ECOL, V10, P947, DOI 10.1046/j.1365-294X.2001.01244.x; Chen J, 2009, THESIS NANJING FORES; Chen KM, 2008, MOL ECOL, V17, P4276, DOI 10.1111/j.1365-294X.2008.03911.x; Cheng YP, 2005, MOL ECOL, V14, P2075, DOI 10.1111/j.1365-294X.2005.02567.x; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; CRANDALL KA, 1993, GENETICS, V134, P959; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DumolinLapegue S, 1997, GENETICS, V146, P1475; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FERRIS C, 1993, MOL ECOL, V2, P337, DOI 10.1111/j.1365-294X.1993.tb00026.x; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Hallam A, 1994, OUTLINE PHANEROZOIC, P1; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hasumi H., 2004, K 1 COUPLED GCM MIRO, V1, P34; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hou XY, 1982, BIOGEOGRAPHY DOMINAN, P8; Huang NH, 2009, J FIRE SCI, V27, P235, DOI 10.1177/0734904108099334; Huang SSF, 2002, MOL ECOL, V11, P2349, DOI 10.1046/j.1365-294X.2002.01624.x; Kanno M, 2004, J PLANT RES, V117, P311, DOI 10.1007/s10265-004-0160-8; KIMURA M, 1964, GENETICS, V49, P561; Li J, 2007, FOREST ECOL MANAG, V243, P94, DOI 10.1016/j.foreco.2007.02.012; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Matsumoto A, 2009, BOTANY, V87, P145, DOI 10.1139/B08-121; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; NEI M, 1983, GENETICS, V105, P207; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ohi T, 2003, AM J BOT, V90, P1645, DOI 10.3732/ajb.90.11.1645; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qi XS, 2012, NEW PHYTOL, V196, P617, DOI 10.1111/j.1469-8137.2012.04242.x; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Qiu YX, 2009, NEW PHYTOL, V183, P480, DOI 10.1111/j.1469-8137.2009.02876.x; Qiu YX, 2009, MOL PHYLOGENET EVOL, V51, P281, DOI 10.1016/j.ympev.2009.01.016; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ross G. J. B., 1994, ACTA BOT YUNNANICA, V5, P23; Sakaguchi S, 2012, MOL ECOL, V21, P3823, DOI 10.1111/j.1365-294X.2012.05652.x; Shen L, 2005, HEREDITY, V94, P396, DOI 10.1038/sj.hdy.6800616; Shi Y., 2006, QUATERNARY GLACIATIO, P65; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Swofford DL, 2003, PAUP PHYLOGENETIC AN, P5; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian B, 2009, J BIOGEOGR, V36, P2148, DOI 10.1111/j.1365-2699.2009.02157.x; Wang J., 1988, J WUHAN BOT RES, V6, P121; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; Wang L, 1985, J BEIJING FOR COLL, V3, P57; Watanabe K, 2006, AM J BOT, V93, P442, DOI 10.3732/ajb.93.3.442; Xu X., 1996, ACTA PALAEONTOL SIN, V35, P175; Yu G, 2000, J BIOGEOGR, V27, P635, DOI 10.1046/j.1365-2699.2000.00431.x; Zhang L.W., 2012, AGR ARCHAE, V3, P208; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhao Xuefeng, 2009, Acta Theriologica Sinica, V29, P160; Zheng YQ, 2003, SCI CHINA SER D, V46, P753, DOI 10.1360/03yd0502; Zhou J., 2008, J SW FOREST COLL, V28, P1; [周建云 Zhou Jianyun], 2003, [西北林学院学报, Journal of Northwest Forestry College], V18, P33; Zhou JY, 2008, J SW FORESTRY, V28, P9; Zhou Zhe-Kun, 2005, Acta Botanica Yunnanica, V27, P449; Zhou Zhe-Kun, 1993, Acta Botanica Yunnanica, V15, P21	74	80	84	3	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47268	10.1371/journal.pone.0047268	http://dx.doi.org/10.1371/journal.pone.0047268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115642	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200033
J	Francart, T; McDermott, H				Francart, Tom; McDermott, Hugh			Speech Perception and Localisation with SCORE Bimodal: A Loudness Normalisation Strategy for Combined Cochlear Implant and Hearing Aid Stimulation	PLOS ONE			English	Article							RECOGNITION; MASKERS	A significant fraction of newly implanted cochlear implant recipients use a hearing aid in their non-implanted ear. SCORE bimodal is a sound processing strategy developed for this configuration, aimed at normalising loudness perception and improving binaural loudness balance. Speech perception performance in quiet and noise and sound localisation ability of six bimodal listeners were measured with and without application of SCORE. Speech perception in quiet was measured either with only acoustic, only electric, or bimodal stimulation, at soft and normal conversational levels. For speech in quiet there was a significant improvement with application of SCORE. Speech perception in noise was measured for either steady-state noise, fluctuating noise, or a competing talker, at conversational levels with bimodal stimulation. For speech in noise there was no significant effect of application of SCORE. Modelling of interaural loudness differences in a long-term-average-speech-spectrum-weighted click train indicated that left-right discrimination of sound sources can improve with application of SCORE. As SCORE was found to leave speech perception unaffected or to improve it, it seems suitable for implementation in clinical devices.	[Francart, Tom] Katholieke Univ Leuven, Dept Neurosci, ExpORL, Louvain, Belgium; [Francart, Tom; McDermott, Hugh] Bion Inst, Melbourne, Vic, Australia; [McDermott, Hugh] Univ Melbourne, Melbourne, Vic, Australia	KU Leuven; Bionics Institute; University of Melbourne	Francart, T (corresponding author), Katholieke Univ Leuven, Dept Neurosci, ExpORL, Louvain, Belgium.	tom.francart@med.kuleuven.be			European Commission [PIOF-GA-2009-252730]; Victorian Government; Cochlear Ltd.; Flemish Government	European Commission(European CommissionEuropean Commission Joint Research Centre); Victorian Government; Cochlear Ltd.; Flemish Government(European Commission)	Cochlear Ltd. provided financial support. Tom Francart was sponsored by a Post Doctoral Fellowship of the Fund for Scientific Research of the Flemish Government and a Marie Curie International Outgoing Fellowship of the European Commission, grant agreement number PIOF-GA-2009-252730. The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standards Institute, 1997, ANSI S3 5 METH CALC; BYRNE D, 1990, EAR HEARING, V11, P40, DOI 10.1097/00003446-199002000-00009; Ching T, 2010, INT J AUDIOL S1, V49, P4; Ching T Y C, 2007, Trends Amplif, V11, P161, DOI 10.1177/1084713807304357; Dawson PW, 2011, EAR HEARING, V32, P382, DOI 10.1097/AUD.0b013e318201c200; Francart T, 2012, J SPEECH LANG UNPUB; Francart T, 2012, HEAR RES IN PRESS; Francart T, 2008, J NEUROSCI METH, V172, P283, DOI 10.1016/j.jneumeth.2008.04.020; Francart T, 2008, AUDIOL NEURO-OTOL, V13, P309, DOI 10.1159/000124279; Francart T, 2011, J ACOUST SOC AM, V130, P2817, DOI 10.1121/1.3641414; Francart T, 2011, INT J AUDIOL, V50, P2, DOI 10.3109/14992027.2010.505582; Francart T, 2009, JARO-J ASSOC RES OTO, V10, P131, DOI 10.1007/s10162-008-0145-8; Gatehouse S, 2006, INT J AUDIOL, V45, P130, DOI 10.1080/14992020500429518; MCDERMOTT HJ, 1992, J ACOUST SOC AM, V91, P3367, DOI 10.1121/1.402826; McDermott H, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/065007; McKay CM, 2003, J ACOUST SOC AM, V113, P2054, DOI 10.1121/1.1558378; MILLS AW, 1960, J ACOUST SOC AM, V32, P132, DOI 10.1121/1.1907864; Moore BCJ, 1997, AUDIT NEUROSCI, V3, P289; Moore Brian C J, 2008, Trends Amplif, V12, P103, DOI 10.1177/1084713808317819; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; Vandali AE, 2000, EAR HEARING, V21, P608, DOI 10.1097/00003446-200012000-00008; Varsavsky A, 2012, IEEE T NEUR IN PRESS	22	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e45385	10.1371/journal.pone.0045385	http://dx.doi.org/10.1371/journal.pone.0045385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115622	Green Published, gold			2022-12-25	WOS:000310310200009
J	Ma, YL; Kong, QB; Hua, H; Luo, T; Jiang, YF				Ma, Yanli; Kong, Qingbin; Hua, Hui; Luo, Ting; Jiang, Yangfu			Aflatoxin B1 Up-Regulates Insulin Receptor Substrate 2 and Stimulates Hepatoma Cell Migration	PLOS ONE			English	Article							MAMMARY-TUMOR METASTASIS; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; GROWTH; ACTIVATION; IGF; MICE; CHLOROPHYLLIN; MUTATIONS; INSIGHTS	Aflatoxin B1 (AFB1) is a potent carcinogen that can induce hepatocellular carcinoma. AFB1-8,9-exo-epoxide, one of AFB1 metabolites, acts as a mutagen to react with DNA and induce gene mutations, including the tumor suppressor p53. In addition, AFB1 reportedly stimulates IGF receptor activation. Aberrant activation of IGF-I receptor (IGF-IR) signaling is tightly associated with various types of human tumors. In the current study, we investigated the effects of AFB1 on key elements in IGF-IR signaling pathway, and the effects of AFB1 on hepatoma cell migration. The results demonstrated that AFB1 induced IGF-IR, Akt, and Erk1/2 phosphorylation in hepatoma cell lines HepG2 and SMMC-7721, and an immortalized human liver cell line Chang liver. AFB1 also down-regulated insulin receptor substrate (IRS) 1 but paradoxically up-regulated IRS2 through preventing proteasomal degradation. Treatment of hepatoma cells and Chang liver cells with IGF- IR inhibitor abrogated AFB1-induced Akt and Erk1/2 phosphorylation. In addition, IRS2 knockdown suppressed AFB1-induced Akt and Erk1/2 phosphorylation. Finally, AFB1 stimulated hepatoma cell migration. IGF-IR inhibitor or IRS2 knockdown suppressed AFB1-induced hepatoma cell migration. These data demonstrate that AFB1 stimulates hepatoma cell migration through IGF-IR/IRS2 axis.	[Ma, Yanli; Kong, Qingbin; Hua, Hui; Jiang, Yangfu] Sichuan Univ, W China Hosp, Sect Signal Transduct & Mol Targeted Therapy, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Luo, Ting] Sichuan Univ, W China Hosp, Ctr Canc, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Jiang, YF (corresponding author), Sichuan Univ, W China Hosp, Sect Signal Transduct & Mol Targeted Therapy, State Key Lab Biotherapy, Chengdu 610064, Peoples R China.	jyangfu@scu.edu.cn	Jiang, Yangfu/AAX-2645-2020	Jiang, Yangfu/0000-0002-8696-2651	National Natural Science Foundation of China [81272215, 30973435, 30900554]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grants 81272215 and 30973435 to YJ, grant 30900554 to HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissan M, 2005, AM J PATHOL, V167, P869, DOI 10.1016/S0002-9440(10)62058-5; Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Egner PA, 2001, P NATL ACAD SCI USA, V98, P14601, DOI 10.1073/pnas.251536898; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Han CH, 2006, ONCOL REP, V16, P1205; Hoang CD, 2004, CANCER RES, V64, P7479, DOI 10.1158/0008-5472.CAN-04-1898; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Jubert C, 2009, CANCER PREV RES, V2, P1015, DOI 10.1158/1940-6207.CAPR-09-0099; Kelly VP, 2000, CANCER RES, V60, P957; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kensler TW, 1997, CANCER EPIDEM BIOMAR, V6, P127; Kim B, 2004, ONCOGENE, V23, P130, DOI 10.1038/sj.onc.1206924; Kim SO, 1996, CANCER RES, V56, P3831; Lee YI, 2000, ONCOGENE, V19, P3717, DOI 10.1038/sj.onc.1203694; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Paget V, 2008, MUTAT RES-GEN TOX EN, V656, P55, DOI 10.1016/j.mrgentox.2008.07.009; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Scharf JG, 2003, HORM METAB RES, V35, P685; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Smela ME, 2002, P NATL ACAD SCI USA, V99, P6655, DOI 10.1073/pnas.102167699; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Ubagai T, 2010, TOXICOL IN VITRO, V24, P783, DOI 10.1016/j.tiv.2009.12.022; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; Wild CP, 2009, CANCER LETT, V286, P22, DOI 10.1016/j.canlet.2009.02.053; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Woo LL, 2011, TOXICOL SCI, V122, P38, DOI 10.1093/toxsci/kfr087	28	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47961	10.1371/journal.pone.0047961	http://dx.doi.org/10.1371/journal.pone.0047961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112878	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200121
J	Nakagawa-Toyama, Y; Zhang, S; Krieger, M				Nakagawa-Toyama, Yumiko; Zhang, Songwen; Krieger, Monty			Dietary Manipulation and Social Isolation Alter Disease Progression in a Murine Model of Coronary Heart Disease	PLOS ONE			English	Article							DOUBLE KNOCKOUT MICE; PSYCHOSOCIAL RISK-FACTORS; E-DEFICIENT MOUSE; RECEPTOR SR-BI; APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CARDIAC DYSFUNCTION; LIPOPROTEIN METABOLISM; CYNOMOLGUS MONKEYS	Background: Mice with a deficiency in the HDL receptor SR-BI and low expression of a modified apolipoprotein E gene (SR-BI KO/ApoeR61(h/h)) called 'HypoE' when fed an atherogenic, 'Paigen' diet develop occlusive, atherosclerotic coronary arterial disease (CHD), myocardial infarctions (MI), and heart dysfunction and die prematurely (50% mortality similar to 40 days after initiation of this diet). Because few murine models share with HypoE mice these cardinal, human-like, features of CHD, HypoE mice represent a novel, small animal, diet-inducible and genetically tractable model for CHD. To better describe the properties of this model, we have explored the effects of varying the composition and timing of administration of atherogenic diets, as well as social isolation vs. group housing, on these animals. Methodology/Principal Findings: HypoE mice were maintained on a standard lab chow diet (control) until two months of age. Subsequently they received one of three atherogenic diets (Paigen, Paigen without cholate, Western) or control diet for varying times and were housed in groups or singly, and we determined the plasma cholesterol levels, extent of cardiomegaly and/or survival. The rate of disease progression could be reduced by lowering the severity of the atherogenic diet and accelerated by social isolation. Disease could be induced by Paigen diets either containing or free of cholate. We also established conditions under which CHD could be initiated by an atherogenic diet and then subsequently, by replacing this diet with standard lab chow, hypercholesterolemia could be reduced and progression to early death prevented. Conclusions/Significance: HypoE mice provide a powerful, surgery-free, diet-'titratable' small animal model that can be used to study the onset of recovery from occlusive, atherosclerotic CHD and heart failure due to MI. HypoE mice can be used for the analysis of the effects of environment (diet, social isolation) on a variety of features of cardiovascular disease.	[Nakagawa-Toyama, Yumiko; Zhang, Songwen; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Krieger, M (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	krieger@mit.edu			United States National Institutes of Health, Heart Lung and Blood Institute	United States National Institutes of Health, Heart Lung and Blood Institute	The United States National Institutes of Health, Heart Lung and Blood Institute funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson IJ, 2009, AM J PHYSIOL-REG I, V296, pR663, DOI 10.1152/ajpregu.90768.2008; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Bernberg E, 2008, STRESS, V11, P381, DOI 10.1080/10253890701824051; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Braun A, 2008, ATHEROSCLEROSIS, V198, P77, DOI 10.1016/j.atherosclerosis.2007.10.012; Brummett BH, 2001, PSYCHOSOM MED, V63, P267, DOI 10.1097/00006842-200103000-00010; Bunker SJ, 2003, MED J AUSTRALIA, V178, P272, DOI 10.5694/j.1326-5377.2003.tb05193.x; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; Carter CS, 2003, PHYSIOL BEHAV, V79, P383, DOI 10.1016/S0031-9384(03)00151-3; CLARKSON TB, 1984, J LIPID RES, V25, P1629; DeVries AC, 2007, PSYCHONEUROENDOCRINO, V32, P587, DOI 10.1016/j.psyneuen.2007.04.007; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Grippo AJ, 2007, PSYCHONEUROENDOCRINO, V32, P966, DOI 10.1016/j.psyneuen.2007.07.004; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; KAPLAN JR, 1984, STROKE, V15, P994, DOI 10.1161/01.STR.15.6.994; KAPLAN JR, 1991, LAB ANIM SCI, V41, P334; Karackattu SL, 2006, ARTERIOSCL THROM VAS, V26, P548, DOI 10.1161/01.ATV.0000202662.63876.02; Karackattu SL, 2005, ARTERIOSCL THROM VAS, V25, P803, DOI 10.1161/01.ATV.0000158310.64498.ac; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kumari M, 2003, STRESS, V6, P297, DOI 10.1080/10253890310001619461; LIN AH, 1995, ATHEROSCLEROSIS, V115, P85, DOI 10.1016/0021-9150(94)05502-A; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; O'Keefe James H., 2004, Comprehensive Therapy, V30, P37, DOI 10.1007/s12019-004-0022-2; Ondrejcakova M, 2009, CAN J PHYSIOL PHARM, V87, P137, DOI 10.1139/Y08-108; Petersson M, 2002, PROG BRAIN RES, V139, P281; Raffai RL, 2005, ARTERIOSCL THROM VAS, V25, P436, DOI 10.1161/01.ATV.0000152613.83243.12; Raffai RL, 2002, J BIOL CHEM, V277, P11064, DOI 10.1074/jbc.M111222200; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Samokhin AO, 2010, ARTERIOSCL THROM VAS, V30, P1166, DOI 10.1161/ATVBAHA.110.203976; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; VAMVAKOPOULOS NV, 1995, MEDIAT INFLAMM, V4, P163, DOI 10.1155/S0962935195000275; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; VOGT TM, 1992, J CLIN EPIDEMIOL, V45, P659, DOI 10.1016/0895-4356(92)90138-D; Watson SL, 1998, ATHEROSCLEROSIS, V137, P259, DOI 10.1016/S0021-9150(97)00277-3; Wsol A, 2008, J PHYSIOL PHARMACOL, V59, P123; Yamada K, 2000, PHYSIOL BEHAV, V68, P555, DOI 10.1016/S0031-9384(99)00214-0; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563	42	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47965	10.1371/journal.pone.0047965	http://dx.doi.org/10.1371/journal.pone.0047965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112879	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200122
J	Nebbia, G; Peppa, D; Schurich, A; Khanna, P; Singh, HD; Cheng, Y; Rosenberg, W; Dusheiko, G; Gilson, R; ChinAleong, J; Kennedy, P; Maini, MK				Nebbia, Gaia; Peppa, Dimitra; Schurich, Anna; Khanna, Pooja; Singh, Harsimran D.; Cheng, Yang; Rosenberg, William; Dusheiko, Geoffrey; Gilson, Richard; ChinAleong, Joanne; Kennedy, Patrick; Maini, Mala K.			Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection	PLOS ONE			English	Article							TIM-3 EXPRESSION; GALECTIN-9; IMMUNITY; BINDING	The S-type lectin galectin-9 binds to the negative regulatory molecule Tim-3 on T cells and induces their apoptotic deletion or functional inactivation. We investigated whether galectin-9/Tim-3 interactions contribute to the deletion and exhaustion of the antiviral T cell response in chronic hepatitis B virus infection (CHB). We found Tim-3 to be expressed on a higher percentage of CD4 and CD8 T cells from patients with CHB than healthy controls (p < 0.0001) and to be enriched on activated T cells and those infiltrating the HBV-infected liver. Direct ex vivo examination of virus-specific CD8 T cells binding HLA-A2/peptide multimers revealed that Tim-3 was more highly upregulated on HBV-specific CD8 T cells than CMV-specific CD8 T cells or the global CD8 T cell population in patients with CHB (p < 0.001) or than on HBV-specific CD8 after resolution of infection. T cells expressing Tim-3 had an impaired ability to produce IFN-gamma and TNF-alpha upon recognition of HBV-peptides and were susceptible to galectin-9-triggered cell death in vitro. Galectin-9 was detectable at increased concentrations in the sera of patients with active CHB-related liver inflammation (p = 0.02) and was strongly expressed by Kupffer cells within the liver sinusoidal network. Tim-3 blockade resulted in enhanced expansion of HBV-specific CD8 T cells able to produce cytokines and mediate cytotoxicity in vitro. Blocking PD-1 in combination with Tim-3 enhanced the number of patients from whom functional antiviral responses could be recovered and/or the strength of responses, indicating that these coinhibitory molecules play a non-redundant role in driving T cell exhaustion in CHB. Patients taking antivirals able to potently suppress HBV viraemia continued to express Tim-3 on their T cells and respond to Tim-3 blockade. In summary, both Tim-3 and galectin-9 are increased in CHB and may contribute to the inhibition and deletion of T cells as they infiltrate the HBV-infected liver.	[Nebbia, Gaia; Peppa, Dimitra; Schurich, Anna; Khanna, Pooja; Cheng, Yang; Maini, Mala K.] UCL, Div Infect & Immun, London, England; [Khanna, Pooja; Singh, Harsimran D.; Rosenberg, William; Dusheiko, Geoffrey] UCL, Ctr Hepatol, London, England; [Gilson, Richard] UCL, Ctr Sexual Hlth, London, England; [Gilson, Richard] UCL, HIV, London, England; [ChinAleong, Joanne; Kennedy, Patrick] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Digest Dis, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; Queen Mary University London	Maini, MK (corresponding author), UCL, Div Infect & Immun, London, England.	m.maini@ucl.ac.uk	Rosenberg, William/ABA-1071-2021	Rosenberg, William/0000-0002-2732-2304; peppa, dimitra/0000-0002-9281-5471; Maini, Mala/0000-0001-6384-1462; Schurich, Anna/0000-0002-2525-3114	Wellcome Trust/Academy of Medical Sciences; Medical Research Council (Clinical Research Training Fellowship) [G0902009, G0801213]; Bristol-Myers Squibb; MRC [G0902009, G0901374, G0801213] Funding Source: UKRI; Medical Research Council [G0901374, G0902009, G0801213] Funding Source: researchfish	Wellcome Trust/Academy of Medical Sciences(Wellcome Trust); Medical Research Council (Clinical Research Training Fellowship); Bristol-Myers Squibb(Bristol-Myers Squibb); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by The Wellcome Trust/Academy of Medical Sciences (starter grant to GN), the Medical Research Council (Clinical Research Training Fellowship G0902009 to DP and grant G0801213 to MKM) and a Bristol-Myers Squibb unrestricted educational grant to GD and MKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabraba EB, 2007, J IMMUNOL METHODS, V326, P139, DOI 10.1016/j.jim.2007.06.014; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boni C, 2003, J HEPATOL, V39, P595, DOI 10.1016/S0168-8278(03)00292-7; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Guidotti LG, 1996, IMMUNITY, V4, P25, DOI 10.1016/S1074-7613(00)80295-2; Jayaraman P, 2010, J EXP MED, V207, P2343, DOI 10.1084/jem.20100687; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Mengshol JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009504; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Oikawa T, 2006, J IMMUNOL, V177, P4281, DOI 10.4049/jimmunol.177.7.4281; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Reignat S, 2002, J EXP MED, V195, P1089, DOI 10.1084/jem.20011723; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Sehrawat S, 2009, J IMMUNOL, V182, P3191, DOI 10.4049/jimmunol.0803673; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wu W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-113; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	27	195	209	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47648	10.1371/journal.pone.0047648	http://dx.doi.org/10.1371/journal.pone.0047648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112829	Green Published, gold			2022-12-25	WOS:000310310200062
J	Saqui-Salces, M; Coves-Datson, E; Veniaminova, NA; Waghray, M; Syu, LJ; Dlugosz, AA; Merchant, JL				Saqui-Salces, Milena; Coves-Datson, Evelyn; Veniaminova, Natalia A.; Waghray, Meghna; Syu, Li-Jyun; Dlugosz, Andrzej A.; Merchant, Juanita L.			Inflammation and Gli2 Suppress Gastrin Gene Expression in a Murine Model of Antral Hyperplasia	PLOS ONE			English	Article							SONIC HEDGEHOG; BINDING-SITE; MICE LACKING; ACTIVIN-A; INDUCTION; ACTIVATION; PROTEIN; CANCER; GROWTH; FOLLISTATIN	Chronic inflammation in the stomach can lead to gastric cancer. We previously reported that gastrin-deficient (Gast(-/-)) mice develop bacterial overgrowth, inflammatory infiltrate, increased Il-1 beta expression, antral hyperplasia and eventually antral tumors. Since Hedgehog (Hh) signaling is active in gastric cancers but its role in precursor lesions is poorly understood, we examined the role of inflammation and Hh signaling in antral hyperplasia. LacZ reporter mice for Sonic hedgehog (Shh), Gli1, and Gli2 expression bred onto the Gast(-/-) background revealed reduced Shh and Gli1 expression in the antra compared to wild type controls (WT). Gli2 expression in the Gast(-/-) corpus was unchanged. However in the hyperplastic Gast(-/-) antra, Gli2 expression increased in both the mesenchyme and epithelium, whereas expression in WT mice remained exclusively mesenchymal. These observations suggested that Gli2 is differentially regulated in the hyperplastic Gast(-/-) antrum versus the corpus and by a Shh ligand-independent mechanism. Moreover, the proinflammatory cytokines Il-1 beta and Il-11, which promote gastric epithelial proliferation, were increased in the Gast(-/-) stomach along with Infc. To test if inflammation could account for elevated epithelial Gli2 expression in the Gast(-/-) antra, the human gastric cell line AGS was treated with IL-1 beta and was found to increase GLI2 but decrease GLI1 levels. IL-1 beta also repressed human GAST gene expression. Indeed, GLI2 but not GLI1 or GLI3 expression repressed gastrin luciferase reporter activity by similar to 50 percent. Moreover, chromatin immunoprecipitation of GLI2 in AGS cells confirmed that GLI2 directly binds to the GAST promoter. Using a mouse model of constitutively active epithelial GLI2 expression, we found that activated GLI2 repressed Gast expression but induced Il-1 beta gene expression and proliferation in the gastric antrum, along with a reduction of the number of G-cells. In summary, epithelial Gli2 expression was sufficient to stimulate Il-1 beta expression, repress Gast gene expression and increase proliferation, leading to antral hyperplasia.	[Saqui-Salces, Milena; Coves-Datson, Evelyn; Veniaminova, Natalia A.; Waghray, Meghna; Merchant, Juanita L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Syu, Li-Jyun; Dlugosz, Andrzej A.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Merchant, JL (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	merchanj@umich.edu	Merchant, Juanita/AAF-8277-2019	Merchant, Juanita/0000-0002-6559-8184; Saqui-Salces, Milena/0000-0001-5848-0092	National Institutes of Health [P01-DK62041]; NATIONAL CANCER INSTITUTE [R01CA087837, R01CA118875, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045729, P01DK062041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health grant P01-DK62041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CB, 2002, DEVELOPMENT, V129, P4753; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Camargo MC, 2011, GUT, V60, P1644, DOI 10.1136/gut.2010.236737; Chakravorty M, 2009, INT J BIOCHEM CELL B, V41, P1502, DOI 10.1016/j.biocel.2008.12.017; CORREA P, 1988, CANCER RES, V48, P3554; Datta De D, 2011, PLOS ONE, V6, pe14775, DOI [10.1371/journal.pone.0014775, DOI 10.1371/J0URNAL.P0NE.0014775.PUBMED:21445336]; DEMBINSKI AB, 1979, ENDOCRINOLOGY, V105, P769, DOI 10.1210/endo-105-3-769; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Eichberger T, 2008, J BIOL CHEM, V283, P12426, DOI 10.1074/jbc.M707117200; Florio P, 2007, REPROD SCI, V14, P29, DOI 10.1177/1933719106298191; Ford MG, 1997, J CLIN INVEST, V99, P2762, DOI 10.1172/JCI119466; Friis-Hansen L, 1998, AM J PHYSIOL-GASTR L, V274, pG561, DOI 10.1152/ajpgi.1998.274.3.G561; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Howlader N, 2012, SEER CANC STAT REV 1; Howlett M., 2011, GUT; Howlett M, 2009, GASTROENTEROLOGY, V136, P967, DOI 10.1053/j.gastro.2008.12.003; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Johnson RW, 2011, CANCER RES, V71, P822, DOI 10.1158/0008-5472.CAN-10-2993; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Kang WQ, 2008, BIOCHEM BIOPH RES CO, V376, P573, DOI 10.1016/j.bbrc.2008.09.031; Kang WQ, 2005, LAB INVEST, V85, P702, DOI 10.1038/labinvest.3700260; Kim SK, 2000, GENE DEV, V14, P1866; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; MAJUMDAR APN, 1982, AM J PHYSIOL, V242, pG135, DOI 10.1152/ajpgi.1982.242.2.G135; Merchant JL, 2005, GASTROENTEROLOGY, V129, P1079, DOI 10.1053/j.gastro.2005.07.038; Merchant JL, 1996, MOL CELL BIOL, V16, P6644; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; Saqui-Salces M, 2010, BBA-MOL CELL RES, V1803, P786, DOI 10.1016/j.bbamcr.2010.03.008; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHIOTANI A, 1995, AM J PHYSIOL-GASTR L, V269, pG458, DOI 10.1152/ajpgi.1995.269.3.G458; Singh P, 2000, CURR OPIN GASTROEN, V16, P68, DOI 10.1097/00001574-200001000-00013; Takaishi S, 2009, AM J PATHOL, V175, P365, DOI 10.2353/ajpath.2009.081165; Tomita H, 2011, GASTROENTEROLOGY, V140, P879, DOI 10.1053/j.gastro.2010.11.037; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; WALSH JH, 1975, NEW ENGL J MED, V292, P1324, DOI 10.1056/NEJM197506192922505; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Yoshino O, 2011, FERTIL STERIL, V96, P118, DOI 10.1016/j.fertnstert.2011.05.006; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zavros Y, 2002, GASTROENTEROLOGY, V122, P119, DOI 10.1053/gast.2002.30298; Zavros Y, 2007, J BIOL CHEM, V282, P33265, DOI 10.1074/jbc.M707090200	50	12	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48039	10.1371/journal.pone.0048039	http://dx.doi.org/10.1371/journal.pone.0048039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110168	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200142
J	Mertins, B; Psakis, G; Grosse, W; Back, KC; Salisowski, A; Reiss, P; Koert, U; Essen, LO				Mertins, Barbara; Psakis, Georgios; Grosse, Wolfgang; Back, Katrin Christiane; Salisowski, Anastasia; Reiss, Philipp; Koert, Ulrich; Essen, Lars-Oliver			Flexibility of the N-Terminal mVDAC1 Segment Controls the Channel's Gating Behavior	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; PLANAR LIPID-BILAYERS; ANTI-APOPTOTIC PROTEINS; HIGH-LEVEL EXPRESSION; MITOCHONDRIAL CHANNEL; ESCHERICHIA-COLI; BETA-BARREL; SELECTIVE CHANNEL; VDAC CHANNELS; VOLTAGE	Since the solution of the molecular structures of members of the voltage dependent anion channels (VDACs), the N-terminal alpha-helix has been the main focus of attention, since its strategic location, in combination with its putative conformational flexibility, could define or control the channel's gating characteristics. Through engineering of two double-cysteine mVDAC1 variants we achieved fixing of the N-terminal segment at the bottom and midpoint of the pore. Whilst cross-linking at the midpoint resulted in the channel remaining constitutively open, cross-linking at the base resulted in an "asymmetric" gating behavior, with closure only at one electric fields orientation depending on the channel's orientation in the lipid bilayer. Additionally, and while the native channel adopts several well-defined closed states (S1 and S2), the cross-linked variants showed upon closure a clear preference for the S2 state. With native-channel characteristics restored following reduction of the cysteines, it is evident that the conformational flexibility of the N-terminal segment plays indeed a major part in the control of the channel's gating behavior.	[Mertins, Barbara; Psakis, Georgios; Grosse, Wolfgang; Back, Katrin Christiane; Salisowski, Anastasia; Reiss, Philipp; Koert, Ulrich; Essen, Lars-Oliver] Univ Marburg, Dept Chem, Marburg, Germany	Philipps University Marburg	Essen, LO (corresponding author), Univ Marburg, Dept Chem, Marburg, Germany.	essen@chemie.uni-marburg.de	Psakis, Georgios/ABK-6136-2022; Essen, Lars-Oliver/L-3862-2016	Psakis, Georgios/0000-0003-3727-2694; Essen, Lars-Oliver/0000-0003-4272-4026; Psakis, Georgios/0000-0002-9594-3305; Grosse, Wolfgang/0000-0001-9373-0907	Deutsche Forschungsgemeinschaft [ES 152/8-1, KO 1349/14-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (ES 152/8-1 and KO 1349/14-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BEAN RC, 1969, J GEN PHYSIOL, V53, P741, DOI 10.1085/jgp.53.6.741; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BlachlyDyson E, 1997, MOL CELL BIOL, V17, P5727, DOI 10.1128/MCB.17.10.5727; Chen M, 2008, P NATL ACAD SCI USA, V105, P6272, DOI 10.1073/pnas.0711561105; Cheneke BR, 2011, BIOCHEMISTRY-US, V50, P4987, DOI 10.1021/bi200454j; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Colombini M, 1996, Ion Channels, V4, P169; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; DORING C, 1985, J MEMBRANE BIOL, V83, P81, DOI 10.1007/BF01868740; Eddy MT, 2012, J AM CHEM SOC, V134, P6375, DOI 10.1021/ja300347v; Engelhardt H, 2007, J MEMBRANE BIOL, V216, P93, DOI 10.1007/s00232-007-9038-8; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; Gillis KD, 1995, TECHNIQUES MEMBRANE; Gincel D, 2000, J BIOENERG BIOMEMBR, V32, P571, DOI 10.1023/A:1005670527340; Grosse W, 2010, BIOORGAN MED CHEM, V18, P7716, DOI 10.1016/j.bmc.2010.03.044; Hiller S, 2010, TRENDS BIOCH SCI; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Hladky S, 1970, DISCRETENESS CONDUCA; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Krammer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027994; Krasilnikov OV, 1998, J MEMBRANE BIOL, V161, P83; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee KI, 2011, BIOPHYS J, V100, P611, DOI 10.1016/j.bpj.2010.12.3708; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; LYNCH BA, 1991, P NATL ACAD SCI USA, V88, P10402, DOI 10.1073/pnas.88.23.10402; Marques EJ, 2004, BBA-BIOMEMBRANES, V1661, P68, DOI 10.1016/j.bbamem.2003.11.018; McDonald BM, 2009, FEBS LETT, V583, P739, DOI 10.1016/j.febslet.2009.01.039; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; NELSON M, 1992, METHOD ENZYMOL, V216, P279; Papworth C, 1996, STRATEGIES, V9, P4; Pavlov E, 2005, BBA-BIOENERGETICS, V1710, P96, DOI 10.1016/j.bbabio.2005.09.006; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rui HA, 2011, BIOPHYS J, V100, P602, DOI 10.1016/j.bpj.2010.12.3711; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066; Studer A, 2011, BIOSENS BIOELECTRON, V26, P1924, DOI 10.1016/j.bios.2010.06.008; Summers WAT, 2010, BIOCHEM CELL BIOL, V88, P425, DOI [10.1139/O09-115, 10.1139/o09-115]; Teijido O, 2012, J BIOL CHEM; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; Tornroth-Horsefield S, 2008, P NATL ACAD SCI USA, V105, P19565, DOI 10.1073/pnas.0810654106; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zachariae U, 2012, STRUCTURE, V20, P1540, DOI 10.1016/j.str.2012.06.015; ZIZI M, 1995, J MEMBRANE BIOL, V144, P121	57	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47938	10.1371/journal.pone.0047938	http://dx.doi.org/10.1371/journal.pone.0047938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110136	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000310193600038
J	Ndenga, BA; Simbauni, JA; Mbugi, JP; Githeko, AK				Ndenga, Bryson A.; Simbauni, Jemimah A.; Mbugi, Jenard P.; Githeko, Andrew K.			Physical, Chemical and Biological Characteristics in Habitats of High and Low Presence of Anopheline Larvae in Western Kenya Highlands	PLOS ONE			English	Article							CONTROLLING AQUATIC STAGES; DAR-ES-SALAAM; MALARIA VECTORS; SPATIAL-DISTRIBUTION; MICROBIAL LARVICIDES; MOSQUITO LARVAE; WATER BODIES; GAMBIAE S.L.; LAND-COVER; ARABIENSIS	Background: Characteristics of aquatic habitats determine whether mosquitoes will oviposit, hatch, develop, pupate and successfully emerge into adults or not, thus influencing which mosquito species will occupy a habitat. This study determined whether physiochemical and biological characteristics differ between habitats with high and low presence of anopheline larvae. Methods: Physical, chemical and biological characteristics were evaluated in selected habitats twice per month within three highland valleys in western Kenya. Aquatic macro-organisms were sampled using a sweep-net. Colorimetric methods were used to determine levels of iron, phosphate, nitrate, ammonium and nitrite in water samples. Generalized Estimating Equations (GEE) was used to compare parameters between the two categories of anopheline presence. Results: Habitats with high anopheline presence had greater abundance of mosquito aquatic stages and tadpoles and two times more levels of nitrate in water, whereas habitats with low anopheline presence had wider biofilm cover and higher levels of iron in water. Conclusion: Habitats of high and low presence of anopheline larvae, which differed in a number of physical, chemical and biological characteristics, were identified in valleys within western Kenya highlands. Differences in habitat characteristics are critical in determining the number of anopheline larvae that will fully develop and emerge into adults.	[Ndenga, Bryson A.; Simbauni, Jemimah A.; Mbugi, Jenard P.] Kenyatta Univ, Dept Zool Sci, Nairobi, Kenya; [Ndenga, Bryson A.; Githeko, Andrew K.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya	Kenyatta University; Kenya Medical Research Institute	Ndenga, BA (corresponding author), Kenyatta Univ, Dept Zool Sci, Nairobi, Kenya.	bndenga@yahoo.com			World Health Organization (WHO); Valent BioSciences Corporation; commercial source "Valent BioSciences Corporation"	World Health Organization (WHO)(World Health Organization); Valent BioSciences Corporation; commercial source "Valent BioSciences Corporation"	This work was funded by the World Health Organization (WHO) Special Programme for Research and Training in Tropical Diseases (TDR)-Research Training Grant (RTG) and Valent BioSciences Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research study received part of its funding from a commercial source "Valent BioSciences Corporation". The authors declare that they have no competing interest relating to employment, consultancy, patents, and products in development or on the market. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 1987, SUPPLEMENT ANOPHELIN; [Anonymous], 1968, ANOPHELINAE AFR S SA; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241; Carlson JC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-33; Chen H, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-17; Chen H, 2006, AM J TROP MED HYG, V75, P246, DOI 10.4269/ajtmh.2006.75.246; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Edillo FE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-35; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; Gu WD, 2005, AM J TROP MED HYG, V73, P546, DOI 10.4269/ajtmh.2005.73.546; Gu WD, 2008, AM J TROP MED HYG, V78, P2, DOI 10.4269/ajtmh.2008.78.2; Himeidan YE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-234; Howard AFV, 2008, ACTA TROP, V105, P67, DOI 10.1016/j.actatropica.2007.09.010; Huang J, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-87; Impoinvil DE, 2008, J AM MOSQUITO CONTR, V24, P457, DOI 10.2987/5739.1; Jarju LBS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-170; Kankaew Prasan, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1153; Kengluechal Ampornpan, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P46; Killeen GF, 2006, AM J TROP MED HYG, V74, P517, DOI 10.4269/ajtmh.2006.74.517; KRAMER JP, 1964, B WORLD HEALTH ORGAN, V31, P475; Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-128; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Majambere S, 2008, AM J TROP MED HYG, V79, P19, DOI 10.4269/ajtmh.2008.79.19; Marten GG, 1996, J VECTOR ECOL, V21, P122; Minakawa N, 2005, AM J TROP MED HYG, V73, P157, DOI 10.4269/ajtmh.2005.73.157; Minakawa N, 2005, J MED ENTOMOL, V42, P295, DOI 10.1603/0022-2585(2005)042[0295:RBOOAG]2.0.CO;2; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Munga S, 2006, AM J TROP MED HYG, V74, P69, DOI 10.4269/ajtmh.2006.74.69; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Mutuku FM, 2006, AM J TROP MED HYG, V74, P44, DOI 10.4269/ajtmh.2006.74.44; Muturi EJ, 2007, J MED ENTOMOL, V44, P336, DOI 10.1603/0022-2585(2007)44[336:MSSAPF]2.0.CO;2; Mwangangi Joseph M., 2007, Journal of Vector Borne Diseases, V44, P44; Mwangangi JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-114; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Ndenga B, 2011, PLOS ONE, V6, P4; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Omlin FX, 2007, AM J TROP MED HYG, V77, P264, DOI 10.4269/ajtmh.2007.77.264; Robert V, 1998, J MED ENTOMOL, V35, P948, DOI 10.1093/jmedent/35.6.948; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; Shililu J, 2007, AM J TROP MED HYG, V76, P103, DOI 10.4269/ajtmh.2007.76.103; Wotton RS, 2005, BIOSCIENCE, V55, P137, DOI 10.1641/0006-3568(2005)055[0137:SFAOWB]2.0.CO;2	46	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47975	10.1371/journal.pone.0047975	http://dx.doi.org/10.1371/journal.pone.0047975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110145	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600042
J	Wu, ZY; Jiang, HQ; Zhang, L; Xu, X; Zhang, XJ; Kang, ZH; Song, DL; Zhang, J; Guan, M; Gu, YX				Wu, Zhiyuan; Jiang, Hanqiang; Zhang, Lei; Xu, Xiao; Zhang, Xinju; Kang, Zhihua; Song, Donglei; Zhang, Jin; Guan, Ming; Gu, Yuxiang			Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population	PLOS ONE			English	Article							EPIDEMIOLOGIC FEATURES; POLYMORPHISM; PREVALENCE; LINKAGE; JAPAN; EAST	Background: Moyamoya disease (MMD) is an uncommon cerebrovascular disorder characterized by progressive occlusion of the internal carotid artery causing cerebral ischemia and hemorrhage. Genetic factors in the etiology and pathogenesis of MMD are being increasingly recognized. Previous studies have shown that the RNF213 gene was related to MMD susceptibility in the Japanese population. However, there is no large scale study of the association between this gene and MMD in the Chinese Han population. Thus we designed this case-control study to validate the R4810K mutation and to define the further spectrum of RNF213 mutations in Han Chinese. Methodology/Principal Findings: Genotyping of the R4810K mutation in the RNF213 gene was performed in 170 MMD cases and 507 controls from a Chinese Han population. The R4810K mutation was identified in 22 of 170 MMD cases (13%), including 21 heterozygotes and a single familial homozygote. Two of the 507 controls (0.4%) were heterozygous R4810K carriers. The R4810K mutation greatly increased the risk for MMD (OR = 36.7, 95% CI: 8.6 similar to 156.6, P = 6.1 E-15). The allele frequency of R4810K was significantly different between patients with ischemia and hemorrhage (OR = 5.4, 95% CI: 1.8 similar to 16.1, P = 0.001). Genomic sequencing covering RNF213 exon 40 to exon 68 also identified eight other non-R4810K variants; P4007R, Q4367L, A4399T, T4586P, L4631V, E4950D, A5021V and M5136I. Among them A4399T polymorphism was found in 28/170 cases (16.5%) and 45/507 controls (8.9%) and was associated with MMD (OR = 2.0, 95% CI: 1.2 similar to 3.3, P = 0.004), especially with hemorrhage (OR = 2.8, 95% CI: 1.2 similar to 6.5, P = 0.014). Conclusions: RNF213 mutations are associated with MMD susceptibility in Han Chinese. The ischemic type MMD is particularly related to the R4810K mutation. However, A4399T is also a susceptible variant for MMD, primarily associated with hemorrhage. Identification of novel variants in the RNF213 gene further highlights the genetic heterogeneity of MMD.	[Wu, Zhiyuan; Kang, Zhihua; Guan, Ming] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China; [Jiang, Hanqiang; Song, Donglei; Gu, Yuxiang] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Zhang, Lei] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Equipment, Shanghai 200433, Peoples R China; [Xu, Xiao; Zhang, Xinju; Guan, Ming] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Cent Lab, Shanghai 200433, Peoples R China; [Zhang, Jin] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Nursing, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Guan, M (corresponding author), Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China.	guanming88@yahoo.com; guyuxiang1972@yahoo.com.cn	gu, yu/GSD-4507-2022; Kang, Zhihua/AAE-8175-2020	KANG, ZHIHUA/0000-0001-8153-8846				Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Fukui M, 2000, NEUROPATHOLOGY, V20, pS61, DOI 10.1046/j.1440-1789.2000.00300.x; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Hung CC, 1997, CLIN NEUROL NEUROSUR, V99, pS23, DOI 10.1016/S0303-8467(97)00036-X; Ibrahimi DM, 2010, CHILD NERV SYST, P1; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Janda P, 2009, J AM OSTEOPATH ASS, V109; Jea A, 2005, PEDIATRICS, V116, pE694, DOI 10.1542/peds.2005-0568; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Liu WY, 2012, NEUROL MED-CHIR, V52, P299, DOI 10.2176/nmc.52.299; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Liu Wanyang, 2010, Environmental Health and Preventive Medicine, V15, P94, DOI 10.1007/s12199-009-0116-7; Miao W, 2010, CLIN NEUROL NEUROSUR, V112, P199, DOI 10.1016/j.clineuro.2009.11.009; Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Roder C, 2010, ACTA NEUROCHIR, P1; Roder C, 2010, J HUM GENET, V55, P711, DOI 10.1038/jhg.2010.103; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Scott RM, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS.APR09.INTRO; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Seol HJ, 2006, CHILD NERV SYST, V22, P1143, DOI 10.1007/s00381-006-0089-4; Smith ER, 2010, NEUROSURG CLIN N AM, V21, P543, DOI 10.1016/j.nec.2010.03.007; Uchino K, 2005, NEUROLOGY, V65, P956, DOI 10.1212/01.wnl.0000176066.33797.82; Wakai K, 1997, CLIN NEUROL NEUROSUR, V99, pS1, DOI 10.1016/S0303-8467(97)00031-0; Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930	28	89	100	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e48179	10.1371/journal.pone.0048179	http://dx.doi.org/10.1371/journal.pone.0048179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110205	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600051
J	Ganner, T; Bubner, P; Eibinger, M; Mayrhofer, C; Plank, H; Nidetzky, B				Ganner, Thomas; Bubner, Patricia; Eibinger, Manuel; Mayrhofer, Claudia; Plank, Harald; Nidetzky, Bernd			Dissecting and Reconstructing Synergism IN SITU VISUALIZATION OF COOPERATIVITY AMONG CELLULASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; CRYSTALLINE CELLULOSE; ENZYMATIC-HYDROLYSIS; CELLOBIOHYDROLASE-I; ENDOGLUCANASE-I; CATALYTIC CORE; ENZYMES; SUBSTRATE; BIOFUELS; LONGIBRACHIATUM	Cellulose is the most abundant biopolymer and a major reservoir of fixed carbon on earth. Comprehension of the elusive mechanism of its enzymatic degradation represents a fundamental problem at the interface of biology, biotechnology, and materials science. The interdependence of cellulose disintegration and hydrolysis and the synergistic interplay among cellulases is yet poorly understood. Here we report evidence from in situ atomic force microscopy (AFM) that delineates degradation of a polymorphic cellulose substrate as a dynamic cycle of alternating exposure and removal of crystalline fibers. Direct observation shows that chain-end-cleaving cellobiohydrolases (CBH I, CBH II) and an internally chain-cleaving endoglucanase (EG), the major components of cellulase systems, take on distinct roles: EG and CBH II make the cellulose surface accessible for CBH I by removing amorphous-unordered substrate areas, thus exposing otherwise embedded crystalline-ordered nanofibrils of the cellulose. Subsequently, these fibrils are degraded efficiently by CBH I, thereby uncovering new amorphous areas. Without prior action of EG and CBH II, CBH I was poorly active on the cellulosic substrate. This leads to the conclusion that synergism among cellulases is morphology-dependent and governed by the cooperativity between enzymes degrading amorphous regions and those targeting primarily crystalline regions. The surface-disrupting activity of cellulases therefore strongly depends on mesoscopic structural features of the substrate: size and packing of crystalline fibers are key determinants of the overall efficiency of cellulose degradation.	[Ganner, Thomas; Plank, Harald] Graz Univ Technol, Inst Electron Microscopy & Fine Struct Res, A-8010 Graz, Austria; [Ganner, Thomas; Mayrhofer, Claudia; Plank, Harald] Ctr Electron Microscopy, A-8010 Graz, Austria; [Bubner, Patricia; Eibinger, Manuel; Nidetzky, Bernd] Graz Univ Technol, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria	Graz University of Technology; Graz University of Technology	Plank, H (corresponding author), Graz Univ Technol, Inst Electron Microscopy & Fine Struct Res, Steyrergasse 17, A-8010 Graz, Austria.	harald.plank@felmi-zfe.at; bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643	Austrian Science Fund FWF [P 24156-B21]	Austrian Science Fund FWF(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (Grant P 24156-B21, to B. N.).	Bansal P, 2012, BIORESOURCE TECHNOL, V107, P243, DOI 10.1016/j.biortech.2011.12.063; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Becker D, 2001, BIOCHEM J, V356, P19, DOI 10.1042/0264-6021:3560019; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bubner P, 2012, J BIOL CHEM, V287, P2759, DOI 10.1074/jbc.M111.257717; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Druzhinina IS, 2012, FUNGAL GENET BIOL, V49, P358, DOI 10.1016/j.fgb.2012.02.004; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; GOYAL A, 1991, BIORESOURCE TECHNOL, V36, P37, DOI 10.1016/0960-8524(91)90098-5; Graham-Rowe D, 2011, NATURE, V474, pS6, DOI 10.1038/474S06a; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hu JG, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-36; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jarvis M, 2003, NATURE, V426, P611, DOI 10.1038/426611a; Josefsson P, 2008, BIOMACROMOLECULES, V9, P249, DOI 10.1021/bm700980b; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koivula A, 1996, PROTEIN ENG, V9, P691, DOI 10.1093/protein/9.8.691; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Kubicek CP, 1996, FUNGAL GENET BIOL, V20, P105, DOI 10.1006/fgbi.1996.0025; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Levine SE, 2010, BIOTECHNOL BIOENG, V107, P37, DOI 10.1002/bit.22789; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mansfield SD, 1999, BIOTECHNOL PROGR, V15, P804, DOI 10.1021/bp9900864; Marx MC, 2001, SOIL BIOL BIOCHEM, V33, P1633, DOI 10.1016/S0038-0717(01)00079-7; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; NIDETZKY B, 1994, BIOCHEM J, V298, P705, DOI 10.1042/bj2980705; NIEVES RA, 1991, APPL ENVIRON MICROB, V57, P3163, DOI 10.1128/AEM.57.11.3163-3170.1991; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Sturcova A, 2004, BIOMACROMOLECULES, V5, P1333, DOI 10.1021/bm034517p; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Wang JP, 2012, LANGMUIR, V28, P9664, DOI 10.1021/la301030f; Yang B, 2006, BIOTECHNOL BIOENG, V94, P1122, DOI 10.1002/bit.20942; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhou W, 2010, BIOTECHNOL BIOENG, V107, P224, DOI 10.1002/bit.22814	48	58	59	2	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43215	43222		10.1074/jbc.M112.419952	http://dx.doi.org/10.1074/jbc.M112.419952			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118223	Green Published, hybrid			2022-12-25	WOS:000312940800003
J	Gabrielli, N; Ayte, J; Hidalgo, E				Gabrielli, Natalia; Ayte, Jose; Hidalgo, Elena			Cells Lacking Pfh1, a Fission Yeast Homolog of Mammalian Frataxin Protein, Display Constitutive Activation of the Iron Starvation Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING FACTOR PHP4; FRIEDREICHS-ATAXIA; OXIDATIVE STRESS; GENE-EXPRESSION; DEFICIENCY; PAP1; ACCUMULATION; ACONITASE; FEP1; CARDIOMYOPATHY	Friedreich ataxia is a genetic disease caused by deficiencies in frataxin. This protein has homologs not only in higher eukaryotes but also in bacteria, fungi, and plants. The function of this protein is still controversial. We have identified a frataxin homolog in fission yeast, and we have analyzed whether its depletion leads to any of the phenotypes observed in other organisms. Cells deleted in pfh1 are sensitive to growth under aerobic conditions, display increased levels of total iron, hallmarks of oxidative stress such as protein carbonylation, decreased aconitase activity, and lower levels of oxygen consumption compared with wild-type cells. This mitochondrial protein seems to be important for iron and/or reactive oxygen species homeostasis. We have analyzed the proteome of cells devoid of Pfh1, and we determined that gene products up-and down-regulated upon iron depletion in wild-type cells are constitutively misregulated in this mutant. Because of the particular signaling pathway components governing the iron starvation response in fission yeast, our experiments suggest that cells lacking Pfh1 display a decrease of cytosolic available iron that triggers activation of Grx4, the common regulator of the iron starvation gene expression program. Our Schizosaccharomyces pombe Delta pfh1 strain constitutes a new and useful model system to study Friedreich ataxia.	[Gabrielli, Natalia; Ayte, Jose; Hidalgo, Elena] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Dept Ciencies Expt & Salut, Barcelona 08003, Spain	Pompeu Fabra University	Hidalgo, E (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Dept Ciencies Expt & Salut, C Dr Aiguader 88, Barcelona 08003, Spain.	elena.hidalgo@upf.edu	Hidalgo, Elena/K-2919-2014; Ayte, Jose/L-5217-2014	Hidalgo, Elena/0000-0002-3768-6785; Ayte, Jose/0000-0002-6354-0536	Spanish Ministry of Science and Innovation [BFU2009-06933, BFU2012-32045]; PLAN E; FEDER; Spanish Program Consolider-Ingenio [CSD 2007-0020]; Generalitat de Catalunya (Spain) [SGR2009-196]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PLAN E; FEDER(European Commission); Spanish Program Consolider-Ingenio; Generalitat de Catalunya (Spain)(Generalitat de Catalunya)	This work was supported in part by Spanish Ministry of Science and Innovation Grants BFU2009-06933 and BFU2012-32045, PLAN E, FEDER, by Spanish Program Consolider-Ingenio 2010 Grant CSD 2007-0020, and by Generalitat de Catalunya (Spain) Grant SGR2009-196 (to E. H.).	Alfa C, 1993, EXPT FISSION YEAST L; Armstrong JS, 2010, FASEB J, V24, P2152, DOI 10.1096/fj.09-143222; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Calvo IA, 2012, NUCLEIC ACIDS RES, V40, P4816, DOI 10.1093/nar/gks141; Calvo IA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006619; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castillo EA, 2003, J BIOL CHEM, V278, P40565, DOI 10.1074/jbc.M305859200; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Garcia-Santamarina S, 2011, J PROTEOMICS, V74, P2476, DOI 10.1016/j.jprot.2011.05.030; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Leupold U., 1970, METHODS CELL PHYSL, V4, P169; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Puccio H, 2000, HUM MOL GENET, V9, P887, DOI 10.1093/hmg/9.6.887; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	52	15	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43042	43051		10.1074/jbc.M112.421735	http://dx.doi.org/10.1074/jbc.M112.421735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23115244	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000312501600060
J	Alkharfy, KM; Al-Daghri, NM; Vanhoutte, PM; Krishnaswamy, S; Xu, AM				Alkharfy, Khalid M.; Al-Daghri, Nasser M.; Vanhoutte, Paul M.; Krishnaswamy, Soundararajan; Xu, Aimin			Serum Retinol-Binding Protein 4 as a Marker for Cardiovascular Disease in Women	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; INSULIN-RESISTANCE; PLASMA BIOMARKER; LDL-CHOLESTEROL; ADIPOSE-TISSUE; RISK-FACTORS; ADIPOCYTE; OBESITY; ASSOCIATION	Background: Elevated serum level of retinol-binding protein 4 (RBP4) has been associated with obesity-related comorbidities including insulin resistance, dyslipidemia and hypertension. Objectives: The present study examined the relationship between serum level of RBP4 and various risk factors related to cardiovascular disease (CVD) in men and women. Methods: 284 subjects (139 males, 145 females), grouped into healthy (n = 60), obese diabetes (n = 60), non-obese diabetes (n = 60), obese non-diabetes (n = 60) and patients with CVD (n = 44), were assessed for anthropometric and biochemical parameters related to obesity, diabetes and CVD. In addition, serum levels of several adipokines, including fatty acid binding protein 4 (FABP4) and lipocalin 2 (LCN2) and RBP4 were measured using specific immunoassays. Results: Serum RBP4 level correlated significantly with principal component derived from known risk factors of CVD (beta = 0.20+/-0.06, P = 0.002). Significance of this correlation was limited to women (beta = 0.20+/-0.06, P = 0.002) and it persisted even after adjusting for BMI (beta = 0.1960.06, P = 0.002). Overall (n = 284) serum RBP4 values significantly correlated with FABP4 (R = 0.19, p = 0.001). Serum FABP4 level of CVD subjects was significantly higher than healthy control (P = 0.001) and non-obese diabetes (P = 0.04) groups, but this difference was attributable to differences in BMI. Serum LCN2 level correlated well with RBP4 (R = 0.15, P = 0.008) and FABP4 (R = 0.36, P<0.001), but did not differ significantly between CVD and other groups. Conclusions: Results of this study indicate a significant correlation between serum RBP4 and various established risk factors for CVD and suggest RBP4 may serve as an independent predictor of CVD in women.	[Alkharfy, Khalid M.] King Saud Univ, Dept Clin Pharm, Coll Pharm, Riyadh, Saudi Arabia; [Al-Daghri, Nasser M.] King Saud Univ, Coll Sci, Dept Biochem, Riyadh 11451, Saudi Arabia; [Alkharfy, Khalid M.; Al-Daghri, Nasser M.; Krishnaswamy, Soundararajan] King Saud Univ, Coll Sci, Biomarkers Res Program, Riyadh 11451, Saudi Arabia; [Vanhoutte, Paul M.; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Med, Fac Med, Hong Kong, Hong Kong, Peoples R China	King Saud University; King Saud University; King Saud University; University of Hong Kong; University of Hong Kong	Alkharfy, KM (corresponding author), King Saud Univ, Dept Clin Pharm, Coll Pharm, Riyadh, Saudi Arabia.	alkharfy@ksu.edu.sa	Xu, Aimin/D-3291-2013; Al-Daghri, Nasser/G-7736-2011; Al-Daghri, Nasser/A-8360-2011	Xu, Aimin/0000-0002-0668-033X; Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725	Distinguished Professor Fellowship Program, King Saud University, Riyadh, Saudi Arabia	Distinguished Professor Fellowship Program, King Saud University, Riyadh, Saudi Arabia	This study was supported by a grant from Distinguished Professor Fellowship Program, King Saud University, Riyadh, Saudi Arabia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbustini E, 1999, AM HEART J, V138, pS55, DOI 10.1016/S0002-8703(99)70321-2; Broch M, 2010, PHYSIOL RES, V59, P299, DOI 10.33549/physiolres.931714; Cabre A, 2007, J INTERN MED, V262, P496, DOI 10.1111/j.1365-2796.2007.01849.x; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Daniels LB, 2012, J AM COLL CARDIOL, V59, P1101, DOI 10.1016/j.jacc.2011.11.046; Everett CJ, 2005, AM J CARDIOL, V95, P986, DOI 10.1016/j.amjcard.2004.12.043; Friebe D, 2011, INT J PEDIATR OBES, V6, pE345, DOI 10.3109/17477166.2010.491228; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Hillier TA, 2006, DIABETOLOGIA, V49, P1528, DOI 10.1007/s00125-006-0266-8; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hsu BG, 2010, CIRC J, V74, P327, DOI 10.1253/circj.CJ-09-0568; Hsu FC, 2009, J GERONTOL A-BIOL, V64, P581, DOI 10.1093/gerona/glp005; Huang G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-52; Ingelsson E, 2009, ATHEROSCLEROSIS, V206, P239, DOI 10.1016/j.atherosclerosis.2009.02.029; Johnson R, 1997, CLIN CHEM, V43, P2183; Kazemi MR, 2005, ARTERIOSCL THROM VAS, V25, P1220, DOI 10.1161/01.ATV.0000159163.52632.1b; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kos K, 2011, CLIN ENDOCRINOL, V74, P197, DOI 10.1111/j.1365-2265.2010.03892.x; Lee JW, 2007, OBESITY, V15, P2225, DOI 10.1038/oby.2007.264; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Miyoshi T, 2010, ATHEROSCLEROSIS, V211, P164, DOI 10.1016/j.atherosclerosis.2010.01.032; Mohlig M, 2007, EUR J ENDOCRINOL, V157, P195, DOI 10.1530/EJE-07-0102; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; Rhee EJ, 2009, EUR J ENDOCRINOL, V160, P165, DOI 10.1530/EJE-08-0665; Stejskal D, 2006, EUR J CLIN INVEST, V36, P621, DOI 10.1111/j.1365-2362.2006.01696.x; Tso AWK, 2011, NEUROLOGY, V76, P1968, DOI 10.1212/WNL.0b013e31821e54b3; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Villablanca AC, 2010, CLIN SCI, V119, P493, DOI 10.1042/CS20100248; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wu J, 2012, CLIN BIOCHEM, V45, P619, DOI 10.1016/j.clinbiochem.2012.02.022; Xiang YF, 2011, DIABETES CARE, V34, P1639, DOI 10.2337/dc11-0039; Xiao Yang, 2010, Zhonghua Yi Xue Za Zhi, V90, P231; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yeung DCY, 2009, DIABETES CARE, V32, P132, DOI 10.2337/dc08-1333; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	38	36	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48612	10.1371/journal.pone.0048612	http://dx.doi.org/10.1371/journal.pone.0048612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119072	Green Published, gold			2022-12-25	WOS:000310600500181
J	Ban, YH; Tang, M; Chen, H; Xu, ZY; Zhang, HH; Yang, YR				Ban, Yihui; Tang, Ming; Chen, Hui; Xu, Zhouying; Zhang, Haihan; Yang, Yurong			The Response of Dark Septate Endophytes (DSE) to Heavy Metals in Pure Culture	PLOS ONE			English	Article							WOOD-ROTTING FUNGI; ROOTS; TOLERANCE; GROWTH; COPPER; CADMIUM; ACCUMULATION; MYCORRHIZAL; GLUTATHIONE; STRESS	Dark septate endophytes (DSE) occur widely in association with plants exposed to heavy metal stress. However, little is known about the response of DSE exposed to heavy metals. In this study, five DSE were isolated from the roots of Astragalus adsurgens Pall. seedlings growing on lead-zinc mine tailings in China. Based on morphological characteristics and DNA sequence analyses, the isolates were identified as Gaeumannomyces cylindrosporus, Paraphoma chrysanthemicola, Phialophora mustea, Exophiala salmonis, and Cladosporium cladosporioides. G. cylindrosporus was selected to explore responses to Pb stress. Scanning electron microscopic observations of G. cylindrosporus grown on solid medium revealed curling of hyphae and formation of hyphal coils in response to Pb. In contrast, in liquid medium, hyphae became thick and swollen with an increase in Pb (II) concentration. We interpret that these changes are related to the variation in cell wall components. We also demonstrated that fungal melanin content increased with the addition of Pb(II). Melanin, as an important component in the cell wall, is known to be an essential antioxidant responsible for decreasing heavy metal toxicity. We also measured the total soluble protein content and glutathione (GSH) concentrations in G. cylindrosporus and found that they initially increased and then decreased with the increase of Pb(II) concentrations. The antioxidant enzyme activities were also examined, and the results showed that superoxide dismutase (SOD) activity was significantly positively correlated with Pb(II) concentrations (r = 0.957, P < 0.001). Collectively, our observations indicate that the intracellular antioxidant systems, especially fungal melanin, play an important role in abating the hazards of heavy metals.	[Ban, Yihui; Xu, Zhouying] NW A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Tang, Ming; Chen, Hui; Yang, Yurong] NW A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Zhang, Haihan] Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian, Shannxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Xi'an University of Architecture & Technology	Tang, M (corresponding author), NW A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	tangm@nwsuaf.edu.cn		Tang, Ming/0000-0002-8158-6300	National Natural Science Foundation of China [31170607, 31170567]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1035]; PhD Programs Foundation of Education Ministry of China [20100204110033, 20110204130001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); PhD Programs Foundation of Education Ministry of China	This research was supported by the National Natural Science Foundation of China (31170607, 31170567), Program for Changjiang Scholars and Innovative Research Team in University of China (IRT1035) and the PhD Programs Foundation of Education Ministry of China (20100204110033, 20110204130001), http:// www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addy HD, 2005, CAN J BOT, V83, P1, DOI [10.1139/B04-171, 10.1139/b04-171]; Aebi H., 1983, METHOD ENZYMAT AN, P276, DOI DOI 10.1016/J.REPROTOX.2005.05.003; Ahlich K, 1996, NEW PHYTOL, V132, P259, DOI 10.1111/j.1469-8137.1996.tb01845.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; ASHIDA J, 1963, PROTOPLASMA, V57, P27, DOI 10.1007/BF01252044; Bai ZH, 2003, CRIT REV BIOTECHNOL, V23, P267, DOI 10.1080/07388550390449294; Bai ZH, 2003, BIOTECHNOL BIOENG, V82, P691, DOI 10.1002/bit.10614; Baldrian P, 2003, ENZYME MICROB TECH, V32, P78, DOI 10.1016/S0141-0229(02)00245-4; Barrow JR, 2001, MYCORRHIZA, V11, P199, DOI 10.1007/s005720100111; BRUENGER FW, 1967, RADIAT RES, V32, P1, DOI 10.2307/3572300; Canovas D, 2004, J BIOL CHEM, V279, P51234, DOI 10.1074/jbc.M408622200; Carrillo-Gonzalez R, 2012, BIOL TRACE ELEM RES, V146, P388, DOI 10.1007/s12011-011-9267-7; Collin-Hansen C, 2005, MYCOLOGIA, V97, P973, DOI 10.3852/mycologia.97.5.973; Deram A, 2008, SOIL BIOL BIOCHEM, V40, P845, DOI 10.1016/j.soilbio.2007.09.023; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; DURAK I, 1993, CLIN CHIM ACTA, V214, P103, DOI 10.1016/0009-8981(93)90307-P; ELLIS DH, 1974, CAN J MICROBIOL, V20, P1379, DOI 10.1139/m74-212; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fogarty RV, 1996, ENZYME MICROB TECH, V19, P311, DOI 10.1016/0141-0229(96)00002-6; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; GADD GM, 1984, T BRIT MYCOL SOC, V82, P546, DOI 10.1016/S0007-1536(84)80021-2; Gadd GM, 2001, FEMS MICROBIOL LETT, V204, P311, DOI 10.1016/S0378-1097(01)00399-8; Gallego SM, 1996, PLANT SCI, V121, P151, DOI 10.1016/S0168-9452(96)04528-1; Granero S, 2002, ENVIRON INT, V28, P159, DOI 10.1016/S0160-4120(02)00024-7; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Guillen Y, 2008, WORLD J MICROB BIOT, V24, P31, DOI 10.1007/s11274-007-9434-3; Halliwell B., 2007, FREE RADICALS BIOL M; Hartley J, 1997, PLANT SOIL, V189, P303, DOI 10.1023/A:1004255006170; Hegedus N, 2007, WORLD J MICROB BIOT, V23, P1339, DOI 10.1007/s11274-007-9368-9; Hou WH, 2007, PLANT PHYSIOL BIOCH, V45, P62, DOI 10.1016/j.plaphy.2006.12.005; Huang DL, 2010, CHEMOSPHERE, V81, P1091, DOI 10.1016/j.chemosphere.2010.09.029; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 2001, MYCORRHIZA, V11, P207, DOI 10.1007/s005720100112; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Lanfranco L, 2002, EUR J HISTOCHEM, V46, P341; [李芳 Li Fang], 2003, [环境科学学报, Acta Scientiae Circumstantiae], V23, P807; Li HY, 2012, FUNGAL ECOL, V5, P309, DOI 10.1016/j.funeco.2011.06.002; Likar M, 2009, SCI TOTAL ENVIRON, V407, P6179, DOI 10.1016/j.scitotenv.2009.08.045; LILLY WW, 1992, MICROBIOS, V72, P227; Machuca A, 2001, WORLD J MICROB BIOT, V17, P687, DOI 10.1023/A:1012929112523; Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001; Mandyam K, 2005, STUD MYCOL, P173; MARX DH, 1969, PHYTOPATHOLOGY, V59, P153; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MORSELT AFW, 1986, PLANT SOIL, V96, P417, DOI 10.1007/BF02375146; Ott T, 2002, FEMS MICROBIOL ECOL, V42, P359, DOI 10.1111/j.1574-6941.2002.tb01025.x; Pervez A, 2009, WORLD APPL SCI J, V7, P1498; Pocsi I, 2004, ADV MICROB PHYSIOL, V49, P1, DOI 10.1016/S0065-2911(04)49001-8; Regvar M, 2010, PLANT SOIL, V330, P345, DOI 10.1007/s11104-009-0207-7; Ruttens A, 2006, ENVIRON POLLUT, V144, P524, DOI 10.1016/j.envpol.2006.01.038; SAIZJIMENEZ C, 1984, CURR MICROBIOL, V10, P281, DOI 10.1007/BF01577142; Selosse MA, 2004, CR BIOL, V327, P639, DOI 10.1016/j.crvi.2003.12.008; Singh RP, 1997, CHEMOSPHERE, V34, P2467, DOI 10.1016/S0045-6535(97)00087-8; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todorova D, 2008, J APPL MICROBIOL, V104, P178, DOI 10.1111/j.1365-2672.2007.03538.x; Valix M, 2001, MINER ENG, V14, P499, DOI 10.1016/S0892-6875(01)00037-1; VIARENGO A, 1993, COMP BIOCHEM PHYS C, V104, P355, DOI 10.1016/0742-8413(93)90001-2; WESSELS JGH, 1986, INT REV CYTOL, V104, P37, DOI 10.1016/S0074-7696(08)61923-3; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wu LQ, 2008, MYCORRHIZA, V18, P79, DOI 10.1007/s00572-007-0159-9; Yuan ZL, 2011, PLANT BIOSYST, V145, P495, DOI 10.1080/11263504.2010.544863; Zhan FD, 2011, WORLD J MICROB BIOT, V27, P2483, DOI 10.1007/s11274-011-0712-8; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhang HH, 2012, J MICROBIOL, V50, P91, DOI 10.1007/s12275-012-1159-9; Zhang YJ, 2008, J MICROBIOL, V46, P624, DOI 10.1007/s12275-008-0163-6	69	60	79	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47968	10.1371/journal.pone.0047968	http://dx.doi.org/10.1371/journal.pone.0047968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118914	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500050
J	Chemes, LB; Glavina, J; Alonso, LG; Marino-Buslje, C; Gay, GD; Sanchez, IE				Chemes, Lucia B.; Glavina, Juliana; Alonso, Leonardo G.; Marino-Buslje, Cristina; de Prat Gay, Gonzalo; Sanchez, Ignacio E.			Sequence Evolution of the Intrinsically Disordered and Globular Domains of a Model Viral Oncoprotein	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS E7; RETINOBLASTOMA TUMOR-SUPPRESSOR; MUTUAL INFORMATION; PHD FINGER; PROTEIN; PHOSPHORYLATION; BINDING; RECOGNITION; MECHANISM; IDENTIFICATION	In the present work, we have used the papillomavirus E7 oncoprotein to pursue structure-function and evolutionary studies that take into account intrinsic disorder and the conformational diversity of globular domains. The intrinsically disordered (E7N) and globular (E7C) domains of E7 show similar degrees of conservation and co-evolution. We found that E7N can be described in terms of conserved and coevolving linear motifs separated by variable linkers, while sequence evolution of E7C is compatible with the known homodimeric structure yet suggests other activities for the domain. Within E7N, inter-residue relationships such as residue co-evolution and restricted intermotif distances map functional coupling and co-occurrence of linear motifs that evolve in a coordinate manner. Within E7C, additional cysteine residues proximal to the zinc-binding site may allow redox regulation of E7 function. Moreover, we describe a conserved binding site for disordered domains on the surface of E7C and suggest a putative target linear motif. Both homodimerization and peptide binding activities of E7C are also present in the distantly related host PHD domains, showing that these two proteins share not only structural homology but also functional similarities, and strengthening the view that they evolved from a common ancestor. Finally, we integrate the multiple activities and conformations of E7 into a hierarchy of structure-function relationships.	[Chemes, Lucia B.; Alonso, Leonardo G.; de Prat Gay, Gonzalo] Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina; [Chemes, Lucia B.; Alonso, Leonardo G.; Marino-Buslje, Cristina; de Prat Gay, Gonzalo] IIBBA CONICET, Buenos Aires, DF, Argentina; [Glavina, Juliana; Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Prot Physiol Lab, Buenos Aires, DF, Argentina; [Marino-Buslje, Cristina] Fdn Inst Leloir, Struct Bioinformat Lab, Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Leloir Institute	Gay, GD (corresponding author), Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina.	gpg@leloir.org.ar; isanchez@qb.fcen.uba.ar	Marino-Buslje, Cristina/J-7438-2019	Marino-Buslje, Cristina/0000-0002-6564-1920; Prat Gay, Gonzalo/0000-0001-5748-6863; Glavina, Juliana/0000-0001-6336-1290; Chemes, Lucia Beatriz/0000-0003-0192-9906; Sanchez, Ignacio Enrique/0000-0003-4284-9013; Alonso, Leonardo Gabriel/0000-0002-0596-703X	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-1052]; Instituto Nacional de Cancer [2012-2014]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional del Cancer	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Instituto Nacional de Cancer; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Instituto Nacional del Cancer	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-1052) (http://www.agencia.gov.ar) and by Instituto Nacional de Cancer (Basic Research Grant 2012-2014). LBC holds a postodctoral fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). LGA, CMB, GDPG and IES are career researchers from CONICET. JG holds a graduate fellowship from Instituto Nacional del Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LG, 2006, BIOCHEMISTRY-US, V45, P657, DOI 10.1021/bi0522549; Alonso LG, 2004, BIOCHEMISTRY-US, V43, P3310, DOI 10.1021/bi036037o; Alonso LG, 2002, BIOCHEMISTRY-US, V41, P10510, DOI 10.1021/bi025579n; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Brehm A, 1999, EMBO J, V18, P2449, DOI 10.1093/emboj/18.9.2449; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Chemes L. B., 2011, FLEXIBLE VIRUSES STR, V1, P313; Chemes LB, 2012, J MOL BIOL; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Chica C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006052; Clements A, 2000, BIOCHEMISTRY-US, V39, P16033, DOI 10.1021/bi002111g; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022427; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Daughdrill GW, 2007, J MOL EVOL, V65, P277, DOI 10.1007/s00239-007-9011-2; Davey N. E., 2011, MOL BIOSYST; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; de Souza RF, 2010, BBA-GENE REGUL MECH, V1799, P302, DOI 10.1016/j.bbagrm.2009.10.006; Dong WL, 2001, J VIROL METHODS, V98, P91, DOI 10.1016/S0166-0934(01)00361-5; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; FIRZLAFF J M, 1989, New Biologist, V1, P44; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Herbst LH, 2009, VIROLOGY, V383, P131, DOI 10.1016/j.virol.2008.09.022; Jeong CS, 2012, BIOCOMPUT-PAC SYM, P140; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Liang YJ, 2008, INT J BIOCHEM CELL B, V40, P2431, DOI 10.1016/j.biocel.2008.04.003; Lichtarge O, 2010, CURR OPIN STRUC BIOL, V20, P351, DOI 10.1016/j.sbi.2010.04.002; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Miller TCR, 2010, J MOL BIOL, V401, P969, DOI 10.1016/j.jmb.2010.07.007; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Nakamura Y, 2007, J MOL BIOL, V370, P80, DOI 10.1016/j.jmb.2007.04.037; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Ohlenschlager O, 2006, ONCOGENE, V25, P5953, DOI 10.1038/sj.onc.1209584; Penrose KJ, 2004, J BIOL CHEM, V279, P22430, DOI 10.1074/jbc.M314340200; Radusky LG, 2011, FUNCTIONAL MOTIF SEA; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Singh M, 2005, J BIOL CHEM, V280, P37868, DOI 10.1074/jbc.M504877200; Smal C, 2009, BIOCHEMISTRY-US, V48, P11939, DOI 10.1021/bi901415k; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Suhrer SJ, 2009, NUCLEIC ACIDS RES, V37, pW539, DOI 10.1093/nar/gkp411; Szalkowski AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020488; Terai M, 2002, J VIROL, V76, P10020, DOI 10.1128/JVI.76.19.10020-10023.2002; Thompson JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018093; Todorovic B, 2011, J VIROL, V85, P10048, DOI 10.1128/JVI.00643-11; Tomaic V, 2009, ONCOGENE, V28, P1, DOI 10.1038/onc.2008.365; Tomita Y, 2007, VIRUS GENES, V35, P243, DOI 10.1007/s11262-006-0055-y; Toth-Petroczy A, 2008, OPEN PROTEOM J, V1, P46, DOI [10.2174/1875039700801010046, DOI 10.2174/1875039700801010046]; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016	62	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47661	10.1371/journal.pone.0047661	http://dx.doi.org/10.1371/journal.pone.0047661			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118886	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500029
J	Marino, JS; Iler, J; Dowling, AR; Chua, S; Bruning, JC; Coppari, R; Hill, JW				Marino, Joseph S.; Iler, Jeffrey; Dowling, Abigail R.; Chua, Streamson; Bruning, Jens C.; Coppari, Roberto; Hill, Jennifer W.			Adipocyte Dysfunction in a Mouse Model of Polycystic Ovary Syndrome (PCOS): Evidence of Adipocyte Hypertrophy and Tissue-Specific Inflammation	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; NECROSIS-FACTOR-ALPHA; THECA-INTERSTITIAL CELLS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FAT DISTRIBUTION; KAPPA-B; DIABETES-MELLITUS; POMC NEURONS; VISCERAL FAT	Clinical research shows an association between polycystic ovary syndrome (PCOS) and chronic inflammation, a pathological state thought to contribute to insulin resistance. The underlying pathways, however, have not been defined. The purpose of this study was to characterize the inflammatory state of a novel mouse model of PCOS. Female mice lacking leptin and insulin receptors in pro-opiomelanocortin neurons (IR/LepR(POMC) mice) and littermate controls were evaluated for estrous cyclicity, ovarian and adipose tissue morphology, and body composition by QMR and CT scan. Tissue-specific macrophage infiltration and cytokine mRNA expression were measured, as well as circulating cytokine levels. Finally, glucose regulation during pregnancy was evaluated as a measure of risk for diabetes development. Forty-five percent of IR/LepR(POMC) mice showed reduced or absent ovulation. IR/LepR(POMC) mice also had increased fat mass and adipocyte hypertrophy. These traits accompanied elevations in macrophage accumulation and inflammatory cytokine production in perigonadal adipose tissue, liver, and ovary. These mice also exhibited gestational hyperglycemia as predicted. This report is the first to show the presence of inflammation in IR/LepR(POMC) mice, which develop a PCOS-like phenotype. Thus, IR/LepR(POMC) mice may serve as a new mouse model to clarify the involvement of adipose and liver tissue in the pathogenesis and etiology of PCOS, allowing more targeted research on the development of PCOS and potential therapeutic interventions.	[Marino, Joseph S.; Iler, Jeffrey; Dowling, Abigail R.; Hill, Jennifer W.] Univ Toledo, Med Ctr, Ctr Diabet & Endocrine Res, Dept Physiol & Pharmacol, Toledo, OH 43606 USA; [Hill, Jennifer W.] Univ Toledo, Med Ctr, Dept Obstet Gynecol, Toledo, OH 43606 USA; [Chua, Streamson] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Chua, Streamson] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA; [Bruning, Jens C.] Univ Cologne, Dept Mouse Genet & Metab, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Bruning, Jens C.] Univ Cologne, Dept Internal Med 2, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Coppari, Roberto] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res Pharmacol & Psychiat, Dallas, TX 75390 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Yeshiva University; Yeshiva University; University of Cologne; University of Cologne; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hill, JW (corresponding author), Univ Toledo, Med Ctr, Ctr Diabet & Endocrine Res, Dept Physiol & Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA.	JenniferW.Hill@utoledo.edu	Coppari, Roberto/B-4799-2014; Hill, Jennifer/AAD-8415-2019	Hill, Jennifer/0000-0001-7482-9215; COPPARI, Roberto/0000-0003-1288-6948; Marino, Joseph/0000-0002-6207-5986	NIH [R00HD056491, R21HD071529]; Cancer Biology Fund of the University of Toledo Foundation;  [1PL1DK081182];  [1UL1RR024923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD071529] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD056491] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, PL1DK081182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Biology Fund of the University of Toledo Foundation; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R00HD056491 and R21HD071529 to JWH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge Laura Nedorezov for excellent technical help and Aktar Ali for Metabolic Phenotyping Core support (supported by 1PL1DK081182 and 1UL1RR024923). Ovarian histology was provided by the UTSW Molecular Pathology Core Laboratory and the University of Toledo Advanced Microscopy & Imaging Center Facility (supported by the Cancer Biology Fund of the University of Toledo Foundation). This work was supported by NIH grants R00HD056491 and R21HD071529 to JWH.	Austin RL, 2008, DIABETES, V57, P2066, DOI 10.2337/db07-0763; Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Barber TM, 2008, J CLIN ENDOCR METAB, V93, P999, DOI 10.1210/jc.2007-2117; Battaglia C, 2011, ACTA OBSTET GYN SCAN, V90, P600, DOI 10.1111/j.1600-0412.2011.01124.x; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Benoit SC, 2002, J NEUROSCI, V22, P9048; Beranek JT, 2005, ANN RHEUM DIS, V64, P342; BINGEL AS, 1969, J REPROD FERTIL, V19, P215; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carmina E, 2004, FERTIL STERIL, V82, P661, DOI 10.1016/j.fertnstert.2004.01.041; Carmina E, 2007, J CLIN ENDOCR METAB, V92, P2500, DOI 10.1210/jc.2006-2725; Carmina E, 2009, FERTIL STERIL, V91, P1332, DOI 10.1016/j.fertnstert.2008.03.007; Chazenbalk G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017834; Chen MJ, 2009, FERTIL STERIL, V92, P2041, DOI 10.1016/j.fertnstert.2009.06.009; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Christian RC, 2003, J CLIN ENDOCR METAB, V88, P2562, DOI 10.1210/jc.2003-030334; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; De Jonghe BC, 2011, AM J PHYSIOL-ENDOC M, V300, pE1002, DOI 10.1152/ajpendo.00639.2010; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; DeUgarte CM, 2005, FERTIL STERIL, V83, P1454, DOI 10.1016/j.fertnstert.2004.11.070; Devlieger R, 2008, ACTA OBSTET GYN SCAN, V87, P1266, DOI 10.1080/00016340802443863; Dolfing JG, 2011, HUM REPROD, V26, P1495, DOI 10.1093/humrep/der070; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Ewens KG, 2010, J CLIN ENDOCR METAB, V95, P2306, DOI 10.1210/jc.2009-2703; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Franks S, 2009, ENDOCRINOLOGY, V150, P3983, DOI 10.1210/en.2009-0652; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gonzalez F, 2006, J CLIN ENDOCR METAB, V91, P1508, DOI 10.1210/jc.2005-2327; Gonzalez F, 2012, STEROIDS, V77, P300, DOI 10.1016/j.steroids.2011.12.003; Gonzalez F, 2010, CYTOKINE, V51, P240, DOI 10.1016/j.cyto.2010.06.008; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Gottfried E, 2008, SCAND J IMMUNOL, V67, P453, DOI 10.1111/j.1365-3083.2008.02091.x; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hill JW, CELL METAB, V11, P286; HOLTE J, 1994, J CLIN ENDOCR METAB, V78, P1052, DOI 10.1210/jc.78.5.1052; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Kalsbeek A, 2010, ANN NY ACAD SCI, V1212, P114, DOI 10.1111/j.1749-6632.2010.05800.x; Karabulut A, 2012, GYNECOL ENDOCRINOL, V28, P111, DOI 10.3109/09513590.2011.589929; Kelly CCJ, 2001, J CLIN ENDOCR METAB, V86, P2453, DOI 10.1210/jc.86.6.2453; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Kristensen SL, 2010, HUM REPROD, V25, P3117, DOI 10.1093/humrep/deq273; Kuchenbecker WKH, 2011, HUM REPROD, V26, P2505, DOI 10.1093/humrep/der229; Kuchenbecker WKH, 2010, J CLIN ENDOCR METAB, V95, P2107, DOI 10.1210/jc.2009-1915; Kunisch E, 2004, ANN RHEUM DIS, V63, P774, DOI 10.1136/ard.2003.013029; Li ZP, 2003, CURR OPIN GASTROEN, V19, P565, DOI 10.1097/00001574-200311000-00009; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Liu ZL, 2009, ENDOCRINOLOGY, V150, P3360, DOI 10.1210/en.2008-1532; Lo JC, 2006, J CLIN ENDOCR METAB, V91, P1357, DOI 10.1210/jc.2005-2430; Manneras-Holm L, 2011, J CLIN ENDOCR METAB, V96, pE304, DOI 10.1210/jc.2010-1290; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Marshall JC, 2006, J CLIN ENDOCR METAB, V91, P393, DOI 10.1210/jc.2005-2665; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Norman RJ, 2001, HUM REPROD, V16, P1995, DOI 10.1093/humrep/16.9.1995; Oakley OR, 2010, ENDOCRINOLOGY, V151, P4551, DOI 10.1210/en.2009-1444; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; ORTEGA I, 2011, FERTIL STERIL S1, V96, pS114; Pasquali R, 2006, BJOG-INT J OBSTET GY, V113, P1148, DOI 10.1111/j.1471-0528.2006.00990.x; Piotrowski PC, 2005, J SOC GYNECOL INVEST, V12, p319A; Puder JJ, 2005, J CLIN ENDOCR METAB, V90, P6014, DOI 10.1210/jc.2005-1002; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Spaczynski RZ, 1999, BIOL REPROD, V61, P993, DOI 10.1095/biolreprod61.4.993; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Szukiewicz D, 1998, J MED, V29, P259; Tarkun Ilhan, 2006, Metabolic Syndrome and Related Disorders, V4, P122, DOI 10.1089/met.2006.4.122; Toulis KA, 2009, FERTIL STERIL, V92, P667, DOI 10.1016/j.fertnstert.2008.06.045; Townson David H, 2003, Reprod Biol Endocrinol, V1, P94, DOI 10.1186/1477-7827-1-94; Villa J, 2011, CURR DIABETES REP, V11, P179, DOI 10.1007/s11892-011-0189-8; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yildiz BO, 2008, J CLIN ENDOCR METAB, V93, P162, DOI 10.1210/jc.2007-1834; Zhan YT, 2010, WORLD J GASTROENTERO, V16, P4652, DOI 10.3748/wjg.v16.i37.4652; Zhang HM, 2009, NUTR METAB CARDIOVAS, V19, P736, DOI 10.1016/j.numecd.2008.12.016	86	21	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48643	10.1371/journal.pone.0048643	http://dx.doi.org/10.1371/journal.pone.0048643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119079	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500187
J	Rauhut, OWM; Heyng, AM; Lopez-Arbarello, A; Hecker, A				Rauhut, Oliver W. M.; Heyng, Alexander M.; Lopez-Arbarello, Adriana; Hecker, Andreas			A New Rhynchocephalian from the Late Jurassic of Germany with a Dentition That Is Unique amongst Tetrapods	PLOS ONE			English	Article							SPHENODONTIAN DIAPSIDA LEPIDOSAURIA; TOOTH PLATES; REPTILIA; FOSSIL; EVOLUTION; TUATARA; TAMAULIPAS; MECHANICS; LIZARDS; GROWTH	Background: Rhynchocephalians, the sister group of squamates (lizards and snakes), are only represented by the single genus Sphenodon today. This taxon is often considered to represent a very conservative lineage. However, rhynchocephalians were common during the late Triassic to latest Jurassic periods, but rapidly declined afterwards, which is generally attributed to their supposedly adaptive inferiority to squamates and/or Mesozoic mammals, which radiated at that time. New finds of Mesozoic rhynchocephalians can thus provide important new information on the evolutionary history of the group. Principle Findings: A new fossil relative of Sphenodon from the latest Jurassic of southern Germany, Oenosaurus muehlheimensis gen. et sp. nov., presents a dentition that is unique amongst tetrapods. The dentition of this taxon consists of massive, continuously growing tooth plates, probably indicating a crushing dentition, thus representing a previously unknown trophic adaptation in rhynchocephalians. Conclusions/Significance: The evolution of the extraordinary dentition of Oenosaurus from the already highly specialized Zahnanlage generally present in derived rhynchocephalians demonstrates an unexpected evolutionary plasticity of these animals. Together with other lines of evidence, this seriously casts doubts on the assumption that rhynchocephalians are a conservative and adaptively inferior lineage. Furthermore, the new taxon underlines the high morphological and ecological diversity of rhynchocephalians in the latest Jurassic of Europe, just before the decline of this lineage on this continent. Thus, selection pressure by radiating squamates or Mesozoic mammals alone might not be sufficient to explain the demise of the clade in the Late Mesozoic, and climate change in the course of the fragmentation of the supercontinent of Pangaea might have played a major role.	[Rauhut, Oliver W. M.; Lopez-Arbarello, Adriana] Univ Munich, Bayer Staatssammlung Palaontol Geol, Munich, Germany; [Rauhut, Oliver W. M.; Lopez-Arbarello, Adriana] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Rauhut, Oliver W. M.; Heyng, Alexander M.] Univ Munich, GeoBioCtr, Munich, Germany; [Hecker, Andreas] Max Planck Gesell, Munich, Germany	University of Munich; University of Munich; University of Munich; Max Planck Society	Rauhut, OWM (corresponding author), Univ Munich, Bayer Staatssammlung Palaontol Geol, Munich, Germany.	o.rauhut@lrz.uni-muenchen.de	Rauhut, Oliver/AAG-1029-2020; Lopez-Arbarello, Adriana/N-1834-2018	Lopez-Arbarello, Adriana/0000-0002-2924-3319; Rauhut, Oliver/0000-0003-3958-603X				Apesteguia S, 2003, NATURE, V425, P609, DOI 10.1038/nature01995; Apesteguia S, 2007, INVESTIGACION CIENCI, V367, P54; Bell PR, 2009, ANAT REC, V292, P1338, DOI 10.1002/ar.20978; BENTON MJ, 1984, PALAEONTOLOGY, V27, P737; Campbell KSW, 2007, PALAEONTOL Z, V81, P146, DOI 10.1007/BF02988389; CARROLL RL, 1994, IN THE SHADOW OF THE DINOSAURS, P70; Cocude-Michel M., 1963, Nouvelles Archives du Museum d'Histoire Naturelle de Lyon, VNo. 7, P1; COPE ED, 1871, P AM ASS ADV SCI, V19, P194; DALRYMPLE GH, 1979, J HERPETOL, V13, P303, DOI 10.2307/1563324; DIDIER DA, 1994, J MORPHOL, V222, P73, DOI 10.1002/jmor.1052220108; Dupret Vincent, 2004, Revue de Paleobiologie Volume Special, V9, P61; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; Evans S. E., 2010, LECT NOTES EARTH SCI, P22; Evans SE, 2001, ZOOL J LINN SOC-LOND, V133, P309, DOI 10.1006/zjls.2000.0266; Evans Susan E., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P195; FRASER NC, 1988, PHILOS T ROY SOC B, V321, P125, DOI 10.1098/rstb.1988.0092; FRASER NC, 1988, GEOL MAG, V125, P117, DOI 10.1017/S0016756800009523; FRASER NC, 1989, ZOOL J LINN SOC-LOND, V96, P413, DOI 10.1111/j.1096-3642.1989.tb02521.x; FRASER NC, 1982, PALAEONTOLOGY, V25, P709; Fuersich FT, 2007, PALAEOGEOGR PALAEOCL, V243, P92, DOI 10.1016/j.palaeo.2006.07.007; GORNIAK GC, 1982, J MORPHOL, V171, P321, DOI 10.1002/jmor.1051710307; Gunther A., 1867, P R SOC LONDON, V15, P460; Haeckel E. H., 1866, GENERELLE MORPHOLOGI; HALLAM A, 1984, PALAEOGEOGR PALAEOCL, V47, P195, DOI 10.1016/0031-0182(84)90094-4; Harrison HS, 1901, Q J MICROSC SCI, V44, P161; Heckert AB, 2008, PALAEONTOLOGY, V51, P827, DOI 10.1111/j.1475-4983.2008.00786.x; Jones MEH, 2009, FRONT ORAL BIOL, V13, P9, DOI 10.1159/000242382; Jones MEH, 2008, J MORPHOL, V269, P945, DOI 10.1002/jmor.10634; Jones MEH, 2009, P ROY SOC B-BIOL SCI, V276, P1385, DOI 10.1098/rspb.2008.1785; JONES MEH, 2006, NEW MEXICO MUSEUM NA, V37, P548; Kalthoff DC, 2011, J MORPHOL, V272, P641, DOI 10.1002/jmor.10937; Lopez-Arbarello A, 2011, J SYST PALAEONTOL, V9, P197, DOI 10.1080/14772019.2010.493751; Lund R., 1992, P35; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Meiri S, 2008, GLOBAL ECOL BIOGEOGR, V17, P724, DOI 10.1111/j.1466-8238.2008.00414.x; Milner Angela C., 2000, P316, DOI 10.1017/CBO9780511535505.022; Muller J, 2003, NATURWISSENSCHAFTEN, V90, P473, DOI 10.1007/s00114-003-0461-0; ORVIG T, 1976, ZOOL SCR, V5, P79, DOI 10.1111/j.1463-6409.1976.tb00684.x; ORVIG T, 1985, ZOOL SCR, V14, P55, DOI 10.1111/j.1463-6409.1985.tb00178.x; Peyer B, 1968, COMP ODONTOLOGY; POUGH FH, 1973, ECOLOGY, V54, P837, DOI 10.2307/1935678; Reilly SM, 2006, P ROY SOC B-BIOL SCI, V273, P1563, DOI 10.1098/rspb.2006.3489; Reynoso VH, 2005, J VERTEBR PALEONTOL, V25, P646, DOI 10.1671/0272-4634(2005)025[0646:PEOAVA]2.0.CO;2; Reynoso VH, 1997, J VERTEBR PALEONTOL, V17, P52, DOI 10.1080/02724634.1997.10010953; Reynoso VH, 1996, J VERTEBR PALEONTOL, V16, P210, DOI 10.1080/02724634.1996.10011309; Reynoso VH, 2000, J PALEONTOL, V74, P133, DOI 10.1666/0022-3360(2000)074<0133:AUASRD>2.0.CO;2; RIEPPEL O, 1992, J HERPETOL, V26, P80, DOI 10.2307/1565028; Rieppel O, 2008, ZOOL J LINN SOC-LOND, V152, P131, DOI 10.1111/j.1096-3642.2007.00337.x; Robinson P.L., 1976, Linnean Soc Symp Ser, V3, P43; SCHMID Dieter U., 2005, Zitteliana Reihe B, V26, P31; SUES HD, 1994, J VERTEBR PALEONTOL, V14, P327, DOI 10.1080/02724634.1994.10011563; Ung CYJ, 2004, CLIN EXP OPHTHALMOL, V32, P614, DOI 10.1111/j.1442-9071.2004.00912.x; WHITESIDE DI, 1986, PHILOS T ROY SOC B, V312, P379, DOI 10.1098/rstb.1986.0014; WILLISTON S. W., 1925, OSTEOLOGY REPTILES; WU XC, 1994, IN THE SHADOW OF THE DINOSAURS, P38	55	34	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e46839	10.1371/journal.pone.0046839	http://dx.doi.org/10.1371/journal.pone.0046839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118861	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500010
J	Burns, JC; Yoo, JJ; Atala, A; Jackson, JD				Burns, Joseph C.; Yoo, James J.; Atala, Anthony; Jackson, John D.			MYC Gene Delivery to Adult Mouse Utricles Stimulates Proliferation of Postmitotic Supporting Cells In Vitro	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SENSORY HAIR-CELLS; INNER-EAR; C-MYC; RETINOBLASTOMA PROTEIN; GROWTH-FACTORS; CYCLE REENTRY; MICE LACKING; E-CADHERIN; REGENERATION	The inner ears of adult humans and other mammals possess a limited capacity for regenerating sensory hair cells, which can lead to permanent auditory and vestibular deficits. During development and regeneration, undifferentiated supporting cells within inner ear sensory epithelia can self-renew and give rise to new hair cells; however, these otic progenitors become depleted postnatally. Therefore, reprogramming differentiated supporting cells into otic progenitors is a potential strategy for restoring regenerative potential to the ear. Transient expression of the induced pluripotency transcription factors, Oct3/4, Klf4, Sox2, and c-Myc reprograms fibroblasts into neural progenitors under neural-promoting culture conditions, so as a first step, we explored whether ectopic expression of these factors can reverse supporting cell quiescence in whole organ cultures of adult mouse utricles. Co-infection of utricles with adenoviral vectors separately encoding Oct3/4, Klf4, Sox2, and the degradation-resistant T58A mutant of c-Myc (c-MycT58A) triggered significant levels of supporting cell S-phase entry as assessed by continuous BrdU labeling. Of the four factors, c-MycT58A alone was both necessary and sufficient for the proliferative response. The number of BrdU-labeled cells plateaued between 5-7 days after infection, and then decreased similar to 60% by 3 weeks, as many cycling cells appeared to enter apoptosis. Switching to differentiation-promoting culture medium at 5 days after ectopic expression of c-MycT58A temporarily attenuated the loss of BrdU-labeled cells and accompanied a very modest but significant expansion of the sensory epithelium. A small number of the proliferating cells in these cultures labeled for the hair cell marker, myosin VIIA, suggesting they had begun differentiating towards a hair cell fate. The results indicate that ectopic expression of c-MycT58A in combination with methods for promoting cell survival and differentiation may restore regenerative potential to supporting cells within the adult mammalian inner ear.	[Burns, Joseph C.; Yoo, James J.; Atala, Anthony; Jackson, John D.] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Wake Forest University	Burns, JC (corresponding author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA.	joburns@wakehealth.edu	Burns, Joseph/HHD-1604-2022; Yoo, James J./L-4850-2017	Atala, Anthony/0000-0001-8186-2160	Rena Shulsky David Foundation	Rena Shulsky David Foundation	This work was supported by the Rena Shulsky David Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; Batsche E, 1999, ONCOGENE, V18, P5662, DOI 10.1038/sj.onc.1202927; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Brandon CS, 2012, JOVE-J VIS EXP, DOI 10.3791/3734; Burns JC, 2012, J ASS RES OTOLARYNGO; Burns J, 2008, J COMP NEUROL, V511, P396, DOI 10.1002/cne.21849; Burns JC, 2012, J NEUROSCI, V32, P6570, DOI 10.1523/JNEUROSCI.6274-11.2012; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; Chen P, 2003, NAT CELL BIOL, V5, P422, DOI 10.1038/ncb976; Chen P, 1999, DEVELOPMENT, V126, P1581; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Collado MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023861; Collado MS, 2011, J NEUROSCI, V31, P11855, DOI 10.1523/JNEUROSCI.2525-11.2011; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Davies D, 2007, EUR J NEUROSCI, V25, P985, DOI 10.1111/j.1460-9568.2007.05355.x; De Filippis L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003310; Dominguez-Frutos E, 2011, J NEUROSCI, V31, P7178, DOI 10.1523/JNEUROSCI.0785-11.2011; DOVER R, 1988, J CELL SCI, V89, P359; Driver EC, 2010, TRANSFECTION MOUSE C, p[34, 31]; Efe Jem A., 2011, Science Progress, V94, P298, DOI 10.3184/003685011X13131588500975; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; GORDON RE, 1980, CANCER RES, V40, P4467; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gu RD, 2007, EUR J NEUROSCI, V25, P1363, DOI 10.1111/j.1460-9568.2007.05414.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Ho R, 2011, J CELL PHYSIOL, V226, P868, DOI 10.1002/jcp.22450; Holt JR, 1999, J NEUROPHYSIOL, V81, P1881, DOI 10.1152/jn.1999.81.4.1881; Hu ZQ, 2007, P NATL ACAD SCI USA, V104, P16675, DOI 10.1073/pnas.0704576104; Huang MQ, 2011, CELL CYCLE, V10, P337, DOI 10.4161/cc.10.2.14640; Hume CR, 2003, JARO-J ASSOC RES OTO, V4, P422, DOI 10.1007/s10162-002-3008-8; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jones JM, 2006, J NEUROSCI, V26, P550, DOI 10.1523/JNEUROSCI.3859-05.2006; Kanzaki S, 2006, HEARING RES, V214, P28, DOI 10.1016/j.heares.2006.01.014; KARN J, 1989, ONCOGENE, V4, P773; Kawamoto K, 2001, MOL THER, V4, P575, DOI 10.1006/mthe.2001.0490; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; KELLEY MW, 1995, J NEUROSCI, V15, P3013; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kirkegaard M, 2005, J COMP NEUROL, V492, P132, DOI 10.1002/cne.20736; Kopecky B, 2011, DEV DYNAM, V240, P1373, DOI 10.1002/dvdy.22620; Laine H, 2007, J NEUROSCI, V27, P1434, DOI 10.1523/JNEUROSCI.4956-06.2007; Laine H, 2010, DEV BIOL, V337, P134, DOI 10.1016/j.ydbio.2009.10.027; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Lin V, 2011, J NEUROSCI, V31, P15329, DOI 10.1523/JNEUROSCI.2057-11.2011; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Loponen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027360; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Lu ZJ, 2008, DEV NEUROBIOL, V68, P1059, DOI 10.1002/dneu.20635; Luebke AE, 2001, HUM GENE THER, V12, P773, DOI 10.1089/104303401750148702; Luscher B, 2012, GENE, V494, P145, DOI 10.1016/j.gene.2011.12.027; Mantela J, 2005, DEVELOPMENT, V132, P2377, DOI 10.1242/dev.01834; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Meyers JR, 2007, J NEUROSCI, V27, P4313, DOI 10.1523/JNEUROSCI.5023-06.2007; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; Oesterle EC, 2011, CELL CYCLE, V10, P1237, DOI 10.4161/cc.10.8.15301; Ono K, 2009, MOL CELL NEUROSCI, V42, P391, DOI 10.1016/j.mcn.2009.08.011; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pocsfalvi G, 2011, J PROTEOME RES, V10, P5326, DOI 10.1021/pr200584y; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rocha-Sanchez SM, 2011, J NEUROSCI, V31, P8883, DOI 10.1523/JNEUROSCI.5821-10.2011; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Schlecker C, 2011, GENE THERAPY; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shou JY, 2003, MOL CELL NEUROSCI, V23, P169, DOI 10.1016/S1044-7431(03)00066-6; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Staecker H, 2007, OTOL NEUROTOL, V28, P223, DOI 10.1097/MAO.0b013e31802b3225; Sulg M, 2010, J NEUROCHEM, V112, P1513, DOI 10.1111/j.1471-4159.2009.06563.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; Weber T, 2008, P NATL ACAD SCI USA, V105, P781, DOI 10.1073/pnas.0708061105; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010; Zhai SQ, 2005, J NEUROBIOL, V65, P282, DOI 10.1002/neu.20190; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng JL, 1997, J NEUROSCI, V17, P216, DOI 10.1523/JNEUROSCI.17-01-00216.1997	98	22	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48704	10.1371/journal.pone.0048704	http://dx.doi.org/10.1371/journal.pone.0048704			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119091	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705600054
J	Dixon, CI; Walker, SE; King, SL; Stephens, DN				Dixon, Claire I.; Walker, Sophie E.; King, Sarah L.; Stephens, David N.			Deletion of the gabra2 Gene Results in Hypersensitivity to the Acute Effects of Ethanol but Does Not Alter Ethanol Self Administration	PLOS ONE			English	Article							CONDITIONED EMOTIONAL RESPONSE; GABA(A) RECEPTORS; ALCOHOL DEPENDENCE; ALPHA-2 SUBUNIT; SPINAL-CORD; ADULT-RAT; ASSOCIATION; MICE; SUBTYPES; BRAIN	Human genetic studies have suggested that polymorphisms of the GABRA2 gene encoding the GABA(A) alpha 2-subunit are associated with ethanol dependence. Variations in this gene also convey sensitivity to the subjective effects of ethanol, indicating a role in mediating ethanol-related behaviours. We therefore investigated the consequences of deleting the alpha 2-subunit on the ataxic and rewarding properties of ethanol in mice. Ataxic and sedative effects of ethanol were explored in GABAA alpha 2-subunit wildtype (WT) and knockout (KO) mice using a Rotarod apparatus, wire hang and the duration of loss of righting reflex. Following training, KO mice showed shorter latencies to fall than WT littermates under ethanol (2 g/kg i.p.) in both Rotarod and wire hang tests. After administration of ethanol (3.5 g/kg i.p.), KO mice took longer to regain the righting reflex than WT mice. To ensure the acute effects are not due to the gabra2 deletion affecting pharmacokinetics, blood ethanol concentrations were measured at 20 minute intervals after acute administration (2 g/kg i.p.), and did not differ between genotypes. To investigate ethanol's rewarding properties, WT and KO mice were trained to lever press to receive increasing concentrations of ethanol on an FR4 schedule of reinforcement. Both WT and KO mice self-administered ethanol at similar rates, with no differences in the numbers of reinforcers earned. These data indicate a protective role for alpha 2-subunits, against the acute sedative and ataxic effects of ethanol. However, no change was observed in ethanol self administration, suggesting the rewarding effects of ethanol remain unchanged.	[Dixon, Claire I.; Walker, Sophie E.; King, Sarah L.; Stephens, David N.] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Sussex	Stephens, DN (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	d.stephens@sussex.ac.uk		Walker, Sophie/0000-0001-8120-7000; King, Sarah/0000-0002-7412-9558	Medical Research Council [G0600874, G0802715, G1000008]; MRC [G0600874, G1000008, G0802715] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by Medical Research Council grants G0600874, G0802715 and G1000008.	Agrawal A, 2008, ADDICTION, V103, P1027, DOI 10.1111/j.1360-0443.2008.02236.x; Barbaccia ML, 1999, EUR J PHARMACOL, V384, pR1, DOI 10.1016/S0014-2999(99)00678-0; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Blednov YA, 2011, J PHARMACOL EXP THER, V336, P145, DOI 10.1124/jpet.110.171645; Boehm SL, 2004, BIOCHEM PHARMACOL, V68, P1581, DOI 10.1016/j.bcp.2004.07.023; Bohlhalter S, 1996, J NEUROSCI, V16, P283, DOI 10.1523/jneurosci.16-01-00283.1996; Covault J, 2004, AM J MED GENET B, V129B, P104, DOI 10.1002/ajmg.b.30091; Dick DM, 2006, BEHAV GENET, V36, P577, DOI 10.1007/s10519-005-9041-8; Dixon CI, 2008, PHARMACOL BIOCHEM BE, V90, P1, DOI 10.1016/j.pbb.2008.01.015; Dixon CI, 2010, P NATL ACAD SCI USA, V107, P2289, DOI 10.1073/pnas.0910117107; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Enoch MA, 2006, AM J MED GENET B, V141B, P599, DOI 10.1002/ajmg.b.30336; Enoch MA, 2010, BIOL PSYCHIAT, V67, P20, DOI 10.1016/j.biopsych.2009.08.019; FAHLKE C, 1994, PHARMACOL BIOCHEM BE, V47, P345, DOI 10.1016/0091-3057(94)90020-5; HANSEN S, 1995, ALCOHOL, V12, P397, DOI 10.1016/0741-8329(95)00008-F; Haughey HM, 2008, GENES BRAIN BEHAV, V7, P447, DOI 10.1111/j.1601-183X.2007.00369.x; June HL, 2003, NEUROPSYCHOPHARMACOL, V28, P2124, DOI 10.1038/sj.npp.1300239; Khisti RT, 2004, ALCOHOL CLIN EXP RES, V28, P1249, DOI 10.1097/01.ALC.0000134232.44210.06; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Kralic JE, 2002, NEUROPHARMACOLOGY, V43, P685, DOI 10.1016/S0028-3908(02)00174-0; Lappalainen J, 2005, ALCOHOL CLIN EXP RES, V29, P493, DOI 10.1097/01.ALC.0000158938.97464.90; Lind PA, 2008, ALCOHOL CLIN EXP RES, V32, P1721, DOI 10.1111/j.1530-0277.2008.00768.x; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Lydall GJ, 2011, NEUROSCI LETT, V500, P162, DOI 10.1016/j.neulet.2011.05.240; Morris HV, 2008, PHARMACOL BIOCHEM BE, V90, P9, DOI 10.1016/j.pbb.2008.02.010; Morris HV, 2006, EUR J NEUROSCI, V23, P2495, DOI 10.1111/j.1460-9568.2006.04775.x; Onori N, 2010, ALCOHOL CLIN EXP RES, V34, P659, DOI 10.1111/j.1530-0277.2009.01135.x; PERSOHN E, 1991, NEUROSCIENCE, V42, P497, DOI 10.1016/0306-4522(91)90392-2; Pierucci-Lagha A, 2005, NEUROPSYCHOPHARMACOL, V30, P1193, DOI 10.1038/sj.npp.1300688; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Ponomarev I, 2006, J NEUROSCI, V26, P5673, DOI 10.1523/JNEUROSCI.0860-06.2006; Roberto M, 2004, J NEUROSCI, V24, P10159, DOI 10.1523/JNEUROSCI.3004-04.2004; Roh S, 2010, ALCOHOL CLIN EXP RES; Ruiz A, 2003, NEURON, V39, P961, DOI 10.1016/S0896-6273(03)00559-2; Sakai JT, 2010, DRUG ALCOHOL DEPEN, V106, P199, DOI 10.1016/j.drugalcdep.2009.08.015; SAMSON HH, 1986, ALCOHOL CLIN EXP RES, V10, P436, DOI 10.1111/j.1530-0277.1986.tb05120.x; Schwarzer C, 2001, J COMP NEUROL, V433, P526, DOI 10.1002/cne.1158; Tauber M, 2003, EUR J NEUROSCI, V18, P2599, DOI 10.1046/j.1460-9568.2003.02988.x; Ueno S, 1999, BRIT J PHARMACOL, V127, P377, DOI 10.1038/sj.bjp.0702563; Villafuerte S, 2011, MOL PSYCHIAT; Wafford KA, 2004, BIOCHEM SOC T, V32, P553, DOI 10.1042/BST0320553; Wakita M, 2012, J PHARMACOL EXP THER, V341, P809, DOI 10.1124/jpet.111.189126; Weiner JL, 2006, PHARMACOL THERAPEUT, V111, P533, DOI 10.1016/j.pharmthera.2005.11.002; Yang ARST, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00123; Zhu PJ, 2006, J NEUROPHYSIOL, V96, P433, DOI 10.1152/jn.01380.2005	45	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47135	10.1371/journal.pone.0047135	http://dx.doi.org/10.1371/journal.pone.0047135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115637	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200026
J	Shi, B; Gao, W; Wang, J				Shi, Bing; Gao, Wei; Wang, Juan			Sequence Fingerprints of MicroRNA Conservation	PLOS ONE			English	Article							GC CONTENT EVOLUTION; SIGNALING NETWORK; PROTEIN EVOLUTION; GENES; SITES; RNAS; ROBUSTNESS; DATABASE; TARGETS; ORIGIN	It is known that the conservation of protein-coding genes is associated with their sequences both various species, such as animals and plants. However, the association between microRNA (miRNA) conservation and their sequences in various species remains unexplored. Here we report the association of miRNA conservation with its sequence features, such as base content and cleavage sites, suggesting that miRNA sequences contain the fingerprints for miRNA conservation. More interestingly, different species show different and even opposite patterns between miRNA conservation and sequence features. For example, mammalian miRNAs show a positive/negative correlation between conservation and AU/GC content, whereas plant miRNAs show a negative/positive correlation between conservation and AU/GC content. Further analysis puts forward the hypothesis that the introns of protein-coding genes may be a main driving force for the origin and evolution of mammalian miRNAs. At the 5' end, conserved miRNAs have a preference for base U, while less-conserved miRNAs have a preference for a non-U base in mammals. This difference does not exist in insects and plants, in which both conserved miRNAs and less-conserved miRNAs have a preference for base U at the 5' end. We further revealed that the non-U preference at the 5' end of less-conserved mammalian miRNAs is associated with miRNA function diversity, which may have evolved from the pressure of a highly sophisticated environmental stimulus the mammals encountered during evolution. These results indicated that miRNA sequences contain the fingerprints for conservation, and these fingerprints vary according to species. More importantly, the results suggest that although species share common mechanisms by which miRNAs originate and evolve, mammals may develop a novel mechanism for miRNA origin and evolution. In addition, the fingerprint found in this study can be predictor of miRNA conservation, and the findings are helpful in achieving a clearer understanding of miRNA function and evolution.	[Shi, Bing; Gao, Wei] Peking Univ, Hosp 3, Dept Cardiol, Beijing 100871, Peoples R China; [Shi, Bing; Wang, Juan] Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China	Peking University; Peking University	Shi, B (corresponding author), Peking Univ, Hosp 3, Dept Cardiol, Beijing 100871, Peoples R China.	dr_shibing@bjmu.edu.cn; wjuan@hsc.pku.edu.cn			NSFC [81170225]	NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the NSFC (grant No. 81170225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benovoy D, 2005, MOL BIOL EVOL, V22, P1865, DOI 10.1093/molbev/msi176; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Borenstein E, 2006, P NATL ACAD SCI USA, V103, P6593, DOI 10.1073/pnas.0510600103; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; Cui QH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-21; Cullen BR, 2009, CELL, V136, P592, DOI 10.1016/j.cell.2009.01.048; DEWIT E, 2009, GENOME RES; Galtier N, 2003, TRENDS GENET, V19, P65, DOI 10.1016/S0168-9525(02)00002-1; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo XY, 2007, FEBS LETT, V581, P1015, DOI 10.1016/j.febslet.2007.01.088; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li L, 2012, GENOME RES, V22, P1222, DOI 10.1101/gr.128819.111; Liang H, 2009, MOL BIOL EVOL, V26, P1195, DOI 10.1093/molbev/msp053; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Peng Jie-Jun, 2008, Yichuan, V30, P1550, DOI 10.3724/SP.J.1005.2008.01550; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Szollosi GJ, 2009, MOL BIOL EVOL, V26, P867, DOI 10.1093/molbev/msp008; Technau U, 2008, NATURE, V455, P1184, DOI 10.1038/4551184a; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; ZHANG Q, 2008, SNP ANAL REVEALS EVO; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	32	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48256	10.1371/journal.pone.0048256	http://dx.doi.org/10.1371/journal.pone.0048256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110219	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200162
J	Xu, M; Chen, G; Wang, SY; Liao, MJ; Frank, JA; Bower, KA; Zhang, Z; Shi, XL; Luo, J				Xu, Mei; Chen, Gang; Wang, Siying; Liao, Mingjun; Frank, Jacqueline A.; Bower, Kimberly A.; Zhang, Zhuo; Shi, Xianglin; Luo, Jia			Double-Stranded RNA-Dependent Protein Kinase Regulates the Motility of Breast Cancer Cells	PLOS ONE			English	Article							LIM-KINASE; COFILIN PHOSPHORYLATION; P38 MAPK; SPHINGOSINE 1-PHOSPHATE; ACTIN REORGANIZATION; UP-REGULATION; PKR; ACTIVATION; MIGRATION; INVASION	Double-stranded RNA (dsRNA)-dependent protein kinase (PKR) is an interferon-induced protein kinase that plays a central role in the anti-viral process. Due to its pro-apoptotic and anti-proliferative action, there is an increased interest in PKR modulation as an anti-tumor strategy. PKR is overexpressed in breast cancer cells; however, the role of PKR in breast cancer cells is unclear. The expression/activity of PKR appears inversely related to the aggressiveness of breast cancer cells. The current study investigated the role of PKR in the motility/migration of breast cancer cells. The activation of PKR by a synthesized dsRNA (PIC) significantly decreased the motility of several breast cancer cell lines (BT474, MDA-MB231 and SKBR3). PIC inhibited cell migration and blocked cell membrane ruffling without affecting cell viability. PIC also induced the reorganization of the actin cytoskeleton and impaired the formation of lamellipodia. These effects of PIC were reversed by the pretreatment of a selective PKR inhibitor. PIC also activated p38 mitogen-activated protein kinase (MAPK) and its downstream MAPK-activated protein kinase 2 (MK2). PIC-induced activation of p38 MAPK and MK2 was attenuated by the PKR inhibitor and the PKR siRNA, but a selective p38 MAPK inhibitor (SB203580) or other MAPK inhibitors did not affect PKR activity, indicating that PKR is upstream of p38 MAPK/MK2. Cofilin is an actin severing protein and regulates membrane ruffling, lamellipodia formation and cell migration. PIC inhibited cofilin activity by enhancing its phosphorylation at Ser3. PIC activated LIM kinase 1 (LIMK1), an upstream kinase of cofilin in a p38 MAPK-dependent manner. We concluded that the activation of PKR suppressed cell motility by regulating the p38 MAPK/MK2/LIMK/cofilin pathway.	[Xu, Mei; Chen, Gang; Wang, Siying; Liao, Mingjun; Frank, Jacqueline A.; Bower, Kimberly A.; Luo, Jia] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY 40536 USA; [Wang, Siying] Anhui Med Univ, Dept Pathophysiol, Sch Basic Med, Hefei, Anhui, Peoples R China; [Zhang, Zhuo; Shi, Xianglin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY USA	University of Kentucky; Anhui Medical University; University of Kentucky	Luo, J (corresponding author), Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY 40536 USA.	jialuo888@uky.edu	Zhang, Zhuo/B-8601-2012; Shi, Xianglin/B-8588-2012; Luo, Jia/E-4674-2012	Luo, Jia/0000-0002-6968-3618	NIH grant [AA017226]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015407, R01AA017226] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research is supported by a NIH grant (AA017226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2008, CELL SIGNAL, V20, P534, DOI 10.1016/j.cellsig.2007.11.006; Balachandran Siddharth, 2007, V383, P277, DOI 10.1007/978-1-59745-335-6_18; Bamburg JR, 2011, MOL MICROBIOL, V81, P851, DOI 10.1111/j.1365-2958.2011.07759.x; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia MC, 2009, J BIOL CHEM, V284, P20936, DOI 10.1074/jbc.M109.020271; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Haines GK, 1996, TUMOR BIOL, V17, P5, DOI 10.1159/000217961; Iordanov MS, 2000, MOL CELL BIOL, V20, P617, DOI 10.1128/MCB.20.2.617-627.2000; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Jiang W G, 1995, Eur J Surg Oncol, V21, P307, DOI 10.1016/S0748-7983(95)91690-3; Jovceva E, 2007, J CELL SCI, V120, P1888, DOI 10.1242/jcs.004366; Ke ZJ, 2009, ALCOHOL CLIN EXP RES, V33, P1097, DOI 10.1111/j.1530-0277.2009.00931.x; Kim SH, 2000, ONCOGENE, V19, P3086, DOI 10.1038/sj.onc.1203632; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Lee GW, 2012, ACTA PHYSIOL, V204, P513, DOI 10.1111/j.1748-1716.2011.02359.x; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Mounir Z, 2010, FUTURE ONCOL, V6, P643, DOI 10.2217/FON.10.45; Nussbaum JM, 2003, CANCER LETT, V196, P207, DOI 10.1016/S0304-3835(03)00276-3; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Peters GA, 2009, BIOCHEMISTRY-US, V48, P7441, DOI 10.1021/bi900433y; Raven JF, 2008, CELL CYCLE, V7, P1146, DOI 10.4161/cc.7.9.5811; Savinova O, 1999, INT J BIOCHEM CELL B, V31, P175, DOI 10.1016/S1357-2725(98)00140-X; Shir A, 2003, SEMIN CANCER BIOL, V13, P309, DOI 10.1016/S1044-579X(03)00045-2; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Spaziani A, 2006, J BIOL CHEM, V281, P10983, DOI 10.1074/jbc.M512536200; Stupack DG, 2000, IMMUNOL RES, V21, P83, DOI 10.1385/IR:21:2-3:83; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Vicente-Manzanares M, 2011, METHODS MOL BIOL, V769, P1, DOI 10.1007/978-1-61779-207-6_1; Vorburger Stephan A, 2004, Am J Pharmacogenomics, V4, P189, DOI 10.2165/00129785-200404030-00006; Wang F, 1999, EXP CELL RES, V247, P17, DOI 10.1006/excr.1998.4327; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Xu M, 2007, AM J PHYSIOL-CELL PH, V293, pC1309, DOI 10.1152/ajpcell.00014.2007; Xu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-285; Xu M, 2010, ALCOHOL CLIN EXP RES, V34, P751, DOI 10.1111/j.1530-0277.2010.01147.x; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119	43	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47721	10.1371/journal.pone.0047721	http://dx.doi.org/10.1371/journal.pone.0047721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112838	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200072
J	Yadaiah, M; Sudhamalla, B; Rao, PN; Roy, KR; Ramakrishna, D; Syed, GH; Ramaiah, KVA; Bhuyan, AK				Yadaiah, Madasu; Sudhamalla, Babu; Rao, P. Nageswara; Roy, Karnati R.; Ramakrishna, Dasari; Syed, Gulam Hussain; Ramaiah, Kolluru V. A.; Bhuyan, Abani K.			Arrested cell proliferation through cysteine protease activity of eukaryotic ribosomal protein S4	FASEB JOURNAL			English	Article						Turner syndrome; human embryonic kidney cells	CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BLEOMYCIN HYDROLASE; ANGSTROM RESOLUTION; EXTRARIBOSOMAL FUNCTIONS; 30S SUBUNIT; RNA; EXPRESSION; DNA; TRANSCRIPTION	S4 is an integral protein of the smaller subunit of cytosolic ribosome. In prokaryotes, it regulates the synthesis of ribosomal proteins by feedback inhibition of the alpha-operon gene expression, and it facilitates ribosomal RNA synthesis by direct binding to RNA polymerase. However, functional roles of S4 in eukaryotes are poorly understood, although its deficiency in humans is thought to produce Turner syndrome. We report here that wheat S4 is a cysteine protease capable of abrogating total protein synthesis in an actively translating cell-free system of rabbit reticulocytes. The translation-blocked medium, imaged by atomic force microscopy, scanning electron microscopy, and transmission electron microscopy, shows dispersed polysomes, and the disbanded polyribosome elements aggregate to form larger bodies. We also show that human embryonic kidney cells transfected with recombinant wheat S4 are unable to grow and proliferate. The mutant S4 protein, where the putative active site residue Cys 41 is replaced by a phenylalanine, can neither suppress protein synthesis nor arrest cell proliferation, suggesting that the observed phenomenon arises from the cysteine protease attribute of S4. The results also inspire many questions concerning in vivo significance of extraribosomal roles of eukaryotic S4 performed through its protease activity.-Yadaiah, M., Sudhamalla, B., Rao, P. N., Roy, K. R., Ramakrishna, D., Hussain Syed, G., Ramaiah, K. V. A., Bhuyan, A. K. Arrested cell proliferation through cysteine protease activity of eukaryotic ribosomal protein S4. FASEB J. 27, 803-810 (2013). www.fasebj.org	[Yadaiah, Madasu; Sudhamalla, Babu; Rao, P. Nageswara; Ramakrishna, Dasari; Bhuyan, Abani K.] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India; [Roy, Karnati R.; Syed, Gulam Hussain; Ramaiah, Kolluru V. A.; Bhuyan, Abani K.] Univ Hyderabad, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Bhuyan, AK (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India.	akbsc@uohyd.ernet.in	Syed, Gulam/N-7842-2013; Madasu, Yadaiah/G-5031-2013	Madasu, Yadaiah/0000-0002-3536-6905; Syed, Gulam/0000-0001-8540-6162; Ramaiah, Kolluru/0000-0002-3478-5294	India Council of Scientific and Industrial Research [38(1037)/02/EMR-II]; Department of Biotechnology [BRB/10/622/2008]; Department of Science and Technology (DST) [4/1/2003-SF]; DST Promotion of University Research and Scientific Excellence (PURSE) funds	India Council of Scientific and Industrial Research; Department of Biotechnology; Department of Science and Technology (DST)(Department of Science & Technology (India)); DST Promotion of University Research and Scientific Excellence (PURSE) funds	This research was supported by grants from the India Council of Scientific and Industrial Research [38(1037)/02/EMR-II], the Department of Biotechnology (BRB/10/622/2008), and the Department of Science and Technology (DST; 4/1/2003-SF) to A. K. B. and by DST Promotion of University Research and Scientific Excellence (PURSE) funds to K.R.R.	Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; BRAUN HP, 1994, BBA-GENE STRUCT EXPR, V1218, P435, DOI 10.1016/0167-4781(94)90200-3; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; Davies C, 1998, EMBO J, V17, P4545, DOI 10.1093/emboj/17.16.4545; DEAN D, 1980, P NATL ACAD SCI-BIOL, V77, P3590, DOI 10.1073/pnas.77.6.3590; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Flygare J, 2007, BLOOD, V109, P980, DOI 10.1182/blood-2006-07-038232; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Maisnier-Patin S, 2007, J MOL BIOL, V366, P207, DOI 10.1016/j.jmb.2006.11.047; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; NOWOTNY V, 1988, BIOCHEMISTRY-US, V27, P7051, DOI 10.1021/bi00418a057; O'Farrell PA, 1999, STRUCT FOLD DES, V7, P619, DOI 10.1016/S0969-2126(99)80083-5; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rzychon M, 2004, ACTA BIOCHIM POL, V51, P861; Sayers EW, 2000, BIOCHEMISTRY-US, V39, P13602, DOI 10.1021/bi0013391; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schumacher AM, 2006, BIOCHEMISTRY-US, V45, P13614, DOI 10.1021/bi060413y; Takeda A, 1996, J BIOCHEM-TOKYO, V120, P353; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; VARTIKAR JV, 1989, J MOL BIOL, V209, P221, DOI 10.1016/0022-2836(89)90274-X; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Yadaiah M, 2012, PROTEIN EXPRES PURIF, V81, P55, DOI 10.1016/j.pep.2011.09.003; YATES JL, 1980, CELL, V21, P517, DOI 10.1016/0092-8674(80)90489-4; YATES JL, 1980, P NATL ACAD SCI-BIOL, V77, P1837, DOI 10.1073/pnas.77.4.1837; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zheng WJ, 1998, MOL CELL BIOL, V18, P3580, DOI 10.1128/MCB.18.6.3580; ZINN AR, 1994, MOL CELL BIOL, V14, P2485, DOI 10.1128/MCB.14.4.2485	36	3	3	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2013	27	2					803	810		10.1096/fj.12-217752	http://dx.doi.org/10.1096/fj.12-217752			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23118024				2022-12-25	WOS:000314358000038
J	Chu, PC; Chuang, HC; Kulp, SK; Chen, CS				Chu, Po-Chen; Chuang, Hsiao-Ching; Kulp, Samuel K.; Chen, Ching-Shih			The mRNA-stabilizing Factor HuR Protein Is Targeted by beta-TrCP Protein for Degradation in Response to Glycolysis Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENT; CASPASE-MEDIATED CLEAVAGE; POSTTRANSCRIPTIONAL REGULATION; COLON-CANCER; KAPPA-B; EXPRESSION; BINDING; ALPHA; PHOSPHORYLATION; CYCLOOXYGENASE-2	The mRNA-stabilizing protein HuR acts a stress response protein whose function and/or protein stability are modulated by diverse stress stimuli through posttranslational modifications. Here, we report a novel mechanism by which metabolic stress facilitates proteasomal degradation of HuR in cancer cells. In response to the glucose transporter inhibitor CG-5, HuR translocates to the cytoplasm, where it is targeted by the ubiquitin E3 ligase beta-TrCP1 for degradation. The cytoplasmic localization of HuR is facilitated by PKC alpha-mediated phosphorylation at Ser-318 as the Ser-318 -> alanine substitution abolishes the ability of the resulting HuR to bind PKC alpha and to undergo nuclear export. The mechanistic link between beta-TrCP1 and HuR degradation was supported by the ability of ectopically expressed beta-TrCP1 to mimic CG-5 to promote HuR degradation and by the protective effect of dominant negative inhibition of beta-TrCP1 on HuR ubiquitination and degradation. Substrate targeting of HuR by beta-TrCP1 was further verified by coimmunoprecipitation and in vitro GST pull-down assays and by the identification of a beta-TrCP1 recognition site. Although HuR does not contain a DSG destruction motif, we obtained evidence that beta-TrCP1 recognizes an unconventional motif, (296)EEAMAIAS(304), in the RNA recognition motif 3. Furthermore, mutational analysis indicates that IKK alpha-dependent phosphorylation at Ser-304 is crucial to the binding of HuR to beta-TrCP1. Mechanistically, this HuR degradation pathway differs from that reported for heat shock and hypoxia, which underlies the complexity in the regulation of HuR turnover under different stress stimuli. The ability of glycolysis inhibitors to target the expression of oncogenic proteins through HuR degradation might foster novel strategies for cancer therapy.	[Chu, Po-Chen; Chuang, Hsiao-Ching; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Div Med Chem, Coll Pharm, Columbus, OH 43210 USA; [Chu, Po-Chen; Chuang, Hsiao-Ching; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Chen, Ching-Shih] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Cheng Kung University	Chen, CS (corresponding author), Ohio State Univ, Div Med Chem, Coll Pharm, 500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu			National Cancer Institute Public Health Service [R01CA112250]; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	National Cancer Institute Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute Public Health Service Grant R01CA112250.	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Chae MJ, 2009, EXP MOL MED, V41, P824, DOI 10.3858/emm.2009.41.11.088; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Davis M, 2002, GENE DEV, V16, P439, DOI 10.1101/gad.218702; Denkert C, 2006, MODERN PATHOL, V19, P1261, DOI 10.1038/modpathol.3800645; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Embade N, 2012, HEPATOLOGY, V55, P1237, DOI 10.1002/hep.24795; Erkinheimo TL, 2003, CANCER RES, V63, P7591; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Kim HH, 2008, CELL CYCLE, V7, P3371; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kim HH, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/981487; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Niesporek S, 2008, INT J ONCOL, V32, P341; Song IS, 2005, J BIOL CHEM, V280, P28230, DOI 10.1074/jbc.M413103200; Srikantan S, 2012, FRONT BIOSCI-LANDMRK, V17, P189, DOI 10.2741/3921; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Wang DS, 2012, J MED CHEM, V55, P3827, DOI 10.1021/jm300015m; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Wei SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047298; Wei SO, 2010, J BIOL CHEM, V285, P9780, DOI 10.1074/jbc.M109.065466; Yoshida K, 2008, ONCOGENE, V27, P1183, DOI 10.1038/sj.onc.1210722; Zou TT, 2006, J BIOL CHEM, V281, P19387, DOI 10.1074/jbc.M602344200	36	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43639	43650		10.1074/jbc.M112.393678	http://dx.doi.org/10.1074/jbc.M112.393678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115237	Green Published, hybrid			2022-12-25	WOS:000312940800044
J	Crother, TR; Ma, J; Jupelli, M; Chiba, N; Chen, S; Slepenkin, A; Alsabeh, R; Peterson, E; Shimada, K; Arditi, M				Crother, Timothy R.; Ma, Jun; Jupelli, Madhulika; Chiba, Norika; Chen, Shuang; Slepenkin, Anatoly; Alsabeh, Randa; Peterson, Ellena; Shimada, Kenichi; Arditi, Moshe			Plasmacytoid Dendritic Cells Play a Role for Effective Innate Immune Responses during Chlamydia pneumoniae Infection in Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NK CELLS; IFN-GAMMA; MOUSE; ACTIVATION; RESISTANCE; SURVIVAL	Plasmacytoid dendritic cells (pDCs) are known for their robust antiviral response and their pro-tolerance effects towards allergic diseases and tissue engraftments. However, little is known about the role pDCs may play during a bacterial infection, including pulmonary Chlamydia pneumoniae (CP). In this study, we investigated the role of pDCs during pulmonary CP infection. Our results revealed that depletion of pDCs during acute CP infection in mice results in delayed and reduced lung inflammation, with an early delay in cellular recruitment and significant reduction in early cytokine production in the lungs. This was followed by impaired and delayed bacterial clearance from the lungs which then resulted in a severe and prolonged chronic inflammation and iBALT like structures containing large numbers of B and T cells in these animals. We also observed that increasing the pDC numbers in the lung by FLT3L treatment experimentally results in greater lung inflammation during acute CP infection. In contrast to these results, restimulation of T-cells in the draining lymph nodes of pDC-depleted mice induced greater amounts of proinflammatory cytokines than we observed in control mice. These results suggest that pDCs in the lung may provide critical proinflammatory innate immune responses in response to CP infection, but are suppressive towards adaptive immune responses in the lymph node. Thus pDCs in the lung and the draining lymph node appear to have different roles and phenotypes during acute CP infection and may play a role in host immune responses.	[Ma, Jun; Arditi, Moshe] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [Slepenkin, Anatoly; Peterson, Ellena] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Alsabeh, Randa] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Irvine; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Arditi, M (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.	moshe.arditi@cshs.org	Crother, Timothy R/E-2879-2010	Crother, Timothy R/0000-0001-8465-6127	National Institutes of Health [HL-66436, AI-067995]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067995, R56AI067995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants HL-66436 and AI-067995 (to MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang DKY, 2010, J IMMUNOL, V184, P5429, DOI 10.4049/jimmunol.1000128; Barr DP, 2007, EUR J IMMUNOL, V37, P1334, DOI 10.1002/eji.200636362; Bjoerck P, 2011, J IMMUNOL, V186, P1477, DOI 10.4049/jimmunol.1000454; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Crother TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020784; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; del Rio ML, 2011, TRANSPL INT, V24, P501, DOI 10.1111/j.1432-2277.2011.01220.x; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; Hadeiba H, 2012, IMMUNITY, V36, P438, DOI 10.1016/j.immuni.2012.01.017; Hochrein Hubertus, 2008, V183, P153; Kool M, 2011, J LEUKOCYTE BIOL, V90, P1177, DOI 10.1189/jlb.0610342; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Mach N, 2000, CANCER RES, V60, P3239; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Persson CM, 2010, EUR J IMMUNOL, V40, P2155, DOI 10.1002/eji.200940098; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rothfuchs AG, 2006, J IMMUNOL, V176, P6982, DOI 10.4049/jimmunol.176.11.6982; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Schroeder NWJ, 2008, J ALLERGY CLIN IMMUN, V122, P595, DOI 10.1016/j.jaci.2008.06.038; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Solodova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018543; Sorrentino R, 2010, AM J RESP CELL MOL, V43, P422, DOI 10.1165/rcmb.2009-0224OC; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Tam MA, 2011, IMMUNOL LETT, V138, P104, DOI 10.1016/j.imlet.2011.03.007; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298	36	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48655	10.1371/journal.pone.0048655	http://dx.doi.org/10.1371/journal.pone.0048655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119083	Green Published, gold			2022-12-25	WOS:000310600500191
J	Li, Y; Varala, K; Moose, SP; Hudson, ME				Li, Ying; Varala, Kranthi; Moose, Stephen P.; Hudson, Matthew E.			The Inheritance Pattern of 24 nt siRNA Clusters in Arabidopsis Hybrids Is Influenced by Proximity to Transposable Elements	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; SMALL RNAS; NUCLEOTIDE-SEQUENCE; PARENTAL INBREDS; DNA METHYLATION; MAIZE; HETEROSIS; FERTILIZATION; POLYMORPHISM; REVEALS	Hybrids often display increased size and growth, and thus are widely cultivated in agriculture and horticulture. Recent discoveries demonstrating the important regulatory roles of small RNAs have greatly improved our understanding of many basic biological questions, and could illuminate the molecular basis for the enhanced growth and size of hybrid plants. We profiled small RNAs by deep sequencing to characterize the inheritance patterns of small RNA levels in reciprocal hybrids of two Arabidopsis thaliana accessions, Columbia and Landsberg erecta. We find 24-nt siRNAs predominate among those small RNAs that are differentially expressed between the parents. Following hybridization, the transposable element (TE)-derived siRNAs are often inherited in an additive manner, whereas siRNAs associated with protein-coding genes are often down-regulated in hybrids to the levels observed for the parent with lower relative siRNA levels. Among the protein-coding genes that exhibit this pattern, genes that function in pathogen defense, abiotic stress tolerance, and secondary metabolism are significantly enriched. Small RNA clusters from protein-coding genes where a TE is present within one kilobase show a different predominant inheritance pattern (additive) from those that do not (low-parent dominance). Thus, down-regulation in the form of low-parent dominance is likely the default pattern of inheritance for genic siRNA, and a different inheritance mechanism for TE siRNA is suggested.	[Li, Ying; Varala, Kranthi; Moose, Stephen P.; Hudson, Matthew E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Moose, Stephen P.; Hudson, Matthew E.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Hudson, ME (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	mhudson@illinois.edu	Varala, Kranthi/A-2954-2013; Varala, Kranthi/AHD-3960-2022; Hudson, Matthew E/A-4438-2008	Varala, Kranthi/0000-0003-1051-6636; Varala, Kranthi/0000-0003-1051-6636; Hudson, Matthew E/0000-0002-4737-0936; Li, Ying/0000-0002-5258-7355	NSF [0922512]; Division Of Integrative Organismal Systems [0922512] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by a grant from the NSF (http://www.nsf.gov/) Plant Genome Research Program, # 0922512 to MEH and SPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Barber WT, 2012, P NATL ACAD SCI USA, V109, P10444, DOI 10.1073/pnas.1202073109; Barth S, 2003, HEREDITY, V91, P36, DOI 10.1038/sj.hdy.6800276; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birchler JA, 2010, PLANT CELL, V22, P2105, DOI 10.1105/tpc.110.076133; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Darwin CR, 1876, EFFECTS CROSS SELF F; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Erhard KF, 2009, SCIENCE, V323, P1201, DOI 10.1126/science.1164508; Fujimoto R, 2012, P NATL ACAD SCI USA, V109, P7109, DOI 10.1073/pnas.1204464109; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Greaves IK, 2012, P NATL ACAD SCI USA, V109, P3570, DOI 10.1073/pnas.1201043109; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; GRUENDLER P, 1989, NUCLEIC ACIDS RES, V17, P6395, DOI 10.1093/nar/17.15.6395; Guo M, 2008, PLANT MOL BIOL, V66, P551, DOI 10.1007/s11103-008-9290-z; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hazzouri RM, 2008, GENETICS, V179, P581, DOI 10.1534/genetics.107.085761; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Hoecker N, 2008, GENETICS, V179, P1275, DOI 10.1534/genetics.108.088278; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Kidner CA, 2003, TRENDS GENET, V19, P13, DOI 10.1016/S0168-9525(02)00011-2; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Y, 2011, PLANT PHYSIOL, V156, P2124, DOI 10.1104/pp.111.179416; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; Meyer S, 2007, PLANT MOL BIOL, V63, P381, DOI 10.1007/s11103-006-9095-x; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Pea G, 2008, PLANT SCI, V174, P17, DOI 10.1016/j.plantsci.2007.09.005; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Qu W, 2009, GENOME RES, V19, P1309, DOI 10.1101/gr.089151.108; REDEI GP, 1962, Z VEREBUNGSL, V93, P164; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Shen HS, 2012, PLANT CELL, V24, P875, DOI 10.1105/tpc.111.094870; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; Sun QX, 2004, PLANT SCI, V166, P651, DOI 10.1016/j.plantsci.2003.10.033; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swanson-Wagner RA, 2009, SCIENCE, V326, P1118, DOI 10.1126/science.1178294; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Tollenaar M, 1999, CROP SCI, V39, P1597, DOI 10.2135/cropsci1999.3961597x; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; UNFRIED I, 1989, NUCLEIC ACIDS RES, V17, P7513, DOI 10.1093/nar/17.18.7513; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Vaucheret Herve, 2005, Sci STKE, V2005, ppe43, DOI 10.1126/stke.3002005pe43; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wang ZK, 2006, THEOR APPL GENET, V113, P1283, DOI 10.1007/s00122-006-0382-3; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Zhang HY, 2008, MOL PLANT, V1, P720, DOI 10.1093/mp/ssn022; Zhuang Y, 2007, GENETICS, V177, P1987, DOI 10.1534/genetics.107.080325	57	33	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47043	10.1371/journal.pone.0047043	http://dx.doi.org/10.1371/journal.pone.0047043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118865	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500014
J	Zocher, G; Saleh, O; Heim, JB; Herbst, DA; Heide, L; Stehle, T				Zocher, Georg; Saleh, Orwah; Heim, Joel B.; Herbst, Dominik A.; Heide, Lutz; Stehle, Thilo			Structure-Based Engineering Increased the Catalytic Turnover Rate of a Novel Phenazine Prenyltransferase	PLOS ONE			English	Article							AROMATIC PRENYLTRANSFERASES; PROTEIN-STRUCTURE; BIOSYNTHESIS; PRENYLATION; SYNTHASE; CRYSTALLOGRAPHY; IDENTIFICATION; OVERPRODUCTION; FERMENTATION; PURIFICATION	Prenyltransferases (PTs) catalyze the regioselective transfer of prenyl moieties onto aromatic substrates in biosynthetic pathways of microbial secondary metabolites. Therefore, these enzymes contribute to the chemical diversity of natural products. Prenylation is frequently essential for the pharmacological properties of these metabolites, including their antibiotic and antitumor activities. Recently, the first phenazine PTs, termed EpzP and PpzP, were isolated and biochemically characterized. The two enzymes play a central role in the biosynthesis of endophenazines by catalyzing the regiospecific prenylation of 5,10-dihydrophenazine-1-carboxylic acid (dhPCA) in the secondary metabolism of two different Streptomyces strains. Here we report crystal structures of EpzP in its unliganded state as well as bound to S-thiolodiphosphate (SPP), thus defining the first three-dimensional structures for any phenazine PT. A model of a ternary complex resulted from in silico modeling of dhPCA and site-directed mutagenesis. The structural analysis provides detailed insight into the likely mechanism of phenazine prenylation. The catalytic mechanism suggested by the structure identifies amino acids that are required for catalysis. Inspection of the structures and the model of the ternary complex furthermore allowed us to rationally engineer EpzP variants with up to 14-fold higher catalytic reaction rate compared to the wild-type enzyme. This study therefore provides a solid foundation for additional enzyme modifications that should result in efficient, tailor-made biocatalysts for phenazines production.	[Saleh, Orwah; Heide, Lutz] Univ Tubingen, Inst Pharmaceut, Tubingen, Germany; [Zocher, Georg; Heim, Joel B.; Herbst, Dominik A.; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Vanderbilt University	Heide, L (corresponding author), Univ Tubingen, Inst Pharmaceut, Tubingen, Germany.	lutz.heide@uni-tuebingen.de; thilo.stehle@uni-tuebingen.de	Heim, Joel Benjamin/K-3615-2016	Heim, Joel Benjamin/0000-0001-9702-9480; Herbst, Dominik A./0000-0003-4671-5493; Heide, Lutz/0000-0001-7809-7453	German Federal Ministry of Education and Research (BMBF GenBioCom); Tishrin University, Syria	German Federal Ministry of Education and Research (BMBF GenBioCom)(Federal Ministry of Education & Research (BMBF)); Tishrin University, Syria	This work was supported by a grant from the German Federal Ministry of Education and Research (BMBF GenBioCom) to LH and by a scholarship from Tishrin University, Syria to OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; Bringmann G, 2007, J ORG CHEM, V72, P4198, DOI 10.1021/jo0703404; de Andrade-Neto VF, 2004, BIOORG MED CHEM LETT, V14, P1145, DOI 10.1016/j.bmcl.2003.12.069; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gebhardt K, 2002, J ANTIBIOT, V55, P794, DOI 10.7164/antibiotics.55.794; Grundmann A, 2005, MICROBIOL-SGM, V151, P2199, DOI 10.1099/mic.0.27962-0; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Jost M, 2010, J AM CHEM SOC, V132, P17849, DOI 10.1021/ja106817c; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kumano T, 2010, J BIOL CHEM, V285, P39663, DOI 10.1074/jbc.M110.153957; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laursen JB, 2004, CHEMINFORM, V35; Li SM, 2010, NAT PROD REP, V27, P57, DOI 10.1039/b909987p; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Metzger U, 2010, J MOL BIOL, V404, P611, DOI 10.1016/j.jmb.2010.09.067; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OMURA S, 1989, J ANTIBIOT, V42, P1037, DOI 10.7164/antibiotics.42.1037; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Saleh O, 2009, PHYTOCHEMISTRY, V70, P1728, DOI 10.1016/j.phytochem.2009.05.009; Saleh O, 2009, J BIOL CHEM, V284, P14439, DOI 10.1074/jbc.M901312200; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Schultz AW, 2010, J NAT PROD, V73, P373, DOI 10.1021/np9006876; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seeger K, 2011, MICROB BIOTECHNOL, V4, P252, DOI 10.1111/j.1751-7915.2010.00234.x; SHINYA K, 1993, J ORG CHEM, V58, P4170, DOI 10.1021/jo00067a069; SHINYA K, 1991, TETRAHEDRON LETT, V32, P943, DOI 10.1016/S0040-4039(00)92126-9; Steffan N, 2007, CHEMBIOCHEM, V8, P1298, DOI 10.1002/cbic.200700107; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Thalladi VR, 2000, NEW J CHEM, V24, P143, DOI 10.1039/a908744c; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang Y, 2012, BIOCHEMISTRY; Yin WB, 2007, CHEMBIOCHEM, V8, P1154, DOI 10.1002/cbic.200700079; Yin WB, 2009, J BIOL CHEM, V284, P100, DOI 10.1074/jbc.M807606200; Yu X, 2011, CHEMBIOCHEM, V12, P2280, DOI 10.1002/cbic.201100413; Zou HX, 2011, APPL MICROBIOL BIOT, V89, P1443, DOI 10.1007/s00253-010-2956-x	51	17	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48427	10.1371/journal.pone.0048427	http://dx.doi.org/10.1371/journal.pone.0048427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119011	Green Submitted, gold, Green Published			2022-12-25	WOS:000310600500131
J	Butler, RE; Brodin, P; Jang, J; Jang, MS; Robertson, BD; Gicquel, B; Stewart, GR				Butler, Rachel E.; Brodin, Priscille; Jang, Jichan; Jang, Mi-Seon; Robertson, Brian D.; Gicquel, Brigitte; Stewart, Graham R.			The Balance of Apoptotic and Necrotic Cell Death in Mycobacterium tuberculosis Infected Macrophages Is Not Dependent on Bacterial Virulence	PLOS ONE			English	Article							RECEPTOR-INTERACTING PROTEIN; CASPASE-INDEPENDENT PATHWAY; PROGRAMMED NECROSIS; ADAPTIVE IMMUNITY; HOST MACROPHAGES; T-LYMPHOCYTES; STRAIN H37RV; INDUCTION; RELEASE; MONOCYTES/MACROPHAGES	Background: An important mechanism of Mycobacterium tuberculosis pathogenesis is the ability to control cell death pathways in infected macrophages: apoptotic cell death is bactericidal, whereas necrotic cell death may facilitate bacterial dissemination and transmission. Methods: We examine M. tuberculosis control of spontaneous and chemically induced macrophage cell death using automated confocal fluorescence microscopy, image analysis, flow cytometry, plate-reader based vitality assays, and M. tuberculosis strains including H37Rv, and isogenic virulent and avirulent strains of the Beijing lineage isolate GC1237. Results: We show that bacterial virulence influences the dynamics of caspase activation and the total level of cytotoxicity. We show that the powerful ability of M. tuberculosis to inhibit exogenously stimulated apoptosis is abrogated by loss of virulence. However, loss of virulence did not influence the balance of macrophage apoptosis and necrosis - both virulent and avirulent isogenic strains of GC1237 induced predominantly necrotic cell death compared to H37Rv which induced a higher relative level of apoptosis. Conclusions: This reveals that macrophage necrosis and apoptosis are independently regulated during M. tuberculosis infection of macrophages. Virulence affects the level of host cell death and ability to inhibit apoptosis but other strain-specific characteristics influence the ultimate mode of host cell death and alter the balance of apoptosis and necrosis.	[Butler, Rachel E.; Stewart, Graham R.] Univ Surrey, Div Microbial Sci, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Brodin, Priscille; Jang, Jichan; Jang, Mi-Seon] Inst Pasteur Korea, Seoul, South Korea; [Brodin, Priscille] Inst Pasteur, F-59019 Lille, France; [Robertson, Brian D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, MRC Ctr Mol Bacteriol & Infect, London, England; [Gicquel, Brigitte] Inst Pasteur, Paris, France	University of Surrey; Institut Pasteur Korea; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Imperial College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Butler, RE (corresponding author), Univ Surrey, Div Microbial Sci, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	R.Shrimpton@surrey.ac.uk; G.Stewart@surrey.ac.uk	Brodin, Priscille/N-6979-2019; Brodin, Priscille/E-5802-2014	Brodin, Priscille/0000-0003-0991-7344; Brodin, Priscille/0000-0003-0991-7344; Stewart, Graham/0000-0002-6867-6248; deboosere, Nathalie/0000-0002-2873-5485; Robertson, Brian D./0000-0001-5785-5307	Wellcome Trust [WT090242MA]; European Community (TB-MACS) [LSHP-CT-2006-037732]; TB-VIR [200973]; Institut Pasteur Korea; MRC [MR/J006874/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Community (TB-MACS); TB-VIR; Institut Pasteur Korea; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust WT090242MA http://www.wellcome.ac.uk/, the European Community (TB-MACS, Grant no LSHP-CT-2006-037732 and TB-VIR, Grant nr 200973) http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/ and the Institut Pasteur Korea. The funders provided financial means to undertake the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfo RBV, 2006, EUR J IMMUNOL, V36, P345, DOI 10.1002/eji.200535202; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Brodin P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001100; Butler RE, 2010, CELL MICROBIOL, V12, P1186, DOI 10.1111/j.1462-5822.2010.01463.x; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Ciaramella A, 2004, J INFECT DIS, V190, P1167, DOI 10.1086/423850; Dao DN, 2004, INFECT IMMUN, V72, P2067, DOI 10.1128/IAI.72.4.2067-2074.2004; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Dhiman R, 2007, BBA-GEN SUBJECTS, V1770, P649, DOI 10.1016/j.bbagen.2006.11.016; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Eklund D, 2010, CLIN VACCINE IMMUNOL, V17, P513, DOI 10.1128/CVI.00446-09; Fenistein D, 2008, CYTOM PART A, V73A, P958, DOI 10.1002/cyto.a.20627; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Loeuillet C, 2006, J IMMUNOL, V177, P6245, DOI 10.4049/jimmunol.177.9.6245; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Obregon-Henao A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029970; Oddo M, 1998, J IMMUNOL, V160, P5448; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; Sanchez A, 2009, SCAND J IMMUNOL, V69, P20, DOI 10.1111/j.1365-3083.2008.02193.x; Santucci MB, 2000, J INFECT DIS, V181, P1506, DOI 10.1086/315371; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Winau F, 2004, CELL MICROBIOL, V6, P599, DOI 10.1111/j.1462-5822.2004.00408.x; Wong KW, 2011, CELL MICROBIOL, V13, P1371, DOI 10.1111/j.1462-5822.2011.01625.x; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x	50	23	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47573	10.1371/journal.pone.0047573	http://dx.doi.org/10.1371/journal.pone.0047573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118880	gold, Green Published			2022-12-25	WOS:000310705600013
J	Wong, MV; Jiang, SZ; Palasingam, P; Kolatkar, PR				Wong, Marie Vivian; Jiang, Sizun; Palasingam, Paaventhan; Kolatkar, Prasanna R.			A Divalent Ion Is Crucial in the Structure and Dominant-Negative Function of ID Proteins, a Class of Helix-Loop-Helix Transcription Regulators	PLOS ONE			English	Article							DNA-BINDING; CELL-CYCLE; E-BOX; DOMAIN; RECOGNITION; INHIBITION; EXPRESSION; COMPLEXES; SOFTWARE; DISTINCT	Inhibitors of DNA binding and differentiation (ID) proteins, a dominant-negative group of helix-loop-helix (HLH) transcription regulators, are well-characterized key players in cellular fate determination during development in mammals as well as Drosophila. Although not oncogenes themselves, their upregulation by various oncogenic proteins (such as Ras, Myc) and their inhibitory effects on cell cycle proteins (such as pRb) hint at their possible roles in tumorigenesis. Furthermore, their potency as inhibitors of cellular differentiation, through their heterodimerization with subsequent inactivation of the ubiquitous E proteins, suggest possible novel roles in engineering induced pluripotent stem cells (iPSCs). We present the high-resolution 2.1 angstrom crystal structure of ID2 (HLH domain), coupled with novel biochemical insights in the presence of a divalent ion, possibly calcium (Ca2+), in the loop of ID proteins, which appear to be crucial for the structure and activity of ID proteins. These new insights will pave the way for new rational drug designs, in addition to current synthetic peptide options, against this potent player in tumorigenesis as well as more efficient ways for stem cells reprogramming.	[Wong, Marie Vivian; Jiang, Sizun; Palasingam, Paaventhan; Kolatkar, Prasanna R.] Genome Inst Singapore, Lab Struct Biochem, Singapore, Singapore; [Wong, Marie Vivian; Kolatkar, Prasanna R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Kolatkar, PR (corresponding author), Genome Inst Singapore, Lab Struct Biochem, Singapore, Singapore.	kolatkarp@gis.a-star.edu.sg	Jiang, Sizun/AAO-2333-2020	Jiang, Sizun/0000-0001-6149-3142; kolatkar, prasanna/0000-0003-4970-5944; Wong-Erasmus, Marie/0000-0003-0066-6606	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences; Agency for Science, Technology and Research (A*STAR), Singapore	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	Diffraction data were collected at beamline X29 of the National Synchrotron Light Source (NSLS) supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences. Funding for laboratory reagents to PRK and open access charge: Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmadpour F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032136; BARINAGA M, 1991, SCIENCE, V251, P1176, DOI 10.1126/science.1848724; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bhattacharya A, 2011, CELL, V147, P881, DOI 10.1016/j.cell.2011.08.055; BIGGS J, 1992, P NATL ACAD SCI USA, V89, P1512, DOI 10.1073/pnas.89.4.1512; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chaudhary J, 2005, BIOL REPROD, V72, P1205, DOI 10.1095/biolreprod.104.035717; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; CHRISTY BA, 1991, P NATL ACAD SCI USA, V88, P1815, DOI 10.1073/pnas.88.5.1815; CORNELIUSSEN B, 1994, NATURE, V368, P760, DOI 10.1038/368760a0; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong ZQ, 2010, ORAL ONCOL, V46, P154, DOI 10.1016/j.oraloncology.2009.11.005; Eletsky A, 2011, PDB ID 2LFH SOLUTION; ELLENBERGER T, 1994, GENE DEV, V8, P970, DOI 10.1101/gad.8.8.970; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; Hermann S, 1998, CELL CALCIUM, V23, P135, DOI 10.1016/S0143-4160(98)90112-9; Hong SH, 2011, J CELL SCI, V124, P1445, DOI 10.1242/jcs.077511; Ishii R, 2012, EMBO J; Israel MA, 1999, CANCER RES, V59, p1726S; Langlands K, 1997, J BIOL CHEM, V272, P19785, DOI 10.1074/jbc.272.32.19785; Liu J, 2000, BIOCHEM BIOPH RES CO, V273, P1042, DOI 10.1006/bbrc.2000.3055; Longo A, 2008, PDB ID 2QL2 CRYSTAL; Ma PC, 1994, PDB ID 1MDY CRYSTAL; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mern DS, 2010, BRIT J CANCER, V103, P1237, DOI 10.1038/sj.bjc.6605897; Moon J-H, 2011, J MOL CELL BIOL; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Ng CKL, 2012, NUCL ACIDS RES; Niola F, 2012, NAT CELL BIOL; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEDERSEN CJ, 1967, J AM CHEM SOC, V89, P7017, DOI 10.1021/ja01002a035; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; PESCE S, 1993, MOL CELL BIOL, V13, P7874, DOI 10.1128/MCB.13.12.7874; RIECHMANN V, 1994, NUCLEIC ACIDS RES, V22, P749, DOI 10.1093/nar/22.5.749; Romero-Lanman EE, 2012, STEM CELLS DEV, V21, P384, DOI 10.1089/scd.2011.0428; Simossis VA, NUCL ACIDS RES, V33, pW289; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; Wibley J, 1996, BBA-PROTEIN STRUCT M, V1294, P138, DOI 10.1016/0167-4838(96)00008-8; Wong MV, 2012, ACTA CRYSTAL UNPUB F	47	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48591	10.1371/journal.pone.0048591	http://dx.doi.org/10.1371/journal.pone.0048591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119064	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705600051
J	Gillespie, MJ; Stanley, D; Chen, HL; Donald, JA; Nicholas, KR; Moore, RJ; Crowley, TM				Gillespie, Meagan J.; Stanley, Dragana; Chen, Honglei; Donald, John A.; Nicholas, Kevin R.; Moore, Robert J.; Crowley, Tamsyn M.			Functional Similarities between Pigeon 'Milk' and Mammalian Milk: Induction of Immune Gene Expression and Modification of the Microbiota	PLOS ONE			English	Article							VIRUS-INDUCED EXPRESSION; EPIDERMAL GROWTH-FACTOR; GUT MICROBIOTA; IN-VITRO; SALMONELLA-TYPHIMURIUM; ANTIVIRAL CYTOKINES; PROLACTIN; COMPONENTS; SYSTEM; INHIBITION	Pigeon 'milk' and mammalian milk have functional similarities in terms of nutritional benefit and delivery of immunoglobulins to the young. Mammalian milk has been clearly shown to aid in the development of the immune system and microbiota of the young, but similar effects have not yet been attributed to pigeon 'milk'. Therefore, using a chicken model, we investigated the effect of pigeon 'milk' on immune gene expression in the Gut Associated Lymphoid Tissue (GALT) and on the composition of the caecal microbiota. Chickens fed pigeon 'milk' had a faster rate of growth and a better feed conversion ratio than control chickens. There was significantly enhanced expression of immune-related gene pathways and interferon-stimulated genes in the GALT of pigeon 'milk'-fed chickens. These pathways include the innate immune response, regulation of cytokine production and regulation of B cell activation and proliferation. The caecal microbiota of pigeon 'milk'-fed chickens was significantly more diverse than control chickens, and appears to be affected by prebiotics in pigeon 'milk', as well as being directly seeded by bacteria present in pigeon 'milk'. Our results demonstrate that pigeon 'milk' has further modes of action which make it functionally similar to mammalian milk. We hypothesise that pigeon 'lactation' and mammalian lactation evolved independently but resulted in similarly functional products.	[Gillespie, Meagan J.; Stanley, Dragana; Chen, Honglei; Moore, Robert J.; Crowley, Tamsyn M.] CSIRO Anim Food & Hlth Sci, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Gillespie, Meagan J.; Donald, John A.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia; [Nicholas, Kevin R.; Crowley, Tamsyn M.] Deakin Univ, Ctr Chem & Biotechnol, Geelong, Vic 3217, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Deakin University; Deakin University	Gillespie, MJ (corresponding author), CSIRO Anim Food & Hlth Sci, Australian Anim Hlth Lab, Geelong, Vic, Australia.	Meagan.gillespie@csiro.au	Stanley, Dragana/AAC-2596-2020; Gillespie, Meagan/H-1879-2013; Moore, Robert J/D-8352-2011; Donald, John/B-4656-2012	Stanley, Dragana/0000-0001-7019-4726; Moore, Robert J/0000-0002-0776-5861; Craven, Meagan/0000-0001-5962-3403; Crowley, Tamsyn/0000-0002-3698-8917; Donald, John/0000-0001-5930-2642	Deakin University; CSIRO	Deakin University; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	MG was supported by Deakin University and CSIRO PhD scholarships. This study was funded by CSIRO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkerroum N, 2010, INT J DAIRY TECHNOL, V63, P320, DOI 10.1111/j.1471-0307.2010.00584.x; Berghall H, 2006, MICROBES INFECT, V8, P2138, DOI 10.1016/j.micinf.2006.04.005; BRANDTZAEG P, 1989, GASTROENTEROLOGY, V97, P1562, DOI 10.1016/0016-5085(89)90406-X; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chichlowski M, 2011, ANNU REV FOOD SCI T, V2, P331, DOI 10.1146/annurev-food-022510-133743; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cooper CA, 2011, TRANSGENIC RES, V20, P1235, DOI 10.1007/s11248-011-9489-7; Cregan MD, 2002, EXP PHYSIOL, V87, P207, DOI 10.1113/eph8702327; Davies WL, 1939, BIOCHEM J, V33, P898, DOI 10.1042/bj0330898; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Field CJ, 2005, J NUTR, V135, P1; FRELINGER JA, 1971, SCIENCE, V171, P1260, DOI 10.1126/science.171.3977.1260; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Garofalo R, 2010, J PEDIATR-US, V156, pS36, DOI 10.1016/j.jpeds.2009.11.019; Gillespie MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-452; GOLDMAN AS, 1993, PEDIATR INFECT DIS J, V12, P664, DOI 10.1097/00006454-199308000-00008; GOUDSWAARD J, 1979, DEV COMP IMMUNOL, V3, P307, DOI 10.1016/S0145-305X(79)80027-0; GUARESCHI C., 1936, Bollettino della Societa Italiana di Biologia Sperimentale, V11, P411; HEGDE SN, 1973, INDIAN J EXP BIOL, V11, P238; Hernandez-Hernandez O, 2012, FOOD MICROBIOL, V30, P355, DOI 10.1016/j.fm.2011.12.022; HINTON A, 1995, AVIAN DIS, V39, P309, DOI 10.2307/1591872; Hinton A, 1996, J APPL BACTERIOL, V81, P188, DOI 10.1111/j.1365-2672.1996.tb04498.x; Hinton A, 1997, J APPL MICROBIOL, V82, P780, DOI 10.1046/j.1365-2672.1997.00156.x; Honjo T, 2006, GUT ASS LYMPHOID TIS; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; LeLoach J. R CDE, 1992, PROBIOTIC CONTROL SA; Lkhider M, 1996, ENDOCRINOLOGY, V137, P4969, DOI 10.1210/en.137.11.4969; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; MALO C, 1982, GASTROENTEROLOGY, V83, P28; MATTHEWS THJ, 1976, LANCET, V2, P1387; McAveney KM, 2000, MOL ENDOCRINOL, V14, P295, DOI 10.1210/me.14.2.295; Michie CA, 1998, EUR CYTOKINE NETW, V9, P123; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nagpal R, 2011, ECOL FOOD NUTR, V50, P63, DOI 10.1080/03670244.2011.539161; OPLETAMADSEN K, 1991, AM J PHYSIOL, V260, pG807, DOI 10.1152/ajpgi.1991.260.6.G807; PACE DM, 1952, GROWTH, V16, P279; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Prevost J, 1962, P 13 INT ORN C, V2, P1085; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Riddle O, 1933, AM J PHYSIOL, V105, P191, DOI 10.1152/ajplegacy.1933.105.1.191; Schwartz S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r32; SHETTY S, 1992, BIOCHIM BIOPHYS ACTA, V1117, P193, DOI 10.1016/0304-4165(92)90079-A; SHETTY S, 1993, EXPERIENTIA, V49, P925, DOI 10.1007/BF01952612; SHETTY S, 1990, FOLIA MICROBIOL, V35, P240, DOI 10.1007/BF02820491; SHETTY S, 1994, ARCH INT PHYSIOL BIO, V102, P277, DOI 10.3109/13813459409003944; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stanley D, 2012, VET MICROBIOL; Stelwagen K, 2009, J ANIM SCI, V87, P3, DOI 10.2527/jas.2008-1377; STUDER-THIERSCH A, 1967, Zoologische Garten, V34, P159; van Hooijdonk ACM, 2000, BRIT J NUTR, V84, pS127; Wagstrom EA, 2000, VIRAL IMMUNOL, V13, P383, DOI 10.1089/08828240050144699; Wally J, 2007, BIOMETALS, V20, P249, DOI 10.1007/s10534-006-9062-7; West LJ, 2002, HUM EXP TOXICOL, V21, P499, DOI 10.1191/0960327102ht288oa; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yin YS, 2010, ISME J, V4, P367, DOI 10.1038/ismej.2009.128; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Yu-Lee LY, 2001, LUPUS, V10, P691, DOI 10.1191/096120301717164921; Zuppa AA, 2010, BIOACTIVE FOODS IN PROMOTING HEALTH: PROBIOTICS AND PREBIOTICS, P441, DOI 10.1016/B978-0-12-374938-3.00027-X	66	23	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48363	10.1371/journal.pone.0048363	http://dx.doi.org/10.1371/journal.pone.0048363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110233	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500063
J	Klubicova, K; Danchenko, M; Skultety, L; Berezhna, VV; Uvackova, L; Rashydov, NM; Hajduch, M				Klubicova, Katarina; Danchenko, Maksym; Skultety, Ludovit; Berezhna, Valentyna V.; Uvackova, Lubica; Rashydov, Namik M.; Hajduch, Martin			Soybeans Grown in the Chernobyl Area Produce Fertile Seeds that Have Increased Heavy Metal Resistance and Modified Carbon Metabolism	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; PINUS-SYLVESTRIS L.; PROTEOMIC ANALYSIS; PLANT ADAPTATION; EXPRESSION; RADIATION; PROTEINS; GENE; IDENTIFICATION; ESTABLISHMENT	Plants grow and reproduce in the radioactive Chernobyl area, however there has been no comprehensive characterization of these activities. Herein we report that life in this radioactive environment has led to alteration of the developing soybean seed proteome in a specific way that resulted in the production of fertile seeds with low levels of oil and beta-conglycinin seed storage proteins. Soybean seeds were harvested at four, five, and six weeks after flowering, and at maturity from plants grown in either non-radioactive or radioactive plots in the Chernobyl area. The abundance of 211 proteins was determined. The results confirmed previous data indicating that alterations in the proteome include adaptation to heavy metal stress and mobilization of seed storage proteins. The results also suggest that there have been adjustments to carbon metabolism in the cytoplasm and plastids, increased activity of the tricarboxylic acid cycle, and decreased condensation of malonyl-acyl carrier protein during fatty acid biosynthesis.	[Klubicova, Katarina; Danchenko, Maksym; Uvackova, Lubica; Hajduch, Martin] Slovak Acad Sci, Dept Reprod & Dev Biol, Inst Plant Genet & Biotechnol, Nitra, Slovakia; [Hajduch, Martin] Slovak Acad Sci, Inst Chem, Ctr Excellence White Green Biotechnol, Nitra, Slovakia; [Danchenko, Maksym; Berezhna, Valentyna V.; Rashydov, Namik M.] Inst Cell Biol & Genet Engn, Dept Biophys & Radiobiol, Kiev, Ukraine; [Skultety, Ludovit] Slovak Acad Sci, Inst Virol, Bratislava, Slovakia; [Skultety, Ludovit] Slovak Acad Sci, Ctr Mol Med, Bratislava, Slovakia	Slovak Academy of Sciences; Slovak Academy of Sciences; National Academy of Sciences Ukraine; Institute of Cell Biology & Genetic Engineering of the National Academy of Sciences of Ukraine; Slovak Academy of Sciences; Slovak Academy of Sciences	Hajduch, M (corresponding author), Slovak Acad Sci, Dept Reprod & Dev Biol, Inst Plant Genet & Biotechnol, Nitra, Slovakia.	hajduch@savba.sk	Klubicova, Katarina/X-9379-2019; Uváčková, Ľubica/AHB-3162-2022; Danchenko, Maksym/G-7793-2015; Skultety, Ludovit/N-2160-2014; Skultety, Ludovit/ABA-6982-2020	Klubicova, Katarina/0000-0003-0927-0253; Danchenko, Maksym/0000-0002-3676-0728; Skultety, Ludovit/0000-0002-9830-6459; Uvackova, Lubica/0000-0002-7589-7444	Seventh Framework Program of the European Union - International Reintegration Grant [MIRG-CT-2007-200165]; Scientific Grant Agency of the Ministry of Education of the Slovak Republic; Academy of Sciences [VEGA-2/0126/11]; Slovak Research and Development Agency [APVV-0740-11]; Research & Development Operational Program; ERDF - Centre of Excellence for White-Green Biotechnology [ITMS 26220120054]; National Scholarship Program of the Slovak Republic	Seventh Framework Program of the European Union - International Reintegration Grant; Scientific Grant Agency of the Ministry of Education of the Slovak Republic; Academy of Sciences(Egyptian Academy of Scientific Research & Technology (ASRT)); Slovak Research and Development Agency(Slovak Research and Development Agency); Research & Development Operational Program; ERDF - Centre of Excellence for White-Green Biotechnology; National Scholarship Program of the Slovak Republic	This research was supported by the Seventh Framework Program of the European Union - International Reintegration Grant (MIRG-CT-2007-200165), Scientific Grant Agency of the Ministry of Education of the Slovak Republic and the Academy of Sciences (VEGA-2/0126/11), the Slovak Research and Development Agency (APVV-0740-11), and Research & Development Operational Program funded by the ERDF - Centre of Excellence for White-Green Biotechnology (ITMS 26220120054). MD was supported by the National Scholarship Program of the Slovak Republic. This paper reflects only the author's views and the Community is not liable for any use that might be made of information contained herein.	ADAMS CA, 1981, PLANT CELL PHYSIOL, V22, P1011; Aghaei K, 2009, AMINO ACIDS, V36, P91, DOI 10.1007/s00726-008-0036-7; Agrawal GK, 2008, PLANT PHYSIOL, V148, P504, DOI 10.1104/pp.108.119222; Akbar E, 2009, EUR J SCI RES, V29, P396; Andriotis VME, 2010, NEW PHYTOL, V185, P649, DOI 10.1111/j.1469-8137.2009.03113.x; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berlizov AN, 2005, J RADIOANAL NUCL CH, V263, P307, DOI 10.1007/s10967-005-0054-9; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUDDE RJA, 1991, PLANT PHYSIOL, V95, P131, DOI 10.1104/pp.95.1.131; Cornish-Bowden A, 1996, FUNDAMENTALS ENZYME; Danchenko M, 2009, J PROTEOME RES, V8, P2915, DOI 10.1021/pr900034u; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; FELL D, 1996, UNDERSTANDING CONTRO; Fernie AR, 2012, PLANT PHYSIOL, V158, P1139, DOI 10.1104/pp.112.193235; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fuller HJ, 1930, SCIENCE, V72, P535, DOI 10.1126/science.72.1873.535; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Hajduch M, 2005, PLANT PHYSIOL, V137, P1397, DOI 10.1104/pp.104.056614; Harada E, 2001, J PLANT PHYSIOL, V158, P655, DOI 10.1078/0176-1617-00314; Hectors K, 2010, J EXP BOT, V61, P4339, DOI 10.1093/jxb/erq235; Hills MJ, 2004, CURR OPIN PLANT BIOL, V7, P302, DOI 10.1016/j.pbi.2004.03.003; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; KAUPPINEN S, 1988, CARLSBERG RES COMMUN, V53, P357, DOI 10.1007/BF02983311; Klubicova K, 2010, ENVIRON SCI TECHNOL, V44, P6940, DOI 10.1021/es100895s; Komatsu S, 2011, J PROTEOME RES, V10, P3993, DOI 10.1021/pr2001918; Kovalchuk I, 2004, PLANT PHYSIOL, V135, P357, DOI 10.1104/pp.104.040477; Kovalchuk O, 2000, NATURE, V407, P583, DOI 10.1038/35036692; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V529, P13, DOI 10.1016/S0027-5107(03)00103-9; Kovalchuk O, 2003, MUTAT RES-FUND MOL M, V525, P93, DOI 10.1016/S0027-5107(03)00006-X; Koyama H, 2000, PLANT CELL PHYSIOL, V41, P1030, DOI 10.1093/pcp/pcd029; Kuchma O, 2011, MUTAT RES-GEN TOX EN, V725, P29, DOI 10.1016/j.mrgentox.2011.07.003; Lemoine R, 2000, BBA-BIOMEMBRANES, V1465, P246, DOI 10.1016/S0005-2736(00)00142-5; MEINKE DW, 1981, PLANTA, V153, P130, DOI 10.1007/BF00384094; Meyerhof O, 1943, J BIOL CHEM, V149, P71; MEYERHOF O, 1945, J BIOL CHEM, V157, P105; Miernyk JA, 2011, SEX PLANT REPROD, V24, P9, DOI 10.1007/s00497-010-0149-5; OHLROGGE JB, 1984, PLANT PHYSIOL, V74, P622, DOI 10.1104/pp.74.3.622; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Rajjou L, 2006, PLANT PHYSIOL, V141, P910, DOI 10.1104/pp.106.082057; Regente M, 2001, PHYSIOL MOL PLANT P, V59, P275, DOI 10.1006/pmpp.2001.0365; REID EE, 1977, PLANT PHYSIOL, V59, P842, DOI 10.1104/pp.59.5.842; RIPP KG, 1988, PLANT PHYSIOL, V88, P1435, DOI 10.1104/pp.88.4.1435; Rolleston FS, 1972, CURRENT TOPICS CELLU, V5, P47; Rotundo JL, 2009, FIELD CROP RES, V110, P147, DOI 10.1016/j.fcr.2008.07.012; Sales MP, 2000, PLANT PHYSIOL, V124, P515, DOI 10.1104/pp.124.2.515; Schmidt MA, 2011, PLANT PHYSIOL, V156, P330, DOI 10.1104/pp.111.173807; STEFFENS JC, 1990, ANNU REV PLANT PHYS, V41, P553, DOI 10.1146/annurev.pp.41.060190.003005; Vornam B, 2012, J ENVIRON RADIOACTIV, V106, P20, DOI 10.1016/j.jenvrad.2011.11.001; Weber H, 2005, ANNU REV PLANT BIOL, V56, P253, DOI 10.1146/annurev.arplant.56.032604.144201; Williams LE, 2000, TRENDS PLANT SCI, V5, P283, DOI 10.1016/S1360-1385(00)01681-2; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Xu J, 2008, MOL BIOTECHNOL, V38, P91, DOI 10.1007/s12033-007-9005-8; Zhang JT, 2011, J PROTEOME RES, V10, P1904, DOI 10.1021/pr101140n; Zhang YX, 2006, MOL BIOTECHNOL, V32, P205, DOI 10.1385/MB:32:3:205	56	22	23	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48169	10.1371/journal.pone.0048169	http://dx.doi.org/10.1371/journal.pone.0048169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110204	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500046
J	Han, XY; Kennan, RM; Steer, DL; Smith, AI; Whisstock, JC; Rood, JI				Han, Xiaoyan; Kennan, Ruth M.; Steer, David L.; Smith, A. Ian; Whisstock, James C.; Rood, Julian I.			The AprV5 Subtilase Is Required for the Optimal Processing of All Three Extracellular Serine Proteases from Dichelobacter nodosus	PLOS ONE			English	Article							OVINE FOOTROT PATHOGEN; AMINO-ACID; BASIC PROTEASE; SECRETION; VIRULENCE; SEQUENCE; IDENTIFICATION; TRANSFORMATION; SPECIFICITY; PROTEINASE	Dichelobacter nodosus is the principal causative agent of ovine footrot and its extracellular proteases are major virulence factors. Virulent isolates of D. nodosus secrete three subtilisin-like serine proteases: AprV2, AprV5 and BprV. These enzymes are each synthesized as precursor molecules that include a signal (pre-) peptide, a pro-peptide and a C-terminal extension, which are processed to produce the mature active forms. The function of the C-terminal regions of these proteases and the mechanism of protease processing and secretion are unknown. AprV5 contributes to most of the protease activity secreted by D. nodosus. To understand the role of the C-terminal extension of AprV5, we constructed a series of C-terminal-deletion mutants in D. nodosus by allelic exchange. The proteases present in the resultant mutants and their complemented derivatives were examined by protease zymogram analysis, western blotting and mass spectrometry. The results showed that the C-terminal region of AprV5 is required for the normal expression of protease activity, deletion of this region led to a delay in the processing of these enzymes. D. nodosus is an unusual bacterium in that it produces three closely related extracellular serine proteases. We have now shown that one of these enzymes, AprV5, is responsible for its own maturation, and for the optimal cleavage of AprV2 and BprV, to their mature active forms. These studies have increased our understanding of how this important pathogen processes these virulence-associated extracellular proteases and secretes them into its external environment.	[Han, Xiaoyan; Kennan, Ruth M.; Steer, David L.; Smith, A. Ian; Whisstock, James C.; Rood, Julian I.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia; [Han, Xiaoyan; Kennan, Ruth M.; Rood, Julian I.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Steer, David L.; Smith, A. Ian; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University; Monash University	Rood, JI (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia.	julian.rood@monash.edu	han, xiao/HDN-9782-2022; Rood, Julian I/A-4858-2008	Rood, Julian I/0000-0003-2126-7209; Smith, Ian/0000-0002-4143-2892; Whisstock, James/0000-0003-4200-5611	Australia Research Council (ARC); ARC Federation Fellowship; Victorian State Government (Department of Business and Innovation); Australian Government's National Collaborative Research Infrastructure Strategy scheme	Australia Research Council (ARC)(Australian Research Council); ARC Federation Fellowship(Australian Research Council); Victorian State Government (Department of Business and Innovation); Australian Government's National Collaborative Research Infrastructure Strategy scheme(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was supported by grants from the Australia Research Council (ARC) to the ARC Centre of Excellence in Structural and Functional Microbial Genomics and the award of an ARC Federation Fellowship to J.C.W. The Monash Biomedical Proteomics Facility is supported by funds from both the Victorian State Government (Department of Business and Innovation) and through the Australian Government's National Collaborative Research Infrastructure Strategy scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MJ, 2007, INFECT IMMUN, V75, P3070, DOI 10.1128/IAI.00139-07; Bergeron F, 2000, J MOL ENDOCRINOL, V24, P1, DOI 10.1677/jme.0.0240001; Billington SJ, 1996, FEMS MICROBIOL LETT, V145, P147, DOI 10.1111/j.1574-6968.1996.tb08570.x; Bloomfield GA, 1997, MICROBIOL-UK, V143, P553, DOI 10.1099/00221287-143-2-553; Cedzich A, 2009, J BIOL CHEM, V284, P14068, DOI 10.1074/jbc.M900370200; Coutte L, 2001, EMBO J, V20, P5040, DOI 10.1093/emboj/20.18.5040; Han XY, 2008, J BACTERIOL, V190, P3323, DOI 10.1128/JB.01807-07; Han XY, 2007, J BACTERIOL, V189, P5022, DOI 10.1128/JB.00138-07; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Kennan RM, 1998, FEMS MICROBIOL LETT, V169, P383, DOI 10.1111/j.1574-6968.1998.tb13344.x; Kennan RM, 2001, J BACTERIOL, V183, P4451, DOI 10.1128/JB.183.15.4451-4458.2001; Kennan RM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001210; Kim DW, 1997, FEMS MICROBIOL LETT, V157, P39, DOI 10.1111/j.1574-6968.1997.tb12750.x; KLAUSER T, 1993, BIOESSAYS, V15, P799, DOI 10.1002/bies.950151205; KORTT AA, 1994, BIOCHEM MOL BIOL INT, V34, P1157; KORTT AA, 1994, BIOCHEM MOL BIOL INT, V34, P1167; KORTT AA, 1993, BIOCHEM MOL BIOL INT, V29, P989; KORTT AA, 1994, BIOCHEM J, V299, P521, DOI 10.1042/bj2990521; LILLEY GG, 1992, EUR J BIOCHEM, V210, P13, DOI 10.1111/j.1432-1033.1992.tb17385.x; LILLEY GG, 1995, BIOCHEM MOL BIOL INT, V36, P101; LIU D, 1993, RES VET SCI, V55, P124, DOI 10.1016/0034-5288(93)90046-I; MENARD R, 1993, J BACTERIOL, V175, P5899; Palanisamy SKA, 2010, FEMS MICROBIOL LETT, V302, P39, DOI 10.1111/j.1574-6968.2009.01831.x; RIFFKIN MC, 1993, GENE, V137, P259, DOI 10.1016/0378-1119(93)90017-W; Riffkin MC, 1995, GENE, V167, P279, DOI 10.1016/0378-1119(95)00664-8; Rood JI, 2002, CURR TOP MICROBIOL, V264, P47; Sambrook J, 2001, MOL CLONING LAB MANU; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; SHIKATA S, 1993, J BIOCHEM, V114, P723, DOI 10.1093/oxfordjournals.jbchem.a124244; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SKERMAN TM, 1975, J GEN MICROBIOL, V87, P107, DOI 10.1099/00221287-87-1-107; Stewart D. J., 1989, Footrot and foot abscess of ruminants., P5; STEWART DJ, 1979, RES VET SCI, V27, P99, DOI 10.1016/S0034-5288(18)32866-2; Turner DPJ, 2002, INFECT IMMUN, V70, P4447, DOI 10.1128/IAI.70.8.4447-4461.2002; VOS P, 1991, PROTEIN ENG, V4, P479, DOI 10.1093/protein/4.4.479; Wong W, 2011, J BIOL CHEM, V286, P42180, DOI 10.1074/jbc.M111.298711; Yan BQ, 2009, EXTREMOPHILES, V13, P725, DOI 10.1007/s00792-009-0263-1; Zhou A, 1998, J BIOL CHEM, V273, P11107, DOI 10.1074/jbc.273.18.11107	39	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47932	10.1371/journal.pone.0047932	http://dx.doi.org/10.1371/journal.pone.0047932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112874	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200112
J	McIntosh, AM; Bennett, C; Dickson, D; Anestis, SF; Watts, DP; Webster, TH; Fontenot, MB; Bradley, BJ				McIntosh, Annick M.; Bennett, Calvin; Dickson, Dara; Anestis, Stephanie F.; Watts, David P.; Webster, Timothy H.; Fontenot, M. Babette; Bradley, Brenda J.			The Apolipoprotein E (APOE) Gene Appears Functionally Monomorphic in Chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DOMAIN INTERACTION; WILD CHIMPANZEES; E POLYMORPHISM; DNA-SEQUENCES; HEART-DISEASE; NATIONAL-PARK; EVOLUTION; RISK; ONSET	Background: The human apolipoprotein E (APOE) gene is polymorphic, with three primary alleles (E2, E3, E4) that differ at two key non-synonymous sites. These alleles are functionally different in how they bind to lipoproteins, and this genetic variation is associated with phenotypic variation for several medical traits, including cholesterol levels, cardiovascular health, Alzheimer's disease risk, and longevity. The relative frequencies of these alleles vary across human populations, and the evolution and maintenance of this diversity is much debated. Previous studies comparing human and chimpanzee APOE sequences found that the chimpanzee sequence is most similar to the human E4 allele, although the resulting chimpanzee protein might function like the protein coded for by the human E3 allele. However, these studies have used sequence data from a single chimpanzee and do not consider whether chimpanzees, like humans, show intra-specific and subspecific variation at this locus. Methodology and Principal Findings: To examine potential intraspecific variation, we sequenced the APOE gene of 32 chimpanzees. This sample included 20 captive individuals representing the western subspecies (P. troglodytes verus) and 12 wild individuals representing the eastern subspecies (P.t. schweinfurthii). Variation in our resulting sequences was limited to one non-coding, intronic SNP, which showed fixed differences between the two subspecies. We also compared APOE sequences for all available ape genera and fossil hominins. The bonobo APOE protein is identical to that of the chimpanzee, and the Denisovan APOE exhibits all four human-specific, non-synonymous changes and appears functionally similar to the human E4 allele. Conclusions: We found no coding variation within and between chimpanzee populations, suggesting that the maintenance of functionally diverse APOE polymorphisms is a unique feature of human evolution.	[McIntosh, Annick M.; Bennett, Calvin; Dickson, Dara; Anestis, Stephanie F.; Watts, David P.; Webster, Timothy H.; Bradley, Brenda J.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Fontenot, M. Babette] Univ Louisiana Lafayette, Div Behav Sci, New Iberia Res Ctr, Lafayette, LA 70504 USA	Yale University; University of Louisiana Lafayette; New Iberia Research Center	Bradley, BJ (corresponding author), Yale Univ, Dept Anthropol, New Haven, CT 06520 USA.	brenda.bradley@yale.edu	Webster, Timothy/H-5530-2019	Webster, Timothy/0000-0003-1174-2395	Howard Hughes Medical Institute's Undergraduate Science Education Program [52005912]; National Institutes of Health National Center for Research Resources [RR015087, RR014491, RR016483]; U.S. National Science Foundation [SBR-9253590, BCS-0215622, IOB-0516644]; L.S.B. Leakey Foundation (leakeyfoundation.org); National Geographic Society; Wenner-Gren Foundation for Anthropological Research (wennergren.org); Yale University; University of Michigan; STFC [ST/G008582/1] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR015087, C06RR014491, C06RR016483] Funding Source: NIH RePORTER; Science and Technology Facilities Council [ST/G008582/1] Funding Source: researchfish	Howard Hughes Medical Institute's Undergraduate Science Education Program; National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. National Science Foundation(National Science Foundation (NSF)); L.S.B. Leakey Foundation (leakeyfoundation.org); National Geographic Society(National Geographic Society); Wenner-Gren Foundation for Anthropological Research (wennergren.org); Yale University; University of Michigan(University of Michigan System); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Funding provided by the following: Howard Hughes Medical Institute's Undergraduate Science Education Program (Grant #52005912 to Yale University), National Institutes of Health National Center for Research Resources (Grants RR015087, RR014491, RR016483), U.S. National Science Foundation (SBR-9253590, BCS-0215622, IOB-0516644), L.S.B. Leakey Foundation (leakeyfoundation.org), National Geographic Society, Wenner-Gren Foundation for Anthropological Research (wennergren.org), Yale University, and University of Michigan. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Acevedo SF, 2010, PEDIATR RES, V67, P293, DOI 10.1203/PDR.0b013e3181cb8e68; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; Berna F, 2012, P NATL ACAD SCI USA, V109, pE1215, DOI 10.1073/pnas.1117620109; Boesch Christophe, 2002, BEHAV DIVERSITY CHIM; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bullido MJ, 1998, NAT GENET, V18, P69, DOI 10.1038/ng0198-69; Charlesworth B, 1996, CURR BIOL, V6, P20, DOI 10.1016/S0960-9822(02)00411-6; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DONG LM, 1994, J BIOL CHEM, V269, P22358; Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053; Drenos F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010022; Edwards SV, 2000, EVOLUTION, V54, P1839; Ehara H, 2012, WORLD J DIABETES, V3, P54, DOI 10.4239/wjd.v3.i3.54; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Enard W, 2012, J MOL MED, V90, P471, DOI 10.1007/s00109-012-0901-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farlow MR, 2004, NEUROLOGY, V63, P1898, DOI 10.1212/01.WNL.0000144279.21502.B7; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2004, Q REV BIOL, V79, P3, DOI 10.1086/381662; Finch CE, 1999, NEUROBIOL AGING, V20, P407, DOI 10.1016/S0197-4580(99)00053-6; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; HANLON CS, 1995, ATHEROSCLEROSIS, V112, P85, DOI 10.1016/0021-9150(94)05402-5; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HILL K, 1982, J HUM EVOL, V11, P521, DOI 10.1016/S0047-2484(82)80107-3; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kulminski AM, 2011, AGING CELL, V10, P533, DOI 10.1111/j.1474-9726.2011.00689.x; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martin GM, 1999, NEUROBIOL AGING, V20, P441, DOI 10.1016/S0197-4580(99)00078-0; MCLEAN JW, 1984, J BIOL CHEM, V259, P6498; MENZEL HJ, 1983, ARTERIOSCLEROSIS, V3, P310, DOI 10.1161/01.ATV.3.4.310; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Noonan JP, 2010, GENOME RES, V20, P547, DOI 10.1101/gr.076000.108; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Singh PP, 2006, ANN HUM BIOL, V33, P279, DOI 10.1080/03014460600594513; Stanford CB, 1996, AM ANTHROPOL, V98, P96, DOI 10.1525/aa.1996.98.1.02a00090; Stengard JH, 2010, CIRC-CARDIOVASC GENE, V3, P22, DOI 10.1161/CIRCGENETICS.109.862748; Surbeck M, 2008, CURR BIOL, V18, pR906, DOI 10.1016/j.cub.2008.08.040; Terio KA, 2011, J ZOO WILDLIFE MED, V42, P597, DOI 10.1638/2010-0237.1; Trotter JH, 2011, FUNCT ECOL, V25, P40, DOI 10.1111/j.1365-2435.2010.01780.x; Uehara S, 1997, PRIMATES, V38, P193, DOI 10.1007/BF02382009; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Ward H, 2009, ARCH INTERN MED, V169, P1424, DOI 10.1001/archinternmed.2009.234; Watts David P., 2012, P313; Watts DP, 2002, INT J PRIMATOL, V23, P1, DOI 10.1023/A:1013270606320; Wrangham RW, 2009, CATCHING FIRE COOKIN; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu N, 2003, GENETICS, V164, P1511	65	43	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47760	10.1371/journal.pone.0047760	http://dx.doi.org/10.1371/journal.pone.0047760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112842	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200076
J	Satti, H; McLaughlin, MM; Hedt-Gauthier, B; Atwood, SS; Omotayo, DB; Ntlamelle, L; Seung, KJ				Satti, Hind; McLaughlin, Megan M.; Hedt-Gauthier, Bethany; Atwood, Sidney S.; Omotayo, David B.; Ntlamelle, Likhapha; Seung, Kwonjune J.			Outcomes of Multidrug-Resistant Tuberculosis Treatment with Early Initiation of Antiretroviral Therapy for HIV Co-Infected Patients in Lesotho	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; SOUTH-AFRICA; CLINICAL-OUTCOMES; RISK-FACTORS; OUTBREAK; COMMUNITY; METAANALYSIS; IMPACT	Background: Although the importance of concurrent treatment for multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection has been increasingly recognized, there have been few studies reporting outcomes of MDR-TB and HIV co-treatment. We report final outcomes of comprehensive, integrated MDR-TB and HIV treatment in Lesotho and examine factors associated with death or treatment failure. Methods: We reviewed clinical charts of all adult patients who initiated MDR-TB treatment in Lesotho between January 2008 and September 2009. We calculated hazard ratios (HR) and used multivariable Cox proportional hazards regression to identify predictors of poor outcomes. Results: Of 134 confirmed MDR-TB patients, 83 (62%) were cured or completed treatment, 46 (34%) died, 3 (2%) transferred, 1 (1%) defaulted, and 1 (1%) failed treatment. Treatment outcomes did not differ significantly by HIV status. Among the 94 (70%) patients with HIV co-infection, 53% were already on antiretroviral therapy (ART) before MDR-TB treatment initiation, and 43% started ART a median of 16 days after the start of the MDR-TB regimen. Among HIV co-infected patients who died, those who had not started ART before MDR-TB treatment had a shorter median time to death (80 days vs. 138 days, p = 0.065). In multivariable analysis, predictors of increased hazard of failure or death were low and severely low body mass index (HR 2.75, 95% confidence interval [CI] 1.27-5.93; HR 5.50, 95% CI 2.38-12.69), and a history of working in South Africa (HR 2.37, 95% CI 1.24-4.52). Conclusions: Favorable outcomes can be achieved in co-infected patients using a community-based treatment model when both MDR-TB and HIV disease are treated concurrently and treatment is initiated promptly.	[Satti, Hind; McLaughlin, Megan M.; Omotayo, David B.; Ntlamelle, Likhapha; Seung, Kwonjune J.] Partners Hlth, Maseru, Lesotho; [Satti, Hind; Hedt-Gauthier, Bethany] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [McLaughlin, Megan M.; Atwood, Sidney S.; Seung, Kwonjune J.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Satti, H (corresponding author), Partners Hlth, Maseru, Lesotho.	hsatti@pih.org		Atwood, Sidney/0000-0001-8865-6300	Department of Global Health and Social Medicine Research Core at Harvard Medical School	Department of Global Health and Social Medicine Research Core at Harvard Medical School	BHG and SSA received support from the Department of Global Health and Social Medicine Research Core at Harvard Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONUCCI G, 1995, JAMA-J AM MED ASSOC, V274, P143, DOI 10.1001/jama.274.2.143; Basu S, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-11; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; *CDCP, 2007, MAN DRUG INT TREATM; Centers for Disease Control and Prevention, 2003, MMWR, V52; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; FISCHL MA, 1992, ANN INTERN MED, V117, P177, DOI 10.7326/0003-4819-117-3-177; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Friedland Gerald, 2007, Curr Infect Dis Rep, V9, P252, DOI 10.1007/s11908-007-0039-7; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Ministry of Health and Social Welfare, 2009, DEM HLTH SURV; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Moro ML, 1998, AIDS, V12, P1095, DOI 10.1097/00002030-199809000-00017; Munsiff SS, 2006, INT J TUBERC LUNG D, V10, P639; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Palacios E, 2012, INT J TUBERC LUNG D, V16, P348, DOI 10.5588/ijtld.11.0473; Park HH, 2009, AM J IND MED, V52, P901, DOI 10.1002/ajim.20767; Pepper DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004520; Perumal R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-243; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; USAID TB Care II, 2011, COMM BAS CAR DRUG RE; Waisman JL, 2001, MEDICINA-BUENOS AIRE, V61, P810; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2011, WHOHTMTB20113; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2011, TB DAT TUB COUNTR PR	40	41	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e46943	10.1371/journal.pone.0046943	http://dx.doi.org/10.1371/journal.pone.0046943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115633	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200021
J	Sedlacek, J; Schmid, B; Matthies, D; Albrecht, M				Sedlacek, Janosch; Schmid, Bernhard; Matthies, Diethart; Albrecht, Matthias			Inbreeding Depression under Drought Stress in the Rare Endemic Echium wildpretii (Boraginaceae) on Tenerife, Canary Islands	PLOS ONE			English	Article							PLANT GENTIANELLA-GERMANICA; INTRODUCED HONEY-BEES; POPULATION-SIZE; ENVIRONMENTAL-STRESS; POLLEN-LIMITATION; PROGENY FITNESS; OUTBREEDING DEPRESSION; BIODIVERSITY HOTSPOTS; HABITAT FRAGMENTATION; REPRODUCTIVE SUCCESS	How climate-change induced environmental stress may alter the effects of inbreeding in patchy populations of rare species is poorly understood. We investigated the fitness of progeny from experimental self-and cross-pollinations in eight populations of different size of Echium wildpretii, a rare endemic plant of the arid subalpine zone of the Canarian island of Tenerife. As control treatments we used open pollination and autonomous selfing. The seed set of open-pollinated flowers was 55% higher than that of autonomously selfed flowers, showing the importance of animal pollination for reproductive success. The seed set, seed mass and germination rate of seedlings of hand-selfed flowers was similar to that of hand-crossed flowers, indicating weak inbreeding depression (seed set -4.4%, seed mass -4.1%, germination -7.3%). Similarly, under normal watering there were no significant effects of inbreeding on seedling survival (-3.0%). However, under low watering of seedlings inbreeding depression was high (survival -50.2%). Seed set of open- and hand-outcrossed-pollinated flowers was higher in large than in small populations, possibly due to more frequent biparental inbreeding in the latter. However, later measures of progeny fitness were not significantly influenced by population size. We predict that increasing drought duration and frequency due to climate change and reductions of population sizes may increase inbreeding depression in this charismatic plant species and thus threaten its future survival in the longer term.	[Sedlacek, Janosch; Schmid, Bernhard; Albrecht, Matthias] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Matthies, Diethart] Univ Marburg, Dept Ecol, Marburg, Germany; [Albrecht, Matthias] Res Stn Agroscope Reckenholz Tanikon, Zurich, Switzerland	University of Zurich; Philipps University Marburg; Swiss Federal Research Station Agroscope	Albrecht, M (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	matthias.albrecht@art.admin.ch	Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214; Matthies, Diethart/0000-0003-2439-0501	University of Zurich	University of Zurich	This research was funded by the University of Zurich including special funds "Bologna II'' for Master's projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 1996, ECOLOGY, V77, P1779, DOI 10.2307/2265783; Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Alonso C, 2010, OIKOS, V119, P1192, DOI 10.1111/j.1600-0706.2009.18026.x; Angeloni F, 2011, BIOL CONSERV, V144, P35, DOI 10.1016/j.biocon.2010.08.016; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Berglund H, 2009, AM NAT, V174, P94, DOI 10.1086/598501; Bernasconi G, 2003, OIKOS, V102, P217, DOI 10.1034/j.1600-0706.2003.12598.x; Bramwell D., 1990, FLORES SILVESTRES IS; Byers DL, 1998, AM J BOT, V85, P644, DOI 10.2307/2446533; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Colling G, 2004, AM J BOT, V91, P1774, DOI 10.3732/ajb.91.11.1774; Crawley MJ, 2005, STAT INTRO USING R; Dauber J, 2010, J ECOL, V98, P188, DOI 10.1111/j.1365-2745.2009.01590.x; Dudash MR, 2000, CONSERV BIOL SER, V4, P35; Dupont YL, 2004, BIOL CONSERV, V118, P301, DOI 10.1016/j.biocon.2003.09.010; Egli P, 2001, BASIC APPL ECOL, V2, P223, DOI 10.1078/1439-1791-00048; Fischer M, 1998, J ECOL, V86, P195, DOI 10.1046/j.1365-2745.1998.00246.x; Fischer M, 1997, AM J BOT, V84, P1685, DOI 10.2307/2446466; Fordham DA, 2010, BIODIVERS CONSERV, V19, P329, DOI 10.1007/s10531-008-9529-7; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Gomez Campo, 1996, LIBRO ROJO ESPECIES; GREEN BF, 1960, PSYCHOMETRIKA, V25, P127, DOI 10.1007/BF02288577; Hauser TP, 1996, EVOLUTION, V50, P1119, DOI 10.2307/2410652; Heliyanto B, 2006, J EVOLUTION BIOL, V19, P1327, DOI 10.1111/j.1420-9101.2005.01067.x; HESCHEL MS, 1995, CONSERV BIOL, V9, P126, DOI 10.1046/j.1523-1739.1995.09010126.x; Hoffmann AA, 1993, EVOLUTIONARY GENETIC; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; JOHNSTON MO, 1992, EVOLUTION, V46, P688, DOI [10.2307/2409638, 10.1111/j.1558-5646.1992.tb02076.x]; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Kirkpatrick M, 2000, AM NAT, V155, P154, DOI 10.1086/303312; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Koelewijn HP, 1998, EVOLUTION, V52, P692, DOI 10.1111/j.1558-5646.1998.tb03694.x; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Leimu R, 2010, ANN NY ACAD SCI, V1195, P84, DOI 10.1111/j.1749-6632.2010.05450.x; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; LYNCH M, 1990, EVOLUTION, V44, P1725, DOI [10.2307/2409502, 10.1111/j.1558-5646.1990.tb05244.x]; Marrero-Gomez MV, 2007, BIOL CONSERV, V136, P552, DOI 10.1016/j.biocon.2007.01.010; Melser C, 1999, HEREDITY, V83, P162, DOI 10.1038/sj.hdy.6885680; Melser C, 1997, SEX PLANT REPROD, V10, P305, DOI 10.1007/s004970050103; Montaner C, 2001, THEOR APPL GENET, V102, P375, DOI 10.1007/s001220051656; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; OLESEN JM, 1988, ACTA BOT NEERL, V37, P509, DOI 10.1111/j.1438-8677.1988.tb02157.x; Paland S, 2003, EVOLUTION, V57, P2242, DOI 10.1111/j.0014-3820.2003.tb00236.x; Paschke M, 2005, BASIC APPL ECOL, V6, P325, DOI 10.1016/j.baae.2005.02.005; Paschke M, 2002, AM J BOT, V89, P1250, DOI 10.3732/ajb.89.8.1250; Paton David C., 1997, Victorian Naturalist (Blackburn), V114, P23; PEDERSON DG, 1968, HEREDITY, V23, P127, DOI 10.1038/hdy.1968.11; Poon A, 2000, EVOLUTION, V54, P1467, DOI 10.1111/j.0014-3820.2000.tb00693.x; Pysek P, 2006, J BIOGEOGR, V33, P2040, DOI 10.1111/j.1365-2699.2006.01578.x; Riginos C, 2007, AM J BOT, V94, P1984, DOI 10.3732/ajb.94.12.1984; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; Rymer PD, 2005, BIOL CONSERV, V123, P521, DOI 10.1016/j.biocon.2005.01.002; Sheridan PM, 2000, AM J BOT, V87, P1628, DOI 10.2307/2656739; Soutar D., 2011, INTRO GENSTAT WINDOW; Sperling FN, 2004, CLIMATIC CHANGE, V65, P103, DOI 10.1023/B:CLIM.0000037488.33377.bf; Valido A, 2004, J BIOGEOGR, V31, P1945, DOI 10.1111/j.1365-2699.2004.01116.x; Valido A, 2002, ACTA OECOL, V23, P413, DOI 10.1016/S1146-609X(02)01167-0; Waller DM, 2008, EVOLUTION, V62, P917, DOI 10.1111/j.1558-5646.2008.00325.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Willi Y, 2005, HEREDITY, V95, P437, DOI 10.1038/sj.hdy.6800732	64	17	19	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47415	10.1371/journal.pone.0047415	http://dx.doi.org/10.1371/journal.pone.0047415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115645	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000310310200037
J	Thomas, E; van Zonneveld, M; Loo, J; Hodgkin, T; Galluzzi, G; van Etten, J				Thomas, Evert; van Zonneveld, Maarten; Loo, Judy; Hodgkin, Toby; Galluzzi, Gea; van Etten, Jacob			Present Spatial Diversity Patterns of Theobroma cacao L. in the Neotropics Reflect Genetic Differentiation in Pleistocene Refugia Followed by Human-Influenced Dispersal	PLOS ONE			English	Article							AMAZONIAN ECOSYSTEMS; ALLELIC RICHNESS; POPULATION; DOMESTICATION; CONSERVATION; LANDSCAPE; RESPONSES; CLIMATE; ORIGIN	Cacao (Theobroma cacao L.) is indigenous to the Amazon basin, but is generally believed to have been domesticated in Mesoamerica for the production of chocolate beverage. However, cacao's distribution of genetic diversity in South America is also likely to reflect pre-Columbian human influences that were superimposed on natural processes of genetic differentiation. Here we present the results of a spatial analysis of the intra-specific diversity of cacao in Latin America, drawing on a dataset of 939 cacao trees genotypically characterized by means of 96 SSR markers. To assess continental diversity patterns we performed grid-based calculations of allelic richness, Shannon diversity and Nei gene diversity, and distinguished different spatially coherent genetic groups by means of cluster analysis. The highest levels of genetic diversity were observed in the Upper Amazon areas from southern Peru to the Ecuadorian Amazon and the border areas between Colombia, Peru and Brazil. On the assumption that the last glaciation (22,000-13,000 BP) had the greatest pre-human impact on the current distribution and diversity of cacao, we modeled the species' Pleistocene niche suitability and overlaid this with present-day diversity maps. The results suggest that cacao was already widely distributed in the Western Amazon before the onset of glaciation. During glaciations, cacao populations were likely to have been restricted to several refugia where they probably underwent genetic differentiation, resulting in a number of genetic clusters which are representative for, or closest related to, the original wild cacao populations. The analyses also suggested that genetic differentiation and geographical distribution of a number of other clusters seem to have been significantly affected by processes of human management and accompanying genetic bottlenecks. We discuss the implications of these results for future germplasm collection and in situ, on farm and ex situ conservation of cacao.	[Thomas, Evert; van Zonneveld, Maarten; Galluzzi, Gea; van Etten, Jacob] Biovers Int, Reg Off Amer, Cali, Colombia; [van Zonneveld, Maarten] Univ Ghent, Fac Biosci Engn, B-9000 Ghent, Belgium; [Loo, Judy; Hodgkin, Toby] Biovers Int, Rome, Italy	Alliance; Bioversity International; Ghent University; Alliance; Bioversity International	Thomas, E (corresponding author), Biovers Int, Reg Off Amer, Cali, Colombia.	Evert.thomas@gmail.com		van Etten, Jacob/0000-0001-7554-2558				[Anonymous], 2010, VERS 1; Bartley BGD, 2005, GENETIC DIVERSITY OF CACAO AND ITS UTILIZATION: BOTANY, PRODUCTION AND USES, P1, DOI 10.1079/9780851996196.0000; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P1977, DOI 10.1111/j.1365-2486.2006.01228.x; Bonaccorso E, 2006, DIVERS DISTRIB, V12, P157, DOI 10.1111/j.1366-9516.2005.00212.x; Bush Mark B., 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000100002; Bush MB, 1996, BIOL CONSERV, V76, P219, DOI 10.1016/0006-3207(95)00122-0; Cheesman E. E., 1944, TROP AGRIC [TRINIDAD], V21, P144; Clement C. R., 2010, Diversity, V2, P72; Clement CR, 1999, ECON BOT, V53, P203, DOI 10.1007/BF02866499; Comps B, 2001, GENETICS, V157, P389; D'Horta FM, 2011, MOL ECOL, V20, P1923, DOI 10.1111/j.1365-294X.2011.05063.x; de Almeida CFG, 1987, REV THEOBROMA, V17, P65; Dickau R., 2005, THESIS TEMPLE U PHIL; FRANKEL OH, 1995, CONSERVATION PLANT B, P79; Frankel OH, 1995, CONSERVATION PLANT B; Fuller DQ, 2011, HOLOCENE, V21, P743, DOI 10.1177/0959683611398052; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; Haffer J, 2001, AMAZONIANA, V16, P579; Henderson JS, 2007, P NATL ACAD SCI USA, V104, P18937, DOI 10.1073/pnas.0708815104; Hijmans R.J., 2001, PLANT GENETIC RESOUR, V127, P15, DOI DOI 10.1016/j.compositesa.2008.10.018; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holderegger R, 2006, LANDSCAPE ECOL, V21, P793, DOI 10.1007/s10980-005-6058-6; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T., 2011, TUTORIAL DISCRIMINAN; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kindt R., 2005, WORLD; Lachenaud P, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008011; LAURENT V, 1994, THEOR APPL GENET, V88, P193, DOI 10.1007/BF00225897; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loor RG, 2009, TREE GENET GENOMES, V5, P421, DOI 10.1007/s11295-008-0196-3; Loor RG, 2012, PLANT AN GEN 20 C JA; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Motamayor J. C., 2002, P77, DOI 10.1079/9780851995229.0077; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Patino Rodriguez VM, 2002, HIST DISPERSION FRUT; Pautasso M, 2009, PERSPECT PLANT ECOL, V11, P157, DOI 10.1016/j.ppees.2009.01.003; Pennington RT, 2004, PHILOS T R SOC B, V359, P515, DOI 10.1098/rstb.2003.1435; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Powis TG, 2011, P NATL ACAD SCI USA, V108, P8595, DOI 10.1073/pnas.1100620108; R Core Team, 2016, R FDN STAT COMP; Resende HC, 2010, BIOL J LINN SOC, V101, P949, DOI 10.1111/j.1095-8312.2010.01534.x; Sankovski A, 2000, TECHNOL FORECAST SOC, V63, P263, DOI 10.1016/S0040-1625(99)00100-6; Schroth G, 2011, BIODIVERS CONSERV, V20, P1635, DOI 10.1007/s10531-011-0052-x; Sereno ML, 2006, CONSERV GENET, V7, P13, DOI 10.1007/s10592-005-7568-0; Shepard GH, 2011, ECON BOT, V65, P44, DOI 10.1007/s12231-011-9151-6; Silva CRS, 2011, HEREDITY, V106, P973, DOI 10.1038/hdy.2010.145; Solomon SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002738; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Thomas E, 2012, HUM ECOL, V40, P355, DOI 10.1007/s10745-012-9488-1; Trognitz B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016056; van Etten J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012060; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Zhang DP, 2006, ANN BOT-LONDON, V98, P647, DOI 10.1093/aob/mcl146; Zhang DP, 2012, GENET RESOUR CROP EV, V59, P239, DOI 10.1007/s10722-011-9680-y; Zhang DP, 2009, TREE GENET GENOMES, V5, P595, DOI 10.1007/s11295-009-0212-2	62	79	85	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47676	10.1371/journal.pone.0047676	http://dx.doi.org/10.1371/journal.pone.0047676			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112832	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200065
J	Madenspacher, JH; Azzam, KM; Gong, WH; Gowdy, KM; Vitek, MP; Laskowitz, DT; Remaley, AT; Wang, JM; Fessler, MB				Madenspacher, Jennifer H.; Azzam, Kathleen M.; Gong, Wanghua; Gowdy, Kymberly M.; Vitek, Michael P.; Laskowitz, Daniel T.; Remaley, Alan T.; Wang, Ji Ming; Fessler, Michael B.			Apolipoproteins and Apolipoprotein Mimetic Peptides Modulate Phagocyte Trafficking through Chemotactic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; A-I; BIOLOGICAL-PROPERTIES; DENSITY-LIPOPROTEIN; IMMUNE-RESPONSES; HUMAN MONOCYTES; MURINE MODEL; LUNG INJURY; APOA-I; INFLAMMATION	The plasma lipoprotein-associated apolipoproteins (apo) A-I and apoE have well described anti-inflammatory actions in the cardiovascular system, and mimetic peptides that retain these properties have been designed as therapeutics. The anti-inflammatory mechanisms of apolipoprotein mimetics, however, are incompletely defined. Whether circulating apolipoproteins and their mimetics regulate innate immune responses at mucosal surfaces, sites where transvascular emigration of leukocytes is required during inflammation, remains unclear. Herein, we report that Apoai(-/-) and Apoe(-/-) mice display enhanced recruitment of neutrophils to the airspace in response to both inhaled lipopolysaccharide and direct airway inoculation with CXCL1. Conversely, treatment with apoA-I (L-4F) or apoE (COG1410) mimetic peptides reduces airway neutrophilia. We identify suppression of CXCR2-directed chemotaxis as a mechanism underlying the apolipoprotein effect. Pursuing the possibility that L-4F might suppress chemotaxis through heterologous desensitization, we confirmed that L-4F itself induces chemotaxis of human PMNs and monocytes. L-4F, however, fails to induce a calcium flux. Further exploring structure-function relationships, we studied the alternate apoA-I mimetic L-37pA, a bihelical analog of L-4F with two Leu-Phe substitutions. We find that L-37pA induces calcium and chemotaxis through formyl peptide receptor (FPR) 2/ALX, whereas its D-stereoisomer (i.e. D-37pA) blocks L-37pA signaling and induces chemotaxis but not calcium flux through an unidentified receptor. Taken together, apolipoprotein mimetic peptides are novel chemotactic agents that possess complex structure-activity relationships to multiple receptors, displaying anti-inflammatory efficacy against innate immune responses in the airway.	[Madenspacher, Jennifer H.; Azzam, Kathleen M.; Gowdy, Kymberly M.; Fessler, Michael B.] NIEHS, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA; [Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, NIH, Frederick, MD 21702 USA; [Vitek, Michael P.; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; [Vitek, Michael P.] Cognosci Inc, Res Triangle Pk, NC 27709 USA; [Remaley, Alan T.] NHLBI, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Gong, Wanghua] SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Science Applications International Corporation (SAIC); SAIC-Frederick	Fessler, MB (corresponding author), 111 TW Alexander Dr,POB 12233,MD D2-01, Res Triangle Pk, NC 27709 USA.	fesslerm@niehs.nih.gov	Fessler, Michael B/C-6323-2019	Fessler, Michael B/0000-0002-8262-8613; Vitek, Michael/0000-0001-8140-8048	National Institutes of Health Intramural Research Program NIEHS [Z01 ES102005]; NCI, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010015, ZIABC010725] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102005, ZICES102546] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program NIEHS; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program NIEHS Grant Z01 ES102005.; Supported in part by funds from the NCI, National Institutes of Health, under Contract HHSN261200800001E and the Intramural Research Program of the NCI, National Institutes of Health.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Bae YS, 2003, J IMMUNOL, V171, P6807, DOI 10.4049/jimmunol.171.12.6807; BLACKBURN WD, 1991, J LIPID RES, V32, P1911; Bloedon LT, 2008, J LIPID RES, V49, P1344, DOI 10.1194/jlr.P800003-JLR200; Bocharov AV, 2004, J BIOL CHEM, V279, P36072, DOI 10.1074/jbc.M314264200; BREWER HB, 1986, METHOD ENZYMOL, V128, P223; Burli RW, 2006, BIOORG MED CHEM LETT, V16, P3713, DOI 10.1016/j.bmcl.2006.04.068; Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Dai LJ, 2010, J LIPID RES, V51, P2695, DOI 10.1194/jlr.M008086; Datta G, 2001, J LIPID RES, V42, P1096; Deng XY, 1999, BLOOD, V94, P1165, DOI 10.1182/blood.V94.4.1165.416k23_1165_1173; Diederich W, 2001, ATHEROSCLEROSIS, V159, P313, DOI 10.1016/S0021-9150(01)00518-4; Filep JG, 2009, J CELL BIOCHEM, V108, P1039, DOI 10.1002/jcb.22351; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Getz GS, 2010, CURR ATHEROSCLER REP, V12, P96, DOI 10.1007/s11883-010-0097-4; Hu JY, 2001, J LEUKOCYTE BIOL, V70, P155; Kim TH, 2010, AM J RESP CRIT CARE, V182, P633, DOI 10.1164/rccm.200905-0659OC; Klein C, 1998, NAT BIOTECHNOL, V16, P1334, DOI 10.1038/4310; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Le YY, 2001, CYTOKINE GROWTH F R, V12, P91, DOI 10.1016/S1359-6101(01)00003-X; Le YY, 2000, CLIN IMMUNOL, V96, P236, DOI 10.1006/clim.2000.4896; Le YY, 1999, J IMMUNOL, V163, P6777; Lee HY, 2008, J IMMUNOL, V181, P4332, DOI 10.4049/jimmunol.181.6.4332; LIN CT, 1986, J CLIN INVEST, V78, P947, DOI 10.1172/JCI112685; MARSHALL GR, 1990, P NATL ACAD SCI USA, V87, P487, DOI 10.1073/pnas.87.1.487; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Murphy AJ, 2010, CLIN EXP PHARMACOL P, V37, P710, DOI 10.1111/j.1440-1681.2009.05338.x; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Navab M, 2010, ARTERIOSCL THROM VAS, V30, P164, DOI 10.1161/ATVBAHA.109.187518; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Shen WP, 2000, BIOCHEM BIOPH RES CO, V272, P276, DOI 10.1006/bbrc.2000.2770; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Sogawa Y, 2011, IMMUNOLOGY, V132, P441, DOI 10.1111/j.1365-2567.2010.03367.x; Sogawa Y, 2011, J PHARMACOL SCI, V115, P63, DOI 10.1254/jphs.10194FP; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Tabet F, 2010, ARTERIOSCL THROM VAS, V30, P246, DOI 10.1161/ATVBAHA.109.200196; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Yan YJ, 2006, LIFE SCI, V79, P210, DOI 10.1016/j.lfs.2006.02.011; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Ying GG, 2004, J IMMUNOL, V172, P7078, DOI 10.4049/jimmunol.172.11.7078; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496	50	29	30	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43730	43740		10.1074/jbc.M112.377192	http://dx.doi.org/10.1074/jbc.M112.377192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118226	hybrid, Green Published			2022-12-25	WOS:000312940800052
J	Wier, EM; Neighoff, J; Sun, X; Fu, K; Wan, FY				Wier, Eric M.; Neighoff, Jordan; Sun, Xin; Fu, Kai; Wan, Fengyi			Identification of an N-terminal Truncation of the NF-kappa B p65 Subunit That Specifically Modulates Ribosomal Protein S3-dependent NF-kappa B Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENIC ESCHERICHIA-COLI; CASPASE-3-MEDIATED CLEAVAGE; SIGNALING PATHWAYS; INDUCED APOPTOSIS; CELL-DEATH; ACTIVATION; PHOSPHORYLATION; INFECTION; ALPHA; INFLAMMATION	NF-kappa B is a pleiotrophic transcription factor that plays a prominent regulatory role in various cellular processes. Although previous efforts have focused on its activation, how NF-kappa B selects specific target genes in response to discrete signals remains puzzling. In addition to the well defined Rel protein components of NF-kappa B, the ribosomal protein S3 (RPS3) was identified to be an essential component of specific NF-kappa B complexes. RPS3 synergistically interacts with the NF-kappa B p65 subunit to achieve optimal binding and transactivation of a subset of NF-kappa B target genes, thus providing regulatory specificity. Emerging evidence suggests an important role for the RPS3-p65 interaction in context-specific NF-kappa B gene transcription. The food-borne pathogen Escherichia coli O157:H7 impacts the transcription of a subset of NF-kappa B target genes encoding proinflammatory cytokines and chemokines in host cells by preventing the nuclear translocation of RPS3, but not p65. The N terminus of p65 is crucial for RPS3 binding. Although several p65 N-terminal fragments are generated by either protease cleavage or alternative mRNA splicing under certain pathophysiological conditions, the role of these fragments in modulating NF-kappa B signaling, in particular RPS3-dependent selective gene transcription, has not been fully characterized. Here we report that an N-terminal fragment of p65 (amino acids 21-186) can selectively modulate NF-kappa B gene transcription by competing for RPS3 binding to p65. This 21-186 fragment preferentially localizes in the cytoplasm where it delays stimuli-induced RPS3 nuclear translocation, without affecting the nuclear translocation of p65. Our findings thus uncover a new cytoplasmic function for the N-terminal domain of p65 and provide a novel strategy for selective inhibition of NF-kappa B gene transcription.	[Wier, Eric M.; Neighoff, Jordan; Sun, Xin; Fu, Kai; Wan, Fengyi] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wan, FY (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, 615 N Wolfe St,W8041, Baltimore, MD 21205 USA.	fwan@jhsph.edu		Sun, Xin/0000-0003-2424-8011; Wier, Eric/0000-0003-3824-410X	National Institutes of Health [R00CA137171]; National Cancer Institute [T32CA009110]; NATIONAL CANCER INSTITUTE [R00CA137171, T32CA009110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R00CA137171 (to F. W.). This work was also supported by National Cancer Institute Training Grant T32CA009110 (to E. M. W.).	Barnitz RA, 2010, J VIROL, V84, P6410, DOI 10.1128/JVI.02273-09; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Christian J, 2010, J BIOL CHEM, V285, P41320, DOI 10.1074/jbc.M110.152280; Coiras M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-109; DELOUKAS P, 1993, HUM MOL GENET, V2, P1895, DOI 10.1093/hmg/2.11.1895; Gao XF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00137; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kang KH, 2001, J BIOL CHEM, V276, P24638, DOI 10.1074/jbc.M101291200; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Lee RM, 1999, GENE DEV, V13, P718, DOI 10.1101/gad.13.6.718; Leeman JR, 2008, GENE, V423, P97, DOI 10.1016/j.gene.2008.07.015; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lu T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001966; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Mokhtari D, 2009, AM J PHYSIOL-ENDOC M, V297, pE1067, DOI 10.1152/ajpendo.00212.2009; Muhlen S, 2011, J BIOL CHEM, V286, P5100, DOI 10.1074/jbc.M110.172254; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Neuzil J, 2001, BIOCHEMISTRY-US, V40, P4686, DOI 10.1021/bi002498n; Neves BM, 2010, AM J PATHOL, V177, P2898, DOI 10.2353/ajpath.2010.100367; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pearson JS, 2011, MOL MICROBIOL, V80, P219, DOI 10.1111/j.1365-2958.2011.07568.x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, MOL CELL, V45, P1, DOI 10.1016/j.molcel.2011.12.023; Pham TH, 2012, INFECT IMMUN, V80, P2133, DOI 10.1128/IAI.06358-11; POGUEGEILE K, 1991, MOL CELL BIOL, V11, P3842, DOI 10.1128/MCB.11.8.3842; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; Shames SR, 2011, CELL MICROBIOL, V13, P1542, DOI 10.1111/j.1462-5822.2011.01640.x; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Turner DJ, 2007, ANN SURG, V245, P415, DOI 10.1097/01.sla.0000236631.72698.99; UEDA A, 1994, J IMMUNOL, V153, P2052; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; YAO KS, 1995, BIOCHEM PHARMACOL, V49, P275, DOI 10.1016/0006-2952(94)00544-V; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zhu Ning-xi, 2003, Zhonghua Xue Ye Xue Za Zhi, V24, P14	51	25	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43019	43029		10.1074/jbc.M112.388694	http://dx.doi.org/10.1074/jbc.M112.388694			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23115242	Green Published, hybrid			2022-12-25	WOS:000312501600058
J	Chen, LX; Zhang, ZQ; Ewers, BE				Chen, Lixin; Zhang, Zhiqiang; Ewers, Brent E.			Urban Tree Species Show the Same Hydraulic Response to Vapor Pressure Deficit across Varying Tree Size and Environmental Conditions	PLOS ONE			English	Article							CANOPY STOMATAL CONDUCTANCE; SAP FLOW; STAND TRANSPIRATION; SOIL-MOISTURE; THERMAL DISSIPATION; WATER TRANSPORT; RAIN-FOREST; DROUGHT; HEAT; PINE	Background: The functional convergence of tree transpiration has rarely been tested for tree species growing under urban conditions even though it is of significance to elucidate the relationship between functional convergence and species differences of urban trees for establishing sustainable urban forests in the context of forest water relations. Methodology/Principal Findings: We measured sap flux of four urban tree species including Cedrus deodara, Zelkova schneideriana, Euonymus bungeanus and Metasequoia glyptostroboides in an urban park by using thermal dissipation probes (TDP). The concurrent microclimate conditions and soil moisture content were also measured. Our objectives were to examine 1) the influence of tree species and size on transpiration, and 2) the hydraulic control of urban trees under different environmental conditions over the transpiration in response to VPD as represented by canopy conductance. The results showed that the functional convergence between tree diameter at breast height (DBH) and tree canopy transpiration amount (E-c) was not reliable to predict stand transpiration and there were species differences within same DBH class. Species differed in transpiration patterns to seasonal weather progression and soil water stress as a result of varied sensitivity to water availability. Species differences were also found in their potential maximum transpiration rate and reaction to light. However, a same theoretical hydraulic relationship between G(c) at VPD = 1 kPa (G(cref)) and the G(c) sensitivity to VPD (-dG(c)/dlnVPD) across studied species as well as under contrasting soil water and R-s conditions in the urban area. Conclusions/Significance: We concluded that urban trees show the same hydraulic regulation over response to VPD across varying tree size and environmental conditions and thus tree transpiration could be predicted with appropriate assessment of G(cref).	[Chen, Lixin; Zhang, Zhiqiang] Beijing Forestry Univ, Coll Soil & Water Conservat, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China; [Ewers, Brent E.] Univ Wyoming, Dept Bot, Program Ecol, Laramie, WY 82071 USA	Beijing Forestry University; University of Wyoming	Zhang, ZQ (corresponding author), Beijing Forestry Univ, Coll Soil & Water Conservat, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China.	Zhqzhang@bjfu.edu.cn	Ewers, Brent E/A-9696-2008	Ewers, Brent/0000-0001-6647-7475	Ministry of Science and Technology, People's Republic of China [2011BAD38B03-2]; Directorate For Geosciences [0910731] Funding Source: National Science Foundation	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The financial support for the study was from Ministry of Science and Technology, People's Republic of China through China National Scientific and Technical Innovation Research Project for 12th Five Year Planning (Grant No. 2011BAD38B03-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril M, 1998, ACTA OECOL, V19, P377, DOI 10.1016/S1146-609X(98)80042-8; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Asbjornsen H, 2007, FOREST ECOL MANAG, V247, P209, DOI 10.1016/j.foreco.2007.04.043; Benyon RG, 2001, AGR WATER MANAGE, V50, P65, DOI 10.1016/S0378-3774(00)00121-9; Berninger F, 2000, PLANT CELL ENVIRON, V23, P1025, DOI 10.1046/j.1365-3040.2000.00624.x; Bittner S, 2010, AGR FOREST METEOROL, V150, P1347, DOI 10.1016/j.agrformet.2010.06.006; Bush SE, 2008, OECOLOGIA, V156, P13, DOI 10.1007/s00442-008-0966-5; Bush SE, 2010, TREE PHYSIOL, V30, P1545, DOI 10.1093/treephys/tpq096; Chen LX, 2011, J HYDROL, V402, P388, DOI 10.1016/j.jhydrol.2011.03.034; Cienciala E, 2000, J HYDROL, V236, P109, DOI 10.1016/S0022-1694(00)00291-2; Clearwater MJ, 1999, TREE PHYSIOL, V19, P681; Dierick D, 2009, AGR FOREST METEOROL, V149, P1317, DOI 10.1016/j.agrformet.2009.03.003; Ewers BE, 2005, PLANT CELL ENVIRON, V28, P660, DOI 10.1111/j.1365-3040.2005.01312.x; Ewers BE, 2001, CAN J FOREST RES, V31, P198, DOI 10.1139/cjfr-31-2-198; Fisher RA, 2007, GLOBAL CHANGE BIOL, V13, P2361, DOI 10.1111/j.1365-2486.2007.01417.x; Ford CR, 2007, AGR FOREST METEOROL, V145, P176, DOI 10.1016/j.agrformet.2007.04.010; Franks PJ, 2004, TREE PHYSIOL, V24, P865, DOI 10.1093/treephys/24.8.865; Gartner K, 2009, FOREST ECOL MANAG, V258, P590, DOI 10.1016/j.foreco.2009.04.028; GRANIER A, 1994, TREE PHYSIOL, V14, P1383, DOI 10.1093/treephys/14.12.1383; Granier A, 2000, AGR FOREST METEOROL, V100, P291, DOI [10.1016/S0168-1923(99)00151-3, 10.1016/0168-1923(95)02252-X]; GRANIER A, 1987, TREE PHYSIOL, V3, P309, DOI 10.1093/treephys/3.4.309; Hedblom M, 2010, J BIOGEOGR, V37, P1302, DOI 10.1111/j.1365-2699.2010.02299.x; Heisler G.M., 2000, URBAN ECOSYST, V4, P193, DOI [DOI 10.1023/A:1012210710900, 10.1023/A:1012210710900]; Herbst M, 2007, FOREST ECOL MANAG, V250, P176, DOI 10.1016/j.foreco.2007.05.013; Hogg EH, 1997, J GEOPHYS RES-ATMOS, V102, P28929, DOI 10.1029/96JD03881; Hogg EH, 1997, TREE PHYSIOL, V17, P501; Holscher D, 2005, TREES-STRUCT FUNCT, V19, P628, DOI 10.1007/s00468-005-0426-3; Huang YQ, 2011, J HYDROL, V402, P135, DOI 10.1016/j.jhydrol.2011.03.013; Iida S, 2005, J HYDROL, V315, P154, DOI 10.1016/j.jhydrol.2005.03.024; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Katul GG, 2009, PLANT CELL ENVIRON, V32, P968, DOI 10.1111/j.1365-3040.2009.01977.x; KAUFMANN MR, 1985, FOREST ECOL MANAG, V13, P235, DOI 10.1016/0378-1127(85)90037-4; Komatsu H, 2010, FOREST ECOL MANAG, V260, P1295, DOI 10.1016/j.foreco.2010.06.040; Kumagai T, 2004, J HYDROL, V287, P237, DOI 10.1016/j.jhydrol.2003.10.002; Lagergren F, 2002, AGR FOREST METEOROL, V112, P67, DOI 10.1016/S0168-1923(02)00060-6; Li YY, 2008, NEW PHYTOL, V177, P558, DOI 10.1111/j.1469-8137.2007.02272.x; Licata JA, 2011, ECOHYDROLOGY, V4, P83, DOI 10.1002/eco.125; Linton MJ, 1998, FUNCT ECOL, V12, P906, DOI 10.1046/j.1365-2435.1998.00275.x; Liu WD, 2009, THEOR APPL CLIMATOL, V96, P201, DOI 10.1007/s00704-008-0024-6; Llorens P, 2010, HYDROL PROCESS, V24, P3053, DOI 10.1002/hyp.7720; Lundblad M, 2002, BASIC APPL ECOL, V3, P229, DOI 10.1078/1439-1791-00099; Macfarlane C, 2010, FOREST ECOL MANAG, V260, P96, DOI 10.1016/j.foreco.2010.04.005; Mackay DS, 2003, J HYDROL, V277, P230, DOI 10.1016/S0022-1694(03)00130-6; MacKay DS, 2002, GLOBAL CHANGE BIOL, V8, P1253, DOI 10.1046/j.1365-2486.2002.00554.x; Markesteijn L, 2011, NEW PHYTOL, V191, P480, DOI 10.1111/j.1469-8137.2011.03708.x; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; Meinzer FC, 2005, FUNCT ECOL, V19, P558, DOI 10.1111/j.1365-2435.2005.01017.x; Meinzer FC, 1999, OECOLOGIA, V121, P293, DOI 10.1007/s004420050931; Meinzer FC, 2004, TREE PHYSIOL, V24, P901, DOI 10.1093/treephys/24.8.901; Meinzer FC, 2001, TREE PHYSIOL, V21, P19, DOI 10.1093/treephys/21.1.19; MORISON JIL, 1983, PLANT PHYSIOL, V71, P789, DOI 10.1104/pp.71.4.789; Murphy DJ, 2011, INT J CLIMATOL, V31, P1222, DOI 10.1002/joc.2145; Nardini A, 2003, TREES-STRUCT FUNCT, V17, P529, DOI 10.1007/s00468-003-0265-z; Novick K, 2009, ADV WATER RESOUR, V32, P809, DOI 10.1016/j.advwatres.2009.02.004; O'Brien JJ, 2004, PLANT CELL ENVIRON, V27, P551, DOI 10.1111/j.1365-3040.2003.01160.x; Ogawa K, 2010, PLANT ECOL, V211, P79, DOI 10.1007/s11258-010-9774-1; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Oren R, 2001, OECOLOGIA, V127, P549, DOI 10.1007/s004420000622; Palomo MJ, 2002, AGR WATER MANAGE, V55, P15, DOI 10.1016/S0378-3774(01)00182-2; Pataki DE, 2011, ECOL APPL, V21, P661, DOI 10.1890/09-1717.1; Pratt RB, 2007, NEW PHYTOL, V174, P787, DOI 10.1111/j.1469-8137.2007.02061.x; Rizk AA, 2010, ENERG BUILDINGS, V42, P1711, DOI 10.1016/j.enbuild.2010.05.005; Schafer KVR, 2000, PLANT CELL ENVIRON, V23, P365, DOI 10.1046/j.1365-3040.2000.00553.x; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Sperry JS, 2000, AGR FOREST METEOROL, V104, P13, DOI 10.1016/S0168-1923(00)00144-1; Sperry JS, 1998, PLANT CELL ENVIRON, V21, P347, DOI 10.1046/j.1365-3040.1998.00287.x; Steppe K, 2010, AGR FOREST METEOROL, V150, P1046, DOI 10.1016/j.agrformet.2010.04.004; Tognetti R, 2009, AGR FOREST METEOROL, V149, P1229, DOI 10.1016/j.agrformet.2009.02.008; Valentine HT, 2012, NEW PHYTOL, V194, P961, DOI 10.1111/j.1469-8137.2012.04123.x; van Dijk AIJM, 2007, FOREST ECOL MANAG, V251, P1, DOI 10.1016/j.foreco.2007.06.010; Wallace J, 2010, J HYDROL, V384, P107, DOI 10.1016/j.jhydrol.2010.01.015; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; West AG, 2008, ECOL APPL, V18, P911, DOI 10.1890/06-2094.1; Wullschleger SD, 2001, FOREST ECOL MANAG, V143, P205, DOI 10.1016/S0378-1127(00)00518-1; YONEDA T, 1990, Ecological Research, V5, P111, DOI 10.1007/BF02348467; Yong JWH, 1997, PLANT CELL ENVIRON, V20, P1213, DOI 10.1046/j.1365-3040.1997.d01-27.x; Yunusa IAM, 2010, AGR FOREST METEOROL, V150, P1234, DOI 10.1016/j.agrformet.2010.05.007; Zeppel MJB, 2008, J HYDROL, V349, P200, DOI 10.1016/j.jhydrol.2007.11.001; Zhang HP, 1999, TREE PHYSIOL, V19, P563; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zwieniecki MA, 2007, PLANT CELL ENVIRON, V30, P910, DOI 10.1111/j.1365-3040.2007.001681.x	81	20	21	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47882	10.1371/journal.pone.0047882	http://dx.doi.org/10.1371/journal.pone.0047882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118904	Green Submitted, gold, Green Published			2022-12-25	WOS:000310600500042
J	Chubiz, LM; Lee, MC; Delaney, NF; Marx, CJ				Chubiz, Lon M.; Lee, Ming-Chun; Delaney, Nigel F.; Marx, Christopher J.			FREQ-Seq: A Rapid, Cost-Effective, Sequencing-Based Method to Determine Allele Frequencies Directly from Mixed Populations	PLOS ONE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; 10,000-GENERATION EXPERIMENT; BENEFICIAL MUTATIONS; CLONAL INTERFERENCE; POOLED DNA; ADAPTATION; METHYLOBACTERIUM; SELECTION; GROWTH	Understanding evolutionary dynamics within microbial populations requires the ability to accurately follow allele frequencies through time. Here we present a rapid, cost-effective method (FREQ-Seq) that leverages Illumina next-generation sequencing for localized, quantitative allele frequency detection. Analogous to RNA-Seq, FREQ-Seq relies upon counts from the > 10(5) reads generated per locus per time-point to determine allele frequencies. Loci of interest are directly amplified from a mixed population via two rounds of PCR using inexpensive, user-designed oligonucleotides and a bar-coded bridging primer system that can be regenerated in-house. The resulting bar-coded PCR products contain the adapters needed for Illumina sequencing, eliminating further library preparation. We demonstrate the utility of FREQ-Seq by determining the order and dynamics of beneficial alleles that arose as a microbial population, founded with an engineered strain of Methylobacterium, evolved to grow on methanol. Quantifying allele frequencies with minimal bias down to 1% abundance allowed effective analysis of SNPs, small in-dels and insertions of transposable elements. Our data reveal large-scale clonal interference during the early stages of adaptation and illustrate the utility of FREQ-Seq as a cost-effective tool for tracking allele frequencies in populations.	[Chubiz, Lon M.; Lee, Ming-Chun; Delaney, Nigel F.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Marx, Christopher J.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cmarx@oeb.harvard.edu			National Science Foundation [DEB-0845893]; National Institutes of Health [GM078209]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078209] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by funding from National Science Foundation (DEB-0845893) and National Institutes of Health (GM078209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Chou HH, 2012, CELL REP, V1, P133, DOI 10.1016/j.celrep.2011.12.003; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Delaney NF, 2013, JALA-J LAB AUTOM, V18, P171, DOI 10.1177/2211068212460237; Desai MM, 2007, CURR BIOL, V17, P385, DOI 10.1016/j.cub.2007.01.072; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; FUTUYMA D., 2009, EVOLUTION; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; HELLING RB, 1987, GENETICS, V116, P349; Herbon N, 2003, GENOMICS, V81, P510, DOI 10.1016/S0888-7543(02)00035-6; Hill WG, 2007, GENET RES, V89, P311, DOI 10.1017/S001667230800949X; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; Kirov G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-27; Krueger F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016607; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lee MC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002651; Lee MC, 2009, EVOLUTION, V63, P2816, DOI 10.1111/j.1558-5646.2009.00757.x; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; Monsion B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-85; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P45, DOI 10.1046/j.1462-2920.1999.00003.x; Papadopoulos D, 1999, P NATL ACAD SCI USA, V96, P3807, DOI 10.1073/pnas.96.7.3807; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Pena MI, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.43; Schneider D, 2000, GENETICS, V156, P477; THOMAS CM, 1980, J BACTERIOL, V141, P213, DOI 10.1128/JB.141.1.213-222.1980; Werner M, 2002, HUM MUTAT, V20, P57, DOI 10.1002/humu.10094; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wilkening S, 2005, BIOTECHNIQUES, V39, P853, DOI 10.2144/000112027; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	41	32	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47959	10.1371/journal.pone.0047959	http://dx.doi.org/10.1371/journal.pone.0047959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118913	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500049
J	Dias, FD; dos Santos, ALS; Lery, LMS; Silva, TLAE; Oliveira, MM; Bisch, PM; Saraiva, EM; Souto-Padron, TC; Lopes, AH				Dias, Felipe de Almeida; Souza dos Santos, Andre Luis; Santos Lery, Leticia Miranda; Alves e Silva, Thiago Luiz; Oliveira, Mauricio Martins; Bisch, Paulo Mascarello; Saraiva, Elvira Maria; Souto-Padron, Thais Cristina; Lopes, Angela Hampshire			Evidence That a Laminin-Like Insect Protein Mediates Early Events in the Interaction of a Phytoparasite with Its Vector's Salivary Gland	PLOS ONE			English	Article							TRYPANOSOMA-RANGELI; PHYTOMONAS-SERPENS; ONCOPELTUS-FASCIATUS; RHODNIUS-PROLIXUS; BINDING PROTEIN; LEISHMANIA-DONOVANI; SURFACE PROTEIN; CHAIN REVEALS; MILKWEED BUG; BASAL LAMINA	Phytomonas species are plant parasites of the family Trypanosomatidae, which are transmitted by phytophagous insects. Some Phytomonas species cause major agricultural damages. The hemipteran Oncopeltus fasciatus is natural and experimental host for several species of trypanosomatids, including Phytomonas spp. The invasion of the insect vectors' salivary glands is one of the most important events for the life cycle of Phytomonas species. In the present study, we show the binding of Phytomonas serpens at the external face of O. fasciatus salivary glands by means of scanning electron microscopy and the in vitro interaction of living parasites with total proteins from the salivary glands in ligand blotting assays. This binding occurs primarily through an interaction with a 130 kDa salivary gland protein. The mass spectrometry of the trypsin-digest of this protein matched 23% of human laminin-5 beta 3 chain precursor sequence by 16 digested peptides. A protein sequence search through the transcriptome of O. fasciatus embryo showed a partial sequence with 51% similarity to human laminin beta 3 subunit. Anti-human laminin-5 beta 3 chain polyclonal antibodies recognized the 130 kDa protein by immunoblotting. The association of parasites with the salivary glands was strongly inhibited by human laminin-5, by the purified 130 kDa insect protein, and by polyclonal antibodies raised against the human laminin-5 beta 3 chain. This is the first report demonstrating that a laminin-like molecule from the salivary gland of O. fasciatus acts as a receptor for Phytomonas binding. The results presented in this investigation are important findings that will support further studies that aim at developing new approaches to prevent the transmission of Phytomonas species from insects to plants and vice-versa.	[Dias, Felipe de Almeida; Souza dos Santos, Andre Luis; Alves e Silva, Thiago Luiz; Oliveira, Mauricio Martins; Saraiva, Elvira Maria; Souto-Padron, Thais Cristina; Lopes, Angela Hampshire] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Ilha Fundao, Rio de Janeiro, Brazil; [Dias, Felipe de Almeida] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ilha Fundao, Rio de Janeiro, Brazil; [Santos Lery, Leticia Miranda; Bisch, Paulo Mascarello] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ilha Fundao, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Lopes, AH (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Ilha Fundao, Rio de Janeiro, Brazil.	angela.lopes@micro.ufrj.br	Mascarello Bisch, Paulo/GRF-5572-2022; Lopes, Angela/AAX-2501-2021; Saraiva, Elvira M/L-2864-2017; Santos, André/Z-5853-2019; LA Silva, Thiago/L-7699-2016; Dias, Felipe/L-7390-2013	Saraiva, Elvira M/0000-0002-6388-5286; Santos, André/0000-0003-0821-8592; LA Silva, Thiago/0000-0002-8520-5405; Dias, Felipe/0000-0003-2074-1052; Hampshire Lopes, Angela/0000-0003-0660-4596; Lery, Leticia/0000-0002-5733-8294	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM)	This work was supported by grants from the Brazilian Agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 1999, PARASITOLOGY, V119, P331, DOI 10.1017/S0031182099004874; Akaki M, 2005, J EXP BIOL, V208, P3211, DOI 10.1242/jeb.01756; Al-Olayan EM, 2002, SCIENCE, V295, P677, DOI 10.1126/science.1067159; Arrighi RBG, 2005, J EXP BIOL, V208, P2497, DOI 10.1242/jeb.01664; Bandyopadhyay K, 2002, EUR J BIOCHEM, V269, P1622, DOI 10.1046/j.1432-1327.2002.02793.x; Bandyopadhyay K, 2001, J BIOCHEM, V130, P141, DOI 10.1093/oxfordjournals.jbchem.a002953; Basseri HR, 2002, EXP PARASITOL, V100, P226, DOI 10.1016/S0014-4894(02)00026-7; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Bonner J, 2002, DEV BIOL, V249, P57, DOI 10.1006/dbio.2002.0750; BOUCHARA JP, 1990, INFECT IMMUN, V58, P48, DOI 10.1128/IAI.58.1.48-54.1990; BROCKMOLLER J, 1985, BIOL CHEM H-S, V366, P901, DOI 10.1515/bchm3.1985.366.2.901; BRONSKILL JOAN F., 1958, CANADIAN JOUR ZOOL, V36, P961, DOI 10.1139/z58-081; BROOKER BE, 1971, PROTOPLASMA, V73, P191, DOI 10.1007/BF01275594; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; Camargo EP, 1994, ADV DISEASE VECTOR R, P333; CHI HC, 1988, NUCLEIC ACIDS RES, V16, P7205, DOI 10.1093/nar/16.14.7205; CHI HC, 1989, J BIOL CHEM, V264, P1543; Court FA, 2006, CURR OPIN NEUROBIOL, V16, P501, DOI 10.1016/j.conb.2006.08.005; Crouch ML, 1999, MICROBIOL-SGM, V145, P2835, DOI 10.1099/00221287-145-10-2835; d'Avila-Levy CM, 2006, CURR MICROBIOL, V52, P439, DOI 10.1007/s00284-005-0222-8; d'Avila-Levy CM, 2006, FEMS MICROBIOL LETT, V254, P149, DOI 10.1111/j.1574-6968.2005.00022.x; de Oliveira MA, 2001, J INVERTEBR PATHOL, V77, P22, DOI 10.1006/jipa.2000.4988; Dey R, 2006, MOL CELL BIOCHEM, V281, P27, DOI 10.1007/s11010-006-0171-y; Dias FD, 2007, J BIOMOL SCREEN, V12, P1006, DOI 10.1177/1087057107307146; Dollet M, 2000, J EUKARYOT MICROBIOL, V47, P569, DOI 10.1111/j.1550-7408.2000.tb00091.x; Dos-Santos ALA, 2012, INT J PARASITOL, V42, P819, DOI 10.1016/j.ijpara.2012.05.011; Elias CGR, 2008, EXP PARASITOL, V120, P343, DOI 10.1016/j.exppara.2008.08.011; ELLIS DS, 1980, Z PARASITENKD, V62, P63, DOI 10.1007/BF00925367; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Feder D, 1999, MEM I OSWALDO CRUZ, V94, P771, DOI 10.1590/S0074-02761999000600011; FESSLER JH, 1989, ANNU REV CELL BIOL, V5, P309, DOI 10.1146/annurev.cb.05.110189.001521; Francischetti IMB, 2007, INSECT BIOCHEM MOLEC, V37, P903, DOI 10.1016/j.ibmb.2007.04.007; Ghosh A, 1999, BIOCHEM J, V337, P551, DOI 10.1042/0264-6021:3370551; GIORDANO R, 1994, MOL BIOCHEM PARASIT, V65, P85, DOI 10.1016/0166-6851(94)90117-1; Giordano R, 1999, J BIOL CHEM, V274, P3461, DOI 10.1074/jbc.274.6.3461; Gonzalez A, 2005, INFECT IMMUN, V73, P2486, DOI 10.1128/IAI.73.4.2486-2495.2005; HANSON WL, 1963, J PROTOZOOL, V10, P233, DOI 10.1111/j.1550-7408.1963.tb01668.x; HECKER H, 1990, PARASITOL RES, V76, P311, DOI 10.1007/BF00928185; Hurd H, 2006, PARASITOLOGY, V132, pS33, DOI 10.1017/S0031182006000849; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; JANKEVICIUS JV, 1989, J PROTOZOOL, V36, P265, DOI 10.1111/j.1550-7408.1989.tb05361.x; Lewis ER, 1973, SCANNING ELECTRON MI, P767; Liao Jiang-Lin, 2011, Genomics Proteomics & Bioinformatics, V9, P229, DOI 10.1016/S1672-0229(11)60026-0; Lonsdale-Eccles JD, 2002, TRENDS PARASITOL, V18, P17, DOI 10.1016/S1471-4922(01)02120-1; Lopes Angela H., 2010, Open Parasitology Journal, V4, P30; LOPES JD, 1985, SCIENCE, V229, P275, DOI 10.1126/science.3160113; LOPES JD, 1988, BRAZ J MED BIOL RES, V21, P1269; LOPEZRIBOT JL, 1994, INFECT IMMUN, V62, P742; Mahairaki V, 2005, MOL BIOCHEM PARASIT, V140, P119, DOI 10.1016/j.molbiopara.2004.11.012; Marques MAM, 2001, J MED MICROBIOL, V50, P23, DOI 10.1099/0022-2615-50-1-23; MCGHEE RB, 1964, J PROTOZOOL, V11, P555, DOI 10.1111/j.1550-7408.1964.tb01798.x; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; MCMAHON JP, 1995, J CLIN INVEST, V96, P1010, DOI 10.1172/JCI118086; Meirelles RMS, 2005, PARASITOL RES, V97, P259, DOI 10.1007/s00436-005-1433-4; MONTELL DJ, 1988, CELL, V53, P463, DOI 10.1016/0092-8674(88)90166-3; Mueller AK, 2010, INT J PARASITOL, V40, P1229, DOI 10.1016/j.ijpara.2010.05.005; Nacer A, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-33; Nicholas K.B., 1997, EMBNEW NEWS, V4, P1; OHNO M, 1991, CONNECT TISSUE RES, V25, P251, DOI 10.3109/03008209109029161; Palatnik-de-Sousa CB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-197; PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2; PIMENTA PFP, 1992, SCIENCE, V256, P1812, DOI 10.1126/science.1615326; PIMENTA PFP, 1994, P NATL ACAD SCI USA, V91, P9155, DOI 10.1073/pnas.91.19.9155; Podlipaev SA, 2000, MEM I OSWALDO CRUZ, V95, P517, DOI 10.1590/S0074-02762000000400013; Ramakrishnan C, 2011, INT J PARASITOL, V41, P1029, DOI 10.1016/j.ijpara.2011.05.007; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Richards A, 1996, EUR J BIOCHEM, V238, P813, DOI 10.1111/j.1432-1033.1996.0813w.x; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Romeiro A, 2003, J INVERTEBR PATHOL, V82, P41, DOI 10.1016/S0022-2011(02)00176-3; ROOSE JP, 1995, J LAB CLIN MED, V125, P433; ROSENFELD MG, 1992, ANN NY ACAD SCI, V657, P1, DOI 10.1111/j.1749-6632.1992.tb22754.x; Sakata N, 1999, ZBL BAKT-INT J MED M, V289, P217; Santos ALS, 2006, INT J PARASITOL, V36, P47, DOI 10.1016/j.ijpara.2005.09.004; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; Scharfstein Julio, 2008, V47, P140; SCHAUB GA, 1988, PARASITOL RES, V75, P88, DOI 10.1007/BF00932706; Schneider M, 2001, J INVERTEBR PATHOL, V78, P135, DOI 10.1006/jipa.2001.5054; Shimoji Y, 1999, P NATL ACAD SCI USA, V96, P9857, DOI 10.1073/pnas.96.17.9857; Silva FCE, 1998, EXP PARASITOL, V88, P240, DOI 10.1006/expr.1998.4227; Simpson DC, 2005, ELECTROPHORESIS, V26, P1291, DOI 10.1002/elps.200410132; Sturm NR, 2007, INFECT GENET EVOL, V7, P570, DOI 10.1016/j.meegid.2007.04.002; SWITALSKI LM, 1984, J BIOL CHEM, V259, P3734; Tieszen KL, 1989, Z PARASITENKD, V71, P179; Vlachou D, 2001, MOL BIOCHEM PARASIT, V112, P229, DOI 10.1016/S0166-6851(00)00371-6; Votypka J, 2010, MOL PHYLOGENET EVOL, V54, P243, DOI 10.1016/j.ympev.2009.10.014; Wolfstetter G, 2012, CELL MOL LIFE SCI, V69, P267, DOI 10.1007/s00018-011-0652-3; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0	92	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48170	10.1371/journal.pone.0048170	http://dx.doi.org/10.1371/journal.pone.0048170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118944	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500075
J	Su, HM; Lin, TH; Hsu, PC; Lee, CS; Lee, WH; Chen, SC; Voon, WC; Lai, WT; Sheu, SH				Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Lee, Chee-Siong; Lee, Wen-Hsien; Chen, Szu-Chia; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			Association of Chronic Kidney Disease and Peripheral Artery Disease with Inappropriate Left Ventricular Mass	PLOS ONE			English	Article							BLOOD-PRESSURE INDEX; ANKLE-BRACHIAL INDEX; VASCULAR-DISEASE; RISK-FACTORS; HYPERTROPHY; PREVALENCE; MORTALITY; HEART; CALCIFICATION; CREATININE	Inappropriate left ventricular mass index (LVM) may develop as a response to particular hemodynamic and metabolic alterations. Inappropriate LVM and peripheral artery disease (PAD) characterized by abnormally low or high ankle-brachial index (ABI) are common in chronic kidney disease (CKD) patients, in whom there may be a close and cause-effect relationship. The aim of this study is to assess whether CKD and abnormal ABI has an independent and additive association with inappropriate LVM. A total of 1110 patients were included in the study. Inappropriate LVM was defined as observed LVM more than 28% of the predicted value. The ABI was measured using an ABI-form device. PAD was defined as ABI <0.9 or >= 1.3 in either leg. Multivariate analysis showed that patients with estimated glomerular filtration rate (eGFR) <45 ml/min/1.73 m(2) (odds ratio [OR], 1.644; P = 0.011) and PAD (OR, 2.082; P = 0.002) were independently associated with inappropriate LVM. The interaction between eGFR <45 ml/min/1.73 m(2) and PAD on inappropriate LVM was statistically significant (P = 0.044). Besides, eGFR <45 ml/min/1.73 m(2) (change in observed/predicted LVM, 19.949; P<0.001) and PAD (change in observed/predicted LVM, 11.818; P = 0.003) were also significantly associated with observed/predicted LVM. Our findings show that eGFR <45 ml/min/1.73 m(2) and PAD are independently and additively associated with inappropriate LVM and observed/predicted LVM. Assessments of eGFR and ABI may be useful in identifying patients with inappropriate LVM.	[Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Lee, Chee-Siong; Lee, Wen-Hsien; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Su, Ho-Ming; Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Ho-Ming; Lin, Tsung-Hsien; Lee, Chee-Siong; Chen, Szu-Chia; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Chen, SC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	scarchenone@yahoo.com.tw	蘇, 河名/AAE-9843-2019	Su, Ho-Ming/0000-0003-0247-3250; Lin, Tsung-Hsien/0000-0002-7226-8730				Aboyans V, 2008, J VASC SURG, V48, P1197, DOI 10.1016/j.jvs.2008.06.005; Chen SC, 2012, HYPERTENS RES, V35, P832, DOI 10.1038/hr.2012.40; Chinali M, 2007, J HYPERTENS, V25, P1073, DOI 10.1097/HJH.0b013e32803fb60c; Cioffi G, 2011, J HYPERTENS, V29, P565, DOI 10.1097/HJH.0b013e3283424188; de Simone G, 2002, HYPERTENSION, V40, P470, DOI 10.1161/01.HYP.0000034740.99323.8A; de Simone G, 1998, HYPERTENSION, V31, P1077, DOI 10.1161/01.HYP.31.5.1077; de Simone G, 2001, J HYPERTENS, V19, P119, DOI 10.1097/00004872-200101000-00016; de Vinuesa SG, 2005, KIDNEY INT, V67, pS44, DOI 10.1111/j.1523-1755.2005.09310.x; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fishbane S, 1996, AM J KIDNEY DIS, V27, P668, DOI 10.1016/S0272-6386(96)90101-8; FOWKES FGR, 1991, INT J EPIDEMIOL, V20, P384, DOI 10.1093/ije/20.2.384; Fu WC, 2006, NEPHROLOGY, V11, P9, DOI 10.1111/j.1440-1797.2006.00534.x; Guerrero A, 2006, NEPHROL DIAL TRANSPL, V21, P3525, DOI 10.1093/ndt/gfl470; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Ix JH, 2010, J AM COLL CARDIOL, V55, P342, DOI 10.1016/j.jacc.2009.11.010; Leskinen Y, 2002, AM J KIDNEY DIS, V40, P472, DOI 10.1053/ajkd.2002.34885; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2001, AM J KIDNEY DIS, V38, P1398, DOI 10.1053/ajkd.2001.29275; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Levin A, 1996, AM J KIDNEY DIS, V27, P347, DOI 10.1016/S0272-6386(96)90357-1; Nardi E, 2009, J HYPERTENS, V27, P633, DOI 10.1097/HJH.0b013e3283220ecd; Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x; Niederhoffer N, 1997, HYPERTENSION, V29, P999, DOI 10.1161/01.HYP.29.4.999; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; O'Hare AM, 2002, J AM SOC NEPHROL, V13, P497, DOI 10.1681/ASN.V132497; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; ORCHARD TJ, 1993, DIABETES CARE, V16, P1199, DOI 10.2337/diacare.16.8.1199; PEDERSEN TR, 1994, LANCET, V344, P1383; Ritz E, 2006, AM J MED, V119, p31S, DOI 10.1016/j.amjmed.2006.01.012; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; ROMAN MJ, 1995, J AM COLL CARDIOL, V25, P83, DOI 10.1016/0735-1097(94)00316-I; Shinohara K, 2004, KIDNEY INT, V65, P936, DOI 10.1111/j.1523-1755.2004.00468.x; Su HM, 2012, PLOS ONE IN PRESS; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; WEBB AT, 1993, EUR J VASCULAR SURG, V7, P523, DOI 10.1016/S0950-821X(05)80364-0; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48422	10.1371/journal.pone.0048422	http://dx.doi.org/10.1371/journal.pone.0048422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119010	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500130
J	Verschooten, L; Barrette, K; Van Kelst, S; Romero, NR; Proby, C; De Vos, R; Agostinis, P; Garmyn, M				Verschooten, Lien; Barrette, Kathleen; Van Kelst, Sofie; Romero, Noemi Rubio; Proby, Charlotte; De Vos, Rita; Agostinis, Patrizia; Garmyn, Marjan			Autophagy Inhibitor Chloroquine Enhanced the Cell Death Inducing Effect of the Flavonoid Luteolin in Metastatic Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							DOUBLE-EDGED-SWORD; TARGETING AUTOPHAGY; CANCER PREVENTION; SKIN-CANCER; IN-VIVO; APOPTOSIS; PROTEIN; INDUCTION; AKT; EXTRACT	Background: Flavonoids are widely proposed as very interesting compounds with possible chemopreventive and therapeutic capacities. Methods & Results: In this study, we showed that in vitro treatment with the flavonoid Luteolin induced caspase-dependent cell death in a model of human cutaneous squamous cell carcinoma (SCC) derived cells, representing a matched pair of primary tumor and its metastasis. Notably, no cytotoxic effects were observed in normal human keratinocytes when treated with similar doses of Luteolin. Luteolin-induced apoptosis was accompanied by inhibition of AKT signaling, and sensitivity decreased with tumor progression, as the primary MET1 SCC cells were considerably more sensitive to Luteolin than the isogenic metastatic MET4 cells. Extensive intracellular vacuolization was observed in Luteolin-treated MET4 cells, which were characterized as acidic lysosomal vacuoles, suggesting the involvement of autophagy. Transmission electron microscopy, mRFP-GFP-LC3 assay and p62 protein degradation, confirmed that Luteolin stimulated the autophagic process in the metastatic MET4 cells. Blocking autophagy using chloroquine magnified Luteolin-induced apoptosis in the metastatic SCC cells. Conclusion: Together, these results suggest that Luteolin has the capacity to induce selectively apoptotic cell death both in primary cutaneous SCC cells and in metastatic SCC cells in combination with chloroquine, an inhibitor of autophagosomal degradation. Hence, Luteolin might be a promising agent for the treatment of cutaneous SCC.	[Verschooten, Lien; Barrette, Kathleen; Van Kelst, Sofie; Garmyn, Marjan] Katholieke Univ Leuven, Univ Hosp Leuven, Louvain, Belgium; [Verschooten, Lien; Barrette, Kathleen; Van Kelst, Sofie; Garmyn, Marjan] Katholieke Univ Leuven, Dept Oncol, Louvain, Belgium; [Romero, Noemi Rubio; Agostinis, Patrizia] Katholieke Univ Leuven, Lab Cell Death & Therapy, Louvain, Belgium; [Proby, Charlotte] Univ Dundee, Canc Res UK Canc Ctr Dundee, Coll Med Dent & Nursing, Dundee, Scotland	KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University of Dundee	Garmyn, M (corresponding author), Katholieke Univ Leuven, Univ Hosp Leuven, Louvain, Belgium.	Marjan.Garmyn@med.kuleuven.be	Agostinis, Patrizia/AAO-2468-2020; Agostinis, Patrizia/ABI-1177-2020	Agostinis, Patrizia/0000-0003-1314-2115	Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen [SB/0661432]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0491.05]; Catholic University of Leuven [OT/04/42]; Cancer Research UK [13044] Funding Source: researchfish	Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Catholic University of Leuven(KU Leuven); Cancer Research UK(Cancer Research UK)	Funding was provided by the Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (personal PhD grant L.V.: SB/0661432), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (grant G.0491.05), and Catholic University of Leuven (grant OT/04/42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Boukamp Petra, 2005, J Dtsch Dermatol Ges, V3, P493, DOI 10.1111/j.1610-0387.2005.05037.x; Brusselmans K, 2005, J BIOL CHEM, V280, P5636, DOI 10.1074/jbc.M408177200; Byun S, 2010, CANCER RES, V70, P2415, DOI 10.1158/0008-5472.CAN-09-4093; Cai QY, 1997, CANCER LETT, V119, P99, DOI 10.1016/S0304-3835(97)00261-9; Chahar Maheep K, 2011, Pharmacogn Rev, V5, P1, DOI 10.4103/0973-7847.79093; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Claerhout S, 2010, INT J CANCER, V127, P2790, DOI 10.1002/ijc.25300; Courtois SJ, 1997, EXP CELL RES, V233, P135, DOI 10.1006/excr.1997.3537; de Vries E, 2005, BRIT J DERMATOL, V152, P481, DOI [10.1111/j.1365-2133.2005.06386.x, 10.1111/J.1365-2133.2005.06386.X]; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Delmulle L, 2008, PHYTOTHER RES, V22, P197, DOI 10.1002/ptr.2286; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Duan WJ, 2010, J PHARMACOL SCI, V113, P48, DOI 10.1254/jphs.09315FP; GILCHREST BA, 1983, J INVEST DERMATOL, V81, pS184, DOI 10.1111/1523-1747.ep12541084; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gurudutt VV, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/502723; Hoare M, 2011, SEMIN CANCER BIOL, V21, P397, DOI 10.1016/j.semcancer.2011.09.004; Hou DX, 2010, ANTIOXID REDOX SIGN, V13, P691, DOI 10.1089/ars.2009.2816; Huang HC, 2010, J AGR FOOD CHEM, V58, P8699, DOI 10.1021/jf101003v; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klappan AK, 2012, HISTOCHEM CELL BIOL, V137, P25, DOI 10.1007/s00418-011-0869-0; Korolchuk VI, 2011, AUTOPHAGY, V7, P927, DOI 10.4161/auto.7.8.15862; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Le Tourneau C, 2008, HEMATOL ONCOL CLIN N, V22, P1209, DOI 10.1016/j.hoc.2008.08.002; Leblanc KG, 2011, DERMATOL SURG, V37, P744, DOI [10.1111/j.1524-4725.2011.01973..x, 10.1111/j.1524-4725.2011.01973.x]; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Mancias JD, 2011, ONCOTARGET, V2, P1302; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Martinez JC, 2004, DERMATOL SURG, V30, P679, DOI 10.1111/j.1524-4725.2004.30156.x; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; MERFORT I, 1994, PHARMAZIE, V49, P509; Nakamura Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-100; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pedro M, 2006, TOXICOL LETT, V164, P24, DOI 10.1016/j.toxlet.2005.11.007; Proby CM, 2000, EXP DERMATOL, V9, P104, DOI 10.1034/j.1600-0625.2000.009002104.x; Rao PS, 2012, INT J CANCER, V130, P2703, DOI 10.1002/ijc.26308; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Sim GS, 2007, ARCH PHARM RES, V30, P290, DOI 10.1007/BF02977608; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Uchiyama Y, 2001, ARCH HISTOL CYTOL, V64, P233, DOI 10.1679/aohc.64.233; Ueda H, 2003, BIOL PHARM BULL, V26, P560, DOI 10.1248/bpb.26.560; Verschooten L, 2010, J INVEST DERMATOL, V130, P2277, DOI 10.1038/jid.2010.124; Weng CJ, 2012, CANCER METAST REV, V31, P323, DOI 10.1007/s10555-012-9347-y; White E, 2008, AUTOPHAGY, V4, P399, DOI 10.4161/auto.5907; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yan JQ, 2012, BIOCHEM BIOPH RES CO, V417, P842, DOI 10.1016/j.bbrc.2011.12.055; Yan W, 2011, AM J CANCER RES, V1, P275; Zavos G, 2011, INT J DERMATOL, V50, P1496, DOI 10.1111/j.1365-4632.2011.04939.x; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	59	70	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48264	10.1371/journal.pone.0048264	http://dx.doi.org/10.1371/journal.pone.0048264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110223	gold, Green Submitted, Green Published			2022-12-25	WOS:000310262500056
J	Beland, K; Lapierre, P; Djilali-Saiah, I; Alvarez, F				Beland, Kathie; Lapierre, Pascal; Djilali-Saiah, Idriss; Alvarez, Fernando			Liver Restores Immune Homeostasis after Local Inflammation despite the Presence of Autoreactive T Cells	PLOS ONE			English	Article							VASCULAR ADHESION PROTEIN-1; AUTOIMMUNE HEPATITIS; ENDOTHELIAL-CELLS; PERIPHERAL TOLERANCE; INFLAMED LIVER; MURINE MODEL; LYMPHOCYTES; EXPRESSION; DEATH; HEPATOCYTES	The liver must keep equilibrium between immune tolerance and immunity in order to protect itself from pathogens while maintaining tolerance to food antigens. An imbalance between these two states could result in an inflammatory liver disease. The aims of this study were to identify factors responsible for a break of tolerance and characterize the subsequent restoration of liver immune homeostasis. A pro-inflammatory environment was created in the liver by the co-administration of TLR ligands CpG and Poly(I:C) in presence or absence of activated liver-specific autoreactive CD8(+) T cells. Regardless of autoreactive CD8(+) T cells, mice injected with CpG and Poly(I:C) showed elevated serum ALT levels and a transient liver inflammation. Both CpG/Poly(I:C) and autoreactive CD8(+)T cells induced expression of TLR9 and INF-gamma by the liver, and an up-regulation of homing and adhesion molecules CXCL9, CXCL10, CXCL16, ICAM-1 and VCAM-1. Transferred CFSE-labeled autoreactive CD8(+) T cells, in presence of TLR3 and 9 ligands, were recruited by the liver and spleen and proliferated. This population then contracted by apoptosis through intrinsic and extrinsic pathways. Up-regulation of FasL and PD-L1 in the liver was observed. In conclusion, TLR-mediated activation of the innate immune system results in a pro-inflammatory environment that promotes the recruitment of lymphocytes resulting in bystander hepatitis. Despite this pro-inflammatory environment, the presence of autoreactive CD8(+) T cells is not sufficient to sustain an autoimmune response against the liver and immune homeostasis is rapidly restored through the apoptosis of T cells.	[Beland, Kathie; Lapierre, Pascal; Djilali-Saiah, Idriss; Alvarez, Fernando] CHU St Justine, Div Gastroenterol Hepatol & Nutr, Montreal, PQ, Canada; [Djilali-Saiah, Idriss; Alvarez, Fernando] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Alvarez, Fernando] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite de Montreal	Alvarez, F (corresponding author), CHU St Justine, Div Gastroenterol Hepatol & Nutr, Montreal, PQ, Canada.	fernando.alvarez@umontreal.ca	Lapierre, Pascal/ABD-2247-2021	Lapierre, Pascal/0000-0002-2753-3566	Canadian Institutes of Health Research grant [MOP-86506]; Canadian Institutes of Health Research (CIHR)/Canadian Association for the Study of the Liver (CASL)	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)/Canadian Association for the Study of the Liver (CASL)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research grant (MOP-86506) to FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr Alain Lamarre for providing NP396-404 tetramers. P.L. holds a Canadian Institutes of Health Research (CIHR)/Canadian Association for the Study of the Liver (CASL) hepatology fellowship.	Arai K, 2002, CELL IMMUNOL, V219, P48, DOI 10.1016/S0008-8749(02)00584-1; Beland K, 2009, WORLD J GASTROENTERO, V15, P1025, DOI 10.3748/wjg.15.1025; Benseler V, 2011, P NATL ACAD SCI USA, V108, P16735, DOI 10.1073/pnas.1112251108; Bertolino P, 1999, INT IMMUNOL, V11, P1225, DOI 10.1093/intimm/11.8.1225; Bonder CS, 2005, IMMUNITY, V23, P153, DOI 10.1016/j.immuni.2005.06.007; Chhabra A, 2010, VACCINE, V28, P4566, DOI 10.1016/j.vaccine.2010.04.074; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Djilali-Saiah I, 2002, J IMMUNOL, V169, P4889, DOI 10.4049/jimmunol.169.9.4889; Dong HD, 2004, IMMUNITY, V20, P327, DOI 10.1016/S1074-7613(04)00050-0; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Ehl S, 1998, J EXP MED, V187, P763, DOI 10.1084/jem.187.5.763; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gallegos-Orozco JF, 2010, REV MED CHILE, V138, P1302, DOI [/S0034-98872010001100016, 10.4067/S0034-98872010001100016]; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Guy CS, 2006, HEPATOLOGY, V43, P1231, DOI 10.1002/hep.21201; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Holz LE, 2008, GASTROENTEROLOGY, V135, P989, DOI 10.1053/j.gastro.2008.05.078; HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2; Hudrisier D, 2001, J BIOL CHEM, V276, P19396, DOI 10.1074/jbc.M008864200; Hunter KW, 2004, IMMUNOL LETT, V93, P71, DOI 10.1016/j.imlet.2004.02.006; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; John B, 2004, J IMMUNOL, V172, P5222, DOI 10.4049/jimmunol.172.9.5222; Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Lapierre P, 2006, J AUTOIMMUN, V26, P82, DOI 10.1016/j.jaut.2005.11.001; Leroy V, 2003, HEPATOLOGY, V38, P829, DOI 10.1053/jhep.2003.50410; Limmer A, 1998, EUR J IMMUNOL, V28, P2395, DOI 10.1002/(SICI)1521-4141(199808)28:08<2395::AID-IMMU2395>3.0.CO;2-D; Ma LL, 2009, LIVER TRANSPLANT, V15, P915, DOI 10.1002/lt.21771; Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020; Mehal WZ, 1999, J IMMUNOL, V163, P3202; Okada C, 2005, LIVER INT, V25, P595, DOI 10.1111/j.1478-3231.2005.01043.x; Oran A, 1997, BRIT J DERMATOL, V136, P519, DOI 10.1046/j.1365-2133.1997.6081584.x; Roth E, 2004, J IMMUNOL, V172, P1588, DOI 10.4049/jimmunol.172.3.1588; Sacher T, 2002, EUR J IMMUNOL, V32, P3628, DOI 10.1002/1521-4141(200212)32:12<3628::AID-IMMU3628>3.0.CO;2-E; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Tahara K, 2001, SURG ENDOSC-ULTRAS, V15, P946, DOI 10.1007/s004640090114; Wang YQ, 2003, ONCOL REP, V10, P909; Wong BLW, 2009, AM J PATHOL, V174, P1319, DOI 10.2353/ajpath.2009.080708; Wu H, 2008, ENDOCRINOLOGY, V149, P4402, DOI 10.1210/en.2007-1776; Zorde-Khvalevsky E, 2009, HEPATOLOGY, V50, P198, DOI 10.1002/hep.22973	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48192	10.1371/journal.pone.0048192	http://dx.doi.org/10.1371/journal.pone.0048192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110209	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200157
J	Park, KH; Lee, YM; Hong, HL; Kim, T; Park, HJ; Park, SY; Moon, SM; Chong, YP; Kim, SH; Lee, SO; Choi, SH; Jeong, JY; Kim, MN; Woo, JH; Kim, YS				Park, Ki-Ho; Lee, Yu-Mi; Hong, Hyo-Lim; Kim, Tark; Park, Hyun Jung; Park, So-Youn; Moon, Song Mi; Chong, Yong Pil; Kim, Sung-Han; Lee, Sang-Oh; Choi, Sang-Ho; Jeong, Jin-Yong; Kim, Mi-Na; Woo, Jun Hee; Kim, Yang Soo			Persistent Catheter-Related Staphylococcus aureus Bacteremia after Catheter Removal and Initiation of Antimicrobial Therapy	PLOS ONE			English	Article							RISK-FACTORS; VANCOMYCIN; INFECTION; RESISTANCE; COMPLICATIONS; ENDOCARDITIS; SUSCEPTIBILITY; ENHANCEMENT; MULTICENTER; OUTCOMES	Objectives: Catheter-related Staphylococcus aureus bacteremia (CRSAB) occasionally persists despite catheter removal and initiation of appropriate antimicrobial therapy. The aim of this study was to determine the incidence, risk factors, and outcomes of persistent CRSAB after catheter removal and initiation of antimicrobial therapy. Methods: Consecutive patients with CRSAB were prospectively included from over a 41-month period. We compared the clinical features, 40 bacterial virulence genes, and outcomes between patients with persistent CRSAB (i.e., bacteremia for >3 days after catheter removal and initiation of appropriate antimicrobial therapy) and non-persistent CRSAB. Results: Among the 220 episodes of CRSAB, the catheter was kept in place in 17 (6%) and removed in 203 (94%) cases. In 43 (21%) of the 203 episodes, bacteremia persisted for >3 days after catheter removal and initiation of antimicrobial therapy. Methicillin resistance (Odds ratio [OR], 9.01; 95% confidence interval [CI], 3.05-26.61; P < 0.001), non-catheter prosthetic devices (OR, 5.37; 95% CI, 1.62-17.80; P = 0.006), and renal failure (OR, 3.23; 95% CI, 1.48-7.08; P = 0.003) were independently associated with persistent CRSAB. Patients with persistent CRSAB were more like to experience complication than were those with non-persistent CRSAB (72% vs. 15%; P < 0.001). Among all episodes due to methicillin-resistant S. aureus, persistent CRSAB isolates were associated with accessory gene regulator (agr) group II (P = .04), but presence of other bacterial virulence genes, distribution of vancomycin minimum inhibitory concentration distribution, and frequency of vancomycin heteroresistance did not differ between the groups. Conclusions: In patients with CRSAB, bacteremia persisted in 21% of cases despite catheter removal and initiation of antimicrobial therapy. Methicillin resistance, renal failure, and non-catheter prosthetic devices were independent risk factors for persistent CRSAB, which was associated with a higher rate of complications.	[Park, Ki-Ho; Lee, Yu-Mi; Hong, Hyo-Lim; Kim, Tark; Park, Hyun Jung; Park, So-Youn; Moon, Song Mi; Chong, Yong Pil; Kim, Sung-Han; Lee, Sang-Oh; Choi, Sang-Ho; Jeong, Jin-Yong; Woo, Jun Hee; Kim, Yang Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea; [Park, Ki-Ho; Lee, Yu-Mi; Hong, Hyo-Lim; Kim, Tark; Park, Hyun Jung; Park, So-Youn; Moon, Song Mi; Chong, Yong Pil; Kim, Sung-Han; Lee, Sang-Oh; Choi, Sang-Ho; Jeong, Jin-Yong; Woo, Jun Hee; Kim, Yang Soo] Univ Ulsan, Ctr Antimicrobial Resistance & Microbial Genet, Seoul, South Korea; [Jeong, Jin-Yong] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Kim, Mi-Na] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, YS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Infect Dis, Seoul, South Korea.	yskim@amc.seoul.kr	Lee, Sang-Oh/AGV-5413-2022; Chong, Yong Pil/AAB-2623-2021	Lee, Sang-Oh/0000-0003-1381-8787; Hong, Hyo-Lim/0000-0003-2147-1381; Choi, Sang-Ho/0000-0002-4972-4531	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0029936]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Future-based Technology Development Program (Bio Fields) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant numbers: 2011-0029936).	Campbell SJ, 2008, J CLIN MICROBIOL, V46, P678, DOI 10.1128/JCM.01822-07; Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097; Chang Feng-Yee, 2000, Journal of Microbiology Immunology and Infection, V33, P63; Chang FY, 2003, MEDICINE, V82, P322, DOI 10.1097/01.md.0000091185.93122.40; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; FANG GD, 1993, ANN INTERN MED, V119, P560, DOI 10.7326/0003-4819-119-7_Part_1-199310010-00003; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Fowler VG, 2005, CLIN INFECT DIS, V40, P695, DOI 10.1086/427806; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Ghanem GA, 2007, MEDICINE, V86, P54, DOI 10.1097/MD.0b013e318030d344; Hawkins C, 2007, ARCH INTERN MED, V167, P1861, DOI 10.1001/archinte.167.17.1861; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; KEANE WF, 1986, AM J PATHOL, V122, P169; Kim SH, 2008, ANTIMICROB AGENTS CH, V52, P192, DOI 10.1128/AAC.00700-07; Lodise TP, 2003, CLIN INFECT DIS, V36, P1418, DOI 10.1086/375057; MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301; MALANOSKI GJ, 1995, ARCH INTERN MED, V155, P1161, DOI 10.1001/archinte.155.11.1161; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Moise-Broder PA, 2004, CLIN INFECT DIS, V38, P1700, DOI 10.1086/421092; Murdoch DR, 2001, CLIN INFECT DIS, V32, P647, DOI 10.1086/318704; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Raad I, 2004, ANN INTERN MED, V140, P18, DOI 10.7326/0003-4819-140-1-200401060-00007; RAAD II, 1992, CLIN INFECT DIS, V14, P75, DOI 10.1093/clinids/14.1.75; SCHLIEVERT PM, 1982, INFECT IMMUN, V36, P123, DOI 10.1128/IAI.36.1.123-128.1982; Sendi P, 2011, J INFECTION, V63, P17, DOI 10.1016/j.jinf.2011.05.005; SMALL PM, 1990, ANTIMICROB AGENTS CH, V34, P1227, DOI 10.1128/AAC.34.6.1227; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; VANHOLDER R, 1994, NEPHROL DIAL TRANSPL, V9, P1271; VERGHESE A, 1985, MEDICINE, V64, P394, DOI 10.1097/00005792-198511000-00004; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e46389	10.1371/journal.pone.0046389	http://dx.doi.org/10.1371/journal.pone.0046389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115627	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200014
J	Withers, JB; Ashvetiya, T; Beemon, KL				Withers, Johanna B.; Ashvetiya, Tamara; Beemon, Karen L.			Exclusion of Exon 2 Is a Common mRNA Splice Variant of Primate Telomerase Reverse Transcriptases	PLOS ONE			English	Article							CELLS; SEQUENCE; PROTEIN; HTERT; EXPRESSION; TISSUES; ENZYME; SITE; CHROMOSOMES; ASSOCIATION	Telomeric sequences are added by an enzyme called telomerase that is made of two components: a catalytic protein called telomerase reverse transcriptase (TERT) and an integral RNA template (TR). Telomerase expression is tightly regulated at each step of gene expression, including alternative splicing of TERT mRNA. While over a dozen different alternative splicing events have been reported for human TERT mRNA, these were all in the 3' half of the coding region. We were interested in examining splicing of the 5' half of hTERT mRNA, especially since exon 2 is unusually large (1.3 kb). Internal mammalian exons are usually short, typically only 50 to 300 nucleotides, and most long internal exons are alternatively processed. We used quantitative RT-PCR and high-throughput sequencing data to examine the variety and quantity of mRNA species generated from the hTERT locus. We determined that there are approximately 20-40 molecules of hTERT mRNA per cell in the A431 human cell line. In addition, we describe an abundant, alternatively-spliced mRNA variant that excludes TERT exon 2 and was seen in other primates. This variant causes a frameshift and results in translation termination in exon 3, generating a 12 kDa polypeptide.	[Withers, Johanna B.; Ashvetiya, Tamara; Beemon, Karen L.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Beemon, KL (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	KLB@jhu.edu			Public Health Service Grants [RO1CA124596]; National Cancer Institute [RO1CA48746]; NATIONAL CANCER INSTITUTE [R01CA124596, R01CA048746] Funding Source: NIH RePORTER	Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by Public Health Service Grants RO1CA124596 and RO1CA48746 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Beattie TL, 2000, MOL BIOL CELL, V11, P3329, DOI 10.1091/mbc.11.10.3329; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bolisetty MT, 2012, NUCL ACIDS RES, DOI 10:1093/nar/gks652; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrington L, 1997, GENE DEV, V11, P3109, DOI 10.1101/gad.11.23.3109; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; HOFFMAN BE, 1992, GENE DEV, V6, P2554, DOI 10.1101/gad.6.12b.2554; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Kelleher C, 2002, TRENDS BIOCHEM SCI, V27, P572, DOI 10.1016/S0968-0004(02)02206-5; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Moriarty TJ, 2004, MOL CELL BIOL, V24, P3720, DOI 10.1128/MCB.24.9.3720-3733.2004; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Reddel RR, 2003, CANCER LETT, V194, P155, DOI 10.1016/S0304-3835(02)00702-4; Robart AR, 2011, CELL, V42, P1; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Romi E, 2007, P NATL ACAD SCI USA, V104, P8791, DOI 10.1073/pnas.0703157104; Saeboe-Larssen S, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-26; Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339; Sykorova E, 2009, BIOL CELL, V101, P375, DOI 10.1042/BC20080205; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Ulaner GA, 1997, MOL HUM REPROD, V3, P769, DOI 10.1093/molehr/3.9.769; Ulaner GA, 1998, CANCER RES, V58, P4168; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Withers JB, 2011, J CELL BIOCHEM, V112, P3085, DOI 10.1002/jcb.23272; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Wright WE, 1996, DEV GENET, V18, P173; Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370; Xu D, 1999, BRIT J CANCER, V80, P1156, DOI 10.1038/sj.bjc.6690480; Yi XM, 1999, MOL CELL BIOL, V19, P3989; Yi XM, 2000, NEOPLASIA, V2, P433, DOI 10.1038/sj.neo.7900113; Yi XM, 2001, NUCLEIC ACIDS RES, V29, P4818, DOI 10.1093/nar/29.23.4818; Zentilin L, 2007, NAT PROTOC, V2, P2092, DOI 10.1038/nprot.2007.299	54	18	21	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48016	10.1371/journal.pone.0048016	http://dx.doi.org/10.1371/journal.pone.0048016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110161	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200137
J	Lim, J; Iyer, A; Suen, JY; Seow, V; Reid, RC; Brown, L; Fairlie, DP				Lim, Junxian; Iyer, Abishek; Suen, Jacky Y.; Seow, Vernon; Reid, Robert C.; Brown, Lindsay; Fairlie, David P.			C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling	FASEB JOURNAL			English	Article						adipose inflammation; complement; GPCR; metabolism; immunity	ADIPOSE-TISSUE; INSULIN-RESISTANCE; COMPLEMENT; INFLAMMATION; RECEPTOR; CELLS; INFILTRATION; LIPOLYSIS; PATHWAY; C5L2	Mammalian survival depends on metabolizing nutrients, storing energy, and combating infection. Complement activation in blood triggers energy-depleting immune responses to fight infections. Here we identify surprising energy-conserving roles for complement proteins C5a and C3a and their receptors, C5aR and C3aR, roles that are contraindicated in complement biology. Rats fed a high-carbohydrate high-fat diet developed obesity, visceral adiposity, adipose inflammation, glucose/insulin intolerance, and cardiovascular dysfunction that correlated with increased plasma C3a, adipose C5aR, and C3aR. These in vivo changes were dramatically attenuated by receptor-selective antagonists of either C5aR (5 mg/kg/d p.o.) or C3aR (30 mg/kg/d p.o.), which both reduced pro-inflammatory adipokines and altered expression of inflammatory genes in adipose tissue. In vitro C5a and C3a (100 nM) exhibited novel insulin-like effects on 3T3-L1 adipocytes, promoting energy conservation by increasing glucose and fatty acid uptake while inhibiting cAMP signaling and lipolysis, and induced PGE2 release from macrophages, effects all blocked by each respective antagonist (10 mu M). These studies reveal important new links between complement signaling and metabolism, highlight new complement functions on adipocytes and in adipose tissue, demonstrate how aberrant immune responses may exacerbate obesity and metabolic dysfunction, and show that targeting C3aR or C5aR with antagonists is a new strategy for treating metabolic dysfunction.-Lim, J., Iyer, A., Suen, J. Y., Seow, V., Reid, R. C., Brown, L., Fairlie, D. P. C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling. FASEB J. 27, 822-831 (2013). www.fasebj.org	[Lim, Junxian; Iyer, Abishek; Suen, Jacky Y.; Seow, Vernon; Reid, Robert C.; Brown, Lindsay; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Brown, Lindsay] Univ So Queensland, Fac Sci, Toowoomba, Qld 4350, Australia	University of Queensland; University of Southern Queensland	Brown, L (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	lindsay.brown@usq.edu.au; d.fairlie@imb.uq.edu.au	Fairlie, David P/F-8865-2014; Reid, Robert/D-8041-2012; Iyer, Abishek/C-9767-2017; Lim, Junxian/J-2275-2017; Suen, Jacky/G-4077-2015	Fairlie, David P/0000-0002-7856-8566; Reid, Robert/0000-0002-0829-239X; Iyer, Abishek/0000-0001-9533-5265; Lim, Junxian/0000-0002-8309-0704; Suen, Jacky/0000-0002-0309-2524	Australian Research Council [DP1093245]; Federation Fellowship [FF0668733]; Australian National Health and Medical Research Council [631534]; Senior Principal Research Fellowship [APP1027369]; Institute for Molecular Bioscience; University of Queensland	Australian Research Council(Australian Research Council); Federation Fellowship; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Senior Principal Research Fellowship; Institute for Molecular Bioscience; University of Queensland(University of Queensland)	The authors thank the Australian Research Council (grant DP1093245), Federation Fellowship FF0668733, the Australian National Health and Medical Research Council (grant 631534), and Senior Principal Research Fellowship APP1027369 (to D. F.) for funding, and the Institute for Molecular Bioscience and The University of Queensland for Ph.D. scholarships (to J.L. and V. S.). Author contributions: J.L., A. I., and D. F. wrote the manuscript with important editorial input from L. B.; J.L. and A. I. contributed most research results with help on gene expression and cell regulation from J.S. and V. S., all working in the laboratories of D. F. and L. B.; R. R. synthesized and characterized the key antagonists.; J.L., A. I., L. B., and D. F. designed the experiments. The authors declare no conflicts of interest.	Ames RS, 2001, J IMMUNOL, V166, P6341, DOI 10.4049/jimmunol.166.10.6341; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Engstrom G, 2005, DIABETOLOGIA, V48, P2525, DOI 10.1007/s00125-005-0021-6; Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Iyer A, 2010, BRIT J PHARMACOL, V159, P1408, DOI 10.1111/j.1476-5381.2010.00637.x; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Johswich K, 2006, J BIOL CHEM, V281, P39088, DOI 10.1074/jbc.M609734200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; KAWAMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P732, DOI 10.1073/pnas.78.2.732; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Li P, 2010, NATURE, V464, P1287, DOI 10.1038/4641287a; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Phillips CM, 2009, AM J CLIN NUTR, V90, P1665, DOI 10.3945/ajcn.2009.28101; Proctor LM, 2004, BRIT J PHARMACOL, V142, P756, DOI 10.1038/sj.bjp.0705819; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Scola AM, 2007, J BIOL CHEM, V282, P3664, DOI 10.1074/jbc.M609178200; Scully CCG, 2010, J MED CHEM, V53, P4938, DOI 10.1021/jm1003705; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Suen JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013809; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; van Lith LHC, 2009, J BIOMOL SCREEN, V14, P1067, DOI 10.1177/1087057109341407; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Weyer C, 2000, DIABETES CARE, V23, P779, DOI 10.2337/diacare.23.6.779; Wong AK, 1998, J MED CHEM, V41, P3417, DOI 10.1021/jm9800651; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto N, 2010, ANAL BIOCHEM, V404, P238, DOI 10.1016/j.ab.2010.05.012; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang JH, 2007, AM J PHYSIOL-ENDOC M, V292, pE1433, DOI 10.1152/ajpendo.00664.2006	42	88	93	2	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					822	831		10.1096/fj.12-220582	http://dx.doi.org/10.1096/fj.12-220582			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23118029				2022-12-25	WOS:000314358000040
J	Yereddi, NR; Cusdin, FS; Namadurai, S; Packman, LC; Monie, TP; Slavny, P; Clare, JJ; Powell, AJ; Jackson, AP				Yereddi, Nikitha R.; Cusdin, Fiona S.; Namadurai, Sivakumar; Packman, Len C.; Monie, Tom P.; Slavny, Peter; Clare, Jeffrey J.; Powell, Andrew J.; Jackson, Antony P.			The immunoglobulin domain of the sodium channel beta 3 subunit contains a surface-localized disulfide bond that is required for homophilic binding	FASEB JOURNAL			English	Article						cell adhesion molecule; evolutionary trace analysis; mass spectrometry	AUXILIARY SUBUNIT; CELL-ADHESION; EXTRACELLULAR DOMAIN; NEURITE OUTGROWTH; MAMMALIAN-CELLS; PROTEIN; EXPRESSION; GLYCOSYLATION; INACTIVATION; MODULATION	The beta subunits of voltage-gated sodium (Na-v) channels possess an extracellular immunoglobulin (Ig) domain that is related to the L1 family of cell-adhesion molecules (CAMs). Here we show that in HEK293 cells, secretion of the free Ig domain of the beta 3 subunit is reduced significantly when it is coexpressed with the full-length beta 3 and beta 1 subunits but not with the beta 2 subunit. Using immunoprecipitation, we show that the beta 3 subunit can mediate trans homophilic-binding via its Ig domain and that the beta 3-Ig domain can associate heterophilically with the beta 1 subunit. Evolutionary tracing analysis and structural modeling identified a cluster of surface-localized amino acids fully conserved between the Ig domains of all known beta 3 and beta 1 sequences. A notable feature of this conserved surface cluster is the presence of two adjacent cysteine residues that previously we have suggested may form a disulfide bond. We now confirm the presence of the disulfide bond in beta 3 using mass spectrometry, and we show that its integrity is essential for the association of the full-length, membrane-anchored beta 3 subunit with itself. However, selective reduction of this surface disulfide bond did not inhibit homophilic binding of the purified beta 3-Ig domain in free solution. Hence, the disulfide bond itself is unlikely to be part of the homophilic binding site. Rather, we suggest that its integrity ensures the Ig domain of the membrane-tethered beta 3 subunit adopts the correct orientation for productive association to occur in vivo.-Yereddi, N. R., Cusdin, F. S., Namadurai, S., Packman, L. C., Monie, T. P., Slavny, P., Clare, J. C., Powell, A. J., Jackson, A. P. The immunoglobulin domain of the sodium channel beta 3 subunit contains a surface-localized disulfide bond that is required for homophilic binding. FASEB J. 27, 568-580 (2013). www.fasebj.org	[Yereddi, Nikitha R.; Cusdin, Fiona S.; Namadurai, Sivakumar; Packman, Len C.; Monie, Tom P.; Slavny, Peter; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Cusdin, Fiona S.; Clare, Jeffrey J.; Powell, Andrew J.] GlaxoSmithKline, Stevenage, Herts, England	University of Cambridge; GlaxoSmithKline	Jackson, AP (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	apj10@bioc.cam.ac.uk		Powell, Andrew/0000-0003-1540-537X; Monie, Tom/0000-0003-4097-1680; Jackson, Antony Philip/0000-0002-2895-7387; Slavny, Peter/0000-0003-0757-8326	Cambridge University; U.K. Biotechnology and Biological Sciences Research Council; GlaxoSmithKline; Wellcome Trust [WT085090MA]	Cambridge University(University of Cambridge); U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); Wellcome Trust(Wellcome Trust)	N.R.Y. was supported by funds from Cambridge University. F. S. C. was supported by a Collaborative Awards in Science and Engineering (CASE) studentship from the U.K. Biotechnology and Biological Sciences Research Council and funds from GlaxoSmithKline. T. P. M. was supported by a Wellcome Trust Career Development Award (WT085090MA). The authors thank John McCafferty for helping with Gateway cloning technology and Jamie Ashby for helpful comments.	BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brackenbury W. J., FRONT PHARM, V2, P53; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chahine M., FRONT PHARM, V2, P70; Chapple SDJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-49; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Condreay JP, 1999, P NATL ACAD SCI USA, V96, P127, DOI 10.1073/pnas.96.1.127; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Cusdin FS, 2010, J BIOL CHEM, V285, P33404, DOI 10.1074/jbc.M110.114058; Davis TH, 2004, J BIOL CHEM, V279, P51424, DOI 10.1074/jbc.M410830200; FILBIN MT, 1991, NEURON, V7, P845, DOI 10.1016/0896-6273(91)90286-9; FILBIN MT, 1993, J CELL BIOL, V122, P451, DOI 10.1083/jcb.122.2.451; Gallegos-Perez JL, 2005, ANAL BIOCHEM, V346, P311, DOI 10.1016/j.ab.2005.08.003; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Hakim P., 2009, ACTA PHYSL OXF, V198, P47; Hakim P, 2008, PROG BIOPHYS MOL BIO, V98, P251, DOI 10.1016/j.pbiomolbio.2009.01.005; Innis CA, 2000, PROTEIN ENG, V13, P839, DOI 10.1093/protein/13.12.839; Isom LL, 1996, NATURE, V383, P307, DOI 10.1038/383307b0; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Klaile E, 2009, J CELL BIOL, V187, P553, DOI 10.1083/jcb.200904149; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; McEwen DP, 2009, NEUROSCI LETT, V462, P272, DOI 10.1016/j.neulet.2009.07.020; Meadows LS, 2002, J NEUROSCI, V22, P10699; Meadows LS, 2002, NEUROSCIENCE, V114, P745, DOI 10.1016/S0306-4522(02)00242-7; Merrick EC, 2010, PFLUG ARCH EUR J PHY, V460, P743, DOI 10.1007/s00424-009-0739-y; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shah BS, 2001, J PHYSIOL-LONDON, V534, P763, DOI 10.1111/j.1469-7793.2001.t01-1-00763.x; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; van Gassen KLI, 2009, EPILEPSIA, V50, P957, DOI 10.1111/j.1528-1167.2008.02015.x; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wouters MA, 2007, CURR PROTEIN PEPT SC, V8, P484, DOI 10.2174/138920307782411464; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Yu EJ, 2005, BIOCHEM J, V392, P519, DOI 10.1042/BJ20050518; Yu FH, 2003, J NEUROSCI, V23, P7577	50	20	21	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					568	580		10.1096/fj.12-209445	http://dx.doi.org/10.1096/fj.12-209445			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23118027	hybrid, Green Published			2022-12-25	WOS:000314358000016
J	Aslibekyan, S; Goodarzi, MO; Frazier-Wood, AC; Yan, XF; Irvin, MR; Kim, E; Tiwari, HK; Guo, XQ; Straka, RJ; Taylor, KD; Tsai, MY; Hopkins, PN; Korenman, SG; Borecki, IB; Chen, YDI; Ordovas, JM; Rotter, JI; Arnett, DK				Aslibekyan, Stella; Goodarzi, Mark O.; Frazier-Wood, Alexis C.; Yan, Xiaofei; Irvin, Marguerite R.; Kim, Eric; Tiwari, Hemant K.; Guo, Xiuqing; Straka, Robert J.; Taylor, Kent D.; Tsai, Michael Y.; Hopkins, Paul N.; Korenman, Stanley G.; Borecki, Ingrid B.; Chen, Yii-Der I.; Ordovas, Jose M.; Rotter, Jerome I.; Arnett, Donna K.			Variants Identified in a GWAS Meta-Analysis for Blood Lipids Are Associated with the Lipid Response to Fenofibrate	PLOS ONE			English	Article							CHOLESTERYL ESTER TRANSFER; GENOME-WIDE ASSOCIATION; DIET NETWORK; APOLIPOPROTEIN-E; LOWERING DRUGS; GENETICS; POLYMORPHISM; THERAPY; HDL; PHARMACOGENOMICS	A recent large-scale meta-analysis of genome-wide studies has identified 95 loci, 59 of them novel, as statistically significant predictors of blood lipid traits; we tested whether the same loci explain the observed heterogeneity in response to lipid-lowering therapy with fenofibrate. Using data from the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN, n = 861) we fit linear mixed models with the genetic markers as predictors and high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, total cholesterol, and triglyceride concentrations as outcomes. For all four traits, we analyzed both baseline levels and changes in response to treatment with fenofibrate. For the markers that were significantly associated with fenofibrate response, we fit additional models evaluating potential epistatic interactions. All models were adjusted for age, sex, and study center as fixed effects, and pedigree as a random effect. Statistically significant associations were observed between the rs964184 polymorphism near APOA1 (P-value <= 0.0001) and fenofibrate response for HDL and triglycerides. The association was replicated in the Pharmacogenetics of Hypertriglyceridemia in Hispanics study (HyperTG, n = 267). Suggestive associations with fenofibrate response were observed for markers in or near PDE3A, MOSC1, FLJ36070, CETP, the APOE-APOC1-APOC4-APOC2, and CILP2. Finally, we present strong evidence for epistasis (P-value for interaction = 0.0006 in GOLDN, 0.05 in HyperTG) between rs10401969 near CILP2 and rs4420638 in the APOE-APOC1-APOC4-APOC2 cluster with total cholesterol response to fenofibrate. In conclusion, we present evidence linking several novel and biologically relevant genetic polymorphisms to lipid lowering drug response, as well as suggesting novel gene-gene interactions in fenofibrate pharmacogenetics.	[Aslibekyan, Stella; Frazier-Wood, Alexis C.; Irvin, Marguerite R.; Arnett, Donna K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Frazier-Wood, Alexis C.; Tiwari, Hemant K.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Goodarzi, Mark O.; Yan, Xiaofei; Kim, Eric; Guo, Xiuqing; Taylor, Kent D.; Chen, Yii-Der I.; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Straka, Robert J.] Univ Minnesota, Coll Pharm, Expt & Clin Pharmacol Dept, Sch Publ Hlth, Minneapolis, MN 55455 USA; [Tsai, Michael Y.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Borecki, Ingrid B.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Hopkins, Paul N.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Korenman, Stanley G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ordovas, Jose M.] Ctr Nacl Invest Cardiovasc, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain; [Ordovas, Jose M.] Inst Madrilen Estudios Avanzados Alimentac, Madrid, Spain; [Ordovas, Jose M.] Tufts Univ, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Tufts University; United States Department of Agriculture (USDA)	Aslibekyan, S (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	saslibek@uab.edu	Rotter, Jerome/AAY-6598-2021; Goodarzi, Mark/AAH-7106-2021; Wood, Lekki/B-8053-2010; Ordovas, Jose/B-8727-2013	Goodarzi, Mark/0000-0001-6364-5103; Wood, Lekki/0000-0001-7616-2119; Ordovas, Jose/0000-0002-7581-5680; Tsai, Michael/0000-0001-7553-3408; Straka, Robert/0000-0002-9541-7823	NHLBI [U01HL072524, R01HL076771, UL1TR000124, P30-DK063491, U19HL069757]; Cedars-Sinai Winnick Clinical Scholars Award; Cedars-Sinai Board of Governors' Chair in Medical Genetics	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cedars-Sinai Winnick Clinical Scholars Award; Cedars-Sinai Board of Governors' Chair in Medical Genetics	This work has been funded by the NHLBI grants U01HL072524, R01HL076771, UL1TR000124, P30-DK063491, and U19HL069757. Further support came from the Cedars-Sinai Winnick Clinical Scholars Award (MOG) and the Cedars-Sinai Board of Governors' Chair in Medical Genetics (JIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslibekyan S, 2012, PHARMACOGENET GENOM, V22, P191, DOI 10.1097/FPC.0b013e32834fdd41; Brautbar A, 2011, ATHEROSCLEROSIS, V219, P737, DOI 10.1016/j.atherosclerosis.2011.08.015; Brisson D, 2002, PHARMACOGENETICS, V12, P313, DOI 10.1097/00008571-200206000-00007; Cirillo DJ, 2002, AM J EPIDEMIOL, V155, P842, DOI 10.1093/aje/155.9.842; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; de Haan W, 2009, BBA-MOL CELL BIOL L, V1791, P191, DOI 10.1016/j.bbalip.2008.12.008; Evans D, 2012, CIRC-CARDIOVASC GENE, V5, P5, DOI 10.1161/CIRCGENETICS.111.962548; Foucher C, 2004, PHARMACOGENETICS, V14, P823, DOI 10.1097/00008571-200412000-00005; Guerin M, 1996, ARTERIOSCL THROM VAS, V16, P763, DOI 10.1161/01.ATV.16.6.763; Irvin MR, 2010, CIRC-CARDIOVASC GENE, V3, P462, DOI 10.1161/CIRCGENETICS.110.950667; Kajinami K, 2005, ATHEROSCLEROSIS, V180, P407, DOI 10.1016/j.atherosclerosis.2004.12.019; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Liu Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001338; Liu YJ, 2009, PHARMACOGENET GENOM, V19, P161, DOI 10.1097/FPC.0b013e32831e030e; Pereira NL, 2009, NAT REV CARDIOL, V6, P632, DOI 10.1038/nrcardio.2009.154; Schmitz G, 2007, CURR OPIN LIPIDOL, V18, P164, DOI 10.1097/MOL.0b013e3280555083; Shen J, 2011, J CARDIOVAS IN PRESS; Smith JA, 2008, EUR J HUM GENET, V16, P603, DOI 10.1038/sj.ejhg.5202003; Talmud PJ, 2011, CURR OPIN LIPIDOL, V22, P106, DOI 10.1097/MOL.0b013e3283423f81; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Hoogt CC, 2007, J LIPID RES, V48, P1763, DOI 10.1194/jlr.M700108-JLR200; Weissglas-Volkov D, 2010, CIRC-CARDIOVASC GENE, V3, P31, DOI 10.1161/CIRCGENETICS.109.908004	23	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48663	10.1371/journal.pone.0048663	http://dx.doi.org/10.1371/journal.pone.0048663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119086	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500194
J	Gaayeb, L; BiramSarr, J; Ndiath, MO; Hanon, JB; Debrie, AS; Seck, M; Schacht, AM; Remoue, F; Hermann, E; Riveau, G				Gaayeb, Lobna; BiramSarr, Jean; Ndiath, Mamadou O.; Hanon, Jean-Baptiste; Debrie, Anne-Sophie; Seck, Modou; Schacht, Anne-Marie; Remoue, Franck; Hermann, Emmanuel; Riveau, Gilles			Seroprevalence of Pertussis in Senegal: A Prospective Study	PLOS ONE			English	Article							FILAMENTOUS HEMAGGLUTININ; BORDETELLA-PERTUSSIS; VACCINATION; EPIDEMIOLOGY; INFECTION; ANTIBODIES; DIAGNOSIS; TOXIN; SENSITIVITY; COMMUNITY	Background: Pertussis, also known as whooping cough, is a vaccine-preventable respiratory disease caused by Bordetella pertussis infection, against which Senegalese children are immunized with the diphtheria-tetanus-whole cell pertussis vaccine (DTwP). Seroepidemiology of pertussis has been widely described in industrialized countries, but rare are the studies referring to it in developing countries. Methods: We conducted a longitudinal survey in Northern Senegal to investigate the epidemiology of B. pertussis by evaluating the IgG antibody (Ab) response against pertussis toxin (PT). A cohort of 410 children aged 1 to 9 from five villages in the Middle Senegal River Valley were followed-up for 18 months. During that period, five visits were made to assess the immunological status of the children. Principal Findings: PT-specific IgG responses were significantly different according to age. Until the age of 3, there was a decrease in the Ab response, which then increased in the older groups. Assessment of IgG antibodies to PT (IgG-PT) suggested evidence of recent exposures to the pathogen. Surprisingly, in one of the five villages the average Ab response to PT was very low at all ages during the first 6 months of the study. At the third visit, IgG-PT concentrations peaked to very high levels, to slightly decline at the end of the survey. This indicates an outbreak of B. pertussis, whereas in the other villages a pertussis endemic profile could be observed. Conclusions: Pertussis is endemic in Northern Senegal despite the introduction of vaccination. The circulation of the bacteria seems to differ between geographic locations and over time. A more complete understanding of the epidemiology of pertussis and its environmental determinants could provide information to adapt vaccination programs.	[Gaayeb, Lobna; Hanon, Jean-Baptiste; Debrie, Anne-Sophie; Schacht, Anne-Marie; Hermann, Emmanuel; Riveau, Gilles] Inst Pasteur, CIIL, INSERM, CNRS,U1019,UMR8204, F-59019 Lille, France; [Hermann, Emmanuel] Univ Lille Nord France, Lille, France; [Gaayeb, Lobna; BiramSarr, Jean; Hanon, Jean-Baptiste; Seck, Modou; Schacht, Anne-Marie; Hermann, Emmanuel; Riveau, Gilles] Biomed Res Ctr EPLS, St Louis, Senegal; [Ndiath, Mamadou O.] IRD Campus Int Hann, Lab Paludol, URMITE UMR198, Dakar, Senegal; [Remoue, Franck] Univ Montpellier 1 & 2, UMR MIVEGEC, IRD224, IRD,CREC,CNRS5290, Cotonou, Benin	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD)	Gaayeb, L (corresponding author), Inst Pasteur, CIIL, INSERM, CNRS,U1019,UMR8204, F-59019 Lille, France.	lobna.gaayeb@gmail.com	HERMANN, Emmanuel/X-6168-2019; Hermann, Emmanuel/C-6376-2008	HERMANN, Emmanuel/0000-0003-0971-4918; Hermann, Emmanuel/0000-0003-0971-4918; Hanon, Jean-Baptiste/0000-0003-1601-9980; Debrie, Anne-Sophie/0000-0003-0570-4413	French Region Nord-Pas de Calais; Pasteur Institute of Lille (France)	French Region Nord-Pas de Calais(Region Hauts-de-France); Pasteur Institute of Lille (France)	Lobna Gaayeb received support from the French Region Nord-Pas de Calais (http://www.nordpasdecalais.fr) and the Pasteur Institute of Lille (France) (http://www.pasteur-lille.fr). EPLS Biomedical Research Centre (http://www.espoir-sante.org) supported field investigation in the frame of the PAL-Fleuve program (http://www.espoir-sante.org/etudes/en-cours/palfleuve.html). CIIL (http://u1019.lille.inserm.fr) provided support for the achievement of the immunological assays. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Sin M, 2009, PEDIATR INFECT DIS J, V28, P242, DOI 10.1097/INF.0b013e31818a5d69; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P385; BARENKAMP SJ, 1992, INFECT IMMUN, V60, P1302, DOI 10.1128/IAI.60.4.1302-1313.1992; Broutin H, 2005, MICROBES INFECT, V7, P593, DOI 10.1016/j.micinf.2004.12.018; Broutin H, 2004, P ROY SOC B-BIOL SCI, V271, P2091, DOI 10.1098/rspb.2004.2847; Broutin H, 2004, VACCINE, V22, P594, DOI 10.1016/j.vaccine.2003.07.018; Broutin H, 2010, P ROY SOC B-BIOL SCI, V277, P3239, DOI 10.1098/rspb.2010.0994; Cherry JD, 2010, CLIN INFECT DIS, V51, P663, DOI 10.1086/655826; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; Edwards KM, 2005, PEDIATR INFECT DIS J, V24, pS104, DOI 10.1097/01.inf.0000166154.47013.47; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; Gerlach G, 2001, MICROBES INFECT, V3, P61, DOI 10.1016/S1286-4579(00)01353-8; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; Guiso N, 2011, HUMAN VACCINES, P7; Hallander HO, 2009, APMIS, V117, P797, DOI 10.1111/j.1600-0463.2009.02530.x; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Hendrikx LH, 2011, VACCINE, V29, P1431, DOI 10.1016/j.vaccine.2010.12.033; Lacombe K, 2004, VACCINE, V23, P623, DOI 10.1016/j.vaccine.2004.07.007; Preziosi MP, 2003, VACCINE, V21, P1853, DOI 10.1016/S0264-410X(03)00007-0; Preziosi MP, 2002, AM J EPIDEMIOL, V155, P891, DOI 10.1093/aje/155.10.891; Riffelmann M, 2010, J CLIN MICROBIOL, V48, P4459, DOI 10.1128/JCM.01371-10; Simondon F, 1997, VACCINE, V15, P1606, DOI 10.1016/S0264-410X(97)00100-X; Simondon F, 1998, CLIN DIAGN LAB IMMUN, V5, P130, DOI 10.1128/CDLI.5.2.130-134.1998; Versteegh FGA, 2005, EPIDEMIOL INFECT, V133, P737, DOI 10.1017/S0950268805003833; Vincent JM, 2000, CLIN INFECT DIS, V30, P534, DOI 10.1086/313707; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010; Zepp F, 2011, LANCET INFECT DIS, V11, P557, DOI 10.1016/S1473-3099(11)70007-X	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48684	10.1371/journal.pone.0048684	http://dx.doi.org/10.1371/journal.pone.0048684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119090	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500198
J	Lv, F; Xu, XB; Zhang, SC; Wang, LL; Wang, N; He, B; Wang, JD				Lv, Fang; Xu, Xiangbo; Zhang, Shucheng; Wang, Lili; Wang, Ning; He, Bin; Wang, Jiedong			Repeated Abortion Affects Subsequent Pregnancy Outcomes in BALB/c Mice	PLOS ONE			English	Article							MIFEPRISTONE-INDUCED ABORTION; INDUCED BLOCKING FACTOR; TISSUE FACTOR; COMPLICATIONS; ACTIVATION; EXPRESSION; HISTORY; TYPE-2; RISK; LINK	Aim: In this study, we aimed to establish a mouse model of repeated medical termination of pregnancy in order to determine subsequent outcomes. Methods: A model of mifepristone (RU 486)-induced medical abortion was established in BALB/c mice to facilitate the investigation of the impact of medical abortion on subsequent pregnancies, including litter sizes and newborn birth weights. Pregnant mice were sacrificed to examine midterm pregnancy status, investigate the frequency of fetal resorption, and measure placental function gene expression by real-time PCR and immunohistochemistry. Offspring liver mRNA was harvested for real-time PCR to determine gene expression and assess the effects of abortion on offspring development. Results: Mice subjected to 2 previous medical abortions experienced spontaneous abortions in subsequent pregnancies. Medical abortion caused reduced reproductive capacity and affected placental dysfunction, with reduced expression of tissue factor (TF) and genes encoding proteins involved in metabolic functions relevant to pregnancy, such as 11 beta-hydroxysteroid dehydrogenase 1/2 (11 beta-HSD1/2) and glucocorticoid receptor (GR). Reduced expression was also observed for platelet endothelial cell adhesion molecule-1 (CD31) and vascular endothelial growth factor (VEGF). In offspring from subsequent pregnancies, genes involved in lipid metabolism, which may enhance key lipid transcription factors, such as PPARA and PPARG, as well as GR/11 beta-HSD1, were downregulated in the liver. In addition, the sperm motility of the F1 males reduced. Conclusion: Repeated medical abortion impaired the reproductive function of female mice, significantly affecting the outcomes of subsequent pregnancies. The impact of repeated abortions on the offspring of subsequent pregnancies was also noteworthy and deserves further exploration. Thus, this model provides a useful means to study the mechanisms underlying the above phenomena, which will ultimately benefit the health of women and their children.	[Lv, Fang; Xu, Xiangbo; Zhang, Shucheng; Wang, Lili; Wang, Ning; He, Bin; Wang, Jiedong] Natl Res Inst Family Planning, Reprod Physiol Lab, Beijing, Peoples R China; [Lv, Fang; Wang, Lili; Wang, Jiedong] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China	National Research Institute for Family Planning - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, B (corresponding author), Natl Res Inst Family Planning, Reprod Physiol Lab, Beijing, Peoples R China.	hebox@263.net; jdwangmail-hr@yahoo.com.cn	wang, lili/HDL-7210-2022		National Nature Science Foundation of China [30901608]; Central Public-interest Scientific Institution Basal Research Fund [2009GJSSJKA02]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public-interest Scientific Institution Basal Research Fund	This work was supported by the National Nature Science Foundation of China (number 30901608) and Central Public-interest Scientific Institution Basal Research Fund (Grant number 2009GJSSJKA02). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmed A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013663; [Anonymous], 1979, Lancet, V1, P142; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barak Y, 2008, PPAR RES, V2008, DOI 10.1155/2008/142082; BOBE P, 1986, CELL IMMUNOL, V98, P477, DOI 10.1016/0008-8749(86)90306-0; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cheng Y, 2004, INT J GYNECOL OBSTET, V87, P199, DOI 10.1016/j.ijgo.2004.06.010; Clark DA, 1998, J IMMUNOL, V160, P545; Cleasby ME, 2003, ENDOCRINOLOGY, V144, P999, DOI 10.1210/en.2002-220559; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Creinin Mitchell D., 2000, American Journal of Obstetrics and Gynecology, V183, pS3; Cross JC, 2003, ANN NY ACAD SCI, V995, P84, DOI 10.1111/j.1749-6632.2003.tb03212.x; Cupp AS, 2003, J ANDROL, V24, P736; Donaldson K, 1994, J Obstet Gynecol Neonatal Nurs, V23, P555, DOI 10.1111/j.1552-6909.1994.tb01921.x; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Girardi G, 2006, J EXP MED, V203, P2165, DOI 10.1084/jem.20061022; Glass CK, 2006, J CLIN INVEST, V116, P556, DOI 10.1172/JCI27913; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Heikinheimo O, 2008, CONTRACEPTION, V78, P149, DOI 10.1016/j.contraception.2008.03.013; Henshaw S K, 1987, Perspect Int Planif Fam, P12; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, pS30, DOI 10.2307/2991869; Horton TH, 2005, AM J HUM BIOL, V17, P34, DOI 10.1002/ajhb.20092; Jawerbaum A, 2011, PLACENTA, V32, pS212, DOI 10.1016/j.placenta.2010.12.002; Junli G, 2010, CHINESE J OBSTET GYN, P447; LAKSHMI V, 1988, ENDOCRINOLOGY, V123, P2390, DOI 10.1210/endo-123-5-2390; Liang H, 2011, CONTRACEPTION, V84, P609, DOI 10.1016/j.contraception.2011.03.013; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; PAZOL K, 2011, MMWR MORBID MORTAL W, V60, P1; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Seckl JR, 2004, CURR OPIN PHARMACOL, V4, P597, DOI 10.1016/j.coph.2004.09.001; Seshan SV, 2009, BLOOD, V114, P1675, DOI 10.1182/blood-2009-01-199117; Shah PS, 2009, BJOG-INT J OBSTET GY, V116, P1425, DOI 10.1111/j.1471-0528.2009.02278.x; Shi-qiang C, 2008, MATERN CHILD HLTH J, P1264; Sun YL, 2003, INT J EPIDEMIOL, V32, P449, DOI 10.1093/ije/dyg093; Symonds ME, 2009, NAT REV ENDOCRINOL, V5, P604, DOI 10.1038/nrendo.2009.195; SzekeresBartho J, 1997, CELL IMMUNOL, V177, P194, DOI 10.1006/cimm.1997.1090; SZEKERESBARTHO J, 1990, AM J OBSTET GYNECOL, V163, P1320, DOI 10.1016/0002-9378(90)90713-H; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008; van Beek JP, 2004, J CLIN ENDOCR METAB, V89, P5614, DOI 10.1210/jc.2004-0113; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Westfall JM, 1998, J WOMENS HEALTH, V7, P991, DOI 10.1089/jwh.1998.7.991; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; WHORWOOD CB, 1995, MOL CELL ENDOCRINOL, V110, pR7, DOI 10.1016/0303-7207(95)03546-J; World Health Organization, 2003, SAF AB TECHN POL GUI; Wu S, 2000, J Am Med Womens Assoc (1972), V55, P197; Wu Shang-chun, 2010, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V32, P479, DOI 10.3881/j.issn.1000-503X.2010.05.001; Zhou WJ, 2003, ACTA OBSTET GYN SCAN, V82, P177, DOI 10.1080/j.1600-0412.2003.00005.x; Zhu QX, 2009, HUM REPROD, V24, P315, DOI 10.1093/humrep/den426	56	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48384	10.1371/journal.pone.0048384	http://dx.doi.org/10.1371/journal.pone.0048384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119001	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500121
J	Raftogianni, A; Stamatakis, A; Papadopoulou, A; Vougas, K; Anagnostopoulos, AK; Stylianopoulou, F; Tsangaris, GT				Raftogianni, Androniki; Stamatakis, Antonios; Papadopoulou, Angeliki; Vougas, Konstantinos; Anagnostopoulos, Athanasios K.; Stylianopoulou, Fotini; Tsangaris, George Th			Effects of an Early Experience of Reward through Maternal Contact or Its Denial on Laterality of Protein Expression in the Developing Rat Hippocampus	PLOS ONE			English	Article							NEONATAL NOVELTY EXPOSURE; HEMISPHERIC-ASYMMETRY; PROTEOMIC ANALYSIS; BRAIN ASYMMETRY; CEREBRAL-CORTEX; ANIMAL-MODELS; SCHIZOPHRENIA; ENVIRONMENT; HANDEDNESS; DISORDERS	Laterality is a basic characteristic of the brain which is detectable early in life. Although early experiences affect laterality of the mature brain, there are no reports on their immediate neurochemical effects during neonatal life, which could provide evidence as to the mechanisms leading to the lateralized brain. In order to address this issue, we determined the differential protein expression profile of the left and right hippocampus of 13-day-old rat control (CTR) pups, as well as following exposure to an early experience involving either receipt (RER) or denial (DER) of the expected reward of maternal contact. Proteomic analysis was performed by 2-dimensional polyacrylamide gel electrophoresis (PAGE) followed by mass spectroscopy. The majority of proteins found to be differentially expressed either between the three experimental groups (DER, RER, CTR) or between the left and right hemisphere were cytoskeletal (34%), enzymes of energy metabolism (32%), and heat shock proteins (17%). In all three groups more proteins were up-regulated in the left compared to the right hippocampus. Tubulins were found to be most often up-regulated, always in the left hippocampus. The differential expression of beta-tubulin, beta-actin, dihydropyrimidinase like protein 1, glial fibrillary acidic protein (GFAP) and Heat Shock protein 70 revealed by the proteomic analysis was in general confirmed by Western blots. Exposure to the early experience affected brain asymmetry: In the RER pups the ratio of proteins up-regulated in the left hippocampus to those in the right was 1.8, while the respective ratio was 3.6 in the CTR and 3.4 in the DER. Our results could contribute to the elucidation of the cellular mechanisms mediating the effects of early experiences on the vulnerability for psychopathology, since proteins shown in our study to be differentially expressed (e. g. tubulins, dihydropyrimidinase like proteins, 14-3-3 protein, GFAP, ATP synthase, alpha-internexin) have also been identified in proteomic analyses of post-mortem brains from psychiatric patients.	[Raftogianni, Androniki; Stamatakis, Antonios; Stylianopoulou, Fotini] Univ Athens, Sch Hlth Sci, Dept Basic Sci, Lab Biol Biochem, Athens, Greece; [Papadopoulou, Angeliki; Vougas, Konstantinos; Anagnostopoulos, Athanasios K.; Tsangaris, George Th] BRFAA, Prote Res Unit, Athens, Greece	National & Kapodistrian University of Athens	Stylianopoulou, F (corresponding author), Univ Athens, Sch Hlth Sci, Dept Basic Sci, Lab Biol Biochem, Athens, Greece.	fstilian@nurs.uoa.gr	STYLIANOPOULOU, FOTINI/B-1403-2008; Anagnostopoulos, Athanasios/AAF-5809-2021; Tsangaris, George/Q-6139-2019; Stamatakis, A./J-5294-2019	Anagnostopoulos, Athanasios/0000-0001-5161-7850; Stamatakis, A./0000-0003-2480-5578; Raftogianni, Androniki/0000-0002-1850-8916; Vougas, Konstantinos/0000-0002-8873-4740	"IKY" (Hellenic State Foundation for Scholarships); University of Athens (Greece) [70/4/7825, 70/4/8923]	"IKY" (Hellenic State Foundation for Scholarships); University of Athens (Greece)	The study was supported by an "IKY" (Hellenic State Foundation for Scholarships) scholarship to A.R. and by the special account for research of the University of Athens (Greece); grant number 70/4/7825 to F.S. and special account for research of the University of Athens (Greece); grant number 70/4/8923 to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO D, 1993, BRAIN RES BULL, V32, P11, DOI 10.1016/0361-9230(93)90312-Y; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Bianchi M, 2003, SYNAPSE, V49, P188, DOI 10.1002/syn.10230; Bianchi M, 2009, EUR NEUROPSYCHOPHARM, V19, P778, DOI 10.1016/j.euroneuro.2009.06.005; BIANKI VL, 1981, INT J NEUROSCI, V15, P37, DOI 10.3109/00207458108985844; Bingman VR, 2006, CORTEX, V42, P99, DOI 10.1016/S0010-9452(08)70329-0; Carboni L, 2006, NEUROSCIENCE, V137, P1237, DOI 10.1016/j.neuroscience.2005.10.045; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chiron C, 1997, BRAIN, V120, P1057, DOI 10.1093/brain/120.6.1057; CHIRON C, 1995, DEV MED CHILD NEUROL, V37, P849; DEMARTINEZ MSG, 1986, J NEUROCHEM, V46, P1382; DEMARTINEZ MSG, 1985, BRAIN RES, V339, P315, DOI 10.1016/0006-8993(85)90097-6; DENENBERG VH, 1981, BEHAV BRAIN SCI, V4, P1, DOI 10.1017/S0140525X00007330; DENENBERG VH, 1978, SCIENCE, V201, P1150, DOI 10.1126/science.684436; Diamantopoulou A, 2011, NEUROSCIENCE, V181, P89, DOI 10.1016/j.neuroscience.2011.03.002; Diamantopoulou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033793; DIAMOND MC, 1983, EXP NEUROL, V81, P1, DOI 10.1016/0014-4886(83)90153-X; Duque A, 2012, BRAIN STRUCT FUNCT, V217, P459, DOI 10.1007/s00429-011-0350-9; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; English JA, 2009, PROTEOMICS, V9, P3368, DOI 10.1002/pmic.200900015; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fountoulakis M, 2005, J CHROMATOGR B, V819, P115, DOI 10.1016/j.jchromb.2005.01.037; Gannon PJ, 1998, SCIENCE, V279, P220, DOI 10.1126/science.279.5348.220; GESCHWIND N, 1985, ARCH NEUROL-CHICAGO, V42, P428, DOI 10.1001/archneur.1985.04060050026008; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; GUARNERI P, 1988, NEUROCHEM RES, V13, P209, DOI 10.1007/BF00971534; Guest PC, 2004, BRAIN RES, V1002, P1, DOI 10.1016/j.brainres.2003.11.064; Hanlon FM, 2005, BEHAV NEUROSCI, V119, P863, DOI 10.1037/0735-7044.119.4.863; Heim C, 2010, DEV PSYCHOBIOL, V52, P671, DOI 10.1002/dev.20494; Johnston-Wilson NL, 2000, MOL PSYCHIATR, V5, P142, DOI 10.1038/sj.mp.4000696; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Kristofikova Z, 2004, NEUROCHEM RES, V29, P671, DOI 10.1023/B:NERE.0000018837.27383.ff; Lehmann J, 1999, PHARMACOL BIOCHEM BE, V64, P705, DOI 10.1016/S0091-3057(99)00150-1; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Marais L, 2009, METAB BRAIN DIS, V24, P569, DOI 10.1007/s11011-009-9156-3; Moretti A, 2003, MOL PSYCHIATR, V8, P773, DOI 10.1038/sj.mp.4001353; Moskal JR, 2006, HIPPOCAMPUS, V16, P629, DOI 10.1002/hipo.20198; OKE A, 1980, BRAIN RES, V188, P269, DOI 10.1016/0006-8993(80)90575-2; Orman R, 2007, NEUROSCIENCE, V144, P797, DOI 10.1016/j.neuroscience.2006.10.017; Panagiotaropoulos T, 2009, NEUROBIOL LEARN MEM, V91, P2, DOI 10.1016/j.nlm.2008.09.007; Parker KC, 2009, J PROTEOME RES, V8, P3265, DOI 10.1021/pr800873q; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piubelli C, 2011, NEUROSCIENCE, V176, P349, DOI 10.1016/j.neuroscience.2010.12.043; Pryce CR, 2005, NEUROSCI BIOBEHAV R, V29, P649, DOI 10.1016/j.neubiorev.2005.03.011; Qiu AQ, 2009, NEUROIMAGE, V47, P1221, DOI 10.1016/j.neuroimage.2009.05.054; Raftogianni A, 2012, NEUROSCIENCE; Samara A, 2011, HIPPOCAMPUS, V21, P108, DOI 10.1002/hipo.20727; SCHNEIDER LH, 1982, NEUROSCI LETT, V33, P281, DOI 10.1016/0304-3940(82)90385-8; Stevenson CW, 2008, NEUROSCIENCE, V155, P852, DOI 10.1016/j.neuroscience.2008.06.013; Sullivan RM, 2006, BRAIN RES, V1076, P49, DOI 10.1016/j.brainres.2005.12.100; Sullivan RM, 2002, PSYCHONEUROENDOCRINO, V27, P99, DOI 10.1016/S0306-4530(01)00038-5; Sun L, 2003, J BIOL CHEM, V278, P38301, DOI 10.1074/jbc.M212801200; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Szego EM, 2010, EUR NEUROPSYCHOPHARM, V20, P96, DOI 10.1016/j.euroneuro.2009.11.003; Tang AC, 2004, DEV PSYCHOBIOL, V44, P84, DOI 10.1002/dev.10158; Tang AC, 2003, NEUROREPORT, V14, P1553, DOI 10.1097/00001756-200308260-00002; Tang AC, 2002, BEHAV BRAIN RES, V131, P1, DOI 10.1016/S0166-4328(01)00330-8; Tang AC, 2008, HIPPOCAMPUS, V18, P5, DOI 10.1002/hipo.20370; Tang AC, 2011, BEHAV BRAIN RES, V221, P91, DOI 10.1016/j.bbr.2011.02.047; Uys JDK, 2008, NEUROCHEM RES, V33, P1724, DOI 10.1007/s11064-008-9615-y; Verstynen T, 2001, NEUROREPORT, V12, P3019, DOI 10.1097/00001756-200110080-00008; Woolard AA, 2012, PSYCHIAT RES-NEUROIM, V201, P48, DOI 10.1016/j.pscychresns.2011.07.016; Yang C, 2009, BEHAV BRAIN RES, V205, P518, DOI 10.1016/j.bbr.2009.08.008	68	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48337	10.1371/journal.pone.0048337	http://dx.doi.org/10.1371/journal.pone.0048337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118990	Green Submitted, gold, Green Published			2022-12-25	WOS:000310600500109
J	Roberts, BLT; Patel, K; Brown, HH; Borchelt, DR				Roberts, Brittany L. T.; Patel, Kinaree; Brown, Hilda H.; Borchelt, David R.			Role of Disulfide Cross-Linking of Mutant SOD1 in the Formation of Inclusion-Body-Like Structures	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE 1; MOLECULAR-WEIGHT COMPLEXES; MOTOR-NEURON DEGENERATION; COPPER-BINDING-SITE; ALPHA-B-CRYSTALLIN; WILD-TYPE; TRANSGENIC MICE; FAMILIAL ALS; CU,ZN-SUPEROXIDE DISMUTASE	Background: Pathologic aggregates of superoxide dismutase 1 (SOD1) harboring mutations linked to familial amyotrophic lateral sclerosis (fALS) have been shown to contain aberrant intermolecular disulfide cross-links. In prior studies, we observed that intermolecular bonding was not necessary in the formation of detergent-insoluble SOD1 complexes by mutant SOD1, but we were unable to assess whether this type of bonding may be important for pathologic inclusion formation. In the present study, we visually assess the formation of large inclusions by fusing mutant SOD1 to yellow fluorescent protein (YFP). Methodology/Principal Findings: Experimental constructs possessing mutations at all cysteine residues in SOD1 (sites 6, 57, 111, and 146 to F,S,Y,R or G,S,Y,R, respectively) were shown to maintain a high propensity of inclusion formation despite the inability to form disulfide cross-links. Interestingly, although aggregates form when all cysteines were mutated, double mutants of the ALS mutation C6G with an experimental mutation C111S exhibited low aggregation propensity. Conclusions/Significance: Overall, this study is an extension of previous work demonstrating that cysteine residues in mutant SOD1 play a role in modulating aggregation and that intermolecular disulfide bonds are not required to produce large intracellular inclusion-like structures.	[Roberts, Brittany L. T.; Patel, Kinaree; Brown, Hilda H.; Borchelt, David R.] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, SantaFe HealthCare Alzheimers Dis Res Ctr,McKnigh, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, SantaFe HealthCare Alzheimers Dis Res Ctr,McKnigh, Gainesville, FL 32610 USA.	drb1@ufl.edu			National Institutes of Neurological Disorders and Stroke [P01 NS049134-07]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work funded by the National Institutes of Neurological Disorders and Stroke (P01 NS049134-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Corcoran LJ, 2004, CURR BIOL, V14, P488, DOI 10.1016/j.cub.2004.03.003; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Fei EK, 2006, BIOCHEM BIOPH RES CO, V347, P406, DOI 10.1016/j.bbrc.2006.06.092; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2010, ARCH BIOCHEM BIOPHYS, V503, P175, DOI 10.1016/j.abb.2010.07.027; Karch CM, 2010, J NEUROCHEM, V113, P1092, DOI 10.1111/j.1471-4159.2010.06572.x; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Ogihara NL, 1996, BIOCHEMISTRY-US, V35, P2316, DOI 10.1021/bi951930b; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; Prudencio M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-77; Prudencio M, 2010, HUM MOL GENET, V19, P4774, DOI 10.1093/hmg/ddq408; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Prudencio M, 2009, J NEUROCHEM, V108, P1009, DOI 10.1111/j.1471-4159.2008.05839.x; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Urushitani M, 2008, FASEB J, V22, P2476, DOI 10.1096/fj.07-092783; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Wang J, 2007, J BIOL CHEM, V282, P345, DOI 10.1074/jbc.M604503200; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Witan H, 2009, NEUROBIOL DIS, V36, P331, DOI 10.1016/j.nbd.2009.07.024; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024	45	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47838	10.1371/journal.pone.0047838	http://dx.doi.org/10.1371/journal.pone.0047838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118898	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500038
J	Frokiaer, H; Henningsen, L; Metzdorff, SB; Weiss, G; Roller, M; Flanagan, J; Fromentin, E; Ibarra, A				Frokiaer, Hanne; Henningsen, Louise; Metzdorff, Stine Broeng; Weiss, Gudrun; Roller, Marc; Flanagan, John; Fromentin, Emilie; Ibarra, Alvin			Astragalus Root and Elderberry Fruit Extracts Enhance the IFN-beta Stimulatory Effects of Lactobacillus acidophilus in Murine-Derived Dendritic Cells	PLOS ONE			English	Article							POLYSACCHARIDES; INTERFERON; LIPOPOLYSACCHARIDE; MEMBRANACEUS; PROBIOTICS; RESPONSES; IMMUNITY; GENES; ALPHA	Many foods and food components boost the immune system, but little data are available regarding the mechanisms by which they do. Bacterial strains have disparate effects in stimulating the immune system. Indendritic cells, the gramnegative bacteria Escherichia coli upregulates proinflammatory cytokines, whereas gram-positive Lactobacillus acidophilus induces a robust interferon (IFN)-beta response. The immune-modulating effects of astragalus root and elderberry fruit extracts were examined in bone marrow-derived murine dendritic cells that were stimulated with L. acidophilus or E. coli. IFN-beta and other cytokines were measured by ELISA and RT-PCR. Endocytosis of fluorescence-labeled dextran and L. acidophilus in the presence of elderberry fruit or astragalus root extract was evaluated in dendritic cells. Our results show that both extracts enhanced L. acidophilus-induced IFN-beta production and slightly decreased the proinflammatory response to E. coli. The enhanced IFN-beta production was associated with upregulation of toll-like receptor 3 and to a varying degree, the cytokines IL-12, IL-6, IL-1 beta and TNF-alpha. Both extracts increased endocytosis in immature dendritic cells, and only slightly influenced the viability of the cells. In conclusion, astragalus root and elderberry fruit extracts increase the IFN-beta inducing activity of L. acidophilus in dendritic cells, suggesting that they may exert antiviral and immune-enhancing activity.	[Frokiaer, Hanne; Henningsen, Louise; Metzdorff, Stine Broeng; Weiss, Gudrun] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Roller, Marc] Naturex SA, Avignon, France; [Ibarra, Alvin] Naturex Inc, S Hackensack, NJ USA; [Flanagan, John; Fromentin, Emilie] Naturex Spain, Quart De Poblet, Spain	University of Copenhagen	Frokiaer, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark.	hafr@sund.ku.dk		Ibarra, Alvin/0000-0003-3952-8489	Naturex	Naturex	Naturex is involved in the research/development and marketing/sales of astragalus root and elderberry fruit extracts as ingredients for the food, cosmetic, and nutraceutical industries. Therefore, Naturex has a commercial interest in this publication. The University of Copenhagen was paid by Naturex to perform and report the scientific work that formed the basis of this publication. The University of Copenhagen and Naturex declare that the data in this report represent a true and faithful representation of the work that has been performed. The financial assistance from Naturex is gratefully acknowledged. The study was designed in collaboration between Naturex and the University of Copenhagen, data collection and analysis was conducted by the University of Copenhagen, the decision to publish and preparation of the manuscript was done in collaboration between the two institutions.; The authors have read the journal's policy and have the following conflicts: Naturex is involved in the research/development and marketing/sales of astragalus root and elderberry fruit extracts as ingredients for the food, cosmetic, and nutraceutical industries. Therefore, Naturex has a commercial interest in this publication. The University of Copenhagen was paid by Naturex to perform and report the scientific work that formed the basis of this publication. The University of Copenhagen and Naturex declare that the data in this report represent a true and faithful representation of the work that has been performed. The financial assistance from Naturex is gratefully acknowledged. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The following authors are employees at Naturex: Marc Roller: Naturex SA, Site d'Agroparc BP 1218, 84911 Avignon Cedex 9, France, Emilie Fromentin: Naturex Spain, S. L. Autovia A3, Salida 343, 46930 Quart de Poblet, Spain, and Alvin Ibarra: Naturex Inc, 375 Huyler St., South Hackensack, NJ 07606, USA. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. There is no patent to declare..	[Anonymous], 2005, Altern Med Rev, V10, P51; [Anonymous], 2003, ALTERN MED REV, V8, P72; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cummings JH, 2004, EUR J NUTR, V43, P118, DOI 10.1007/s00394-004-1205-4; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Durgnat JM, 2005, FOOD ADDIT CONTAM A, V22, P1224, DOI 10.1080/02652030500199439; Girbes T, 1996, BIOCHEM J, V315, P343, DOI 10.1042/bj3150343; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jungo F, 2001, CYTOKINE, V14, P272, DOI 10.1006/cyto.2001.0884; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Li SP, 2009, POULTRY SCI, V88, P519, DOI 10.3382/ps.2008-00365; Lien Eric Jung-Chi, 2010, Curr Drug Discov Technol, V7, P13; Liu J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479426; Liu QY, 2010, J ETHNOPHARMACOL, pS0378; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mach L, 1996, BIOCHEM J, V315, P1061, DOI 10.1042/bj3151061; Mao XF, 2005, J ANIM SCI, V83, P2775; MUMCUOGLU M, 1986, EXP HEMATOL, V14, P946; Pan MH, 2009, J AGR FOOD CHEM, V57, P4467, DOI 10.1021/jf900612n; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puertollano MA, 2011, CURR TOP MED CHEM, V11, P1752; Rogers J, 2005, EXP BIOL MED, V230, P645; Sciacca FL, 2000, J NEUROVIROL, V6, pS33; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Takei M, 2004, BIOCHEM PHARMACOL, V68, P441, DOI 10.1016/j.bcp.2004.04.015; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; Vlachojannis JE, 2010, PHYTOTHER RES, V24, P1, DOI 10.1002/ptr.2729; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Weiss G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011065; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wismar R, 2011, MOL NUTR FOOD RES, V55, P443, DOI 10.1002/mnfr.201000230; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zeuthen LH, 2008, IMMUNOLOGY, V124, P489, DOI 10.1111/j.1365-2567.2007.02800.x	35	16	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47878	10.1371/journal.pone.0047878	http://dx.doi.org/10.1371/journal.pone.0047878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118903	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600019
J	Lederlin, M; Ozier, A; Dournes, G; Ousova, O; Girodet, PO; Begueret, H; Marthan, R; Montaudon, M; Laurent, F; Berger, P				Lederlin, Mathieu; Ozier, Annaig; Dournes, Gael; Ousova, Olga; Girodet, Pierre-Olivier; Begueret, Hugues; Marthan, Roger; Montaudon, Michel; Laurent, Francois; Berger, Patrick			In Vivo Micro-CT Assessment of Airway Remodeling in a Flexible OVA-Sensitized Murine Model of Asthma	PLOS ONE			English	Article							BRONCHIAL SMOOTH-MUSCLE; RESOLUTION COMPUTED-TOMOGRAPHY; OBSTRUCTIVE PULMONARY-DISEASE; EXHALED NITRIC-OXIDE; WALL ATTENUATION; UNRESTRAINED PLETHYSMOGRAPHY; ALLERGIC-ASTHMA; INFLAMMATION; SPUTUM; LUNG	Airway remodeling is a major pathological feature of asthma. Up to now, its quantification still requires invasive methods. In this study, we aimed at determining whether in vivo micro-computed tomography (micro-CT) is able to demonstrate allergen-induced airway remodeling in a flexible mouse model of asthma. Sixty Balb/c mice were challenged intranasally with ovalbumin or saline at 3 different endpoints (Days 35, 75, and 110). All mice underwent plethysmography at baseline and just prior to respiratory-gated micro-CT. Mice were then sacrificed to assess bronchoalveolar lavage and lung histology. From micro-CT images (voxel size = 46 x46 x46 mu m), the numerical values of total lung attenuation, peribronchial attenuation (PBA), and PBA normalized by total lung attenuation were extracted. Each parameter was compared between OVA and control mice and correlation coefficients were calculated between micro-CT and histological data. As compared to control animals, ovalbumin-sensitized mice exhibited inflammation alone (Day 35), remodeling alone (Day 110) or both inflammation and remodeling (Day 75). Normalized PBA was significantly greater in mice exhibiting bronchial remodeling either alone or in combination with inflammation. Normalized PBA correlated with various remodeling markers such as bronchial smooth muscle size or peribronchial fibrosis. These findings suggest that micro-CT may help monitor remodeling non-invasively in asthmatic mice when testing new drugs targeting airway remodeling in pre-clinical studies.	[Lederlin, Mathieu; Ozier, Annaig; Dournes, Gael; Ousova, Olga; Girodet, Pierre-Olivier; Begueret, Hugues; Marthan, Roger; Montaudon, Michel; Laurent, Francois; Berger, Patrick] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, CIC 0005, U1045, F-33000 Bordeaux, France; [Lederlin, Mathieu; Ozier, Annaig; Dournes, Gael; Ousova, Olga; Girodet, Pierre-Olivier; Begueret, Hugues; Marthan, Roger; Montaudon, Michel; Laurent, Francois; Berger, Patrick] Ctr Rech Cardiothorac Bordeaux, INSERM, U1045, CIC 0005, F-33000 Bordeaux, France; [Lederlin, Mathieu; Ozier, Annaig; Dournes, Gael; Girodet, Pierre-Olivier; Begueret, Hugues; Marthan, Roger; Montaudon, Michel; Laurent, Francois; Berger, Patrick] CHU Bordeaux, Serv Imagerie Thorac & Cardiovasc, Serv Explorat Fonct Resp, Serv Anatomopathol,CIC 0005, F-33604 Pessac, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Lederlin, M (corresponding author), Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, CIC 0005, U1045, F-33000 Bordeaux, France.	mathieu.lederlin@chu-bordeaux.fr	LEDERLIN, Mathieu/ABC-8116-2020; Berger, Patrick/D-8779-2012	Berger, Patrick/0000-0003-4702-0343; Dournes, Gael/0000-0002-0251-6639; Montaudon, Michel/0000-0002-1488-9678; Girodet, Pierre-Olivier/0000-0002-9298-9711; Marthan, Roger/0000-0001-5412-5712				Adler A, 2004, J APPL PHYSIOL, V97, P286, DOI 10.1152/japplphysiol.00821.2003; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bara I, 2010, EUR RESPIR J, V36, P1174, DOI 10.1183/09031936.00019810; Bartling SH, 2008, EUR RADIOL, V18, P1375, DOI 10.1007/s00330-008-0903-3; Begueret H, 2007, THORAX, V62, P8, DOI 10.1136/thx.2006.062141; Berger P, 1999, EUR RESPIR J, V14, P1394, DOI 10.1183/09031936.99.14613949; Berlyne GS, 2000, J ALLERGY CLIN IMMUN, V106, P638, DOI 10.1067/mai.2000.109622; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Chen DL, 2010, J MAGN RESON IMAGING, V32, P1409, DOI 10.1002/jmri.22385; Cox G, 2007, NEW ENGL J MED, V356, P1327, DOI 10.1056/NEJMoa064707; Davies DE, 1999, ALLERGY, V54, P771; Ford NL, 2005, MED PHYS, V32, P2888, DOI 10.1118/1.2013007; Gupta S, 2010, THORAX, V65, P775, DOI 10.1136/thx.2010.136374; Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051; Holgate ST, 2000, AM J RESP CRIT CARE, V162, pS113, DOI 10.1164/ajrccm.162.supplement_2.ras-12; Jatakanon A, 1998, THORAX, V53, P91, DOI 10.1136/thx.53.2.91; Kaminska M, 2009, J ALLERGY CLIN IMMUN, V124, P45, DOI 10.1016/j.jaci.2009.03.049; Kannan MS, 2003, AM J PHYSIOL-LUNG C, V285, pL29, DOI 10.1152/ajplung.00085.2003; Kasahara K, 2002, THORAX, V57, P242, DOI 10.1136/thorax.57.3.242; Koo V, 2006, CELL ONCOL, V28, P127; Kumar RK, 2001, PHARMACOL THERAPEUT, V91, P93, DOI 10.1016/S0163-7258(01)00149-8; Lederlin M, 2012, AM J ROENTGENOL, V198, P800, DOI 10.2214/AJR.11.6895; Lederlin M, 2010, EUR RADIOL, V20, P128, DOI 10.1007/s00330-009-1541-0; Lee SH, 2012, AM J RESP CELL MOL, V46, P842, DOI 10.1165/rcmb.2011-0369OC; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Lundblad LKA, 2007, EUR RESPIR J, V30, P805, DOI 10.1183/09031936.00091307; Lundblad LKA, 2002, J APPL PHYSIOL, V93, P1198, DOI 10.1152/japplphysiol.00080.2002; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; Ramos-Barbon D, 2010, AM J RESP CRIT CARE, V182, P317, DOI 10.1164/rccm.200905-0745OC; Takeda K, 2001, AM J PHYSIOL-LUNG C, V281, pL394, DOI 10.1152/ajplung.2001.281.2.L394; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Tulic MK, 2003, CHEST, V123, p348S, DOI 10.1378/chest.123.3_suppl.348S; Vignola AM, 2004, EUR RESPIR J, V24, P910, DOI 10.1183/09031936.04.00032603; Washko GR, 2009, J APPL PHYSIOL, V107, P185, DOI 10.1152/japplphysiol.00216.2009; Yamabayashi C, 2012, AM J RESP CELL MOL, V47, P170, DOI 10.1165/rcmb.2011-0350OC; Yamashiro T, 2010, AM J ROENTGENOL, V195, P363, DOI 10.2214/AJR.09.3653	37	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48493	10.1371/journal.pone.0048493	http://dx.doi.org/10.1371/journal.pone.0048493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119036	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705600047
J	Mundinger, TA; Sommerfeld, A; Reinehr, R; Spatz, JP; Haussinger, D; Boehm, H				Mundinger, Tabea A.; Sommerfeld, Annika; Reinehr, Roland; Spatz, Joachim P.; Hauessinger, Dieter; Boehm, Heike			Investigating Cell-ECM Contact Changes in Response to Hypoosmotic Stimulation of Hepatocytes In Vivo with DW-RICM	PLOS ONE			English	Article							INTERFERENCE CONTRAST MICROSCOPY; PERFUSED-RAT-LIVER; VOLUME REGULATION; ADHESION; INTEGRINS; ACTIVATION; MECHANISMS; INVOLVEMENT; RECEPTOR; SYSTEM	Hepatocyte volume regulation has been shown to play an important role in cellular metabolism, proliferation, viability and especially in hepatic functions such as bile formation and proteolysis. Recent studies on liver explants led to the assumption that cell volume changes present a trigger for outside-in signaling via integrins, a protein family involved in mediating cellular response to binding to the extracellular matrix (ECM). However, it remains elusive how these volume change related signaling events are transducted on a single cell level and how these events are influenced and controlled by ECM interactions. One could speculate that an increase in cell volume leads to an increase in integrin/ECM contacts which causes activation of integrins, which act as mechano-sensors. In order to test this idea, it was an important issue to quantify the cell volume-dependence of the contact areas between the cell and the surrounding ECM. In this study we used two wavelength reflection interference contrast microscopy (DW-RICM) to directly observe the dynamics of cell-substrate contacts, mimicking cell-ECM interactions, in response to a controlled and well-defined volume change induced by hypoosmotic stimulation. This is the first time a non-invasive, label-free method is used to uncover a volume change related response of in vitro hepatocytes in real time. The cell cluster analysis we present here agrees well with previous studies on ex vivo whole liver explants. Moreover, we show that the increase in contact area after cell swelling is a reversible process, while the reorganisation of contacts depends on the type of ECM molecules presented to the cells. As our method complements common whole liver studies providing additional insight on a cell cluster level, we expect this technique to be particular suitable for further detailed studies of osmotic stimulation not only in hepatocytes, but also other cell types.	[Mundinger, Tabea A.; Spatz, Joachim P.; Boehm, Heike] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Mundinger, Tabea A.; Spatz, Joachim P.; Boehm, Heike] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany; [Sommerfeld, Annika; Reinehr, Roland; Hauessinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, D-40225 Dusseldorf, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf	Boehm, H (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	heike.boehm@is.mpg.de	Boehm, Heike/I-8473-2016; Spatz, Joachim P/A-1107-2017; Reinehr, Roland/G-6118-2016	Boehm, Heike/0000-0002-7124-4913; Spatz, Joachim P/0000-0003-3419-9807; Oswald, Tabea/0000-0001-9150-3487	Max Planck Society, DFG [SFB 575, SFB 974]	Max Planck Society, DFG(Max Planck SocietyGerman Research Foundation (DFG))	This work was supported by the Max Planck Society, DFG, SFB 575 "Experimental Hepatology" and SFB 974 "Communication and System Relevance in Liver Injury and Regeneration". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; BEREITERHAHN J, 1979, J CELL BIOL, V82, P767, DOI 10.1083/jcb.82.3.767; BOYER JL, 1988, SEMIN LIVER DIS, V8, P308, DOI 10.1055/s-2008-1040552; Braun D, 1998, PHYS REV LETT, V81, P5241, DOI 10.1103/PhysRevLett.81.5241; CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199; Dahl vom S, 2003, J BIOL CHEM, V278, P27088; Dahl vom S, 1991, EUR J BIOCHEM, V198, P73; Dahl vom S, 1995, BIOCHEM J, V308, P529; Fenz SF, 2011, ADV MATER, V23, P2622, DOI 10.1002/adma.201004097; Gohlke H, 2012, HEPATOLOGY; GRAF J, 1995, BIOPHYS J, V68, P1359, DOI 10.1016/S0006-3495(95)80308-5; GRAF J, 1984, P NATL ACAD SCI-BIOL, V81, P6516, DOI 10.1073/pnas.81.20.6516; Groulx N, 2006, J MEMBRANE BIOL, V214, P43, DOI 10.1007/s00232-006-0080-8; Haussinger D, 2006, ACTA PHYSIOL, V187, P249, DOI 10.1111/j.1748-1716.2006.01542.x; HAUSSINGER D, 1992, TRENDS PHARMACOL SCI, V13, P371, DOI 10.1016/0165-6147(92)90114-L; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Haussinger D, 1996, BIOCHEM J, V313, P697; HAUSSINGER D, 1990, HEPATOLOGY, V11, P243, DOI 10.1002/hep.1840110214; Haussinger Dieter, 2004, Molecular Aspects of Medicine, V25, P221, DOI 10.1016/j.mam.2004.02.001; Huang ZH, 2010, SOFT MATTER, V6, P1948, DOI 10.1039/b925373d; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kultz D, 1998, CONTRIB NEPHROL, V123, P94, DOI 10.1159/000059923; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LANG F, 1989, PFLUG ARCH EUR J PHY, V413, P209, DOI 10.1007/BF00583532; Lieleg O, 2011, TRENDS CELL BIOL, V21, P543, DOI 10.1016/j.tcb.2011.06.002; Limozin L, 2007, BIOPHYS J, V93, P3300, DOI 10.1529/biophysj.107.105544; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; Lipowsky R., 1995, P521; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Monzel C, 2012, SOFT MATTER, V8, P6128, DOI 10.1039/c2sm07458c; Monzel C, 2009, CHEMPHYSCHEM, V10, P2828, DOI 10.1002/cphc.200900645; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; PFALLER W, 1993, J CELL PHYSIOL, V154, P248, DOI 10.1002/jcp.1041540206; Pierres A, 2008, BIOPHYS J, V94, P4114, DOI 10.1529/biophysj.107.125278; Raedler J., 1992, LANGMUIR, V8, P848; Reinehr R, 2002, HEPATOLOGY, V36, P602, DOI 10.1053/jhep.2002.35447; Reinehr R, 2010, J BIOL CHEM, V285, P29348, DOI 10.1074/jbc.M110.155135; Reinehr R, 2010, J BIOL CHEM, V285, P25904, DOI 10.1074/jbc.M110.125781; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Schilling J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021901; Schliess F, 2004, J BIOL CHEM, V279, P21294, DOI 10.1074/jbc.M313901200; Schliess F, 2007, FEBS J, V274, P5799, DOI 10.1111/j.1742-4658.2007.06100.x; Schliess F, 2007, METHOD ENZYMOL, V428, P129, DOI 10.1016/S0076-6879(07)28007-3; Selhuber-Unkel C, 2010, BIOPHYS J, V98, P543, DOI 10.1016/j.bpj.2009.11.001; Selhuber-Unkel C, 2008, BIOPHYS J, V95, P5424, DOI 10.1529/biophysj.108.139584; Sengupta K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.088101; Smith AS, 2008, P NATL ACAD SCI USA, V105, P6906, DOI 10.1073/pnas.0801706105	47	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48100	10.1371/journal.pone.0048100	http://dx.doi.org/10.1371/journal.pone.0048100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110181	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500035
J	Klymiuk, I; Kenner, L; Adler, T; Busch, DH; Boersma, A; Irmler, M; Gailus-Durner, V; Fuchs, H; Leitner, N; Muuller, M; Kuhn, R; Schlederer, M; Treise, I; de Angelis, MH; Beckers, J				Klymiuk, Ingeborg; Kenner, Lukas; Adler, Thure; Busch, Dirk H.; Boersma, Auke; Irmler, Martin; Gailus-Durner, Valerie; Fuchs, Helmut; Leitner, Nicole; Mueller, Mathias; Kuehn, Ralf; Schlederer, Michaela; Treise, Irina; de Angelis, Martin Hrabe; Beckers, Johannes			In Vivo Functional Requirement of the Mouse Ifitm1 Gene for Germ Cell Development, Interferon Mediated Immune Response and Somitogenesis	PLOS ONE			English	Article							CANCER CELLS; ESOPHAGEAL CANCER; EXPRESSION; PROTEIN; FAMILY; MICROARRAY; PROSTATE; BREAST; MARKER; GAMMA	The mammalian Interferon induced transmembrane protein 1 (Ifitm1) gene was originally identified as a member of a gene family highly inducible by type I and type II interferons. Based on expression analyses, it was suggested to be required for normal primordial germ cell migration. The knockdown of Ifitm1 in mouse embryos provided evidence for a role in somitogenesis. We generated the first targeted knockin allele of the Ifitm1 gene to systematically reassess all inferred functions. Sperm motility and the fertility of male and female mutant mice are as in wild type littermates. Embryonic somites and the adult vertebral column appear normal in homozygous Ifitm1 knockout mice, demonstrating that Ifitm1 is not essential for normal segmentation of the paraxial mesoderm. Proportions of leucocyte subsets, including granulocytes, monocytes, B-cells, T-cells, NK-cells, and NKT-cells, are unchanged in mutant mice. Based on a normal immune response to Listeria monocytogenes infection, there is no evidence for a dysfunction in downstream IFN gamma signaling in Ifitm1 mutant mice. Expression from the Ifitm1 locus from E8.5 to E14.5 is highly dynamic. In contrast, in adult mice, Ifitm1 expression is highly restricted and strong in the bronchial epithelium. Intriguingly, IFITM1 is highly overexpressed in tumor epithelia cells of human squamous cell carcinomas and in adenocarcinomas of NSCLC patients. These analyses underline the general importance of targeted in vivo studies for the functional annotation of the mammalian genome. The first comprehensive description of the Ifitm1 expression pattern provides a rational basis for the further examination of Ifitm1 gene functions. Based on our data, the fact that IFITM1 can function as a negative regulator of cell proliferation, and because the gene maps to chromosome band 11p15.5, previously associated with NSCLC, it is likely that IFITM1 in man has a key role in tumor formation.	[Klymiuk, Ingeborg; Adler, Thure; Boersma, Auke; Irmler, Martin; Gailus-Durner, Valerie; Leitner, Nicole; Treise, Irina; de Angelis, Martin Hrabe; Beckers, Johannes] Helmholtz Zentrum Munchen GmbH, Inst Expt Genet & German Mouse Clin, Neuherberg, Germany; [Kenner, Lukas] Med Univ Vienna, Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Kenner, Lukas] Med Univ Vienna, Inst Clin Pathol, Vienna, Austria; [Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Boersma, Auke] Univ Vet Med Vienna, Inst Lab Anim Sci & Biomodels Austria, Vienna, Austria; [Leitner, Nicole; Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Kuehn, Ralf] Helmholtz Zentrum Munchen GmbH, Inst Dev Genet, Neuherberg, Germany; [Schlederer, Michaela] Ludwig Boltzmann Gesell, Ludwig Boltzmann Inst Canc Res, Vienna, Austria	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ludwig Boltzmann Institute; Medical University of Vienna; Medical University of Vienna; Technical University of Munich; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ludwig Boltzmann Institute	Klymiuk, I (corresponding author), Helmholtz Zentrum Munchen GmbH, Inst Expt Genet & German Mouse Clin, Neuherberg, Germany.	ingeborg.klymiuk@medunigraz.at; beckers@helmholtz-muenchen.de	Gailus-Durner, Valerie/M-7337-2014; Irmler, Martin/B-3317-2013; Klymiuk, Ingeborg/ABG-9952-2021; Kühn, Ralf/U-1278-2017; Beckers, Johannes/K-7237-2012; de Angelis, Martin Hrabe/F-5531-2012; Fuchs, Helmut/M-7347-2014	Irmler, Martin/0000-0003-3169-479X; Kühn, Ralf/0000-0003-1694-9803; Beckers, Johannes/0000-0001-7874-3822; de Angelis, Martin Hrabe/0000-0002-7898-2353; Fuchs, Helmut/0000-0002-5143-2677; Kenner, Lukas/0000-0003-2184-1338; Klymiuk, Ingeborg/0000-0001-8755-0037; Muller, Mathias/0000-0002-7879-3552	German Federal Ministry of Education and Research [01GS0850, 01GS0852]; Infrafrontier [01KX1012]; Fonds zur Forderung der wissenschaftlichen Forschung [P-18478-B12]; Genome Research-Austria project Inflammobiota	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Infrafrontier; Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Genome Research-Austria project Inflammobiota	This work was funded by the German Federal Ministry of Education and Research (NGFN45 Plus grant numbers 01GS0850 to JB and 01GS0852 to DHB) and Infrafrontier (grant number 01KX1012 to German Mouse Clinic). LK is supported by the Fonds zur Forderung der wissenschaftlichen Forschung (P-18478-B12) and Genome Research-Austria project Inflammobiota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyerli CB, 2005, LEUKEMIA RES, V29, P283, DOI 10.1016/j.leukres.2004.07.007; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Arion D, 2007, BIOL PSYCHIAT, V62, P711, DOI 10.1016/j.biopsych.2006.12.021; Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; Busch PC, 1998, CANCER SURV, V32, P149; Chambers KF, 2009, PROSTATE, V69, P1411, DOI 10.1002/pros.20986; Chattopadhyay I, 2009, ONCOL REP, V21, P1135, DOI 10.3892/or_00000333; Craig FE, 2007, DIAGN MOL PATHOL, V16, P158, DOI 10.1097/PDM.0b013e31804f54a9; DEBLANDRE GA, 1995, J BIOL CHEM, V270, P23860, DOI 10.1074/jbc.270.40.23860; EVANS SS, 1990, BLOOD, V76, P2583; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Fuchs H, 2009, CURR PHARM BIOTECHNO, V10, P236, DOI 10.2174/138920109787315051; Fumoto S, 2008, INT J ONCOL, V32, P413; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gyorffy B, 2008, INT J GYNECOL CANCER, V18, P1215, DOI 10.1111/j.1525-1438.2007.01169.x; Hatano H, 2008, CLIN CANCER RES, V14, P6097, DOI 10.1158/1078-0432.CCR-07-4761; Hofman VJ, 2007, MODERN PATHOL, V20, P974, DOI 10.1038/modpathol.3800930; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kita K, 2003, RADIAT RES, V160, P302, DOI 10.1667/RR3039; Lacham-Kaplan O, 2004, REPRODUCTION, V128, P147, DOI 10.1530/rep.1.00220; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Luszczek W, 2010, MOL CANCER THER, V9, P2309, DOI 10.1158/1535-7163.MCT-10-0309; Mallon AM, 2008, NUCLEIC ACIDS RES, V36, pD715, DOI 10.1093/nar/gkm728; Morgan H, 2010, NUCLEIC ACIDS RES, V38, pD577, DOI 10.1093/nar/gkp1007; Nesaretnam K, 2004, ANN NY ACAD SCI, V1031, P143, DOI 10.1196/annals.1331.014; Nibbe RK, 2009, MOL CELL PROTEOMICS, V8, P827, DOI 10.1074/mcp.M800428-MCP200; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; QUINN P, 1985, FERTIL STERIL, V44, P493; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; Rogers CD, 2006, CANCER BIOL THER, V5, P1383, DOI 10.4161/cbt.5.10.3323; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Schild-Hay LJ, 2009, CANCER RES, V69, P1150, DOI 10.1158/0008-5472.CAN-08-2806; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Smith RA, 2006, GENES IMMUN, V7, P113, DOI 10.1038/sj.gene.6364278; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Tanaka SS, 2002, MECH DEVELOP, V119, pS261, DOI 10.1016/S0925-4773(03)00126-6; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Tran YK, 1996, CANCER RES, V56, P2916; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Tsai MH, 2007, CANCER RES, V67, P3845, DOI 10.1158/0008-5472.CAN-06-4250; Wildenberg ME, 2008, EUR J IMMUNOL, V38, P2024, DOI 10.1002/eji.200738008; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Wylie C, 2005, DEV CELL, V9, P723, DOI 10.1016/j.devcel.2005.11.009; Xu Y, 2009, ACTA BIOCH BIOPH SIN, V41, P488, DOI 10.1093/abbs/gmp034; Yang G, 2007, ONCOGENE, V26, P594, DOI 10.1038/sj.onc.1209807; Yang Y, 2005, CANCER LETT, V221, P191, DOI 10.1016/j.canlet.2004.08.022; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	51	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e44609	10.1371/journal.pone.0044609	http://dx.doi.org/10.1371/journal.pone.0044609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115618	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000310310200005
J	Nishikawa, S; Nishitani, S; Fujisawa, TX; Noborimoto, I; Kitahara, T; Takamura, T; Shinohara, K				Nishikawa, Saori; Nishitani, Shota; Fujisawa, Takashi X.; Noborimoto, Ippei; Kitahara, Takayuki; Takamura, Tsunehiko; Shinohara, Kazuyuki			Perceived Parental Rejection Mediates the Influence of Serotonin Transporter Gene (5-HTTLPR) Polymorphisms on Impulsivity in Japanese Adults	PLOS ONE			English	Article							ACUTE TRYPTOPHAN DEPLETION; REGION 5-HTTLPR; ASSOCIATION; PERSONALITY; BEHAVIOR; NEUROTICISM; DEPRESSION; GENOTYPE; ANXIETY; STRESS	This study examined (1) the interrelationships among 5-HTTLPR genotype, perceived parental rejection, and impulsivity, and (2) meditational models in which perceived paternal/maternal rejection mediates the relationship between the 5-HTTLPR genotype and impulsive behaviour. Participants included 403 adults (152 males and 252 females, mean age = 24.20) who provided genetic data and a set of the questionnaires (BIS11; Barratt Impulsiveness Scale-11 and EMBU; Egna Minnen av Batraffande Uppfostran). Using SEM (Structural Equation Modeling), we evaluated 3 models for both direct and indirect relationships between 5-HTTLPR (5HTT) and Impulsivity (IMP), via maternal/fraternal rejection (MAT/FAT). In model 1, the direct path from 5HTT and IMP was not significant across the mother's and father's analysis. Models 2 and 3 assessed the indirect influence of 5HTT on IMP through MOT/FAT. The paths of models 2 and 3 were all significant and showed a good fit between the hypothesized model and data. Furthermore, the effects of the 5-HTTLPR genotype on impulsiveness in this Japanese sample were particularly accounted for by perceived rejection from the mother or father. The effects from the parents appeared to be robust especially among males. These results may help elucidate the specific pathways of risk in relation to genetic and environment influences on impulsive phenotypes.	[Nishikawa, Saori; Nishitani, Shota; Fujisawa, Takashi X.; Noborimoto, Ippei; Kitahara, Takayuki; Takamura, Tsunehiko; Shinohara, Kazuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurobiol & Behav, Nagasaki 852, Japan; [Nishikawa, Saori] Hiroshima Univ, Phoenix Leader Educ Program, Higashihiroshima 724, Japan	Nagasaki University; Hiroshima University	Shinohara, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurobiol & Behav, Nagasaki 852, Japan.	kazuyuki@nagasaki-u.ac.jp	Fujisawa, Takashi/Z-4461-2019; Nishitani, Shota/S-5975-2016	Nishitani, Shota/0000-0002-6234-295X				Aluja A, 2009, J PSYCHIATR RES, V43, P906, DOI 10.1016/j.jpsychires.2008.11.008; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bilderbeck AC, 2011, BIOL PSYCHIAT, V69, P720, DOI 10.1016/j.biopsych.2010.12.038; Browne M. W., 1993, SOCIOL METHOD RES, P136; Brummett BH, 2008, BIOL PSYCHOL, V78, P200, DOI 10.1016/j.biopsycho.2008.03.002; Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Fox NA, 2005, PSYCHOL SCI, V16, P921, DOI 10.1111/j.1467-9280.2005.01637.x; Gerra G, 2007, AM J MED GENET B, V144B, P52, DOI 10.1002/ajmg.b.30388; He QH, 2010, NEUROPHARMACOLOGY, V59, P518, DOI 10.1016/j.neuropharm.2010.07.008; Heils A, 1996, J NEUROCHEM, V66, P2621; Holmes-Smith P, 2000, INTRO STRUCTURAL EQU; Joreskog K.G., 1993, LISREL 8 STRUCTURAL; Lage GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016927; Lu X., 2008, OPEN FAMILY STUDIES, V1, P17; Marazziti D, 2010, NEUROPSYCH DIS TREAT, V6, P9; Middeldorp CM, 2007, BEHAV GENET, V37, P294, DOI 10.1007/s10519-006-9139-7; Mileva-Seitz V, 2011, GENES BRAIN BEHAV, V10, P325, DOI 10.1111/j.1601-183X.2010.00671.x; Moberg T, 2011, J AFFECT DISORDERS, V132, P173, DOI 10.1016/j.jad.2011.01.018; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Munafo MR, 2005, AM J MED GENET B, V135B, P10, DOI 10.1002/ajmg.b.30162; Munafo MR, 2004, NICOTINE TOB RES, V6, P583, DOI 10.1080/14622200410001734030; Paaver M, 2008, PROG NEURO-PSYCHOPH, V32, P1263, DOI 10.1016/j.pnpbp.2008.03.021; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PERRIS C, 1980, ACTA PSYCHIAT SCAND, V61, P265, DOI 10.1111/j.1600-0447.1980.tb00581.x; Ray LA, 2009, ADDICT BIOL, V14, P238, DOI 10.1111/j.1369-1600.2008.00120.x; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Sakado K, 2003, AM J MED GENET B, V121B, P71, DOI 10.1002/ajmg.b.20063; Sanchez-Martin JR, 2011, PSYCHONEUROENDOCRINO, V36, P750, DOI 10.1016/j.psyneuen.2010.10.011; Someya T, 2001, PSYCHIAT CLIN NEUROS, V55, P111, DOI 10.1046/j.1440-1819.2001.00796.x; Someya T, 1997, SEISHIN IGAKU, V38, P1065; SPSS, 2009, PASW STAT WIND REL 1; Straus MA, 1998, BEHAV SCI LAW, V16, P353, DOI 10.1002/(SICI)1099-0798(199822)16:3<353::AID-BSL313>3.0.CO;2-O; van Roekel E, 2010, J CHILD PSYCHOL PSYC, V51, P747, DOI 10.1111/j.1469-7610.2010.02225.x; Walderhaug E, 2010, NEUROSCI LETT, V473, P208, DOI 10.1016/j.neulet.2010.02.048	37	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47608	10.1371/journal.pone.0047608	http://dx.doi.org/10.1371/journal.pone.0047608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112823	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200056
J	Porphyre, T; Giotis, ES; Lloyd, DH; Dorothea, K; Stark, C				Porphyre, Thibaud; Giotis, Efstathios Stamatios; Lloyd, David Hugh; Dorothea, Katharina; Staerk, Clementine			A Metapopulation Model to Assess the Capacity of Spread of Meticillin-Resistant Staphylococcus aureus ST398 in Humans	PLOS ONE			English	Article							GLOBAL SENSITIVITY-ANALYSIS; NASAL CARRIAGE; MRSA; TRANSMISSION; PREVALENCE; QUANTIFICATION; CONTACT; PIGS; UK	The emergence of the livestock-associated clone of meticillin-resistant Staphylococcus aureus (MRSA) ST398 is a serious public health issue throughout Europe. In The Netherlands a stringent 'search-and-destroy' policy has been adopted, keeping low the level of MRSA prevalence. However, reports have recently emerged of transmission events between humans showing no links to livestock, contradicting belief that MRSA ST398 is poorly transmissible in humans. The question regarding the transmissibility of MRSA ST398 in humans therefore remains of great interest. Here, we investigated the capacity of MRSA ST398 to spread into an entirely susceptible human population subject to the effect of a single MRSA-positive commercial pig farm. Using a stochastic, discrete-time metapopulation model, we explored the effect of varying both the probability of persistent carriage and that of acquiring MRSA due to contact with pigs on the transmission dynamics of MRSA ST398 in humans. In particular, we assessed the value and key determinants of the basic reproduction ratio (R-o) for MRSA ST398. Simulations showed that the presence of recurrent exposures with pigs in risky populations allows MRSA ST398 to persist in the metapopulation and transmission events to occur beyond the farming community, even when the probability of persistent carriage is low. We further showed that persistent carriage should occur in less than 10% of the time for MRSA ST398 to conserve epidemiological characteristics similar to what has been previously reported. These results indicate that implementing control policy that only targets human carriers may not be sufficient to control MRSA ST398 in the community if it remains in pigs. We argue that farm-level control measures should be implemented if an eradication programme is to be considered.	[Porphyre, Thibaud; Giotis, Efstathios Stamatios; Lloyd, David Hugh; Dorothea, Katharina; Staerk, Clementine] Royal Vet Coll, Dept Vet Clin Sci, Vet Epidemiol & Publ Hlth Grp, Hatfield, Herts, England	University of London; University of London Royal Veterinary College	Porphyre, T (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Epidemiol Grp, Ashworth Labs, Edinburgh, Midlothian, Scotland.	t.porphyre@gmail.com	Giotis, Efstathios S/AAI-9779-2021; Giotis, Efstathios S/C-4976-2011; Staerk, Katharina D/M-4186-2013; Porphyre, Thibaud/N-7581-2018	Giotis, Efstathios S/0000-0001-8908-7824; Giotis, Efstathios S/0000-0002-5991-3678; Staerk, Katharina D/0000-0002-0553-5499; Porphyre, Thibaud/0000-0002-8552-9899	EU-HEALTH Project PILGRIM [223050]; Centre of Expertise on Animal Disease Outbreaks (EPIC) of the Scottish government	EU-HEALTH Project PILGRIM; Centre of Expertise on Animal Disease Outbreaks (EPIC) of the Scottish government	The authors gratefully acknowledge funding from the EU-HEALTH Project PILGRIM (223050) of the Seventh Framework Programme (FP7). TP is currently funded by the Centre of Expertise on Animal Disease Outbreaks (EPIC) of the Scottish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup F, 2006, ANTIMICROBIAL REISTA, V442; Alarcon P, 2011, PREV VET MED, V98, P19, DOI 10.1016/j.prevetmed.2010.09.022; ANDERSON R M, 1991; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2; Broens EM, 2011, PREV VET MED, V98, P182, DOI 10.1016/j.prevetmed.2010.10.010; Broens EM, 2012, VET MICROBIOL, V155, P381, DOI 10.1016/j.vetmic.2011.09.010; Cuny C, 2008, MICROB DRUG RESIST, V14, P307, DOI 10.1089/mdr.2008.0845; Diekmann O, 1990, J MATH BIOL, V35, P503; European Food Safety Authority, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1377; French GL, 2010, INT J ANTIMICROB AG, V36, pS3, DOI 10.1016/S0924-8579(10)70003-0; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gilbert MJ, 2012, OCCUP ENVIRON MED, V69, P472, DOI 10.1136/oemed-2011-100069; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Keeling M.J., 2008, MODELING INFECT DIS; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Kock R, 2012, APPL ENV MI IN PRESS, DOI [10.1128/aem.00212-00212, DOI 10.1128/AEM.00212-00212]; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Loeffler A, 2010, J HOSP INFECT, V74, P282, DOI 10.1016/j.jhin.2009.09.020; Loeffler A, 2009, J HOSP INFECT, V72, P269, DOI 10.1016/j.jhin.2009.04.002; Makowski D, 2006, RELIAB ENG SYST SAFE, V91, P1142, DOI 10.1016/j.ress.2005.11.015; McBryde ES, 2004, J HOSP INFECT, V58, P104, DOI 10.1016/j.jhin.2004.06.010; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Neumann MB, 2009, WATER RES, V43, P997, DOI 10.1016/j.watres.2008.11.049; R Core Team, 2021, R LANG ENV STAT COMP; RSPCA, 2010, RSPCA STAND PIGS; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Smith Tara C, 2009, PLoS One, V4, pe4258, DOI 10.1371/journal.pone.0004258; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van Cleef BAGL, 2010, EPIDEMIOL INFECT, V138, P756, DOI 10.1017/S0950268810000245; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	42	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47504	10.1371/journal.pone.0047504	http://dx.doi.org/10.1371/journal.pone.0047504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112817	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000310310200045
J	van den Wollenberg, DJM; Dautzenberg, IJC; van den Hengel, SK; Cramer, SJ; de Groot, RJ; Hoeben, RC				van den Wollenberg, Diana J. M.; Dautzenberg, Iris J. C.; van den Hengel, Sanne K.; Cramer, Steve J.; de Groot, Raoul J.; Hoeben, Rob C.			Isolation of Reovirus T3D Mutants Capable of Infecting Human Tumor Cells Independent of Junction Adhesion Molecule-A	PLOS ONE			English	Article							SIALIC-ACID; HEPARAN-SULFATE; MAMMALIAN REOVIRUS; TYPE-3 REOVIRUS; PROTEIN SIGMA-3; PHASE-I; APOPTOSIS; BINDING; VIRUS; ONCOLYSIS	Mammalian Reovirus is a double-stranded RNA virus with a distinctive preference to replicate in and lyse transformed cells. On that account, Reovirus type 3 Dearing (T3D) is clinically evaluated as oncolytic agent. The therapeutic efficacy of this approach depends in part on the accessibility of the reovirus receptor Junction Adhesion Molecule-A (JAM-A) on the target cells. Here, we describe the isolation and characterization of reovirus T3D mutants that can infect human tumor cells independent of JAM-A. The JAM-A-independent (jin) mutants were isolated on human U118MG glioblastoma cells, which do not express JAM-A. All jin mutants harbour mutations in the S1 segments close to the region that encodes the sialic acid-binding pocket in the shaft of the spike protein. In addition, two of the jin mutants encode spike proteins with a Q336R substitution in their head domain. The jin mutants can productively infect a wide range of cell lines that resist wt reovirus T3D infection, including chicken LMH cells, hamster CHO cells, murine endothelioma cells, human U2OS and STA-ET2.1 cells, but not primary human fibroblasts. The jin-mutants rely on the presence of sialic-acid residues on the cell surface for productive infection, as is evident from wheat germ agglutinin (WGA) inhibition experiments, and from the jin-reovirus resistance of CHO-Lec2 cells, which have a deficiency of sialic-acids on their glycoproteins. The jin mutants may be useful as oncolytic agents for use in tumors in which JAM-A is absent or inaccessible.	[van den Wollenberg, Diana J. M.; Dautzenberg, Iris J. C.; van den Hengel, Sanne K.; Cramer, Steve J.; Hoeben, Rob C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [de Groot, Raoul J.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Div Virol, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University	Hoeben, RC (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands.	r.c.hoeben@lumc.nl	Dautzenberg, Iris/ABB-3162-2020; Hoeben, Rob C./A-5771-2008	Dautzenberg, Iris/0000-0001-5821-2936; Hoeben, Rob C./0000-0001-9443-8377; van den Wollenberg, Diana/0000-0002-7360-3182	European Union [512087]	European Union(European Commission)	This work was supported by the European Union through the 6th Framework Program GIANT (Contract No. 512087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain T, 2007, MOL THER, V15, P1512, DOI 10.1038/sj.mt.6300207; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Barton ES, 2001, VIROLOGY, V290, P173, DOI 10.1006/viro.2001.1160; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bauer PH, 1999, J VIROL, V73, P5826, DOI 10.1128/JVI.73.7.5826-5832.1999; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; BORSA J, 1979, J GEN VIROL, V45, P161, DOI 10.1099/0022-1317-45-1-161; BORSA J, 1981, VIROLOGY, V111, P191, DOI 10.1016/0042-6822(81)90664-4; Byrnes AP, 2000, J VIROL, V74, P644, DOI 10.1128/JVI.74.2.644-651.2000; Campbell JA, 2005, J VIROL, V79, P7967, DOI 10.1128/JVI.79.13.7967-7978.2005; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chandran K, 2003, TRENDS MICROBIOL, V11, P374, DOI 10.1016/S0966-842X(03)00178-1; Chappell JD, 1997, J VIROL, V71, P1834, DOI 10.1128/JVI.71.3.1834-1841.1997; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Connolly JL, 2002, J VIROL, V76, P1632, DOI 10.1128/JVI.76.4.1632-1641.2002; Connolly JL, 2001, J VIROL, V75, P4029, DOI 10.1128/JVI.75.9.4029-4039.2001; Danthi P, 2006, J VIROL, V80, P1261, DOI 10.1128/JVI.80.3.1261-1270.2006; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Forsyth P, 2008, MOL THER, V16, P627, DOI 10.1038/sj.mt.6300403; Gollamudi R, 2010, INVEST NEW DRUG, V28, P641, DOI 10.1007/s10637-009-9279-8; Guglielmi KM, 2006, CURR TOP MICROBIOL, V309, P1; Gutwein P, 2009, BIOCHEM BIOPH RES CO, V380, P387, DOI 10.1016/j.bbrc.2009.01.100; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hulst MM, 2000, J VIROL, V74, P9553, DOI 10.1128/JVI.74.20.9553-9561.2000; Jane-Valbuena J, 2002, J VIROL, V76, P5184, DOI 10.1128/JVI.76.10.5184-5197.2002; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kelly K, 2009, EXPERT OPIN BIOL TH, V9, P817, DOI 10.1517/14712590903002039; Kim M, 2007, J MICROBIOL, V45, P187; KLEIN B, 1990, EXP CELL RES, V191, P256, DOI 10.1016/0014-4827(90)90012-Y; Koshiba H, 2009, INT J GYNECOL CANCER, V19, P208, DOI 10.1111/IGC.0b013e31819bc6e9; Kovar H, 1997, ONCOGENE, V15, P2225, DOI 10.1038/sj.onc.1201397; LEONE G, 1992, CELL, V71, P479, DOI 10.1016/0092-8674(92)90516-F; Lopez-Bueno A, 2006, J VIROL, V80, P1563, DOI 10.1128/JVI.80.3.1563-1573.2006; Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005; Morris AP, 2006, CELL COMMUN ADHES, V13, P233, DOI 10.1080/15419060600877978; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Norman KL, 2005, DRUG DISCOV TODAY, V10, P847, DOI 10.1016/S1359-6446(05)03483-5; Norman KL, 2000, J CLIN INVEST, V105, P1035, DOI 10.1172/JCI9871; Norman KL, 2004, P NATL ACAD SCI USA, V101, P11099, DOI 10.1073/pnas.0404310101; O'Donnell SM, 2003, INT REV IMMUNOL, V22, P477, DOI 10.1080/08830180305212; OBESO J, 1990, LAB INVEST, V63, P259; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Reiter DM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002166; RUBIN DH, 1992, J CLIN INVEST, V90, P2536, DOI 10.1172/JCI116147; SaCarvalho D, 1997, J VIROL, V71, P5115, DOI 10.1128/JVI.71.7.5115-5123.1997; Schelling P, 2007, J BIOL CHEM, V282, P11582, DOI 10.1074/jbc.M610805200; Smakman N, 2005, J VIROL, V79, P14981, DOI 10.1128/JVI.79.23.14981-14985.2005; Smakman N, 2006, THESIS U UTRECHT; Smakman N, 2006, CANCER RES, V66, P5403, DOI 10.1158/0008-5472.CAN-05-4108; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Tyler KL, 1998, CURR TOP MICROBIOL, V233, P93; Tyler KL, 2001, MAMMALIAN REOVIRUSES, P1729; van den Wollenberg DJM, 2008, GENE THER, V15, P1567, DOI 10.1038/gt.2008.118; van Houdt WJ, 2008, CANCER GENE THER, V15, P284, DOI 10.1038/cgt.2008.2; Vidal L, 2008, CLIN CANCER RES, V14, P7127, DOI 10.1158/1078-0432.CCR-08-0524; VIRGIN HW, 1991, J VIROL, V65, P6772, DOI 10.1128/JVI.65.12.6772-6781.1991; Vives RR, 2006, CURR GENE THER, V6, P35, DOI 10.2174/156652306775515565; Wilson GJ, 2002, J VIROL, V76, P9832, DOI 10.1128/JVI.76.19.9832-9843.2002	60	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48064	10.1371/journal.pone.0048064	http://dx.doi.org/10.1371/journal.pone.0048064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110175	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200146
J	Hall, KT; Lembo, AJ; Kirsch, I; Ziogas, DC; Douaiher, J; Jensen, KB; Conboy, LA; Kelley, JM; Kokkotou, E; Kaptchuk, TJ				Hall, Kathryn T.; Lembo, Anthony J.; Kirsch, Irving; Ziogas, Dimitrios C.; Douaiher, Jeffrey; Jensen, Karin B.; Conboy, Lisa A.; Kelley, John M.; Kokkotou, Efi; Kaptchuk, Ted J.			Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome	PLOS ONE			English	Article							COMT VAL(158)MET POLYMORPHISM; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; CLINICAL-TRIALS; END-POINT; GENOTYPE; DOPAMINE; METAANALYSIS; IMPROVEMENT; RESPONSES	Identifying patients who are potential placebo responders has major implications for clinical practice and trial design. Catechol-O-methyltransferase (COMT), an important enzyme in dopamine catabolism plays a key role in processes associated with the placebo effect such as reward, pain, memory and learning. We hypothesized that the COMT functional val158met polymorphism, was a predictor of placebo effects and tested our hypothesis in a subset of 104 patients from a previously reported randomized controlled trial in irritable bowel syndrome (IBS). The three treatment arms from this study were: no-treatment ("waitlist"), placebo treatment alone ("limited") and, placebo treatment "augmented" with a supportive patient-health care provider interaction. The primary outcome measure was change from baseline in IBS-Symptom Severity Scale (IBS-SSS) after three weeks of treatment. In a regression model, the number of methionine alleles in COMT val158met was linearly related to placebo response as measured by changes in IBS-SSS (p = .035). The strongest placebo response occurred in met/met homozygotes treated in the augmented placebo arm. A smaller met/met associated effect was observed with limited placebo treatment and there was no effect in the waitlist control. These data support our hypothesis that the COMT val158met polymorphism is a potential biomarker of placebo response.	[Hall, Kathryn T.; Kaptchuk, Ted J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Hall, Kathryn T.; Lembo, Anthony J.; Kirsch, Irving; Jensen, Karin B.; Conboy, Lisa A.; Kelley, John M.; Kokkotou, Efi; Kaptchuk, Ted J.] Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA; [Lembo, Anthony J.; Kokkotou, Efi] Beth Israel Deaconess Med Ctr, Dept Gastroenterol, Boston, MA 02215 USA; [Kirsch, Irving] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England; [Ziogas, Dimitrios C.] Univ Athens, Dept Internal Med, Athens, Greece; [Douaiher, Jeffrey] Dept Surg, Baltimore, MD USA; [Jensen, Karin B.; Kelley, John M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA USA; [Kelley, John M.] Endicott Coll, Beverly, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Plymouth; National & Kapodistrian University of Athens; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hall, KT (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA.	kthall@bidmc.harvard.edu	Conboy, Lisa/ABC-5173-2021; Kirsch, Irving/P-9316-2019	Conboy, Lisa/0000-0003-2218-7841; Ziogas, Dimitrios C./0000-0003-2620-4004; Jensen, Karin/0000-0003-2521-3160	NCCAM-NIH [R01 AT004662, K24 AT004095, 3R01AT004662-02S1, T32 AT000051, R21 AT002860]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004662] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT002860] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095, T32AT000051] Funding Source: NIH RePORTER	NCCAM-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The funding received for this study came from NCCAM-NIH grants # R01 AT004662, K24 AT004095, 3R01AT004662-02S1, T32 AT000051 and R21 AT002860. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apud JA, 2007, NEUROPSYCHOPHARMACOL, V32, P1011, DOI 10.1038/sj.npp.1301227; BRANCH WT, 1991, ANN INTERN MED, V114, P482, DOI 10.7326/0003-4819-114-6-482; Campbell DT, 1999, PRIMER REGRESSION AR, Vxxi; Chang L, 2010, AM J GASTROENTEROL, V105, P722, DOI 10.1038/ajg.2010.49; Conboy LA, 2010, SOC SCI MED, V70, P479, DOI 10.1016/j.socscimed.2009.10.024; Dai F, 2010, SPINE J, V10, P949, DOI 10.1016/j.spinee.2010.07.387; Diamond A, 2007, CEREB CORTEX, V17, pI161, DOI [10.1093/cercor/bhm082, 10.1093/cercor/blini082]; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Dorn SD, 2007, NEUROGASTROENT MOTIL, V19, P630, DOI 10.1111/j.1365-2982.2007.00937.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Egnew TR, 2011, FAM MED, V43, P99; Farrell SM, 2012, BIOL PSYCHIAT, V71, P538, DOI 10.1016/j.biopsych.2011.12.023; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Ford AC, 2010, ALIMENT PHARM THER, V32, P144, DOI 10.1111/j.1365-2036.2010.04328.x; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; Gordon S, 2003, DIGEST DIS SCI, V48, P1317, DOI 10.1023/A:1024159226274; Jensen KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006016; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2008, CONTEMP CLIN TRIALS, V29, P587, DOI 10.1016/j.cct.2008.02.002; Kelley JM, 2009, PSYCHOSOM MED, V71, P789, DOI 10.1097/PSY.0b013e3181acee12; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lembo T, 2001, AM J GASTROENTEROL, V96, P2662; Leuchter AF, 2009, J CLIN PSYCHOPHARM, V29, P372, DOI 10.1097/JCP.0b013e3181ac4aaf; Loggia ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027764; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Mangel AW, 1998, J INT MED RES, V26, P76, DOI 10.1177/030006059802600203; Massat I, 2011, NEUROSCI LETT, V498, P218, DOI 10.1016/j.neulet.2011.05.012; Mayer EA, 2009, FUNCTIONAL PAIN SYND, pxviii; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Miller FG, 2009, PERSPECT BIOL MED, V52, P518, DOI 10.1353/pbm.0.0115; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Patel SM, 2005, NEUROGASTROENT MOTIL, V17, P332, DOI 10.1111/j.1365-2982.2005.00650.x; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; Roussos P, 2009, BIOL PSYCHIAT, V66, P997, DOI 10.1016/j.biopsych.2009.07.008; Saito YA, 2002, AM J GASTROENTEROL, V97, P1910; Schmack K, 2008, NEUROIMAGE, V42, P1631, DOI 10.1016/j.neuroimage.2008.06.019; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Shapiro AK, 1997, POWERFUL PLACEBO ANC, Vxi; Solis-Ortiz S, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-67; Tchivileva IE, 2010, PHARMACOGENET GENOM, V20, P239, DOI 10.1097/FPC.0b013e328337f9ab; Truong TT, 2009, GASTROENTEROLOGY, V136, pA74; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Whalley B, 2008, J PSYCHOSOM RES, V64, P537, DOI 10.1016/j.jpsychores.2007.11.007; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Winterer G, 2003, BRAIN RES REV, V43, P134, DOI 10.1016/S0165-0173(03)00205-4; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x	57	134	138	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e48135	10.1371/journal.pone.0048135	http://dx.doi.org/10.1371/journal.pone.0048135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110189	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600048
J	Grundstrom, J; Reimer, JM; Magnusson, SE; Nilsson, G; Wernersson, S; Hellman, L				Grundstrom, Jeanette; Reimer, Jenny M.; Magnusson, Sofia E.; Nilsson, Gunnar; Wernersson, Sara; Hellman, Lars			Human Cord Blood Derived Immature Basophils Show Dual Characteristics, Expressing Both Basophil and Eosinophil Associated Proteins	PLOS ONE			English	Article							MAST-CELL PROTEASE-8; MAJOR BASIC-PROTEIN; MAMMALIAN EVOLUTION; SERINE PROTEASES; CHYMASE LOCUS; DIFFERENTIATION; IL-4; IDENTIFICATION; PROGENITORS; MARKER	Basophils are blood cells of low abundance associated with allergy, inflammation and parasite infections. To study the transcriptome of mature circulating basophils cells were purified from buffy coats by density gradient centrifugations and two-step magnetic cell sorting. However, after extensive analysis the cells were found to be transcriptionally inactive and almost completely lack functional mRNA. In order to obtain transcriptionally active immature basophils for analysis of their transcriptome, umbilical cord blood cells were therefore cultured in the presence of interleukin (IL)-3 for 9 days and basophils were enriched by removing non-basophils using magnetic cell sorting. The majority of purified cells demonstrated typical metachromatic staining with Alcian blue dye (95%) and expression of surface markers Fc epsilon RI and CD203c, indicating a pure population of cells with basophil-like phenotype. mRNA was extracted from these cells and used to construct a cDNA library with approximately 600 000 independent clones. This library served as tool to determine the mRNA frequencies for a number of hematopoietic marker proteins. It was shown that these cells express basophil/mast cell-specific transcripts, i.e. beta-tryptase, serglycin and Fc epsilon RI alpha-chain, to a relatively low degree. In contrast, the library contained a high number of several eosinophil-associated transcripts such as: major basic protein (MBP), charcot leyden crystal (CLC), eosinophil cationic protein (ECP), eosinophil derived neurotoxin (EDN) and eosinophil peroxidase (EPO). Out of these transcripts, MBP and EPO were the most frequently observed, representing 8% and 3.2% of the total mRNA pool, respectively. Moreover, in a proteome analysis of cultured basophils we identified MBP and EPO as the two most prominent protein bands, suggesting a good correlation between protein and mRNA analyses of these cells. The mixed phenotype observed for these cells strengthens the conclusion that eosinophils and basophils are closely linked during human hematopoietic development. The dual phenotype also indicates that other cytokines than IL-3 or cell surface interactions are needed to obtain the full basophil specific phenotype in vivo.	[Grundstrom, Jeanette; Reimer, Jenny M.; Magnusson, Sofia E.; Wernersson, Sara; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Grundstrom, Jeanette; Nilsson, Gunnar] Karolinska Inst, Dept Med, Clin Immunol & Allergy Unit, Stockholm, Sweden; [Reimer, Jenny M.; Magnusson, Sofia E.] Isconova AB, Uppsala, Sweden; [Wernersson, Sara] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Swedish University of Agricultural Sciences	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	lars.hellman@icm.uu.se	Wernersson, Sara/N-8830-2019; Wernersson, Sara/D-4580-2011	Wernersson, Sara/0000-0003-3067-7875; Wernersson, Sara/0000-0003-3067-7875; Nilsson, Gunnar/0000-0001-6795-5512	Swedish Research Council (VR-M)	Swedish Research Council (VR-M)(Swedish Research Council)	This work was supported by the Swedish Research Council (VR-M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; AROCK M, 1993, J IMMUNOL, V151, P1441; Blom T, 1996, SCAND J IMMUNOL, V44, P54, DOI 10.1046/j.1365-3083.1996.d01-84.x; BLOM T, 1992, EUR J IMMUNOL, V22, P2025, DOI 10.1002/eji.1830220811; BOYCE JA, 1995, J EXP MED, V182, P49, DOI 10.1084/jem.182.1.49; Buhring HJ, 2004, INT ARCH ALLERGY IMM, V133, P317, DOI 10.1159/000077351; Buhring HJ, 1999, BLOOD, V94, P2343; Charles N, 2009, IMMUNITY, V30, P533, DOI 10.1016/j.immuni.2009.02.008; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DENBURG JA, 1985, BLOOD, V66, P312; Ehrlich P, 1879, ARCH ANAT PHYSL, P166; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Hallgren J, 2007, IMMUNOL REV, V217, P8, DOI 10.1111/j.1600-065X.2007.00502.x; Hallgren J, 2011, ADV EXP MED BIOL, V716, P14, DOI 10.1007/978-1-4419-9533-9_2; Hellman L, 2007, BIOMED PHARMACOTHER, V61, P34, DOI 10.1016/j.biopha.2006.10.001; Jogie-Brahim S, 2004, J ALLERGY CLIN IMMUN, V113, P1086, DOI 10.1016/j.jaci.2004.02.032; Karasuyama H, 2011, TRENDS IMMUNOL, V32, P125, DOI 10.1016/j.it.2010.11.006; Karasuyama H, 2009, NAT REV IMMUNOL, V9, P9, DOI 10.1038/nri2458; Kepley CL, 1998, J LEUKOCYTE BIOL, V64, P474, DOI 10.1002/jlb.64.4.474; KEPLEY CL, 1995, J IMMUNOL, V154, P6548; Khodoun MV, 2004, J EXP MED, V200, P857, DOI 10.1084/jem.20040598; KISHI K, 1985, LEUKEMIA RES, V9, P381, DOI 10.1016/0145-2126(85)90060-8; Li HM, 1996, J IMMUNOL, V156, P4833; Lunderius C, 2001, IMMUNOGENETICS, V53, P225, DOI 10.1007/s002510100316; Lunderius C, 2000, EUR J IMMUNOL, V30, P3396, DOI 10.1002/1521-4141(2000012)30:12<3396::AID-IMMU3396>3.0.CO;2-O; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P1022, DOI 10.1002/(SICI)1521-4141(199803)28:03<1022::AID-IMMU1022>3.0.CO;2-1; MAYER P, 1989, BLOOD, V74, P613; McEuen AR, 2001, J ALLERGY CLIN IMMUN, V107, P842, DOI 10.1067/mai.2001.114650; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mitre E, 2004, J IMMUNOL, V172, P2439, DOI 10.4049/jimmunol.172.4.2439; Nakajima T, 2001, BLOOD, V98, P1127, DOI 10.1182/blood.V98.4.1127; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Ohnmacht C, 2010, J IMMUNOL, V184, P344, DOI 10.4049/jimmunol.0901841; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Plager DA, 1999, J BIOL CHEM, V274, P14464, DOI 10.1074/jbc.274.20.14464; Poorafshar M, 2000, EUR J IMMUNOL, V30, P2660, DOI 10.1002/1521-4141(200009)30:9<2660::AID-IMMU2660>3.0.CO;2-I; Reimer JM, 2006, ALLERGY, V61, P1063, DOI 10.1111/j.1398-9995.2006.01149.x; SAITO H, 1988, P NATL ACAD SCI USA, V85, P2288, DOI 10.1073/pnas.85.7.2288; Schneider E, 2010, EUR CYTOKINE NETW, V21, P142, DOI 10.1684/ecn.2010.0197; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; TAKEMORI N, 1988, AM J CLIN PATHOL, V89, P702, DOI 10.1093/ajcp/89.5.702; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; VALENT P, 1989, P NATL ACAD SCI USA, V86, P5542, DOI 10.1073/pnas.86.14.5542; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; WEIL SC, 1987, P NATL ACAD SCI USA, V84, P2057, DOI 10.1073/pnas.84.7.2057	51	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48308	10.1371/journal.pone.0048308	http://dx.doi.org/10.1371/journal.pone.0048308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118978	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000310600500098
J	Harrison, CB; Selemidis, S; Guida, E; King, PT; Sobey, CG; Drummond, GR				Harrison, Craig B.; Selemidis, Stavros; Guida, Elizabeth; King, Paul T.; Sobey, Christopher G.; Drummond, Grant R.			NOX2 beta: A Novel Splice Variant of NOX2 That Regulates NADPH Oxidase Activity in Macrophages	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY-BURST; EXPRESSION; ROS	Nox2 oxidase is one isoform in a family of seven NADPH oxidases that generate reactive oxygen species (ROS) and thereby contribute to physiological and pathological processes including host defense, redox signaling and oxidative tissue damage. While alternative mRNA splicing has been shown to influence the activity of several Nox-family proteins, functionally relevant splice variants of Nox2 have not previously been identified. We immunoscreened several mouse tissues and cells for the presence of truncated Nox2 proteins and identified a 30 kDa protein in lung, spleen and macrophages. RTPCR analysis of mRNA from primary and immortalised (RAW264.7) mouse macrophages, and from human alveolar macrophages, identified a truncated Nox2 transcript which, upon sequence analysis, was found to be a product of the 'exon skipping' mode of alternative splicing, lacking exons 4-10 of the Nox2 gene. The predicted protein is comparable in size to that identified by immunoscreening and contains two transmembrane helices and an extended cytosolic C-terminus with binding sites for NADPH and the Nox organiser protein p47phox. Importantly, selective siRNA-mediated knockdown of the transcript reduced expression of the 30 kDa protein in macrophages, and suppressed phorbol ester-stimulated ROS production by 50%. We thus provide the first evidence that Nox2 undergoes alternative mRNA splicing to yield a 30 kDa protein - herein termed Nox2 beta - that regulates NADPH oxidase activity in macrophages from mice and humans. The discovery of Nox2 beta paves the way for future examination of its role in physiological and pathological processes.	[Harrison, Craig B.; Selemidis, Stavros; Guida, Elizabeth; Sobey, Christopher G.; Drummond, Grant R.] Monash Univ, Dept Pharmacol, Vasc Biol & Immunopharmacol Grp, Clayton, Vic 3168, Australia; [King, Paul T.] Monash Med Ctr, Dept Med Resp Med, Clayton, Vic 3168, Australia	Monash University; Monash University	Selemidis, S (corresponding author), Monash Univ, Dept Pharmacol, Vasc Biol & Immunopharmacol Grp, Clayton, Vic 3168, Australia.	stavros.selemidis@monash.edu	Sobey, Christopher G/A-2786-2008	Sobey, Christopher G/0000-0001-6525-9097; Selemidis, Stavros/0000-0002-3989-7615; Drummond, Grant/0000-0001-8556-9738	National Health and Medical Research Council of Australia [606472, 1006017, 545942, 570861, 606488, 1010984]; Australian Research Council [FT120100876]; National Heart Foundation of Australia [G 09M 4398, G 10M 5218]; Cancer Council of Victoria [606674]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Heart Foundation of Australia(National Heart Foundation of Australia); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	Sources of funding included: National Health and Medical Research Council of Australia (www.nhmrc.gov.au/) for Fellowship and Project Grant Support (I.D. 606472, 1006017, 545942, 570861, 606488 and 1010984), the Australian Research Council (www.arc.gov.au) for fellowship support (FT120100876), the National Heart Foundation of Australia (www.heartfoundation.org.au/) for Grant-in-Aid support (G 09M 4398 and G 10M 5218) and the Cancer Council of Victoria (www.cancervic.org.au) for Project Grant support (606674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa N, 2006, BIOCHEM J, V398, P303, DOI 10.1042/BJ20060300; Archer SL, 1999, P NATL ACAD SCI USA, V96, P7944, DOI 10.1073/pnas.96.14.7944; Bjorgvinsdottir H, 1996, BLOOD, V87, P2005, DOI 10.1182/blood.V87.5.2005.bloodjournal8752005; Coso S, 2012, ANTIOXID REDOX SIGN, V16, P1229, DOI 10.1089/ars.2011.4489; DELEO FR, 1995, P NATL ACAD SCI USA, V92, P7110, DOI 10.1073/pnas.92.15.7110; Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Goyal P, 2005, BIOCHEM BIOPH RES CO, V329, P32, DOI 10.1016/j.bbrc.2005.01.089; Harper RW, 2005, ARCH BIOCHEM BIOPHYS, V435, P323, DOI 10.1016/j.abb.2004.12.021; Heidari Y, 2004, GENE, V335, P133, DOI 10.1016/j.gene.2004.03.019; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Li JM, 2007, FREE RADICAL BIO MED, V43, P976, DOI 10.1016/j.freeradbiomed.2007.06.001; Murdoch CE, 2011, BASIC RES CARDIOL, V106, P527, DOI 10.1007/s00395-011-0179-7; Peshavariya H, 2009, ANTIOXID REDOX SIGN, V11, P2399, DOI [10.1089/ars.2009.2579, 10.1089/ARS.2009.2579]; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Porwol T, 2001, RESP PHYSIOL, V128, P331, DOI 10.1016/S0034-5687(01)00310-3; QUIE PG, 1967, J CLIN INVEST, V46, P668, DOI 10.1172/JCI105568; Rae J, 1998, AM J HUM GENET, V62, P1320, DOI 10.1086/301874; Segal AW, 1996, MOL MED TODAY, V2, P129, DOI 10.1016/1357-4310(96)88723-5; Selemidis S, 2008, PHARMACOL THERAPEUT, V120, P254, DOI 10.1016/j.pharmthera.2008.08.005; Vlahos R, 2012, TRENDS PHARMACOL SCI, V33, P3, DOI 10.1016/j.tips.2011.09.001; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271	27	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48326	10.1371/journal.pone.0048326	http://dx.doi.org/10.1371/journal.pone.0048326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118986	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500106
J	Kiwelu, IE; Novitsky, V; Margolin, L; Baca, J; Manongi, R; Sam, N; Shao, J; McLane, MF; Kapiga, SH; Essex, M				Kiwelu, Ireen E.; Novitsky, Vladimir; Margolin, Lauren; Baca, Jeannie; Manongi, Rachel; Sam, Noel; Shao, John; McLane, Mary F.; Kapiga, Saidi H.; Essex, M.			HIV-1 Subtypes and Recombinants in Northern Tanzania: Distribution of Viral Quasispecies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DISEASE PROGRESSION; DUAL INFECTION; HOTEL WORKERS; MBEYA REGION; FEMALE BAR; IN-DEPTH; SUPERINFECTION; DIVERSITY; MULTIPLE	This study analyzed the distribution and prevalence of HIV-1 subtypes, multiplicity of HIV-1 infection, and frequency of inter-subtype recombination among HIV-1-infected female bar and hotel workers in Moshi, Kilimanjaro Region, Tanzania, from 2004 to 2007. The HIV-1 viral sequences spanning the V1-C5 region of HIV-1 env gp120 were analyzed from 50 subjects by single genome amplification and sequencing (SGA/S) technique. A total of 1740 sequences were amplified and sequenced from the HIV-1 proviral DNA template. The median env sequences analyzed per subject per two time points was 38 (IQR 28-50) over one year of HIV infection. In a subset of 14 subjects, a total of 239 sequences were obtained from HIV-1 RNA template at the baseline visit. The most prevalent HIV-1 subtypes were A1 (56%) and C (30%), while HIV-1 subtype D and inter-subtype recombinant viruses were found in 6% and 8% of subjects respectively. Transmission of multiple HIV-1 variants was evident in 27% of the subjects infected with pure HIV-1 subtypes A1, C, or D. The HIV-1 inter-subtype recombinants were found in 8% including HIV-1 C/A, D/A, and complex mosaic recombinants. Multiple viral variants were found in two subjects infected with inter-subtype recombinants. One subject harbored quasispecies of both pure HIV-1 A1 and C/A recombinant. The other subject was infected with two complex mosaic inter-subtype recombinant variants belonging to subtype D. HIV-1 multiple infections and ongoing recombination contribute significantly to the genetic diversity of circulating HIV-1 in Tanzania and have important implications for vaccine design and the development of therapeutic strategies.	[Kiwelu, Ireen E.; Manongi, Rachel; Sam, Noel; Kapiga, Saidi H.; Essex, M.] Kilimanjaro Reprod Hlth Program, Moshi, Tanzania; [Kiwelu, Ireen E.; Manongi, Rachel; Sam, Noel; Shao, John] Tumaini Univ, Kilimanjaro Christian Med Ctr & Coll, Moshi, Tanzania; [Novitsky, Vladimir; Margolin, Lauren; Baca, Jeannie; McLane, Mary F.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kapiga, Saidi H.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine	Essex, M (corresponding author), Kilimanjaro Reprod Hlth Program, Moshi, Tanzania.	messex@hsph.harvard.edu		Kapiga, Saidi/0000-0003-1753-4060	National Institutes of Health Fogarty Center AIDS International Training and Research Program [D43 TW000004]; Medical Research Council [G0901756] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER; MRC [G0901756] Funding Source: UKRI	National Institutes of Health Fogarty Center AIDS International Training and Research Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by National Institutes of Health Fogarty Center AIDS International Training and Research Program grant D43 TW000004 (IEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arroyo MA, 2004, AIDS RES HUM RETROV, V20, P895, DOI 10.1089/0889222041725235; Blish CA, 2008, J VIROL, V82, P12094, DOI 10.1128/JVI.01730-08; Butto S, 1997, AIDS, V11, P694; Casado C, 2007, J INFECT DIS, V196, P895, DOI 10.1086/520885; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; Dugan KA, 2002, J FORENSIC SCI, V47, P811; Esparza J, 2000, LANCET, V355, P2061, DOI 10.1016/S0140-6736(00)02360-6; Fang GW, 2004, AIDS, V18, P153, DOI 10.1097/00002030-200401230-00003; Gerhardt M, 2005, J VIROL, V79, P8249, DOI 10.1128/JVI.79.13.8249-8261.2005; Gottlieb GS, 2004, LANCET, V363, P619, DOI 10.1016/S0140-6736(04)15596-7; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hoelscher M, 1998, AIDS RES HUM RETROV, V14, P139, DOI 10.1089/aid.1998.14.139; Hoelscher M, 2001, AIDS, V15, P1461, DOI 10.1097/00002030-200108170-00002; HolmHansen C, 1996, APMIS, V104, P459, DOI 10.1111/j.1699-0463.1996.tb00742.x; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Kiwelu IE, 2005, AIDS RES HUM RETROV, V21, P897, DOI 10.1089/aid.2005.21.897; Kiwelu IE, 2003, AIDS RES HUM RETROV, V19, P57, DOI 10.1089/08892220360473970; Kiwelu IEE, 2000, AIDS RES HUM RETROV, V16, P1191, DOI 10.1089/088922200415054; Koelsch KK, 2003, AIDS, V17, pF11, DOI 10.1097/00002030-200305020-00001; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Koulinska IN, 2001, AIDS RES HUM RETROV, V17, P423, DOI 10.1089/088922201750102508; Kozaczynska K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-59; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kuritzkes DR, 2008, J INFECT DIS, V197, P638, DOI 10.1086/527417; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Los Alamos National Laboratory, 2012, REC ID PROGR V3 0; McCutchan FE, 2005, J VIROL, V79, P11693, DOI 10.1128/JVI.79.18.11693-11704.2005; MCKEGANEY NP, 1994, AIDS, V8, P1215, DOI 10.1097/00002030-199409000-00002; Mgalla Z, 1997, AIDS CARE, V9, P407, DOI 10.1080/713613167; Nofemela A, 2011, VIROLOGY, V415, P107, DOI 10.1016/j.virol.2010.12.027; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0; Nyombi BM, 2008, AIDS RES HUM RETROV, V24, P761, DOI 10.1089/aid.2007.0311; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Pernas M, 2006, JAIDS-J ACQ IMM DEF, V42, P12, DOI 10.1097/01.qai.0000214810.65292.73; Piantadosi A, 2008, AIDS RES HUM RETROV, V24, P1221, DOI 10.1089/aid.2008.0100; Piantadosi A, 2007, PLOS PATHOG, V3, P1745, DOI 10.1371/journal.ppat.0030177; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RAMBAUT A, 2009, FIGTREE; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; Renjifo B, 1999, AIDS, V13, P1613, DOI 10.1097/00002030-199909100-00003; Renjifo B, 1998, AIDS RES HUM RETROV, V14, P635, DOI 10.1089/aid.1998.14.635; Robbins KE, 1996, AIDS RES HUM RETROV, V12, P1389, DOI 10.1089/aid.1996.12.1389; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SIWKA W, 1994, AIDS RES HUM RETROV, V10, P1753, DOI 10.1089/aid.1994.10.1753; Smith DM, 2005, AIDS, V19, P1251, DOI 10.1097/01.aids.0000180095.12276.ac; Ssemwanga D, 2011, VIROLOGY, V411, P113, DOI 10.1016/j.virol.2010.12.025; Stanford University HIV Drug Resistance Database, 2006, REGA HIV 1 SUBT TOOL; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tebit DM, 2007, AIDS REV, V9, P75; Tovanabutra S, 2010, AIDS RES HUM RETROV, V26, P123, DOI 10.1089/aid.2009.0115; Vallari A, 2011, J VIROL, V85, P1403, DOI 10.1128/JVI.02005-10; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Yang OO, 2005, J VIROL, V79, P15368, DOI 10.1128/JVI.79.24.15368-15375.2005; Yerly S, 2004, AIDS, V18, P1413, DOI 10.1097/01.aids.0000131330.28762.0c; ZWART G, 1993, AIDS, V7, P467, DOI 10.1097/00002030-199304000-00003	73	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47605	10.1371/journal.pone.0047605	http://dx.doi.org/10.1371/journal.pone.0047605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118882	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000310600500026
J	Micale, L; Loviglio, MN; Manzoni, M; Fusco, C; Augello, B; Migliavacca, E; Cotugno, G; Monti, E; Borsani, G; Reymond, A; Merla, G				Micale, Lucia; Loviglio, Maria Nicla; Manzoni, Marta; Fusco, Carmela; Augello, Bartolomeo; Migliavacca, Eugenia; Cotugno, Grazia; Monti, Eugenio; Borsani, Giuseppe; Reymond, Alexandre; Merla, Giuseppe			A Fish-Specific Transposable Element Shapes the Repertoire of p53 Target Genes in Zebrafish	PLOS ONE			English	Article							FACTOR-BINDING-SITES; NON-GENIC SEQUENCES; DNA-DAMAGE; EVOLUTION; PROTEIN; GENOME; FAMILY; EXAPTATION; DATABASE; PATTERNS	Transposable elements, as major components of most eukaryotic organisms' genomes, define their structural organization and plasticity. They supply host genomes with functional elements, for example, binding sites of the pleiotropic master transcription factor p53 were identified in LINE1, Alu and LTR repeats in the human genome. Similarly, in this report we reveal the role of zebrafish (Danio rerio) EnSpmN6_DR non-autonomous DNA transposon in shaping the repertoire of the p53 target genes. The multiple copies of EnSpmN6_DR and their embedded p53 responsive elements drive in several instances p53-dependent transcriptional modulation of the adjacent gene, whose human orthologs were frequently previously annotated as p53 targets. These transposons define predominantly a set of target genes whose human orthologs contribute to neuronal morphogenesis, axonogenesis, synaptic transmission and the regulation of programmed cell death. Consistent with these biological functions the orthologs of the EnSpmN6_DR-colonized loci are enriched for genes expressed in the amygdala, the hippocampus and the brain cortex. Our data pinpoint a remarkable example of convergent evolution: the exaptation of lineage-specific transposons to shape p53-regulated neuronal morphogenesis-related pathways in both a hominid and a teleost fish.	[Loviglio, Maria Nicla; Migliavacca, Eugenia; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Micale, Lucia; Loviglio, Maria Nicla; Fusco, Carmela; Augello, Bartolomeo; Cotugno, Grazia; Merla, Giuseppe] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Manzoni, Marta; Monti, Eugenio; Borsani, Giuseppe] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy	University of Lausanne; IRCCS Casa Sollievo Della Sofferenza; University of Brescia	Reymond, A (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	alexandre.reymond@unil.ch; g.merla@operapadrepio.it	merla, giuseppe/K-4627-2012; Augello, Bartolomeo/B-1927-2017; Kutalik, Zoltan/HHZ-5697-2022; Fusco, Carmela/H-2964-2016; Micale, Lucia/K-3909-2016; Borsani, Giuseppe/B-1709-2010	merla, giuseppe/0000-0001-5078-928X; Augello, Bartolomeo/0000-0001-7475-6976; Kutalik, Zoltan/0000-0001-8285-7523; Fusco, Carmela/0000-0001-7794-6046; Reymond, Alexandre/0000-0003-1030-8327; Borsani, Giuseppe/0000-0003-0110-1148; MONTI, Eugenio/0000-0002-4742-7445; Micale, Lucia/0000-0003-3604-194X	Swiss National Science Foundation; SNSF Sinergia grant; Italian Ministry of Health (Ricerca Corrente); Fondazione Cariplo	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNSF Sinergia grant; Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); Fondazione Cariplo(Fondazione Cariplo)	This work was supported by the Swiss National Science Foundation and a SNSF Sinergia grant to AR, by the Italian Ministry of Health (Ricerca Corrente 20010-11) to GM and by the "Fondazione Cariplo" to E. Monti and GB. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bao W, 2008, REPBASE REPORTS, P1260; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Botti E, 2012, CELL CYCLE, V11, P648, DOI 10.4161/cc.11.4.19359; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; Caratozzolo MF, 2012, CELL CYLE IN PRESS; Casola C, 2008, MOL BIOL EVOL, V25, P29, DOI 10.1093/molbev/msm221; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conley AB, 2008, TRENDS GENET, V24, P53, DOI 10.1016/j.tig.2007.11.008; Cui F, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-2; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Emera D, 2012, MOL BIOL EVOL, V29, P239, DOI 10.1093/molbev/msr189; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Grillo G, 2003, NUCLEIC ACIDS RES, V31, P3608, DOI 10.1093/nar/gkg548; Guo L, 2010, CELL CYCLE, V9, P1998, DOI 10.4161/cc.9.10.11732; Harris CR, 2009, ONCOGENE, V28, P3857, DOI 10.1038/onc.2009.246; Harrow J, 2012, GENOME RES; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Jacobs WB, 2006, J NEUROCHEM, V97, P1571, DOI 10.1111/j.1471-4159.2006.03980.x; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee KC, 2008, ONCOGENE, V27, P629, DOI 10.1038/sj.onc.1210695; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lu WG, 2001, ONCOGENE, V20, P3206, DOI 10.1038/sj.onc.1204412; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Madden SL, 1997, ONCOGENE, V15, P1079, DOI 10.1038/sj.onc.1201091; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Menendez D, 2010, DISCOV MED, V10, P94; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Miled C, 2005, CANCER RES, V65, P5096, DOI 10.1158/0008-5472.CAN-04-4232; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Ninan I, 2010, J NEUROSCI, V30, P8866, DOI 10.1523/JNEUROSCI.1405-10.2010; Okumura F, 2010, J CELL SCI, V123, P2238, DOI 10.1242/jcs.068981; Polavarapu N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-226; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; van der Aa LM, 2012, DEV COMP IMMUNOL, V36, P433, DOI 10.1016/j.dci.2011.08.010; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Werren JH, 2011, P NATL ACAD SCI USA, V108, P10863, DOI 10.1073/pnas.1102343108; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Zhurkin V. B., 2003, Journal of Biomolecular Structure and Dynamics, V20, P858; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987	69	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e46642	10.1371/journal.pone.0046642	http://dx.doi.org/10.1371/journal.pone.0046642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118857	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500008
J	Schneider, S; Ludtke, S; Schroder-Tittmann, K; Wechsler, C; Meyer, D; Tittmann, K				Schneider, Stefan; Luedtke, Stefan; Schroeder-Tittmann, Kathrin; Wechsler, Cindy; Meyer, Danilo; Tittmann, Kai			A Delta 38 Deletion Variant of Human Transketolase as a Model of Transketolase-Like Protein 1 Exhibits No Enzymatic Activity	PLOS ONE			English	Article							DIPHOSPHATE-DEPENDENT ENZYME; YEAST TRANSKETOLASE; CIRCULAR-DICHROISM; THIAMIN CATALYSIS; UROTHELIAL CANCER; PATIENT SURVIVAL; BAKERS YEAST; TKTL1; INHIBITORS; OVEREXPRESSION	Besides transketolase (TKT), a thiamin-dependent enzyme of the pentose phosphate pathway, the human genome encodes for two closely related transketolase-like proteins, which share a high sequence identity with TKT. Transketolase-like protein 1 (TKTL1) has been implicated in cancerogenesis as its cellular expression levels were reported to directly correlate with invasion efficiency of cancer cells and patient mortality. It has been proposed that TKTL1 exerts its function by catalyzing an unusual enzymatic reaction, a hypothesis that has been the subject of recent controversy. The most striking difference between TKTL1 and TKT is a deletion of 38 consecutive amino acids in the N-terminal domain of the former, which constitute part of the active site in authentic TKT. Our structural and sequence analysis suggested that TKTL1 might not possess transketolase activity. In order to test this hypothesis in the absence of a recombinant expression system for TKTL1 and resilient data on its biochemical properties, we have engineered and biochemically characterized a "pseudo-TKTL1" Delta 38 deletion variant of human TKT (TKT Delta 38) as a viable model of TKTL1. Although the isolated protein is properly folded under in vitro conditions, both thermal stability as well as stability of the TKT-specific homodimeric assembly are markedly reduced. Circular dichroism and NMR spectroscopic analysis further indicates that TKT Delta 38 is unable to bind the thiamin cofactor in a specific manner, even at superphysiological concentrations. No transketolase activity of TKT Delta 38 can be detected for conversion of physiological sugar substrates thus arguing against an intrinsically encoded enzymatic function of TKTL1 in tumor cell metabolism.	[Tittmann, Kai] Univ Gottingen, Albrecht von Haller Inst, D-3400 Gottingen, Germany; Univ Gottingen, Dept Bioanalyt, Gottingen Ctr Mol Biosci, D-3400 Gottingen, Germany	University of Gottingen; University of Gottingen	Tittmann, K (corresponding author), Univ Gottingen, Albrecht von Haller Inst, D-3400 Gottingen, Germany.	ktittma@gwdg.de			Deutsche Forschungsgemeinschaft [FOR 1296]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been supported by the Deutsche Forschungsgemeinschaft (FOR 1296, grant to K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asztalos P, 2007, BIOCHEMISTRY-US, V46, P12037, DOI 10.1021/bi700844m; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Boros LG, 1997, CANCER RES, V57, P4242; Coy JF, 2005, CLIN LAB, V51, P257; Coy JF, 1996, GENOMICS, V32, P309, DOI 10.1006/geno.1996.0124; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; HEINRICH CP, 1971, BIOCHEM BIOPH RES CO, V44, P275, DOI 10.1016/0006-291X(71)90595-X; Heroux M, 1996, METAB BRAIN DIS, V11, P81, DOI 10.1007/BF02080933; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jordan F, 2005, BIOORG CHEM, V33, P190, DOI 10.1016/j.bioorg.2005.02.001; KOCHETOV GA, 1970, FEBS LETT, V9, P265, DOI 10.1016/0014-5793(70)80372-6; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Langbein S, 2005, ANN ONCOL, V16, P292; Le Huerou Y, 2008, BIOORG MED CHEM LETT, V18, P505, DOI 10.1016/j.bmcl.2007.11.100; Maslova AO, 2012, BIOCHEMISTRY-MOSCOW+, V77, P296, DOI 10.1134/S000629791203008X; Mayer A, 2011, ADV EXP MED BIOL, V701, P123, DOI 10.1007/978-1-4419-7756-4_17; Mayer A, 2010, INT J ONCOL, V37, P265, DOI 10.3892/ijo_00000674; Mitschke L, 2010, J BIOL CHEM, V285, P31559, DOI 10.1074/jbc.M110.149955; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; NIXON PF, 1984, EUR J CLIN INVEST, V14, P278, DOI 10.1111/j.1365-2362.1984.tb01181.x; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P1297, DOI 10.1016/S1357-2725(98)00095-8; Schenk G, 1997, J MOL EVOL, V44, P552, DOI 10.1007/PL00006179; Schmid F.X., 1997, PROTEIN STRUCTURE PR; Schneider G, 1998, BBA-PROTEIN STRUCT M, V1385, P387, DOI 10.1016/S0167-4838(98)00082-X; Singleton CK, 1996, BIOCHEMISTRY-US, V35, P15865, DOI 10.1021/bi9616920; SPRENGER GA, 1995, EUR J BIOCHEM, V230, P525; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P2206, DOI 10.1016/j.bmcl.2007.11.101; Thomas AA, 2008, BIOORG MED CHEM LETT, V18, P509, DOI 10.1016/j.bmcl.2007.11.098; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Volker HU, 2007, EUR ARCH OTO-RHINO-L, V264, P1431, DOI 10.1007/s00405-007-0394-x; Wikner C, 1997, BIOCHEMISTRY-US, V36, P15643, DOI 10.1021/bi971606b; Zerilli M, 2008, CANCER, V113, P936, DOI 10.1002/cncr.23683	32	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48321	10.1371/journal.pone.0048321	http://dx.doi.org/10.1371/journal.pone.0048321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118983	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500103
J	Zieman, SJ; Kamineni, A; Ix, JH; Barzilay, J; Djousse, L; Kizer, JR; Biggs, ML; de Boer, IH; Chonchol, M; Gottdiener, JS; Selvin, E; Newman, AB; Kuller, LH; Siscovick, DS; Mukamal, KJ				Zieman, Susan J.; Kamineni, Aruna; Ix, Joachim H.; Barzilay, Joshua; Djousse, Luc; Kizer, Jorge R.; Biggs, Mary L.; de Boer, Ian H.; Chonchol, Michel; Gottdiener, John S.; Selvin, Elizabeth; Newman, Anne B.; Kuller, Lewis H.; Siscovick, David S.; Mukamal, Kenneth J.			Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults	PLOS ONE			English	Article							CARDIOVASCULAR-HEALTH; ATHEROSCLEROSIS RISK; DIABETES-MELLITUS; CARDIAC STRUCTURE; GLYCEMIC CONTROL; DISEASE; GLYCATION; COMMUNITIES; MORTALITY; PRESSURE	Objective: Arterial and ventricular stiffening are characteristics of diabetes and aging which confer significant morbidity and mortality; advanced glycation endproducts (AGE) are implicated in this stiffening pathophysiology. We examined the association between HbA(1c), an AGE, with arterial and ventricular stiffness measures in older individuals without diabetes. Research Design & Methods: Baseline HbA(1c) was measured in 830 participants free of diabetes defined by fasting glucose or medication use in the Cardiovascular Health Study, a population-based cohort study of adults aged >= 65 years. We performed cross-sectional analyses using baseline exam data including echocardiography, ankle and brachial blood pressure measurement, and carotid ultrasonography. We examined the adjusted associations between HbA(1c) and multiple arterial and ventricular stiffness measures by linear regression models and compared these results to the association of fasting glucose (FG) with like measures. Results: HbA(1c) was correlated with fasting and 2-hour postload glucose levels (r = 0.21; p < 0.001 for both) and positively associated with greater body-mass index and black race. In adjusted models, HbA(1c) was not associated with any measure of arterial or ventricular stiffness, including pulse pressure (PP), carotid intima-media thickness, ankle-brachial index, endarterial elastance, or left ventricular mass (LVM). FG levels were positively associated with systolic, diastolic and PP and LVM. Conclusions: In this sample of older adults without diabetes, HbA(1c) was not associated with arterial or ventricular stiffness measures, whereas FG levels were. The role of AGE in arterial and ventricular stiffness in older adults may be better assessed using alternate AGE markers.	[Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Zieman, Susan J.; Selvin, Elizabeth] NIA, NIH, Bethesda, MD 20892 USA; [Kamineni, Aruna] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA; [Ix, Joachim H.] Univ Calif San Diego, Div Nephrol Hypertens, La Jolla, CA 92093 USA; [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA; [Barzilay, Joshua] Kaiser Permanente, Div Endocrinol, Tucker, GA USA; [Djousse, Luc] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Aging, Boston, MA 02115 USA; [Djousse, Luc] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Kizer, Jorge R.] Cornell Univ, Weill Med Coll, Dept Med & Publ Hlth, New York, NY 10021 USA; [Biggs, Mary L.; de Boer, Ian H.; Siscovick, David S.] Univ Washington, Dept Biostat & Med, Seattle, WA 98195 USA; [Chonchol, Michel] Univ Colorado Denver, Dept Med, Hlth Sci Ctr, Denver, CO USA; [Gottdiener, John S.] Univ Maryland, Sch Med, Div Cardiol, Baltimore, MD 21201 USA; [Selvin, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Newman, Anne B.; Kuller, Lewis H.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Kaiser Permanente; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Cornell University; University of Washington; University of Washington Seattle; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mukamal, KJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	kmukamal@bidmc.harvard.edu	Newman, Anne B./C-6408-2013; Mukamal, Kenneth/GVR-7978-2022; Djousse, Luc/F-5033-2017; de Boer, Ian/GYJ-3282-2022	Newman, Anne B./0000-0002-0106-1150; Djousse, Luc/0000-0002-9902-3047; 	National Heart, Lung, and Blood Institute (NHLBI) [R01HL094555]; NIDDK [K01DK076595]; NHLBI [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055222, N01HC045133, N01HC015103, N01HC075150, N01HC035129, N01HC085079, N01HC085086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094555, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research reported in this article was supported by grant R01HL094555 from the National Heart, Lung, and Blood Institute (NHLBI) (KM, LD, JI and JK), NIDDK grant K01DK076595 (ES) and contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295 from the NHLBI, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, DIABETES CARE, V32, P1327; Avendano GF, 1999, DIABETES, V48, P1443, DOI 10.2337/diabetes.48.7.1443; Behan Kristina Jackson, 2006, Clin Lab Sci, V19, P225; Bella JN, 2002, CIRCULATION, V105, P1928, DOI 10.1161/01.CIR.0000015076.37047.D9; Chonchol M, 2010, NUTR METAB CARDIOVAS, V20, P15, DOI 10.1016/j.numecd.2009.02.007; CUSHMAN M, 1995, CLIN CHEM, V41, P264; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gardin J M, 1992, J Am Soc Echocardiogr, V5, P63; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Kuller LH, 2000, ARTERIOSCL THROM VAS, V20, P823, DOI 10.1161/01.ATV.20.3.823; Lee M, 1997, AM HEART J, V133, P36, DOI 10.1016/S0002-8703(97)70245-X; McNeely MJ, 2009, DIABETES CARE; Mozaffarian D, 2006, AM J CARDIOL, V97, P216, DOI 10.1016/j.amjcard.2005.08.025; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; ROBBINS J, 1995, J AM GERIATR SOC, V43, P855, DOI 10.1111/j.1532-5415.1995.tb05526.x; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schram MT, 2005, HYPERTENSION, V46, P232, DOI 10.1161/01.HYP.0000164574.60279.ba; Selvin E, 2005, DIABETES CARE, V28, P1965, DOI 10.2337/diacare.28.8.1965; Selvin E, 2005, ARCH INTERN MED, V165, P1910, DOI 10.1001/archinte.165.16.1910; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Selvin E, 2006, DIABETES CARE, V29, P877, DOI 10.2337/diacare.29.04.06.dc05-2018; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; TELL GS, 1994, HYPERTENSION, V23, P59, DOI 10.1161/01.HYP.23.1.59; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29; Zieman SJ, 2004, DRUGS, V64, P459, DOI 10.2165/00003495-200464050-00001; Zieman SJ, 2007, J HYPERTENS, V25, P577, DOI 10.1097/HJH.0b013e328013e7dd	31	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47941	10.1371/journal.pone.0047941	http://dx.doi.org/10.1371/journal.pone.0047941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118911	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705600020
J	Swali, A; McMullen, S; Hayes, H; Gambling, L; McArdle, HJ; Langley-Evans, SC				Swali, Angelina; McMullen, Sarah; Hayes, Helen; Gambling, Lorraine; McArdle, Harry J.; Langley-Evans, Simon C.			Processes Underlying the Nutritional Programming of Embryonic Development by Iron Deficiency in the Rat	PLOS ONE			English	Article							LOW-PROTEIN DIETS; BLOOD-PRESSURE; MATERNAL UNDERNUTRITION; EPIGENETIC MODIFICATION; HEMOPHILIC SYNOVITIS; GENE-EXPRESSION; FETAL EXPOSURE; WEANLING RATS; PREGNANCY; RESTRICTION	Poor iron status is a global health issue, affecting two thirds of the world population to some degree. It is a particular problem among pregnant women, in both developed and developing countries. Feeding pregnant rats a diet deficient in iron is associated with both hypertension and reduced nephron endowment in adult male offspring. However, the mechanistic pathway leading from iron deficiency to fetal kidney development remains elusive. This study aimed to establish the underlying processes associated with iron deficiency by assessing gene and protein expression changes in the rat embryo, focussing on the responses occurring at the time of the nutritional insult. Analysis of microarray data showed that iron deficiency in utero resulted in the significant up-regulation of 979 genes and down-regulation of 1545 genes in male rat embryos (d13). Affected processes associated with these genes included the initiation of mitosis, BAD-mediated apoptosis, the assembly of RNA polymerase II preinitiation complexes and WNT signalling. Proteomic analyses highlighted 7 proteins demonstrating significant up-regulation with iron deficiency and the down-regulation of 11 proteins. The main functions of these key proteins included cell proliferation, protein transport and folding, cytoskeletal remodelling and the proteasome complex. In line with our recent work, which identified the perturbation of the proteasome complex as a generalised response to in utero malnutrition, we propose that iron deficiency alone leads to a more specific failure in correct protein folding and transport. Such an imbalance in this delicate quality-control system can lead to cellular dysfunction and apoptosis. Therefore these findings offer an insight into the underlying mechanisms associated with the development of the embryo during conditions of poor iron status, and its health in adult life.	[Swali, Angelina; McMullen, Sarah; Langley-Evans, Simon C.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Hayes, Helen; Gambling, Lorraine; McArdle, Harry J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	University of Nottingham; University of Aberdeen	Swali, A (corresponding author), Univ Nottingham, Sch Biosci, Loughborough, Leics, England.	angelina.swali@nottingham.ac.uk	McMullen, Sarah/H-8652-2012; Langley-Evans, Simon/AAR-4181-2020; Langley-Evans, Simon C/F-3564-2012	Langley-Evans, Simon C/0000-0002-1969-8416; Hayes, Helen/0000-0001-5186-2696; Swali, Angelina/0000-0002-6428-6373	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F005245/1]; Biotechnology and Biological Sciences Research Council [BB/F005245/1] Funding Source: researchfish; BBSRC [BB/F005245/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) (grant number BB/F005245/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Andersen HS, 2006, J NUTR, V136, P1171, DOI 10.1093/jn/136.5.1171; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 1997, BRIT MED BULL, V53, P96; Bennis-Taleb N, 1999, J NUTR, V129, P1613, DOI 10.1093/jn/129.8.1613; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Bogdarina I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009237; Breen EC, 2003, J CELL BIOCHEM, V88, P848, DOI 10.1002/jcb.10398; Chechi Kanta, 2006, Exp Clin Cardiol, V11, P129; CROWE C, 1995, J PHYSIOL-LONDON, V488, P515, DOI 10.1113/jphysiol.1995.sp020986; Dwyer CM, 1995, REPROD FERT DEVELOP, V7, P1285, DOI 10.1071/RD9951285; Franco MDP, 2002, J CARDIOVASC PHARM, V39, P369, DOI 10.1097/00005344-200203000-00008; Gaj S, 2008, GENES NUTR, V3, P153, DOI 10.1007/s12263-008-0094-1; Gambling L, 2004, J PHYSIOL-LONDON, V561, P195, DOI 10.1113/jphysiol.2004.068825; Gambling L, 2003, J PHYSIOL-LONDON, V552, P603, DOI 10.1113/jphysiol.2003.051383; Gambling L, 2009, AM J PHYSIOL-REG I, V296, pR1063, DOI 10.1152/ajpregu.90793.2008; Hakobyan N, 2004, BLOOD, V104, P2060, DOI 10.1182/blood-2003-12-4231; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; LAI AC, 1984, J NUTR SCI VITAMINOL, V30, P285, DOI 10.3177/jnsv.30.285; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; LANGLEYEVANS SC, 1994, CLIN NUTR, V13, P319, DOI 10.1016/0261-5614(94)90056-6; Lewis RM, 2001, METABOLISM, V50, P562, DOI 10.1053/meta.2001.22516; Lewis RM, 2002, BRIT J NUTR, V88, P283, DOI 10.1079/BJN2002656; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lisle SJM, 2003, BRIT J NUTR, V90, P33, DOI 10.1079/BJN2003881; Lone FW, 2004, TROP MED INT HEALTH, V9, P486, DOI 10.1111/j.1365-3156.2004.01222.x; MCARDLE HJ, 1982, J REPROD FERTIL, V66, P529; Rhinn H, 2008, ANAL BIOCHEM, V372, P116, DOI 10.1016/j.ab.2007.08.023; Roseboom T J, 2000, Ned Tijdschr Geneeskd, V144, P2488; Marin ECS, 2008, RENAL FAILURE, V30, P547, DOI 10.1080/08860220802060448; SCHOLL TO, 1992, AM J CLIN NUTR, V55, P985, DOI 10.1093/ajcn/55.5.985; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Swali A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023189; Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004; Wen FQ, 2002, BLOOD, V100, P912, DOI 10.1182/blood-2002-02-0390; Woodall SM, 1996, PEDIATR RES, V40, P438, DOI 10.1203/00006450-199609000-00012; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676	41	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48133	10.1371/journal.pone.0048133	http://dx.doi.org/10.1371/journal.pone.0048133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110188	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500039
J	Alos, J; Palmer, M; Arlinghaus, R				Alos, Josep; Palmer, Miquel; Arlinghaus, Robert			Consistent Selection towards Low Activity Phenotypes When Catchability Depends on Encounters among Human Predators and Fish	PLOS ONE			English	Article							FISHERIES-INDUCED SELECTION; HARVEST SELECTION; BEHAVIORAL TRAITS; VULNERABILITY; ECOLOGY; EVOLUTION; PERSPECTIVE; LANDSCAPE	Together with life-history and underlying physiology, the behavioural variability among fish is one of the three main trait axes that determines the vulnerability to fishing. However, there are only a few studies that have systematically investigated the strength and direction of selection acting on behavioural traits. Using in situ fish behaviour revealed by telemetry techniques as input, we developed an individual-based model (IBM) that simulated the Lagrangian trajectory of prey (fish) moving within a confined home range (HR). Fishers exhibiting various prototypical fishing styles targeted these fish in the model. We initially hypothesised that more active and more explorative individuals would be systematically removed under all fished conditions, in turn creating negative selection differentials on low activity phenotypes and maybe on small HR. Our results partly supported these general predictions. Standardised selection differentials were, on average, more negative on HR than on activity. However, in many simulation runs, positive selection pressures on HR were also identified, which resulted from the stochastic properties of the fishes' movement and its interaction with the human predator. In contrast, there was a consistent negative selection on activity under all types of fishing styles. Therefore, in situations where catchability depends on spatial encounters between human predators and fish, we would predict a consistent selection towards low activity phenotypes and have less faith in the direction of the selection on HR size. Our study is the first theoretical investigation on the direction of fishery-induced selection of behaviour using passive fishing gears. The few empirical studies where catchability of fish was measured in relation to passive fishing techniques, such as gill-nets, traps or recreational fishing, support our predictions that fish in highly exploited situations are, on average, characterised by low swimming activity, stemming, in part, from negative selection on swimming activity.	[Alos, Josep; Palmer, Miquel] IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, Esporles, Illes Balears, Spain; [Arlinghaus, Robert] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Arlinghaus, Robert] Humboldt Univ, Fac Agr & Hort, Inland Fisheries Management Lab, Berlin, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Alos, J (corresponding author), IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, Esporles, Illes Balears, Spain.	pep.alos@uib.es	Arlinghaus, Robert/E-3340-2010; Arlinghaus, Robert/J-6171-2019; Palmer, Miquel/E-3561-2013	Arlinghaus, Robert/0000-0003-2861-527X; Alos, Josep/0000-0003-4385-9539; Miquel, Palmer/0000-0002-7875-3673	research project CONFLICT [CGL2008-00958]; REC2 [CTM2011-23835]; Spanish Ministry of Economy and Competitiveness (MINECO); project ARTEVIGO [09MMA022402PR]; Galician Government, Spain; German Federal Ministry for Education and Research (BMBF) through the Program for Social-Ecological Research for the project Besatzfisch [01UU0907]	research project CONFLICT; REC2; Spanish Ministry of Economy and Competitiveness (MINECO); project ARTEVIGO; Galician Government, Spain; German Federal Ministry for Education and Research (BMBF) through the Program for Social-Ecological Research for the project Besatzfisch(Federal Ministry of Education & Research (BMBF))	This work was supported by the research project CONFLICT (grant # CGL2008-00958) and REC2 (grant # CTM2011-23835), both of them funded by the Spanish Ministry of Economy and Competitiveness (MINECO, http://www.mineco.gob.es/). Additional funding was received from the research project ARTEVIGO (grant # 09MMA022402PR) financed by the Galician Government, Spain. RA also received additional funding from the German Federal Ministry for Education and Research (BMBF) through the Program for Social-Ecological Research for the project Besatzfisch (grant # 01UU0907, www.besatz-fisch.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Alos J, 2012, MAR ECOL PROG SER, V460, P207, DOI 10.3354/meps09755; Alos J, 2011, MAR ECOL PROG SER, V427, P173, DOI 10.3354/meps09042; Arlinghaus R, 2009, EVOL APPL, V2, P335, DOI 10.1111/j.1752-4571.2009.00081.x; Arnason E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005529; Bartumeus F, 2008, EUR PHYS J-SPEC TOP, V157, P157, DOI 10.1140/epjst/e2008-00638-6; Bertrand S, 2007, ECOL APPL, V17, P331, DOI 10.1890/06-0303; Binder TR, 2012, T AM FISH SOC, V141, P1252, DOI 10.1080/00028487.2012.688919; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cooke SJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P480, DOI 10.1086/520618; Dunlop ES, 2009, EVOL APPL, V2, P371, DOI 10.1111/j.1752-4571.2009.00089.x; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; Gardiner C. W., 1990, HDB STOCHASTIC METHO; Heino M, 2002, B MAR SCI, V70, P639; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Hunt LM, 2011, ECOL APPL, V21, P2555, DOI 10.1890/10-1237.1; Huntingford FA, 2010, J FISH BIOL, V76, P1576, DOI 10.1111/j.1095-8649.2010.02582.x; Jakobsdottir KB, 2011, EVOL APPL, V4, P562, DOI 10.1111/j.1752-4571.2010.00176.x; James A, 2011, J R SOC INTERFACE, V8, P1233, DOI 10.1098/rsif.2011.0200; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kallayil JK, 2003, FISH RES, V61, P125, DOI 10.1016/S0165-7836(02)00181-9; Klefoth T, 2012, BEHAV ECOL SOCIOBIOL, V66, P547, DOI 10.1007/s00265-011-1303-2; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lokkeborg Svein, 2010, P105, DOI 10.1002/9780813810966.ch5; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; Matsumura S, 2012, BIOSCIENCE IN PRESS; Matsumura S, 2011, EVOL ECOL, V25, P711, DOI 10.1007/s10682-010-9444-8; Mehner T, 2011, EVOL ECOL, V25, P547, DOI 10.1007/s10682-011-9468-8; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Olsen EM, 2012, ECOL EVOL, V2, P1549, DOI 10.1002/ece3.244; Olsen EM, 2011, EVOL ECOL, V25, P695, DOI 10.1007/s10682-010-9427-9; Palmer M, 2011, MAR ECOL PROG SER, V430, P87, DOI 10.3354/meps09109; Parkinson EA, 2004, CAN J FISH AQUAT SCI, V61, P1658, DOI 10.1139/F04-101; Parsons DM, 2011, CAN J FISH AQUAT SCI, V68, P632, DOI 10.1139/F11-005; Philipp DP, 2009, T AM FISH SOC, V138, P189, DOI 10.1577/T06-243.1; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Redpath TD, 2010, CAN J FISH AQUAT SCI, V67, P1983, DOI 10.1139/F10-120; Redpath TD, 2009, EVOL APPL, V2, P312, DOI 10.1111/j.1752-4571.2009.00078.x; RIJNSDORP AD, 1993, OECOLOGIA, V96, P391, DOI 10.1007/BF00317510; RUDSTAM LG, 1984, CAN J FISH AQUAT SCI, V41, P1252, DOI 10.1139/f84-151; Saura M, 2010, FRESHWATER BIOL, V55, P923, DOI 10.1111/j.1365-2427.2009.02346.x; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Stenseth NC, 2009, NATURE, V457, P803, DOI 10.1038/457803a; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; Turchin Peter, 1998; Uusi-Heikkila S, 2008, TRENDS ECOL EVOL, V23, P419, DOI 10.1016/j.tree.2008.04.006; Viswanathan GM, 2010, NATURE, V465, P1018, DOI 10.1038/4651018a; Wilson ADM, 2011, CAN J FISH AQUAT SCI, V68, P749, DOI 10.1139/F2011-019	57	85	85	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48030	10.1371/journal.pone.0048030	http://dx.doi.org/10.1371/journal.pone.0048030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110164	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200139
J	Kidokoro-Kobayashi, M; Iwakura, M; Fujiwara-Tsujii, N; Fujiwara, S; Sakura, M; Sakamoto, H; Higashi, S; Hefetz, A; Ozaki, M				Kidokoro-Kobayashi, Midori; Iwakura, Misako; Fujiwara-Tsujii, Nao; Fujiwara, Shingo; Sakura, Midori; Sakamoto, Hironori; Higashi, Seigo; Hefetz, Abraham; Ozaki, Mamiko			Chemical Discrimination and Aggressiveness via Cuticular Hydrocarbons in a Supercolony-Forming Ant, Formica yessensis	PLOS ONE			English	Article							NESTMATE-RECOGNITION CUES; WASMANNIA-AUROPUNCTATA; MICROSATELLITE LOCI; CATAGLYPHIS-IBERICA; COLONY; HYMENOPTERA; ODOR; DIET	Background: Territorial boundaries between conspecific social insect colonies are maintained through nestmate recognition systems. However, in supercolony-forming ants, which have developed an extraordinary social organization style known as unicoloniality, a single supercolony extends across large geographic distance. The underlying mechanism is considered to involve less frequent occurrence of intraspecific aggressive behaviors, while maintaining interspecific competition. Thus, we examined whether the supercolony-forming species, Formica yessensis has a nestmate recognition system similar to that of the multicolonial species, Camponotus japonicus with respect to the cuticular hydrocarbon-sensitive sensillum (CHC sensillum), which responds only to non-nestmate CHCs. We further investigated whether the sensory system reflects on the apparent reduced aggression between non-nestmates typical to unicolonial species. Methodology/Principal Findings: F. yessensis constructs supercolonies comprising numerous nests and constitutes the largest supercolonies in Japan. We compared the within-colony or between-colonies' (1) similarity in CHC profiles, the nestmate recognition cues, (2) levels of the CHC sensillar response, (3) levels of aggression between workers, as correlated with geographic distances between nests, and (4) their genetic relatedness. Workers from nests within the supercolony revealed a greater similarity of CHC profiles compared to workers from colonies outside it. Total response of the active CHC sensilla stimulated with conspecific alien CHCs did not increase as much as in case of C. japonicus, suggesting that discrimination of conspecific workers at the peripheral system is limited. It was particularly limited among workers within a supercolony, but was fully expressed for allospecific workers. Conclusions/Significance: We demonstrate that chemical discrimination between nestmates and non-nestmates in F. yessensis was not clear cut, probably because this species has only subtle intraspecific differences in the CHC pattern that typify within a supercolony. Such an incomplete chemical discrimination via the CHC sensilla is thus an important factor contributing to decreased occurrence of intraspecific aggressive behavior especially within a supercolony.	[Kidokoro-Kobayashi, Midori; Sakura, Midori; Ozaki, Mamiko] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan; [Iwakura, Misako; Fujiwara, Shingo; Sakamoto, Hironori; Higashi, Seigo] Hokkaido Univ, Grad Sch Environm Sci, Course Anim Ecol, Sapporo, Hokkaido 060, Japan; [Fujiwara-Tsujii, Nao] Kyoto Inst Technol, Venture Lab, Kyoto 606, Japan; [Hefetz, Abraham] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, Tel Aviv, Israel	Kobe University; Hokkaido University; Kyoto Institute of Technology; Tel Aviv University	Ozaki, M (corresponding author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan.	mamiko@port.kobe-u.ac.jp	Hefetz, Abraham/I-3853-2015		Japan Ministry of Education, Science and Culture [17207003]; Hyogo Science and Technology Association; Research Fellow of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23657012] Funding Source: KAKEN	Japan Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association; Research Fellow of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by the Japan Ministry of Education, Science and Culture (17207003 to S. Higashi), Hyogo Science and Technology Association (to M. Ozaki), and Research Fellow of the Japan Society for the Promotion of Science.(to M. Kidokoro-Kobayashi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchinson J., 1986, STAT ANAL COMPOSITIO; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Bonavita-Cougourdan A, 1986, J ENTOMOL SCI, V22, P1; Boulay R, 2003, P ROY SOC B-BIOL SCI, V270, P971, DOI 10.1098/rspb.2002.2325; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; Brandstaetter AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021383; Brandt M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-71; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Chapuisat M, 1996, MOL ECOL, V5, P599, DOI 10.1111/j.1365-294X.1996.tb00354.x; CHERIX D, 1980, INSECT SOC, V27, P226, DOI 10.1007/BF02223666; Dahbi A, 1998, BEHAV ECOL SOCIOBIOL, V42, P349, DOI 10.1007/s002650050447; Dahbi A, 1997, PHYSIOL ENTOMOL, V22, P13, DOI 10.1111/j.1365-3032.1997.tb01135.x; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Goodwyn PP, 2009, J INSECT PHYSIOL, V55, P855, DOI 10.1016/j.jinsphys.2009.06.001; Goudet, 2001, GENETICS, V140, P1413; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Gyllenstrand N, 2002, MOL ECOL NOTES, V2, P67, DOI 10.1046/j.1471-8286.2002.00152.x; Hasegawa E, 2004, MOL ECOL NOTES, V4, P200, DOI 10.1111/j.1471-8286.2004.00614.x; HIGASHI S, 1976, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V20, P359; HIGASHI S, 1979, Japanese Journal of Ecology, V29, P257; Higashi S., 1978, Japanese Journal of Ecology, V28, P307; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Holldobler B., 1990, pi; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holzer B, 2006, J EVOLUTION BIOL, V19, P2031, DOI 10.1111/j.1420-9101.2006.01133.x; Jourdan H, 2001, SOCIOBIOLOGY, V38, P283; Knaden M, 2003, J INSECT BEHAV, V16, P717, DOI 10.1023/B:JOIR.0000007706.38674.73; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Lahav S, 2001, J CHEM ECOL, V27, P927, DOI 10.1023/A:1010382919227; Leniaud L, 2011, BIOL J LINN SOC, V104, P866, DOI 10.1111/j.1095-8312.2011.01772.x; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; PRICE WP, 1975, INSECT ECOLOGY; PROVOST E, 1993, INSECT BIOCHEM MOLEC, V23, P945, DOI 10.1016/0965-1748(93)90112-6; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Sanada-Morimura S, 2003, BEHAV ECOL, V14, P713, DOI 10.1093/beheco/arg057; Silverman J, 2001, NATURWISSENSCHAFTEN, V88, P73, DOI 10.1007/s001140000198; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Ugelvig VL, 2008, BMC BIOL, DOI [10.1186/1741-7007-6-11, DOI 10.1186/1741-7007-6-11]; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2115, DOI 10.1007/BF01207442; Vonshak M, 2010, BIOL INVASIONS, V12, P1825, DOI 10.1007/s10530-009-9593-2; Vonshak M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1667, DOI 10.1007/s00265-009-0775-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wetterer JK, 1999, AFR ENTOMOL, V7, P292	51	14	14	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e46840	10.1371/journal.pone.0046840	http://dx.doi.org/10.1371/journal.pone.0046840			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115632	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200020
J	Li, SY; Wang, YN; Xu, PF; Pu, F; Li, DY; Fan, YB; Gong, GL; Luo, YJ				Li, Shuyu; Wang, Yanan; Xu, Pengfei; Pu, Fang; Li, Deyu; Fan, Yubo; Gong, Gaolang; Luo, Yuejia			Surface Morphology of Amygdala Is Associated with Trait Anxiety	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; SHAPE-ANALYSIS; HIPPOCAMPUS; MODULATION; CHILDREN; NETWORK; FEAR; VARIABILITY; MORPHOMETRY; ACTIVATION	Previous neuroimaging studies have suggested a role of amygdala in trait anxiety level, in which amygdala was typically treated as a whole. To date, it remains unknown whether the morphology of specific subregions of amygdala are associated with trait anxiety. Here, we employed a shape analysis approach to locate the association between its morphology and trait anxiety on the surface of amygdala. 24 healthy young participants were included. The boundary of amygdala for each subject was first manually outlined using high-resolution magnetic resonance (MR) image, followed by 3D surface reconstruction and parameterization using spherical harmonic description. Two point-wise metrics, direct displacement between the individual surface and atlas surface and its normal projection, were used to quantify the surface morphology of amygdala. Statistical analysis revealed significant correlations between the two surface metrics and trait anxiety levels, which were located around the lateral and central nucleus of right amygdala. Our results provided localized information for the association between amygdala and trait anxiety, and suggested a central role of the lateral and central nucleus of right amygdala on trait anxiety.	[Xu, Pengfei; Gong, Gaolang; Luo, Yuejia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Shuyu] Beihang Univ, Sch Biol Sci & Med Engn, State Key Lab Software Dev Environm, Beijing, Peoples R China; [Li, Shuyu; Wang, Yanan; Pu, Fang; Li, Deyu; Fan, Yubo] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China	Beijing Normal University; Beihang University; Beihang University	Gong, GL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	gaolang.gong@bnu.edu.cn; luoyj@bnu.edu.cn			National Science Foundation of China [81171403, 81071212, 30700182, 31000499, 91132704]; 973 program [2013CB837300]; State Key Laboratory of Software Development Environment [SKLSDE-2011ZX-10]; Global Research Initiative Program, NIH [1R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); State Key Laboratory of Software Development Environment; Global Research Initiative Program, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the National Science Foundation of China (81171403, 81071212, 30700182, 31000499, and 91132704), the 973 program (2013CB837300), State Key Laboratory of Software Development Environment (SKLSDE-2011ZX-10), and Global Research Initiative Program, NIH (1R01TW007897).	Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Blackmon K, 2011, PSYCHIAT RES-NEUROIM, V194, P296, DOI 10.1016/j.pscychresns.2011.05.007; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; Bourne VJ, 2011, NEUROPSYCHOLOGIA, V49, P1343, DOI 10.1016/j.neuropsychologia.2011.02.008; Brechbuhler C, 1995, DESCRIPTION ANAL 3 D; Cates J, 2008, LECT NOTES COMPUT SC, V5241, P477, DOI 10.1007/978-3-540-85988-8_57; Chung MK, 2003, NEUROIMAGE, V18, P198, DOI 10.1016/S1053-8119(02)00017-4; Chung MK, 2010, NEUROIMAGE, V53, P491, DOI 10.1016/j.neuroimage.2010.06.032; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dager SR, 2007, AM J NEURORADIOL, V28, P672; DAVIDSON RA, 1992, NEUROPSYCHOLOGIA, V30, P1053, DOI 10.1016/0028-3932(92)90098-7; De Bellis MD, 2000, BIOL PSYCHIAT, V48, P51, DOI 10.1016/S0006-3223(00)00835-0; Ding JR, 2011, MAGN RESON IMAGING, V29, P701, DOI 10.1016/j.mri.2011.02.013; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Endler NS, 2001, J ANXIETY DISORD, V15, P231, DOI 10.1016/S0887-6185(01)00060-3; ENDLER NS, 1990, AUST J PSYCHOL, V42, P207, DOI 10.1080/00049539008260119; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Golland P, 2005, MED IMAGE ANAL, V9, P69, DOI 10.1016/j.media.2004.07.003; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hyde LW, 2011, NEUROPSYCHOLOGIA, V49, P651, DOI 10.1016/j.neuropsychologia.2010.08.025; Karchemskiy A, 2011, PSYCHIAT RES-NEUROIM, V194, P319, DOI 10.1016/j.pscychresns.2011.03.006; Kim HJ, 2012, NEUROIMAGE, V60, P2054, DOI 10.1016/j.neuroimage.2012.02.025; Kim JE, 2010, ARCH GEN PSYCHIAT, V67, P1187, DOI 10.1001/archgenpsychiatry.2010.148; Kim N, 2011, NEUROSCI LETT, V488, P65, DOI 10.1016/j.neulet.2010.11.005; Kronenberg G, 2009, J PSYCHIATR RES, V43, P1112, DOI 10.1016/j.jpsychires.2009.03.007; Li SY, 2010, CEREB CORTEX, V20, P25, DOI 10.1093/cercor/bhp074; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nobre MJ, 2011, BRAIN RES, V1421, P20, DOI 10.1016/j.brainres.2011.09.013; de la Mora MP, 2012, NEUROSCIENCE, V201, P252, DOI 10.1016/j.neuroscience.2011.10.045; Peterson BS, 2007, ARCH GEN PSYCHIAT, V64, P1281, DOI 10.1001/archpsyc.64.11.1281; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Posener JA, 2003, AM J PSYCHIAT, V160, P83, DOI 10.1176/appi.ajp.160.1.83; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Qiu AQ, 2008, NEUROIMAGE, V42, P1430, DOI 10.1016/j.neuroimage.2008.04.257; REY M, 1988, NEUROPSYCHOLOGIA, V26, P167, DOI 10.1016/0028-3932(88)90040-1; Schienle A, 2005, NEUROPSYCHOBIOLOGY, V51, P86, DOI 10.1159/000084165; Shen L, 2005, ALZH ASS INT C PREV; Shen L, 2006, IMAGE VISION COMPUT, V24, P743, DOI 10.1016/j.imavis.2006.01.011; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spielberger CD, 1970, CORSINI ENCY PSYCHOL; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Tamburo RJ, 2009, INT J GERIATR PSYCH, V24, P837, DOI 10.1002/gps.2167; Taylor JE, 2003, ANN PROBAB, V31, P533; Veer IM, 2011, NEUROIMAGE, V57, P1534, DOI 10.1016/j.neuroimage.2011.05.074; Vinkers CH, 2010, PHYSIOL BEHAV, V99, P395, DOI 10.1016/j.physbeh.2009.12.006; Yushkevich PA, 2009, NEUROIMAGE, V44, P385, DOI 10.1016/j.neuroimage.2008.08.042; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	51	7	7	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47817	10.1371/journal.pone.0047817	http://dx.doi.org/10.1371/journal.pone.0047817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112851	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200086
J	Pradhan, R; Shrestha, U; Gautam, SC; Thorson, S; Shrestha, K; Yadav, BK; Kelly, DF; Adhikari, N; Pollard, AJ; Murdoch, DR				Pradhan, Rahul; Shrestha, Umesh; Gautam, Samir C.; Thorson, Stephen; Shrestha, Kabindra; Yadav, Bharat K.; Kelly, Dominic F.; Adhikari, Neelam; Pollard, Andrew J.; Murdoch, David R.			Bloodstream Infection among Children Presenting to a General Hospital Outpatient Clinic in Urban Nepal	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; SEROTYPE PARATYPHI-A; INVASIVE PNEUMOCOCCAL DISEASE; MURINE TYPHUS; NALIDIXIC-ACID; BETA-LACTAMASE; REDUCED SUSCEPTIBILITY; TREATMENT FAILURE; RICKETTSIA-TYPHI; FEBRILE ILLNESS	Background: There are limited data on the etiology and characteristics of bloodstream infections in children presenting in hospital outpatient settings in South Asia. Previous studies in Nepal have highlighted the importance of murine typhus as a cause of febrile illness in adults and enteric fever as a leading bacterial cause of fever among children admitted to hospital. Methods: We prospectively studied a total of 1084 febrile children aged between 2 months and 14 years presenting to a general hospital outpatient department in Kathmandu Valley, Nepal, over two study periods (summer and winter). Blood from all patients was tested by conventional culture and by real-time PCR for Rickettsia typhi. Results: Putative etiological agents for fever were identified in 164 (15%) patients. Salmonella enterica serovar Typhi (S. Typhi) was identified in 107 (10%), S. enterica serovar Paratyphi A (S. Paratyphi) in 30 (3%), Streptococcus pneumoniae in 6 (0.6%), S. enterica serovar Typhimurium in 2 (0.2%), Haemophilus influenzae type b in 1 (0.1%), and Escherichia coli in 1 (0.1%) patient. S. Typhi was the most common organism isolated from blood during both summer and winter. Twenty-two (2%) patients were PCR positive for R. typhi. No significant demographic, clinical and laboratory features distinguished culture positive enteric fever and murine typhus. Conclusions: Salmonella infections are the leading cause of bloodstream infection among pediatric outpatients with fever in Kathmandu Valley. Extension of immunization programs against invasive bacterial disease to include the agents of enteric fever and pneumococcus could improve the health of children in Nepal.	[Pradhan, Rahul; Shrestha, Umesh; Gautam, Samir C.; Thorson, Stephen; Shrestha, Kabindra; Adhikari, Neelam] Patan Acad Hlth Sci, Dept Pediat, Pediat Res Unit, Lalitpur, Nepal; [Yadav, Bharat K.] Patan Acad Hlth Sci, Gen Practice & Emergency Med, Lalitpur, Nepal; [Kelly, Dominic F.; Pollard, Andrew J.] Univ Oxford, Dept Pediat, Oxford Vaccine Grp, Oxford OX1 2JD, England; [Kelly, Dominic F.; Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Murdoch, David R.] Canterbury Hlth Labs, Microbiol Unit, Christchurch, New Zealand	University of Oxford; University of Oxford; University of Otago; Canterbury Health Laboratories	Pradhan, R (corresponding author), Patan Acad Hlth Sci, Dept Pediat, Pediat Res Unit, Lalitpur, Nepal.	philiprahul@hotmail.com	Murdoch, David/A-2012-2009	Kelly, Dominic/0000-0002-6063-8896	University of Oxford by PneumoADIP (Pneumococcal Vaccines Accelerated Development and Introduction Plan); Hib Initiative at Johns Hopkins University; Global Alliance for Vaccine and Immunisation; Vaccine Fund	University of Oxford by PneumoADIP (Pneumococcal Vaccines Accelerated Development and Introduction Plan); Hib Initiative at Johns Hopkins University; Global Alliance for Vaccine and Immunisation; Vaccine Fund	This work was supported by a part of the grant for invasive bacterial diseases surveillance to the University of Oxford by PneumoADIP (Pneumococcal Vaccines Accelerated Development and Introduction Plan) and Hib Initiative at Johns Hopkins University. PneumoADIP and the Hib initiative are funded in full by Global Alliance for Vaccine and Immunisation and the Vaccine Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2012, J MED MICROBIOL, V61, P1032, DOI 10.1099/jmm.0.044065-0; Al Naiemi N, 2008, J CLIN MICROBIOL, V46, P2794, DOI 10.1128/JCM.00676-08; Amatya N M, 2007, JNMA J Nepal Med Assoc, V46, P112; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; Blacksell SD, 2007, T ROY SOC TROP MED H, V101, P686, DOI 10.1016/j.trstmh.2007.02.015; Clinical and Laboratory Standards Institute (CLSI), 2014, CLIN LAB STANDARDS I; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Dimitrov T, 2007, J MED MICROBIOL, V56, P277, DOI 10.1099/jmm.0.46773-0; Dolecek C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002188; Factor SH, 2001, B WORLD HEALTH ORGAN, V79, P1096; GHAFOOR A, 1990, REV INFECT DIS, V12, pS907; HALLE S, 1980, J CLIN MICROBIOL, V12, P343, DOI 10.1128/JCM.12.3.343-350.1980; Henry KM, 2007, MOL CELL PROBE, V21, P17, DOI 10.1016/j.mcp.2006.06.002; Hidalgo M, 2008, AM J TROP MED HYG, V78, P321, DOI 10.4269/ajtmh.2008.78.321; Joshi S, 2007, T ROY SOC TROP MED H, V101, P308, DOI 10.1016/j.trstmh.2006.05.009; Kadhiravan T, 2008, J MED MICROBIOL, V57, P1046, DOI 10.1099/jmm.0.47822-0; KELLY DJ, 1995, CLIN DIAGN LAB IMMUN, V2, P356, DOI 10.1128/CDLI.2.3.356-360.1995; Kelly DF, 2011, INT J INFECT DIS, V15, pE17, DOI 10.1016/j.ijid.2010.05.021; Khan MI, 2006, B WORLD HEALTH ORGAN, V84, P72, DOI 10.2471/BLT.05.023630; Krishnan P, 2009, INDIAN J PATHOL MICR, V52, P505, DOI 10.4103/0377-4929.56140; Kularatne SAM, 2003, TROP MED INT HEALTH, V8, P803, DOI 10.1046/j.1365-3156.2003.01108.x; Kumar Y, 2009, J INFECT DEV COUNTR, V3, P467, DOI 10.3855/jidc.419; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Mathai E, 2001, ANN TROP MED PARASIT, V95, P395, DOI 10.1080/00034980120065804; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Naheed A, 2010, INT J INFECT DIS, V14, pE93, DOI 10.1016/j.ijid.2009.11.023; Nizami Shaikh Qamaruddin, 2006, JPMA Journal of the Pakistan Medical Association, V56, P163; Nkemngu NJ, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-49; Nogueras MM, 2006, AM J TROP MED HYG, V74, P123, DOI 10.4269/ajtmh.2006.74.123; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Owais A, 2010, PEDIATR INFECT DIS J, V29, P1035, DOI 10.1097/INF.0b013e3181e39f8b; Owais A, 2010, TROP MED INT HEALTH, V15, P1029, DOI 10.1111/j.1365-3156.2010.02591.x; Parry CM, 2004, T ROY SOC TROP MED H, V98, P413, DOI 10.1016/j.trstmh.2003.10.014; Pfeifer Y, 2009, EMERG INFECT DIS, V15, P1533, DOI 10.3201/eid1509.090567; Pokharel BM, 2006, INT J INFECT DIS, V10, P434, DOI 10.1016/j.ijid.2006.07.001; Purcell K, 2007, EMERG INFECT DIS, V13, P926, DOI 10.3201/eid1306.061566; Renuka K, 2004, MICROB DRUG RESIST, V10, P146, DOI 10.1089/1076629041310028; Rotimi VO, 2008, J MED MICROBIOL, V57, P881, DOI 10.1099/jmm.0.47509-0; Rupali P, 2004, DIAGN MICR INFEC DIS, V49, P1, DOI 10.1016/j.diagmicrobio.2003.12.002; Saha SK, 2001, PEDIATR INFECT DIS J, V20, P521, DOI 10.1097/00006454-200105000-00010; Shalev H, 2006, SCAND J INFECT DIS, V38, P451, DOI 10.1080/00365540500540459; Sharma N, 2004, Kathmandu Univ Med J (KUMJ), V2, P188; Sharma N. K., 2007, DISTRICT PROFILE NEP; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Sur D, 2009, NEW ENGL J MED, V361, P335, DOI 10.1056/NEJMoa0807521; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; Williams EJ, 2009, CLIN INFECT DIS, V48, pS114, DOI 10.1086/596488; Woods CW, 2006, T ROY SOC TROP MED H, V100, P1063, DOI 10.1016/j.trstmh.2005.12.011; Zimmerman MD, 2008, EMERG INFECT DIS, V14, P1656, DOI 10.3201/eid1410.080236	50	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47531	10.1371/journal.pone.0047531	http://dx.doi.org/10.1371/journal.pone.0047531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115652	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200048
J	Dorjsuren, D; Kim, D; Vyjayanti, VN; Maloney, DJ; Jadhav, A; Wilson, DM; Simeonov, A				Dorjsuren, Dorjbal; Kim, Daemyung; Vyjayanti, Vaddadi N.; Maloney, David J.; Jadhav, Ajit; Wilson, David M., III; Simeonov, Anton			Diverse Small Molecule Inhibitors of Human Apurinic/Apyrimidinic Endonuclease APE1 Identified from a Screen of a Large Public Collection	PLOS ONE			English	Article							BASE EXCISION-REPAIR; ENHANCES CELLULAR-SENSITIVITY; HUMAN ABASIC ENDONUCLEASE; MAJOR HUMAN; DNA-DAMAGE; STATISTICAL PARAMETER; SITE RECOGNITION; CANCER; CONSEQUENCES; PROTEIN	The major human apurinic/apyrimidinic endonuclease APE1 plays a pivotal role in the repair of base damage via participation in the DNA base excision repair (BER) pathway. Increased activity of APE1, often observed in tumor cells, is thought to contribute to resistance to various anticancer drugs, whereas down-regulation of APE1 sensitizes cells to DNA damaging agents. Thus, inhibiting APE1 repair endonuclease function in cancer cells is considered a promising strategy to overcome therapeutic agent resistance. Despite ongoing efforts, inhibitors of APE1 with adequate drug-like properties have yet to be discovered. Using a kinetic fluorescence assay, we conducted a fully-automated high-throughput screen (HTS) of the NIH Molecular Libraries Small Molecule Repository (MLSMR), as well as additional public collections, with each compound tested as a 7-concentration series in a 4 mu L reaction volume. Actives identified from the screen were subjected to a panel of confirmatory and counterscreen tests. Several active molecules were identified that inhibited APE1 in two independent assay formats and exhibited potentiation of the genotoxic effect of methyl methanesulfonate with a concomitant increase in AP sites, a hallmark of intracellular APE1 inhibition; a number of these chemotypes could be good starting points for further medicinal chemistry optimization. To our knowledge, this represents the largest-scale HTS to identify inhibitors of APE1, and provides a key first step in the development of novel agents targeting BER for cancer treatment.	[Vyjayanti, Vaddadi N.; Wilson, David M., III] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Dorjsuren, Dorjbal; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton] NIH, NIH Chem Genom Ctr, Natl Ctr Adv Translat Sci, Bethesda, MD USA; [Vyjayanti, Vaddadi N.] Cheongju Univ, Dept Gen Engn, Cheongju, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Cheongju University	Wilson, DM (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	wilsonda@mail.nih.gov; asimeono@mail.nih.gov	Wilson, David M/AAK-5409-2021	Wilson, David M/0000-0002-8945-0395; Jadhav, Ajit/0000-0001-7955-1451	Molecular Libraries Initiative of the National Institutes of Health (NIH) Roadmap for Medical Research [1 R03 MH092154-01, U54MH084681]; Intramural Research Program of NIA, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000750] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health (NIH) Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NIA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Molecular Libraries Initiative of the National Institutes of Health (NIH) Roadmap for Medical Research (grants 1 R03 MH092154-01 (DMWIII) and U54MH084681 (AS)) and the Intramural Research Program of NIA, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Auparakkitanon S, 2006, ANTIMICROB AGENTS CH, V50, P2197, DOI 10.1128/AAC.00119-06; Bapat A, 2010, J PHARMACOL EXP THER, V334, P988, DOI 10.1124/jpet.110.169128; Bapat A, 2009, ANTIOXID REDOX SIGN, V11, P651, DOI [10.1089/ars.2008.2218, 10.1089/ARS.2008.2218]; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fortini P, 2003, BIOCHIMIE, V85, P1053, DOI 10.1016/j.biochi.2003.11.003; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Heyduk T, 2002, NAT BIOTECHNOL, V20, P171, DOI 10.1038/nbt0202-171; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Hong H, 1998, ANTIVIR CHEM CHEMOTH, V9, P461, DOI 10.1177/095632029800900602; Hwang JS, 2010, BIOORG MED CHEM LETT, V20, P3785, DOI 10.1016/j.bmcl.2010.04.054; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jadhav A, 2010, J MED CHEM, V53, P37, DOI 10.1021/jm901070c; Karran P, 2003, BIOCHIMIE, V85, P1149, DOI 10.1016/j.biochi.2003.10.007; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; Lea WA, 2011, EXPERT OPIN DRUG DIS, V6, P17, DOI 10.1517/17460441.2011.537322; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; McNeill DR, 2007, MOL CANCER RES, V5, P61, DOI 10.1158/1541-7786.MCR-06-0329; McNeill DR, 2009, MOL CANCER RES, V7, P897, DOI 10.1158/1541-7786.MCR-08-0519; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; Naidu MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023679; Powell SN, 2009, DNA REPAIR, V8, P1153, DOI 10.1016/j.dnarep.2009.04.011; Rai G, 2012, J MED CHEM, V55, P3101, DOI 10.1021/jm201537d; Rishton GM, 1997, DRUG DISCOV TODAY, V2, P382, DOI 10.1016/S1359-6446(97)01083-0; Roberts G, 2000, J CHEM INF COMP SCI, V40, P1302, DOI 10.1021/ci0000631; Screpanti E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011603; Seiple LA, 2008, MOL PHARMACOL, V73, P669, DOI 10.1124/mol.107.042622; Sharma RA, 2007, MOL ASPECTS MED, V28, P345, DOI 10.1016/j.mam.2007.06.002; Shimozono N, 2004, Patent No. [WO/2003/074501, 2003074501]; Simeonov A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005740; Sultana R, 2012, INT J CANC IN PRESS; Sun WY, 2006, BIOORG MED CHEM LETT, V16, P1468, DOI 10.1016/j.bmcl.2005.12.057; Walensky L. D., 2011, PCT Int. Pat. Appl., Patent No. [WO/2011/094708, 2011094708, WO 2011094708]; Wang L, 2011, SCIENCE, V333, P765, DOI 10.1126/science.1201662; Wilson DM, 2010, CELL MOL LIFE SCI, V67, P3621, DOI 10.1007/s00018-010-0488-2; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wilson DM, 2005, J MOL BIOL, V345, P1003, DOI 10.1016/j.jmb.2004.11.028; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Xia GY, 2011, J MED CHEM, V54, P2409, DOI 10.1021/jm101549k; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004; Zawahir Z, 2009, J MED CHEM, V52, P20, DOI 10.1021/jm800739m; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	54	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47974	10.1371/journal.pone.0047974	http://dx.doi.org/10.1371/journal.pone.0047974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110144	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600041
J	Swaidani, S; Cheng, G; Lauer, ME; Sharma, M; Mikecz, K; Hascall, VC; Aronica, MA				Swaidani, Shadi; Cheng, Georgiana; Lauer, Mark E.; Sharma, Manisha; Mikecz, Katalin; Hascall, Vincent C.; Aronica, Mark A.			TSG-6 Protein Is Crucial for the Development of Pulmonary Hyaluronan Deposition, Eosinophilia, and Airway Hyperresponsiveness in a Murine Model of Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; FACTOR-STIMULATED GENE-6; EXTRACELLULAR-MATRIX; LINK MODULE; LUNG INJURY; INFLAMMATION; MOUSE; GLYCOSAMINOGLYCANS; EXPRESSION; CHALLENGE	Hyaluronan (HA) deposition is often correlated with mucosal inflammatory responses, where HA mediates both protective and pathological responses. By modifying the HA matrix, Tnfip6 (TNF-alpha-induced protein-6; also known as TSG-6 (TNF-stimulated gene-6)) is thought to potentiate anti-inflammatory and anti-plasmin effects that are inhibitory to leukocyte extravasation. In this study, we examined the role of endogenous TSG-6 in the pathophysiological responses associated with acute allergic pulmonary inflammation. Compared with wildtype littermate controls, TSG-6(-/-) mice exhibited attenuated inflammation marked by a significant decrease in pulmonary HA concentrations measured in the bronchoalveolar lavage and lung tissue. Interestingly, despite the equivalent induction of both humoral and cellular Th2 immunity and the comparable levels of cytokines and chemokines typically associated with eosinophilic pulmonary inflammation, airway eosinophilia was significantly decreased in TSG-6(-/-) mice. Most importantly, contrary to their counterpart wild-type littermates, TSG-6(-/-) mice were resistant to the induction of airway hyperresponsiveness and manifested improved lung mechanics in response to methacholine challenge. Our study demonstrates that endogenous TSG-6 is dispensable for the induction of Th2 immunity but is essential for the robust increase in pulmonary HA deposition, propagation of acute eosinophilic pulmonary inflammation, and development of airway hyperresponsiveness. Thus, TSG-6 is implicated in the experimental murine model of allergic pulmonary inflammation and is likely to contribute to the pathogenesis of asthma.	[Swaidani, Shadi; Cheng, Georgiana; Sharma, Manisha; Aronica, Mark A.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Swaidani, Shadi] Cleveland Clin, Dept Immunol, Lerner Res Inst, Cleveland, OH 44195 USA; [Lauer, Mark E.; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; [Aronica, Mark A.] Cleveland Clin, Resp Inst, Cleveland, OH 44195 USA; [Mikecz, Katalin] Rush Univ, Med Ctr, Sect Mol Med, Dept Orthoped Surg, Chicago, IL 60612 USA; [Mikecz, Katalin] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Rush University; Rush University	Aronica, MA (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	aronicm@ccf.org		Mikecz, Katalin/0000-0003-1506-4296; Swaidani, Shadi/0000-0003-1506-4472	National Institutes of Health from NIAID [AI067816]; National Institutes of Health from NHLBI [HL081064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103453, P01HL081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067816] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI067816 from NIAID (to M. A. A.) and Grant HL081064 from NHLBI (to V. C. H. and M.A.A.).	Aronica MA, 1999, J IMMUNOL, V163, P5116; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Burgess JK, 2009, PHARMACOL THERAPEUT, V122, P19, DOI 10.1016/j.pharmthera.2008.12.002; Cantor JO, 1999, CONNECT TISSUE RES, V40, P97, DOI 10.3109/03008209909029105; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Culley FJ, 2003, EUR J IMMUNOL, V33, P1302, DOI 10.1002/eji.200323509; DARIUS H, 1994, EUR J PHARMACOL, V258, P207, DOI 10.1016/0014-2999(94)90482-0; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fuchs B, 2008, CURR DRUG TARGETS, V9, P495, DOI 10.2174/138945008784533589; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Herrerias A, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-30; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Honda K, 2003, J EXP MED, V198, P533, DOI 10.1084/jem.20022218; Irvin CG, 2003, RESPIR RES, V4, DOI 10.1186/rr199; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2010, ANAT REC, V293, P982, DOI 10.1002/ar.21102; Kahmann JD, 2000, STRUCTURE, V8, P763, DOI 10.1016/S0969-2126(00)00163-5; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kumar RK, 2008, CURR DRUG TARGETS, V9, P485, DOI 10.2174/138945008784533561; LAITINEN A, 1994, ALLERGY PROC, V15, P323, DOI 10.2500/108854194778816436; Lauer ME, 2013, J BIOL CHEM, V288, P423, DOI 10.1074/jbc.M112.389882; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lilly CM, 2005, AM J RESP CRIT CARE, V171, P579, DOI 10.1164/rccm.200404-532OC; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Monzon ME, 2006, AM J RESP CELL MOL, V34, P135, DOI 10.1165/rcmb.2005-0256OC; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Negrini D, 2008, INTENS CARE MED, V34, P610, DOI 10.1007/s00134-007-0962-y; NEY P, 1991, EICOSANOIDS, V4, P21; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Papakonstantinou E, 2009, BRIT J PHARMACOL, V157, P1111, DOI 10.1111/j.1476-5381.2009.00279.x; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Pettipher R, 2008, BRIT J PHARMACOL, V153, pS191, DOI 10.1038/sj.bjp.0707488; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; SAHU S, 1978, BIOCHEM J, V173, P565, DOI 10.1042/bj1730565; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Spik I, 2005, J IMMUNOL, V174, P3703, DOI 10.4049/jimmunol.174.6.3703; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; Wisniewski HG, 1996, J IMMUNOL, V156, P1609	59	45	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					412	422		10.1074/jbc.M112.389874	http://dx.doi.org/10.1074/jbc.M112.389874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23118230	hybrid, Green Published			2022-12-25	WOS:000313197200042
J	Cao, H; Li, LP; Zhang, MZ				Cao, He; Li, Liping; Zhang, Mingzhi			Epidemiology of Patients Hospitalized for Ocular Trauma in the Chaoshan Region of China, 2001-2010	PLOS ONE			English	Article							EYE INJURY; OPEN-GLOBE; RISK-FACTORS; UNITED-STATES; POPULATION; SINGAPORE; PREVALENCE; TRENDS	Background: The burden and pattern of ocular trauma in China are poorly known and not well studied. We aimed at studying the epidemiological characteristics of patients hospitalized for ocular trauma at major ophthalmology departments in the largest industrial base of plastic toys in China. Methods: A retrospective study of ocular trauma cases admitted to 3 tertiary hospitals in China from 1st January 2001 to 31st December 2010 was performed. Results: The study included a total of 3,644 injured eyes from 3,559 patients over the 10-year period: 2,008 (55.1%) openg-lobe injuries, 1,580 (43.4%) closed-globe injuries, 41 (1.1%) chemical injuries, 15 (0.4%) thermal injuries and 678 (18.6%) ocular adnexal injuries. The mean age of the patients was 29.0 +/- 16.8 years with a male-to-female ratio of 5.2:1 (P=0.007). The most frequent types of injury were work-related injuries (1,656, 46.5%) and home-related injuries (715, 20.1%). The majority of injuries in males (56.2%) and females (36.0%) occurred in the 15-44 age group and 0-14 age group, respectively. The final visual acuity correlated with the initial visual acuity (Spearman's correlation coefficient = 0.659; P<0.001). The Ocular Trauma Score also correlated with the final visual acuity (Spearman's correlation coefficient = 0.655; P<0.001). Conclusions: This analysis provides an epidemiological study of patients who were hospitalized for ocular trauma. Preventive efforts are important for both work-related and home-related eye injuries.	[Cao, He; Li, Liping] Shantou Univ, Coll Med, Injury Prevent Res Ctr, Shantou, Guangdong, Peoples R China; [Zhang, Mingzhi] Joint Shantou Int Eye Ctr, Shantou, Guangdong, Peoples R China	Shantou University	Li, LP (corresponding author), Shantou Univ, Coll Med, Injury Prevent Res Ctr, Shantou, Guangdong, Peoples R China.	lpli@stu.edu.cn						Altintas L, 2011, ULUS TRAVMA ACIL CER, V17, P334, DOI 10.5505/tjtes.2011.78861; Augsberger J, 2008, GEN OPHTHALMOLOGY; Bhogal G, 2007, J PUBLIC HEALTH, V29, P72, DOI 10.1093/pubmed/fdl074; Blackburn J, 2012, J OCCUP ENVIRON MED, V54, P42, DOI 10.1097/JOM.0b013e3182398e1a; BLOMDAHL S, 1984, ACTA OPHTHALMOL, V62, P378; Brophy M, 2006, PEDIATRICS, V117, pE1263, DOI 10.1542/peds.2005-1950; Chang CH, 2008, GRAEF ARCH CLIN EXP, V246, P223, DOI 10.1007/s00417-007-0733-z; Chua D, 2011, OPHTHAL EPIDEMIOL, V18, P281, DOI 10.3109/09286586.2011.628775; Cillino S, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-6; Desai P, 1996, BRIT J OPHTHALMOL, V80, P592, DOI 10.1136/bjo.80.7.592; El-Mekawey HE, 2011, CLIN OPHTHALMOL, V5, P955, DOI 10.2147/OPTH.S21761; Han SB, 2010, J TRAUMA, V69, pE66, DOI 10.1097/TA.0b013e3181cc8461; Hossain M M, 2011, Mymensingh Med J, V20, P377; Jafari Alireza Keshtkar, 2010, International Ophthalmology, V30, P691, DOI 10.1007/s10792-010-9401-0; Kanoff JM, 2010, AM J OPHTHALMOL, V150, P265, DOI 10.1016/j.ajo.2010.02.015; Khatry SK, 2004, BRIT J OPHTHALMOL, V88, P456, DOI 10.1136/bjo.2003.030700; Kim JH, 2007, J TRAUMA, V62, P746, DOI 10.1097/01.ta.0000231557.58471.e3; KLOPFER J, 1992, ARCH OPHTHALMOL-CHIC, V110, P838, DOI 10.1001/archopht.1992.01080180110037; Kuhn F, 2004, J FR OPHTALMOL, V27, P206, DOI 10.1016/S0181-5512(04)96122-0; Kuhn F, 1996, OPHTHALMOLOGY, V103, P240; Kuhn Ferenc, 2002, Ophthalmol Clin North Am, V15, P163, DOI 10.1016/S0896-1549(02)00007-X; Loon SC, 2009, CLIN EXP OPHTHALMOL, V37, P362, DOI 10.1111/j.1442-9071.2009.02035.x; Macdonald ECA, 2009, BRIT J OPHTHALMOL, V93, P1177, DOI 10.1136/bjo.2008.154831; Maneschg OA, 2011, KLIN MONATSBL AUGENH, V228, P801, DOI 10.1055/s-0029-1245756; Mansouri M, 2009, RETINA, V29, P114; McCarty CA, 1999, OPHTHALMOLOGY, V106, P1847, DOI 10.1016/S0161-6420(99)90361-5; McGwin G, 2006, INVEST OPHTH VIS SCI, V47, P521, DOI 10.1167/iovs.05-0909; McGwin G, 2005, ARCH OPHTHALMOL-CHIC, V123, P970, DOI 10.1001/archopht.123.7.970; McGwin G, 2005, ARCH OPHTHALMOL-CHIC, V123, P662, DOI 10.1001/archopht.123.5.662; Mela EK, 2005, OPHTHAL EPIDEMIOL, V12, P185, DOI 10.1080/09286580590964801; Mieler W, 2001, PRINCIPLES PRACTICE, V2, P5179; Negrel A D, 1998, Ophthalmic Epidemiol, V5, P143, DOI 10.1076/opep.5.3.143.8364; Nordberg E, 2000, E AFR MED J, V77, pS1; Ojabo C O, 2011, Niger J Med, V20, P114; Onakpoya OH, 2010, OPHTHAL EPIDEMIOL, V17, P315, DOI 10.3109/09286586.2010.508352; Owens PL, 2011, HEALTHCARE COST UTIL; Pandita A, 2012, NEW ZEAL MED J, V125, P61; Rao LG, 2010, INDIAN J OPHTHALMOL, V58, P321, DOI 10.4103/0301-4738.64116; Raymond S, 2010, CLIN EXP OPHTHALMOL, V38, P566, DOI 10.1111/j.1442-9071.2010.02296.x; Rofail M, 2006, CLIN EXP OPHTHALMOL, V34, P783, DOI 10.1111/j.1442-9071.2006.01309.x; Saeed A, 2010, INJURY, V41, P86, DOI 10.1016/j.injury.2009.01.118; Shah M, 2008, GRAEF ARCH CLIN EXP, V246, P191, DOI 10.1007/s00417-007-0698-y; Smith ARE, 2006, CLIN EXP OPHTHALMOL, V34, P252, DOI 10.1111/j.1442-9071.2006.01200.x; Soliman MM, 2008, GRAEF ARCH CLIN EXP, V246, P205, DOI 10.1007/s00417-007-0720-4; Soylu Merih, 2010, International Ophthalmology, V30, P143, DOI 10.1007/s10792-009-9300-4; TIELSCH JM, 1989, ARCH OPHTHALMOL-CHIC, V107, P519, DOI 10.1001/archopht.1989.01070010533025; Tomazzoli L, 2003, EUR J OPHTHALMOL, V13, P710, DOI 10.1177/112067210301300808; Vats S, 2008, INDIAN J OPHTHALMOL, V56, P313; Woo JH, 2006, ANN ACAD MED SINGAP, V35, P706	49	40	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48377	10.1371/journal.pone.0048377	http://dx.doi.org/10.1371/journal.pone.0048377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118997	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500117
J	Kaplan, GG; Szyszkowicz, M; Fichna, J; Rowe, BH; Porada, E; Vincent, R; Madsen, K; Ghosh, S; Storr, M				Kaplan, Gilaad G.; Szyszkowicz, Mieczyslaw; Fichna, Jakub; Rowe, Brian H.; Porada, Eugeniusz; Vincent, Renaud; Madsen, Karen; Ghosh, Subrata; Storr, Martin			Non-Specific Abdominal Pain and Air Pollution: A Novel Association	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; URBAN PARTICULATE MATTER; IRRITABLE-BOWEL-SYNDROME; GENDER-DIFFERENCES; CASE-CROSSOVER; DISEASE; HEALTH; MICE; CARE; INFLAMMATION	Background: We studied whether short-term exposure to air pollution was associated with non-specific abdominal pain in epidemiologic and animal studies. Methods: Patients visiting the emergency department with non-specific abdominal pain were identified in Edmonton (1992 to 2002, n = 95,173) and Montreal (1997 to 2002, n = 25,852). We calculated the daily concentrations for ozone (O-3), nitrogen dioxide (NO2), sulfur dioxide (SO2), carbon monoxide (CO), and particles < 10 (PM10) or < 2.5 (PM2.5) mu m. A case crossover study design was used to estimate the odds ratio (OR) and 95% confidence interval (CI) associated with an increase in the interquartile range of the air pollutants. We investigated differential effects by age and sex. Mice were gavaged with urban particle extracts. In animal models, colonic motility was tested, and visceral abdominal pain was measured using a writhing test, and behavioral response to oil of mustard and neostigmine. Motility and pain was measured acutely (1.5 hours after gavage) and chronically (7-days and 21-days after gavage). Results: Emergency department visits for non-specific abdominal pain were primarily by women between the ages of 15-24 years. Individuals aged 15 to 24 years were at increased risk of non-specific abdominal pain in Edmonton (same day CO: OR = 1.04, 95% CI = 1.02-1.06; and NO2: OR = 1.06, 95% CI = 1.03-1.09). The risk of air pollution among 15-24 year olds in Montreal was significantly positive (same day CO: OR = 1.11, 95% CI = 1.05-1.17; NO2: OR = 1.09, 95% CI = 1.01-1.16; SO2: OR = 1.17, 95% CI = 1.10-1.25; PM2.5: OR = 1.09, 95% CI = 1.04-1.15). Abdominal pain was increased by an acute gavage of pollution extract but not to chronic exposure to pollutants. Colonic transit was delayed following chronic but not acute exposure with the pollutants. Conclusions: Epidemiological and animal data suggest that short-term exposure to air pollution may trigger non-specific abdominal pain in young individuals.	[Porada, Eugeniusz; Vincent, Renaud] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Madsen, Karen] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB, Canada; [Kaplan, Gilaad G.; Ghosh, Subrata; Storr, Martin] Univ Calgary, Dept Med, Calgary, AB, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Storr, Martin] Univ Munich, Dept Med, Munich, Germany; [Fichna, Jakub] Med Univ Lodz, Dept Biomol Chem, Lodz, Poland	Health Canada; University of Calgary; University of Calgary; University of Alberta; University of Alberta; University of Munich; Medical University Lodz	Szyszkowicz, M (corresponding author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	mietek.szyszkowicz@hc-sc.gc.ca	Ghosh, Subrata/AAC-2676-2021; Szyszkowicz, Mieczysław/N-2490-2019; Madsen, Karen L/H-5898-2011; Kaplan, Gil/AAH-2335-2021; Fichna, Jakub/S-6641-2016	Ghosh, Subrata/0000-0002-1713-7797; Kaplan, Gil/0000-0003-2719-0556; Fichna, Jakub/0000-0002-8443-4417; Vincent, Renaud/0000-0002-5223-9174; Szyszkowicz, Mieczyslaw/0000-0001-7022-3267	Health Canada; Alberta IBD Consortium; Tier I Century Canada Research Chair in Evidence-Based Emergency Medicine from the Canadian Institutes for health Research through the Government of Canada (Ottawa, Ontario)	Health Canada; Alberta IBD Consortium; Tier I Century Canada Research Chair in Evidence-Based Emergency Medicine from the Canadian Institutes for health Research through the Government of Canada (Ottawa, Ontario)	Funding was provided by Health Canada and The Alberta IBD Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Gilaad Kaplan is a Canadian Institutes of Health Research New Investigator and a Population Health Investigator from Alberta-Innovates Health Solutions. Dr. Rowe's research is supported by a Tier I Century Canada Research Chair in Evidence-Based Emergency Medicine from the Canadian Institutes for health Research through the Government of Canada (Ottawa, Ontario).	Bartra J, 2007, J INVEST ALLERG CLIN, V17, P3; Beamish LA, 2011, J CROHNS COLITIS, V5, P279, DOI 10.1016/j.crohns.2011.02.017; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Decadt B, 1999, BRIT J SURG, V86, P1383, DOI 10.1046/j.1365-2168.1999.01239.x; DOSHI M, 1994, BRIT J SURG, V81, P1216, DOI 10.1002/bjs.1800810848; Dubinsky MC, 2002, AM J GASTROENTEROL, V97, P2333; Dybdahl M, 2003, CARCINOGENESIS, V24, P1759, DOI 10.1093/carcin/bgg147; Eijkelkamp N, 2007, AM J PHYSIOL-GASTR L, V293, pG749, DOI 10.1152/ajpgi.00114.2007; Fichna J, 2010, REGUL PEPTIDES, V162, P109, DOI 10.1016/j.regpep.2010.01.001; Gach K, 2010, PEPTIDES, V31, P1617, DOI 10.1016/j.peptides.2010.04.018; GORHAM ED, 1989, CAN J PUBLIC HEALTH, V80, P96; Guthery SL, 2004, J PEDIATR-US, V144, P589, DOI 10.1016/j.jpeds.2004.02.029; Heitkemper MM, 2008, NUTR CLIN PRACT, V23, P275, DOI 10.1177/0884533608318672; JESS P, 1982, AM J SURG, V144, P338, DOI 10.1016/0002-9610(82)90015-0; Kaplan GG, 2010, AM J GASTROENTEROL; Kaplan GG, 2009, CAN MED ASSOC J, V181, P591, DOI 10.1503/cmaj.082068; Kish L, 2011, GASTROENTEROLOGY, V140, pS46; Ladwig KH, 2000, EUR J EPIDEMIOL, V16, P511, DOI 10.1023/A:1007629920752; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; Last JA, 2005, TOXICOL APPL PHARM, V208, P117, DOI 10.1016/j.taap.2005.02.001; LIPPMANN M, 1980, BRIT J IND MED, V37, P337; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; LUKENS TW, 1993, ANN EMERG MED, V22, P690, DOI 10.1016/S0196-0644(05)81849-9; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; NAWAR EW, 2007, ADV DATA, V386, P1; OBYRNE JM, 1991, IRISH J MED SCI, V160, P344, DOI 10.1007/BF02957891; RAHEJA SK, 1990, J ROY SOC MED, V83, P10, DOI 10.1177/014107689008300106; ROTH RP, 1972, JAPCA J AIR WASTE MA, V22, P706, DOI 10.1080/00022470.1972.10469703; Sajani SZ, 2010, J EXPO SCI ENV EPIDE; Sanders DS, 2006, ANN ROY COLL SURG, V88, P92, DOI 10.1308/003588406x85751; Sanders DS, 2005, ANN SURG, V242, P201, DOI 10.1097/01.sla.0000171301.35513.cf; SHERIDAN WG, 1992, ANN ROY COLL SURG, V74, P181; Stieb DM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-25; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Thomson EM, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-6; Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC; Villeneuve PJ, 2006, EUR J EPIDEMIOL, V21, P689, DOI 10.1007/s10654-006-9050-9; Vincent R, 2001, Res Rep Health Eff Inst, P5; VINCENT R, 2001, RES REP HLTH EFF I, P55; Zemek R, 2010, ENVIRON HEALTH PERSP, V118, P1631, DOI 10.1289/ehp.0901675	41	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47669	10.1371/journal.pone.0047669	http://dx.doi.org/10.1371/journal.pone.0047669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118887	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500030
J	Lehallier, B; Rampin, O; Saint-Albin, A; Jerome, N; Ouali, C; Maurin, Y; Bonny, JM				Lehallier, Benoist; Rampin, Olivier; Saint-Albin, Audrey; Jerome, Nathalie; Ouali, Christian; Maurin, Yves; Bonny, Jean-Marie			Brain Processing of Biologically Relevant Odors in the Awake Rat, as Revealed by Manganese-Enhanced MRI	PLOS ONE			English	Article							OLFACTORY-BULB; PIRIFORM CORTEX; FOS EXPRESSION; IN-VIVO; ACTIVATION; PATHWAYS; PATTERNS; SYSTEM; MEMRI; REPRESENTATIONS	Background: So far, an overall view of olfactory structures activated by natural biologically relevant odors in the awake rat is not available. Manganese-enhanced MRI (MEMRI) is appropriate for this purpose. While MEMRI has been used for anatomical labeling of olfactory pathways, functional imaging analyses have not yet been performed beyond the olfactory bulb. Here, we have used MEMRI for functional imaging of rat central olfactory structures and for comparing activation maps obtained with odors conveying different biological messages. Methodology/Principal Findings: Odors of male fox feces and of chocolate flavored cereals were used to stimulate conscious rats previously treated by intranasal instillation of manganese (Mn). MEMRI activation maps showed Mn enhancement all along the primary olfactory cortex. Mn enhancement elicited by male fox feces odor and to a lesser extent that elicited by chocolate odor, differed from that elicited by deodorized air. This result was partly confirmed by c-Fos immunohistochemistry in the piriform cortex. Conclusion/Significance: By providing an overall image of brain structures activated in awake rats by odorous stimulation, and by showing that Mn enhancement is differently sensitive to different stimulating odors, the present results demonstrate the interest of MEMRI for functional studies of olfaction in the primary olfactory cortex of laboratory small animals, under conditions close to natural perception. Finally, the factors that may cause the variability of the MEMRI signal in response to different odor are discussed.	[Lehallier, Benoist; Bonny, Jean-Marie] INRA, QuaPA UR370, F-63122 St Genes Champanelle, France; [Rampin, Olivier; Saint-Albin, Audrey; Jerome, Nathalie; Ouali, Christian; Maurin, Yves] INRA, NOeMI UR1197, Jouy En Josas, France	INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bonny, JM (corresponding author), INRA, QuaPA UR370, F-63122 St Genes Champanelle, France.	jean-marie.bonny@clermont.inra.fr						Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Chen W, 2009, BEHAV BRAIN RES, V201, P8, DOI 10.1016/j.bbr.2009.01.019; Chuang KH, 2010, NEUROIMAGE, V49, P1350, DOI 10.1016/j.neuroimage.2009.09.060; Chuang KH, 2009, MAGN RESON IMAGING, V27, P594, DOI 10.1016/j.mri.2008.10.006; Chuang KH, 2009, MAGN RESON MED, V61, P1528, DOI 10.1002/mrm.21962; Chuang KH, 2009, NEUROIMAGE, V44, P363, DOI 10.1016/j.neuroimage.2008.08.046; Cross DJ, 2004, NEUROIMAGE, V23, P1326, DOI 10.1016/j.neuroimage.2004.07.038; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Datiche F, 2001, BRAIN RES BULL, V55, P95, DOI 10.1016/S0361-9230(01)00499-3; De Groof G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014337; Febo M, 2011, BRAIN RES, V1382, P118, DOI 10.1016/j.brainres.2010.11.092; Febo M, 2009, BRAIN RES, V1302, P183, DOI 10.1016/j.brainres.2009.09.043; Ferris CF, 2006, J NEUROENDOCRINOL, V18, P307, DOI 10.1111/j.1365-2826.2006.01424.x; Forster S, 2010, J ALZHEIMERS DIS, V22, P581, DOI 10.3233/JAD-2010-091549; Funk D, 2000, NEUROSCIENCE, V98, P403, DOI 10.1016/S0306-4522(00)00217-7; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; Huang W, 2011, NEUROSCI LETT, V489, P74, DOI 10.1016/j.neulet.2010.11.069; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Johnson BA, 2010, J COMP NEUROL, V518, P1542, DOI 10.1002/cne.22289; Kulkarni P, 2012, BEHAV BRAIN RES, V230, P201, DOI 10.1016/j.bbr.2012.02.002; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lehallier B, 2012, MAGN RESON IMAGING, V30, P62, DOI 10.1016/j.mri.2011.08.009; Lehallier B, 2011, MAGN RESON IMAGING, V29, P1304, DOI 10.1016/j.mri.2011.07.014; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Martin C, 2007, NEUROIMAGE, V38, P1, DOI 10.1016/j.neuroimage.2007.04.022; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Nordhoy W, 2004, MAGN RESON MED, V52, P506, DOI 10.1002/mrm.20199; OGAWA S, 1990, MAGNET RESON MED, V16, P9, DOI 10.1002/mrm.1910160103; Pautler RG, 2002, NEUROIMAGE, V16, P441, DOI 10.1006/nimg.2002.1075; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Petzold GC, 2008, NEURON, V58, P897, DOI 10.1016/j.neuron.2008.04.029; Qureshy A, 2000, J NEUROPHYSIOL, V84, P1656, DOI 10.1152/jn.2000.84.3.1656; Rampin O, 2012, EUR J NEUROSCI, V35, P97, DOI 10.1111/j.1460-9568.2011.07940.x; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Savic I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008651; Schepkin VD, 2010, MAGN RESON IMAGING, V28, P400, DOI 10.1016/j.mri.2009.10.002; Schroeder BE, 2001, NEUROSCIENCE, V105, P535, DOI 10.1016/S0306-4522(01)00221-4; Schwarz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008974; SHARP FR, 1977, J NEUROPHYSIOL, V40, P800, DOI 10.1152/jn.1977.40.4.800; Shulman RG, 1999, P NATL ACAD SCI USA, V96, P3245, DOI 10.1073/pnas.96.6.3245; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Van der Linden A, 2007, NMR BIOMED, V20, P522, DOI 10.1002/nbm.1131; VERNETMA.E, 1968, CR ACAD SCI D NAT, V267, P331; Wilson DA, 2011, NEURON, V72, P506, DOI 10.1016/j.neuron.2011.10.027; Woo CC, 2007, CHEM SENSES, V32, P51, DOI 10.1093/chemse/bjl035; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	54	13	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48491	10.1371/journal.pone.0048491	http://dx.doi.org/10.1371/journal.pone.0048491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119035	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500150
J	Li, SC; Martijn, C; Cui, T; Essaghir, A; Luque, RM; Demoulin, JB; Castano, JP; Oberg, K; Giandomenico, V				Li, Su-Chen; Martijn, Cecile; Cui, Tao; Essaghir, Ahmed; Luque, Raul M.; Demoulin, Jean-Baptiste; Castano, Justo P.; Oberg, Kjell; Giandomenico, Valeria			The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells	PLOS ONE			English	Article							ONCOLYTIC ADENOVIRUS; GENE-EXPRESSION; DOWN-REGULATION; ANNEXIN A1; CANCER; PROTEIN; RECEPTORS; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION	Octreotide is a widely used synthetic somatostatin analogue that significantly improves the management of neuroendocrine tumours (NETs). Octreotide acts through somatostatin receptors (SSTRs). However, the molecular mechanisms leading to successful disease control or symptom management, especially when SSTRs levels are low, are largely unknown. We provide novel insights into how octreotide controls NET cells. CNDT2.5 cells were treated from 1 day up to 16 months with octreotide and then were profiled using Affymetrix microarray analysis. Quantitative real-time PCR and western blot analyses were used to validate microarray profiling in silico data. WST-1 cell proliferation assay was applied to evaluate cell growth of CNDT2.5 cells in the presence or absence of 1 mM octreotide at different time points. Moreover, laser capture microdissected tumour cells and paraffin embedded tissue slides from SI-NETs at different stages of disease were used to identify transcriptional and translational expression. Microarrays analyses did not reveal relevant changes in SSTR expression levels. Unexpectedly, six novel genes were found to be upregulated by octreotide: annexin A1 (ANXA1), rho GTPase-activating protein 18 (ARHGAP18), epithelial membrane protein 1 (EMP1), growth/differentiation factor 15 (GDF15), TGF-beta type II receptor (TGFBR2) and tumour necrosis factor (ligand) superfamily member 15 (TNFSF15). Furthermore, these novel genes were expressed in tumour tissues at transcript and protein levels. We suggest that octreotide may use a potential novel framework to exert its beneficial effect as a drug and to convey its action on neuroendocrine cells. Thus, six novel genes may regulate cell growth and differentiation in normal and tumour neuroendocrine cells and have a role in a novel octreotide mechanism system.	[Li, Su-Chen; Cui, Tao; Oberg, Kjell; Giandomenico, Valeria] Uppsala Univ, Dept Med Sci, Sci Life Lab, Uppsala, Sweden; [Martijn, Cecile] Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care, Sci Life Lab, Uppsala, Sweden; [Essaghir, Ahmed; Demoulin, Jean-Baptiste] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Luque, Raul M.; Castano, Justo P.] Univ Cordoba, Hosp Univ Reina Sofia, Dept Cell Biol Physiol & Immunol, Inst Maimonides Invest Biomed IMIBIC, Cordoba, Spain; [Luque, Raul M.; Castano, Justo P.] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Cordoba, Spain; [Oberg, Kjell] Univ Uppsala Hosp, Ctr Excellence Endocrine Tumours, Uppsala, Sweden	Uppsala University; Uppsala University; Universite Catholique Louvain; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Uppsala University; Uppsala University Hospital	Giandomenico, V (corresponding author), Uppsala Univ, Dept Med Sci, Sci Life Lab, Uppsala, Sweden.	valeria.giandomenico@medsci.uu.se	Oberg, Kjell/AAG-7118-2019; Castaño, Justo P/A-7124-2010; Raul, Luque Huertas/M-6948-2018	Castaño, Justo P/0000-0002-3145-7287; Luque, Raul M./0000-0002-7585-1913; Demoulin, Jean-Baptiste/0000-0002-8016-6689	Lions Cancerforskningsfond; Tore Nilssons Stiftelse for Medicinsk Forskning and Erik; Karin och Gosta Selander Stiftelse; Ministerio de Ciencia e Innovacion, Spain [RYC-2007-00186/BFU2008-01136-BFI, BFU2010-19300]; Junta de Andalucia, Spain [BIO-0139/CTS-5051]	Lions Cancerforskningsfond; Tore Nilssons Stiftelse for Medicinsk Forskning and Erik; Karin och Gosta Selander Stiftelse; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission)	This work was supported by funding from the Lions Cancerforskningsfond, Tore Nilssons Stiftelse for Medicinsk Forskning and Erik, Karin och Gosta Selander Stiftelse and by grants RYC-2007-00186/BFU2008-01136-BFI, BFU2010-19300 (Ministerio de Ciencia e Innovacion, Spain) and BIO-0139/CTS-5051 (Junta de Andalucia, Spain). CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander VM, 2010, INT J CLIN EXP MED, V3, P95; Arnold R, 2000, DIGESTION, V62, P84, DOI 10.1159/000051861; Bellam N, 2010, CANCER TREAT RES, V155, P85, DOI 10.1007/978-1-4419-6033-7_5; Boudreaux JP, 2010, PANCREAS, V39, P753, DOI 10.1097/MPA.0b013e3181ebb2a5; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Chua YJ, 2010, J CLIN ONCOL, V28, pE41, DOI 10.1200/JCO.2009.26.0612; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Cui T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016010; Culler MD, 2011, CANCER METAST REV, V30, P9, DOI 10.1007/s10555-011-9293-0; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; De Martino MC, 2010, PROG BRAIN RES, V182, P255, DOI 10.1016/S0079-6123(10)82011-4; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Gustafsson BI, 2008, CURR OPIN ONCOL, V20, P1, DOI 10.1097/CCO.0b013e3282f1c595; Hofland LJ, 2003, ENDOCR REV, V24, P28, DOI 10.1210/er.2000-0001; Hruban RH, 2010, WHO CLASSIFICATION T, V4; Hur GY, 2007, EXP MOL MED, V39, P367, DOI 10.1038/emm.2007.41; Jain A, 2005, P NATL ACAD SCI USA, V102, P11858, DOI 10.1073/pnas.0502113102; Joshi JP, 2011, BIOCHEM PHARMACOL, V82, P1090, DOI 10.1016/j.bcp.2011.07.082; KAKU M, 1980, GANN, V71, P596; Kidd M, 2008, CANCER-AM CANCER SOC, V112, P1404, DOI 10.1002/cncr.23303; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Kulke MH, 2011, J CLIN ONCOL, V29, P934, DOI 10.1200/JCO.2010.33.2056; Leja J, 2011, GENE THER, V18, P1052, DOI 10.1038/gt.2011.54; Leja J, 2007, CLIN CANCER RES, V13, P2455, DOI 10.1158/1078-0432.CCR-06-2532; Leja J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008916; Leu FP, 2008, MOL CANCER RES, V6, P1029, DOI 10.1158/1541-7786.MCR-07-2073; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; Martinez-Alonso M, 2009, J INT MED RES, V37, P1813, DOI 10.1177/147323000903700617; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Modlin IM, 2006, J CLIN ENDOCR METAB, V91, P2340, DOI 10.1210/jc.2006-0110; Msaouel P, 2009, EXPERT OPIN INV DRUG, V18, P1297, DOI 10.1517/13543780903176399; Oberg KE, 2010, ANN ONCOL, V21, P72, DOI 10.1093/annonc/mdq290; Oberg KE, 2011, CLIN ONCOL-UK, V6, P49; Oberg KE, 2010, GASTROENTEROLOGY, V139, P742, DOI 10.1053/j.gastro.2010.07.002; Oberg KE, 2009, J CLIN ONCOL, V27, P4635, DOI 10.1200/JCO.2009.23.6711; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Petrella A, 2006, CANCER BIOL THER, V5, P643, DOI 10.4161/cbt.5.6.2700; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Rodrigo JP, 2011, HUM PATHOL, V42, P88, DOI 10.1016/j.humpath.2010.05.017; Saeed AI, 2006, METHODS ENZYMOL, V411, P134; Schreiber TH, 2011, ADV EXP MED BIOL, V691, P289, DOI 10.1007/978-1-4419-6612-4_30; Sethi G, 2009, ADV EXP MED BIOL, V647, P207, DOI 10.1007/978-0-387-89520-8_15; Sideris L, 2012, ONCOLOGIST, V17, P747, DOI 10.1634/theoncologist.2011-0458; Staff AC, 2010, GYNECOL ONCOL, V118, P237, DOI 10.1016/j.ygyno.2010.05.032; Strosberg J, 2010, WORLD J GASTROENTERO, V16, P2963, DOI 10.3748/wjg.v16.i24.2963; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Van Buren G, 2007, CLIN CANCER RES, V13, P4704, DOI 10.1158/1078-0432.CCR-06-2723; Vikman S, 2005, ACTA ONCOL, V44, P32, DOI 10.1080/02841860510007404; Walter T, 2011, NEUROENDOCRINOLOGY, V94, P200, DOI 10.1159/000328134; Wimmel A, 2003, GUT, V52, P1308, DOI 10.1136/gut.52.9.1308; Wu SV, 2011, ENDOCRINOLOGY, V152, P126, DOI 10.1210/en.2010-0997; You B, 2011, J CLIN PHARM; Zhang J, 2011, J CLIN PATHOL, V64, P25, DOI 10.1136/jcp.2010.082404; Zinovyeva MV, 2010, DIS ESOPHAGUS, V23, P260, DOI 10.1111/j.1442-2050.2009.01008.x	57	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48411	10.1371/journal.pone.0048411	http://dx.doi.org/10.1371/journal.pone.0048411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119007	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500127
J	Montgomery, P; Ryus, CR; Dolan, CS; Dopson, S; Scott, LM				Montgomery, Paul; Ryus, Caitlin R.; Dolan, Catherine S.; Dopson, Sue; Scott, Linda M.			Sanitary Pad Interventions for Girls' Education in Ghana: A Pilot Study	PLOS ONE			English	Article								Background: Increased education of girls in developing contexts is associated with a number of important positive health, social, and economic outcomes for a community. The event of menarche tends to coincide with girls' transitions from primary to secondary education and may constitute a barrier for continued school attendance and performance. Following the MRC Framework for Complex Interventions, a pilot controlled study was conducted in Ghana to assess the role of sanitary pads in girls' education. Methods: A sample of 120 schoolgirls between the ages of 12 and 18 from four villages in Ghana participated in a non-randomized trial of sanitary pad provision with education. The trial had three levels of treatment: provision of pads with puberty education; puberty education alone; or control (no pads or education). The primary outcome was school attendance. Results: After 3 months, providing pads with education significantly improved attendance among participants, (lambda 0.824, F = 3.760, p<.001). After 5 months, puberty education alone improved attendance to a similar level (M = 91.26, SD = 7.82) as sites where pads were provided with puberty education (Rural M=89.74, SD = 9.34; Periurban M=90.54, SD = 17.37), all of which were higher than control (M = 84.48, SD = 12.39). The total improvement through pads with education intervention after 5 months was a 9% increase in attendance. After 3 months, providing pads with education significantly improved attendance among participants. The changes in attendance at the end of the trial, after 5 months, were found to be significant by site over time. With puberty education alone resulting in a similar attendance level. Conclusion: This pilot study demonstrated promising results of a low-cost, rapid-return intervention for girls' education in a developing context. Given the considerable development needs of poorer countries and the potential of young women there, these results suggest that a large-scale cluster randomized trial is warranted.	[Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Oxford, Oxon, England; [Ryus, Caitlin R.; Dolan, Catherine S.; Dopson, Sue; Scott, Linda M.] Univ Oxford, Said Business Sch, Oxford, Oxon, England	University of Oxford; University of Oxford	Montgomery, P (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford, Oxon, England.	paul.montgomery@spi.ox.ac.uk	Ryus, Caitlin/AAJ-5207-2021	Dolan, catherine/0000-0003-3939-6607; Ryus, Caitlin/0000-0001-5526-030X	Templeton College at Oxford University; John Fell Fund at Oxford University; Green Templeton College - at Oxford University	Templeton College at Oxford University; John Fell Fund at Oxford University; Green Templeton College - at Oxford University	The study was funded by Templeton College, the John Fell Fund and Green Templeton College - all at Oxford University. Pads were supplied by Proctor and Gamble. No supporter of the study had any influence over the publication of any results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire S, 2007, OXF DEV STUD, V35, P347, DOI 10.1080/13600810701701863; Bollen KA, 2002, POP STUD-J DEMOG, V56, P81, DOI 10.1080/00324720213796; Buckley T, 1988, BLOOD MAGIC THE ANTH; Burrows A, 2005, J REPROD INFANT PSYC, V23, P235, DOI 10.1080/02646830500165846; CARE, 2010, POWER WITHIN; Commonwealth Secretariat and Healthlink Worldwide, 2001, GENDER AND RELATIONS; Craig P, 2008, BMJ, V337; Dasgupta A, 2008, Indian J Community Med, V33, P77, DOI 10.4103/0970-0218.40872; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Dolan C, MENSTRUATION SANITAR; Kirk J, 2006, MENSTRUATION AND BOD; Lloyd CB, 2009, NEW LESSONS THE POWE; Mahon T., 2010, Gender and Development, V18, P99, DOI 10.1080/13552071003600083; McGregor JA, 2009, STUDIES IOD; Plan International, 2009, BECAUSE I AM A GIRL; Sen A.K., 1999, DEV FREEDOM; Sommer M, 2009, J ADOLESCENCE, V30, P1; Ten V. T. A., 2007, MENSTRUAL HYGIENE A; United Nations, 2004, WORLD POPULATION MON	20	77	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48274	10.1371/journal.pone.0048274	http://dx.doi.org/10.1371/journal.pone.0048274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WJ	23118968	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500087
J	Sweeney-Reed, CM; Riddell, PM; Ellis, JA; Freeman, JE; Nasuto, SJ				Sweeney-Reed, Catherine M.; Riddell, Patricia M.; Ellis, Judi A.; Freeman, Jayne E.; Nasuto, Slawomir J.			Neural Correlates of True and False Memory in Mild Cognitive Impairment	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; ALZHEIMERS-DISEASE; WORKING-MEMORY; EPISODIC MEMORY; RECOGNITION MEMORY; EEG SYNCHRONIZATION; PHASE SYNCHRONIZATION; OLDER-ADULTS; ALPHA OSCILLATIONS; HILBERT SPECTRUM	The goal of this research was to investigate the changes in neural processing in mild cognitive impairment. We measured phase synchrony, amplitudes, and event-related potentials in veridical and false memory to determine whether these differed in participants with mild cognitive impairment compared with typical, age-matched controls. Empirical mode decomposition phase locking analysis was used to assess synchrony, which is the first time this analysis technique has been applied in a complex cognitive task such as memory processing. The technique allowed assessment of changes in frontal and parietal cortex connectivity over time during a memory task, without a priori selection of frequency ranges, which has been shown previously to influence synchrony detection. Phase synchrony differed significantly in its timing and degree between participant groups in the theta and alpha frequency ranges. Timing differences suggested greater dependence on gist memory in the presence of mild cognitive impairment. The group with mild cognitive impairment had significantly more frontal theta phase locking than the controls in the absence of a significant behavioural difference in the task, providing new evidence for compensatory processing in the former group. Both groups showed greater frontal phase locking during false than true memory, suggesting increased searching when no actual memory trace was found. Significant inter-group differences in frontal alpha phase locking provided support for a role for lower and upper alpha oscillations in memory processing. Finally, fronto-parietal interaction was significantly reduced in the group with mild cognitive impairment, supporting the notion that mild cognitive impairment could represent an early stage in Alzheimer's disease, which has been described as a 'disconnection syndrome'.	[Sweeney-Reed, Catherine M.] Otto von Guericke Univ, Fac Med, Univ Clin Neurol & Stereotact Neurosurg, Memory & Consciousness Res Grp, Magdeburg, Germany; [Riddell, Patricia M.; Ellis, Judi A.; Freeman, Jayne E.] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Sweeney-Reed, Catherine M.; Nasuto, Slawomir J.] Univ Reading, Sch Syst Engn, Cybernet Res Grp, Reading, Berks, England	Otto von Guericke University; University of Reading; University of Reading	Sweeney-Reed, CM (corresponding author), Otto von Guericke Univ, Fac Med, Univ Clin Neurol & Stereotact Neurosurg, Memory & Consciousness Res Grp, Magdeburg, Germany.	Catherine.Sweeney-Reed@med.ovgu.de	Riddell, Patricia/S-3724-2019	Sweeney-Reed, Catherine/0000-0002-3684-1245; Nasuto, Slawomir/0000-0001-9414-9049; Riddell, Patricia/0000-0002-4916-2057	Economic and Social Research Council(E.R.S.C.) [RES-474-25-0014]; Economic and Social Research Council [RES-474-25-0014] Funding Source: researchfish	Economic and Social Research Council(E.R.S.C.); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Economic and Social Research Council(E.R.S.C.) http://www.esrc.ac.uk/. Dr. P.M. Riddell, RES-474-25-0014): funding for the EEG recording equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Albert MS, 1997, BRAIN COGNITION, V35, P284; Andrade AO, 2008, INFORM SCIENCES, V178, P2176, DOI 10.1016/j.ins.2007.12.013; ANDRADE AO, 2003, NOVEL SPECTRAL REPRE, V25, P2598; [Anonymous], 1998, U S FLORIDA WORD ASS; Atkinson R.C., 1974, CONT DEV MATH PSYCHO; Babiloni C, 2004, EUR J NEUROSCI, V19, P2583, DOI 10.1111/j.0953-816X.2004.03333.x; Babiloni C, 2004, NEUROIMAGE, V21, P1576, DOI 10.1016/j.neuroimage.2003.11.023; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1000, DOI 10.1016/j.clinph.2005.12.028; Baddeley A, 1998, J INT NEUROPSYCH SOC, V4, P523, DOI 10.1017/S135561779800513X; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Balocchi R, 2004, CHAOS SOLITON FRACT, V20, P171, DOI 10.1016/S0960-0779(03)00441-7; Balota DA, 1999, COGNITIVE NEUROPSYCH, V16, P361, DOI 10.1080/026432999380834; Bartlett F.C., 1932, REMEMBERING STUDY EX; Belanger S, 2010, NEUROPSYCHOLOGIA, V48, P581, DOI 10.1016/j.neuropsychologia.2009.10.021; Bennett IJ, 2006, J CLIN EXP NEUROPSYC, V28, P1408, DOI 10.1080/13803390500409583; Brainerd CJ, 1998, J EXP CHILD PSYCHOL, V71, P81, DOI 10.1006/jecp.1998.2464; Bruns A, 2004, J NEUROSCI METH, V137, P321, DOI 10.1016/j.jneumeth.2004.03.002; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Budson AE, 2000, NEUROPSYCHOLOGY, V14, P277, DOI 10.1037//0894-4105.14.2.277; Budson AE, 2002, BRAIN, V125, P2750, DOI 10.1093/brain/awf277; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chan SCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040215; Christman SD, 2004, BRAIN COGNITION, V56, P313, DOI 10.1016/j.bandc.2004.08.005; Clark CR, 2001, INT J PSYCHOPHYSIOL, V42, P161, DOI 10.1016/S0167-8760(01)00164-7; Curran T, 2001, J COGNITIVE NEUROSCI, V13, P201, DOI 10.1162/089892901564261; Dauwels J, 2010, CURR ALZHEIMER RES, V7, P487, DOI 10.2174/156720510792231720; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Duzel E, 2005, NEUROIMAGE, V25, P690, DOI 10.1016/j.neuroimage.2004.11.038; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Fabiani M, 2000, J COGNITIVE NEUROSCI, V12, P941, DOI 10.1162/08989290051137486; FARGE M, 1992, ANNU REV FLUID MECH, V24, P395, DOI 10.1146/annurev.fl.24.010192.002143; FASANO G, 1987, MON NOT R ASTRON SOC, V225, P155, DOI 10.1093/mnras/225.1.155; Fell J, 2003, EUR J NEUROSCI, V17, P1082, DOI 10.1046/j.1460-9568.2003.02522.x; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fernandez G, 1999, SCIENCE, V285, P1582, DOI 10.1126/science.285.5433.1582; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Frodl T, 2002, PSYCHOPHYSIOLOGY, V39, P175, DOI 10.1017/S0048577201392077; Gallo DA, 2006, NEUROPSYCHOLOGY, V20, P625, DOI 10.1037/0894-4105.20.6.625; Ganushchak LY, 2009, PSYCHOPHYSIOLOGY, V46, P410, DOI 10.1111/j.1469-8986.2008.00774.x; Geng HY, 2007, BRAIN RES, V1136, P154, DOI 10.1016/j.brainres.2006.12.027; Gevins A, 1995, ELECTROENCEPHALOGR C, V97, P850; Ghassemi F, 2010, NEUROPHYSIOLOGY, V42; Ginter J, 2001, J NEUROSCI METH, V110, P113, DOI 10.1016/S0165-0270(01)00424-1; GoldmanRakic P, 1997, NATURE, V386, P559, DOI 10.1038/386559a0; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gonsalves B, 2000, NAT NEUROSCI, V3, P1316, DOI 10.1038/81851; Greenaway MC, 2006, COGN BEHAV NEUROL, V19, P79, DOI 10.1097/01.wnn.0000208290.57370.a3; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Grinsted A., 2004, CROSS WAVELET WAVELE; Gross J, 2005, NEUROIMAGE, P26; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; HAXBY JV, 1988, NEUROLOGY, V38, P1853, DOI 10.1212/WNL.38.12.1853; Hogan MJ, 2003, INT J PSYCHOPHYSIOL, V49, P147, DOI 10.1016/S0167-8760(03)00118-1; Holmes JB, 1998, J EXP PSYCHOL LEARN, V24, P1026, DOI 10.1037/0278-7393.24.4.1026; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang NE, 2003, ANAL TIME SERIES USI; Hudon C, 2006, NEUROPSYCHOLOGY, V20, P566, DOI 10.1037/0894-4105.20.5.566; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; Jiang Zheng-yan, 2005, J Zhejiang Univ Sci B, V6, P1213, DOI 10.1631/jzus.2005.B1213; Jiang Zheng-yan, 2006, J Zhejiang Univ Sci B, V7, P357, DOI 10.1631/jzus.2006.B0357; Jiang Zheng-yan, 2005, J Zhejiang Univ Sci B, V6, P259, DOI 10.1007/BF02842462; Johnson MK, 1997, PSYCHOL SCI, V8, P250, DOI 10.1111/j.1467-9280.1997.tb00421.x; Karrasch M, 2005, ACTA NEUROL SCAND, V111, P172, DOI 10.1111/j.1600-0404.2005.00380.x; Klimesch W, 2005, EXP PSYCHOL, V52, P99, DOI 10.1027/1618-3169.52.2.99; Klimesch W, 2003, BEHAV BRAIN SCI, V26, P743, DOI 10.1017/S0140525X03370165; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2001, NEUROSCI LETT, V302, P49, DOI 10.1016/S0304-3940(01)01656-1; Klimesch W, 1995, MEMORY PROCESSING DE, V95; Knyazeva MG, 2010, NEUROBIOL AGING, V31, P1132, DOI 10.1016/j.neurobiolaging.2008.07.019; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Koutstaal W, 1997, J MEM LANG, V37, P555, DOI 10.1006/jmla.1997.2529; Kramer MA, 2007, INT J NEURAL SYST, V17, P61, DOI 10.1142/S0129065707000932; Lachaux JP, 2000, INT J BIFURCAT CHAOS, V10, P2429, DOI 10.1142/S0218127400001560; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Leo M, 2010, LECT NOTES ARTIF INT, V5998, P219, DOI 10.1007/978-3-642-12159-3_20; Liang H, 2000, MED BIOL ENG COMPUT, V38, P35, DOI 10.1007/BF02344686; Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892; Locatelli T, 1998, ELECTROEN CLIN NEURO, V106, P229, DOI 10.1016/S0013-4694(97)00129-6; Lowry R., 1998, VASSARSTATS WEB SITE; Magrin-Chagnolleau I., 1999, 69 ANN INT M SEG, P1949, DOI DOI 10.1190/1.1820932; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Mandzia J, 2002, BRAIN COGNITION, V49, P225, DOI 10.1006/brcg.2001.1472; McKeown MJ, 2005, I IEEE EMBS C NEUR E, P679; Meinecke FC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.084102; MOLGEDEY L, 1994, PHYS REV LETT, V72, P3634, DOI 10.1103/PhysRevLett.72.3634; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MOUNTJOY CQ, 1983, NEUROBIOL AGING, V4, P1, DOI 10.1016/0197-4580(83)90048-9; Myers LJ, 2004, P ANN INT IEEE EMBS, V26, P4669; Naghavi HR, 2005, CONSCIOUS COGN, V14, P390, DOI 10.1016/j.concog.2004.10.003; Nessler D, 2001, COGNITIVE BRAIN RES, V10, P283, DOI 10.1016/S0926-6410(00)00049-5; Nicolaou N, 2007, J VLSI SIGNAL PROCES; Norman KA, 1997, MEM COGNITION, V25, P838, DOI 10.3758/BF03211328; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Nyberg L, 1996, P NATL ACAD SCI USA, V93, P11280, DOI 10.1073/pnas.93.20.11280; Parkin AJ, 1996, BRAIN COGNITION, V32, P14, DOI 10.1006/brcg.1996.0055; PEACOCK JA, 1983, MON NOT R ASTRON SOC, V202, P615, DOI 10.1093/mnras/202.3.615; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Phillips S, 2009, INT J PSYCHOPHYSIOL, V73, P350, DOI 10.1016/j.ijpsycho.2009.05.011; Pierce BH, 2005, NEUROPSYCHOLOGY, V19, P411, DOI 10.1037/0894-4105.19.4.411; Pigorini A, 2011, J NEUROSCI METH, V198, P236, DOI 10.1016/j.jneumeth.2011.04.013; Pijnenburg YAL, 2004, CLIN NEUROPHYSIOL, V115, P1332, DOI 10.1016/j.clinph.2003.12.029; Pogarell O, 2005, J NEUROL NEUROSUR PS, V76, P109, DOI 10.1136/jnnp.2004.036566; Press W. H., 1992, ART SCI COMPUTING; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; RABINOWITZ JC, 1982, CAN J PSYCHOL, V36, P325, DOI 10.1037/h0080643; REDER LM, 1986, J EXP PSYCHOL LEARN, V12, P72, DOI 10.1037/0278-7393.12.1.72; Richardson-Klavehn A, 2010, ACT REMEMBERING; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Rugg MD, 2003, TRENDS COGN SCI, V7, P313, DOI 10.1016/S1364-6613(03)00131-1; Sandrini M, 2003, J COGNITIVE NEUROSCI, V15, P855, DOI 10.1162/089892903322370771; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Satzger W, 1999, PHARMACOPSYCHIATRY, P205; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2004, NEUROSCI LETT, V354, P123, DOI 10.1016/j.neulet.2003.10.002; Schack B, 2005, INT J PSYCHOPHYSIOL, V57, P105, DOI 10.1016/j.ijpsycho.2005.03.016; Schacter DL, 1996, NEUROPSYCHOLOGIA, V34, P793, DOI 10.1016/0028-3932(95)00165-4; Schacter DL, 2004, NEURON, V44, P149, DOI 10.1016/j.neuron.2004.08.017; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 2001, PHILOS T R SOC B, V356, P1385, DOI 10.1098/rstb.2001.0938; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; Schiff SJ, 2005, NEUROINFORMATICS, V3, P315, DOI 10.1385/NI:3:4:315; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Sherwin BB, 2000, J AM GERIATR SOC, V48, P431, DOI 10.1111/j.1532-5415.2000.tb04703.x; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Stadler MA, 1999, MEM COGNITION, V27, P494, DOI 10.3758/BF03211543; Stam CJ, 2000, NEUROSCI LETT, V286, P115, DOI 10.1016/S0304-3940(00)01109-5; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P708, DOI 10.1016/j.clinph.2004.09.022; Stam CJ, 2003, HUM BRAIN MAPP, V19, P63, DOI 10.1002/hbm.10106; Stam CJ, 2003, ACTA NEUROL SCAND, V108, P90, DOI 10.1034/j.1600-0404.2003.02067.x; Summerfield C, 2005, NEUROREPORT, V16, P117, DOI 10.1097/00001756-200502080-00008; Sweeney-Reed C, 2004, IEEE ENG MED BIOL ST, P15; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; Sweeney-Reed C.M, 2005, IEEE ENG MED BIOL ST, P21; Sweeney-Reed CM, 2009, J NEUROSCI METH, V184, P54, DOI 10.1016/j.jneumeth.2009.07.023; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tcheslavski GV, 2005, Proceedings of the Second IASTED International Multi-Conference on Automation, Control, and Information Technology - Signal and Image Processing, P164; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; UNDERWOOD BJ, 1965, J EXP PSYCHOL, V70, P122, DOI 10.1037/h0022014; van der Hiele K, 2007, NEUROBIOL AGING, V28, P85, DOI 10.1016/j.neurobiolaging.2005.11.006; van Deursen JA, 2009, BRAIN COGNITION, V69, P592, DOI 10.1016/j.bandc.2008.12.007; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Walla P, 2005, J NEURAL TRANSM, V112, P713, DOI 10.1007/s00702-004-0215-y; Wang X, 2012, NEUROSCIENC IN PRESS; WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Wilding EL, 2006, CLIN EEG NEUROSCI, V37, P315, DOI 10.1177/155005940603700409; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Wimber M, 2010, J NEUROSCI, V30, P13272, DOI 10.1523/JNEUROSCI.0588-10.2010; Yang AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014612; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; YONELINAS AP, 1994, CAN J EXP PSYCHOL, V48, P516, DOI 10.1037/1196-1961.48.4.516; Zakanis KK, 2002, METAANALYSIS APOE GE; Zaudig M, 1992, Int Psychogeriatr, V4 Suppl 2, P203; Zhou ZX, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046008; Ziehe A., 1998, ICANN 98. Proceedings of the 8th International Conference on Artificial Neural Networks, P675	170	13	14	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48357	10.1371/journal.pone.0048357	http://dx.doi.org/10.1371/journal.pone.0048357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118992	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500111
J	Zhou, T; Ko, EA; Gu, WJ; Lim, I; Bang, H; Ko, JH				Zhou, Tong; Ko, Eun A.; Gu, Wanjun; Lim, Inja; Bang, Hyoweon; Ko, Jae-Hong			Non-Silent Story on Synonymous Sites in Voltage-Gated Ion Channel Genes	PLOS ONE			English	Article							OPTIMAL CODONS ASSOCIATE; DROSOPHILA-MELANOGASTER; TRANSLATIONAL ACCURACY; PURIFYING SELECTION; POTASSIUM CHANNELS; SPLICING ENHANCERS; EVOLUTION; USAGE; MUTATIONS; PROTEINS	Synonymous mutations are usually referred to as "silent", but increasing evidence shows that they are not neutral in a wide range of organisms. We looked into the relationship between synonymous codon usage bias and residue importance of voltage-gated ion channel proteins in mice, rats, and humans. We tested whether translationally optimal codons are associated with transmembrane or channel-forming regions, i.e., the sites that are particularly likely to be involved in the closing and opening of an ion channel. Our hypothesis is that translationally optimal codons are preferred at the sites within transmembrane domains or channel-forming regions in voltage-gated ion channel genes to avoid mistranslation-induced protein misfolding or loss-of-function. Using the Mantel-Haenszel procedure, which applies to categorical data, we found that translationally optimal codons are more likely to be used at transmembrane residues and the residues involved in channel-forming. We also found that the conservation level at synonymous sites in the transmembrane region is significantly higher than that in the non-transmembrane region. This study provides evidence that synonymous sites in voltage-gated ion channel genes are not neutral. Silent mutations at channel-related sites may lead to dysfunction of the ion channel.	[Lim, Inja; Bang, Hyoweon; Ko, Jae-Hong] Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea; [Zhou, Tong] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA; [Zhou, Tong] Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Ko, Eun A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Gu, Wanjun] Southeast Univ, Minist Educ China, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China	Chung Ang University; Chung Ang University Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; Ministry of Education, China; Southeast University - China	Ko, JH (corresponding author), Chung Ang Univ, Coll Med, Dept Physiol, Seoul 156756, South Korea.	akdongyi01@cau.ac.kr	Gu, Wanjun/P-5389-2019; Gu, Wanjun/B-3998-2010	Gu, Wanjun/0000-0003-4501-0539; 	Korea Research Foundation; Korean Government (MOEHRD) [KRF-2011-0016587]	Korea Research Foundation(National Research Foundation of Korea); Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This work was supported by the Korea Research Foundation (http://www.krf.or.kr) Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-2011-0016587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1994, GENETICS, V136, P927; Baker EH, 2000, BRIT J CLIN PHARMACO, V49, P185, DOI 10.1046/j.1365-2125.2000.00159.x; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Camerino DC, 2008, ADV GENET, V64, P81, DOI 10.1016/S0065-2660(08)00804-3; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chamary JV, 2005, TRENDS GENET, V21, P256, DOI 10.1016/j.tig.2005.03.001; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; Fodor AA, 2009, ANNU REV PHYSIOL, V71, P19, DOI 10.1146/annurev.physiol.010908.163124; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hoede C, 2006, PLOS GENET, V2, P1697, DOI 10.1371/journal.pgen.0020176; Hughes AL, 2009, GENE, V440, P50, DOI 10.1016/j.gene.2009.03.012; Hurst LD, 2009, NAT REV GENET, V10, P83, DOI 10.1038/nrg2506; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Krasznai Z, 2005, ARCH IMMUNOL THER EX, V53, P127; Lee Y, 2010, PROTEOMICS, V10, P4163, DOI 10.1002/pmic.201000229; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MANTEL N, 1959, J NATL CANCER I, V22, P719; MASON WT, 1988, J EXP BIOL, V139, P287; Morton BR, 2001, GENETICS, V159, P347; Palidwor GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013431; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Richard P, 2007, NEUROMUSCULAR DISORD, V17, P409, DOI 10.1016/j.nmd.2007.01.018; Schwartz JL, 1997, APPL ENVIRON MICROB, V63, P3978, DOI 10.1128/AEM.63.10.3978-3984.1997; Shah JH, 2008, ADV EXP MED BIOL, V614, P145, DOI 10.1007/978-0-387-74911-2_17; Sharman JL, 2011, NUCLEIC ACIDS RES, V39, pD534, DOI 10.1093/nar/gkq1062; Shrivastava IH, 2006, BIOPHYS J, V90, P3929, DOI 10.1529/biophysj.105.080093; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Stoletzki N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-224; Subramanian S, 2011, MOL BIOL EVOL, V28, P2687, DOI 10.1093/molbev/msr097; Thorneloe KS, 2005, CAN J PHYSIOL PHARM, V83, P215, DOI 10.1139/Y05-016; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Warnecke T, 2007, MOL BIOL EVOL, V24, P2755, DOI 10.1093/molbev/msm210; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xia XH, 1996, GENETICS, V144, P1309; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Zhou T, 2010, MOL BIOL EVOL, V27, P1912, DOI 10.1093/molbev/msq077; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	50	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48541	10.1371/journal.pone.0048541	http://dx.doi.org/10.1371/journal.pone.0048541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119053	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500166
J	Pathi, S; Jutooru, I; Chadalapaka, G; Nair, V; Lee, SO; Safe, S				Pathi, Satya; Jutooru, Indira; Chadalapaka, Gayathri; Nair, Vijayalekshmi; Lee, Syng-Ook; Safe, Stephen			Aspirin Inhibits Colon Cancer Cell and Tumor Growth and Downregulates Specificity Protein (Sp) Transcription Factors	PLOS ONE			English	Article							NF-KAPPA-B; ACETYL SALICYLIC-ACID; COLORECTAL-CANCER; INDUCED APOPTOSIS; FACTOR EXPRESSION; ANGIOGENESIS; SURVIVAL; DEGRADATION; CLEAVAGE; CURCUMIN	Acetylsalicylic acid (aspirin) is highly effective for treating colon cancer patients postdiagnosis; however, the mechanisms of action of aspirin in colon cancer are not well defined. Aspirin and its major metabolite sodium salicylate induced apoptosis and decreased colon cancer cell growth and the sodium salt of aspirin also inhibited tumor growth in an athymic nude mouse xenograft model. Colon cancer cell growth inhibition was accompanied by downregulation of Sp1, Sp3 and Sp4 proteins and decreased expression of Sp-regulated gene products including bcl-2, survivin, VEGF, VEGFR1, cyclin D1, c-MET and p65 (NF kappa B). Moreover, we also showed by RNA interference that beta-catenin, an important target of aspirin in some studies, is an Sp-regulated gene. Aspirin induced nuclear caspase-dependent cleavage of Sp1, Sp3 and Sp4 proteins and this response was related to sequestration of zinc ions since addition of zinc sulfate blocked aspirin-mediated apoptosis and repression of Sp proteins. The results demonstrate an important underlying mechanism of action of aspirin as an anticancer agent and, based on the rapid metabolism of aspirin to salicylate in humans and the high salicylate/aspirin ratios in serum, it is likely that the anticancer activity of aspirin is also due to the salicylate metabolite.	[Pathi, Satya; Jutooru, Indira; Chadalapaka, Gayathri; Nair, Vijayalekshmi; Safe, Stephen] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Lee, Syng-Ook; Safe, Stephen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Safe, S (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	ssafe@cvm.tamu.edu		Lee, Syng-Ook/0000-0002-8958-8634	National Institutes of Health [R01 CA136571]; Texas AgriLife Research; NATIONAL CANCER INSTITUTE [R01CA136571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas AgriLife Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health (R01 CA136571) and Texas AgriLife Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim M, 2005, MOL PHARMACOL, V68, P317, DOI 10.1124/mol.105.011825; Abdelrahim M, 2004, CANCER RES, V64, P6740, DOI 10.1158/0008-5472.CAN-04-0713; Abdelrahim M, 2006, J NATL CANCER I, V98, P855, DOI 10.1093/jnci/djj232; Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; BASLAS RK, 1979, EXPERIENTIA, V35, P455, DOI 10.1007/BF01922702; Borthwick GM, 2006, FASEB J, V20, P2009, DOI 10.1096/fj.06-5987com; Bos CL, 2006, ONCOGENE, V25, P6447, DOI 10.1038/sj.onc.1209658; Chadalapaka G, 2008, CANCER RES, V68, P5345, DOI 10.1158/0008-5472.CAN-07-6805; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Chimienti F, 2001, BIOCHEM PHARMACOL, V62, P51, DOI 10.1016/S0006-2952(01)00624-4; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Chintharlapalli S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-371; Chintharlapalli S, 2009, INT J CANCER, V125, P1965, DOI 10.1002/ijc.24530; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Din FVN, 2005, BRIT J CANCER, V92, P1137, DOI 10.1038/sj.bjc.6602455; Din FVN, 2004, BRIT J CANCER, V91, P381, DOI 10.1038/sj.bjc.6601913; Elwood PC, 2009, LANCET, V373, P1301, DOI 10.1016/S0140-6736(09)60243-9; Ghezzo F, 2005, INT J ONCOL, V26, P697; Hagos GK, 2007, MOL CANCER THER, V6, P2230, DOI 10.1158/1535-7163.MCT-07-0069; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Hunt RH, 2009, ANN MED, V41, P423, DOI 10.1080/07853890902887295; Jacobs EJ, 2007, JNCI-J NATL CANCER I, V99, P608, DOI 10.1093/jnci/djk132; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Jutooru I, 2010, MOL PHARMACOL, V78, P226, DOI 10.1124/mol.110.064451; Jutooru I, 2010, EXP CELL RES, V316, P2174, DOI 10.1016/j.yexcr.2010.04.027; Kim EY, 2001, NEUROBIOL DIS, V8, P774; Kim KM, 2005, J BIOL CHEM, V280, P41047, DOI 10.1074/jbc.M503713200; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Michel S, 2000, TRACE ELEMENTS IN MAN AND ANIMALS 10, P1003; Nollet F, 1996, GENOMICS, V32, P413, DOI 10.1006/geno.1996.0136; Olguin HJ, 2004, BIOPHARM DRUG DISPOS, V25, P1, DOI 10.1002/bdd.379; Pathi SS, 2011, MOL CANCER RES, V9, P195, DOI 10.1158/1541-7786.MCR-10-0363; Piedrafita FJ, 1997, MOL CELL BIOL, V17, P6348, DOI 10.1128/MCB.17.11.6348; SAITO H, 1982, Journal of Toxicological Sciences, V7, P177; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Shtivelband MI, 2003, J THROMB HAEMOST, V1, P2225, DOI 10.1046/j.1538-7836.2003.00446.x; Stark LA, 2007, CARCINOGENESIS, V28, P968, DOI 10.1093/carcin/bgl220; Wang YT, 2008, J MOL BIOL, V380, P869, DOI 10.1016/j.jmb.2008.05.043; Yurochko AD, 1997, J VIROL, V71, P4638, DOI 10.1128/JVI.71.6.4638-4648.1997	40	93	100	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48208	10.1371/journal.pone.0048208	http://dx.doi.org/10.1371/journal.pone.0048208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110215	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500052
J	Haugland, GT; Jakobsen, RA; Vestvik, N; Ulven, K; Stokka, L; Wergeland, HI				Haugland, Gyri T.; Jakobsen, Ragnhild Aakre; Vestvik, Nils; Ulven, Kristian; Stokka, Lene; Wergeland, Heidrun I.			Phagocytosis and Respiratory Burst Activity in Lumpsucker (Cyclopterus lumpus L.) Leucocytes Analysed by Flow Cytometry	PLOS ONE			English	Article							SALMO-SALAR L.; HEAD KIDNEY MACROPHAGES; DENDRITIC-LIKE CELL; ATLANTIC SALMON; CYTOCHEMICAL CHARACTERIZATION; PROFESSIONAL PHAGOCYTES; MONOCLONAL-ANTIBODIES; INNATE IMMUNITY; COD; GRANULOCYTES	In the present study, we have isolated leucocytes from peripheral blood, head kidney and spleen from lumpsucker (Cyclopterus lumpus L.), and performed functional studies like phagocytosis and respiratory burst, as well as morphological and cytochemical analyses. Different leucocytes were identified, such as lymphocytes, monocytes/macrophages and polymorphonuclear cells with bean shaped or bilobed nuclei. In addition, cells with similar morphology as described for dendritic cells in trout were abundant among the isolated leucocytes. Flow cytometry was successfully used for measuring phagocytosis and respiratory burst activity. The phagocytic capacity and ability were very high, and cells with different morphology in all three leucocyte preparations phagocytised beads rapidly. Due to lack of available cell markers, the identity of the phagocytic cells could not be determined. The potent non-specific phagocytosis was in accordance with a high number of cells positive for myeloperoxidase, an enzyme involved in oxygen-dependent killing mechanism present in phagocytic cells. Further, high respiratory burst activity was present in the leucocytes samples, verifying a potent oxygen-dependent degradation. At present, the specific antibody immune response could not be measured, as immunoglobulin or B-cells have not yet been isolated. Therefore, analyses of the specific immune response in this fish species await further clarification. The present study presents the first analyses of lumpsucker immunity and also the first within the order Scopaeniformes.	[Haugland, Gyri T.; Jakobsen, Ragnhild Aakre; Ulven, Kristian; Stokka, Lene; Wergeland, Heidrun I.] Univ Bergen, Dept Biol, Bergen, Norway; [Vestvik, Nils] Aqua Kompetanse AS, Flatanger, Norway	University of Bergen	Haugland, GT (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	gyri.haugland@bio.uib.no			University of Bergen, Norway	University of Bergen, Norway	This project is funded by University of Bergen, Norway [http://www.uib.no]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaallaei N, 2010, P NATL ACAD SCI USA, V107, P18079, DOI 10.1073/pnas.1000467107; Ainsworth A. Jerald, 1992, Annual Review of Fish Diseases, V2, P123, DOI 10.1016/0959-8030(92)90060-B; Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; Bassity E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033196; Burrows AS, 2001, J APPL ICHTHYOL, V17, P77, DOI 10.1046/j.1439-0426.2001.00250.x; Chaves-Pozo E, 2005, J LEUKOCYTE BIOL, V78, P345, DOI 10.1189/jlb.0205120; Connor MA, 2009, MOL IMMUNOL, V46, P953, DOI 10.1016/j.molimm.2008.09.025; Crowhurst MO, 2002, INT J DEV BIOL, V46, P483; DAVENPORT J, 1989, J FISH BIOL, V35, P829, DOI 10.1111/j.1095-8649.1989.tb03034.x; do Vale A, 2002, FISH SHELLFISH IMMUN, V13, P183, DOI 10.1006/fsim.2001.0394; Esteban MA, 1998, CELL TISSUE RES, V293, P133, DOI 10.1007/s004410051105; Esteban MA, 1997, ANAT RECORD, V248, P533; FANG LS, 1990, COMP BIOCHEM PHYS B, V97, P37, DOI 10.1016/0305-0491(90)90174-R; Ganassin Rosemarie C., 2000, P631, DOI 10.1016/B978-012529650-2/50047-0; GARAVINI C, 1981, HISTOCHEMISTRY, V72, P75, DOI 10.1007/BF00496781; Haugland GT, 2010, J IMMUNOL METHODS, V362, P10, DOI 10.1016/j.jim.2010.07.008; Kalgraff CAK, 2011, FISH SHELLFISH IMMUN, V31, P381, DOI 10.1016/j.fsi.2011.05.028; LAMAS J, 1994, FISH SHELLFISH IMMUN, V4, P201, DOI 10.1006/fsim.1994.1019; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lovy J, 2006, DEV COMP IMMUNOL, V30, P259, DOI 10.1016/j.dci.2005.06.003; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006; Magnadottir B, 2001, FISH SHELLFISH IMMUN, V11, P75, DOI 10.1006/fsim.2000.0296; MESEGUER J, 1994, HISTOCHEMISTRY, V102, P37, DOI 10.1007/BF00271047; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; MUDGE SM, 1986, J FISH BIOL, V29, P737, DOI 10.1111/j.1095-8649.1986.tb04989.x; Overland HS, 2010, FISH SHELLFISH IMMUN, V28, P193, DOI 10.1016/j.fsi.2009.10.021; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Pettersen EF, 2000, FISH SHELLFISH IMMUN, V10, P695, DOI 10.1006/fsim.2000.0284; Pettersen EF, 2008, FISH SHELLFISH IMMUN, V25, P809, DOI 10.1016/j.fsi.2008.08.014; Pilstrom L, 2005, FISHERIES SCI, V71, P961, DOI 10.1111/j.1444-2906.2005.01052.x; Ronneseth A, 2007, FISH SHELLFISH IMMUN, V23, P493, DOI 10.1016/j.fsi.2006.08.017; Rowley A.F., 1988, P19; Secombes C. J., 1996, The fish immune system: organism, pathogen, and environment, P63; Sepulcre MP, 2007, MOL IMMUNOL, V44, P2009, DOI 10.1016/j.molimm.2006.09.022; Sepulcre MP, 2002, CELL TISSUE RES, V308, P97, DOI 10.1007/s00441-002-0531-1; Shigdar S, 2009, FISH SHELLFISH IMMUN, V26, P731, DOI 10.1016/j.fsi.2009.03.010; Sorensen KK, 1997, J FISH DIS, V20, P93, DOI 10.1046/j.1365-2761.1997.d01-112.x; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Steiro K, 1998, J FISH DIS, V21, P335, DOI 10.1046/j.1365-2761.1998.00110.x; Zapata Agustin G., 1996, Fish Physiology, V15, P1; Zinkl J.G., 1991, Comparative Haematology International, V1, P187, DOI 10.1007/BF00235368	44	30	33	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47909	10.1371/journal.pone.0047909	http://dx.doi.org/10.1371/journal.pone.0047909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112870	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200106
J	Liang, XD; Zhang, L; Wan, YF; Yu, XY; Guo, YM; Chen, XP; Tan, C; Huang, TL; Shen, HJ; Chen, XY; Li, H; Lv, K; Sun, F; Chen, SG; Guo, J				Liang, Xiaodi; Zhang, Lin; Wan, Yufeng; Yu, Xinyang; Guo, Yiming; Chen, Xiaoping; Tan, Cheng; Huang, Tianle; Shen, Hanjie; Chen, Xianyun; Li, Hongying; Lv, Ke; Sun, Fei; Chen, Shanguang; Guo, Jinhu			Changes in the Diurnal Rhythms during a 45-Day Head-Down Bed Rest	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; TRIGONOSCELIS-GIGAS; DESERT BEETLE; SPACE; HUMANS; CLOCK; SLEEP; SPACEFLIGHT; CORTISOL; COUNTERMEASURE	In spaceflight human circadian rhythms and sleep patterns are likely subject to change, which consequently disturbs human physiology, cognitive abilities and performance efficiency. However, the influence of microgravity on sleep and circadian clock as well as the underlying mechanisms remain largely unknown. Placing volunteers in a prone position, whereby their heads rest at an angle of -6 degrees below horizontal, mimics the microgravity environment in orbital flight. Such positioning is termed head-down bed rest (HDBR). In this work, we analysed the influence of a 45-day HDBR on physiological diurnal rhythms. We examined urinary electrolyte and hormone excretion, and the results show a dramatic elevation of cortisol levels during HDBR and recovery. Increased diuresis, melatonin and testosterone were observed at certain periods during HDBR. In addition, we investigated the changes in urination and defecation frequencies and found that the rhythmicity of urinary frequency during lights-off during and after HDBR was higher than control. The grouped defecation frequency data exhibits rhythmicity before and during HDBR but not after HDBR. Together, these data demonstrate that HDBR can alter a number of physiological processes associated with diurnal rhythms.	[Liang, Xiaodi; Zhang, Lin; Wan, Yufeng; Yu, Xinyang; Guo, Yiming; Huang, Tianle; Shen, Hanjie; Chen, Xianyun; Li, Hongying; Guo, Jinhu] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Minist Educ,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Xiaoping; Tan, Cheng; Lv, Ke; Chen, Shanguang] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Sun, Fei] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Sun, Fei] Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Guo, J (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Minist Educ,Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China.	guojinhu@mail.sysu.edu.cn	Sun, Fei/N-2850-2013; ZHANG, LIN/GYD-9123-2022; zhan, lin/AAP-5149-2020	Wan, Yufeng/0000-0002-5155-675X; Guo, Yiming/0000-0002-4212-3784	National 973 Program of China [2011CB711000, 2012CB947600]; National Natural Science Foundation of China [31071122, 31171119]; Fundamental Research Funds for the Central Universities of China [11lgzd08]; Laboratory Opening Funds for Undergraduates of Sun Yat-sen University [KF201126]; Research Fund for the Doctoral Program of Higher Education of China [20110171110030]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Laboratory Opening Funds for Undergraduates of Sun Yat-sen University; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National 973 Program of China (No. 2011CB711000 and 2012CB947600), the National Natural Science Foundation of China (No. 31071122 and No. 31171119), the Fundamental Research Funds for the Central Universities of China (11lgzd08), the Laboratory Opening Funds for Undergraduates of Sun Yat-sen University (KF201126) and the Research Fund for the Doctoral Program of Higher Education of China (20110171110030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPATOV AM, 1994, BIOL RHYTHM RES, V25, P168, DOI 10.1080/09291019409360284; ARBEILLE P, 1992, AVIAT SPACE ENVIR MD, V63, P9; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; ASCHOFF J, 1971, SCIENCE, V171, P213, DOI 10.1126/science.171.3967.213; Bechtold DA, 2010, TRENDS PHARMACOL SCI, V31, P191, DOI 10.1016/j.tips.2010.01.002; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BOWDEN RE, 1977, PROSTAGLANDINS, V14, P151, DOI 10.1016/0090-6980(77)90164-2; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Cermakian N, 2009, OBES REV, V10, P25, DOI 10.1111/j.1467-789X.2009.00660.x; Dijk DJ, 2001, AM J PHYSIOL-REG I, V281, pR1647, DOI 10.1152/ajpregu.2001.281.5.R1647; Gettler LT, 2011, AM J HUM BIOL, V23, P609, DOI 10.1002/ajhb.21187; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Gundel A, 1997, J SLEEP RES, V6, P1, DOI 10.1046/j.1365-2869.1997.00028.x; Hoban-Higgins TM, 2003, J INSECT PHYSIOL, V49, P671, DOI 10.1016/S0022-1910(03)00068-4; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V299, pG549, DOI 10.1152/ajpgi.00147.2010; Hoogerwerf WA, 2010, AM J PHYSIOL-GASTR L, V298, pG143, DOI 10.1152/ajpgi.00402.2009; Manolagas SC, 2009, BONE, V45, pS120, DOI 10.1016/j.bone.2009.07.021; Meza-Figueroa D, 2008, EPIDEMIOLOGY, V19, pS226; Millet C, 2001, CLIN PHYSIOL, V21, P172, DOI 10.1046/j.1365-2281.2001.00315.x; Monk TH, 1998, J BIOL RHYTHM, V13, P188, DOI 10.1177/074873098129000039; Morishima K, 1997, J Gravit Physiol, V4, pS41; NARDUCCI F, 1987, GUT, V28, P17, DOI 10.1136/gut.28.1.17; Pavy-Le Traon A, 1998, EUR J APPL PHYSIOL, V77, P50; Rao SSC, 2001, AM J PHYSIOL-GASTR L, V280, pG629, DOI 10.1152/ajpgi.2001.280.4.G629; Regnard J, 2001, AM J KIDNEY DIS, V38, P668, DOI 10.1053/ajkd.2001.27753; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; ROSE RM, 1972, J ENDOCRINOL, V54, P177, DOI 10.1677/joe.0.0540177; Schimmel M, 2001, BIOL RHYTHM RES, V32, P341, DOI 10.1076/brhm.32.3.341.1340; Schimmerling W, 2003, ADV SPACE RES, V31, P27, DOI 10.1016/S0273-1177(02)00653-1; Sharpley CF, 2012, REV NEUROSCIENCE, V23, P111, DOI 10.1515/RNS.2011.058; Shiraishi M, 2003, BIOMED PHARMACOTHER, V57, p35S, DOI 10.1016/j.biopha.2003.08.005; STAMPI C, 1994, J CLIN PHARMACOL, V34, P518, DOI 10.1002/j.1552-4604.1994.tb04996.x; Stein TP, 1999, AM J PHYSIOL-ENDOC M, V276, pE155; SULZMAN FM, 1984, SCIENCE, V225, P232, DOI 10.1126/science.11540800; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Vuillerme N, 2008, EXP BRAIN RES, V186, P503, DOI 10.1007/s00221-007-1249-9; Zhang L, 2011, FEBS LETT, V585, P1400, DOI 10.1016/j.febslet.2011.03.018; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106; Zwart SR, 2007, BONE, V40, P529, DOI 10.1016/j.bone.2006.09.014	39	15	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47984	10.1371/journal.pone.0047984	http://dx.doi.org/10.1371/journal.pone.0047984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110150	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200127
J	Nazeri, M; Jusoff, K; Madani, N; Mahmud, AR; Bahman, AR; Kumar, L				Nazeri, Mona; Jusoff, Kamaruzaman; Madani, Nima; Mahmud, Ahmad Rodzi; Bahman, Abdul Rani; Kumar, Lalit			Predictive Modeling and Mapping of Malayan Sun Bear (Helarctos malayanus) Distribution Using Maximum Entropy	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; HABITAT; BIODIVERSITY; PERFORMANCE; IMPROVE; NUMBERS	One of the available tools for mapping the geographical distribution and potential suitable habitats is species distribution models. These techniques are very helpful for finding poorly known distributions of species in poorly sampled areas, such as the tropics. Maximum Entropy (MaxEnt) is a recently developed modeling method that can be successfully calibrated using a relatively small number of records. In this research, the MaxEnt model was applied to describe the distribution and identify the key factors shaping the potential distribution of the vulnerable Malayan Sun Bear (Helarctos malayanus) in one of the main remaining habitats in Peninsular Malaysia. MaxEnt results showed that even though Malaysian sun bear habitat is tied with tropical evergreen forests, it lives in a marginal threshold of bio-climatic variables. On the other hand, current protected area networks within Peninsular Malaysia do not cover most of the sun bears potential suitable habitats. Assuming that the predicted suitability map covers sun bears actual distribution, future climate change, forest degradation and illegal hunting could potentially severely affect the sun bear's population.	[Kumar, Lalit] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Nazeri, Mona; Jusoff, Kamaruzaman; Madani, Nima] Univ Putra Malaysia, Fac Forestry, Serdang, Malaysia; [Mahmud, Ahmad Rodzi] Univ Putra Malaysia, Fac Engn, Serdang, Malaysia; [Bahman, Abdul Rani] Univ Putra Malaysia, Fac Vet Med, Serdang, Malaysia	University of New England; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Kumar, L (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	lkumar@une.edu.au	Kumar, Lalit/A-6397-2011; Madani, Nima/A-2840-2016; Kamaruzaman, Jusoff/F-1014-2010	Kumar, Lalit/0000-0002-9205-756X; Madani, Nima/0000-0003-2853-7611; Kamaruzaman, Jusoff/0000-0001-5020-1618; Nazeri, Mona/0000-0003-1865-7636	Ministry of Science, Technology and Innovation Malaysia (MOSTI) Top-down Science Fund [MOSTI.S.180.010.S062970]; Habitat and Ecology Modeling Mapping Project (Faculty of Forestry UPM)	Ministry of Science, Technology and Innovation Malaysia (MOSTI) Top-down Science Fund; Habitat and Ecology Modeling Mapping Project (Faculty of Forestry UPM)	This work was supported financially by the Ministry of Science, Technology and Innovation Malaysia (MOSTI) Top-down Science Fund No. MOSTI.S.180.010.S062970 for the Malayan Sun Bear Project (Faculty of Veterinary Medicine UPM) and the Habitat and Ecology Modeling Mapping Project (Faculty of Forestry UPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Augeri D.M., 2005, THESIS U CAMBRIDGE C; Calenge C, 2008, ECOLOGY, V89, P555, DOI 10.1890/06-1750.1; Carroll C, 2010, BIOL CONSERV, V143, P1432, DOI 10.1016/j.biocon.2010.03.018; Elith J, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P39; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, DIVERSITY DISTRIBUTI; Frederick C, 2010, THERIOGENOLOGY, V74, P1121, DOI 10.1016/j.theriogenology.2010.05.010; Fredrikkson G, 2005, URSUS, V16, P130, DOI 10.2192/1537-6176(2005)016[0130:HBCIEK]2.0.CO;2; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hirzel AH, 2004, ECOLOGICAL REQUIREME; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Imam E, 2009, ECOL MODEL, V220, P3621, DOI 10.1016/j.ecolmodel.2009.06.044; IUCN, 1996, RED LIST THREAT AN; Jackson CR, 2011, J NAT CONSERV, V19, P87, DOI 10.1016/j.jnc.2010.06.006; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; MEDIAS-France, 2008, GLOBCOVER LAND COV V; Meijaarad E, 2005, LIFE LOGGING RECONCI, P349; Mingyang L, 2008, ACTA ECOL SIN, V28, P4253, DOI [10.1016/S1872-2032(08)60080-3, DOI 10.1016/S1872-2032(08)60080-3]; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peh KSH, 2005, BIOL CONSERV, V123, P489, DOI 10.1016/j.biocon.2005.01.010; Peyton B., 1999, BEARS STATUS SURVEY; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2004, ACM; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; Sodhi N. S., 2006, SE ASIAN BIODIVERSIT; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Steinmetz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014509; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Suarez-Seoane S, 2008, ECOL MODEL, V219, P17, DOI 10.1016/j.ecolmodel.2008.07.035; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Wong ST, 2004, BIOL CONSERV, V119, P169, DOI 10.1016/j.biocon.2003.10.029; Wong ST, 2002, URSUS, V13, P127; Zafra-Calvo N, 2010, BIOL CONSERV, V143, P787, DOI 10.1016/j.biocon.2009.12.022	47	54	55	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48104	10.1371/journal.pone.0048104	http://dx.doi.org/10.1371/journal.pone.0048104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110182	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200149
J	Wrzus, C; Brandmaier, AM; von Oertzen, T; Muller, V; Wagner, GG; Riediger, M				Wrzus, Cornelia; Brandmaier, Andreas M.; von Oertzen, Timo; Mueller, Viktor; Wagner, Gert G.; Riediger, Michaela			A New Approach for Assessing Sleep Duration and Postures from Ambulatory Accelerometry	PLOS ONE			English	Article							QUALITY INDEX; CIRCADIAN-RHYTHMS; BODY MOVEMENTS; OLDER-ADULTS; NIGHT SLEEP; ACTIGRAPHY; METAANALYSIS; POSITIONS; PARAMETERS; MORTALITY	Interest in the effects of sleeping behavior on health and performance is continuously increasing-both in research and with the general public. Ecologically valid investigations of this research topic necessitate the measurement of sleep within people's natural living contexts. We present evidence that a new approach for ambulatory accelerometry data offers a convenient, reliable, and valid measurement of both people's sleeping duration and quality in their natural environment. Ninety-two participants (14-83 years) wore acceleration sensors on the sternum and right thigh while spending the night in their natural environment and following their normal routine. Physical activity, body posture, and change in body posture during the night were classified using a newly developed classification algorithm based on angular changes of body axes. The duration of supine posture and objective indicators of sleep quality showed convergent validity with self-reports of sleep duration and quality as well as external validity regarding expected age differences. The algorithms for classifying sleep postures and posture changes very reliably distinguished postures with 99.7% accuracy. We conclude that the new algorithm based on body posture classification using ambulatory accelerometry data offers a feasible and ecologically valid approach to monitor sleeping behavior in sizable and heterogeneous samples at home.	[Wrzus, Cornelia; Riediger, Michaela] Max Planck Inst Human Dev, Res Grp Affect Lifespan, Berlin, Germany; [Brandmaier, Andreas M.; Mueller, Viktor] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [von Oertzen, Timo] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Wagner, Gert G.] German Inst Econ Res, Berlin, Germany	Max Planck Society; Max Planck Society; University of Virginia; DIW Berlin - Deutsches Institut fur Wirtschaftsforschung	Wrzus, C (corresponding author), Max Planck Inst Human Dev, Res Grp Affect Lifespan, Berlin, Germany.	wrzus@mpib-berlin.mpg.de	Müller, Viktor/AAX-4429-2021; Brandmaier, Andreas M/E-9096-2014; Riediger, Michaela/ABC-3345-2021; Wagner, Gert G./AIC-8679-2022	Brandmaier, Andreas M/0000-0001-8765-6982; Riediger, Michaela/0000-0001-5206-3626; Muller, Viktor/0000-0002-3716-5445	German Federal Ministry for Education and Research; Max Planck Society [01UW0706, MPI001]	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	This research was funded by the German Federal Ministry for Education and Research (http://www.bmbf.de/en/) and by the Max Planck Society (http://www.mpg.de/en); grants 01UW0706 and MPI001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Beaudreau SA, 2012, SLEEP MED, V13, P36, DOI 10.1016/j.sleep.2011.04.005; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; DEKONINCK J, 1992, SLEEP, V15, P143, DOI 10.1093/sleep/15.2.143; DEKONINCK J, 1983, SLEEP, V6, P52, DOI 10.1093/sleep/6.1.52; FEINBERG I, 1967, J PSYCHIAT RES, V5, P107, DOI 10.1016/0022-3956(67)90027-1; FURNHAM A, 1982, PERS INDIV DIFFER, V3, P311, DOI 10.1016/0191-8869(82)90051-4; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Giganti F, 2008, BRAIN RES BULL, V75, P66, DOI 10.1016/j.brainresbull.2007.07.022; Gordon SJ, 2004, INTERNET J ALLIED HL, V2, P1; Gori S, 2004, BRAIN RES BULL, V63, P393, DOI 10.1016/j.brainresbull.2003.12.012; Grandner MA, 2010, SLEEP MED REV, V14, P191, DOI 10.1016/j.smrv.2009.07.006; Groeger JA, 2004, J SLEEP RES, V13, P359, DOI 10.1111/j.1365-2869.2004.00418.x; JeanLouis G, 1997, PERCEPT MOTOR SKILL, V85, P219, DOI 10.2466/pms.1997.85.1.219; Kahn E, 1970, J NERV MENT DIS, V148, P495; Kline CE, 2010, SLEEP BIOL RHYTHMS, V8, P42, DOI 10.1111/j.1479-8425.2009.00422.x; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; LORRAIN D, 1986, PERCEPT MOTOR SKILL, V63, P352, DOI 10.2466/pms.1986.63.2.352; Lorrain D, 1998, SLEEP, V21, P335, DOI 10.1093/sleep/21.4.335; Mathie MJ, 2004, MED BIOL ENG COMPUT, V42, P679, DOI 10.1007/BF02347551; Mehra R, 2007, J AM GERIATR SOC, V55, P1356, DOI 10.1111/j.1532-5415.2007.01290.x; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Pollak CP, 2001, SLEEP, V24, P957, DOI 10.1093/sleep/24.8.957; Quinlan JR, 1986, PHYSIOL MEAS, V1, P81; Richard W, 2006, EUR ARCH OTO-RHINO-L, V263, P946, DOI 10.1007/s00405-006-0090-2; Roberts RE, 2000, AM J PSYCHIAT, V157, P81, DOI 10.1176/ajp.157.1.81; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Sahlin C, 2009, SLEEP MED, V10, P1025, DOI 10.1016/j.sleep.2008.12.008; Spira AP, 2012, J GERONTOL A-BIOL, V67, P433, DOI 10.1093/gerona/glr172; Taylor MF, 1993, ESRC DATA ARCH B, V53, P7; Vitiello MV, 2009, CURR DIR PSYCHOL SCI, V18, P316, DOI 10.1111/j.1467-8721.2009.01659.x; Wagner G. G., 2007, SCHMOLLERS JB, V127, P139, DOI DOI 10.2139/SSRN.1028709; Walsh JH, 2008, SLEEP, V31, P1543, DOI 10.1093/sleep/31.11.1543	36	31	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48089	10.1371/journal.pone.0048089	http://dx.doi.org/10.1371/journal.pone.0048089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110178	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200148
J	Carpi, A; Rossi, G; Romani, R; Di Coscio, G; Nicolini, A; Simoncini, T; Russo, M; Mechanick, J				Carpi, Angelo; Rossi, Giuseppe; Romani, Rossana; Di Coscio, Giancarlo; Nicolini, Andrea; Simoncini, Tommaso; Russo, Matteo; Mechanick, Jeffrey			Are Risk Factors Common to Thyroid Cancer and Nodule? A Forty Years Observational Time-Trend Study	PLOS ONE			English	Article							NEEDLE-ASPIRATION BIOPSY; PREOPERATIVE SELECTION; CHERNOBYL ACCIDENT; POPULATION; CARCINOMA; CYTOLOGY; DISEASES; EPIDEMIOLOGY; NODULARITY; COHORT	A progressive increase in the incidence of thyroid cancer (TC) has been reported over the last few decades. This either reflects the increased number of newly discovered and accurately selected thyroid nodules with more sensitive technologies and a relative more potent carcinogenic effect of pathogenetic factors in malignant, but not benign nodules. This observational time-trend study addresses this issue by analysing the proportion of TC within 8411 consecutive thyroid nodule (TN) patients evaluated in Pisa by the same pathology Department and individual clinician over a four-decade period. From 1972 to 1979 surgery was used to detect TC among the TN patients: 1140 TN patients were operated on and 35 cancers were detected (3.1% of all the TN patients). Subsequently, needle aspiration techniques were used to select TN for surgery. From 1980 to 1992, 5403 TN patients were examined, 483 were selected for surgery, and 150 cancers were found (2.8% of all the TN patients). From 1993 to 2010, 1568 TN patients were examined, 143 were selected for surgery, and 46 cancers were found (2.9% of all the TN patients). Therefore, in the University Hospital of Pisa, and independent of preoperative TN selection protocols, these proportions of TN eventually found to harbor TC remained statistically unchanged over 40 years (p = 0.810). This finding suggests that pathogenic risk factors and more sensitive diagnostic technologies did not differentially affect the incidence of TN and TC.	[Carpi, Angelo; Nicolini, Andrea; Simoncini, Tommaso] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Rossi, Giuseppe] CNR, Inst Clin Physiol, Unit Epidemiol & Biostat, I-56100 Pisa, Italy; [Romani, Rossana; Di Coscio, Giancarlo] Univ Hosp, Dept Oncol Pathol, Pisa, Italy; [Russo, Matteo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Russo, Matteo] IRCCS San Raffaele Pisana, Dept Cellular & Mol Pathol, Rome, Italy; [Mechanick, Jeffrey] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone, New York, NY USA	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa; Azienda Ospedaliero Universitaria Pisana; Sapienza University Rome; IRCCS San Raffaele Pisana; Icahn School of Medicine at Mount Sinai	Carpi, A (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.	angelo.carpi@med.unipi.it	Simoncini, Tommaso/AAC-1879-2019; Rossi, Giuseppe/G-7838-2012	Simoncini, Tommaso/0000-0002-2971-0079; Nicolini, Andrea/0000-0002-5178-9510				Bartolazzi A, 2008, LANCET ONCOL, V9, P543, DOI 10.1016/S1470-2045(08)70132-3; Bozhok Y, 2009, CANCER CYTOPATHOL, V117, P73, DOI 10.1002/cncy.20002; Carlotta B, 2011, EPIDEMIOL PREV, V35, P216; Carpi A, 2007, HISTOPATHOLOGY, V51, P249, DOI 10.1111/j.1365-2559.2007.02764.x; Carpi A, 2006, BRIT J CANCER, V95, P204, DOI 10.1038/sj.bjc.6603232; Carpi A, 1999, AM J CLIN ONCOL-CANC, V22, P65, DOI 10.1097/00000421-199902000-00016; Carpi A, 1996, J CLIN ONCOL, V14, P1704, DOI 10.1200/JCO.1996.14.5.1704; Carpi A, 2010, ANN MED, V42, P70, DOI 10.3109/07853890903439778; Dal Maso L, 2011, ANN ONCOL, V22, P957, DOI 10.1093/annonc/mdq467; DAVANZO B, 1995, CANCER EPIDEM BIOMAR, V4, P193; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; DICOSCIO G, 1983, RECENTI ACQUISIZIONI, P69; Drozd V, 2002, J PEDIATR ENDOCR MET, V15, P979; DUFFY BJ, 1950, J CLIN ENDOCRINOL, V10, P1296, DOI 10.1210/jcem-10-10-1296; Emral R, 2003, EUR J ENDOCRINOL, V148, P497, DOI 10.1530/eje.0.1480497; Farahati J, 2004, THYROID, V14, P141, DOI 10.1089/105072504322880382; Franceschi S, 1999, CANCER CAUSE CONTROL, V10, P583, DOI 10.1023/A:1008907227706; Hamburger JI, 1981, CONTROVERSIES IN CLI, P237; Inskip PD, 1997, RADIAT RES, V147, P225, DOI 10.2307/3579424; Kasatkina EP, 1997, EUR J PEDIATR, V156, P916, DOI 10.1007/s004310050742; Knobel M, 2007, ARQ BRAS ENDOCRINOL, V51, P701, DOI 10.1590/S0004-27302007000500007; Leenhardt L, 2011, ANN ENDOCRINOL-PARIS, V72, P136, DOI 10.1016/j.ando.2011.03.025; Martin HE, 1930, ANN SURG, V92, P169, DOI 10.1097/00000658-193008000-00002; METTLER FA, 1992, JAMA-J AM MED ASSOC, V268, P616, DOI 10.1001/jama.268.5.616; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; Rago T, 2010, EUR J ENDOCRINOL, V162, P763, DOI 10.1530/EJE-09-0895; Reiners C, 2009, HORM-INT J ENDOCRINO, V8, P185, DOI 10.14310/horm.2002.1234; Takahashi T, 1999, TOHOKU J EXP MED, V187, P363, DOI 10.1620/tjem.187.363; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; Zhu CR, 2009, THYROID, V19, P1061, DOI 10.1089/thy.2008.0342	30	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47758	10.1371/journal.pone.0047758	http://dx.doi.org/10.1371/journal.pone.0047758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118895	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500035
J	Goel, A; Wilkins, MR				Goel, Apurv; Wilkins, Marc R.			Dynamic Hubs Show Competitive and Static Hubs Non-Competitive Regulation of Their Interaction Partners	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; IN-VIVO; YEAST; PHOSPHORYLATION; PHO85; IDENTIFICATION; VISUALIZATION; SPECIFICITY	Date hub proteins have 1 or 2 interaction interfaces but many interaction partners. This raises the question of whether all partner proteins compete for the interaction interface of the hub or if the cell carefully regulates aspects of this process? Here, we have used real-time rendering of protein interaction networks to analyse the interactions of all the 1 or 2 interface hubs of Saccharomyces cerevisiae during the cell cycle. By integrating previously determined structural and gene expression data, and visually hiding the nodes (proteins) and their edges (interactions) during their troughs of expression, we predict when interactions of hubs and their partners are likely to exist. This revealed that 20 out of all 36 one-or two-interface hubs in the yeast interactome fell within two main groups. The first was dynamic hubs with static partners, which can be considered as 'competitive hubs'. Their interaction partners will compete for the interaction interface of the hub and the success of any interaction will be dictated by the kinetics of interaction (abundance and affinity) and subcellular localisation. The second was static hubs with dynamic partners, which we term 'non-competitive hubs'. Regulatory mechanisms are finely tuned to lessen the presence and/or effects of competition between the interaction partners of the hub. It is possible that these regulatory processes may also be used by the cell for the regulation of other, non-cell cycle processes.	[Goel, Apurv; Wilkins, Marc R.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia	University of New South Wales Sydney	Wilkins, MR (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia.	m.wilkins@unsw.edu.au			Australian Federal Government's EIF Super Science Initiative; New South Wales State Government Science Leveraging Fund; University of New South Wales; Australian Postgraduate Award; New South Wales Systems Biology Initiative	Australian Federal Government's EIF Super Science Initiative; New South Wales State Government Science Leveraging Fund; University of New South Wales; Australian Postgraduate Award(Australian Government); New South Wales Systems Biology Initiative	This work was supported by Australian Federal Government's EIF Super Science Initiative, the New South Wales State Government Science Leveraging Fund and the University of New South Wales. AG acknowledges the support of an Australian Postgraduate Award and the New South Wales Systems Biology Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bartholomew CR, 2009, EUKARYOT CELL, V8, P560, DOI 10.1128/EC.00111-08; Batada NN, 2007, PLOS BIOL, V5, P1202, DOI 10.1371/journal.pbio.0050154; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benton BK, 1997, MOL CELL BIOL, V17, P5067, DOI 10.1128/MCB.17.9.5067; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Edgington NP, 2001, J CELL SCI, V114, P4599; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gauthier NP, 2010, NUCLEIC ACIDS RES, V38, pD699, DOI 10.1093/nar/gkp1044; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Goel A, 2011, PROTEOMICS, V11, P2672, DOI 10.1002/pmic.201000546; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Higurashi M, 2008, PROTEIN SCI, V17, P72, DOI 10.1110/ps.073196308; Ho E, 2008, J PROTEOME RES, V7, P104, DOI 10.1021/pr070274m; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Huang DQ, 1998, MOL CELL BIOL, V18, P3289, DOI 10.1128/MCB.18.6.3289; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Komurov K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100149; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Ladbury JE, 2012, TRENDS BIOCHEM SCI, V37, P173, DOI 10.1016/j.tibs.2012.01.001; Lew DJ, 1997, MOL CELLULAR BIOL YE, P607; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Pruyne D, 2000, J CELL SCI, V113, P571; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; R Core Team, 2021, R LANG ENV STAT COMP; Rua D, 2001, CURR OPIN MICROBIOL, V4, P720, DOI 10.1016/S1369-5274(01)00274-0; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Wilkins MR, 2008, TRENDS BIOCHEM SCI, V33, P195, DOI 10.1016/j.tibs.2008.03.001; Wu XM, 2009, PROTEOMICS, V9, P4812, DOI 10.1002/pmic.200900053; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	52	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48209	10.1371/journal.pone.0048209	http://dx.doi.org/10.1371/journal.pone.0048209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118954	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500082
J	Labhardt, ND; Lejone, T; Setoko, M; Poka, M; Ehmer, J; Pfeiffer, K; Kiuvu, PZ; Lynen, L				Labhardt, Niklaus Daniel; Lejone, Thabo; Setoko, Matse'liso; Poka, Matalenyane; Ehmer, Jochen; Pfeiffer, Karolin; Kiuvu, Patrice Zinga; Lynen, Lutgarde			A Clinical Prediction Score in Addition to WHO Criteria for Anti-Retroviral Treatment Failure in Resource-Limited Settings - Experience from Lesotho	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; THERAPY FAILURE; MORTALITY; RESISTANCE; COUNTRIES; OUTCOMES; PROGRAM; ADULTS	Objective: To assess the positive predictive value (PPV) of a clinical score for viral failure among patients fulfilling the WHO-criteria for anti-retroviral treatment (ART) failure in rural Lesotho. Methods: Patients fulfilling clinical and/or immunological WHO failure-criteria were enrolled. The score includes the following predictors: Prior ART exposure (1 point), CD4-count below baseline (1), 25% and 50% drop from peak CD4-count (1 and 2), hemoglobin drop >= 1 g/dL (1), CD4 count < 100/mu l after 12 months (1), new onset papular pruritic eruption (1), and adherence < 95% (3). A nurse assessed the score the day blood was drawn for viral load (VL). Reported confidence intervals (CI) were calculated using Wilsons method. Results: Among 1'131 patients on ART >= 6 months, 134 (11.8%) had immunological and/or clinical failure, 104 (78%) had blood drawn (13 died, 10 lost to follow-up, 7 did not show up). From 92 (88%) a result could be obtained (2 samples hemolysed, 10 lost). Out of these 92 patients 47 (51%) had viral failure (>= 5000 copies), 27 (29%) viral suppression (< 40) and 18 (20%) intermediate viremia (40-4999). Overall, 20 (22%) had a score >= 5. A score >= 5 had a PPV of 100% to detect a VL > 40 copies (95%CI: 84-100), and of 90% to detect a VL >= 5000 copies (70-97). Within the score, adherence < 95%, CD4-count < 100/mu l and papular pruritic eruption were the strongest single predictors. Among 47 patients failing, 8 (17%) died before or within 4 weeks after being switched. Overall mortality was 4 (20%) among those with score >= 5 and 4 (5%) if score < 5 (OR 4.3; 95% CI: 0.96-18.84, p = 0.057). Conclusion: A score >= 5 among patients fulfilling WHO-criteria had a PPV of 100% for a detectable VL and 90% for viral failure. In settings without regular access to VL-testing,this PPV may be considered high enough to switch this patient-group to second-line treatment without confirmatory VL-test.	[Labhardt, Niklaus Daniel; Lejone, Thabo; Setoko, Matse'liso; Kiuvu, Patrice Zinga] Seboche Hosp, Botha Bothe, Lesotho; [Poka, Matalenyane] Lesotho Cent Lab, Maseru, Lesotho; [Ehmer, Jochen; Pfeiffer, Karolin] SolidarMed Switzerland, Luzern, Switzerland; [Lynen, Lutgarde] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Labhardt, ND (corresponding author), Seboche Hosp, Botha Bothe, Lesotho.	niklaus.labhardt@gmail.com; tbotouch@yahoo.com	Lejone, Thabo Ishmael/AAB-6951-2019; Lynen, Lutgarde/A-1212-2014; Lynen, Lutgarde/AAT-9180-2020; Labhardt, Niklaus/J-8542-2019	Lejone, Thabo Ishmael/0000-0003-1724-1532; Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; Labhardt, Niklaus/0000-0003-3599-1791				Abouyannis M, 2011, AIDS, V25, P1627, DOI 10.1097/QAD.0b013e328349a414; [Anonymous], 2010, ANT THER AD AD REC P; Badri M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-89; Bisson GP, 2006, AIDS, V20, P1613, DOI 10.1097/01.aids.0000238407.00874.dc; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Castelnuovo B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/736938; Egger M, 2012, CD4 CELL RESPONSE VI, V634; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Hosseinipour Mina C, 2010, Curr HIV/AIDS Rep, V7, P168, DOI 10.1007/s11904-010-0046-4; Kanapathipillai R, 2011, TROP MED INT HLTH; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Levison JH, 2011, ANTIVIR THER, V16, P853, DOI 10.3851/IMP1819; Lynen L, 2009, JAIDS-J ACQ IMM DEF, V52, P40, DOI 10.1097/QAI.0b013e3181af6705; Marinucci F, 2011, CYTOM PART A, V79A, P368, DOI 10.1002/cyto.a.21064; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Saag M, 2012, CLUSTER RANDOMIZED T; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x	22	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47937	10.1371/journal.pone.0047937	http://dx.doi.org/10.1371/journal.pone.0047937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118910	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500048
J	Xu, ZH; Yang, Q; Ma, L; Liu, SB; Chen, GS; Wu, YM; Li, XQ; Liu, G; Zhao, MG				Xu, Zhao-hui; Yang, Qi; Ma, Lan; Liu, Shui-bing; Chen, Guang-sheng; Wu, Yu-mei; Li, Xiao-qiang; Liu, Gang; Zhao, Ming-gao			Deficits in LTP Induction by 5-HT2A Receptor Antagonist in a Mouse Model for Fragile X Syndrome	PLOS ONE			English	Article							LONG-TERM-POTENTIATION; ANTERIOR CINGULATE CORTEX; ANTIPSYCHOTIC-DRUG; SEROTONIN 5-HT2A; PAIRED-PULSE; FEAR MEMORY; IN-VIVO; M100907; PROTEIN; MICE	Fragile X syndrome is a common inherited form of mental retardation caused by the lack of fragile X mental retardation protein (FMRP) because of Fmr1 gene silencing. Serotonin (5-HT) is significantly increased in the null mutants of Drosophila Fmr1, and elevated 5-HT brain levels result in cognitive and behavioral deficits in human patients. The serotonin type 2A receptor (5-HT2AR) is highly expressed in the cerebral cortex; it acts on pyramidal cells and GABAergic interneurons to modulate cortical functions. 5-HT2AR and FMRP both regulate synaptic plasticity. Therefore, the lack of FMRP may affect serotoninergic activity. In this study, we determined the involvement of FMRP in the 5-HT modulation of synaptic potentiation with the use of primary cortical neuron culture and brain slice recording. Pharmacological inhibition of 5HT2AR by R-96544 or ketanserin facilitated long-term potentiation (LTP) in the anterior cingulate cortex (ACC) of WT mice. The prefrontal LTP induction was dependent on the activation of NMDARs and elevation of postsynaptic Ca2+ concentrations. By contrast, inhibition of 5-HT2AR could not restore the induction of LTP in the ACC of Fmr1 knock-out mice. Furthermore, 5-HT2AR inhibition induced AMPA receptor GluR1 subtype surface insertion in the cultured ACC neurons of Fmr1 WT mice, however, GluR1 surface insertion by inhibition of 5-HT2AR was impaired in the neurons of Fmr1KO mice. These findings suggested that FMRP was involved in serotonin receptor signaling and contributed in GluR1 surface expression induced by 5-HT2AR inactivation.	[Liu, Gang] PLA, Dept Orthopaed & Traumatol, Nanjing Gen Hosp Najing Mil Commend, Nanjing, Peoples R China; [Xu, Zhao-hui; Yang, Qi; Ma, Lan; Liu, Shui-bing; Wu, Yu-mei; Li, Xiao-qiang; Zhao, Ming-gao] Fourth Mil Med Univ, Dept Pharmacol, Sch Pharm, Xian 710032, Peoples R China; [Chen, Guang-sheng] Xian Childs Hosp, Dept Pathol, Xian, Peoples R China	Air Force Military Medical University	Liu, G (corresponding author), PLA, Dept Orthopaed & Traumatol, Nanjing Gen Hosp Najing Mil Commend, Nanjing, Peoples R China.	liugene@hotmail.com; minggao@fmmu.edu.cn	Li, Xiao-Qiang/AAA-5094-2019	Zhao, Ming-gao/0000-0002-7539-3887	National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian GK, 1997, NEUROPHARMACOLOGY, V36, P589, DOI 10.1016/S0028-3908(97)00051-8; Arvanov VL, 1998, NEUROPSYCHOPHARMACOL, V18, P197, DOI 10.1016/S0893-133X(97)00126-7; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Calcagno E, 2009, J NEUROCHEM, V108, P521, DOI 10.1111/j.1471-4159.2008.05789.x; Carlsson ML, 1999, J NEURAL TRANSM, V106, P123, DOI 10.1007/s007020050144; Clark K, 2008, EUR J NEUROSCI, V28, P279, DOI 10.1111/j.1460-9568.2008.06337.x; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Fink KB, 2007, PHARMACOL REV, V59, P360, DOI 10.1124/pr.107.07103; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Gray JA, 2007, MOL PSYCHIATR, V12, P904, DOI 10.1038/sj.mp.4002062; Hasuo H, 2002, J NEUROSCI, V22, P7509; HESS G, 1994, NEUROSCIENCE, V61, P225, DOI 10.1016/0306-4522(94)90226-7; Higgins GA, 2003, PSYCHOPHARMACOLOGY, V170, P309, DOI 10.1007/s00213-003-1549-0; Jakab RL, 2000, J COMP NEUROL, V417, P337, DOI 10.1002/(SICI)1096-9861(20000214)417:3<337::AID-CNE7>3.0.CO;2-O; Lucas G, 2000, J NEUROCHEM, V74, P693, DOI 10.1046/j.1471-4159.2000.740693.x; Mirjana C, 2004, NEUROPSYCHOPHARMACOL, V29, P1637, DOI 10.1038/sj.npp.1300479; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Porras G, 2002, NEUROPSYCHOPHARMACOL, V26, P311, DOI 10.1016/S0893-133X(01)00333-5; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Sari Y, 1999, NEUROSCIENCE, V88, P899, DOI 10.1016/S0306-4522(98)00256-5; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Toyoda H, 2006, REV NEUROSCIENCE, V17, P403; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Wang RY, 1998, BRAIN RES, V779, P309, DOI 10.1016/S0006-8993(97)01174-8; Wang RY, 1998, NEUROPSYCHOPHARMACOL, V19, P74; Wei F, 1999, J NEUROSCI, V19, P9346; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhang YQ, 2005, MOL CELL PROTEOMICS, V4, P278, DOI 10.1074/mcp.M400174-MCP200; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014; Zhao MG, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-11; Zhuo M, 2002, DRUG DISCOV TODAY, V7, P259, DOI 10.1016/S1359-6446(01)02138-9	37	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48741	10.1371/journal.pone.0048741	http://dx.doi.org/10.1371/journal.pone.0048741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119095	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500202
J	Cilia, M; Peter, KA; Bereman, MS; Howe, K; Fish, T; Smith, D; Gildow, F; MacCoss, MJ; Thannhauser, TW; Gray, SM				Cilia, Michelle; Peter, Kari A.; Bereman, Michael S.; Howe, Kevin; Fish, Tara; Smith, Dawn; Gildow, Fredrick; MacCoss, Michael J.; Thannhauser, Theodore W.; Gray, Stewart M.			Discovery and Targeted LC-MS/MS of Purified Polerovirus Reveals Differences in the Virus-Host Interactome Associated with Altered Aphid Transmission	PLOS ONE			English	Article							BARLEY YELLOW DWARF; THAUMATIN-LIKE PROTEINS; BEAN MOSAIC-VIRUS; BUSHY STUNT VIRUS; TO-CELL MOVEMENT; LUTEOVIRUS TRANSMISSION; READTHROUGH PROTEIN; DISULFIDE BONDS; COAT PROTEIN; SCHIZAPHIS-GRAMINUM	Circulative transmission of viruses in the Luteoviridae, such as cereal yellow dwarf virus (CYDV), requires a series of precisely orchestrated interactions between virus, plant, and aphid proteins. Natural selection has favored these viruses to be retained in the phloem to facilitate acquisition and transmission by aphids. We show that treatment of infected oat tissue homogenate with sodium sulfite reduces transmission of the purified virus by aphids. Transmission electron microscopy data indicated no gross change in virion morphology due to treatments. However, treated virions were not acquired by aphids through the hindgut epithelial cells and were not transmitted when injected directly into the hemocoel. Analysis of virus preparations using nanoflow liquid chromatography coupled to tandem mass spectrometry revealed a number of host plant proteins co-purifying with viruses, some of which were lost following sodium sulfite treatment. Using targeted mass spectrometry, we show data suggesting that several of the virus-associated host plant proteins accumulated to higher levels in aphids that were fed on CYDV-infected plants compared to healthy plants. We propose two hypotheses to explain these observations, and these are not mutually exclusive: (a) that sodium sulfite treatment disrupts critical virion-host protein interactions required for aphid transmission, or (b) that host infection with CYDV modulates phloem protein expression in a way that is favorable for virus uptake by aphids. Importantly, the genes coding for the plant proteins associated with virus may be examined as targets in breeding cereal crops for new modes of virus resistance that disrupt phloem-virus or aphid-irus interactions.	[Cilia, Michelle; Howe, Kevin; Fish, Tara; Thannhauser, Theodore W.; Gray, Stewart M.] ARS, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA; [Cilia, Michelle; Smith, Dawn; Gray, Stewart M.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Peter, Kari A.; Gildow, Fredrick] Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; [Bereman, Michael S.; MacCoss, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	United States Department of Agriculture (USDA); Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Washington; University of Washington Seattle	Cilia, M (corresponding author), ARS, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA.	mlc68@cornell.edu; smg3@cornell.edu			USDA NRI Grant [2007-04567]; NSF BREAD Grant [IOS-1109989]; NIH Grant [P41 GM103533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	USDA NRI Grant; NSF BREAD Grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	USDA NRI Grant 2007-04567, NSF BREAD Grant IOS-1109989, and NIH Grant P41 GM103533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey JL, 1962, TECHNIQUES PROTEIN C, pxii; Bencharki B, 2010, MOL PLANT MICROBE IN, V23, P799, DOI 10.1094/MPMI-23-6-0799; Benitez-Alfonso Y, 2009, P NATL ACAD SCI USA, V106, P3615, DOI 10.1073/pnas.0808717106; Bereman MS, 2012, PROTEOMICS, V12, P1134, DOI 10.1002/pmic.201200042; Biro J, 2012, PLANT PHYSIOL BIOCH, V52, P162, DOI 10.1016/j.plaphy.2011.12.010; Brizard JP, 2006, MOL CELL PROTEOMICS, V5, P2279, DOI 10.1074/mcp.M600173-MCP200; Bruyere A, 1997, VIROLOGY, V230, P323, DOI 10.1006/viro.1997.8476; Burrows ME, 2007, HEREDITY, V98, P106, DOI 10.1038/sj.hdy.6800909; Burrows ME, 2006, PHYTOPATHOLOGY, V96, P828, DOI 10.1094/PHYTO-96-0828; CECIL R, 1955, BIOCHEM J, V60, P496, DOI 10.1042/bj0600496; Chavez JD, 2012, J PROTEOME RES, V11, P2968, DOI 10.1021/pr300041t; Chay CA, 1996, VIROLOGY, V219, P57, DOI 10.1006/viro.1996.0222; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Cilia M, 2011, J VIROL, V85, P2148, DOI 10.1128/JVI.01504-10; Cilia M, 2011, J INSECT PHYSIOL, V57, P179, DOI 10.1016/j.jinsphys.2010.11.001; Cilia M, 2009, J Biomol Tech, V20, P201; Cilia M, 2012, J INTEGR AGR, V11, P249, DOI 10.1016/S2095-3119(12)60009-4; Cilia M, 2011, PROTEOMICS, V11, P2440, DOI 10.1002/pmic.201000519; Cilia ML, 2004, CURR OPIN CELL BIOL, V16, P500, DOI 10.1016/j.ceb.2004.08.002; Cristea IM, 2006, J BIOL CHEM, V281, P30269, DOI 10.1074/jbc.M603980200; Cristea IM, 2010, J VIROL, V84, P7803, DOI 10.1128/JVI.00139-10; Cristea IM, 2010, J VIROL, V84, P6720, DOI 10.1128/JVI.01983-09; Dafoe NJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-191; Dafoe NJ, 2009, J PROTEOME RES, V8, P2341, DOI 10.1021/pr800968r; DAMSTEEGT VD, 1992, PLANT DIS, V76, P1155, DOI 10.1094/PD-76-1155; Dong AW, 2005, PLANT PHYSIOL, V138, P1446, DOI 10.1104/pp.105.060509; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; FILICHKIN SA, 1994, VIROLOGY, V205, P290, DOI 10.1006/viro.1994.1645; Fridborg I, 2003, MOL PLANT MICROBE IN, V16, P132, DOI 10.1094/MPMI.2003.16.2.132; Fujiki Y, 2002, PLANT CELL PHYSIOL, V43, P275, DOI 10.1093/pcp/pcf032; Gildow F.E., 1987, Current Topics in Vector Research, V4, P93; GILDOW FE, 1980, VIROLOGY, V104, P97, DOI 10.1016/0042-6822(80)90368-2; GILL CC, 1975, VIROLOGY, V66, P440, DOI 10.1016/0042-6822(75)90216-0; Glanz S, 2006, NUCLEIC ACIDS RES, V34, P5337, DOI 10.1093/nar/gkl611; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Gray Stewart M, 2008, Curr Protoc Microbiol, VChapter 16, DOI 10.1002/9780471729259.mc16b01s10; HAMMOND J, 1983, J GEN VIROL, V64, P667, DOI 10.1099/0022-1317-64-3-667; Haupt S, 2005, J GEN VIROL, V86, P2891, DOI 10.1099/vir.0.81101-0; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; HULL R, 1977, VIROLOGY, V79, P58, DOI 10.1016/0042-6822(77)90334-8; Iglesias VA, 2000, PLANT J, V21, P157, DOI 10.1046/j.1365-313x.2000.00658.x; Jarsch IK, 2011, MOL PLANT MICROBE IN, V24, P7, DOI 10.1094/MPMI-07-10-0166; Kaplan IB, 2007, J GEN VIROL, V88, P1821, DOI 10.1099/vir.0.82837-0; Karren JB, 1993, UTAH STATE U EXTENSI; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lam WS, 2005, J CELL SCI, V118, P3037, DOI 10.1242/jcs.02443; Lee L, 2005, J VIROL, V79, P1207, DOI 10.1128/JVI.79.2.1207-1214.2005; Li CY, 2001, VIROLOGY, V286, P125, DOI 10.1006/viro.2001.0929; Lin MK, 2009, MOL CELL PROTEOMICS, V8, P343, DOI 10.1074/mcp.M800420-MCP200; Liu X, 2011, J CHEM ECOL, V37, P472, DOI 10.1007/s10886-011-9949-9; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matthews REF, 2002, MATTHEWS PLANT VIROL, P75; MCPHEE JR, 1956, BIOCHEM J, V64, P22, DOI 10.1042/bj0640022; OLSON AJ, 1983, J MOL BIOL, V171, P61, DOI 10.1016/S0022-2836(83)80314-3; Papura D, 2002, ARCH VIROL, V147, P1881, DOI 10.1007/s00705-002-0859-6; Peiffer ML, 1997, J GEN VIROL, V78, P495, DOI 10.1099/0022-1317-78-3-495; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peter KA, 2009, J VIROL, V83, P5419, DOI 10.1128/JVI.02312-08; Peter KA, 2008, J GEN VIROL, V89, P2037, DOI 10.1099/vir.0.83625-0; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; PIERPOINT WS, 1966, BIOCHEM J, V98, P567, DOI 10.1042/bj0980567; Prakash A, 2009, J PROTEOME RES, V8, P2733, DOI 10.1021/pr801028b; Raffaele S, 2009, PLANT SIGNAL BEHAV, V4; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; Raffaele S, 2009, PLANT CELL, V21, P1541, DOI 10.1105/tpc.108.064279; REUTENAUER A, 1993, VIROLOGY, V195, P692, DOI 10.1006/viro.1993.1420; Revollon S, 2010, VIROLOGY, V402, P303, DOI 10.1016/j.virol.2010.03.037; RICHMOND V, 1966, BIOCHIM BIOPHYS ACTA, V127, P499, DOI 10.1016/0304-4165(66)90403-X; ROBINSON IK, 1982, NATURE, V297, P563, DOI 10.1038/297563a0; ROCHOW WF, 1964, VIROLOGY, V24, P310, DOI 10.1016/0042-6822(64)90169-2; Rojo E, 2002, PLANT CELL, V14, P969, DOI 10.1105/tpc.002196; Salazar L., 1997, TECHNIQUES PLANT VIR; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Seddas P, 2006, ARCH VIROL, V151, P967, DOI 10.1007/s00705-005-0669-8; Seddas P, 2004, VIROLOGY, V325, P399, DOI 10.1016/j.virol.2004.05.014; SILVA AM, 1987, J MOL BIOL, V197, P69, DOI 10.1016/0022-2836(87)90610-3; Sozzani R, 2010, NATURE, V466, P128, DOI 10.1038/nature09143; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; THANNHAUSER TW, 1985, BIOCHEMISTRY-US, V24, P7681, DOI 10.1021/bi00347a027; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; THANNHAUSER TW, 1987, METHOD ENZYMOL, V143, P115; TOLIN SA, 1983, PHYTOPATHOLOGY, V73, P899, DOI 10.1094/Phyto-73-899; Tomazela DM, 2010, ANAL CHEM, V82, P2561, DOI 10.1021/ac1001433; VANRENSB.NJ, 1967, ARCH BIOCHEM BIOPHYS, V121, P729, DOI 10.1016/0003-9861(67)90060-4; WANG JY, 1995, VIROLOGY, V206, P954, DOI 10.1006/viro.1995.1018; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yang XL, 2008, J VIROL, V82, P291, DOI 10.1128/JVI.01736-07; Zhang X, 2010, P NATL ACAD SCI USA, V107, P6292, DOI 10.1073/pnas.0913403107	93	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48177	10.1371/journal.pone.0048177	http://dx.doi.org/10.1371/journal.pone.0048177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118947	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705600027
J	Sobrero, P; Schluter, JP; Lanner, U; Schlosser, A; Becker, A; Valverde, C				Sobrero, Patricio; Schlueter, Jan-Philip; Lanner, Ulrike; Schlosser, Andreas; Becker, Anke; Valverde, Claudio			Quantitative Proteomic Analysis of the Hfq-Regulon in Sinorhizobium meliloti 2011	PLOS ONE			English	Article							RNA CHAPERONE HFQ; GLUTAMINE-SYNTHETASE; STRESS RESISTANCE; GENE-EXPRESSION; MESSENGER-RNAS; SOLUBLE-RNAS; CELL-CULTURE; AMINO-ACIDS; PROTEIN; BINDING	Riboregulation stands for RNA-based control of gene expression. In bacteria, small non-coding RNAs (sRNAs) are a major class of riboregulatory elements, most of which act at the post-transcriptional level by base-pairing target mRNA genes. The RNA chaperone Hfq facilitates antisense interactions between target mRNAs and regulatory sRNAs, thus influencing mRNA stability and/or translation rate. In the alpha-proteobacterium Sinorhizobium meliloti strain 2011, the identification and detection of multiple sRNAs genes and the broadly pleitropic phenotype associated to the absence of a functional Hfq protein both support the existence of riboregulatory circuits controlling gene expression to ensure the fitness of this bacterium in both free living and symbiotic conditions. In order to identify target mRNAs subject to Hfq-dependent riboregulation, we have compared the proteome of an hfq mutant and the wild type S. meliloti by quantitative proteomics following protein labelling with N-15. Among 2139 univocally identified proteins, a total of 195 proteins showed a differential abundance between the Hfq mutant and the wild type strain; 65 proteins accumulated >= 2-fold whereas 130 were downregulated (<= 0.5-fold) in the absence of Hfq. This profound proteomic impact implies a major role for Hfq on regulation of diverse physiological processes in S. meliloti, from transport of small molecules to homeostasis of iron and nitrogen. Changes in the cellular levels of proteins involved in transport of nucleotides, peptides and amino acids, and in iron homeostasis, were confirmed with phenotypic assays. These results represent the first quantitative proteomic analysis in S. meliloti. The comparative analysis of the hfq mutant proteome allowed identification of novel strongly Hfq-regulated genes in S. meliloti.	[Sobrero, Patricio; Valverde, Claudio] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Lab Bioquim Microbiol & Interacc Biol Suelo, Buenos Aires, DF, Argentina; [Schlueter, Jan-Philip; Becker, Anke] Univ Freiburg, Inst Biol 3, Freiburg, Germany; [Lanner, Ulrike; Schlosser, Andreas] Ctr Biol Syst Anal ZBSA, Core Facil Prote, Freiburg, Germany	University of Freiburg	Valverde, C (corresponding author), Univ Nacl Quilmes, Dept Ciencia & Tecnol, Lab Bioquim Microbiol & Interacc Biol Suelo, Buenos Aires, DF, Argentina.	cvalver@unq.edu.ar	Valverde, Claudio F/I-3375-2019	Sobrero, Patricio Martin/0000-0002-3923-8038; Valverde, Claudio/0000-0001-8296-1291; Becker, Anke/0000-0003-4561-9184	ANPCyT, Argentina [PICT 2007-700, PME 2006-1730]; CONICET, Argentina [PIP 2009-2271]; Universidad Nacional de Quilmes, Argentina [PUNQ 0395/07]; German Research Foundation [SPP 1258]; DAAD-MINCyT, Germany-Argentina joint project [DA/09/08]	ANPCyT, Argentina(ANPCyT); CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Quilmes, Argentina; German Research Foundation(German Research Foundation (DFG)); DAAD-MINCyT, Germany-Argentina joint project	This work was supported by grants PICT 2007-700 and PME 2006-1730 (ANPCyT, Argentina), PIP 2009-2271 (CONICET, Argentina), PUNQ 0395/07 (Universidad Nacional de Quilmes, Argentina), priority programme SPP 1258 (German Research Foundation) and DA/09/08 (DAAD-MINCyT, Germany-Argentina joint project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002138; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Auweter SD, 2011, J BIOL CHEM, V286, P24023, DOI 10.1074/jbc.M111.224600; Balbontin R, 2010, MOL MICROBIOL, V78, P380, DOI 10.1111/j.1365-2958.2010.07342.x; Barra-Bily L, 2010, J BACTERIOL, V192, P1719, DOI 10.1128/JB.01429-09; Barra-Bily L, 2010, J BACTERIOL, V192, P1710, DOI 10.1128/JB.01427-09; Beisel CL, 2010, FEMS MICROBIOL REV, V34, P866, DOI 10.1111/j.1574-6976.2010.00241.x; BENDER RA, 1977, J BACTERIOL, V129, P1001, DOI 10.1128/JB.129.2.1001-1009.1977; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Caswell CC, 2012, MOL MICROBIOL, V85, P345, DOI 10.1111/j.1365-2958.2012.08117.x; Chao TC, 2005, APPL ENVIRON MICROB, V71, P5969, DOI 10.1128/AEM.71.10.5969-5982.2005; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Deak V, 2010, J BACTERIOL, V192, P1617, DOI 10.1128/JB.01335-09; del Val C, 2007, MOL MICROBIOL, V66, P1080, DOI 10.1111/j.1365-2958.2007.05978.x; del Val C, 2012, RNA BIOL, V9, P119, DOI 10.4161/rna.18643; Diestra E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008301; Dietrich M, 2009, FEBS J, V276, P5507, DOI 10.1111/j.1742-4658.2009.07234.x; Eggenhofer E, 2004, MOL MICROBIOL, V52, P701, DOI 10.1111/j.1365-2958.2004.04022.x; Emadali A, 2009, M S-MED SCI, V25, P835, DOI 10.1051/medsci/20092510835; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gao MS, 2010, MOL PLANT MICROBE IN, V23, P355, DOI 10.1094/MPMI-23-4-0355; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Gibson KE, 2007, J BACTERIOL, V189, P3591, DOI 10.1128/JB.01834-06; Ikeda Y, 2011, MOL MICROBIOL, V79, P419, DOI 10.1111/j.1365-2958.2010.07454.x; Johnston AWB, 2007, BIOMETALS, V20, P501, DOI 10.1007/s10534-007-9085-8; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; KAMINSKI PA, 1994, P NATL ACAD SCI USA, V91, P4663, DOI 10.1073/pnas.91.11.4663; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert A, 2001, J BACTERIOL, V183, P4709, DOI 10.1128/JB.183.16.4709-4717.2001; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mauchline TH, 2006, P NATL ACAD SCI USA, V103, P17933, DOI 10.1073/pnas.0606673103; McIntosh M, 2008, J BACTERIOL, V190, P5308, DOI 10.1128/JB.00063-08; MEADE HM, 1977, P NATL ACAD SCI USA, V74, P2076, DOI 10.1073/pnas.74.5.2076; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Mulley G, 2011, MOL MICROBIOL, V80, P149, DOI 10.1111/j.1365-2958.2011.07565.x; Nogales J, 2009, FEMS MICROBIOL LETT, V293, P177, DOI 10.1111/j.1574-6968.2009.01527.x; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Otto A, 2012, CURR OPIN MICROBIOL; Platero R, 2004, APPL ENVIRON MICROB, V70, P4349, DOI 10.1128/AEM.70.7.4349-4355.2004; Povolo S, 2000, ARCH MICROBIOL, V174, P42, DOI 10.1007/s002030000171; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Rodionov DA, 2006, PLOS COMPUT BIOL, V2, P1568, DOI 10.1371/journal.pcbi.0020163; Salvail H, 2012, WIRES RNA, V3, P26, DOI 10.1002/wrna.102; Santos MR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-180; Schinko E, 2009, PHYTOCHEMISTRY, V70, P1787, DOI 10.1016/j.phytochem.2009.09.002; Schluter JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-245; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sobrero P, 2012, CRIT REV MICROBIOL; Sobrero P, 2011, ARCH MICROBIOL, V193, P629, DOI 10.1007/s00203-011-0701-1; SOMERVILLE JE, 1983, J BACTERIOL, V156, P168, DOI 10.1128/JB.156.1.168-176.1983; Soufi B, 2010, J PROTEOME RES, V9, P3638, DOI 10.1021/pr100150w; Sousa SA, 2010, MICROBIOL-SGM, V156, P896, DOI 10.1099/mic.0.035139-0; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Taga ME, 2010, MOL PLANT MICROBE IN, V23, P1643, DOI 10.1094/MPMI-07-10-0151; TOMASZ A, 1960, P NATL ACAD SCI USA, V46, P324, DOI 10.1073/pnas.46.3.324; Torres-Quesada O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-71; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Valverde C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-416; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Vogels MW, 2011, PROTEOMICS, V11, P4477, DOI 10.1002/pmic.201100224; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilms I, 2011, MOL MICROBIOL, V80, P492, DOI 10.1111/j.1365-2958.2011.07589.x; Yurgel SN, 2011, MOL PLANT MICROBE IN; Yurgel SN, 2010, J BACTERIOL, V192, P2473, DOI 10.1128/JB.01657-09; Yurgel SN, 2008, P NATL ACAD SCI USA, V105, P18958, DOI 10.1073/pnas.0808048105; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	78	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48494	10.1371/journal.pone.0048494	http://dx.doi.org/10.1371/journal.pone.0048494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119037	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600048
J	Zaldumbide, A; Carlotti, F; Goncalves, MA; Knaan-Shanzer, S; Cramer, SJ; Roep, BO; Wiertz, EJHJ; Hoeben, RC				Zaldumbide, Arnaud; Carlotti, Francoise; Goncalves, Manuel A.; Knaan-Shanzer, Shoshan; Cramer, Steve J.; Roep, Bart O.; Wiertz, Emmanuel J. H. J.; Hoeben, Rob C.			Adenoviral Vectors Stimulate Glucagon Transcription in Human Mesenchymal Stem Cells Expressing Pancreatic Transcription Factors	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; ISLET-LIKE CLUSTERS; IN-VITRO; PRECURSOR CELLS; STROMAL CELLS; BETA-CELLS; PROTEIN; GENERATION; LIVER; REPLICATION	Viral gene carriers are being widely used as gene transfer systems in (trans) differentiation and reprogramming strategies. Forced expression of key regulators of pancreatic differentiation in stem cells, liver cells, pancreatic duct cells, or cells from the exocrine pancreas, can lead to the initiation of endocrine pancreatic differentiation. While several viral vector systems have been employed in such studies, the results reported with adenovirus vectors have been the most promising in vitro and in vivo. In this study, we examined whether the viral vector system itself could impact the differentiation capacity of human bone-marrow derived mesenchymal stem cells (hMSCs) toward the endocrine lineage. Lentivirus-mediated expression of Pdx-1, Ngn-3, and Maf-A alone or in combination does not lead to robust expression of any of the endocrine hormones (i.e. insulin, glucagon and somatostatin) in hMSCs. Remarkably, subsequent transduction of these genetically modified cells with an irrelevant early region 1 (E1)-deleted adenoviral vector potentiates the differentiation stimulus and promotes glucagon gene expression in hMSCs by affecting the chromatin structure. This adenovirus stimulation was observed upon infection with an E1-deleted adenovirus vector, but not after exposure to helper-dependent adenovirus vectors, pointing at the involvement of genes retained in the E1-deleted adenovirus vector in this phenomenon. Lentivirus mediated expression of the adenovirus E4-ORF3 mimics the adenovirus effect. From these data we conclude that E1-deleted adenoviral vectors are not inert gene-transfer vectors and contribute to the modulation of the cellular differentiation pathways.	[Zaldumbide, Arnaud; Goncalves, Manuel A.; Knaan-Shanzer, Shoshan; Cramer, Steve J.; Hoeben, Rob C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Carlotti, Francoise] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Roep, Bart O.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Wiertz, Emmanuel J. H. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Zaldumbide, A (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands.	a.zaldumbide@lumc.nl	Roep, Bart/AAD-7609-2021; Goncalves, Manuel AFV/V-2248-2019; Hoeben, Rob C./A-5771-2008; Carlotti, Françoise/H-1060-2014; Carlotti, Françoise/AAN-5018-2021	Goncalves, Manuel AFV/0000-0002-8111-1073; Hoeben, Rob C./0000-0001-9443-8377; Carlotti, Françoise/0000-0001-7929-8468; Carlotti, Françoise/0000-0001-7929-8468	Dutch Diabetes Research Funds [DFN 2005.00.0212, DFN 2007.00.0015, 2008.40.001]	Dutch Diabetes Research Funds	This work has been supported by the Dutch Diabetes Research Funds (grants DFN 2005.00.0212, DFN 2007.00.0015 and Expert Center Grant 2008.40.001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlotti F, 2005, CANCER GENE THER, V12, P627, DOI 10.1038/sj.cgt.7700825; Carlotti F, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/892453; Carlotti F, 2010, ISLETS, V2, P164, DOI 10.4161/isl.2.3.11449; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Fallaux FJ, 1998, HUM GENE THER, V9, P1909, DOI 10.1089/hum.1998.9.13-1909; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Goncalves MAFV, 2002, J VIROL, V76, P10734, DOI 10.1128/JVI.76.21.10734-10744.2002; Goncalves MAFV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003084; Goodrum FD, 1999, J VIROL, V73, P7474, DOI 10.1128/JVI.73.9.7474-7488.1999; Gorisch SM, 2004, P NATL ACAD SCI USA, V101, P13221, DOI 10.1073/pnas.0402958101; Greer AE, 2011, VIROLOGY, V417, P161, DOI 10.1016/j.virol.2011.05.017; Havenga MJE, 2001, J VIROL, V75, P3335, DOI 10.1128/JVI.75.7.3335-3342.2001; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Holkers M, 2006, BIOTECHNIQUES, V41, P711, DOI 10.2144/000112307; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Knaan-Shanzer S, 2005, STEM CELLS, V23, P1598, DOI 10.1634/stemcells.2005-0016; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Li YH, 2007, J CELL PHYSIOL, V211, P36, DOI 10.1002/jcp.20897; Limbert C, 2011, CYTOTHERAPY, V13, P802, DOI 10.3109/14653249.2011.571248; Martina Y, 2007, VIRUS RES, V130, P71, DOI 10.1016/j.virusres.2007.05.019; Moriscot C, 2005, STEM CELLS, V23, P594, DOI 10.1634/stemcells.2004-0123; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Mosley AL, 2003, J BIOL CHEM, V278, P19660, DOI 10.1074/jbc.M212375200; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Mutskov V, 2007, STEM CELLS, V25, P3223, DOI 10.1634/stemcells.2007-0325; Patsalo V, 2012, J BIOL CHEM, V287, P22573, DOI 10.1074/jbc.M112.344234; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Shepard RN, 2004, J VIROL, V78, P9924, DOI 10.1128/JVI.78.18.9924-9935.2004; Shepard RN, 2003, J VIROL, V77, P8593, DOI 10.1128/JVI.77.15.8593-8595.2003; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Tang Xiao-long, 2011, Beijing Da Xue Xue Bao Yi Xue Ban, V43, P421; Tauber B, 2001, GENE, V278, P1, DOI 10.1016/S0378-1119(01)00722-3; Tayaramma T, 2006, STEM CELLS, V24, P2858, DOI 10.1634/stemcells.2006-0109; Ullman AJ, 2008, J VIROL, V82, P7325, DOI 10.1128/JVI.00723-08; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Wilson LM, 2009, STEM CELLS, V27, P2703, DOI 10.1002/stem.229; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	45	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48093	10.1371/journal.pone.0048093	http://dx.doi.org/10.1371/journal.pone.0048093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110179	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500034
J	Jones, SG; Kulldorff, M				Jones, Stephen G.; Kulldorff, Martin			Influence of Spatial Resolution on Space-Time Disease Cluster Detection	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE; HEALTH; EXAMPLE; TESTS; POWER; CARE	Background: Utilizing highly precise spatial resolutions within disease outbreak detection, such as the patients' address, is most desirable as this provides the actual residential location of the infected individual(s). However, this level of precision is not always readily available or only available for purchase, and when utilized, increases the risk of exposing protected health information. Aggregating data to less precise scales (e.g., ZIP code or county centroids) may mitigate this risk but at the expense of potentially masking smaller isolated high risk areas. Methods: To experimentally examine the effect of spatial data resolution on space-time cluster detection, we extracted administrative medical claims data for 122500 viral lung episodes occurring during 2007-2010 in Tennessee. We generated 10000 spatial datasets with varying cluster location, size and intensity at the address-level. To represent spatial data aggregation (i.e., reduced resolution), we then created 10000 corresponding datasets both at the ZIP code and county level for a total of 30000 datasets. Using the space-time permutation scan statistic and the SaTScan (TM) cluster software, we evaluated statistical power, sensitivity and positive predictive values of outbreak detection when using exact address locations compared to ZIP code and county level aggregations. Results: The power to detect disease outbreaks did not largely diminish when using spatially aggregated data compared to more precise address information. However, aggregations negatively impacted the ability to more accurately determine the exact spatial location of the outbreak, particularly in smaller clusters (<800 km(2)). Conclusions: Spatial aggregations do not necessitate a loss of power or sensitivity; rather, the relationship is more complex and involves simultaneously considering relative risk within the cluster and cluster size. The likelihood of spatially over-estimating outbreaks by including geographical areas outside the actual disease cluster increases with aggregated data.	[Jones, Stephen G.] BlueCross BlueShield Tennessee, Dept Med Informat, Chattanooga, TN USA; [Kulldorff, Martin] Harvard Univ, Sch Med, Dept Populat Sci, Boston, MA USA; [Kulldorff, Martin] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Jones, SG (corresponding author), BlueCross BlueShield Tennessee, Dept Med Informat, Chattanooga, TN USA.	stephen_jones@bcbst.com		Kulldorff, Martin/0000-0002-5284-2993	National Cancer Institute [R01CA165057]; NATIONAL CANCER INSTITUTE [R01CA165057] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	SJ received no funding to conduct this study but was employed by BCBST at the time of study completion. MK was funded by the National Cancer Institute grant# R01CA165057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AM, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-6; Armstrong MP, 1999, STAT MED, V18, P497, DOI 10.1002/(SICI)1097-0258(19990315)18:5<497::AID-SIM45>3.3.CO;2-R; Duncan G., 1991, STAT SCI, V6, P219, DOI DOI 10.1214/SS/1177011681; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; Eisen RJ, 2006, AM J TROP MED HYG, V75, P669, DOI 10.4269/ajtmh.2006.75.669; Huang L, 2007, BIOMETRICS, V63, P109, DOI 10.1111/j.1541-0420.2006.00661.x; Jeffery C, 2009, J AM MED INFORM ASSN, V16, P847, DOI 10.1197/jamia.M2788; Jones SG, 2012, JAMIA IN PRESS; Jones SG, 2012, SPAT SPATIO-TEMPORAL, V3, P205, DOI 10.1016/j.sste.2012.01.001; Jones SG, 2010, HEALTH SERV RES, V45, P316, DOI 10.1111/j.1475-6773.2009.01044.x; Kleinman K, 2004, AM J EPIDEMIOL, V159, P217, DOI 10.1093/aje/kwh029; Koo D, 1999, Eff Clin Pract, V2, P247; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 2003, COMPUT STAT DATA AN, V42, P665, DOI 10.1016/S0167-9473(02)00160-3; Kulldorff M, 2010, SATSCAN SOFTW SPAT S; Kwan M, 2004, CARTOGRAPHICA, V39, P15, DOI DOI 10.3138/X204-4223-57MK-8273; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Mostashari F, 2003, EMERG INFECT DIS, V9, P641; Olson KL, 2006, AM J PUBLIC HEALTH, V96, P2002, DOI 10.2105/AJPH.2005.069526; Ozonoff A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-52; Platt R, 2003, J URBAN HEALTH, V80, pI25; Rutherford GW, 1998, AM J PREV MED, V14, P53, DOI 10.1016/S0749-3797(97)00039-1; Schmiedel S, 2012, SPAT SPATIO-TEMPORAL, V3, P235, DOI 10.1016/j.sste.2012.02.011; Song C, 2003, INT J HEALTH GEOGR, V2, P9, DOI [10.1186/1476-072X-2-9, DOI 10.1186/1476-072X-2-9]; US Census Bureau, 2009, 2005 2009 AM COMM SU; Yih W Katherine, 2004, MMWR Suppl, V53, P43	26	34	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48036	10.1371/journal.pone.0048036	http://dx.doi.org/10.1371/journal.pone.0048036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110167	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200141
J	Ma, DY; Zhang, KX; Zhang, MY; Xin, SN; Liu, XL; Han, ZX; Shao, YH; Liu, SW				Ma, Deying; Zhang, Kexin; Zhang, Mingyue; Xin, Shengnan; Liu, Xiaoli; Han, Zongxi; Shao, Yuhao; Liu, Shengwang			Identification, Expression and Activity Analyses of Five Novel Duck Beta-Defensins	PLOS ONE			English	Article							RICH ANTIMICROBIAL PEPTIDES; SALMONELLA-ENTERITIDIS; HUMAN BETA-DEFENSIN-2; INFLUENZA-VIRUS; ANTIBACTERIAL; PERSPECTIVE; DISCOVERY; PROTEIN; HBD-1	In the current study, five novel avian beta-defensins (AvBDs) were identified and characterized in tissues from Peking ducks (Anas platyrhynchos). The nucleotide sequences of these cDNAs comprised 198 bp, 182 bp, 201 bp, 204 bp, and 168 bp, and encoded 65, 60, 66, 67, and 55 amino acids, respectively. Homology, characterization and comparison of these genes with AvBD from other avian species confirmed that they were Apl_AvBD1, 3, 5, 6, and 16. Recombinant AvBDs were produced and purified by expressing these genes in Escherichia coli. In addition, peptides were synthesized according to the respective AvBD sequences. Investigation of the antibacterial activity of the Apl_AvBDs showed that all of them exhibited antibacterial activity against all 12 bacteria investigated (P<0.05 or P<0.01). In addition, the antibacterial activity of all of the AvBDs against M. tetragenus and P. multocida decreased significantly in the presence of 150 mM NaCl (P<0.01). None of the AvBDs showed hemolytic activity. Consistent with their broad-spectrum antibacterial activity, the five novel Apl_AvBDs inhibited replication of duck hepatitis virus (DHV) in vitro significantly (P<0.05). The mRNA expression of all five Apl_AvBD in most tissues, including immune organs and the liver, was upregulated in response to DHV infection at different time points. These findings provide evidence that these defensins activate the immune response to combat microbial infection.	[Ma, Deying; Zhang, Kexin; Zhang, Mingyue; Xin, Shengnan] NE Agr Univ, Colleage Anim Sci & Technol, Harbin, Peoples R China; [Zhang, Kexin; Zhang, Mingyue; Xin, Shengnan; Liu, Xiaoli; Han, Zongxi; Shao, Yuhao; Liu, Shengwang] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Ma, DY (corresponding author), NE Agr Univ, Colleage Anim Sci & Technol, Harbin, Peoples R China.	mdy296@yahoo.cn; swliu@hvri.ac.cn	Zhang, Mingyue/AAV-1264-2021; zhang, ke/AAH-8217-2019; Liu, Xiaoli/HGE-7614-2022		National Natural Science Foundation of China [30972110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (30972110). The funder had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian A, 2001, REGUL PEPTIDES, V101, P157, DOI 10.1016/S0167-0115(01)00282-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chong KT, 2008, VIROLOGY, V380, P136, DOI 10.1016/j.virol.2008.07.024; Chong KT, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-75; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594; Grubor B, 2004, CLIN DIAGN LAB IMMUN, V11, P599, DOI 10.1128/CDLI.11.3.599-607.2004; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; Ma DY, 2008, PROTEIN EXPRES PURIF, V58, P284, DOI 10.1016/j.pep.2007.11.017; Ma DY, 2009, J MICROBIOL BIOTECHN, V19, P1447, DOI 10.4014/jmb.0904.04028; Ma DY, 2012, J PEPT SCI, V18, P224, DOI 10.1002/psc.1437; Ma DY, 2012, COMP IMMUNOL MICROB, V35, P197, DOI 10.1016/j.cimid.2012.01.006; Ma DY, 2011, MOL IMMUNOL, V49, P84, DOI 10.1016/j.molimm.2011.07.019; Ma DY, 2009, J MICROBIOL, V47, P610, DOI 10.1007/s12275-009-0068-z; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; RODRIGUE DC, 1990, EPIDEMIOL INFECT, V105, P21, DOI 10.1017/S0950268800047609; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Sadeyen JR, 2006, MICROBES INFECT, V8, P1308, DOI 10.1016/j.micinf.2005.12.014; SAS Institute Inc, 1996, SAS US GUID STAT; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shin SY, 2001, BIOCHEM BIOPH RES CO, V285, P1046, DOI 10.1006/bbrc.2001.5280; Sugiarto H, 2006, INT J ANTIMICROB AG, V27, P229, DOI 10.1016/j.ijantimicag.2005.10.013; van Dijk A, 2008, VET IMMUNOL IMMUNOP, V124, P1, DOI 10.1016/j.vetimm.2007.12.006; Veldhuizen EJA, 2008, MOL IMMUNOL, V45, P386, DOI 10.1016/j.molimm.2007.06.001; Virella-Lowell I, 2000, GENE THER, V7, P1783, DOI 10.1038/sj.gt.3301268; Wang RQ, 2010, APPL MICROBIOL BIOT, V87, P1395, DOI 10.1007/s00253-010-2591-6; White DG, 2001, NEW ENGL J MED, V345, P1147, DOI 10.1056/NEJMoa010315; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yu K, 2002, J PEPT RES, V60, P1, DOI 10.1034/j.1399-3011.2002.01968.x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	38	17	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47743	10.1371/journal.pone.0047743	http://dx.doi.org/10.1371/journal.pone.0047743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112840	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200074
J	Soon, FF; Suino-Powell, KM; Li, J; Yong, EL; Xu, HE; Melcher, K				Soon, Fen-Fen; Suino-Powell, Kelly M.; Li, Jun; Yong, Eu-Leong; Xu, H. Eric; Melcher, Karsten			Abscisic Acid Signaling: Thermal Stability Shift Assays as Tool to Analyze Hormone Perception and Signal Transduction	PLOS ONE			English	Article							STRUCTURAL BASIS; PROTEIN-KINASES; SCREENING METHODS; ABA; IDENTIFICATION; ACTIVATION; MECHANISM; BINDING; OST1; PHOSPHATASES	Abscisic acid (ABA) is a plant hormone that plays important roles in growth and development. ABA is also the central regulator to protect plants against abiotic stresses, such as drought, high salinity, and adverse temperatures, and ABA signaling is therefore a promising biotechnological target for the generation of crops with increased stress resistance. Recently, a core signal transduction pathway has been established, in which ABA receptors, type 2C protein phosphatases, and AMPK-related protein kinases control the regulation of transcription factors, ion channels, and enzymes. Here we use a simple protein thermal stability shift assay to independently validate key aspects of this pathway and to demonstrate the usefulness of this technique to detect and characterize very weak (Kd >= 50 mu M) interactions between receptors and physiological and synthetic agonists, to determine and analyze protein-protein interactions, and to screen small molecule inhibitors.	[Soon, Fen-Fen; Suino-Powell, Kelly M.; Li, Jun; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, NE, Lab Struct Sci, Grand Rapids, MI USA; [Soon, Fen-Fen; Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Natl Univ Hosp, Singapore 117595, Singapore; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, State Key Lab Drug Res,VARISIMM Ctr,Ctr Struct &, Shanghai 200031, Peoples R China	Van Andel Institute; National University of Singapore; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Xu, HE (corresponding author), Van Andel Res Inst, NE, Lab Struct Sci, Grand Rapids, MI USA.	eric.xu@vai.org; Karsten.Melcher@vai.org	Xu, H. Eric/ABD-7487-2021; Melcher, Karsten/AAZ-3861-2020	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Yong, Eu-Leong/0000-0001-6511-770X	Jay and Betty Van Andel Foundation and Amway (China) Limited (HEX); National Institutes of Health (HEX); Singapore Biomedical Research Council (ELY); NUS Graduate School for Integrative Sciences & Engineering (NGS); Singapore National Medical Research Council [R-174-000-137-275]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102545] Funding Source: NIH RePORTER	Jay and Betty Van Andel Foundation and Amway (China) Limited (HEX); National Institutes of Health (HEX)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Biomedical Research Council (ELY); NUS Graduate School for Integrative Sciences & Engineering (NGS); Singapore National Medical Research Council(National Medical Research Council, Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Jay and Betty Van Andel Foundation and Amway (China) Limited (HEX); National Institutes of Health (HEX), and the Singapore Biomedical Research Council (ELY). FFS was supported by an overseas PhD scholarship from the NUS Graduate School for Integrative Sciences & Engineering (NGS) and by a grant from the Singapore National Medical Research Council (R-174-000-137-275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Doyle ML, 2001, CURRENT PROTOCOLS PR, P24; Dupeux F, 2011, PLANT PHYSIOL, V156, P106, DOI 10.1104/pp.110.170894; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Hao Q, 2011, MOL CELL, V42, P662, DOI 10.1016/j.molcel.2011.05.011; Hao Q, 2010, J BIOL CHEM, V285, P28946, DOI 10.1074/jbc.M110.149005; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Indyk L, 1998, METHOD ENZYMOL, V295, P350; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Kelner A, 2004, PLANT PHYSIOL, V136, P3255, DOI 10.1104/pp.104.046151; Kranz JK, 2011, METHOD ENZYMOL, V493, P277, DOI 10.1016/B978-0-12-381274-2.00011-X; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Melcher K, 2010, NAT STRUCT MOL BIOL, V17, P1102, DOI 10.1038/nsmb.1887; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Ng LM, 2011, P NATL ACAD SCI USA, V108, P21259, DOI 10.1073/pnas.1118651109; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peterson FC, 2010, NAT STRUCT MOL BIOL, V17, P1109, DOI 10.1038/nsmb.1898; Phillips Kevin, 2011, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1028s94; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xie T, 2011, J BIOL CHEM; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yuan XQ, 2010, J BIOL CHEM, V285, P28953, DOI 10.1074/jbc.M110.160192; Zubriene A, 2009, INT J MOL SCI, V10, P2662, DOI 10.3390/ijms10062662	47	13	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47857	10.1371/journal.pone.0047857	http://dx.doi.org/10.1371/journal.pone.0047857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112859	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200094
J	Bras, JLA; Alves, VD; Carvalho, AL; Najmudin, S; Prates, JAM; Ferreira, LMA; Bolam, DN; Romao, MJ; Gilbert, HJ; Fontes, CMGA				Bras, Joana L. A.; Alves, Victor D.; Carvalho, Ana Luia; Najmudin, Shabir; Prates, Jose A. M.; Ferreira, Luis M. A.; Bolam, David N.; Romao, Maria Joao; Gilbert, Harry J.; Fontes, Carlos M. G. A.			Novel Clostridium thermocellum Type I Cohesin-Dockerin Complexes Reveal a Single Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CELLULOSOME; SPECIFICITY; INSIGHTS; SYSTEM	Protein-protein interactions play a pivotal role in a large number of biological processes exemplified by the assembly of the cellulosome. Integration of cellulosomal components occurs through the binding of type I cohesin modules located in a non-catalytic molecular scaffold to type I dockerin modules located at the C terminus of cellulosomal enzymes. The majority of type I dockerins display internal symmetry reflected by the presence of two essentially identical cohesin-binding surfaces. Here we report the crystal structures of two novel Clostridium thermocellum type I cohesin-dockerin complexes (CohOlpC-Doc124A and CohOlpA-Doc918). The data revealed that the two dockerins, Doc918 and Doc124A, are unusual because they lack the structural symmetry required to support a dual binding mode. Thus, in both cases, cohesin recognition is dominated by residues located at positions 11, 12, and 19 of one of the dockerin binding surfaces. The alternative binding mode is not possible (Doc918) or highly limited (Doc124A) because residues that assume the critical interacting positions, when dockerins are reoriented by 180, make steric clashes with the cohesin. In common with a third dockerin (Doc258) that also presents a single binding mode, Doc124A directs the appended cellulase, Cel124A, to the surface of C. thermocellum and not to cellulosomes because it binds preferentially to type I cohesins located at the cell envelope. Although there are a few exceptions, such as Doc918 described here, these data suggest that there is considerable selective pressure for the evolution of a dual binding mode in type I dockerins that direct enzymes into cellulosomes.	[Bras, Joana L. A.; Alves, Victor D.; Najmudin, Shabir; Prates, Jose A. M.; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.] Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, P-1300477 Lisbon, Portugal; [Carvalho, Ana Luia; Romao, Maria Joao] FCT UNL, Dept Quim, REQUIMTE CQFB, P-2829516 Caparica, Portugal; [Bolam, David N.; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Universidade de Lisboa; Newcastle University - UK	Alves, VD (corresponding author), Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Sanidade Anim, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	vdalves@fmv.utl.pt; cafontes@fmv.utl.pt	UCIBIO, U Cienc Biom Apl/F-7948-2017; Carvalho, Ana Luísa/G-5638-2011; Prates, José A M/K-9934-2013; Romao, Maria J/A-4115-2013	UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Carvalho, Ana Luísa/0000-0002-3824-0240; Prates, José A M/0000-0003-1032-5987; Romao, Maria J/0000-0002-3004-0543; Ferreira, Luis/0000-0002-3543-9166; Alves, Victor Diogo/0000-0002-8430-4380; Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454; Bras, Joana/0000-0002-1141-5530; Bolam, David/0000-0003-0314-3122	Fundacao para a Ciencia e a Tecnologia [PEst-C/EQB/LA0006/2011, PTDC/BIA-PRO/69732/2006, PTDC/QUI-BIQ/100359/2008, PTDC/BIA-PRO/103980/2008, SFRH/BD/38667/2007]; BBSRC [BB/G016224/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G016224/1] Funding Source: researchfish; Fundação para a Ciência e a Tecnologia [PTDC/QUI-BIQ/100359/2008, PTDC/BIA-PRO/103980/2008, PTDC/BIA-PRO/69732/2006] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e a Tecnologia Grants PEst-C/EQB/LA0006/2011, PTDC/BIA-PRO/69732/2006, PTDC/QUI-BIQ/100359/2008, and PTDC/BIA-PRO/103980/2008.; Supported by Fundacao para a Ciencia e a Tecnologia individual fellowship SFRH/BD/38667/2007.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BAYER EA, 1986, J BACTERIOL, V167, P828, DOI 10.1128/jb.167.3.828-836.1986; Bayer EA, 2008, CHEM REC, V8, P364, DOI 10.1002/tcr.20160; Beguin P, 1998, BIOCHEM SOC T, V26, P178, DOI 10.1042/bst0260178; Bras JLA, 2012, METHOD ENZYMOL, V510, P395, DOI 10.1016/B978-0-12-415931-0.00021-5; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Carvalho AL, 2005, J MOL BIOL, V349, P909, DOI 10.1016/j.jmb.2005.04.037; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leibovitz E, 1996, J BACTERIOL, V178, P3077, DOI 10.1128/jb.178.11.3077-3084.1996; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16165, DOI 10.1073/pnas.0605381103; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Pinheiro BA, 2009, BIOCHEM J, V424, P375, DOI 10.1042/BJ20091152; SALAMITOU S, 1994, J BACTERIOL, V176, P2822, DOI 10.1128/JB.176.10.2822-2827.1994; SALAMITOU S, 1992, FEBS LETT, V304, P89, DOI 10.1016/0014-5793(92)80595-8; TOKATLIDIS K, 1991, FEBS LETT, V291, P185, DOI 10.1016/0014-5793(91)81279-H; Urzhumtseva L, 2009, ACTA CRYSTALLOGR D, V65, P297, DOI 10.1107/S0907444908044296; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	33	22	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44394	44405		10.1074/jbc.M112.407700	http://dx.doi.org/10.1074/jbc.M112.407700			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23118225	Green Published, hybrid			2022-12-25	WOS:000312938600036
J	Resenberger, UK; Muller, V; Munter, LM; Baier, M; Multhaup, G; Wilson, MR; Winklhofer, KF; Tatzelt, J				Resenberger, Ulrike K.; Mueller, Veronika; Munter, Lisa M.; Baier, Michael; Multhaup, Gerd; Wilson, Mark R.; Winklhofer, Konstanze F.; Tatzelt, Joerg			The Heat Shock Response Is Modulated by and Interferes with Toxic Effects of Scrapie Prion Protein and Amyloid beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; IN-VIVO; A-BETA; CAENORHABDITIS-ELEGANS; NEUROBLASTOMA-CELLS; MONOCLONAL-ANTIBODY; IDENTIFIES VARIANTS; MISFOLDED PROTEINS; CHAPERONE PROTEINS	The heat shock response (HSR) is an evolutionarily conserved pathway designed to maintain proteostasis and to ameliorate toxic effects of aberrant protein folding. We have studied the modulation of the HSR by the scrapie prion protein (PrPSc) and amyloid beta peptide (A beta) and investigated whether an activated HSR or the ectopic expression of individual chaperones can interfere with PrPSc- or A beta-induced toxicity. First, we observed different effects on the HSR under acute or chronic exposure of cells to PrPSc or A beta. In chronically exposed cells the threshold to mount a stress response was significantly increased, evidenced by a decreased expression of Hsp72 after stress, whereas an acute exposure lowered the threshold for stress-induced expression of Hsp72. Next, we employed models of PrPSc- and A beta-induced toxicity to demonstrate that the induction of the HSR ameliorates the toxic effects of both PrPSc and A beta. Similarly, the ectopic expression of cytosolic Hsp72 or the extracellular chaperone clusterin protected against PrPSc- or A beta-induced toxicity. However, toxic signaling induced by a pathogenic PrP mutant located at the plasma membrane was prevented by an activated HSR or Hsp72 but not by clusterin, indicating a distinct mode of action of this extracellular chaperone. Our study supports the notion that different pathological protein conformers mediate toxic effects via similar cellular pathways and emphasizes the possibility to exploit the heat shock response therapeutically.	[Resenberger, Ulrike K.; Mueller, Veronika; Winklhofer, Konstanze F.; Tatzelt, Joerg] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Munter, Lisa M.; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Munter, Lisa M.; Multhaup, Gerd] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 0G4, Canada; [Baier, Michael] Robert Koch Inst, D-13302 Berlin, Germany; [Wilson, Mark R.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Winklhofer, Konstanze F.; Tatzelt, Joerg] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany	University of Munich; Free University of Berlin; McGill University; Robert Koch Institute; University of Wollongong; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Tatzelt, J (corresponding author), Univ Munich, Adolf Butenandt Inst, Schillerstr 44, D-80336 Munich, Germany.	Joerg.Tatzelt@med.uni-muenchen.de	Wilson, Mark R/B-3254-2018	Wilson, Mark R/0000-0002-9551-7445; Winklhofer, Konstanze/0000-0002-7256-8231; Munter, Lisa/0000-0001-5736-1462; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft [SFB 596, GRK1123, SFB 740]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	The work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596, GRK1123 (to G. M.) and SFB 740 (to L. M. M. and G. M.)) and by the Max Planck Society.	Alier K, 2011, J NEUROSCI, V31, P16292, DOI 10.1523/JNEUROSCI.4367-11.2011; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; BEHL C, 1993, NEUROSCI LETT, V154, P1, DOI 10.1016/0304-3940(93)90156-F; Beland M, 2012, J NEUROSCI, V32, P13255, DOI 10.1523/JNEUROSCI.2236-12.2012; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Dabbs R. A., 2011, TOP CURR CH IN PRESS; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Freixes M, 2004, ACTA NEUROPATHOL, V108, P295, DOI 10.1007/s00401-004-0891-6; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Humphreys D, 1997, BIOCHEMISTRY-US, V36, P15233, DOI 10.1021/bi9703507; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jurivich D.A., 1994, BIOL HEAT SHOCK PROT, P417; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KENWARD N, 1994, J NEUROCHEM, V62, P1870; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lindquist SL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004507; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Narayan P, 2012, NAT STRUCT MOL BIOL, V19, P79, DOI 10.1038/nsmb.2191; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger UK, 2011, TOP CURR CHEM, V305, P101, DOI 10.1007/128_2011_160; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Sakthivelu V, 2011, J BIOL CHEM, V286, P8901, DOI 10.1074/jbc.M110.185470; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Schatzl HM, 1997, J VIROL, V71, P8821; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; Solomon IH, 2010, CURR ISSUES MOL BIOL, V12, P51; Steele AD, 2008, P NATL ACAD SCI USA, V105, P13626, DOI 10.1073/pnas.0806319105; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Tuite MF, 2011, TOP CURR CHEM, V305, P257, DOI 10.1007/128_2011_172; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; VOELLMY R, 1985, P NATL ACAD SCI USA, V82, P4949, DOI 10.1073/pnas.82.15.4949; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Weissmann C, 1996, COLD SPRING HARB SYM, V61, P511; WELCH WJ, 1986, J CELL BIOL, V103, P2035, DOI 10.1083/jcb.103.5.2035; Welch WJ, 1998, NATURE, V392, P23, DOI 10.1038/32049; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Winklhofer KF, 2000, BIOL CHEM, V381, P463, DOI 10.1515/BC.2000.061; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Winklhofer KF, 2001, J BIOL CHEM, V276, P45160, DOI 10.1074/jbc.M104873200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wyatt AR, 2011, CELL MOL LIFE SCI, V68, P3919, DOI [10.1007/s00018-011-0684-8, 10.1007/s00018-011-0684-8)]; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	103	5	6	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43765	43776		10.1074/jbc.M112.389007	http://dx.doi.org/10.1074/jbc.M112.389007			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115236	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000312940800055
J	Candille, SI; Absher, DM; Beleza, S; Bauchet, M; McEvoy, B; Garrison, NA; Li, JZ; Myers, RM; Barsh, GS; Tang, H; Shriver, MD				Candille, Sophie I.; Absher, Devin M.; Beleza, Sandra; Bauchet, Marc; McEvoy, Brian; Garrison, Nanibaa' A.; Li, Jun Z.; Myers, Richard M.; Barsh, Gregory S.; Tang, Hua; Shriver, Mark D.			Genome-Wide Association Studies of Quantitatively Measured Skin, Hair, and Eye Pigmentation in Four European Populations	PLOS ONE			English	Article							HUMAN IRIS COLOR; GENETIC-DETERMINANTS; RISK; POLYMORPHISMS; EVOLUTION; VARIANTS; LINKAGE; HERC2; MC1R; OCA2	Pigmentation of the skin, hair, and eyes varies both within and between human populations. Identifying the genes and alleles underlying this variation has been the goal of many candidate gene and several genome-wide association studies (GWAS). Most GWAS for pigmentary traits to date have been based on subjective phenotypes using categorical scales. But skin, hair, and eye pigmentation vary continuously. Here, we seek to characterize quantitative variation in these traits objectively and accurately and to determine their genetic basis. Objective and quantitative measures of skin, hair, and eye color were made using reflectance or digital spectroscopy in Europeans from Ireland, Poland, Italy, and Portugal. A GWAS was conducted for the three quantitative pigmentation phenotypes in 176 women across 313,763 SNP loci, and replication of the most significant associations was attempted in a sample of 294 European men and women from the same countries. We find that the pigmentation phenotypes are highly stratified along axes of European genetic differentiation. The country of sampling explains approximately 35% of the variation in skin pigmentation, 31% of the variation in hair pigmentation, and 40% of the variation in eye pigmentation. All three quantitative phenotypes are correlated with each other. In our two-stage association study, we reproduce the association of rs1667394 at the OCA2/HERC2 locus with eye color but we do not identify new genetic determinants of skin and hair pigmentation supporting the lack of major genes affecting skin and hair color variation within Europe and suggesting that not only careful phenotyping but also larger cohorts are required to understand the genetic architecture of these complex quantitative traits. Interestingly, we also see that in each of these four populations, men are more lightly pigmented in the unexposed skin of the inner arm than women, a fact that is underappreciated and may vary across the world.	[Candille, Sophie I.; Beleza, Sandra; Garrison, Nanibaa' A.; Tang, Hua] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Absher, Devin M.; Myers, Richard M.; Barsh, Gregory S.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Bauchet, Marc; Shriver, Mark D.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [McEvoy, Brian] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	Stanford University; HudsonAlpha Institute for Biotechnology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Trinity College Dublin; University of Michigan System; University of Michigan	Candille, SI (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	scand@stanford.edu; huatang@stanford.edu	Garrison, Nanibaa' A./AAT-4477-2020	Garrison, Nanibaa' A./0000-0002-6228-3216; Beleza, Sandra/0000-0002-7004-3431; Shriver, Mark/0000-0003-0006-0479; Li, Jun/0000-0001-6727-0812	Science Foundation of Ireland through the University College Dublin [04.W4/B643]; National Institute Justice [2008-DN-BX-K125]; National Institute of General Medical Sciences (NIGMS) [GM073059]; National Institutes of Health National Human Genome Research Institute [NIH/NHGRI 5 T32 HG000044]; National Research Service Award (NRSA) National Institutes of Health (NIH) [5F31GM76893]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BPD/21887/2005]; Stanford University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073059, F31GM076893] Funding Source: NIH RePORTER	Science Foundation of Ireland through the University College Dublin(Science Foundation Ireland); National Institute Justice(US National Institute of Justice); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Research Service Award (NRSA) National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Stanford University(Stanford University); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This investigation was supported by grants to MDS from the Science Foundation of Ireland Walton Fellowship through the University College Dublin (04.W4/B643) and from the National Institute Justice (2008-DN-BX-K125) and by grant GM073059 from the National Institute of General Medical Sciences (NIGMS) to HT. SIC and NAG were supported by an Institutional Training Grant in Genome Science from the National Institutes of Health National Human Genome Research Institute (NIH/NHGRI 5 T32 HG000044). NAG was also supported by the National Research Service Award (NRSA) National Institutes of Health (NIH) Predoctoral Fellowship Award for Minority Students (5F31GM76893). SB was supported by Fundacao para a Ciencia e Tecnologia (FCT, SFRH/BPD/21887/2005) and the Stanford University Dean's postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; Branicki W, 2011, HUM GENET, V129, P443, DOI 10.1007/s00439-010-0939-8; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; Dessinioti C, 2011, PHOTOCHEM PHOTOBIOL, V87, P978, DOI 10.1111/j.1751-1097.2011.00970.x; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Frudakis T, 2007, HUM GENET, V122, P311, DOI 10.1007/s00439-007-0401-8; Gerstenblith MR, 2010, PIGM CELL MELANOMA R, V23, P587, DOI 10.1111/j.1755-148X.2010.00730.x; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Kayser M, 2008, AM J HUM GENET, V82, P411, DOI 10.1016/j.ajhg.2007.10.003; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Latreille J, 2009, PHOTOCHEM PHOTOBIOL, V85, P1451, DOI 10.1111/j.1751-1097.2009.00594.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000934; Madrigal L, 2007, AM J PHYS ANTHROPOL, V132, P470, DOI 10.1002/ajpa.20453; Moskvina V, 2010, HUM HERED, V70, P141, DOI 10.1159/000313854; Nan HM, 2009, INT J CANCER, V125, P909, DOI 10.1002/ijc.24327; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Norton HL, 2006, AM J PHYS ANTHROPOL, V130, P254, DOI 10.1002/ajpa.20343; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Parra EJ, 2007, YEARB PHYS ANTHROPOL, V50, P85, DOI 10.1002/ajpa.20727; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Shriver MD, 2000, AM J PHYS ANTHROPOL, V112, P17, DOI 10.1002/(SICI)1096-8644(200005)112:1<17::AID-AJPA3>3.0.CO;2-D; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sturm RA, 2009, PIGM CELL MELANOMA R, V22, P544, DOI 10.1111/j.1755-148X.2009.00606.x; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Takiwaki Hirotsugu, 1998, Journal of Medical Investigation, V44, P121; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Walsh S, 2012, FORENSIC SCI INT-GEN, V6, P330, DOI 10.1016/j.fsigen.2011.07.009	48	75	76	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48294	10.1371/journal.pone.0048294	http://dx.doi.org/10.1371/journal.pone.0048294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118974	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500094
J	Chen, JY; Feng, L; Zhang, HL; Li, JC; Yang, XW; Cao, XL; Liu, L; Qin, HY; Liang, YM; Han, H				Chen, Jing-Yuan; Feng, Lei; Zhang, Hai-Long; Li, Jun-Chang; Yang, Xin-Wei; Cao, Xiu-Li; Liu, Li; Qin, Hong-Yan; Liang, Ying-Min; Han, Hua			Differential Regulation of Bone Marrow-Derived Endothelial Progenitor Cells and Endothelial Outgrowth Cells by the Notch Signaling Pathway	PLOS ONE			English	Article							NEOVASCULARIZATION CAPACITY; LIVER-REGENERATION; FACTOR-I; CXCR4; TRANSPLANTATION; ANGIOGENESIS; RECRUITMENT; EXPRESSION; MOBILIZATION; THERAPY	Endothelial progenitor cells (EPCs) are heterogeneous populations of cells that participate in vasculogenesis and promote tissue regeneration. However the different roles of EPC populations in vasculogenesis and tissue regeneration, as well as their regulation and mechanisms remain elusive. In the present study, we cultured bone marrow (BM)-derived early EPCs (EEPCs) and endothelial outgrowth cells (EOCs), and investigated their roles in liver regeneration and their regulation by the Notch signaling pathway. We found that Notch signaling exhibited different effects on the proliferation and migration of EEPCs and EOCs. Our results also showed that while EEPCs failed to form vessel-like structures in a three dimensional sprouting model in vitro, EOCs could sprout and form endothelial cords, and this was regulated by the Notch signaling. We further showed that, by using a conditional knockout model of RBP-J (the critical transcription factor mediating Notch signaling), Notch signaling differentially regulates EEPCs and EOCs. In a partial hepatectomy (PHx) model, EEPCs Notch-dependently benefitted liver regeneration with respect to liver function and hepatocyte proliferation and apoptosis. In contrast, EOCs appeared not directly involved in the recovery of liver function and the increase of hepatocytes. These data suggested that the RBP-J-mediated Notch signaling differentially regulated the two types of EPCs, which showed different roles in liver regeneration.	[Chen, Jing-Yuan; Liu, Li; Liang, Ying-Min; Han, Hua] Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710032, Peoples R China; [Feng, Lei; Zhang, Hai-Long; Li, Jun-Chang; Yang, Xin-Wei; Cao, Xiu-Li; Qin, Hong-Yan; Han, Hua] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Chen, JY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710032, Peoples R China.	liangym@fmmu.edu.cn; huahan@fmmu.edu.cn			National Natural Science Foundation of China [30830067, 30871090, 81072972, 30873229]; Ministry of Science and Technology of China [2009CB521706, 2011ZXJ09101-02C]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the National Natural Science Foundation of China (30830067, 30871090, 81072972, 30873229) and the Ministry of Science and Technology of China (2009CB521706, 2011ZXJ09101-02C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Beaudry P, 2007, J PEDIATR SURG, V42, P1190, DOI 10.1016/j.jpedsurg.2007.02.034; Beeres SLMA, 2008, HEART, V94, P1214, DOI 10.1136/hrt.2008.149476; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; George AL, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-24; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hatch Heather M., 2002, Cloning and Stem Cells, V4, P339, DOI 10.1089/153623002321025014; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ishikawa M, 2004, STEM CELLS DEV, V13, P344, DOI 10.1089/1547328041797435; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Mavier P, 2004, AM J PATHOL, V165, P1969, DOI 10.1016/S0002-9440(10)63248-8; Medina RJ, 2011, MOL MED, V17, P1045, DOI 10.2119/molmed.2011.00129; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Nakamura T, 2007, GASTROENTEROLOGY, V133, P91, DOI 10.1053/j.gastro.2007.03.110; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Ueno T, 2006, MED MOL MORPHOL, V39, P16, DOI 10.1007/s00795-006-0311-1; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007572; Wang L, 2009, HEPATOLOGY, V49, P268, DOI 10.1002/hep.22579; Wang YC, 2009, J BIOL CHEM, V284, P15993, DOI 10.1074/jbc.M901144200; Williams CK, 2008, CANCER RES, V68, P1889, DOI 10.1158/0008-5472.CAN-07-2181; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Zhang SJ, 2006, CELL RES, V16, P577, DOI 10.1038/sj.cr.7310075	46	7	11	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e43643	10.1371/journal.pone.0043643	http://dx.doi.org/10.1371/journal.pone.0043643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118846	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500002
J	Grycova, L; Holendova, B; Bumba, L; Bily, J; Jirku, M; Lansky, Z; Teisinger, J				Grycova, Lenka; Holendova, Blanka; Bumba, Ladislav; Bily, Jan; Jirku, Michaela; Lansky, Zdenek; Teisinger, Jan			Integrative Binding Sites within Intracellular Termini of TRPV1 Receptor	PLOS ONE			English	Article							VANILLOID RECEPTOR; CAPSAICIN RECEPTOR; PLASMA-MEMBRANE; PAIN PATHWAY; C-TERMINUS; PROTEIN; CALMODULIN; CHANNELS; RECOGNITION; SENSITIVITY	TRPV1 is a nonselective cation channel that integrates wide range of painful stimuli. It has been shown that its activity could be modulated by intracellular ligands PIP2 or calmodulin (CaM). The detailed localization and description of PIP2 interaction sites remain unclear. Here, we used synthesized peptides and purified fusion proteins of intracellular regions of TRPV1 expressed in E. coli in combination with fluorescence anisotropy and surface plasmon resonance measurements to characterize the PIP2 binding to TRPV1. We characterized one PIP2 binding site in TRPV1 N-terminal region, residues F189-V221, and two independent PIP2 binding sites in C-terminus: residues K688-K718 and L777-S820. Moreover we show that two regions, namely F189-V221 and L777-S820, overlap with previously localized CaM binding sites. For all the interactions the equilibrium dissociation constants were estimated. As the structural data regarding C-terminus of TRPV1 are lacking, restraint-based molecular modeling combined with ligand docking was performed providing us with structural insight to the TRPV1/PIP2 binding. Our experimental results are in excellent agreement with our in silico predictions.	[Grycova, Lenka; Holendova, Blanka; Bily, Jan; Jirku, Michaela; Lansky, Zdenek; Teisinger, Jan] Acad Sci Czech Republic, Inst Physiol, Vvi, Prague, Czech Republic; [Bumba, Ladislav] Acad Sci Czech Republic, Inst Microbiol, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Grycova, L (corresponding author), Acad Sci Czech Republic, Inst Physiol, Vvi, Prague, Czech Republic.	l.grycova@biomed.cas.cz; teisingr@biomed.cas.cz	Bumba, Ladislav/ABC-9943-2020; Lansky, Zdenek/M-4548-2014; Bumba, Ladislav/H-2494-2014; Teisinger, Jan/B-7122-2012; Vodičková, Michaela/O-8121-2017; Grycova, Lenka/B-7118-2012; Holendova, Blanka/A-7170-2016	Bumba, Ladislav/0000-0001-6659-5447; Lansky, Zdenek/0000-0001-8474-053X; Vodičková, Michaela/0000-0002-0163-1432; Grycova, Lenka/0000-0002-6476-3627; Holendova, Blanka/0000-0002-3904-8189	 [GACR P205/10/P308];  [GACR 301/10/1159];  [GACR P304/12G069];  [RVO:67985823];  [RVO 61388971]	; ; ; ; 	This project was supported by grants GACR P205/10/P308, GACR 301/10/1159 and GACR P304/12G069(http://www.gacr.cz/), RVO:67985823, RVO 61388971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Dietrich A, 2005, PFLUG ARCH EUR J PHY, V451, P72, DOI 10.1007/s00424-005-1460-0; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Friedlova E, 2010, NEUROCHEM INT, V56, P363, DOI 10.1016/j.neuint.2009.11.009; Grycova L, 2007, ARCH BIOCHEM BIOPHYS, V465, P389, DOI 10.1016/j.abb.2007.06.035; Grycova L, 2008, BIOCHEM BIOPH RES CO, V375, P680, DOI 10.1016/j.bbrc.2008.08.094; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansen SG, 2011, NATURE; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Holakovska B, 2011, AMINO ACIDS, V40, P741, DOI 10.1007/s00726-010-0712-2; Hurley JH, 2001, CURR OPIN CELL BIOL, V13, P146, DOI 10.1016/S0955-0674(00)00191-5; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lima CD, 1997, STRUCTURE, V5, P763, DOI 10.1016/S0969-2126(97)00231-1; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	39	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48437	10.1371/journal.pone.0048437	http://dx.doi.org/10.1371/journal.pone.0048437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119017	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500136
J	Huang, J; Gamble, D; Sarnlertsophon, K; Wang, XQ; Hsiao, S				Huang, Juan; Gamble, Darik; Sarnlertsophon, Kristine; Wang, Xiaoqin; Hsiao, Steven			Feeling Music: Integration of Auditory and Tactile Inputs in Musical Meter Perception	PLOS ONE			English	Article							BEAT PERCEPTION; ASSOCIATION CORTEX; MOTOR; RHYTHMS; PREMOTOR; HEARING; TOUCH; SEE	Musicians often say that they not only hear, but also "feel" music. To explore the contribution of tactile information in "feeling" musical rhythm, we investigated the degree that auditory and tactile inputs are integrated in humans performing a musical meter recognition task. Subjects discriminated between two types of sequences, 'duple' (march-like rhythms) and 'triple' (waltz-like rhythms) presented in three conditions: 1) Unimodal inputs (auditory or tactile alone), 2) Various combinations of bimodal inputs, where sequences were distributed between the auditory and tactile channels such that a single channel did not produce coherent meter percepts, and 3) Simultaneously presented bimodal inputs where the two channels contained congruent or incongruent meter cues. We first show that meter is perceived similarly well (70%-85%) when tactile or auditory cues are presented alone. We next show in the bimodal experiments that auditory and tactile cues are integrated to produce coherent meter percepts. Performance is high (70%-90%) when all of the metrically important notes are assigned to one channel and is reduced to 60% when half of these notes are assigned to one channel. When the important notes are presented simultaneously to both channels, congruent cues enhance meter recognition (90%). Performance drops dramatically when subjects were presented with incongruent auditory cues (10%), as opposed to incongruent tactile cues (60%), demonstrating that auditory input dominates meter perception. We believe that these results are the first demonstration of cross-modal sensory grouping between any two senses.	[Huang, Juan; Sarnlertsophon, Kristine; Hsiao, Steven] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; [Huang, Juan; Sarnlertsophon, Kristine; Hsiao, Steven] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Huang, Juan; Gamble, Darik; Wang, Xiaoqin] Johns Hopkins Univ, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Hsiao, S (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	Steven.Hsiao@jhu.edu			Brain Sciences Institute (BSI) at the Johns Hopkins University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003180] Funding Source: NIH RePORTER	Brain Sciences Institute (BSI) at the Johns Hopkins University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by a grant from the Brain Sciences Institute (BSI) at the Johns Hopkins University. The BSI had no role in the study design, data collection, preparation of the manuscript and analysis or in the decision to publish the findings.	Bendor D, 2006, CURRENT OPINION NEUR, V16; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bresciani JP, 2008, BRAIN RES BULL, V75, P753, DOI 10.1016/j.brainresbull.2008.01.009; Brochard R, 2003, PSYCHOL SCI, V14, P362, DOI 10.1111/1467-9280.24441; Brochard R, 2008, BRAIN RES, V1223, P59, DOI 10.1016/j.brainres.2008.05.050; Caetano G, 2006, NEUROIMAGE, V29, P15, DOI 10.1016/j.neuroimage.2005.07.023; Chubbuck JG, 1966, J HOPKINS APL TE MAY, P18; Clarke Eric F., 1999, PSYCHOL MUSIC, P473, DOI DOI 10.1016/B978-012213564-4/50014-7; Cooper Grosvenor W., 1960, THE RHYTHMIC STRUCTU; Drake C, 2000, MUSIC PERCEPT, V18, P1; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Fraisse P., 1982, PSYCHOL MUSIC, V1, P149, DOI [DOI 10.1016/B978-0-12-213562-0.50010-3, 10.1016/B978-0-12-213562-0.50010-3]; Gobbele R, 2003, NEUROIMAGE, V20, P503, DOI 10.1016/S1053-8119(03)00312-4; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2012, EXP BRAIN RES, V220, P51, DOI 10.1007/s00221-012-3114-8; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hannon EE, 2005, COGNITIVE PSYCHOL, V50, P354, DOI 10.1016/j.cogpsych.2004.09.003; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hsiao SS, 2011, THE NEUROBIOLOGY OF, P141; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Keller PE, 2005, PSYCHOL RES-PSYCH FO, V69, P292, DOI 10.1007/s00426-004-0182-9; Lerdahl F., 1983, GENERATIVE THEORY TO; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; PALMER C, 1990, J EXP PSYCHOL HUMAN, V16, P728, DOI 10.1037/0096-1523.16.4.728; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2008, BRAIN COGNITION, V67, P94, DOI 10.1016/j.bandc.2007.11.007; Phillips-Silver J, 2007, COGNITION, V105, P533, DOI 10.1016/j.cognition.2006.11.006; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; RANDEL Don Michael, 1986, NEW HARVARD DICT MUS; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; Schurmann M, 2006, NEUROIMAGE, V30, P1325, DOI 10.1016/j.neuroimage.2005.11.020; Soto-Faraco S, 2009, BEHAV BRAIN RES, V196, P145, DOI 10.1016/j.bbr.2008.09.018; Spence C, 2012, THE NEW HANDBOOK OF; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Trainor L, 2008, NATURE, V453, P598, DOI 10.1038/453598a; Trainor LJ, 2009, CORTEX, V45, P35, DOI 10.1016/j.cortex.2007.10.014; Trehub SE, 2006, COGNITION, V100, P73, DOI 10.1016/j.cognition.2005.11.006; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	44	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48496	10.1371/journal.pone.0048496	http://dx.doi.org/10.1371/journal.pone.0048496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WJ	23119038	Green Published, gold			2022-12-25	WOS:000310600500151
J	Krogh, J; Videbech, P; Thomsen, C; Gluud, C; Nordentoft, M				Krogh, Jesper; Videbech, Poul; Thomsen, Carsten; Gluud, Christian; Nordentoft, Merete			DEMO-II Trial. Aerobic Exercise versus Stretching Exercise in Patients with Major Depression-A Randomised Clinical Trial	PLOS ONE			English	Article							RATING-SCALE; DISORDERS; METAANALYSIS; ASSOCIATION	Background: The effect of referring patients from a clinical setting to a pragmatic exercise intervention for depressive symptoms, cognitive function, and metabolic variables has yet to be determined. Methods: Outpatients with major depression (DSM-IV) were allocated to supervised aerobic or stretching exercise groups during a three months period. The primary outcome was the Hamilton depression score (HAM-D-17). Secondary outcomes were cognitive function, cardiovascular risk markers, and employment related outcomes. Results: 56 participants were allocated to the aerobic exercise intervention versus 59 participants to the stretching exercise group. Post intervention the mean difference between groups was -0.78 points on the HAM-D-17 (95% CI -3.2 to 1.6; P=.52). At follow-up, the participants in the aerobic exercise group had higher maximal oxygen uptake (mean difference 4.4 l/kg/min; 95% CI 1.7 to 7.0; P=.001) and visuospatial memory on Rey's Complex Figure Test (mean difference 3.2 points; 95% CI 0.9 to 5.5; P=.007) and lower blood glucose levels (mean difference 0.2 mmol/l; 95% CI 0.0 to 0.5; P=.04) and waist circumference (mean difference 2.2 cm; 95% CI 0.3 to 4.1; P=.02) compared with the stretching exercise group. Conclusions: The results of this trial does not support any antidepressant effect of referring patients with major depression to a three months aerobic exercise program. Due to lower recruitment than anticipated, the trial was terminated prior to reaching the pre-defined sample size of 212 participants; therefore the results should be interpreted in that context. However, the DEMO-II trial does suggest that an exercise program for patients with depression offer positive short-term effects on maximal oxygen uptake, visuospatial memory, fasting glucose levels, and waist circumference. Trial Registration: ClinicalTrials.gov NCT00695552	[Krogh, Jesper; Nordentoft, Merete] Univ Copenhagen, Fac Hlth Sci, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark; [Videbech, Poul] Hosp Psychiat, Dept Biol Psychiat, Inst Basic Psychiat Res, Risskov, Denmark; [Thomsen, Carsten] Univ Copenhagen, Rigshosp, Fac Hlth Sci, Dept Radiol, DK-2100 Copenhagen, Denmark; [Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark	University of Copenhagen; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Krogh, J (corresponding author), Univ Copenhagen, Fac Hlth Sci, Mental Hlth Ctr Copenhagen, Copenhagen, Denmark.	jesper.krogh@regionh.dk	Gluud, Christian/AAY-1027-2021; Videbech, Poul/B-1924-2008; Gluud, Christian/HGB-3191-2022; Krogh, Jesper/C-6876-2013; Nordentoft, Merete/AAH-3253-2019	Gluud, Christian/0000-0002-8861-0799; Videbech, Poul/0000-0003-0127-4348; Nordentoft, Merete/0000-0003-4895-7023; Krogh, Jesper/0000-0003-4834-6724	Trygfonden; Nordea-Danmark fonden; Helsefonden; Ase and Ejnar Danielsen's fond	Trygfonden; Nordea-Danmark fonden; Helsefonden; Ase and Ejnar Danielsen's fond	Trygfonden (an insurance company), Nordea-Danmark fonden (a bank), Helsefonden (public fund), and Ase and Ejnar Danielsen's fond (a family foundation) funded this trial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson IM, 2008, J PSYCHOPHARMACOL, V22, P343, DOI 10.1177/0269881107088441; Andersen L. B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P318; Angevaren M, 2008, COCHRANE DATABASE SY; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bech P, 2009, ACTA PSYCHIAT SCAND, V120, P400, DOI 10.1111/j.1600-0447.2009.01445.x; Bech P, 1999, MINI INT NEUROPSYKIA; Beck A., 1996, PEARSON; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Crone Diane, 2008, Issues Ment Health Nurs, V29, P1088, DOI 10.1080/01612840802319837; Dantzer R, 2008, NATURE REV, P946; Davidson JR, 2010, J CLIN PSYCHIAT SE1, V71; Dunn AL, 2005, AM J PREV MED, P281; ENDICOTT J, 1981, ARCH GEN PSYCHIAT, V38, P98; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Gomez-Merino D, 2001, NEUROSCI LETT, V301, P143, DOI 10.1016/S0304-3940(01)01626-3; Hamilton M, 1959, BR J MED PSYCHOL, P3250; Hammar A, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.026.2009; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Hoffman BM, 2008, MED SCI SPORT EXER, V40, P1344, DOI 10.1249/MSS.0b013e31816b877c; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Kadoglou N, 2007, EUR J CARDIOV PREV R, P14837; Khatri P, 2001, J AGING PHYS ACTIV, V9, P43, DOI 10.1123/japa.9.1.43; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Krogh J, 2011, J CLIN PSYCHIAT, V72, P529, DOI 10.4088/JCP.08r04913blu; Krogh J, 2009, J CLIN PSYCHIAT, V70, P790, DOI 10.4088/JCP.08m04241; Krogsboll LT, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-1; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P899, DOI 10.4088/JCP.v68n0612; LIFE Grp, 2011, CLIN REHABIL, V25, P579, DOI 10.1177/0269215510392075; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Mather AS, 2002, BRIT J PSYCHIAT, V180, P411, DOI 10.1192/bjp.180.5.411; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mead GE, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004366.PUB6; Meyers J. E, 1995, REY COMPLEX FIGURES; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Pajonk FG, 2010, ARCH GEN PSYCHIAT, V67, P133, DOI 10.1001/archgenpsychiatry.2009.193; Parker BA, 2011, RES Q EXERCISE SPORT, V82, P585, DOI 10.1080/02701367.2011.10599793; Pasco JA, 2010, BRIT J PSYCHIAT, V197, P372, DOI 10.1192/bjp.bp.109.076430; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; SMITH A, 1967, ARCH NEUROL-CHICAGO, V17, P78, DOI 10.1001/archneur.1967.00470250082008; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thomas GN, 2010, CURR DIABETES REV, V6, P378, DOI 10.2174/157339910793499092; Trivedi MH, 2011, J CLIN PSYCHIAT, V72, P677, DOI 10.4088/JCP.10m06743; Wechscler D, 1981, WECHSLER ADULT INTEL; Wechsler DW., 1955, WAIS 3 WECHSLER ADUL; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263	52	69	70	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48316	10.1371/journal.pone.0048316	http://dx.doi.org/10.1371/journal.pone.0048316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118981	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500101
J	Yu, Q; Huo, HW; Zhang, YP; Guo, HZ				Yu, Qiang; Huo, Hongwei; Zhang, Yipu; Guo, Hongzhi			PairMotif: A New Pattern-Driven Algorithm for Planted (l, d) DNA Motif Search	PLOS ONE			English	Article							DISCOVERY; SIGNALS	Motif search is a fundamental problem in bioinformatics with an important application in locating transcription factor binding sites (TFBSs) in DNA sequences. The exact algorithms can report all (l, d) motifs and find the best one under a specific objective function. However, it is still a challenging task to identify weak motifs, since either a large amount of memory or execution time is required by current exact algorithms. A new exact algorithm, PairMotif, is proposed for planted (l, d) motif search (PMS) in this paper. To effectively reduce both candidate motifs and scanned l-mers, multiple pairs of l-mers with relatively large distances are selected from input sequences to restrict the search space. Comparisons with several recently proposed algorithms show that PairMotif requires less storage space and runs faster on most PMS instances. Particularly, among the algorithms compared, only PairMotif can solve the weak instance (27, 9) within 10 hours. Moreover, the performance of PairMotif is stable over the sequence length, which allows it to identify motifs in longer sequences. For the real biological data, experimental results demonstrate the validity of the proposed algorithm.	[Yu, Qiang; Huo, Hongwei; Zhang, Yipu; Guo, Hongzhi] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China	Xidian University	Huo, HW (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.	hongweihuo1234@gmail.com	Zhang, Yipu/AGX-1691-2022; Huo, Hongwei/AAM-1200-2020		National Natural Science Foundation of China [61173025]; Research Fund for the Doctoral Program of Higher Education of China [20100203110010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China, Grant No. 61173025, and Research Fund for the Doctoral Program of Higher Education of China, Grant No. 20100203110010. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bi C, 2009, IEEE ACM T COMPUT BI, V6, P370, DOI 10.1109/TCBB.2008.103; Blanchette M., 2001, P 5 ANN INT C COMP M, P49; Boucher C, 2007, LECT N BIOINFORMAT, V4645, P149; Buhler J, 2002, J COMPUT BIOL, V9, P225, DOI 10.1089/10665270252935430; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Carvalho A.M., 2005, P 3 AS PAC BIOINF C, V1, P273; Chin HCL, 2005, P 3 AS PAC BIOINF C, P261; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Davila J, 2007, IEEE ACM T COMPUT BI, V4, P544, DOI 10.1109/TCBB.2007.70241; Davila J, 2006, LECT NOTES COMPUT SC, V3992, P822, DOI 10.1007/11758525_110; Dinh H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-410; Eskin E, 2002, BIOINFORMATICS, V18, pS354, DOI DOI 10.1093/BIOINFORMATICS/18.SUPPL_1.S354.; Evans PA, 2003, LECT NOTES COMPUT SC, V2748, P47; Evans PA, 2003, THEOR COMPUT SCI, V306, P407, DOI 10.1016/S0304-3975(03)00320-7; Fratkin E, 2006, BIOINFORMATICS, V22, pE150, DOI 10.1093/bioinformatics/btl243; Ho ES, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-14; Huang CW, 2011, IEEE ACM T COMPUT BI, V8, P959, DOI 10.1109/TCBB.2010.92; Jones NC, 2004, INTRO BIOINFORMATICS, P83; Kuksa PP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S1; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Li N, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-8; Liu X, 2001, Pac Symp Biocomput, P127; Marsan L, 2000, J COMPUT BIOL, V7, P345, DOI 10.1089/106652700750050826; Miller AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013897; Pavesi G., 2001, BIOINFORMATICS, V17, pS207; Pevzner P A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P269; Pisanti N, 2006, LECT NOTES COMPUT SC, V3887, P757, DOI 10.1007/11682462_69; Rajasekaran S, 2011, BMC RES NOTES, V4; Sagot MF, 1998, LECT NOTES COMPUT SC, V1380, P374, DOI 10.1007/BFb0054337; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053	31	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48442	10.1371/journal.pone.0048442	http://dx.doi.org/10.1371/journal.pone.0048442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119020	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500139
J	Zecchi, L; Lo Piano, A; Suzuki, Y; Canas, C; Takeyasu, K; Ayora, S				Zecchi, Lisa; Lo Piano, Ambra; Suzuki, Yuki; Canas, Cristina; Takeyasu, Kunio; Ayora, Silvia			Characterization of the Holliday Junction Resolving Enzyme Encoded by the Bacillus subtilis Bacteriophage SPP1	PLOS ONE			English	Article							ARRESTED REPLICATION FORKS; T7 ENDONUCLEASE I; ESCHERICHIA-COLI; DNA-REPLICATION; NUCLEOTIDE-SEQUENCE; GENE-EXPRESSION; PHAGE SPP1; RECOMBINATION; HELICASE; GENOME	Recombination-dependent DNA replication, which is a central component of viral replication restart, is poorly understood in Firmicutes bacteriophages. Phage SPP1 initiates unidirectional theta DNA replication from a discrete replication origin (oriL), and when replication progresses, the fork might stall by the binding of the origin binding protein G38P to the late replication origin (oriR). Replication restart is dependent on viral recombination proteins to synthesize a linear head-to-tail concatemer, which is the substrate for viral DNA packaging. To identify new functions involved in this process, uncharacterized genes from phage SPP1 were analyzed. Immediately after infection, SPP1 transcribes a number of genes involved in recombination and replication from P-E2 and P-E3 promoters. Resequencing the region corresponding to the last two hypothetical genes transcribed from the P-E2 operon (genes 44 and 45) showed that they are in fact a single gene, reannotated here as gene 44, that encodes a single polypeptide, named gene 44 product (G44P, 27.5 kDa). G44P shares a low but significant degree of identity in its C-terminal region with virus-encoded RusA-like resolvases. The data presented here demonstrate that G44P, which is a dimer in solution, binds with high affinity but without sequence specificity to several double-stranded DNA recombination intermediates. G44P preferentially cleaves Holliday junctions, but also, with lower efficiency, replicated D-loops. It also partially complemented the loss of RecU resolvase activity in B. subtilis cells. These in vitro and in vivo data suggest a role for G44P in replication restart during the transition to concatemeric viral replication.	[Zecchi, Lisa; Lo Piano, Ambra; Canas, Cristina; Ayora, Silvia] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain; [Suzuki, Yuki; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Kyoto University	Ayora, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain.	sayora@cnb.csic.es	Ayora, Silvia/D-2552-2009; Suzuki, Yuki/H-9950-2015	Ayora, Silvia/0000-0003-3121-1786; Suzuki, Yuki/0000-0003-1848-0105	Spanish Ministry of Science and Innovation [BFU2009-09520]; MEXT of Japan; Japan Society for the Promotion of Science (JSPS); Japan-Spain Bilateral Joint Project Award [JSPS-CSIC 2010JP0017]; EU	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan-Spain Bilateral Joint Project Award; EU(European Commission)	The research was partially financed by the Spanish Ministry of Science and Innovation (Grant BFU2009-09520 to S.A.), Grant-in-aid for Priority Area from the MEXT of Japan and Japan Society for the Promotion of Science (JSPS) to K.T., and Japan-Spain Bilateral Joint Project Award (JSPS-CSIC 2010JP0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Juan C. Alonso for providing us with strains and phages, for his interest in the project, and for his critical reading of the manuscript. David Sherratt providing us with the plasmid and strain to produce the chi-structures. Three anonymous referees provided helpful comments, which improved the manuscript, and Melissa Stauffer edited the text. A.L.P. received a contract from Community of Madrid, L.Z. was a recipient of a EU Leonardo grant, and Y.S. was a recipient of the JSPS (Japan Society for the Promotion of Science) research fellowship.	Alonso JC, 1997, GENE, V204, P201, DOI 10.1016/S0378-1119(97)00547-7; Alonso JC, 2006, BACTERIOPHAGES, P331; AMANN EP, 1981, MOL GEN GENET, V182, P299, DOI 10.1007/BF00269674; Ayora S, 1998, FEBS LETT, V439, P59, DOI 10.1016/S0014-5793(98)01337-4; Ayora S, 1999, J MOL BIOL, V288, P71, DOI 10.1006/jmbi.1999.2662; Ayora S, 2004, P NATL ACAD SCI USA, V101, P452, DOI 10.1073/pnas.2533829100; Ayora S, 2002, NUCLEIC ACIDS RES, V30, P2280, DOI 10.1093/nar/30.11.2280; Ayora S, 2002, J BIOL CHEM, V277, P35969, DOI 10.1074/jbc.M204467200; Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x; Bailey S, 2003, J BIOL CHEM, V278, P15304, DOI 10.1074/jbc.M209300200; BEHRENS B, 1979, MOL GEN GENET, V175, P351, DOI 10.1007/BF00397235; BELIKOV S, 1995, NUCLEIC ACIDS RES, V23, P310, DOI 10.1093/nar/23.2.310; Bidnenko E, 1998, MOL MICROBIOL, V28, P823, DOI 10.1046/j.1365-2958.1998.00845.x; Bolt EL, 2000, J MOL BIOL, V304, P165, DOI 10.1006/jmbi.2000.4196; BURGER KJ, 1978, MOL GEN GENET, V166, P277, DOI 10.1007/BF00267619; Canas C, 2008, NUCLEIC ACIDS RES, V36, P5242, DOI 10.1093/nar/gkn500; Canas C, 2011, J MOL BIOL, V410, P39, DOI 10.1016/j.jmb.2011.05.008; CHAI S, 1993, GENE, V129, P41, DOI 10.1016/0378-1119(93)90694-X; CHAI S, 1992, J MOL BIOL, V224, P87, DOI 10.1016/0022-2836(92)90578-8; Chan SN, 1997, J BIOL CHEM, V272, P14873, DOI 10.1074/jbc.272.23.14873; Chan SN, 1998, NUCLEIC ACIDS RES, V26, P1560, DOI 10.1093/nar/26.7.1560; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Dixit A, 2011, J BIOL CHEM; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Golz S, 1999, J MOL BIOL, V285, P1131, DOI 10.1006/jmbi.1998.2399; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; Khan SA, 2005, PLASMID, V53, P126, DOI 10.1016/j.plasmid.2004.12.008; Kimura T, 2010, J BACTERIOL, V192, P6209, DOI 10.1128/JB.00625-10; Lo Piano A, 2011, VIRUS RES, V160, P1, DOI 10.1016/j.virusres.2011.06.009; Macmaster R, 2006, NUCLEIC ACIDS RES, V34, P5577, DOI 10.1093/nar/gkl447; Mahdi AA, 1996, J MOL BIOL, V257, P561, DOI 10.1006/jmbi.1996.0185; MANLY KF, 1969, VIROLOGY, V37, P177, DOI 10.1016/0042-6822(69)90197-4; Martinez-Jimenez MI, 2005, J MOL BIOL, V351, P1007, DOI 10.1016/j.jmb.2005.06.064; Martinez-Jimenez MI, 2002, NUCLEIC ACIDS RES, V30, P5056, DOI 10.1093/nar/gkf650; MCCULLOCH R, 1994, EMBO J, V13, P1844, DOI 10.1002/j.1460-2075.1994.tb06453.x; Mesa P, 2006, J MOL BIOL, V357, P1077, DOI 10.1016/j.jmb.2005.12.027; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Missich R, 1997, J MOL BIOL, V270, P50, DOI 10.1006/jmbi.1997.1060; PEDRE X, 1994, J MOL BIOL, V236, P1324, DOI 10.1016/0022-2836(94)90061-2; Rafferty JB, 2003, STRUCTURE, V11, P1557, DOI 10.1016/j.str.2003.11.004; RATCLIFF SW, 1979, MOL GEN GENET, V168, P165, DOI 10.1007/BF00431442; RIVA S, 1968, J MOL BIOL, V35, P347, DOI 10.1016/S0022-2836(68)80029-4; SADOWSKI PD, 1974, J VIROL, V13, P226, DOI 10.1128/JVI.13.1.226-229.1974; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Sharples GJ, 2002, MOL MICROBIOL, V44, P549, DOI 10.1046/j.1365-2958.2002.02916.x; Sharples GJ, 2001, MOL MICROBIOL, V39, P823, DOI 10.1046/j.1365-2958.2001.02284.x; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Tarkowski TA, 2002, GENES CELLS, V7, P351, DOI 10.1046/j.1365-2443.2002.00531.x; Tavares P, 1996, J MOL BIOL, V264, P954, DOI 10.1006/jmbi.1996.0689; WEISE F, 1994, VIROLOGY, V202, P1046, DOI 10.1006/viro.1994.1436; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Yadav T, 2012, NUCL ACIDS RES; Zerbib D, 1997, J MOL BIOL, V270, P663, DOI 10.1006/jmbi.1997.1157	54	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48440	10.1371/journal.pone.0048440	http://dx.doi.org/10.1371/journal.pone.0048440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119018	Green Submitted, gold, Green Published			2022-12-25	WOS:000310600500137
J	Panda, A; Begum, T; Ghosh, TC				Panda, Arup; Begum, Tina; Ghosh, Tapash Chandra			Insights into the Evolutionary Features of Human Neurodegenerative Diseases	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; GENE-EXPRESSION LEVELS; DISORDER; AGGREGATION; LENGTH; YEAST; ASSOCIATION; PATHOLOGY; NETWORKS; SEQUENCE	Comparative analyses between human disease and non-disease genes are of great interest in understanding human disease gene evolution. However, the progression of neurodegenerative diseases (NDD) involving amyloid formation in specific brain regions is still unknown. Therefore, in this study, we mainly focused our analysis on the evolutionary features of human NDD genes with respect to non-disease genes. Here, we observed that human NDD genes are evolutionarily conserved relative to non-disease genes. To elucidate the conserved nature of NDD genes, we incorporated the evolutionary attributes like gene expression level, number of regulatory miRNAs, protein connectivity, intrinsic disorder content and relative aggregation propensity in our analysis. Our studies demonstrate that NDD genes have higher gene expression levels in favor of their lower evolutionary rates. Additionally, we observed that NDD genes have higher number of different regulatory miRNAs target sites and also have higher interaction partners than the non-disease genes. Moreover, miRNA targeted genes are known to have higher disorder content. In contrast, our analysis exclusively established that NDD genes have lower disorder content. In favor of our analysis, we found that NDD gene encoded proteins are enriched with multi interface hubs (party hubs) with lower disorder contents. Since, proteins with higher disorder content need to adapt special structure to reduce their aggregation propensity, NDD proteins found to have elevated relative aggregation propensity (RAP) in support of their lower disorder content. Finally, our categorical regression analysis confirmed the underlined relative dominance of protein connectivity, 3'UTR length, RAP, nature of hubs (singlish/multi interface) and disorder content for such evolutionary rates variation between human NDD genes and non-disease genes.	[Panda, Arup; Begum, Tina; Ghosh, Tapash Chandra] Bose Inst, Bioinformat Ctr, Kolkata, India	Department of Science & Technology (India); Bose Institute	Ghosh, TC (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, India.	tapash@boseinst.ernet.in		Begum, Tina/0000-0003-3618-473X	Department of Science & Technology. Government of India	Department of Science & Technology. Government of India(Department of Science & Technology (India))	This work was supported by the Department of Science & Technology. Government of India (www.dst.gov.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V306, P303, DOI 10.1016/S0006-291X(03)00971-9; Ashe PC, 2001, PROG NEURO-PSYCHOPH, V25, P691, DOI 10.1016/S0278-5846(01)00159-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Begum T, 2010, J MOL EVOL, V71, P60, DOI 10.1007/s00239-010-9364-9; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bortoluzzi S, 2003, PHYSIOL GENOMICS, V15, P223, DOI 10.1152/physiolgenomics.00095.2003; Cachon-Gonzalez MB, 2006, P NATL ACAD SCI USA, V103, P10373, DOI 10.1073/pnas.0603765103; Castellani RJ, 1999, ALZ DIS ASSOC DIS, V13, P232, DOI 10.1097/00002093-199910000-00010; Chakraborty S, 2011, EVOLUTIONARY BIOLOGY: CONCEPTS, BIODIVERSITY, MACROEVOLUTION AND GENOME EVOLUTION, P51, DOI 10.1007/978-3-642-20763-1_4; Chakraborty S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-155; Chen SCC, 2011, MOL BIOL EVOL, V28, P2513, DOI 10.1093/molbev/msr068; Chen YW, 2008, MOL BIOL EVOL, V25, P1530, DOI 10.1093/molbev/msn122; Cheng C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-431; Crunkhorn S, 2012, NAT REV DRUG DISCOV, V11, P22, DOI 10.1038/nrd3634; Das S, 2011, IUBMB LIFE, V63, P478, DOI 10.1002/iub.498; De Simone A, 2012, P NATL ACAD SCI USA, V109, P6951, DOI 10.1073/pnas.1118048109; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fernandez A, 2009, GENOME RES, V19, P2185, DOI 10.1101/gr.094441.109; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Ghofrani M., 2000, Indian Journal of Pediatrics, V67, P539, DOI 10.1007/BF02760490; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Li W, 2004, MOL CELL BIOL, V24, P3295, DOI 10.1128/MCB.24.8.3295-3306.2004; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Manna B, 2009, GENE, V434, P50, DOI 10.1016/j.gene.2008.12.013; Marais G, 2001, J MOL EVOL, V52, P275, DOI 10.1007/s002390010155; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Park J, 2012, HUM MOL GENET, V21, P46, DOI 10.1093/hmg/ddr436; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Perry VH, 2011, CEREBRAL PLASTICITY, P315; Podder S, 2010, MOL BIOL EVOL, V27, P934, DOI 10.1093/molbev/msp297; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; PRUSINER SB, 1994, ANNU REV NEUROSCI, V17, P311, DOI 10.1146/annurev.ne.17.030194.001523; Raychaudhuri S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005566; Reumers J, 2009, OPEN BIOL, V2, P176; Rossoll W, 2009, RESULTS PROBL CELL D, V48, P289, DOI 10.1007/400_2009_4; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Sen K, 2012, GENE, V501, P164, DOI 10.1016/j.gene.2012.04.013; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tan MAF, 2010, MOL GENET METAB, V99, P142, DOI 10.1016/j.ymgme.2009.09.006; Tang CSM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000603; Traeger EC, 1998, PEDIATR NEUROL, V18, P207, DOI 10.1016/S0887-8994(97)00185-9; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; Vellodi A, 2005, BRIT J HAEMATOL, V128, P413, DOI 10.1111/j.1365-2141.2004.05293.x; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wenning GK, 2009, J NEUROL, V256, P1791, DOI 10.1007/s00415-009-5173-8; Wheeler TM, 2008, NEUROTHERAPEUTICS, V5, P592, DOI 10.1016/j.nurt.2008.08.001; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	71	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48336	10.1371/journal.pone.0048336	http://dx.doi.org/10.1371/journal.pone.0048336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118989	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600040
J	Kawano, H; Katsurabayashi, S; Kakazu, Y; Yamashita, Y; Kubo, N; Kubo, M; Okuda, H; Takasaki, K; Kubota, K; Mishima, K; Fujiwara, M; Harata, NC; Iwasaki, K				Kawano, Hiroyuki; Katsurabayashi, Shutaro; Kakazu, Yasuhiro; Yamashita, Yuta; Kubo, Natsuko; Kubo, Masafumi; Okuda, Hideto; Takasaki, Kotaro; Kubota, Kaori; Mishima, Kenichi; Fujiwara, Michihiro; Harata, N. Charles; Iwasaki, Katsunori			Long-Term Culture of Astrocytes Attenuates the Readily Releasable Pool of Synaptic Vesicles	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CAT VISUAL-CORTEX; SILENT SYNAPSES; HIPPOCAMPAL-NEURONS; ACTIVE ZONE; NEUROTRANSMITTER RELEASE; EXCITATORY SYNAPSES; TRANSMITTER RELEASE; CNS SYNAPTOGENESIS; CELL-CULTURE	The astrocyte is a major glial cell type of the brain, and plays key roles in the formation, maturation, stabilization and elimination of synapses. Thus, changes in astrocyte condition and age can influence information processing at synapses. However, whether and how aging astrocytes affect synaptic function and maturation have not yet been thoroughly investigated. Here, we show the effects of prolonged culture on the ability of astrocytes to induce synapse formation and to modify synaptic transmission, using cultured autaptic neurons. By 9 weeks in culture, astrocytes derived from the mouse cerebral cortex demonstrated increases in beta-galactosidase activity and glial fibrillary acidic protein (GFAP) expression, both of which are characteristic of aging and glial activation in vitro. Autaptic hippocampal neurons plated on these aging astrocytes showed a smaller amount of evoked release of the excitatory neurotransmitter glutamate, and a lower frequency of miniature release of glutamate, both of which were attributable to a reduction in the pool of readily releasable synaptic vesicles. Other features of synaptogenesis and synaptic transmission were retained, for example the ability to induce structural synapses, the presynaptic release probability, the fraction of functional presynaptic nerve terminals, and the ability to recruit functional AMPA and NMDA glutamate receptors to synapses. Thus the presence of aging astrocytes affects the efficiency of synaptic transmission. Given that the pool of readily releasable vesicles is also small at immature synapses, our results are consistent with astrocytic aging leading to retarded synapse maturation.	[Kawano, Hiroyuki; Katsurabayashi, Shutaro; Yamashita, Yuta; Kubo, Natsuko; Kubo, Masafumi; Okuda, Hideto; Takasaki, Kotaro; Kubota, Kaori; Mishima, Kenichi; Fujiwara, Michihiro; Iwasaki, Katsunori] Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, Fukuoka 81401, Japan; [Mishima, Kenichi; Iwasaki, Katsunori] Fukuoka Univ, AIG Collaborat Res Inst Aging & Brain Sci, Fukuoka 81401, Japan; [Kakazu, Yasuhiro; Harata, N. Charles] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA USA	Fukuoka University; Fukuoka University; University of Iowa	Katsurabayashi, S (corresponding author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Neuropharmacol, 8-19-1 Nanakuma, Fukuoka 81401, Japan.	shutarok@fukuoka-u.ac.jp; iwasakik@fukuoka-u.ac.jp		Harata, N. Charles/0000-0003-3287-4549	Japan Society for the Promotion of Science [23700476]; Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research [23700476] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Suzuken Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Young Scientists (B) 23700476 from the Japan Society for the Promotion of Science to S. K., and a grant from the Suzuken Memorial Foundation to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Aksenova MV, 1999, J NEUROSCI RES, V58, P308, DOI 10.1002/(SICI)1097-4547(19991015)58:2<308::AID-JNR11>3.0.CO;2-#; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Amenta F, 1998, MICROSC RES TECHNIQ, V43, P29, DOI 10.1002/(SICI)1097-0029(19981001)43:1<29::AID-JEMT5>3.0.CO;2-H; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bertrand SJ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-38; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Brewer GJ, 2005, EXP GERONTOL, V40, P426, DOI 10.1016/j.exger.2005.03.007; Burgalossi A, 2012, NAT PROTOC, V7, P1351, DOI 10.1038/nprot.2012.074; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Costantini C, 2010, J MOL NEUROSCI, V40, P342, DOI 10.1007/s12031-009-9305-5; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gekel I, 2008, J NEUROSCI, V28, P7991, DOI 10.1523/JNEUROSCI.0268-08.2008; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Horner PJ, 2000, J NEUROSCI, V20, P2218; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Itami C, 2003, P NATL ACAD SCI USA, V100, P13069, DOI 10.1073/pnas.2131948100; Jacobs S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-132; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kakazu Y, 2012, SYNAPSE, V66, P807, DOI 10.1002/syn.21571; Kakazu Y, 2012, SYNAPSE, V66, P453, DOI 10.1002/syn.21534; KATZ B, 1979, PROC R SOC SER B-BIO, V205, P369, DOI 10.1098/rspb.1979.0070; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim MJ, 2007, EXP MOL MED, V39, P14, DOI 10.1038/emm.2007.3; KOHAMA SG, 1995, NEUROBIOL AGING, V16, P59, DOI 10.1016/0197-4580(95)80008-F; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Lalo U, 2011, AGING CELL, V10, P392, DOI 10.1111/j.1474-9726.2011.00682.x; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Libersat F, 2004, MOL NEUROBIOL, V29, P303, DOI 10.1385/MN:29:3:303; Libersat F, 2002, J COMP NEUROL, V450, P153, DOI 10.1002/cne.10318; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moulder KL., 2010, JOVE-J VIS EXP, V35, P1676; Moulder KL, 2008, J NEUROSCI, V28, P5159, DOI 10.1523/JNEUROSCI.5317-07.2008; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; MULLER CM, 1990, GLIA, V3, P487, DOI 10.1002/glia.440030607; MULLER CM, 1989, NATURE, V342, P427, DOI 10.1038/342427a0; OCALLAGHAN JP, 1991, NEUROBIOL AGING, V12, P171, DOI 10.1016/0197-4580(91)90057-Q; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Segovia G, 2001, MECH AGEING DEV, V122, P1, DOI 10.1016/S0047-6374(00)00225-6; SHOLL DA, 1953, J ANAT, V87, P387; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Suzuki H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039562; Ting JT, 2007, P NATL ACAD SCI USA, V104, P353, DOI 10.1073/pnas.0608807104; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van der Loo B, 1998, EXP CELL RES, V241, P309, DOI 10.1006/excr.1998.4035; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003; Zhao S, 2007, DEV NEUROSCI-BASEL, V29, P84, DOI 10.1159/000096213	85	35	35	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48034	10.1371/journal.pone.0048034	http://dx.doi.org/10.1371/journal.pone.0048034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110166	gold, Green Submitted, Green Published			2022-12-25	WOS:000310262500031
J	Aronov, D; Fee, MS				Aronov, Dmitriy; Fee, Michale S.			Natural Changes in Brain Temperature Underlie Variations in Song Tempo during a Mating Behavior	PLOS ONE			English	Article							GANGLIA-FOREBRAIN CIRCUIT; CRICKET ACOUSTIC COMMUNICATION; CONTEXT-DEPENDENT CHANGES; HYPOTHALAMIC TEMPERATURE; SEQUENCE GENERATION; NEURAL MECHANISMS; LOCALIZATION; RECOGNITION; VARIABILITY; MODULATION	The song of a male zebra finch is a stereotyped motor sequence whose tempo varies with social context - whether or not the song is directed at a female bird - as well as with the time of day. The neural mechanisms underlying these changes in tempo are unknown. Here we show that brain temperature recorded in freely behaving male finches exhibits a global increase in response to the presentation of a female bird. This increase strongly correlates with, and largely explains, the faster tempo of songs directed at a female compared to songs produced in social isolation. Furthermore, we find that the observed diurnal variations in song tempo are also explained by natural variations in brain temperature. Our findings suggest that brain temperature is an important variable that can influence the dynamics of activity in neural circuits, as well as the temporal features of behaviors that some of these circuits generate.	[Aronov, Dmitriy; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Aronov, D (corresponding author), Princeton Univ, Carl Icahn Lab, Princeton, NJ 08544 USA.	daronov@princeton.edu		Fee, Michale/0000-0001-7539-1745	United States National Institute of Mental Health [R01MH067105]; Hertz Foundation Silvio Micali Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER	United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hertz Foundation Silvio Micali Fellowship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by United States National Institute of Mental Health R01MH067105 (MSF) and by the Hertz Foundation Silvio Micali Fellowship, www.hertzfoundation.org (DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1991, CORTICONICS; ABRAMS R, 1964, AM J PHYSIOL, V206, P641, DOI 10.1152/ajplegacy.1964.206.3.641; Andalman AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025461; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; BAUER M, 1987, J COMP PHYSIOL A, V161, P95, DOI 10.1007/BF00609458; BLUMBERG MS, 1987, PHYSIOL BEHAV, V39, P367, DOI 10.1016/0031-9384(87)90236-8; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; Farries MA, 2002, J NEUROSCI, V22, P3776; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fee MS, 2011, CURR OPIN NEUROBIOL; FOSTER JA, 1992, J EXP BIOL, V162, P295; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hampton CM, 2009, J NEUROPHYSIOL, V101, P3235, DOI 10.1152/jn.91089.2008; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Hara E, 2009, P ROY SOC B-BIOL SCI, V276, P279, DOI 10.1098/rspb.2008.1138; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Horita H, 2010, J COMP NEUROL, V518, P2873, DOI 10.1002/cne.22370; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Kao MH, 2008, J NEUROSCI, V28, P13232, DOI 10.1523/JNEUROSCI.2250-08.2008; Katz PS, 2004, J NEUROPHYSIOL, V92, P1904, DOI 10.1152/jn.00864.2003; Kiyatkin EA, 2007, EUR J APPL PHYSIOL, V101, P3, DOI 10.1007/s00421-007-0450-7; Kubikova L, 2010, J COMP NEUROL, V518, P741, DOI 10.1002/cne.22255; Leblois A, 2012, EUR J NEUROSCI, V35, P1771, DOI 10.1111/j.1460-9568.2012.08095.x; Leblois A, 2010, J NEUROSCI, V30, P5730, DOI 10.1523/JNEUROSCI.5974-09.2010; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; McGregor PK, 2005, ANIMAL COMMUNICATION; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Philippot P., 1999, SOCIAL CONTEXT NONVE; PIRES A, 1992, J COMP PHYSIOL A, V171, P69, DOI 10.1007/BF00195962; PIRES A, 1992, J COMP PHYSIOL A, V171, P79, DOI 10.1007/BF00195963; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Stepanek L, 2010, J NEUROPHYSIOL, V104, P2474, DOI 10.1152/jn.00977.2009; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Williams H, 1999, TLS-TIMES LIT SUPPL, P16; Yamaguchi A, 2008, J NEUROPHYSIOL, V100, P3134, DOI 10.1152/jn.01309.2007; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZANN R, 1996, ZEBRA FINCH	48	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47856	10.1371/journal.pone.0047856	http://dx.doi.org/10.1371/journal.pone.0047856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112858	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200093
J	Boldt, L; Yellowlees, D; Leggat, W				Boldt, Lynda; Yellowlees, David; Leggat, William			Hyperdiversity of Genes Encoding Integral Light-Harvesting Proteins in the Dinoflagellate Symbiodinium sp	PLOS ONE			English	Article							ALGA PORPHYRIDIUM-CRUENTUM; CHLOROPHYLL-A-PROTEINS; PERIDININ-CHLOROPHYLL; BINDING-PROTEIN; AMPHIDINIUM-CARTERAE; MAXIMUM-LIKELIHOOD; GONYAULAX-POLYEDRA; ANTENNA PROTEINS; GLENODINIUM-SP; CHL A/B	The superfamily of light-harvesting complex (LHC) proteins is comprised of proteins with diverse functions in light-harvesting and photoprotection. LHC proteins bind chlorophyll (Chl) and carotenoids and include a family of LHCs that bind Chl a and c. Dinophytes (dinoflagellates) are predominantly Chl c binding algal taxa, bind peridinin or fucoxanthin as the primary carotenoid, and can possess a number of LHC subfamilies. Here we report 11 LHC sequences for the chlorophyll a-chlorophyll c(2)-peridinin protein complex (acpPC) subfamily isolated from Symbiodinium sp. C3, an ecologically important peridinin binding dinoflagellate taxa. Phylogenetic analysis of these proteins suggests the acpPC subfamily forms at least three clades within the Chl a/c binding LHC family; Clade 1 clusters with rhodophyte, cryptophyte and peridinin binding dinoflagellate sequences, Clade 2 with peridinin binding dinoflagellate sequences only and Clades 3 with heterokontophytes, fucoxanthin and peridinin binding dinoflagellate sequences.	[Boldt, Lynda; Leggat, William] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Boldt, Lynda; Yellowlees, David; Leggat, William] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Leggat, William] James Cook Univ, Comparat Genom Ctr, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University	Leggat, W (corresponding author), James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia.	bill.leggat@jcu.edu.au	Leggat, Bill/AAJ-8929-2020; Leggat, William/C-4532-2012; Yellowlees, David/A-5379-2013	Leggat, Bill/0000-0003-4148-2555; 	Australian Research Council Centre of Excellence for Coral Reef Studies; James Cook University Graduate Research School	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); James Cook University Graduate Research School	This work was supported by the Australian Research Council Centre of Excellence for Coral Reef Studies (http://www.coralcoe.org.au) and James Cook University Graduate Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ambarsari I, 1997, MAR ECOL PROG SER, V159, P303, DOI 10.3354/meps159303; Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Boldt L., 2009, P 11 ICRS, P118; CHANG SS, 1982, PROC R SOC SER B-BIO, V215, P191, DOI 10.1098/rspb.1982.0037; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DemmigAdams B, 1996, TRENDS PLANT SCI, V1, P21, DOI 10.1016/S1360-1385(96)80019-7; Dittami SM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-365; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Eppard M, 2000, PLANT BIOLOGY, V2, P283, DOI 10.1055/s-2000-3702; GAGNE G, 1992, PLANT MOL BIOL, V18, P429, DOI 10.1007/BF00040659; GOVIND NS, 1990, PROC R SOC SER B-BIO, V240, P187, DOI 10.1098/rspb.1990.0033; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; GREEN BR, 1994, PHOTOSYNTH RES, V39, P149, DOI 10.1007/BF00029382; GROSSMAN A, 1990, MOL GEN GENET, V224, P91, DOI 10.1007/BF00259455; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAIDAK DJ, 1966, SCIENCE, V152, P212, DOI 10.1126/science.152.3719.212; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hill R, 2012, CORAL REEFS, V31, P963, DOI 10.1007/s00338-012-0914-z; HILLER RG, 1995, FEBS LETT, V363, P175, DOI 10.1016/0014-5793(95)00297-M; Hiller RG, 2001, MOL GENET GENOMICS, V266, P254, DOI 10.1007/s004380100551; HILLER RG, 1993, PHOTOCHEM PHOTOBIOL, V57, P125, DOI 10.1111/j.1751-1097.1993.tb02267.x; Hofmann E, 1996, SCIENCE, V272, P1788, DOI 10.1126/science.272.5269.1788; HOULNE G, 1988, MOL GEN GENET, V213, P479, DOI 10.1007/BF00339619; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IGLESIASPRIETO R, 1991, P ROY SOC B-BIOL SCI, V246, P275, DOI 10.1098/rspb.1991.0155; Jansson S, 1999, PLANT MOL BIOL REP, V17, P221, DOI 10.1023/A:1007620508007; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; KISHORE R, 1993, P NATL ACAD SCI USA, V90, P11845, DOI 10.1073/pnas.90.24.11845; Kobiyama A, 2005, EUR J PROTISTOL, V41, P277, DOI 10.1016/j.ejop.2005.06.002; Koziol AG, 2008, MOL BIOL EVOL, V25, P92, DOI 10.1093/molbev/msm232; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Larkum T, 1996, TRENDS PLANT SCI, V1, P247; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LEE DH, 1993, J BIOL CHEM, V268, P8842; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Leggat W, 2011, J EXP MAR BIOL ECOL, V408, P120, DOI 10.1016/j.jembe.2011.07.032; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Nassoury N, 2003, J CELL SCI, V116, P2867, DOI 10.1242/jcs.00517; NORRIS BJ, 1994, PLANT MOL BIOL, V24, P673, DOI 10.1007/BF00023563; Nosenko T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-173; Okamoto OK, 2003, GENE, V321, P73, DOI 10.1016/j.gene.2003.07.003; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; Patron NJ, 2005, J MOL BIOL, V348, P1015, DOI 10.1016/j.jmb.2005.03.030; PREZELIN BB, 1976, PLANTA, V130, P225, DOI 10.1007/BF00387826; Puerta MVS, 2005, DNA RES, V12, P151, DOI 10.1093/dnares/12.2.151; Reichman JR, 2003, MOL BIOL EVOL, V20, P2143, DOI 10.1093/molbev/msg233; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; ROMAN SJ, 1988, PLANT PHYSIOL, V88, P594, DOI 10.1104/pp.88.3.594; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Sambrook J, 2001, MOL CLONING LAB MANU; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; TAN S, 1995, PHOTOSYNTH RES, V45, P1, DOI 10.1007/BF00032230; Tan S, 1997, PLANT MOL BIOL, V33, P157, DOI 10.1023/A:1005715528297; Tan S, 1997, PHOTOSYNTH RES, V53, P129, DOI 10.1023/A:1005815321295; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Voolstra CR, 2009, COMP BIOCHEM PHYS D, V4, P67, DOI 10.1016/j.cbd.2008.11.001; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; WOLFE GR, 1994, NATURE, V367, P566, DOI 10.1038/367566a0; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	75	28	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47456	10.1371/journal.pone.0047456	http://dx.doi.org/10.1371/journal.pone.0047456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112815	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000310310200040
J	Khaidakov, M; Mitra, S; Wang, XW; Ding, ZF; Bora, N; Lyzogubov, V; Romeo, F; Schichman, SA; Mehta, JL				Khaidakov, Magomed; Mitra, Sona; Wang, Xianwei; Ding, Zufeng; Bora, Nalini; Lyzogubov, Valery; Romeo, Francesco; Schichman, Steven A.; Mehta, Jawahar L.			Large Impact of Low Concentration Oxidized LDL on Angiogenic Potential of Human Endothelial Cells: A Microarray Study	PLOS ONE			English	Article							OX-LDL; EXPRESSION; RECEPTOR; PHOSPHOLIPIDS; PROTECTS; MICRORNA; COMPLEX; GROWTH; GENES; VEGF	Oxidized LDL (ox-LDL) is a key factor in atherogenesis. It is taken up by endothelial cells primarily by ox-LDL receptor-1 (LOX-1). To elucidate transcriptional responses, we performed microarray analysis on human coronary artery endothelial cells (HCAECs) exposed to small physiologic concentration of ox-LDL-5 mu g/ml for 2 and 12 hours. At 12 hours, cultures treated with ox-LDL exhibited broad shifts in transcriptional activity involving almost 1500 genes (>1.5 fold difference, p<0.05). Resulting transcriptome was enriched for genes associated with cell adhesion (p<0.002), angiogenesis (p<0.0002) and migration (p<0.006). Quantitative PCR analysis revealed that LOX-1 expression in HCAECs is at least an order of magnitude greater than the expression of other major ox-LDL specific receptors CD36 and MSR1. In keeping with the data on LOX- 1 expression, pre-treatment of HCAECs with LOX- 1 neutralizing antibody resulted in across-the-board inhibition of cellular response to ox-LDL. Ox-LDL upregulated a number of pro-angiogenic genes including multiple receptors, ligands and transcription factors and altered the expression of a number of genes implicated in both stimulation and inhibition of apoptosis. From a functional standpoint, physiologic concentrations of ox-LDL stimulated tube formation and inhibited susceptibility to apoptosis in HCAECs. In addition, ox-LDL exposure resulted in upregulation of miR-1974, miR-1978 and miR-21 accompanied with significant over-presentation of their target genes in the downregulated portion of ox-LDL transcriptome. Our observations indicate that ox-LDL at physiologic concentrations induces broad transcriptional responses which are mediated by LOX- 1, and are, in part, shaped by ox-LDL-dependent miRNAs. We also suggest that angiogenic effects of ox-LDL are partially based on upregulation of several receptors that render cells hypersensitive to angiogenic stimuli.	[Khaidakov, Magomed; Mitra, Sona; Wang, Xianwei; Ding, Zufeng; Bora, Nalini; Lyzogubov, Valery; Romeo, Francesco; Schichman, Steven A.; Mehta, Jawahar L.] Cent Arkansas Healthcare Syst, Little Rock, AR USA; [Khaidakov, Magomed; Mitra, Sona; Wang, Xianwei; Ding, Zufeng; Bora, Nalini; Lyzogubov, Valery; Romeo, Francesco; Schichman, Steven A.; Mehta, Jawahar L.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Romeo, Francesco] Univ Roma Tor Vergata, Dipartimento Med Interna, Rome, Italy	University of Arkansas System; University of Arkansas Medical Sciences; University of Rome Tor Vergata	Khaidakov, M (corresponding author), Cent Arkansas Healthcare Syst, Little Rock, AR USA.	mkhaidakov@uams.edu; MehtaJL@uams.edu	Mehta, jl/AAB-8832-2019; Wang, Xianwei/AAN-8915-2020; Mehta, JL/AAG-7572-2020; Ding, Zufeng/ABD-6116-2020	Mehta, jl/0000-0003-0384-2097; Wang, Xianwei/0000-0002-1490-8736; 	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, Washington, DC	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, Washington, DC(US Department of Veterans Affairs)	This study was supported by funds from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, Washington, DC. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Bochkov VN, 2006, CIRC RES, V99, P900, DOI 10.1161/01.RES.0000245485.04489.ee; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chen CH, 1997, ARTERIOSCL THROM VAS, V17, P1303, DOI 10.1161/01.ATV.17.7.1303; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272; Estrach S, 2011, CIRC RES, V109, P172, DOI 10.1161/CIRCRESAHA.111.240622; Gillotte KL, 2000, J LIPID RES, V41, P824; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Inoue M, 2001, ARTERIOSCL THROM VAS, V21, P560, DOI 10.1161/01.ATV.21.4.560; Itabe H, 2009, CLIN REV ALLERG IMMU, V37, P4, DOI 10.1007/s12016-008-8095-9; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Li DY, 2005, CARDIOVASC RES, V68, P353, DOI 10.1016/j.cardiores.2005.09.009; Li John Zhong, 2007, Novartis Found Symp, V286, P155; Li R, 2011, BIOCHEM BIOPH RES CO, V417, P619; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Mattaliano MD, 2011, AM J PHYSIOL-CELL PH, V296, pC1329; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Mehta JL, 2006, J AM COLL CARDIOL, V48, P980, DOI 10.1016/j.jacc.2006.06.001; Mehta JL, 1998, BIOCHEM BIOPH RES CO, V248, P511, DOI 10.1006/bbrc.1998.9004; Ogura S, 2009, CIRC J, V73, P1993, DOI 10.1253/circj.CJ-09-0587; Park SH, 2005, J BIOCHEM MOL BIOL, V38, P9; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Qin B, 2011, BIOCHEM BIOPH RES CO, V410, P127, DOI 10.1016/j.bbrc.2011.05.118; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Semlitsch M, 2011, DNA REPAIR, V10, P848, DOI 10.1016/j.dnarep.2011.05.004; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Xie XP, 2010, ACTA BIOCHIM POL, V57, P393	39	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47421	10.1371/journal.pone.0047421	http://dx.doi.org/10.1371/journal.pone.0047421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115646	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200039
J	Hori, N; Yamane, M; Kouno, K; Sato, K				Hori, Naohiro; Yamane, Mariko; Kouno, Kaori; Sato, Kenzo			Induction of DNA Demethylation Depending on Two Sets of Sox2 and Adjacent Oct3/4 Binding Sites (Sox-Oct Motifs) within the Mouse H19/Insulin-like Growth Factor 2 (Igf2) Imprinted Control Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL REGULATION; PATERNAL METHYLATION; GENE-EXPRESSION; CPG ISLAND; H19 LOCUS; PROMOTER; COMPLEX; ELEMENTS; OCTAMER	DNA demethylation is used to establish and maintain an unmethylated state. The molecular mechanisms to induce DNA demethylation at a particular genomic locus remain unclear. The mouse H19/insulin-like growth factor 2 (Igf2) imprinted control region (ICR) is a methylation state-sensitive insulator that regulates transcriptional activation of both genes. The unmethylated state of the ICR established in female germ cells is maintained during development, resisting the wave of genome-wide de novo methylation. We previously demonstrated that a DNA fragment (fragment b) derived from this ICR-induced DNA demethylation when it was transfected into undifferentiated mouse embryonal carcinoma cell lines. Moreover, two octamer motifs within fragment b were necessary to induce this DNA demethylation. Here, we demonstrated that both octamer motifs and their flanking sequences constitute Sox-Oct motifs (SO1 and SO2) and that the SO1 region, which requires at least four additional elements, including the SO2 region, contributes significantly to the induction of high-frequency DNA demethylation as a Sox-Oct motif. Moreover, RNAi-mediated inhibition of Oct3/4 expression in P19 cells resulted in a reduced DNA demethylation frequency of fragment b but not of the adenine phosphoribosyltransferase gene CpG island. The Sox motif of SO1 could function as a sensor for a hypermethylated state of the ICR to repress demethylation activity. These results indicate that Sox-Oct motifs in the ICR determine the cell type, DNA region, and allele specificity of DNA demethylation. We propose a link between the mechanisms for maintenance of the unmethylated state of the H19/Igf2 ICR and the undifferentiated cell-specific induction of DNA demethylation.	[Hori, Naohiro; Yamane, Mariko; Kouno, Kaori; Sato, Kenzo] Tottori Univ, Div Mol Biol, Dept Mol & Cellular Biol, Sch Life Sci,Fac Med, Yonago, Tottori 6838503, Japan; [Hori, Naohiro; Sato, Kenzo] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori 6838503, Japan	Tottori University; Tottori University	Hori, N (corresponding author), Tottori Univ, Div Mol Biol, Dept Mol & Cellular Biol, Sch Life Sci,Fac Med, Nishi Cho 86, Yonago, Tottori 6838503, Japan.	horinao@med.tottori-u.ac.jp		Yamane, Mariko/0000-0001-8354-174X				Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Demars J, 2010, HUM MOL GENET, V19, P803, DOI 10.1093/hmg/ddp549; Hori N, 2002, J BIOL CHEM, V277, P27960, DOI 10.1074/jbc.M202280200; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Kirillov A, 1996, NAT GENET, V13, P435, DOI 10.1038/ng0895-435; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Rand E, 2004, CURR BIOL, V14, P1007, DOI 10.1016/j.cub.2004.05.041; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Savage J, 2009, STEM CELLS, V27, P1231, DOI 10.1002/stem.57; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Xia CH, 2007, DIFFERENTIATION, V75, P912, DOI 10.1111/j.1432-0436.2007.00188.x	30	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					44006	44016		10.1074/jbc.M112.424580	http://dx.doi.org/10.1074/jbc.M112.424580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115243	hybrid, Green Published			2022-12-25	WOS:000312940800075
J	Ohlig, S; Pickhinke, U; Sirko, S; Bandari, S; Hoffmann, D; Dreier, R; Farshi, P; Gotz, M; Grobe, K				Ohlig, Stefanie; Pickhinke, Ute; Sirko, Svetlana; Bandari, Shyam; Hoffmann, Daniel; Dreier, Rita; Farshi, Pershang; Goetz, Magdalena; Grobe, Kay			An Emerging Role of Sonic Hedgehog Shedding as a Modulator of Heparan Sulfate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-RANGE ACTIVITY; PSEUDO-ACTIVE-SITE; CHOLESTEROL MODIFICATION; CELLULAR CHOLESTEROL; MORPHOGEN GRADIENTS; LIPID RAFTS; TOUT-VELU; PROTEIN; DROSOPHILA; FORM	Major developmental morphogens of the Hedgehog (Hh) family act at short range and long range to direct cell fate decisions in vertebrate and invertebrate tissues. To this end, Hhs are released from local sources and act at a distance on target cells that express the Hh receptor Patched. However, morphogen secretion and spreading are not passive processes because all Hhs are synthesized as dually (N- and C-terminal) lipidated proteins that firmly tether to the surface of producing cells. On the cell surface, Hhs associate with each other and with heparan sulfate (HS) proteoglycans. This raises the question of how Hh solubilization and spreading is achieved. We recently discovered that Sonic hedgehog (Shh) is solubilized by proteolytic processing (shedding) of lipidated peptide termini in vitro. Because unprocessed N termini block Patched receptor binding sites in the cluster, we further suggested that their proteolytic removal is required for simultaneous Shh activation. In this work we confirm inactivity of unprocessed protein clusters and demonstrate restored biological Shh function upon distortion or removal of N-terminal amino acids and peptides. We further show that N-terminal Shh processing targets and inactivates the HS binding Cardin-Weintraub (CW) motif, resulting in soluble Shh clusters with their HS binding capacities strongly reduced. This may explain the ability of Shh to diffuse through the HS-containing extracellular matrix, whereas other HS-binding proteins are quickly immobilized. Our in vitro findings are supported by the presence of CW-processed Shh in murine brain samples, providing the first in vivo evidence for Shh shedding and subsequent solubilization of N-terminal-truncated proteins.	[Ohlig, Stefanie; Pickhinke, Ute; Bandari, Shyam; Dreier, Rita; Farshi, Pershang; Grobe, Kay] Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Sirko, Svetlana; Goetz, Magdalena] Univ Munich, Inst Physiol Genom, D-80336 Munich, Germany; [Hoffmann, Daniel] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany	University of Munster; University of Munich; University of Duisburg Essen	Grobe, K (corresponding author), Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	kgrobe@uni-muenster.de	Grobe, Kay/F-2399-2011; Hoffmann, Daniel/B-1314-2018; Sirko, Swetlana/O-5725-2019; Hoffmann, Daniel/P-5624-2019	Hoffmann, Daniel/0000-0003-2973-7869; Sirko, Swetlana/0000-0001-5950-616X; Hoffmann, Daniel/0000-0003-2973-7869	German Research Council (DFG) [SFB 492-B15]; Heinrich-Hertz fellowship; DFG fellowship [GRK1549/1]	German Research Council (DFG)(German Research Foundation (DFG)); Heinrich-Hertz fellowship; DFG fellowship(German Research Foundation (DFG))	This work was supported by German Research Council (DFG) Grant SFB 492-B15 and a Heinrich-Hertz fellowship (to K. G.) and DFG fellowship GRK1549/1 (to S. O., S. B., and U. P.).	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Amanai K, 2001, DEVELOPMENT, V128, P5119; Ayers KL, 2010, DEV CELL, V18, P605, DOI 10.1016/j.devcel.2010.02.015; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chan JA, 2009, NAT NEUROSCI, V12, P409, DOI 10.1038/nn.2287; Chang SC, 2011, J BIOL CHEM, V286, P44391, DOI 10.1074/jbc.M111.285361; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Creanga A, 2012, GENE DEV, V26, P1312, DOI 10.1101/gad.191866.112; Dawber RJ, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-21; Dierker T, 2009, J BIOL CHEM, V284, P32562, DOI 10.1074/jbc.M109.044867; Dierker T, 2009, J BIOL CHEM, V284, P8013, DOI 10.1074/jbc.M806838200; Dreier R, 2008, J BIOL CHEM, V283, P1104, DOI 10.1074/jbc.M703336200; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Farshi P, 2011, J BIOL CHEM, V286, P23608, DOI 10.1074/jbc.M110.206474; Gallet A, 2006, DEVELOPMENT, V133, P407, DOI 10.1242/dev.02212; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Kohtz JD, 2001, DEVELOPMENT, V128, P2351; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lee JD, 2001, DEV BIOL, V233, P122, DOI 10.1006/dbio.2001.0218; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Liu XQ, 2000, ANNU REV GENET, V34, P61, DOI 10.1146/annurev.genet.34.1.61; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Micchelli CA, 2002, DEVELOPMENT, V129, P843; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Ohlig S, 2011, DEV CELL, V20, P764, DOI 10.1016/j.devcel.2011.05.010; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Peters C, 2004, P NATL ACAD SCI USA, V101, P8531, DOI 10.1073/pnas.0308449101; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rubin JB, 2002, DEVELOPMENT, V129, P2223; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Walev I, 2000, J LEUKOCYTE BIOL, V68, P865; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039; Zimina EP, 2005, J BIOL CHEM, V280, P34019, DOI 10.1074/jbc.M503751200	70	43	45	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43708	43719		10.1074/jbc.M112.356667	http://dx.doi.org/10.1074/jbc.M112.356667			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118222	Green Published, hybrid			2022-12-25	WOS:000312940800050
J	Bianchi, G; Morandi, F; Cilli, M; Daga, A; Bocelli-Tyndall, C; Gambini, C; Pistoia, V; Raffaghello, L				Bianchi, Giovanna; Morandi, Fabio; Cilli, Michele; Daga, Antonio; Bocelli-Tyndall, Chiara; Gambini, Claudio; Pistoia, Vito; Raffaghello, Lizzia			Close Interactions between Mesenchymal Stem Cells and Neuroblastoma Cell Lines Lead to Tumor Growth Inhibition	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; IN-VIVO; METASTATIC NEUROBLASTOMA; HEMATOPOIETIC-STEM; DELIVERY VEHICLES; CANCER-CELLS; N-MYC; MODEL; PROLIFERATION	Mesenchymal stem cells (MSCs) have attracted much interest in oncology since they exhibit marked tropism for the tumor microenvironment and support or suppress malignant cell growth depending on the tumor model tested. The aim of this study was to investigate the role of MSCs in the control of the growth of neuroblastoma (NB), which is the second most common solid tumor in children. In vivo experiments showed that systemically administered MSCs, under our experimental conditions, did not home to tumor sites and did not affect tumor growth or survival. However, MSCs injected intratumorally in an established subcutaneous NB model reduced tumor growth through inhibition of proliferation and induction of apoptosis of NB cells and prolonged the survival of hMSC-treated mice. The need for contact between MSCs and NB cells was further supported by in vitro experiments. In particular, MSCs were found to be attracted by NB cells, and to affect NB cell proliferation with different results depending on the cell line tested. Moreover, NB cells, after pre-incubation with hMSCs, acquired a more invasive behavior towards CXCL12 and the bone marrow, i.e., the primary site of NB metastases. In conclusion, this study demonstrates that functional cross-talk between MSCs and NB cell lines used in our experiments can occur only within short range interaction. Thus, this report does not support the clinical use of MSCs as vehicles for selective delivery of antitumor drugs at the NB site unless chemotherapy and/or radiotherapy create suitable local conditions for MSCs recruitment.	[Bianchi, Giovanna; Morandi, Fabio; Pistoia, Vito; Raffaghello, Lizzia] Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy; [Cilli, Michele] San Martino Natl Inst Canc Res, Anim Res Facil, Genoa, Italy; [Daga, Antonio] Natl Inst Canc Res, Dept Translat Oncol, Genoa, Italy; [Bocelli-Tyndall, Chiara] Univ Basel, Dept Rheumatol, CH-4003 Basel, Switzerland; [Gambini, Claudio] Ist Giannina Gaslini, Pathol Lab, I-16148 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Basel; University of Genoa; IRCCS Istituto Giannina Gaslini	Raffaghello, L (corresponding author), Ist Giannina Gaslini, Lab Oncol, I-16148 Genoa, Italy.	lizziaraffaghello@ospedale-gaslini.ge.it	Daga, Antonio/Z-2417-2019; Cilli, Michele/AAB-8529-2019; Bianchi, Giovanna/J-5904-2016; Morandi, Fabio/I-1185-2012	Daga, Antonio/0000-0001-5845-8530; Bianchi, Giovanna/0000-0002-0888-3616; Raffaghello, Lizzia/0000-0003-2357-0607; Cilli, Michele/0000-0003-4083-8986; Morandi, Fabio/0000-0002-2849-7595	My First AIRC Grant (Lizzia Raffaghello); FIRC	My First AIRC Grant (Lizzia Raffaghello)(Fondazione AIRC per la ricerca sul cancro); FIRC(Fondazione AIRC per la ricerca sul cancro)	The work was supported by My First AIRC Grant (Lizzia Raffaghello). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Giovanna Bianchi is a recipient of a FIRC fellowship.	Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; BIEDLER JL, 1978, CANCER RES, V38, P3751; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; CORNAGLIAFERRARIS P, 1990, PEDIATR RES, V27, P1, DOI 10.1203/00006450-199001000-00001; Cousin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006278; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Djouad F, 2006, TRANSPLANTATION, V82, P1060, DOI 10.1097/01.tp.0000236098.13804.0b; Du WL, 2008, AM J PATHOL, V173, P1153, DOI 10.2353/ajpath.2008.070309; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Garcia-Castro J, 2010, CANCER GENE THER, V17, P476, DOI 10.1038/cgt.2010.4; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; GROSS N, 1992, INT J CANCER, V52, P85, DOI 10.1002/ijc.2910520116; Gutova M, 2008, STEM CELLS, V26, P1406, DOI 10.1634/stemcells.2008-0141; Hall B, 2007, INT J HEMATOL, V86, P8, DOI 10.1532/IJH97.06230; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Johann PD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-501; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kidd S, 2010, CYTOTHERAPY, V12, P615, DOI 10.3109/14653241003631815; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Klopp AH, 2007, CANCER RES, V67, P11687, DOI 10.1158/0008-5472.CAN-07-1406; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lode HN, 1997, J NATL CANCER I, V89, P1586, DOI 10.1093/jnci/89.21.1586; LONGO L, 1988, J CANCER RES CLIN, V114, P636, DOI 10.1007/BF00398190; Lotfi R, 2011, EUR J IMMUNOL, V41, P2021, DOI 10.1002/eji.201041324; Lu YR, 2008, CANCER BIOL THER, V7, P245, DOI 10.4161/cbt.7.2.5296; Ma M, 2011, CANCER LETT, V312, P1, DOI 10.1016/j.canlet.2011.06.028; Mader EK, 2009, CLIN CANCER RES, V15, P7246, DOI 10.1158/1078-0432.CCR-09-1292; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Patel SA, 2010, J IMMUNOL, V184, P5885, DOI 10.4049/jimmunol.0903143; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qiao L, 2008, CANCER LETT, V269, P67, DOI 10.1016/j.canlet.2008.04.032; Qiao L, 2008, CELL RES, V18, P500, DOI 10.1038/cr.2008.40; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Secchiero P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011140; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Shoji M, 2011, J ATHEROSCLER THROMB, V18, P464, DOI 10.5551/jat.6213; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sohara Y, 2005, CANCER RES, V65, P1129, DOI 10.1158/0008-5472.CAN-04-2853; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; Torsvik A, 2012, CANC TREAT REV; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yong RL, 2009, CANCER RES, V69, P8932, DOI 10.1158/0008-5472.CAN-08-3873; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004	65	22	23	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48654	10.1371/journal.pone.0048654	http://dx.doi.org/10.1371/journal.pone.0048654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119082	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500190
J	Chuang, CY; Sung, WW; Wang, L; Lin, WL; Yeh, KT; Su, MC; Hsin, CH; Lee, SY; Wu, BC; Cheng, YW; Lee, H				Chuang, Chun-Yi; Sung, Wen-Wei; Wang, Lee; Lin, Wea-Long; Yeh, Kun-Tu; Su, Mao-Chang; Hsin, Chun-Han; Lee, Shiann-Yann; Wu, Buor-Chang; Cheng, Ya-Wen; Lee, Huei			Differential Impact of IL-10 Expression on Survival and Relapse between HPV16-Positive and -Negative Oral Squamous Cell Carcinomas	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CANCER; INTERLEUKIN-10; RISK; PREVALENCE; TYPE-16; CAVITY; HEAD; ASSOCIATION; CLEARANCE	Human papillomavirus (HPV) is a risk factor in a subset of oropharyngeal cancer; however, the contribution of HPV in the malignancy of oral squamous cell carcinomas (OSCC) is not fully understood in Taiwanese. Herein, 61 patients with no risk factors and 117 patients with one or more risk factors were enrolled in this study. HPV16/18 infection rate in non-smokers, non-drinkers and non-betel quid chewers was higher than their counterparts. The development of HPV-infected cancer has been shown to be associated with interleukin-10 (IL-10) expression. To this end, IL-10 mRNA expression in OSCC tumors was evaluated by real-time RT-PCR. Data showed that HPV-positive patients had higher IL-10 mRNA levels than in HPV-negative patients. Kaplan-Meier and Cox-regression analysis indicated that the prognostic significance of IL-10 mRNA on overall survival and relapse free survival was only observed in HPV-positive OSCC, but not in HPV-negative OSCC. Mechanistically, the elevation of IL-10 by E6 was responsible for increased colony formation and migration capability in OSCC cells. Therefore, we suggest that IL-10 induced by E6 promotes cell growth and migration capability and consequent poor survival and relapse in HPV-positive OSCC.	[Chuang, Chun-Yi; Sung, Wen-Wei; Cheng, Ya-Wen; Lee, Huei] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Sung, Wen-Wei; Lee, Huei] Chung Shan Med Univ, Inst Med & Mol Toxicol, Taichung, Taiwan; [Chuang, Chun-Yi; Sung, Wen-Wei; Yeh, Kun-Tu; Su, Mao-Chang; Hsin, Chun-Han] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lin, Wea-Long] Chung Shan Med Univ, Dept Pathol, Taichung, Taiwan; [Chuang, Chun-Yi; Su, Mao-Chang; Hsin, Chun-Han; Lee, Shiann-Yann] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Wu, Buor-Chang] Chung Shan Med Univ Hosp, Dept Oral & Maxillofacial Surg, Taichung, Taiwan; [Yeh, Kun-Tu] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Cheng, Ya-Wen; Lee, Huei] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Wang, Lee] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Taipei Medical University; Chung Shan Medical University	Lee, H (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	hl@tmu.edu.tw	Sung, Wen-Wei/P-5053-2019	Sung, Wen-Wei/0000-0002-2375-0029	Chung Shan Medical University Hospital [CSH-2010-C-023]	Chung Shan Medical University Hospital	This work was jointly supported by grants from the Chung Shan Medical University Hospital (CSH-2010-C-023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding sources for this study.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chen PCH, 2002, J ORAL PATHOL MED, V31, P317, DOI 10.1034/j.1600-0714.2002.00129.x; Chen WJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-27; Chen YW, 2012, J SURG ONCOL; Cheng YW, 2008, CLIN CANCER RES, V14, P7173, DOI 10.1158/1078-0432.CCR-08-0850; Cheng YW, 2001, CANCER RES, V61, P2799; Chien CY, 2008, ORAL ONCOL, V44, P174, DOI 10.1016/j.oraloncology.2007.01.018; Chung CH, 2005, J ORAL PATHOL MED, V34, P460, DOI 10.1111/j.1600-0714.2005.00332.x; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dahlgren L, 2004, INT J CANCER, V112, P1015, DOI 10.1002/ijc.20490; Dai M, 2004, CANCER RES, V64, P468, DOI 10.1158/0008-5472.CAN-03-3284; El-Sherif AM, 2001, J PATHOL, V195, P179, DOI 10.1002/path.929; Gillison ML, 2006, J CLIN ONCOL, V24, P5623, DOI 10.1200/JCO.2006.07.1829; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Ha PK, 2002, CLIN CANCER RES, V8, P1203; Huang LW, 2010, GYNECOL OBSTET INVES, V70, P73, DOI 10.1159/000291199; Huber GF, 2011, CANCER; Jalouli J, 2012, ANTICANCER RES, V32, P571; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim R, 2006, CANCER RES, V66, P5527, DOI 10.1158/0008-5472.CAN-05-4128; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kuo KT, 2008, MODERN PATHOL, V21, P376, DOI 10.1038/modpathol.3800979; Lee CH, 2003, BRIT J CANCER, V88, P366, DOI 10.1038/sj.bjc.6600727; Lee LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040767; Lee SS, 2008, J FORMOS MED ASSOC, V107, P355, DOI 10.1016/S0929-6646(08)60100-X; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Lopes V, 2011, ORAL ONCOL, V47, P698, DOI 10.1016/j.oraloncology.2011.04.022; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mindiola R, 2008, INVEST CLIN, V49, P533; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Reddout Nicole, 2007, Infect Agent Cancer, V2, P21, DOI 10.1186/1750-9378-2-21; Sanjiv K, 2012, INT J CANCER, V130, P1440, DOI 10.1002/ijc.26142; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shrestha S, 2007, CANCER EPIDEM BIOMAR, V16, P1626, DOI 10.1158/1055-9965.EPI-06-0881; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Sung WW, 2011, CLIN CANCER RES, V17, P5991, DOI 10.1158/1078-0432.CCR-11-0227; Syrjanen S, 2009, VIRCHOWS ARCH, V455, P505, DOI 10.1007/s00428-009-0850-7; Vicari AP, 2004, IMMUNOL REV, V202, P223, DOI 10.1111/j.0105-2896.2004.00216.x; WANG PD, 1994, SOC BIOL, V41, P143; Wu DW, 2011, CLIN CANCER RES, V17, P1895, DOI 10.1158/1078-0432.CCR-10-2316; Zeng L, 2010, CYTOKINE, V49, P294, DOI 10.1016/j.cyto.2009.11.015; Zhu CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036294	48	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47541	10.1371/journal.pone.0047541	http://dx.doi.org/10.1371/journal.pone.0047541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118878	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500023
J	Debruille, JB; Brodeur, MB; Porras, CF				Debruille, J. Bruno; Brodeur, Mathieu B.; Franco Porras, Carolina			N300 and Social Affordances: A Study with a Real Person and a Dummy as Stimuli	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; KNOWLEDGE INHIBITION; RESPONSE-INHIBITION; OCCIPITOTEMPORAL CORTEX; N400-LIKE POTENTIALS; SEMANTIC MEMORY; REACTION-TIMES; OBJECTS; PERCEPTION	Pictures of objects have been shown to automatically activate affordances, that is, actions that could be performed with the object. Similarly, pictures of faces are likely to activate social affordances, that is, interactions that would be possible with the person whose face is being presented. Most interestingly, if it is the face of a real person that is shown, one particular type of social interactions can even be carried out while event-related potentials (ERPs) are recorded. Indeed, subtle eye movements can be made to achieve an eye contact with the person with minimal artefacts on the EEG. The present study thus used the face of a real person to explore the electrophysiological correlates of affordances in a situation where some of them (i.e., eye contacts) are actually performed. The ERPs this person elicited were compared to those evoked by another 3D stimulus: a real dummy, and thus by a stimulus that should also automatically activate eye contact affordances but with which such affordances could then be inhibited since they cannot be carried out with an object. The photos of the person and of the dummy were used as matching stimuli that should not activate social affordances as strongly as the two 3D stimuli and for which social affordances cannot be carried out. The fronto-central N300s to the real dummy were found of greater amplitudes than those to the photos and to the real person. We propose that these greater N300s index the greater inhibition needed after the stronger activations of affordances induced by this 3D stimulus than by the photos. Such an inhibition would not have occurred in the case of the real person because eye contacts were carried out.	[Debruille, J. Bruno; Brodeur, Mathieu B.] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Debruille, J. Bruno; Brodeur, Mathieu B.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Debruille, J. Bruno] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Franco Porras, Carolina] Ctr Higiene Mental Les Corts, Barcelona, Spain	McGill University; McGill University	Debruille, JB (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	bruno.debruille@mcgill.ca	Debruille, J. Bruno/E-3115-2016	Debruille, J. Bruno/0000-0001-8285-7427	National Sciences and Engineering Research Council of Canada [194517-02]; Fonds de la Recherche en Sante du Quebec (FRSQ) [10084]; FRSQ [15171]	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	This study was supported by the grant 194517-02 from the National Sciences and Engineering Research Council of Canada allocated to the first author who was supported by the scholarship 10084 from the Fonds de la Recherche en Sante du Quebec (FRSQ). MBB was supported by the fellowship 15171 from the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; [Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; BARRETT SE, 1988, NEUROPSYCHOLOGIA, V26, P105, DOI 10.1016/0028-3932(88)90034-6; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; BESSON M, 1992, J COGNITIVE NEUROSCI, V4, P132, DOI 10.1162/jocn.1992.4.2.132; Bobes MA, 2000, COGNITIVE BRAIN RES, V9, P249, DOI 10.1016/S0926-6410(00)00003-3; Bonini L, 2011, ANN NY ACAD SCI, V1225, P166, DOI 10.1111/j.1749-6632.2011.06002.x; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Debruille JB, 2007, BRAIN RES REV, V56, P472, DOI 10.1016/j.brainresrev.2007.10.001; Debruille JB, 2008, BRAIN RES, V1187, P167, DOI 10.1016/j.brainres.2007.10.021; Debruille JB, 2009, NEUROPSYCHOLOGIA, V47, P506, DOI 10.1016/j.neuropsychologia.2008.10.007; Debruille JB, 1996, COGNITIVE BRAIN RES, V4, P133, DOI 10.1016/0926-6410(96)00032-8; Debruille JB, 1998, BRAIN LANG, V62, P202, DOI 10.1006/brln.1997.1904; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ellis R, 2000, BRIT J PSYCHOL, V91, P451, DOI 10.1348/000712600161934; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Ganis G, 2008, NEUROIMAGE, V42, P1714, DOI 10.1016/j.neuroimage.2008.07.004; Gibbs RW, 2010, STUD HIST PHILOS SCI, V41, P305, DOI 10.1016/j.shpsa.2010.07.004; Gibson J.J., 1977, PERCEIVING ACTING KN, P67, DOI DOI 10.2307/1421838; Gibson JJ, 1979, ECOLOGICAL APPROACH; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Greenhouse G. W, 1959, PSYCHOMETRIKA, V24, P1582, DOI 10.1007/BF02289823; Grezes J, 2002, NEUROPSYCHOLOGIA, V40, P212, DOI 10.1016/S0028-3932(01)00089-6; Jemel B, 2005, NEUROPSYCHOLOGIA, V43, P2024, DOI 10.1016/j.neuropsychologia.2005.03.016; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Jonkman LM, 2007, CLIN NEUROPHYSIOL, V118, P1069, DOI 10.1016/j.clinph.2007.01.017; Kable JW, 2006, J COGNITIVE NEUROSCI, V18, P1498, DOI 10.1162/jocn.2006.18.9.1498; Kazmerski VA, 1997, NEUROPSY NEUROPSY BE, V10, P32; Kiefer M, 2011, J COGNITIVE NEUROSCI, V23, P1864, DOI 10.1162/jocn.2010.21543; KOUNIOS J, 1992, J EXP PSYCHOL GEN, V121, P459, DOI 10.1037/0096-3445.121.4.459; KRAMER AF, 1987, J EXP PSYCHOL LEARN, V13, P76, DOI 10.1037/0278-7393.13.1.76; Kutas M., 2006, HDB PSYCHOLINGUISTIC; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; McPherson WB, 1999, PSYCHOPHYSIOLOGY, V36, P53, DOI 10.1017/S0048577299971196; Mecklinger A, 2004, EXP PSYCHOL, V51, P258, DOI 10.1027/1618-3169.51.4.258; Ocklenburg S, 2011, NEUROIMAGE, V55, P1771, DOI 10.1016/j.neuroimage.2011.01.035; Olivares EI, 2008, INT J PSYCHOPHYSIOL, V68, P59, DOI 10.1016/j.ijpsycho.2008.01.003; Philiastides MG, 2007, J NEUROSCI, V27, P13082, DOI 10.1523/JNEUROSCI.3540-07.2007; Ponkanen LM, 2008, NEUROREPORT, V19, P497, DOI 10.1097/WNR.0b013e3282f7c4d3; Renoult L, 2012, CLIN NEUROPHYSIOL, V123, P741, DOI 10.1016/j.clinph.2011.08.025; Renoult L, 2011, J COGNITIVE NEUROSCI, V23, P905, DOI 10.1162/jocn.2009.21410; Renoult L, 2010, BIOL PSYCHOL, V84, P206, DOI 10.1016/j.biopsycho.2010.01.014; Roche RAP, 2005, EXP BRAIN RES, V160, P60, DOI 10.1007/s00221-004-1985-z; Rossion B, 2008, NEUROIMAGE, V39, P1959, DOI 10.1016/j.neuroimage.2007.10.011; Schendan HE, 2010, BRAIN RES, V1329, P124, DOI 10.1016/j.brainres.2010.01.062; Schendan HE, 2009, NEUROIMAGE, V44, P1423, DOI 10.1016/j.neuroimage.2008.09.061; Sehatpour P, 2006, NEUROIMAGE, V29, P605, DOI 10.1016/j.neuroimage.2005.07.049; Sitnikova T, 2006, BIOL PSYCHOL, V71, P326, DOI 10.1016/j.biopsycho.2005.07.003; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Symes E, 2005, VIS COGN, V12, P1337, DOI 10.1080/13506280444000445; Tipper SP, 2006, PSYCHON B REV, V13, P493, DOI 10.3758/BF03193875; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Vachon F, 2012, J COGNITIVE NEUROSCI, V24, P611, DOI 10.1162/jocn_a_00149; van Elk M, 2010, BIOL PSYCHOL, V85, P134, DOI 10.1016/j.biopsycho.2010.06.004; Van Strien JW, 2005, NEUROIMAGE, V26, P952, DOI 10.1016/j.neuroimage.2005.03.003; Wiggett AJ, 2011, J COGNITIVE NEUROSCI, V23, P1765, DOI 10.1162/jocn.2010.21552; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2; Wu YC, 2007, BRAIN LANG, V101, P234, DOI 10.1016/j.bandl.2006.12.003; YOUNG MP, 1992, PSYCHOPHYSIOLOGY, V29, P664, DOI 10.1111/j.1469-8986.1992.tb02044.x; Zebrowitz LA, 2010, SCI SOCIAL VISION	67	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47922	10.1371/journal.pone.0047922	http://dx.doi.org/10.1371/journal.pone.0047922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WJ	23118908	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500046
J	Persson, K; Esberg, A; Claesson, R; Stromberg, N				Persson, Karina; Esberg, Anders; Claesson, Rolf; Stromberg, Nicklas			The Pilin Protein FimP from Actinomyces oris: Crystal Structure and Sequence Analyses	PLOS ONE			English	Article							STABILIZING ISOPEPTIDE; ELECTRON-MICROSCOPY; PILUS ADHESIN; STREPTOCOCCUS; NAESLUNDII; SURFACE; BONDS; CRYSTALLOGRAPHY; RECOGNITION; BINDING	The Actinomyces oris type-1 pili are important for the initial formation of dental plaque by binding to salivary proteins that adhere to the tooth surface. Here we present the X-ray structure of FimP, the protein that is polymerized into the type-1 pilus stalk, assisted by a pili-specific sortase. FimP consists of three tandem IgG-like domains. The middle and C-terminal domains contain one autocatalyzed intramolecular isopeptide bond each, a feature used by Gram-positive bacteria for stabilization of surface proteins. While the N-terminal domain harbours all the residues necessary for forming an isopeptide bond, no such bond is observed in the crystal structure of this unpolymerized form of FimP. The monomer is further stabilized by one disulfide bond each in the N- and C-terminal domains as well as by a metal-coordinated loop protruding from the C-terminal domain. A lysine, predicted to be crucial for FimP polymerization by covalent attachment to a threonine from another subunit, is located at the rim of a groove lined with conserved residues. The groove may function as a docking site for the sortase-FimP complex. We also present sequence analyses performed on the genes encoding FimP as well as the related FimA, obtained from clinical isolates.	[Persson, Karina] Umea Univ, Dept Chem, Umea, Sweden; [Esberg, Anders; Claesson, Rolf; Stromberg, Nicklas] Umea Univ, Dept Odontol Cariol, Umea, Sweden	Umea University; Umea University	Persson, K (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	karina.persson@chem.umu.se			Swedish Research Council; County Council of Vasterbotten; foundations from Umea University, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); County Council of Vasterbotten; foundations from Umea University, Sweden	This work was supported by the Swedish Research Council, The County Council of Vasterbotten and foundations from Umea University, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Chen P, 2007, INFECT IMMUN, V75, P4181, DOI 10.1128/IAI.01955-06; Cisar J O, 1997, Adv Dent Res, V11, P168; CISAR JO, 1995, GLYCOBIOLOGY, V5, P655, DOI 10.1093/glycob/5.7.655; Daep CA, 2008, INFECT IMMUN, V76, P3273, DOI 10.1128/IAI.00366-08; Daniels R, 2010, J BIOL CHEM, V285, P3300, DOI 10.1074/jbc.M109.081398; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Drobni M, 2006, THESIS UMEA U; Drobni M, 2006, INFECT IMMUN, V74, P6293, DOI 10.1128/IAI.00068-06; El Mortaji L, 2012, BIOCHEM J, V441, P833, DOI 10.1042/BJ20111397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; Geibel S, 2011, ADV EXP MED BIOL, V715, P159, DOI 10.1007/978-94-007-0940-9_10; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Henssge U, 2009, INT J SYST EVOL MICR, V59, P509, DOI 10.1099/ijs.0.000950-0; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mishra A, 2010, MOL MICROBIOL; Mishra A, 2011, MOL MICROBIOL, V81, P1205, DOI 10.1111/j.1365-2958.2011.07745.x; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Paterson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022095; Persson K, 2011, ACTA CRYSTALLOGR F, V67, P1207, DOI 10.1107/S1744309111025929; Persson K, 2011, ACTA CRYSTALLOGR D, V67, P212, DOI 10.1107/S0907444911004215; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; STROMBERG N, 1990, J BIOL CHEM, V265, P11251; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vengadesan K, 2011, J MOL BIOL, V407, P731, DOI 10.1016/j.jmb.2011.02.024; Wu C, 2011, J BACTERIOL; YANAGAWA R, 1968, JPN J VET RES, V16, P31; Yeung MK, 1998, INFECT IMMUN, V66, P1482, DOI 10.1128/IAI.66.4.1482-1491.1998	48	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48364	10.1371/journal.pone.0048364	http://dx.doi.org/10.1371/journal.pone.0048364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118994	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500113
J	Tveden-Nyborg, P; Vogt, L; Schjoldager, JG; Jeannet, N; Hasselholt, S; Paidi, MD; Christen, S; Lykkesfeldt, J				Tveden-Nyborg, Pernille; Vogt, Lucile; Schjoldager, Janne G.; Jeannet, Natalie; Hasselholt, Stine; Paidi, Maya D.; Christen, Stephan; Lykkesfeldt, Jens			Maternal Vitamin C Deficiency during Pregnancy Persistently Impairs Hippocampal Neurogenesis in Offspring of Guinea Pigs	PLOS ONE			English	Article							INCREASED OXIDATIVE STRESS; MORRIS WATER MAZE; ASCORBIC-ACID; TRANSPORTER SVCT2; DEHYDROASCORBIC ACID; RAT-BRAIN; SPATIAL MEMORY; GROWTH; NEURONS; VOLUME	While having the highest vitamin C (VitC) concentrations in the body, specific functions of VitC in the brain have only recently been acknowledged. We have shown that postnatal VitC deficiency in guinea pigs causes impairment of hippocampal memory function and leads to 30% less neurons. This study investigates how prenatal VitC deficiency affects postnatal hippocampal development and if any such effect can be reversed by postnatal VitC repletion. Eighty pregnant Dunkin Hartley guinea pig dams were randomized into weight stratified groups receiving High (900 mg) or Low (100 mg) VitC per kg diet. Newborn pups (n = 157) were randomized into a total of four postnatal feeding regimens: High/High (Control); High/Low (Depleted), Low/Low (Deficient); and Low/High (Repleted). Proliferation and migration of newborn cells in the dentate gyrus was assessed by BrdU labeling and hippocampal volumes were determined by stereology. Prenatal VitC deficiency resulted in a significant reduction in postnatal hippocampal volume (P<0.001) which was not reversed by postnatal repletion. There was no difference in postnatal cellular proliferation and survival rates in the hippocampus between dietary groups, however, migration of newborn cells into the granular layer of the hippocampus dentate gyrus was significantly reduced in prenatally deficient animals (P<0.01). We conclude that a prenatal VitC deficiency in guinea pigs leads to persistent impairment of postnatal hippocampal development which is not alleviated by postnatal repletion. Our findings place attention on a yet unrecognized consequence of marginal VitC deficiency during pregnancy.	[Vogt, Lucile; Jeannet, Natalie; Christen, Stephan] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Tveden-Nyborg, Pernille; Schjoldager, Janne G.; Hasselholt, Stine; Paidi, Maya D.; Lykkesfeldt, Jens] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Christen, Stephan] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of Bern; University of Copenhagen; University of California System; University of California San Francisco	Christen, S (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	stephan.christen@ifik.unibe.ch; jopl@life.ku.dk	Kummer, Juerg/B-3322-2011; Lykkesfeldt, Jens/A-1072-2011; Christen, Stephan/B-8602-2009	Lykkesfeldt, Jens/0000-0002-6514-8407; Tveden-Nyborg, Pernille/0000-0002-5574-5742	Danish National Research Council [FSS271-08-0763]; LIFEPHARM Centre in Denmark; Swiss National Science Foundation [310030_120725]	Danish National Research Council(Danmarks Grundforskningsfond); LIFEPHARM Centre in Denmark; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grants from the Danish National Research Council (#FSS271-08-0763) and the LIFEPHARM Centre in Denmark to JL and the Swiss National Science Foundation (310030_120725) to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano A, 2010, ARCH BIOCHEM BIOPHYS, V496, P38, DOI 10.1016/j.abb.2010.01.012; Blandau RJ, 1939, AM J ANAT, V64, P303, DOI 10.1002/aja.1000640204; Dalm S, 2000, BEHAV RES METH INS C, V32, P134, DOI 10.3758/BF03200795; DOBBING J, 1970, BRAIN RES, V17, P115, DOI 10.1016/0006-8993(70)90311-2; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dringenberg HC, 2001, BEHAV BRAIN RES, V124, P97, DOI 10.1016/S0166-4328(01)00188-7; Frikke-Schmidt H, 2011, BRIT J NUTR, V105, P54, DOI 10.1017/S0007114510003077; Guidi S, 2005, HIPPOCAMPUS, V15, P285, DOI 10.1002/hipo.20050; Haramoto M, 2008, J HEALTH SCI, V54, P43, DOI 10.1248/jhs.54.43; Harrison FE, 2010, FREE RADICAL BIO MED, V49, P821, DOI 10.1016/j.freeradbiomed.2010.06.008; Harrison FE, 2010, BRAIN RES, V1349, P143, DOI 10.1016/j.brainres.2010.06.037; Harrison FE, 2010, BRAIN RES, V1348, P181, DOI 10.1016/j.brainres.2010.05.090; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hollander dB, 2012, J NEUROL NEUROSUR PS, V83, P83; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; KRATZING CC, 1985, J NEUROCHEM, V44, P1623, DOI 10.1111/j.1471-4159.1985.tb08804.x; Lee JY, 2003, J NEUROSCI RES, V73, P156, DOI 10.1002/jnr.10647; Lykkesfeldt J, 2000, ANAL BIOCHEM, V282, P89, DOI 10.1006/abio.2000.4592; Lykkesfeldt J, 2002, FREE RADICAL RES, V36, P567, DOI 10.1080/1071576022411256; Lykkesfeldt J, 2007, BRIT J NUTR, V98, P1116, DOI 10.1017/S0007114507787457; Lykkesfeldt J, 2007, CANCER EPIDEM BIOMAR, V16, P2513, DOI 10.1158/1055-9965.EPI-07-0639; Lykkesfeldt J, 2012, NUTR RES, V32, P66, DOI 10.1016/j.nutres.2011.11.005; Lyuesfeldt J, 2005, MECH AGEING DEV, V126, P892, DOI 10.1016/j.mad.2005.03.010; Mallard EC, 1999, SCHIZOPHR RES, V40, P11, DOI 10.1016/S0920-9964(99)00041-9; MEFFORD IN, 1981, BRAIN RES, V212, P223, DOI 10.1016/0006-8993(81)90056-1; Meredith ME, 2011, BIOCHEM BIOPH RES CO, V414, P737, DOI 10.1016/j.bbrc.2011.09.146; MILBY K, 1982, NEUROSCI LETT, V28, P169, DOI 10.1016/0304-3940(82)90147-1; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Mun GH, 2006, J NEUROSCI RES, V83, P919, DOI 10.1002/jnr.20751; NORKUS EP, 1981, J NUTR, V111, P624, DOI 10.1093/jn/111.4.624; NORKUS EP, 1979, J NUTR, V109, P2205, DOI 10.1093/jn/109.12.2205; NORKUS EP, 1975, ANN NY ACAD SCI, V258, P401, DOI 10.1111/j.1749-6632.1975.tb29298.x; Prasad PD, 1998, BBA-BIOMEMBRANES, V1369, P141, DOI 10.1016/S0005-2736(97)00215-0; Qiu S, 2007, J NEUROSCI RES, V85, P1046, DOI 10.1002/jnr.21204; Rajan DP, 1999, BIOCHEM BIOPH RES CO, V262, P762, DOI 10.1006/bbrc.1999.1272; Rakipovski G, 2011, DIABETES VASC DIS RE, V8, P295, DOI 10.1177/1479164111421033; Rapisarda C, 1977, Arch Sci Biol (Bologna), V61, P1; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Smith AD, 2009, AM J CLIN NUTR, V89, p707S, DOI 10.3945/ajcn.2008.26947D; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Sury MD, 2008, NEUROBIOL DIS, V32, P142, DOI 10.1016/J.nbd.2008.07.006; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Thompson DK, 2008, ANN NEUROL, V63, P642, DOI 10.1002/ana.21367; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Tveden-Nyborg P, 2012, BASIC CLIN PHARMACOL, V110, P524, DOI 10.1111/j.1742-7843.2011.00852.x; Tveden-Nyborg P, 2009, AM J CLIN NUTR, V90, P540, DOI 10.3945/ajcn.2009.27954; Tveden-Nyborg P, 2009, REDOX REP, V14, P2, DOI 10.1179/135100009X392412; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wolf H, 2001, NEUROBIOL AGING, V22, P177, DOI 10.1016/S0197-4580(00)00238-4; Yucel M, 2008, ARCH GEN PSYCHIAT, V65, P694, DOI 10.1001/archpsyc.65.6.694	52	46	49	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48488	10.1371/journal.pone.0048488	http://dx.doi.org/10.1371/journal.pone.0048488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119033	Green Published, gold			2022-12-25	WOS:000310600500149
J	Muczynski, V; Lecureuil, C; Messiaen, S; Guerquin, MJ; N'Tumba-Byn, T; Moison, D; Hodroj, W; Benjelloun, H; Baijer, J; Livera, G; Frydman, R; Benachi, A; Habert, R; Rouiller-Fabre, V				Muczynski, Vincent; Lecureuil, Charlotte; Messiaen, Sebastien; Guerquin, Marie-Justine; N'Tumba-Byn, Thierry; Moison, Delphine; Hodroj, Wassim; Benjelloun, Hinde; Baijer, Jan; Livera, Gabriel; Frydman, Rene; Benachi, Alexandra; Habert, Rene; Rouiller-Fabre, Virginie			Cellular and Molecular Effect of MEHP Involving LXR alpha in Human Fetal Testis and Ovary	PLOS ONE			English	Article							IN-UTERO EXPOSURE; N-BUTYL PHTHALATE; LIVER X RECEPTORS; GENE-EXPRESSION; RAT TESTIS; DI(N-BUTYL) PHTHALATE; TESTICULAR DYSGENESIS; DIBUTYL PHTHALATE; MONO-(2-ETHYLHEXYL) PHTHALATE; TESTOSTERONE PRODUCTION	Background: Phthalates have been shown to have reprotoxic effects in rodents and human during fetal life. Previous studies indicate that some members of the nuclear receptor (NR) superfamilly potentially mediate phthalate effects. This study aimed to assess if expression of these nuclear receptors are modulated in the response to MEHP exposure on the human fetal gonads in vitro. Methodology/Principal Findings: Testes and ovaries from 7 to 12 gestational weeks human fetuses were exposed to 10(-4) M MEHP for 72 h in vitro. Transcriptional level of NRs and of downstream genes was then investigated using TLDA (TaqMan Low Density Array) and qPCR approaches. To determine whether somatic or germ cells of the testis are involved in the response to MEHP exposure, we developed a highly efficient cytometric germ cell sorting approach. In vitro exposure of fetal testes and ovaries to MEHP up-regulated the expression of LXR alpha, SREBP members and of downstream genes involved in the lipid and cholesterol synthesis in the whole gonad. In sorted testicular cells, this effect is only observable in somatic cells but not in the gonocytes. Moreover, the germ cell loss induced by MEHP exposure, that we previously described, is restricted to the male gonad as oogonia density is not affected in vitro. Conclusions/Significance: We evidenced for the first time that phthalate increases the levels of mRNA for LXRa, and SREBP members potentially deregulating lipids/cholesterol synthesis in human fetal gonads. Interestingly, this novel effect is observable in both male and female whereas the germ cell apoptosis is restricted to the male gonad. Furthermore, we presented here a novel and potentially very useful flow cytometric cell sorting method to analyse molecular changes in germ cells versus somatic cells.	[Muczynski, Vincent; Lecureuil, Charlotte; Messiaen, Sebastien; Guerquin, Marie-Justine; N'Tumba-Byn, Thierry; Moison, Delphine; Hodroj, Wassim; Livera, Gabriel; Habert, Rene; Rouiller-Fabre, Virginie] Univ Paris Diderot, Lab Dev Gonads, Unit Stem Cells & Radiat, Fontenay Aux Roses, France; [Muczynski, Vincent; Lecureuil, Charlotte; Messiaen, Sebastien; Guerquin, Marie-Justine; N'Tumba-Byn, Thierry; Moison, Delphine; Hodroj, Wassim; Livera, Gabriel; Habert, Rene; Rouiller-Fabre, Virginie] CEA, DSV, iRCM, SCSR,LDG, F-92265 Fontenay Aux Roses, France; [Muczynski, Vincent; Lecureuil, Charlotte; Messiaen, Sebastien; Guerquin, Marie-Justine; N'Tumba-Byn, Thierry; Moison, Delphine; Hodroj, Wassim; Livera, Gabriel; Habert, Rene; Rouiller-Fabre, Virginie] INSERM, U967, F-92265 Fontenay Aux Roses, France; [Benjelloun, Hinde; Baijer, Jan] CEA DSV iRCM SCSR, Flow Cytometry Facil, F-92265 Fontenay Aux Roses, France; [Frydman, Rene; Benachi, Alexandra] Univ Paris 11, Hop Antoine Beclere, Serv Gynecol Obstet, F-92141 Clamart, France	UDICE-French Research Universities; Universite Paris Cite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay	Rouiller-Fabre, V (corresponding author), Univ Paris Diderot, Lab Dev Gonads, Unit Stem Cells & Radiat, Fontenay Aux Roses, France.	virginie.rouiller-fabre@cea.fr	Lécureuil, Charlotte/B-4841-2016; LIVERA, Gabriel/F-5740-2019	Lécureuil, Charlotte/0000-0002-7339-9185; LIVERA, Gabriel/0000-0001-8436-4730; ROUILLER-FABRE, Virginie/0000-0002-3927-5701; GUERQUIN, Marie-Justine/0000-0002-1752-7250; Habert, Rene/0000-0002-6045-0324	Universite Paris Diderot Sorbonne Paris Cite; Commissariat a l'Energie Atomique, INSERM; Agence Nationale pour la Recherche [2008-2010]; Ministere de L'Ecologie et du Developpement Durable (STORm grant) [2010-2012]; Region Ile-de-France; Ministere de l'Education Nationale de la Recherche et de la Technologie; Association pour la Recherche sur le Cancer	Universite Paris Diderot Sorbonne Paris Cite; Commissariat a l'Energie Atomique, INSERM; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ministere de L'Ecologie et du Developpement Durable (STORm grant); Region Ile-de-France(Region Ile-de-France); Ministere de l'Education Nationale de la Recherche et de la Technologie; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by Universite Paris Diderot Sorbonne Paris Cite, the Commissariat a l'Energie Atomique, INSERM, the Agence Nationale pour la Recherche. (Phtalatestis grant 2008-2010) and Ministere de L'Ecologie et du Developpement Durable (STORm grant, INERIS, 2010-2012). This work was also supported by funds from Region Ile-de-France. VM is supported by a fellowship from the Ministere de l'Education Nationale de la Recherche et de la Technologie and a grant from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenard G, 2010, ENVIRON HEALTH PERSP, V118, P331, DOI 10.1289/ehp.0900975; Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020; Boekelheide K, 2009, MICROSC RES TECHNIQ, V72, P629, DOI 10.1002/jemt.20684; Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015; Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870; Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649; El-Hajjaji FZ, 2011, BBA-MOL BASIS DIS, V1812, P974, DOI 10.1016/j.bbadis.2011.02.004; Ellero-Simatos S, 2011, J PROTEOME RES, V10, P5493, DOI 10.1021/pr200765v; Eveillard A, 2009, BIOCHEM PHARMACOL, V77, P1735, DOI 10.1016/j.bcp.2009.02.023; Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217; Ferrara D, 2006, ENDOCRINOLOGY, V147, P5352, DOI 10.1210/en.2006-0527; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Gaido KW, 2007, TOXICOL SCI, V97, P491, DOI 10.1093/toxsci/kfm049; Guerquin MJ, 2010, DEV BIOL, V346, P320, DOI 10.1016/j.ydbio.2010.08.002; Guerquin MJ, 2009, HUM REPROD, V24, P670, DOI 10.1093/humrep/den410; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hurst CH, 2004, TOXICOL APPL PHARM, V199, P266, DOI 10.1016/j.taap.2003.11.028; Ito Y, 2007, ARCH TOXICOL, V81, P219, DOI 10.1007/s00204-006-0141-x; Johnson KJ, 2007, BIOL REPROD, V77, P978, DOI 10.1095/biolreprod.107.062950; Johnson KJ, 2011, TOXICOL SCI, V120, P460, DOI 10.1093/toxsci/kfr020; Kavlock R, 2002, REPROD TOXICOL, V16, P489, DOI 10.1016/S0890-6238(02)00033-3; Kleymenova E, 2005, BIOL REPROD, V73, P482, DOI 10.1095/biolreprod.104.037184; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146; Lambrot R, 2006, J CLIN ENDOCR METAB, V91, P2696, DOI 10.1210/jc.2005-2113; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Latini G, 2008, PPAR RES, V2008, DOI 10.1155/2008/359267; Le Bouffant R, 2010, HUM REPROD, V25, P2579, DOI 10.1093/humrep/deq195; Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169; Lehraiki A, 2009, TOXICOL SCI, V111, P372, DOI 10.1093/toxsci/kfp153; Li H, 2003, BIOL REPROD, V69, P1964, DOI 10.1095/biolreprod.103.018895; Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550; Lin H, 2008, P NATL ACAD SCI USA, V105, P7218, DOI 10.1073/pnas.0709260105; Lin Ling, 2008, Zhonghua Yufang Yixue Zazhi, V42, P177; Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404; Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671; Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809; Maranghi F, 2010, REPROD TOXICOL, V29, P427, DOI 10.1016/j.reprotox.2010.03.002; Martinez-Arguelles DB, 2011, BIOL REPROD, V85, P51, DOI 10.1095/biolreprod.110.089920; McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676; McKinnell C, 2009, HUM REPROD, V24, P2244, DOI 10.1093/humrep/dep200; Mitchell RT, 2012, J CLIN ENDOCR METAB, V97, pE341, DOI 10.1210/jc.2011-2411; Mouzat K, 2012, MOL CELL ENDOCRINOL; Moyer B, 2012, REPROD TOXICOL; Muczynski V, 2012, TOXICOL APPL PHARM; O'Shaughnessy PJ, 2011, REPRODUCTION, V141, P37, DOI 10.1530/REP-10-0365; Omezzine A, 2003, ENDOCRINOLOGY, V144, P648, DOI 10.1210/en.2002-220692; Pauls K, 2006, HUM REPROD, V21, P397, DOI 10.1093/humrep/dei325; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Qin J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003285; Sonne SB, 2009, CANCER RES, V69, P5241, DOI 10.1158/0008-5472.CAN-08-4554; Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viennois E, 2011, EXPERT OPIN THER TAR, V15, P219, DOI 10.1517/14728222.2011.547853; Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277; Volle DH, 2009, J CLIN INVEST, V119, P3752, DOI 10.1172/JCI38521; Ward JM, 1998, TOXICOL PATHOL, V26, P240, DOI 10.1177/019262339802600208	59	33	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48266	10.1371/journal.pone.0048266	http://dx.doi.org/10.1371/journal.pone.0048266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118965	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705600036
J	Signarovitz, AL; Ray, HJ; Yu, JJ; Guentzel, MN; Chambers, JP; Klose, KE; Arulanandam, BP				Signarovitz, Aimee L.; Ray, Heather J.; Yu, Jieh-Juen; Guentzel, M. N.; Chambers, James P.; Klose, Karl E.; Arulanandam, Bernard P.			Mucosal Immunization with Live Attenuated Francisella novicida U112 Delta iglB Protects against Pulmonary F-tularensis SCHU S4 in the Fischer 344 Rat Model	PLOS ONE			English	Article							VACCINE STRAIN LVS; CD4(+) T-CELLS; INTRANASAL VACCINATION; INTRACELLULAR BACTERIUM; RESPIRATORY TULAREMIA; IMMUNE-RESPONSES; IMMUNOGLOBULIN-A; GAMMA-INTERFERON; SECRETION SYSTEM; SUBSP NOVICIDA	The need for an efficacious vaccine against Francisella tularensis is a consequence of its low infectious dose and high mortality rate if left untreated. This study sought to characterize a live attenuated subspecies novicida-based vaccine strain (U112 Delta iglB) in an established second rodent model of pulmonary tularemia, namely the Fischer 344 rat using two distinct routes of vaccination ( intratracheal [i.t.] and oral). Attenuation was verified by comparing replication of U112 Delta iglB with wild type parental strain U112 in F344 primary alveolar macrophages. U112 Delta iglB exhibited an LD50> 10(7) CFU compared to the wild type (LD50 = 5 x 10(6) CFU i.t.). Immunization with 10(7) CFU U112 Delta iglB by i.t. and oral routes induced antigen-specific IFN-gamma and potent humoral responses both systemically (IgG2a>IgG1 in serum) and at the site of mucosal vaccination (respiratory/intestinal compartment). Importantly, vaccination with U112 Delta iglB by either i.t. or oral routes provided equivalent levels of protection (50% survival) in F344 rats against a subsequent pulmonary challenge with similar to 25 LD50 (1.25 x 10(4) CFU) of the highly human virulent strain SCHU S4. Collectively, these results provide further evidence on the utility of a mucosal vaccination platform with a defined subsp. novicida U112 Delta iglB vaccine strain in conferring protective immunity against pulmonary tularemia.	[Signarovitz, Aimee L.; Ray, Heather J.; Yu, Jieh-Juen; Guentzel, M. N.; Chambers, James P.; Klose, Karl E.; Arulanandam, Bernard P.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Signarovitz, Aimee L.; Ray, Heather J.; Yu, Jieh-Juen; Guentzel, M. N.; Chambers, James P.; Klose, Karl E.; Arulanandam, Bernard P.] Univ Texas San Antonio, Ctr Excellence Infect Genom, San Antonio, TX USA; [Signarovitz, Aimee L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio	Arulanandam, BP (corresponding author), Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX USA.	bernard.arulanandam@utsa.edu	Arulanandam, Bernard P/O-9501-2014	Ray, Heather/0000-0003-0292-8403	National Institutes of Health [P01 AI057986]; Army Research Office of the Department of Defense [W911NF-11-1-0136]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office of the Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research has been performed with funding provided by the National Institutes of Health (Grant P01 AI057986) and the Army Research Office of the Department of Defense under Contract No. W911NF-11-1-0136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Barker JR, 2007, ANN NY ACAD SCI, V1105, P138, DOI 10.1196/annals.1409.010; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Bitsaktsis C, 2009, J IMMUNOL, V182, P4899, DOI 10.4049/jimmunol.0803242; BOLTZNITULESCU G, 1987, J LEUKOCYTE BIOL, V41, P83, DOI 10.1002/jlb.41.1.83; Bosio CM, 2001, INFECT IMMUN, V69, P194, DOI 10.1128/IAI.69.1.194-203.2001; Branger CG, 2009, VACCINE, V27, P5363, DOI 10.1016/j.vaccine.2009.06.078; Cazorla SI, 2008, INFECT IMMUN, V76, P324, DOI 10.1128/IAI.01163-07; Cha HR, 2011, J IMMUNOL, V187, P3044, DOI 10.4049/jimmunol.1100402; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2009, VACCINE; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; DAMOISEAUX JGMC, 1989, J LEUKOCYTE BIOL, V46, P556, DOI 10.1002/jlb.46.6.556; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Dietrich G, 2003, VACCINE, V21, P678, DOI 10.1016/S0264-410X(02)00579-0; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; DOWNS CM, 1947, J IMMUNOL, V56, P217; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; Duckett NS, 2005, INFECT IMMUN, V73, P2306, DOI 10.1128/IAI.73.4.2306-2311.2005; Elkins KL, 1999, INFECT IMMUN, V67, P6002, DOI 10.1128/IAI.67.11.6002-6007.1999; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Engwall KS., 1983, J TISSUE CULT METHOD, V8, P91, DOI [10.1007/BF02099246, DOI 10.1007/BF02099246]; Gosselin EJ, 2005, HUM IMMUNOL, V66, P1039, DOI 10.1016/j.humimm.2005.08.240; Hara H, 2004, J ALZHEIMERS DIS, V6, P483; Hara H, 2011, VACCINE, V29, P7474, DOI 10.1016/j.vaccine.2011.07.057; Hu K, 2011, VACCINE, V29, P1455, DOI 10.1016/j.vaccine.2010.12.031; Huang CF, 2008, J PEDIATR GASTR NUTR, V46, P262, DOI 10.1097/MPG.0b013e318156050d; Huang CF, 2011, APMIS, V119, P468, DOI 10.1111/j.1600-0463.2011.02761.x; Ireland PM, 2011, MICROBIOLOGY; Isherwood KE, 2005, ADV DRUG DELIVER REV, V57, P1403, DOI 10.1016/j.addr.2005.01.030; Jia QM, 2010, INFECT IMMUN, V78, P4341, DOI 10.1128/IAI.00192-10; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kim TH, 2011, J INFECT DIS; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; KuoLee R, 2007, VACCINE, V25, P3781, DOI 10.1016/j.vaccine.2007.02.014; Kweon MN, 2011, CYTOKINE, V54, P1, DOI 10.1016/j.cyto.2010.12.014; Liu JR, 2007, BIOTECHNIQUES, V43, P487, DOI 10.2144/000112574; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Nallaparaju KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018201; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; *NAT RES COUNC, 2006, OV CHALL DEV COUNT A; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; OLSUFIEV N. G., 1959, JOUR HYG EPIDEMIOL MICROBIOL AND IMMUNOL, V3, P138; Pammit MA, 2006, INFECT IMMUN, V74, P2063, DOI 10.1128/IAI.74.4.2063-2071.2006; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Powell HJ, 2008, IMMUNOL CELL BIOL, V86, P515, DOI 10.1038/icb.2008.31; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Quarry JE, 2007, VACCINE, V25, P2011, DOI 10.1016/j.vaccine.2006.11.054; Ray HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009952; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; Raymond CR, 2009, MICROB PATHOGENESIS, V46, P231, DOI 10.1016/j.micpath.2009.01.002; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; Sabirov A, 2008, VACCINE, V26, P1566, DOI 10.1016/j.vaccine.2008.01.027; Sabirov A, 2006, VACCINE, V24, P5584, DOI 10.1016/j.vaccine.2006.04.033; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Sedgmen BJ, 2004, IMMUNOL CELL BIOL, V82, P10, DOI 10.1111/j.1440-1711.2004.01214.x; Shen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013349; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Tanaka N, 2007, VACCINE, V25, P2680, DOI 10.1016/j.vaccine.2006.10.014; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; West TE, 2008, MICROBES INFECT, V10, P773, DOI 10.1016/j.micinf.2008.04.008; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005	76	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47639	10.1371/journal.pone.0047639	http://dx.doi.org/10.1371/journal.pone.0047639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118885	gold, Green Submitted, Green Published			2022-12-25	WOS:000310705600014
J	Christiansen, P; Harris, JM				Christiansen, Per; Harris, John M.			Variation in Craniomandibular Morphology and Sexual Dimorphism in Pantherines and the Sabercat Smilodon fatalis	PLOS ONE			English	Article							PREY SIZE RELATIONSHIPS; CHARACTER DISPLACEMENT; PREDATORY BEHAVIOR; CANINE SIZE; MALE LIONS; BODY-SIZE; PHYLOGENETIC ANALYSES; CRANIAL MORPHOLOGY; LARGE CARNIVORES; AFRICAN SAVANNA	Sexual dimorphism is widespread among carnivorans, and has been an important evolutionary factor in social ecology. However, its presence in sabertoothed felids remains contentious. Here we present a comprehensive analysis of extant Panthera and the sabertoothed felid Smilodon fatalis. S. fatalis has been reported to show little or no sexual dimorphism but to have been intraspecifically variable in skull morphology. We found that large and small specimens of S. fatalis could be assigned to male and female sexes with similar degrees of confidence as Panthera based on craniomandibular shape. P. uncia is much less craniomandibularly variable and has low levels of sexual size-dimorphism. Shape variation in S. fatalis probably reflects sexual differences. Craniomandibular size-dimorphism is lower in S. fatalis than in Panthera except P. uncia. Sexual dimorphism in felids is related to more than overall size, and S. fatalis and the four large Panthera species show marked and similar craniomandibular and dental morphometric sexual dimorphism, whereas morphometric dimorphism in P. uncia is less. Many morphometric-sexually dimorphic characters in Panthera and Smilodon are related to bite strength and presumably to killing ecology. This suggests that morphometric sexual dimorphism is an evolutionary adaptation to intraspecific resource partitioning, since large males with thicker upper canines and stronger bite forces would be able to hunt larger prey than females, which is corroborated by feeding ecology in P. leo. Sexual dimorphism indicates that S. fatalis could have been social, but it is unlikely that it lived in fusion-fission units dominated by one or a few males, as in sub-Saharan populations of P. leo. Instead, S. fatalis could have been solitary and polygynous, as most extant felids, or it may have lived in unisexual groups, as is common in P. leo persica.	[Christiansen, Per] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark; [Harris, John M.] George C Page Museum, Los Angeles, CA USA	Aalborg University	Christiansen, P (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark.	pc@bio.aau.dk						AKERSTEN W A, 1985, Contributions in Science (Los Angeles), P1; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Bailey T.N., 1993, AFRICAN LEOPARD; Bauer H, 2003, MAMM BIOL, V68, P239, DOI 10.1078/1616-5047-00090; Bennett S.C., 1992, Journal of Vertebrate Paleontology, V12, P422; Blomqvist, 1984, INT PEDIGREE BOOK SN, V4, P3; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; BRODIE ED, 1983, HERPETOLOGICA, V39, P67; Burger J, 2006, EUR J WILDLIFE RES, V52, P54, DOI 10.1007/s10344-005-0009-z; Burger J, 2004, MOL PHYLOGENET EVOL, V30, P841, DOI 10.1016/j.ympev.2003.07.020; Cabrera A., 1932, Trabajos del Museo Ciencias Madrid, V57, P1; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Carbone C, 2009, BIOL LETTERS, V5, P81, DOI 10.1098/rsbl.2008.0526; Caro T., 1994, CHEETAHS SERENGETI P; Chapman Ralph E., 1997, P83; CHELLAM R, 1993, SYM ZOOL S, P409; CHEVERUD JM, 1985, EVOLUTION, V39, P1335, DOI 10.1111/j.1558-5646.1985.tb05699.x; Christiansen P, 2006, ANN ENTOMOL SOC AM, V99, P342, DOI 10.1603/0013-8746(2006)099[0342:SPIGMS]2.0.CO;2; Christiansen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002807; Christiansen P, 2008, MAMM BIOL, V73, P58, DOI 10.1016/j.mambio.2007.06.003; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Christiansen P, 2006, J MORPHOL, V267, P1186, DOI 10.1002/jmor.10468; Christiansen P, 2011, ZOOL J LINN SOC-LOND, V162, P220, DOI 10.1111/j.1096-3642.2010.00675.x; Christiansen P, 2009, J VERTEBR PALEONTOL, V29, P934, DOI 10.1671/039.029.0314; Christiansen P, 2008, CLADISTICS, V24, P977, DOI 10.1111/j.1096-0031.2008.00226.x; CONNER J, 1988, EVOLUTION, V42, P736, DOI 10.1111/j.1558-5646.1988.tb02492.x; COOK D, 1987, AUST J ZOOL, V35, P123, DOI 10.1071/ZO9870123; Cracraft J, 1998, ANIM CONSERV, V1, P139, DOI 10.1111/j.1469-1795.1998.tb00021.x; DAYAN T, 1990, AM NAT, V136, P39, DOI 10.1086/285081; DAYAN T, 1994, ECOLOGY, V75, P1063, DOI 10.2307/1939430; DAYAN T, 1989, ECOLOGY, V70, P1526, DOI 10.2307/1938210; DAYAN T, 1992, BIOL J LINN SOC, V45, P315, DOI 10.1111/j.1095-8312.1992.tb00647.x; Dayan Tamar, 1996, P243; Dharmakumarsinhji KS, 1950, J BOMBAY NATURAL HIS, V49, P685; Divyabhanusinh, 2005, STORY ASIAS LIONS; DODSON P, 1976, J PALEONTOL, V50, P929; Driscoll CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004125; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; ELLIOTT JP, 1978, CAN J ZOOL, V56, P1726, DOI 10.1139/z78-237; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Felidae Martin L.D., 1998, EVOLUTION TERTIARY M, P236; Figuerola J, 1999, BIOL J LINN SOC, V67, P1; Filiz Halit, 2006, Acta Adriatica, V47, P37; Fowler J., 2003, PRACTICAL STAT FIELD; Friess M, 1997, BIOM HUM ETY ANTHR, V15, P19; Funston PJ, 2003, J ZOOL, V259, P131, DOI 10.1017/S0952836902003126; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Galton Peter M., 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V11, P674; Gibbons J.W., 1990, Herpetological Monographs, P1; Gidaszewski NA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-110; GILBERT DA, 1991, J HERED, V82, P378, DOI 10.1093/oxfordjournals.jhered.a111107; Gittleman JL, 1997, J ZOOL, V242, P97, DOI 10.1111/j.1469-7998.1997.tb02932.x; GONYEA W J, 1976, Paleobiology, V2, P332; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; GRINNELL J, 1995, ANIM BEHAV, V49, P95, DOI 10.1016/0003-3472(95)80157-X; Guggisberg CAW, 1975, WILD CATS WORLD; Haas Sarah K., 2005, Mammalian Species, P1; HANBY JP, 1987, ANIM BEHAV, V35, P161, DOI 10.1016/S0003-3472(87)80221-X; Hanby JP, 1979, SERENGETI DYNAMICS E, P249; HARVEY PH, 1978, J ZOOL, V186, P475; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Heald F, 1989, J VERTEBRATE PALEO S, V9, p24A; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; HEINSOHN R, 1995, SCIENCE, V269, P1260, DOI 10.1126/science.7652573; Hemmer H., 1968, Veroeffentlichungen der Zoologischen Staatssammlung Muenchen, V12, P155; HEMMER H, 1972, Mammalian Species, V20, P1; HEMMER H, 1974, Veroeffentlichungen der Zoologischen Staatssammlung (Muenchen), V17, P167; Hendrickson SL, 2000, ANIM CONSERV, V3, P135; Herler J, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-4; Jackson R. M., 1996, THESIS U LONDON, P233; Jackson RM, 1996, THESIS U LONDON ENGL; Jacobshagen B, 1988, HDB VERGLEICHENDEN B, V1, P328; JANZEN FJ, 1991, EVOLUTION, V45, P435, DOI 10.1111/j.1558-5646.1991.tb04417.x; Jerdon T.C., 1867, MAMMALS INDIA NATURA, DOI [10.5962/bhl.title.54173, DOI 10.5962/BHL.TITLE.54173]; Johnson GD, 2009, BIOL LETTERS, V5, P235, DOI 10.1098/rsbl.2008.0722; JOSLIN P, 1984, Journal of the Bombay Natural History Society, V81, P648; Kawano K, 2004, AM NAT, V163, P1, DOI 10.1086/379796; Kawano K, 2003, ANN ENTOMOL SOC AM, V96, P503, DOI 10.1603/0013-8746(2003)096[0503:CDISBC]2.0.CO;2; KAY RF, 1988, AM J PHYS ANTHROPOL, V77, P385, DOI 10.1002/ajpa.1330770311; Kays RW, 2002, CAN J ZOOL, V80, P471, DOI 10.1139/Z02-024; Khorozyan Igor G., 2006, Russian Journal of Theriology, V5, P41; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Kitchener AC, 2000, ANIM CONSERV, V3, P113, DOI 10.1111/j.1469-1795.2000.tb00236.x; Kurten B., 1955, Acta Zoologica Fennica, V90, P1; Kurten B., 1973, Commentationes biol, VNo. 63, P1; Kurten B., 1990, Journal of Vertebrate Paleontology, V10, P158; Kurten B., 1980, PLEISTOCENE MAMMALS; LARSEN T, 1971, J WILDLIFE MANAGE, V35, P374, DOI 10.2307/3799617; Larson SE, 1997, ZOO BIOL, V16, P107, DOI 10.1002/(SICI)1098-2361(1997)16:2<107::AID-ZOO2>3.3.CO;2-M; Leutenegger W., 1982, International Journal of Primatology, V3, P387, DOI 10.1007/BF02693740; LEUTENEGGER W, 1982, FOLIA PRIMATOL, V37, P163, DOI 10.1159/000156031; Lindenfors P, 1998, BIOL J LINN SOC, V64, P413, DOI 10.1006/bijl.1998.0237; Loy A, 2004, ITAL J ZOOL, V71, P27, DOI 10.1080/11250000409356547; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; LYNCH JM, 1993, BIOL ENVIRON, V93B, P97; Marcus L.F., 1984, P159; MARTIN L D, 1980, Transactions of the Nebraska Academy of Sciences, V8, P141; Mazak JH, 2006, MAMM BIOL, V71, P268, DOI 10.1016/j.mambio.2006.02.007; Mazak JH, 2010, J ZOOL, V281, P194, DOI 10.1111/j.1469-7998.2010.00694.x; Mazak JH, 2004, MAMM BIOL, V69, P392, DOI 10.1078/1616-5047-00161; Mazak V, 1983, NEUE BREHM BUCHEREI; McCall S, 2003, BRAIN BEHAV EVOLUT, V61, P159, DOI 10.1159/000069752; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen-Samuels JA, 2010, J ZOOL, V280, P271, DOI 10.1111/j.1469-7998.2009.00659.x; Meachen-Samuels J, 2009, BIOL J LINN SOC, V96, P784, DOI 10.1111/j.1095-8312.2008.01169.x; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Meers Mason B., 2002, Historical Biology, V16, P1; Meiri S, 2005, ECOLOGY, V86, P1432, DOI 10.1890/04-1503; Menard Henry W, 1947, BULL SO CALIFORNIA ACAD SCI, V46, P127; Merriam J.C., 1932, CARNEGIE I WASHINGTO, V442, P1; Mestel R, 1993, DISCOVER, P50; Miller G. J., 1968, Contributions in Science, VNo. 131, P1; Miththapala S, 1996, CONSERV BIOL, V10, P1115, DOI 10.1046/j.1523-1739.1996.10041115.x; NELSON E. W., 1933, JOUR MAMMAL, V14, P221, DOI 10.2307/1373821; O'Keefe F. Robin, 2009, Contributions in Science (Los Angeles), P1; OLI MK, 1994, J MAMMAL, V75, P998, DOI 10.2307/1382482; Otte D., 1979, P1; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; Owens IPF, 1998, P ROY SOC B-BIOL SCI, V265, P397, DOI 10.1098/rspb.1998.0308; Packer C, 1997, SCI AM, V276, P52, DOI 10.1038/scientificamerican0597-52; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Palmqvist P, 2007, J VERTEBR PALEONTOL, V27, P160, DOI 10.1671/0272-4634(2007)27[160:AROTDO]2.0.CO;2; PARKER GA, 1992, J FISH BIOL, V41, P1, DOI 10.1111/j.1095-8649.1992.tb03864.x; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; PLAVCAN JM, 1995, J HUM EVOL, V28, P245, DOI 10.1006/jhev.1995.1019; Pocock R. I., 1939, Novitates Zoologicae, V41, P406; POCOCK R. I., 1929, JOUR BOMBAY NAT HIST SOC, V33, P505; POCOCK R. I., 1932, PROC ZOOL SOC LONDON, V1932, P543; Pocock R. I., 1939, FAUNA BRIT INDIA INC, V1; Pocock R.I., 1930, J BOMBAY NATURAL HIS, V1, P63; Pocock RI, 1909, P ZOOL SOC LOND, V1909, P204; Pocock RI, 1930, J BOMBAY NATURAL HIS, V34, P307; Prevosti FJ, 2010, AMEGHINIANA, V47, P239, DOI 10.5710/AMGH.v47i2.9; RADINSKY L, 1978, AM NAT, V112, P815, DOI 10.1086/283325; RADINSKY L, 1975, BRAIN BEHAV EVOLUT, V11, P214, DOI 10.1159/000123634; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; RALLS K, 1977, AM NAT, V111, P917, DOI 10.1086/283223; Rieger I., 1980, P1; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 2004, TPSRELW VER 1 39; Rohlf FJ, 2004, TPSDIG DIGITIZE LAND; ROSSOLIMO O L, 1974, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V79, P23; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; Schaller G. B., 1972, SERENGETI LION STUDY; Schaller GB., 1977, MOUNTAIN MONARCHS; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SCHWANER TD, 1990, J HERPETOL, V24, P320, DOI 10.2307/1564405; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; SEYMOUR K L, 1989, Mammalian Species, P1, DOI 10.2307/3504096; SHAW C A, 1985, Contributions in Science (Los Angeles), P1; SHINE R, 1978, OECOLOGIA, V33, P269, DOI 10.1007/BF00348113; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Short R.V., 1994, DIFFERENCES SEXES; Shu-jin Luo, 2006, Zoological Research, V27, P441; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; Slaughter B. H., 1963, Texas Journal of Science, V15, P68; SMITH JLD, 1989, ANIM BEHAV, V37, P1; SMUTS GL, 1978, CARNIVORE, V1, P61; Sokal RR, 1995, BIOMETRY; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; STANDER PE, 1992, CAN J ZOOL, V70, P8, DOI 10.1139/z92-002; STANDER PE, 1992, BEHAV ECOL SOCIOBIOL, V29, P445; Sterndale R.A., 1884, NATURAL HIST MAMMALI; Sunquist M. E., 1981, SMITHSONIAN CONTRIB, V336, P1, DOI DOI 10.5479/SI.00810282.336; Sunquist ME, 2002, WILD CATS WORLD; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; Thoren S, 2006, AM J PHYS ANTHROPOL, V130, P50, DOI 10.1002/ajpa.20321; TURNER A, 1984, ANN ZOOL FENN, V21, P1; Turner A., 1997, BIG CATS THEIR FOSSI; Uphyrkina O, 2001, MOL ECOL, V10, P2617, DOI 10.1046/j.0962-1083.2001.01350.x; Van Valkenburgh B, 2002, J VERTEBR PALEONTOL, V22, P164, DOI 10.1671/0272-4634(2002)022[0164:SDSBAI]2.0.CO;2; VANORSDOL KG, 1985, J ZOOL, V206, P97; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; VEZINA AF, 1985, OECOLOGIA, V67, P555, DOI 10.1007/BF00790027; Weckerly FW, 1998, J MAMMAL, V79, P33, DOI 10.2307/1382840; Werdelin L., 2010, BIOL CONSERVATION WI, P60; Werner F., 1939, Zoologische Garten Leipzig, V10, P224; WIIG O, 1986, ACTA THERIOL, V31, P147; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WRIGHT BRUCE S., 1960, JOUR WILDLIFE MANAGEMENT, V24, P1, DOI 10.2307/3797350; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wynter-Blyth M. A., 1950, Journal of the Bombay Natural History Society, V49, P456; Yamaguchi N, 2009, BIOL J LINN SOC, V98, P85, DOI 10.1111/j.1095-8312.2009.01249.x; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zelditch ML, 2000, SM S COMP E, P37; ZELDITCH ML, 1992, EVOLUTION, V46, P1164, DOI 10.1111/j.1558-5646.1992.tb00626.x	197	30	31	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48352	10.1371/journal.pone.0048352	http://dx.doi.org/10.1371/journal.pone.0048352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110232	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500062
J	Le, M; Naridze, R; Morrison, J; Biggs, LC; Rhea, L; Schutte, BC; Kaartinen, V; Dunnwald, M				Le, Mark; Naridze, Rachelle; Morrison, Jasmine; Biggs, Leah C.; Rhea, Lindsey; Schutte, Brian C.; Kaartinen, Vesa; Dunnwald, Martine			Transforming Growth Factor Beta 3 Is Required for Excisional Wound Repair In Vivo	PLOS ONE			English	Article							SCAR TISSUE FORMATION; TGF-BETA; EMBRYONIC-DEVELOPMENT; EXPRESSION PATTERNS; KNOCKOUT MICE; CLEFT-PALATE; P38 MAPK; TGF-BETA-3; SKIN; MOUSE	Wound healing is a complex process that relies on proper levels of cytokines and growth factors to successfully repair the tissue. Of particular interest are the members of the transforming growth factor family. There are three TGF-beta isoforms-TGF beta 1, 2, and 3, each isoform showing a unique expression pattern, suggesting that they each play a distinct function during development and repair. Previous studies reported an exclusive role for TGF-beta 3 in orofacial development and a potent anti-scarring effect. However, the role of TGF-beta 3 in excisional wound healing and keratinocyte migration remains poorly understood. We tested the effect of TGF-beta 3 levels on excisional cutaneous wounds in the adult mouse by directly injecting recombinant TGF-beta 3 or neutralizing antibody against TGF-beta 3 (NAB) in the wounds. Our results demonstrate that TGF-beta 3 does not promote epithelialization. However, TGF-beta 3 is necessary for wound closure as wounds injected with neutralizing antibody against TGF-beta 3 showed increased epidermal volume and proliferation in conjunction with a delay in keratinocyte migration. Wild type keratinocytes treated with NAB and Tgfb3-deficient keratinocytes closed an in vitro scratch wound with no delay, suggesting that our in vivo observations likely result from a paracrine effect.	[Le, Mark; Naridze, Rachelle; Morrison, Jasmine; Biggs, Leah C.; Rhea, Lindsey; Dunnwald, Martine] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Schutte, Brian C.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Kaartinen, Vesa] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Iowa; Michigan State University; University of Michigan System; University of Michigan	Dunnwald, M (corresponding author), Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA.	martine-dunnwald@uiowa.edu	Kaartinen, Vesa/AAU-5396-2021; Biggs, Leah/AAA-5825-2022	Biggs, Leah/0000-0002-4990-8664; Kaartinen, Vesa/0000-0002-9432-510X	National Institutes of Health [AR055313, DE16215]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was partially supported by grants from the National Institutes of Health AR055313 (MD) and DE16215 (MD, BCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amendt C, 2002, J CELL SCI, V115, P2189; Amjad SB, 2007, WOUND REPAIR REGEN, V15, P748, DOI 10.1111/j.1524-475X.2007.00281.x; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Baum CL, 2005, DERMATOL SURG, V31, P674; Biggs LC, 2011, J INVEST DERMATOL; Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x; Ferguson MWJ, 2009, LANCET, V373, P1264, DOI 10.1016/S0140-6736(09)60322-6; Fowlis DJ, 1996, CELL GROWTH DIFFER, V7, P679; Gallucci RM, 2004, J INVEST DERMATOL, V122, P764, DOI 10.1111/j.0022-202X.2004.22323.x; Hager B, 1999, J INVEST DERMATOL, V112, P971, DOI 10.1046/j.1523-1747.1999.00605.x; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; LEVINE JH, 1993, AM J PATHOL, V143, P368; Li J, 1999, J BIOL CHEM, V274, P4213, DOI 10.1074/jbc.274.7.4213; Lin HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martinez-Ferrer M, 2010, AM J PATHOL, V176, P98, DOI 10.2353/ajpath.2010.090283; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Murphy KE, 2011, J THEOR BIOL, V272, P145, DOI 10.1016/j.jtbi.2010.12.011; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Occleston NL, 2008, J BIOMAT SCI-POLYM E, V19, P1047, DOI 10.1163/156856208784909345; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PELTON RW, 1990, DEVELOPMENT, V110, P609; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; REYNOLDS AJ, 1993, J INVEST DERMATOL, V101, P577, DOI 10.1111/1523-1747.ep12366032; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SHAH M, 1995, J CELL SCI, V108, P985; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stojadinovic O, 2008, J CELL MOL MED, V12, P2675, DOI 10.1111/j.1582-4934.2008.00321.x; Sugawara T, 2001, CYTOKINE, V15, P328, DOI 10.1006/cyto.2001.0946; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Waddington SN, 2010, MOL THER, V18, P2104, DOI 10.1038/mt.2010.174; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wharton K, 2009, DEVELOPMENT, V136, P3691, DOI 10.1242/dev.040584; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xu X, 2008, DEV CELL, V15, P322, DOI 10.1016/j.devcel.2008.06.004; Xu X, 2006, DEV BIOL, V297, P238, DOI 10.1016/j.ydbio.2006.05.014; Yang LT, 2008, GENESIS, V46, P112, DOI 10.1002/dvg.20372; Yang LT, 2007, DEV BIOL, V312, P384, DOI 10.1016/j.ydbio.2007.09.034; Yew TL, 2011, CELL TRANSPLANT, V20, P693, DOI 10.3727/096368910X550198; Zheng Z, 2011, J INVEST DERMATOL, V131, P769, DOI 10.1038/jid.2010.381	49	56	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48040	10.1371/journal.pone.0048040	http://dx.doi.org/10.1371/journal.pone.0048040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110169	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500032
J	Cardin, V; Sherrington, R; Hemsworth, L; Smith, AT				Cardin, Velia; Sherrington, Rachael; Hemsworth, Lara; Smith, Andrew T.			Human V6: Functional Characterisation and Localisation	PLOS ONE			English	Article							MEDIAL PARIETOOCCIPITAL CORTEX; CORTICAL AREA; BRAIN LOCATION; MACAQUE; SENSITIVITY; RETINOTOPY; EGOMOTION; REVEALS; MOTION; FMRI	Human visual area V6, in the parieto-occipital sulcus, is thought to have an important role in the extraction of optic flow for the monitoring and guidance of self-motion (egomotion) because it responds differentially to egomotion-compatible optic flow when compared to: (a) coherent but egomotion-incompatible flow (Cardin & Smith, 2010), and (b) incoherent motion (Pitzalis et al., 2010). It is not clear, however, whether V6 responds more strongly to egomotion-incompatible global motion than to incoherent motion. This is relevant not only for determining the functional properties of V6, but also in order to choose optimal stimuli for localising V6 accurately with fMRI. Localisation with retinotopic mapping is difficult and there is a need for a simple, reliable method. We conducted an event-related 3T fMRI experiment in which participants viewed a display of dots which either: a) followed a time-varying optic flow trajectory in a single, egomotion-compatible (EC) display; b) formed an egomotion-incompatible (EI) 3 x 3 array of optic flow patches; or c) moved randomly (RM). Results from V6 show an ordering of response magnitudes: EC > EI > RM. Neighbouring areas V3A and V7 responded more strongly to EC than to RM, but about equally to EC and EI. Our results suggest that although V6 may have a general role in the extraction of global motion, in clear contrast to neighbouring motion areas it is especially concerned with encoding EC stimuli. They suggest two strategies for localising V6: (1) contrasting EC and EI; or (2) contrasting EC and RM, which is more sensitive but carries a risk of including voxels from neighbouring regions that also show a EC > RM preference.	[Cardin, Velia; Sherrington, Rachael; Hemsworth, Lara; Smith, Andrew T.] Univ London, Dept Psychol, Egham, Surrey, England	University of London; Royal Holloway University London	Cardin, V (corresponding author), UCL, Cognit Perceptual & Brain Sci Dept, Deafness Cognit & Language Res Ctr, London, England.	velia.cardin@ucl.ac.uk		Smith, Andrew T/0000-0002-4751-6253	Wellcome Trust [082648]; Nuffield Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Nuffield Foundation	This research was supported by a project grant (ref. 082648) from The Wellcome Trust to ATS and a bursary from The Nuffield Foundation to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglini PP, 2002, EXP BRAIN RES, V144, P419, DOI 10.1007/s00221-002-1099-4; Cardin V, 2011, J NEUROPHYSIOL, V106, P1240, DOI 10.1152/jn.01120.2010; Cardin V, 2010, CEREB CORTEX, V20, P1964, DOI 10.1093/cercor/bhp268; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fattori P, 2010, J NEUROSCI, V30, P342, DOI 10.1523/JNEUROSCI.3800-09.2010; Fischer E, 2012, NEURON, V73, P1228, DOI 10.1016/j.neuron.2012.01.022; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 2003, NEUROPSYCHOLOGIA, V41, P1717, DOI 10.1016/S0028-3932(03)00174-X; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; Galletti C, 1999, EUR J NEUROSCI, V11, P3922, DOI 10.1046/j.1460-9568.1999.00817.x; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; Luppino G, 2005, EUR J NEUROSCI, V21, P3056, DOI 10.1111/j.1460-9568.2005.04149.x; Monaco S, 2011, J NEUROPHYSIOL, V106, P2248, DOI 10.1152/jn.01069.2010; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Pitzalis S, 2010, CEREB CORTEX, V20, P411, DOI 10.1093/cercor/bhp112; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Portin K, 1999, P ROY SOC B-BIOL SCI, V266, P981, DOI 10.1098/rspb.1999.0733; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Stenbacka L, 2007, NEUROIMAGE, V34, P342, DOI 10.1016/j.neuroimage.2006.08.029; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053	22	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47685	10.1371/journal.pone.0047685	http://dx.doi.org/10.1371/journal.pone.0047685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112833	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200066
J	Comerci, CJ; Mace, EM; Banerjee, PP; Orange, JS				Comerci, Colin J.; Mace, Emily M.; Banerjee, Pinaki P.; Orange, Jordan S.			CD2 Promotes Human Natural Killer Cell Membrane Nanotube Formation	PLOS ONE			English	Article							RESTING NK CELLS; IMMUNOLOGICAL SYNAPSE; TUNNELING NANOTUBULES; TARGET-CELLS; IMMUNE CELLS; ACTIVATION; LYMPHOCYTES; RECEPTORS; CYTOTOXICITY; POLARIZATION	Membrane nanotubes are thin membranous projections that physically connect two cells. While nanotubes have been studied in human natural killer (NK) cells and are implicated in aiding NK cell cytotoxic function, requirements for their formation to susceptible target cells remain incompletely understood. Here we demonstrate that the CD2-CD58/48 receptor-ligand interaction promotes and is required for nanotube formation in human NK cells. In the CD2(-) NK cell line YTS, a stable CD2 expression variant enabled effective nanotube formation, and was associated with better cytotoxic function. Importantly, only interactions between an NK cell and a susceptible target cell were associated with multiple nanotubes and the number of nanotubes was inversely correlated with their length. Quantitative live cell fluorescence microscopy of CD2 nanotubes revealed time-dependent enrichment and localization of CD2 to the nanotube tip, and blocking CD2 receptor-ligand interactions prevented nanotube formation. Increased nanotube formation was not simply a feature of receptor-ligand pairing, as a KIR-MHC interaction in the same cell line system failed to promote nanotube formation. Additionally, blocking LFA-1-ICAM and 2B4-CD48 receptor-ligand interactions failed to inhibit nanotube formation. Thus only specific receptor-ligand pairs promote nanotubes. CD2 also promoted nanotube formation in ex vivo NK cells suggesting that CD2 plays a crucial role in the generation of nanotubes between an NK cell and its target.	[Mace, Emily M.; Banerjee, Pinaki P.; Orange, Jordan S.] Baylor Coll Med, Dept Pediat, Ctr Human Immunobiol, Houston, TX 77030 USA; [Comerci, Colin J.] Childrens Hosp Philadelphia, Dept Pediat, Res Inst, Philadelphia, PA 19104 USA	Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Orange, JS (corresponding author), Baylor Coll Med, Dept Pediat, Ctr Human Immunobiol, Houston, TX 77030 USA.	orange@bcm.edu		orange, jordan/0000-0001-7117-7725; Mace, Emily/0000-0003-0226-7393	National Institutes of Health grant [AIR01AI067946]; Vagelos Scholars Program in the Molecular Life Sciences at the University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067946] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vagelos Scholars Program in the Molecular Life Sciences at the University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AIR01AI067946 (to JSO). CJC was supported by the Vagelos Scholars Program in the Molecular Life Sciences at the University of Pennsylvania (http://www.sas.upenn.edu/biochem/vspmls.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DF, 2003, J IMMUNOL, V170, P294, DOI 10.4049/jimmunol.170.1.294; BELL GM, 1992, MOL CELL BIOL, V12, P5548, DOI 10.1128/MCB.12.12.5548; Borszcz PD, 2003, EUR J IMMUNOL, V33, P1084, DOI 10.1002/eji.200323582; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Chauveau A, 2010, P NATL ACAD SCI USA, V107, P5545, DOI 10.1073/pnas.0910074107; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Davis DM, 2009, NAT REV IMMUNOL, V9, P543, DOI 10.1038/nri2602; Fassett MS, 2001, P NATL ACAD SCI USA, V98, P14547, DOI 10.1073/pnas.211563598; Galkina SI, 2001, EXP CELL RES, V266, P222, DOI 10.1006/excr.2001.5227; Gismondi A, 1997, J IMMUNOL, V159, P4729; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Kato K, 1998, LEUKOCYTE TYPING, P39; Kim EO, 2010, J BIOL CHEM, V285, P41755, DOI 10.1074/jbc.M110.137976; Krzewski K, 2011, EUR J IMMUNOL, V41, P3323, DOI 10.1002/eji.201141582; McNerney ME, 2006, CURR TOP MICROBIOL, V298, P91; Mentlik AN, 2010, MOL BIOL CELL, V21, P2241, DOI 10.1091/mbc.E09-11-0930; Monaco-Shawver L, 2011, J LEUKOCYTE BIOL, V89, P113, DOI 10.1189/jlb.0410200; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Orange JS, 2011, J CLIN INVEST, V121, P1535, DOI 10.1172/JCI44862; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Orange JS, 2002, P NATL ACAD SCI USA, V99, P11351, DOI 10.1073/pnas.162376099; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sanborn KB, 2009, J IMMUNOL, V182, P6969, DOI 10.4049/jimmunol.0804337; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Sowinski S, 2011, METHODS, V53, P27, DOI 10.1016/j.ymeth.2010.04.002; Theorell J, 2011, J IMMUNOL METHODS, V366, P106, DOI 10.1016/j.jim.2011.01.014; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x	36	18	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47664	10.1371/journal.pone.0047664	http://dx.doi.org/10.1371/journal.pone.0047664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112830	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200063
J	Klomp, A; den Hollander, B; de Bruin, K; Booij, J; Reneman, L				Klomp, Anne; den Hollander, Bjornar; de Bruin, Kora; Booij, Jan; Reneman, Liesbeth			The Effects of Ecstasy (MDMA) on Brain Serotonin Transporters Are Dependent on Age-of-First Exposure in Recreational Users and Animals	PLOS ONE			English	Article							EARLY JUVENILE LIFE; BETA-CIT BINDING; RAT-BRAIN; IN-VIVO; METHYLENEDIOXYMETHAMPHETAMINE MDMA; MONOAMINE TRANSPORTERS; INDUCED NEUROTOXICITY; LONG-TERM; SPECT; NEURONS	Objective: Little is known on the effects of ecstasy (MDMA, a potent 5-HT-releaser and neurotoxin) exposure on brain development in teenagers. The objective of this study was to investigate whether in humans, like previous observations made in animals, the effects of MDMA on the 5-HT system are dependent on age-of-first exposure. Methods: 5-HT transporter (SERT) densities in the frontal cortex and midbrain were assessed with [123 I] b-CIT single photon emission computed tomography in 33 users of ecstasy. Subjects were stratified for early-exposed users (age-at-first exposure 14-18 years; developing brain), and late-exposed users (age-at-first exposure 18-36 years; mature brain). In parallel, we investigated the effects of age experimentally with MDMA in early-exposed (adolescent) rats and late-exposed (adult) rats using the same radioligand. Results: On average, five years after first exposure, we found a strong inverse relationship, wherein age-at-first exposure predicted 79% of the midbrain SERT variability in early (developing brain) exposed ecstasy users, whereas this was only 0.3% in late (mature brain) exposed users (p = 0.007). No such effect was observed in the frontal cortex. In rats, a significant age-BY-treatment effect (p<0.01) was observed as well, however only in the frontal cortex. Conclusions: These age-related effects most likely reflect differences in the maturational stage of the 5-HT projection fields at age-at-first exposure and enhanced outgrowth of the 5-HT system due to 5-HT's neurotrophic effects. Ultimately, our findings stress the need for more knowledge on the effects of pharmacotherapies that alter brain 5-HT levels in the pediatric population.	[Klomp, Anne; Booij, Jan; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, NL-1105 AZ Amsterdam, Netherlands; [Klomp, Anne; den Hollander, Bjornar; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [de Bruin, Kora; Booij, Jan] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Reneman, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	L.Reneman@amc.uva.nl	Booij, Jan/AAD-7159-2019	Reneman, Liesbeth/0000-0002-5912-9971	Academic Medical Center (AMC Fellowship)	Academic Medical Center (AMC Fellowship)	This work is funded by the Academic Medical Center (AMC Fellowship 2007) awarded to LR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre N, 1998, J PHARMACOL EXP THER, V286, P1159; Andersen SL, 2005, TRENDS PHARMACOL SCI, V26, P237, DOI 10.1016/j.tips.2005.03.009; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; ANDERSSON A, 1992, GERONTOLOGY, V38, P127; ARRANZ B, 1993, BRAIN RES, V620, P163, DOI 10.1016/0006-8993(93)90286-V; AZMITIA EC, 1990, BRAIN RES, V510, P97, DOI 10.1016/0006-8993(90)90732-Q; BATTAGLIA G, 1987, J PHARMACOL EXP THER, V242, P911; Booij J, 1997, J NEUROL NEUROSUR PS, V62, P133, DOI 10.1136/jnnp.62.2.133; Boylan CB, 2000, SOMATOSENS MOT RES, V17, P52; Brenhouse HC, 2011, NEUROSCI BIOBEHAV R, V35, P1687, DOI 10.1016/j.neubiorev.2011.04.013; BROENING HW, 1994, J PHARMACOL EXP THER, V271, P285; BRUNELLO N, 1985, EUR J PHARMACOL, V110, P393, DOI 10.1016/0014-2999(85)90573-4; CabreraVera TM, 1997, J PHARMACOL EXP THER, V280, P138; Capela JP, 2009, MOL NEUROBIOL, V39, P210, DOI 10.1007/s12035-009-8064-1; Colado MI, 1997, BRIT J PHARMACOL, V121, P827, DOI 10.1038/sj.bjp.0701201; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; Dahlstrom M, 2000, MOL PSYCHIATR, V5, P514, DOI 10.1038/sj.mp.4000766; de Win MML, 2005, NEUROPSYCHOPHARMACOL, V30, P996, DOI 10.1038/sj.npp.1300683; de Win MML, 2004, EUR NEUROPSYCHOPHARM, V14, P185, DOI 10.1016/S0924-977X(03)00101-9; Elfving B, 2007, SYNAPSE, V61, P882, DOI 10.1002/syn.20443; FARDE L, 1994, SYNAPSE, V16, P93, DOI 10.1002/syn.890160203; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gould RW, 2011, NEUROPHARMACOLOGY, V61, P245, DOI 10.1016/j.neuropharm.2011.04.007; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Lauder J M, 1983, Monogr Neural Sci, V9, P3; LAUDER JM, 1988, DEVELOPMENT, V102, P709; LAUDER JM, 1978, DEV NEUROSCI-BASEL, V1, P15, DOI 10.1159/000112549; Lew R, 1996, J PHARMACOL EXP THER, V276, P855; Lyles J, 2003, BRAIN RES REV, V42, P155, DOI 10.1016/S0165-0173(03)00173-5; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Meyer JS, 2002, ANN NY ACAD SCI, V965, P373; Moll GH, 2000, DEV BRAIN RES, V119, P251, DOI 10.1016/S0165-3806(99)00182-0; OHEARN E, 1988, J NEUROSCI, V8, P2788; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Pirker W, 2000, J NUCL MED, V41, P36; Reneman L, 1999, SYNAPSE, V34, P77, DOI 10.1002/(SICI)1098-2396(199910)34:1<77::AID-SYN9>3.0.CO;2-Y; Reneman L, 2002, SYNAPSE, V46, P199, DOI 10.1002/syn.10130; Reneman L, 2001, LANCET, V358, P1864, DOI 10.1016/S0140-6736(01)06888-X; Reneman L, 2001, ARCH GEN PSYCHIAT, V58, P901, DOI 10.1001/archpsyc.58.10.901; Ricaurte GA, 2000, NEUROPSYCHOBIOLOGY, V42, P5, DOI 10.1159/000026664; Rijks LJ, 1996, SYNAPSE, V23, P201, DOI 10.1002/(SICI)1098-2396(199607)23:3<201::AID-SYN9>3.0.CO;2-C; SCHEFFEL U, 1992, SYNAPSE, V11, P134, DOI 10.1002/syn.890110206; SHEMER AV, 1991, DEV BRAIN RES, V59, P59, DOI 10.1016/0165-3806(91)90029-I; Slotkin TA, 1997, BIOL PSYCHIAT, V41, P172, DOI 10.1016/S0006-3223(96)00215-6; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; van Dyck CH, 2000, NEUROBIOL AGING, V21, P497, DOI 10.1016/S0197-4580(00)00152-4; Wegerer V, 1999, J CHILD ADOL PSYCHOP, V9, P13, DOI 10.1089/cap.1999.9.13; WHITAKERAZMITIA PM, 1989, BRAIN RES, V497, P80, DOI 10.1016/0006-8993(89)90972-4; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Won L, 2002, DEV BRAIN RES, V137, P67, DOI 10.1016/S0165-3806(02)00411-X; WOOLSEY TA, 1975, J COMP NEUROL, V164, P79, DOI 10.1002/cne.901640107	53	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47524	10.1371/journal.pone.0047524	http://dx.doi.org/10.1371/journal.pone.0047524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115651	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200047
J	Ma, S; Kwon, HJ; Huang, Z				Ma, Shang; Kwon, Hyo Jun; Huang, Zhen			A Functional Requirement for Astroglia in Promoting Blood Vessel Development in the Early Postnatal Brain	PLOS ONE			English	Article							RETINAL ANGIOGENESIS; RAT-BRAIN; STROKE; GLIA; PROGENITORS; EXPRESSION; FOREBRAIN; TEMPLATE; ISCHEMIA; DISEASE	Astroglia are a major cell type in the brain and play a key role in many aspects of brain development and function. In the adult brain, astrocytes are known to intimately ensheath blood vessels and actively coordinate local neural activity and blood flow. During development of the neural retina, blood vessel growth follows a meshwork of astrocytic processes. Several genes have also been implicated in retinal astrocytes for regulating vessel development. This suggests a role of astrocytes in promoting angiogenesis throughout the central nervous system. To determine the roles that astrocytes may play during brain angiogenesis, we employ genetic approaches to inhibit astrogliogenesis during perinatal corticogenesis and examine its effects on brain vessel development. We find that conditional deletion from glial progenitors of orc3, a gene required for DNA replication, dramatically reduces glial progenitor cell number in the subventricular zone and astrocytes in the early postnatal cerebral cortex. This, in turn, results in severe reductions in both the density and branching frequency of cortical blood vessels. Consistent with a delayed growth but not regression of vessels, we find neither significant net decreases in vessel density between different stages after normalizing for cortical expansion nor obvious apoptosis of endothelial cells in these mutants. Furthermore, concomitant with loss of astroglial interactions, we find increased endothelial cell proliferation, enlarged vessel luminal size as well as enhanced cytoskeletal gene expression in pericytes, which suggests compensatory changes in vascular cells. Lastly, we find that blood vessel morphology in mutant cortices recovers substantially at later stages, following astrogliosis. These results thus implicate a functional requirement for astroglia in promoting blood vessel growth during brain development.	[Ma, Shang; Kwon, Hyo Jun; Huang, Zhen] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Ma, Shang; Kwon, Hyo Jun; Huang, Zhen] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA; [Ma, Shang] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA; [Kwon, Hyo Jun] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huang, Z (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.	z.huang@neurology.wisc.edu			National Institutes of Health (NIH) [R01 NS076729]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076729] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant R01 NS076729 to ZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the NIH.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Arnold TD, 2012, J NEUROSCI, V32, P1197, DOI 10.1523/JNEUROSCI.5648-11.2012; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Bozoyan L, 2012, J NEUROSCI, V32, P1687, DOI 10.1523/JNEUROSCI.5531-11.2012; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; Ding GL, 2008, STROKE, V39, P1563, DOI 10.1161/STROKEAHA.107.502146; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Hirota S, 2011, DEVELOPMENT, V138, P5157, DOI 10.1242/dev.069153; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Kwon HJ, 2011, DEV BIOL, V351, P25, DOI 10.1016/j.ydbio.2010.12.026; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; McCaslin AFH, 2011, J CEREBR BLOOD F MET, V31, P795, DOI 10.1038/jcbfm.2010.204; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakamura-Ishizu A, 2012, DEV BIOL, V363, P106, DOI 10.1016/j.ydbio.2011.12.027; Ogunshola OO, 2000, DEV BRAIN RES, V119, P139, DOI 10.1016/S0165-3806(99)00125-X; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Weidemann A, 2010, GLIA, V58, P1177, DOI 10.1002/glia.20997; Zerlin M, 1997, J COMP NEUROL, V387, P537, DOI 10.1002/(SICI)1096-9861(19971103)387:4<537::AID-CNE5>3.0.CO;2-3; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	32	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48001	10.1371/journal.pone.0048001	http://dx.doi.org/10.1371/journal.pone.0048001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110156	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200132
J	McCaffery, JM; Marsland, AL; Strohacker, K; Muldoon, MF; Manuck, SB				McCaffery, Jeanne M.; Marsland, Anna L.; Strohacker, Kelley; Muldoon, Matthew F.; Manuck, Stephen B.			Factor Structure Underlying Components of Allostatic Load	PLOS ONE			English	Article							INSULIN-RESISTANCE SYNDROME; CORONARY-HEART-DISEASE; GENOME-WIDE ASSOCIATION; METABOLIC SYNDROME; INFLAMMATORY MARKERS; RATE-VARIABILITY; RISK-FACTORS; SYNDROME PREDICTS; LOCI; MACARTHUR	Allostatic load is a commonly used metric of health risk based on the hypothesis that recurrent exposure to environmental demands (e.g., stress) engenders a progressive dysregulation of multiple physiological systems. Prominent indicators of response to environmental challenges, such as stress-related hormones, sympatho-vagal balance, or inflammatory cytokines, comprise primary allostatic mediators. Secondary mediators reflect ensuing biological alterations that accumulate over time and confer risk for clinical disease but overlap substantially with a second metric of health risk, the metabolic syndrome. Whether allostatic load mediators covary and thus warrant treatment as a unitary construct remains to be established and, in particular, the relation of allostatic load parameters to the metabolic syndrome requires elucidation. Here, we employ confirmatory factor analysis to test: 1) whether a single common factor underlies variation in physiological systems associated with allostatic load; and 2) whether allostatic load parameters continue to load on a single common factor if a second factor representing the metabolic syndrome is also modeled. Participants were 645 adults from Allegheny County, PA (30-54 years old, 82% non- Hispanic white, 52% female) who were free of confounding medications. Model fitting supported a single, second-order factor underlying variance in the allostatic load components available in this study (metabolic, inflammatory and vagal measures). Further, this common factor reflecting covariation among allostatic load components persisted when a latent factor representing metabolic syndrome facets was conjointly modeled. Overall, this study provides novel evidence that the modeled allostatic load components do share common variance as hypothesized. Moreover, the common variance suggests the existence of statistical coherence above and beyond that attributable to the metabolic syndrome.	[McCaffery, Jeanne M.; Strohacker, Kelley] Brown Univ, Dept Psychiat & Human Behav, Miriam Hosp, Providence, RI 02912 USA; [McCaffery, Jeanne M.; Strohacker, Kelley] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA; [Marsland, Anna L.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Muldoon, Matthew F.] Univ Pittsburgh, Sch Med, Inst Heart & Vasc, Pittsburgh, PA USA; [Manuck, Stephen B.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA	Brown University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McCaffery, JM (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Miriam Hosp, Providence, RI 02912 USA.	jeanne_mccaffery@brown.edu		McCaffery, Jeanne/0000-0002-2166-5840; Strohacker, Kelley/0000-0002-2067-8439	National Heart Lung and Blood Institute [P01HL40962]; National Institute of Nursing Research [NR008237]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR008237] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by grants P01HL40962 from the National Heart Lung and Blood Institute (SBM), and NR008237 from the National Institute of Nursing Research (ALM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentler P. M., 2005, EQS 6 STRUCTURAL EQU; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BENTLER PM, 1980, PSYCHOMETRIKA, V45, P289, DOI 10.1007/BF02293905; Bleil ME, 2008, PSYCHOSOM MED, V70, P328, DOI 10.1097/PSY.0b013e31816baefa; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Camm AJ, 1996, CIRCULATION, V93, P1043; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; EDWARDS KL, 1994, ARTERIOSCLER THROMB, V14, P1940, DOI 10.1161/01.ATV.14.12.1940; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Goldman N, 2006, J GERONTOL A-BIOL, V61, P1070, DOI 10.1093/gerona/61.10.1070; HAFFNER SM, 1992, HYPERTENSION, V20, P38, DOI 10.1161/01.HYP.20.1.38; Haffner SM, 2000, BRIT J NUTR, V83, pS67; Halder I, 2010, BRAIN BEHAV IMMUN, V24, P160, DOI 10.1016/j.bbi.2009.09.014; Hung J, 2008, INT J OBESITY, V32, P772, DOI 10.1038/sj.ijo.0803793; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Janszky I, 2004, J INTERN MED, V256, P421, DOI 10.1111/j.1365-2796.2004.01403.x; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Lawlor DA, 2004, AM J EPIDEMIOL, V159, P1013, DOI 10.1093/aje/kwh150; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Leu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019999; Lindblad U, 2001, AM J EPIDEMIOL, V153, P481, DOI 10.1093/aje/153.5.481; Llabre MM, 2012, PSYCHOSOM MED, V74, P169, DOI 10.1097/PSY.0b013e3182433a30; Manuck SB, 2010, PSYCHOSOM MED, V72, P35, DOI 10.1097/PSY.0b013e3181c484dc; Manuck SB, 2011, DEV PSYCHOPATHOL, V23, P69, DOI 10.1017/S0954579410000659; Marsland AL, 2010, METABOLISM, V59, P1801, DOI 10.1016/j.metabol.2010.05.015; McCaffery Jeanne M., 2007, Metabolic Syndrome and Related Disorders, V5, P34, DOI 10.1089/met.2006.0014; MCDONALD RP, 1990, PSYCHOL BULL, V107, P247, DOI 10.1037/0033-2909.107.2.247; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Novak S, 2003, DIABETES OBES METAB, V5, P388, DOI 10.1046/j.1463-1326.2003.00289.x; Pladevall M, 2006, DIABETES CARE, V29, P113, DOI 10.2337/diacare.29.1.113; Pyetan E, 2003, IEEE T BIO-MED ENG, V50, P777, DOI 10.1109/TBME.2003.812158; Pyorala M, 2000, ARTERIOSCL THROM VAS, V20, P538, DOI 10.1161/01.ATV.20.2.538; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; Schmidt MI, 1996, METABOLISM, V45, P699, DOI 10.1016/S0026-0495(96)90134-1; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Shen BJ, 2006, ANN EPIDEMIOL, V16, P131, DOI 10.1016/j.annepidem.2005.06.049; Shen BJ, 2003, AM J EPIDEMIOL, V157, P701, DOI 10.1093/aje/kwg045; Sloan RP, 2007, MOL MED, V13, P178, DOI 10.2119/2006-00112.Sloan; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thayer JF, 2009, J INTERN MED, V265, P439, DOI 10.1111/j.1365-2796.2008.02023.x; Timar O, 2000, CAN J CARDIOL, V16, P779; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Weber EJM, 1991, PSPAT PROGRAM SPECTR, P132; Wilson PWF, 1999, ARCH INTERN MED, V159, P1104, DOI 10.1001/archinte.159.10.1104	58	49	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47246	10.1371/journal.pone.0047246	http://dx.doi.org/10.1371/journal.pone.0047246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112812	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200031
J	Yang, ZG; Hulver, M; McMillan, RP; Cai, LZ; Kershaw, EE; Yu, LQ; Xue, BZ; Shi, H				Yang, Zhenggang; Hulver, Matthew; McMillan, Ryan P.; Cai, Lingzhi; Kershaw, Erin E.; Yu, Liqing; Xue, Bingzhong; Shi, Hang			Regulation of Insulin and Leptin Signaling by Muscle Suppressor of Cytokine Signaling 3 (SOCS3)	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; SKELETAL-MUSCLE; METABOLIC SYNDROME; AMP-KINASE; TYROSINE PHOSPHORYLATION; GLUCOSE-TRANSPORT; DOUBLE REPORTER; ADIPOSE-TISSUE	Skeletal muscle resistance to the key metabolic hormones, leptin and insulin, is an early defect in obesity. Suppressor of cytokine signaling 3 (SOCS3) is a major negative regulator of both leptin and insulin signaling, thereby implicating SOCS3 in the pathogenesis of obesity and associated metabolic abnormalities. Here, we demonstrate that SOCS3 mRNA expression is increased in murine skeletal muscle in the setting of diet-induced and genetic obesity, inflammation, and hyperlipidemia. To further evaluate the contribution of muscle SOCS3 to leptin and insulin resistance in obesity, we generated transgenic mice with muscle-specific overexpression of SOCS3 (MCK/SOCS3 mice). Despite similar body weight, MCK/SOCS3 mice develop impaired systemic and muscle-specific glucose homeostasis and insulin action based on glucose and insulin tolerance tests, hyperinsulinemic-euglycemic clamps, and insulin signaling studies. With regards to leptin action, MCK/SOCS3 mice exhibit suppressed basal and leptin-stimulated activity and phosphorylation of alpha2 AMP-activated protein kinase (alpha 2AMPK) and its downstream target, acetyl-CoA carboxylase (ACC). Muscle SOCS3 overexpression also suppresses leptin-regulated genes involved in fatty acid oxidation and mitochondrial function. These studies demonstrate that SOC3 within skeletal muscle is a critical regulator of leptin and insulin action and that increased SOCS may mediate insulin and leptin resistance in obesity.	[Yang, Zhenggang; Xue, Bingzhong; Shi, Hang] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27106 USA; [Yang, Zhenggang] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Infect Dis Diag & Treatment, Hangzhou 310003, Zhejiang, Peoples R China; [Hulver, Matthew; McMillan, Ryan P.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Cai, Lingzhi; Kershaw, Erin E.] Univ Pittsburgh, Div Endocrinol Diabet & Metab, Pittsburgh, PA USA; [Yu, Liqing] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Xue, Bingzhong; Shi, Hang] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	Wake Forest University; Zhejiang University; Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland College Park; University System of Georgia; Georgia State University	Shi, H (corresponding author), Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27106 USA.	bxue@gsu.edu; hshi3@gsu.edu	Kershaw, Erin E/G-9587-2013	Kershaw, Erin E/0000-0002-3887-4868	National Institute of Health (NIH) [R01DK084172]; American Heart Association (AHA) Mid-Atlantic Affiliate [11GRNT7370080, P30 AG21332, R01HL107500]; AHA Scientist Development [10SDG3900046]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021332] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA) Mid-Atlantic Affiliate; AHA Scientist Development(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute of Health (NIH) grants R01DK084172, American Heart Association (AHA) Mid-Atlantic Affiliate Grant-in-Aid 11GRNT7370080 and P30 AG21332 (to HS), NIH grant R01HL107500 and AHA Scientist Development Grant 10SDG3900046 (to BX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Chen GX, 1996, P NATL ACAD SCI USA, V93, P14795, DOI 10.1073/pnas.93.25.14795; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Eguchi M, 2007, MOL CELL ENDOCRINOL, V267, P38, DOI 10.1016/j.mce.2006.11.009; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Ferrannini E, 1999, EUR J CLIN INVEST, V29, P842; Fisher JS, 2002, AM J PHYSIOL-ENDOC M, V282, pE18, DOI 10.1152/ajpendo.2002.282.1.E18; Frisard MI, 2010, AM J PHYSL ENDOCRINO; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Husain M, 2005, AIDS, V19, P1975, DOI 10.1097/01.aids.0000191918.42110.27; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Muoio DM, 1999, AM J PHYSIOL-ENDOC M, V276, pE913, DOI 10.1152/ajpendo.1999.276.5.E913; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; O'Neill HM, 2012, MOL CELL ENDOCRINOL; Park BH, 2006, J BIOL CHEM, V281, P40283, DOI 10.1074/jbc.M607545200; Peraldi P, 2001, J BIOL CHEM, V276, P24614, DOI 10.1074/jbc.M102209200; Ramsay TG, 2003, J ANIM SCI, V81, P3046; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Steinberg GR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1374, DOI 10.1152/ajpendo.2000.279.6.E1374; Steinberg GR, 2002, AM J PHYSIOL-ENDOC M, V283, pE187, DOI 10.1152/ajpendo.00542.2001; Steinberg GR, 2006, J CLIN ENDOCR METAB, V91, P3592, DOI 10.1210/jc.2006-0638; Suzuki A, 2007, MOL CELL BIOL, V27, P4317, DOI 10.1128/MCB.02222-06; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Wang XF, 2011, ENDOCRINOLOGY, V152, P836, DOI 10.1210/en.2010-0855; Xue B, 2009, MOL CELL BIOL; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200	49	56	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47493	10.1371/journal.pone.0047493	http://dx.doi.org/10.1371/journal.pone.0047493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115649	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200044
J	Zohoori, FV; Shah, K; Mason, J; Shucksmith, J				Zohoori, Fatemeh Vida; Shah, Kamini; Mason, Julie; Shucksmith, Janet			Identifying Factors to Improve Oral Cancer Screening Uptake: A Qualitative Study	PLOS ONE			English	Article							MOUTH CANCER; AWARENESS; MORTALITY; SYMPTOMS; DELAY	Aims: To engage with high risk groups to identify knowledge and awareness of oral cancer signs and symptoms and the factors likely to contribute to improved screening uptake. Methods: Focus group discussions were undertaken with 18 males; 40+ years of age; smokers and/or drinkers (15+ cigarettes per day and/or 15+ units of alcohol per week), irregular dental attenders living in economically deprived areas of Teesside. Results: There was a striking reported lack of knowledge and awareness of oral cancer and its signs and symptoms among the participants. When oral/mouth cancer leaflets produced by Cancer Research UK were presented to the participants, they claimed that they would seek help on noticing such a condition. There was a preference to seek help from their general practitioner rather than their dentist due to perceptions that a dentist is 'inaccessible' on a physical and psychological level, costly, a 'tooth specialist' not a 'mouth specialist', and also not able to prescribe medication and make referrals to specialists. Interestingly, none of the 18 participants who were offered a free oral cancer examination at a dental practice took up this offer. Conclusions: The uptake of oral cancer screening may be improved by increasing knowledge of the existence and signs and symptoms of oral cancer. Other factors that may increase uptake are increased awareness of the role of dentists in diagnosing oral cancer, promotion of oral cancer screening by health professionals during routine health checks, and the use of a "health'' screening setting as opposed to a "dental'' setting for such checks.	[Zohoori, Fatemeh Vida; Mason, Julie; Shucksmith, Janet] Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England; [Shah, Kamini] Tees Publ Hlth, Stockton On Tees, England	University of Teesside	Zohoori, FV (corresponding author), Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England.	v.zohoori@tees.ac.uk		Shucksmith, Janet/0000-0003-3825-413X; Zohoori, Fatemeh Vida/0000-0002-5929-1987	Teesside University Research Fund; Stockton Primary Care Trust	Teesside University Research Fund; Stockton Primary Care Trust	Funding provided by Teesside University Research Fund and Stockton Primary Care Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken SW, 1999, HEAD NECK-J SCI SPEC, V21, P124, DOI 10.1002/(SICI)1097-0347(199903)21:2<124::AID-HED5>3.0.CO;2-A; Chapman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000216; Dolan RW, 1998, OTOLARYNG HEAD NECK, V119, P463, DOI 10.1016/S0194-5998(98)70102-0; Eadie D, 2009, BRIT J CANCER, V101, pS73, DOI 10.1038/sj.bjc.6605395; HOROWITZ AM, 1995, J AM DENT ASSOC, V126, P39, DOI 10.14219/jada.archive.1995.0022; Lowry R, 2009, SOC MARK Q, V15, P99, DOI 10.1080/15245000903304627; Lowry RJ, 1999, BRIT DENT J, V187, P668, DOI 10.1038/sj.bdj.4800363; Lowry RJ, 2007, MOUTH CANC N E PILOT; Market research Society, 1996, COD COND MARK RES SO, P62; OHanlon S, 1997, COMMUNITY DENT ORAL, V25, P371, DOI 10.1111/j.1600-0528.1997.tb00958.x; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Pitiphat W, 2002, J DENT RES, V81, P192, DOI 10.1177/154405910208100310; Scott SE, 2006, COMMUNITY DENT ORAL, V34, P337, DOI 10.1111/j.1600-0528.2006.00290.x; Scott SE, 2009, J PUBLIC HEALTH DENT, V69, P34, DOI 10.1111/j.1752-7325.2008.00095.x; West R, 2006, BRIT DENT J, V200, P167, DOI 10.1038/sj.bdj.4813197	15	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47410	10.1371/journal.pone.0047410	http://dx.doi.org/10.1371/journal.pone.0047410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115644	gold, Green Published			2022-12-25	WOS:000310310200036
J	Wynia-Smith, SL; Brown, MJ; Chirichella, G; Kemalyan, G; Krantz, BA				Wynia-Smith, Sarah L.; Brown, Michael J.; Chirichella, Gina; Kemalyan, Gigi; Krantz, Bryan A.			Electrostatic Ratchet in the Protective Antigen Channel Promotes Anthrax Toxin Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TRANSLOCATION; LETHAL FACTOR; TRANSMEMBRANE PORE; CRYSTAL-STRUCTURE; PROTON GRADIENT; EDEMA FACTORS; MECHANISM; MEMBRANES; CALMODULIN; DELIVERY	Central to the power-stroke and Brownian-ratchet mechanisms of protein translocation is the process through which nonequilibrium fluctuations are rectified or ratcheted by the molecular motor to transport substrate proteins along a specific axis. We investigated the ratchet mechanism using anthrax toxin as a model. Anthrax toxin is a tripartite toxin comprised of the protective antigen (PA) component, a homooligomeric transmembrane translocase, which translocates two other enzyme components, lethal factor (LF) and edema factor (EF), into the cytosol of the host cell under the proton motive force (PMF). The PA-binding domains of LF and EF (LFN and EFN) possess identical folds and similar solution stabilities; however, EFN translocates similar to 10-200-fold slower than LFN, depending on the electrical potential (Delta psi) and chemical potential (Delta pH) compositions of the PMF. From an analysis of LFN/EFN chimera proteins, we identified two 10-residue cassettes comprised of charged sequence that were responsible for the impaired translocation kinetics of EFN. These cassettes have nonspecific electrostatic requirements: one surprisingly prefers acidic residues when driven by either a Delta psi or a Delta pH; the second requires basic residues only when driven by a Delta psi. Through modeling and experiment, we identified a charged surface in the PA channel responsible for charge selectivity. The charged surface latches the substrate and promotes PMF-driven transport. We propose an electrostatic ratchet in the channel, comprised of opposing rings of charged residues, enforces directionality by interacting with charged cassettes in the substrate, thereby generating forces sufficient to drive unfolding.	[Kemalyan, Gigi] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Chirichella, Gina; Krantz, Bryan A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Brown, Michael J.; Krantz, Bryan A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wynia-Smith, Sarah L.; Krantz, Bryan A.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Krantz, BA (corresponding author), 476 Stanley Hall 3220, Berkeley, CA 94720 USA.	bakrantz@berkeley.edu		Wynia-Smith, Sarah/0000-0003-0985-2843; Krantz, Bryan/0000-0002-4911-5824	National Institutes of Health [R01-AI077703]; University of California; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI077703 and University of California start-up funds.	Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Brown MJ, 2011, J BIOL CHEM, V286, P23189, DOI 10.1074/jbc.M111.231167; Collier RJ, 2009, MOL ASPECTS MED, V30, P413, DOI 10.1016/j.mam.2009.06.003; Drum CL, 2002, NATURE, V415, P396, DOI 10.1038/415396a; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Feld GK, 2012, J MOL BIOL, V415, P159, DOI 10.1016/j.jmb.2011.10.035; Feld GK, 2010, NAT STRUCT MOL BIOL, V17, P1383, DOI 10.1038/nsmb.1923; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; Katayama H, 2008, NAT STRUCT MOL BIOL, V15, P754, DOI 10.1038/nsmb.1442; Kintzer AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013888; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; MUELLER P, 1963, J PHYS CHEM-US, V67, P534, DOI 10.1021/j100796a529; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Pentelute BL, 2011, ANGEW CHEM INT EDIT, V50, P2294, DOI 10.1002/anie.201006460; Pentelute BL, 2010, ACS CHEM BIOL, V5, P359, DOI 10.1021/cb100003r; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robinson R.A., 2002, ELECTROLYTE SOLUTION; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Shen YQ, 2005, EMBO J, V24, P929, DOI 10.1038/sj.emboj.7600574; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Thoren KL, 2011, MOL MICROBIOL, V80, P588, DOI 10.1111/j.1365-2958.2011.07614.x; Thoren KL, 2009, P NATL ACAD SCI USA, V106, P21555, DOI 10.1073/pnas.0905880106; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vernier G, 2009, PROTEIN SCI, V18, P1882, DOI 10.1002/pro.199; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864	43	29	29	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43753	43764		10.1074/jbc.M112.419598	http://dx.doi.org/10.1074/jbc.M112.419598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115233	Green Published, hybrid			2022-12-25	WOS:000312940800054
J	Glady, Y; Genty, E; Roeder, JJ				Glady, Yannick; Genty, Emilie; Roeder, Jean-Jacques			Brown Lemurs (Eulemur fulvus) Can Master the Qualitative Version of the Reverse-Reward Contingency	PLOS ONE			English	Article							GORILLA-GORILLA PERFORM; APES PAN-TROGLODYTES; LONG-TERM RETENTION; SELF-CONTROL; SYMBOLIC REPRESENTATIONS; INHIBITORY CONTROL; PREFRONTAL CORTEX; PONGO-PYGMAEUS; QUANTITY; CHOICE	Behavioral flexibility that requires behavioral inhibition has important fitness consequences. One task commonly used to assess behavioral inhibition is the reverse-reward task in which the subject is rewarded by the non selected items. Lemurs were tested for their ability to solve the qualitative version of the reverse-reward task with the choice between identical quantities of different food items instead of different quantities of the same food. Two of four subjects mastered the task without a correction procedure and were able to generalize the acquired rule to novel combinations of food. One of the two subjects competent on the quality version of the task could transfer this ability to different quantities of the same food. Our results are compared to lemurs' performances when tested under the quantitative version in a previous study and those of capuchin monkeys tested under a similar paradigm. The whole results suggest that the qualitative version of the reverse-reward task may be easier to master than its quantitative counterpart and that lemurs perform better than capuchin monkeys as they were able to later transfer the learning rule to the quantitative version of the task.	[Glady, Yannick; Roeder, Jean-Jacques] CNRS, UMR 7178, IPHC DEPE, Strasbourg, France; [Genty, Emilie] UDS, Ctr Primatol, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Roeder, JJ (corresponding author), CNRS, UMR 7178, IPHC DEPE, Strasbourg, France.	j.roeder@aliceadsl.fr						Albiach-Serrano A, 2007, ANIM COGN, V10, P387, DOI 10.1007/s10071-007-0076-5; Anderson JR, 2008, J COMP PSYCHOL, V122, P445, DOI 10.1037/a0012624; Anderson JR, 2004, J COMP PSYCHOL, V118, P58, DOI 10.1037/0735-7036.118.1.58; Anderson JR, 2000, J EXP PSYCHOL ANIM B, V26, P87, DOI 10.1037/0097-7403.26.1.87; Boysen ST, 1996, J EXP PSYCHOL-ANIM B, V22, P76, DOI 10.1037/0097-7403.22.1.76; Boysen ST, 2001, J COMP PSYCHOL, V115, P106, DOI 10.1037/0735-7036.115.1.106; Boysen ST, 1999, ANIM LEARN BEHAV, V27, P229, DOI 10.3758/BF03199679; BOYSEN ST, 1995, J EXP PSYCHOL ANIM B, V21, P82, DOI 10.1037/0097-7403.21.1.82; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Danisman E, 2010, ANIM COGN, V13, P41, DOI 10.1007/s10071-009-0243-y; Fairbanks LA, 1999, BRAIN BEHAV EVOLUT, V53, P305, DOI 10.1159/000006601; FORZANO LB, 1994, LEARN MOTIV, V25, P65, DOI 10.1006/lmot.1994.1004; Genty E, 2004, ANIM BEHAV, V67, P925, DOI 10.1016/j.anbehav.2003.09.007; Genty E, 2007, J COMP PSYCHOL, V121, P354, DOI 10.1037/0735-7036.121.4.354; Genty E, 2011, BEHAV PROCESS, V86, P133, DOI 10.1016/j.beproc.2010.10.006; Genty E, 2006, ANIM BEHAV, V72, P1241, DOI 10.1016/j.anbehav.2006.02.023; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Jackson K, 1996, J EXP ANAL BEHAV, V66, P29, DOI 10.1901/jeab.1996.66-29; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; Kralik JD, 2005, J COMP PSYCHOL, V119, P78, DOI 10.1037/0735-7036.119.1.78; Kralik JD, 2002, J COMP PSYCHOL, V116, P39, DOI 10.1037//0735-7036.116.1.39; LOGUE AW, 1992, PSYCHOL REC, V42, P189, DOI 10.1007/BF03399597; MAZUR JE, 1978, J EXP ANAL BEHAV, V30, P11, DOI 10.1901/jeab.1978.30-11; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Murray EA, 2005, ANIM BEHAV, V69, P991, DOI 10.1016/j.anbehav.2004.06.034; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Sakagami M, 2006, NEURAL NETWORKS, V19, P1255, DOI 10.1016/j.neunet.2006.05.040; Shifferman EM, 2009, ANIM COGN, V12, P547, DOI 10.1007/s10071-009-0215-2; Shumaker RW, 2001, J COMP PSYCHOL, V115, P385, DOI 10.1037//0735-7036.115.4.385; Silberberg A, 1996, J EXP ANAL BEHAV, V66, P143, DOI 10.1901/jeab.1996.66-143; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; TOBIN H, 1993, PSYCHOL REC, V43, P441; Tomasello M, 1997, PRIMATE COGNITION; Uher J, 2008, J COMP PSYCHOL, V122, P204, DOI 10.1037/0735-7036.122.2.204; Vlamings PHJM, 2006, J EXP PSYCHOL-ANIM B, V32, P60, DOI 10.1037/0097-7403.32.1.60; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122	36	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48378	10.1371/journal.pone.0048378	http://dx.doi.org/10.1371/journal.pone.0048378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118998	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500118
J	Maroja, LS; Alschuler, R; McMillan, WO; Jiggins, CD				Maroja, Luana S.; Alschuler, Rebecca; McMillan, W. Owen; Jiggins, Chris D.			Partial Complementarity of the Mimetic Yellow Bar Phenotype in Heliconius Butterflies	PLOS ONE			English	Article							WARNING COLOR; GENETIC-BASIS; CONVERGENT EVOLUTION; MULLERIAN MIMICRY; PELVIC REDUCTION; HYBRID ZONES; DIVERGENCE; RADIATIONS; PATTERNS; ERATO	Heliconius butterflies are an excellent system for understanding the genetic basis of phenotypic change. Here we document surprising diversity in the genetic control of a common phenotype. Two disjunct H. erato populations have each recruited the Cr and/or Sd loci that control similar yellow hindwing patterns, but the alleles involved partially complement one another indicating either multiple origins for the patterning alleles or developmental drift in genetic control of similar patterns. We show that in these H. erato populations cr and sd are epistatically interacting and that the parental origin of alleles can explain phenotypes of backcross individuals. In contrast, mimetic H. melpomene populations with identical phenotypes (H. m. rosina and H. m. amaryllis) do not show genetic complementation (F(1)s and F(2)s are phenotypically identical to parentals). Finally, we report hybrid female inviability in H. m. melpomene x H. m. rosina crosses (previously only female infertility had been reported) and presence of standing genetic variation for alternative color alleles at the Yb locus in true breeding H. melpomene melpomene populations (expressed when in a different genomic background) that could be an important source of variation for the evolution of novel phenotypes or a result of developmental drift. Although recent work has emphasized the simple genetic control of wing pattern in Heliconius, we show there is underlying complexity in the allelic variation and epistatic interactions between major patterning loci.	[Maroja, Luana S.; Alschuler, Rebecca] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [McMillan, W. Owen] Smithsonian Trop Res Inst, Panama City, Panama; [Jiggins, Chris D.] Univ Cambridge, Dept Zool, Cambridge, England	Williams College; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Cambridge	Maroja, LS (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	lsm1@williams.edu	Jiggins, Chris D/B-9960-2008; Jiggins, Chris/T-4296-2019	Jiggins, Chris D/0000-0002-7809-062X; Jiggins, Chris/0000-0002-7809-062X; McMillan, W. Owen/0000-0003-2805-2745	Leverhulme Trust; BBSRC; NSF [DBI-0923119, DEB-0844244, DEB-0715096]; Williams College	Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF(National Science Foundation (NSF)); Williams College	This work was funded by a Leverhulme Trust award to C.D.J., a BBSRC grant to C.D.J. and L. S. M., NSF grants to W.O.M. (DBI-0923119, DEB-0844244, DEB-0715096) and a Williams College undergraduate research assistantship to R. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Baxter SW, 2008, GENETICS, V180, P1567, DOI 10.1534/genetics.107.082982; Baxter SW, 2010, PLOS GENETICS, V6; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; BROWN KS, 1974, PROC R SOC SER B-BIO, V187, P369, DOI 10.1098/rspb.1974.0082; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Ferguson L, 2010, MOL ECOL, V19, P240, DOI 10.1111/j.1365-294X.2009.04475.x; Flanagan NS, 2004, P NATL ACAD SCI USA, V101, P9704, DOI 10.1073/pnas.0306243101; Hines HM, 2011, P NATL ACAD SCI USA, V108, P19666, DOI 10.1073/pnas.1110096108; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jiggins CD, 2005, GENETICS, V171, P557, DOI 10.1534/genetics.104.034686; Jiggins CD, 1997, P ROY SOC B-BIOL SCI, V264, P1167, DOI 10.1098/rspb.1997.0161; Jiggins CD, 2001, EVOLUTION, V55, P1631, DOI 10.1111/j.0014-3820.2001.tb00682.x; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kronforst MR, 2006, GENETICS, V174, P535, DOI 10.1534/genetics.106.059527; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; MALLET J, 1989, PROC R SOC SER B-BIO, V236, P163, DOI 10.1098/rspb.1989.0019; MALLET J, 1991, NATURE, V354, P368, DOI 10.1038/354368a0; MALLET J, 1986, HEREDITY, V56, P191, DOI 10.1038/hdy.1986.31; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Nadeau NJ, 2010, TRENDS GENET, V26, P484, DOI 10.1016/j.tig.2010.08.004; Naisbit RE, 2003, EVOL DEV, V5, P269, DOI 10.1046/j.1525-142X.2003.03034.x; Nijhout H. F., 1991, DEV EVOLUTION BUTTER; Pohl N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-99; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Quek SP, 2010, P NATL ACAD SCI USA, V107, P7365, DOI 10.1073/pnas.0911572107; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Rosenblum EB, 2010, P NATL ACAD SCI USA, V107, P2113, DOI 10.1073/pnas.0911042107; Rosser N, 2012, BIOL J LINN SOC, V105, P479, DOI 10.1111/j.1095-8312.2011.01814.x; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x	38	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48627	10.1371/journal.pone.0048627	http://dx.doi.org/10.1371/journal.pone.0048627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119074	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500182
J	Tuo, S; Nakashima, K; Pringle, JR				Tuo, Shanshan; Nakashima, Kenichi; Pringle, John R.			Apparent Defect in Yeast Bud-Site Selection Due to a Specific Failure to Splice the Pre-mRNA of a Regulator of Cell-Type-Specific Transcription	PLOS ONE			English	Article							U2 SNRNP PROTEIN; GENE DELETION; POLARITY; PATTERN; LOCALIZATION; EXPRESSION; RETENTION; PRODUCTS; INTRONS; GROWTH	The yeast Saccharomyces cerevisiae normally selects bud sites (and hence axes of cell polarization) in one of two distinct patterns, the axial pattern of haploid cells and the bipolar pattern of diploid cells. Although many of the proteins involved in bud-site selection are known, it is likely that others remain to be identified. Confirming a previous report (Ni and Snyder, 2001, Mol. Biol. Cell 12, 2147-2170), we found that diploids homozygous for deletions of IST3/SNU17 or BUD13 do not show normal bipolar budding. However, these abnormalities do not reflect defects in the apparatus of bipolar budding. Instead, the absence of Ist3 or Bud13 results in a specific defect in the splicing of the MATa1 pre-mRNA, which encodes a repressor that normally blocks expression of haploid-specific genes in diploid cells. When Mata1 protein is lacking, Axl1, a haploid-specific protein critical for the choice between axial and bipolar budding, is expressed ectopically in diploid cells and disrupts bipolar budding. The involvement of Ist3 and Bud13 in pre-mRNA splicing is by now well known, but the degree of specificity shown here for MATa1 pre-mRNA, which has no obvious basis in the pre-mRNA structure, is rather surprising in view of current models for the functions of these proteins. Moreover, we found that deletion of PML1, whose product is thought to function together with Ist3 and Bud13 in a three-protein retention-and-splicing (RES) complex, had no detectable effect on the splicing in vivo of either MATa1 or four other pre-mRNAs.	[Tuo, Shanshan; Nakashima, Kenichi; Pringle, John R.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University	Pringle, JR (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	jpringle@stanford.edu			National Institutes of Health [GM-31006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031006, R37GM031006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health Grant GM-31006. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Brooks MA, 2009, NUCLEIC ACIDS RES, V37, P129, DOI 10.1093/nar/gkn894; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gottschalk A, 2001, RNA, V7, P1554; Gottschalk A, 2001, MOL CELL BIOL, V21, P3037, DOI 10.1128/MCB.21.9.3037-3046.2001; Guthrie C, 1991, METHODS ENZYMOL, V194; Halme A, 1996, CURR BIOL, V6, P570, DOI 10.1016/S0960-9822(02)00543-2; Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497; Herskowitz I, 1992, MOL CELLULAR BIOL YE, P583; HICKS JB, 1977, GENETICS, V85, P395; Kang PJ, 2004, MOL BIOL CELL, V15, P5145, DOI 10.1091/mbc.E04-07-0600; Khanna M, 2009, RNA, V15, P2174, DOI 10.1261/rna.1790509; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LILLIE SH, 1980, J BACTERIOL, V143, P1384, DOI 10.1128/JB.143.3.1384-1394.1980; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lord M, 2002, CURR BIOL, V12, P1347, DOI 10.1016/S0960-9822(02)01042-4; Lord M, 2000, J CELL BIOL, V151, P1501, DOI 10.1083/jcb.151.7.1501; MILLER AM, 1984, EMBO J, V3, P1061, DOI 10.1002/j.1460-2075.1984.tb01927.x; Moore DD, 1995, GLOB MOB SURV; NAKAZAWA N, 1991, MOL CELL BIOL, V11, P5693, DOI 10.1128/MCB.11.11.5693; NER SS, 1989, MOL CELL BIOL, V9, P4613, DOI 10.1128/MCB.9.11.4613; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pringle JR, 1995, COLD SPRING HARB SYM, V60, P729, DOI 10.1101/SQB.1995.060.01.079; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Rymond Brian C., 1992, V21 PART 2, P143; Sambrook J, 2001, MOL CLONING LAB MANU; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Schenkman LR, 2002, J CELL BIOL, V156, P829, DOI 10.1083/jcb.200107041; Scherrer FW, 2006, RNA, V12, P1361, DOI 10.1261/rna.2276806; Schmidlin T, 2008, FEMS YEAST RES, V8, P276, DOI 10.1111/j.1567-1364.2007.00322.x; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Taheri N, 2000, EMBO J, V19, P6686, DOI 10.1093/emboj/19.24.6686; Trowitzsch S, 2008, J BIOL CHEM, V283, P32317, DOI 10.1074/jbc.M804977200; Trowitzsch S, 2009, J MOL BIOL, V385, P531, DOI 10.1016/j.jmb.2008.10.087; Vincent K, 2003, GENETICS, V164, P895; Wang Q, 2005, MOL CELL BIOL, V25, P10745, DOI 10.1128/MCB.25.24.10745-10754.2005; Wang Q, 2003, MOL CELL BIOL, V23, P7339, DOI 10.1128/MCB.23.20.7339-7349.2003; Zahner JE, 1996, MOL CELL BIOL, V16, P1857	50	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47621	10.1371/journal.pone.0047621	http://dx.doi.org/10.1371/journal.pone.0047621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118884	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500028
J	Van Grootel, TJ; Van der Willigen, RF; Van Opstal, AJ				Van Grootel, Tom J.; Van der Willigen, Robert F.; Van Opstal, A. John			Experimental Test of Spatial Updating Models for Monkey Eye-Head Gaze Shifts	PLOS ONE			English	Article							DOUBLE-MAGNETIC INDUCTION; POSTERIOR PARIETAL NEURONS; SUPERIOR COLLICULUS; SOUND LOCALIZATION; PERISACCADIC MISLOCALIZATION; COROLLARY DISCHARGE; RESPONSE PROPERTIES; OCULOMOTOR SYSTEM; SACCADE TARGETS; NEURAL-CONTROL	How the brain maintains an accurate and stable representation of visual target locations despite the occurrence of saccadic gaze shifts is a classical problem in oculomotor research. Here we test and dissociate the predictions of different conceptual models for head-unrestrained gaze-localization behavior of macaque monkeys. We adopted the double-step paradigm with rapid eye-head gaze shifts to measure localization accuracy in response to flashed visual stimuli in darkness. We presented the second target flash either before (static), or during (dynamic) the first gaze displacement. In the dynamic case the brief visual flash induced a small retinal streak of up to about 20 deg at an unpredictable moment and retinal location during the eye-head gaze shift, which provides serious challenges for the gaze-control system. However, for both stimulus conditions, monkeys localized the flashed targets with accurate gaze shifts, which rules out several models of visuomotor control. First, these findings exclude the possibility that gaze-shift programming relies on retinal inputs only. Instead, they support the notion that accurate eye-head motor feedback updates the gaze-saccade coordinates. Second, in dynamic trials the visuomotor system cannot rely on the coordinates of the planned first eye-head saccade either, which rules out remapping on the basis of a predictive corollary gaze-displacement signal. Finally, because gaze-related head movements were also goal-directed, requiring continuous access to eye-in-head position, we propose that our results best support a dynamic feedback scheme for spatial updating in which visuomotor control incorporates accurate signals about instantaneous eye- and head positions rather than relative eye-and head displacements.	[Van Grootel, Tom J.; Van der Willigen, Robert F.; Van Opstal, A. John] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Biophys, NL-6525 ED Nijmegen, Netherlands; [Van Grootel, Tom J.] Max Planck Inst Biol Cybernet, Tubingen, Germany	Radboud University Nijmegen; Max Planck Society	Van Opstal, AJ (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Biophys, NL-6525 ED Nijmegen, Netherlands.	j.vanopstal@donders.ru.nl	Van Grootel, Tom/B-1885-2010; van Opstal, John/D-1907-2010	Van Grootel, Tom/0000-0001-6372-4573; van Opstal, John/0000-0001-5957-5712	Earth and Life Sciences (ALW) section of the Netherlands Organization for Scientific Research [NWO-ALW/VICI 865.05.003]; Radboud University Nijmegen	Earth and Life Sciences (ALW) section of the Netherlands Organization for Scientific Research; Radboud University Nijmegen	This research was supported by the Earth and Life Sciences (ALW) section of the Netherlands Organization for Scientific Research (NWO-ALW/VICI 865.05.003; AJVO, TJVG, RFVDW), and the Radboud University Nijmegen (AJVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; BOUR LJ, 1984, IEEE T BIO-MED ENG, V31, P419, DOI 10.1109/TBME.1984.325281; Bremen P, 2007, J NEUROPHYSIOL, V98, P3759, DOI 10.1152/jn.00886.2007; Bremen P, 2007, J NEUROSCI METH, V160, P75, DOI 10.1016/j.jneumeth.2006.08.012; Bremen P, 2010, BIOL CYBERN, V103, P415, DOI 10.1007/s00422-010-0408-4; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; COLBY CL, 1993, PROG BRAIN RES, V95, P307, DOI 10.1016/S0079-6123(08)60378-7; Crawford JD, 2011, ANNU REV NEUROSCI, V34, P309, DOI 10.1146/annurev-neuro-061010-113749; Crawford JD, 2003, CURR OPIN NEUROBIOL, V13, P655, DOI 10.1016/j.conb.2003.10.009; CRAWFORD JD, 1991, SCIENCE, V252, P1551, DOI 10.1126/science.2047862; DASSONVILLE P, 1992, VISUAL NEUROSCI, V9, P261, DOI 10.1017/S0952523800010671; DeSouza JFX, 2011, J NEUROSCI, V31, P18313, DOI 10.1523/JNEUROSCI.0990-11.2011; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; GALIANA HL, 1992, ANN N Y ACAD SCI, V656, P452; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Goossens HHLM, 1997, J NEUROPHYSIOL, V78, P533, DOI 10.1152/jn.1997.78.1.533; Goossens HHLM, 1997, EXP BRAIN RES, V114, P542, DOI 10.1007/PL00005663; GUITTON D, 1992, TRENDS NEUROSCI, V15, P174, DOI 10.1016/0166-2236(92)90169-9; GUITTON D, 1987, J NEUROPHYSIOL, V58, P427, DOI 10.1152/jn.1987.58.3.427; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HALLETT PE, 1976, VISION RES, V16, P99, DOI 10.1016/0042-6989(76)90083-3; Hamker FH, 2011, PHILOS T R SOC B, V366, P554, DOI 10.1098/rstb.2010.0229; HARRIS CM, 1995, VISION RES, V35, P691, DOI 10.1016/0042-6989(94)00163-G; Keith GP, 2010, J NEUROPHYSIOL, V103, P117, DOI 10.1152/jn.91191.2008; Klier EM, 2003, PROG BRAIN RES, V142, P109; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; LAURUTIS VP, 1986, J PHYSIOL-LONDON, V373, P209, DOI 10.1113/jphysiol.1986.sp016043; Li CSR, 1999, J NEUROPHYSIOL, V81, P1827, DOI 10.1152/jn.1999.81.4.1827; MATIN L, 1965, SCIENCE, V148, P1485, DOI 10.1126/science.148.3676.1485; MAYS LE, 1980, SCIENCE, V208, P1163, DOI 10.1126/science.6769161; OTTES FP, 1984, VISION RES, V24, P1169, DOI 10.1016/0042-6989(84)90172-X; Pola J, 2004, VISION RES, V44, P2799, DOI 10.1016/j.visres.2004.06.008; Press W. H., 1992, ART SCI COMPUTING; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; SPARKS DL, 1987, J NEUROPHYSIOL, V58, P300, DOI 10.1152/jn.1987.58.2.300; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P64, DOI 10.1152/jn.1983.49.1.64; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Van Barneveld DCPBM, 2011, EUR J NEUROSCI, V34, P1149, DOI 10.1111/j.1460-9568.2011.07844.x; Van Barneveld DCPBM, 2011, J NEUROSCI, V31, P10558, DOI 10.1523/JNEUROSCI.0998-11.2011; van Wetter SMCI, 2008, J NEUROPHYSIOL, V100, P1848, DOI 10.1152/jn.90276.2008; Van Wetter SMCI, 2008, J VISION, V8, DOI 10.1167/8.14.8; VANOPSTAL AJ, 1990, EXP BRAIN RES, V79, P143, DOI 10.1007/BF00228883; VANOPSTAL AJ, 1995, J NEUROPHYSIOL, V74, P1593, DOI 10.1152/jn.1995.74.4.1593; Versnel H, 2009, J NEUROSCI, V29, P9725, DOI 10.1523/JNEUROSCI.5459-08.2009; Vliegen J, 2005, J NEUROPHYSIOL, V94, P4300, DOI 10.1152/jn.00027.2005; Vliegen J, 2004, J NEUROSCI, V24, P9291, DOI 10.1523/JNEUROSCI.2671-04.2004; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Wang XL, 2007, NAT NEUROSCI, V10, P640, DOI 10.1038/nn1878; Ziesche A, 2011, J NEUROSCI, V31, P17392, DOI 10.1523/JNEUROSCI.3407-11.2011; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	55	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47606	10.1371/journal.pone.0047606	http://dx.doi.org/10.1371/journal.pone.0047606			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118883	Green Published, gold			2022-12-25	WOS:000310600500027
J	Bridge, T; Beaman, R; Done, T; Webster, J				Bridge, Tom; Beaman, Robin; Done, Terry; Webster, Jody			Predicting the Location and Spatial Extent of Submerged Coral Reef Habitat in the Great Barrier Reef World Heritage Area, Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; FISH POPULATIONS; SHELF MARGIN; CONSERVATION; BIODIVERSITY; FUTURE; DEEP; CONNECTIVITY; ASSEMBLAGES	Aim: Coral reef communities occurring in deeper waters have received little research effort compared to their shallow-water counterparts, and even such basic information as their location and extent are currently unknown throughout most of the world. Using the Great Barrier Reef as a case study, habitat suitability modelling is used to predict the distribution of deep-water coral reef communities on the Great Barrier Reef, Australia. We test the effectiveness of a range of geophysical and environmental variables for predicting the location of deep-water coral reef communities on the Great Barrier Reef. Location: Great Barrier Reef, Australia. Methods: Maximum entropy modelling is used to identify the spatial extent of two broad communities of habitat-forming megabenthos phototrophs and heterotrophs. Models were generated using combinations of geophysical substrate properties derived from multibeam bathymetry and environmental data derived from Bio-ORACLE, combined with georeferenced occurrence records of mesophotic coral communities from autonomous underwater vehicle, remotely operated vehicle and SCUBA surveys. Model results are used to estimate the total amount of mesophotic coral reef habitat on the GBR. Results: Our models predict extensive but previously undocumented coral communities occurring both along the continental shelf-edge of the Great Barrier Reef and also on submerged reefs inside the lagoon. Habitat suitability for phototrophs is highest on submerged reefs along the outer-shelf and the deeper flanks of emergent reefs inside the GBR lagoon, while suitability for heterotrophs is highest in the deep waters along the shelf-edge. Models using only geophysical variables consistently outperformed models incorporating environmental data for both phototrophs and heterotrophs. Main Conclusion: Extensive submerged coral reef communities that are currently undocumented are likely to occur throughout the Great Barrier Reef. High-quality bathymetry data can be used to identify these reefs, which may play an important role in resilience of the GBR ecosystem to climate change.	[Bridge, Tom] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bridge, Tom] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Beaman, Robin] James Cook Univ, Sch Earth & Environm Sci, Cairns, Qld, Australia; [Done, Terry] Australian Inst Marine Sci, Townsville, Qld, Australia; [Webster, Jody] Univ Sydney, Sch Earth Sci, Geocoastal Res Grp, Sydney, NSW 2006, Australia	James Cook University; James Cook University; James Cook University; Australian Institute of Marine Science; University of Sydney	Bridge, T (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	thomas.bridge@jcu.edu.au	Bridge, Tom/J-2693-2014	Bridge, Tom/0000-0003-3951-284X	Australian Marine National Facility; National Geographic Society; Natural Environment Research Council; Great Barrier Reef Marine Park Authority; Australian Geographic; L'Oreal; School of Earth and Environmental Sciences, James Cook University	Australian Marine National Facility; National Geographic Society(National Geographic Society); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Great Barrier Reef Marine Park Authority; Australian Geographic; L'Oreal(L'Oreal Group); School of Earth and Environmental Sciences, James Cook University	This project was supported by the Australian Marine National Facility, the National Geographic Society, the Natural Environment Research Council, the Great Barrier Reef Marine Park Authority, Australian Geographic, L'Oreal and the School of Earth and Environmental Sciences, James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey E, 2011, ENCY MODERN CORAL RE; Abbey E, 2011, MAR GEOL, V288, P61, DOI 10.1016/j.margeo.2011.08.006; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Armstrong RA, 2006, CONT SHELF RES, V26, P194, DOI 10.1016/j.csr.2005.10.004; Ayre DJ, 2000, EVOLUTION, V54, P1590; Bare AY, 2010, CORAL REEFS, V29, P369, DOI 10.1007/s00338-010-0600-y; Barrett N, 2001, TECHNICAL REPORT SER; Beaman R., 2010, 25I1A MTSRF REEF RAI, P13; Beaman RJ, 2008, MAR GEOL, V247, P17, DOI 10.1016/j.margeo.2007.08.001; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bridge TCL, 2011, CORAL REEFS, V30, P143, DOI 10.1007/s00338-010-0677-3; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Cappo M, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P161; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Cornell HV, 2000, CORAL REEFS, V19, P37, DOI 10.1007/s003380050224; Corsi F, 1999, CONSERV BIOL, V13, P150, DOI 10.1046/j.1523-1739.1999.97269.x; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Fabricius KE, 2008, ECOLOGY, V89, P3163, DOI 10.1890/08-0005.1; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Harris PT, 2013, ICES J MAR SCI, V70, P284, DOI 10.1093/icesjms/fss165; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hopley D, 2006, J COASTAL RES, V22, P150, DOI 10.2112/05A-0012.1; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Locker SD, 2010, CORAL REEFS, V29, P329, DOI 10.1007/s00338-010-0613-6; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phinn SR, 2012, INT J REMOTE SENS, V33, P3768, DOI 10.1080/01431161.2011.633122; Pitcher CR, 2007, SEABED BIODIVERSITY; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roelfsema CM, 2002, CORAL REEFS, V21, P264, DOI 10.1007/s00338-002-0242-9; Salm R.V., 2006, CORAL REEFS CLIMATE, DOI 10.1029/61CE12; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Tinoco BA, 2009, BIRD CONSERV INT, V19, P63, DOI 10.1017/S0959270908007703; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; Ward TJ, 1999, ECOL APPL, V9, P691; Wolanski E, 1997, NATURWISSENSCHAFTEN, V84, P262, DOI 10.1007/s001140050394; Wright D.J., 2005, ARCGIS BENTHIC TERRA; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	60	41	41	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48203	10.1371/journal.pone.0048203	http://dx.doi.org/10.1371/journal.pone.0048203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118952	gold, Green Published, Green Accepted			2022-12-25	WOS:000310705600029
J	Kawanami, T; Sawaki, T; Sakai, T; Miki, M; Iwao, H; Nakajima, A; Nakamura, T; Sato, T; Fujita, Y; Tanaka, M; Masaki, Y; Fukushima, T; Hirose, Y; Taniguchi, M; Sugimoto, N; Okazaki, T; Umehara, H				Kawanami, Takafumi; Sawaki, Toshioki; Sakai, Tomoyuki; Miki, Miyuki; Iwao, Haruka; Nakajima, Akio; Nakamura, Takuji; Sato, Tomomi; Fujita, Yoshimasa; Tanaka, Masao; Masaki, Yasufumi; Fukushima, Toshihiro; Hirose, Yuko; Taniguchi, Makoto; Sugimoto, Naotoshi; Okazaki, Toshiro; Umehara, Hisanori			Skewed Production of IL-6 and TGF beta by Cultured Salivary Gland Epithelial Cells from Patients with Sjogren's Syndrome	PLOS ONE			English	Article							CYTOKINE MESSENGER-RNA; CLASSIFICATION CRITERIA; SYNDROME REGISTRY; KNOCKOUT MICE; T-CELLS; EXPRESSION; DISEASE; INFLAMMATION; APOPTOSIS; NETWORKS	Objective: patients with Sjogren's syndrome (SS). Methods: SGE cells obtained from 9 SS patients and 6 normal controls were cultured in the presence of exogenous IFN gamma. Cell proliferation and apoptosis in response to IFN gamma were determined by WST1 assay and by FACS analysis. The concentrations of IL-6 and TGF beta secreted into culture supernatants were analyzed by ELISA. Results: IFN gamma did not significantly affect the proliferation or apoptosis of SGE cells. However, IL-6 concentrations were higher, and TGFb concentrations were lower, in culture supernatants of SGE cells from SS patients than from normal controls. Conclusion: Cytokine production by SGE cells from SS patients showed a skewed balance compared with normal controls, with increased IL-6 and decreased TGF beta secretion. This imbalance may be critical in the regulation of Treg/Th17 cells and may foster a pathogenic milieu that may be causative and predictive in SS.	[Kawanami, Takafumi; Sawaki, Toshioki; Sakai, Tomoyuki; Miki, Miyuki; Iwao, Haruka; Nakajima, Akio; Nakamura, Takuji; Sato, Tomomi; Fujita, Yoshimasa; Tanaka, Masao; Masaki, Yasufumi; Fukushima, Toshihiro; Hirose, Yuko; Okazaki, Toshiro; Umehara, Hisanori] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa 92002, Japan; [Taniguchi, Makoto] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa 92002, Japan; [Sugimoto, Naotoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Physiol, Kanazawa, Ishikawa 9201192, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa University	Umehara, H (corresponding author), Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa 92002, Japan.	umehara@kanazawa-med.ac.jp	Taniguchi, Makoto/L-5757-2019; Sugimoto, Naotoshi/C-4739-2015	Taniguchi, Makoto/0000-0001-5920-8285; Sugimoto, Naotoshi/0000-0003-1995-5002	Japanese Ministry of Education and Science and Culture [15024236, 15390313, 22249041]; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation [S-2010-4, C2009-4, C2010-1]	Japanese Ministry of Education and Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation	This work was supported by grants 15024236, 15390313 and 22249041 from The Japanese Ministry of Education and Science and Culture, Uehara Memorial Foundation, The Vehicle Racing Commemorative Foundation, and Kanazawa Medical University Research Foundation to T.K. (S-2010-4) and H. U. (C2009-4, C2010-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; DANG H, 1995, J IMMUNOL, V155, P3205; Daniels TE, 2009, ARTHRIT RHEUM-ARTHR, V61, P711, DOI 10.1002/art.24397; Dong Lingli, 2007, Current Immunology Reviews, V3, P289; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; FOX RI, 1994, J IMMUNOL, V152, P5532; Hjelmervik TOR, 2005, ARTHRITIS RHEUM, V52, P1534, DOI 10.1002/art.21006; Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319; Malladi AS, 2012, ARTHRIT CARE RES, V64, P911, DOI 10.1002/acr.21610; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Nakabayashi T, 1997, J IMMUNOL, V158, P5527; Nishimoto N, 2005, BLOOD, V106, P2627, DOI 10.1182/blood-2004-12-4602; Ogawa N, 2004, CLIN IMMUNOL, V112, P235, DOI 10.1016/j.clim.2004.03.008; Ogawa N, 2002, ARTHRITIS RHEUM-US, V46, P2730, DOI 10.1002/art.10577; Ohyama Y, 1996, ARTHRITIS RHEUM, V39, P1376, DOI 10.1002/art.1780390816; OXHOLM P, 1992, AUTOIMMUNITY, V12, P185, DOI 10.3109/08916939209148458; Ping L, 2005, ARTHRITIS RHEUM-US, V52, P573, DOI 10.1002/art.20789; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Reksten TR, 2009, RHEUMATOLOGY, V48, P1102, DOI 10.1093/rheumatology/kep149; Romagnani S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2392; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Szyszko EA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3220; van Woerkom JM, 2005, ANN RHEUM DIS, V64, P1474, DOI 10.1136/ard.2004.031781; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wakamatsu E, 2006, ARTHRITIS RHEUM-US, V54, P3476, DOI 10.1002/art.22176; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Youinou P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3348	31	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e45689	10.1371/journal.pone.0045689	http://dx.doi.org/10.1371/journal.pone.0045689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118848	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705600002
J	Liu, Y; Gu, SH; Zhang, YJ; Guo, YY; Wang, GR				Liu, Yang; Gu, Shaohua; Zhang, Yongjun; Guo, Yuyuan; Wang, Guirong			Candidate Olfaction Genes Identified within the Helicoverpa armigera Antennal Transcriptome	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; BINDING-PROTEINS; CHEMOSENSORY PROTEINS; PHEROMONE DETECTION; INSECT OLFACTION; MOTH; LEPIDOPTERA; EXPRESSION; FAMILY; ANNOTATION	Antennal olfaction is extremely important for insect survival, mediating key behaviors such as host preference, mate choice, and oviposition site selection. Multiple antennal proteins are involved in olfactory signal transduction pathways. Of these, odorant receptors (ORs) and ionotropic receptors (IRs) confer specificity on olfactory sensory neuron responses. In this study, we identified the olfactory gene repertoire of the economically important agricultural pest moth, Helicoverpa armigera, by assembling the adult male and female antennal transcriptomes. Within the male and female antennal transcriptomes we identified a total of 47 OR candidate genes containing 6 pheromone receptor candidates. Additionally, 12 IR genes as well as 26 odorant-binding proteins and 12 chemosensory proteins were annotated. Our results allow a systematic functional analysis across much of conventional ORs repertoire and newly reported IRs mediating the key olfaction-mediated behaviors of H. armigera.	[Liu, Yang; Gu, Shaohua; Zhang, Yongjun; Guo, Yuyuan; Wang, Guirong] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wang, GR (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	grwang@ippcaas.cn		Liu, Yang/0000-0002-3424-7111	National Natural Science Foundation of China [31071752]; China National "973" Basic Research Program [2012CB114104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National "973" Basic Research Program(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (31071752) and the China National "973" Basic Research Program (2012CB114104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Brigaud I, 2009, FEBS J, V276, P6537, DOI 10.1111/j.1742-4658.2009.07351.x; Chen YA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-416; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; MASSON C, 1990, PHYSIOL REV, V70, P199, DOI 10.1152/physrev.1990.70.1.199; Matthews A, 1999, HELIOTHINE MOTHS AUS; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2009, INT J BIOL SCI, V5, P319; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Patch HM, 2009, CHEM SENSES, V34, P305, DOI 10.1093/chemse/bjp002; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Skiri HT, 2005, J COMP NEUROL, V491, P367, DOI 10.1002/cne.20692; Stern DL, 2010, PLOS GENET, V6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Vogt RG, 2003, BIOCH DIVERSITY ODOR, P391; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Zhang DD, 2010, J INSECT PHYSIOL, V56, P586, DOI 10.1016/j.jinsphys.2009.12.002; Zhang Shuai, 2009, Acta Entomologica Sinica, V52, P728; Zhang TT, 2011, BIOCHEM BIOPH RES CO, V407, P393, DOI 10.1016/j.bbrc.2011.03.032; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9	59	126	154	7	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48260	10.1371/journal.pone.0048260	http://dx.doi.org/10.1371/journal.pone.0048260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110222	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500055
J	Verrel, J; Pradon, D; Vuillerme, N				Verrel, Julius; Pradon, Didier; Vuillerme, Nicolas			Persistence of Motor-Equivalent Postural Fluctuations during Bipedal Quiet Standing	PLOS ONE			English	Article							OF-PRESSURE TRAJECTORIES; INVERTED PENDULUM MODEL; STANCE; COORDINATION; COVARIATION; ORIENTATION; MOVEMENTS; WALKING; ADULTS; FOCUS	Theoretical and empirical work indicates that the central nervous system is able to stabilize motor performance by selectively suppressing task-relevant variability (TRV), while allowing task-equivalent variability (TEV) to occur. During unperturbed bipedal standing, it has previously been observed that, for task variables such as the whole-body center of mass (CoM), TEV exceeds TRV in amplitude. However, selective control (and correction) of TRV should also lead to different temporal characteristics, with TEV exhibiting higher temporal persistence compared to TRV. The present study was specifically designed to test this prediction. Kinematics of prolonged quiet standing (5 minutes) was measured in fourteen healthy young participants, with eyes closed. Using the uncontrolled manifold analysis, postural variability in six sagittal joint angles was decomposed into TEV and TRV with respect to four task variables: (1) center of mass (CoM) position, (2) head position, (3) trunk orientation and (4) head orientation. Persistence of fluctuations within the two variability components was quantified by the time-lagged auto-correlation, with eight time lags between 1 and 128 seconds. The pattern of results differed between task variables. For three of the four task variables (CoM position, head position, trunk orientation), TEV significantly exceeded TRV over the entire 300 s-period. The autocorrelation analysis confirmed our main hypothesis for CoM position and head position: at intermediate and longer time delays, TEV exhibited higher persistence than TRV. Trunk orientation showed a similar trend, while head orientation did not show a systematic difference between TEV and TRV persistence. The combination of temporal and task-equivalent analyses in the present study allow a refined characterization of the dynamic control processes underlying the stabilization of upright standing. The results confirm the prediction, derived from computational motor control, that task-equivalent fluctuations for specific task variables show higher temporal persistence compared to task-relevant fluctuations.	[Verrel, Julius] Max Planck Inst Human Dev, Berlin, Germany; [Pradon, Didier] CHU Raymond Poincare, Garches, France; [Vuillerme, Nicolas] AGIM Lab, Grenoble, France; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut Universitaire de France	Verrel, J (corresponding author), Max Planck Inst Human Dev, Berlin, Germany.	verrel@mpib-berlin.mpg.de; Didier.pradon@rpc.aphhp.fr; nicolas.vuillerme@agim.eu	Nicolas, Vuillerme/C-6692-2009; VUILLERME, Nicolas/U-5767-2019	Nicolas, Vuillerme/0000-0002-5202-4173; Verrel, Julius/0000-0001-5850-5202; VUILLERME, Nicolas/0000-0003-3773-393X				Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bernstein N.A., 1967, COORDINATION REGULAT; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P5; Delignieres D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001089; Dingwell JB, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000856; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; GURFINKEL VS, 1995, NEUROSCIENCE, V68, P229, DOI 10.1016/0306-4522(95)00136-7; GURFINKEL' V S, 1981, Human Physiology (English Translation of Fiziologiya Cheloveka), V7, P155; HOLM S, 1979, SCAND J STAT, V6, P65; Horak F, 1996, HDB PHYSIOL 12, V12, P255; Hsiao-Wecksler ET, 2003, J BIOMECH, V36, P1327, DOI 10.1016/S0021-9290(03)00153-2; Hsu WL, 2007, J NEUROPHYSIOL, V97, P3024, DOI 10.1152/jn.01142.2006; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kavounoudias A, 1999, EXP BRAIN RES, V124, P80, DOI 10.1007/s002210050602; KUO AD, 1993, J BIOMECH, V26, P137, DOI 10.1016/0021-9290(93)90085-S; Latash ML, 2007, MOTOR CONTROL, V11, P276, DOI 10.1123/mcj.11.3.276; Lawrence M. A., 2011, EZ EASY ANAL VISUALI; Martin V, 2009, NEURAL COMPUT, V21, P1371, DOI 10.1162/neco.2008.01-08-698; MERGNER T, 1991, EXP BRAIN RES, V85, P389; Muller H, 2003, BIOL CYBERN, V89, P22, DOI 10.1007/s00422-003-0399-5; Nafati G, 2011, RES Q EXERCISE SPORT, V82, P634, DOI 10.1080/02701367.2011.10599800; Nishikawa K, 2007, INTEGR COMP BIOL, V47, P16, DOI 10.1093/icb/icm024; Nishiwaki Y, 2000, J VESTIBUL RES-EQUIL, V10, P157; Pinter IJ, 2008, J NEUROPHYSIOL, V100, P3197, DOI 10.1152/jn.01312.2007; R Core Team, 2022, R LANG ENV STAT COMP; Reimann H, 2011, VISUAL INFORM SUFFIC; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Schoner G, 2007, MOTOR CONTROL, V11, P259, DOI 10.1123/mcj.11.3.259; Scholz JP, 2007, EXP BRAIN RES, V180, P163, DOI 10.1007/s00221-006-0848-1; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Sternad D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000751; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Todorov E., 2002, ADV NEURAL INFORM PR, V15, P27; van Beers RJ, 2011, RANDOM WALK NATURE M; Verrel J, 2010, NEUROSCIENCE METHODS, V191, P166; Verrel J, 2011, J NEUROSCI METH, V200, P199, DOI 10.1016/j.jneumeth.2011.04.006; Verrel J, 2011, EXP BRAIN RES, V210, P313, DOI 10.1007/s00221-011-2636-9; Vuillerme N, 2007, PSYCHOL RES-PSYCH FO, V71, P192, DOI 10.1007/s00426-005-0018-2; Winter DA, 2004, HUMAN KINETICS; Yen JT, 2010, J R SOC INTERFACE, V7, P801, DOI 10.1098/rsif.2009.0296; Zok M, 2008, MED ENG PHYS, V30, P913, DOI 10.1016/j.medengphy.2007.12.002	44	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48312	10.1371/journal.pone.0048312	http://dx.doi.org/10.1371/journal.pone.0048312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110228	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500058
J	Heyn, H; Ferreira, HJ; Bassas, L; Bonache, S; Sayols, S; Sandoval, J; Esteller, M; Larriba, S				Heyn, Holger; Ferreira, Humberto J.; Bassas, Lluis; Bonache, Sandra; Sayols, Sergi; Sandoval, Juan; Esteller, Manel; Larriba, Sara			Epigenetic Disruption of the PIWI Pathway in Human Spermatogenic Disorders	PLOS ONE			English	Article							Y-CHROMOSOMAL MICRODELETIONS; MESSENGER-RNA TRANSCRIPTS; NOVO DNA METHYLATION; MALE GERM-CELLS; INFERTILE MEN; MOLECULAR DIAGNOSIS; HUMAN SPERM; STEM-CELLS; GENES; MILI	Epigenetic changes are involved in a wide range of common human diseases. Although DNA methylation defects are known to be associated with male infertility in mice, their impact on human deficiency of sperm production has yet to be determined. We have assessed the global genomic DNA methylation profiles in human infertile male patients with spermatogenic disorders by using the Infinium Human Methylation27 BeadChip. Three populations were studied: conserved spermatogenesis, spermatogenic failure due to germ cell maturation defects, and Sertoli cell-only syndrome samples. A disease-associated DNA methylation profile, characterized by targeting members of the PIWI-associated RNA (piRNA) processing machinery, was obtained. Bisulfite genomic sequencing and pyrosequencing in a large cohort (n = 46) of samples validated the altered DNA methylation patterns observed in piRNA-processing genes. In particular, male infertility was associated with the promoter hypermethylation-associated silencing of PIWIL2 and TDRD1. The downstream effects mediated by the epigenetic inactivation of the PIWI pathway genes were a defective production of piRNAs and a hypomethylation of the LINE-1 repetitive sequence in the affected patients. Overall, our data suggest that DNA methylation, at least that affecting PIWIL2/TDRD1, has a role in the control of gene expression in spermatogenesis and its imbalance contributes to an unsuccessful germ cell development that might explain a group of male infertility disorders.	[Heyn, Holger; Ferreira, Humberto J.; Sayols, Sergi; Sandoval, Juan; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain; [Ferreira, Humberto J.] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed, Coimbra, Portugal; [Bassas, Lluis] Androl Serv Fundacio Puigvert, Lab Seminol & Embryol, Barcelona, Catalonia, Spain; [Bonache, Sandra; Larriba, Sara] Bellvitge Biomed Res Inst IDIBELL, Human Mol Genet Grp, Barcelona 08908, Catalonia, Spain; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona 08908, Catalonia, Spain; [Esteller, Manel] ICREA, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universidade de Coimbra; Fundacio Puigvert; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA	Esteller, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain.	mesteller@idibell.cat	LARRIBA, SARA/ABG-9827-2020; sandoval, juan/M-4593-2015; Esteller, Manel/L-5956-2014	LARRIBA, SARA/0000-0003-4579-5452; sandoval, juan/0000-0002-5100-973X; Esteller, Manel/0000-0003-4490-6093; Ferreira, Humberto/0000-0003-0834-2956; Heyn, Holger/0000-0002-3276-1889; Sayols, Sergi/0000-0002-3877-4170; Bonache, Sandra/0000-0002-7395-8143	Fondo de Investigaciones Sanitarias (FIS/FEDER) [PI08-1345, PI09-1727]; European Research Council (ERC) Advanced Grant EPINORC [268626]; Ministerio de Ciencia e Innovacion (MICINN) [SAF2011-22803]; Cellex Foundation; Health Department of the Catalan Government (Generalitat de Catalunya); Sistema Nacional de Salud (SNS) [CES09/020]; Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/33887/2009]; ICREA Funding Source: Custom	Fondo de Investigaciones Sanitarias (FIS/FEDER)(Instituto de Salud Carlos IIIEuropean Commission); European Research Council (ERC) Advanced Grant EPINORC(European Research Council (ERC)); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cellex Foundation(Foundation CELLEX); Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Sistema Nacional de Salud (SNS); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); ICREA(ICREA)	This work was supported by the Fondo de Investigaciones Sanitarias (FIS/FEDER) [grant numbers PI08-1345 and PI09-1727]; the European Research Council (ERC) Advanced Grant EPINORC [grant agreement 268626]; the Ministerio de Ciencia e Innovacion (MICINN) [grant number SAF2011-22803]; the Cellex Foundation and the Health Department of the Catalan Government (Generalitat de Catalunya). S.L. is sponsored by the Researchers Stabilization Program from the Sistema Nacional de Salud (SNS) [CES09/020]. H.J.F. is sponsored by the Portuguese Foundation for Science and Technology (FCT) [reference: SFRH/BD/33887/2009]. M.E. is an Institucio Catalana de Recerca i Estudis Avancats (ICREA) Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cheng YS, 2006, HUM REPROD, V21, P2346, DOI 10.1093/humrep/del163; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Doerksen T, 2000, ENDOCRINOLOGY, V141, P3235, DOI 10.1210/en.141.9.3235; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gianotten J, 2004, HUM REPROD UPDATE, V10, P533, DOI 10.1093/humupd/dmh045; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lin YM, 2006, HUM REPROD, V21, P138, DOI 10.1093/humrep/dei285; Lin YM, 2005, HUM REPROD, V20, P782, DOI 10.1093/humrep/deh647; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schrader M, 2002, HUM REPROD, V17, P2338, DOI 10.1093/humrep/17.9.2338; Schulze W, 1999, HUM REPROD, V14, P82, DOI 10.1093/humrep/14.suppl_1.82; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Simoni M, 1999, INT J ANDROL, V22, P292; Simoni M, 2004, INT J ANDROL, V27, P240, DOI 10.1111/j.1365-2605.2004.00495.x; Siomi MC, 2010, GENE DEV, V24, P636, DOI 10.1101/gad.1899210; Steger K, 2003, MOL HUM REPROD, V9, P331, DOI 10.1093/molehr/gag041; Takashima S, 2009, BIOL REPROD, V81, P155, DOI 10.1095/biolreprod.108.074708; Terribas E, 2010, J ANDROL, V31, P346, DOI 10.2164/jandrol.109.008805; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; WHO World Health Organization Laboratory, 1999, MAN EX HUM SEM SPERM; Yaman R, 2006, MOL REPROD DEV, V73, P390, DOI 10.1002/mrd.20430	50	71	77	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47892	10.1371/journal.pone.0047892	http://dx.doi.org/10.1371/journal.pone.0047892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112866	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200101
J	Hsieh, YC; Jeng, JS; Lin, HJ; Hu, CJ; Yu, CC; Lien, LM; Peng, GS; Chen, CI; Tang, SC; Chi, NF; Tseng, HP; Chern, CM; Hsieh, FI; Bai, CH; Chen, YR; Chiou, HY				Hsieh, Yi-Chen; Jeng, Jiann-Shing; Lin, Huey-Juan; Hu, Chaur-Jong; Yu, Chia-Chen; Lien, Li-Ming; Peng, Giia-Sheun; Chen, Chin-I; Tang, Sung-Chun; Chi, Nai-Fang; Tseng, Hung-Pin; Chern, Chang-Ming; Hsieh, Fang-I; Bai, Chyi-Huey; Chen, Yi-Rhu; Chiou, Hung-Yi		Formosa Stroke Genetic Consortium	Epistasis Analysis for Estrogen Metabolic and Signaling Pathway Genes on Young Ischemic Stroke Patients	PLOS ONE			English	Article							RECEPTOR-ALPHA GENE; HIGH-ORDER INTERACTIONS; NITRIC-OXIDE SYNTHASE; RISK-FACTORS; VAL158MET POLYMORPHISM; POSTMENOPAUSAL WOMEN; BLOOD-PRESSURE; DISEASE; CANCER; SULFOTRANSFERASE	Background: Endogenous estrogens play an important role in the overall cardiocirculatory system. However, there are no studies exploring the hormone metabolism and signaling pathway genes together on ischemic stroke, including sulfotransferase family 1E (SULT1E1), catechol-O-methyl-transferase (COMT), and estrogen receptor alpha(ESR1). Methods: A case-control study was conducted on 305 young ischemic stroke subjects aged <= 50 years and 309 age-matched healthy controls. SULT1E1 -64G/A, COMT Val158Met, ESR1 c. 454-397 T/C and c. 454-351 A/G genes were genotyped and compared between cases and controls to identify single nucleotide polymorphisms associated with ischemic stroke susceptibility. Gene-gene interaction effects were analyzed using entropy-based multifactor dimensionality reduction (MDR), classification and regression tree (CART), and traditional multiple regression models. Results: COMT Val158Met polymorphism showed a significant association with susceptibility of young ischemic stroke among females. There was a two-way interaction between SULT1E1 -64G/A and COMT Val158Met in both MDR and CART analysis. The logistic regression model also showed there was a significant interaction effect between SULT1E1 -64G/A and COMT Val158Met on ischemic stroke of the young (P for interaction = 0.0171). We further found that lower estradiol level could increase the risk of young ischemic stroke for those who carry either SULT1E1 or COMT risk genotypes, showing a significant interaction effect (P for interaction = 0.0174). Conclusions: Our findings support that a significant epistasis effect exists among estrogen metabolic and signaling pathway genes and gene-environment interactions on young ischemic stroke subjects.	[Hsieh, Yi-Chen; Yu, Chia-Chen; Hsieh, Fang-I; Bai, Chyi-Huey; Chen, Yi-Rhu; Chiou, Hung-Yi] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Jeng, Jiann-Shing; Tang, Sung-Chun] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Jeng, Jiann-Shing; Tang, Sung-Chun] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lin, Huey-Juan] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Hu, Chaur-Jong; Chi, Nai-Fang] Taipei Med Univ Hosp, Dept Neurol, Taipei, Taiwan; [Hu, Chaur-Jong; Chi, Nai-Fang] Shuang Ho Hosp, Taipei, Taiwan; [Lien, Li-Ming] Shin Kong Wu Ho Mem Hosp, Dept Neurol, Taipei, Taiwan; [Peng, Giia-Sheun] Tri Serv Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Chin-I] Taipei Med Univ, Wanfang Hosp, Dept Neurol, Taipei, Taiwan; [Tseng, Hung-Pin] Lotung Poh Hosp, Dept Neurol, Ilan, Taiwan; [Chern, Chang-Ming] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chern, Chang-Ming] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Dr Chi Hsing Huang Stroke Res Ctr, Taipei, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chi Mei Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Shuang Ho Hospital; Shin Kong Wu Ho Su Memorial Hospital; Tri-Service General Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University	Chiou, HY (corresponding author), Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan.	hychiou@tmu.edu.tw	Chi, Nai-Fang/G-3561-2016; Chi, Nai-Fang/E-2851-2017; Peng, Giia-Sheun/AAE-4778-2022	Chi, Nai-Fang/0000-0002-2204-4923; Chi, Nai-Fang/0000-0002-2204-4923; JENG, JIANN-SHING/0000-0002-1456-3686; Chou, Chih-Ho/0000-0003-3491-6853; Tsai, Chia-Kuang/0000-0001-7693-1408; Yeh, Shin-Joe/0000-0003-1511-6295; Chung, Chih-Ping/0000-0001-9419-9070; Tsai, Li-Kai/0000-0001-8420-6951; chang, chia-yu/0000-0002-3403-7165; Chiou, Hung Yi/0000-0002-4545-9697; Yang, Fu-Chi/0000-0001-6831-3634; Cheng, Chun-An/0000-0002-0380-7286; Tang, Sung-Chun/0000-0003-3731-5973	National Science Council of Taiwan [NSC97-2321-B-038-002, NSC98-2321-B-038-001, NSC99-2321-B038-001]; Ministry of Education Topnotch Stroke Research Center; Department of Health Center of Excellence for Clinical Trial and Research in Neuroscience [DOH99-TD-B-111-003, DOH100-TD-B-111-003, DOH101-TD-B-111-003]; Dr. Chi-Chin Huang Stroke Research Center	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education Topnotch Stroke Research Center; Department of Health Center of Excellence for Clinical Trial and Research in Neuroscience; Dr. Chi-Chin Huang Stroke Research Center	This study was supported by grants from the National Science Council of Taiwan (NSC97-2321-B-038-002, NSC98-2321-B-038-001, and NSC99-2321-B038-001). Additional support was received from a Ministry of Education Topnotch Stroke Research Center grant and the Department of Health Center of Excellence for Clinical Trial and Research in Neuroscience (DOH99-TD-B-111-003, DOH100-TD-B-111-003, DOH101-TD-B-111-003), and Dr. Chi-Chin Huang Stroke Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Adjei AA, 2003, BRIT J PHARMACOL, V139, P1373, DOI 10.1038/sj.bjp.0705369; Adjei AA, 2002, BIOCHEM BIOPH RES CO, V292, P402, DOI 10.1006/bbrc.2002.6658; AKSOY IA, 1994, BIOCHEM BIOPH RES CO, V200, P1621, DOI 10.1006/bbrc.1994.1637; Annerbrink K, 2008, METABOLISM, V57, P708, DOI 10.1016/j.metabol.2008.01.012; Baba Y, 2010, MENOPAUSE, V17, P506, DOI 10.1097/gme.0b013e3181c7dd41; Banerjee S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-4; Bos MJ, 2008, STROKE, V39, P1324, DOI 10.1161/STROKEAHA.107.494476; Chen DB, 2004, ENDOCRINOLOGY, V145, P113, DOI 10.1210/en.2003-0547; Chen M, 2007, CARCINOGENESIS, V28, P2160, DOI 10.1093/carcin/bgm167; de Valk-de Roo GW, 1999, ARTERIOSCL THROM VAS, V19, P2993, DOI 10.1161/01.ATV.19.12.2993; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dubey RK, 2007, ENDOCRINOLOGY, V148, P4125, DOI 10.1210/en.2007-0514; Dubey RK, 2009, TRENDS ENDOCRIN MET, V20, P374, DOI 10.1016/j.tem.2009.04.007; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; FALANY CN, 1995, J STEROID BIOCHEM, V52, P529, DOI 10.1016/0960-0760(95)00015-R; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hagen K, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-34; Hanke H, 1996, ATHEROSCLEROSIS, V121, P129, DOI 10.1016/0021-9150(95)05710-2; He XF, 2012, MOL BIOL REP; HER C, 1995, GENOMICS, V29, P16, DOI 10.1006/geno.1995.1210; Hirata H, 2008, CANCER-AM CANCER SOC, V112, P1964, DOI 10.1002/cncr.23392; Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Hsieh YC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-1; Hsieh YC, 2009, PUBLIC HEALTH NUTR, V12, P570, DOI 10.1017/S1368980008002875; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Kjaergaard AD, 2007, CIRCULATION, V115, P861, DOI 10.1161/CIRCULATIONAHA.106.615567; Koch W, 2005, CIRCULATION, V112, P2138, DOI 10.1161/CIRCULATIONAHA.105.545913; Krasinski K, 1997, CIRCULATION, V95, P1768; Kunnas T, 2010, ATHEROSCLEROSIS, V211, P200, DOI 10.1016/j.atherosclerosis.2010.01.026; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lehtimaki T, 2002, J MOL MED-JMM, V80, P176, DOI 10.1007/s00109-001-0311-5; Lisabeth LD, 2009, STROKE, V40, P1044, DOI 10.1161/STROKEAHA.108.542993; Markoula S, 2008, STROKE, V39, pE172, DOI 10.1161/STROKEAHA.108.523233; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; MORALES DE, 1995, CIRCULATION, V91, P755, DOI 10.1161/01.CIR.91.3.755; Munshi A, 2010, CLIN CHIM ACTA, V411, P1817, DOI 10.1016/j.cca.2010.08.001; Rebbeck TR, 2006, J NATL CANCER I, V98, P1311, DOI 10.1093/jnci/djj360; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rocca WA, 2012, MENOPAUSE, V19, P272, DOI 10.1097/gme.0b013e31822a9937; Rossouw JE, 2002, CARDIOVASC RES, V53, P550, DOI 10.1016/S0008-6363(01)00478-3; Roten LT, 2011, MOL HUM REPROD, V17, P439, DOI 10.1093/molehr/gar014; Sampei K, 2000, STROKE, V31, P738, DOI 10.1161/01.STR.31.3.738; Schuit SCE, 2004, JAMA-J AM MED ASSOC, V291, P2969, DOI 10.1001/jama.291.24.2969; Shearman AM, 2005, STROKE, V36, P2281, DOI 10.1161/01.STR.0000181088.76518.ec; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Spyridopoulos I, 1997, CIRCULATION, V95, P1505; Udler MS, 2009, INT J CANCER, V125, P2687, DOI 10.1002/ijc.24678; Voutilainen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000181; Walsh BW, 1998, JAMA-J AM MED ASSOC, V279, P1445, DOI 10.1001/jama.279.18.1445; Wise PM, 2001, FRONT NEUROENDOCRIN, V22, P33, DOI 10.1006/frne.2000.0207; Zhang HP, 2000, GENET EPIDEMIOL, V19, P323, DOI 10.1002/1098-2272(200012)19:4<323::AID-GEPI4>3.0.CO;2-5; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	56	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47773	10.1371/journal.pone.0047773	http://dx.doi.org/10.1371/journal.pone.0047773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112845	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200079
J	Kim, K; Lee, K; Rhee, K				Kim, Kyeongmi; Lee, Kwanwoo; Rhee, Kunsoo			CEP90 Is Required for the Assembly and Centrosomal Accumulation of Centriolar Satellites, Which Is Essential for Primary Cilia Formation	PLOS ONE			English	Article							CELLS ANTENNA; PROTEIN; CILIOGENESIS; INTERACTS; PCM-1; LOCALIZATION; ORGANELLE; RAB8	Centriolar satellites are PCM-1-positive granules surrounding centrosomes. Proposed functions of the centriolar satellites include protein targeting to the centrosome, as well as communication between the centrosome and surrounding cytoplasm. CEP90 is a centriolar satellite protein that is critical for spindle pole integrity in mitotic cells. In this study, we examined the biological functions of CEP90 in interphase cells. CEP90 physically interacts with PCM-1 at centriolar satellites, and this interaction is essential for centrosomal accumulation of the centriolar satellites and eventually for primary cilia formation. CEP90 is also required for BBS4 loading on centriolar satellites and its localization in primary cilia. Our results imply that the assembly and transport of centriolar satellites are critical steps for primary cilia formation and ciliary protein recruitment.	[Kim, Kyeongmi; Lee, Kwanwoo; Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea	Seoul National University (SNU)	Rhee, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	rheek@snu.ac.kr			BioImaging Research Center at GIST; Basic Research Program [2010-0022423, 2012R1A2A201003512]; Science Research Center Program of the Ministry of Education, Science and Technology [2011-0006425]; second stage of the Brain Korea 21 Project	BioImaging Research Center at GIST; Basic Research Program; Science Research Center Program of the Ministry of Education, Science and Technology; second stage of the Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This study was supported by grants from the BioImaging Research Center at GIST; the Basic Research Program (grant numbers 2010-0022423 and 2012R1A2A201003512); the Science Research Center Program (grant number 2011-0006425) of the Ministry of Education, Science and Technology; and the second stage of the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barenz F, 2011, EUR J CELL BIOL, V90, P983, DOI 10.1016/j.ejcb.2011.07.007; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Gillingham AK, 2000, EMBO REP, V1, P524; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim K, 2011, J CELL SCI, V124, P338, DOI 10.1242/jcs.078329; Kim K, 2008, EXP CELL RES, V314, P3692, DOI 10.1016/j.yexcr.2008.09.016; Kodani A, 2010, MOL BIOL CELL, V21, P3376, DOI 10.1091/mbc.E10-05-0430; Kubo A, 2003, J CELL SCI, V116, P919, DOI 10.1242/jcs.00282; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Sedjai F, 2010, J CELL SCI, V123, P2391, DOI 10.1242/jcs.065045; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134	20	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48196	10.1371/journal.pone.0048196	http://dx.doi.org/10.1371/journal.pone.0048196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110211	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200159
J	Bernal, AJ; Dolinoy, DC; Huang, D; Skaar, DA; Weinhouse, C; Jirtle, RL				Bernal, Autumn J.; Dolinoy, Dana C.; Huang, Dale; Skaar, David A.; Weinhouse, Caren; Jirtle, Randy L.			Adaptive radiation-induced epigenetic alterations mitigated by antioxidants	FASEB JOURNAL			English	Article						agouti mice; DNA methylation; hormesis; reactive oxygen species	EFFECTS IN-VIVO; IONIZING-RADIATION; DNA METHYLATION; IRRADIATION; YELLOW; EXPRESSION; EFFECTORS; PATTERNS; EXPOSURE; OBESITY	Humans are exposed to low-dose ionizing radiation (LDIR) from a number of environmental and medical sources. In addition to inducing genetic mutations, there is concern that LDIR may also alter the epigenome. Such heritable effects early in life can either be positively adaptive or result in the enhanced formation of diseases, including cancer, diabetes, and obesity. Herein, we show that LDIR significantly increased DNA methylation at the viable yellow agouti (A(vy)) locus in a sex-specific manner (P=0.004). Average DNA methylation was significantly increased in male offspring exposed to doses between 0.7 and 7.6 cGy, with maximum effects at 1.4 and 3.0 cGy (P<0.01). Offspring coat color was concomitantly shifted toward pseudoagouti (P<0.01). Maternal dietary antioxidant supplementation mitigated both the DNA methylation changes and coat color shift in the irradiated offspring. Thus, LDIR exposure during gestation elicits epigenetic alterations that lead to positive adaptive phenotypic changes that are negated with antioxidants, indicating they are mediated in part by oxidative stress. These findings provide evidence that in the isogenic A(vy) mouse model, epigenetic alterations resulting from LDIR play a role in radiation hormesis, bringing into question the assumption that every dose of radiation is harmful.-Bernal, A. J., Dolinoy, D. C., Huang, D., Skaar, D. A., Weinhouse, C., Jirtle, R. J. Adaptive radiation-induced epigenetic alterations mitigated by antioxidants. FASEB J. 27, 665-671 (2013). www.fasebj.org	[Bernal, Autumn J.; Huang, Dale; Skaar, David A.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Dolinoy, Dana C.; Weinhouse, Caren] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Jirtle, Randy L.] Univ Wisconsin, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53706 USA	Duke University; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	Jirtle, RL (corresponding author), Univ Wisconsin, Dept Oncol, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	jirtle@geneimprint.com		Weinhouse, Caren/0000-0002-1257-7267	U.S. Department of Energy [DE-FG02-10ER64931]; Ester B. O'Keeffe Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885, T32ES007062] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); Ester B. O'Keeffe Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Susan K. Murphy for critically reading this manuscript, Theodore Slotkin for assisting with statistical analysis, and Christopher Faulk for agouti mouse photography. The authors also thank Greta Toncheva and the Duke Radiation Dosimetry Laboratory for assistance in determining the intrauterine radiation doses. Financial support from the U.S. Department of Energy (grant DE-FG02-10ER64931) and the Ester B. O'Keeffe Foundation is gratefully acknowledged. The authors declare no conflicts of interest.	Akiba S, 2012, J RADIOL PROT, V32, P1, DOI 10.1088/0952-4746/32/1/1; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bairati I, 2005, JNCI-J NATL CANCER I, V97, P481, DOI 10.1093/jnci/dji095; Calabrese E, 2011, P NATL ACAD SCI USA, V108, P19447, DOI 10.1073/pnas.1117296108; Calabrese EJ, 2009, ARCH TOXICOL, V83, P203, DOI 10.1007/s00204-009-0412-4; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dolinoy DC, 2010, EPIGENETICS-US, V5, P637, DOI 10.4161/epi.5.7.12892; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Ilnytskyy Y, 2009, ENVIRON MOL MUTAGEN, V50, P105, DOI 10.1002/em.20440; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Koturbash I, 2006, ONCOGENE, V25, P4267, DOI 10.1038/sj.onc.1209467; Koturbash I, 2008, MUTAT RES-FUND MOL M, V642, P28, DOI 10.1016/j.mrfmmm.2008.04.002; Koturbash I, 2007, CARCINOGENESIS, V28, P1831, DOI 10.1093/carcin/bgm053; Koturbash I, 2011, MUTAT RES-GEN TOX EN, V722, P114, DOI 10.1016/j.mrgentox.2010.05.007; Kovalchuk O, 2004, MUTAT RES-FUND MOL M, V548, P75, DOI 10.1016/j.mrfmmm.2003.12.016; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Nandakumar V, 2011, CARCINOGENESIS, V32, P597, DOI 10.1093/carcin/bgq282; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rugo RE, 2011, ONCOGENE, V30, P751, DOI 10.1038/onc.2010.480; Saenko V, 2011, CLIN ONCOL-UK, V23, P234, DOI 10.1016/j.clon.2011.01.502; Sanders CL, 2009, RAD HORMESIS LINEAR; Schauer DA, 2009, HEALTH PHYS, V97, P1, DOI 10.1097/01.HP.0000356672.44380.b7; Tawa R, 1998, J RADIAT RES, V39, P271, DOI 10.1269/jrr.39.271; Vaiserman AM, 2011, AGEING RES REV, V10, P413, DOI 10.1016/j.arr.2011.01.004; Wambi CO, 2009, RADIAT RES, V172, P175, DOI 10.1667/RR1589.1; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Williams G, 2000, P NUTR SOC, V59, P385, DOI 10.1017/S0029665100000434; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666	35	75	84	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					665	671		10.1096/fj.12-220350	http://dx.doi.org/10.1096/fj.12-220350			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23118028	Green Published, Green Submitted			2022-12-25	WOS:000314358000025
J	Yu, Y; Mishra, S; Song, XZ; Lasanajak, Y; Bradley, KC; Tappert, MM; Air, GM; Steinhauer, DA; Halder, S; Cotmore, S; Tattersall, P; Agbandje-McKenna, M; Cummings, RD; Smith, DF				Yu, Ying; Mishra, Shreya; Song, Xuezheng; Lasanajak, Yi; Bradley, Konrad C.; Tappert, Mary M.; Air, Gillian M.; Steinhauer, David A.; Halder, Sujata; Cotmore, Susan; Tattersall, Peter; Agbandje-McKenna, Mavis; Cummings, Richard D.; Smith, David F.			Functional Glycomic Analysis of Human Milk Glycans Reveals the Presence of Virus Receptors and Embryonic Stem Cell Biomarkers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSAMINE-SPECIFIC LECTIN; RICINUS-COMMUNIS AGGLUTININ; BINDING-SPECIFICITY; SIALIC ACIDS; MINUTE VIRUS; STRUCTURAL DETERMINANTS; MICROARRAY STRATEGY; COMBINING SITE; OLIGOSACCHARIDES; AFFINITY	Human milk contains a large diversity of free glycans beyond lactose, but their functions are not well understood. To explore their functional recognition, here we describe a shotgun glycan microarray prepared from isolated human milk glycans (HMGs), and our studies on their recognition by viruses, antibodies, and glycan-binding proteins (GBPs), including lectins. The total neutral and sialylated HMGs were derivatized with a bifunctional fluorescent tag, separated by multidimensional HPLC, and archived in a tagged glycan library, which was then used to print a shotgun glycan microarray (SGM). This SGM was first interrogated with well defined GBPs and antibodies. These data demonstrated both the utility of the array and provided preliminary structural information (metadata) about this complex glycome. Anti-TRA-1 antibodies that recognize human pluripotent stem cells specifically recognized several HMGs that were then further structurally defined as novel epitopes for these antibodies. Human influenza viruses and Parvovirus Minute Viruses of Mice also specifically recognized several HMGs. For glycan sequencing, we used a novel approach termed metadata-assisted glycan sequencing (MAGS), in which we combine information from analyses of glycans by mass spectrometry with glycan interactions with defined GBPs and antibodies before and after exoglycosidase treatments on the microarray. Together, these results provide novel insights into diverse recognition functions of HMGs and show the utility of the SGM approach and MAGS as resources for defining novel glycan recognition by GBPs, antibodies, and pathogens.	[Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, Atlanta, GA 30322 USA; [Yu, Ying; Mishra, Shreya; Song, Xuezheng; Lasanajak, Yi; Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Glyc Ctr, Atlanta, GA 30322 USA; [Yu, Ying; Bradley, Konrad C.; Steinhauer, David A.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Tappert, Mary M.; Air, Gillian M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Halder, Sujata; Agbandje-McKenna, Mavis] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32607 USA; [Cotmore, Susan; Tattersall, Peter] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06519 USA	Emory University; Emory University; Emory University; University of Oklahoma System; University of Oklahoma Health Sciences Center; State University System of Florida; University of Florida; Yale University	Cummings, RD (corresponding author), Emory Univ, Sch Med, Dept Biochem, O Wayne Rollins Res Ctr, 1510 Clifton Rd,Ste 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu; dfsmith@emory.edu		Air, Gillian/0000-0001-5724-3108; Bradley, Konrad/0000-0001-8761-6219	National Institutes of Health [GM62116, RO1 GM085448]; National Science Foundation [MCB 0718948]; United States Department of Health and Human Services [HHSN266200700006C]; NATIONAL CANCER INSTITUTE [R01CA029303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, R24GM098791, R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62116 (to the Consortium for Functional Glycomics) and RO1 GM085448 (to D. F. S.). This work was also supported by National Science Foundation Grant MCB 0718948 (to M. A.-M.) and United States Department of Health and Human Services Contract HHSN266200700006C (to the NIAID Centers of Excellence for Influenza Research and Surveillance).	Amonsen M, 2007, J VIROL, V81, P8341, DOI 10.1128/JVI.00718-07; Badcock G, 1999, CANCER RES, V59, P4715; BAENZIGER JU, 1979, J BIOL CHEM, V254, P2400; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Blank D, 2011, ANAL BIOANAL CHEM, V401, P2495, DOI 10.1007/s00216-011-5349-9; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bode L, 2004, THROMB HAEMOSTASIS, V92, P1402, DOI 10.1160/TH04-01-0055; Bode L, 2006, J NUTR, V136, P2127, DOI 10.1093/jn/136.8.2127; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Bradley KC, 2011, VIROLOGY, V413, P169, DOI 10.1016/j.virol.2011.01.027; BREWER CF, 1986, J BIOL CHEM, V261, P7306; Cotmore SF, 2010, J VIROL, V84, P1945, DOI 10.1128/JVI.01563-09; Cummings RD, 2009, MOL BIOSYST, V5, P1087, DOI 10.1039/b907931a; D'Abramo AM, 2005, VIROLOGY, V340, P143, DOI 10.1016/j.virol.2005.06.019; de Paz JL, 2012, METHODS MOL BIOL, V808, P1, DOI 10.1007/978-1-61779-373-8_1; Donovan SM, 2009, BRIT J NUTR, V101, P1267, DOI 10.1017/S0007114508091241; German JB, 2008, NESTLE NUTR WORKS SE, V62, P205, DOI 10.1159/000146322; GREEN ED, 1987, J BIOL CHEM, V262, P12030; GROLLMAN EF, 1969, J CLIN INVEST, V48, P1489, DOI 10.1172/JCI106115; Heimburg-Molinaro Jamie, 2011, Curr Protoc Protein Sci, VChapter 12, DOI 10.1002/0471140864.ps1210s64; IDOTA T, 1995, BIOSCI BIOTECH BIOCH, V59, P417, DOI 10.1271/bbb.59.417; IGLESIAS JL, 1982, EUR J BIOCHEM, V123, P247, DOI 10.1111/j.1432-1033.1982.tb19760.x; KALADAS PM, 1982, ARCH BIOCHEM BIOPHYS, V217, P624, DOI 10.1016/0003-9861(82)90544-6; KALADAS PM, 1983, ARCH BIOCHEM BIOPHYS, V223, P309, DOI 10.1016/0003-9861(83)90596-9; Kannicht Christoph, 2008, V446, P255, DOI 10.1007/978-1-60327-084-7_18; Kobata A, 2000, GLYCOCONJUGATE J, V17, P443, DOI 10.1023/A:1011006122704; KOBATA A, 1969, ARCH BIOCHEM BIOPHYS, V130, P509, DOI 10.1016/0003-9861(69)90063-0; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; KOCHIBE N, 1980, BIOCHEMISTRY-US, V19, P2841, DOI 10.1021/bi00554a004; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Kuntz S, 2008, BRIT J NUTR, V99, P462, DOI 10.1017/S0007114507824068; Kuntz S, 2009, BRIT J NUTR, V101, P1306, DOI 10.1017/S0007114508079622; Liu Y, 2012, METHODS MOL BIOL, V808, P117, DOI 10.1007/978-1-61779-373-8_8; Lopez-Bueno A, 2006, J VIROL, V80, P1563, DOI 10.1128/JVI.80.3.1563-1573.2006; Lyer P N, 1976, Arch Biochem Biophys, V177, P330; Espinosa RM, 2007, BRIT J NUTR, V98, pS74, DOI 10.1017/S0007114507838062; Marionneau S, 2002, GLYCOBIOLOGY, V12, P851, DOI 10.1093/glycob/cwf103; Marionneau S, 2002, GASTROENTEROLOGY, V122, P1967, DOI 10.1053/gast.2002.33661; MATSUMOT.I, 1969, BIOCHIM BIOPHYS ACTA, V194, P180, DOI 10.1016/0005-2795(69)90193-7; Naismith JH, 1996, J BIOL CHEM, V271, P972, DOI 10.1074/jbc.271.2.972; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; Natunen S, 2011, GLYCOBIOLOGY, V21, P1125, DOI 10.1093/glycob/cwq209; Newburg DS, 2005, J NUTR, V135, P1308, DOI 10.1093/jn/135.5.1308; Newburg DS, 2005, ANNU REV NUTR, V25, P37, DOI 10.1146/annurev.nutr.25.050304.092553; Ninonuevo MR, 2006, J AGR FOOD CHEM, V54, P7471, DOI 10.1021/jf0615810; Ninonuevo MR, 2009, NUTR REV, V67, pS216, DOI 10.1111/j.1753-4887.2009.00243.x; PEREIRA MEA, 1978, ARCH BIOCHEM BIOPHYS, V185, P108, DOI 10.1016/0003-9861(78)90149-2; PEREIRA MEA, 1974, BIOCHEMISTRY-US, V13, P3184, DOI 10.1021/bi00712a029; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Ruvoen-Clouet N, 2000, J VIROL, V74, P11950, DOI 10.1128/JVI.74.24.11950-11954.2000; Schack-Nielsen L, 2007, J NUTR, V137, p503S, DOI 10.1093/jn/137.2.503S; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; SMITH DF, 1978, ANAL BIOCHEM, V85, P602, DOI 10.1016/0003-2697(78)90261-0; Song XZ, 2012, METHODS MOL BIOL, V800, P163, DOI 10.1007/978-1-61779-349-3_11; Song XZ, 2011, J BIOL CHEM, V286, P31610, DOI 10.1074/jbc.M111.274217; Song XZ, 2011, NAT METHODS, V8, P85, DOI 10.1038/NMETH.1540; Song XZ, 2009, J BIOL CHEM, V284, P35201, DOI 10.1074/jbc.M109.056119; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Svensson C, 2002, J MOL BIOL, V321, P69, DOI 10.1016/S0022-2836(02)00554-5; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thurl S, 1997, GLYCOCONJUGATE J, V14, P795, DOI 10.1023/A:1018529703106; Thurl S, 2010, BRIT J NUTR, V104, P1261, DOI 10.1017/S0007114510002072; TOLLEFSEN SE, 1983, J BIOL CHEM, V258, P5172; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; WANG WC, 1988, J BIOL CHEM, V263, P4576; Yan LY, 1997, GLYCOCONJUGATE J, V14, P45, DOI 10.1023/A:1018508914551	71	74	75	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44784	44799		10.1074/jbc.M112.425819	http://dx.doi.org/10.1074/jbc.M112.425819			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23115247	hybrid, Green Published			2022-12-25	WOS:000312938600072
J	Medrano, LM; Dema, B; Lopez-Larios, A; Maluenda, C; Bodas, A; Lopez-Palacios, N; Figueredo, MA; Fernandez-Arquero, M; Nunez, C				Maria Medrano, Luz; Dema, Barbara; Lopez-Larios, Arturo; Maluenda, Carlos; Bodas, Andres; Lopez-Palacios, Natalia; Angeles Figueredo, M.; Fernandez-Arquero, Miguel; Nunez, Concepcion			HLA and Celiac Disease Susceptibility: New Genetic Factors Bring Open Questions about the HLA Influence and Gene-Dosage Effects	PLOS ONE			English	Article							HAPLOTYPES; ASSOCIATION; GLUTEN; RISK; POLYMORPHISM; HLA-DQ2.2; ALLELES; REGION	Celiac disease (CD) is a chronic inflammatory disorder triggered after gluten ingestion in genetically susceptible individuals. The major genetic determinants are HLA-DQA1*05 and HLA-DQB1*02, which encode the DQ2 heterodimer. These alleles are commonly inherited in cis with DRB1*03:01, which is associated with numerous immune-related disorders, in some cases contributing with a different amount of risk depending on the haplotype context. We aimed at investigating those possible differences involving DRB1*03:01-carrying haplotypes in CD susceptibility. A family (274 trios) and a case-control sample (369 CD cases/461 controls) were analyzed. DRB1*03: 01-carrying individuals were classified according to the haplotype present (ancestral haplotype (AH) 8.1, AH 18.2 or non-conserved haplotype) after genotyping of HLA-DRB1, -DQA1, -DQB1, -B8, TNF -308, TNF -376 and the TNFa and TNFb microsatellites. We observe that the AH 8.1 confers higher risk than the remaining DRB1*03: 01-carrying haplotypes, and this effect only involves individuals possessing a single copy of DQB1*02. CD risk for these individuals is similar to the one conferred by inherit DQA1*05 and DQB1*02 in trans. It seems that an additional CD susceptibility factor is present in the AH 8.1 but not in other DRB1*03: 01-carrying haplotypes. This factor could be shared with individuals possessing DQ2.5 trans, according to the similar risk observed in those two groups of individuals.	[Maria Medrano, Luz; Dema, Barbara; Lopez-Larios, Arturo; Angeles Figueredo, M.; Fernandez-Arquero, Miguel; Nunez, Concepcion] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, UGC Inmunol, Madrid, Spain; [Maluenda, Carlos; Bodas, Andres] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Serv Pediat, Madrid, Spain; [Lopez-Palacios, Natalia] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Serv Aparato Digest, Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Clinico San Carlos	Nunez, C (corresponding author), Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, UGC Inmunol, Madrid, Spain.	conchita.npardo@gmail.com	de dios, luz maria medrano/K-1946-2016; Núñez, Concepción/H-8517-2017; Palacios, Natalia Lopez/AAZ-7954-2020; Dema, Barbara/AAM-2354-2020	de dios, luz maria medrano/0000-0003-3717-5384; Nunez, Concepcion/0000-0002-9489-1603	Fondo de Investigaciones Sanitarias [PI11/00614, PI10/02876]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by grants from Fondo de Investigaciones Sanitarias (PI11/00614 and PI10/02876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baschal EE, 2009, CLIN IMMUNOL, V132, P203, DOI 10.1016/j.clim.2009.03.530; Bilbao JR, 2006, GENES IMMUN, V7, P550, DOI 10.1038/sj.gene.6364328; Bodd M, 2012, GASTROENTEROLOGY, V142, P552, DOI 10.1053/j.gastro.2011.11.021; Bolognesi E, 2003, TISSUE ANTIGENS, V61, P308, DOI 10.1034/j.1399-0039.2003.00028.x; de la Concha EG, 2000, HUM IMMUNOL, V61, P513, DOI 10.1016/S0198-8859(99)00187-1; de la Concha EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031018; Fallang LE, 2009, NAT IMMUNOL, V10, P1096, DOI 10.1038/ni.1780; Fernandez-Arquero M, 1999, NEUROLOGY, V53, P1361, DOI 10.1212/WNL.53.6.1361; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; KEUNING JJ, 1976, LANCET, V1, P506; Louka AS, 2003, IMMUNOGENETICS, V55, P339, DOI 10.1007/s00251-003-0586-5; NEDOSPASOV SA, 1991, J IMMUNOL, V147, P1053; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; van Heel DA, 2005, BEST PRACT RES CL GA, V19, P323, DOI 10.1016/j.bpg.2005.01.001; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058	17	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48403	10.1371/journal.pone.0048403	http://dx.doi.org/10.1371/journal.pone.0048403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119005	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500125
J	Peng, ZS; Raufman, JP; Xie, GF				Peng, Zhongsheng; Raufman, Jean-Pierre; Xie, Guofeng			Src-Mediated Cross-Talk between Farnesoid X and Epidermal Growth Factor Receptors Inhibits Human Intestinal Cell Proliferation and Tumorigenesis	PLOS ONE			English	Article							COLON-CANCER CELLS; ORPHAN NUCLEAR RECEPTOR; NF-KAPPA-B; CHOLINERGIC-RECEPTOR; BREAST-CANCER; BILE-ACIDS; FXR; GUGGULSTERONE; ACTIVATION; EXPRESSION	Besides its essential role in controlling bile acid and lipid metabolism, the farnesoid X receptor (FXR) protects against intestinal tumorigenesis by promoting apoptosis and inhibiting cell proliferation. However, the mechanisms underlying these anti-proliferative actions of FXR remain to be elucidated. In the present study, we examined the effects of FXR activation (FXR overexpression and treatment with an FXR agonist GW4064) and inactivation (treatment with FXR siRNA and an FXR antagonist guggulsterone) on colon cancer cell proliferation in vitro using human colon cancer cell lines (H508, SNU-C4 and HT-29) and in vivo using xenografts in nude mice. Blocking FXR activity with guggulsterone stimulated time-and dose-dependent EGFR (Tyr845) phosphorylation and ERK activation. In contrast, FXR overexpression and activation with GW4064 attenuated cell proliferation by down-regulating EGFR (Tyr845) phosphorylation and ERK activation. Treatment with guggulsterone and GW4064 also caused dose-dependent changes in Src (Tyr416) phosphorylation. In stably-transfected human colon cancer cells, overexpression of FXR reduced EGFR, ERK, Src phosphorylation and cell proliferation, and in nude mice attenuated the growth of human colon cancer xenografts (64% reduction in tumor volume; 47% reduction in tumor weight; both P<0.01). Moreover, guggulsterone-induced EGFR and ERK phosphorylation and cell proliferation were abolished by inhibiting activation of Src, EGFR and MEK. Collectively these data support the novel conclusion that in human colon cancer cells Src-mediated cross-talk between FXR and EGFR modulates ERK phosphorylation, thereby regulating intestinal cell proliferation and tumorigenesis.	[Peng, Zhongsheng; Raufman, Jean-Pierre; Xie, Guofeng] Univ Maryland, Sch Med, VA Maryland Hlth Care Syst, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Xie, GF (corresponding author), Univ Maryland, Sch Med, VA Maryland Hlth Care Syst, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA.	gxie@medicine.umaryland.edu			National Institute of Diabetes and Digestive and Kidney Diseases [K08 DK-080843, T32 DK067872, R01 CA-107345]; NATIONAL CANCER INSTITUTE [R01CA107345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067872, K08DK080843] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant K08 DK-080843 (G. Xie), T32 DK067872 (J.P. Raufman) and R01 CA-107345 (J.P. Raufman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KS, 2008, CANCER RES, V68, P4406, DOI 10.1158/0008-5472.CAN-07-6696; An MJ, 2009, CANCER LETT, V279, P93, DOI 10.1016/j.canlet.2009.01.026; Belo A, 2011, AM J PHYSIOL-GASTR L, V300, pG749, DOI 10.1152/ajpgi.00306.2010; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Cheng KR, 2005, BIOCHEM PHARMACOL, V70, P1035, DOI 10.1016/j.bcp.2005.07.023; Cheng KR, 2003, CANCER RES, V63, P6744; Cheng KR, 2007, BIOCHEM PHARMACOL, V73, P1001, DOI 10.1016/j.bcp.2006.11.028; De Gottardi A, 2004, DIGEST DIS SCI, V49, P982; Dussault I, 2003, J BIOL CHEM, V278, P7027, DOI 10.1074/jbc.M209863200; Frucht H, 1999, CLIN CANCER RES, V5, P2532; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Giordano C, 2011, ONCOGENE, V30, P4129, DOI 10.1038/onc.2011.124; Haarmann-Stemmann T, 2009, BIOCHEM PHARMACOL, V77, P508, DOI 10.1016/j.bcp.2008.09.013; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Kapoor S, 2008, HEPATOLOGY, V48, P2090, DOI 10.1002/hep.22601; Lax S, 2011, INT J CANC; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; McKay JA, 2002, EUR J CANCER, V38, P2258, DOI 10.1016/S0959-8049(02)00234-4; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Overman MJ, 2007, DIS COLON RECTUM, V50, P1259, DOI 10.1007/s10350-007-0228-3; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Raufman JP, 2008, CANCER RES, V68, P3573, DOI 10.1158/0008-5472.CAN-07-6810; Raufman JP, 2011, BIOCHEM BIOPH RES CO, V415, P319, DOI 10.1016/j.bbrc.2011.10.052; Sarfaraz S, 2008, CARCINOGENESIS, V29, P2011, DOI 10.1093/carcin/bgn180; SATO KI, 1995, BIOCHEM BIOPH RES CO, V215, P1078, DOI 10.1006/bbrc.1995.2574; Shishodia S, 2004, J BIOL CHEM, V279, P47148, DOI 10.1074/jbc.M408093200; Singh SV, 2007, CANCER RES, V67, P7439, DOI 10.1158/0008-5472.CAN-07-0120; Smith DLH, 2010, CARCINOGENESIS, V31, P1100, DOI 10.1093/carcin/bgq050; Swales KE, 2006, CANCER RES, V66, P10120, DOI 10.1158/0008-5472.CAN-06-2399; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; Venook AP, 2005, CANCER-AM CANCER SOC, V103, P2435, DOI 10.1002/cncr.21123; WAN CW, 1988, CANCER LETT, V43, P139, DOI 10.1016/0304-3835(88)90226-1; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Xie GF, 2009, AM J PHYSIOL-GASTR L, V296, pG755, DOI 10.1152/ajpgi.90519.2008; Yang WL, 2000, CARCINOGENESIS, V21, P1789, DOI 10.1093/carcin/21.10.1789; Yarden Y, 2001, EUR J CANCER, V37, pS3	41	34	37	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48461	10.1371/journal.pone.0048461	http://dx.doi.org/10.1371/journal.pone.0048461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119029	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500145
J	Pott, S; Kamrani, NK; Bourque, G; Pettersson, S; Liu, ET				Pott, Sebastian; Kamrani, Nima K.; Bourque, Guillaume; Pettersson, Sven; Liu, Edison T.			PPARG Binding Landscapes in Macrophages Suggest a Genome-Wide Contribution of PU.1 to Divergent PPARG Binding in Human and Mouse	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; ACTIVATED-RECEPTOR-GAMMA; COLONIC EPITHELIAL-CELLS; HUMAN DENDRITIC CELLS; GENE-EXPRESSION; TRANSPOSABLE ELEMENTS; LIPID-METABOLISM; CHIP-SEQ; ADIPOGENESIS; REVEALS	Background: Genome-wide comparisons of transcription factor binding sites in different species can be used to evaluate evolutionary constraints that shape gene regulatory circuits and to understand how the interaction between transcription factors shapes their binding landscapes over evolution. Results: We have compared the PPARG binding landscapes in macrophages to investigate the evolutionary impact on PPARG binding diversity in mouse and humans for this important nuclear receptor. Of note, only 5% of the PPARG binding sites were shared between the two species. In contrast, at the gene level, PPARG target genes conserved between both species constitute more than 30% of the target genes regulated by PPARG ligand in human macrophages. Moreover, the majority of all PPARG binding sites (55-60%) in macrophages show co-occupancy of the lineage-specification factor PU.1 in both species. Exploring the evolutionary dynamics of PPARG binding sites, we observed that PU.1 co-binding to PPARG sites appears to be important for possible PPARG ancestral functions such as lipid metabolism. Thus we speculate that PU.1 may have guided utilization of these species-specific PPARG conserved binding sites in macrophages during evolution. Conclusions: We propose a model in which PU.1 sites may have served as "anchor" loci for the formation of new and functionally relevant PPARG binding sites throughout evolution. As PU.1 is an essential factor in macrophage biology, such an evolutionary mechanism would allow for the establishment of relevant PPARG regulatory modules in a PU.1-dependent manner and yet permit for nuanced regulatory changes in individual species.	[Pott, Sebastian; Kamrani, Nima K.; Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Pott, Sebastian; Kamrani, Nima K.; Bourque, Guillaume; Liu, Edison T.] Genome Inst Singapore, Singapore, Singapore; [Kamrani, Nima K.; Pettersson, Sven] Natl Canc Ctr, Singapore, Singapore	Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National Cancer Centre Singapore (NCCS)	Pettersson, S (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	sven.pettersson@ki.se; liue@gis.a-star.edu.sg	Pettersson, Sven/F-9511-2015; Bourque, Guillaume/AFR-2927-2022	Bourque, Guillaume/0000-0002-3933-9656	Agency for Science, Technology And Research (A*STAR), Singapore; TORNADO under European Commission; Swedish Medical Research Council; Singapore Millennium Foundation	Agency for Science, Technology And Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); TORNADO under European Commission; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Singapore Millennium Foundation(Singapore Millennium Foundation)	This work was funded by the Agency for Science, Technology And Research (A*STAR), Singapore. The authors are also grateful for support from TORNADO (Molecular targets open for regulation by the gut flora new avenues for improved diet to optimize European health) under the Seventh Framework Programme (FP7) of the European Commission, Swedish Medical Research Council and the Singapore Millennium Foundation to Sven Pettersson, Sebastian Pott, and Nima Kamrani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Anderson KL, 1998, BLOOD, V91, P3702, DOI 10.1182/blood.V91.10.3702; Are A, 2008, P NATL ACAD SCI USA, V105, P1943, DOI 10.1073/pnas.0711734105; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Szatmari I, 2007, BLOOD, V110, P3271, DOI 10.1182/blood-2007-06-096222; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	48	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48102	10.1371/journal.pone.0048102	http://dx.doi.org/10.1371/journal.pone.0048102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118933	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500067
J	Tan, HW; Weir, BS; Carter, N; Heenan, PB; Ridgway, HJ; James, EK; Sprent, JI; Young, JPW; Andrews, M				Tan, Heng Wee; Weir, Bevan S.; Carter, Noel; Heenan, Peter B.; Ridgway, Hayley J.; James, Euan K.; Sprent, Janet I.; Young, J. Peter W.; Andrews, Mitchell			Rhizobia with 16S rRNA and nifH Similar to Mesorhizobium huakuii but Novel recA, glnII, nodA and nodC Genes Are Symbionts of New Zealand Carmichaelinae	PLOS ONE			English	Article							NITROGEN-FIXATION; FABACEAE; NODULATION; FLORA; DIVERSIFICATION; CLASSIFICATION; CLIANTHUS; DIVERSITY; STRAINS; SPP.	New Zealand became geographically isolated about 80 million years ago and this separation gave rise to a unique native flora including four genera of legume, Carmichaelia, Clianthus and Montigena in the Carmichaelinae clade, tribe Galegeae, and Sophora, tribe Sophoreae, sub-family Papilionoideae. Ten bacterial strains isolated from NZ Carmichaelinae growing in natural ecosystems grouped close to the Mesorhizobium huakuii type strain in relation to their 16S rRNA and nifH gene sequences. However, the ten strains separated into four groups on the basis of their recA and glnII sequences: all groups were clearly distinct from all Mesorhizobium type strains. The ten strains separated into two groups on the basis of their nodA sequences but grouped closely together in relation to nodC sequences; all nodA and nodC sequences were novel. Seven strains selected and the M. huakuii type strain (isolated from Astragalus sinicus) produced functional nodules on Carmichaelia spp., Clianthus puniceus and A. sinicus but did not nodulate two Sophora species. We conclude that rhizobia closely related to M. huakuii on the basis of 16S rRNA and nifH gene sequences, but with variable recA and glnII genes and novel nodA and nodC genes, are common symbionts of NZ Carmichaelinae.	[Tan, Heng Wee; Ridgway, Hayley J.; Andrews, Mitchell] Lincoln Univ, Fac Agr & Life Sci, Christchurch, New Zealand; [Carter, Noel] Univ Sunderland, Fac Sci Appl, Sunderland SR2 7EE, Durham, England; [Weir, Bevan S.] Landcare Res, Systemat Grp, Auckland, New Zealand; [Heenan, Peter B.] Landcare Res, Allan Herbarium, Christchurch, New Zealand; [James, Euan K.] James Hutton Inst, Dundee, Scotland; [Sprent, Janet I.] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Young, J. Peter W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Lincoln University - New Zealand; University of Sunderland; Landcare Research - New Zealand; Landcare Research - New Zealand; James Hutton Institute; University of Dundee; University of York - UK	Andrews, M (corresponding author), Lincoln Univ, Fac Agr & Life Sci, Christchurch, New Zealand.	Mitchell.andrews@lincoln.ac.nz	Young, Peter/C-1446-2012; Ridgway, Hayley J/J-6720-2013; James, Euan K/K-1135-2012; Tan, Heng Wee/J-1523-2019; Andrews, Mitchell/R-3874-2018; Weir, Bevan/B-5057-2008; Heenan, Peter/AAS-1048-2021	Young, Peter/0000-0001-5259-4830; Ridgway, Hayley J/0000-0002-0735-7649; James, Euan K/0000-0001-7969-6570; Tan, Heng Wee/0000-0001-5795-2449; Andrews, Mitchell/0000-0002-3875-7290; Weir, Bevan/0000-0003-2580-0701; Heenan, Peter/0000-0001-8229-7466	Brian Mason Scientific and Technical Trust; Lincoln University	Brian Mason Scientific and Technical Trust; Lincoln University	This research was supported by the Brian Mason Scientific and Technical Trust and a Lincoln University Doctoral Scholarship (HWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampomah OY, 2011, APPL ENVIRON MICROB, V77, P5513, DOI 10.1128/AEM.00622-11; Andrews M, 2009, ANN APPL BIOL, V155, P1, DOI 10.1111/j.1744-7348.2009.00338.x; Andrews M, 2011, PLANT ECOL DIVERS, V4, P131, DOI 10.1080/17550874.2011.644343; CHEN WX, 1991, INT J SYST BACTERIOL, V41, P275, DOI 10.1099/00207713-41-2-275; CONNOR HE, 1987, NEW ZEAL J BOT, V25, P115, DOI 10.1080/0028825X.1987.10409961; Cummings SP, 2009, ENVIRON MICROBIOL, V11, P2510, DOI 10.1111/j.1462-2920.2009.01975.x; Gu CT, 2007, ARCH MICROBIOL, V188, P355, DOI 10.1007/s00203-007-0256-3; Haukka K, 1998, APPL ENVIRON MICROB, V64, P419; Heenan PB, 2000, NEW ZEAL J BOT, V38, P361; Heenan PB, 2004, BOT J LINN SOC, V146, P439, DOI 10.1111/j.1095-8339.2004.00348.x; Heenan PB, 1998, NEW ZEAL J BOT, V36, P21; Heenan PB, 1998, NEW ZEAL J BOT, V36, P41; Jarvis BDW, 1997, INT J SYST BACTERIOL, V47, P895, DOI 10.1099/00207713-47-3-895; Kobayashi H., 2008, V7, P117; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; Landis CA, 2008, GEOL MAG, V145, P173, DOI 10.1017/S0016756807004268; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lewis G, 2005, LEGUMES WORLD; McGlone MS, 2001, J BIOGEOGR, V28, P199, DOI 10.1046/j.1365-2699.2001.00525.x; POLE M, 1994, J BIOGEOGR, V21, P625, DOI 10.2307/2846036; Poly F, 2001, APPL ENVIRON MICROB, V67, P2255, DOI 10.1128/AEM.67.5.2255-2262.2001; Rogel MA, 2011, SYST APPL MICROBIOL, V34, P96, DOI 10.1016/j.syapm.2010.11.015; SPRENT JI, 2009, LEGUME NODULATION A; Stevens G, 1988, PREHISTORIC NEW ZEAL; Stevens GR, 1985, LANDS IN COLLISION D; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang C. K. C., 2009, Aspects of Applied Biology, P203; Turner SL, 2002, MICROBIOL-SGM, V148, P3330, DOI 10.1099/00221287-148-11-3330; Turner SL, 2000, MOL BIOL EVOL, V17, P309, DOI 10.1093/oxfordjournals.molbev.a026311; Vincent JM, 1970, IBP HDB; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Wagstaff SJ, 1999, AM J BOT, V86, P1346, DOI 10.2307/2656781; Wang H, 2009, PLANT SOIL, V314, P169, DOI 10.1007/s11104-008-9716-z; Weir B., 2006, THESIS; Weir BS, 2004, APPL ENVIRON MICROB, V70, P5980, DOI 10.1128/AEM.70.10.5980-5987.2004; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Young JM, 2004, FEMS MICROBIOL LETT, V238, P125, DOI 10.1016/j.femsle.2004.07.026; Zhang XX, 2000, APPL ENVIRON MICROB, V66, P2988, DOI 10.1128/AEM.66.7.2988-2995.2000	39	17	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47677	10.1371/journal.pone.0047677	http://dx.doi.org/10.1371/journal.pone.0047677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118889	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500032
J	Tourigny, A; Charbonneau, F; Xing, P; Boukrab, R; Rousseau, G; St-Arnaud, R; Brezniceanu, ML				Tourigny, Alexandre; Charbonneau, Fredrick; Xing, Paul; Boukrab, Rania; Rousseau, Guy; St-Arnaud, Rene; Brezniceanu, Marie-Luise			CYP24A1 Exacerbated Activity during Diabetes Contributes to Kidney Tubular Apoptosis via Caspase-3 Increased Expression and Activation	PLOS ONE			English	Article							VITAMIN-D METABOLISM; INSULIN SENSITIVITY; RENAL 25-HYDROXYVITAMIN-D-3-1-ALPHA-HYDROXYLASE; CELLULAR SENESCENCE; GENE-EXPRESSION; NEPHROPATHY; MICE; PATHWAYS; OVEREXPRESSION; P16(INK4A)	Decreases in circulating 25, hydroxyl-vitamin D3 (25 OH D3) and 1,25, dihydroxyl-vitamin D3 (1,25 (OH) 2 D3) have been extensively documented in patients with type 2 diabetes. Nevertheless, the molecular reasons behind this drop, and whether it is a cause or an effect of disease progression is still poorly understood. With the skin and the liver, the kidney is one of the most important sites for vitamin D metabolism. Previous studies have also shown that CYP24A1 (an enzyme implicated in vitamin D metabolism), might play an important role in furthering the progression of kidney lesions during diabetic nephropathy. In this study we show a link between CYP24A1 increase and senescence followed by apoptosis induction in the renal proximal tubules of diabetic kidneys. We show that CYP24A1 expression was increased during diabetic nephropathy progression. This increase derived from protein kinase C activation and increased H2O2 cellular production. CYP24A1 increase had a major impact on cellular phenotype, by pushing cells into senescence, and later into apoptosis. Our data suggest that control of CYP24A1 increase during diabetes has a beneficial effect on senescence induction and caspase-3 increased expression. We concluded that diabetes induces an increase in CYP24A1 expression, destabilizing vitamin D metabolism in the renal proximal tubules, leading to cellular instability and apoptosis, and thereby accelerating tubular injury progression during diabetic nephropathy.	[Tourigny, Alexandre; Charbonneau, Fredrick; Xing, Paul; Boukrab, Rania; Rousseau, Guy; Brezniceanu, Marie-Luise] Univ Montreal, Ctr Rech HSCM, Hop Sacre Coeur de Montreal, Montreal, PQ, Canada; [St-Arnaud, Rene] McGill Univ, Shriners Hosp Children, Montreal, PQ, Canada	Universite de Montreal; McGill University	Brezniceanu, ML (corresponding author), Univ Montreal, Ctr Rech HSCM, Hop Sacre Coeur de Montreal, Montreal, PQ, Canada.	m-l.brezniceanu@crshc.rtss.qc.ca			CR-HSCM (Centre de recherche- Hopital Sacre Coeur de Montreal, Montreal, QC, Canada); research center at Sacre Coeur Hospital in Montreal, QC, CA	CR-HSCM (Centre de recherche- Hopital Sacre Coeur de Montreal, Montreal, QC, Canada); research center at Sacre Coeur Hospital in Montreal, QC, CA	The funds for this study were exclusively provided by starting funds from CR-HSCM (Centre de recherche- Hopital Sacre Coeur de Montreal, Montreal, QC, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the research center at Sacre Coeur Hospital in Montreal, QC, CA.	Abdul Rahim N, 2008, MED J MALAYSIA SA, V63, P71; Artandi SE, 2005, BIOCHEM BIOPH RES CO, V331, P881, DOI 10.1016/j.bbrc.2005.03.211; Bagby SP, 2007, KIDNEY INT, V71, P1199, DOI 10.1038/sj.ki.5002286; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Borissova AM, 2003, INT J CLIN PRACT, V57, P258; Brezniceanu ML, 2007, KIDNEY INT, V71, P912, DOI 10.1038/sj.ki.5002188; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Brezniceanu ML, 2010, J AM SOC NEPHROL, V21, P943, DOI 10.1681/ASN.2009030242; DILWORTH FJ, 1995, J BIOL CHEM, V270, P16766, DOI 10.1074/jbc.270.28.16766; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Harley CB, 1997, CANCER SURV, V29, P263; Helvig CF, 2010, KIDNEY INT, V78, P463, DOI 10.1038/ki.2010.168; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Isakova T, 2011, J RENAL NUTR, V21, P295, DOI 10.1053/j.jrn.2010.07.002; Klaus G, 2008, KIDNEY INT, V73, P141, DOI 10.1038/sj.ki.5002693; Kramer H, 2010, J DIABETES COMPLICAT, V24, P368, DOI 10.1016/j.jdiacomp.2009.10.001; Levin A, 2012, J NEPHROL, V25, P204, DOI 10.5301/JN.2011.8429; Li YC, 2008, CURR DIABETES REP, V8, P464, DOI 10.1007/s11892-008-0080-4; Liu F, 2008, J AM SOC NEPHROL, V19, P269, DOI 10.1681/ASN.2007010074; Liu LL, 2010, PEDIATR DIABETES, V11, P4, DOI 10.1111/j.1399-5448.2009.00519.x; Luczynski W, 2011, EUR J PEDIATR, V170, P891, DOI 10.1007/s00431-010-1372-7; Mansilla S, 2006, EUR J PHARMACOL, V540, P34, DOI 10.1016/j.ejphar.2006.04.035; Matsunuma A, 2004, ENDOCRINOLOGY, V145, P1367, DOI 10.1210/en.2003-1010; Matsunuma A, 2007, ARCH BIOCHEM BIOPHYS, V463, P118, DOI 10.1016/j.abb.2007.02.031; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Muindi JR, 2010, ENDOCRINOLOGY, V151, P4301, DOI 10.1210/en.2009-1156; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Posner GH, 2010, J STEROID BIOCHEM, V121, P13, DOI 10.1016/j.jsbmb.2010.03.065; Peralta SR, 2010, MED CLIN-BARCELONA, V135, P720, DOI 10.1016/j.medcli.2009.09.024; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Samikkannu T, 2006, AM J PHYSIOL-RENAL, V291, pF162, DOI 10.1152/ajprenal.00189.2005; SASAKI M, 1994, CANCER RES, V54, P6090; St-Arnaud R, 2010, J STEROID BIOCHEM, V121, P254, DOI 10.1016/j.jsbmb.2010.02.002; Tai K, 2008, NUTRITION, V24, P279, DOI 10.1016/j.nut.2007.11.006; Teegarden D, 2009, NUTR RES REV, V22, P82, DOI 10.1017/S0954422409389301; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008; Wang Y, 2006, KIDNEY INT, V70, P882, DOI 10.1038/sj.ki.5001624; Whitmore Catherine, 2010, Br J Nurs, V19, P882; Wu J, 2010, AM J PATHOL, V176, P2163, DOI 10.2353/ajpath.2010.090386; Young James B, 2010, Methodist Debakey Cardiovasc J, V6, P20; Zhang Y, 2010, J AM SOC NEPHROL, V21, P966, DOI 10.1681/ASN.2009080872	42	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48652	10.1371/journal.pone.0048652	http://dx.doi.org/10.1371/journal.pone.0048652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119081	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500189
J	Zhang, L; Gao, GH; Li, XF; Ren, SX; Li, AW; Xu, JF; Zhang, J; Zhou, CC				Zhang, Ling; Gao, Guanghui; Li, Xuefei; Ren, Shengxiang; Li, Aiwu; Xu, Jianfang; Zhang, Jie; Zhou, Caicun			Association between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated with Chemotherapy	PLOS ONE			English	Article							CHINESE POPULATION; EXCISION-REPAIR; PHASE-III; CISPLATIN; RISK; PLATINUM; GENES; XPD; GEMCITABINE; EFFICACY	New therapeutic approaches are being developed based on the findings that several genetic abnormalities underlying non-small-cell lung cancer (NSCLC) could influence chemosensitivity. In this study, we assessed whether polymorphisms in genes of nucleotide excision repair (NER) pathway, including ERCC5, ERCC6, MMS19L, CCNH, XPC, RRM1, can affect the tolerability of platinum-based chemotherapy in NSCLC patients. We used AllGloTM probe to assess genotyping and polymorphisms in 388 stage IIIB and IV NSCLC patients treated with platinum-based chemotherapy. MMS19L might be associated with the adverse events of chemotherapy in NSCLC, especially for all grade leucopenia (P=0.020), all grade jaundice (P=0.037) and all grade creatinine increasing (P=0.013). In terms of grade 3/4 adverse events, MMS19L was related with total grade 3/4 adverse events (P=0.024) and grade 3/4 thrombocytopenia (P=0.035), while RRM1 was related with total grade 3/4 adverse events (P=0.047) and grade 3/4 vomiting (P=0.046). ERCC5 was related with more infection (P=0.017). We found that some SNPs in NER pathway genes were correlated with toxicity treated with double chemotherapy in advanced NSCLC patients, especially for SNPs of MMS19L, RRM1 and ERCC5.	[Zhang, Ling; Gao, Guanghui; Li, Xuefei; Ren, Shengxiang; Li, Aiwu; Xu, Jianfang; Zhang, Jie; Zhou, Caicun] Tongji Univ, Inst Canc, Sch Med, Dept Oncol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China	Tongji University	Zhou, CC (corresponding author), Tongji Univ, Inst Canc, Sch Med, Dept Oncol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China.	caicunzhou@yahoo.com.cn			Shanghai Science and Technology Committee [06DZ19502]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	The study was supported by study funding from Shanghai Science and Technology Committee (Grant No. 06DZ19502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bernig T, 2006, EXPERT REV MOL DIAGN, V6, P319, DOI 10.1586/14737159.6.3.319; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Chen SJ, 2010, INT J HYG ENVIR HEAL, V213, P140, DOI 10.1016/j.ijheh.2010.01.004; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Giachino DF, 2007, CLIN CANCER RES, V13, P2876, DOI 10.1158/1078-0432.CCR-06-2543; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Hatfield MD, 2006, DNA REPAIR, V5, P914, DOI 10.1016/j.dnarep.2006.05.007; Kweekel DM, 2009, BRIT J CANCER, V101, P357, DOI 10.1038/sj.bjc.6605134; Lheureux S, 2011, ANTI-CANCER DRUG, V22, P919, DOI 10.1097/CAD.0b013e328349d7f1; Lin ZN, 2008, HUM MUTAT, V29, P113, DOI 10.1002/humu.20610; Melis JPM, 2011, MUTAT RES-REV MUTAT, V728, P107, DOI 10.1016/j.mrrev.2011.07.001; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273; Sakano S, 2010, PHARMACOGENOMICS, V11, P1377, DOI [10.2217/pgs.10.106, 10.2217/PGS.10.106]; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Suk R, 2005, CLIN CANCER RES, V11, P1534, DOI 10.1158/1078-0432.CCR-04-1953; van de Vaart PJM, 2000, INT J CANCER, V89, P160, DOI 10.1002/(SICI)1097-0215(20000320)89:2<160::AID-IJC10>3.0.CO;2-J; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; Wang ZH, 2008, LUNG CANCER, V62, P99, DOI 10.1016/j.lungcan.2008.02.019; Wu WT, 2009, CLIN CANCER RES, V15, P3889, DOI 10.1158/1078-0432.CCR-08-2715; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	27	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48350	10.1371/journal.pone.0048350	http://dx.doi.org/10.1371/journal.pone.0048350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118991	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500110
J	Aivar, P; Fernandez-Orth, J; Gomis-Perez, C; Alberdi, A; Alaimo, A; Rodriguez, MS; Giraldez, T; Miranda, P; Areso, P; Villarroel, A				Aivar, Paloma; Fernandez-Orth, Juncal; Gomis-Perez, Carolina; Alberdi, Araitz; Alaimo, Alessandro; Rodriguez, Manuel S.; Giraldez, Teresa; Miranda, Pablo; Areso, Pilar; Villarroel, Alvaro			Surface Expression and Subunit Specific Control of Steady Protein Levels by the Kv7.2 Helix A-B Linker	PLOS ONE			English	Article							PEST SEQUENCES; C-TERMINUS; POTASSIUM; CALMODULIN; KCNQ2; CHANNELS; PEPTIDES; KCNQ2/KCNQ3; TRAFFICKING; BIRTH	Kv7.2 and Kv7.3 are the main components of the neuronal voltage-dependent M-current, which is a subthreshold potassium conductance that exerts an important control on neuronal excitability. Despite their predominantly intracellular distribution, these channels must reach the plasma membrane in order to control neuronal activity. Thus, we analyzed the amino acid sequence of Kv7.2 to identify intrinsic signals that may control its surface expression. Removal of the interlinker connecting helix A and helix B of the intracellular C-terminus produces a large increase in the number of functional channels at the plasma membrane. Moreover, elimination of this linker increased the steady-state amount of protein, which was not associated with a decrease of protein degradation. The magnitude of this increase was inversely correlated with the number of helix A - helix B linkers present in the tetrameric channel assemblies. In contrast to the remarkable effect on the amount of Kv7.2 protein, removal of the Kv7.2 linker had no detectable impact on the steady-state levels of Kv7.3 protein.	[Aivar, Paloma; Fernandez-Orth, Juncal; Gomis-Perez, Carolina; Alberdi, Araitz; Alaimo, Alessandro; Villarroel, Alvaro] Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, Leioa, Spain; [Areso, Pilar] Univ Basque Country, Dept Farmacol, UPV EHU, Leioa, Spain; [Rodriguez, Manuel S.] CIC BioGUNE CIBERehd, Prote Unit, Derio, Spain; [Giraldez, Teresa; Miranda, Pablo] Hosp Univ Ntra Sra Candelaria, Unidad Invest, Santa Cruz De Tenerife, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE	Villarroel, A (corresponding author), Univ Basque Country, UPV EHU, CSIC, Unidad Biofis, Barrio Sarriena S-N, Leioa, Spain.	alvaro.villarroel@csic.es	Gomis-Perez, Carolina/J-6472-2012; Giraldez, Teresa/G-8970-2015; Alaimo, Alessandro/C-6334-2016; Villarroel, Alvaro/H-5580-2015; Fernandez, Pablo Miranda/V-8388-2017; Arco, Mariangeles/C-6181-2016	Gomis-Perez, Carolina/0000-0002-6818-4403; Giraldez, Teresa/0000-0002-4096-810X; Alaimo, Alessandro/0000-0002-5888-6268; Fernandez, Pablo Miranda/0000-0003-2853-148X; Arco, Mariangeles/0000-0002-0993-7460	VII European framework program; Fondo de Investigaciones Sanitarias [PI071316]; Spanish Ministry of Education [BFU2009-07581, SAF2006-1450]; Spanish Ion Channel Initiative Consolider project [CSD2008-00005]; Basque Government [SAIOTEK SA-2006/00023]; Fundacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation [BES-2008-002314]	VII European framework program; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Spanish Ministry of Education(Spanish Government); Spanish Ion Channel Initiative Consolider project; Basque Government(Basque Government); Fundacion Biofisica Bizkaia; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants from the VII European framework program managed by the Fondo de Investigaciones Sanitarias (PI071316), from the Spanish Ministry of Education (BFU2009-07581 and SAF2006-1450), the Spanish Ion Channel Initiative Consolider project (CSD2008-00005), and the Basque Government (SAIOTEK SA-2006/00023). A. Alaimo was partially funded by Fundacion Biofisica Bizkaia. PA and JFO held a FPI fellowship from the Spanish Ministry of Science and Innovation (BES-2008-002314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; BARNES JA, 1995, MOL CELL BIOCHEM, V149, P17, DOI 10.1007/BF01076559; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Gomez-Posada JC, 2010, J NEUROSCI, V30, P9316, DOI 10.1523/JNEUROSCI.0851-10.2010; Cruz-Vera LR, 2011, CURR OPIN MICROBIOL, V14, P160, DOI 10.1016/j.mib.2011.01.011; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Fahraeus R, 2005, NAT REV MOL CELL BIO, V6, P263, DOI 10.1038/nrm1590; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Gomez-Posada JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025508; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Heusser K, 2005, CURR OPIN NEUROBIOL, V15, P364, DOI 10.1016/j.conb.2005.04.001; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Maljevic S, 2010, PFLUG ARCH EUR J PHY, V460, P277, DOI 10.1007/s00424-010-0831-3; Mikosch M, 2009, CURR OPIN PLANT BIOL, V12, P685, DOI 10.1016/j.pbi.2009.09.020; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Prole DL, 2004, BIOPHYS J, V86, P1454, DOI 10.1016/S0006-3495(04)74214-9; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Soldovieri MV, 2006, J BIOL CHEM, V281, P418, DOI 10.1074/jbc.M510980200; Stewart AP, 2012, J BIOL CHEM, V287, P11870, DOI 10.1074/jbc.M111.336511; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200	40	15	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47263	10.1371/journal.pone.0047263	http://dx.doi.org/10.1371/journal.pone.0047263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115641	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200032
J	Brokamp, C; Todd, J; Montemagno, C; Wendell, D				Brokamp, Cole; Todd, Jacob; Montemagno, Carlo; Wendell, David			Electrophysiology of Single and Aggregate Cx43 Hemichannels	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; CONNEXIN HEMICHANNELS; VOLTAGE-DEPENDENCE; ZONULA OCCLUDENS-1; LINDANE; PH; PHOSPHORYLATION; COMMUNICATION; PERMEABILITY; CONDUCTANCE	Connexin43 (Cx43) is the most ubiquitous gap junction protein in the human body and is essential for cell-to-cell communication in a variety of organs and organ systems. As a result, Cx43 is responsible for mediating both electrical and chemical signals, passing dissolved solutes and small signaling molecules between cells in a coordinated fashion. Here, we explore the electrophysiological properties of hemichannels formed from Cx43 and Cx43 fused to eGFP (Cx43eGFP) and their interactions in a planar lipid membrane (BLM). Unlike in vivo patch clamp experiments, Cx43 was purified and isolated from other membrane constituents allowing elucidation of individual protein responses to various electrical and chemical stimuli. Using this system, we examined hemichannel electrophysiology and the roles of several well-known gap junction blockers, namely: lanthanum, heptanol, carbenoxalone and lindane. We also observed a critical number of hemichannels required for an accelerated conductance increase, an emergent electrical signature indicative of plaque formation.	[Brokamp, Cole; Todd, Jacob; Montemagno, Carlo; Wendell, David] Univ Cincinnati, Engn Res Ctr, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA	University of Cincinnati	Wendell, D (corresponding author), Univ Cincinnati, Engn Res Ctr, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA.	montemcd@uc.edu; wendeldw@uc.edu		Brokamp, Cole/0000-0002-0289-3151	University of Cincinnati	University of Cincinnati	This work was sponsored by internal funds from the University of Cincinnati. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Becker DL, 1998, CELL BIOL INT, V22, P527, DOI 10.1006/cbir.1998.0295; BENNETT MVL, 1994, NATURE, V368, P18, DOI 10.1038/368018a0; Bevans CG, 1999, J BIOL CHEM, V274, P3711, DOI 10.1074/jbc.274.6.3711; Beyer EC, 2002, CURR DRUG TARGETS, V3, P409, DOI 10.2174/1389450023347245; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Bukauskas FF, 2002, J GEN PHYSIOL, V119, P171, DOI 10.1085/jgp.119.2.171; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; Carnarius C, 2012, J BIOL CHEM, V287, P2877, DOI 10.1074/jbc.M111.319871; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Contreras JE, 2003, CELL COMMUN ADHES, V10, P245, DOI 10.1080/15419060390262976; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Cottrell GT, 2005, BBA-BIOMEMBRANES, V1711, P126, DOI 10.1016/j.bbamem.2004.11.013; DAHL G, 1992, BIOPHYS J, V62, P172, DOI 10.1016/S0006-3495(92)81803-9; Dalsenter PR, 1996, HUM EXP TOXICOL, V15, P406, DOI 10.1177/096032719601500508; De Vuyst E, 2007, MOL BIOL CELL, V18, P34, DOI 10.1091/mbc.E06-03-0182; Defamie N, 2001, CARCINOGENESIS, V22, P1537, DOI 10.1093/carcin/22.9.1537; Delmar M, 2004, CARDIOVASC RES, V62, P268, DOI 10.1016/j.cardiores.2003.12.030; EkVitorin JF, 1996, BIOPHYS J, V71, P1273, DOI 10.1016/S0006-3495(96)79328-1; Garcia-Dorado D, 2004, CARDIOVASC RES, V61, P386, DOI 10.1016/j.cardiores.2003.11.039; Gassmann O, 2009, J STRUCT BIOL, V168, P168, DOI 10.1016/j.jsb.2009.02.004; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; GUAN XJ, 1995, TOXICOL APPL PHARM, V130, P79, DOI 10.1006/taap.1995.1011; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HAUSER H, 1975, EUR J BIOCHEM, V58, P133, DOI 10.1111/j.1432-1033.1975.tb02357.x; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Komukai K, 2002, AM J PHYSIOL-HEART C, V283, pH715, DOI 10.1152/ajpheart.01000.2001; Li GH, 2002, CARDIOVASC PATHOL, V11, P158, DOI 10.1016/S1054-8807(02)00102-3; LINDENAU A, 1994, HUM REPROD, V9, P772, DOI 10.1093/oxfordjournals.humrep.a138595; MAZET JL, 1992, EUR J BIOCHEM, V210, P249, DOI 10.1111/j.1432-1033.1992.tb17415.x; Moreno AP, 2002, CIRC RES, V90, P450, DOI 10.1161/hh0402.105667; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Owens LM, 1996, CIRCULATION, V94, P10, DOI 10.1161/01.CIR.94.1.10; RUBIN JB, 1992, P NATL ACAD SCI USA, V89, P3820, DOI 10.1073/pnas.89.9.3820; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Song MB, 2009, EXP BIOL MED, V234, P1192, DOI 10.3181/0902-RM-80; Spray DC, 2002, CURR DRUG TARGETS, V3, P455, DOI 10.2174/1389450023347353; SZYMCZYNSKI GA, 1983, ANDROLOGIA, V15, P696; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; WHITE TW, 1994, NATURE, V371, P208, DOI 10.1038/371208a0; Ye ZC, 2009, GLIA, V57, P258, DOI 10.1002/glia.20754; Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200	43	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47775	10.1371/journal.pone.0047775	http://dx.doi.org/10.1371/journal.pone.0047775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112846	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200080
J	Engel, N; Lisec, J; Piechulla, B; Nebe, B				Engel, Nadja; Lisec, Jan; Piechulla, Birgit; Nebe, Barbara			Metabolic Profiling Reveals Sphingosine-1-Phosphate Kinase 2 and Lyase as Key Targets of (Phyto-) Estrogen Action in the Breast Cancer Cell Line MCF-7 and Not in MCF-12A	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE; PHYTOESTROGEN EXTRACTS; MICROGRAM QUANTITIES; IN-VITRO; GENISTEIN; GROWTH; EXPRESSION; PATHWAYS; ADHESION	To search for new targets of anticancer therapies using phytoestrogens we performed comparative metabolic profiling of the breast cancer cell line MCF-7 and the non-tumorigenic breast cell line MCF-12A. Application of gas chromatographymass spectrometry (GC-MS) revealed significant differences in the metabolic levels after exposure with 17 beta-estradiol, genistein or a composition of phytoestrogens within a native root flax extract. We observed the metabolites 3-(4-hydroxyphenyl)- lactic acid, cis-aconitic acid, 11-beta-hydroxy-progesterone, chenodeoxycholic acid and triacontanoic acid with elevated levels due to estrogen action. Particularly highlighted were metabolites of the sphingolipid metabolism. Sphingosine and its dihydro derivate as well as ethanolaminephosphate were significantly altered after exposure with 1 nM 17 beta-estradiol in the cell line MCF-7, while MCF-12A was not affected. Treatment with genistein and the flax extract normalized the sphingosine concentrations to the basic levels found in MCF-12A cells. We could further demonstrate that the expression levels of the sphingosine metabolizing enzymes: sphingosine-1-phosphate kinase (Sphk) and lyase (S1P lyase) were significantly influenced by estrogens as well as phytoestrogens. The isoform Sphk2 was overexpressed in the tumorigenic cell line MCF-7, while S1P lyase was predominantly expressed in the non-tumorigenic cell line MCF-12A. Importantly, in MCF-7 the weak S1P lyase expression could be significantly increased after exposure with 10 mu M genistein and 1 mu g/ml root flax extract. Here, we present, for the first time, an analysis of metabolic response of phytoestrogens to breast cancer cell lines. The contrasting regulation of sphingolipid enzymes in MCF-7 and MCF-12A render them as preferred targets for future anticancer strategies.	[Engel, Nadja; Nebe, Barbara] Univ Rostock, Dept Cell Biol, Rostock, Germany; [Lisec, Jan] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Piechulla, Birgit] Univ Rostock, Dept Biochem, Rostock, Germany	University of Rostock; Max Planck Society; University of Rostock	Engel, N (corresponding author), Univ Rostock, Dept Cell Biol, Rostock, Germany.	nadja.engel-lutz@uni-rostock.de	Nebe, Barbara -/C-3577-2015	Nebe, Barbara -/0000-0003-2662-0905; Lisec, Jan/0000-0003-1220-2286; Engel, Nadja/0000-0002-6362-9282	Deutsche Krebshilfe Mildred-Scheel [FKZ: 107820]; University of Rostock under the program of the Federal Ministry for Education and Research (BMBF)	Deutsche Krebshilfe Mildred-Scheel; University of Rostock under the program of the Federal Ministry for Education and Research (BMBF)	The authors greatly appreciate the financial support from the Deutsche Krebshilfe Mildred-Scheel (FKZ: 107820; www.krebshilfe.de/dr-mildred-scheel-stiftung.html) and University of Rostock (habilitation scholarship under the program of the Federal Ministry for Education and Research (BMBF)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarzua S, 2007, ANTICANCER RES, V27, P2053; Abarzua S, 2010, ANTICANCER RES, V30, P1587; Allred CD, 2001, CANCER RES, V61, P5045; Borgan E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-628; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; de Lemos ML, 2001, ANN PHARMACOTHER, V35, P1118, DOI 10.1345/aph.10257; Engel N, 2011, J ETHNOPHARMACOL, V137, P1003, DOI 10.1016/j.jep.2011.07.023; Ferreira AK, 2011, J CANC SCI THER, V3, P053; Hilakivi-Clarke L, 2002, J STEROID BIOCHEM, V80, P163, DOI 10.1016/S0960-0760(01)00184-4; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lisec J, 2011, PLANT J, V68, P326, DOI 10.1111/j.1365-313X.2011.04689.x; Long JS, 2010, MOL CELL BIOL, V30, P3827, DOI 10.1128/MCB.01133-09; Low YL, 2005, CANCER EPIDEM BIOMAR, V14, P213; MARKIEWICZ L, 1993, J STEROID BIOCHEM, V45, P399, DOI 10.1016/0960-0760(93)90009-L; MEYER TS, 1965, BIOCHIM BIOPHYS ACTA, V107, P144, DOI 10.1016/0304-4165(65)90403-4; Nebe B, 2006, EUR J CANCER PREV, V15, P405, DOI 10.1097/00008469-200610000-00005; PAGLIACCI MC, 1994, EUR J CANCER, V30A, P1675, DOI 10.1016/0959-8049(94)00262-4; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 2011, CANCER RES, V71, P6576, DOI 10.1158/0008-5472.CAN-11-2364; Rebl H, 2010, INT J ARTIF ORGANS, V33, P738; Satih S, 2010, OMICS, V14, P231, DOI 10.1089/omi.2009.0124; Schramm G, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-39; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Thedinga E, 2007, TOXICOL APPL PHARM, V220, P33, DOI 10.1016/j.taap.2006.12.027; Wang CF, 1997, NUTR CANCER, V28, P236, DOI 10.1080/01635589709514582; Wang TTY, 1996, CARCINOGENESIS, V17, P271, DOI 10.1093/carcin/17.2.271; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498	32	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47833	10.1371/journal.pone.0047833	http://dx.doi.org/10.1371/journal.pone.0047833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112854	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200089
J	Muller, MS; Roelofs, Y; Erikstad, KE; Groothuis, TGG				Muller, Martina S.; Roelofs, Yvonne; Erikstad, Kjell Einar; Groothuis, Ton G. G.			Maternal Androgens Increase Sibling Aggression, Dominance, and Competitive Ability in the Siblicidal Black-Legged Kittiwake (Rissa tridactyla)	PLOS ONE			English	Article							GULL LARUS-MICHAHELLIS; YOLK ANDROGENS; BEGGING BEHAVIOR; EASTERN BLUEBIRDS; ADOPTION; EGGS; TESTOSTERONE; CHICKS; REPRODUCTION; RECOGNITION	Animals and plants routinely produce more offspring than they can afford to rear. Mothers can favour certain young by conferring on them competitive advantages such as a leading position in the birth sequence, more resources or hormones. Avian mothers create hatching asynchrony within a clutch and at the same time bestow the eggs with different concentrations of androgens that may enhance or counteract the competitive advantage experienced by early-hatching "core'' young. In siblicidal birds, core young assume a dominant social position in the nest due to their size advantage and when threatened with starvation fatally attack subdominant later-hatching "marginal'' young. A role for maternal androgens in siblicidal aggression has frequently been suggested but never tested. We studied this in the facultatively siblicidal black-headed kittiwake. We found that marginal eggs contain higher instead of lower concentrations of androgens than core eggs. Surprisingly, exposure to experimentally elevated yolk androgens increased sibling aggression and dominance, even though in nature marginal eggs never produce dominant chicks. We propose the "adoption facilitation hypothesis'' to explain this paradox. This cliff-nesting colonial species has a high adoption rate: ejected marginal kittiwake chicks frequently fall into other nests containing chicks of similar or smaller size and exposure to yolk androgens might help them integrate themselves into a foster nest.	[Muller, Martina S.; Roelofs, Yvonne; Groothuis, Ton G. G.] Univ Groningen, Ctr Behav Neurosci, Groningen, Netherlands; [Erikstad, Kjell Einar] Norwegian Inst Nat, Dept Arctic Ecol, Tromso, Norway	University of Groningen; Norwegian Institute Nature Research	Muller, MS (corresponding author), Univ Groningen, Ctr Behav Neurosci, Groningen, Netherlands.	martina.muller9@gmail.com						Bates D., 2011, PACKAGE LME4 LINEAR, V1; BENGTSSON H, 1983, BEHAV ECOL SOCIOBIOL, V12, P243, DOI 10.1007/BF00290777; Boncoraglio G, 2006, HORM BEHAV, V50, P442, DOI 10.1016/j.yhbeh.2006.05.005; BRAUN BM, 1983, AUK, V100, P469, DOI 10.1093/auk/100.2.469; BROWN KM, 1995, ANIM BEHAV, V49, P321, DOI 10.1006/anbe.1995.0045; Bukacinski D, 2000, ANIM BEHAV, V59, P289, DOI 10.1006/anbe.1999.1298; Cullen E., 1957, Ibis, V99, P275, DOI 10.1111/j.1474-919X.1957.tb01950.x; Dentressangle F, 2008, BEHAV ECOL SOCIOBIOL, V62, P1899, DOI 10.1007/s00265-008-0620-6; Drummond H, 2006, Q REV BIOL, V81, P3, DOI 10.1086/503922; Drummond H, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P337, DOI 10.1007/0-306-47660-6_18; Drummond H, 2008, J AVIAN BIOL, V39, P139, DOI 10.1111/j.0908-8857.2008.04365.x; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Fitzgerald Gerard J., 1992, P238; Forbes S, 2007, AUK, V124, P1, DOI 10.1642/0004-8038(2007)124[1:SSINB]2.0.CO;2; French JB, 2001, COMP BIOCHEM PHYS C, V128, P91, DOI 10.1016/S1532-0456(00)00181-2; GANESHAIAH KN, 1988, OECOLOGIA, V77, P135, DOI 10.1007/BF00380936; Gasparini J, 2007, J EVOLUTION BIOL, V20, P874, DOI 10.1111/j.1420-9101.2007.01315.x; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Glassey B, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P269, DOI 10.1007/0-306-47660-6_14; GRAVES JA, 1980, J ANIM BREED GENET, V54, P267; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hahn DC, 2011, GEN COMP ENDOCR, V172, P423, DOI 10.1016/j.ygcen.2011.04.001; Hatch S. A., 2009, BIRDS N AM ONLINE; Helfenstein F, 2004, CONDOR, V106, P149, DOI 10.1650/7337; Kalmbach E, 2005, BEHAVIOUR, V142, P1515, DOI 10.1163/156853905774831909; Kilner RM, 2004, SCIENCE, V305, P877, DOI 10.1126/science.1098487; Kilner RM, 1999, NATURE, V397, P667, DOI 10.1038/17746; Lack D., 1954, P343; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lengyel S, 1998, AUK, V115, P490, DOI 10.2307/4089211; Leonard ML, 2001, BEHAV ECOL SOCIOBIOL, V49, P170, DOI 10.1007/s002650000290; Leonard ML, 2003, BEHAV ECOL SOCIOBIOL, V4, P561; Ligon RA, 2009, WILSON J ORNITHOL, V121, P830, DOI 10.1676/08-158.1; MAGRATH RD, 1990, BIOL REV, V65, P587, DOI 10.1111/j.1469-185X.1990.tb01239.x; MAINDONALD J, 2010, DATA ANAL GRAPHICS U; Mock D. W., 1997, EVOLUTION SIBLING RI; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Mock DW, 1998, ANIM BEHAV, V56, P1, DOI 10.1006/anbe.1998.0842; Mock DW, 1984, INFANTICIDE COMP EVO, P3; Morris R.D., 1988, P1254; Muller MS, AM NAT IN PRESS; MULLER RE, 1978, AUK, V95, P485; Muller W, 2010, BEHAV ECOL, V21, P493, DOI 10.1093/beheco/arq010; Muller W, 2009, BIOL LETTERS, V5, P586, DOI 10.1098/rsbl.2009.0283; Navara KJ, 2006, FUNCT ECOL, V20, P449, DOI 10.1111/j.1365-2435.2006.01114.x; OGARA BW, 1969, AM J ANAT, V125, P217, DOI 10.1002/aja.1001250206; Oro D, 1999, CAN J ZOOL, V77, P433, DOI 10.1139/cjz-77-3-433; Penteriani V, 2008, IBIS, V150, P816, DOI 10.1111/j.1474-919X.2008.00831.x; PIEROTTI R, 1987, ANIM BEHAV, V35, P435, DOI 10.1016/S0003-3472(87)80268-3; Pilz KM, 2004, HORM BEHAV, V46, P179, DOI 10.1016/j.yhbeh.2004.03.004; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; PLISSNER JH, 1988, AUK, V105, P575, DOI 10.1093/auk/105.3.575; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROBERTS BD, 1994, WILSON BULL, V106, P289; Rubolini D, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-24; SAINO N, 1994, ETHOLOGY, V97, P294; SCHNEIDER JE, 1991, PHYSIOL BEHAV, V49, P135, DOI 10.1016/0031-9384(91)90244-I; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; SHEADER M, 1983, J MAR BIOL ASSOC UK, V63, P517, DOI 10.1017/S0025315400070855; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; STOREY AE, 1992, BEHAVIOUR, V120, P302, DOI 10.1163/156853992X00651; Vallarino A, 2008, THESIS U GLASGOW SCO; Vallarino A, 2012, J ORNITHOL, V153, P513, DOI 10.1007/s10336-011-0772-4; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; von Engelhardt N, 2006, P ROY SOC B-BIOL SCI, V273, P65, DOI 10.1098/rspb.2005.3274; von Engelhardt N, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 4: BIRDS, P91; White J, 2010, ANIM BEHAV, V79, P1095, DOI 10.1016/j.anbehav.2010.02.003; Williams G. C., 1966, P307; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461	73	22	22	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47763	10.1371/journal.pone.0047763	http://dx.doi.org/10.1371/journal.pone.0047763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112843	Green Published, gold			2022-12-25	WOS:000310310200077
J	Panigrahi, SK; Vasileva, A; Wolgemuth, DJ				Panigrahi, Sunil K.; Vasileva, Ana; Wolgemuth, Debra J.			Sp1 Transcription Factor and GATA1 cis-Acting Elements Modulate Testis-Specific Expression of Mouse Cyclin A1	PLOS ONE			English	Article							MALE GERM-LINE; RAT LEYDIG-CELLS; HISTONE H1T GENE; DNA-METHYLATION; DEPENDENT KINASES; CERVICAL-CANCER; DOWN-REGULATION; PROMOTER; DIFFERENTIATION; SPERMATOGENESIS	Cyclin A1 is a male germ cell-specific cell cycle regulator that is essential for spermatogenesis. It is unique among the cyclins by virtue of its highly restricted expression in vivo, being present in pachytene and diplotene spermatocytes and not in earlier or later stages of spermatogenesis. To begin to understand the molecular mechanisms responsible for this narrow window of expression of the mouse cyclin A1 (Ccna1) gene, we carried out a detailed analysis of its promoter. We defined a 170-bp region within the promoter and showed that it is involved in repression of Ccna1 in cultured cells. Within this region we identified known cis-acting transcription factor binding sequences, including an Sp1-binding site and two GATA1-binding sites. Neither Sp1 nor GATA1 is expressed in pachytene spermatocytes and later stages of germ cell differentiation. Sp1 is readily detected at earlier stages of spermatogenesis. Site-directed mutagenesis demonstrated that neither factor alone was sufficient to significantly repress expression driven by the Ccna1 promoter, while concurrent binding of Sp1, and most likely GATA1 and possibly additional factors was inhibitory. Occupancy of Sp1 on the Ccna1 promoter and influence of GATA1-dependent cis-acting elements was confirmed by ChIP analysis in cell lines and most importantly, in spermatogonia. In contrast with many other testis-specific genes, the CpG island methylation status of the Ccna1 promoter was similar among various tissues examined, irrespective of whether Ccna1 was transcriptionally active, suggesting that this regulatory mechanism is not involved in the restricted expression of Ccna1.	[Panigrahi, Sunil K.; Vasileva, Ana; Wolgemuth, Debra J.] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA; [Vasileva, Ana] Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA; [Wolgemuth, Debra J.] Columbia Univ, Dept Obstet & Gynecol, Med Ctr, New York, NY USA; [Wolgemuth, Debra J.] Columbia Univ, Inst Human Nutr, Med Ctr, New York, NY 10032 USA; [Wolgemuth, Debra J.] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Wolgemuth, DJ (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA.	djw3@columbia.edu	cheng, yong/I-4270-2012	Panigrahi, Sunil/0000-0002-0933-2218	NIH [HD034915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034915] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by a grant from the NIH, HD034915, to DJW. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bonny C, 1998, BIOL REPROD, V58, P754, DOI 10.1095/biolreprod58.3.754; Brower JV, 2009, BBA-GENE REGUL MECH, V1789, P198, DOI 10.1016/j.bbagrm.2008.12.005; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Choi SJ, 2003, BLOOD, V101, P3778, DOI 10.1182/blood-2002-08-2641; Clare SE, 1997, J BIOL CHEM, V272, P33028, DOI 10.1074/jbc.272.52.33028; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Gao HB, 1997, ENDOCRINOLOGY, V138, P156, DOI 10.1210/en.138.1.156; Ge RS, 1997, ENDOCRINOLOGY, V138, P3719, DOI 10.1210/en.138.9.3719; GEBARA MM, 1992, MOL CELL BIOL, V12, P1422, DOI 10.1128/MCB.12.4.1422; GRABAREK Z, 1990, NATURE, V345, P132, DOI 10.1038/345132a0; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hoivik EA, 2008, ENDOCRINOLOGY, V149, P5599, DOI 10.1210/en.2008-0104; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; IANNELLO RC, 1993, J BIOL CHEM, V268, P22581; Joshi AR, 2009, BIOCHEM BIOPH RES CO, V378, P595, DOI 10.1016/j.bbrc.2008.11.077; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Ketola I, 2002, EUR J ENDOCRINOL, V147, P397, DOI 10.1530/eje.0.1470397; Kitkumthorn N, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-55; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Kumar AP, 1997, NUCLEIC ACIDS RES, V25, P2012, DOI 10.1093/nar/25.10.2012; Lele KA, 2004, BIOL REPROD, V71, P1340, DOI 10.1095/biolreprod.104.030387; Liao C, 2004, INT J CANCER, V108, P654, DOI 10.1002/ijc.11573; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Lopez-Soto A, 2009, ONCOGENE, V28, P2370, DOI 10.1038/onc.2009.117; Ma WL, 2008, BIOL REPROD, V79, P289, DOI 10.1095/biolreprod.107.067082; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Muir T, 2005, MOL ENDOCRINOL, V19, P2164, DOI 10.1210/me.2004-0473; Muller C, 1999, J BIOL CHEM, V274, P11220, DOI 10.1074/jbc.274.16.11220; Muller C, 2000, MOL CELL BIOL, V20, P3316, DOI 10.1128/MCB.20.9.3316-3329.2000; Muller-Tidow C, 2003, INT J MOL MED, V11, P311; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nickerson HD, 2007, DEV BIOL, V306, P725, DOI 10.1016/j.ydbio.2007.04.009; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Pan B, 2011, MOL HUM REPROD; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Pinheiro A, 2010, MOL GENET METAB, V99, P425, DOI 10.1016/j.ymgme.2009.11.002; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Qamar I, 2009, J BIOL CHEM, V284, P18021, DOI 10.1074/jbc.M900896200; Ravnik SE, 1996, DEV BIOL, V173, P69, DOI 10.1006/dbio.1996.0007; Ravnik SE, 1999, DEV BIOL, V207, P408, DOI 10.1006/dbio.1998.9156; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Sweeney C, 1996, DEVELOPMENT, V122, P53; Tascou S, 2000, BIOL REPROD, V63, P1555, DOI 10.1095/biolreprod63.5.1555; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Wolfe SA, 2003, GENE, V308, P129, DOI 10.1016/S0378-1119(03)00490-6; WOLGEMUTH DJ, 1985, GAMETE RES, V12, P1, DOI 10.1002/mrd.1120120102; Wong EY, 2004, J BIOL CHEM, V279, P55024, DOI 10.1074/jbc.M408886200; Wood MA, 2011, BIOL REPROD, V85, P965, DOI 10.1095/biolreprod.111.093013; Wu S, 2009, MOL CELL BIOL, V29, P6245, DOI 10.1128/MCB.00679-09; Xie WS, 2002, J BIOL CHEM, V277, P17765, DOI 10.1074/jbc.M200954200; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Yanatatsaneejit P, 2011, INT J GYNECOL CANCER, V21, P902, DOI 10.1097/IGC.0b013e3182158683; Yang R, 1997, CANCER RES, V57, P913; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; ZAKERI ZF, 1988, MOL CELL BIOL, V8, P2925, DOI 10.1128/MCB.8.7.2925	65	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47862	10.1371/journal.pone.0047862	http://dx.doi.org/10.1371/journal.pone.0047862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112860	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200095
J	Shin, D; Watanabe, H; Kambara, H; Nambu, A; Isa, T; Nishimura, Y; Koike, Y				Shin, Duk; Watanabe, Hidenori; Kambara, Hiroyuki; Nambu, Atsushi; Isa, Tadashi; Nishimura, Yukio; Koike, Yasuharu			Prediction of Muscle Activities from Electrocorticograms in Primary Motor Cortex of Primates	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; 2-DIMENSIONAL MOVEMENT TRAJECTORIES; LOCAL-FIELD POTENTIALS; HAND MUSCLE; ARM; SIGNALS; RECONSTRUCTION; GRASP; EEG; OSCILLATIONS	Electrocorticography (ECoG) has drawn attention as an effective recording approach for brain-machine interfaces (BMI). Previous studies have succeeded in classifying movement intention and predicting hand trajectories from ECoG. Despite such successes, however, there still remains considerable work for the realization of ECoG-based BMIs as neuroprosthetics. We developed a method to predict multiple muscle activities from ECoG measurements. We also verified that ECoG signals are effective for predicting muscle activities in time varying series when performing sequential movements. ECoG signals were band-pass filtered into separate sensorimotor rhythm bands, z-score normalized, and smoothed with a Gaussian filter. We used sparse linear regression to find the best fit between frequency bands of ECoG and electromyographic activity. The best average correlation coefficient and the normalized root-mean-square error were 0.92 +/- 0.06 and 0.06 +/- 0.10, respectively, in the flexor digitorum profundus finger muscle. The delta (1.5 similar to 4Hz) and gamma 2 (50 gamma 90Hz) bands contributed significantly more strongly than other frequency bands (P<0.001). These results demonstrate the feasibility of predicting muscle activity from ECoG signals in an online fashion.	[Shin, Duk; Kambara, Hiroyuki; Koike, Yasuharu] Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 227, Japan; [Watanabe, Hidenori; Isa, Tadashi; Nishimura, Yukio] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Nambu, Atsushi] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Syst Integrat Physiol, Okazaki, Aichi 4448585, Japan; [Nambu, Atsushi; Isa, Tadashi; Nishimura, Yukio] Grad Univ Adv Studies SOKENDAI, Hayama, Japan; [Nishimura, Yukio] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo, Japan; [Koike, Yasuharu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Tokyo Institute of Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Shin, D (corresponding author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 227, Japan.	shinduk@cns.pi.titech.ac.jp	Shin, Duk/G-9620-2011; Kambara, Hiroyuki/E-4546-2014; Koike, Yasuharu/E-9150-2014	Koike, Yasuharu/0000-0002-8169-0044; Nambu, Atsushi/0000-0003-2153-5445; Watanabe, Hidenori/0000-0002-4641-9523	MEXT of Japan	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is supported by the Strategic Research Program for Brain Sciences from the MEXT of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2010, ANNU REV PSYCHOL, V61, P169, DOI 10.1146/annurev.psych.093008.100503; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Ball T, 2009, NEUROIMAGE, V46, P708, DOI 10.1016/j.neuroimage.2009.02.028; Bansal AK, 2012, J NEUROPHYSIOL, V107, P1337, DOI 10.1152/jn.00781.2011; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chase SM, 2010, J NEUROSCI, V30, P13873, DOI 10.1523/JNEUROSCI.2325-10.2010; Choi K, 2009, NEURAL NETWORKS, V22, P1214, DOI 10.1016/j.neunet.2009.09.003; Flint RD, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046006; Flint RD, 2012, J NEUROPHYSIOL, V108, P18, DOI 10.1152/jn.00832.2011; Ganesh G, 2008, NEUROIMAGE, V42, P1463, DOI 10.1016/j.neuroimage.2008.06.018; Griffin DM, 2008, J NEUROPHYSIOL, V99, P1169, DOI 10.1152/jn.00906.2007; Heliot R, 2010, IEEE T SYST MAN CY A, V40, P732, DOI 10.1109/TSMCA.2010.2044410; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kawase T, 2012, J ROBOT MECHATRON, V24, P205, DOI 10.20965/jrm.2012.p0205; Khan YU, 2010, IET SIGNAL PROCESS, V4, P510, DOI 10.1049/iet-spr.2008.0235; Koike Y, 2006, NEUROSCI RES, V55, P146, DOI 10.1016/j.neures.2006.02.012; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Levine SP, 2000, IEEE T REHABIL ENG, V8, P180, DOI 10.1109/86.847809; Mehring C, 2004, J PHYSIOL-PARIS, V98, P498, DOI 10.1016/j.jphysparis.2005.09.016; Mollazadeh M, 2008, IEEE ENG MED BIO, P5314, DOI 10.1109/IEMBS.2008.4650414; Morrow MM, 2003, J NEUROPHYSIOL, V89, P2279, DOI 10.1152/jn.00632.2002; Nambu I, 2009, NEUROIMAGE, V47, P628, DOI 10.1016/j.neuroimage.2009.04.050; Neal RM, 1996, LECT NOTES STAT, V118; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Nishimura Y, 2009, BRAIN, V132, P709, DOI 10.1093/brain/awn338; Ohara S, 2000, CLIN NEUROPHYSIOL, V111, P2014, DOI 10.1016/S1388-2457(00)00448-X; Parameshwaran D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030514; PFURTSCHELLER G, 1994, NEUROSCI LETT, V174, P93, DOI 10.1016/0304-3940(94)90127-9; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; Sanchez JC, 2008, J NEUROSCI METH, V167, P63, DOI 10.1016/j.jneumeth.2007.04.019; Santucci DM, 2005, EUR J NEUROSCI, V22, P1529, DOI 10.1111/j.1460-9568.2005.04320.x; Sato M, 2001, NEURAL COMPUT, V13, P1649, DOI 10.1162/089976601750265045; Sato M, 2009, VARIATIONAL BAYESIAN; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Schieber MH, 2007, J NEUROPHYSIOL, V97, P70, DOI 10.1152/jn.00544.2006; Shin D, 2009, J NEUROPHYSIOL, V101, P387, DOI 10.1152/jn.00584.2007; Slutzky MW, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026004; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Ting Jo-Anne, 2008, Neural Netw, V21, P1112, DOI 10.1016/j.neunet.2008.06.012; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P390, DOI 10.1016/0013-4694(94)00176-L; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Watanabe H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036006; Weatherall D., 2006, USE NONHUMAN PRIMATE; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yoshimura N, 2012, NEUROIMAGE, V59, P1324, DOI 10.1016/j.neuroimage.2011.08.029; Zhuang J, 2010, IEEE T BIO-MED ENG, V57, P1774, DOI 10.1109/TBME.2010.2047015	57	47	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47992	10.1371/journal.pone.0047992	http://dx.doi.org/10.1371/journal.pone.0047992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110153	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200129
J	Takatani-Nakase, T; Tokuyama, E; Komai, M; Takahashi, K				Takatani-Nakase, Tomoka; Tokuyama, Erika; Komai, Megumi; Takahashi, Koichi			Transcutaneous Immunization System Using a Hydrotropic Formulation Induces a Potent Antigen-Specific Antibody Response	PLOS ONE			English	Article							VACCINE ADJUVANTS; IMMUNE-RESPONSES; T-CELLS; ANAPHYLACTIC REACTION; CYTOKINE PRODUCTION; AW METHOD; SKIN; MICE; PERMEATION; DELIVERY	Background: Transcutaneous immunization (TCI) is a novel vaccination strategy, which is expected to have therapeutic applications. However, to develop effective TCI systems, a simple, non-invasive and safe transdermal formulation is required. This study developed a novel TCI system utilizing the co-administration of a liposoluble absorption enhancer, propylene glycol monocaprylate (PGMC) and hydrosoluble protein antigen without pretreatment of any typical adjuvants and disruption of the skin. Novel transdermal formulations were also prepared with sodium salicylate (NaSal) as a hydrotropic agent to improve the solubility of poorly water-soluble substances. Methodology/Principal Findings: The TCI system, which used a transdermal formulation containing hen lysozyme (HEL) and PGMC, solubilized with NaSal, resulted in a substantial HEL-specific antibody response in an HEL dose-dependent manner even in the absence of potent adjuvants, such as cholera toxin (CT). We also investigated whether NaSal activates antigen-presenting cells in vitro to clarify the mechanisms of antibody production by the hydrotropic formulation. NaSal enhanced the expression of MHC class II molecules and increased the production of IL-12 and TNF-alpha in dendritic cells, which were stimulated by lipopolysaccharide in vitro, indicating that NaSal had an effective adjuvant-like property. Moreover, the use of NaSal in the TCI system did not induce an HEL-specific, IgE-dependent anaphylactic reaction. Conclusion/Significance: Our TCI system using a hydrotropic formulation effectively and safely induced the intended immune response, and this system thus represents a new advantageous method that will result in improved TCI strategies.	[Takatani-Nakase, Tomoka; Tokuyama, Erika; Komai, Megumi; Takahashi, Koichi] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut, Nishinomiya, Hyogo, Japan	Mukogawa Women's University	Takahashi, K (corresponding author), Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmaceut, Koshien Kyuban Cho, Nishinomiya, Hyogo, Japan.	koichi@mukogawa-u.ac.jp						ABRAMSON SB, 1994, BIOCHEM PHARMACOL, V47, P563, DOI 10.1016/0006-2952(94)90189-9; Agrawal S, 2004, INT J PHARMACEUT, V274, P149, DOI 10.1016/j.ijpharm.2004.01.012; Agren LC, 1999, J IMMUNOL, V162, P2432; Alving CR, 2002, VACCINE, V20, pS56, DOI 10.1016/S0264-410X(02)00174-3; Bal SM, 2010, J CONTROL RELEASE, V148, P266, DOI 10.1016/j.jconrel.2010.09.018; BECK L, 1989, CELL IMMUNOL, V123, P1, DOI 10.1016/0008-8749(89)90263-3; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Evstigneev MP, 2006, EUR J PHARM SCI, V28, P59, DOI 10.1016/j.ejps.2005.12.010; Glenn GM, 1999, INFECT IMMUN, V67, P1100, DOI 10.1128/IAI.67.3.1100-1106.1999; Gonzalez-Rodriguez ML, 2011, EXPERT OPIN DRUG DEL, V8, P857, DOI 10.1517/17425247.2011.574610; HSIA J, 1994, METHOD FIND EXP CLIN, V16, P677; Huang YZ, 2010, BIOMATERIALS, V31, P9086, DOI 10.1016/j.biomaterials.2010.08.046; Hunter RL, 2002, VACCINE, V20, pS7, DOI 10.1016/S0264-410X(02)00164-0; Ibrahim SA, 2010, PHARM RES-DORDR, V27, P115, DOI 10.1007/s11095-009-9985-0; Inoue J, 2005, J CONTROL RELEASE, V108, P294, DOI 10.1016/j.jconrel.2005.08.014; Kataoka H, 1997, BIOL PHARM BULL, V20, P714; Kataoka H, 1999, BIOL PHARM BULL, V22, P896; Li N, 2011, VACCINE, V29, P6179, DOI 10.1016/j.vaccine.2011.06.086; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Matsuo K, 2011, J CONTROL RELEASE, V149, P15, DOI 10.1016/j.jconrel.2010.05.012; MCKEE RH, 1946, IND ENG CHEM, V38, P382, DOI 10.1021/ie50436a012; Metz M, 2008, IMMUNOBIOLOGY, V213, P251, DOI 10.1016/j.imbio.2007.10.017; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Neuberg C, 1916, BIOCHEM Z, V76, P107; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pierre MBR, 2011, ARCH DERMATOL RES, V303, P607, DOI 10.1007/s00403-011-1166-4; Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5; Shive CL, 2000, EUR J IMMUNOL, V30, P2422, DOI 10.1002/1521-4141(2000)30:8<2422::AID-IMMU2422>3.0.CO;2-H; Singh M, 2002, PHARM RES-DORDR, V19, P715, DOI 10.1023/A:1016104910582; Skountzou I, 2006, VACCINE, V24, P6110, DOI 10.1016/j.vaccine.2006.05.014; Slutter B, 2011, J CONTROL RELEASE, V154, P123, DOI 10.1016/j.jconrel.2011.02.007; Sugita K, 2007, CLIN EXP IMMUNOL, V147, P176, DOI 10.1111/j.1365-2249.2006.03258.x; Takahashi K, 2001, J CONTROL RELEASE, V73, P351, DOI 10.1016/S0168-3659(01)00359-5; Takahashi K, 2011, J PHARM PHARMACOL, V63, P1008, DOI 10.1111/j.2042-7158.2011.01308.x; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025; Wilson-Welder JH, 2009, J PHARM SCI-US, V98, P1278, DOI 10.1002/jps.21523; WOOD LC, 1992, J CLIN INVEST, V90, P482, DOI 10.1172/JCI115884	38	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47980	10.1371/journal.pone.0047980	http://dx.doi.org/10.1371/journal.pone.0047980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110149	Green Submitted, gold, Green Published			2022-12-25	WOS:000310310200126
J	Vandevijvere, S; Coucke, W; Vanderpas, J; Trumpff, C; Fauvart, M; Meulemans, A; Marie, S; Vincent, MF; Schoos, R; Boemer, F; Vanwynsberghe, T; Philips, E; Eyskens, F; Wuyts, B; Selimaj, V; Van Overmeire, B; Kirkpatrick, C; Van Oyen, H; Moreno-Reyes, R				Vandevijvere, Stefanie; Coucke, Wim; Vanderpas, Jean; Trumpff, Caroline; Fauvart, Maarten; Meulemans, Ann; Marie, Sandrine; Vincent, Marie-Franccise; Schoos, Roland; Boemer, Francois; Vanwynsberghe, Timothy; Philips, Eddy; Eyskens, Francois; Wuyts, Brigitte; Selimaj, Valbona; Van Overmeire, Bart; Kirkpatrick, Christine; Van Oyen, Herman; Moreno-Reyes, Rodrigo			Neonatal Thyroid-Stimulating Hormone Concentrations in Belgium: A Useful Indicator for Detecting Mild Iodine Deficiency?	PLOS ONE			English	Article							CONGENITAL HYPOTHYROIDISM; PREGNANT-WOMEN; TIME; CHILDREN; EUROPE; LEVEL; TOOL	It has been proposed that neonatal thyroid-stimulating hormone (TSH) concentrations are a good indicator of iodine deficiency in the population. A frequency of neonatal TSH concentrations above 5 mU/L below 3% has been proposed as the threshold indicating iodine sufficiency. The objective of the present study was to evaluate feasibility and usefulness of nation-wide neonatal TSH concentration screening results to assess iodine status in Belgium. All newborns born in Belgium during the period 2009-2011 (n = 377713) were included in the study, except those suffering from congenital hypothyroidism and premature neonates. The frequency of neonatal TSH concentrations above 5 mU/L from 2009 to 2011 in Belgium fluctuated between 2.6 and 3.3% in the centres using the same TSH assay. There was a significant inverse association between neonatal TSH level and birth weight. The longer the duration between birth and screening, the lower the TSH level. Neonatal TSH levels were significantly lower in winter than in spring or autumn and significantly lower in spring and summer than in autumn while significantly higher in spring compared to summer. In conclusion, despite that pregnant women in Belgium are mildly iodine deficient, the frequency of neonatal TSH concentrations above 5 mU/L was very low, suggesting that the neonatal TSH threshold proposed for detecting iodine deficiency needs to be re-evaluated. Although neonatal TSH is useful to detect severe iodine deficiency, it should not be recommended presently for the evaluation of iodine status in mildly iodine deficient regions.	[Vandevijvere, Stefanie; Coucke, Wim; Vanderpas, Jean; Trumpff, Caroline; Van Oyen, Herman] Sci Inst Publ Hlth, Brussels, Belgium; [Fauvart, Maarten; Meulemans, Ann] Univ Libre Bruxelles, Lab Pediat, Brussels, Belgium; [Marie, Sandrine; Vincent, Marie-Franccise] Catholic Univ Louvain, B-3000 Louvain, Belgium; [Schoos, Roland; Boemer, Francois] CHU Sart Tilman, Biochim Genet Lab, B-4000 Liege, Belgium; [Vanwynsberghe, Timothy] AZ Sint Jan Brugge, Brugge, Belgium; [Philips, Eddy; Eyskens, Francois] Prov Ctr Opsporing Metabole Aandoening, Antwerp, Belgium; [Wuyts, Brigitte] UZ Gent, Lab Metab Disorders, Ghent, Belgium; [Selimaj, Valbona; Van Overmeire, Bart; Kirkpatrick, Christine; Moreno-Reyes, Rodrigo] Univ Libre Bruxelles, Hop Erasme, Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; University of Liege; Ghent University; Ghent University Hospital; Universite Libre de Bruxelles	Vandevijvere, S (corresponding author), Sci Inst Publ Hlth, Brussels, Belgium.	Stefanie.vandevijvere@wiv-isp.be	Fauvart, Maarten/B-1612-2010; Eyskens, Francois J M/P-3968-2018; Eyskens, Francois/AAW-9963-2021; Coucke, Wim/ABA-9949-2020	Fauvart, Maarten/0000-0002-6256-9193; Eyskens, Francois J M/0000-0003-3981-0142; Coucke, Wim/0000-0002-4290-4628; Meulemans, Ann/0000-0003-3938-2408; BOEMER, Francois/0000-0003-4470-9524; Van Oyen, Herman/0000-0003-2119-4433; Jean, Vanderpas/0000-0003-0623-5612				Boemer F, 2009, J CHROMATOGR B, V877, P2412, DOI 10.1016/j.jchromb.2008.11.004; Burns R, 2008, THYROID, V18, P883, DOI 10.1089/thy.2008.0036; Chan LYS, 2003, ACTA OBSTET GYN SCAN, V82, P28, DOI 10.1034/j.1600-0412.2003.820105.x; CHANOINE JP, 1988, ARCH DIS CHILD, V63, P1207, DOI 10.1136/adc.63.10.1207; Ciardelli R, 2002, EUR J PEDIATR, V161, P519, DOI 10.1007/s00431-002-1021-x; Copeland DL, 2002, PUBLIC HEALTH NUTR, V5, P81, DOI 10.1079/PHN2001306; CORNBLEET PJ, 1979, CLIN CHEM, V25, P432; Costante G, 1997, J ENDOCRINOL INVEST, V20, P251, DOI 10.1007/BF03350296; de Benoist B, 2008, FOOD NUTR BULL, V29, P195, DOI 10.1177/156482650802900305; Delange F, 1997, HORM RES, V48, P51, DOI 10.1159/000185485; Delange F, 2000, EUR J ENDOCRINOL, V143, P189, DOI 10.1530/eje.0.1430189; Delange F, 1998, THYROID, V8, P1185, DOI 10.1089/thy.1998.8.1185; Delange F, 1999, ACTA PAEDIATR, V88, P21, DOI 10.1080/080352599750029303; GLINOER D, 1995, J CLIN ENDOCR METAB, V80, P258, DOI 10.1210/jc.80.1.258; Gordon RC, 2009, AM J CLIN NUTR, V90, P1264, DOI 10.3945/ajcn.2009.28145; Gruneiro-Papendieck L, 2004, HORM RES, V62, P272, DOI 10.1159/000081786; Gyurjyan RH, 2006, EUR J CLIN NUTR, V60, P688, DOI 10.1038/sj.ejcn.1602364; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Konrade I, 2012, THYROID IN PRESS; Kung AWC, 1997, CLIN ENDOCRINOL, V46, P315, DOI 10.1046/j.1365-2265.1997.1310960.x; McDonald SD, 2008, EUR J OBSTET GYN R B, V140, P38, DOI 10.1016/j.ejogrb.2008.02.010; Mikelsaar RV, 1999, HORM RES, V52, P284, DOI 10.1159/000023496; Ordookhani A, 2007, THYROID, V17, P1097, DOI 10.1089/thy.2007.0058; Pearce MS, 2011, EUR J EPIDEMIOL, V26, P405, DOI 10.1007/s10654-011-9571-8; Raiatanavin R, 2007, PUBLIC HEALTH NUTR, V10, P1602, DOI 10.1017/S1368980007360990; Shields B, 2009, J CLIN ENDOCR METAB, V94, P570, DOI 10.1210/jc.2008-0380; SOINI E, 1983, CLIN CHEM, V29, P65; Ng SM, 2011, J PEDIATR ENDOCR MET, V24, P727, DOI 10.1515/JPEM.2011.234; Travers CA, 2006, MED J AUSTRALIA, V184, P617, DOI 10.5694/j.1326-5377.2006.tb00417.x; Vanderpump MPJ, 2011, LANCET, V377, P2007, DOI 10.1016/S0140-6736(11)60693-4; Vandevijvere S, 2012, THYROID IN PRESS; Vandevijvere S, 2012, BRIT J NUTR IN PRESS; Vandevijvere S, 2010, THYROID, V20, P1301, DOI 10.1089/thy.2010.0133; World Health Organization, 1994, IND ASS IOD DEF DIS; Zimmermann MB, 2011, ANN ENDOCRINOL-PARIS, V72, P164, DOI 10.1016/j.ando.2011.03.023; Zimmermann MB, 2005, AM J CLIN NUTR, V82, P388, DOI 10.1093/ajcn/82.2.388	36	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47770	10.1371/journal.pone.0047770	http://dx.doi.org/10.1371/journal.pone.0047770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112844	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200078
J	Piet, JR; Brouwer, MC; Exley, R; van der Veen, S; van de Beek, D; van der Ende, A				Piet, Jurgen R.; Brouwer, Matthijs C.; Exley, Rachel; van der Veen, Stijn; van de Beek, Diederik; van der Ende, Arie			Meningococcal Factor H Binding Protein fHbpd184 Polymorphism Influences Clinical Course of Meningococcal Meningitis	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; VACCINE CANDIDATE; CARRIAGE; GENETICS; DISEASE; VARIANTS; GENOTYPE; FEATURES; ADULTS; AGE	Factor H Binding protein (fHbp) is an important meningococcal virulence factor, enabling the meningococcus to evade the complement system, and a main target for vaccination. Recently, the structure of fHBP complexed with factor H (fH) was published. Two fHbp glutamic acids, E-283 and E-304, form salt bridges with fH, influencing interaction between fHbp and fH. Fifteen amino acids were identified forming hydrogen bonds with fH. We sequenced fHbp of 254 meningococcal isolates from adults with meningococcal meningitis included in a prospective clinical cohort to study the effect of fHbp variants on meningococcal disease severity and outcome. All fHbp of subfamily A had E304 substituted with T304. Of the 15 amino acids in fHbp making hydrogen bonds to fH, 3 were conserved, 11 show a similar distribution between the two fHbp subfamilies as the polymorphism at position 304. The proportion of patients infected with meningococci with fHbp of subfamily A with unfavorable outcome was 2.5-fold lower than that of patients infected with meningococci with fHbp of subfamily B (2 of 40 (5%) vs. 27 of 213 (13%) (P = 0.28). The charge of 2 of 15 amino acids (at position 184 and 306) forming hydrogen bonds was either basic or acidic. The affinity of fHbp(K184) and of fHbp(D184) for recombinant purified human fH was assessed by Surface Plasmon Resonance and showed average K-D of 2.60 x 10(-8) and 1.74 x 10(-8), respectively (ns). Patients infected with meningococci with fHbp(D184) were more likely to develop septic shock during admission (11 of 42 [26%] vs. 19 of 211 [9%]; P = 0.002) resulting in more frequent unfavorable outcome (9 of 42 [21%] vs. 20 of 211 [10%]; P = 0.026). In conclusion, we dentified fHBP(D184) to be associated with septic shock in patients with meningococcal meningitis.	[Piet, Jurgen R.; van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Piet, Jurgen R.; Brouwer, Matthijs C.; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Exley, Rachel; van der Veen, Stijn] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [van der Ende, Arie] Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford	van der Ende, A (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.	A.vanderende@amc.uva.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X; van der Veen, Stijn/0000-0002-8176-391X; van der Ende, Arie/0000-0003-1298-3086	Netherlands Organization for Health Research and Development (ZonMw) [916.76.023, 016.116.358]; Academic Medical Center (AMC Fellowship); Academic Medical Center (AMC PhD scholarship); Wellcome Trust; European Union	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Academic Medical Center (AMC Fellowship); Academic Medical Center (AMC PhD scholarship); Wellcome Trust(Wellcome Trust); European Union(European Commission)	This study has been funded by grants from the Netherlands Organization for Health Research and Development (ZonMw; NWO-Veni grant 2006 [916.76.023], NWO-Vidi grant 2010 [016.116.358], both to D. van de Beek), the Academic Medical Center (AMC Fellowship 2008 to D. van de Beek, AMC PhD scholarship 2008 to J. Piet). A. van der Ende participated in the Sixth Framework Programme of the European Commission, Proposal/Contract no.: 512061 (Network of Excellence "European Virtual Institute for Functional Genomics of Bacterial Pathogens".) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Dr. D. Speijer for stimulating dicussions and critically reading of the manuscript. Dr. P. Gros is acknowledged for his expert help in evaluating the fHbp-fH model structure. D. van de Beek and A. van der Ende participate in the Seventh Framework Programme of the European Commission, Proposal/Contract no.: 279185 (EUCLIDS - The genetic basis of meningococcal and other life threatening bacterial infections of childhood), A. van der Ende participated in the Sixth Framework Programme of the European Commission, Proposal/Contract no.: 512061 (Network of Excellence "European Virtual Institute for Functional Genomics of Bacterial Pathogens".) This publication made use of the Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford [33]: Development of this site has been funded by the Wellcome Trust and European Union.	Beernink PT, 2009, MICROBIOL-SGM, V155, P2873, DOI 10.1099/mic.0.029876-0; Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1; Brouwer MC, 2009, CLIN INFECT DIS, V48, P595, DOI 10.1086/596708; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; de Greeff SC, 2006, PEDIATR INFECT DIS J, V25, P79, DOI 10.1097/01.inf.0000195594.41449.c6; Dunphy KY, 2011, INFECT IMMUN, V79, P353, DOI 10.1128/IAI.00849-10; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Fransen F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000396; Gardner P, 2006, NEW ENGL J MED, V355, P1466, DOI 10.1056/NEJMcp063561; Heckenberg SGB, 2008, MEDICINE, V87, P185, DOI 10.1097/MD.0b013e318180a6b4; Ingram G, 2010, BRAIN, V133, P1602, DOI 10.1093/brain/awq085; JENNETT B, 1975, LANCET, V1, P480; Jennett B., 1981, MANAGEMENT HEAD INJU; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kellerman SE, 2002, J INFECT DIS, V186, P40, DOI 10.1086/341067; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lo H, 2009, LANCET INFECT DIS, V9, P418, DOI 10.1016/S1473-3099(09)70132-X; MacLennan J, 2006, EMERG INFECT DIS, V12, P950; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47973	10.1371/journal.pone.0047973	http://dx.doi.org/10.1371/journal.pone.0047973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110143	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600040
J	Monfregola, J; Johnson, JL; Meijler, MM; Napolitano, G; Catz, SD				Monfregola, Jlenia; Johnson, Jennifer Linda; Meijler, Michael M.; Napolitano, Gennaro; Catz, Sergio Daniel			MUNC13-4 Protein Regulates the Oxidative Response and Is Essential for Phagosomal Maturation and Bacterial Killing in Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; NADPH OXIDASE ACTIVITY; CHRONIC GRANULOMATOUS-DISEASE; BINDING-PROTEIN; AZUROPHILIC GRANULES; RESPIRATORY BURST; SUPEROXIDE ANION; MOUSE MODEL; NOX-FAMILY; RAB27A	Neutrophils use diverse mechanisms to kill pathogens including phagocytosis, exocytosis, generation of reactive oxygen species (ROS), and neutrophil extracellular traps. These mechanisms rely on their ability to mobilize intracellular organelles and to deliver granular cargoes to specific cellular compartments or into the extracellular milieu, but the molecular mechanisms regulating vesicular trafficking in neutrophils are not well understood. MUNC13-4 is a RAB27A effector that coordinates exocytosis in hematopoietic cells, and its deficiency is associated with the human immunodeficiency familial hemophagocytic lymphohistiocytosis type 3. In this work, we have established an essential role for MUNC13-4 in selective vesicular trafficking, phagosomal maturation, and intracellular bacterial killing in neutrophils. Using neutrophils from munc13-4 knock-out (KO) mice, we show that MUNC13-4 is necessary for the regulation of p22(phox)-expressing granule trafficking to the plasma membrane and regulates extracellular ROS production. MUNC13-4 was also essential for the regulation of intracellular ROS production induced by Pseudomonas aeruginosa despite normal trafficking of p22(phox)-expressing vesicles toward the phagosome. Importantly, in the absence of MUNC13-4, phagosomal maturation was impaired as observed by the defective delivery of azurophilic granules and multive-sicular bodies to the phagosome. Significantly, this mechanism was intact in RAB27A KO neutrophils. Intracellular bacterial killing was markedly impaired in MUNC13-4 KO neutrophils. MUNC13-4-deficient cells showed a significant increase in neutrophil extracellular trap formation but were unable to compensate for the impaired bacterial killing. Altogether, these findings characterize novel functions of MUNC13-4 in the innate immune response of the neutrophil and have direct implications for the understanding of immunodeficiencies in patients with MUNC13-4 deficiency.	[Monfregola, Jlenia; Johnson, Jennifer Linda; Napolitano, Gennaro; Catz, Sergio Daniel] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Meijler, Michael M.] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel; [Meijler, Michael M.] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Scripps Research Institute; Ben Gurion University; Ben Gurion University	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	scatz@scripps.edu	Napolitano, Gennaro/O-5377-2016; Monfregola, Jlenia/AAW-9055-2021	Napolitano, Gennaro/0000-0002-8615-4654; Catz, Sergio/0000-0002-1873-0277; Meijler, Michael/0000-0001-7095-1467	National Institutes of Health from the United States Public Health Service [HL088256]; National Center for Research Resources [UL1 RR025774]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088256] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088256 (to S.D.C.) from the United States Public Health Service and UL1 RR025774 from the National Center for Research Resources.	Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; BABIOR BM, 1991, AM J HEMATOL, V37, P263, DOI 10.1002/ajh.2830370410; BABIOR BM, 1990, SEMIN HEMATOL, V27, P247; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; BOXER LA, 1979, J LAB CLIN MED, V93, P506; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Cieutat AM, 1998, BLOOD, V91, P1044, DOI 10.1182/blood.V91.3.1044.1044_1044_1058; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; DAHLGREN C, 1995, BIOCHEM J, V311, P667, DOI 10.1042/bj3110667; Elstak ED, 2011, BLOOD, V118, P1570, DOI 10.1182/blood-2011-02-339523; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gobor T, 2011, J MICROBIOL METH, V84, P299, DOI 10.1016/j.mimet.2010.12.018; Green SP, 2001, J CEREBR BLOOD F MET, V21, P374, DOI 10.1097/00004647-200104000-00006; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; Johnson JL, 2012, MOL BIOL CELL, V23, P1902, DOI 10.1091/mbc.E11-12-1001; Johnson JL, 2011, J BIOL CHEM, V286, P5647, DOI 10.1074/jbc.M110.184762; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Kutter D, 2000, ACTA HAEMATOL-BASEL, V104, P10, DOI 10.1159/000041062; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Lin JS, 2001, CLIN DIAGN LAB IMMUN, V8, P528, DOI 10.1128/CDLI.8.3.528-533.2001; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lundqvist H, 1996, FREE RADICAL BIO MED, V20, P785, DOI 10.1016/0891-5849(95)02189-2; Mahlaoui N, 2007, PEDIATRICS, V120, pE622, DOI 10.1542/peds.2006-3164; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; MARKERT M, 1984, METHOD ENZYMOL, V105, P358; Mattheyses AL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2161018; Matute JD, 2009, BLOOD, V114, P3309, DOI 10.1182/blood-2009-07-231498; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Munafo DB, 2007, BIOCHEM J, V402, P229, DOI 10.1042/BJ20060950; Munafo DB, 2009, J INNATE IMMUN, V1, P527, DOI 10.1159/000235860; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Nold-Petry CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008663; Pacquelet S, 2007, BIOCHEM J, V403, P451, DOI 10.1042/BJ20061184; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Perskvist N, 2002, J CELL SCI, V115, P1321; Pivot-Pajot C, 2008, J IMMUNOL, V180, P6786, DOI 10.4049/jimmunol.180.10.6786; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; Rohr J, 2010, HAEMATOL-HEMATOL J, V95, P2080, DOI 10.3324/haematol.2010.029389; Schwartz J, 2009, J IMMUNOL, V183, P2632, DOI 10.4049/jimmunol.0804110; SENGELOV H, 1992, J BIOL CHEM, V267, P14912; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; SPEERT DP, 1994, J INFECT DIS, V170, P1524, DOI 10.1093/infdis/170.6.1524; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Tunney MM, 2004, ANTIMICROB AGENTS CH, V48, P1879, DOI 10.1128/AAC.48.5.1879-1881.2004; Uriarte Silvia M, 2011, J Immunol, V187, P391, DOI 10.4049/jimmunol.1003112; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Wood SM, 2009, BLOOD, V114, P4117, DOI 10.1182/blood-2009-06-225359; Yokoyama K, 2011, J BIOL CHEM, V286, P5375, DOI 10.1074/jbc.M110.171702; Zhang ST, 2008, BRIT J HAEMATOL, V142, P469, DOI 10.1111/j.1365-2141.2008.07191.x	71	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44603	44618		10.1074/jbc.M112.414029	http://dx.doi.org/10.1074/jbc.M112.414029			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23115246	Green Published, hybrid			2022-12-25	WOS:000312938600057
J	Frase, H; Toth, M; Vakulenko, SB				Frase, Hilary; Toth, Marta; Vakulenko, Sergei B.			Revisiting the Nucleotide and Aminoglycoside Substrate Specificity of the Bifunctional Aminoglycoside Acetyltransferase(6 ')-Ie/Aminoglycoside Phosphotransferase(2 '')-Ia Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBIOTIC-RESISTANCE ENZYME; STAPHYLOCOCCUS-AUREUS; KINETIC MECHANISM; ATP; ENTEROCOCCUS; DETERMINANT; ARBEKACIN; SITE; COLI; IIIA	The bifunctional aminoglycoside-modifying enzyme aminoglycoside acetyltransferase(6')-Ie/aminoglycoside phosphotransferase(2 '')-Ia, or AAC(6')-Ie/APH(2 '')-Ia, is the major source of aminoglycoside resistance in Gram-positive bacterial pathogens. In previous studies, using ATP as the cosubstrate, it was reported that the APH(2 '')-Ia domain of this enzyme is unique among aminoglycoside phosphotransferases, having the ability to inactivate an unusually broad spectrum of aminoglycosides, including 4,6- and 4,5-disubstituted and atypical. We recently demonstrated that GTP, and not ATP, is the preferred cosubstrate of this enzyme. We now show, using competition assays between ATP and GTP, that GTP is the exclusive phosphate donor at intracellular nucleotide levels. In light of these findings, we reevaluated the substrate profile of the phosphotransferase domain of this clinically important enzyme. Steady-state kinetic characterization using the phosphate donor GTP demonstrates that AAC(6')-Ie/APH(2 '')-Ia phosphorylates 4,6-disubstituted aminoglycosides with high efficiency (k(cat)/K-m = 10(5)-10(7) M-1 s(-1)). Despite this proficiency, no resistance is conferred to some of these antibiotics by the enzyme in vivo. We now show that phosphorylation of 4,5-disubstituted and atypical aminoglycosides are negligible and thus these antibiotics are not substrates. Instead, these aminoglycosides tend to stimulate an intrinsic GTPase activity of the enzyme. Taken together, our data show that the bifunctional enzyme efficiently phosphorylates only 4,6-disubstituted antibiotics; however, phosphorylation does not necessarily result in bacterial resistance. Hence, the APH(2 '')-Ia domain of the bifunctional AAC(6')-Ie/APH(2 '')-Ia enzyme is a bona fide GTP-dependent kinase with a narrow substrate profile, including only 4,6-disubstituted aminoglycosides.	[Frase, Hilary; Toth, Marta; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame	Vakulenko, SB (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.	svakulen@nd.edu			National Institutes of Health [RO1 AI057393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI057393 (to S. B. V.).	Azucena E, 1997, J AM CHEM SOC, V119, P2317, DOI 10.1021/ja964278w; Badarau A, 2008, J BIOL CHEM, V283, P7638, DOI 10.1074/jbc.M709645200; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Boehr DD, 2004, BIOCHEMISTRY-US, V43, P9846, DOI 10.1021/bi049135y; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Chow JW, 2000, CLIN INFECT DIS, V31, P586, DOI 10.1086/313949; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P310; Culebras Esther, 1999, Frontiers in Bioscience, V4, pD1, DOI 10.2741/culebras; Daigle DM, 1999, CHEM BIOL, V6, P99, DOI 10.1016/S1074-5521(99)80006-4; De Mey M, 2010, METAB ENG, V12, P477, DOI 10.1016/j.ymben.2010.04.003; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Hotta K, 2000, J ANTIBIOT, V53, P1168, DOI 10.7164/antibiotics.53.1168; Hotta K, 1996, J ANTIBIOT, V49, P458, DOI 10.7164/antibiotics.49.458; Kim C, 2006, J BIOL CHEM, V281, P6964, DOI 10.1074/jbc.M513257200; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; Llano-Sotelo B, 2002, CHEM BIOL, V9, P455, DOI 10.1016/S1074-5521(02)00125-4; MARTEL A, 1983, EUR J BIOCHEM, V133, P515, DOI 10.1111/j.1432-1033.1983.tb07494.x; Matsuo H, 2003, FEBS LETT, V546, P401, DOI 10.1016/S0014-5793(03)00644-6; ROUCH DA, 1987, J GEN MICROBIOL, V133, P3039; Smith CA, 2012, J BIOL CHEM, V287, P12893, DOI 10.1074/jbc.M112.341206; Toth M, 2007, BIOCHEMISTRY-US, V46, P5570, DOI 10.1021/bi6024512; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; UBUKATA K, 1984, ANTIMICROB AGENTS CH, V25, P754, DOI 10.1128/AAC.25.6.754; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; Zhang WL, 2009, CURR OPIN MICROBIOL, V12, P505, DOI 10.1016/j.mib.2009.06.013	30	16	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43262	43269		10.1074/jbc.M112.416453	http://dx.doi.org/10.1074/jbc.M112.416453			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115238	hybrid, Green Published			2022-12-25	WOS:000312940800007
J	Lewis, EM; Wilkinson, AS; Jackson, JS; Mehra, R; Varambally, S; Chinnaiyan, AM; Wilkinson, JC				Lewis, Eric M.; Wilkinson, Amanda S.; Jackson, Jacqueline S.; Mehra, Rohit; Varambally, Sooryanarayana; Chinnaiyan, Arul M.; Wilkinson, John C.			The Enzymatic Activity of Apoptosis-inducing Factor Supports Energy Metabolism Benefiting the Growth and Invasiveness of Advanced Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION ANALYSIS; NF-KAPPA-B; OXIDATIVE STRESS; FACTOR AIF; COLON-CANCER; PROGRESSION; PATHWAYS; HYPOXIA; DEATH; RAS	Apoptosis-inducing factor (AIF) promotes cell death yet also controls mitochondrial homeostasis and energy metabolism. It is unclear how these activities are coordinated, and the impact of AIF upon human disease, in particular cancer, is not well documented. In this study we have explored the contribution of AIF to the progression of prostate cancer. Analysis of archival gene expression data demonstrated that AIF transcript levels are elevated in human prostate cancer, and we found that AIF protein is increased in prostate tumors. Suppression of AIF expression in the prostate cancer cell lines LNCaP, DU145, and PC3 demonstrated that AIF does not contribute to cell toxicity via a variety of chemical death triggers, and growth under nutrient-rich conditions is largely unaffected by AIF ablation. However, under growth stress conditions, AIF depletion from DU145 and PC3 cell lines led to significant reductions in cell survival and growth that were not observed in LNCaP cells. Moreover AIF-deficient PC3 cells exhibited substantial reduction of tumorigenic growth in vivo. This reduced survival correlated with decreased expression of mitochondrial complex I protein subunits and concomitant changes in glucose metabolism. Finally, restoration of AIF-deficient PC3 cells with AIF variants demonstrated that the enzymatic activity of AIF is required for aggressive growth. Overall these studies show that AIF is an important factor for advanced prostate cancer cells and that through control of energy metabolism and redox balance, the enzymatic activity of AIF is critical for this support.	[Lewis, Eric M.; Wilkinson, Amanda S.; Jackson, Jacqueline S.; Wilkinson, John C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Mehra, Rohit; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Mehra, Rohit; Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Varambally, Sooryanarayana; Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	Wake Forest University; Wake Forest Baptist Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Wilkinson, JC (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jcwilkin@wakehealth.edu			National Institutes of Health Grant from the SPORE in Prostate Cancer [P50 CA69568]; Early Detection Research Network [U01 CA111275]; Department of Defense Prostate Cancer Research Program [W81XWH-08-1-0045]; American Cancer Society [RSG-09-166-01-CCG]; NATIONAL CANCER INSTITUTE [P50CA069568, U01CA111275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064249] Funding Source: NIH RePORTER	National Institutes of Health Grant from the SPORE in Prostate Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; Department of Defense Prostate Cancer Research Program(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 CA69568 (to A. M. C.) from the SPORE in Prostate Cancer. This work was also supported by Grant U01 CA111275 (to A. M. C.) from the Early Detection Research Network, Grant W81XWH-08-1-0045 (to J. C. W.) from the Department of Defense Prostate Cancer Research Program, and Grant RSG-09-166-01-CCG (to J. C. W.) from the American Cancer Society.	Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Bernard D, 2003, J CLIN INVEST, V112, P1724; Bhat HK, 2003, P NATL ACAD SCI USA, V100, P3913, DOI 10.1073/pnas.0437929100; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Devi GR, 2004, DRUG NEWS PERSPECT, V17, P127, DOI 10.1358/dnp.2004.17.2.829046; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Galban S, 2009, BIOCHEM J, V417, P765, DOI 10.1042/BJ20081677; Ghafar MA, 2003, PROSTATE, V54, P58, DOI 10.1002/pros.10162; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Huerta S, 2007, J SURG RES, V142, P184, DOI 10.1016/j.jss.2006.12.551; Jeong EG, 2006, APMIS, V114, P867, DOI 10.1111/j.1600-0463.2006.apm_502.x; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LaTulippe E, 2002, CANCER RES, V62, P4499; Lewis EM, 2011, BIOCHEMISTRY-US, V50, P11084, DOI 10.1021/bi201483g; Li SY, 2011, ARCH PATHOL LAB MED, V135, P903, DOI 10.1043/2010-0003-OAR1.1; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Mabjeesh NJ, 2003, CLIN CANCER RES, V9, P2416; Mehraein-Ghomi F, 2010, CANCER RES, V70, P4560, DOI 10.1158/0008-5472.CAN-09-3596; Millan A, 2009, J SURG RES, V151, P163, DOI 10.1016/j.jss.2007.05.020; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Movsas B, 1999, UROLOGY, V53, P11, DOI 10.1016/S0090-4295(98)00500-7; Norris JL, 1999, J BIOL CHEM, V274, P13841, DOI 10.1074/jbc.274.20.13841; Pinthus JH, 2007, NEOPLASIA, V9, P68, DOI 10.1593/neo.06739; Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ravi RK, 1999, J CELL BIOCHEM, V72, P458, DOI 10.1002/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Shiota M, 2010, ONCOGENE, V29, P237, DOI 10.1038/onc.2009.322; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Skyrlas A, 2011, EXP DERMATOL, V20, P674, DOI 10.1111/j.1600-0625.2011.01249.x; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Troutaud D, 2010, CL LYMPH MYELOM LEUK, V10, P118, DOI 10.3816/CLML.2010.n.016; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Welsh JB, 2001, CANCER RES, V61, P5974; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Williams KJ, 2001, BREAST CANCER RES, V3, P328, DOI 10.1186/bcr316; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu QY, 2005, ONCOGENE, V24, P7114, DOI 10.1038/sj.onc.1208853; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang W, 2007, CANCER LETT, V255, P127, DOI 10.1016/j.canlet.2007.04.006	67	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43862	43875		10.1074/jbc.M112.407650	http://dx.doi.org/10.1074/jbc.M112.407650			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118229	Green Published, hybrid			2022-12-25	WOS:000312940800063
J	Radhakrishnan, VM; Putnam, CW; Martinez, JD				Radhakrishnan, Vijayababu M.; Putnam, Charles W.; Martinez, Jesse D.			Activation of Phosphatidylinositol 3-Kinase (PI3K) and Mitogen-activated Protein Kinase (MAPK) Signaling and the Consequent Induction of Transformation by Overexpressed 14-3-3 gamma Protein Require Specific Amino Acids within 14-3-3 gamma N-terminal Variable Region II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA PROTEIN; IMMUNOHISTOCHEMICAL EXPRESSION; STRUCTURAL BASIS; LUNG-CANCER; T-CELLS; 14-3-3-SIGMA; RECEPTOR; TUMOR; CARCINOMA; PATHWAY	Members of the 14-3-3 superfamily regulate numerous cellular functions by binding phosphoproteins. The seven human isoforms (and the myriad of other eukaryotic 14-3-3 proteins) are highly conserved in amino acid sequence and secondary structure, yet there is abundant evidence that the various isoforms manifest disparate as well as common functions. Several of the human 14-3-3 isoforms are dysregulated in certain cancers and thus have been implicated in oncogenesis; experimentally, 14-3-3 gamma behaves as an oncogene, whereas 14-3-3 gamma acts as a tumor suppressor. In this study, we sought to localize these opposing phenotypes to specific regions of the two isoforms and then to individual amino acids therein. Using a bioinformatics approach, six variable regions (VRI-VRVI) were identified. Using this information, two sets of constructs were created in which N-terminal portions (including either VRI-IV or only VRI and VRII) of 14-3-3 gamma and 14-3-3 gamma were swapped; NIH3T3 cells overexpressing the four chimeric proteins were tested for transformation activity (focus formation, growth in soft agar) and activation of PI3K and MAPK signaling. We found that the specific phenotypes of 14-3-3 gamma are associated with the N-terminal 40 amino acids (VRI and VRII); in like fashion, VRI and VRII of 14-3-3 gamma dictated its tumor suppressor function. Using individual amino acid substitutions within the 14-3-3 gamma VRII, we identified two residues required for and two contributing to the gamma-specific phenotypes. Our observations suggest that isoform-specific phenotypes are dictated by a relatively few amino acids within variable regions.	[Martinez, Jesse D.] Univ Arizona, Arizona Canc Ctr, Dept Cell & Mol Med, Tucson, AZ 85724 USA	Arizona Center Cancer Care; University of Arizona	Martinez, JD (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Cell & Mol Med, 1515 N Campbell Ave, Tucson, AZ 85724 USA.	jmartinez@azcc.arizona.edu			National Institutes of Health [CA107510, R56CA107510, CA023074]; NATIONAL CANCER INSTITUTE [R56CA107510, P30CA023074, R01CA107510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA107510, R56CA107510, and CA023074 (to J. D. M.).	Akahira J, 2004, CLIN CANCER RES, V10, P2687, DOI 10.1158/1078-0432.CCR-03-0510; Ballare E, 2001, J CLIN ENDOCR METAB, V86, P3809, DOI 10.1210/jc.86.8.3809; Ballif BA, 2006, J PROTEOME RES, V5, P2372, DOI 10.1021/pr060206k; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Choi JE, 2011, CANCER LETT, V303, P99, DOI 10.1016/j.canlet.2011.01.015; Craparo A, 1997, J BIOL CHEM, V272, P11663; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Fernandez A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-604; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Higaki M, 1996, J BIOL CHEM, V271, P29342, DOI 10.1074/jbc.271.46.29342; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Ito Y, 2003, CANCER LETT, V200, P161, DOI 10.1016/S0304-3835(03)00282-9; Kuramitsu Y, 2010, ANTICANCER RES, V30, P4459; LEFFERS H, 1993, J MOL BIOL, V231, P982, DOI 10.1006/jmbi.1993.1346; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; Meller N, 1996, MOL CELL BIOL, V16, P5782; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Moreira JMA, 2005, MOL CELL PROTEOMICS, V4, P555, DOI 10.1074/mcp.M400205-MCP200; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Okada T, 2006, ANTICANCER RES, V26, P3105; Qi WQ, 2007, MOL CARCINOGEN, V46, P847, DOI 10.1002/mc.20314; Radhakrishnan VM, 2011, GENE CHROMOSOME CANC, V50, P830, DOI 10.1002/gcc.20904; Radhakrishnan VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011433; Rodriguez JA, 2005, WORLD J SURG, V29, P297, DOI 10.1007/s00268-004-7843-0; Sano T, 2004, PATHOL INT, V54, P743, DOI 10.1111/j.1440-1827.2004.01747.x; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Tanaka K, 2004, INT J ONCOL, V25, P1591; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Wakui H, 1997, J BIOL CHEM, V272, P8153, DOI 10.1074/jbc.272.13.8153; Wang WF, 1996, J MOL EVOL, V43, P384; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wurch T, 1998, MOL PHARMACOL, V54, P1088, DOI 10.1124/mol.54.6.1088; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	34	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43300	43311		10.1074/jbc.M112.397877	http://dx.doi.org/10.1074/jbc.M112.397877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115241	hybrid, Green Published			2022-12-25	WOS:000312940800011
J	Benagli, C; Demarta, A; Caminada, A; Ziegler, D; Petrini, O; Tonolla, M				Benagli, Cinzia; Demarta, Antonella; Caminada, AnnaPaola; Ziegler, Dominik; Petrini, Orlando; Tonolla, Mauro			A Rapid MALDI-TOF MS Identification Database at Genospecies Level for Clinical and Environmental Aeromonas Strains	PLOS ONE			English	Article							DESORPTION/IONIZATION-MASS SPECTROMETRY; GENUS AEROMONAS; SP-NOV.; PHYLOGENETIC ANALYSIS; SUBSP NOV.; BIVALVE MOLLUSKS; SALMONICIDA; HYDROPHILA; SEQUENCES; GYRB	The genus Aeromonas has undergone a number of taxonomic and nomenclature revisions over the past 20 years, and new (sub) species and biogroups are continuously described. Standard identification methods such as biochemical characterization have deficiencies and do not allow clarification of the taxonomic position. This report describes the development of a matrix-assisted laser desorption/ ionisation-time of flight mass spectrometry (MALDI-TOF MS) identification database for a rapid identification of clinical and environmental Aeromonas isolates.	[Benagli, Cinzia; Demarta, Antonella; Caminada, AnnaPaola; Petrini, Orlando; Tonolla, Mauro] Inst Microbiol, Bellinzona, Switzerland; [Ziegler, Dominik] Mabritec AG, Riehen, Switzerland; [Tonolla, Mauro] Univ Geneva, Dept Plant Biol, Microbiol Unit, Geneva, Switzerland	University of Geneva	Benagli, C (corresponding author), Inst Microbiol, Bellinzona, Switzerland.	cinzia.benagli@ti.ch	Petrini, Orlando/G-4392-2010	Tonolla, Mauro/0000-0002-8861-7763; Petrini, Orlando/0000-0002-1234-7832				Austin BaA, 1996, GENUS AEROMONAS, P197; Benagli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016424; COLLINS MD, 1993, INT J SYST BACTERIOL, V43, P855, DOI 10.1099/00207713-43-4-855; Demarta A, 2004, SYST APPL MICROBIOL, V27, P343, DOI 10.1078/0723-2020-00276; Demarta A, 2000, EUR J EPIDEMIOL, V16, P447, DOI 10.1023/A:1007675424848; Donohue MJ, 2007, ANAL CHEM, V79, P1939, DOI 10.1021/ac0611420; Donohue MJ, 2006, J MICROBIOL METH, V65, P380, DOI 10.1016/j.mimet.2005.08.005; Esteve C, 2003, INT J SYST EVOL MICR, V53, P1411, DOI 10.1099/ijs.0.02504-0; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Gaia V, 2011, SYST APPL MICROBIOL, V34, P40, DOI 10.1016/j.syapm.2010.11.007; Hahn D, 2011, SYST APPL MICROBIOL, V34, P63, DOI 10.1016/j.syapm.2010.11.009; Harf-Monteil C, 2004, INT J SYST EVOL MICR, V54, P481, DOI 10.1099/ijs.0.02786-0; Hinse D, 2011, SYST APPL MICROBIOL, V34, P52, DOI 10.1016/j.syapm.2010.11.010; Huys G, 2005, SYST APPL MICROBIOL, V28, P604, DOI 10.1016/j.syapm.2005.03.012; Huys G, 2003, INT J SYST EVOL MICR, V53, P885, DOI 10.1099/ijs.0.02357-0; Huys G, 2002, INT J SYST EVOL MICR, V52, P705, DOI [10.1099/ijs.0.01844-0, 10.1099/00207713-52-3-705]; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kupfer M, 2006, INT J SYST EVOL MICR, V56, P2743, DOI 10.1099/ijs.0.63650-0; Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003; Martin-Carnahan A, 2005, BERGEYS MANUAL SYSTE, V2, P557; Martinez-Murcia AJ, 2008, INT J SYST EVOL MICR, V58, P1169, DOI 10.1099/ijs.0.65352-0; MARTINEZ-MURCIA A J, 1991, Microbiologia (Madrid), V7, P106; Martinez-Murcia AJ, 2005, INT MICROBIOL, V8, P259; Martinez-Murcia AJ, 1999, INT J SYST BACTERIOL, V49, P1403, DOI 10.1099/00207713-49-4-1403; Martinez-Murcia A, 2009, CURR MICROBIOL, V58, P76, DOI 10.1007/s00284-008-9278-6; MARTINEZMURCIA AJ, 1992, INT J SYST BACTERIOL, V42, P412, DOI 10.1099/00207713-42-3-412; Minana-Galbis D, 2004, INT J SYST EVOL MICR, V54, P2073, DOI 10.1099/ijs.0.63202-0; Minana-Galbis D, 2004, ENVIRON MICROBIOL, V6, P198, DOI 10.1046/j.1462-2920.2004.00554.x; Minana-Galbis D, 2007, INT J SYST EVOL MICR, V57, P582, DOI 10.1099/ijs.0.64497-0; Minana-Galbis D, 2010, SYST APPL MICROBIOL, V33, P15, DOI 10.1016/j.syapm.2009.11.002; Pavan ME, 2000, INT J SYST EVOL MICR, V50, P1119, DOI 10.1099/00207713-50-3-1119; Pidiyar V, 2002, INT J SYST EVOL MICR, V52, P1723, DOI [10.1099/ijs.0.02019-0, 10.1099/00207713-52-5-1723]; RUIMY R, 1994, INT J SYST BACTERIOL, V44, P416, DOI 10.1099/00207713-44-3-416; Saavedra MJ, 2006, INT J SYST EVOL MICR, V56, P2481, DOI 10.1099/ijs.0.64351-0; Saavedra MJ, 2007, ANTON LEEUW INT J G, V91, P159, DOI 10.1007/s10482-006-9107-5; Sato H, 2011, SYST APPL MICROBIOL, V34, P76, DOI 10.1016/j.syapm.2010.07.003; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Welker M, 2006, PEPTIDES, V27, P2090, DOI 10.1016/j.peptides.2006.03.014; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Yanez MA, 2003, INT J SYST EVOL MICR, V53, P875, DOI 10.1099/ijs.0.02443-0	43	49	51	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48441	10.1371/journal.pone.0048441	http://dx.doi.org/10.1371/journal.pone.0048441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119019	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500138
J	Bohra, R; Schoning, W; Klawitter, J; Brunner, N; Schmitz, V; Shokati, T; Lawrence, R; Arbelaez, MF; Schniedewind, B; Christians, U; Klawitter, J				Bohra, Rahul; Schoening, Wenzel; Klawitter, Jelena; Brunner, Nina; Schmitz, Volker; Shokati, Touraj; Lawrence, Ryan; Arbelaez, Maria Fernanda; Schniedewind, Bjoern; Christians, Uwe; Klawitter, Jost			Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat	PLOS ONE			English	Article							CALCINEURIN INHIBITOR NEPHROTOXICITY; CHRONIC ALLOGRAFT DYSFUNCTION; NOVO KIDNEY-TRANSPLANTATION; HIGH-RESOLUTION H-1-NMR; MAGNETIC-RESONANCE; LONGITUDINAL ASSESSMENT; EXPOSURE CYCLOSPORINE; PATTERN-RECOGNITION; MASS-SPECTROMETRY; OXIDATIVE STRESS	Enhancement of calcineurin inhibitor nephrotoxicity by sirolimus (SRL) is limiting the clinical use of this drug combination. We compared the dose-dependent effects of the structurally related everolimus (EVL) and sirolimus (SRL) alone, and in combination with cyclosporine (CsA), on the rat kidney. Lewis rats were treated by oral gavage for 28 days using a checkerboard dosing format (0, 3.0, 6.0 and 10.0 CsA and 0, 0.5, 1.5 and 3.0 mg/kg/day SRL or EVL, n = 4/dose combination). After 28 days, oxidative stress, energy charge, kidney histologies, glomerular filtration rates, and concentrations of the immunosuppressants were measured along with H-1-magnetic resonance spectroscopy (MRS) and gas chromatography-mass spectrometry profiles of cellular metabolites in urine. The combination of CsA with SRL led to higher urinary glucose concentrations and decreased levels of urinary Krebs cycle metabolites when compared to controls, suggesting that CsA+SRL negatively impacted proximal tubule metabolism. Unsupervised principal component analysis of MRS spectra distinguished unique urine metabolite patterns of rats treated with CsA+SRL from those treated with CsA+EVL and the controls. SRL, but not EVL blood concentrations were inversely correlated with urine Krebs cycle metabolite concentrations. Interestingly, the higher the EVL concentration, the closer urine metabolite patterns resembled those of controls, while in contrast, the combination of the highest doses of CsA+SRL showed the most significant differences in metabolite patterns. Surprisingly in this rat model, EVL and SRL in combination with CsA had different effects on kidney biochemistry, suggesting that further exploration of EVL in combination with low dose calcineurin inhibitors may be of potential benefit.	[Bohra, Rahul; Klawitter, Jelena; Brunner, Nina; Shokati, Touraj; Lawrence, Ryan; Arbelaez, Maria Fernanda; Schniedewind, Bjoern; Christians, Uwe; Klawitter, Jost] Univ Colorado Denver, Dept Anesthesiol, iC42 Clin Res & Dev, Aurora, CO USA; [Schoening, Wenzel; Brunner, Nina; Schmitz, Volker] Abt Allgemein Viszeral & Transplantationschirurg, Charite, Berlin, Germany	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Christians, U (corresponding author), Univ Colorado Denver, Dept Anesthesiol, iC42 Clin Res & Dev, Aurora, CO USA.	uwe.christians@ucdenver.edu	Klawitter, Jost/F-3976-2015	Klawitter, Jost/0000-0002-6413-4820; Schoning, Wenzel/0000-0002-0446-5126; Arbelaez, Maria/0000-0002-3958-1477	Novartis Pharma AG, Basel, Switzerland; United States National Institutes of Health (NIH) [R01 DK065094, R01HD070511, P30 DK048520]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD070511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, R01DK065094] Funding Source: NIH RePORTER	Novartis Pharma AG, Basel, Switzerland; United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported in part by Novartis Pharma AG, Basel, Switzerland, and the United States National Institutes of Health (NIH), grants R01 DK065094, R01HD070511 and P30 DK048520 (Mass Spectrometry Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh TF, 1996, TRANSPLANTATION, V62, P311, DOI 10.1097/00007890-199608150-00002; ANTHONY ML, 1994, ARCH TOXICOL, V69, P99, DOI 10.1007/s002040050144; Bairaktari E, 1998, CLIN CHEM, V44, P1256; Bechstein WO, 2000, TRANSPL INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x; Beckwith-Hall BM, 1998, CHEM RES TOXICOL, V11, P260, DOI 10.1021/tx9700679; Brosnan JT, 2010, MOL GENET METAB, V100, pS49, DOI 10.1016/j.ymgme.2010.02.020; Campistol JM, 2001, TRANSPLANTATION, V71, pSS42; Chapman JR, 2011, CLIN PHARMACOL THER, V90, P207, DOI 10.1038/clpt.2011.117; Chapman JR, 2011, AM J TRANSPLANT, V11, P693, DOI 10.1111/j.1600-6143.2011.03504.x; Christians U, 2000, J CHROMATOGR B, V748, P41, DOI 10.1016/S0378-4347(00)00380-7; Christians U, 2006, THER DRUG MONIT, V28, P39, DOI 10.1097/01.ftd.0000183385.27394.e7; Christians U, 2004, BRIT J PHARMACOL, V143, P388, DOI 10.1038/sj.bjp.0705939; CHRISTIANS U, 1993, PHARMACOL THERAPEUT, V57, P291, DOI 10.1016/0163-7258(93)90059-M; Christians Uwe, 2005, Expert Opin Drug Metab Toxicol, V1, P641, DOI 10.1517/17425255.1.4.641; Christians U, 2011, BIOMARKERS OF KIDNEY DISEASE, P39, DOI 10.1016/B978-0-12-375672-5.10003-9; Fleck C, 1999, PHYSIOL RES, V48, P267; Foxall PJD, 1997, CLIN CANCER RES, V3, P1507; Garrod S, 2001, MAGNET RESON MED, V45, P781, DOI 10.1002/mrm.1106; Gullestad L, 2010, TRANSPLANTATION, V89, P864, DOI 10.1097/TP.0b013e3181cbac2d; Halligan S, 1995, TOXICOL LETT, V81, P15, DOI 10.1016/0378-4274(95)03399-8; HARRISON MP, 1991, BIOCHEM PHARMACOL, V41, P2045, DOI 10.1016/0006-2952(91)90150-4; Haschke M, 2007, CLIN CHEM, V53, P489, DOI 10.1373/clinchem.2006.078972; Hauben M, 1996, PHARMACOTHERAPY, V16, P576; Helderman JH, 2003, AM J TRANSPLANT, V3, P41, DOI 10.1034/j.1600-6143.3.s4.5.x; Holmes E, 1998, NMR BIOMED, V11, P235, DOI 10.1002/(SICI)1099-1492(199806/08)11:4/5<235::AID-NBM507>3.0.CO;2-V; Holt DW, 2003, TRANSPL P, V35, p157S, DOI 10.1016/S0041-1345(03)00214-8; Jacobsen W, 2001, TRANSPLANT P, V33, P514, DOI 10.1016/S0041-1345(00)02116-3; Kahan BD, 2001, TRANSPLANTATION, V71, pSS52; Kahan BD, 2001, TRANSPLANTATION, V71, P1400, DOI 10.1097/00007890-200105270-00008; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Keown P, 2001, TRANSPLANTATION, V72, P1024; Klawitter J, 2012, J PROTEOME IN PRESS; Klawitter J, 2011, RAPID COMMUN MASS SP, V25, P463, DOI 10.1002/rcm.4871; Klawitter J, 2010, CHEM RES TOXICOL, V23, P608, DOI 10.1021/tx900351q; Klawitter J, 2007, ANAL BIOCHEM, V365, P230, DOI 10.1016/j.ab.2007.03.018; Klawitter J, 2010, BRIT J CLIN PHARMACO, V70, P241, DOI 10.1111/j.1365-2125.2010.03689.x; Klawitter J, 2010, J PROTEOME RES, V9, P865, DOI 10.1021/pr900761m; Klawitter J, 2009, CHEM RES TOXICOL, V22, P118, DOI 10.1021/tx800253x; Kovarik JM, 2004, THER DRUG MONIT, V26, P499, DOI 10.1097/00007691-200410000-00007; Kovarik JM, 2001, CLIN PHARMACOL THER, V69, P48, DOI 10.1067/mcp.2001.112969; Lorenz JN, 1999, AM J PHYSIOL-RENAL, V276, pF172, DOI 10.1152/ajprenal.1999.276.1.F172; Nankivell BJ, 2006, TRANSPLANTATION, V81, P643, DOI 10.1097/01.tp.0000190423.82154.01; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Nashan B, 2002, THER DRUG MONIT, V24, P53, DOI 10.1097/00007691-200202000-00010; NICHOLSON JK, 1989, MOL PHARMACOL, V36, P398; Opelz G, 2008, TRANSPLANTATION, V86, P371, DOI 10.1097/TP.0b013e31817fdddb; Podder H, 2001, J AM SOC NEPHROL, V12, P1059, DOI 10.1681/ASN.V1251059; Potena L, 2010, TRANSPLANTATION, V89, P263, DOI 10.1097/TP.0b013e3181c42b95; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; RACUSEN LC, 1988, INT REV EXP PATHOL, V30, P107; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Robertson DG, 2000, TOXICOL SCI, V57, P326, DOI 10.1093/toxsci/57.2.326; Salvadori M, 2009, TRANSPLANTATION, V88, P1194, DOI 10.1097/TP.0b013e3181bb43ec; SATTLER M, 1992, DRUG METAB DISPOS, V20, P753; Schoeppler K, 2011, AM J TRANSPLANT, V11, P414; Schuurman HJ, 1997, TRANSPLANTATION, V64, P32, DOI 10.1097/00007890-199707150-00007; Serkova N, 1999, J PHARMACOL EXP THER, V289, P800; Serkova N, 2000, BRIT J PHARMACOL, V129, P485, DOI 10.1038/sj.bjp.0703079; Serkova N, 2001, BRIT J PHARMACOL, V133, P875, DOI 10.1038/sj.bjp.0704142; Serkova Natalie, 2003, Curr Opin Investig Drugs, V4, P1287; Shihab FS, 2005, AM J TRANSPLANT, V5, P222; Shockcor John P., 2002, Current Topics in Medicinal Chemistry, V2, P35, DOI 10.2174/1568026023394498; Silva HT, 2010, AM J TRANSPLANT, V10, P1401, DOI 10.1111/j.1600-6143.2010.03129.x; Stepkowski SM, 1997, CLIN EXP IMMUNOL, V108, P63, DOI 10.1046/j.1365-2249.1997.d01-984.x; Tharakan JF, 2008, CLIN NUTR, V27, P513, DOI 10.1016/j.clnu.2008.04.014; Wishart DS, 2008, CONTRIB NEPHROL, V160, P76, DOI 10.1159/000125935; Womer KL, 2009, AM J TRANSPLANT, V9, P1265, DOI 10.1111/j.1600-6143.2009.02639.x	68	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48063	10.1371/journal.pone.0048063	http://dx.doi.org/10.1371/journal.pone.0048063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118926	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500060
J	Fonio, E; Benjamini, Y; Golani, I				Fonio, Ehud; Benjamini, Yoav; Golani, Ilan			Short and Long Term Measures of Anxiety Exhibit Opposite Results	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; ANIMAL-MODELS; OPEN-FIELD; FREE EXPLORATION; DRUG DISCOVERY; BEHAVIOR; MICE; VALIDATION; TRAIT; DISORDERS	Animal models of human diseases of the central nervous system, generalized anxiety disorder included, are essential for the study of the brain-behavior interface and obligatory for drug development; yet, these models fail to yield new insights and efficacious drugs. By increasing testing duration hundredfold and arena size tenfold, and comparing the behavior of the common animal model to that of wild mice, we raise concerns that chronic anxiety might have been measured at the wrong time, for the wrong duration, and in the wrong animal. Furthermore, the mice start the experimental session with a short period of transient adaptation to the novel environment (habituation period) and a long period reflecting the respective trait of the mice. Using common measures of anxiety reveals that mice exhibit opposite results during these periods suggesting that chronic anxiety should be measured during the post-habituation period. We recommend tools for measuring the transient period, and provide suggestions for characterizing the post habituation period.	[Fonio, Ehud] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Benjamini, Yoav] Tel Aviv Univ, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel; [Golani, Ilan] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Tel Aviv University; Tel Aviv University	Fonio, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ehud.fonio@weizmann.ac.il			Israel Science Foundation (ISF), of the Israeli Academy of Science [915/05]	Israel Science Foundation (ISF), of the Israeli Academy of Science(Israel Science Foundation)	This study was supported by the Israel Science Foundation (ISF), of the Israeli Academy of Science (Grant #915/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreatini R, 2000, PROG NEURO-PSYCHOPH, V24, P549, DOI 10.1016/S0278-5846(00)00092-0; Bakker VJ, 2004, CONSERV BIOL, V18, P689, DOI 10.1111/j.1523-1739.2004.00149.x; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Belzung C, 1997, BEHAV PHARMACOL, V8, P541, DOI 10.1097/00008877-199711000-00012; BENHAMOU S, 1990, BEHAV PROCESS, V22, P235, DOI 10.1016/0376-6357(91)90097-J; Benjamini Y, 2011, P NATL ACAD SCI USA, V108, P15580, DOI 10.1073/pnas.1014837108; BIGNAMI G, 1988, PHARMACOL BIOCHEM BE, V29, P771, DOI 10.1016/0091-3057(88)90204-3; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Clement Y, 1998, NEUROSCI BIOBEHAV R, V22, P623, DOI 10.1016/S0149-7634(97)00058-4; de Mooij-van Malsen A, 2009, BIOL PSYCHIAT, V66, P1123, DOI 10.1016/j.biopsych.2009.06.016; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; Drai D, 2001, BEHAV BRAIN RES, V125, P133, DOI 10.1016/S0166-4328(01)00290-X; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Ennaceur A, 2008, BEHAV BRAIN RES, V188, P136, DOI 10.1016/j.bbr.2007.10.026; Fonio E, 2006, GENES BRAIN BEHAV, V5, P380, DOI 10.1111/j.1601-183X.2005.00170.x; Fonio E, 2009, P NATL ACAD SCI USA, V106, P21335, DOI 10.1073/pnas.0812513106; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Hall CS, 1936, J COMP PSYCHOL, V22, P345, DOI 10.1037/h0059253; Haller J, 2012, CURR OPIN PSYCHIATR, V25, P59, DOI 10.1097/YCO.0b013e32834de34f; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Honig G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006797; Jain A, 2012, EUR NEUROPSYCHOPHARM, V22, P153, DOI 10.1016/j.euroneuro.2011.07.001; Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koide T, 2011, EXP ANIM TOKYO, V60, P347, DOI 10.1538/expanim.60.347; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; Maroteaux G, 2012, GENES BRAIN BEHAV, V11, P772, DOI 10.1111/j.1601-183X.2012.00820.x; Menard J, 1999, NEUROSCI BIOBEHAV R, V23, P591, DOI 10.1016/S0149-7634(98)00056-6; Nemati F, 2007, BEHAV BRAIN RES, V182, P119, DOI 10.1016/j.bbr.2007.05.016; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Ohl F, 2003, CLIN NEUROSCI RES, V3, P233, DOI 10.1016/S1566-2772(03)00084-7; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rodgers RJ, 1997, BEHAV PHARMACOL, V8, P477, DOI 10.1097/00008877-199711000-00003; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Roy V, 2009, PSYCHOPHARMACOLOGY, V203, P131, DOI 10.1007/s00213-008-1378-2; Sams-Dodd F, 2005, DRUG DISCOV TODAY, V10, P139, DOI 10.1016/S1359-6446(04)03316-1; Steckler T, 2008, ANIMAL TRANSLATIONAL, V1, P117; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Wahlsten D, 2003, GENES BRAIN BEHAV, V2, P71, DOI 10.1034/j.1601-183X.2003.00012.x; WELKER WI, 1957, PSYCHOL REP, V3, P95, DOI 10.2466/pr0.1957.3.g.95; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	46	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48414	10.1371/journal.pone.0048414	http://dx.doi.org/10.1371/journal.pone.0048414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WJ	23119008	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500128
J	Gao, DY; Jimenez-Lopez, JC; Iwata, A; Gill, N; Jackson, SA				Gao, Dongying; Jimenez-Lopez, Jose C.; Iwata, Aiko; Gill, Navdeep; Jackson, Scott A.			Functional and Structural Divergence of an Unusual LTR Retrotransposon Family in Plants	PLOS ONE			English	Article							RICE ORYZA-SATIVA; SWISS-MODEL; TRANSPOSABLE ELEMENTS; CENTROMERIC REGIONS; GENOME SIZE; SEQUENCES; PROMOTER; DYNAMICS; ELECTROSTATICS; IDENTIFICATION	Retrotransposons with long terminal repeats (LTRs) more than 3 kb are not frequent in most eukaryotic genomes. Rice LTR retrotransposon, Retrosat2, has LTRs greater than 3.2 kb and two open reading frames (ORF): ORF1 encodes enzymes for retrotransposition whereas no function can be assigned to ORF0 as it is not found in any other organism. A variety of experimental and in silico approaches were used to determine the origin of Retrosat2 and putative function of ORF0. Our data show that not only is Retrosat2 highly abundant in the Oryza genus, it may yet be active in rice. Homologs of Retrosat2 were identified in maize, sorghum, Arabidopsis and other plant genomes suggesting that the Retrosat2 family is of ancient origin. Several putatively cis-acting elements, some multicopy, that regulate retrotransposon replication or responsiveness to environmental factors were found in the LTRs of Retrosat2. Unlike the ORF1, the ORF0 sequences from Retrosat2 and homologs are divergent at the sequence level, 3D-structures and predicted biological functions. In contrast to other retrotransposon families, Retrosat2 and its homologs are dispersed throughout genomes and not concentrated in the specific chromosomal regions, such as centromeres. The genomic distribution of Retrosat2 homologs varies across species which likely reflects the differing evolutionary trajectories of this retrotransposon family across diverse species.	[Gao, Dongying; Iwata, Aiko; Gill, Navdeep; Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Jimenez-Lopez, Jose C.] High Council Sci Res, Estn Expt Zaidin, Dept Biochem Cell & Mol Biol Plants, Granada, Spain; [Gill, Navdeep] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University System of Georgia; University of Georgia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of British Columbia	Gao, DY (corresponding author), Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA.	dgao@uga.edu; sjackson@uga.edu	Jimenez-Lopez, Jose C./H-5896-2011	Jimenez-Lopez, Jose C./0000-0002-1470-360X; jackson, scott/0000-0002-3172-1607; Iwata-Otsubo, Aiko/0000-0001-9378-3961	National Science Foundation [0424833]; Division of Biological Infrastructure (DBI) [0603927]; Integrated and Organismal Biology (IOS) [0701382]; Molecular and Cellular Biosciences (MCB) [1026200]; Div Of Molecular and Cellular Bioscience [1026200] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division of Biological Infrastructure (DBI); Integrated and Organismal Biology (IOS); Molecular and Cellular Biosciences (MCB); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Science Foundation 0424833, Division of Biological Infrastructure (DBI) 0603927, Integrated and Organismal Biology (IOS) 0701382 and Molecular and Cellular Biosciences (MCB) 1026200 provided funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2007, PLANT J, V52, P342, DOI 10.1111/j.1365-313X.2007.03242.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benachenhou F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005179; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bowen NJ, 2001, GENOME RES, V11, P1527, DOI 10.1101/gr.164201; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; Chang W, 2008, PLANT J, V56, P40, DOI 10.1111/j.1365-313X.2008.03572.x; Cheng ZK, 2001, GENOME RES, V11, P2133, DOI 10.1101/gr.194601; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gao D. Y., 2011, Tropical Plant Biology, V4, P217, DOI 10.1007/s12042-011-9083-4; Gao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032010; Gao DY, 2009, PLANT J, V60, P820, DOI 10.1111/j.1365-313X.2009.04005.x; Gao LH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-18; Goldenberg NM, 2010, CANCER RES, V70, P1277, DOI 10.1158/0008-5472.CAN-09-2905; Goodwin TJD, 2000, GENOME RES, V10, P174, DOI 10.1101/gr.10.2.174; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUNTAKA RV, 1993, MICROBIOL REV, V57, P511, DOI 10.1128/MMBR.57.3.511-521.1993; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jiang N, 2002, GENETICS, V161, P1293; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumekawa N, 1999, MOL GEN GENET, V260, P593, DOI 10.1007/s004380050933; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laten HM, 1998, P NATL ACAD SCI USA, V95, P6897, DOI 10.1073/pnas.95.12.6897; Lauermann V, 1997, GENETICS, V145, P911; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Ling JH, 2003, NUCLEIC ACIDS RES, V31, P4582, DOI 10.1093/nar/gkg646; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Marsano RM, 2005, GENE, V357, P115, DOI [10.1016/j.gene.2005.06.010, 10.1016/j.gene.2005.06.005]; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Matthews CM, 1998, J MOL EVOL, V46, P729, DOI 10.1007/PL00006354; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; MICHAILLE JJ, 1990, NUCLEIC ACIDS RES, V18, P674, DOI 10.1093/nar/18.3.674; Miller JT, 1998, GENETICS, V150, P1615; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; Neumann P, 2003, PLANT MOL BIOL, V53, P399, DOI 10.1023/B:PLAN.0000006945.77043.ce; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Perlman PS, 2004, SCIENCE, V303, P182, DOI 10.1126/science.1093514; Pi W, 2007, P NATL ACAD SCI USA, V107, P12992; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Prudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Skolnick J, 2009, BRIEF BIOINFORM, V10, P378, DOI 10.1093/bib/bbp017; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Takeda S, 1999, PLANT J, V18, P383, DOI 10.1046/j.1365-313X.1999.00460.x; TEMIN HM, 1981, CELL, V27, P1, DOI 10.1016/0092-8674(81)90353-6; Vitte C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-218; Wang H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-382; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wessler SR, 2006, P NATL ACAD SCI USA, V103, P17600, DOI 10.1073/pnas.0607612103; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wright DA, 2002, GENOME RES, V12, P122, DOI 10.1101/gr.196001	68	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48595	10.1371/journal.pone.0048595	http://dx.doi.org/10.1371/journal.pone.0048595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119066	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500175
J	Marko, NF; Weil, RJ				Marko, Nicholas F.; Weil, Robert J.			Non-Gaussian Distributions Affect Identification of Expression Patterns, Functional Annotation, and Prospective Classification in Human Cancer Genomes	PLOS ONE			English	Article							MICROARRAY DATA; GENE ONTOLOGY; NORMALIZATION; DATABASE; PATHWAY; VALUES; TOOL	Introduction: Gene expression data is often assumed to be normally-distributed, but this assumption has not been tested rigorously. We investigate the distribution of expression data in human cancer genomes and study the implications of deviations from the normal distribution for translational molecular oncology research. Methods: We conducted a central moments analysis of five cancer genomes and performed empiric distribution fitting to examine the true distribution of expression data both on the complete-experiment and on the individual-gene levels. We used a variety of parametric and nonparametric methods to test the effects of deviations from normality on gene calling, functional annotation, and prospective molecular classification using a sixth cancer genome. Results: Central moments analyses reveal statistically-significant deviations from normality in all of the analyzed cancer genomes. We observe as much as 37% variability in gene calling, 39% variability in functional annotation, and 30% variability in prospective, molecular tumor subclassification associated with this effect. Conclusions: Cancer gene expression profiles are not normally-distributed, either on the complete-experiment or on the individual-gene level. Instead, they exhibit complex, heavy-tailed distributions characterized by statistically-significant skewness and kurtosis. The non-Gaussian distribution of this data affects identification of differentially-expressed genes, functional annotation, and prospective molecular classification. These effects may be reduced in some circumstances, although not completely eliminated, by using nonparametric analytics. This analysis highlights two unreliable assumptions of translational cancer gene expression analysis: that "small" departures from normality in the expression data distributions are analytically-insignificant and that "robust" gene-calling algorithms can fully compensate for these effects.	[Marko, Nicholas F.] Univ Cambridge, Canc Res United Kingdom Cambridge Res Inst, Cambridge, England; [Marko, Nicholas F.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 9EW, England; [Weil, Robert J.] Cleveland Clin, Brain Tumor & Neurooncol Ctr, Cleveland, OH 44106 USA	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Cleveland Clinic Foundation	Marko, NF (corresponding author), Univ Cambridge, Canc Res United Kingdom Cambridge Res Inst, Cambridge, England.	Nicholas.Marko@cancer.org.uk			American Association of Neurological Surgeons' William P. VanWagenen Fellowship program; United States Department of Defense Breast Cancer Research Program [W81XWH-062-0033]; Melvin Burkhardt chair in neurosurgical oncology; Karen Colina Wilson research endowment within the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic Foundation; Cancer Research UK [19556] Funding Source: researchfish	American Association of Neurological Surgeons' William P. VanWagenen Fellowship program; United States Department of Defense Breast Cancer Research Program(United States Department of Defense); Melvin Burkhardt chair in neurosurgical oncology; Karen Colina Wilson research endowment within the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic Foundation; Cancer Research UK(Cancer Research UK)	NFM is supported by a grant from the American Association of Neurological Surgeons' William P. VanWagenen Fellowship program. RJW is supported in part by Grant No.W81XWH-062-0033 from the United States Department of Defense Breast Cancer Research Program, by the Melvin Burkhardt chair in neurosurgical oncology, and by the Karen Colina Wilson research endowment within the Brain Tumor and Neuro-oncology Center at the Cleveland Clinic Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogner V, 2011, SHOCK, V35, P245, DOI 10.1097/SHK.0b013e3181fc904d; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Casellas J, 2008, ANIM GENET, V39, P89, DOI 10.1111/j.1365-2052.2007.01670.x; Casellas J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038919; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Doric D, 2009, QUAL QUANT, V43, P481, DOI 10.1007/s11135-007-9128-9; ECOG, 2011, TAILORX TRIAL; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Giles PJ, 2003, BIOINFORMATICS, V19, P2254, DOI 10.1093/bioinformatics/btg311; Hardiman Gary, 2008, V448, P21, DOI 10.1007/978-1-59745-205-2_2; Hardin J, 2009, BIOSTATISTICS, V10, P446, DOI 10.1093/biostatistics/kxp003; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Health NIo, 2011, CANC GEN ATL; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson N, 1949, BIOMETRIKA, P36; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katara P, 2010, BIOINFORMATION, V5, P31, DOI 10.6026/97320630005031; Krishnamoorthy K, 2006, STAT TEXTB MONOGR, P1; MANOUKIAN EB, 1988, AM STAT, V42, P77, DOI 10.2307/2685268; Marko NF, 2010, GENOMICS, V95, P16, DOI 10.1016/j.ygeno.2009.09.007; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mathur Sunil, 2005, Appl Bioinformatics, V4, P247, DOI 10.2165/00822942-200504040-00004; Nguyen DV, 2002, BIOINFORMATICS, V18, P1216, DOI 10.1093/bioinformatics/18.9.1216; OHagan A., 1994, KENDALLS ADV THEORY; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Polya G, 1920, MATH Z, V8, P171, DOI 10.1007/BF01206525; Posekany A, 2011, BIOINFORMATICS, V27, P807, DOI 10.1093/bioinformatics/btr018; Posekany A, 2011, MACHINE LEARNING SYS, P63; Seo J, 2006, BIOINFORMATICS, V22, P808, DOI 10.1093/bioinformatics/btk052; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SWOG, 2011, RXPONDER TRIAL; Theilhaber J, 2002, GENOME RES, V12, P165, DOI 10.1101/gr.182601; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Westfall PH, 1993, RESAMPLING BASED MUL, Vxvii; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wong W, DCHIP; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230	47	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e46935	10.1371/journal.pone.0046935	http://dx.doi.org/10.1371/journal.pone.0046935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118863	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500012
J	Schwarzer, A; Wolf, B; Fisher, JL; Schwaab, T; Olek, S; Baron, U; Tomlinson, CR; Seigne, JD; Crosby, NA; Gui, J; Hampton, TH; Fadul, CE; Heaney, JA; Ernstoff, MS				Schwarzer, Adrian; Wolf, Benita; Fisher, Jan L.; Schwaab, Thomas; Olek, Sven; Baron, Udo; Tomlinson, Craig R.; Seigne, John D.; Crosby, Nancy A.; Gui, Jiang; Hampton, Thomas H.; Fadul, Camilo E.; Heaney, John A.; Ernstoff, Marc S.			Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy	PLOS ONE			English	Article							HIGH-DOSE INTERLEUKIN-2; PERIPHERAL-BLOOD; FOXP3 EXPRESSION; IMMUNOTHERAPY; MELANOMA; TRIAL	Purpose: To evaluate CD4(+)CD25(+)FOXP3(+) T regulatory cells (T-REG) and associated immune-regulatory pathways in peripheral blood lymphocytes (PBL) of metastatic renal cell carcinoma (mRCC) patients and healthy volunteers. We subsequently investigated the effects of immunotherapy on circulating T-REG combining an extensive phenotype examination, DNA methylation analysis and global transcriptome analysis. Design: Eighteen patients with mRCC and twelve volunteers (controls) were available for analysis. T-REG phenotype was examined using flow cytometry (FCM). T-REG were also quantified by analyzing the epigenetic status of the FOXP3 locus using methylation specific PCR. As a third approach, RNA of the PBL was hybridized to Affymetrix GeneChip Human Gene 1.0 ST Arrays and the gene signatures were explored using pathway analysis. Results: We observed higher numbers of T-REG in pre-treatment PBL of mRCC patients compared to controls. A significant increase in T-REG was detected in all mRCC patients after the two cycles of immunotherapy. The expansion of T-REG was significantly higher in non-responders than in responding patients. Methylation specific PCR confirmed the FCM data and circumvented the variability and subjectivity of the FCM method. Gene Set Enrichment Analysis (GSEA) of the microarray data showed significant enrichment of FOXP3 target genes, CTLA-4 and TGF-beta associated pathways in the patient cohort. Conclusion: Immune monitoring of the peripheral blood and tumor tissue is important for a wide range of diseases and treatment strategies. Adoption of methodology for quantifying TREG with the least variability and subjectivity will enhance the ability to compare and interpret findings across studies.	[Schwarzer, Adrian; Wolf, Benita; Fisher, Jan L.; Schwaab, Thomas; Crosby, Nancy A.; Fadul, Camilo E.; Ernstoff, Marc S.] Geisel Sch Med Dartmouth, Med Oncol Immunotherapy Grp, Hanover, NH USA; [Fisher, Jan L.; Crosby, Nancy A.; Fadul, Camilo E.; Ernstoff, Marc S.] Geisel Sch Med Dartmouth, Sect Hematol Oncol, Hanover, NH USA; [Olek, Sven; Baron, Udo] Epiontis GmbH, Berlin, Germany; [Tomlinson, Craig R.; Hampton, Thomas H.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA; [Seigne, John D.; Heaney, John A.] Geisel Sch Med Dartmouth, Urol Sect, Dept Surg, Hanover, NH USA; [Gui, Jiang] Geisel Sch Med Dartmouth, Sect Biostat & Epidemiol, Dept Family & Community Med, Hanover, NH USA; [Fadul, Camilo E.; Ernstoff, Marc S.] Geisel Sch Med Dartmouth, Immunotherapy Program, Hanover, NH USA; [Fadul, Camilo E.] Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH USA	Dartmouth College; Dartmouth College; Epiontis GmbH; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College	Ernstoff, MS (corresponding author), Geisel Sch Med Dartmouth, Med Oncol Immunotherapy Grp, Hanover, NH USA.	Marc.S.Ernstoff@Hitchcock.ORG	Schwarzer, Adrian/AAA-2571-2022; Tomlinson, Craig/F-1319-2017; Wolf, Benita/AAX-4507-2020	Wolf, Benita/0000-0001-5673-4239; Tomlinson, Craig/0000-0003-0923-1449; Schwarzer, Adrian/0000-0001-5684-2280; Hampton, Thomas/0000-0003-0543-402X; Baron, Udo/0000-0001-7432-3601	NIH [RO1 CA095648, P20RR016437, P20GM103413, P30CA023108, P42ES007373]; Berlex, Inc. [D0238]; NATIONAL CANCER INSTITUTE [R01CA095648, P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103413] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Berlex, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (RO1 CA095648, P20RR016437, P20GM103413, P30CA023108 and P42ES007373) and Berlex, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sven Olek and Udo Baron work at Epiontis who did contract testing for this study under a collaborative agreement. The authors received funding from Berlex, Inc. for the clinical trial (Protocol D0238) from which patient samples reported on in this paper originated. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; ATKINS MB, 1993, J CLIN ONCOL, V11, P661, DOI 10.1200/JCO.1993.11.4.661; Atzpodien J, 2004, J CLIN ONCOL, V22, P1188, DOI 10.1200/JCO.2004.06.155; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Cesana GC, 2006, J CLIN ONCOL, V24, P1169, DOI 10.1200/JCO.2005.03.6830; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs JFM, 2012, LANCET ONCOL, V13, pE32, DOI 10.1016/S1470-2045(11)70155-3; Jensen HK, 2009, CLIN CANCER RES, V15, P1052, DOI 10.1158/1078-0432.CCR-08-1296; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Motzer RJ, 2000, J CLIN ONCOL, V18, P1928, DOI 10.1200/JCO.2000.18.9.1928; Oberg HH, 2006, SCAND J IMMUNOL, V64, P353, DOI 10.1111/j.1365-3083.2006.01825.x; Onishi H, 2012, ANTICANCER RES, V32, P997; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Schwaab T, 2009, CLIN CANCER RES, V15, P4986, DOI 10.1158/1078-0432.CCR-08-3240; Sehouli J, 2011, EPIGENETICS-US, V6, P236, DOI 10.4161/epi.6.2.13755; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tatsugami K, 2010, J INTERF CYTOK RES, V30, P43, DOI 10.1089/jir.2009.0014; Team RDC, 2010, R LANG ENV STAT COMP; Twine N, 2003, CANCER RES, P1; Wang Y, 2012, J CELL MOL MED, V16, P425, DOI 10.1111/j.1582-4934.2011.01437.x; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Wolf AM, 2003, CLIN CANCER RES, V9, P606; Wolf B, 2012, PLOS ONE; Yao X, 2012, BLOOD, V119, P5688, DOI 10.1182/blood-2011-10-386482; Yi HF, 2006, CELL MOL IMMUNOL, V3, P189; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	41	12	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e46600	10.1371/journal.pone.0046600	http://dx.doi.org/10.1371/journal.pone.0046600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118856	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500007
J	Sliva, D; Loganathan, J; Jiang, JH; Jedinak, A; Lamb, JG; Terry, C; Baldridge, LA; Adamec, J; Sandusky, GE; Dudhgaonkar, S				Sliva, Daniel; Loganathan, Jagadish; Jiang, Jiahua; Jedinak, Andrej; Lamb, John G.; Terry, Colin; Baldridge, Lee Ann; Adamec, Jiri; Sandusky, George E.; Dudhgaonkar, Shailesh			Mushroom Ganoderma lucidum Prevents Colitis-Associated Carcinogenesis in Mice	PLOS ONE			English	Article							DEXTRAN SULFATE SODIUM; ABERRANT CRYPT FOCI; WATER-SOLUBLE EXTRACT; REI-SHI MYCELIA; MALE ICR MICE; BREAST-CANCER; PRENEOPLASTIC LESIONS; COLORECTAL ADENOMA; CULTURED MEDIUM; COLON TUMORS	Background: Epidemiological studies suggest that mushroom intake is inversely correlated with gastric, gastrointestinal and breast cancers. We have recently demonstrated anticancer and anti-inflammatory activity of triterpene extract isolated from mushroom Ganoderma lucidum (GLT). The aim of the present study was to evaluate whether GLT prevents colitis-associated carcinogenesis in mice. Methods/Principal Findings: Colon carcinogenesis was induced by the food-borne carcinogen (2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine [PhIP]) and inflammation (dextran sodium sulfate [DSS]) in mice. Mice were treated with 0, 100, 300 and 500 mg GLT/kg of body weight 3 times per week for 4 months. Cell proliferation, expression of cyclin D1 and COX-2 and macrophage infiltration was assessed by immunohistochemistry. The effect of GLT on XRE/AhR, PXR and rPXR was evaluated by the reporter gene assays. Expression of metabolizing enzymes CYP1A2, CYP3A1 and CYP3A4 in colon tissue was determined by immunohistochemistry. GLT treatment significantly suppressed focal hyperplasia, aberrant crypt foci (ACF) formation and tumor formation in mice exposed to PhIP/DSS. The anti-proliferative effects of GLT were further confirmed by the decreased staining with Ki-67 in colon tissues. PhIP/DSS-induced colon inflammation was demonstrated by the significant shortening of the large intestine and macrophage infiltrations, whereas GLT treatment prevented the shortening of colon lengths, and reduced infiltration of macrophages in colon tissue. GLT treatment also significantly down-regulated PhIP/DSS-dependent expression of cyclin D1, COX-2, CYP1A2 and CYP3A4 in colon tissue. Conclusions: Our data suggest that GLT could be considered as an alternative dietary approach for the prevention of colitisassociated cancer.	[Sliva, Daniel; Loganathan, Jagadish; Jiang, Jiahua; Jedinak, Andrej; Terry, Colin; Dudhgaonkar, Shailesh] Indiana Univ Hlth, Methodist Res Inst, Canc Res Lab, Indianapolis, IN USA; [Sliva, Daniel] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA; [Baldridge, Lee Ann; Sandusky, George E.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN USA; [Sliva, Daniel] Indiana Univ Sch Med, Indiana Univ, Ctr Canc, Indianapolis, IN USA; [Lamb, John G.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; [Adamec, Jiri] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Indiana University System; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Utah System of Higher Education; University of Utah; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sliva, D (corresponding author), Indiana Univ Hlth, Methodist Res Inst, Canc Res Lab, Indianapolis, IN USA.	dsliva@iuhealth.org	Jedinak, Andrej/AAB-7354-2020		Purdue-UAB Botanicals Research Center [P50 AT00477]; National Center for Complementary and Alternative Medicine; National Institutes of Health Office of Dietary Supplements; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER	Purdue-UAB Botanicals Research Center; National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institutes of Health Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This study was supported by the pilot grant to D.S. and J.A. from the Purdue-UAB Botanicals Research Center for age-related diseases (P50 AT00477, Connie M. Weaver, PI) from the National Center for Complementary and Alternative Medicine and the National Institutes of Health Office of Dietary Supplements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec J, 2009, J SEP SCI, V32, P4052, DOI 10.1002/jssc.200900496; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bobek P, 2001, BRIT J BIOMED SCI, V58, P164; Borchers AT, 2008, EXP BIOL MED, V233, P259, DOI 10.3181/0708-MR-227; Cheung C, 2005, CHEM RES TOXICOL, V18, P1471, DOI 10.1021/tx050136g; Dudhgaonkar S, 2009, INT IMMUNOPHARMACOL, V9, P1272, DOI 10.1016/j.intimp.2009.07.011; Dutra RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027122; Graham MJ, 2008, TOXICOLOGY, V254, P184, DOI 10.1016/j.tox.2008.09.002; Gupta AK, 2009, CURR OPIN GASTROEN, V25, P59, DOI 10.1097/MOG.0b013e32831db286; Hara M, 2003, NUTR CANCER, V46, P138, DOI 10.1207/S15327914NC4602_06; Hou XL, 2007, INT J PHARM, V337, P169, DOI 10.1016/j.ijpharm.2006.12.035; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Ishikawa TO, 2011, CARCINOGENESIS, V32, P417, DOI 10.1093/carcin/bgq268; Ishikawa TO, 2010, CARCINOGENESIS, V31, P729, DOI 10.1093/carcin/bgq002; Islam MS, 2008, BRIT J PHARMACOL, V154, P812, DOI 10.1038/bjp.2008.137; Jiang JH, 2004, NUTR CANCER, V49, P209, DOI 10.1207/s15327914nc4902_13; Kikuchi Y, 1997, VIRCHOWS ARCH, V431, P111, DOI 10.1007/s004280050076; Kim HJ, 2002, INT J CANCER, V97, P531, DOI 10.1002/ijc.10111; Kimura Y, 2002, ANTICANCER RES, V22, P3309; Kuhnel D, 2009, ARCH TOXICOL, V83, P763, DOI 10.1007/s00204-009-0406-2; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Lu HM, 2002, INT J MOL MED, V9, P113; Lu HM, 2001, ONCOL REP, V8, P1341; Mabley JG, 2003, AM J PHYSIOL-GASTR L, V284, pG138, DOI 10.1152/ajpgi.00060.2002; Mattila P, 2000, NUTRITION, V16, P694, DOI 10.1016/S0899-9007(00)00341-5; Mori Y, 2005, MUTAGENESIS, V20, P15, DOI 10.1093/mutage/gei001; Nakagama H, 2005, CANCER SCI, V96, P627, DOI 10.1111/j.1349-7006.2005.00107.x; Nakanishi M, 2007, CANCER SCI, V98, P1157, DOI 10.1111/j.1349-7006.2007.00528.x; Nishikawa A, 2005, TOXICOL SCI, V84, P243, DOI 10.1093/toxsci/kfi079; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Rohrmann S, 2009, AM J CLIN NUTR, V89, P1418, DOI 10.3945/ajcn.2008.26658; Shan L, 2002, CARCINOGENESIS, V23, P1561, DOI 10.1093/carcin/23.10.1561; Shin A, 2010, NUTR CANCER, V62, P476, DOI 10.1080/01635580903441212; Sinha R, 2005, CANCER RES, V65, P8034, DOI 10.1158/0008-5472.CAN-04-3429; Sliva D, 2006, LEUKEMIA RES, V30, P767, DOI 10.1016/j.leukres.2005.12.015; Smina TP, 2011, ENVIRON TOXICOL PHAR, V32, P438, DOI 10.1016/j.etap.2011.08.011; Steffensen IL, 1997, CARCINOGENESIS, V18, P1049, DOI 10.1093/carcin/18.5.1049; Sugimura T, 2000, CARCINOGENESIS, V21, P387, DOI 10.1093/carcin/21.3.387; Tanaka T, 2005, CARCINOGENESIS, V26, P229, DOI 10.1093/carcin/bgh292; Tanaka Takuji, 2009, J Carcinog, V8, P5; van Hogezand RA, 2002, SCAND J GASTROENTERO, V37, P48, DOI 10.1080/003655202320621454; Vrekoussis T, 2009, ANTICANCER RES, V29, P4995; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang X, 2007, BIOL PHARM BULL, V30, P1702, DOI 10.1248/bpb.30.1702; WARD JM, 1974, LAB INVEST, V30, P505; Weng CJ, 2009, J AGR FOOD CHEM, V57, P5049, DOI 10.1021/jf900828k; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yang XX, 2010, AM J PATHOL, V176, P733, DOI 10.2353/ajpath.2010.090524; Zhang M, 2009, INT J CANCER, V124, P1404, DOI 10.1002/ijc.24047	51	51	51	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47873	10.1371/journal.pone.0047873	http://dx.doi.org/10.1371/journal.pone.0047873			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118901	Green Published, gold			2022-12-25	WOS:000310705600018
J	Sharma, N; Hollensen, AK; Bak, RO; Staunstrup, NH; Schroder, LD; Mikkelsen, JG				Sharma, Nynne; Hollensen, Anne Kruse; Bak, Rasmus O.; Staunstrup, Nicklas Heine; Schroder, Lisbeth Dahl; Mikkelsen, Jacob Giehm			The Impact of cHS4 Insulators on DNA Transposon Vector Mobilization and Silencing in Retinal Pigment Epithelium Cells	PLOS ONE			English	Article							SLEEPING-BEAUTY TRANSPOSON; EMBRYONIC STEM-CELLS; STABLE TRANSGENE EXPRESSION; JAPANESE MEDAKA FISH; AC-LIKE ELEMENT; GENE-TRANSFER; PIGGYBAC TRANSPOSON; LENTIVIRAL VECTORS; TOL2 ELEMENT; T-CELLS	DNA transposons have become important vectors for efficient non-viral integration of transgenes into genomic DNA. The Sleeping Beauty (SB), piggyBac (PB), and Tol2 transposable elements have distinct biological properties and currently represent the most promising transposon systems for animal transgenesis and gene therapy. A potential obstacle, however, for persistent function of integrating vectors is transcriptional repression of the element and its genetic cargo. In this study we analyze the insulating effect of the 1.2-kb 5'-HS4 chicken beta-globin (cHS4) insulator element in the context of SB, PB, and Tol2 transposon vectors. By examining transgene expression from genomically inserted transposon vectors encoding a marker gene driven by a silencing-prone promoter, we detect variable levels of transcriptional silencing for the three transposon systems in retinal pigment epithelium cells. Notably, the PB system seems less vulnerable to silencing. Incorporation of cHS4 insulator sequences into the transposon vectors results in 2.2-fold and 1.5-fold increased transgene expression levels for insulated SB and PB vectors, respectively, but an improved persistency of expression was not obtained for insulated transgenes. Colony formation assays and quantitative excision assays unveil enhanced SB transposition efficiencies by the inclusion of the cHS4 element, resulting in a significant increase in the stable transfection rate for insulated SB transposon vectors in human cell lines. Our findings reveal a positive impact of cHS4 insulator inclusion for SB and PB vectors in terms of increased transgene expression levels and improved SB stable transfection rates, but also the lack of a long-term protective effect of the cHS4 insulator against progressive transgene silencing in retinal pigment epithelium cells.	[Sharma, Nynne; Hollensen, Anne Kruse; Bak, Rasmus O.; Staunstrup, Nicklas Heine; Schroder, Lisbeth Dahl; Mikkelsen, Jacob Giehm] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University	Mikkelsen, JG (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	giehm@hum-gen.au.dk	Bak, Rasmus O./AAH-9748-2021; Wilson, Matthew H/K-3193-2013; Staunstrup, Nicklas Heine/D-4870-2017	Bak, Rasmus O./0000-0002-7383-0297; Staunstrup, Nicklas Heine/0000-0002-5989-9298; Mikkelsen, Jacob Giehm/0000-0002-1322-3209	The Danish Council for Independent Research, Medical Sciences; The Lundbeck Foundation; The Novo Nordisk Foundation; The Danish National Advanced Technology Foundation; The Foundation of 17-12-1981; Kgl. Hofbuntmager Aage Bangs Foundation; Helga and Peter Kornings Foundation; Novo Scholarship Programme in Biotechnology and Pharmaceutical Sciences; EU (EU-FP6-STREP) [018961]	The Danish Council for Independent Research, Medical Sciences; The Lundbeck Foundation(Lundbeckfonden); The Novo Nordisk Foundation(Novo Nordisk Foundation); The Danish National Advanced Technology Foundation; The Foundation of 17-12-1981; Kgl. Hofbuntmager Aage Bangs Foundation; Helga and Peter Kornings Foundation; Novo Scholarship Programme in Biotechnology and Pharmaceutical Sciences; EU (EU-FP6-STREP)	This work was supported by The Danish Council for Independent Research, Medical Sciences (http://en.fi.dk/councils-commissions/the-danish-councilfor-independent-research/scientific-research-councils/medical-sciences); The Lundbeck Foundation, (http://www.lundbeckfoundation.com); The Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en/); The Danish National Advanced Technology Foundation (http://hoejteknologifonden.dk/en); The Foundation of 17-12-1981 (http://hoejteknologifonden.dk); Kgl. Hofbuntmager Aage Bangs Foundation (http://www.danderm-pdv.is.kkh.dk/h11u-5.htm); Helga and Peter Kornings Foundation (http://www.korningfonden.dk); Novo Scholarship Programme in Biotechnology and Pharmaceutical Sciences (http://www.novozymes.com); and the EU (EU-FP6-STREP, contract number 018961). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Antoniou M, 2003, GENOMICS, V82, P269, DOI 10.1016/S0888-7543(03)00107-1; Aronovich EL, 2011, HUM MOL GENET, V20, pR14, DOI 10.1093/hmg/ddr140; Arumugam PI, 2007, MOL THER, V15, P1863, DOI 10.1038/sj.mt.6300259; Bachmann Andre, 2008, V420, P61, DOI 10.1007/978-1-59745-583-1_4; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Brendel C, 2011, GENE THER; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Dalsgaard T, 2009, MOL THER, V17, P121, DOI 10.1038/mt.2008.224; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Fjord-Larsen L, 2011, GENE THER; Fjord-Larsen L, 2010, MOL THER, V18, P2164, DOI 10.1038/mt.2010.154; FRASER MJ, 1995, VIROLOGY, V211, P397, DOI 10.1006/viro.1995.1422; Galvan DL, 2009, J IMMUNOTHER, V32, P837, DOI 10.1097/CJI.0b013e3181b2914c; Garrison BS, 2007, MOL CELL BIOL, V27, P8824, DOI 10.1128/MCB.00498-07; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Grabundzija I, 2011, METHODS MOL BIOL, V738, P69, DOI 10.1007/978-1-61779-099-7_5; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Handler AM, 2002, INSECT BIOCHEM MOLEC, V32, P1211, DOI 10.1016/S0965-1748(02)00084-X; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; He J, 2005, J VIROL, V79, P13497, DOI 10.1128/JVI.79.21.13497-13508.2005; Huang X, 2008, MOL THER, V16, P580, DOI 10.1038/sj.mt.6300404; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Huang Xin, 2009, V506, P115, DOI 10.1007/978-1-59745-409-4_9; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Izsvak Z, 2010, BIOESSAYS, V32, P756, DOI 10.1002/bies.201000027; Jacobson SG, 2011, ARCH OPHTHALMOL; Jin Z, 2011, GENE THER; Kawakami K, 2005, DEV DYNAM, V234, P244, DOI 10.1002/dvdy.20516; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Li CL, 2008, GENE THER, V15, P49, DOI 10.1038/sj.gt.3303009; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Liang Q, 2009, GENESIS, V47, P404, DOI 10.1002/dvg.20508; Liu GY, 2004, J GENE MED, V6, P574, DOI 10.1002/jgm.486; Manuri PVR, 2010, HUM GENE THER, V21, P427, DOI 10.1089/hum.2009.114; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meir YJJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-28; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; Moerman Donald G., 2008, Briefings in Functional Genomics & Proteomics, V7, P195, DOI 10.1093/bfgp/eln016; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Nakazawa Y, 2011, MOL THER; Nakazawa Y, 2009, J IMMUNOTHER, V32, P826, DOI 10.1097/CJI.0b013e3181ad762b; Orban TI, 2009, STEM CELLS, V27, P1077, DOI 10.1002/stem.45; Pannell D, 2000, EMBO J, V19, P5884, DOI 10.1093/emboj/19.21.5884; Persons DA, 2003, BLOOD, V101, P2175, DOI 10.1182/blood-2002-07-2211; Rivella S, 2000, J VIROL, V74, P4679, DOI 10.1128/JVI.74.10.4679-4687.2000; Sharma N, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn298; Shi XZ, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-5; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Sjeklocha LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029110; Staunstrup NH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-33; Sumiyoshi T, 2009, HUM GENE THER, V20, P1607, DOI 10.1089/hum.2009.109; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Walisko O, 2008, MOL THER, V16, P359, DOI 10.1038/sj.mt.6300366; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wilber A, 2007, STEM CELLS, V25, P2919, DOI 10.1634/stemcells.2007-0026; Williams DA, 2008, MOL THER, V16, P1515, DOI 10.1038/mt.2008.169; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Xue XK, 2009, BLOOD, V114, P1319, DOI 10.1182/blood-2009-03-210005; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007; Zayed H, 2003, NUCLEIC ACIDS RES, V31, P2313, DOI 10.1093/nar/gkg341; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814; Zhang F, 2010, MOL THER, V18, P1640, DOI 10.1038/mt.2010.132; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	79	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48421	10.1371/journal.pone.0048421	http://dx.doi.org/10.1371/journal.pone.0048421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110238	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500066
J	Brandt, T; Kaar, JL; Fersht, AR; Veprintsev, DB				Brandt, Tobias; Kaar, Joel L.; Fersht, Alan R.; Veprintsev, Dmitry B.			Stability of p53 Homologs	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; COOPERATIVE DNA-BINDING; FULL-LENGTH P53; CORE DOMAIN; MUTANT P53; ISOTHERMAL DENATURATION; PROTEIN STABILITY; THERMODYNAMIC STABILITY; ENHANCED STABILITY; CANCER MUTATIONS	Most proteins have not evolved for maximal thermal stability. Some are only marginally stable, as for example, the DNA-binding domains of p53 and its homologs, whose kinetic and thermodynamic stabilities are strongly correlated. Here, we applied high-throughput methods using a real-time PCR thermocycler to study the stability of several full-length orthologs and paralogs of the p53 family of transcription factors, which have diverse functions, ranging from tumour suppression to control of developmental processes. From isothermal denaturation fluorimetry and differential scanning fluorimetry, we found that full-length proteins showed the same correlation between kinetic and thermodynamic stability as their isolated DNA-binding domains. The stabilities of the full-length p53 orthologs were marginal and correlated with the temperature of their organism, paralleling the stability of the isolated DNA-binding domains. Additionally, the paralogs p63 and p73 were significantly more stable and long-lived than p53. The short half-life of p53 orthologs and the greater persistence of the paralogs may be biologically relevant.	[Brandt, Tobias; Kaar, Joel L.; Fersht, Alan R.; Veprintsev, Dmitry B.] MRC Ctr Prot Engn, Cambridge, England; [Brandt, Tobias; Fersht, Alan R.; Veprintsev, Dmitry B.] MRC Lab Mol Biol, Cambridge, England	MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology	Fersht, AR (corresponding author), MRC Ctr Prot Engn, Cambridge, England.	arf25@cam.ac.uk; dmitry.veprintsev@psi.ch	Fersht, Alan R/B-2189-2008; Veprintsev, Dmitry B/H-2228-2012	Veprintsev, Dmitry B/0000-0002-3583-5409; KAAR, JOEL/0000-0002-0794-3955	Cancer Research UK; Medical Research Council; EC; Medical Research Council [MC_EX_G0901534, MC_UP_A024_1010] Funding Source: researchfish; MRC [MC_EX_G0901534, MC_UP_A024_1010] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by Cancer Research UK, the Medical Research Council, and by EC FP6 funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Ashburner M, 1978, GENETICS BIOL DROSOP; Boeckler FM, 2008, P NATL ACAD SCI USA, V105, P10360, DOI 10.1073/pnas.0805326105; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; Epps DE, 2001, ANAL BIOCHEM, V292, P40, DOI 10.1006/abio.2001.5047; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; HILKEN G, 1995, LAB ANIM, V29, P152, DOI 10.1258/002367795780740276; HIPPS DS, 1994, BIOCHEM J, V297, P137, DOI 10.1042/bj2970137; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Ishimaru D, 2009, BIOCHEMISTRY-US, V48, P6126, DOI 10.1021/bi9003028; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; Khoo KH, 2009, J MOL BIOL, V393, P161, DOI 10.1016/j.jmb.2009.08.013; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Matsumura I, 1999, PROTEIN SCI, V8, P731; Matthews M, 2002, LAB ANIMAL, V31, P34; Moll UM, 2004, MOL CANCER RES, V2, P371; Natan E, 2011, J MOL BIOL, V409, P358, DOI 10.1016/j.jmb.2011.03.047; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Patel S, 2008, BIOCHEMISTRY-US, V47, P3235, DOI 10.1021/bi7023207; Sarver RW, 2002, J BIOMOL SCREEN, V7, P21, DOI 10.1177/108705710200700104; Senisterra GA, 2008, J BIOMOL SCREEN, V13, P337, DOI 10.1177/1087057108317825; SERRANO L, 1993, J MOL BIOL, V233, P305, DOI 10.1006/jmbi.1993.1508; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang GZ, 2012, P NATL ACAD SCI USA, V109, P13590, DOI 10.1073/pnas.1211557109; Wilcken R, 2012, P NATL ACAD SCI USA, V109, P13584, DOI 10.1073/pnas.1211550109; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607	45	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47889	10.1371/journal.pone.0047889	http://dx.doi.org/10.1371/journal.pone.0047889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112865	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000310310200100
J	Matsubara, R; Kukita, T; Ichigi, Y; Takigawa, I; Qu, PF; Funakubo, N; Miyamoto, H; Nonaka, K; Kukita, A				Matsubara, Rei; Kukita, Toshio; Ichigi, Yuka; Takigawa, Ippei; Qu, Peng-Fei; Funakubo, Noboru; Miyamoto, Hiroshi; Nonaka, Kazuaki; Kukita, Akiko			Characterization and Identification of Subpopulations of Mononuclear Preosteoclasts Induced by TNF-alpha in Combination with TGF-beta in Rats	PLOS ONE			English	Article							FACTOR-KAPPA-B; OSTEOCLAST PRECURSOR FUSION; RECEPTOR ACTIVATOR; BONE-MARROW; DIRECT STIMULATION; STROMAL CELLS; DC-STAMP; IN-VIVO; C-FMS; DIFFERENTIATION	Osteoclasts are unique multinucleated cells formed by fusion of preosteoclasts derived from cells of the monocyte/macrophage lineage, which are induced by RANKL. However, characteristics and subpopulations of osteoclast precursor cells are poorly understood. We show here that a combination of TNF-alpha, TGF-beta, and M-CSF efficiently generates mononuclear preosteoclasts but not multinucleated osteoclasts (MNCs) in rat bone marrow cultures depleted of stromal cells. Using a rat osteoclast-specific mAb, Kat1, we found that TNF-alpha and TGF-beta specifically increased Kat1(+)c-fms(+) and Kat1(+)c-fms(-) cells but not Kat1(-)c-fms(+) cells. Kat1(-)c-fms(+) cells appeared in early stages of culture, but Kat1(+) c-fms(+) and Kat1(+)c-fms(-) cells increased later. Preosteoclasts induced by TNF-alpha, TGF-beta, and M-CSF rapidly differentiated into osteoclasts in the presence of RANKL and hydroxyurea, an inhibitor of DNA synthesis, suggesting that preosteoclasts are terminally differentiated cells. We further analyzed the expression levels of genes encoding surface proteins in bone marrow macrophages (BMM), preosteoclasts, and MNCs. Preosteoclasts expressed itgam (CD11b) and chemokine receptors CCR1 and CCR2; however, in preosteoclasts the expression of chemokine receptors CCR1 and CCR2 was not up-regulated compared to their expression in BMM. However, addition of RANKL to preosteoclasts markedly increased the expression of CCR1. In contrast, expression of macrophage antigen emr-1 (F4/80) and chemokine receptor CCR5 was down-regulated in preosteoclasts. The combination of TNF-alpha, TGF-beta, and M-CSF induced Kat1(+)CD11b(+) cells, but these cells were also induced by TNF-a alone. In addition, MIP-1 alpha and MCP-1, which are ligands for CCR1 and CCR2, were chemotactic for preosteoclasts, and promoted multinucleation of preosteoclasts. Finally, we found that Kat1(+)c-fms(+) cells were present in bone tissues of rats with adjuvant arthritis. These data demonstrate that TNF-alpha in combination with TGF-beta efficiently generates preosteoclasts in vitro. We delineated characteristics that are useful for identifying and isolating rat preosteoclasts, and found that CCR1 expression was regulated in the fusion step in osteoclastogenesis.	[Matsubara, Rei; Ichigi, Yuka; Takigawa, Ippei; Funakubo, Noboru; Miyamoto, Hiroshi; Kukita, Akiko] Saga Univ, Fac Med, Dept Microbiol, Saga 840, Japan; [Matsubara, Rei; Nonaka, Kazuaki] Kyushu Univ, Fac Dent Sci, Fukuoka 812, Japan	Saga University; Kyushu University	Kukita, A (corresponding author), Saga Univ, Fac Med, Dept Microbiol, Saga 840, Japan.	kukita@cc.saga-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [19592150, 215923]; Nakatomi Health Science Foundation; Grants-in-Aid for Scientific Research [24592806] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nakatomi Health Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by a Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (project no. 19592150 and 215923), and grant awarded by the Nakatomi Health Science Foundation to Dr. A. Kukita. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Dairaghi DJ, 2012, BLOOD, V120, P1449, DOI 10.1182/blood-2011-10-384784; Fox SW, 2008, BIOCHEM BIOPH RES CO, V366, P123, DOI 10.1016/j.bbrc.2007.11.120; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Harada H, 1998, ENDOCRINOLOGY, V139, P3967, DOI 10.1210/en.139.9.3967; Hoshino A, 2010, J BIOL CHEM, V285, P28826, DOI 10.1074/jbc.M109.099424; Houde N, 2009, J BIOL CHEM, V284, P23397, DOI 10.1074/jbc.M109.019372; Ishida N, 2006, J BONE MINER RES, V21, P48, DOI 10.1359/JBMR.051001; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Ishizuka H, 2011, J BONE MINER RES, V26, P169, DOI 10.1002/jbmr.199; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Komano Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2046; Komine M, 2001, BONE, V28, P474, DOI 10.1016/S8756-3282(01)00420-3; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; KUKITA A, 1993, BONE MINER, V23, P113, DOI 10.1016/S0169-6009(08)80048-7; KUKITA A, 1993, BIOCHEM BIOPH RES CO, V196, P1383, DOI 10.1006/bbrc.1993.2406; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Kukita T, 1998, CALCIFIED TISSUE INT, V63, P148, DOI 10.1007/s002239900506; Kukita T, 2001, J ENDOCRINOL, V170, P175, DOI 10.1677/joe.0.1700175; KUKITA T, 1994, J IMMUNOL, V153, P5265; Kukita T, 2001, HISTOCHEM CELL BIOL, V115, P215; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Ogata Y, 1999, J IMMUNOL, V162, P2754; Oursler MJ, 2010, J CELL BIOCHEM, V110, P1058, DOI 10.1002/jcb.22640; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; Sakai H, 2002, ANN RHEUM DIS, V61, P103, DOI 10.1136/ard.61.2.103; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; TAKAHASHI N, 1994, DEV BIOL, V163, P212, DOI 10.1006/dbio.1994.1137; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tow K, 2004, LAB INVEST, V84, P1092, DOI 10.1038/labinvest.3700132; Vallet S, 2007, BLOOD, V110, P3744, DOI 10.1182/blood-2007-05-093294; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910	43	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47930	10.1371/journal.pone.0047930	http://dx.doi.org/10.1371/journal.pone.0047930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110133	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200111
J	Untergasser, A; Bijl, GJM; Liu, W; Bisseling, T; Schaart, JG; Geurts, R				Untergasser, Andreas; Bijl, Gerben J. M.; Liu, Wei; Bisseling, Ton; Schaart, Jan G.; Geurts, Rene			One-Step Agrobacterium Mediated Transformation of Eight Genes Essential for Rhizobium Symbiotic Signaling Using the Novel Binary Vector System pHUGE	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; ROOT-NODULE ORGANOGENESIS; SELECTABLE MARKER GENE; GENOMIC DNA FRAGMENTS; MEDICAGO-TRUNCATULA; PLANT TRANSFORMATION; NODULATION FACTORS; LOTUS-JAPONICUS; HOST-RANGE; CYTOKININ	Advancement in plant research is becoming impaired by the fact that the transfer of multiple genes is difficult to achieve. Here we present a new binary vector for Agrobacterium tumefaciens mediated transformation, pHUGE-Red, in concert with a cloning strategy suited for the transfer of up to nine genes at once. This vector enables modular cloning of large DNA fragments by employing Gateway technology and contains DsRED1 as visual selection marker. Furthermore, an R/Rs inducible recombination system was included allowing subsequent removal of the selection markers in the newly generated transgenic plants. We show the successful use of pHUGE-Red by transferring eight genes essential for Medicago truncatula to establish a symbiosis with rhizobia bacteria as one 74 kb T-DNA into four non-leguminous species; strawberry, poplar, tomato and tobacco. We provide evidence that all transgenes are expressed in the root tissue of the non-legumes. Visual control during the transformation process and subsequent marker gene removal makes the pHUGE-Red vector an excellent tool for the efficient transfer of multiple genes.	[Untergasser, Andreas; Bijl, Gerben J. M.; Liu, Wei; Bisseling, Ton; Geurts, Rene] Wageningen Univ, Dept Plant Sci, Mol Biol Lab, Wageningen, Netherlands; [Schaart, Jan G.] Univ Wageningen & Res Ctr, Wageningen UR Plant Breeding, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Untergasser, A (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	andreas@untergasser.de	Schaart, Jan/AAG-8424-2020; Untergasser, Andreas/AAA-7452-2022; Bisseling, Ton/A-2421-2013; Liu, Wei/J-6317-2013	Liu, Wei/0000-0003-4653-0448	Netherlands Organisation for Scientific Research (NWO) [NWO-ALW 816.02.007, NWO-VIDI 864.06.007]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The financial support of the Netherlands Organisation for Scientific Research (NWO) (NWO-ALW 816.02.007 and NWO-VIDI 864.06.007) is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Borisov AY, 2003, PLANT PHYSIOL, V131, P1009, DOI 10.1104/pp.102.016071; Burrill TJ, 1917, AGR EXPT STATION, V202, P161; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Charpentier M, 2010, CURR OPIN PLANT BIOL, V13, P556, DOI 10.1016/j.pbi.2010.08.003; Chen QJ, 2006, PLANT MOL BIOL, V62, P927, DOI 10.1007/s11103-006-9065-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; Crespi M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.149re11; den Camp RHMO, 2011, PLANT PHYSIOL, V157, P2013, DOI 10.1104/pp.111.187526; den Camp RO, 2011, SCIENCE, V331, P909, DOI 10.1126/science.1198181; EHRHARDT DW, 1992, SCIENCE, V256, P998, DOI 10.1126/science.10744524; Esseling JJ, 2004, PLANT CELL, V16, P933, DOI 10.1105/tpc.019653; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; FRALEY RT, 1986, CRC CR REV PLANT SCI, V4, P1, DOI 10.1080/07352688609382217; Frugier F, 2008, TRENDS PLANT SCI, V13, P115, DOI 10.1016/j.tplants.2008.01.003; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gonzalez-Rizzo S, 2006, PLANT CELL, V18, P2680, DOI 10.1105/tpc.106.043778; Hamilton CM, 1997, GENE, V200, P107, DOI 10.1016/S0378-1119(97)00388-0; Heckmann AB, 2011, MOL PLANT MICROBE IN, V24, P1385, DOI 10.1094/MPMI-05-11-0142; HEIDSTRA R, 1994, PLANT PHYSIOL, V105, P787, DOI 10.1104/pp.105.3.787; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; LEPLE JC, 1992, PLANT CELL REP, V11, P137, DOI 10.1007/BF00232166; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Limpens E, 2004, J EXP BOT, V55, P983, DOI 10.1093/jxb/erh122; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lin L, 2003, P NATL ACAD SCI USA, V100, P5962, DOI 10.1073/pnas.0931425100; Liu YG, 1999, P NATL ACAD SCI USA, V96, P6535, DOI 10.1073/pnas.96.11.6535; Markmann K, 2009, TRENDS PLANT SCI, V14, P77, DOI 10.1016/j.tplants.2008.11.009; Marsh JF, 2007, PLANT PHYSIOL, V144, P324, DOI 10.1104/pp.106.093021; Mathesius U, 2000, MOL PLANT MICROBE IN, V13, P617, DOI 10.1094/MPMI.2000.13.6.617; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Ovchinnikova E, 2011, MOL PLANT MICROBE IN, V24, P1333, DOI 10.1094/MPMI-01-11-0013; Plet J, 2011, PLANT J, V65, P622, DOI 10.1111/j.1365-313X.2010.04447.x; Price NPJ, 1996, CARBOHYD RES, V289, P115, DOI 10.1016/0008-6215(96)00119-X; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Radutoiu S, 2007, EMBO J, V26, P3923, DOI 10.1038/sj.emboj.7601826; Schaart JG, 2004, PLANT BIOTECHNOL J, V2, P233, DOI 10.1111/j.1467-7652.2004.00067.x; Schaart JG, 2002, PLANT CELL REP, V1, P313; SCHAART JG, 2010, PLANT TRANSFORMATION, P229; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Shibata D, 2000, TRENDS PLANT SCI, V5, P354, DOI 10.1016/S1360-1385(00)01689-7; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Song J, 2003, THEOR APPL GENET, V107, P958, DOI 10.1007/s00122-003-1334-9; Stuitje AR, 2003, PLANT BIOTECHNOL J, V1, P301, DOI 10.1046/j.1467-7652.2003.00028.x; Taylor NJ, 2002, DNA CELL BIOL, V21, P963, DOI 10.1089/104454902762053891; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vainstein A, 2011, TRENDS BIOTECHNOL, V29, P363, DOI 10.1016/j.tibtech.2011.03.007; Wang Y, 2005, TRANSGENIC RES, V14, P605, DOI 10.1007/s11248-005-0884-9	58	29	41	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47885	10.1371/journal.pone.0047885	http://dx.doi.org/10.1371/journal.pone.0047885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112864	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200099
J	Eichwald, C; Arnoldi, F; Laimbacher, AS; Schraner, EM; Fraefel, C; Wild, P; Burrone, OR; Ackermann, M				Eichwald, Catherine; Arnoldi, Francesca; Laimbacher, Andrea S.; Schraner, Elisabeth M.; Fraefel, Cornel; Wild, Peter; Burrone, Oscar R.; Ackermann, Mathias			Rotavirus Viroplasm Fusion and Perinuclear Localization Are Dynamic Processes Requiring Stabilized Microtubules	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NONSTRUCTURAL PROTEIN NSP5; MESSENGER-RNA; REVERSE GENETICS; GENOME REPLICATION; AMPLICON VECTORS; MINIMAL PROMOTER; MAMMALIAN-CELLS; AXON TRANSPORT; ALPHA-TUBULIN	Rotavirus viroplasms are cytosolic, electron-dense inclusions corresponding to the viral machinery of replication responsible for viral template transcription, dsRNA genome segments replication and assembly of new viral cores. We have previously observed that, over time, those viroplasms increase in size and decrease in number. Therefore, we hypothesized that this process was dependent on the cellular microtubular network and its associated dynamic components. Here, we present evidence demonstrating that viroplasms are dynamic structures, which, in the course of an ongoing infection, move towards the perinuclear region of the cell, where they fuse among each other, thereby gaining considerably in size and, simultaneouly, explaining the decrease in numbers. On the viral side, this process seems to depend on VP2 for movement and on NSP2 for fusion. On the cellular side, both the temporal transition and the maintenance of the viroplasms are dependent on the microtubular network, its stabilization by acetylation, and, surprisingly, on a kinesin motor of the kinesin-5 family, Eg5. Thus, we provide for the first time deeper insights into the dynamics of rotavirus replication, which can explain the behavior of viroplasms in the infected cell.	[Eichwald, Catherine; Laimbacher, Andrea S.; Schraner, Elisabeth M.; Fraefel, Cornel; Wild, Peter; Ackermann, Mathias] Univ Zurich, Inst Virol, Zurich, Switzerland; [Schraner, Elisabeth M.; Wild, Peter] Univ Zurich, Inst Vet Anat, Zurich, Switzerland; [Arnoldi, Francesca; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Arnoldi, Francesca] Univ Trieste, Dipartimento Clin Sci Med Chirurg & Salute, Trieste, Italy	University of Zurich; University of Zurich; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste	Eichwald, C (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	ceichwald@vetvir.uzh.ch	Arnoldi, Francesca/AAQ-6859-2021; ARNOLDI, Francesca/K-5020-2016	Eichwald, Catherine/0000-0003-0001-4843; ARNOLDI, Francesca/0000-0003-0651-5526; Wild, Peter Johannes/0000-0002-1017-3744; Fraefel, Cornel/0000-0001-7221-6706	University of Zurich	University of Zurich	This work was supported by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; ALTENBURG BC, 1980, J GEN VIROL, V46, P75, DOI 10.1099/0022-1317-46-1-75; Antinone SE, 2010, J VIROL, V84, P13019, DOI 10.1128/JVI.01296-10; Antinone SE, 2010, J VIROL, V84, P1504, DOI 10.1128/JVI.02029-09; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Barro M, 2005, P NATL ACAD SCI USA, V102, P4114, DOI 10.1073/pnas.0408376102; Berois M, 2003, J VIROL, V77, P1757, DOI 10.1128/JVI.77.3.1757-1763.2003; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Cabral-Romero C, 2006, MEM I OSWALDO CRUZ, V101, P603, DOI 10.1590/S0074-02762006000600006; Cahu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003936; Campagna M, 2005, J GEN VIROL, V86, P1481, DOI 10.1099/vir.0.80598-0; Carreno-Torres JJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-350; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Chnaiderman J, 2002, ARCH VIROL, V147, P1899, DOI 10.1007/s00705-002-0856-9; Contin R, 2010, J GEN VIROL, V91, P1782, DOI 10.1099/vir.0.019133-0; D'Antuono A, 2010, VACCINE, V28, P7363, DOI 10.1016/j.vaccine.2010.09.011; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Diefenbach RJ, 2002, J VIROL, V76, P3282, DOI 10.1128/JVI.76.7.3282-3291.2002; Dodding MP, 2011, EMBO J, V30, P3527, DOI 10.1038/emboj.2011.283; Douglas MW, 2004, J BIOL CHEM, V279, P28522, DOI 10.1074/jbc.M311671200; Eichwald C, 2004, P NATL ACAD SCI USA, V101, P16304, DOI 10.1073/pnas.0406691101; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; ESTES MK, 1979, J VIROL, V31, P810, DOI 10.1128/JVI.31.3.810-815.1979; Estes MK, 2007, FIELDS VIROLOGY, P1917; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; Fraefel C, 2007, CURR PROTOC NEUROSCI; Frias AH, 2012, INNATE IMMUN-LONDON, V18, P294, DOI 10.1177/1753425911401930; Gable A, 2012, MOL BIOL CELL, V23, P1254, DOI 10.1091/mbc.E11-09-0820; Gac M, 2010, VIROLOGY, V404, P293, DOI 10.1016/j.virol.2010.05.018; Gonzalez RA, 2000, ARCH VIROL, V145, P1963, DOI 10.1007/s007050070069; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; Guglielmi KM, 2010, J BIOL CHEM, V285, P18123, DOI 10.1074/jbc.R110.117671; Halasz P, 2010, J GEN VIROL, V91, P2007, DOI 10.1099/vir.0.018275-0; Hu L, 2012, J VIROL; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; Kelkar S, 2006, J VIROL, V80, P7781, DOI 10.1128/JVI.00481-06; Komoto S, 2006, P NATL ACAD SCI USA, V103, P4646, DOI 10.1073/pnas.0509385103; Laimbacher AS, 2012, MOL THER; Lawton JA, 2000, ADV VIRUS RES, V55, P185, DOI 10.1016/S0065-3527(00)55004-0; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Lopez S, 2012, CURR OPIN VIROL; Lopez T, 2005, J VIROL, V79, P184, DOI 10.1128/JVI.79.1.184-192.2005; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Monaghan P, 2003, J MICROSC-OXFORD, V212, P62, DOI 10.1046/j.1365-2818.2003.01245.x; Montero H, 2006, J VIROL, V80, P9031, DOI 10.1128/JVI.00437-06; Muresan V, 2012, ARCH BIOCHEM BIOPHYS, V520, P17, DOI 10.1016/j.abb.2011.12.029; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; Patton JT, 1996, J VIROL, V70, P3961, DOI 10.1128/JVI.70.6.3961-3971.1996; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Petit C, 2003, J CELL SCI, V116, P3433, DOI 10.1242/jcs.00613; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Radtke K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000991; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Saeki Y, 2001, MOL THER, V3, P591, DOI 10.1006/mthe.2001.0294; Schepis A, 2007, CELL MICROBIOL, V9, P1960, DOI 10.1111/j.1462-5822.2007.00927.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; Smith GA, 2004, P NATL ACAD SCI USA, V101, P16034, DOI 10.1073/pnas.0404686101; Smith GA, 2001, P NATL ACAD SCI USA, V98, P3466, DOI 10.1073/pnas.061029798; SMITH IL, 1992, VIROLOGY, V186, P74, DOI 10.1016/0042-6822(92)90062-T; Suikkanen S, 2003, J VIROL, V77, P10270, DOI 10.1128/JVI.77.19.10270-10279.2003; Tortorici MA, 2003, J BIOL CHEM, V278, P32673, DOI 10.1074/jbc.M305358200; Trask SD, 2010, P NATL ACAD SCI USA, V107, P18652, DOI 10.1073/pnas.1011948107; Troupin C, 2010, J VIROL, V84, P6711, DOI 10.1128/JVI.00547-10; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Ward BM, 2011, VIROLOGY, V411, P244, DOI 10.1016/j.virol.2010.12.024; Wentz MJ, 1996, ARCH VIROL, P59; Wentz MJ, 1996, J VIROL, V70, P7833, DOI 10.1128/JVI.70.11.7833-7841.1996; Wild P, 2001, MICROSC RES TECHNIQ, V53, P313, DOI 10.1002/jemt.1098; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000; Zambrano JL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-359; Zeng CQY, 1996, J VIROL, V70, P2736, DOI 10.1128/JVI.70.5.2736-2742.1996	86	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47947	10.1371/journal.pone.0047947	http://dx.doi.org/10.1371/journal.pone.0047947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110139	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000310193600039
J	Wang, J; Guillaume, J; Pauwels, N; Van Calenbergh, S; Van Rhijn, I; Zajonc, DM				Wang, Jing; Guillaume, Joren; Pauwels, Nora; Van Calenbergh, Serge; Van Rhijn, Ildiko; Zajonc, Dirk M.			Crystal Structures of Bovine CD1d Reveal Altered alpha GalCer Presentation and a Restricted A ' Pocket Unable to Bind Long-Chain Glycolipids	PLOS ONE			English	Article							T-CELL-RECEPTOR; NKT CELLS; ANTIGEN PRESENTATION; RECOGNITION; SULFATIDE; AUTOIMMUNITY; PROTEINS; FAMILY; MODEL	NKT cells play important roles in immune surveillance. They rapidly respond to pathogens by detecting microbial glycolipids when presented by the non-classical MHC I homolog CD1d. Previously, ruminants were considered to lack NKT cells due to the lack of a functional CD1D gene. However, recent data suggest that cattle express CD1d with unknown function. In an attempt to characterize the function of bovine CD1d, we assessed the lipid binding properties of recombinant Bos taurus CD1d (boCD1d) in vitro. BoCD1d is able to bind glycosphingolipids (GSLs) with fatty acid chain lengths of C-18, while GSLs with fatty acids of C-24 do not bind. Crystal structures of boCD1d bound to a short-chain C-12-di-sulfatide antigen, as well as short-chain C-16-alpha GalCer revealed that the A pocket of boCD1d is restricted in size compared to that of both mouse and human CD1d, explaining the inability of long chain GSL's to bind to boCD1d. Moreover, while di-sulfatide is presented similarly compared to the presentation of sulfatide by mouse CD1d, alpha GalCer is presented differently at the cell surface, due to an amino acid Asp151Asn substitution that results in loss of intimate contacts between the alpha GalCer headgroup and CD1d. The altered alpha GalCer presentation by boCD1d also explains its lack of cross-activation of mouse iNKT cells and raises the interesting question of the nature and function of bovine lipid-reactive T cells.	[Wang, Jing; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA; [Guillaume, Joren; Pauwels, Nora; Van Calenbergh, Serge] Univ Ghent, Lab Med Chem FFW, B-9000 Ghent, Belgium; [Van Rhijn, Ildiko] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Van Rhijn, Ildiko] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA USA	La Jolla Institute for Immunology; Ghent University; Utrecht University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA USA.	dzajonc@liai.org	Van Calenbergh, Serge/A-3167-2008; Wang, Jing/L-5095-2013	Van Calenbergh, Serge/0000-0002-4201-1264; Van Rhijn, Ildiko/0000-0002-1446-5701	National Institute of Health [AI 074952]; NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074952, R56AI074952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants from the National Institute of Health (AI 074952 to DMZ). IVR is supported by a Meervoud subsidy of the NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393) and the National Center for Research Resources (P41RR001209). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; Dascher CC, 1999, J IMMUNOL, V163, P5478; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dvir H, 2010, J IMMUNOL, V184, P2504, DOI 10.4049/jimmunol.0903509; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Facciotti F, 2011, P NATL ACAD SCI USA, V108, P14228, DOI 10.1073/pnas.1108809108; Girardi E, 2010, J IMMUNOL, V185, P376, DOI 10.4049/jimmunol.1000042; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Li YL, 2010, J EXP MED, V207, P2383, DOI 10.1084/jem.20101335; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Nguyen TK, 2012, INT IMMUNOL; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Reinink P, 2009, IMMUNOGENETICS, V61, P541, DOI 10.1007/s00251-009-0384-9; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; van Beeck FAL, 2008, IMMUNOGENETICS, V60, P315, DOI 10.1007/s00251-008-0297-z; Van Rhijn I, 2006, J IMMUNOL, V176, P4888, DOI 10.4049/jimmunol.176.8.4888; Wang J, 2010, P NATL ACAD SCI USA, V107, P1535, DOI 10.1073/pnas.0909479107; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zajonc DM, 2008, P NATL ACAD SCI USA, V105, P17925, DOI 10.1073/pnas.0809814105; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47989	10.1371/journal.pone.0047989	http://dx.doi.org/10.1371/journal.pone.0047989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110152	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600043
J	Nakatsu, Y; Otani, Y; Sakoda, H; Zhang, J; Guo, Y; Okubo, H; Kushiyama, A; Fujishiro, M; Kikuch, T; Fukushima, T; Ohno, H; Tsuchiya, Y; Kamata, H; Nagamachi, A; Inaba, T; Nishimura, F; Katagiri, H; Takahashi, S; Kurihara, H; Uchida, T; Asano, T				Nakatsu, Yusuke; Otani, Yuichiro; Sakoda, Hideyuki; Zhang, Jun; Guo, Ying; Okubo, Hirofumi; Kushiyama, Akifumi; Fujishiro, Midori; Kikuch, Takako; Fukushima, Toshiaki; Ohno, Haruya; Tsuchiya, Yoshihiro; Kamata, Hideaki; Nagamachi, Akiko; Inaba, Toshiya; Nishimura, Fusanori; Katagiri, Hideki; Takahashi, Shin-ichiro; Kurihara, Hiroki; Uchida, Takafumi; Asano, Tomoichiro			Role of Pin1 Protein in the Pathogenesis of Nonalcoholic Steatohepatitis in a Rodent Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL ISOMERASE PIN1; PP2A PHOSPHATASE ACTIVATOR; CRYSTAL-STRUCTURE; CELL-CYCLE; CANCER; ISOMERIZATION; EXPRESSION; FIBROSIS; P53; CONTRIBUTES	Nonalcoholic steatohepatitis (NASH) is a disorder characterized by simultaneous fat accumulation and chronic inflammation in the liver. In this study, Pin1 expression was revealed to be markedly increased in the livers of mice with methionine choline-deficient (MCD) diet-induced NASH, a rodent model of NASH. In addition, Pin1 KO mice were highly resistant to MCD-induced NASH, based on a series of data showing simultaneous fat accumulation, chronic inflammation, and fibrosis in the liver. In terms of Pin1-induced fat accumulation, it was revealed that the expression levels of peroxisome proliferator-activated receptor alpha and its target genes were higher in the livers of Pin1 KO mice than in controls. Thus, resistance of Pin1 KO mice to hepatic steatosis is partially attributable to the lack of Pin1-induced down-regulation of peroxisome proliferator-activated receptor alpha, although multiple other mechanisms are apparently involved. Another mechanism involves the enhancing effect of hematopoietic Pin1 on the expressions of inflammatory cytokines such as tumor necrosis factor and monocyte chemoattractant protein 1 through NF-kappa B activation, eventually leading to hepatic fibrosis. Finally, to distinguish the roles of hematopoietic or nonhematopoietic Pin1 in NASH development, mice lacking Pin1 in either nonhematopoietic or hematopoietic cells were produced by bone marrow transplantation between wild-type and Pin1 KO mice. The mice having nonhematopoietic Pin1 exhibited fat accumulation without liver fibrosis on the MCD diet. Thus, hepatic Pin1 appears to be directly involved in the fat accumulation in hepatocytes, whereas Pin1 in hematopoietic cells contributes to inflammation and fibrosis. In summary, this is the first study to demonstrate that Pin1 plays critical roles in NASH development. This report also raises the possibility that hepatic Pin1 inhibition to the appropriate level might provide a novel therapeutic strategy for NASH.	[Nakatsu, Yusuke; Otani, Yuichiro; Zhang, Jun; Guo, Ying; Okubo, Hirofumi; Fukushima, Toshiaki; Ohno, Haruya; Tsuchiya, Yoshihiro; Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima, Japan; [Sakoda, Hideyuki; Fujishiro, Midori; Kikuch, Takako] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chiyoda Ku, Tokyo, Japan; [Nagamachi, Akiko; Inaba, Toshiya] Hiroshima Univ, Dept Mol Oncol, Hiroshima 7348553, Japan; [Nagamachi, Akiko; Inaba, Toshiya] Hiroshima Univ, Leukemia Program Project, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; [Nishimura, Fusanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Hiroshima 7348553, Japan; [Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Takahashi, Shin-ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Hiroshima University; University of Tokyo; Asahi Life Foundation; Hiroshima University; Hiroshima University; Hiroshima University; Tohoku University; University of Tokyo; University of Tokyo; Tohoku University	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima, Japan.	asano-tky@umin.ac.jp	Kushiyama, Akifumi/A-6386-2011; 祐介, 中津/AAP-8396-2020; Kamata, Hideaki/N-3907-2017; Kushiyama, Akifumi/W-5988-2019	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Nakatsu, Yusuke/0000-0003-3279-1276; Ohno, Haruya/0000-0001-5400-1162; Okubo, Hirofumi/0000-0002-9220-9084; Uchida, Takafumi/0000-0003-3665-4906; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Kurihara, Hiroki/0000-0002-6476-5593	Ministry of Education, Science, Sports, and Culture, Japan; Tsuchiya Foundation; Grants-in-Aid for Scientific Research [23659107, 24790928] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tsuchiya Foundation(Tsuchiya Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for young scientists (B) (to Y. N.), a grant-in-aid for scientific research on innovative areas (to T. A.), a grant-in-aid for scientific research (B) (to T. A.) from the Ministry of Education, Science, Sports, and Culture, Japan, and by Tsuchiya Foundation Grant 2010-2012 (to Y. N.).	Atkinson GP, 2009, ONCOGENE, V28, P3735, DOI 10.1038/onc.2009.232; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chao Y, 2006, MOL CELL, V23, P535, DOI 10.1016/j.molcel.2006.07.027; Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010; Driver Jane A, 2010, Curr Aging Sci, V3, P158; Duvnjak M, 2009, J PHYSIOL PHARMACOL, V60, P57; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Fujimoto Y, 2010, J BIOL CHEM, V285, P3126, DOI 10.1074/jbc.M109.055095; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Haque JA, 2010, LAB INVEST, V90, P1704, DOI 10.1038/labinvest.2010.112; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Kassel KM, 2010, LAB INVEST, V90, P1794, DOI 10.1038/labinvest.2010.143; Kim MR, 2009, CANCER SCI, V100, P1834, DOI 10.1111/j.1349-7006.2009.01260.x; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Leulliot N, 2006, MOL CELL, V23, P413, DOI 10.1016/j.molcel.2006.07.008; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Magnusdottir A, 2006, J BIOL CHEM, V281, P22434, DOI 10.1074/jbc.C600100200; Morais ADS, 2009, J HEPATOL, V50, P489, DOI 10.1016/j.jhep.2008.10.027; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Satapathy SK, 2010, TRENDS ENDOCRIN MET, V21, P668, DOI 10.1016/j.tem.2010.08.003; Schattenberg JM, 2011, CURR OPIN LIPIDOL, V22, P479, DOI 10.1097/MOL.0b013e32834c7cfc; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Tan XG, 2010, CANCER BIOL THER, V9, P111, DOI 10.4161/cbt.9.2.10341; Tomita K, 2008, HEPATOLOGY, V48, P458, DOI 10.1002/hep.22365; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uno M, 2008, HEPATOLOGY, V48, P109, DOI 10.1002/hep.22338; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yun H. J., 2012, MOL CARCINO IN PRESS; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	47	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44526	44535		10.1074/jbc.M112.397133	http://dx.doi.org/10.1074/jbc.M112.397133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23112047	Green Published, hybrid			2022-12-25	WOS:000312938600049
J	Han, YL; Zhang, QY; Li, Y; Guan, SY; Jing, QM; Wang, ZL; Zhao, X; Wang, XZ; Ma, YY; Wang, B; Deng, J; Wang, G; Kim, YH				Han, Ya-Ling; Zhang, Quan-Yu; Li, Yi; Guan, Shao-Yi; Jing, Quan-Min; Wang, Zu-Lu; Zhao, Xin; Wang, Xiao-Zeng; Ma, Ying-Yan; Wang, Bin; Deng, Jie; Wang, Geng; Kim, Young-Hak			Clinical Presentations, Antiplatelet Strategies and Prognosis of Patients with Stent Thrombosis: An Observational Study of 140 Patients	PLOS ONE			English	Article							ELUTING STENT; CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; PLATELET REACTIVITY; MODERN-ERA; IMPLANTATION; PREDICTORS; OUTCOMES; CILOSTAZOL; SIROLIMUS	Background: Until now there has been scarce evidence regarding an optimal antiplatelet strategy and clinical outcomes for patients who had suffered from stent thrombosis (ST). Methods and Results: 140 patients who suffered from stent thrombosis were prospectively registered. Patients received dual (aspirin and 150 mg clopidogrel, N = 66) or triple (additional cilostazol, N = 74) antiplatelet therapy at the physician's discretion. Thereafter platelet reactivity and one year clinical outcomes were analyzed. The primary outcome included the composite of cardiac death, non-fatal myocardial infarction (MI) or stroke at one year, which developed in 41 (29.3%) patients, consisting of 31 (22.1%) cardiac death, 9 (6.4%) non-fatal MI and 1 (1.4%) stroke. Recurrent definite and probable ST according to ARC definition was observed in 8 (5.7%) and 14 (10.0%) patients, respectively. Triple therapy was associated with significantly lower platelet reactivities (50.2 +/- 17.8, % vs. 59.6 +/- 17.2, %, P = 0.002) compared to high dose dual antiplatelet therapy. However, the incidence of primary events (24.3% vs. 34.8%, P = 0.172) did not differ between triple and dual antiplatelet therapies. High on-treatment platelet reactivity (HR: 8.35, 95% CI: 2.234 similar to 30.867, P = 0.002) and diabetes (HR: 3.732, 95% CI: 1.353 similar to 10.298, P = 0.011) were independent predictors of primary events. Conclusions: Patients who suffered from stent thrombosis have a poor prognosis even after revascularization with intensive antiplatelet therapy. Triple antiplatelet therapy was more effective in reducing on-treatment platelet reactivity, compared to high dose dual antiplatelet therapy.	[Han, Ya-Ling; Zhang, Quan-Yu; Li, Yi; Guan, Shao-Yi; Jing, Quan-Min; Wang, Zu-Lu; Zhao, Xin; Wang, Xiao-Zeng; Ma, Ying-Yan; Wang, Bin; Deng, Jie; Wang, Geng] Shenyang No Hosp, Dept Cardiol, Shenyang, Liaoning, Peoples R China; [Kim, Young-Hak] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Han, YL (corresponding author), Shenyang No Hosp, Dept Cardiol, Shenyang, Liaoning, Peoples R China.	hanyl@medmail.com.cn		Wang, Xiaozeng/0000-0003-1979-0287	National Key Technology Research & Development Program of china [2011BAI11B07]; National Natural Science Foundation of China [30800465]; major hightech clinical Army projects [2010gxjs001]	National Key Technology Research & Development Program of china; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); major hightech clinical Army projects	This study was supported by the National Key Technology Research & Development Program in the 12th Five year Plan of china (No. 2011BAI11B07), National Natural Science Foundation of China (No. 30800465), major hightech clinical Army projects (No. 2010gxjs001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Chen KY, 2009, CIRCULATION, V119, P3207, DOI 10.1161/CIRCULATIONAHA.108.822791; Cutlip DE, 2001, CIRCULATION, V103, P1967; Davi G, 2012, PROSTAGLAND IN PRESS; Elsenberg EHAM, 2009, THROMB HAEMOSTASIS, V102, P719, DOI 10.1160/TH09-05-0285; Gao F, 2010, CIRC J, V74, P701, DOI 10.1253/circj.CJ-09-0880; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P432, DOI 10.1016/j.jcin.2011.01.008; Geisler T, 2008, J THROMB HAEMOST, V6, P54; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1827, DOI 10.1016/j.jacc.2005.07.056; Han YL, 2009, AM HEART J, V157, P733, DOI 10.1016/j.ahj.2009.01.006; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kereiakes Dean J, 2004, Rev Cardiovasc Med, V5, P9; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lee SW, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.014; Lemesle G, 2008, ARCH CARDIOVASC DIS, V101, P769, DOI 10.1016/j.acvd.2008.10.006; Li Y, 2011, CHINESE MED J-PEKING, V124, P817, DOI 10.3760/cma.j.issn.0366-6999.2011.06.004; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Orford JL, 2002, J AM COLL CARDIOL, V40, P1567, DOI 10.1016/S0735-1097(02)02374-4; Popovic B, 2005, ARCH MAL COEUR VAISS, V98, P1187; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; RYAN T J, 1988, Journal of the American College of Cardiology, V12, P529; Shaw JA, 2008, CARDIOVASC REVASCULA, V9, P218, DOI 10.1016/j.carrev.2008.05.002; Siller-Matula JM, 2012, INT J CARDI IN PRESS; STEIN B, 1995, CIRCULATION, V91, P979, DOI 10.1161/01.CIR.91.4.979; Takayama T, 2011, J CARDIOL, V58, P92, DOI 10.1016/j.jjcc.2011.07.003; Trabattoni D, 2007, CATHETER CARDIO INTE, V70, P415, DOI 10.1002/ccd.21149; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055; Yeo KK, 2011, CATHETER CA IN PRESS	28	4	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48520	10.1371/journal.pone.0048520	http://dx.doi.org/10.1371/journal.pone.0048520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119044	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500157
J	Wang, XF; Zhou, W; Lu, J; Wang, HB; Xiao, C; Xia, J; Liu, GH				Wang, Xiufang; Zhou, Wen; Lu, Jing; Wang, Haibin; Xiao, Chan; Xia, Jing; Liu, Guihua			Effects of Population Size on Synchronous Display of Female and Male Flowers and Reproductive Output in Two Monoecious Sagittaria Species	PLOS ONE			English	Article							MALE FLORAL DISPLAY; SEX-RATIO; LATIFOLIA ALISMATACEAE; POLLINATOR RESPONSE; GENDER VARIATION; EVOLUTION; POLLEN; CONSEQUENCES; PLASTICITY; ASYNCHRONY	Background: Flowering synchrony and floral sex ratio have the potential to influence the mating opportunities and reproductive success through female function. Here, we examine the variances in synchronous display of female and male function, ratio of male to female flowers per day and subsequently reproductive output in small populations of two monoecious plants, Sagittaria trifolia and Sagittaria graminea. Methodology/Principal Finding: We created plant populations of size 2, 4, 10 and 20 and recorded the daily number of blooming male and female flowers per plant to determine daily floral display, flowering synchrony index and ratio of male to female flowers per day. We also harvested the fruits, counted the seeds and calculated the number of fruits and seeds per flower to measure reproductive success through female function. There is less overlap in flowering time of female and male function in smaller populations than in larger populations. Most importantly, we found that male-biased floral sex ratio and imbalanced display period of female and male function for individual plant can lead to a population-size-dependent ratio of male to female flowers per day. Increasing ratio of male to female flowers per day was generally associated with a greater percentage of fruit production. Conclusions/Significance: Our results highlight the importance of flowering synchrony of female and male function and population-size-dependent ratio of male to female flowers per day for female reproductive success. This finding improves our understanding of a mechanism that reduces reproductive success in small populations.	[Wang, Xiufang; Zhou, Wen; Lu, Jing; Wang, Haibin; Xiao, Chan; Xia, Jing; Liu, Guihua] Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China; [Wang, Xiufang; Zhou, Wen; Lu, Jing; Wang, Haibin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, GH (corresponding author), Chinese Acad Sci, Key Lab Aquat Bot & Watershed Ecol, Wuhan Bot Garden, Wuhan, Peoples R China.	liugh@wbgcas.cn	Lu, Jing/F-7009-2015; Xia, Jing/B-2794-2012	Lu, Jing/0000-0002-8179-4652; Xia, Jing/0000-0003-4762-2053	Key Technology R&D Program of Strategic Bio-resources of Finance Ministry of China [KSCX2-YW-Z-1005]; National Science Foundation of China [30970469]	Key Technology R&D Program of Strategic Bio-resources of Finance Ministry of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the Key Technology R&D Program of Strategic Bio-resources of Finance Ministry of China (KSCX2-YW-Z-1005)(http://www.cas.ac.cn) and the National Science Foundation of China (30970469)(http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 1996, ECOLOGY, V77, P1779, DOI 10.2307/2265783; Ashman TL, 2001, AM NAT, V157, P334, DOI 10.1086/319192; AUGSPURGER CK, 1983, BIOTROPICA, V15, P257, DOI 10.2307/2387650; Busch JW, 2008, TRENDS PLANT SCI, V13, P128, DOI 10.1016/j.tplants.2008.01.002; Calabrese JM, 2004, AM NAT, V164, P25, DOI 10.1086/421443; Calabrese JM, 2008, J ANIM ECOL, V77, P746, DOI 10.1111/j.1365-2656.2008.01385.x; Case AL, 2009, OIKOS, V118, P1250, DOI 10.1111/j.1600-0706.2009.17520.x; Dorken ME, 2004, J ECOL, V92, P32, DOI 10.1111/j.1365-2745.2004.00857.x; Dorken ME, 2003, PLANT SYST EVOL, V237, P99, DOI 10.1007/s00606-002-0243-8; Dorken ME, 2002, EVOLUTION, V56, P31, DOI 10.1111/j.0014-3820.2002.tb00847.x; Elam DR, 2007, P NATL ACAD SCI USA, V104, P549, DOI 10.1073/pnas.0607306104; FREEMAN DC, 1981, EVOLUTION, V35, P194, DOI 10.1111/j.1558-5646.1981.tb04875.x; Glaettli M, 2008, NEW PHYTOL, V179, P1193, DOI 10.1111/j.1469-8137.2008.02532.x; HARDER LD, 1989, AM NAT, V133, P323, DOI 10.1086/284922; Huang SQ, 2006, NEW PHYTOL, V171, P417, DOI 10.1111/j.1469-8137.2006.01766.x; Huang SQ, 1999, ACTA BOT SIN, V41, P726; Huang SQ, 2002, ANN BOT-LONDON, V90, P613, DOI 10.1093/aob/mcf236; KAUL RB, 1979, AM J BOT, V66, P1062, DOI 10.2307/2442571; Kery M, 2003, BASIC APPL ECOL, V4, P197, DOI 10.1078/1439-1791-00142; Klinkhamer PGL, 1997, TRENDS ECOL EVOL, V12, P260, DOI 10.1016/S0169-5347(97)01078-1; KOHN JR, 1985, AM J BOT, V72, P1144, DOI 10.2307/2443461; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; LLOYD DG, 1982, EVOLUTION, V36, P903, DOI 10.1111/j.1558-5646.1982.tb05462.x; LLOYD DG, 1984, EVOL BIOL, V17, P255; McCarthy MA, 1997, ECOL MODEL, V103, P99, DOI 10.1016/S0304-3800(97)00104-X; McCauley DE, 1998, EVOLUTION, V52, P30, DOI 10.1111/j.1558-5646.1998.tb05135.x; MUENCHOW G, 1994, AM J BOT, V81, P568, DOI 10.2307/2445731; Perry LE, 2011, EVOLUTION, V65, P2782, DOI 10.1111/j.1558-5646.2011.01344.x; Sarkissian TS, 2001, ECOLOGY, V82, P360, DOI 10.1890/0012-9658(2001)082[0360:GVISLA]2.0.CO;2; SAS, 2000, SAS US GUID STAT REL; SOLOMON BP, 1989, AM MIDL NAT, V121, P209, DOI 10.2307/2426024; Stehlik I, 2008, P NATL ACAD SCI USA, V105, P10847, DOI 10.1073/pnas.0801964105; THOMSON JD, 1981, EVOLUTION, V35, P1094, DOI 10.1111/j.1558-5646.1981.tb04979.x; van Kleunen M, 2007, OIKOS, V116, P1400, DOI [10.1111/j.2007.0030-1299.16004.x, 10.1111/j.0030-1299.2007.16004.x]; Wang XF, 2000, HEREDITAS, V22, P316; Yakimowski SB, 2011, ANN BOT-LONDON, V108, P765, DOI 10.1093/aob/mcr025	36	5	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48731	10.1371/journal.pone.0048731	http://dx.doi.org/10.1371/journal.pone.0048731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119094	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500201
J	Eady, TN; Belayev, L; Khoutorova, L; Atkins, KD; Zhang, CD; Bazan, NG				Eady, Tiffany N.; Belayev, Ludmila; Khoutorova, Larissa; Atkins, Kristal D.; Zhang, Changde; Bazan, Nicolas G.			Docosahexaenoic Acid Signaling Modulates Cell Survival in Experimental Ischemic Stroke Penumbra and Initiates Long-Term Repair in Young and Aged Rats	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; NEUROPROTECTIN D1; BRAIN; INJURY; PATHWAYS; MEDIATOR; AKT	Background: Docosahexaenoic acid, a major omega-3 essential fatty acid family member, improves behavioral deficit and reduces infarct volume and edema after experimental focal cerebral ischemia. We hypothesize that DHA elicits neuroprotection by inducing AKT/p70S6K phosphorylation, which in turn leads to cell survival and protects against ischemic stroke in young and aged rats. Methods and Results: Rats underwent 2 h of middle cerebral artery occlusion (MCAo). DHA, neuroprotectin D1 (NPD1) or vehicle (saline) was administered 3 h after onset of stroke. Neurological function was evaluated on days 1, 2, 3, and 7. DHA treatment improved functional recovery and reduced cortical, subcortical and total infarct volumes 7 days after stroke. DHA also reduced microglia infiltration and increased the number of astrocytes and neurons when compared to vehicle on days 1 and 7. Increases in p473 AKT and p308 AKT phosphorylation/activation were observed in animals treated with DHA 4 h after MCAo. Activation of other members of the AKT signaling pathway were also observed in DHA treated animals including increases in pS6 at 4 h and pGSK at 24 h. DHA or NPD1 remarkably reduced total and cortical infarct in aged rats. Moreover, we show that in young and aged rats DHA treatment after MCAo potentiates NPD1 biosynthesis. The phosphorylation of p308 AKT or pGSK was not different between groups in aged rats. However, pS6 expression was increased with DHA or NPD1 treatment when compared to vehicle. Conclusions: We suggest that DHA induces cell survival, modulates the neuroinflammatory response and triggers long term restoration of synaptic circuits. Both DHA and NPD1 elicited remarkable protection in aged animals. Accordingly, activation of DHA signaling might provide benefits in the management of ischemic stroke both acutely as well as long term to limit ensuing disabilities.	[Eady, Tiffany N.; Belayev, Ludmila; Khoutorova, Larissa; Atkins, Kristal D.; Zhang, Changde; Bazan, Nicolas G.] Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bazan, NG (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Neurosci Ctr Excellence, New Orleans, LA USA.	nbazan@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) grant [R01 NS046741, RO1 NS065786]; Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD and Other Dual Doctoral Degree Fellows (NIH, National Institute on Aging grant) [F30 AG032841]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065786, R01NS046741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG032841] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) grant; Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD and Other Dual Doctoral Degree Fellows (NIH, National Institute on Aging grant); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This investigation was supported by National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS046741 (NGB) and RO1 NS065786 (LB). TNE is a recipient of the Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD and Other Dual Doctoral Degree Fellows (NIH, National Institute on Aging grant F30 AG032841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Akbar M, 2005, P NATL ACAD SCI USA, V102, P10858, DOI 10.1073/pnas.0502903102; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Bazan NG, 2003, J LIPID RES, V44, P2221, DOI 10.1194/jlr.R300013-JLR200; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Belayev L, 2005, STROKE, V36, P118, DOI 10.1161/01.STR.0000149620.74770.2e; Belayev L, 2012, BASIC NEUROCHEMISTRY: PRINCIPLES OF MOLECULAR, CELLULAR, AND MEDICAL NEUROBIOLOGY, 8THEDITION, P621; Belayev L, 2012, SPR SER TRANSL STROK, P471, DOI 10.1007/978-1-4419-9530-8_24; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Calandria JM, 2009, J BIOL CHEM, V284, P17877, DOI 10.1074/jbc.M109.003988; Chen RL, 2010, NAT REV NEUROL, V6, P256, DOI 10.1038/nrneurol.2010.36; DiNapoli VA, 2008, NEUROBIOL AGING, V29, P753, DOI 10.1016/j.neurobiolaging.2006.12.007; Faghiri Z, 2010, EXP EYE RES, V90, P718, DOI 10.1016/j.exer.2010.03.002; Gao XW, 2010, TRANSL STROKE RES, V1, P202, DOI 10.1007/s12975-010-0017-5; Guo MQ, 2007, J MOL NEUROSCI, V33, P67, DOI 10.1007/s12031-007-0046-z; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; KIMELBERG HK, 1989, SCI AM, V260, P66, DOI 10.1038/scientificamerican0489-66; Kimelberg HK, 1989, SCI AM, V4, P74; Kimelberg HK, 1989, SCI AM, V4, P76; Liu FD, 2009, J CEREBR BLOOD F MET, V29, P792, DOI 10.1038/jcbfm.2009.5; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Niemoller Tiffany D., 2009, V99, P46, DOI 10.1159/000192994; Pignataro G, 2011, CURR OPIN PHARMACOL, V11, P378, DOI 10.1016/j.coph.2011.05.003; Popa-Wagner A, 2007, CURR NEUROVASC RES, V4, P216; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; TOWER DB, 1992, PROG BRAIN RES, V94, P3; Towfighi A, 2011, STROKE, V42, P2351, DOI 10.1161/STROKEAHA.111.621904; Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	38	65	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e46151	10.1371/journal.pone.0046151	http://dx.doi.org/10.1371/journal.pone.0046151			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118851	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705600003
J	Enault, J; Zatylny-Gaudin, C; Bernay, B; Lefranc, B; Leprince, J; Baudy-Floc'h, M; Henry, J				Enault, Jeremy; Zatylny-Gaudin, Celine; Bernay, Benoit; Lefranc, Benjamin; Leprince, Jerome; Baudy-Floc'h, Michele; Henry, Joel			A Complex Set of Sex Pheromones Identified in the Cuttlefish Sepia officinalis	PLOS ONE			English	Article							BORNE PROTEIN PHEROMONES; STIMULATE MATE ATTRACTION; INTERSPECIFIC ATTRACTIVENESS; OCTADECANEUROPEPTIDE ODN; APLYSIA-CALIFORNICA; REGULATORY PEPTIDES; SIGNAL PEPTIDES; GENE ONTOLOGY; ANALOGS; FAMILY	Background: The cephalopod mollusk Sepia officinalis can be considered as a relevant model for studying reproduction strategies associated to seasonal migrations. Using transcriptomic and peptidomic approaches, we aim to identify peptide sex pheromones that are thought to induce the aggregation of mature cuttlefish in their egg-laying areas. Results: To facilitate the identification of sex pheromones, 576 5'-expressed sequence tags (ESTs) were sequenced from a single cDNA library generated from accessory sex glands of female cuttlefish. Our analysis yielded 223 unique sequences composed of 186 singletons and 37 contigs. Three major redundant ESTs called SP alpha, SP alpha' and SP beta were identified as good candidates for putative sex pheromone transcripts and are part of the 87 unique sequences classified as unknown. The alignment of translated SP alpha and SP alpha' revealed a high level of conservation, with 98.4% identity. Translation led to a 248-amino acid precursor containing six peptides with multiple putative disulfide bonds. The alignment of SP alpha-alpha' with SP beta revealed a partial structural conservation, with 37.3% identity. Translation of SP beta led to a 252-amino acid precursor containing five peptides. The occurrence of a signal peptide on SP alpha, SP alpha' and SP beta showed that the peptides were secreted. RT-PCR and mass spectrometry analyses revealed a co-localization of transcripts and expression products in the oviduct gland. Preliminary in vitro experiments performed on gills and penises revealed target organs involved in mating and ventilation. Conclusions: The analysis of the accessory sex gland transcriptome of Sepia officinalis led to the identification of peptidic sex pheromones. Although preliminary functional tests suggested the involvement of the alpha 3 and beta 2 peptides in ventilation and mating stimulation, further functional investigations will make it possible to identify the complete set of biological activities expected from waterborne pheromones.	[Enault, Jeremy; Zatylny-Gaudin, Celine; Henry, Joel] Univ Caen Basse Normandie, Biol Mollusques Marins & Ecosyst Associes, FRE CNRS BIOMEA 3484, Caen, France; [Bernay, Benoit; Henry, Joel] Univ Caen Basse Normandie, Post Genom Platform PROTEOGEN, IFR ICORE 146, Caen, France; [Lefranc, Benjamin; Leprince, Jerome] Univ Rouen, INSERM, IFRMP23, PRIMACEN,U982, Mont St Aignan, France; [Baudy-Floc'h, Michele] Univ Rennes 1, UMR CNRS 6226, Rennes, France	Universite de Caen Normandie; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes	Henry, J (corresponding author), Univ Caen Basse Normandie, Biol Mollusques Marins & Ecosyst Associes, FRE CNRS BIOMEA 3484, Caen, France.	joel.henry@unicaen.fr	Leprince, Jerome/N-9083-2017	Zatylny-Gaudin, Celine/0000-0001-9258-9876; Leprince, Jerome/0000-0002-7814-9927; Lefranc, Benjamin/0000-0002-0367-2414	Ph.D. grant of the "Comite Regional de Basse-Normandy''	Ph.D. grant of the "Comite Regional de Basse-Normandy''	This work was supported by a Ph.D. grant of the "Comite Regional de Basse-Normandy''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASPEY WP, 1976, BEHAV BIOL, V17, P301, DOI 10.1016/S0091-6773(76)90662-3; AUDESIRK TE, 1979, BIOL BULL, V157, P407, DOI 10.2307/1541026; AUDESIRK TE, 1977, BEHAV BIOL, V20, P235, DOI 10.1016/S0091-6773(77)90799-4; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernay B, 2005, BIOCHEM BIOPH RES CO, V338, P1037, DOI 10.1016/j.bbrc.2005.10.034; Bernay B, 2004, BIOCHEM BIOPH RES CO, V314, P215, DOI 10.1016/j.bbrc.2003.12.085; Bernay B, 2006, PEPTIDES, V27, P1259, DOI 10.1016/j.peptides.2005.11.025; Boal JG, 2010, J CHEM ECOL, V36, P834, DOI 10.1007/s10886-010-9816-0; Boal JG, 1998, J EXP MAR BIOL ECOL, V230, P183, DOI 10.1016/S0022-0981(98)00068-9; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BOUCAUDCAMOU E, 1991, CUTTLEFISH, P179; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cummins SF, 2008, PEPTIDES, V29, P152, DOI 10.1016/j.peptides.2007.07.031; Cummins SE, 2005, PEPTIDES, V26, P121, DOI 10.1016/j.peptides.2004.07.017; Cummins SF, 2006, PEPTIDES, V27, P597, DOI 10.1016/j.peptides.2005.08.026; Cummins SF, 2005, PEPTIDES, V26, P351, DOI 10.1016/j.peptides.2004.10.024; Cummins SF, 2004, J BIOL CHEM, V279, P25614, DOI 10.1074/jbc.M313585200; Fan XM, 1997, MOL BRAIN RES, V48, P167, DOI 10.1016/S0169-328X(97)00154-X; Garden RW, 1998, P NATL ACAD SCI USA, V95, P3972, DOI 10.1073/pnas.95.7.3972; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JAHANPARWAR B, 1976, PHYSIOLOGY, V19, P240; Le Marec O, 2011, J MED CHEM, V54, P4806, DOI 10.1021/jm200418c; Leprince J, 1998, J MED CHEM, V41, P4433, DOI 10.1021/jm980275d; Leprince J, 2001, EUR J BIOCHEM, V268, P6045, DOI 10.1046/j.0014-2956.2001.02533.x; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Painter SD, 1998, BIOL BULL-US, V194, P120, DOI 10.2307/1543042; Painter SD, 2004, P NATL ACAD SCI USA, V101, P6929, DOI 10.1073/pnas.0306339101; Painter SD, 2003, BIOL BULL-US, V205, P16, DOI 10.2307/1543441; PAINTER SD, 1989, BEHAV NEURAL BIOL, V51, P222, DOI 10.1016/S0163-1047(89)90857-1; Ross LG, 1999, ANESTHETIC SEDATIVE, P46; Schein CH, 2001, BIOPHYS J, V81, P463, DOI 10.1016/S0006-3495(01)75714-1; SOLE NA, 1992, J ORG CHEM, V57, P5399, DOI 10.1021/jo00046a022; Susswein AJ, 2004, PEPTIDES, V25, P1523, DOI 10.1016/j.peptides.2003.11.027; SUSSWEIN AJ, 1983, BEHAV NEURAL BIOL, V39, P203, DOI 10.1016/S0163-1047(83)90859-2; Walters JR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-592; Zatylny C, 2000, BIOCHEM BIOPH RES CO, V276, P1013, DOI 10.1006/bbrc.2000.3595; Zatylny C, 2000, BIOCHEM BIOPH RES CO, V275, P217, DOI 10.1006/bbrc.2000.3286; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	44	5	5	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e46531	10.1371/journal.pone.0046531	http://dx.doi.org/10.1371/journal.pone.0046531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118854	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600005
J	Bai, J; Abdul-Rahman, MF; Rifkin-Graboi, A; Chong, YS; Kwek, K; Saw, SM; Godfrey, KM; Gluckman, PD; Fortier, MV; Meaney, MJ; Qiu, AQ				Bai, Jordan; Abdul-Rahman, Muhammad Farid; Rifkin-Graboi, Anne; Chong, Yap-Seng; Kwek, Kenneth; Saw, Seang-Mei; Godfrey, Keith M.; Gluckman, Peter D.; Fortier, Marielle V.; Meaney, Michael J.; Qiu, Anqi			Population Differences in Brain Morphology and Microstructure among Chinese, Malay, and Indian Neonates	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; HUMAN FETAL-BRAIN; AFRICAN-AMERICAN; SCHIZOPHRENIA; ABNORMALITIES; CHILDREN; WHITE	We studied a sample of 75 Chinese, 73 Malay, and 29 Indian healthy neonates taking part in a cohort study to examine potential differences in neonatal brain morphology and white matter microstructure as a function of ethnicity using both structural T2-weighted magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI). We first examined the differences in global size and morphology of the brain among the three groups. We then constructed the T2-weighted MRI and DTI atlases and employed voxel-based analysis to investigate ethnic differences in morphological shape of the brain from the T2-weighted MRI, and white matter microstructure measured by fractional anisotropy derived from DTI. Compared with Malay neonates, the brains of Indian neonates' tended to be more elongated in anterior and posterior axis relative to the superior-inferior axis of the brain even though the total brain volume was similar among the three groups. Although most anatomical regions of the brain were similar among Chinese, Malay, and Indian neonates, there were anatomical variations in the spinal-cerebellar and cortical-striatal-thalamic neural circuits among the three populations. The population-related brain regions highlighted in our study are key anatomical substrates associated with sensorimotor functions.	[Bai, Jordan; Abdul-Rahman, Muhammad Farid; Qiu, Anqi] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Rifkin-Graboi, Anne; Meaney, Michael J.; Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Chong, Yap-Seng] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 117548, Singapore; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal Fetal Med, Singapore, Singapore; [Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Godfrey, Keith M.] Southampton NIHR Nutr Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, Med Res Council Lifecourse Epidemiol Unit, Southampton, Hants, England; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Fortier, Marielle V.] KK Womens & Childrens Hosp, Dept Diagnost & Intervent Imaging, Singapore, Singapore; [Meaney, Michael J.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Meaney, Michael J.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2T5, Canada; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton; University of Auckland; KK Women's & Children's Hospital; McGill University; McGill University; National University of Singapore	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Qiu, Anqi/H-2267-2011; Rifkin-Graboi, Anne/AAH-3658-2022; Rifkin-Graboi, Anne/AFM-0959-2022; Meaney, Michael/N-5931-2019	Qiu, Anqi/0000-0002-0215-6338; Rifkin-Graboi, Anne/0000-0002-7641-4678; Godfrey, Keith/0000-0002-4643-0618; Chong, Yap Seng/0000-0002-7232-8473	National Medical Research Council, Singapore [NMRC/TCR/004-NUS/2008]; A*STAR [SICS-09/1/1/001]; National Institute for Health Research through the Southampton NIHR Nutrition Biomedical Research Centre; Young Investigator Award at the National University of Singapore [NUSYIA FY10 P07]; National University of Singapore [MOE AcRF Tier 1]; MRC [MC_UP_A620_1017] Funding Source: UKRI; Medical Research Council [MC_UP_A620_1017] Funding Source: researchfish	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); A*STAR(Agency for Science Technology & Research (A*STAR)); National Institute for Health Research through the Southampton NIHR Nutrition Biomedical Research Centre; Young Investigator Award at the National University of Singapore(National University of Singapore); National University of Singapore(National University of Singapore); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is funded by the National Medical Research Council, Singapore, NMRC/TCR/004-NUS/2008, and A*STAR SICS-09/1/1/001. KMG is supported by the National Institute for Health Research through the Southampton NIHR Nutrition Biomedical Research Centre. AQ is supported by the Young Investigator Award at the National University of Singapore (NUSYIA FY10 P07), and the National University of Singapore MOE AcRF Tier 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angold A, 2002, ARCH GEN PSYCHIAT, V59, P893, DOI 10.1001/archpsyc.59.10.893; Ashtari M, 2005, BIOL PSYCHIAT, V57, P448, DOI 10.1016/j.biopsych.2004.11.047; Castellanos FX, 2003, AM J PSYCHIAT, V160, P1693, DOI 10.1176/appi.ajp.160.9.1693; Dibbets P, 2010, NEUROPSYCHOLOGY, V24, P413, DOI 10.1037/a0018997; Du J, 2011, NEUROIMAGE, V56, P162, DOI 10.1016/j.neuroimage.2011.01.067; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; FRIED PA, 1992, NEUROTOXICOL TERATOL, V14, P299, DOI 10.1016/0892-0362(92)90036-A; Goldman AL, 2008, BIOL PSYCHIAT, V63, P475, DOI 10.1016/j.biopsych.2007.06.006; Hoon AH, 2009, DEV MED CHILD NEUROL, V51, P697, DOI 10.1111/j.1469-8749.2009.03306.x; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Isamah N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013642; Ivanov I, 2010, AM J PSYCHIAT, V167, P397, DOI 10.1176/appi.ajp.2009.09030398; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Lebel C, 2011, NEUROPSYCHOL REV, V21, P102, DOI 10.1007/s11065-011-9163-0; Lee JS, 2005, J KOREAN MED SCI, V20, P483, DOI 10.3346/jkms.2005.20.3.483; Lim CS, 2011, EARLY INTERV PSYCHIA, V5, P242, DOI 10.1111/j.1751-7893.2011.00260.x; Miller TW, 2009, CLIN PSYCHOL REV, V29, P77, DOI 10.1016/j.cpr.2008.10.001; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Rushton JP, 1997, INTELLIGENCE, V25, P7, DOI 10.1016/S0160-2896(97)90004-0; SHINOHARA T, 1977, APPL NEUROPHYSIOL, V39, P251; Sim K, 2006, J NEURAL TRANSM, V113, P907, DOI 10.1007/s00702-005-0363-8; Soh SE, 2012, ASIA PAC ALLERGY, V2, P144, DOI 10.5415/apallergy.2012.2.2.144; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Vadakkumpadan F, 2006, INT J NEUROSCI, V116, P407, DOI 10.1080/00207450500505662; VANDERKNAAP MS, 1990, NEURORADIOLOGY, V31, P459, DOI 10.1007/BF00340123; Wu YW, 2011, PEDIATRICS, V127, pE674, DOI 10.1542/peds.2010-1656; Yoshida S, 2010, DEV MED CHILD NEUROL, V52, P935, DOI 10.1111/j.1469-8749.2010.03669.x	30	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47816	10.1371/journal.pone.0047816	http://dx.doi.org/10.1371/journal.pone.0047816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026VC	23112850	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000310310200085
J	Caysa, H; Hoffmann, S; Luetzkendorf, J; Mueller, LP; Unverzagt, S; Mader, K; Mueller, T				Caysa, Henrike; Hoffmann, Stefan; Luetzkendorf, Jana; Mueller, Lutz Peter; Unverzagt, Susanne; Maeder, Karsten; Mueller, Thomas			Monitoring of Xenograft Tumor Growth and Response to Chemotherapy by Non-Invasive In Vivo Multispectral Fluorescence Imaging	PLOS ONE			English	Article							PANCREATIC-CANCER; METASTATIC MODELS; ORTHOTOPIC MODEL; PROTEIN; MOUSE; BRIGHT; LINES	A continuous monitoring of the whole tumor burden of individuals in orthotopic tumor models is a desirable aim and requires non-invasive imaging methods. Here we investigated whether quantification of a xenograft tumor intrinsic fluorescence signal can be used to evaluate tumor growth and response to chemotherapy. Stably fluorescence protein (FP) expressing cell clones of colorectal carcinoma and germ cell tumor lines were generated by lentiviral transduction using the FPs eGFP, dsRed2, TurboFP635, and mPlum. Applying subcutaneous tumor models in different experimental designs, specific correlations between measured total fluorescence intensity (FI) and the tumor volume (V) could be established. The accuracy of correlation of FI and V varied depending on the cell model used. The application of deep-red FP expressing xenografts (TurboFP635, mPlum) was observed to result in improved correlations. This was also reflected by the results of a performed error analysis. In a model of visceral growing mPlum tumors, measurements of FI could be used to follow growth and response to chemotherapy. However, in some cases final necropsy revealed the existence of additional, deeper located tumors that had not been detected in vivo by their mPlum signal. Consistently, only the weights of the tumors that were detected in vivo based on their mPlum signal correlated with FI. In conclusion, as long as tumors are visualized by their fluorescence signal the FI can be used to evaluate tumor burden. Deep-red FPs are more suitable for in vivo applications as compared to eGFP and dsRed2.	[Caysa, Henrike; Luetzkendorf, Jana; Mueller, Lutz Peter; Mueller, Thomas] Univ Halle Wittenberg, Dept Internal Med Oncol Hematol 4, Halle, Germany; [Caysa, Henrike; Hoffmann, Stefan; Maeder, Karsten] Univ Halle Wittenberg, Inst Pharm, Halle, Germany; [Unverzagt, Susanne] Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Mueller, T (corresponding author), Univ Halle Wittenberg, Dept Internal Med Oncol Hematol 4, Halle, Germany.	thomas.mueller@medizin.uni-halle.de	Mueller, Thomas/ABE-4197-2020; Müller, Lutz/ABE-2941-2020; Unverzagt, Susanne/AGE-2574-2022	/0000-0003-1613-6976; Lutzkendorf, Jana/0000-0002-5781-9266	Federal State of Saxony-Anhalt [FKZ 3646A/0907]; DFG(German Research Foundation) [MA-164817-1]	Federal State of Saxony-Anhalt; DFG(German Research Foundation)(German Research Foundation (DFG))	This work was supported by the Federal State of Saxony-Anhalt (grant No. FKZ 3646A/0907) and the DFG(German Research Foundation)(grant No. MA-164817-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021; Bouvet M, 2005, CANCER RES, V65, P9829, DOI 10.1158/0008-5472.CAN-05-1548; Bouvet M, 2002, CANCER RES, V62, P1534; Bouvet M, 2009, MINERVA CHIR, V64, P521; Brown H., 1999, APPL MIXED MODELS ME; CASPER J, 1987, INT J ANDROL, V10, P105, DOI 10.1111/j.1365-2605.1987.tb00171.x; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Gros SJ, 2010, INT J CANCER, V126, P2671, DOI 10.1002/ijc.24980; Hasegawa S, 2000, CANCER GENE THER, V7, P1336, DOI 10.1038/sj.cgt.0237; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2009, CLIN EXP METASTAS, V26, P345, DOI 10.1007/s10585-008-9205-z; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Kerbel RS, 2003, CANCER BIOL THER, V2, pS134; KUBOTA T, 1994, J CELL BIOCHEM, V56, P4, DOI 10.1002/jcb.240560103; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Levenson RM, 2008, ILAR J, V49, P78, DOI 10.1093/ilar.49.1.78; Levenson RM, 2009, BIOTECHNIQUES PROTOC, V2009, P35; Luetzkendorf J, 2010, J CELL MOL MED, V14, P2292, DOI 10.1111/j.1582-4934.2009.00794.x; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; Mansfield JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032458; Sandhu GS, 2010, WIRES SYST BIOL MED, V2, P398, DOI 10.1002/wsbm.71; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Stell A, 2007, Q J NUCL MED MOL IM, V51, P127; Tam JM, 2007, MOL IMAGING, V6, P269, DOI 10.2310/7290.2007.00023; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Winnard PT, 2006, NEOPLASIA, V8, P796, DOI 10.1593/neo.06304; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206	31	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47927	10.1371/journal.pone.0047927	http://dx.doi.org/10.1371/journal.pone.0047927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112873	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200110
J	Chien, YT; Huang, SW				Chien, Yu-Tung; Huang, Shao-Wei			Accurate Prediction of Protein Catalytic Residues by Side Chain Orientation and Residue Contact Density	PLOS ONE			English	Article							ACTIVE-SITES; SEQUENCE; ENZYMES; TEMPLATES; MACHINE	Prediction of protein catalytic residues provides useful information for the studies of protein functions. Most of the existing methods combine both structure and sequence information but heavily rely on sequence conservation from multiple sequence alignments. The contribution of structure information is usually less than that of sequence conservation in existing methods. We found a novel structure feature, residue side chain orientation, which is the first structure-based feature that achieves prediction results comparable to that of evolutionary sequence conservation. We developed a structure-based method, Enzyme Catalytic residue Side-chain Arrangement (EXIA), which is based on residue side chain orientations and backbone flexibility of protein structure. The prediction that uses EXIA outperforms existing structure-based features. The prediction quality of combing EXIA and sequence conservation exceeds that of the state-of-the-art prediction methods. EXIA is designed to predict catalytic residues from single protein structure without needing sequence or structure alignments. It provides invaluable information when there is no sufficient or reliable homology information for target protein. We found that catalytic residues have very special side chain orientation and designed the EXIA method based on the newly discovered feature. It was also found that EXIA performs well for a dataset of enzymes without any bounded ligand in their crystallographic structures.	[Chien, Yu-Tung; Huang, Shao-Wei] Tzu Chi Univ, Dept Med Informat, Hualien, Taiwan	Tzu Chi University	Huang, SW (corresponding author), Tzu Chi Univ, Dept Med Informat, Hualien, Taiwan.	swhwang.orz@gmail.com			National Science Council, Taiwan [101-2218-E-320-001-]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by grant (101-2218-E-320-001-) of National Science Council, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Ben-Shimon A, 2005, J MOL BIOL, V351, P309, DOI 10.1016/j.jmb.2005.06.047; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Cilia E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-115; Fischer JD, 2008, BIOINFORMATICS, V24, P613, DOI 10.1093/bioinformatics/btm626; Huang SW, 2008, THEOR CHEM ACC, V121, P197, DOI 10.1007/s00214-008-0465-0; Huang SW, 2011, CURR PROTEIN PEPT SC, V12, P574, DOI 10.2174/138920311796957676; La D, 2005, PROTEINS, V58, P309, DOI 10.1002/prot.20321; Lin CP, 2008, PROTEINS, V72, P929, DOI 10.1002/prot.21983; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Ota M, 2003, J MOL BIOL, V327, P1053, DOI 10.1016/S0022-2836(03)00207-9; Pande S, 2007, 2007 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P247; Petrova NV, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-312; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Sacquin-Mora S, 2007, PROTEINS, V67, P350, DOI 10.1002/prot.21353; Shih CH, 2012, PROTEINS, V80, P1647, DOI 10.1002/prot.24058; Somarowthu S, 2012, BIOINFORMATICS, V28, P2078, DOI 10.1093/bioinformatics/bts321; Sterner B, 2007, J COMPUT BIOL, V14, P1058, DOI 10.1089/cmb.2007.0042; Tang YR, 2008, PROTEIN ENG DES SEL, V21, P295, DOI 10.1093/protein/gzn003; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Torrance JW, 2005, J MOL BIOL, V347, P565, DOI 10.1016/j.jmb.2005.01.044; Wallace AC, 1996, PROTEIN SCI, V5, P1001; Wei Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-119; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433	28	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47951	10.1371/journal.pone.0047951	http://dx.doi.org/10.1371/journal.pone.0047951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110141	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200118
J	Kos, M; van den Brink, D; Snijders, TM; Rijpkema, M; Franke, B; Fernandez, G; Hagoort, P				Kos, Miriam; van den Brink, Danielle; Snijders, Tineke M.; Rijpkema, Mark; Franke, Barbara; Fernandez, Guillen; Hagoort, Peter			CNTNAP2 and Language Processing in Healthy Individuals as Measured with ERPs	PLOS ONE			English	Article							BRAIN POTENTIALS; SENTENCE COMPREHENSION; INHERITED SPEECH; FOXP2 GENE; DISORDER; SYNTAX; N400; INTEGRATION; EXPRESSION; SEMANTICS	The genetic FOXP2-CNTNAP2 pathway has been shown to be involved in the language capacity. We investigated whether a common variant of CNTNAP2 (rs7794745) is relevant for syntactic and semantic processing in the general population by using a visual sentence processing paradigm while recording ERPs in 49 healthy adults. While both AA homozygotes and T-carriers showed a standard N400 effect to semantic anomalies, the response to subject-verb agreement violations differed across genotype groups. T-carriers displayed an anterior negativity preceding the P600 effect, whereas for the AA group only a P600 effect was observed. These results provide another piece of evidence that the neuronal architecture of the human faculty of language is shaped differently by effects that are genetically determined.	[Kos, Miriam; van den Brink, Danielle; Snijders, Tineke M.; Rijpkema, Mark; Franke, Barbara; Fernandez, Guillen; Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain, NL-6525 ED Nijmegen, Netherlands; [van den Brink, Danielle] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Snijders, Tineke M.] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands; [Snijders, Tineke M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neuroscience, Dept Child & Adolescent Psychiat, Utrecht, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6525 ED Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Max Planck Society	Kos, M (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain, NL-6525 ED Nijmegen, Netherlands.	m.kos@donders.ru.nl; p.hagoort@donders.ru.nl	Franke, Barbara/D-4836-2009; Rijpkema, Mark/D-1974-2010; van den Brink, Danielle/D-6485-2012; Fernandez, Guillen/B-3771-2009; Snijders, Tineke M/A-3431-2013; Hagoort, Peter/B-7417-2012	Franke, Barbara/0000-0003-4375-6572; Rijpkema, Mark/0000-0002-8495-4703; Fernandez, Guillen/0000-0002-5522-0604; Snijders, Tineke/0000-0002-2442-0451	SPINOZA prize from the Netherlands Organization for Scientific Research (NWO)	SPINOZA prize from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a SPINOZA prize from the Netherlands Organization for Scientific Research (NWO) to Peter Hagoort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Baaijen RH, 1993, CELEX LEXICAL DATABA; Baggio G, 2011, LANG COGNITIVE PROC, V26, P1338, DOI 10.1080/01690965.2010.542671; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Bishop D, 2009, ANN NY ACAD SCI, V1156, P1, DOI 10.1111/j.1749-6632.2009.04419.x; Bornkessel-Schlesewsky I, 2011, BRAIN LANG, V117, P133, DOI 10.1016/j.bandl.2010.09.010; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Feuk L, 2006, AM J HUM GENET, V79, P965, DOI 10.1086/508902; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Folia V, 2011, BIOLINGUISTICS, V5, P105; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Gold R, 2010, BRAIN LANG, V113, P124, DOI [10.1016/j.band1.2010.03.002, 10.1016/j.bandl.2010.03.002]; Gregor A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-106; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hagoort P., 2009, BIOL FDN ORIGIN SYNT; Hasting AS, 2008, J COGNITIVE NEUROSCI, V20, P1207, DOI 10.1162/jocn.2008.20083; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kos M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00222; Kuperberg GR, 2008, NEUROIMAGE, V40, P367, DOI 10.1016/j.neuroimage.2007.10.009; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Laszlo S, 2011, PSYCHOPHYSIOLOGY, V48, P176, DOI 10.1111/j.1469-8986.2010.01058.x; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; MacDermot KD, 2005, AM J HUM GENET, V76, P1074, DOI 10.1086/430841; Mancini S, 2011, BRAIN RES, V1410, P64, DOI 10.1016/j.brainres.2011.06.055; Molinaro N, 2011, CORTEX, V47, P908, DOI 10.1016/j.cortex.2011.02.019; Nakabayashi K, 2001, GENOMICS, V73, P108, DOI 10.1006/geno.2001.6517; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Peter B, 2011, J NEURODEV DISORD, V3, P39, DOI 10.1007/s11689-010-9065-0; Pijnacker J, 2010, NEUROPSYCHOLOGIA, V48, P2940, DOI 10.1016/j.neuropsychologia.2010.06.003; Poot M, 2010, NEUROGENETICS, V11, P81, DOI 10.1007/s10048-009-0205-1; Ramus Franck, 2009, COGNITIVE NEUROSCIEN, P855; Scharff C, 2011, PHILOS T R SOC B, V366, P2124, DOI 10.1098/rstb.2011.0001; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Snijders TM, 2010, MORE WORDS NEURAL GE, DOI http://hdl.handle.net/2066/77569; Steer CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012633; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Stromswold K, 2001, LANGUAGE, V77, P647, DOI 10.1353/lan.2001.0247; Swaab T, 1997, J COGNITIVE NEUROSCI, V9, P39, DOI 10.1162/jocn.1997.9.1.39; de Meerendonk N, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00163.x; van de Meerendonk N, 2011, NEUROIMAGE, V54, P2350, DOI 10.1016/j.neuroimage.2010.10.022; van den Brink D, 2001, J COGNITIVE NEUROSCI, V13, P967, DOI 10.1162/089892901753165872; Van der Beek L, 2001, ALPINO DEPENDENCY TR, P8; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Watkins KE, 1999, AM J HUM GENET, V65, P1215, DOI 10.1086/302631; Whalley HC, 2011, AM J MED GENET B, V156B, P941, DOI 10.1002/ajmg.b.31241; Whitehouse AJO, 2011, GENES BRAIN BEHAV, V10, P451, DOI 10.1111/j.1601-183X.2011.00684.x; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	61	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e46995	10.1371/journal.pone.0046995	http://dx.doi.org/10.1371/journal.pone.0046995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026VC	23115634	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200022
J	Neves, AGM; Serva, M				Neves, Armando G. M.; Serva, Maurizio			Extremely Rare Interbreeding Events Can Explain Neanderthal DNA in Living Humans	PLOS ONE			English	Article							HUMAN-EVOLUTION; GENEALOGICAL TREES; MITOCHONDRIAL-DNA; INDIVIDUALS; ANCESTORS; HOMININ; SIBERIA; GENOME	Considering the recent experimental discovery of Green et al that present-day non-Africans have 1 to 4% of their nuclear DNA of Neanderthal origin, we propose here a model which is able to quantify the genetic interbreeding between two subpopulations with equal fitness, living in the same geographic region. The model consists of a solvable system of deterministic ordinary differential equations containing as a stochastic ingredient a realization of the neutral Wright-Fisher process. By simulating the stochastic part of the model we are able to apply it to the interbreeding ofthe African ancestors of Eurasians and Middle Eastern Neanderthal subpopulations and estimate the only parameter of the model, which is the number of individuals per generation exchanged between subpopulations. Our results indicate that the amount of Neanderthal DNA in living non-Africans can be explained with maximum probability by the exchange of a single pair of individuals between the subpopulations at each 77 generations, but larger exchange frequencies are also allowed with sizeable probability. The results are compatible with a long coexistence time of 130,000 years, a total interbreeding population of order 10(4) individuals, and with all living humans being descendants of Africans both for mitochondrial DNA and Y chromosome.	[Neves, Armando G. M.] Univ Fed Minas Gerais, Dept Matemat, Belo Horizonte, MG, Brazil; [Serva, Maurizio] Univ Aquila, Dipartimento Ingn & Sci Informaz & Matemat, I-67100 Laquila, Italy	Universidade Federal de Minas Gerais; University of L'Aquila	Neves, AGM (corresponding author), Univ Fed Minas Gerais, Dept Matemat, Belo Horizonte, MG, Brazil.	aneves@mat.ufmg.br	Serva, Maurizio/AAU-8091-2021	serva, maurizio/0000-0002-8117-1834; Neves, Armando/0000-0003-1602-6881	CNPq, an agency of the Brazilian Ministry for Science and Technology	CNPq, an agency of the Brazilian Ministry for Science and Technology(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AGMN was funded during this work by a scholarship from CNPq, an agency of the Brazilian Ministry for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Yosef O, 1999, CHRONOLOGY MIDDLE PA, P39; Buchanan M, 2011, NEWSCIENTIST; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chang JT, 1999, ADV APPL PROBAB, V31, P1002, DOI 10.1239/aap/1029955256; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Currat M, 2011, P NATL ACAD SCI USA, V108, P15129, DOI 10.1073/pnas.1107450108; Derrida B, 1999, PHYS REV LETT, V82, P1987, DOI 10.1103/PhysRevLett.82.1987; Derrida B, 2000, PHYSICA A, V281, P1, DOI 10.1016/S0378-4371(00)00031-5; Derrida B, 2000, J THEOR BIOL, V203, P303, DOI 10.1006/jtbi.2000.1095; Ewens W. J., 1979, MATH POPULATION GENE; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Felsenstein J., 2011, THEORETICAL EVOLUTIO; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Harder B, 2002, NATL GEOGRAPHIC NEWS; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krings M, 2000, NAT GENET, V26, P144, DOI 10.1038/79855; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Neves AGM, 2006, PHYSICA A, V368, P132, DOI 10.1016/j.physa.2005.11.055; Neves AGM, 2006, BIOMAT 2006; Neves AGM, 2005, BIOMAT 2005; Neves AGM, 2011, BIOMAT IN PRESS; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Serva M, 2004, PHYSICA A, V332, P387, DOI 10.1016/j.physa.2003.10.038; Serva M, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07011; Serva M, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/10/P10013; Stringer C, 2003, NATURE, V423, P692, DOI 10.1038/423692a; Templeton AR, 2010, P NATL ACAD SCI USA, V107, P6376, DOI 10.1073/pnas.0910647107; Templeton AR, 2005, YEARB PHYS ANTHROPOL, V48, P33, DOI 10.1002/ajpa.20351; Thorne AG, 2003, SCI AM, V13; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Wong K, 2010, SCI AM, V302, P72; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	34	13	13	0	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47076	10.1371/journal.pone.0047076	http://dx.doi.org/10.1371/journal.pone.0047076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112810	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200024
J	Umeda, T; Seki, K; Sato, M; Nishimura, Y; Kawato, M; Isa, T				Umeda, Tatsuya; Seki, Kazuhiko; Sato, Masa-aki; Nishimura, Yukio; Kawato, Mitsuo; Isa, Tadashi			Population Coding of Forelimb Joint Kinematics by Peripheral Afferents in Monkeys	PLOS ONE			English	Article							PENETRATING MICROELECTRODE ARRAY; 2-DIMENSIONAL LIMB MOVEMENTS; MUSCLE-SPINDLE FEEDBACK; DORSAL-ROOT GANGLIA; POSITION SENSE; SKIN; STIMULATION; ENSEMBLES; HUMANS; HAND	Various peripheral receptors provide information concerning position and movement to the central nervous system to achieve complex and dexterous movements of forelimbs in primates. The response properties of single afferent receptors to movements at a single joint have been examined in detail, but the population coding of peripheral afferents remains poorly defined. In this study, we obtained multichannel recordings from dorsal root ganglion (DRG) neurons in cervical segments of monkeys. We applied the sparse linear regression (SLiR) algorithm to the recordings, which selects useful input signals to reconstruct movement kinematics. Multichannel recordings of peripheral afferents were performed by inserting multi-electrode arrays into the DRGs of lower cervical segments in two anesthetized monkeys. A total of 112 and 92 units were responsive to the passive joint movements or the skin stimulation with a painting brush in Monkey 1 and Monkey 2, respectively. Using the SLiR algorithm, we reconstructed the temporal changes of joint angle, angular velocity, and acceleration at the elbow, wrist, and finger joints from temporal firing patterns of the DRG neurons. By automatically selecting a subset of recorded units, the SLiR achieved superior generalization performance compared with a regularized linear regression algorithm. The SLiR selected not only putative muscle units that were responsive to only the passive movements, but also a number of putative cutaneous units responsive to the skin stimulation. These results suggested that an ensemble of peripheral primary afferents that contains both putative muscle and cutaneous units encode forelimb joint kinematics of non-human primates.	[Umeda, Tatsuya; Seki, Kazuhiko; Nishimura, Yukio; Isa, Tadashi] NINS, NIPS, Dept Dev Physiol, Okazaki, Aichi, Japan; [Seki, Kazuhiko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neurophysiol, Kodaira, Tokyo 187, Japan; [Seki, Kazuhiko; Nishimura, Yukio] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Sato, Masa-aki] Adv Telecommun Res Inst Int ATR, Neural Informat Anal Labs, Kyoto, Japan; [Kawato, Mitsuo] Adv Telecommun Res Inst Int ATR, Computat Neurosci Labs, Kyoto, Japan; [Isa, Tadashi] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Hayama, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST); Advanced Telecommunications Research Institute International; Advanced Telecommunications Research Institute International; Graduate University for Advanced Studies - Japan	Umeda, T (corresponding author), NINS, NIPS, Dept Dev Physiol, Okazaki, Aichi, Japan.	umeda@nips.ac.jp			"Brain Machine Interface Development" under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan	"Brain Machine Interface Development" under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by "Brain Machine Interface Development" under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimonetti JM, 2007, J PHYSIOL-LONDON, V580, P649, DOI 10.1113/jphysiol.2006.123075; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aoyagi Y, 2003, J NEUROSCI METH, V128, P9, DOI 10.1016/S0165-0270(03)00143-2; Bergenheim M, 2000, EXP BRAIN RES, V134, P301, DOI 10.1007/s002210000471; Branner A, 2004, IEEE T BIO-MED ENG, V51, P146, DOI 10.1109/TBME.2003.820321; Branner A, 2000, BRAIN RES BULL, V51, P293, DOI 10.1016/S0361-9230(99)00231-2; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Collins DF, 1996, J PHYSIOL-LONDON, V496, P857, DOI 10.1113/jphysiol.1996.sp021733; Collins DF, 2005, J NEUROPHYSIOL, V94, P1699, DOI 10.1152/jn.00191.2005; Collins DF, 2000, J PHYSIOL-LONDON, V529, P505, DOI 10.1111/j.1469-7793.2000.00505.x; Cordo PJ, 2011, J NEUROPHYSIOL, V105, P1879, DOI 10.1152/jn.00201.2010; CRASKE B, 1977, SCIENCE, V196, P71, DOI 10.1126/science.841342; Darian-Smith C, 2005, J COMP NEUROL, V491, P27, DOI 10.1002/cne.20686; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; EDIN BB, 1991, J NEUROPHYSIOL, V65, P657, DOI 10.1152/jn.1991.65.3.657; FERRELL WR, 1987, J PHYSIOL-LONDON, V386, P63, DOI 10.1113/jphysiol.1987.sp016522; FERRELL WR, 1992, EXP PHYSIOL, V77, P331, DOI 10.1113/expphysiol.1992.sp003592; Figueiredo MAT, 2003, IEEE T IMAGE PROCESS, V12, P906, DOI 10.1109/TIP.2003.814255; Fitzsimmons NA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.003.2009; GANDEVIA SC, 1985, BRAIN, V108, P965, DOI 10.1093/brain/108.4.965; GANDEVIA SC, 1976, J PHYSIOL-LONDON, V260, P387, DOI 10.1113/jphysiol.1976.sp011521; Ganesh G, 2008, NEUROIMAGE, V42, P1463, DOI 10.1016/j.neuroimage.2008.06.018; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; HAGBARTH KE, 1969, ACTA PHYSIOL SCAND, V76, P321, DOI 10.1111/j.1748-1716.1969.tb04475.x; HAGBARTH KE, 1968, EXP NEUROL, V22, P674, DOI 10.1016/0014-4886(68)90156-8; HAGBARTH KE, 1967, ACTA PHYSIOL SCAND, V69, P121, DOI 10.1111/j.1748-1716.1967.tb03498.x; HAGBARTH KE, 1969, ELECTROEN CLIN NEURO, V26, P341; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; Jones KE, 2001, J PHYSIOL-LONDON, V536, P635, DOI 10.1111/j.1469-7793.2001.0635c.xd; Kim SP, 2006, J NEURAL ENG, V3, P145, DOI 10.1088/1741-2560/3/2/009; Koike Y, 2006, NEUROSCI RES, V55, P146, DOI 10.1016/j.neures.2006.02.012; LOEB GE, 1976, BRAIN RES, V103, P381, DOI 10.1016/0006-8993(76)90810-6; Matthews BHC, 1933, J PHYSIOL-LONDON, V78, P1; Matthews P. B. C., 1972, MAMMALIAN MUSCLE REC; MCCLOSKEY DI, 1983, BRAIN, V106, P21, DOI 10.1093/brain/106.1.21; Nambu I, 2009, NEUROIMAGE, V47, P628, DOI 10.1016/j.neuroimage.2009.04.050; Nordhausen CT, 1996, BRAIN RES, V726, P129; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Roll JP, 2009, J NEUROPHYSIOL, V101, P816, DOI 10.1152/jn.91075.2008; Roll JP, 2000, EXP BRAIN RES, V134, P311, DOI 10.1007/s002210000472; ROUSCHE PJ, 1992, ANN BIOMED ENG, V20, P413, DOI 10.1007/BF02368133; SANES JN, 1984, P NATL ACAD SCI-BIOL, V81, P979, DOI 10.1073/pnas.81.3.979; Sato M, 2004, NEUROIMAGE, V23, P806, DOI 10.1016/j.neuroimage.2004.06.037; Sato M, 2001, NEURAL COMPUT, V13, P1649, DOI 10.1162/089976601750265045; SCOTT SH, 1994, J NEUROSCI, V14, P7529; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Stein RB, 2004, J PHYSIOL-LONDON, V560, P883, DOI 10.1113/jphysiol.2004.068668; Ting Jo-Anne, 2008, Neural Netw, V21, P1112, DOI 10.1016/j.neunet.2008.06.012; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; VALLBO AB, 1968, EXP NEUROL, V21, P270, DOI 10.1016/0014-4886(68)90041-1; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; Watanabe H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036006; Weber DJ, 2007, J NEURAL ENG, V4, pS168, DOI 10.1088/1741-2560/4/3/S04; Weber DJ, 2006, IEEE T NEUR SYS REH, V14, P240, DOI 10.1109/TNSRE.2006.875575; Weber DJ, 2011, IEEE T NEUR SYS REH, V19, P501, DOI 10.1109/TNSRE.2011.2163145; Weinstein S, 1968, SKIN SENSES CC THOMA, P84; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050	60	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47749	10.1371/journal.pone.0047749	http://dx.doi.org/10.1371/journal.pone.0047749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112841	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200075
J	Vailati, A; Zinnato, L; Cerbino, R				Vailati, Alberto; Zinnato, Luca; Cerbino, Roberto			How Archer Fish Achieve a Powerful Impact: Hydrodynamic Instability of a Pulsed Jet in Toxotes jaculatrix	PLOS ONE			English	Article							TONGUE PROJECTION; BALLISTIC TONGUE; DROP IMPACT; DYNAMICS; SURFACES	Archer fish knock down insects anchored to vegetation by hitting them with a precisely aimed jet of water. The striking force of the jet at the impact is such to overcome the strong anchoring forces of insects. The origin of the effectiveness of such hunting mechanism has been long searched for inside of the fish, in the unsuccessful attempt to identify internal structures dedicated to the amplification of muscular power. Here we perform a kinematic analysis of the jet emitted by two specimens of Toxotes jaculatrix. We estimate that at the impact the jet conveys a typical specific power of about 3000 W/kg, which is well above the maximum specific power of the order of 500 W/kg deliverable by a vertebrate muscle. Unexpectedly, we find that the amplification of muscular power occurs outside of the fish, and is due to a hydrodynamic instability of the jet akin to those occurring in Drop-on-Demand inkjet printing. The investigated fish are found to modulate the velocity of the jet at the orifice to favor the formation of a single, large, water drop that hits the prey abruptly with a large momentum. The observed mechanism represents a remarkable example of use of an external hydrodynamic lever that does possibly not entail the high evolutionary cost needed for the development of highly specialized internal structures dedicated to the storing of mechanical energy.	[Vailati, Alberto; Zinnato, Luca] Univ Milan, Dipartimento Fis, Milan, Italy; [Cerbino, Roberto] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Segrate, MI, Italy	University of Milan; University of Milan	Vailati, A (corresponding author), Univ Milan, Dipartimento Fis, Milan, Italy.	alberto.vailati@unimi.it	Cerbino, Roberto/A-2286-2008; Vailati, Alberto/B-2299-2009	Cerbino, Roberto/0000-0003-0434-7741; Vailati, Alberto/0000-0002-3119-6021				Anderson CV, 2010, P NATL ACAD SCI USA, V107, P5495, DOI 10.1073/pnas.0910778107; Castrejon-Pita JR, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036306; COOKER MJ, 1995, J FLUID MECH, V297, P193, DOI 10.1017/S0022112095003053; de Gans BJ, 2004, ADV MATER, V16, P203, DOI 10.1002/adma.200300385; de Groot JH, 2004, P ROY SOC B-BIOL SCI, V271, P761, DOI 10.1098/rspb.2003.2637; Deban SM, 1997, NATURE, V389, P27, DOI 10.1038/37898; Deban SM, 2007, J EXP BIOL, V210, P655, DOI 10.1242/jeb.02664; Eggers J, 1997, REV MOD PHYS, V69, P865, DOI 10.1103/RevModPhys.69.865; Eggers J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/3/036601; Eggers J, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3432498; ELSHOUD GCA, 1985, ZOOMORPHOLOGY, V105, P240, DOI 10.1007/BF00311967; FRITH HR, 1995, J EXP BIOL, V198, P1863; Gorb S, 2001, J EXP BIOL, V204, P1421; Gorb SN, 2004, J EXP BIOL, V207, P2917, DOI 10.1242/jeb.01127; Josserand C, 2003, PHYS FLUIDS, V15, P1650, DOI 10.1063/1.1572815; Lord Rayleigh F.R.S., 1879, P LOND MATH SOC, V10, P4; Luling K. H., 1958, Zeitschrift fuer Morphologie und Oekologie der Tiere, V47, P529, DOI 10.1007/BF00389870; MEIER GEA, 1992, EXP FLUIDS, V12, P173, DOI 10.1007/BF00188256; Milburn M, 1976, J ZOOL LONDON, V180, P234; Muller UK, 2004, SCIENCE, V304, P217; Myers GS., 1952, AQUARIUM J, V23, P210; Rioboo R, 2002, EXP FLUIDS, V33, P112, DOI [10.1007/s00348-002-0431-X, 10.1007/s00348-002-0431-x]; Schlosser JA., 1764, PHILOS T R SOC LOND, V54, P89, DOI DOI 10.1098/RSTL.1764.0016; Shumaker R.W., 2011, ANIMAL TOOL BEHAV US; Smith HM., 1936, NAT HIST, V38, P2; STORK NE, 1980, J EXP BIOL, V88, P91; Timmermans PJA, 2000, BEHAV PROCESS, V52, P21, DOI 10.1016/S0376-6357(00)00107-8; Timmermans PJA, 2004, PHYSIOL BEHAV, V81, P101, DOI 10.1016/j.physbeh.2004.01.010; Weis-Fogh T., 1977, SCALE EFFECTS ANIMAL; Yarin AL, 2006, ANNU REV FLUID MECH, V38, P159, DOI 10.1146/annurev.fluid.38.050304.092144; Zolotnitsky N, 1902, ARCH ZOOLIGIE EXPT G, V10, P74	31	19	19	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47867	10.1371/journal.pone.0047867	http://dx.doi.org/10.1371/journal.pone.0047867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112861	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200096
J	Azziz-Baumgartner, E; Cabrera, AM; Chang, L; Calli, R; Kusznierz, G; Baez, C; Yedlin, P; Zamora, AM; Cuezzo, R; Sarrouf, EB; Uboldi, A; Herrmann, J; Zerbini, E; Uez, O; Cordeiro, POR; Chavez, P; Han, G; Antman, J; Coronado, F; Bresee, J; Kosacoff, M; Widdowson, MA; Echenique, H				Azziz-Baumgartner, Eduardo; Maria Cabrera, Ana; Chang, Loretta; Calli, Rogelio; Kusznierz, Gabriela; Baez, Clarisa; Yedlin, Pablo; Maria Zamora, Ana; Cuezzo, Romina; Beatriz Sarrouf, Elena; Uboldi, Andrea; Herrmann, Juan; Zerbini, Elsa; Uez, Osvaldo; Rico Cordeiro, Pedro Osvaldo; Chavez, Pollyanna; Han, George; Antman, Julian; Coronado, Fatima; Bresee, Joseph; Kosacoff, Marina; Widdowson, Marc-Alain; Echenique, Horacio			Mortality, Severe Acute Respiratory Infection, and Influenza-Like Illness Associated with Influenza A(H1N1)pdm09 in Argentina, 2009	PLOS ONE			English	Article								Introduction: While there is much information about the burden of influenza A(H1N1)pdm09 in North America, little data exist on its burden in South America. Methods: During April to December 2009, we actively searched for persons with severe acute respiratory infection and influenza-like illness (ILI) in three sentinel cities. A proportion of case-patients provided swabs for influenza testing. We estimated the number of case-patients that would have tested positive for influenza by multiplying the number of untested case-patients by the proportion who tested positive. We estimated rates by dividing the estimated number of case-patients by the census population after adjusting for the proportion of case-patients with missing illness onset information and ILI case-patients who visited physicians multiple times for one illness event. Results: We estimated that the influenza A(H1N1) pdm09 mortality rate per 100,000 person-years (py) ranged from 1.5 among persons aged 5-44 years to 5.6 among persons aged >= 65 years. A(H1N1)pdm09 hospitalization rates per 100,000 py ranged between 26.9 among children aged <5 years to 41.8 among persons aged >= 65 years. Influenza A(H1N1) pdm09 ILI rates per 100 py ranged between 1.6 among children aged <5 to 17.1 among persons aged 45-64 years. While 9 (53%) of 17 influenza A(H1N1)pdm09 decedents with available data had obesity and 7 (17%) of 40 had diabetes, less than 4% of surviving influenza A(H1N1)pdm09 case-patients had these pre-existing conditions (p <= 0.001). Conclusion: Influenza A(H1N1)pdm09 caused a similar burden of disease in Argentina as in other countries. Such disease burden suggests the potential value of timely influenza vaccinations.	[Azziz-Baumgartner, Eduardo; Chavez, Pollyanna; Coronado, Fatima; Bresee, Joseph; Widdowson, Marc-Alain] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Maria Cabrera, Ana; Antman, Julian; Kosacoff, Marina; Echenique, Horacio] Minist Salud Nacion, Direcc Epidemiol, Buenos Aires, DF, Argentina; [Chang, Loretta; Han, George] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Calli, Rogelio; Maria Zamora, Ana; Cuezzo, Romina; Beatriz Sarrouf, Elena] Minist Salud Publ Prov Tucuman, Direcc Epidemiol, San Miguel De Tucuman, Argentina; [Kusznierz, Gabriela; Zerbini, Elsa] Inst Nacl Enfermedades Resp, Santa Fe, Santa Fe, Argentina; [Baez, Clarisa] Minist Salud Prov Buenos Aires, Buenos Aires, DF, Argentina; [Uboldi, Andrea; Herrmann, Juan] Minist Salud Publ Santa Fe, Santa Fe, Santa Fe, Argentina; [Uez, Osvaldo] Inst Nacl Epidemiol Dr Juan H Jara, Serv Virol, Mar De Plata, Argentina; [Rico Cordeiro, Pedro Osvaldo] Org Panamer Salud, Buenos Aires, DF, Argentina	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Azziz-Baumgartner, E (corresponding author), US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	Eha9@cdc.gov		Widdowson, Marc-Alain/0000-0002-0682-6933; Zerbini, Elsa/0000-0001-5101-0151				Atmar RL, 1996, J CLIN MICROBIOL, V34, P2604, DOI 10.1128/JCM.34.10.2604-2606.1996; Azziz-Baumgartner E, 2012, ISIRV IN PRESS; Azziz-Baumgartner E, 2011, WHO B; Balanzat AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033670; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Castrodale L., 2009, Morbidity and Mortality Weekly Report, V58, P1341; CDC, 2011, PEOPL HIGH RISK DEV; CDC, 2009, H1N1 FLU SIT UPD; CDC, 2009, PROT REALT RTPCR INF; Clara A, 2012, WHO B; Dawood F, 2012, LANCET INFECT DIS, V3099, P70121; Health AMo, 2010, WINT CAMP ARG 2010; Homaira N, 2012, B WORLD HEALTH ORGAN, V90, P12; Homaira N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032056; IEDCR, 2009, TRIAG PAND H1N1 CAS, P3; Imaz M. Susana, 2006, Rev. chil. infectol., V23, P297; Kusznierz Gabriela F., 2002, Rev Panam Salud Publica, V12, P26, DOI 10.1590/S1020-49892002000700005; *PAHO, 2006, PAHO CDC GEN PROT IN; WHO, 2007, REC LAB PROC DET AV	19	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47540	10.1371/journal.pone.0047540	http://dx.doi.org/10.1371/journal.pone.0047540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118877	Green Published, gold			2022-12-25	WOS:000310600500022
J	Li, YP; Zhu, W; Tao, JP; Xin, P; Liu, MY; Li, JB; Wei, M				Li, Yapeng; Zhu, Wei; Tao, Jianping; Xin, Ping; Liu, Mingya; Li, Jingbo; Wei, Meng			Fasudil Protects the Heart against Ischemia-Reperfusion Injury by Attenuating Endoplasmic Reticulum Stress and Modulating SERCA Activity: The Differential Role for PI3K/Akt and JAK2/STAT3 Signaling Pathways	PLOS ONE			English	Article							RHO-KINASE INHIBITOR; ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL-INFARCTION; ER STRESS; CARDIAC-FUNCTION; ATPASE 2B; CA2+; EXPRESSION; APOPTOSIS; ACTIVATION	Disordered calcium homeostasis can lead to endoplasmic reticulum (ER) stress. Our previous data showed that time course activation of ER stress contributes to time-related increase in ischemia-reperfusion (I/R) injury. However, it has not been tested whether PI3K/Akt and JAK2/STAT3 pathways play differential roles in reducing ER stress to protect the heart. In the present study, using fasudil which is a specific inhibitor of ROCK, we aimed to investigate whether improved SERCA expression and activity accounts for reduced ER stress by ROCK inhibition, specifically whether PI3K/Akt and JAK2/STAT3 pathways are differentially involved in modulating SERCA activity to reduce ER stress and hence I/R injury. The results showed that during the reperfusion period following 45 min of coronary ligation the infarct size (IS) increased from 3 h of reperfusion (45.4 +/- 5.57%) to 24 h reperfusion (64.21 +/- 5.43, P<0.05), which was associated with ER stress dependent apoptosis signaling activation including CHOP, Caspase-12 and JNK (P<0.05, respectively). The dynamic ER stress activation was also related to impaired SERCA activity at 24 h of reperfusion. Administration of fasudil at 10 mg/Kg significantly attenuated ROCK activation during reperfusion and resulted in an improved SERCA activity which was closely associated with decreases in temporal activation of ER stress and IS changes. Interestingly, while both PI3K/Akt and JAK2/STAT3 signaling pathways played equal role in the protection offered by ROCK inhibition at 3 h of reperfusion, the rescued SERCA expression and activity at 24 h of reperfusion by fasudil was mainly due to JAK2/STAT3 activation, in which PI3K/Akt signaling shared much less roles.	[Li, Yapeng; Zhu, Wei; Tao, Jianping; Xin, Ping; Liu, Mingya; Li, Jingbo; Wei, Meng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Hosp 6, Div Cardiol,State Key Discipline Div, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhu, W (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Hosp 6, Div Cardiol,State Key Discipline Div, Shanghai 200030, Peoples R China.	weizhu65@yahoo.com; weim.sjtu6h@hotmail.com	Zhu, Wei/GPF-4284-2022		National Natural Science Foundation of China [81070110, 81100099]; Shanghai Science and TecThehnology Innovation Research Program [11410701900]; Shanghai Jiao Tong University Sixth Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and TecThehnology Innovation Research Program; Shanghai Jiao Tong University Sixth Hospital	National Natural Science Foundation of China (#81070110 to M. Wei; #81100099 to P. Xin); Shanghai Science and TecThehnology Innovation Research Program (#11410701900 to M. Wei); institutional financial support of Shanghai Jiao Tong University Sixth Hospital (to W.Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Y, 2006, CARDIOVASC RES, V70, P346, DOI 10.1016/j.cardiores.2006.02.020; Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Caspersen C, 2000, J BIOL CHEM, V275, P22363, DOI 10.1074/jbc.M001569200; Cool AR, 2009, J MOL CELL CARDIOL, V46, P225, DOI 10.1016/j.yjmcc.2008.10.013; Dally S, 2010, J MOL CELL CARDIOL, V48, P633, DOI 10.1016/j.yjmcc.2009.11.012; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Garcia-Dorado D, 2004, CARDIOVASC RES, V61, P363, DOI 10.1016/j.cardiores.2003.12.020; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Gurusamy N, 2008, J MOL CELL CARDIOL, V44, P419, DOI 10.1016/j.yjmcc.2007.10.005; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Kasseckert SA, 2009, CARDIOVASC RES, V83, P381, DOI 10.1093/cvr/cvp065; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; KIM HW, 1990, J BIOL CHEM, V265, P1702; Kudo T, 2008, CELL DEATH DIFFER, V15, P364, DOI 10.1038/sj.cdd.4402276; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Lecour S, 2009, J MOL CELL CARDIOL, V46, P607, DOI 10.1016/j.yjmcc.2009.01.003; Li Y, 2009, CARDIOVASC RES, V84, P100, DOI 10.1093/cvr/cvp189; Liu XH, 2008, SHOCK, V30, P422, DOI 10.1097/SHK.0b013e318164ca29; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938; Masumoto A, 2001, HYPERTENSION, V38, P1307, DOI 10.1161/hy1201.096541; Mykytenko J, 2007, BASIC RES CARDIOL, V102, P90, DOI 10.1007/s00395-006-0625-0; Nicolaou P, 2009, CIRC RES, V104, P1012, DOI 10.1161/CIRCRESAHA.108.189811; O'Donnell JM, 2009, J MOL CELL CARDIOL, V47, P614, DOI 10.1016/j.yjmcc.2009.08.031; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Paschen W, 1996, NEUROSCI LETT, V217, P41; Piper HM, 2004, CARDIOVASC RES, V61, P365, DOI 10.1016/j.cardiores.2003.12.012; Rivard AL, 2007, AM J CHINESE MED, V35, P279, DOI 10.1142/S0192415X07004813; Shibata I, 2008, CARDIOVASC DRUG THER, V22, P293, DOI 10.1007/s10557-008-6106-y; Skyschally A, 2009, CIRC RES, V104, P15, DOI 10.1161/CIRCRESAHA.108.186429; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Talukder MAH, 2007, AM J PHYSIOL-HEART C, V293, pH2418, DOI 10.1152/ajpheart.00663.2007; Talukder MAH, 2009, CARDIOVASC RES, V84, P345, DOI 10.1093/cvr/cvp264; Tang WH, 2010, J MOL CELL CARDIOL, V49, P58, DOI 10.1016/j.yjmcc.2009.12.003; Tao JP, 2011, AM J PHYSIOL-HEART C, V301, pH1471, DOI 10.1152/ajpheart.00097.2011; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Vangheluwe P, 2003, CELL CALCIUM, V34, P457, DOI 10.1016/S0143-4160(03)00126-X; Vangheluwe P, 2007, CELL CALCIUM, V42, P281, DOI 10.1016/j.ceca.2007.01.001; Vitadello M, 2003, FASEB J, V17, P923, DOI 10.1096/fj.02-0644fje; Wang LC, 2008, EUR J PHARMACOL, V580, P271, DOI 10.1016/j.ejphar.2007.10.068; Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82; Xin P, 2010, AM J PHYSIOL-HEART C, V298, pH1819, DOI 10.1152/ajpheart.01102.2009; Yada T, 2006, CLIN HEMORHEOL MICRO, V34, P177; Zhang GG, 2009, PEPTIDES, V30, P1109, DOI 10.1016/j.peptides.2009.03.024; Zhao ZQ, 2000, J SURG RES, V94, P133, DOI 10.1006/jsre.2000.6029; Zhu JH, 2008, EUR J CARDIO-THORAC, V34, P661, DOI 10.1016/j.ejcts.2008.05.035; ZUCCHI R, 1994, CIRC RES, V74, P271, DOI 10.1161/01.RES.74.2.271	54	59	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48115	10.1371/journal.pone.0048115	http://dx.doi.org/10.1371/journal.pone.0048115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118936	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500069
J	Porter, MA; Dobson-Stone, C; Kwok, JBJ; Schofield, PR; Beckett, W; Tassabehji, M				Porter, Melanie A.; Dobson-Stone, Carol; Kwok, John B. J.; Schofield, Peter R.; Beckett, William; Tassabehji, May			A Role for Transcription Factor GTF2IRD2 in Executive Function in Williams-Beuren Syndrome	PLOS ONE			English	Article							TFII-I FAMILY; INDIVIDUAL-DIFFERENCES; MENTAL-RETARDATION; NEURAL MECHANISMS; CHILDREN; GENE; PHENOTYPE; DELETIONS; COGNITION; HEMIZYGOSITY	Executive functions are amongst the most heritable cognitive traits with twin studies indicating a strong genetic origin. However genes associated with this domain are unknown. Our research into the neurodevelopmental disorder Williams-Beuren syndrome (WBS) has identified a gene within the causative recurrent 1.5/1.6 Mb heterozygous microdeletion on chromosome 7q11.23, which may be involved in executive functioning. Comparative genome array screening of 55 WBS patients revealed a larger similar to 1.8 Mb microdeletion in 18% of cases, which results in the loss of an additional gene, the transcription factor GTF2IRD2. The GTF gene family of transcription factors (GTF2I, GTF2IRD1 and GTF2IRD2) are all highly expressed in the brain, and GTF2I and GTF2IRD1 are involved in the pathogenesis of the cognitive and behavioural phenotypes associated with WBS. A multi-level analysis of cognitive, behavioural and psychological functioning in WBS patients showed that those with slightly larger deletions encompassing GTF2IRD2 were significantly more cognitively impaired in the areas of spatial functioning, social reasoning, and cognitive flexibility (a form of executive functioning). They also displayed significantly more obsessions and externalizing behaviours, a likely manifestation of poor cognitive flexibility and executive dysfunction. We provide the first evidence for a role for GTF2IRD2 in higher-level (executive functioning) abilities and highlight the importance of integrating detailed molecular characterisation of patients with comprehensive neuropsychological profiling to uncover additional genotype-phenotype correlations. The identification of specific genes which contribute to executive function has important neuropsychological implications in the treatment of patients with conditions like WBS, and will allow further studies into their mechanism of action.	[Porter, Melanie A.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Dobson-Stone, Carol; Kwok, John B. J.; Schofield, Peter R.] Neurosci Res Australia, Sydney, NSW, Australia; [Dobson-Stone, Carol; Kwok, John B. J.; Schofield, Peter R.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Beckett, William; Tassabehji, May] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Beckett, William; Tassabehji, May] Univ Manchester, Manchester, Lancs, England	Macquarie University; Neuroscience Research Australia; University of New South Wales Sydney; University of Manchester; University of Manchester	Porter, MA (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	melanie.porter@mq.edu.au; m.tassabehji@manchester.ac.uk	; Schofield, Peter/C-9669-2011	Porter, Melanie/0000-0003-3281-1732; Dobson-Stone, Carol/0000-0002-2211-0257; Kwok, John/0000-0001-9574-6195; Schofield, Peter/0000-0003-2967-9662	APEX Australia research grant [901029]; Macquarie University Research Development Scheme [627011]; Welcome Trust [061183]; Medical Research Council [86335]; MRC [G0800554] Funding Source: UKRI; Medical Research Council [G0800554] Funding Source: researchfish	APEX Australia research grant; Macquarie University Research Development Scheme; Welcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an APEX Australia research grant [#901029 to MP]; a Macquarie University Research Development Scheme [#627011 to MP]; a Welcome Trust Grant [#061183 to MT] and a Medical Research Council grant [#86335 to MT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Benton AL, 1983, BENTON TEST FACIAL R; Benton AL, 1983, BENTON JUDGMENT LINE; BORG I, 1995, J MED GENET, V32, P692, DOI 10.1136/jmg.32.9.692; Chimge NO, 2008, P NATL ACAD SCI USA, V105, P9006, DOI 10.1073/pnas.0803051105; Collette JC, 2009, J HUM GENET, V54, P193, DOI 10.1038/jhg.2009.5; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P318, DOI 10.1037/0894-4105.19.3.318; Dodd HF, 2010, J INTELL DISABIL RES, V54, P194, DOI 10.1111/j.1365-2788.2009.01241.x; Dodd HF, 2009, J MENT HEALTH RES IN, V2, P89, DOI 10.1080/19315860902725867; Dutra RL, 2011, CLINICS, V66, P959, DOI 10.1590/S1807-59322011000600007; Eckert MA, 2006, NEUROIMAGE, V33, P39, DOI 10.1016/j.neuroimage.2006.05.062; Elliot C., 1990, DIFFERENTIAL ABILITY; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Ferrero GB, 2010, EUR J HUM GENET, V18, P33, DOI 10.1038/ejhg.2009.108; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Gothelf D, 2008, AM J MED GENET A, V146A, P2753, DOI 10.1002/ajmg.a.32507; Heller R, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e99; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Jackowski AP, 2009, EUR J PAEDIATR NEURO, V13, P305, DOI 10.1016/j.ejpn.2008.07.002; Jarrold C, 1998, J CHILD PSYCHOL PSYC, V39, P511; Jones AR, 2009, NAT REV NEUROSCI, V10, P821, DOI 10.1038/nrn2722; Jurado LAP, 2003, HORM RES, V59, P106, DOI 10.1159/000067836; Jurado LAP, 1996, AM J HUM GENET, V59, P781; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Marenco S, 2007, P NATL ACAD SCI USA, V104, P15117, DOI 10.1073/pnas.0704311104; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Metcalfe K, 2005, CLIN DYSMORPHOL, V14, P61, DOI 10.1097/00019605-200504000-00002; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Nakamura M, 1999, J INTELL DISABIL RES, V43, P562, DOI 10.1046/j.1365-2788.1999.00237.x; NICKERSON E, 1995, AM J HUM GENET, V56, P1156; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; O'Leary J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023868; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Pezzini G, 1999, DEV NEUROPSYCHOL, V15, P141, DOI 10.1080/87565649909540742; Pober BR, 1996, CHILD ADOL PSYCH CL, V5, P929, DOI 10.1016/S1056-4993(18)30341-9; Porter MA, 2005, DEV NEUROPSYCHOL, V27, P275, DOI 10.1207/s15326942dn2702_5; Porter MA, 2008, J AUTISM DEV DISORD, V38, P806, DOI 10.1007/s10803-007-0447-4; Porter MA, 2007, NEUROPSYCHOLOGIA, V45, P2839, DOI 10.1016/j.neuropsychologia.2007.05.006; Porter MA, 2006, DEV NEUROPSYCHOL, V30, P771, DOI 10.1207/s15326942dn3003_1; Porter MA, 2009, CHILD NEUROPSYCHOL, V15, P359, DOI 10.1080/09297040802577881; Rae C, 1998, NEUROLOGY, V51, P33, DOI 10.1212/WNL.51.1.33; Ravizza SM, 2008, NEUROPSYCHOLOGIA, V46, P2924, DOI 10.1016/j.neuropsychologia.2008.06.006; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; Roy AL, 2006, ACS CHEM BIOL, V1, P619, DOI 10.1021/cb6004323; Rubia K, 2010, HUM BRAIN MAPP, V31, P287, DOI 10.1002/hbm.20864; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Sparrow S. S., 2005, VINELAND ADAPTIVE BE, V2nd, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Stromme P, 2002, J CHILD NEUROL, V17, P269, DOI 10.1177/088307380201700406; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tager-Flusberg H, 2000, COGNITION, V76, P59, DOI 10.1016/S0010-0277(00)00069-X; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 2003, HUM MOL GENET, V12, pR229, DOI 10.1093/hmg/ddg299; Tassabehji M, 1999, AM J HUM GENET, V64, P118, DOI 10.1086/302214; THAL D, 1989, J SPEECH HEAR RES, V32, P489, DOI 10.1044/jshr.3203.489; Tipney HJ, 2004, EUR J HUM GENET, V12, P551, DOI 10.1038/sj.ejhg.5201174; van de Vosse E, 2009, J HUM GENET, V54, P313, DOI 10.1038/jhg.2009.24; Wang MS, 1999, AM J MED GENET, V86, P34, DOI 10.1002/(SICI)1096-8628(19990903)86:1<34::AID-AJMG7>3.3.CO;2-W; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311; Woodcock R.W., 1989, WOODCOCK JOHNSON PSY; Yoshida W, 2010, J NEUROSCI, V30, P10744, DOI 10.1523/JNEUROSCI.5895-09.2010; Young EJ, 2008, GENES BRAIN BEHAV, V7, P224, DOI 10.1111/j.1601-183X.2007.00343.x	67	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47457	10.1371/journal.pone.0047457	http://dx.doi.org/10.1371/journal.pone.0047457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118870	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500016
J	Schwartz, R; Pell, MD				Schwartz, Rachel; Pell, Marc D.			Emotional Speech Processing at the Intersection of Prosody and Semantics	PLOS ONE			English	Article							AFFECT DECISION TASK; FACIAL EXPRESSIONS; ERP EVIDENCE; AUDIOVISUAL INTEGRATION; HUMAN-COMMUNICATION; BRAIN POTENTIALS; PERCEPTION; RECOGNITION; WORD; LANGUAGE	The ability to accurately perceive emotions is crucial for effective social interaction. Many questions remain regarding how different sources of emotional cues in speech (e. g., prosody, semantic information) are processed during emotional communication. Using a cross-modal emotional priming paradigm (Facial affect decision task), we compared the relative contributions of processing utterances with single-channel (prosody-only) versus multi-channel (prosody and semantic) cues on the perception of happy, sad, and angry emotional expressions. Our data show that emotional speech cues produce robust congruency effects on decisions about an emotionally related face target, although no processing advantage occurred when prime stimuli contained multi-channel as opposed to single-channel speech cues. Our data suggest that utterances with prosodic cues alone and utterances with combined prosody and semantic cues both activate knowledge that leads to emotional congruency (priming) effects, but that the convergence of these two information sources does not always heighten access to this knowledge during emotional speech processing.	[Schwartz, Rachel; Pell, Marc D.] McGill Univ, Montreal, PQ, Canada	McGill University	Schwartz, R (corresponding author), McGill Univ, Montreal, PQ, Canada.	rachel.schwartz@mail.mcgill.ca	Pell, Marc D./AAL-3121-2021	Pell, Marc D./0000-0002-9947-1552; Schwartz, Rachel/0000-0001-8125-9492	Natural Sciences and Engineering Research Council of Canada [RGPIN/203708-2006]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The research was financed by the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca/index_eng.asp; RGPIN/203708-2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguert M, 2010, J SPEECH LANG HEAR R, V53, P1629, DOI 10.1044/1092-4388(2010/08-0078); Astesano C, 2004, COGNITIVE BRAIN RES, V18, P172, DOI 10.1016/j.cogbrainres.2003.10.002; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Beaucousin V, 2007, CEREB CORTEX, V17, P339, DOI 10.1093/cercor/bhj151; Borod JC, 2000, COGNITION EMOTION, V14, P193, DOI 10.1080/026999300378932; Bostanov V, 2004, PSYCHOPHYSIOLOGY, V41, P259, DOI 10.1111/j.1469-8986.2003.00142.x; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; BRITTON BK, 1982, J EDUC PSYCHOL, V74, P51, DOI 10.1037/0022-0663.74.1.51; Bryant GA, 2002, METAPHOR SYMBOL, V17, P99, DOI 10.1207/S15327868MS1702_2; Carroll NC, 2005, Q J EXP PSYCHOL-A, V58, P1173, DOI 10.1080/02724980443000539; Cheang HS, 2008, SPEECH COMMUN, V50, P366, DOI 10.1016/j.specom.2007.11.003; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; De Gelder B., 2006, BIOL THEORY, V1, P130, DOI [10.1162/biot.2006.1.2.130, DOI 10.1162/biot.2006.1.2.130]; Edlund J, 2009, P INT 2009 BRIGHT UK; Efron D., 1941, GESTURES ENV; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; EKMAN P., 1969, SEMIOTICA, V1, P49, DOI DOI 10.1515/SEMI.1969.1.1.49; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Giles H., 1992, CONTEXTS ACCOMMODATI, P1, DOI DOI 10.1017/CBO9780511663673.001; Grimshaw GM, 1998, BRAIN COGNITION, V36, P108, DOI 10.1006/brcg.1997.0949; Hsu SM, 2008, COGN AFFECT BEHAV NE, V8, P282, DOI 10.3758/CABN.8.3.282; Jaywant A, 2012, SPEECH COMMUN, V54, P1, DOI 10.1016/j.specom.2011.05.011; Kitayama S, 2002, COGNITION EMOTION, V16, P29, DOI 10.1080/0269993943000121; Kitayama S, 1994, HEARTS EYE EMOTIONAL, P41; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Niedenthal PM, 1997, COGNITION EMOTION, V11, P403, DOI 10.1080/026999397379863; NIEDENTHAL PM, 1990, J EXP SOC PSYCHOL, V26, P505, DOI 10.1016/0022-1031(90)90053-O; Nygaard LC, 2008, J EXP PSYCHOL HUMAN, V34, P1017, DOI 10.1037/0096-1523.34.4.1017; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Paulmann S, 2011, MOTIV EMOTION, V35, P192, DOI 10.1007/s11031-011-9206-0; Paulmann S, 2010, COGN AFFECT BEHAV NE, V10, P230, DOI 10.3758/CABN.10.2.230; Paulmann S, 2009, NEUROREPORT, V20, P1603, DOI 10.1097/WNR.0b013e3283320e3f; Paulmann S, 2009, J PSYCHOPHYSIOL, V23, P63, DOI 10.1027/0269-8803.23.2.63; Pell MD, 2008, SPEECH COMMUN, V50, P519, DOI 10.1016/j.specom.2008.03.006; Pell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027256; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Pell MD, 2009, J NONVERBAL BEHAV, V33, P107, DOI 10.1007/s10919-008-0065-7; Pell MD, 2005, J NONVERBAL BEHAV, V29, P193, DOI 10.1007/s10919-005-7720-z; Pell MD, 2005, J NONVERBAL BEHAV, V29, P45, DOI 10.1007/s10919-004-0889-8; Pell MD, 2001, J ACOUST SOC AM, V109, P1668, DOI 10.1121/1.1352088; Regenbogen C, 2012, COGNITION EMOTION, P37; Regenbogen C, 2012, NEUROIMAGE, V60, P2346, DOI 10.1016/j.neuroimage.2012.02.043; Rockwell P, 2000, J PSYCHOLINGUIST RES, V29, P483, DOI 10.1023/A:1005120109296; Schirmer A, 2005, COGNITIVE BRAIN RES, V24, P442, DOI 10.1016/j.cogbrainres.2005.02.022; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2002, COGNITIVE BRAIN RES, V14, P228, DOI 10.1016/S0926-6410(02)00108-8; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Shuster LI, 2009, BRAIN LANG, V111, P66, DOI 10.1016/j.bandl.2009.06.003; Techentin C, 2009, BRAIN COGNITION, V70, P201, DOI 10.1016/j.bandc.2009.02.003; Tracy JL, 2008, EMOTION, V8, P81, DOI 10.1037/1528-3542.8.1.81; Vroomen I. I., 2004, HDB MULTISENSORY PRO, P581; Wambacq IJA, 2004, COGNITIVE BRAIN RES, V20, P427, DOI 10.1016/j.cogbrainres.2004.03.015; WELKOWITZ J, 1973, J CONSULT CLIN PSYCH, V41, P472, DOI 10.1037/h0035328; Woodland J, 2011, METAPHOR SYMBOL, V26, P227, DOI 10.1080/10926488.2011.583197; Wurm LH, 2001, COGNITION EMOTION, V15, P831, DOI 10.1080/02699930143000086	63	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47279	10.1371/journal.pone.0047279	http://dx.doi.org/10.1371/journal.pone.0047279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WJ	23118868	gold, Green Published			2022-12-25	WOS:000310600500015
J	Alari-Pahissa, E; Notario, L; Lorente, E; Vega-Ramos, J; Justel, A; Lopez, D; Villadangos, JA; Lauzurica, P				Alari-Pahissa, Elisenda; Notario, Laura; Lorente, Elena; Vega-Ramos, Javier; Justel, Ana; Lopez, Daniel; Villadangos, Jose A.; Lauzurica, Pilar			CD69 Does Not Affect the Extent of T Cell Priming	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ACTIVATION ANTIGEN EA-1; VIRUS-INFECTED CELLS; DENDRITIC CELLS; RHEUMATOID-ARTHRITIS; LISTERIA-MONOCYTOGENES; LECTIN RECEPTORS; IMMUNE-RESPONSE; HUMAN-B; LYMPHOCYTES	CD69 is rapidly upregulated on T cells upon activation. In this work we show that this is also the case for CD69 expression on dendritic cells (DC). Thus, the expression kinetics of CD69 on both cell types is reminiscent of the one of costimulatory molecules. Using mouse models of transgenic T cells, we aimed at evaluating the effect of monoclonal antibody (MAb)-based targeting and gene deficiency of CD69 expressed by either DC or T cells on the extent of antigen (Ag)-specific T cell priming, which could be the result of a putative role in costimulation as well as on DC maturation and Ag-processing and presentation. CD69 targeting or deficiency of DC did not affect their expression of costimulatory molecules nor their capacity to induce Ag-specific T cell proliferation in in vitro assays. Also, CD69 targeting or deficiency of transgenic T cells did not affect the minimal proliferative dose for different peptide agonists in vitro. In in vivo models of transgenic T cell transfer and local Ag injection, CD69 deficiency of transferred T cells did not affect the extent of the proliferative response in Ag-draining lymph nodes (LN). In agreement with these results, CD69 MAb targeting or gene deficiency of Vaccinia-virus (VACV) infected mice did not affect the endogenous formation of virus-specific CD8(+) T cell populations at the peak of the primary immune response. Altogether our results argue against a possible role in costimulation or an effect on Ag processing and presentation for CD69.	[Alari-Pahissa, Elisenda; Notario, Laura; Lorente, Elena; Lopez, Daniel; Lauzurica, Pilar] Inst Salud Carlos III, Madrid, Spain; [Alari-Pahissa, Elisenda] Univ Barcelona, Dept Fisiol, Barcelona, Spain; [Vega-Ramos, Javier; Villadangos, Jose A.] Univ Melbourne, Dept Microbiol & Immunol, Inst Bio21, Melbourne, Vic, Australia; [Vega-Ramos, Javier; Villadangos, Jose A.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Melbourne, Vic, Australia; [Justel, Ana] Univ Autonoma Madrid, Fac Matemat, Madrid, Spain	Instituto de Salud Carlos III; University of Barcelona; University of Melbourne; University of Melbourne; Autonomous University of Madrid	Lauzurica, P (corresponding author), Inst Salud Carlos III, Madrid, Spain.	lauzurica@isciii.es	lauzurica, pilar/B-4397-2013; Lorente, Elena/B-1219-2019; Justel, Ana/A-3955-2010; López, Daniel/I-2632-2014; Villadangos, Jose A/AAU-1404-2020; Vega-Ramos, Javier/A-9931-2015	Lorente, Elena/0000-0002-2246-6851; Justel, Ana/0000-0003-3335-0579; López, Daniel/0000-0003-0268-5878; Villadangos, Jose A/0000-0001-6771-8891; Vega-Ramos, Javier/0000-0002-9516-3624; lauzurica, pilar/0000-0001-6579-1948	Spanish Ministry of Education and Science; Ministerio de Educacion, Ciencia y Tecnologia [SAF2007-64310, SAF2010-15649]; La Fundacio La Marato de TV3	Spanish Ministry of Education and Science(Spanish Government); Ministerio de Educacion, Ciencia y Tecnologia(Spanish Government); La Fundacio La Marato de TV3	E. Alari-Pahissa was supported by predoctoral fellowships from the Spanish Ministry of Education and Science. This work was supported by grants (SAF2007-64310 and SAF2010-15649) from the Ministerio de Educacion, Ciencia y Tecnologia and La Fundacio La Marato de TV3 2004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alari-Pahissa E, 2012, J LEUKOCYTE BIOL, V92, P145, DOI 10.1189/jlb.1011499; Atzeni F, 2004, CLIN EXP RHEUMATOL, V22, P331; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Bohler T, 1999, EUR J PEDIATR, V158, P638, DOI 10.1007/s004310051167; Carrero JA, 2006, J EXP MED, V203, P933, DOI 10.1084/jem.20060045; CEBRIAN M, 1988, J EXP MED, V168, P1621, DOI 10.1084/jem.168.5.1621; COSULICH ME, 1987, P NATL ACAD SCI USA, V84, P4205, DOI 10.1073/pnas.84.12.4205; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Esplugues E, 2005, BLOOD, V105, P4399, DOI 10.1182/blood-2004-10-3854; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; Feng HP, 2005, J IMMUNOL, V175, P421, DOI 10.4049/jimmunol.175.1.421; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Firat H, 1999, EUR J IMMUNOL, V29, P3112, DOI 10.1002/(SICI)1521-4141(199910)29:10<3112::AID-IMMU3112>3.0.CO;2-Q; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; HARA T, 1986, J EXP MED, V164, P1988, DOI 10.1084/jem.164.6.1988; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Hodge G, 2004, CLIN EXP IMMUNOL, V135, P125, DOI 10.1111/j.1365-2249.2004.02346.x; Iannone F, 1996, BRIT J RHEUMATOL, V35, P397; Ishikawa S, 1998, J IMMUNOL, V161, P1267; Iwashiro M, 2001, P NATL ACAD SCI USA, V98, P9226, DOI 10.1073/pnas.151174198; LAFFON A, 1991, J CLIN INVEST, V88, P546, DOI 10.1172/JCI115338; Lauzurica P, 2000, BLOOD, V95, P2312, DOI 10.1182/blood.V95.7.2312.007k16_2312_2320; Lorente E, 2012, J BIOL CHEM, V287, P9990, DOI 10.1074/jbc.M111.314856; Lorente E, 2012, J VIROL, V86, P527, DOI 10.1128/JVI.05737-11; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; NAKAMURA S, 1989, J EXP MED, V169, P677, DOI 10.1084/jem.169.3.677; Ortiz AM, 2002, RHEUMATOL INT, V21, P182, DOI 10.1007/s00296-001-0161-z; PortalesPerez D, 1997, LUPUS, V6, P48, DOI 10.1177/096120339700600107; RASMUSSEN AM, 1994, J IMMUNOL, V153, P4997; RESTIFO NP, 1995, J IMMUNOL, V154, P4414; RISSO A, 1989, EUR J IMMUNOL, V19, P323, DOI 10.1002/eji.1830190216; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sancho D, 2006, J LEUKOCYTE BIOL, V80, P1233, DOI 10.1189/jlb.1205749; SANTIS AG, 1992, EUR J IMMUNOL, V22, P1253, DOI 10.1002/eji.1830220521; TESTI R, 1989, J IMMUNOL, V143, P1123; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; van Vliet SJ, 2008, IMMUNOL CELL BIOL, V86, P580, DOI 10.1038/icb.2008.55; VanderHove LE, 1997, CLIN EXP IMMUNOL, V109, P501, DOI 10.1046/j.1365-2249.1997.4771375.x; Vega-Ramos J, 2010, IMMUNOL CELL BIOL, V88, P707, DOI 10.1038/icb.2010.62; Vremec D, 2010, INNATE IMMUN; Vremec David, 2008, V415, P163, DOI 10.1007/978-1-59745-570-1_10; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; ZIEGLER SF, 1994, J IMMUNOL, V152, P1228; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	46	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48593	10.1371/journal.pone.0048593	http://dx.doi.org/10.1371/journal.pone.0048593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119065	Green Published, gold			2022-12-25	WOS:000310705600052
J	Grant, WF; Nicol, LE; Thorn, SR; Grove, KL; Friedman, JE; Marks, DL				Grant, Wilmon F.; Nicol, Lindsey E.; Thorn, Stephanie R.; Grove, Kevin L.; Friedman, Jacob E.; Marks, Daniel L.			Perinatal Exposure to a High-Fat Diet Is Associated with Reduced Hepatic Sympathetic Innervation in One-Year Old Male Japanese Macaques	PLOS ONE			English	Article							NF-KAPPA-B; NEUROPEPTIDE-Y; CARDIOVASCULAR-DISEASE; NONHUMAN PRIMATE; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; NERVE-STIMULATION; MAMMALIAN LIVER; ACTIVATION; FETAL	Our group recently demonstrated that maternal high-fat diet (HFD) consumption is associated with non-alcoholic fatty liver disease, increased apoptosis, and changes in gluconeogenic gene expression and chromatin structure in fetal nonhuman primate (NHP) liver. However, little is known about the long-term effects that a HFD has on hepatic nervous system development in offspring, a system that plays an important role in regulating hepatic metabolism. Utilizing immunohistochemistry and Real-Time PCR, we quantified sympathetic nerve fiber density, apoptosis, inflammation, and other autonomic components in the livers of fetal and one-year old Japanese macaques chronically exposed to a HFD. We found that HFD exposure in-utero and throughout the postnatal period (HFD/HFD), when compared to animals receiving a CTR diet for the same developmental period (CTR/CTR), is associated with a 1.7 fold decrease in periportal sympathetic innervation, a 5 fold decrease in parenchymal sympathetic innervation, and a 2.5 fold increase in hepatic apoptosis in the livers of one-year old male animals. Additionally, we observed an increase in hepatic inflammation and a decrease in a key component of the cholinergic anti-inflammatory pathway in one-year old HFD/HFD offspring. Taken together, these findings reinforce the impact that continuous exposure to a HFD has in the development of long-term hepatic pathologies in offspring and highlights a potential neuroanatomical basis for hepatic metabolic dysfunction.	[Grant, Wilmon F.; Marks, Daniel L.] Oregon Hlth & Sci Univ, Neurosci Grad Program, Portland, OR 97201 USA; [Grant, Wilmon F.; Nicol, Lindsey E.; Marks, Daniel L.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Grove, Kevin L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA; [Nicol, Lindsey E.; Marks, Daniel L.] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA; [Thorn, Stephanie R.; Friedman, Jacob E.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Marks, DL (corresponding author), Oregon Hlth & Sci Univ, Neurosci Grad Program, Portland, OR 97201 USA.	marksd@ohsu.edu	Marks, Daniel/C-3712-2009	Thorn, Stephanie/0000-0001-6183-8155; Wesolowski, Stephanie/0000-0001-7523-0394	NIH [DK-79194, RR00163, DK-062155, DK-078590]; Burroughs-Wellcome Trust Translational Research Award; Oregon Child Health Research Center Grant [5K12 HD057588-03, HD046420 T32]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD057588] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090964, R01DK078590, R01DK062155, R01DK079194, K01DK090199] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Trust Translational Research Award; Oregon Child Health Research Center Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH grants DK-79194 (to K.L. Grove), RR00163 (to K.L. Grove and ONPRC), DK-062155 (to J.E. Friedman), DK-078590 and the Burroughs-Wellcome Trust Translational Research Award (to D.L. Marks), the Oregon Child Health Research Center Grant 5K12 HD057588-03 (to L.E.N) and HD046420 T32 (to W.F Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1989, J EPIDEMIOL COMMUN H, V43, P237, DOI 10.1136/jech.43.3.237; Barzilay JI, 2003, METAB SYNDR RELAT D, V1, P55, DOI 10.1089/154041903321648252; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Burcelin R, 2000, DIABETES, V49, P1643, DOI 10.2337/diabetes.49.10.1643; BURT AD, 1989, HEPATOLOGY, V9, P839, DOI 10.1002/hep.1840090608; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Delalande JM, 2004, ANAT REC PART A, V280A, P848, DOI 10.1002/ar.a.20090; Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x; Ding WG, 1997, MICROSC RES TECHNIQ, V39, P365, DOI 10.1002/(SICI)1097-0029(19971115)39:4<365::AID-JEMT6>3.0.CO;2-G; Fan L, 2012, INT J OBES LOND, P1; FEHER E, 1991, DIGESTION, V50, P194, DOI 10.1159/000200761; FORSSMANN WG, 1977, J CELL BIOL, V74, P299, DOI 10.1083/jcb.74.1.299; FRANCAVILLA A, 1986, GASTROENTEROLOGY, V91, P1263, DOI 10.1016/S0016-5085(86)80026-9; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Glavas MM, 2008, J COMP NEUROL, V506, P194, DOI 10.1002/cne.21543; GOEHLER LE, 1991, CELL TISSUE RES, V265, P287, DOI 10.1007/BF00398076; GRANGER GA, 1968, NATURE, V218, P1253, DOI 10.1038/2181253a0; Granger SW, 2003, CYTOKINE HDB, P825; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; Grayson BE, 2010, ENDOCRINOLOGY, V151, P1622, DOI 10.1210/en.2009-1019; Grayson BE, 2006, NEUROSCIENCE, V143, P975, DOI 10.1016/j.neuroscience.2006.08.055; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harada H, 2001, J APPL PHYSIOL, V91, P2816, DOI 10.1152/jappl.2001.91.6.2816; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; la Fleur SE, 1999, J NEUROENDOCRINOL, V11, P643; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; NOBIN A, 1978, CELL TISSUE RES, V195, P371; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Poynard T, 2003, J HEPATOL, V38, P257, DOI 10.1016/S0168-8278(02)00413-0; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; SHIMAZU T, 1962, BIOCHIM BIOPHYS ACTA, V65, P373, DOI 10.1016/0006-3002(62)91064-8; SHIMAZU T, 1966, NATURE, V210, P1178, DOI 10.1038/2101178a0; SHIMAZU T, 1965, SCIENCE, V150, P1607, DOI 10.1126/science.150.3703.1607; SHIMAZU T, 1967, SCIENCE, V156, P1256, DOI 10.1126/science.156.3779.1256; Shimazu T., 1996, LIVER INNERVATION, P23; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Suter M, 2011, FASEB J; Tiniakos DG, 2008, VIRCHOWS ARCH, V452, P435, DOI 10.1007/s00428-007-0569-2; van den Hoek AM, 2008, DIABETES, V57, P2304, DOI 10.2337/db07-1658; Yi CX, 2010, BBA-MOL BASIS DIS, V1802, P416, DOI 10.1016/j.bbadis.2010.01.006; Yi CX, 2009, DIABETES, V58, P1998, DOI 10.2337/db09-0385; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	52	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48119	10.1371/journal.pone.0048119	http://dx.doi.org/10.1371/journal.pone.0048119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118937	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705600025
J	Atanasovska, B; Bozhinovski, G; Plaseska-Karanfilska, D; Chakalova, L				Atanasovska, Biljana; Bozhinovski, Georgi; Plaseska-Karanfilska, Dijana; Chakalova, Lyubomira			Efficient Detection of Mediterranean beta-Thalassemia Mutations by Multiplex Single-Nucleotide Primer Extension	PLOS ONE			English	Article							GLOBIN GENE-MUTATIONS; PRENATAL-DIAGNOSIS; MOLECULAR ANALYSIS; RAPID DETECTION; NUCLEIC-ACIDS; AMPLIFIED DNA; PCR; HEMOGLOBINOPATHIES; POLYMORPHISMS; HYBRIDIZATION	beta-Thalassemias and abnormal hemoglobin variants are among the most common hereditary abnormalities in humans. Molecular characterization of the causative genetic variants is an essential part of the diagnostic process. In geographic areas with high hemoglobinopathy prevalence, such as the Mediterranean region, a limited number of genetic variants are responsible for the majority of hemoglobinopathy cases. Developing reliable, rapid and cost-effective mutation-specific molecular diagnostic assays targeting particular populations greatly facilitates routine hemoglobinopathy investigations. We developed a one-tube single-nucleotide primer extension assay for the detection of eight common Mediterranean beta-thalassemia mutations: Codon 5 (-CT); CCT(Pro)->C-, Codon 6 (-A); GAG(Glu)->G-G, Codon 8 (-AA); AAG(Lys)->-G, IVS-I-1 (G->A), IVS-I-6 (T->C), IVS-I-110 (G->A), Codon 39 (C->T), and IVS-II-745 (C->G), as well as the hemoglobin S variant beta 6(A3) Glu>Val. We validated the new assay using previously genotyped samples obtaining 100% agreement between independent genotyping methods. Our approach, applicable in a range of Mediterranean countries, offers a combination of high accuracy and rapidity exploiting standard techniques and widely available equipment. It can be further adapted to particular populations by including/excluding assayed mutations. We facilitate future modifications by providing detailed information on assay design.	[Atanasovska, Biljana; Bozhinovski, Georgi; Plaseska-Karanfilska, Dijana; Chakalova, Lyubomira] Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol, Skopje, Macedonia; [Chakalova, Lyubomira] Bulgarian Acad Sci, Inst Mol Biol, Dept Mol Biol Cell Cycle, BU-1113 Sofia, Bulgaria	Bulgarian Academy of Sciences	Chakalova, L (corresponding author), Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol, Skopje, Macedonia.	chakalova@bio21.bas.bg	Karanfilska, Dijana Plaseska/P-6096-2018	Karanfilska, Dijana Plaseska/0000-0001-8877-2416	Research Center for Genetic Engineering and Biotechnology; Research Potential Grant of the 7th EC Framework Program [229458]	Research Center for Genetic Engineering and Biotechnology; Research Potential Grant of the 7th EC Framework Program	This work was supported by core funding of the Research Center for Genetic Engineering and Biotechnology. LC was supported by a Research Potential Grant of the 7th EC Framework Program (No. 229458) coordinated by DPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig SM, 2006, HAEMATOLOGICA, V91, P13; Bang-Ce Ye, 2004, Haematologica, V89, P1010; Bardarova K, 2001, BALKAN J MED GENET, V4, P33; Battistella S, 2008, CLIN CHEM, V54, P1657, DOI 10.1373/clinchem.2008.107870; CAI SP, 1988, BLOOD, V71, P1357; Chan OTM, 2010, AM J CLIN PATHOL, V133, P700, DOI 10.1309/AJCP7HQ2KWGHECIO; Colah R, 2010, EXPERT REV HEMATOL, V3, P103, DOI [10.1586/ehm.09.74, 10.1586/EHM.09.74]; Cremonesi L, 2007, HEMOGLOBIN, V31, P289, DOI 10.1080/03630260701459366; Davalieva K, 2010, MACED J CHEM CHEM EN, V29, P57; DIANZANI I, 1991, GENOMICS, V11, P48, DOI 10.1016/0888-7543(91)90100-S; DIAZCHICO JC, 1988, BIOCHIM BIOPHYS ACTA, V949, P43, DOI 10.1016/0167-4781(88)90052-8; Dimitrov RA, 2004, BIOPHYS J, V87, P215, DOI 10.1529/biophysj.103.020743; DIMOVSKI A, 1990, HEMOGLOBIN, V14, P15, DOI 10.3109/03630269009002251; Ding CM, 2004, P NATL ACAD SCI USA, V101, P10762, DOI 10.1073/pnas.0403962101; EFREMOV DG, 1991, HEMOGLOBIN, V15, P525, DOI 10.3109/03630269109027900; EFREMOV GD, 1990, HAEMATOLOGICA, V75, P31; EFREMOV GD, 1978, HEMOGLOBIN, V2, P197, DOI 10.3109/03630267809007068; Efremov GD, 2007, HEMOGLOBIN, V31, P1, DOI 10.1080/03630260601056726; Foglieni B, 2004, CLIN CHEM, V50, P73, DOI 10.1373/clinchem.2003.023077; Foglieni Barbara, 2008, V444, P169, DOI 10.1007/978-1-59745-066-9_13; Galbiati S, 2007, ELECTROPHORESIS, V28, P4289, DOI 10.1002/elps.200700181; Ghanem Nada, 1992, Human Mutation, V1, P229, DOI 10.1002/humu.1380010310; Giambona A, 2011, BLOOD CELL MOL DIS, V46, P282, DOI 10.1016/j.bcmd.2011.01.006; Gill P, 2008, MOL CELL PROBE, V22, P103, DOI 10.1016/j.mcp.2007.10.001; Hattori Y, 2002, INT J HEMATOL, V76, P90, DOI 10.1007/BF03165095; Henderson S, 2009, CLIN BIOCHEM, V42, P1745, DOI 10.1016/j.clinbiochem.2009.05.012; Huisman THJ, 1997, SYLLABUS THALASSEMIA; Hung CC, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-62; KOBAYASHI M, 1995, MOL CELL PROBE, V9, P175, DOI 10.1006/mcpr.1995.0027; Lappin S, 2001, J MOL DIAGN, V3, P178, DOI 10.1016/S1525-1578(10)60670-8; Li BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028078; Madjunkova S, 2012, GENET TEST MOL BIOMA, V16, P259, DOI 10.1089/gtmb.2011.0173; MAGGIO A, 1993, BLOOD, V81, P239; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Mirasena S, 2008, HEMOGLOBIN, V32, P403, DOI 10.1080/03630260701798391; Noveski P, 2010, BALK J MED GENET, V13, P11; Oner R, 2000, HEMOGLOBIN, V24, P195, DOI 10.3109/03630260008997527; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Plaseski T, 2012, J ANDROL, V33, P675, DOI 10.2164/jandrol.111.013995; Shaji RV, 2003, CLIN CHEM, V49, P777, DOI 10.1373/49.5.777; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; TAKAHASHIFUJII A, 1994, MOL CELL PROBE, V8, P385, DOI 10.1006/mcpr.1994.1055; Tan JA, 2008, PRENAT DIAGN, V14, P1077; Thongnoppakhun W, 2009, J MOL DIAGN, V11, P334, DOI 10.2353/jmoldx.2009.080151; Trent Ronald J A, 2006, Clin Biochem Rev, V27, P27; Vrettou C, 2003, CLIN CHEM, V49, P769, DOI 10.1373/49.5.769; Wang W, 2003, CLIN CHEM, V49, P209, DOI 10.1373/49.2.209; Weatherall DJ, 2008, CURR MOL MED, V8, P592, DOI 10.2174/156652408786241375; Weatherall DJ, 2003, OXFORD TXB MED, P676; Ye BC, 2007, GENET TEST, V11, P75, DOI 10.1089/gte.2006.0502; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48167	10.1371/journal.pone.0048167	http://dx.doi.org/10.1371/journal.pone.0048167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110203	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500045
J	Tsutsui, T; Yamaji, N; Huang, CF; Motoyama, R; Nagamura, Y; Ma, JF				Tsutsui, Tomokazu; Yamaji, Naoki; Huang, Chao Feng; Motoyama, Ritsuko; Nagamura, Yoshiaki; Ma, Jian Feng			Comparative Genome-Wide Transcriptional Analysis of Al-Responsive Genes Reveals Novel Al Tolerance Mechanisms in Rice	PLOS ONE			English	Article							ALUMINUM TOLERANCE; GERMIN-LIKE; QUANTITATIVE TRAIT; OXIDATIVE STRESS; TRANSPORTER GENE; IDENTIFICATION; RESISTANCE; TOXICITY; PLANTS; DETOXIFICATION	Rice (Oryza sativa) is the most aluminum (Al)-tolerant crop among small-grain cereals, but the mechanism underlying its high Al resistance is still not well understood. To understand the mechanisms underlying high Al-tolerance, we performed a comparative genome-wide transcriptional analysis by comparing expression profiling between the Al-tolerance cultivar (Koshihikari) and an Al-sensitive mutant star1 (SENSITIVE TO AL RHIZOTOXICITY 1) in both the root tips and the basal roots. Exposure to 20 mu M AlCl3 for 6 h resulted in up-regulation (higher than 3-fold) of 213 and 2015 genes including 185 common genes in the root tips of wild-type and the mutant, respectively. On the other hand, in the basal root, genes up-regulated by Al were 126 and 2419 including 76 common genes in the wild-type and the mutant, respectively. These results indicate that Al-response genes are not only restricted to the root tips, but also in the basal root region. Analysis with genes up-or down-regulated only in the wild-type reveals that there are other mechanisms for Al-tolerance except for a known transcription factor ART1-regulated one in rice. These mechanisms are related to nitrogen assimilation, secondary metabolite synthesis, cell-wall synthesis and ethylene synthesis. Although the exact roles of these putative tolerance genes remain to be examined, our data provide a platform for further work on Al-tolerance in rice.	[Tsutsui, Tomokazu; Yamaji, Naoki; Huang, Chao Feng; Ma, Jian Feng] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Motoyama, Ritsuko; Nagamura, Yoshiaki] Natl Inst Agrobiol Sci, Genome Resource Ctr, Div Genome & Biodivers Res, Tsukuba, Ibaraki, Japan	Okayama University; National Institute of Agrobiological Sciences - Japan	Ma, JF (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan.	maj@rib.okayama-u.ac.jp	Huang, Chao-Feng/J-1415-2012; Ma, Jianfeng/GZB-0110-2022; Feng, Jian/C-7213-2009; Huang, Chao-Feng/K-4159-2019; YAMAJI, Naoki/B-2524-2011	Huang, Chao-Feng/0000-0002-1486-741X; Feng, Jian/0000-0003-3411-827X; Huang, Chao-Feng/0000-0002-1486-741X; YAMAJI, Naoki/0000-0002-7499-3004	Ministry of Education, Culture, Sports, Science and Technology of Japan [22119002]; Ministry of Agriculture, Forestry and Fisheries of Japan [IPG-0006]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	The research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 22119002 to JFM) and by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, IPG-0006 to JFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter C, 2000, J BIOL CHEM, V275, P36726, DOI 10.1074/jbc.M006461200; Chandran D, 2008, PLANTA, V228, P151, DOI 10.1007/s00425-008-0726-0; Chandran D, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-89; Chen RF, 2006, ANN BOT-LONDON, V98, P389, DOI 10.1093/aob/mcl110; Chen ZC, 2012, PLANT PHYSIOL, V159, P1624, DOI 10.1104/pp.112.199778; Coutinho PM, 1999, ROY SOC CH, P3; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Delhaize E, 2012, TRENDS PLANT SCI, V17, P341, DOI 10.1016/j.tplants.2012.02.008; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Goodwin SB, 2009, BIOL PLANTARUM, V53, P85, DOI 10.1007/s10535-009-0012-4; Gucciardo S, 2007, J EXP BOT, V58, P1161, DOI 10.1093/jxb/erl282; Hamberger B, 2004, P NATL ACAD SCI USA, V101, P2209, DOI 10.1073/pnas.0307307101; Hoekenga OA, 2003, PLANT PHYSIOL, V132, P936, DOI 10.1104/pp.103.023085; Houde M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-400; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones DL, 2006, PLANT CELL ENVIRON, V29, P1309, DOI 10.1111/j.1365-3040.2006.01509.x; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kumari M, 2008, MOL GENET GENOMICS, V279, P339, DOI 10.1007/s00438-007-0316-z; Lin CM, 2000, PLANT PHYSIOL, V122, P379, DOI 10.1104/pp.122.2.379; Ma JF, 2003, J INORG BIOCHEM, V97, P46, DOI 10.1016/S0162-0134(03)00245-9; Ma JF, 2002, PLANT CELL PHYSIOL, V43, P652, DOI 10.1093/pcp/pcf081; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Maron LG, 2008, NEW PHYTOL, V179, P116, DOI 10.1111/j.1469-8137.2008.02440.x; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mattiello L, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-196; Meriga B, 2004, J PLANT PHYSIOL, V161, P63, DOI 10.1078/0176-1617-01156; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Sharma P, 2007, PLANT CELL REP, V26, P2027, DOI 10.1007/s00299-007-0416-6; Sun P, 2007, PLANT CELL PHYSIOL, V48, P1229, DOI 10.1093/pcp/pcm077; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Tsutsui T, 2011, PLANT PHYSIOL, V156, P925, DOI 10.1104/pp.111.175802; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Xiong J, 2012, J EXP BOT, V63, P33, DOI 10.1093/jxb/err268; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yokosho K, 2011, PLANT J, V68, P1061, DOI 10.1111/j.1365-313X.2011.04757.x; Zhang ZY, 2011, PLANT CELL REP, V30, P1701, DOI 10.1007/s00299-011-1078-y; Zhao CR, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-32	45	34	34	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48197	10.1371/journal.pone.0048197	http://dx.doi.org/10.1371/journal.pone.0048197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110212	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500049
J	Hashida, K; Kitao, Y; Sudo, H; Awa, Y; Maeda, S; Mori, K; Takahashi, R; Iinuma, M; Hori, O				Hashida, Koji; Kitao, Yasuko; Sudo, Hirofumi; Awa, Yoshitaka; Maeda, Shinichiro; Mori, Kazutoshi; Takahashi, Ryosuke; Iinuma, Munekazu; Hori, Osamu			ATF6alpha Promotes Astroglial Activation and Neuronal Survival in a Chronic Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; IN-VIVO; DEATH; INTERLEUKIN-6; ASTROCYTES; MECHANISMS; NEUROTOXIN	Accumulating evidence suggests a crucial role for the unfolded protein response (UPR) in Parkinson's disease (PD). In this study, we investigated the relevance of the UPR in a mouse model of chronic MPTP/probenecid (MPTP/P) injection, which causes severe and persistent degeneration of dopaminergic neurons. Enhanced activation of the UPR branches, including ATF6 alpha and PERK/eIF2 alpha/ATF4, was observed after MPTP/P injections into mice. Deletion of the ATF6 alpha gene accelerated neuronal degeneration and ubiquitin accumulation relatively early in the MPTP/P injection course. Surprisingly, astroglial activation was strongly suppressed, and production of the brain-derived neurotrophic factor (BDNF) and anti-oxidative genes, such as heme oxygenase-1 (HO-1) and xCT, in astrocytes were reduced in ATF6 alpha -/- mice after MPTP/ P injections. Decreased BDNF expression in ATF6 alpha -/- mice was associated with decreased expression of GRP78, an ATF6 alpha-dependent molecular chaperone in the ER. Decreased HO-1 and xCT levels were associated with decreased expression of the ATF4-dependent pro-apoptotic gene CHOP. Consistent with these results, administration of the UPR-activating reagent tangeretin (5,6,7,8,4'-pentamethoxyflavone; IN19) into mice enhanced the expression of UPR-target genes in both dopaminergic neurons and astrocytes, and promoted neuronal survival after MPTP/P injections. These results suggest that the UPR is activated in a mouse model of chronic MPTP/P injection, and contributes to the survival of nigrostriatal dopaminergic neurons, in part, through activated astrocytes.	[Hashida, Koji; Kitao, Yasuko; Sudo, Hirofumi; Awa, Yoshitaka; Maeda, Shinichiro; Hori, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat, Kanazawa, Ishikawa, Japan; [Hashida, Koji; Kitao, Yasuko; Sudo, Hirofumi; Awa, Yoshitaka; Maeda, Shinichiro; Mori, Kazutoshi; Takahashi, Ryosuke; Hori, Osamu] JST, CREST, Tokyo, Japan; [Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan; [Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Iinuma, Munekazu] Gifu Pharmaceut Univ, Lab Pharmacognosy, Gifu, Japan	Kanazawa University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; Gifu Pharmaceutical University	Hori, O (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat, Kanazawa, Ishikawa, Japan.	osamuh3@staff.kanazawa-u.ac.jp	Mori, Kazutoshi/AAW-5449-2020; Mori, Kazutoshi/K-6106-2015		Ministry of Education, Science, Technology, Sports and Culture of Japan [23500440]; Grants-in-Aid for Scientific Research [23500440] Funding Source: KAKEN	Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in Aid for Scientific Research (23500440) from the Ministry of Education, Science, Technology, Sports and Culture of Japan, http:// www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Datla KP, 2001, NEUROREPORT, V12, P3871, DOI 10.1097/00001756-200112040-00053; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Egawa N, 2011, J BIOL CHEM, V286, P7947, DOI 10.1074/jbc.M110.156430; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Hori O, 1996, J NEUROCHEM, V66, P973; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Kitao Y, 2007, HUM MOL GENET, V16, P50, DOI 10.1093/hmg/ddl439; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; MAEDA Y, 1994, J EXP MED, V180, P2297, DOI 10.1084/jem.180.6.2297; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Schintu N, 2009, NEUROTOX RES, V16, P127, DOI 10.1007/s12640-009-9061-x; Shimohama S, 2003, TRENDS MOL MED, V9, P360, DOI 10.1016/S1471-4914(03)00117-5; Silva RM, 2005, J NEUROCHEM, V95, P974, DOI 10.1111/j.1471-4159.2005.03428.x; Takano K, 2007, AM J PHYSIOL-CELL PH, V292, pC353, DOI 10.1152/ajpcell.00388.2006; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; TANAKA T, 1987, YAKUGAKU ZASSHI, V107, P315, DOI 10.1248/yakushi1947.107.4_315; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamaguchi A, 1999, J CELL BIOL, V147, P1195, DOI 10.1083/jcb.147.6.1195; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	26	78	82	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47950	10.1371/journal.pone.0047950	http://dx.doi.org/10.1371/journal.pone.0047950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112876	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200117
J	Kalinowski, FC; Giles, KM; Candy, PA; Ali, A; Ganda, C; Epis, MR; Webster, RJ; Leedman, PJ				Kalinowski, Felicity C.; Giles, Keith M.; Candy, Patrick A.; Ali, Alishum; Ganda, Clarissa; Epis, Michael R.; Webster, Rebecca J.; Leedman, Peter J.			Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; SQUAMOUS CARCINOMA; PLUS CETUXIMAB; PHASE-II; IN-VITRO; MICRORNA; EXPRESSION; EGFR; LINES; RESISTANCE	Elevated expression and activity of the epidermal growth factor receptor (EGFR)/protein kinase B (Akt) signaling pathway is associated with development, progression and treatment resistance of head and neck cancer (HNC). Several studies have demonstrated that microRNA-7 (miR-7) regulates EGFR expression and Akt activity in a range of cancer cell types via its specific interaction with the EGFR mRNA 3'-untranslated region (3'-UTR). In the present study, we found that miR-7 regulated EGFR expression and Akt activity in HNC cell lines, and that this was associated with reduced growth in vitro and in vivo of cells (HN5) that were sensitive to the EGFR tyrosine kinase inhibitor (TKI) erlotinib (Tarceva). miR-7 acted synergistically with erlotinib to inhibit growth of erlotinib-resistant FaDu cells, an effect associated with increased inhibition of Akt activity. Microarray analysis of HN5 and FaDu cell lines transfected with miR-7 identified a common set of downregulated miR-7 target genes, providing insight into the tumor suppressor function of miR-7. Furthermore, we identified several target miR-7 mRNAs with a putative role in the sensitization of FaDu cells to erlotinib. Together, these data support the coordinate regulation of Akt signaling by miR-7 in HNC cells and suggest the therapeutic potential of miR-7 alone or in combination with EGFR TKIs in this disease.	[Kalinowski, Felicity C.; Giles, Keith M.; Candy, Patrick A.; Ali, Alishum; Ganda, Clarissa; Epis, Michael R.; Webster, Rebecca J.; Leedman, Peter J.] Western Australian Inst Med Res, Lab Canc Med, Perth, WA, Australia; [Kalinowski, Felicity C.; Giles, Keith M.; Candy, Patrick A.; Ali, Alishum; Ganda, Clarissa; Epis, Michael R.; Webster, Rebecca J.; Leedman, Peter J.] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [Candy, Patrick A.; Leedman, Peter J.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Leedman, PJ (corresponding author), Western Australian Inst Med Res, Lab Canc Med, Perth, WA, Australia.	peter.leedman@waimr.uwa.edu.au	Leedman, Peter J/O-4044-2014	Kalinowski, Felicity/0000-0002-3923-8898	National Health and Medical Research Council of Australia and the Medical Research Commercialization Fund of Australia	National Health and Medical Research Council of Australia and the Medical Research Commercialization Fund of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia and the Medical Research Commercialization Fund of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanell J, 2001, CANCER RES, V61, P6500; Baba Y, 2012, J ONCOL, V2012, DOI 10.1155/2012/986725; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Bauman JE, 2012, CURR OPIN ONCOL; Becker RA., 1988, NEW S LANGUAGE PROGR; Bliesath J., 2012, CANC LETT; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051; Cuellar TL, 2005, J ENDOCRINOL, V187, P327, DOI 10.1677/joe.1.06426; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; EASTY DM, 1981, BRIT J CANCER, V43, P772, DOI 10.1038/bjc.1981.115; Emlet DR, 2007, MOL CANCER THER, V6, P2664, DOI 10.1158/1535-7163.MCT-07-0079; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Fang YX, 2012, HEPATOLOGY; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Hickinson DM, 2009, CTS-CLIN TRANSL SCI, V2, P183, DOI 10.1111/j.1752-8062.2009.00099.x; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kong D, 2011, ONCOGENE; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; KWOK TT, 1991, BRIT J CANCER, V64, P251, DOI 10.1038/bjc.1991.286; Kwon CY, 2010, INT J ONCOL, V37, P837, DOI 10.3892/ijo_00000734; Lee KM, 2011, RADIOTHER ONCOL, V101, P171, DOI 10.1016/j.radonc.2011.05.050; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler-Ragg J, 2008, EXPERT OPIN INV DRUG, V17, P1517, DOI 10.1517/13543784.17.10.1517 ; McFarland D C, 2000, Methods Cell Sci, V22, P63, DOI 10.1023/A:1009838416621; Mehra R, 2011, DRUG RESIST UPDATE, V14, P260, DOI 10.1016/j.drup.2011.08.002; Miyata Y, 2005, MOL CELL BIOCHEM, V274, P171, DOI 10.1007/s11010-005-2949-8; Mut M, 2012, INT J BIOCHEM CELL B, V44, P302, DOI 10.1016/j.biocel.2011.10.025; O-charoenrat P, 2000, CANCER RES, V60, P1121; Parker BJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S32; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Tanida S, 2004, GASTROENTEROLOGY, V127, P559, DOI 10.1053/j.gastro.2004.05.017; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yao Z, 2010, P NATL ACAD SCI	63	59	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47067	10.1371/journal.pone.0047067	http://dx.doi.org/10.1371/journal.pone.0047067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115635	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200023
J	Kramer, H; Sempos, C; Cao, GC; Luke, A; Shoham, D; Cooper, R; Durazo-Arvizu, R				Kramer, Holly; Sempos, Chris; Cao, Guichan; Luke, Amy; Shoham, David; Cooper, Richard; Durazo-Arvizu, Ramon			Mortality Rates Across 25-Hydroxyvitamin D (25[OH] D) Levels among Adults with and without Estimated Glomerular Filtration Rate < 60 ml/min/1.73 m(2) : The Third National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; VITAMIN-D DEFICIENCY; SERUM PARATHYROID-HORMONE; HYPOVITAMINOSIS-D; D SUPPLEMENTATION; RISK; PREVALENCE; CALCIUM; METAANALYSIS; CANCER	Background: Previous studies exploring the association between 25[OH]D levels and mortality in adults with and without kidney disease utilized 25[OH]D thresholds that have recently been scrutinized by the Institute of Medicine Committee to Review Dietary References Intakes for Vitamin D and Calcium. Objective: We explored all-cause mortality rates across the spectrum of 25[OH]D levels over an eighteen-year follow-up among adults with and without an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m(2). Design: The study included 1,097 U.S. adults with eGFR <60 ml/min/1.73 m(2) and 14, 002 adults with eGFR >= 60 ml/min/1.73 m2. Mortality rates and rate ratios (RR) across 25[OH]D groups were calculated with Poisson regression and restricted cubic splines while adjusting for covariates. Results: Prevalence of 25[OH]D levels <30 and <20 ng/ml among adults with eGFR <60 ml/min/1.73 m(2) was 76.5% (population estimate 6.2 million) and 35.4% (population estimate 2.9 million), respectively. Among adults with eGFR >= 60 ml/min/1.73 m(2), 70.5% had 25[OH] D levels <30 ng/ml (population estimate 132.2 million) while 30.3% had 25[OH]D levels <20 ng/ml (population estimate 56.8 million). Significantly higher mortality rates were noted among individuals with 25[OH]D levels <12 ng/ml compared to referent group (24 to <30 ng/ml): RR1.41 (95% CI 1.17, 1.71) among individuals with eGFR <60 ml/min/1.73 m(2) and RR 1.32 (95% CI 1.13, 1.56) among individuals with eGFR >= 60 ml/min/1.73 m(2) after adjustment for covariates including co-morbid conditions. Mortality rates were fairly similar across all 25[OH]D groups with levels >20 ng/ml after adjustment for all covariates. Conclusions: Regardless of presence of eGFR <60 ml/min/1.73 m(2), mortality rates across groups with 25[OH] D levels 2040 ng/ml are similar.	[Kramer, Holly; Cao, Guichan; Luke, Amy; Shoham, David; Cooper, Richard; Durazo-Arvizu, Ramon] Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; [Kramer, Holly] Loyola Univ, Med Ctr, Dept Med, Maywood, IL 60153 USA; [Kramer, Holly] Loyola Univ, Med Ctr, Div Nephrol & Hypertens, Maywood, IL 60153 USA; [Sempos, Chris] NIH, Off Dietary Supplements, Bethesda, MD 20892 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; National Institutes of Health (NIH) - USA	Kramer, H (corresponding author), Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	hkramer@lumc.edu		Kramer, Holly/0000-0002-6374-837X	National Institutes of Health [1R01DK90360-1A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by a grant from the National Institutes of Health (1R01DK90360-1A1). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adami S, 2008, BONE, V42, P267, DOI 10.1016/j.bone.2007.10.003; Aloia JF, 2006, AM J CLIN NUTR, V84, P602, DOI 10.1093/ajcn/84.3.602; [Anonymous], 2010, SURVEY OPERATIONS MA; [Anonymous], 2010, NHANES 3 LINKED MORT; [Anonymous], 1996, NATL CTR HLTH STAT S; [Anonymous], 1992, INT STAT CLASSIFICAT; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Cawthon PM, 2010, J CLIN ENDOCR METAB, V95, P4625, DOI 10.1210/jc.2010-0638; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Emanuele E, 2012, ATHEROSCLEROSIS, V223, P280, DOI 10.1016/j.atherosclerosis.2012.05.017; Greenberg ER, 2005, ANN INTERN MED, V142, P75, DOI 10.7326/0003-4819-142-1-200501040-00112; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2008, CURR OPIN ENDOCRINOL, V15, P489, DOI 10.1097/MED.0b013e328317ca6c; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; LaClair RE, 2005, AM J KIDNEY DIS, V45, P1026, DOI 10.1053/j.ajkd.2005.02.029; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Malabanan A, 1998, LANCET, V351, P805, DOI 10.1016/S0140-6736(05)78933-9; Mehrotra R, 2008, CLIN J AM SOC NEPHRO, V3, P1144, DOI 10.2215/CJN.05781207; Mehrotra R, 2009, KIDNEY INT, V76, P977, DOI 10.1038/ki.2009.288; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Melamed ML, 2009, J AM SOC NEPHROL, V20, P2631, DOI 10.1681/ASN.2009030283; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Michos ED, 2009, FUTUR CARDIOL, V5, P15, DOI 10.2217/14796678.5.1.15; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Norman AW, 2008, AM J CLIN NUTR, V88, P1455, DOI 10.3945/ajcn.2008.27049; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pilz S, 2008, STROKE, V39, P2611, DOI 10.1161/STROKEAHA.107.513655; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Zittermann A, 2012, AM J CLIN NUTR, V95, P91, DOI 10.3945/ajcn.111.014779; 1991, INT CLASSIFICATION D	41	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47458	10.1371/journal.pone.0047458	http://dx.doi.org/10.1371/journal.pone.0047458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112816	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200041
J	Moreira, ND; Vitoriano-Souza, J; Roatt, BM; Vieira, PMD; Ker, HG; Cardoso, JMD; Giunchetti, RC; Carneiro, CM; de Lana, M; Reis, AB				Moreira, Nadia das Dores; Vitoriano-Souza, Juliana; Roatt, Bruno Mendes; de Abreu Vieira, Paula Melo; Ker, Henrique Gama; de Oliveira Cardoso, Jamille Mirelle; Giunchetti, Rodolfo Cordeiro; Carneiro, Claudia Martins; de Lana, Marta; Reis, Alexandre Barbosa			Parasite Burden in Hamsters Infected with Two Different Strains of Leishmania (Leishmania) infantum: "Leishman Donovan Units'' versus Real-Time PCR	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; VISCERAL LEISHMANIASIS; SALIVARY PROTEIN; DNA; QUANTIFICATION; VACCINE; MODEL; DOGS; IMMUNE; SUPPRESSION	To develop and test new therapeutics and immune prophylaxis strategies for visceral leishmaniasis (VL), understanding tissue parasitism evolution after experimental infection with Leishmania infantum is important. Experimental infection in a hamster model (Mesocricetus auratus) reproduces several typical aspects of canine and human VL that are closely related to the inoculum's route. We quantified the parasitism in the liver and spleen of hamsters experimentally infected by various routes (intradermal, intraperitoneal, and intracardiac [IC]) and different strains of L. infantum (MHOM/BR/74/PP75 and Wild) and compared two different methodologies to evaluate tissue parasitism (Leishman Donovan units [LDU] and real-time qPCR). In addition, the quantification of specific total-IgG in the serum of uninfected and infected hamsters was determined by ELISA. The animals were followed for 1, 3, 6 and 9 months post-infection for survival analysis. We found that infection with the Wild strain by the IC route resulted in higher mortality. Positive antibody (IgG) responses were detected with higher peaks at 6 and 9 months in the IC group inoculated with PP75 strain. However, in animals infected with the Wild strain the IgG levels were elevated in all infected groups during all the time evaluated. We also observed by LDU analysis that the IC route lead to higher parasitism in the liver and spleen with both strains. Furthermore, qPCR showed higher sensitivity for identifying animals with low parasitic burden. In conclusion, qPCR can be useful for assessing parasitism in the spleen and liver of a hamster model infected with L. infantum independent of the route of infection, and this technique may become an essential tool for assessing parasite density in the hamster model after experimental treatment or immunization with potential vaccine candidates.	[Moreira, Nadia das Dores; Vitoriano-Souza, Juliana; Roatt, Bruno Mendes; de Abreu Vieira, Paula Melo; Ker, Henrique Gama; de Oliveira Cardoso, Jamille Mirelle; Giunchetti, Rodolfo Cordeiro; Carneiro, Claudia Martins; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol NUPEB, Lab Imunopatol, Ouro Preto, MG, Brazil; [Carneiro, Claudia Martins; de Lana, Marta; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Escola Farm, Dept Anal Clin, Lab Pesquisas Clin, Ouro Preto, MG, Brazil; [de Lana, Marta] Univ Fed Ouro Preto, Escola Farm, Dept Anal Clin, Nucleo Pesquisas Ciencias Biol NUPEB,Lab Doenca C, Ouro Preto, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto	Reis, AB (corresponding author), Univ Fed Ouro Preto, Nucleo Pesquisas Ciencias Biol NUPEB, Lab Imunopatol, Ouro Preto, MG, Brazil.	alexreis@nupeb.ufop.br	Roatt, Bruno M/R-5502-2016; carneiro, claudia m/B-6205-2013; Reis, Alexandre Barbosa/I-9945-2014; carneiro, Claudia Martins/AAP-4455-2020; Giunchetti, Rodolfo/O-9878-2014	Roatt, Bruno M/0000-0001-5281-3263; Reis, Alexandre Barbosa/0000-0001-8123-4164; carneiro, Claudia Martins/0000-0002-6002-857X; Lana, Marta/0000-0002-1565-4707; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Universidade Federal de Ouro Preto (UFOP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINHAZIM AA, 1993, AM J VET RES, V54, P113; Bretagne S, 2001, CLIN DIAGN LAB IMMUN, V8, P828, DOI 10.1128/CDLI.8.4.828-831.2001; BUNNMORENO MM, 1985, CLIN EXP IMMUNOL, V59, P427; Carrion J, 2006, PARASITE IMMUNOL, V28, P173, DOI 10.1111/j.1365-3024.2006.00817.x; Carrion J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-150; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; da Silva RN, 2010, ANN TROP MED PARASIT, V104, P137, DOI 10.1179/136485910X12647085215453; da Silva RAA, 2011, ACTA TROP, V120, P185, DOI 10.1016/j.actatropica.2011.08.007; Dea-Ayuela MA, 2007, VET RES COMMUN, V31, P703, DOI 10.1007/s11259-007-0040-5; DEGRAVE W, 1994, MEM I OSWALDO CRUZ, V89, P463, DOI 10.1590/S0074-02761994000300032; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; EVANS TG, 1990, J PARASITOL, V76, P212, DOI 10.2307/3283018; FRUTH U, 1993, J IMMUNOL, V150, P1857; Galai Y, 2011, J CLIN MICROBIOL, V49, P3150, DOI 10.1128/JCM.00267-11; Garg R, 2006, INDIAN J MED RES, V123, P439; GIFAWESEN C, 1989, INFECT IMMUN, V57, P3091, DOI 10.1128/IAI.57.10.3091-3096.1989; Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105; Gupta R, 2012, J ANTIMICROB CHEMOTH, V67, P440, DOI 10.1093/jac/dkr485; Gupta S, 2011, ANTIMICROB AGENTS CH, V55, P3461, DOI 10.1128/AAC.00137-11; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Hommel M, 1995, ANN TROP MED PARASIT, V89, P55, DOI 10.1080/00034983.1995.11813015; Kaye PM, 2004, IMMUNOL REV, V201, P239, DOI 10.1111/j.0105-2896.2004.00188.x; Kushawaha PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035670; Manna L, 2008, ANN NY ACAD SCI, V1149, P358, DOI 10.1196/annals.1428.018; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Masih S, 2011, EXP PARASITOL, V129, P55, DOI 10.1016/j.exppara.2011.05.014; Mathias R, 2001, BRAZ J MED BIOL RES, V34, P539, DOI 10.1590/S0100-879X2001000400015; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994; Nieto A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-39; OTT KJ, 1967, J PARASITOL, V53, P641, DOI 10.2307/3276733; Paranhos-Silva M, 2003, VET PARASITOL, V114, P97, DOI 10.1016/S0304-4017(03)00132-8; Piscopo TV, 2006, POSTGRAD MED J, V82, P649, DOI 10.1136/pgmj.2006.047340; Poot JSS, 2006, INTERVET INTERNATION, P57; Prajapati VK, 2012, J INFECT DIS, V205, P333, DOI 10.1093/infdis/jir735; Pulido SA, 2012, ACTA TROP, V122, P36, DOI 10.1016/j.actatropica.2011.11.015; Quaresma PF, 2009, ACTA TROP, V111, P289, DOI 10.1016/j.actatropica.2009.05.008; Reimao JQ, 2012, EXP PARASITOL, V130, P195, DOI 10.1016/j.exppara.2012.01.010; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Requena JM, 2000, VET IMMUNOL IMMUNOP, V76, P269, DOI 10.1016/S0165-2427(00)00221-X; Rica-Capela MJ, 2003, PARASITOL RES, V89, P163, DOI 10.1007/s00436-002-0738-9; Rodrigues V, 1998, INFECT IMMUN, V66, P1233, DOI 10.1128/IAI.66.3.1233-1236.1998; Rolao N, 2007, EXP PARASITOL, V115, P270, DOI 10.1016/j.exppara.2006.09.013; Stauber L. A., 1995, SOME PHYSL ASPECTS C, P76; Sudarshan M, 2011, J ANTIMICROB CHEMOTH, V66, P1751, DOI 10.1093/jac/dkr185; Tupperwar N, 2008, DIAGN MICR INFEC DIS, V61, P23, DOI 10.1016/j.diagmicrobio.2007.12.013; Vasconcellos RCS, 1996, BRAZ J MED BIOL RES, V29, P615; Verma S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010107; Volpini AC, 2004, ACTA TROP, V90, P31, DOI 10.1016/j.actatropica.2003.10.008; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WILSON ME, 1987, J PARASITOL, V73, P55, DOI 10.2307/3282344	53	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47907	10.1371/journal.pone.0047907	http://dx.doi.org/10.1371/journal.pone.0047907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112869	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200105
J	Baldissera, R; Rodrigues, ENL; Hartz, SM				Baldissera, Ronei; Rodrigues, Everton N. L.; Hartz, Sandra M.			Metacommunity Composition of Web-Spiders in a Fragmented Neotropical Forest: Relative Importance of Environmental and Spatial Effects	PLOS ONE			English	Article							BETA-DIVERSITY; ATLANTIC FOREST; SPECIES RICHNESS; ECOLOGICAL DATA; ASSEMBLAGES; LANDSCAPE; BIODIVERSITY; PATTERNS; COMMUNITIES; ARACHNIDA	The distribution of beta diversity is shaped by factors linked to environmental and spatial control. The relative importance of both processes in structuring spider metacommunities has not yet been investigated in the Atlantic Forest. The variance explained by purely environmental, spatially structured environmental, and purely spatial components was compared for a metacommunity of web spiders. The study was carried out in 16 patches of Atlantic Forest in southern Brazil. Field work was done in one landscape mosaic representing a slight gradient of urbanization. Environmental variables encompassed plot-and patch-level measurements and a climatic matrix, while principal coordinates of neighbor matrices (PCNMs) acted as spatial variables. A forward selection procedure was carried out to select environmental and spatial variables influencing web-spider beta diversity. Variation partitioning was used to estimate the contribution of pure environmental and pure spatial effects and their shared influence on beta-diversity patterns, and to estimate the relative importance of selected environmental variables. Three environmental variables (bush density, land use in the surroundings of patches, and shape of patches) and two spatial variables were selected by forward selection procedures. Variation partitioning revealed that 15% of the variation of beta diversity was explained by a combination of environmental and PCNM variables. Most of this variation (12%) corresponded to pure environmental and spatially environmental structure. The data indicated that (1) spatial legacy was not important in explaining the web-spider beta diversity; (2) environmental predictors explained a significant portion of the variation in web-spider composition; (3) one-third of environmental variation was due to a spatial structure that jointly explains variation in species distributions. We were able to detect important factors related to matrix management influencing the web-spider beta-diversity patterns, which are probably linked to historical deforestation events.	[Baldissera, Ronei; Hartz, Sandra M.] Univ Fed Rio Grande do Sul, Dept Ecol, Programa Posgrad Ecol, Porto Alegre, RS, Brazil; [Rodrigues, Everton N. L.] Univ Fed Rio Grande do Sul, Dept Zool, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Baldissera, R (corresponding author), Univ Fed Rio Grande do Sul, Dept Ecol, Programa Posgrad Ecol, Porto Alegre, RS, Brazil.	roneibaldissera@yahoo.com.br	Hartz, Sandra Maria/A-8052-2012	Hartz, Sandra Maria/0000-0002-6536-1072; Rodrigues, Everton/0000-0002-9814-0954	CNPq [140220/2008-9, 306816/2010-5]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We thank the landowners of Torres Municipality for their kind permission to enter and use forest patches, especially Mr. Pedro Magnus. We acknowledge Vagner Rodrigues Silva for his help in the fieldwork. Drs. Sandra C. Muller (UFRGS), Luiz Alexandre Campos (UFRGS), Cristina Stenert (Unisinos), Thomas Levinsohn (UNICAMP), Luiz Ernesto Costa-Schmidt (USP) and Leandro Duarte (UFRGS) made valuable suggestions during the manuscript preparation. RB and SMH received CNPq doctoral and researcher scholarships (# 140220/2008-9 and # 306816/2010-5 respectively). Spider collection was permitted under license number 15260-1 (IBAMA - Brazilian Environmental Institute).	Alaruikka D, 2002, J INSECT CONSERV, V6, P195, DOI 10.1023/A:1024432830064; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Antonini Y, 2005, FRAGMENTACAO ECOSSIS, P239; Baldissera R, 2004, BIOL CONSERV, V118, P403, DOI 10.1016/j.biocon.2003.09.017; Baldissera R, 2008, AUSTRAL ECOL, V33, P45, DOI 10.1111/j.1442-9993.2007.01789.x; Baldissera Ronei, 2010, Neotropical Biology and Conservation, V5, P77, DOI 10.4013/nbc.2010.52.02; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bonaldo AB, 2007, IHERINGIA SER ZOOL, V97, P143, DOI 10.1590/S0073-47212007000200003; Bonte D, 2006, ANIM BEHAV, V72, P655, DOI 10.1016/j.anbehav.2005.11.026; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Bowman J, 2002, CONSERV ECOL, V6; [BRASIL. Ministerio da Agricultura e Reforma Agraria. Secretaria Nacional de Irrigacao. Departamento Nacional de Meteorologia], 1992, NORM CLIM 1961 1990; Brasil. Ministerio do Planejamento Orcamento e Gestao. Instituto Brasileiro de Geografia e Estatistica. Diretoria de Geociencias, 2004, MAP VEG BRAS; Carvalho JC, 2011, DIVERS DISTRIB, V17, P225, DOI 10.1111/j.1472-4642.2010.00731.x; Chen KC, 2004, ZOOL STUD, V43, P598; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cushman SA, 2002, LANDSCAPE ECOL, V17, P637, DOI 10.1023/A:1021571603605; Dobrovolski R, 2006, THESIS U FEDERAL RIO; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Finch OD, 2008, BIODIVERS CONSERV, V17, P2849, DOI 10.1007/s10531-008-9400-x; Floren A, 2005, J ARACHNOL, V33, P323, DOI 10.1636/05-22.1; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; Jimenez-Valverde A, 2010, INSECT CONSERV DIVER, V3, P51, DOI 10.1111/j.1752-4598.2009.00067.x; Keil P, 2012, J BIOGEOGR, V39, P1473, DOI 10.1111/j.1365-2699.2012.02701.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Magurran A.E., 2004, ECOLOGICAL DIVERSITY, V1nd; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Metzger JP, 2010, NAT CONSERVACAO, V8, P92, DOI 10.4322/natcon.00801017; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Muff P, 2009, INSECT CONSERV DIVER, V2, P36, DOI 10.1111/j.1752-4598.2008.00037.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PAJUNEN T, 1995, ECOGRAPHY, V18, P62, DOI 10.1111/j.1600-0587.1995.tb00119.x; Pardini R, 2009, BIOL CONSERV, V142, P1178, DOI 10.1016/j.biocon.2009.02.010; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Pillar VD, 2001, MULTIVARIATE EXPLORA; Pinto-Leite CM, 2008, J ARACHNOL, V36, P448, DOI 10.1636/CT07-123.1; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rinaldi Isabela M. P., 2008, Acta Biologica Paranaense, V37, P165; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Schmidt MH, 2005, J APPL ECOL, V42, P281, DOI 10.1111/j.1365-2664.2005.01014.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Spector S, 2002, CONSERV BIOL, V16, P1480, DOI 10.1046/j.1523-1739.2002.00573.x; Suter RB, 1999, J ARACHNOL, V27, P281; Uehara-Prado M, 2009, BIOL CONSERV, V142, P1220, DOI 10.1016/j.biocon.2009.01.008; Uetz G.W., 1991, P325; Van De Meutter F, 2007, ECOLOGY, V88, P1687, DOI 10.1890/06-0333.1; Veech JA, 2009, PARTITION 3 0 USERS; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Williams PH, 1996, P ROY SOC B-BIOL SCI, V263, P579, DOI 10.1098/rspb.1996.0087; Yanoviak SP, 2003, STUD NEOTROP FAUNA E, V38, P145, DOI 10.1076/snfe.38.2.145.15922	63	19	23	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e48099	10.1371/journal.pone.0048099	http://dx.doi.org/10.1371/journal.pone.0048099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110180	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193600046
J	Fowler, AK; Hewetson, A; Agrawal, RG; Dagda, M; Dagda, R; Moaddel, R; Balbo, S; Sanghvi, M; Chen, YK; Hogue, RJ; Bergeson, SE; Henderson, GI; Kruman, II				Fowler, Anna-Kate; Hewetson, Aveline; Agrawal, Rajiv G.; Dagda, Marisela; Dagda, Raul; Moaddel, Ruin; Balbo, Silvia; Sanghvi, Mitesh; Chen, Yukun; Hogue, Ryan J.; Bergeson, Susan E.; Henderson, George I.; Kruman, Inna I.			Alcohol-induced One-carbon Metabolism Impairment Promotes Dysfunction of DNA Base Excision Repair in Adult Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE; GENOMIC INSTABILITY; CELL-DEATH; DAMAGE; APOPTOSIS; FOLATE; MECHANISMS; CANCER; ACETALDEHYDE; DEFICIENCY	The brain is one of the major targets of chronic alcohol abuse. Yet the fundamental mechanisms underlying alcohol-mediated brain damage remain unclear. The products of alcohol metabolism cause DNA damage, which in conditions of DNA repair dysfunction leads to genomic instability and neural death. We propose that one-carbon metabolism (OCM) impairment associated with long term chronic ethanol intake is a key factor in ethanol-induced neurotoxicity, because OCM provides cells with DNA precursors for DNA repair and methyl groups for DNA methylation, both critical for genomic stability. Using histological (immunohistochemistry and stereological counting) and biochemical assays, we show that 3-week chronic exposure of adult mice to 5% ethanol (Lieber-Decarli diet) results in increased DNA damage, reduced DNA repair, and neuronal death in the brain. These were concomitant with compromised OCM, as evidenced by elevated homocysteine, a marker of OCM dysfunction. We conclude that OCM dysfunction plays a causal role in alcohol-induced genomic instability in the brain because OCM status determines the alcohol effect on DNA damage/repair and genomic stability. Short ethanol exposure, which did not disturb OCM, also did not affect the response to DNA damage, whereas additional OCM disturbance induced by deficiency in a key OCM enzyme, methylenetetrahydrofolate reductase (MTHFR) in Mthfr(+/-) mice, exaggerated the ethanol effect on DNA repair. Thus, the impact of long term ethanol exposure on DNA repair and genomic stability in the brain results from OCM dysfunction, and MTHFR mutations such as Mthfr 677C -> T, common in human population, may exaggerate the adverse effects of ethanol on the brain.	[Fowler, Anna-Kate; Hewetson, Aveline; Agrawal, Rajiv G.; Dagda, Marisela; Chen, Yukun; Hogue, Ryan J.; Bergeson, Susan E.; Henderson, George I.; Kruman, Inna I.] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA; [Dagda, Raul] Texas Tech Univ, Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79430 USA; [Moaddel, Ruin; Sanghvi, Mitesh] NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA; [Balbo, Silvia] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Minnesota System; University of Minnesota Twin Cities	Kruman, II (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA.	inna.kruman@ttuhsc.edu	Sanghvi, Mitesh/C-6740-2013; Moaddel, Ruin/AAE-3378-2020; Chen, Yu/Y-3292-2019	Moaddel, Ruin/0000-0002-6812-0127; Balbo, Silvia/0000-0002-7686-0504	Foundation for Alcohol Research; South Plains Alcohol and Addiction Research Center; National Institute of Health Intramural Research Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010114] Funding Source: NIH RePORTER	Foundation for Alcohol Research; South Plains Alcohol and Addiction Research Center; National Institute of Health Intramural Research Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Foundation for Alcohol Research (to I. I. K.), the South Plains Alcohol and Addiction Research Center and in part, by National Institute of Health Intramural Research Program (to R.M.).	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Andrabi SA, 2004, BRAIN RES, V1017, P98, DOI 10.1016/j.brainres.2004.05.038; Aras R, 2012, BRAIN RES, V1450, P102, DOI 10.1016/j.brainres.2012.02.056; Bailey LB, 2003, J NUTR, V133, p3748S, DOI 10.1093/jn/133.11.3748S; Balbo S, 2008, CANCER EPIDEM BIOMAR, V17, P3026, DOI 10.1158/1055-9965.EPI-08-0117; Benassi-Evans B, 2011, MUTAGENESIS, V26, P421, DOI 10.1093/mutage/geq110; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Brooks PJ, 2008, DNA REPAIR, V7, P834, DOI 10.1016/j.dnarep.2008.01.017; Cabelof DC, 2003, CANCER RES, V63, P5799; Celtikci B, 2009, ANTI-CANCER DRUG, V20, P787, DOI 10.1097/CAD.0b013e32832f4aa8; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Domazet-Damjanov D., 2009, OPEN BIOL J, V2, P149; Duthie SJ, 2000, NUTR CANCER, V37, P245, DOI 10.1207/S15327914NC372_18; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; FANG JL, 1995, CARCINOGENESIS, V16, P2177, DOI 10.1093/carcin/16.9.2177; Fang JL, 1997, CARCINOGENESIS, V18, P627, DOI 10.1093/carcin/18.4.627; Fenech M, 2010, MECH AGEING DEV, V131, P236, DOI 10.1016/j.mad.2010.02.004; Finckbone V, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.003.2009; Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Halsted CH, 2002, J NUTR, V132, p2367S, DOI 10.1093/jn/132.8.2367S; Hamid A, 2009, FEBS J, V276, P2175, DOI 10.1111/j.1742-4658.2009.06959.x; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; Hirano T, 2011, INT J ENV RES PUB HE, V8, P2895, DOI 10.3390/ijerph8072895; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Job MO, 2007, BIOL PSYCHIAT, V62, P627, DOI 10.1016/j.biopsych.2006.11.016; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Kanoh M, 1999, CIRCULATION, V99, P2757, DOI 10.1161/01.CIR.99.21.2757; Kastan MB, 1997, CURR TOP MICROBIOL, V221, P1; KEANE B, 1989, ALCOHOL ALCOHOLISM, V24, P299, DOI 10.1093/oxfordjournals.alcalc.a044916; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kulkarni A, 2008, AM J HUM GENET, V82, P539, DOI 10.1016/j.ajhg.2008.01.009; Ljungman M, 2005, MUTAT RES-FUND MOL M, V577, P203, DOI 10.1016/j.mrfmmm.2005.02.014; Loo DT, 2011, METHODS MOL BIOL, V682, P3, DOI 10.1007/978-1-60327-409-8_1; Martin SA, 2010, J PATHOL, V220, P281, DOI 10.1002/path.2631; Mayor-Olea A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-104; McKillop IH, 2009, SEMIN LIVER DIS, V29, P222, DOI 10.1055/s-0029-1214377; McMurray CT, 2005, MUTAT RES-FUND MOL M, V577, P260, DOI 10.1016/j.mrfmmm.2005.03.006; Miller AM, 2010, ALCOHOL CLIN EXP RES, V34, P719, DOI 10.1111/j.1530-0277.2009.01141.x; Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nelson BC, 2003, ANAL CHEM, V75, P775, DOI 10.1021/ac0204799; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Rao KS, 2007, NAT CLIN PRACT NEURO, V3, P162, DOI 10.1038/ncpneuro0448; Sairanen T, 2009, ACTA NEUROPATHOL, V118, P541, DOI 10.1007/s00401-009-0559-3; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Sun AY, 2001, J BIOMED SCI, V8, P37, DOI 10.1007/BF02255969; Wang MY, 2006, CHEM RES TOXICOL, V19, P319, DOI 10.1021/tx0502948; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Zhang HH, 2010, DNA REPAIR, V9, P898, DOI 10.1016/j.dnarep.2010.06.003	55	19	19	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43533	43542		10.1074/jbc.M112.401497	http://dx.doi.org/10.1074/jbc.M112.401497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118224	hybrid, Green Published			2022-12-25	WOS:000312940800034
J	Wranik, BJ; Christensen, EL; Schaefer, G; Jackman, JK; Vendel, AC; Eaton, D				Wranik, Bernd J.; Christensen, Erin L.; Schaefer, Gabriele; Jackman, Janet K.; Vendel, Andrew C.; Eaton, Dan			LUZ-Y, a Novel Platform for the Mammalian Cell Production of Full-length IgG-bispecific Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; MONOCLONAL-ANTIBODY; HER2; RECEPTORS; MOLECULES; VARIANTS; SITES	The ability of bispecific antibodies to simultaneously bind two unique antigens has great clinical potential. However, most approaches utilized to generate bispecific antibodies yield antibody-like structures that diverge significantly from the structure of archetype human IgG, and those that do approach structural similarity to native antibodies are often challenging to engineer and manufacture. Here, we present a novel platform for the mammalian cell production of bispecific antibodies that differ from their parental mAbs by only a single point mutation per heavy chain. Central to this platform is the addition of a leucine zipper to the C terminus of the C(H)3 domain of the antibody that is sufficient to drive the heterodimeric assembly of antibody heavy chains and can be readily removed post-purification. Using this approach, we developed various antibody constructs including one-armed Abs, bispecific antibodies that utilize a common light chain, and bispecific antibodies that pair light chains to their cognate heavy chains via peptide tethers. We have applied this technology to various antibody pairings and will demonstrate the engineering, purification, and biological activity of these antibodies herein.	[Wranik, Bernd J.; Christensen, Erin L.; Vendel, Andrew C.; Eaton, Dan] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Schaefer, Gabriele] Genentech Inc, Dept Res Oncol, San Francisco, CA USA; [Jackman, Janet K.] Genentech Inc, Dept Discovery Immunol, San Francisco, CA USA; [Vendel, Andrew C.] Lilly Biotechnol Ctr San Diego, San Diego, CA 92121 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Eaton, D (corresponding author), Genentech Inc, Dept Prot Chem, 1 DNA Way MS63, San Francisco, CA 94080 USA.	dle@gene.com		Schaefer, Gabriele/0000-0001-9727-3555				Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; deKruif J, 1996, J BIOL CHEM, V271, P7630, DOI 10.1074/jbc.271.13.7630; Fischer N, 2007, PATHOBIOLOGY, V74, P3, DOI 10.1159/000101046; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; HARRIS RJ, 1995, J CHROMATOGR A, V705, P129, DOI 10.1016/0021-9673(94)01255-D; Hollander N, 2009, IMMUNOTHERAPY-UK, V1, P211, DOI 10.2217/1750743X.1.2.211; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Kontermann RE, 2010, CURR OPIN MOL THER, V12, P176; KOSTELNY SA, 1992, J IMMUNOL, V148, P1547; Krysan DJ, 1999, J BIOL CHEM, V274, P23229, DOI 10.1074/jbc.274.33.23229; Kuwada SK, 2004, INT J CANCER, V109, P291, DOI 10.1002/ijc.11686; Li JSS, 2005, J BIOL CHEM, V280, P38513, DOI 10.1074/jbc.M508449200; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; PRUSS RM, 1978, NATURE, V274, P272, DOI 10.1038/274272a0; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Schaefer G, 2007, CANCER RES, V67, P1228, DOI 10.1158/0008-5472.CAN-06-3493; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schaefer W, 2011, P NATL ACAD SCI USA, V108, P11187, DOI 10.1073/pnas.1019002108; STAERZ UD, 1985, NATURE, V314, P628, DOI 10.1038/314628a0; STAERZ UD, 1986, P NATL ACAD SCI USA, V83, P1453, DOI 10.1073/pnas.83.5.1453; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Wines BD, 2000, J IMMUNOL, V164, P5313, DOI 10.4049/jimmunol.164.10.5313	25	27	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43331	43339		10.1074/jbc.M112.397869	http://dx.doi.org/10.1074/jbc.M112.397869			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118228	Green Published, hybrid			2022-12-25	WOS:000312940800014
J	Yang, CX; Cao, ML; Liu, H; He, YQ; Xu, J; Du, Y; Liu, YW; Wang, WJ; Cui, L; Hu, JJ; Gao, F				Yang, Cuixia; Cao, Manlin; Liu, Hua; He, Yiqing; Xu, Jing; Du, Yan; Liu, Yiwen; Wang, Wenjuan; Cui, Lian; Hu, Jiajie; Gao, Feng			The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-MEDIATED MOTILITY; T-CELLS; PERICELLULAR MATRIX; SIGNALING PATHWAYS; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; VASCULAR-DISEASE; RECEPTOR FAMILY; BINDING DOMAIN; TISSUE-INJURY	CD44 is a major cell surface receptor for the glycosaminoglycan hyaluronan (HA). Native high molecular weight hyaluronan (nHA) and oligosaccharides of hyaluronan (oHA) provoke distinct biological effects upon binding to CD44. Despite the importance of such interactions, however, the feature of binding with CD44 at the cell surface and the molecular basis for functional distinction between different sizes of HA is still unclear. In this study we investigated the effects of high and low molecular weight hyaluronan on CD44 clustering. For the first time, we provided direct evidence for a strong relationship between HA size and CD44 clustering in vivo. In CD44-transfected COS-7 cells, we showed that exogenous nHA stimulated CD44 clustering, which was disrupted by oHA. Moreover, naturally expressed CD44 was distributed into clusters due to abundantly expressed nHA in HK-2 cells (human renal proximal tubule cells) and BT549 cells (human breast cancer cell line) without exogenous stimulation. Our results suggest that native HA binding to CD44 selectively induces CD44 clustering, which could be inhibited by oHA. Finally, we demonstrated that HA regulates cell adhesion in a manner specifically dependent on its size. oHA promoted cell adhesion while nHA showed no effects. Our results might elucidate a molecular- and/or cellular-based mechanism for the diverse biological activities of nHA and oHA.	[Yang, Cuixia; He, Yiqing; Du, Yan; Liu, Yiwen; Cui, Lian; Hu, Jiajie; Gao, Feng] Shanghai Jiao Tong Univ, Dept Mol Biol Lab, Sch Med, Shanghai 200233, Peoples R China; [Cao, Manlin] Shanghai Jiao Tong Univ, Dept Rehabil Med, Sch Med, Shanghai 200233, Peoples R China; [Liu, Hua; Xu, Jing; Wang, Wenjuan] Shanghai Jiao Tong Univ, Dept Clin Lab, Sch Med, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, F (corresponding author), Shanghai Jiao Tong Univ, Dept Mol Biol Lab, Shanghai Peoples Hosp 6, Sch Med, 600 Yishan Rd, Shanghai 200233, Peoples R China.	gao3507@126.com	liu, yi/GXE-9662-2022		Science and Technology Commission of Shanghai Municipality [08411952700]; National Natural Science Foundation of China [81071814, 81172027, 81272479]; Program of Shanghai Subject Chief Scientist [11XD1404000]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist	This work was supported by the Science and Technology Commission of Shanghai Municipality (Key Technology Support Programme, 08411952700), the National Natural Science Foundation of China (81071814, 81172027, 81272479), and the Program of Shanghai Subject Chief Scientist (11XD1404000).	A-Ayoubi A, 2008, J CELL BIOCHEM, V105, P875, DOI 10.1002/jcb.21889; Banerji S, 2010, J BIOL CHEM, V285, P10724, DOI 10.1074/jbc.M109.047647; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Boraldi F, 2003, TISSUE CELL, V35, P37, DOI 10.1016/S0040-8166(02)00101-5; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; Camenisch TD, 2000, AM J RESP CELL MOL, V23, P431, DOI 10.1165/ajrcmb.23.4.f201; Chalkiadaki G, 2011, CANCER LETT, V312, P235, DOI 10.1016/j.canlet.2011.08.016; Estess P, 1998, J CLIN INVEST, V102, P1173, DOI 10.1172/JCI4235; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Ezzell RM, 1997, EXP CELL RES, V231, P14, DOI 10.1006/excr.1996.3451; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; Gao F, 2008, CLIN INVEST MED, V31, pE106, DOI 10.25011/cim.v31i3.3467; Gao F, 2006, J BIOMED MATER RES B, V78B, P385, DOI 10.1002/jbm.b.30499; Gao F, 2010, MATRIX BIOL, V29, P107, DOI 10.1016/j.matbio.2009.11.002; Gares SL, 1998, J LEUKOCYTE BIOL, V64, P781, DOI 10.1002/jlb.64.6.781; Gares SL, 1999, SCAND J IMMUNOL, V50, P626; Gribbon P, 2000, BIOCHEM J, V350, P329, DOI 10.1042/0264-6021:3500329; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang H, 2002, J BIOL CHEM, V277, P10531, DOI 10.1074/jbc.M108654200; KATOH S, 1995, J EXP MED, V182, P419, DOI 10.1084/jem.182.2.419; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; Kothapalli D, 2008, J BIOL CHEM, V283, P31823, DOI 10.1074/jbc.M802934200; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Liu Dacai, 1998, Frontiers in Bioscience, V3, pD631; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Nagy JI, 1996, CELL GROWTH DIFFER, V7, P745; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Spessotto P, 2002, J CELL BIOL, V158, P1133, DOI 10.1083/jcb.200202120; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Thiagarajan P, 1996, CELL ADHES COMMUN, V4, P317, DOI 10.3109/15419069609010775; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Wang YZ, 2011, EXP BIOL MED, V236, P84, DOI 10.1258/ebm.2010.010206; Wolny PM, 2010, J BIOL CHEM, V285, P30170, DOI 10.1074/jbc.M110.137562; Wong NKY, 2008, J IMMUNOL, V181, P7033, DOI 10.4049/jimmunol.181.10.7033; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	63	188	194	3	75	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43094	43107		10.1074/jbc.M112.349209	http://dx.doi.org/10.1074/jbc.M112.349209			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23118219	Green Published, hybrid			2022-12-25	WOS:000312501600065
J	Awad, H; Abas, M; Elgharably, H; Tripathi, R; Theofilos, T; Bhandary, S; Sai-Sudhakar, C; Sen, CK; Roy, S				Awad, Hamdy; Abas, Motaz; Elgharably, Haytham; Tripathi, Ravi; Theofilos, Tykie; Bhandary, Sujatha; Sai-Sudhakar, Chittoor; Sen, Chandan K.; Roy, Sashwati			Endogenous Opioids in Wound-Site Neutrophils of Sternotomy Patients	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; BETA-ENDORPHIN; LEUKOSIALIN CD43; PAIN; BLOOD; ACTIVATION; ENKEPHALIN; NB1; GLYCOPROTEIN; INFLAMMATION	Background: Postoperative pain management is a critical aspect of patient care. The inflammatory state of the post-sternotomy surgical wound sensitizes nerve endings, causing pain. Unrelieved or improperly managed pain compromises wound healing. Peripheral opioid receptors play a major role in analgesia, particularly under inflammatory conditions where both opioid receptor expression and efficacy are increased. Leukocytic opioid peptides include beta-endorphin (END), met-enkephalin (ENK), and dynorphin-A (DYN), with END and ENK being predominant. Methodology/Principal Findings: This work represents the first study of inflammatory cells collected from post-sternotomy wounds of patients undergoing cardiac surgery including coronary artery bypass grafting (CABG). Wound fluid (WF) and cells were collected from sternal wounds using a JP Blake drain at 24, 48, and 72 hours post sternum closure. Anti-CD15 staining and flow cytometry revealed that polymorphonuclear neutrophils (PMN) are the predominant cells present in wound fluid collected post-surgery. Compared to peripheral blood (PB) derived PMN, significant increases in CD177+/CD66b+ PMN were observed suggesting activation of wound-site PMN. Such activation was associated with higher levels of opioid peptide expression in PMN derived from WF. Indeed, increased level of opioid peptides in sternal wound environment was noted 72 h post-surgery. We demonstrate that WF contains factors that can significantly induce POMC transcription in human PMNs. IL-10 and IL-4 were abundant in WF and both cytokines significantly induced POMC gene expression suggesting that WF factors such as IL-10 and IL-4 contribute towards increased opioid peptide expression in wound-site PMN. Conclusions/Significance: This approach provided a unique opportunity to study the cross-talk between inflammation and opioid peptides in PMN at a sternotomy wound-site. Wound-site PMN exhibited induction of END and ENK. In addition, sternal wound fluid significantly induced END expression in PMN. Taken together, these data constitute first clinical evidence that human wound-site PMNs are direct contributors of opioids at the sternal wound-site.	[Awad, Hamdy; Abas, Motaz; Elgharably, Haytham; Tripathi, Ravi; Theofilos, Tykie; Bhandary, Sujatha; Sai-Sudhakar, Chittoor; Sen, Chandan K.; Roy, Sashwati] Ohio State Univ, Comprehens Wound Ctr, Columbus, OH 43210 USA; Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Awad, Hamdy; Abas, Motaz; Tripathi, Ravi; Theofilos, Tykie; Bhandary, Sujatha] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Anesthesiol, Wexner Med Ctr, Columbus, OH 43210 USA	Ohio State University; Ohio State University; Ohio State University	Roy, S (corresponding author), Ohio State Univ, Comprehens Wound Ctr, Columbus, OH 43210 USA.	sashwati.roy@osumc.edu	Sen, Chandan K/A-8762-2013; Tripathi, Ravi/E-4210-2011; Roy, sashwati/E-3990-2011; Tripathi, Ravi/ABB-2563-2020		NIDDK [R01 DK076566]; NIGMS [GM069589, GM 077185]; NCRR [UL1RR025755]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077185, R01GM069589] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Wound healing research in the authors' laboratory is funded by NIDDK R01 DK076566 (SR), NIGMS GM069589 & GM 077185 (CKS) and NCRR UL1RR025755. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Bayat B, 2010, J IMMUNOL, V184, P3889, DOI 10.4049/jimmunol.0903136; BERKOW RL, 1985, BLOOD, V65, P71; Busch-Dienstfertig M, 2010, BRAIN BEHAV IMMUN, V24, P683, DOI 10.1016/j.bbi.2009.10.013; Buvanendran A, 2009, ANESTH ANALG, V109, P959, DOI 10.1213/ane.0b013e3181ac1746; Drinkwater S L, 2002, Int J Low Extrem Wounds, V1, P184; Ganesh K, 2012, J IMMUNOL; GUILLEMIN R, 1977, SCIENCE, V197, P1367, DOI 10.1126/science.197601; Kamphuis S, 1997, J NEUROIMMUNOL, V79, P91, DOI 10.1016/S0165-5728(97)00113-6; Kapitzke Daniel, 2005, Ther Clin Risk Manag, V1, P279; Kinhult J, 2003, CLIN EXP ALLERGY, V33, P1141, DOI 10.1046/j.1365-2222.2003.01682.x; Kissel K, 2001, EUR J IMMUNOL, V31, P1301, DOI 10.1002/1521-4141(200105)31:5<1301::AID-IMMU1301>3.0.CO;2-J; Kissin I, 2010, ANESTH ANALG, V110, P780, DOI 10.1213/ANE.0b013e3181cde882; KITA T, 1979, EUR J BIOCHEM, V93, P213, DOI 10.1111/j.1432-1033.1979.tb12813.x; LaMendola J, 1997, FEBS LETT, V404, P19, DOI 10.1016/S0014-5793(97)00078-1; Machelska H, 2007, NEUROPEPTIDES, V41, P355, DOI 10.1016/j.npep.2007.06.001; Mambole AS, 2008, J BIOL CHEM, V283, P23627, DOI 10.1074/jbc.M710286200; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Nijhuis J, 2009, OBESITY, V17, P2014, DOI 10.1038/oby.2009.113; Ohta K, 2000, ENDOCR J, V47, P487, DOI 10.1507/endocrj.47.487; RIEU P, 1992, EUR J IMMUNOL, V22, P3021, DOI 10.1002/eji.1830221138; Rittner HL, 2008, BRIT J ANAESTH, V101, P40, DOI 10.1093/bja/aen078; Rittner Heike L, 2007, Curr Rheumatol Rep, V9, P503, DOI 10.1007/s11926-007-0081-3; Rittner HL, 2005, J LEUKOCYTE BIOL, V78, P1215, DOI 10.1189/jlb.0405223; ROSSIER J, 1977, LIFE SCI, V21, P847, DOI 10.1016/0024-3205(77)90414-3; ROSSIER J, 1977, P NATL ACAD SCI USA, V74, P5162, DOI 10.1073/pnas.74.11.5162; SCHAFER M, 1994, P NATL ACAD SCI USA, V91, P4219, DOI 10.1073/pnas.91.10.4219; STEIN C, 1993, LANCET, V342, P321, DOI 10.1016/0140-6736(93)91471-W; STEIN C, 1990, P NATL ACAD SCI USA, V87, P5935, DOI 10.1073/pnas.87.15.5935; STEIN C, 1995, ANN MED, V27, P219, DOI 10.3109/07853899509031962; Stroncek DF, 2007, CURR OPIN HEMATOL, V14, P688, DOI 10.1097/MOH.0b013e3282efed9e; STRONCEK DF, 1990, BLOOD, V75, P744; SZEKANECZ Z, 1995, CLIN IMMUNOL IMMUNOP, V76, P180, DOI 10.1006/clin.1995.1113; Tazzari PL, 2003, VOX SANG, V85, P109, DOI 10.1046/j.1423-0410.2003.00326.x; Tegeder I, 2003, BRAIN, V126, P1092, DOI 10.1093/brain/awg115; White PF, 2003, ANESTHESIOLOGY, V99, P918, DOI 10.1097/00000542-200310000-00026; Wolff JC, 2006, TRANSFUSION, V46, P132, DOI 10.1111/j.1537-2995.2005.00676.x	37	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47569	10.1371/journal.pone.0047569	http://dx.doi.org/10.1371/journal.pone.0047569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118879	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500024
J	Juurik, T; Ilves, H; Teras, R; Ilmjarv, T; Tavita, K; Ukkivi, K; Teppo, A; Mikkel, K; Kivisaar, M				Juurik, Triinu; Ilves, Heili; Teras, Riho; Ilmjaerv, Tanel; Tavita, Kairi; Ukkivi, Kaert; Teppo, Annika; Mikkel, Katren; Kivisaar, Maia			Mutation Frequency and Spectrum of Mutations Vary at Different Chromosomal Positions of Pseudomonas putida	PLOS ONE			English	Article							STATIONARY-PHASE MUTAGENESIS; NUCLEOID-ASSOCIATED PROTEINS; ESCHERICHIA-COLI; FRAMESHIFT MUTATION; ADAPTIVE MUTATION; DNA-REPLICATION; LAGGING-STRAND; TRANSCRIPTION; MECHANISMS; SEQUENCE	It is still an open question whether mutation rate can vary across the bacterial chromosome. In this study, the occurrence of mutations within the same mutational target sequences at different chromosomal locations of Pseudomonas putida was monitored. For that purpose we constructed two mutation detection systems, one for monitoring the occurrence of a broad spectrum of mutations and transposition of IS element IS1411 inactivating LacI repressor, and another for detecting 1-bp deletions. Our results revealed that both the mutation frequency and the spectrum of mutations vary at different chromosomal positions. We observed higher mutation frequencies when the direction of transcription of the mutational target gene was opposite to the direction of replisome movement in the chromosome and vice versa, lower mutation frequency was accompanied with co-directional transcription and replication. Additionally, asymmetry of frameshift mutagenesis at homopolymeric and repetitive sequences during the leading and lagging-strand replication was found. The transposition frequency of IS1411 was also affected by the chromosomal location of the target site, which implies that regional differences in chromosomal topology may influence transposition of this mobile element. The occurrence of mutations in the P. putida chromosome was investigated both in growing and in stationary-phase bacteria. We found that the appearance of certain mutational hot spots is strongly affected by the chromosomal location of the mutational target sequence especially in growing bacteria. Also, artificial increasing transcription of the mutational target gene elevated the frequency of mutations in growing bacteria.	[Kivisaar, Maia] Univ Tartu, Inst Mol & Cell Biol, Dept Genet, EE-50090 Tartu, Estonia; Estonian Bioctr, Tartu, Estonia	University of Tartu; Estonian Biocentre	Kivisaar, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Genet, Ulikooli 18, EE-50090 Tartu, Estonia.	maia.kivisaar@ut.ee	Teras, Riho/ABA-8761-2021	Ilmjarv, Tanel/0000-0002-2524-498X; Ilves, Heili/0000-0001-5275-4160	Estonian Science Foundation [7376, 7019, 7458]; Estonian Ministry of Research and Education [SF0180031s08]; Howard Hughes Medical Institute International Research Scholars Program [55005614]	Estonian Science Foundation; Estonian Ministry of Research and Education(Ministry of Education and Research, Estonia); Howard Hughes Medical Institute International Research Scholars Program(Howard Hughes Medical Institute)	This work was supported by Estonian Science Foundation grants 7376 (MK), 7019 (RT) and 7458 (HI), by funding of Targeted Financing Project SF0180031s08 to MK from Estonian Ministry of Research and Education, and by grant #55005614 to MK from the Howard Hughes Medical Institute International Research Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation the manuscript.	Adams MH, 1959, BACTERIOPHAGES; ADAMS WT, 1987, J MOL BIOL, V194, P391, DOI 10.1016/0022-2836(87)90669-3; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Baath E, 1998, MICROBIAL ECOL, V36, P316, DOI 10.1007/s002489900118; BAYLEY SA, 1977, MOL GEN GENET, V154, P203, DOI 10.1007/BF00330838; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; BENZER S, 1961, P NATL ACAD SCI USA, V47, P403, DOI 10.1073/pnas.47.3.403; Bharatant SM, 2004, GENETICS, V166, P681, DOI 10.1534/genetics.166.2.681; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; CARIELLO NF, 1994, CARCINOGENESIS, V15, P2281, DOI 10.1093/carcin/15.10.2281; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Dame RT, 2005, MOL MICROBIOL, V56, P858, DOI 10.1111/j.1365-2958.2005.04598.x; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Erill I, 2006, NUCLEIC ACIDS RES, V34, P66, DOI 10.1093/nar/gkj412; FARABAUGH PJ, 1978, NATURE, V274, P765, DOI 10.1038/274765a0; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fijalkowska IJ, 1998, P NATL ACAD SCI USA, V95, P10020, DOI 10.1073/pnas.95.17.10020; Fix D, 2008, DNA REPAIR, V7, P1289, DOI 10.1016/j.dnarep.2008.04.008; Foster PL, 1999, ANNU REV GENET, V33, P57, DOI 10.1146/annurev.genet.33.1.57; FOSTER PL, 1995, P NATL ACAD SCI USA, V92, P5487, DOI 10.1073/pnas.92.12.5487; FOSTER PL, 1994, SCIENCE, V265, P407, DOI 10.1126/science.8023164; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Gawel D, 2002, J BACTERIOL, V184, P4449, DOI 10.1128/JB.184.16.4449-4454.2002; Gawel D, 2002, MUTAT RES-FUND MOL M, V501, P129, DOI 10.1016/S0027-5107(02)00020-9; Goosen N, 2008, DNA REPAIR, V7, P353, DOI 10.1016/j.dnarep.2007.09.002; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hudson RE, 2002, MOL BIOL EVOL, V19, P85, DOI 10.1093/oxfordjournals.molbev.a003986; ISBERG RR, 1982, CELL, V30, P9, DOI 10.1016/0092-8674(82)90006-X; Jatsenko T, 2010, MUTAT RES-FUND MOL M, V683, P106, DOI 10.1016/j.mrfmmm.2009.10.015; Kallastu A, 1998, J BACTERIOL, V180, P5306, DOI 10.1128/JB.180.20.5306-5312.1998; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; Kasak L, 1997, P NATL ACAD SCI USA, V94, P3134, DOI 10.1073/pnas.94.7.3134; Kim N, 2007, DNA REPAIR, V6, P1285, DOI 10.1016/j.dnarep.2007.02.023; Kivisaar M, 2003, ENVIRON MICROBIOL, V5, P814, DOI 10.1046/j.1462-2920.2003.00488.x; Kivisaar M, 2010, FEMS MICROBIOL LETT, V312, P1, DOI 10.1111/j.1574-6968.2010.02027.x; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; Lind PA, 2008, P NATL ACAD SCI USA, V105, P17878, DOI 10.1073/pnas.0804445105; Maki H, 2002, ANNU REV GENET, V36, P279, DOI 10.1146/annurev.genet.36.042602.094806; Maliszewska-Tkaczyk M, 2000, P NATL ACAD SCI USA, V97, P12678, DOI 10.1073/pnas.220424697; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; Martina MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033701; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mira A, 2002, MOL BIOL EVOL, V19, P1350, DOI 10.1093/oxfordjournals.molbev.a004196; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; NURK A, 1991, GENE, V102, P13, DOI 10.1016/0378-1119(91)90531-F; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Ojangu EL, 2000, J BACTERIOL, V182, P6707, DOI 10.1128/JB.182.23.6707-6713.2000; Pato ML, 1996, MOL MICROBIOL, V22, P283, DOI 10.1046/j.1365-2958.1996.00115.x; PIEGORSCH WW, 1994, GENETICS, V136, P403; Pomerantz RT, 2010, CELL CYCLE, V9, P2537, DOI 10.4161/cc.9.13.12122; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; POULSEN LK, 1995, J BACTERIOL, V177, P5840, DOI 10.1128/jb.177.20.5840-5845.1995; Pybus C, 2010, J BACTERIOL, V192, P3321, DOI 10.1128/JB.00354-10; Regenhardt D, 2002, ENVIRON MICROBIOL, V4, P912, DOI 10.1046/j.1462-2920.2002.00368.x; Reimers JM, 2004, MICROBIOL-SGM, V150, P1457, DOI 10.1099/mic.0.26954-0; Rodriguez C, 2002, J BACTERIOL, V184, P5599, DOI 10.1128/JB.184.20.5599-5608.2002; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; Sanchez-Romero JM, 1998, APPL ENVIRON MICROB, V64, P4040; Saumaa S, 2002, J BACTERIOL, V184, P6957, DOI 10.1128/JB.184.24.6957-6965.2002; Saumaa S, 2007, J BACTERIOL, V189, P5504, DOI 10.1128/JB.00518-07; SCHAAPER RM, 1986, J MOL BIOL, V189, P273, DOI 10.1016/0022-2836(86)90509-7; Sharma RC, 1996, BIOTECHNIQUES, V20, P42; SHARP PM, 1989, SCIENCE, V246, P808, DOI 10.1126/science.2683084; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; STREISINGER G, 1985, GENETICS, V109, P633; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tegova R, 2004, J BACTERIOL, V186, P2735, DOI 10.1128/JB.186.9.2735-2744.2004; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Travers A, 2005, NAT REV MICROBIOL, V3, P157, DOI 10.1038/nrmicro1088; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x	87	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48511	10.1371/journal.pone.0048511	http://dx.doi.org/10.1371/journal.pone.0048511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119042	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500155
J	Kaur, J; Reinhardt, DP				Kaur, Jasvir; Reinhardt, Dieter P.			Immobilized Metal Affinity Chromatography Co-Purifies TGF-beta 1 with Histidine-Tagged Recombinant Extracellular Proteins	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SIGNAL-TRANSDUCTION; ELASTIC FIBER; FIBRILLIN-1; MICROFIBRILS; RECEPTOR; ACTIVATION; BINDING; INTEGRINS; CELLS	Extracellular recombinant proteins are commonly produced using HEK293 cells as histidine-tagged proteins facilitating purification by immobilized metal affinity chromatography (IMAC). Based on gel analyses, this one-step purification typically produces proteins of high purity. Here, we analyzed the presence of TGF-beta 1 in such IMAC purifications using recombinant extracellular fibrillin-1 fragments as examples. Analysis of various purified recombinant fibrillin-1 fragments by ELISA consistently revealed the presence of picomolar concentrations of active and latent TGF-beta 1, but not of BMP-2. These quantities of TGF-beta 1 were not detectable by Western blotting and mass spectrometry. However, the amounts of TGF-beta 1 were sufficient to consistently trigger Smad2 phosphorylation in fibroblasts. The purification mechanism was analyzed to determine whether the presence of TGF-beta 1 in these protein preparations represents a specific or non-specific co-purification of TGF-beta 1 with fibrillin-1 fragments. Control purifications using conditioned medium from non-transfected 293 cells yielded similar amounts of TGF-beta 1 after IMAC. IMAC of purified TGF-beta 1 and the latency associated peptide showed that these proteins bound to the immobilized nickel ions. These data clearly demonstrate that TGF-beta 1 was co-purified by specific interactions with nickel, and not by specific interactions with fibrillin-1 fragments. Among various chromatographic methods tested for their ability to eliminate TGF-beta 1 from fibrillin-1 preparations, gel filtration under high salt conditions was highly effective. As various recombinant extracellular proteins purified in this fashion are frequently used for experiments that can be influenced by the presence of TGF-beta 1, these findings have far-reaching implications for the required chromatographic schemes and quality controls.	[Kaur, Jasvir; Reinhardt, Dieter P.] McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Reinhardt, Dieter P.] McGill Univ, Fac Dent, Montreal, PQ, Canada	McGill University; McGill University	Reinhardt, DP (corresponding author), McGill Univ, Fac Med, Dept Anat & Cell Biol, Montreal, PQ, Canada.	dieter.reinhardt@mcgill.ca	Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872	Canadian Institutes of Health Research [MOP-106494]; Natural Sciences and Engineering Research Council of Canada [RGPIN 375738-09]; Canada Foundation for Innovation; Canada Research Chairs; Reseau de recherche en sante buccodentaire et osseuse	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Reseau de recherche en sante buccodentaire et osseuse	This work was supported by the Canadian Institutes of Health Research (MOP-106494), the Natural Sciences and Engineering Research Council of Canada (RGPIN 375738-09), the Canada Foundation for Innovation, the Canada Research Chairs, and the Reseau de recherche en sante buccodentaire et osseuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kettle S, 2000, INT J BIOCHEM CELL B, V32, P201, DOI 10.1016/S1357-2725(99)00120-X; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; LAIHO M, 1990, J BIOL CHEM, V265, P18518; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; LOW FN, 1962, ANAT REC, V142, P131, DOI 10.1002/ar.1091420205; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; MORGAN TL, 1991, EXP CELL RES, V197, P125, DOI 10.1016/0014-4827(91)90489-H; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; ROSS R, 1969, J CELL BIOL, V40, P366, DOI 10.1083/jcb.40.2.366; Ruggiero F, 2008, METHODS, V45, P75, DOI 10.1016/j.ymeth.2008.01.003; Saito M, 2011, J BIOL CHEM, V286, P38602, DOI 10.1074/jbc.M111.243451; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Simpson RJ., 2007, COLD SPRING HARB PRO, V2007, P4701, DOI 10. 1101/pdb. prot4727; TAIPALE J, 1994, J CELL BIOL, V124, P171, DOI 10.1083/jcb.124.1.171; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Zhang Y, 1998, J BIOL CHEM, V273, P33054, DOI 10.1074/jbc.273.49.33054; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	43	12	13	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48629	10.1371/journal.pone.0048629	http://dx.doi.org/10.1371/journal.pone.0048629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119075	Green Submitted, gold, Green Published			2022-12-25	WOS:000310600500183
J	Latinne, A; Waengsothorn, S; Rojanadilok, P; Eiamampai, K; Sribuarod, K; Michaux, JR				Latinne, Alice; Waengsothorn, Surachit; Rojanadilok, Prateep; Eiamampai, Krairat; Sribuarod, Kriangsak; Michaux, Johan R.			Combined Mitochondrial and Nuclear Markers Revealed a Deep Vicariant History for Leopoldamys neilli, a Cave-Dwelling Rodent of Thailand	PLOS ONE			English	Article							POPULATION-GENETICS DATA; GEOGRAPHIC RANGE; MARTINOS VOLE; NULL ALLELES; EVOLUTION; SOFTWARE; INFERENCE; PROGRAM; PHYLOGEOGRAPHY; DISPERSAL	Background: Historical biogeography and evolutionary processes of cave taxa have been widely studied in temperate regions. However, Southeast Asian cave ecosystems remain largely unexplored despite their high scientific interest. Here we studied the phylogeography of Leopoldamys neilli, a cave-dwelling murine rodent living in limestone karsts of Thailand, and compared the molecular signature of mitochondrial and nuclear markers. Methodology/Principal Findings: We used a large sampling (n = 225) from 28 localities in Thailand and a combination of mitochondrial and nuclear markers with various evolutionary rates (two intronic regions and 12 microsatellites). The evolutionary history of L. neilli and the relative role of vicariance and dispersal were investigated using ancestral range reconstruction analysis and Approximate Bayesian computation (ABC). Both mitochondrial and nuclear markers support a large-scale population structure of four main groups (west, centre, north and northeast) and a strong finer structure within each of these groups. A deep genealogical divergence among geographically close lineages is observed and denotes a high population fragmentation. Our findings suggest that the current phylogeographic pattern of this species results from the fragmentation of a widespread ancestral population and that vicariance has played a significant role in the evolutionary history of L. neilli. These deep vicariant events that occurred during Plio-Pleistocene are related to the formation of the Central Plain of Thailand. Consequently, the western, central, northern and northeastern groups of populations were historically isolated and should be considered as four distinct Evolutionarily Significant Units (ESUs). Conclusions/Significance: Our study confirms the benefit of using several independent genetic markers to obtain a comprehensive and reliable picture of L. neilli evolutionary history at different levels of resolution. The complex genetic structure of Leopoldamys neilli is supported by congruent mitochondrial and nuclear markers and has been influenced by the geological history of Thailand during Plio-Pleistocene.	[Latinne, Alice; Michaux, Johan R.] Univ Liege, Inst Bot, Lab Genet Microorganismes, Liege, Belgium; [Waengsothorn, Surachit] Thailand Inst Sci & Technol Res, Environm & Resources Technol Dept, Pathum Thani, Thailand; [Eiamampai, Krairat] Bung Boraphet Wildlife Res Stn, Nakhon Sawan, Thailand; [Rojanadilok, Prateep] Doi Chiang Dao Wildlife Res Stn, Chiang Mai, Thailand; [Sribuarod, Kriangsak] Khlong Saeng Wildlife Res Stn, Surat Thani, Thailand; [Michaux, Johan R.] UMR CBGP INRA IRD Cirad Montpellier SupAgro, INRA, Montferrier Sur Lez, France	University of Liege; Thailand Institute of Science & Technological Research; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Latinne, A (corresponding author), Univ Liege, Inst Bot, Lab Genet Microorganismes, Liege, Belgium.	alice.latinne@ulg.ac.be		Latinne, Alice/0000-0003-1249-2025	Belgian FRS-FNRS (Fonds de la Recherche Scientifique); Belgian FRS-FNRS; University of Liege (Patrimoine); Communaute francaise de Belgique	Belgian FRS-FNRS (Fonds de la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); Belgian FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); University of Liege (Patrimoine); Communaute francaise de Belgique(Australian Research Council)	This work was supported by a Belgian FRS-FNRS (Fonds de la Recherche Scientifique) fellowship to AL (mandat "aspirant") and to JRM (mandat "chercheur qualifie"), and a financial grant from the Belgian FRS-FNRS ("credits pour brefs sejours a l'etranger" to AL and JRM and credits from the "Fonds de la Recherche Fondamentale Collective (FRFC)" to JRM), from the University of Liege (Patrimoine) and from the Communaute francaise de Belgique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Jean-Pierre, 1996, Acta Zoologica Cracoviensia, V39, P35; Arias JS, 2011, CLADISTICS, V27, P617, DOI 10.1111/j.1096-0031.2011.00353.x; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Balloux F, 2010, HEREDITY, V104, P419, DOI 10.1038/hdy.2009.122; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Buzan EV, 2010, CONSERV GENET, V11, P1783, DOI 10.1007/s10592-010-0071-2; Castleberry SB, 2002, J MAMMAL, V83, P1058, DOI 10.1644/1545-1542(2002)083<1058:MDAOPS>2.0.CO;2; Chaimanee Y, 1998, THAI STUD BIODIVERS, V3; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Corbet GB, 1992, THE MAMMALS OF THE I; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver DC, 2009, FRESHWATER BIOL, V54, P918, DOI 10.1111/j.1365-2427.2007.01856.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DHEERADILOK P, 1995, QUATERN INT, V26, P49, DOI 10.1016/1040-6182(94)00045-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; ESCAP Economic and Social Commission for Asia and the Pacific, 2001, ATLAS OF MINERAL RES, V16; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gillieson D., 2005, THE PHYSICAL GEOGRAP, P157; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hare MP, 1999, MOL ECOL, V8, P1750, DOI 10.1046/j.1365-294x.1999.00738-1.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Holsinger John R., 2005, P591; HOWARTH F G, 1987, International Journal of Speleology, V16, P1; Howarth FG, 1980, EVOLUTION, V28, P365, DOI DOI 10.2307/2407402; Howarth Francis G., 2005, P17; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jacobs Louis L., 2005, P63; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Krystufek B, 2007, MOL ECOL, V16, P1221, DOI 10.1111/j.1365-294X.2007.03235.x; Latinne A, 2011, CONSERV GENET, V12, P1495, DOI 10.1007/s10592-011-0248-3; Latinne A, 2011, CONSERV GENET RESOUR, V3, P511, DOI 10.1007/s12686-011-9391-x; Latinne AS., 2011, INT C ENV SUPP FOOD, P176; Lekagul B, 1988, MAMMALS OF THAILAND; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; Lunde DP, 2008, IUCN RED LIST OF THR; Michaux Jacques, 1997, Geobios Memoire Special (Villeurbanne), V20, P379; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Musser GG, 2005, MAMMAL SPECIES WORLD, P894; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nutalaya P, 1986, P WORKSH EC GEOL TEC, P35; Pages M, 2012, PLOS ONE, V7; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Peck Stewart B., 1993, Memoires de Biospeologie, V20, P19; Porter ML, 2007, J CAVE KARST STUD, V69, P179; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Rambaut A., 2007, TRACER V1 4; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Rivera MAJ, 2002, MOL PHYLOGENET EVOL, V25, P1, DOI 10.1016/S1055-7903(02)00353-6; Riviere-Dobigny T, 2011, J MAMMAL, V92, P620, DOI 10.1644/10-MAMM-A-028.1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; ROSENBERG NA, 2002, MODERN DEV THEORETIC, P130; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sinsakul S, 2000, J ASIAN EARTH SCI, V18, P415, DOI 10.1016/S1367-9120(99)00075-9; Sket B, 2008, J NAT HIST, V42, P1549, DOI 10.1080/00222930801995762; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thiramongkol N, 1983, WORKSH STRAT CORR TH, P188; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vermeulen JJ, 1999, BIODIVERSITY AND CUL; Villacorta C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-7; Waengsothorn S., 2007, THAILAND NATURAL HIS, V2, P31; Waengsothorn Surachit, 2009, Kasetsart Journal Natural Sciences, V43, P118; WILEY EO, 1988, ANNU REV ECOL SYST, V19, P513, DOI 10.1146/annurev.es.19.110188.002501; Winkler AJ, 2002, J HUM EVOL, V42, P237, DOI 10.1006/jhev.2001.0501; World Bank, 2004, THAILAND ENVIRONMENT; Zheng S, 1993, QUATERNARY RODENTS O	85	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47670	10.1371/journal.pone.0047670	http://dx.doi.org/10.1371/journal.pone.0047670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118888	Green Published, gold			2022-12-25	WOS:000310600500031
J	Ojala, M; Rajala, K; Pekkanen-Mattila, M; Miettinen, M; Huhtala, H; Aalto-Setala, K				Ojala, Marisa; Rajala, Kristiina; Pekkanen-Mattila, Mari; Miettinen, Marinka; Huhtala, Heini; Aalto-Setala, Katriina			Culture Conditions Affect Cardiac Differentiation Potential of Human Pluripotent Stem Cells	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; NEURAL PRECURSORS; BIOLOGICAL-ACTIVITY; FEEDER LAYERS; COPY NUMBER; LINES; GROWTH; CARDIOMYOCYTES; ENDODERM; DERIVATION	Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), are capable of differentiating into any cell type in the human body and thus can be used in studies of early human development, as cell models for different diseases and eventually also in regenerative medicine applications. Since the first derivation of hESCs in 1998, a variety of culture conditions have been described for the undifferentiated growth of hPSCs. In this study, we cultured both hESCs and hiPSCs in three different culture conditions: on mouse embryonic fibroblast (MEF) and SNL feeder cell layers together with conventional stem cell culture medium containing knockout serum replacement and basic fibroblast growth factor (bFGF), as well as on a Matrigel matrix in mTeSR1 medium. hPSC lines were subjected to cardiac differentiation in mouse visceral endodermal-like (END-2) co-cultures and the cardiac differentiation efficiency was determined by counting both the beating areas and Troponin T positive cells, as well as studying the expression of OCT-3/4, mesodermal Brachyury T and NKX2.5 and endodermal SOX-17 at various time points during END-2 differentiation by q-RT-PCR analysis. The most efficient cardiac differentiation was observed with hPSCs cultured on MEF or SNL feeder cell layers in stem cell culture medium and the least efficient cardiac differentiation was observed on a Matrigel matrix in mTeSR1 medium. Further, hPSCs cultured on a Matrigel matrix in mTeSR1 medium were found to be more committed to neural lineage than hPSCs cultured on MEF or SNL feeder cell layers. In conclusion, culture conditions have a major impact on the propensity of the hPSCs to differentiate into a cardiac lineage.	[Ojala, Marisa; Rajala, Kristiina; Pekkanen-Mattila, Mari; Miettinen, Marinka; Aalto-Setala, Katriina] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Ojala, Marisa; Rajala, Kristiina; Pekkanen-Mattila, Mari; Miettinen, Marinka; Aalto-Setala, Katriina] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Aalto-Setala, Katriina] Tampere Univ Hosp, Ctr Heart, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University; Tampere University Hospital	Aalto-Setala, K (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	katriina.aalto-setala@uta.fi		Ojala, Marisa/0000-0003-1796-2153; Pekkanen-Mattila, Mari/0000-0002-8621-4303	Academy of Finland; Finnish Foundation for Cardiovascular Research; Biocenter Finland; Finnish Funding Agency for Technology and Innovation; Competitive Research Funding of the Pirkanmaa Hospital District; Alfred Kordelin Foundation	Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Biocenter Finland; Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Competitive Research Funding of the Pirkanmaa Hospital District; Alfred Kordelin Foundation	This study was funded by the Academy of Finland, the Finnish Foundation for Cardiovascular Research, Biocenter Finland, the Finnish Funding Agency for Technology and Innovation, Competitive Research Funding of the Pirkanmaa Hospital District and the Alfred Kordelin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Axell MZ, 2009, J NEUROSCI METH, V184, P275, DOI 10.1016/j.jneumeth.2009.08.015; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Benzing C, 2006, NEUROREPORT, V17, P1675, DOI 10.1097/01.wnr.0000236861.01210.72; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Bettiol E, 2007, DIFFERENTIATION, V75, P669, DOI 10.1111/j.1432-0436.2007.00174.x; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; Chin ACP, 2010, STEM CELLS DEV, V19, P753, DOI 10.1089/scd.2009.0210; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122; Forsyth NR, 2008, REGEN MED, V3, P817, DOI 10.2217/17460751.3.6.817; Freund C, 2008, STEM CELLS, V26, P724, DOI 10.1634/stemcells.2007-0617; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Hakala H, 2009, TISSUE ENG PT A, V15, P1775, DOI 10.1089/ten.tea.2008.0316; Hisamatsu-Sakamoto M, 2008, STEM CELLS, V26, P72, DOI 10.1634/stemcells.2007-0744; Hudson JE, 2011, STEM CELLS DEV; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lagarkova MA, 2010, IN VITRO CELL DEV-AN, V46, P284, DOI 10.1007/s11626-010-9282-6; Lahti A.L., 2011, DIS MODEL MECH; Larijani MR, 2011, STEM CELLS DEV, V20, P1911, DOI 10.1089/scd.2010.0517; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; MUMMERY CL, 1991, DIFFERENTIATION, V46, P51, DOI 10.1111/j.1432-0436.1991.tb00865.x; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Ohnuki M, 2009, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC04A02S9; Pekkanen-Mattila M, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/875059; Pekkanen-Mattila M, 2009, ANN MED, V41, P360, DOI 10.1080/07853890802609542; Peterson SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023018; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Skottman H, 2006, STEM CELLS, V24, P151, DOI 10.1634/stemcells.2004-0189; Skottman H, 2005, STEM CELLS, V23, P1343, DOI 10.1634/stemcells.2004-0341; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Tavakoli T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-44; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	59	27	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48659	10.1371/journal.pone.0048659	http://dx.doi.org/10.1371/journal.pone.0048659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119085	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500193
J	Oprea-Lager, DE; Vincent, AD; van Moorselaar, RJA; Gerritsen, WR; van den Eertwegh, AJM; Eriksson, J; Boellaard, R; Hoekstra, OS				Oprea-Lager, Daniela E.; Vincent, Andrew D.; van Moorselaar, Reindert J. A.; Gerritsen, Winald R.; van den Eertwegh, Alfons J. M.; Eriksson, Jonas; Boellaard, Ronald; Hoekstra, Otto S.			Dual-Phase PET-CT to Differentiate [F-18]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; C-11-CHOLINE PET/CT; F-18-CHOLINE PET/CT; BIOCHEMICAL RELAPSE; CHOLINE PET/CT; PSA; F-18-FLUOROCHOLINE; F-18; LOCALIZATION; EXPERIENCE	Purpose: To investigate whether time-trends of enhanced [F-18]Fluoromethylcholine ([F-18]FCH) in lymph nodes (LN) of prostate cancer (PCa) patients can help to discriminate reactive from malignant ones, and whether single time point standardized uptake value (SUV) measurements also suffice. Procedures: 25 PCa patients with inguinal (presumed benign) and enlarged pelvic LN (presumed malignant) showing enhanced [F-18]FCH uptake at dual-phase PET-CT were analyzed. Associations between LN status (benign versus malignant) and SUVmax and SUVmeanA50, determined at 2 min (early) and 30 min (late) post injection, were assessed. We considered two time-trends of [F-18]FCH uptake: type A (SUV early > SUV late) and type B (SUV late >= SUV early). Histopathology and/or follow-up were used to confirm the assumption that LN with type A pattern are benign, and LN with type B pattern malignant. Results: Analysis of 54 nodes showed that LN status, time-trends, and 'late' (30 min p.i.) SUVmax and SUVmeanA50 parameters were strongly associated (P<0.0001). SUVmax relative difference was the best LN status predictor. All but one inguinal LN showed a decreasing [F-18]FCH uptake over time (pattern A), while 95% of the pelvic nodes presented a stable or increasing uptake (pattern B) type. Conclusions: Time-trends of enhanced [F-18]FCH uptake can help to characterize lymph nodes in prostate cancer patients. Single time-point SUV measurements, 30 min p.i., may be a reasonable alternative for predicting benign versus malignant status of lymph nodes, but this remains to be validated in non-enlarged pelvic lymph nodes.	[Oprea-Lager, Daniela E.; Eriksson, Jonas; Boellaard, Ronald; Hoekstra, Otto S.] Vrije Univ Amsterdam Med Ctr, Dept Nucl Med & PET Res, Amsterdam, Netherlands; [Vincent, Andrew D.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Biometr, Amsterdam, Netherlands; [van Moorselaar, Reindert J. A.] Vrije Univ Amsterdam Med Ctr, Dept Urol, Amsterdam, Netherlands; [Gerritsen, Winald R.] St Radboud Univ, Med Ctr, Dept Oncol, Nijmegen, Netherlands; [Gerritsen, Winald R.; van den Eertwegh, Alfons J. M.] Vrije Univ Amsterdam Med Ctr, Dept Oncol, Amsterdam, Netherlands; [Eriksson, Jonas] Uppsala Univ, Dept Med Chem, Uppsala, Sweden	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Uppsala University	Oprea-Lager, DE (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Nucl Med & PET Res, Amsterdam, Netherlands.	d.oprea-lager@vumc.nl	Eriksson, Jonas/E-8373-2012; Oprea-Lager, Daniela E./J-9582-2013; gerritsen, Winald/H-8031-2014	Eriksson, Jonas/0000-0003-0241-092X; Oprea-Lager, Daniela-Elena/0000-0001-9447-2305; Boellaard, Ronald/0000-0002-0313-5686				[Anonymous], 2001, J LABELLED COMP RADI, V44, P1052; Bauman G, 2012, PROSTATE CANCER P D, V15, P45, DOI 10.1038/pcan.2011.35; Beer AJ, 2011, MOL IMAGING BIOL, V13, P352, DOI 10.1007/s11307-010-0337-6; Beheshti M, 2010, RADIOLOGY, V254, P925, DOI 10.1148/radiol.09090413; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Breeuwsma AJ, 2010, INT J RADIAT ONCOL, V77, P60; Castellucci P, 2009, J NUCL MED, V50, P1394, DOI 10.2967/jnumed.108.061507; Cheebsumon P, 2011, J NUCL MED, V52, P1550, DOI 10.2967/jnumed.111.088914; Cimitan M, 2006, EUR J NUCL MED MOL I, V33, P1387, DOI 10.1007/s00259-006-0150-2; DeGrado TR, 2001, CANCER RES, V61, P110; DeGrado TR, 2002, J NUCL MED, V43, P92; DeGrado TR, 2001, J NUCL MED, V42, P1805; Egevad L, 2012, ARCH PATHOL LAB MED, V136, P426, DOI 10.5858/arpa.2011-0495-RA; Frings V, 2010, J NUCL MED, V51, P1870, DOI 10.2967/jnumed.110.077255; Fuccio C, 2011, EUR J RADIOL, V80, pE50, DOI 10.1016/j.ejrad.2010.07.023; Fuccio C, 2010, ANN NUCL MED, V24, P485, DOI 10.1007/s12149-010-0390-x; Hara T, 1998, J NUCL MED, V39, P990; Hartemink Koen J, 2010, Ned Tijdschr Geneeskd, V154, pA1884; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Heinisch M, 2006, MOL IMAGING BIOL, V8, P43, DOI 10.1007/s11307-005-0023-2; Hovels AM, 2008, CLIN RADIOL, V63, P387, DOI 10.1016/j.crad.2007.05.022; Igerc I, 2008, EUR J NUCL MED MOL I, V35, P976, DOI 10.1007/s00259-007-0686-9; Inoue S, 2011, CUAJ-CAN UROL ASSOC, V5, P254, DOI 10.5489/cuaj.10159; Iwata R, 2002, APPL RADIAT ISOTOPES, V57, P347, DOI 10.1016/S0969-8043(02)00123-9; Jadvar H, 2011, J NUCL MED, V52, P81, DOI 10.2967/jnumed.110.077941; Jager GJ, 1996, AM J ROENTGENOL, V167, P1503, DOI 10.2214/ajr.167.6.8956585; Krause BJ, 2008, EUR J NUCL MED MOL I, V35, P18, DOI 10.1007/s00259-007-0581-4; Kwee SA, 2006, J NUCL MED, V47, P262; Sandi AK, 2007, SEMIN NUCL MED, V37, P420, DOI 10.1053/j.semnuclmed.2007.07.003; Pelosi E, 2008, RADIOL MED, V113, P895, DOI 10.1007/s11547-008-0263-8; Picchio M, 2011, EUR UROL, V59, P51, DOI 10.1016/j.eururo.2010.09.004; Price DT, 2002, J UROLOGY, V168, P273, DOI 10.1016/S0022-5347(05)64906-3; Reske SN, 2006, J NUCL MED, V47, P1249; Rinnab L, 2007, BJU INT, V100, P786, DOI 10.1111/j.1464-410X.2007.07083.x; Scher B, 2007, EUR J NUCL MED MOL I, V34, P45, DOI 10.1007/s00259-006-0190-7; Schillaci O, 2010, NUCL MED COMMUN, V31, P39, DOI 10.1097/MNM.0b013e328330adc5; Tokuda Y, 2010, AM J SURG PATHOL, V34, P1862, DOI 10.1097/PAS.0b013e3181fc679e; Weekermann D, 2007, J UROLOGY, V177, P916, DOI 10.1016/j.juro.2006.10.074	38	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48430	10.1371/journal.pone.0048430	http://dx.doi.org/10.1371/journal.pone.0048430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119014	Green Published, gold			2022-12-25	WOS:000310600500134
J	Suo, YJ; Huang, YY; Liu, YH; Shi, CL; Shi, XM				Suo, Yujuan; Huang, Yanyan; Liu, Yanhong; Shi, Chunlei; Shi, Xianming			The Expression of Superoxide Dismutase (SOD) and a Putative ABC Transporter Permease Is Inversely Correlated during Biofilm Formation in Listeria monocytogenes 4b G	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; ESCHERICHIA-COLI; RESISTANCE; CIPROFLOXACIN; TEMPERATURE; PATTERNS; ADHESION; GROWTH; SIGB; PCR	Little is known about the molecular basis of biofilm formation in Listeria monocytogenes. The superoxide dismutase (SOD) of the deletion mutant of lm.G_1771 gene, which encodes for a putative ABC transporter permease, is highly expressed in biofilm. In this study, the sod gene deletion mutant Delta sod, and double deletion mutant of the sod and lm.G_1771 genes Delta 1771 Delta sod were used to investigate the role of SOD and its relationship to the expression of the putative ABC transporter permease in biofilm formation. Our results showed that the ability to form a biofilm was significantly reduced in the Delta sod mutant and the Delta 1771 Delta sod double mutant. Both Delta sod and Delta 1771 Delta sod mutants exhibited slow growth phenotypes and produced more reactive oxygen species (ROS). The growth was inhibited in the mutants by methyl viologen (MV, internal oxygen radical generator) treatment. In addition, the expression of one oxidation resistance gene (kat), two stress regulators encoding genes (perR and sigB), and one DNA repair gene (recA) were analyzed in both the wild-type L. monocytogenes 4b G and the deletion mutants by RT-qPCR. The expression levels of the four genes were increased in the deletion mutants when biofilms were formed. Taken together, our data indicated that SOD played an important role in biofilm formation through coping with the oxidant burden in deficient antioxidant defenses.	[Suo, Yujuan; Huang, Yanyan; Shi, Chunlei; Shi, Xianming] Shanghai Jiao Tong Univ, Sch Agr & Biol, MOST USDA Joint Res Ctr Food Safety, Shanghai 200030, Peoples R China; [Suo, Yujuan; Huang, Yanyan; Shi, Chunlei; Shi, Xianming] Shanghai Jiao Tong Univ, Sch Agr & Biol, Bor Luh Food Safety Ctr, Shanghai 200030, Peoples R China; [Liu, Yanhong] ARS, Mol Characterizat Foodborne Pathogens Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; United States Department of Agriculture (USDA)	Shi, XM (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, MOST USDA Joint Res Ctr Food Safety, Shanghai 200030, Peoples R China.	xmshi@sjtu.edu.cn	Liu, Yanhong/L-7093-2019; huang, yan/GWM-4747-2022; Shi, Chunlei/A-6428-2013	Liu, Yanhong/0000-0002-0759-7597; Shi, Chunlei/0000-0002-5847-7122	National Natural Science Foundation of China [31171690, 30972485, U1031003]; Ministry of Science and Technology of China [2012AA101601, 2012BAK17B10, 2011DFA31220]; General Administration for Quality Supervision, Inspection and Quarantine of the People's Republic of China [20111K147]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); General Administration for Quality Supervision, Inspection and Quarantine of the People's Republic of China	National Natural Science Foundation of China (grant No. 31171690, 30972485, U1031003) (http://www.nsfc.gov.cn/); Ministry of Science and Technology of China (grant No. 2012AA101601, 2012BAK17B10 and 2011DFA31220) (http://www.most.gov.cn/); General Administration for Quality Supervision, Inspection and Quarantine of the People's Republic of China (No. 20111K147) (http://www.aqsiq.gov.cn/). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiassa V, 2010, BIOCHEM BIOPH RES CO, V393, P84, DOI 10.1016/j.bbrc.2010.01.083; Miranda JEA, 2011, FEMS MICROBIOL LETT, V315, P23, DOI 10.1111/j.1574-6968.2010.02164.x; Azizoglu RO, 2010, APPL ENVIRON MICROB, V76, P6998, DOI 10.1128/AEM.01223-10; Ballal A, 2009, J BACTERIOL, V191, P3301, DOI 10.1128/JB.01496-08; Bayir H, 2005, CRIT CARE MED, V33, pS498, DOI 10.1097/01.CCM.0000186787.64500.12; Biswas S, 2011, ANTIMICROB AGENTS CH, V55, P1460, DOI 10.1128/AAC.01094-10; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; Desroche N, 2005, J MICROBIOL METH, V60, P325, DOI 10.1016/j.mimet.2004.10.010; Droge W, 2003, ADV EXP MED BIOL, V543, P191; Duffy G, 1997, J APPL MICROBIOL, V83, P95, DOI 10.1111/j.1361-5072.1997.00195.x; Geier H, 2008, APPL ENVIRON MICROB, V74, P1798, DOI 10.1128/AEM.02066-07; HASSAN HM, 1977, J BIOL CHEM, V252, P7667; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kim YH, 2006, PROTEOMICS, V6, P6181, DOI 10.1002/pmic.200600320; Kuzminov A, 1996, BIOESSAYS, V18, P757, DOI 10.1002/bies.950180911; Paez PL, 2010, FEMS MICROBIOL LETT, V303, P101, DOI 10.1111/j.1574-6968.2009.01867.x; Mostertz J, 2003, MOL GENET GENOMICS, V269, P640, DOI 10.1007/s00438-003-0877-4; Nightingale KK, 2005, J BACTERIOL, V187, P5537, DOI 10.1128/JB.187.16.5537-5551.2005; Norwood DE, 2000, J APPL MICROBIOL, V88, P512, DOI 10.1046/j.1365-2672.2000.00990.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Oliver HF, 2010, APPL ENVIRON MICROB, V76, P4216, DOI 10.1128/AEM.00031-10; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Purkrtova S, 2010, CZECH J FOOD SCI, V28, P326, DOI 10.17221/153/2010-CJFS; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; Smoot LM, 1998, J FOOD PROTECT, V61, P1286, DOI 10.4315/0362-028X-61.10.1286; Tompkin RB, 2002, J FOOD PROTECT, V65, P709, DOI 10.4315/0362-028X-65.4.709; Tremoulet F, 2002, FEMS MICROBIOL LETT, V210, P25, DOI 10.1016/S0378-1097(02)00571-2; van der Veen S, 2011, CURR OPIN BIOTECH, V22, P136, DOI 10.1016/j.copbio.2010.11.012; van der Veen S, 2010, APPL ENVIRON MICROB, V76, P7854, DOI 10.1128/AEM.01519-10; van der Veen S, 2010, APPL ENVIRON MICROB, V76, P1992, DOI 10.1128/AEM.02680-09; VASCONCELOS JAP, 1994, APPL ENVIRON MICROB, V60, P2360, DOI 10.1128/AEM.60.7.2360-2366.1994; Werbrouck H, 2007, J MICROBIOL METH, V69, P306, DOI 10.1016/j.mimet.2007.01.017; Zhu XN, 2011, FOODBORNE PATHOG DIS, V8, P495, DOI 10.1089/fpd.2010.0697; Zhu XN, 2008, APPL ENVIRON MICROB, V74, P7675, DOI 10.1128/AEM.01229-08	37	30	38	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48467	10.1371/journal.pone.0048467	http://dx.doi.org/10.1371/journal.pone.0048467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119031	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500147
J	Taniguchi, M; Yamamoto, N; Nakagawa, T; Ogino, E; Ito, J				Taniguchi, Mirei; Yamamoto, Norio; Nakagawa, Takayuki; Ogino, Eriko; Ito, Juichi			Identification of Tympanic Border Cells as Slow-Cycling Cells in the Cochlea	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; INNER-EAR; HAIR-CELLS; ACOUSTIC TRAUMA; GUINEA-PIGS; MOUSE; PROLIFERATION; LOCATION; MATH1; REGENERATION	Mammalian cochlear sensory epithelial cells are believed to possess minimal regenerative potential because they halt proliferation during late stage of embryogenesis and never regenerate after birth. This means that sensorineural hearing loss caused by the death of cochlear sensory epithelial cells is a permanent condition. However, stem cells were recently identified in neonatal mice following dissociation of their inner ear organs. This suggests that regenerative therapy for sensorineural hearing loss may be possible. Unfortunately, dissociation distorts the microanatomy of the inner ear, making it difficult to determine the precise location of stem cells in unaltered specimens. To develop new therapeutic approaches based on sensory epithelial cell regeneration, the location of these stem cells must be elucidated. Stem cells normally proliferate at a slow rate in adult organs. In fact, so-called label-retaining cells, or slow-cycling cells, of the brain and skin are recognized as stem cells. In this study, using the exogenous proliferation marker, 5'-bromo-2'-deoxyuridine (BrdU) in combination with the endogenous proliferation marker Ki-67, we identified tympanic border cells. These cells, which are located beneath the basilar membrane in vivo, represent slow-cycling cells of the murine cochlea. Immunohistochemically, these cells stained positive for the immature cell marker Nestin. But it will be difficult to achieve regeneration of the cochlear function because these slow-cycling cells disappear in the mature murine cochlea.	[Taniguchi, Mirei; Yamamoto, Norio; Nakagawa, Takayuki; Ogino, Eriko; Ito, Juichi] Kyoto Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kyoto, Japan	Kyoto University	Yamamoto, N (corresponding author), Kyoto Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Kyoto, Japan.	yamamoto@ent.kuhp.kyoto-u.ac.jp		Ogino-Nishimura, Eriko/0000-0001-7659-4034; Yamamoto, Norio/0000-0001-8924-0710	Ministry of Education, Culture, Sports, Science and Technology in Japan [21890121, 22791595, 24592545, 23229009]; Japan Society for Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This project was supported by a Grant-in-Aid for Young Scientists (Start-up) (21890121) to EO, a Grant-in-Aid for Young Scientists (B) (22791595) and a Grant-in-Aid for Scientific Research (C) (24592545) to NY, and a Grant-in-Aid for Scientific Research (S) (23229009) to JI from the Ministry of Education, Culture, Sports, Science and Technology in Japan and Japan Society for Promotion of Science; http://www.jsps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Capuco AV, 2007, EXP BIOL MED, V232, P1381, DOI 10.3181/0703-RM-58; Chai RJ, 2011, JARO-J ASSOC RES OTO, V12, P455, DOI 10.1007/s10162-011-0267-2; Chen P, 2002, DEVELOPMENT, V129, P2495; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; GIROD DA, 1989, HEARING RES, V42, P175, DOI 10.1016/0378-5955(89)90143-3; Kamiya K, 2001, BRAIN RES, V901, P296, DOI 10.1016/S0006-8993(01)02300-9; Kawamoto K, 2003, J NEUROSCI, V23, P4395; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li FS, 2010, J GASTROENTEROL, V45, P113, DOI 10.1007/s00535-009-0139-2; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Lopez IA, 2004, INT J DEV NEUROSCI, V22, P205, DOI 10.1016/j.ijdevneu.2004.04.006; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; OGAWA M, 1993, BLOOD, V81, P2844; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ontiveros CS, 2008, PROSTATE, V68, P1263, DOI 10.1002/pros.20770; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; QUESENBERRY P, 1979, NEW ENGL J MED, V301, P755, DOI 10.1056/NEJM197910043011404; ROBERSON DW, 1994, AM J OTOL, V15, P28; RUBEL EW, 1995, SCIENCE, V267, P701, DOI 10.1126/science.7839150; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Savary E, 2007, STEM CELLS, V25, P332, DOI 10.1634/stemcells.2006-0303; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SLEPECKY NB, 1996, COCHLEA, V8, P44; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Yamasoba T, 2003, NEUROSCI LETT, V347, P171, DOI 10.1016/S0304-3940(03)00675-X; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753	37	13	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48544	10.1371/journal.pone.0048544	http://dx.doi.org/10.1371/journal.pone.0048544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119055	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500168
J	Yang, M; Wu, YM; Lu, YM; Liu, CY; Sun, JL; Liao, M; Qin, M; Mo, LJ; Gao, Y; Lu, Z; Wu, CL; Zhang, YJ; Zhang, HY; Qin, X; Hu, YL; Zhang, SJ; Li, JL; Dong, M; Zheng, SL; Xu, JF; Yang, XB; Tan, AH; Mo, ZN				Yang, Ming; Wu, Yongming; Lu, Yanmei; Liu, Changyuan; Sun, Jielin; Liao, Ming; Qin, Min; Mo, Linjian; Gao, Yong; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Zhang, Haiying; Qin, Xue; Hu, Yanling; Zhang, Shijun; Li, Jianling; Dong, Min; Zheng, S. Lilly; Xu, Jianfeng; Yang, Xiaobo; Tan, Aihua; Mo, Zengnan			Genome-Wide Scan Identifies Variant in TNFSF13 Associated with Serum IgM in a Healthy Chinese Male Population	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-CELL GROWTH; B-CELL; NATURAL IGM; APRIL; TACI; IMMUNODEFICIENCY; IMMUNOGLOBULIN; DISEASE	IgM provides a first line of defense during microbial infections. Serum IgM levels are detected routinely in clinical practice. And IgM is a genetically complex trait. We conducted a two-stage genome-wide association study (GWAS) to identify genetic variants affecting serum IgM levels in a Chinese population of 3495, including 1999 unrelated subjects in the first stage and 1496 independent individuals in the second stage. Our data show that a common single nucleotide polymorphism (SNP), rs11552708 located in the TNFSF13 gene was significantly associated with IgM levels (p=5.00x10(-7) in first stage, p=1.34x10(-3) in second stage, and p=4.22x10(-9) when combined). Besides, smoking was identified to be associated with IgM levels in both stages (P<0.05), but there was no significant interaction between smoking and the identified SNP (P>0.05). It is suggested that TNFSF13 may be a susceptibility gene affecting serum IgM levels in Chinese male population.	[Yang, Ming; Wu, Yongming; Lu, Yanmei; Liu, Changyuan; Liao, Ming; Qin, Min; Mo, Linjian; Gao, Yong; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Zhang, Haiying; Qin, Xue; Hu, Yanling; Zhang, Shijun; Li, Jianling; Dong, Min; Yang, Xiaobo; Tan, Aihua; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China; [Sun, Jielin; Zheng, S. Lilly; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Wu, Yongming; Liao, Ming; Mo, Linjian; Gao, Yong; Lu, Zheng; Wu, Chunlei; Zhang, Youjie; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi, Peoples R China; [Zhang, Haiying; Yang, Xiaobo] Guangxi Med Univ, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China; [Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Hu, Yanling] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi, Peoples R China; [Zhang, Shijun] Guangxi Med Univ, Dept Pharmacol, Nanning, Guangxi, Peoples R China; [Li, Jianling] Guangxi Med Univ, Affiliated Hosp 1, Inst Cardiovasc Dis, Nanning, Guangxi, Peoples R China; [Xu, Jianfeng] Van Andel Res Inst, Ctr Genet Epidemiol, Grand Rapids, MI USA; [Xu, Jianfeng] Fudan Univ, Fudan VARI Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Inst Urol, Huashan Hosp, Shanghai 200433, Peoples R China; [Tan, Aihua] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Chemotherapy, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Wake Forest University; Wake Forest Baptist Medical Center; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Van Andel Institute; Fudan University; Fudan University; Guangxi Medical University	Yang, XB (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China.	yxbo21021@163.com; tanaihua2010@gmail.com; zengnanmo@hotmail.com	Zhang, Youjie/F-7346-2016; Yang, Xiaobo/G-3854-2016	Zhang, Youjie/0000-0002-6035-8536; mo, zengnan/0000-0002-3047-3138	National Natural Science Foundation of China [30945204]; Provincial department of Finance, Guangxi Zhuang Autonomous Region, China [2009GJCJ150, 201012MS060, 2012GXNSFFA060009]; Provincial department of Education, Guangxi Zhuang Autonomous Region, China [2009GJCJ150, 201012MS060, 2012GXNSFFA060009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial department of Finance, Guangxi Zhuang Autonomous Region, China; Provincial department of Education, Guangxi Zhuang Autonomous Region, China	The work described in this article is supported by grants from the National Natural Science Foundation of China (grant 30945204), the Provincial departments of Finance and Education, Guangxi Zhuang Autonomous Region, China (grants 2009GJCJ150 and 201012MS060, and the Guangxi Science Fund for Distinguished Young Scholars 2012GXNSFFA060009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; Castellanos-Rubio A, 2012, AUTOIMMUNITY, V45, P264, DOI 10.3109/08916934.2011.637531; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Chen JY, 2006, CLIN EXP IMMUNOL, V143, P281, DOI 10.1111/j.1365-2249.2005.02984.x; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Doi M, 2010, J INVEST ALLERG CLIN, V20, P413; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; FELLAH JS, 1992, EUR J IMMUNOL, V22, P2595, DOI 10.1002/eji.1830221019; Greenfield TK, 2000, AM J PUBLIC HEALTH, V90, P47, DOI 10.2105/AJPH.90.1.47; Gronwall C, 2012, CLIN IMMUNOL, V142, P390, DOI 10.1016/j.clim.2012.01.002; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; KALFF MW, 1969, CLIN EXP IMMUNOL, V5, P469; Kaveri SV, 2012, J IMMUNOL, V188, P939, DOI 10.4049/jimmunol.1102107; Khare SD, 2001, TRENDS IMMUNOL, V22, P61, DOI 10.1016/S1471-4906(00)01843-3; KOHLER PF, 1985, J CLIN INVEST, V75, P883, DOI 10.1172/JCI111787; Koyama T, 2003, RHEUMATOLOGY, V42, P980, DOI 10.1093/rheumatology/keg270; Lee YH, 2007, RHEUMATOLOGY, V46, P1274, DOI 10.1093/rheumatology/kem093; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Osman W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032683; Poodt AEJ, 2009, CLIN EXP IMMUNOL, V156, P35, DOI 10.1111/j.1365-2249.2008.03863.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Salzer U, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-3; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Stein JV, 2002, J CLIN INVEST, V109, P1587, DOI 10.1172/JCI200215034; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Tan AH, 2011, METABOLISM, V60, P1186, DOI 10.1016/j.metabol.2011.01.002; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	38	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47990	10.1371/journal.pone.0047990	http://dx.doi.org/10.1371/journal.pone.0047990			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118916	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500052
J	Zhang, LS; Wang, SQ; Xu, WR; Wang, RL; Wang, JF				Zhang, Li-Song; Wang, Shu-Qing; Xu, Wei-Ren; Wang, Run-Ling; Wang, Jing-Fang			Scaffold-Based Pan-Agonist Design for the PPAR alpha, PPAR beta and PPAR gamma Receptors	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; MOLECULAR-DYNAMICS SIMULATIONS; PERSONALIZED DRUG DESIGN; HUMAN CYTOCHROME-P450; ALPHA/GAMMA AGONIST; INSULIN SENSITIVITY; SKELETAL-MUSCLE; DELTA; SELECTIVITY; IMPROVEMENT	As important members of nuclear receptor superfamily, Peroxisome proliferator-activated receptors (PPAR) play essential roles in regulating cellular differentiation, development, metabolism, and tumorigenesis of higher organisms. The PPAR receptors have 3 identified subtypes: PPAR alpha, PPAR beta and PPAR gamma, all of which have been treated as attractive targets for developing drugs to treat type 2 diabetes. Due to the undesirable side-effects, many PPAR agonists including PPAR alpha/gamma and PPAR beta/gamma dual agonists are stopped by US FDA in the clinical trials. An alternative strategy is to design novel pan-agonist that can simultaneously activate PPAR alpha, PPAR beta and PPAR gamma. Under such an idea, in the current study we adopted the core hopping algorithm and glide docking procedure to generate 7 novel compounds based on a typical PPAR pan-agonist LY465608. It was observed by the docking procedures and molecular dynamics simulations that the compounds generated by the core hopping and glide docking not only possessed the similar functions as the original LY465608 compound to activate PPAR alpha, PPAR beta and PPAR gamma receptors, but also had more favorable conformation for binding to the PPAR receptors. The additional absorption, distribution, metabolism and excretion (ADME) predictions showed that the 7 compounds (especially Cpd#1) hold high potential to be novel lead compounds for the PPAR pan-agonist. Our findings can provide a new strategy or useful insights for designing the effective pan-agonists against the type 2 diabetes.	[Zhang, Li-Song; Wang, Shu-Qing; Wang, Run-Ling] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China; [Xu, Wei-Ren] Tianjin Inst Pharmaceut Res, Tianjin, Peoples R China; [Wang, Jing-Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai 200030, Peoples R China; [Wang, Jing-Fang] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Tianjin Medical University; Shanghai Jiao Tong University; Chinese Academy of Sciences	Wang, RL (corresponding author), Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China.	wangrunling@tijmu.edu.cn; jfwang8113@sjtu.edu.cn	Csermely, Peter/J-2067-2017; Wang, Jingfang/Q-2597-2018	Csermely, Peter/0000-0001-9234-0659; Wang, Jingfang/0000-0002-1355-5481	National Natural Science Foundation of China [20972112, 21202120, 31200547]; Research Fund for the Doctoral Program Foundation of Institutions of Higher Education of China [20091202110010, 20110073120078]; China Postdoctoral Science Foundation [2011M500532, 2012M510758]; Tianjin Medical University Foundation [2011KY43]; Key Program of Tianjin Municipal Natural Science Foundation [09JCZDJC21600]; Tianjin Institute of Pharmaceutical Research (TIPR)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program Foundation of Institutions of Higher Education of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tianjin Medical University Foundation; Key Program of Tianjin Municipal Natural Science Foundation; Tianjin Institute of Pharmaceutical Research (TIPR)	This work was supported the grants from the National Natural Science Foundation of China (No.20972112, 21202120 and 31200547), Research Fund for the Doctoral Program Foundation of Institutions of Higher Education of China (Nos.20091202110010 and 20110073120078), China Postdoctoral Science Foundation (Nos.2011M500532 and 2012M510758), Tianjin Medical University Foundation (No.2011KY43), Key Program of Tianjin Municipal Natural Science Foundation (No.09JCZDJC21600), and Tianjin Institute of Pharmaceutical Research (TIPR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Blaschke F, 2006, ARTERIOSCL THROM VAS, V26, P28, DOI 10.1161/01.ATV.0000191663.12164.77; Buse JB, 2005, CLIN THER, V27, P1181, DOI 10.1016/j.clinthera.2005.08.005; Cabrero A, 1999, BIOCHEM BIOPH RES CO, V260, P547, DOI 10.1006/bbrc.1999.0926; Calkin Anna C, 2003, Curr Opin Investig Drugs, V4, P444; Chen Q, 2011, CURR DRUG METAB, V12, P436, DOI 10.2174/138920011795495259; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; Fagerberg B, 2005, DIABETOLOGIA, V48, P1716, DOI 10.1007/s00125-005-1846-8; Gu H, 2010, CHINESE SCI BULL, V55, P2677, DOI 10.1007/s11434-010-3257-6; Kasuga J, 2008, BIOORG MED CHEM LETT, V18, P4525, DOI 10.1016/j.bmcl.2008.07.046; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Li J, 2011, J CHEM INF MODEL, V51, P3217, DOI 10.1021/ci2004016; Lian P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018587; Luquet S, 2005, BBA-MOL BASIS DIS, V1740, P313, DOI 10.1016/j.bbadis.2004.11.011; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Pickavance LC, 2005, BRIT J PHARMACOL, V144, P308, DOI 10.1038/sj.bjp.0706041; Ping J, 2012, CURR DRUG METAB, V13, P1024, DOI 10.2174/138920012802138606; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JF, 2008, PROTEIN PEPTIDE LETT, V15, P27; Wang JF, 2007, BIOCHEM BIOPH RES CO, V355, P513, DOI 10.1016/j.bbrc.2007.01.185; Wang JF, 2012, J MOL MODEL, V18, P2717, DOI 10.1007/s00894-011-1295-x; Wang JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031048; Wang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018414; Wang JF, 2010, CHINESE SCI BULL, V55, P1877, DOI 10.1007/s11434-009-3697-z; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044079; Wang Y, 2012, J CHEM INF MODEL, V52, P2422, DOI [10.1021/ci3030451, 10.1021/ci3003045]; Wang Y, 2010, J CHEM INF MODEL, V50, P875, DOI 10.1021/ci900458u; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Zeng QK, 2009, BIOTECHNOL LETT, V31, P1025, DOI 10.1007/s10529-009-9980-x; Zimmet P, 2003, DIABETIC MED, V20, P693, DOI 10.1046/j.1464-5491.2003.01052.x	40	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48453	10.1371/journal.pone.0048453	http://dx.doi.org/10.1371/journal.pone.0048453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119024	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500142
J	Metais, JY; Winkler, T; Geyer, JT; Calado, RT; Aplan, PD; Eckhaus, MA; Dunbar, CE				Metais, Jean-Yves; Winkler, Thomas; Geyer, Julia T.; Calado, Rodrigo T.; Aplan, Peter D.; Eckhaus, Michael A.; Dunbar, Cynthia E.			BCL2A1a Over-Expression in Murine Hematopoietic Stem and Progenitor Cells Decreases Apoptosis and Results in Hematopoietic Transformation	PLOS ONE			English	Article							RETROVIRAL VECTOR INTEGRATION; ACUTE MYELOID-LEUKEMIA; BCL-2 FAMILY-MEMBER; NF-KAPPA-B; GENE-THERAPY; HEMATOLOGICAL MALIGNANCIES; TRANSCRIPTIONAL TARGET; MOUSE MODEL; A1; MICE	We previously reported the development of a lethal myeloid sarcoma in a non-human primate model utilizing retroviral vectors to genetically modify hematopoietic stem and progenitor cells. This leukemia was characterized by insertion of the vector provirus into the BCL2A1 gene, with resultant BCL2A1 over-expression. There is little information on the role of this anti-apoptotic member of the BCL2 family in hematopoiesis or leukemia induction. Therefore we studied the impact of Bcl2a1a lentiviral over-expression on murine hematopoietic stem and progenitor cells. We demonstrated the anti-apoptotic function of this protein in hematopoietic cells, but did not detect any impact of Bcl2a1a on in vitro cell growth or cell cycle kinetics. In vivo, we showed a higher propensity of HSCs over-expressing Bcl2a1a to engraft and contribute to hematopoiesis. Mice over-expressing Bcl2a1a in the hematologic compartment eventually developed an aggressive malignant disease characterized as a leukemia/lymphoma of B-cell origin. Secondary transplants carried out to investigate the primitive origin of the disease revealed the leukemia was transplantable. Thus, Bcl2a1 should be considered as a protooncogene with a potential role in both lymphoid and myeloid leukemogenesis, and a concerning site for insertional activation by integrating retroviral vectors utilized in hematopoietic stem cell gene therapy.	[Metais, Jean-Yves; Winkler, Thomas; Calado, Rodrigo T.; Dunbar, Cynthia E.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Geyer, Julia T.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Calado, Rodrigo T.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, BR-14049 Ribeirao Preto, Brazil; [Aplan, Peter D.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Eckhaus, Michael A.] NIH, Div Vet Resources, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cornell University; Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Dunbar, CE (corresponding author), NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA.	dunbarc@nhlbi.nih.gov	Aplan, Peter D/K-9064-2016; Calado, Rodrigo T./G-2619-2011; Winkler, Thomas/S-3787-2017	Calado, Rodrigo T./0000-0002-7966-6029; Winkler, Thomas/0000-0002-8072-0168; Dunbar, Cynthia/0000-0002-7645-838X	intramural research programs of the National Heart Lung and Blood Institute (CED) of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC010378] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020] Funding Source: NIH RePORTER	intramural research programs of the National Heart Lung and Blood Institute (CED) of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the intramural research programs of the National Heart Lung and Blood Institute (CED) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Carrio R, 1996, AM J PATHOL, V149, P2133; CHOI SS, 1995, ONCOGENE, V11, P1693; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; D'Souza BN, 2004, J VIROL, V78, P1800, DOI 10.1128/JVI.78.4.1800-1816.2004; DSaEipper C, 1996, CANCER RES, V56, P3879; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Hatakeyama S, 1998, INT IMMUNOL, V10, P631, DOI 10.1093/intimm/10.5.631; Jenal M, 2010, LEUKEMIA, V24, P1073, DOI 10.1038/leu.2010.26; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Kelly PF, 2003, BLOOD CELL MOL DIS, V30, P132, DOI 10.1016/S1079-9796(03)00005-6; Kenny JJ, 1997, ONCOGENE, V14, P997, DOI 10.1038/sj.onc.1200898; Kitada S, 2002, ONCOGENE, V21, P3459, DOI 10.1038/sj.onc.1205327; Ko JK, 2003, FEBS LETT, V551, P29, DOI 10.1016/S0014-5793(03)00872-X; Kraunus J, 2004, GENE THER, V11, P1568, DOI 10.1038/sj.gt.3302309; Kustikova Olga S., 2008, V430, P255, DOI 10.1007/978-1-59745-182-6_18; LIN EY, 1993, J IMMUNOL, V151, P1979; Lin EY, 1996, BLOOD, V87, P983, DOI 10.1182/blood.V87.3.983.bloodjournal873983; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Metais JY, 2010, GENE THER, V17, P799, DOI 10.1038/gt.2010.24; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Morita E, 2001, J VIROL, V75, P7555, DOI 10.1128/JVI.75.16.7555-7563.2001; Nagy B, 2003, BRIT J HAEMATOL, V120, P434, DOI 10.1046/j.1365-2141.2003.04121.x; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; ORLOFSKY A, 1991, CELL REGUL, V2, P403, DOI 10.1091/mbc.2.5.403; Ottina E, 2012, BLOOD, V119, P6032, DOI 10.1182/blood-2011-12-399089; Sadat MA, 2009, GENE THER, V16, P1452, DOI 10.1038/gt.2009.96; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Seggewiss R, 2006, BLOOD, V107, P3865, DOI 10.1182/blood-2005-10-4108; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Van Etten RA, 2001, BLOOD CELL MOL DIS, V27, P201, DOI 10.1006/bcmd.2000.0370; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	40	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48267	10.1371/journal.pone.0048267	http://dx.doi.org/10.1371/journal.pone.0048267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118966	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705600037
J	Thurgood, J; Hooper, S; Siew, M; Wallace, M; Dubsky, S; Kitchen, M; Jamison, RA; Carnibella, R; Fouras, A				Thurgood, Jordan; Hooper, Stuart; Siew, Melissa; Wallace, Megan; Dubsky, Stephen; Kitchen, Marcus; Jamison, R. Aidan; Carnibella, Richard; Fouras, Andreas			Functional Lung Imaging during HFV in Preterm Rabbits	PLOS ONE			English	Article							FREQUENCY OSCILLATORY VENTILATION; ELECTRICAL-IMPEDANCE TOMOGRAPHY; END-EXPIRATORY PRESSURE; TIDAL VOLUME; CONVENTIONAL VENTILATION; GAS-TRANSPORT; INFANTS; INJURY; VELOCIMETRY; STRATEGIES	Although high frequency ventilation (HFV) is an effective mode of ventilation, there is limited information available in regard to lung dynamics during HFV. To improve the knowledge of lung function during HFV we have developed a novel lung imaging and analysis technique. The technique can determine complex lung motion information in vivo with a temporal resolution capable of observing HFV dynamics. Using high-speed synchrotron based phase contrast X-ray imaging and cross-correlation analysis, this method is capable of recording data in more than 60 independent regions across a preterm rabbit lung in excess of 300 frames per second (fps). This technique is utilised to determine regional intra-breath lung mechanics of preterm rabbit pups during HFV. Whilst ventilated at fixed pressures, each animal was ventilated at frequencies of 1, 3, 5 and 10 Hz. A 50% decrease in delivered tidal volume was measured at 10 Hz compared to 1 Hz, yet at the higher frequency a 500% increase in minute activity was measured. Additionally, HFV induced greater homogeneity of lung expansion activity suggesting this ventilation strategy potentially minimizes tissue damage and improves gas mixing. The development of this technique permits greater insight and further research into lung mechanics and may have implications for the improvement of ventilation strategies used to support severe pulmonary trauma and disease.	[Thurgood, Jordan; Dubsky, Stephen; Jamison, R. Aidan; Carnibella, Richard; Fouras, Andreas] Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia; [Hooper, Stuart; Siew, Melissa; Wallace, Megan] Monash Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia; [Kitchen, Marcus] Monash Univ, Sch Phys, Melbourne, Vic 3004, Australia	Monash University; Monash University; Monash University	Thurgood, J (corresponding author), Monash Univ, Dept Mech & Aerosp Engn, Melbourne, Vic 3004, Australia.	jordan.thurgood@monash.edu	Fouras, Andreas/A-9410-2008; Kitchen, Marcus/A-1355-2008	Fouras, Andreas/0000-0002-8933-1759; Kitchen, Marcus/0000-0002-0029-6660; Hooper, Stuart/0000-0003-1676-4825; Wallace, Megan/0000-0001-5785-5120; Dubsky, Stephen/0000-0001-8355-7362; Siew, Melissa/0000-0003-3014-2379	Australian Research Council [DP110101498]; National Health and Medical Research Council [491103]; Victorian Governments Operational Infrastructure Support Program; Japan Synchrotron Radiation Research Institute; International Synchrotron Access Program (ISAP); Australian Government	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Governments Operational Infrastructure Support Program; Japan Synchrotron Radiation Research Institute; International Synchrotron Access Program (ISAP); Australian Government(Australian GovernmentCGIAR)	Research is funded by the Australian Research Council (DP110101498), the National Health and Medical Research Council (491103), Victorian Governments Operational Infrastructure Support Program and supported by beamtime grants from the Japan Synchrotron Radiation Research Institute. We acknowledge travel funding provided by the International Synchrotron Access Program (ISAP) managed by the Australian Synchrotron and funded by the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Bayat S, 2008, EUR J RADIOL, V68, pS78, DOI 10.1016/j.ejrad.2008.04.043; Biederer J, 2010, J MAGN RESON IMAGING, V32, P1388, DOI 10.1002/jmri.22386; BOHN DJ, 1980, J APPL PHYSIOL, V48, P710, DOI 10.1152/jappl.1980.48.4.710; Brazelton TB, 2001, CRIT CARE MED, V29, P2349, DOI 10.1097/00003246-200112000-00018; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; BUTLER WJ, 1980, ANESTH ANALG, V59, P577; Carney David, 2005, Crit Care Med, V33, pS122, DOI 10.1097/01.CCM.0000155928.95341.BC; CHANG HK, 1984, J APPL PHYSIOL, V56, P553, DOI 10.1152/jappl.1984.56.3.553; Cheney M, 1999, SIAM REV, V41, P85, DOI 10.1137/S0036144598333613; CLARK RH, 1994, J PEDIATR-US, V124, P661, DOI 10.1016/S0022-3476(05)81352-6; Cools F, 2010, LANCET, V375, P2082, DOI 10.1016/S0140-6736(10)60278-4; Dunlop S, 2006, PHYSIOL MEAS, V27, P1151, DOI 10.1088/0967-3334/27/11/008; Easley RB, 2009, RESP PHYSIOL NEUROBI, V165, P54, DOI 10.1016/j.resp.2008.10.010; Fouras A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3115643; Fouras A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2783978; Fouras A, 2008, EXP FLUIDS, V44, P317, DOI 10.1007/s00348-007-0404-1; Fouras A, 2007, EXP FLUIDS, V42, P799, DOI 10.1007/s00348-007-0293-3; Fouras A, 2012, ANN BIOMED ENG, V40, P1160, DOI 10.1007/s10439-011-0493-0; Fouras A, 2009, CLIN EXP PHARMACOL P, V36, P238, DOI 10.1111/j.1440-1681.2008.05102.x; Frerichs I, 2007, PHYSIOL MEAS, V28, pS261, DOI 10.1088/0967-3334/28/7/S19; Habib RH, 2002, AM J RESP CRIT CARE, V166, P950, DOI 10.1164/rccm.200205-398OC; Hager DN, 2007, CRIT CARE MED, V35, P1522, DOI 10.1097/01.CCM.0000266586.04676.55; Hemberg O, 2003, APPL PHYS LETT, V83, P1483, DOI 10.1063/1.1602157; Heraty KB, 2008, ANN BIOMED ENG, V36, P1856, DOI 10.1007/s10439-008-9557-1; Hoffman EA, 2004, ACAD RADIOL, V11, P1370, DOI 10.1016/j.acra.2004.09.005; Hooper SB, 2007, FASEB J, V21, P3329, DOI 10.1096/fj.07-8208com; Imai Y, 2001, J APPL PHYSIOL, V91, P1836, DOI 10.1152/jappl.2001.91.4.1836; Jamison RA, 2011, ANN BIOMED ENG, V39, P1643, DOI 10.1007/s10439-011-0260-2; Kitchen MJ, 2008, PHYS MED BIOL, V53, P6065, DOI 10.1088/0031-9155/53/21/012; Kitchen MJ, 2010, J INSTRUM, V5, DOI 10.1088/1748-0221/5/02/T02002; Krishnan JA, 2000, CHEST, V118, P795, DOI 10.1378/chest.118.3.795; Lee SJ, 2003, J APPL PHYS, V94, P3620, DOI 10.1063/1.1599981; Lewis RA, 2005, PHYS MED BIOL, V50, P5031, DOI 10.1088/0031-9155/50/21/006; Luecke Thomas, 2005, Crit Care Med, V33, pS155, DOI 10.1097/01.CCM.0000155916.47455.DF; Mulreany DG, 2009, ACAD RADIOL, V16, P718, DOI 10.1016/j.acra.2008.12.003; Pellicano A, 2009, INTENS CARE MED, V35, P1990, DOI 10.1007/s00134-009-1628-8; Pillow J Jane, 2005, Crit Care Med, V33, pS135; Pillow JJ, 1999, J APPL PHYSIOL, V87, P407, DOI 10.1152/jappl.1999.87.1.407; Rimensberger PC, 1999, CRIT CARE MED, V27, P1940, DOI 10.1097/00003246-199909000-00037; Rimensberger PC, 2000, PEDIATRICS, V105, P1202, DOI 10.1542/peds.105.6.1202; Scalfaro P, 2001, CRIT CARE MED, V29, P1925, DOI 10.1097/00003246-200110000-00013; Seah AS, 2011, ANN BIOMED ENG, V39, P1505, DOI 10.1007/s10439-010-0237-6; SHABTAI Y, 1989, J APPL PHYSIOL, V66, P1127, DOI 10.1152/jappl.1989.66.3.1127; Siew ML, 2009, J APPL PHYSIOL, V106, P1487, DOI 10.1152/japplphysiol.91591.2008; SLUTSKY AS, 1981, J CLIN INVEST, V68, P1475, DOI 10.1172/JCI110400; Slutsky AS, 2002, NEW ENGL J MED, V347, P630, DOI 10.1056/NEJMp020082; SLUTSKY AS, 1980, SCIENCE, V209, P609, DOI 10.1126/science.6771872; SMITH BE, 1990, BRIT J ANAESTH, V65, P130, DOI 10.1093/bja/65.1.130; Sud S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2327; Terekhov M, 2010, J MAGN RESON IMAGING, V32, P887, DOI 10.1002/jmri.22318; Thome U, 1998, J APPL PHYSIOL, V84, P1520, DOI 10.1152/jappl.1998.84.5.1520; Tustison NJ, 2011, ACAD RADIOL, V18, P402, DOI 10.1016/j.acra.2010.10.019; van Beek EJR, 2008, CLIN CHEST MED, V29, P195, DOI 10.1016/j.ccm.2007.12.003; van Genderingen HR, 2004, CRIT CARE MED, V32, P787, DOI 10.1097/01.CCM.0000114823.16604.19; van Kaam AH, 2007, CRIT CARE MED, V35, P925, DOI 10.1097/01.CCM.0000256724.70601.3A; Weber K, 2000, J APPL PHYSIOL, V89, P364, DOI 10.1152/jappl.2000.89.1.364; Wolf GK, 2010, PHYSIOL MEAS, V31, pS85, DOI 10.1088/0967-3334/31/8/S07; Wolf U, 2010, MAGN RESON MED, V64, P1479, DOI 10.1002/mrm.22528; Wood B, 2002, CRIT CARE MED, V30, P1523, DOI 10.1097/00003246-200207000-00021; Wunsch H, 2005, ANESTH ANALG, V100, P1765, DOI 10.1213/01.ANE.0000145070.52315.F2	61	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48122	10.1371/journal.pone.0048122	http://dx.doi.org/10.1371/journal.pone.0048122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118938	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600026
J	Wundrow, EJ; Carrillo, J; Gabler, CA; Horn, KC; Siemann, E				Wundrow, Emily J.; Carrillo, Juli; Gabler, Christopher A.; Horn, Katherine C.; Siemann, Evan			Facilitation and Competition among Invasive Plants: A Field Experiment with Alligatorweed and Water Hyacinth	PLOS ONE			English	Article							POSITIVE INTERACTIONS; NATURAL COMMUNITIES; MELTDOWN; CONSEQUENCES; PREDATION; HABITATS; IMPACTS; FISHES; PREY	Ecosystems that are heavily invaded by an exotic species often contain abundant populations of other invasive species. This may reflect shared responses to a common factor, but may also reflect positive interactions among these exotic species. Armand Bayou (Pasadena, TX) is one such ecosystem where multiple species of invasive aquatic plants are common. We used this system to investigate whether presence of one exotic species made subsequent invasions by other exotic species more likely, less likely, or if it had no effect. We performed an experiment in which we selectively removed exotic rooted and/or floating aquatic plant species and tracked subsequent colonization and growth of native and invasive species. This allowed us to quantify how presence or absence of one plant functional group influenced the likelihood of successful invasion by members of the other functional group. We found that presence of alligatorweed (rooted plant) decreased establishment of new water hyacinth (free-floating plant) patches but increased growth of hyacinth in established patches, with an overall net positive effect on success of water hyacinth. Water hyacinth presence had no effect on establishment of alligatorweed but decreased growth of existing alligatorweed patches, with an overall net negative effect on success of alligatorweed. Moreover, observational data showed positive correlations between hyacinth and alligatorweed with hyacinth, on average, more abundant. The negative effect of hyacinth on alligatorweed growth implies competition, not strong mutual facilitation (invasional meltdown), is occurring in this system. Removal of hyacinth may increase alligatorweed invasion through release from competition. However, removal of alligatorweed may have more complex effects on hyacinth patch dynamics because there were strong opposing effects on establishment versus growth. The mix of positive and negative interactions between floating and rooted aquatic plants may influence local population dynamics of each group and thus overall invasion pressure in this watershed.	[Wundrow, Emily J.; Carrillo, Juli; Gabler, Christopher A.; Horn, Katherine C.; Siemann, Evan] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA	Rice University	Siemann, E (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA.	siemann@rice.edu		Gabler, Christopher/0000-0001-9311-7248	Brown Teaching Grant; Ford Foundation; Wray-Todd Fellowships; Lodieska Stockbridge Vaughn Fellowship; National Science Foundation pre-doctoral fellowship	Brown Teaching Grant; Ford Foundation; Wray-Todd Fellowships; Lodieska Stockbridge Vaughn Fellowship; National Science Foundation pre-doctoral fellowship(National Science Foundation (NSF))	Financial support was provided by a Brown Teaching Grant (ES), the Ford Foundation (JAC), Wray-Todd Fellowships (KCH, CAG), a Lodieska Stockbridge Vaughn Fellowship (CAG), and a National Science Foundation pre-doctoral fellowship (JAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; Relva MA, 2010, BIOL INVASIONS, V12, P303, DOI 10.1007/s10530-009-9623-0; Belote RT, 2006, BIOL INVASIONS, V8, P1629, DOI 10.1007/s10530-005-3932-8; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Bicudo DD, 2007, FRESHWATER BIOL, V52, P1120, DOI 10.1111/j.1365-2427.2007.01738.x; Boschilia SM, 2008, OECOLOGIA, V156, P203, DOI 10.1007/s00442-008-0983-4; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Buchingham GR, 2002, USDA FOREST SERVICE, P5; Bulleri F, 2008, PLOS BIOL, V6, P1136, DOI 10.1371/journal.pbio.0060162; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Center TD, 2002, USDA FOREST SERVICE, P5; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Crain CM, 2004, ECOLOGY, V85, P2539, DOI 10.1890/03-0745; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Dray FJ, 2002, USDA FOREST SERVICE, P5; Geng YP, 2007, ECOL RES, V22, P255, DOI 10.1007/s11284-006-0017-9; GOLDBERG DE, 1992, AM NAT, V139, P771, DOI 10.1086/285357; Griffen BD, 2008, J ANIM ECOL, V77, P32, DOI 10.1111/j.1365-2656.2007.01304.x; Grosholz ED, 2005, P NATL ACAD SCI USA, V102, P1088, DOI 10.1073/pnas.0308547102; Harding KC, 2006, INVAD NAT SPRING SER, P371, DOI 10.1007/1-4020-4925-0_17; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Julien MH, 2000, P 2 M GLOB WORK GROU; Kim Y, 2000, WATER RES, V34, P3285, DOI 10.1016/S0043-1354(00)00068-3; King RB, 2006, CAN J ZOOL, V84, P108, DOI 10.1139/Z05-182; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; LeBrun EG, 2012, J ANIM ECOL, V81, P884, DOI 10.1111/j.1365-2656.2012.01954.x; Lenz TI, 2003, AUSTRAL ECOL, V28, P480, DOI 10.1046/j.1442-9993.2003.01304.x; LYNCH M, 1979, LIMNOL OCEANOGR, V24, P253, DOI 10.4319/lo.1979.24.2.0253; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Montgomery WI, 2012, BIOL INVASIONS, V14, P1111, DOI 10.1007/s10530-011-0142-4; Nunez MA, 2008, AUSTRAL ECOL, V33, P317, DOI 10.1111/j.1442-9993.2007.01819.x; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Ruesink JL, 2007, MAR ECOL PROG SER, V331, P1, DOI 10.3354/meps331001; Scheffer M, 2003, P NATL ACAD SCI USA, V100, P4040, DOI 10.1073/pnas.0737918100; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Schultz R, 2012, HYDROBIOLOGIA, V684, P1, DOI 10.1007/s10750-011-0978-8; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Tecco PA, 2006, AUSTRAL ECOL, V31, P293, DOI 10.1111/j.1442-9993.2006.01557.x; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Travis JMJ, 2004, ANIM CONSERV, V7, P321, DOI 10.1017/S1367943004001507	50	22	24	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48444	10.1371/journal.pone.0048444	http://dx.doi.org/10.1371/journal.pone.0048444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119021	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600043
J	Keshari, RS; Jyoti, A; Dubey, M; Kothari, N; Kohli, M; Bogra, J; Barthwal, MK; Dikshit, M				Keshari, Ravi S.; Jyoti, Anupam; Dubey, Megha; Kothari, Nikhil; Kohli, Monica; Bogra, Jaishri; Barthwal, Manoj K.; Dikshit, Madhu			Cytokines Induced Neutrophil Extracellular Traps Formation: Implication for the Inflammatory Disease Condition	PLOS ONE			English	Article							OXIDE-MEDIATED AUGMENTATION; OXYGEN SPECIES GENERATION; NECROSIS-FACTOR-ALPHA; IL-8 GENE-EXPRESSION; NITRIC-OXIDE; REACTIVE OXYGEN; POLYMORPHONUCLEAR LEUKOCYTES; INTERLEUKIN-1 BETA; RESPIRATORY BURST; SEVERE SEPSIS	Neutrophils (PMNs) and cytokines have a critical role to play in host defense and systemic inflammatory response syndrome (SIRS). Neutrophil extracellular traps (NETs) have been shown to extracellularly kill pathogens, and inflammatory potential of NETs has been shown. Microbial killing inside the phagosomes or by NETs is mediated by reactive oxygen and nitrogen species (ROS/RNS). The present study was undertaken to assess circulating NETs contents and frequency of NETs generation by isolated PMNs from SIRS patients. These patients displayed significant augmentation in the circulating myeloperoxidase (MPO) activity and DNA content, while PMA stimulated PMNs from these patients, generated more free radicals and NETs. Plasma obtained from SIRS patients, if added to the PMNs isolated from healthy subjects, enhanced NETs release and free radical formation. Expressions of inflammatory cytokines (IL-1 beta, TNF alpha and IL-8) in the PMNs as well as their circulating levels were significantly augmented in SIRS subjects. Treatment of neutrophils from healthy subjects with TNF alpha, IL-1 beta, or IL-8 enhanced free radicals generation and NETs formation, which was mediated through the activation of NADPH oxidase and MPO. Pre-incubation of plasma from SIRS with TNF alpha, IL-1 beta, or IL-8 antibodies reduced the NETs release. Role of IL-1 beta, TNFa alpha and IL-8 thus seems to be involved in the enhanced release of NETs in SIRS subjects.	[Keshari, Ravi S.; Jyoti, Anupam; Dubey, Megha; Barthwal, Manoj K.; Dikshit, Madhu] Cent Drug Res Inst, CSIR, Div Pharmacol, Lucknow 226001, Uttar Pradesh, India; [Kothari, Nikhil; Kohli, Monica; Bogra, Jaishri] Chhatrapati Shahuji Maharaj Med Univ, Dept Anaesthesia, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University	Dikshit, M (corresponding author), Cent Drug Res Inst, CSIR, Div Pharmacol, Lucknow 226001, Uttar Pradesh, India.	madhu_dikshit@cdri.res.in	dubey, megha/AAG-9570-2020	dubey, megha/0000-0001-7119-6504; Jyoti, Anupam/0000-0002-4135-7466	Department of Biotechnology-INDIGO project [BT/IN/New Indigo/08/MD/2010]; Council of Scientific and Industrial Research, India	Department of Biotechnology-INDIGO project; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by a financial grant to Madhu Dikshit from the Department of Biotechnology-INDIGO project (BT/IN/New Indigo/08/MD/2010). Award of research fellowships to RSK, AJ and MD from the Council of Scientific and Industrial Research, India is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; Blackwell TS, 1996, BRIT J ANAESTH, V77, P110, DOI 10.1093/bja/77.1.110; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brandolini L, 1996, J LEUKOCYTE BIOL, V59, P427, DOI 10.1002/jlb.59.3.427; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; COLOTTA F, 1992, BLOOD, V80, P2012; Dias IHK, 2011, J CLIN PERIODONTOL, V38, P1, DOI 10.1111/j.1600-051X.2010.01628.x; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; DULARAY B, 1990, J LEUKOCYTE BIOL, V47, P158, DOI 10.1002/jlb.47.2.158; Fanning NF, 1999, SHOCK, V11, P167, DOI 10.1097/00024382-199903000-00003; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; FERRANTE A, 1988, INT ARCH ALLER A IMM, V86, P82, DOI 10.1159/000234610; Filep JG, 1998, J IMMUNOL, V161, P5656; Fortin CF, 2010, SHOCK, V33, P344, DOI 10.1097/SHK.0b013e3181c0f068; Freitas M, 2009, ANAL CHIM ACTA, V649, P8, DOI 10.1016/j.aca.2009.06.063; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gupta A, 2006, ANN NY ACAD SCI, V1075, P118, DOI 10.1196/annals.1368.015; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Keshari RS, 2012, CYTOM PART A, V81A, P238, DOI 10.1002/cyto.a.21178; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kothari N, 2012, ACTA ANAESTH SCAND, V56, P307, DOI 10.1111/j.1399-6576.2011.02607.x; Kothari N, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.09.001; Kumar S, 2010, CYTOM PART A, V77A, P1038, DOI 10.1002/cyto.a.20975; Li JP, 2010, SCAND J IMMUNOL, V72, P284, DOI 10.1111/j.1365-3083.2010.02422.x; Lin JA, 2011, J AGR FOOD CHEM, V59, P105, DOI 10.1021/jf103455g; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Longhurst C, 1996, IMMUNOLOGY, V87, P334, DOI 10.1046/j.1365-2567.1996.463529.x; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Martins PS, 2003, SHOCK, V20, P208, DOI 10.1097/01.shk.0000079425.52617.db; Megens RTA, 2012, THROMB HAEMOSTASIS, V107, P597, DOI 10.1160/TH11-09-0650; Mitaka C, 2003, SHOCK, V19, P305, DOI 10.1097/00024382-200304000-00002; Paape MJ, 2003, VET RES, V34, P597, DOI 10.1051/vetres:2003024; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Patel S, 2010, NITRIC OXIDE-BIOL CH, V22, P226, DOI 10.1016/j.niox.2010.01.001; Pattison DI, 2006, CURR MED CHEM, V13, P3271, DOI 10.2174/092986706778773095; Prokopowicz Z, 2012, ARCH IMMUNOL THER EX, V60, P43, DOI 10.1007/s00005-011-0156-8; Quattrone S, 2004, MOL HUM REPROD, V10, P325, DOI 10.1093/molehr/gah040; Radkowski M, 2004, J GEN VIROL, V85, P47, DOI 10.1099/vir.0.19491-0; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sethi S, 1999, BLOOD, V93, P333, DOI 10.1182/blood.V93.1.333.401k15_333_340; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Sharma P, 2004, J LEUKOCYTE BIOL, V75, P1070, DOI 10.1189/jlb.0903415; SULLIVAN GW, 1989, J LEUKOCYTE BIOL, V45, P389, DOI 10.1002/jlb.45.5.389; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Trzeciak S, 2007, ANN EMERG MED, V49, P88, DOI 10.1016/j.annemergmed.2006.08.021; VANDERVORT AL, 1994, J IMMUNOL, V152, P4102; WRIGHT CD, 1989, BIOCHEM BIOPH RES CO, V160, P813, DOI 10.1016/0006-291X(89)92506-0; Wu F, 2008, J CELL PHYSIOL, V217, P207, DOI 10.1002/jcp.21495; Yang F, 2002, CRIT CARE MED, V30, P650, DOI 10.1097/00003246-200203000-00026; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855; Zouki C, 2001, J LEUKOCYTE BIOL, V69, P815	62	206	222	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48111	10.1371/journal.pone.0048111	http://dx.doi.org/10.1371/journal.pone.0048111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110185	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500037
J	Pluess, T; Jarosik, V; Pysek, P; Cannon, R; Pergl, J; Breukers, A; Bacher, S				Pluess, Therese; Jarosik, Vojtech; Pysek, Petr; Cannon, Ray; Pergl, Jan; Breukers, Annemarie; Bacher, Sven			Which Factors Affect the Success or Failure of Eradication Campaigns against Alien Species?	PLOS ONE			English	Article							PLANT; INVASIONS; IMPACT; CLASSIFICATION; COMMUNITIES; PATTERNS; EUROPE; TOOL	Although issues related to the management of invasive alien species are receiving increasing attention, little is known about which factors affect the likelihood of success of management measures. We applied two data mining techniques, classification trees and boosted trees, to identify factors that relate to the success of management campaigns aimed at eradicating invasive alien invertebrates, plants and plant pathogens. We assembled a dataset of 173 different eradication campaigns against 94 species worldwide, about a half of which (50.9%) were successful. Eradications in man-made habitats, greenhouses in particular, were more likely to succeed than those in (semi-) natural habitats. In man-made habitats the probability of success was generally high in Australasia, while in Europe and the Americas it was higher for local infestations that are easier to deal with, and for international campaigns that are likely to profit from cross-border cooperation. In (semi-) natural habitats, eradication campaigns were more likely to succeed for plants introduced as an ornamental and escaped from cultivation prior to invasion. Averaging out all other factors in boosted trees, pathogens, bacteria and viruses were most, and fungi the least likely to be eradicated; for plants and invertebrates the probability was intermediate. Our analysis indicates that initiating the campaign before the extent of infestation reaches the critical threshold, starting to eradicate within the first four years since the problem has been noticed, paying special attention to species introduced by the cultivation pathway, and applying sanitary measures can substantially increase the probability of eradication success. Our investigations also revealed that information on socioeconomic factors, which are often considered to be crucial for eradication success, is rarely available, and thus their relative importance cannot be evaluated. Future campaigns should carefully document socioeconomic factors to enable tests of their importance.	[Jarosik, Vojtech; Pysek, Petr; Pergl, Jan] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Pluess, Therese; Bacher, Sven] Univ Fribourg, Dept Biol, Ecol & Evolut Unit, CH-1700 Fribourg, Switzerland; [Jarosik, Vojtech; Pysek, Petr] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Cannon, Ray] Food & Environm Res Agcy, York, N Yorkshire, England; [Breukers, Annemarie] LEI, Wageningen, Netherlands	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Fribourg; Charles University Prague; Food & Environment Research Agency; Wageningen University & Research	Pergl, J (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	pergl@ibot.cas.cz	Bacher, Sven/F-5431-2010; Pysek, Petr/B-1957-2012; Pergl, Jan/H-1071-2011	Bacher, Sven/0000-0001-5147-7165; Pergl, Jan/0000-0002-0045-1974	European Commission [KBBE-212459]; Academy of Sciences of the Czech Republic [RVO 67985939]; Ministry of Education, Youth and Sports of the Czech Republic; Praemium Academiae award from the Academy of Sciences of the Czech Republic; SCIEX (project ALIEN)	European Commission(European CommissionEuropean Commission Joint Research Centre); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Praemium Academiae award from the Academy of Sciences of the Czech Republic; SCIEX (project ALIEN)	Work on this paper was supported by the European Commission under grant agreement number KBBE-212459, 7th Framework Programme, project PRATIQUE: Enhancement of Pest Risk Analysis Techniques. PP, VJ and JP acknowledge further the support from long-term research development project no. RVO 67985939 (Academy of Sciences of the Czech Republic) and institutional resources of Ministry of Education, Youth and Sports of the Czech Republic. PP acknowledges the support by the Praemium Academiae award from the Academy of Sciences of the Czech Republic and JP from SCIEX (project ALIEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R. H. A., 2009, Bulletin OEPP, V39, P87, DOI 10.1111/j.1365-2338.2009.02246.x; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Blackburn TM, 2001, J BIOGEOGR, V28, P927, DOI 10.1046/j.1365-2699.2001.00597.x; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; BOMFORD M, 1995, WILDLIFE SOC B, V23, P249; Bourg NA, 2005, ECOLOGY, V86, P2793, DOI 10.1890/04-1666; Breiman L, 2004, RANDOM FORESTS TM IM; Brockerhoff Eckehard G., 2010, New Zealand Journal of Forestry Science, V40, pS117; Clout M, 2002, TURNING TIDE BIOL IN; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dahlsten D., 1989, ERADICATION EXOTIC P; DAVIES CE, 2003, EUNIS HABITAT CLASSI; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; FAO, 2007, GLOSS PHYT TERMS ISP; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Friedman J. H., 1999, TECHNICAL REPORT; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; Genovesi Piero, 2007, V193, P385; Hanspach J, 2008, PERSPECT PLANT ECOL, V10, P241, DOI 10.1016/j.ppees.2008.05.001; Hochachka WM, 2007, J WILDLIFE MANAGE, V71, P2427, DOI 10.2193/2006-503; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Jarosik V, 2011, ENCY BIOL INVASIONS, P104; Kettunen M., 2009, TECHNICAL SUPPORT EU; Krivanek M, 2006, DIVERS DISTRIB, V12, P319, DOI 10.1111/j.1366-9516.2006.00249.x; Lambdon PW, 2008, PRESLIA, V80, P101; Leung B, 2012, ECOL LETT, V15, P1475, DOI 10.1111/ele.12003; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Mack R.N., 2000, BIOL INVASIONS, V2, P111, DOI DOI 10.1023/A:1010088422771; Mack R. N, 2002, TURNING TIDE ERADICA, P164; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471; Nentwig W, 2010, CONSERV BIOL, V24, P302, DOI 10.1111/j.1523-1739.2009.01289.x; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pluess T, 2012, BIOL INVASIONS, V14, P1365, DOI 10.1007/s10530-011-0160-2; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Rejmanek M., 2002, TURNING TIDE ERADICA, P249; Simberloff D, 2003, WEED SCI, V51, P247, DOI 10.1614/0043-1745(2003)051[0247:EPIATO]2.0.CO;2; Simberloff D, 2003, CONSERV BIOL, V17, P83, DOI 10.1046/j.1523-1739.2003.02028.x; Simberloff D., 2008, BIOL INVASIONS, V7, P5; Simberloff D, 2009, BIOL INVASIONS, V11, P149, DOI 10.1007/s10530-008-9317-z; Sosnowski MR, 2009, PLANT PATHOL, V58, P621, DOI 10.1111/j.1365-3059.2009.02042.x; Steinberg D., 1995, CART TREE STRUCTURED; Steinberg G, 2006, CART 6 0 USERS MANUA; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Weber J, 2009, J ENVIRON MANAGE, V90, P798, DOI 10.1016/j.jenvman.2008.01.012; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106	53	88	92	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48157	10.1371/journal.pone.0048157	http://dx.doi.org/10.1371/journal.pone.0048157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110197	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500043
J	Bertulat, B; De Bonis, ML; Della Ragione, F; Lehmkuhl, A; Milden, M; Storm, C; Jost, KL; Scala, S; Hendrich, B; D'Esposito, M; Cardoso, MC				Bertulat, Bianca; De Bonis, Maria Luigia; Della Ragione, Floriana; Lehmkuhl, Anne; Milden, Manuela; Storm, Christian; Jost, K. Laurence; Scala, Simona; Hendrich, Brian; D'Esposito, Maurizio; Cardoso, M. Cristina			MeCP2 Dependent Heterochromatin Reorganization during Neural Differentiation of a Novel Mecp2-Deficient Embryonic Stem Cell Reporter Line	PLOS ONE			English	Article							CPG-BINDING-PROTEIN; RETT-SYNDROME; TRANSCRIPTIONAL REPRESSOR; DNA METHYLATION; CONSTITUTIVE HETEROCHROMATIN; CHROMOSOMAL-PROTEIN; EXPRESSION; GENE; LOCALIZATION; NEURONS	The X-linked Mecp2 is a known interpreter of epigenetic information and mutated in Rett syndrome, a complex neurological disease. MeCP2 recruits HDAC complexes to chromatin thereby modulating gene expression and, importantly regulates higher order heterochromatin structure. To address the effects of MeCP2 deficiency on heterochromatin organization during neural differentiation, we developed a versatile model for stem cell in vitro differentiation. Therefore, we modified murine Mecp2 deficient (Mecp2(-/y)) embryonic stem cells to generate cells exhibiting green fluorescent protein expression upon neural differentiation. Subsequently, we quantitatively analyzed heterochromatin organization during neural differentiation in wild type and in Mecp2 deficient cells. We found that MeCP2 protein levels increase significantly during neural differentiation and accumulate at constitutive heterochromatin. Statistical analysis of Mecp2 wild type neurons revealed a significant clustering of heterochromatin per nuclei with progressing differentiation. In contrast we found Mecp2 deficient neurons and astroglia cells to be significantly impaired in heterochromatin reorganization. Our results (i) introduce a new and manageable cellular model to study the molecular effects of Mecp2 deficiency, and (ii) support the view of MeCP2 as a central protein in heterochromatin architecture in maturating cells, possibly involved in stabilizing their differentiated state.	[De Bonis, Maria Luigia; Della Ragione, Floriana; D'Esposito, Maurizio] Inst Genet & Biophys Buzzati Traverso, Naples, Italy; [Bertulat, Bianca; Lehmkuhl, Anne; Milden, Manuela; Storm, Christian; Jost, K. Laurence; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Della Ragione, Floriana; D'Esposito, Maurizio] Ist Ricovero Cura Carattere Sci Neuromed, Pozzilli, Italy; [Hendrich, Brian] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England; [Hendrich, Brian] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Technical University of Darmstadt; IRCCS Neuromed; University of Cambridge; University of Cambridge	D'Esposito, M (corresponding author), Inst Genet & Biophys Buzzati Traverso, Naples, Italy.	desposit@igb.cnr.it; Cardoso@bio.tu-darmstadt.de	D'Esposito, Maurizio/AAY-6376-2020; Hendrich, Brian/AAG-5898-2020; scala, simona/AAB-3067-2021; D'Esposito, Maurizio/J-9205-2016; Della Ragione, Floriana/B-9051-2015	Hendrich, Brian/0000-0002-0231-3073; scala, simona/0000-0001-5757-8530; Della Ragione, Floriana/0000-0003-1643-6418	European E-RARE EuroRett network (BMBF) [01GM0811]; Deutsche Forschungsgemeinschaft [CA198/7-1]; UE Initial Training Network Project DISCHROM [238242]; EPIGENOMICS FLAGSHIP PROJECT EPIGEN, MIUR-CNR; Neuromed fellowship; Medical Research Council [G0600275, G0800784B, G0800784] Funding Source: researchfish; MRC [G0600275, G0800784] Funding Source: UKRI	European E-RARE EuroRett network (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); UE Initial Training Network Project DISCHROM; EPIGENOMICS FLAGSHIP PROJECT EPIGEN, MIUR-CNR; Neuromed fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants of the European E-RARE EuroRett network (BMBF grant 01GM0811) and the Deutsche Forschungsgemeinschaft (grant CA198/7-1) to M.C. Cardoso. M. D'Esposito was supported by the UE Initial Training Network Project no238242 "DISCHROM'' and by the EPIGENOMICS FLAGSHIP PROJECT EPIGEN, MIUR-CNR. S. Scala was supported by a Neuromed fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins NL, 2011, BIOCHEM CELL BIOL, V89, P1, DOI 10.1139/O10-112; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Armstrong L, 2012, STEM CELL REV REP, V8, P67, DOI 10.1007/s12015-011-9300-4; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Baccarini P., 1908, GIORN BOT ITAL, V15, P189; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Balmer D, 2003, J MOL MED-JMM, V81, P61, DOI 10.1007/s00109-002-0396-5; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 1995, J CELL SCI, P37; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Chadwick LH, 2007, CURR OPIN GENET DEV, V17, P121, DOI 10.1016/j.gde.2007.02.003; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chao HT, 2012, NAT NEUROSCI, V15, P176, DOI 10.1038/nn.3027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheval H, 2012, HUM MOL GENET, V21, P3806, DOI 10.1093/hmg/dds208; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; DEsposito M, 1996, MAMM GENOME, V7, P533, DOI 10.1007/s003359900157; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; de Leon-Guerrero SD, 2011, EUR J NEUROSCI, V33, P1563, DOI 10.1111/j.1460-9568.2011.07658.x; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; FERNANDEZ G., 2007, P 2007 SAS GLOB FOR; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HEITZ E., 1929, BER DEUTSCH BOT GES, V47, P274; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Jost KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026499; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kudo S, 2001, BRAIN DEV-JPN, V23, pS165, DOI 10.1016/S0387-7604(01)00345-X; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Littell R. C., 2006, SAS SYSTEM MIXED MOD; Littell RC, 1998, J ANIM SCI, V76, P1216; Liu Y, 2003, J CELL BIOCHEM, V88, P29, DOI 10.1002/jcb.10281; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marchi M, 2007, EPIGENETICS-US, V2, P187, DOI 10.4161/epi.2.3.5057; Matarazzo V, 2004, MOL CELL NEUROSCI, V27, P44, DOI 10.1016/j.mcn.2004.05.005; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; Moser E. B., 2004, P 29 ANN SAS US GROU; Nan XH, 2001, BRAIN DEV-JPN, V23, pS32, DOI 10.1016/S0387-7604(01)00333-3; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, CIBA F SYMP, V214, P6; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nectoux J, 2012, J NEUROSCI RES, V90, P990, DOI 10.1002/jnr.23001; OCHMAN H, 1988, GENETICS, V120, P621; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Rett A, 1966, Wien Med Wochenschr, V116, P723; Samaco RC, 2011, J NEUROSCI, V31, P7951, DOI 10.1523/JNEUROSCI.0169-11.2011; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Singleton MK, 2011, NEUROBIOL DIS, V43, P190, DOI 10.1016/j.nbd.2011.03.011; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Terranova R, 2005, EXP CELL RES, V310, P344, DOI 10.1016/j.yexcr.2005.07.031; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wade PA, 2001, ONCOGENE, V20, P3166, DOI 10.1038/sj.onc.1204340; Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395; Wilson PG, 2006, STEM CELL REV, V2, P67, DOI 10.1385/SCR:2:1:67; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	80	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47848	10.1371/journal.pone.0047848	http://dx.doi.org/10.1371/journal.pone.0047848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112857	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200092
J	Bethmann, A; Scheich, H; Brechmann, A				Bethmann, Anja; Scheich, Henning; Brechmann, Andre			The Temporal Lobes Differentiate between the Voices of Famous and Unknown People: An Event-Related fMRI Study on Speaker Recognition	PLOS ONE			English	Article							FAMILIAR-ONLY EXPERIENCES; SEMANTIC INFORMATION; PERSONALLY FAMILIAR; AUDITORY-CORTEX; SOCIAL BRAIN; FACE; PERCEPTION; SPEECH; IDENTIFICATION; ACTIVATION	It is widely accepted that the perception of human voices is supported by neural structures located along the superior temporal sulci. However, there is an ongoing discussion to what extent the activations found in fMRI studies are evoked by the vocal features themselves or are the result of phonetic processing. To show that the temporal lobes are indeed engaged in voice processing, short utterances spoken by famous and unknown people were presented to healthy young participants whose task it was to identify the familiar speakers. In two event-related fMRI experiments, the temporal lobes were found to differentiate between familiar and unfamiliar voices such that named voices elicited higher BOLD signal intensities than unfamiliar voices. Yet, the temporal cortices did not only discriminate between familiar and unfamiliar voices. Experiment 2, which required overtly spoken responses and allowed to distinguish between four familiarity grades, revealed that there was a fine-grained differentiation between all of these familiarity levels with higher familiarity being associated with larger BOLD signal amplitudes. Finally, we observed a gradual response change such that the BOLD signal differences between unfamiliar and highly familiar voices increased with the distance of an area from the transverse temporal gyri, especially towards the anterior temporal cortex and the middle temporal gyri. Therefore, the results suggest that (the anterior and non-superior portions of) the temporal lobes participate in voice-specific processing independent from phonetic components also involved in spoken speech material.	[Bethmann, Anja; Brechmann, Andre] Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN)	Bethmann, A (corresponding author), Leibniz Inst Neurobiol, Special Lab Noninvas Brain Imaging, Magdeburg, Germany.	bethmann@lin-magdeburg.de		Brechmann, Andre/0000-0003-3903-0840	Deutsche Forschungsgemeinschaft [SFB/TRR62]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [SFB/TRR62]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Andics A, 2010, NEUROIMAGE, V52, P1528, DOI 10.1016/j.neuroimage.2010.05.048; Barbarotto R, 1995, NEUROCASE, V1, P107, DOI 10.1093/neucas/1.2.107; Barton JJS, 2003, NEUROLOGY, V61, P220, DOI 10.1212/01.WNL.0000071229.11658.F8; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Birkett PB, 2007, NEUROREPORT, V18, P1375, DOI 10.1097/WNR.0b013e3282aa43a3; Blank H, 2011, J NEUROSCI, V31, P12906, DOI 10.1523/JNEUROSCI.2091-11.2011; Bredart S, 2009, EUR J COGN PSYCHOL, V21, P1013, DOI 10.1080/09541440802591821; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Busigny T, 2009, NEUROCASE, V15, P485, DOI 10.1080/13554790902971141; Chan D, 2009, BRAIN, V132, P1287, DOI 10.1093/brain/awp037; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Damjanovic L, 2007, MEM COGNITION, V35, P1205, DOI 10.3758/BF03193594; Davis MH, 2003, J NEUROSCI, V23, P3423; ELLIS AW, 1989, BRAIN, V112, P1469, DOI 10.1093/brain/112.6.1469; EVANS JJ, 1995, BRAIN, V118, P1, DOI 10.1093/brain/118.1.1; Fecteau S, 2004, NEUROIMAGE, V23, P840, DOI 10.1016/j.neuroimage.2004.09.019; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Gainotti G, 2003, BRAIN, V126, P792, DOI 10.1093/brain/awg092; Gainotti G, 2008, CORTEX, V44, P238, DOI 10.1016/j.cortex.2006.09.001; Gainotti G, 2011, NEUROPSYCHOLOGIA, V49, P2273, DOI 10.1016/j.neuropsychologia.2011.04.027; Gainotti G, 2010, BRAIN RES, V1307, P103, DOI 10.1016/j.brainres.2009.10.009; Gentileschi V, 2001, COGN NEUROPSYCHOL, V18, P439, DOI 10.1080/02643290125835; Gentileschi V, 1999, NEUROCASE, V5, P407, DOI 10.1080/13554799908402735; Giovanello KS, 2003, NEUROCASE, V9, P15, DOI 10.1076/neur.9.1.15.14369; Giraud AL, 2001, J COGNITIVE NEUROSCI, V13, P754, DOI 10.1162/08989290152541421; Glosser G, 2003, NEUROLOGY, V61, P81, DOI 10.1212/01.WNL.0000073621.18013.E1; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Gorno-Tempini ML, 2004, CORTEX, V40, P631, DOI 10.1016/S0010-9452(08)70159-X; Gorno-Tempini ML, 2001, BRAIN, V124, P2087, DOI 10.1093/brain/124.10.2087; Grabowski TJ, 2001, HUM BRAIN MAPP, V13, P199, DOI 10.1002/hbm.1033; Hailstone JC, 2011, BRAIN, V134, P2535, DOI 10.1093/brain/awr205; Hailstone JC, 2010, NEUROPSYCHOLOGIA, V48, P1104, DOI 10.1016/j.neuropsychologia.2009.12.011; Hanley JR, 2009, MEMORY, V17, P830, DOI 10.1080/09658210903264175; Hanley JR, 1998, Q J EXP PSYCHOL-A, V51, P179, DOI 10.1080/713755751; Hanley JR, 2000, Q J EXP PSYCHOL-A, V53, P1105, DOI 10.1080/02724980050156317; Humphries C, 2001, NEUROREPORT, V12, P1749, DOI 10.1097/00001756-200106130-00046; Imaizumi S, 1997, NEUROREPORT, V8, P2809, DOI 10.1097/00001756-199708180-00031; Joubert S, 2006, J NEUROL, V253, P1447, DOI 10.1007/s00415-006-0232-x; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Latinus M, 2011, CEREB CORTEX, V21, P2820, DOI 10.1093/cercor/bhr077; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Meyer K, 2009, TRENDS NEUROSCI, V32, P376, DOI 10.1016/j.tins.2009.04.002; Meyer M, 2005, COGNITIVE BRAIN RES, V24, P291, DOI 10.1016/j.cogbrainres.2005.02.008; Nakamura K, 2000, BRAIN, V123, P1903, DOI 10.1093/brain/123.9.1903; Nakamura K, 2001, NEUROPSYCHOLOGIA, V39, P1047, DOI 10.1016/S0028-3932(01)00037-9; Papagno C, 1998, NEUROPSYCHOLOGIA, V36, P669, DOI 10.1016/S0028-3932(97)00142-5; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Pelphrey KA, 2011, J CHILD PSYCHOL PSYC, V52, P631, DOI 10.1111/j.1469-7610.2010.02349.x; Poeppel D, 2004, NEUROPSYCHOLOGIA, V42, P183, DOI 10.1016/j.neuropsychologia.2003.07.010; Pourtois G, 2005, NEUROIMAGE, V24, P1214, DOI 10.1016/j.neuroimage.2004.10.038; Rama P, 2005, NEUROIMAGE, V24, P224, DOI 10.1016/j.neuroimage.2004.08.024; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; Relander K, 2009, BRAIN RES, V1252, P143, DOI 10.1016/j.brainres.2008.11.050; Ross LA, 2010, NEUROIMAGE, V49, P3452, DOI 10.1016/j.neuroimage.2009.11.012; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Seeley WW, 2005, NEUROLOGY, V64, P1384, DOI 10.1212/01.WNL.0000158425.46019.5C; Seidenberg M, 2002, NEUROPSYCHOLOGIA, V40, P446, DOI 10.1016/S0028-3932(01)00096-3; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SERGENT J, 1994, ATTENTION PERFORM, V15, P203; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Simmons WK, 2003, COGN NEUROPSYCHOL, V20, P451, DOI 10.1080/02643290342000032; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; Stevens AA, 2004, COGNITIVE BRAIN RES, V18, P162, DOI 10.1016/j.cogbrainres.2003.10.008; Sugiura M, 2001, NEUROIMAGE, V13, P877, DOI 10.1006/nimg.2001.0747; Sugiura M, 2006, NEUROIMAGE, V31, P853, DOI 10.1016/j.neuroimage.2006.01.002; Sugiura M, 2009, J COGNITIVE NEUROSCI, V21, P1855, DOI 10.1162/jocn.2008.21150; Talairach J, 1988, 3 DIMENSIONAL PROPOR; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Thierry G, 2003, NEURON, V38, P499, DOI 10.1016/S0896-6273(03)00199-5; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Tippett LJ, 2000, COGNITIVE NEUROPSYCH, V17, P241, DOI 10.1080/026432900380599; VANLANCKER D, 1987, NEUROPSYCHOLOGIA, V25, P829, DOI 10.1016/0028-3932(87)90120-5; VANLANCKER D, 1985, J PHONETICS, V13, P19, DOI 10.1016/S0095-4470(19)30723-5; VANLANCKER DR, 1989, J CLIN EXP NEUROPSYC, V11, P665, DOI 10.1080/01688638908400923; von Kriegstein K, 2005, J COGNITIVE NEUROSCI, V17, P367, DOI 10.1162/0898929053279577; Vouloumanos A, 2001, J COGNITIVE NEUROSCI, V13, P994, DOI 10.1162/089892901753165890; Warren JD, 2006, NEUROIMAGE, V31, P1389, DOI 10.1016/j.neuroimage.2006.01.034; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	89	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47626	10.1371/journal.pone.0047626	http://dx.doi.org/10.1371/journal.pone.0047626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112826	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200059
J	Cieniewski-Bernard, C; Montel, V; Berthoin, S; Bastide, B				Cieniewski-Bernard, Caroline; Montel, Valerie; Berthoin, Serge; Bastide, Bruno			Increasing O-GlcNAcylation Level on Organ Culture of Soleus Modulates the Calcium Activation Parameters of Muscle Fibers	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINE; PROTECTS NEONATAL CARDIOMYOCYTES; ISCHEMIA-REPERFUSION INJURY; TROPONIN-T ISOFORMS; GLCNAC MODIFICATION; LINKED GLYCOSYLATION; RAT; PHOSPHORYLATION; PROTEINS; PUGNAC	O-N-acetylglucosaminylation is a reversible post-translational modification which presents a dynamic and highly regulated interplay with phosphorylation. New insights suggest that O-GlcNAcylation might be involved in striated muscle physiology, in particular in contractile properties such as the calcium activation parameters. By the inhibition of O-GlcNAcase, we investigated the effect of the increase of soleus O-GlcNAcylation level on the contractile properties by establishing T/pCa relationships. We increased the O-GlcNAcylation level on soleus biopsies performing an organ culture of soleus treated or not with PUGNAc or Thiamet-G, two O-GlcNAcase inhibitors. The enhancement of O-GlcNAcylation pattern was associated with an increase of calcium affinity on slow soleus skinned fibers. Analysis of the glycoproteins pattern showed that this effect is solely due to O-GlcNAcylation of proteins extracted from skinned biopsies. We also characterized the O-GlcNAcylated contractile proteins using a proteomic approach, and identified among others troponin T and I as being O-GlcNAc modified. We quantified the variation of O-GlcNAc level on all these identified proteins, and showed that several regulatory contractile proteins, predominantly fast isoforms, presented a drastic increase in their O-GlcNAc level. Since the only slow isoform of contractile protein presenting an increase of O-GlcNAc level was MLC2, the effect of enhanced O-GlcNAcylation pattern on calcium activation parameters could involve the O-GlcNAcylation of sMLC2, without excluding that an unidentified O-GlcNAc proteins, such as TnC, could be potentially involved in this mechanism. All these data strongly linked O-GlcNAcylation to the modulation of contractile activity of skeletal muscle.	[Cieniewski-Bernard, Caroline; Montel, Valerie; Bastide, Bruno] Univ Lille 1, Univ Lille Nord France, Lab Act Phys Muscle & Sante, EA4488,IFR114,IRP2B, Villeneuve Dascq, France; [Berthoin, Serge] Univ Lille, Univ Lille Nord France, Lab Act Phys Muscle & Sante, EA4488,IFR114,IRP2B, Villeneuve Dascq, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Bastide, B (corresponding author), Univ Lille 1, Univ Lille Nord France, Lab Act Phys Muscle & Sante, EA4488,IFR114,IRP2B, Villeneuve Dascq, France.	bruno.bastide@univ-lille1.fr	Cieniewski-Bernard, Caroline/AAR-8967-2021; Cieniewski-Bernard, Caroline/AAK-7477-2021; Serge, Berthoin/F-1635-2018	Serge, Berthoin/0000-0001-7577-0673; Montel, Valerie/0000-0002-7286-4209; Cieniewski-Bernard, Caroline/0000-0003-1449-0357; Bastide, bruno/0000-0002-7544-463X	Association Francaise contre les Myopathies [13890]; Centre National d'Etudes Spatiales [4800000580]	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	This work was supported by grants from the Association Francaise contre les Myopathies (no13890) and the Centre National d'Etudes Spatiales (4800000580). The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.	Arias EB, 2005, ACTA PHYSIOL SCAND, V183, P281, DOI 10.1111/j.1365-201X.2004.01403.x; Arias EB, 2004, DIABETES, V53, P921, DOI 10.2337/diabetes.53.4.921; Bastide B, 2002, PFLUG ARCH EUR J PHY, V444, P345, DOI 10.1007/s00424-002-0833-x; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Cieniewski-Bernard C, 2006, J APPL PHYSIOL, V100, P1499, DOI 10.1152/japplphysiol.00865.2005; Cieniewski-Bernard C, 2004, MOL CELL PROTEOMICS, V3, P577, DOI 10.1074/mcp.M400024-MCP200; Cieniewski-Bernard C, 2009, J MUSCLE RES CELL M, V30, P281, DOI 10.1007/s10974-010-9201-1; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hedou J, 2007, J BIOL CHEM, V282, P10360, DOI 10.1074/jbc.M606787200; Hedou J, 2009, PROTEOMICS, V9, P2139, DOI 10.1002/pmic.200800617; Huang P, 2011, AM J PHYSIOL-CELL PH, V300, pC456, DOI 10.1152/ajpcell.00124.2010; Jin JP, 2000, AM J PHYSIOL-CELL PH, V279, pC1067, DOI 10.1152/ajpcell.2000.279.4.C1067; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Kischel P, 2005, AM J PHYSIOL-CELL PH, V289, pC437, DOI 10.1152/ajpcell.00365.2004; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Lefebvre T, 2010, BBA-GEN SUBJECTS, V1800, P67, DOI 10.1016/j.bbagen.2009.08.008; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Mehdy A, 2012, J BIOCHEM, V151, P439, DOI 10.1093/jb/mvs012; MOUNIER Y, 1989, PFLUG ARCH EUR J PHY, V415, P136, DOI 10.1007/BF00370583; Not LG, 2010, CRIT CARE MED, V38, P562, DOI 10.1097/CCM.0b013e3181cb10b3; PERSECHINI A, 1985, J BIOL CHEM, V260, P7951; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; STACE PB, 1990, FEBS LETT, V273, P91, DOI 10.1016/0014-5793(90)81058-V; STEPHENSON GMM, 1993, PFLUG ARCH EUR J PHY, V424, P30, DOI 10.1007/BF00375099; Stubbs KA, 2009, ANGEW CHEM INT EDIT, V48, P1300, DOI 10.1002/anie.200804583; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Szczesna D, 2002, J APPL PHYSIOL, V92, P1661, DOI 10.1152/japplphysiol.00858.2001; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara Natasha E., 2008, V464, P227; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zou LY, 2007, SHOCK, V27, P402, DOI 10.1097/01.shk.0000245031.31859.29	41	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48218	10.1371/journal.pone.0048218	http://dx.doi.org/10.1371/journal.pone.0048218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110217	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200160
J	Cooksley-Decasper, S; Reiser, H; Thommen, DS; Biedermann, B; Neidhart, M; Gawinecka, J; Cathomas, G; Franzeck, FC; Wyss, C; Klingenberg, R; Nanni, P; Roschitzki, B; Matter, C; Wolint, P; Emmert, MY; Husmann, M; Amann-Vesti, B; Maier, W; Gay, S; Luscher, TF; von Eckardstein, A; Hof, D				Cooksley-Decasper, Seraina; Reiser, Hans; Thommen, Daniela S.; Biedermann, Barbara; Neidhart, Michel; Gawinecka, Joanna; Cathomas, Gieri; Franzeck, Fabian C.; Wyss, Christophe; Klingenberg, Roland; Nanni, Paolo; Roschitzki, Bernd; Matter, Christian; Wolint, Petra; Emmert, Maximilian Y.; Husmann, Marc; Amann-Vesti, Beatrice; Maier, Wilibald; Gay, Steffen; Luescher, Thomas F.; von Eckardstein, Arnold; Hof, Danielle			Antibody Phage Display Assisted Identification of Junction Plakoglobin as a Potential Biomarker for Atherosclerosis	PLOS ONE			English	Article							RISK; EXPRESSION; INFLAMMATION; MECHANISMS; FRAGMENTS; MUTATION; CADHERIN; DISEASE; HEART	To date, no plaque-derived blood biomarker is available to allow diagnosis, prognosis or monitoring of atherosclerotic vascular diseases. In this study, specimens of thrombendarterectomy material from carotid and iliac arteries were incubated in protein-free medium to obtain plaque and control secretomes for subsequent subtractive phage display. The selection of nine plaque secretome-specific antibodies and the analysis of their immunopurified antigens by mass spectrometry led to the identification of 22 proteins. One of them, junction plakoglobin (JUP-81) and its smaller isoforms (referred to as JUP-63, JUP- 55 and JUP- 30 by molecular weight) were confirmed by immunohistochemistry and immunoblotting with independent antibodies to be present in atherosclerotic plaques and their secretomes, coronary thrombi of patients with acute coronary syndrome (ACS) and macrophages differentiated from peripheral blood monocytes as well as macrophage-like cells differentiated from THP1 cells. Plasma of patients with stable coronary artery disease (CAD) (n = 15) and ACS (n = 11) contained JUP- 81 at more than 2- and 14-fold higher median concentrations, respectively, than plasma of CAD-free individuals (n = 13). In conclusion, this proof of principle study identified and verified JUP isoforms as potential plasma biomarkers for atherosclerosis. Clinical validation studies are needed to determine its diagnostic efficacy and clinical utility as a biomarker for diagnosis, prognosis or monitoring of atherosclerotic vascular diseases.	[Cooksley-Decasper, Seraina; Reiser, Hans; Gawinecka, Joanna; von Eckardstein, Arnold; Hof, Danielle] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Cooksley-Decasper, Seraina; Neidhart, Michel; Matter, Christian; Maier, Wilibald; Gay, Steffen; Luescher, Thomas F.; von Eckardstein, Arnold] Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Thommen, Daniela S.; Biedermann, Barbara] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Neidhart, Michel; Gay, Steffen] Univ Zurich Hosp, Inst Expt Rheumatol, CH-8091 Zurich, Switzerland; [Cathomas, Gieri] Cantonal Inst Pathol, Liestal, Switzerland; [Franzeck, Fabian C.; Wyss, Christophe; Klingenberg, Roland; Matter, Christian; Maier, Wilibald; Luescher, Thomas F.] Univ Zurich Hosp, Dept Cardiol & Cardiovasc Physiol, CH-8091 Zurich, Switzerland; [Nanni, Paolo; Roschitzki, Bernd] FGCZ, Zurich, Switzerland; [Wolint, Petra; Emmert, Maximilian Y.] Univ Zurich Hosp, Dept Cardiovasc Surg, CH-8091 Zurich, Switzerland; [Husmann, Marc; Amann-Vesti, Beatrice] Univ Zurich Hosp, Dept Angiol, CH-8091 Zurich, Switzerland; [Reiser, Hans; von Eckardstein, Arnold] Competence Ctr Syst Physiol & Metab Dis CC SPMD, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Basel; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	von Eckardstein, A (corresponding author), Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland.	Harnold.voneckardstein@usz.ch	Thommen, Daniela/AAS-1669-2020; Stefanadis, Christodoulos/ABH-2232-2020	Thommen, Daniela/0000-0002-7431-2854; Neidhart, Michel/0000-0002-9656-5967; Stefanadis, Christodoulos/0000-0001-5974-6454; Gawinecka, Joanna/0000-0003-3859-0934; Nanni, Paolo/0000-0001-8429-3557	Zurich Center for Integrative Human Physiology (ZIHP); Olga Mayenfisch Foundation; Hartmann Mueller Foundation; Walter L. & Johanna Wolf Foundation; Swiss Heart Foundation; Swiss National Science Foundation	Zurich Center for Integrative Human Physiology (ZIHP); Olga Mayenfisch Foundation; Hartmann Mueller Foundation; Walter L. & Johanna Wolf Foundation; Swiss Heart Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was financially supported by a joint grant from the Zurich Center for Integrative Human Physiology (ZIHP) (www.zihp.uzh.ch), by a grant from the Olga Mayenfisch Foundation, by the Hartmann Mueller Foundation (www.hms.uzh.ch), the Walter L. & Johanna Wolf Foundation, the Swiss Heart Foundation (www.swissheart.ch) and the Swiss National Science Foundation (www.snf.ch) (SPUM - Special Program University Medicine, ACS inflammation) (www.spum-acs.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allport JR, 1997, J EXP MED, V186, P517, DOI 10.1084/jem.186.4.517; Asimaki A, 2007, AM J HUM GENET, V81, P964, DOI 10.1086/521633; Baker JO, 2011, HEART, V97, P447, DOI 10.1136/hrt.2010.205617; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Bobryshev YV, 1999, CARDIOVASC RES, V43, P1003, DOI 10.1016/S0008-6363(99)00125-X; Cochrane GR, 2010, NUCLEIC ACIDS RES, V38, pD1, DOI 10.1093/nar/gkp1077; Corti R, 2011, EUR HEART J, V32, P1709, DOI 10.1093/eurheartj/ehr068; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; de Kleijn DPV, 2010, ARTERIOSCL THROM VAS, V30, P612, DOI 10.1161/ATVBAHA.109.194944; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; deWildt RMT, 1996, EUR J IMMUNOL, V26, P629, DOI 10.1002/eji.1830260319; Duran MC, 2003, PROTEOMICS, V3, P973, DOI 10.1002/pmic.200300389; Franzeck FC, 2012, ATHEROSCLEROSIS, V220, P282, DOI 10.1016/j.atherosclerosis.2011.10.035; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Kampoli AM, 2009, TRENDS MOL MED, V15, P323, DOI 10.1016/j.molmed.2009.06.001; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Kodama Y, 2010, ADV EXP MED BIOL, V680, P125, DOI 10.1007/978-1-4419-5913-3_15; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Martinez-Pinna R, 2011, ARTERIOSCL THROM VAS, V31, P935, DOI 10.1161/ATVBAHA.110.214429; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Momiyama Yukihiko, 2007, Top Magn Reson Imaging, V18, P349; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Revkin JH, 2007, PHARMACOL REV, V59, P40, DOI 10.1124/pr.59.1.1; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Sattar N, 2010, ATHEROSCLEROSIS, V209, P295, DOI 10.1016/j.atherosclerosis.2009.09.016; Siegel DL, 2008, IMMUNOL RES, V42, P118, DOI 10.1007/s12026-008-8044-y; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Sun C, 2012, ARTERIOSCLE IN PRESS, P32; Tunon J, 2010, J AM COLL CARDIOL, V55, P2009, DOI 10.1016/j.jacc.2010.01.036; Wang TJ, 2011, CIRCULATION, V123, P551, DOI 10.1161/CIRCULATIONAHA.109.912568; Willemsen R, 2008, CYTOM PART A, V73A, P1093, DOI 10.1002/cyto.a.20644	35	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47985	10.1371/journal.pone.0047985	http://dx.doi.org/10.1371/journal.pone.0047985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110151	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000310310200128
J	Flys, T; Gonzalez, R; Sued, O; Conejero, JS; Kestler, E; Sosa, N; McKenzie-White, J; Monzon, II; Torres, CR; Page, K				Flys, Tamara; Gonzalez, Rosalba; Sued, Omar; Conejero, Juana Suarez; Kestler, Edgar; Sosa, Nestor; McKenzie-White, Jane; Irene Monzon, Irma; Torres, Carmen-Rosa; Page, Kathleen			A Novel Educational Strategy Targeting Health Care Workers in Underserved Communities in Central America to Integrate HIV into Primary Medical Care	PLOS ONE			English	Article							WEB; PROFESSIONS; INFORMATION	Background: Current educational strategies to integrate HIV care into primary medical care in Central America have traditionally targeted managers or higher-level officials, rather than local health care workers (HCWs). We developed a complementary online and on-site interactive training program to reach local HCWs at the primary care level in underserved communities. Methods: The training program targeted physicians, nurses, and community HCWs with limited access to traditional onsite training in Panama, Nicaragua, Dominican Republic, and Guatemala. The curriculum focused on principles of HIV care and health systems using a tutor-supported blended educational approach of an 8-week online component, a weeklong on-site problem-solving workshop, and individualized project-based interventions. Results: Of 258 initially active participants, 225 (225/258 = 87.2%) successfully completed the online component and the top 200 were invited to the on-site workshop. Of those, 170 (170/200 = 85%) attended the on-site workshop. In total, 142 completed all three components, including the project phase. Quantitative and qualitative evaluation instruments included knowledge assessments, reflexive essays, and acceptability surveys. The mean pre and post-essay scores demonstrating understanding of social determinants, health system organization, and integration of HIV services were 70% and 87.5%, respectively, with an increase in knowledge of 17.2% (p<0.001). The mean pre- and post-test scores evaluating clinical knowledge were 70.9% and 90.3%, respectively, with an increase in knowledge of 19.4% (p<0.001). A survey of Likert scale and open-ended questions demonstrated overwhelming participant satisfaction with course content, structure, and effectiveness in improving their HIV-related knowledge and skills. Conclusion: This innovative curriculum utilized technology to target HCWs with limited access to educational resources. Participants benefited from technical skills acquired through the process, and could continue working within their underserved communities while participating in the online component and then implement interventions that successfully converted theoretical knowledge to action to improve integration of HIV care into primary care.	[Flys, Tamara; McKenzie-White, Jane; Page, Kathleen] Johns Hopkins Sch Med, Baltimore, MD USA; [Gonzalez, Rosalba; Sosa, Nestor] Gorgas Mem Inst, Panama City, Panama; [Sued, Omar; Conejero, Juana Suarez] Pan Amer Hlth Org, Washington, DC USA; [Kestler, Edgar; Irene Monzon, Irma] Ctr Invest Epidemiol Salud Sexual & Reprod CIESAR, Guatemala City, Guatemala; [Torres, Carmen-Rosa] US Dept Hlth & Human Serv HHS, Washington, DC USA	Johns Hopkins University; Johns Hopkins Medicine; Instituto Conmemorativo Gorgas de Estudios de la Salud; Pan American Health Organization	Flys, T (corresponding author), Johns Hopkins Sch Med, Baltimore, MD USA.	tflys1@jhmi.edu	Sued, Omar/H-3325-2019	Sued, Omar/0000-0001-5818-770X	Health Diplomacy Program, Office of Global Affairs, United States Department of Health and Human Services (HHS) [GHSGH090016-01-0]; HHS	Health Diplomacy Program, Office of Global Affairs, United States Department of Health and Human Services (HHS); HHS(United States Department of Health & Human Services)	This project was supported by Grant Number GHSGH090016-01-0 from the Health Diplomacy Program, Office of Global Affairs, United States Department of Health and Human Services (HHS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Office of Global Affairs, or HHS. As this program was funded by HHS under a cooperative agreement, the program manager for HHS Carmen-Rosa Torres, had an extensive role in the development, deployment, and analysis of the training program, and critically revised the manuscript.	Barczyk J, 2010, INT J PUBLIC HEALTH, V55, P693, DOI 10.1007/s00038-010-0179-7; Campbell M, 2008, INT J NURS STUD, V45, P750, DOI 10.1016/j.ijnurstu.2006.12.011; Canchihuaman FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019318; Carr S., 2000, CHRON HIGHER EDUC, V46, pA39; Chandrasekhar CP, 2001, B WORLD HEALTH ORGAN, V79, P850; Consejo de Ministros de Salud de Centroamerica, 2010, PLAN ESTR REG 8 SIDA; Cook DA, 2004, MED TEACH, V26, P599, DOI 10.1080/01421590400004932; Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Cook DA, 2007, CLIN MED, V7, P37, DOI 10.7861/clinmedicine.7-1-37; Cook DA, 2010, MED EDUC, V44, P765, DOI 10.1111/j.1365-2923.2010.03723.x; Cook DA, 2010, ACAD MED, V85, P909, DOI 10.1097/ACM.0b013e3181d6c319; Dean AG, 2007, EPI INFO DATABASE ST; Epstein RM, 2007, NEW ENGL J MED, V356, P387, DOI 10.1056/NEJMra054784; Frank JR, 2010, MED TEACH, V32, P631, DOI 10.3109/0142159X.2010.500898; Harden RM, 2005, J CONTIN EDUC HEALTH, V25, P43, DOI 10.1002/chp.8; Murray B., 2001, ELEARN MAGAZINE; *PAN AM HLTH ORG, 2005, REG HIV STI PLAN HLT; Pan American Health Organization, 2007, HLTH SYST PROF GUAT; Pan American Health Organization, 2007, HLTH SYST PROF DOM R; Pan American Health Organization, 2009, IN REG EL TRANSM MAT; Pan American Health Organization, 2007, HLTH SYST PROF PAN; Pan American Health Organization, 2005, 7 REG M OBS HUM RES; Pan American Health Organization, 2007, HLTH SYST PROF NIC; Rovai A. P, 2002, INT REV RES OPEN DIS; Smith L, 2005, MED TEACH, V27, P396, DOI 10.1080/01421590500086649; Toro PL, 2012, J ASS NURSES AIDS CA; Willett LL, 2009, TEACH LEARN MED, V21, P87, DOI 10.1080/10401330902791206; World Health Organization, 2008, UN ACC SCAL PRIOR HI	28	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e46426	10.1371/journal.pone.0046426	http://dx.doi.org/10.1371/journal.pone.0046426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115628	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200015
J	Froger, N; Cadetti, L; Lorach, H; Martins, J; Bemelmans, AP; Dubus, E; Degardin, J; Pain, D; Forster, V; Chicaud, L; Ivkovic, I; Simonutti, M; Fouquet, S; Jammoul, F; Leveillard, T; Benosman, R; Sahel, JA; Picaud, S				Froger, Nicolas; Cadetti, Lucia; Lorach, Henri; Martins, Joao; Bemelmans, Alexis-Pierre; Dubus, Elisabeth; Degardin, Julie; Pain, Dorothee; Forster, Valerie; Chicaud, Laurent; Ivkovic, Ivana; Simonutti, Manuel; Fouquet, Stephane; Jammoul, Firas; Leveillard, Thierry; Benosman, Ryad; Sahel, Jose-Alain; Picaud, Serge			Taurine Provides Neuroprotection against Retinal Ganglion Cell Degeneration	PLOS ONE			English	Article							ANGLE-CLOSURE GLAUCOMA; AMINO-ACIDS; RAT RETINA; VIGABATRIN TOXICITY; PHOTORECEPTOR LOSS; DIABETES-MELLITUS; OPTIC ATROPHY; SECONDARY; DEFICIENCY; TRANSPORT	Retinal ganglion cell (RGC) degeneration occurs in numerous retinal diseases leading to blindness, either as a primary process like in glaucoma, or secondary to photoreceptor loss. However, no commercial drug is yet directly targeting RGCs for their neuroprotection. In the 70s, taurine, a small sulfonic acid provided by nutrition, was found to be essential for the survival of photoreceptors, but this dependence was not related to any retinal disease. More recently, taurine deprivation was incriminated in the retinal toxicity of an antiepileptic drug. We demonstrate here that taurine can improve RGC survival in culture or in different animal models of RGC degeneration. Taurine effect on RGC survival was assessed in vitro on primary pure RCG cultures under serum-deprivation conditions, and on NMDA-treated retinal explants from adult rats. In vivo, taurine was administered through the drinking water in two glaucomatous animal models (DBA/2J mice and rats with vein occlusion) and in a model of Retinitis pigmentosa with secondary RGC degeneration (P23H rats). After a 6-day incubation, 1 mM taurine significantly enhanced RGCs survival (+68%), whereas control RGCs were cultured in a taurine-free medium, containing all natural amino-acids. This effect was found to rely on taurine-uptake by RGCs. Furthermore taurine (1 mM) partly prevented NMDA-induced RGC excitotoxicity. Finally, taurine supplementation increased RGC densities both in DBA/2J mice, in rats with vein occlusion and in P23H rats by contrast to controls drinking taurine-free water. This study indicates that enriched taurine nutrition can directly promote RGC survival through RGC intracellular pathways. It provides evidence that taurine can positively interfere with retinal degenerative diseases.	[Froger, Nicolas; Cadetti, Lucia; Lorach, Henri; Martins, Joao; Bemelmans, Alexis-Pierre; Dubus, Elisabeth; Degardin, Julie; Pain, Dorothee; Forster, Valerie; Chicaud, Laurent; Ivkovic, Ivana; Simonutti, Manuel; Fouquet, Stephane; Jammoul, Firas; Leveillard, Thierry; Benosman, Ryad; Sahel, Jose-Alain; Picaud, Serge] Inst Vis, INSERM, UMR 968, Paris, France; [Froger, Nicolas; Cadetti, Lucia; Lorach, Henri; Martins, Joao; Bemelmans, Alexis-Pierre; Dubus, Elisabeth; Degardin, Julie; Pain, Dorothee; Forster, Valerie; Chicaud, Laurent; Ivkovic, Ivana; Simonutti, Manuel; Fouquet, Stephane; Jammoul, Firas; Leveillard, Thierry; Benosman, Ryad; Sahel, Jose-Alain; Picaud, Serge] Univ Paris 06, UMR S 968, Inst Vis, Paris, France; [Froger, Nicolas; Cadetti, Lucia; Lorach, Henri; Martins, Joao; Bemelmans, Alexis-Pierre; Dubus, Elisabeth; Degardin, Julie; Pain, Dorothee; Forster, Valerie; Chicaud, Laurent; Ivkovic, Ivana; Simonutti, Manuel; Fouquet, Stephane; Jammoul, Firas; Leveillard, Thierry; Benosman, Ryad; Sahel, Jose-Alain; Picaud, Serge] CNRS, UMR7210, Inst Vis, Paris, France; [Leveillard, Thierry; Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [Benosman, Ryad] Univ Paris 06, Inst Syst Intelligents & Robot, Paris, France; [Benosman, Ryad] CNRS, UMR7222, Paris, France; [Sahel, Jose-Alain] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain; Picaud, Serge] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] French Acad Sci, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); University of London; University College London; Fondation Adolphe de Rothschild	Froger, N (corresponding author), Inst Vis, INSERM, UMR 968, Paris, France.	nicolas.froger@inserm.fr; serge.picaud@inserm.fr	Léveillard, Thierry/AAR-1804-2020; Picaud, Serge/H-4012-2014; Sahel, Jose-Alain/F-3172-2017; Bemelmans, Alexis-Pierre/H-4476-2019	Léveillard, Thierry/0000-0001-5692-8770; Picaud, Serge/0000-0002-0548-5145; Sahel, Jose-Alain/0000-0002-4831-1153; Bemelmans, Alexis-Pierre/0000-0001-7605-5225; LORACH, HENRI/0000-0003-4337-2798; Martins, Joao/0000-0001-7764-286X	Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie (Paris VI); Fondation Ophtalmologique A. de Rothschild (Paris); Agence Nationale pour la Recherche (ANR: GLAUCOME); European Community [HEALTH-F2-2010-242013]; Federation des Aveugles de France, IRRP; city of Paris; Regional Council of Ile-de-France; Fondation pour la Recherche Medicale; Fundacao para a Ciencia e a Tecnologia	Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie (Paris VI); Fondation Ophtalmologique A. de Rothschild (Paris); Agence Nationale pour la Recherche (ANR: GLAUCOME)(French National Research Agency (ANR)); European Community(European Commission); Federation des Aveugles de France, IRRP; city of Paris(Region Ile-de-France); Regional Council of Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Institut National de la Sante et de la Recherche Medicale, Universite Pierre et Marie Curie (Paris VI), the Fondation Ophtalmologique A. de Rothschild (Paris), Agence Nationale pour la Recherche (ANR: GLAUCOME), the European Community contrat TREATRUSH (no HEALTH-F2-2010-242013), the Federation des Aveugles de France, IRRP, the city of Paris, the Regional Council of Ile-de-France. L. Cadetti and NF received postdoctoral fellowships from the Fondation pour la Recherche Medicale, JM a doctoral fellowship from the Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araie M, 2009, CLIN RELEVANCE OCULA; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Brons C, 2004, EUR J CLIN NUTR, V58, P1239, DOI 10.1038/sj.ejcn.1601955; Buncic JR, 2004, OPHTHALMOLOGY, V111, P1935, DOI 10.1016/j.ophtha.2004.03.036; BUNIN AY, 1992, VESTN OFTALMOL, V108, P13; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chen F, 2010, OPHTHALMIC RES, V44, P105, DOI 10.1159/000312818; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Danesh-Meyer HV, 2009, AM J OPHTHALMOL, V148, P186, DOI 10.1016/j.ajo.2009.03.029; El Idrissi A, 2008, AMINO ACIDS, V34, P321, DOI 10.1007/s00726-006-0396-9; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; FRANCONI F, 1995, AM J CLIN NUTR, V61, P1115, DOI 10.1093/ajcn/61.5.1115; Frisen L, 2003, ACTA OPHTHALMOL SCAN, V81, P466, DOI 10.1034/j.1600-0420.2003.00125.x; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; Garcia-Ayuso D, 2010, EXP EYE RES, V91, P800, DOI 10.1016/j.exer.2010.10.003; Gaucher D, 2012, AMINO ACIDS IN PRESS; HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; IMAKI H, 1987, J NEUROSCI RES, V18, P602, DOI 10.1002/jnr.490180414; Jammoul F, 2010, MOL CELL NEUROSCI, V43, P414, DOI 10.1016/j.mcn.2010.01.008; Jammoul F, 2009, ANN NEUROL, V65, P98, DOI 10.1002/ana.21526; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; KENDELL KR, 1995, INVEST OPHTH VIS SCI, V36, P200; Kim ES, 2003, ADV EXP MED BIOL, V526, P277; Kolomiets B, 2010, NEUROBIOL DIS, V38, P47, DOI 10.1016/j.nbd.2009.12.025; Kubota T, 1996, GRAEF ARCH CLIN EXP, V234, P351, DOI 10.1007/BF00190710; LAKE N, 1988, VISION RES, V28, P1071, DOI 10.1016/0042-6989(88)90133-2; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; MACAIONE S, 1974, J NEUROCHEM, V22, P887, DOI 10.1111/j.1471-4159.1974.tb04313.x; Madl JE, 2005, AM J VET RES, V66, P791, DOI 10.2460/ajvr.2005.66.791; Mittag TW, 2000, INVEST OPHTH VIS SCI, V41, P3451; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; PANDA S, 1992, INVEST OPHTH VIS SCI, V33, P2532; Pasantes-Morales H, 2002, METAB BRAIN DIS, V17, P183, DOI 10.1023/A:1019926122125; PASANTESMORALES H, 1983, J NEUROSCI RES, V9, P135, DOI 10.1002/jnr.490090205; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Rascher K, 2004, VISION RES, V44, P2091, DOI 10.1016/j.visres.2004.03.027; Ravindran J, 2001, J NEUROL NEUROSUR PS, V70, P787, DOI 10.1136/jnnp.70.6.787; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; SCHMIDT SY, 1985, INVEST OPHTH VIS SCI, V26, P679; Seki M, 2008, PROG BRAIN RES, V173, P495, DOI 10.1016/S0079-6123(08)01134-5; Shao A, 2008, REGUL TOXICOL PHARM, V50, P376, DOI 10.1016/j.yrtph.2008.01.004; Shuaib A, 2003, ADV EXP MED BIOL, V526, P421; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tomi M, 2008, BBA-BIOMEMBRANES, V1778, P2138, DOI 10.1016/j.bbamem.2008.04.012; TORNQUIST P, 1986, GRAEF ARCH CLIN EXP, V224, P21, DOI 10.1007/BF02144127; Vallazza-Deschamps G, 2005, EUR J NEUROSCI, V22, P1013, DOI 10.1111/j.1460-9568.2005.04306.x; Villegas-Perez MP, 1998, J COMP NEUROL, V392, P58, DOI 10.1002/(SICI)1096-9861(19980302)392:1<58::AID-CNE5>3.0.CO;2-O; Wild JM, 2006, INVEST OPHTH VIS SCI, V47, P917, DOI 10.1167/iovs.05-0854; Wu JY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S1; Yamori Y, 2006, J HYPERTENS, V24, P1499, DOI 10.1097/01.hjh.0000239284.12691.2e; Young TL, 2005, CURR BIOL, V15, P501, DOI 10.1016/j.cub.2005.02.027	56	60	61	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e42017	10.1371/journal.pone.0042017	http://dx.doi.org/10.1371/journal.pone.0042017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115615	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200002
J	Sapi, E; Bastian, SL; Mpoy, CM; Scott, S; Rattelle, A; Pabbati, N; Poruri, A; Burugu, D; Theophilus, PAS; Pham, TV; Datar, A; Dhaliwal, NK; MacDonald, A; Rossi, MJ; Sinha, SK; Luecke, DF				Sapi, Eva; Bastian, Scott L.; Mpoy, Cedric M.; Scott, Shernea; Rattelle, Amy; Pabbati, Namrata; Poruri, Akhila; Burugu, Divya; Theophilus, Priyanka A. S.; Pham, Truc V.; Datar, Akshita; Dhaliwal, Navroop K.; MacDonald, Alan; Rossi, Michael J.; Sinha, Saion K.; Luecke, David F.			Characterization of Biofilm Formation by Borrelia burgdorferi In vitro	PLOS ONE			English	Article							CYSTIC FORMS; ANTIBIOTIC-TREATMENT; MORPHOLOGY; ALGINATE; BIOSYNTHESIS; PERSISTENCE	Borrelia burgdorferi, the causative agent of Lyme disease, has long been known to be capable of forming aggregates and colonies. It was recently demonstrated that Borrelia burgdorferi aggregate formation dramatically changes the in vitro response to hostile environments by this pathogen. In this study, we investigated the hypothesis that these aggregates are indeed biofilms, structures whose resistance to unfavorable conditions are well documented. We studied Borrelia burgdorferi for several known hallmark features of biofilm, including structural rearrangements in the aggregates, variations in development on various substrate matrices and secretion of a protective extracellular polymeric substance (EPS) matrix using several modes of microscopic, cell and molecular biology techniques. The atomic force microscopic results provided evidence that multilevel rearrangements take place at different stages of aggregate development, producing a complex, continuously rearranging structure. Our results also demonstrated that Borrelia burgdorferi is capable of developing aggregates on different abiotic and biotic substrates, and is also capable of forming floating aggregates. Analyzing the extracellular substance of the aggregates for potential exopolysaccharides revealed the existence of both sulfated and nonsulfated/carboxylated substrates, predominately composed of an alginate with calcium and extracellular DNA present. In summary, we have found substantial evidence that Borrelia burgdorferi is capable of forming biofilm in vitro. Biofilm formation by Borrelia species might play an important role in their survival in diverse environmental conditions by providing refuge to individual cells.	[Sapi, Eva; Bastian, Scott L.; Mpoy, Cedric M.; Scott, Shernea; Rattelle, Amy; Pabbati, Namrata; Poruri, Akhila; Burugu, Divya; Theophilus, Priyanka A. S.; Pham, Truc V.; Datar, Akshita; Dhaliwal, Navroop K.; MacDonald, Alan; Rossi, Michael J.; Luecke, David F.] Univ New Haven, Dept Biol & Environm Sci, Lyme Dis Res Grp, West Haven, CT 06516 USA; [Sinha, Saion K.] Univ New Haven, Dept Phys, West Haven, CT USA	University New Haven; University New Haven	Sapi, E (corresponding author), Univ New Haven, Dept Biol & Environm Sci, Lyme Dis Res Grp, West Haven, CT 06516 USA.	esapi@newhaven.edu	MacDonald, Alan Bruce/AAX-9220-2020	Poruri, Akhila/0000-0003-3033-061X	Turn the Corner Foundation; Lyme Disease Association; Lyme Research Alliance; University of New Haven	Turn the Corner Foundation; Lyme Disease Association; Lyme Research Alliance; University of New Haven	This work was supported by grants from the Turn the Corner Foundation, the Lyme Disease Association, Lyme Research Alliance and the University of New Haven to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERER E, 1991, J CLIN MICROBIOL, V29, P764, DOI 10.1128/JCM.29.4.764-772.1991; Alban PS, 2000, MICROBIOL-SGM, V146, P119, DOI 10.1099/00221287-146-1-119; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; ANDERSON AJ, 1987, J GEN MICROBIOL, V133, P1045; BANERJEE PC, 1985, J BACTERIOL, V161, P458, DOI 10.1128/JB.161.1.458-460.1985; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; Barthold SW, 2010, ANTIMICROB AGENTS CH, V54, P643, DOI 10.1128/AAC.00788-09; Bastian S, 2011, THESIS U NEW HAVEN W; Bransa SS, 2005, TRENDS MICROBIOL, V13, P20; Brorson O, 1998, INFECT, V26, P44; BURGDORFER W, 1989, REV INFECT DIS, V11, pS1442; Clementi F, 1997, CRIT REV BIOTECHNOL, V17, P327, DOI 10.3109/07388559709146618; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dunham-Ems SM, 2009, J CLIN INVEST, V119, P3652, DOI 10.1172/JCI39401; Eisendle K, 2007, AM J CLIN PATHOL, V127, P213, DOI 10.1309/3369XXFPEQUNEP5C; Embers ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029914; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Gruntar I, 2001, APMIS, V109, P383, DOI 10.1034/j.1600-0463.2001.090507.x; HAMPP EG, 1951, J BACTERIOL, V62, P347, DOI 10.1128/JB.62.3.347-349.1951; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Hodzic E, 2008, ANTIMICROB AGENTS CH, V52, P1728, DOI 10.1128/AAC.01050-07; Hoyle B D, 1991, Prog Drug Res, V37, P91; KERSTEN A, 1995, ANTIMICROB AGENTS CH, V39, P1127, DOI 10.1128/AAC.39.5.1127; KURTTI TJ, 1987, J CLIN MICROBIOL, V25, P2054, DOI 10.1128/JCM.25.11.2054-2058.1987; LIEGNER KB, 1993, J AM ACAD DERMATOL, V28, P312, DOI 10.1016/0190-9622(93)70043-S; MacDonald AB, 2006, MED HYPOTHESES, V67, P819, DOI 10.1016/j.mehy.2006.04.025; Miklossy J, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-40; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Murgia R, 2004, APMIS, V112, P57, DOI 10.1111/j.1600-0463.2004.apm1120110.x; Mursic VP, 1996, INFECTION, V24, P218, DOI 10.1007/BF01781096; PREACMURSIC V, 1989, INFECTION, V17, P355, DOI 10.1007/BF01645543; Remminghorst U, 2006, BIOTECHNOL LETT, V28, P1701, DOI 10.1007/s10529-006-9156-x; Ristow P, 2008, MICROBIOL-SGM, V154, P1309, DOI 10.1099/mic.0.2007/014746-0; Sapi E, 2008, AM J CLIN PATHOL, V129, P988; Sapi Eva, 2011, Infect Drug Resist, V4, P97, DOI 10.2147/IDR.S19201; Singh R, 2003, APPL ENVIRON MICROB, V69, P3412, DOI 10.1128/AEM.69.6.3412-3420.2003; SPICER SS, 1960, AM J CLIN PATHOL, V33, P453, DOI 10.1093/ajcp/33.5_ts.453; Srivastava SY, 2009, VECTOR-BORNE ZOONOT, V9, P323, DOI 10.1089/vbz.2008.0148; STEERE AC, 1994, ARTHRITIS RHEUM-US, V37, P878, DOI 10.1002/art.1780370616; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Straubinger RK, 1997, J CLIN MICROBIOL, V35, P111, DOI 10.1128/JCM.35.1.111-116.1997; Vesey PM, 2004, MICROBIOL-SGM, V150, P2401, DOI 10.1099/mic.0.26816-0; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	45	73	80	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48277	10.1371/journal.pone.0048277	http://dx.doi.org/10.1371/journal.pone.0048277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110225	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200165
J	Mendelev, N; Mehta, SL; Idris, H; Kumari, S; Li, PA				Mendelev, Natalia; Mehta, Suresh L.; Idris, Haza; Kumari, Santosh; Li, P. Andy			Selenite Stimulates Mitochondrial Biogenesis Signaling and Enhances Mitochondrial Functional Performance in Murine Hippocampal Neuronal Cells	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; NUCLEAR CONTROL; BRAIN-INJURY; SUPPLEMENTATION; SELENOPROTEINS; ACTIVATION; APOPTOSIS; EBSELEN; PATHWAY	Supplementation of selenium has been shown to protect cells against free radical mediated cell damage. The objectives of this study are to examine whether supplementation of selenium stimulates mitochondrial biogenesis signaling pathways and whether selenium enhances mitochondrial functional performance. Murine hippocampal neuronal HT22 cells were treated with sodium selenite for 24 hours. Mitochondrial biogenesis markers, mitochondrial respiratory rate and activities of mitochondrial electron transport chain complexes were measured and compared to non-treated cells. The results revealed that treatment of selenium to the HT22 cells elevated the levels of nuclear mitochondrial biogenesis regulators PGC-1 alpha and NRF1, as well as mitochondrial proteins cytochrome c and cytochrome c oxidase IV (COX IV). These effects are associated with phosphorylation of Akt and cAMP response element-binding (CREB). Supplementation of selenium significantly increased mitochondrial respiration and improved the activities of mitochondrial respiratory complexes. We conclude that selenium activates mitochondrial biogenesis signaling pathway and improves mitochondrial function. These effects may be associated with modulation of AKT-CREB pathway.	[Mendelev, Natalia; Mehta, Suresh L.; Idris, Haza; Kumari, Santosh; Li, P. Andy] N Carolina Cent Univ, Dept Pharmaceut Sci, BRITE, Durham, NC USA; [Li, P. Andy] Ningxia Med Univ, Dept Pathol, Ningxia, Peoples R China	University of North Carolina; North Carolina Central University; Ningxia Medical University	Li, PA (corresponding author), N Carolina Cent Univ, Dept Pharmaceut Sci, BRITE, Durham, NC USA.	pli@nccu.edu		Mendelev, Natalia/0000-0001-8596-2986; /0000-0002-5634-5230	National Institutes of Health [7R01DK075476]; Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Golden Leaf Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from the National Institutes of Health (7R01DK075476). The BRITE (Biomanufacturing Research Institute and Technology Enterprise) is partially funded by the Golden Leaf Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, BIOL TRACE ELEM RES, V139, P81, DOI 10.1007/s12011-010-8643-z; Ahmad N, 2006, AM J PHYSIOL-HEART C, V290, pH2402, DOI 10.1152/ajpheart.00737.2005; Ansari MA, 2004, BIOL TRACE ELEM RES, V101, P73, DOI 10.1385/BTER:101:1:73; Bergeron R, 2004, AM J PHYSIOL-ENDOC M, V281, pE1340; Bordoni A, 2005, J AGR FOOD CHEM, V53, P490, DOI 10.1021/jf049426d; Desai VG, 2001, ARCH BIOCHEM BIOPHYS, V394, P255, DOI 10.1006/abbi.2001.2548; Heath JC, 2010, NEUROTOXICOLOGY, V31, P169, DOI 10.1016/j.neuro.2010.01.003; Hoffmann PR, 2007, J IMMUNOL, V179, P3258, DOI 10.4049/jimmunol.179.5.3258; Jackson-Rosario SE, 2010, METALLOMICS, V2, P112, DOI 10.1039/b917141j; Jung U, 2001, FREE RADICAL BIO MED, V31, P479, DOI 10.1016/S0891-5849(01)00604-9; Kabuyama Y, 2007, GENES CELLS, V12, P1235, DOI 10.1111/j.1365-2443.2007.01127.x; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; Maher P, 2006, ANTIOXID REDOX SIGN, V8, P1941, DOI 10.1089/ars.2006.8.1941; Maraldi T, 2011, NEUROTOXICOLOGY, V32, P180, DOI 10.1016/j.neuro.2010.10.008; McLean CW, 2005, DEV NEUROSCI-BASEL, V27, P169, DOI 10.1159/000085989; Mehta SL, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-79; Mitsui A, 2002, ANTIOXID REDOX SIGN, V4, P693, DOI 10.1089/15230860260220201; Ozbal S, 2008, NEUROSCI LETT, V438, P265, DOI 10.1016/j.neulet.2008.03.091; Panee J, 2007, INT J BIOL SCI, V3, P335; Panee J, 2007, J BIOL CHEM, V282, P23759, DOI 10.1074/jbc.M702267200; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Porciuncula LO, 2001, NEUROSCI LETT, V299, P217, DOI 10.1016/S0304-3940(01)01519-1; Rosner M, 2007, AMINO ACIDS, V32, P341, DOI 10.1007/s00726-007-0509-0; Santamaria A, 2005, SYNAPSE, V58, P258, DOI 10.1002/syn.20206; Sarker KP, 2003, J NEUROCHEM, V87, P1345, DOI 10.1046/j.1471-4159.2003.02096.x; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Stapleton SR, 2000, CELL MOL LIFE SCI, V57, P1874, DOI 10.1007/PL00000669; Stone CA, 2010, NUTR REV, V68, P671, DOI 10.1111/j.1753-4887.2010.00337.x; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wang Q, 2007, ACTA PHARMACOL SIN, V28, P19, DOI 10.1111/j.1745-7254.2007.00469.x; Wang Y, 2009, REDOX REP, V14, P243, DOI 10.1179/135100009X12525712409896; Wojewoda M, 2011, INT J BIOCHEM CELL B, V43, P1178, DOI 10.1016/j.biocel.2011.04.011; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xiao R, 2006, NEUROTOXICOLOGY, V27, P478, DOI 10.1016/j.neuro.2006.01.008; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Yeo JE, 2007, BBA-MOL BASIS DIS, V1772, P1199, DOI 10.1016/j.bbadis.2007.09.004; Yoon SO, 2001, FASEB J, V15, P111, DOI 10.1096/fj.01-0398fje; Yousuf S, 2007, BRAIN RES, V1147, P218, DOI 10.1016/j.brainres.2007.01.143	41	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47910	10.1371/journal.pone.0047910	http://dx.doi.org/10.1371/journal.pone.0047910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110128	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400024
J	El Ati, J; Traissac, P; Delpeuch, F; Aounallah-Skhiri, H; Beji, C; Eymard-Duvernay, S; Bougatef, S; Kolsteren, P; Maire, B; Ben Romdhane, H				El Ati, Jalila; Traissac, Pierre; Delpeuch, Francis; Aounallah-Skhiri, Hajer; Beji, Chiraz; Eymard-Duvernay, Sabrina; Bougatef, Souha; Kolsteren, Patrick; Maire, Bernard; Ben Romdhane, Habiba			Gender Obesity Inequities Are Huge but Differ Greatly According to Environment and Socio-Economics in a North African Setting: A National Cross-Sectional Study in Tunisia	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION TRANSITION; WAIST CIRCUMFERENCE; INCOME COUNTRIES; CUTOFF POINTS; PREVALENCE; HEALTH; DISEASE; EQUITY; WOMEN	Introduction: Southern Mediterranean countries have experienced a marked increase in the prevalence of obesity whose consequences for gender related health inequities have been little studied. We assessed gender obesity inequalities and their environmental and socio-economic modifiers among Tunisian adults. Methods: Cross-sectional survey in 2005; national, 3 level random cluster sample of 35-70 years Tunisians (women: n = 2964, men: n = 2379). Overall adiposity was assessed by BMI = weight(kg)/height(m)(2) and obesity was BMI >= 30, WHtR = waist circumference to height ratio defined abdominal obesity as WHtR >= 0.6. Gender obesity inequality measure was women versus men Prevalence Proportion Odds-Ratio (OR); models featuring gender x covariate interaction assessed variation of gender obesity inequalities with area (urban versus rural), age, marital status or socio-economic position (profession, education, household income proxy). Results: BMI was much higher among women (28.4(0.2)) versus men (25.3(0.1)), P<0.0001) as was obesity (37.0% versus 13.3%, OR = 3.8[3.1-7.4], P<0.0001) and abdominal obesity (42.6% versus 15.6%, 4.0[3.3-4.8], P<0.0001). Gender obesity inequalities (women versus men adjusted OR) were higher in urban (OR = 3.3[1.3-8.7]) than rural (OR = 2.0[0.7-5.5]) areas. These gender obesity inequalities were lower for subjects with secondary education or more (OR = 3.3[1.3-8.6]), than among those with no schooling (OR = 6.9[2.0-23.3]). They were also lower for those with upper/intermediate profession (OR = 1.4[0.5-4.3]) or even employees/workers OR = 2.3[1.0-5.4] than those not professionaly active at all (OR = 3.3[1.3-8.6]). Similar results were observed for addominal obesity. Conclusion: The huge overall gender obesity inequities (women much more corpulent than men) were higher in urban settings, but lower among subjects of higher education and professional activity. Reasons for gender inequalities in obesity and their variation with socio-economic position should be sought so that appropriate policies to reduce these inequalities can be implemented in Tunisia and similar settings.	[Traissac, Pierre; Delpeuch, Francis; Eymard-Duvernay, Sabrina; Maire, Bernard] IRD, NUTRIPASS Res Unit, IRD UM2 UM1, Montpellier, France; [El Ati, Jalila; Beji, Chiraz] INNTA Natl Inst Nutr & Food Technol, Tunis, Tunisia; [Aounallah-Skhiri, Hajer; Bougatef, Souha] INSP Natl Inst Publ Hlth, Tunis, Tunisia; [Kolsteren, Patrick] Inst Trop Med, B-2000 Antwerp, Belgium; [Ben Romdhane, Habiba] Fac Med, Epidemiol & Prevent Cardiovasc Dis Unit, Tunis, Tunisia	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Tunis-El-Manar; Institut National de Nutrition Technologie Alimentaire; Institute of Tropical Medicine (ITM); Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT)	Traissac, P (corresponding author), IRD, NUTRIPASS Res Unit, IRD UM2 UM1, Montpellier, France.	pierre.traissac@ird.fr	ATI, Jalila EL/Y-5467-2018	EL ATI, Jalila/0000-0002-8715-455X; Traissac, Pierre/0000-0002-3184-5597	European Union (INCO: Med Projects Epidemiological Transition And Health Impact in North Africa) [ICA3-CT-2002-10011]; INNTA (National Nutrition Institute of Tunisia); INSP (Tunisian National Public Health Institute); IRD (Institut de Recherche pour le Developpement, France)	European Union (INCO: Med Projects Epidemiological Transition And Health Impact in North Africa); INNTA (National Nutrition Institute of Tunisia); INSP (Tunisian National Public Health Institute); IRD (Institut de Recherche pour le Developpement, France)	This research was funded by the European Union (INCO: Med Projects (1998-2002) Epidemiological Transition And Health Impact in North Africa - Contract Number: ICA3-CT-2002-10011), INNTA (National Nutrition Institute of Tunisia), INSP (Tunisian National Public Health Institute) and IRD (Institut de Recherche pour le Developpement, France). Study design, data collection and analysis, decision to publish and preparation of the manuscript involved personnel from those governemental institutions but they nevertheless conducted the study and the writing according to the best academic practice independently of any recommendations from the funders.	Al-Lawati JA, 2008, PUBLIC HEALTH NUTR, V11, P102, DOI 10.1017/S1368980007000183; Allender S, 2008, J URBAN HEALTH, V85, P938, DOI 10.1007/s11524-008-9325-4; [Anonymous], NAT STAT I TUN RES 2; Aounallah-Skhiri H, 2008, PUBLIC HEALTH NUTR, V11, P1306, DOI 10.1017/S1368980008002693; Aounallah-Skhiri H, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-38; Arambepola C, 2008, TROP MED INT HEALTH, V13, P448, DOI 10.1111/j.1365-3156.2008.02021.x; Ashwell M., 2011, OPEN OBESITY J, V3, P78, DOI [10.2174/1876823701103010078, DOI 10.2174/1876823701103010078]; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Batnitzky A, 2008, SOCIOL HEALTH ILL, V30, P445, DOI 10.1111/j.1467-9566.2007.01067.x; Batnitzky AK, 2011, HEALTH PLACE, V17, P345, DOI 10.1016/j.healthplace.2010.11.012; Belahsen R, 2004, PUBLIC HEALTH NUTR, V7, P523, DOI 10.1079/PHN2003570; Beltaifa L, 2009, OBES REV, V10, P145, DOI 10.1111/j.1467-789X.2008.00543.x; Ben Romdhane H, 2012, HYPERTENS RES, V35, P341, DOI 10.1038/hr.2011.198; Ben Romdhane H, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-9; Benjelloun S, 2002, PUBLIC HEALTH NUTR, V5, P135, DOI 10.1079/PHN2001285; Bouguerra R, 2007, DIABETES OBES METAB, V9, P859, DOI 10.1111/j.1463-1326.2006.00667.x; Bouguerra R, 2007, EUR J CLIN NUTR, V61, P160, DOI 10.1038/sj.ejcn.1602478; Boutayeb A, INT J EQUITY HLTH, V10, P23; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Charrad M, 2007, WASHINGTON LEE LAW R, V64, P1513; Chebel M, 1995, ENCY AMOUR ISLAM ERO; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Delisle HF, 2008, ANN NY ACAD SCI, V1136, P172, DOI 10.1196/annals.1425.026; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; El Rhazi K, 2011, PUBLIC HEALTH NUTR, V14, P160, DOI 10.1017/S1368980010001825; El-Zanaty F., 2009, EGYPT DEMOGRAPHIC HL, DOI DOI 10.1177/0049475514561330; Elasmi M, 2009, REV EPIDEMIOL SANTE, V57, P87, DOI 10.1016/j.respe.2008.12.010; Elmadfa I, 2009, FORUM NUTR, V62, P1, DOI [10.1159/000244607, 10.1159/000242367]; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2009, AM J CLIN NUTR, V89, P1213, DOI 10.3945/ajcn.2008.26698; Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219; Greenland S, 2008, MODERN EPIDEMIOLOGY, P329; Greenland S, 2008, MODERN EPIDEMIOLOGY, P303; Handoussa H, 2010, INT C WOM YOUTH AR D; Hausmann R., 2010, GLOBAL GENDER GAP RE; Holdsworth M, 2009, ANN NUTR METAB, V55; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Institut National de Sante Publique, 2007, ENQ NAT SANT TRANS E; Jaoudi I, 2010, GENDER DIFFERENCES H; Korn E. L., 1999, ANAL HLTH SURVEYS; Lauritsen JM, 2000, EPIDATA DATA ENTRY D; Levy P, 1999, SAMPLING POPULATIONS; Lohman T. G., 1998, ANTROPOMETRIC STANDA; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mejean C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-265; Mobaraki A. E. H., 2010, Eastern Mediterranean Health Journal, V16, P113; Mokhtar N, 2001, J NUTR, V131, p887S, DOI 10.1093/jn/131.3.887S; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Moss NE, 2002, SOC SCI MED, V54, P649, DOI 10.1016/S0277-9536(01)00115-0; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; OKOJIE CEE, 1994, SOC SCI MED, V39, P1237, DOI 10.1016/0277-9536(94)90356-5; Papandreou C, 2008, OBES REV, V9, P389, DOI 10.1111/j.1467-789X.2007.00466.x; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; POPKIN BM, 1994, NUTR REV, V52, P285, DOI 10.1111/j.1753-4887.1994.tb01460.x; Rguibi M, 2007, OBES REV, V8, P11, DOI 10.1111/j.1467-789X.2006.00260.x; Robinson WR, 2009, AM J CLIN NUTR, V89, P1204, DOI 10.3945/ajcn.2007.25751; Searle S.R., 1987, LINEAR MODELS UNBALA; StataCorp, 2011, STAT STAT SOFTW REL, P173; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Tlili F., 2002, STAPS, V57, P53, DOI DOI 10.3917/STA.057.0053; Tlili F, 2008, ECOL FOOD NUTR, V47, P399, DOI 10.1080/03670240802003942; United Nations Development Programme (UNDP), 2008, HUM DEV REP 2007 200; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	69	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48153	10.1371/journal.pone.0048153	http://dx.doi.org/10.1371/journal.pone.0048153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WJ	23118943	Green Published, gold			2022-12-25	WOS:000310600500074
J	Granell, R; Sterne, JAC; Henderson, J				Granell, Raquel; Sterne, Jonathan A. C.; Henderson, John			Associations of Different Phenotypes of Wheezing Illness in Early Childhood with Environmental Variables Implicated in the Aetiology of Asthma	PLOS ONE			English	Article							MATERNAL SMOKING; AIRWAY FUNCTION; LUNG-FUNCTION; EARLY-LIFE; TOBACCO-SMOKE; RISK; PREGNANCY; EXPOSURE; AGE; INFANTS	Rationale: Asthma is a complex heterogeneous disease that has increased in prevalence in many industrialised countries. However, the causes of asthma inception remain elusive. Consideration of sub-phenotypes of wheezing may reveal important clues to aetiological risk factors. Methods: Longitudinal phenotypes capturing population heterogeneity in wheezing reports from birth to 7 years were derived using latent class analysis in the Avon Longitudinal Study of Parents and Children (ALSPAC). Probability of class membership was used to examine the association between five wheezing phenotypes (transient early, prolonged early, intermediate-onset, late-onset, persistent) and early life risk factors for asthma. Results: Phenotypes had similar patterns and strengths of associations with early environmental factors. Comparing transient early with prolonged early wheezing showed a similar pattern of association with most exposure variables considered in terms of the direction of the effect estimates but with prolonged early wheezing tending to have stronger associations than transient early wheezing except for parity and day care attendance. Conclusions: Associations with early life risk factors suggested that prolonged early wheeze might be a severe form of transient early wheezing. Although differences were found in the associations of early life risk factors with individual phenotypes, these did not point to novel aetiological pathways. Persistent wheezing phenotype has features suggesting overlap of early and late-onset phenotypes.	[Granell, Raquel; Sterne, Jonathan A. C.; Henderson, John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Bristol	Granell, R (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	raquel.granell@bris.ac.uk	Sterne, Jonathan/Z-3106-2019; Granell, Raquel/AAB-5256-2022; Granell, Raquel/AAY-4846-2020	Sterne, Jonathan/0000-0001-8496-6053; Granell, Raquel/0000-0002-4890-4012; 	Wellcome Trust [092731]; UK Medical Research Council [0401540]; MRC [G0401540] Funding Source: UKRI; Medical Research Council [G0401540, G9815508] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10168] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC study. R Granell was supported by the UK Medical Research Council (Grant no. 0401540). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Apelberg BJ, 2001, J ALLERGY CLIN IMMUN, V107, P455, DOI 10.1067/mai.2001.113240; Baker D, 1999, J EPIDEMIOL COMMUN H, V53, P636, DOI 10.1136/jech.53.10.636; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Dezateux C, 1999, AM J RESP CRIT CARE, V159, P403, DOI 10.1164/ajrccm.159.2.9712029; Dezateux C, 2001, THORAX, V56, P680, DOI 10.1136/thorax.56.9.680; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Elliott L, 2008, J ALLERGY CLIN IMMUN, V122, P49, DOI 10.1016/j.jaci.2008.04.001; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; Gilliland FD, 2000, THORAX, V55, P271, DOI 10.1136/thorax.55.4.271; Gilliland FD, 2001, AM J RESP CRIT CARE, V163, P429, DOI 10.1164/ajrccm.163.2.2006009; Henderson J, 2009, ARCH DIS CHILD, V94, P333, DOI 10.1136/adc.2008.143636; Henderson J, 2008, THORAX; Jaakkola JJK, 2006, J ALLERGY CLIN IMMUN, V118, P823, DOI 10.1016/j.jaci.2006.06.043; Kerkhof M, 2009, ALLERGY, V64, P1202, DOI 10.1111/j.1398-9995.2009.02016.x; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MARTINEZ FD, 1991, AM REV RESPIR DIS, V143, P312, DOI 10.1164/ajrccm/143.2.312; MARTINEZ FD, 1988, NEW ENGL J MED, V319, P1112, DOI 10.1056/NEJM198810273191702; Martinez Fernando D, 2009, Proc Am Thorac Soc, V6, P272, DOI 10.1513/pats.200808-092RM; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Stick SM, 1996, LANCET, V348, P1060, DOI 10.1016/S0140-6736(96)04446-7; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Torrent M, 2007, AM J RESP CRIT CARE, V176, P446, DOI 10.1164/rccm.200607-916OC; Villamor E, 2009, AM J EPIDEMIOL, V169, P1337, DOI 10.1093/aje/kwp054; Willers SM, 2008, AM J RESP CRIT CARE, V178, P124, DOI 10.1164/rccm.200710-1544OC; 2006, LANCET, V368, P705	30	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48359	10.1371/journal.pone.0048359	http://dx.doi.org/10.1371/journal.pone.0048359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118993	Green Submitted, gold, Green Published			2022-12-25	WOS:000310600500112
J	Iorns, E; Drews-Elger, K; Ward, TM; Dean, S; Clarke, J; Berry, D; El Ashry, D; Lippman, M				Iorns, Elizabeth; Drews-Elger, Katherine; Ward, Toby M.; Dean, Sonja; Clarke, Jennifer; Berry, Deborah; El Ashry, Dorraya; Lippman, Marc			A New Mouse Model for the Study of Human Breast Cancer Metastasis	PLOS ONE			English	Article							GROWTH-FACTOR PDGF; RECEPTOR	Breast cancer is the most common cancer in women, and this prevalence has a major impact on health worldwide. Localized breast cancer has an excellent prognosis, with a 5-year relative survival rate of 85%. However, the survival rate drops to only 23% for women with distant metastases. To date, the study of breast cancer metastasis has been hampered by a lack of reliable metastatic models. Here we describe a novel in vivo model using human breast cancer xenografts in NOD scid gamma (NSG) mice; in this model human breast cancer cells reliably metastasize to distant organs from primary tumors grown within the mammary fat pad. This model enables the study of the entire metastatic process from the proper anatomical site, providing an important new approach to examine the mechanisms underlying breast cancer metastasis. We used this model to identify gene expression changes that occur at metastatic sites relative to the primary mammary fat pad tumor. By comparing multiple metastatic sites and independent cell lines, we have identified several gene expression changes that may be important for tumor growth at distant sites.	[Iorns, Elizabeth; Drews-Elger, Katherine; Dean, Sonja; Clarke, Jennifer; El Ashry, Dorraya; Lippman, Marc] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Iorns, Elizabeth; Drews-Elger, Katherine; Dean, Sonja; Clarke, Jennifer; El Ashry, Dorraya; Lippman, Marc] Univ Miami, Miller Sch Med, Div Hematol & Oncol, Miami, FL 33136 USA; [Ward, Toby M.] Stanford Univ, Sch Med, SCI, Stanford, CA 94305 USA; [Iorns, Elizabeth] Sci Exchange Inc, Palo Alto, CA USA; [Berry, Deborah] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA	University of Miami; University of Miami; Stanford University; Georgetown University	Lippman, M (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	mlippman@med.miami.edu		Clarke, Jennifer/0000-0002-2723-7249; Drews-Elger, Katherine/0000-0001-9540-0610	University of Miami	University of Miami	This work was funded by an endowment from the University of Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss J, 2007, CLIN CANCER RES, V13, P7029, DOI 10.1158/1078-0432.CCR-07-0587; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Carvalho I, 2005, BREAST CANCER RES, V7, pR788, DOI 10.1186/bcr1304; Chiu KH, 2011, J PROTEOME RES, V10, P1110, DOI 10.1021/pr1008724; Driouch K, 2000, BREAST CANCER RES, V2, pP701; Fang WB, 2011, CLIN EXP METASTAS, V28, P351, DOI 10.1007/s10585-011-9373-0; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; LASFARGUES EY, 1978, J NATL CANCER I, V61, P967; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Li XL, 2012, ONCOL REP, V28, P375, DOI 10.3892/or.2012.1792; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; SEYMOUR L, 1994, BREAST CANCER RES TR, V32, P229, DOI 10.1007/BF00665774; SEYMOUR L, 1993, BREAST CANCER RES TR, V26, P247, DOI 10.1007/BF00665802; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Wang F, 2012, ANN SURG ONCOL, V19, P2753, DOI 10.1245/s10434-011-2194-1	21	106	111	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47995	10.1371/journal.pone.0047995	http://dx.doi.org/10.1371/journal.pone.0047995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118918	Green Published, gold			2022-12-25	WOS:000310600500054
J	Lin, TL; Yang, FL; Yang, AS; Peng, HP; Li, TL; Tsai, MD; Wu, SH; Wang, JT				Lin, Tzu-Lung; Yang, Feng-Ling; Yang, An-Suei; Peng, Hung-Pin; Li, Tsung-Lin; Tsai, Ming-Daw; Wu, Shih-Hsiung; Wang, Jin-Town			Amino Acid Substitutions of MagA in Klebsiella pneumoniae Affect the Biosynthesis of the Capsular Polysaccharide	PLOS ONE			English	Article							LIVER-ABSCESS; ESCHERICHIA-COLI; VIRULENCE DETERMINANT; SEROTYPE K1; MEMBRANE; RMPA; PATHOGEN; DISEASE; GENES	Mucoviscosity-associated gene A (magA) of Klebsiella pneumoniae contributes to K1 capsular polysaccharide (CPS) biosynthesis. Based on sequence homology and gene alignment, the magA gene has been predicted to encode a Wzy-type CPS polymerase. Sequence alignment with the Wzy_C and RfaL protein families (which catalyze CPS or lipopolysaccharide (LPS) biosynthesis) and topological analysis has suggested that eight highly conserved residues, including G308, G310, G334, G337, R290, P305, H323, and N324, were located in a hypothetical loop region. Therefore, we used site-directed mutagenesis to study the role of these residues in CPS production, and to observe the consequent phenotypes such as mucoviscosity, serum and phagocytosis resistance, and virulence (as assessed in mice) in pyogenic liver abscess strain NTUH-K2044. Alanine substitutions at R290 or H323 abolished all of these properties. The G308A mutant was severely impaired for these functions. The G334A mutant remained mucoid with decreased CPS production, but its virulence was significantly reduced in vivo. No phenotypic change was observed for strains harboring magA G310A, G337A, P305A, or N324A mutations. Therefore, R290, G308, H323, and G334 are functionally important residues of the MagA (Wzy) protein of K. pneumoniae NTUH-K2044, capsular type K1. These amino acids are also likely to be important for the function of Wzy in other capsular types in K. pneumoniae and other species bearing Wzy_C family proteins.	[Yang, Feng-Ling; Tsai, Ming-Daw; Wu, Shih-Hsiung] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lin, Tzu-Lung; Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Yang, An-Suei; Peng, Hung-Pin; Li, Tsung-Lin] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital	Tsai, MD (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	mdtsai@gate.sinica.edu.tw; shwu@gate.sinica.edu.tw; wangjt@ntu.edu.tw	Tsai, Ming-Daw/G-4689-2019	Tsai, Ming-Daw/0000-0003-1374-0414; Yang, An-Suei/0000-0002-4699-873X	Genomics Research Center (GRC); Academia Sinica; National Health Research Institute; National Research Program for Genomic Medicine (NRPGM); National Science Council; National Taiwan University; National Taiwan University Hospital; Liver Disease Prevention and Treatment Research Foundation in Taiwan	Genomics Research Center (GRC); Academia Sinica(Academia Sinica - Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); National Research Program for Genomic Medicine (NRPGM)(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Taiwan University Hospital(National Taiwan University); Liver Disease Prevention and Treatment Research Foundation in Taiwan	This work was supported by grants funding from Genomics Research Center (GRC), Academia Sinica, National Health Research Institute, National Research Program for Genomic Medicine (NRPGM), National Science Council, National Taiwan University, National Taiwan University Hospital, and the Liver Disease Prevention and Treatment Research Foundation in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Ho JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021664; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsu CR, 2011, MICROBIOL-SGM, V157, P3446, DOI 10.1099/mic.0.050336-0; Islam ST, 2010, MBIO, V1, DOI 10.1128/mBio.00189-10; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Mitaku S, 2002, BIOINFORMATICS, V18, P608, DOI 10.1093/bioinformatics/18.4.608; MULFORD CA, 1983, P NATL ACAD SCI-BIOL, V80, P1159, DOI 10.1073/pnas.80.5.1159; NASSIF X, 1989, MOL MICROBIOL, V3, P1349, DOI 10.1111/j.1365-2958.1989.tb00116.x; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; Pan YJ, 2011, INFECT IMMUN, V79, P997, DOI 10.1128/IAI.00906-10; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shu HY, 2009, MICROBIOL-SGM, V155, P4170, DOI 10.1099/mic.0.029017-0; Taroni C, 2000, PROTEIN ENG, V13, P89, DOI 10.1093/protein/13.2.89; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Wu MF, 2009, INFECT IMMUN, V77, P615, DOI 10.1128/IAI.00931-08; Yang Ching-Cheng, 2004, Journal of Microbiology Immunology and Infection, V37, P176; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yeh KM, 2010, J INFECT DIS, V201, P1259, DOI 10.1086/606010	34	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e46783	10.1371/journal.pone.0046783	http://dx.doi.org/10.1371/journal.pone.0046783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118860	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500009
J	Poduri, A; Owens, AP; Howatt, DA; Moorleghen, JJ; Balakrishnan, A; Cassis, LA; Daugherty, A				Poduri, Aruna; Owens, A. Phillip, III; Howatt, Deborah A.; Moorleghen, Jessica J.; Balakrishnan, Anju; Cassis, Lisa A.; Daugherty, Alan			Regional Variation in Aortic AT1b Receptor mRNA Abundance Is Associated with Contractility but Unrelated to Atherosclerosis and Aortic Aneurysms	PLOS ONE			English	Article							BLOOD-PRESSURE REGULATION; E-DEFICIENT MICE; RENIN-ANGIOTENSIN SYSTEM; AT(1A) RECEPTOR; EXPRESSION; MOUSE; INFUSION; LESIONS; PROGRESSION; VESSELS	Background: Angiotensin II (AngII), the main bioactive peptide of the renin angiotensin system, exerts most of its biological actions through stimulation of AngII type 1 (AT1) receptors. This receptor is expressed as 2 structurally similar subtypes in rodents, termed AT1a and AT1b. Although AT1a receptors have been studied comprehensively, roles of AT1b receptors in the aorta have not been defined. Methodology/Results: We initially compared the regional distribution of AT1b receptor mRNA with AT1a receptor mRNA in the aorta. mRNA abundance of both subtypes increased from the proximal to the distal aorta, with the greatest abundance in the infra-renal region. Corresponding to the high mRNA abundance for both receptors, only aortic rings from the infra-renal aorta contracted in response to AngII stimulation. Despite the presence of both receptor transcripts, deletion of AT1b receptors, but not AT1a receptors, diminished AngII-induced contractility. To determine whether absence of AT1b receptors influenced aortic pathologies, we bred AT1b receptor deficient mice into an LDL receptor deficient background. Mice were fed a diet enriched in saturated fat and infused with AngII (1,000 ng/kg/min). Parameters that could influence development of aortic pathologies, including systolic blood pressure and plasma cholesterol concentrations, were not impacted by AT1b receptor deficiency. Absence of AT1b receptors also had no effect on size of aortic atherosclerotic lesions and aortic aneurysms in both the ascending and abdominal regions. Conclusions/Significance: Regional abundance of AT1b receptor mRNA coincided with AngII-induced regional contractility, but it was not associated with AngII-induced aortic pathologies.	[Poduri, Aruna; Owens, A. Phillip, III; Howatt, Deborah A.; Moorleghen, Jessica J.; Balakrishnan, Anju; Daugherty, Alan] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Cassis, Lisa A.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA; [Daugherty, Alan] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Daugherty, A (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA.	Alan.Daugherty@uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Institute of Health [HL80100, HL107319]; American Heart Association Great Rivers [10POST3140016]; American Heart Association Ohio Valley [0615222B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080100, R01HL107319] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Great Rivers; American Heart Association Ohio Valley(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research work was supported by grants from National Institute of Health (HL80100 and HL107319). Aruna Poduri was supported by an American Heart Association Great Rivers Affiliate Postdoctoral fellowship (10POST3140016) and A. Phillip Owens III was supported by an American Heart Association Ohio Valley Affiliate Predoctoral fellowship (0615222B) for the data presented in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Cassis LA, 2007, ARTERIOSCL THROM VAS, V27, P380, DOI 10.1161/01.ATV.0000254680.71485.92; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2005, METHODS, V36, P129, DOI 10.1016/j.ymeth.2004.11.008; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; DAUGHERTY A, 2009, J VIS EXP, V1291; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Daugherty A, 2010, CLIN SCI, V118, P681, DOI 10.1042/CS20090372; Henriques T, 2008, ARTERIOSCL THROM VAS, V28, P1251, DOI 10.1161/ATVBAHA.107.160382; INAGAMI T, 1994, EUR HEART J, V15, P104, DOI 10.1093/eurheartj/15.suppl_D.104; IWAI N, 1992, FEBS LETT, V298, P257, DOI 10.1016/0014-5793(92)80071-N; KAKAR SS, 1992, BIOCHEM BIOPH RES CO, V183, P1090, DOI 10.1016/S0006-291X(05)80302-X; Li HP, 2011, AM J PHYSIOL-REG I, V301, pR1067, DOI 10.1152/ajpregu.00124.2011; Lu H, 2012, BRIT J PHARMACOL, V165, P2000, DOI 10.1111/j.1476-5381.2011.01712.x; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Oliverio MI, 1998, P NATL ACAD SCI USA, V95, P15496, DOI 10.1073/pnas.95.26.15496; Oliverio MI, 1997, AM J PHYSIOL-RENAL, V272, pF515, DOI 10.1152/ajprenal.1997.272.4.F515; Owens AP, 2011, ARTERIOSCL THROM VAS, V31, P2813, DOI 10.1161/ATVBAHA.111.238642; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; SASAMURA H, 1992, BIOCHEM BIOPH RES CO, V185, P253, DOI 10.1016/S0006-291X(05)80983-0; Subramanian V, 2010, CIRC RES, V107, P953, DOI 10.1161/CIRCRESAHA.110.219089; Swafford AN, 2007, AM J HYPERTENS, V20, P335, DOI 10.1016/j.amjhyper.2006.09.007; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Uchida HA, 2010, ATHEROSCLEROSIS, V211, P399, DOI 10.1016/j.atherosclerosis.2010.02.034; Wang Y. X., 2006, HDB MOUSE MODELS CAR, V125; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Weiss D, 2001, CIRCULATION, V103, P448; YOSHIDA H, 1992, BIOCHEM BIOPH RES CO, V186, P1042, DOI 10.1016/0006-291X(92)90852-C; Zhang X, 2012, CIRC RES, V110, pE73, DOI 10.1161/CIRCRESAHA.111.253880; Zhou YB, 2005, J MOL CELL CARDIOL, V38, P693, DOI 10.1016/j.yjmcc.2005.02.009; Zhou YB, 2003, CIRC RES, V93, P1089, DOI 10.1161/01.RES.0000101912.01071.FF; Zhu ZM, 1998, HYPERTENSION, V31, P1171, DOI 10.1161/01.HYP.31.5.1171	40	34	35	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48462	10.1371/journal.pone.0048462	http://dx.doi.org/10.1371/journal.pone.0048462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119030	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500146
J	Angarica, VE; Sancho, J				Espinosa Angarica, Vladimir; Sancho, Javier			Protein Dynamics Governed by Interfaces of High Polarity and Low Packing Density	PLOS ONE			English	Article							INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE; EXCHANGE MASS-SPECTROMETRY; STATE HYDROGEN-EXCHANGE; MOLTEN-GLOBULE STATE; NATIVE-STATE; SOLVENT ACCESSIBILITIES; SULFOLOBUS-SOLFATARICUS; FOLDING INTERMEDIATE; STRUCTURAL-ANALYSIS; SEQUENCE	The folding pathway, three-dimensional structure and intrinsic dynamics of proteins are governed by their amino acid sequences. Internal protein surfaces with physicochemical properties appropriate to modulate conformational fluctuations could play important roles in folding and dynamics. We show here that proteins contain buried interfaces of high polarity and low packing density, coined as LIPs: Light Interfaces of high Polarity, whose physicochemical properties make them unstable. The structures of well-characterized equilibrium and kinetic folding intermediates indicate that the LIPs of the corresponding native proteins fold late and are involved in local unfolding events. Importantly, LIPs can be identified using very fast and uncomplicated computational analysis of protein three-dimensional structures, which provides an easy way to delineate the protein segments involved in dynamics. Since LIPs can be retained while the sequences of the interacting segments diverge significantly, proteins could in principle evolve new functional features reusing pre-existing encoded dynamics. Large-scale identification of LIPS may contribute to understanding evolutionary constraints of proteins and the way protein intrinsic dynamics are encoded.	[Espinosa Angarica, Vladimir; Sancho, Javier] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, E-50009 Zaragoza, Spain; [Espinosa Angarica, Vladimir; Sancho, Javier] Univ Zaragoza, Biocomputat & Complex Syst Phys Inst BIFI, Joint Unit BIFI IQFR, CSIC, E-50009 Zaragoza, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza	Sancho, J (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, E-50009 Zaragoza, Spain.	jsancho@unizar.es	Sancho, javier/AAA-1225-2019	Sancho, javier/0000-0002-2879-9200; Espinosa Angarica, Vladimir/0000-0002-3268-8730	Banco Santander Central Hispano; Fundacion Carolina and Universidad de Zaragoza; JAE-CSIC doctoral fellowship; Ministerio de Ciencia e Innovacion (MICINN), Spain [BFU2010-16297]; Grupo Protein Targets B89 [DGA, Spain]	Banco Santander Central Hispano; Fundacion Carolina and Universidad de Zaragoza; JAE-CSIC doctoral fellowship; Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Grupo Protein Targets B89 [DGA, Spain]	VEA was supported by Banco Santander Central Hispano, Fundacion Carolina and Universidad de Zaragoza and is now a recipient of a JAE-CSIC doctoral fellowship. JS would like to acknowledge financial support from grants BFU2010-16297 [Ministerio de Ciencia e Innovacion (MICINN), Spain] and Grupo Protein Targets B89 [DGA, Spain]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuso-Tejedor S, 2011, J MOL BIOL, V406, P604, DOI 10.1016/j.jmb.2010.12.027; Ayuso-Tejedor S, 2010, J MOL BIOL, V400, P922, DOI 10.1016/j.jmb.2010.05.050; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bai YW, 2006, CHEM REV, V106, P1757, DOI 10.1021/cr040432i; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Bernado P, 2006, BIOPHYS J, V91, P4536, DOI 10.1529/biophysj.106.087528; Bhardwaj N, 2009, PROTEIN SCI, V18, P1230, DOI 10.1002/pro.132; Campos LA, 2004, J MOL BIOL, V344, P239, DOI 10.1016/j.jmb.2004.08.081; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Estrada J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-104; Eyal E, 2004, J COMPUT CHEM, V25, P712, DOI 10.1002/jcc.10420; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Forsyth WR, 2002, J MOL BIOL, V320, P1119, DOI 10.1016/S0022-2836(02)00557-0; Freire E, 1997, PURE APPL CHEM, V69, P2253, DOI 10.1351/pac199769112253; Gu Z, 2007, J MOL BIOL, V374, P528, DOI 10.1016/j.jmb.2007.09.024; Gu ZY, 2007, J MOL BIOL, V368, P582, DOI 10.1016/j.jmb.2007.02.027; Hilser VJ, 2006, CHEM REV, V106, P1545, DOI 10.1021/cr040423+; Hilser VJ, 1996, J MOL BIOL, V262, P756, DOI 10.1006/jmbi.1996.0550; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Krishna MMG, 2007, PROTEIN SCI, V16, P1946, DOI 10.1110/ps.072922307; Kuwajima K, 1996, FASEB J, V10, P102, DOI 10.1096/fasebj.10.1.8566530; Langdon GM, 2001, PROTEINS, V43, P476, DOI 10.1002/prot.1059; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Liu T, 2012, J AM SOC MASS SPECTR, V23, P43, DOI 10.1007/s13361-011-0267-9; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47177, DOI 10.1074/jbc.M405792200; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Miyashita O, 2003, P NATL ACAD SCI USA, V100, P12570, DOI 10.1073/pnas.2135471100; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Muralidhara BK, 2008, J MOL BIOL, V377, P232, DOI 10.1016/j.jmb.2007.12.068; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rother K, 2009, NUCLEIC ACIDS RES, V37, pD393, DOI 10.1093/nar/gkn769; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Salvatella X, 2005, P NATL ACAD SCI USA, V102, P12389, DOI 10.1073/pnas.0408226102; Schell D, 2006, PROTEINS, V63, P278, DOI 10.1002/prot.20826; Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Seeliger D, 2007, PROTEINS, V68, P595, DOI 10.1002/prot.21447; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Team RDC, 2019, R LANG ENV STAT COMP; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Tuinstra RL, 2008, P NATL ACAD SCI USA, V105, P5057, DOI 10.1073/pnas.0709518105; Vertrees J, 2005, BIOINFORMATICS, V21, P3318, DOI 10.1093/bioinformatics/bti520; Voss NR, 2005, J MOL BIOL, V346, P477, DOI 10.1016/j.jmb.2004.11.072	57	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48212	10.1371/journal.pone.0048212	http://dx.doi.org/10.1371/journal.pone.0048212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110216	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500053
J	Kang, SL; Liu, Y; Sun, D; Zhou, CL; Liu, AY; Xu, CY; Hao, YL; Li, DY; Yan, CD; Sun, H				Kang, Shoulei; Liu, Ying; Sun, Di; Zhou, Chunle; Liu, Aiying; Xu, Chuanying; Hao, Yanling; Li, Dongye; Yan, Changdong; Sun, Hong			Chronic Activation of the G Protein-Coupled Receptor 30 with Agonist G-1 Attenuates Heart Failure	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; EXPRESSION; RAT; CONTRACTION; HYPOXIA; GPR30; GPER	G protein-coupled receptor (GPR) 30 is a novel estrogen receptor. Recent studies suggest that activation of the GPR30 confers rapid cardioprotection in isolated rat heart. It is unknown whether chronic activation of GPR30 is beneficial or not for heart failure. In this study we investigated the cardiac effect of sustained activation or inhibition of GPR30. Female Sprague-Dawley rats were divided into 7 groups #2Q1: sham surgery (Sham), bilateral ovariectomy (OVX), OVX+estrogen (E-2), OVX+isoproterenol (ISO), OVX+ISO+G-1, OVX+ISO+E-2+G15, OVX+ISO+E-2. ISO (85 mg/kgx17 day, sc) was given to make the heart failure models. G-1(120 mu g/kg.d x 14 day) was used to activate GPR30 and G15 (190 mu g/kg.d x 14 day) was used to inhibit GPR30. Concentration of brain natriuretic peptide in serum, masson staining in isolated heart, contractile function and the expression of beta(1) and beta(2)- adrenergic receptor (AR) of ventricular myocytes were also determined. Our data showed that ISO treatment led to heart failure in OVX rats. G-1 or E2 treatment decreased concentration of brain natriuretic peptide, reduced cardiac fibrosis, and enhanced contraction of the heart. Combined treatment with beta(1) (CGP20712A) and beta(2)-AR (ICI118551) antagonist abolished the improvement of myocardial function induced by G-1. We also found that chronic treatment with G-1 normalized the expression of beta(1)-AR and increased the expression of beta(2)-AR. Our results indicate that chronic activation of the GPR30 with its agonist G-1 attenuates heart failure by normalizing the expression of beta(1)-AR and increasing the expression of beta(2)-AR.	[Li, Dongye] Xuzhou Med Coll Affiliated Hosp, Inst Cardiovasc Dis Res, Xuzhou 221002, Peoples R China; [Kang, Shoulei; Liu, Ying; Sun, Di; Zhou, Chunle; Liu, Aiying; Xu, Chuanying; Hao, Yanling; Yan, Changdong; Sun, Hong] Xuzhou Med Coll, Dept Physiol, Xuzhou 221002, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Li, DY (corresponding author), Xuzhou Med Coll Affiliated Hosp, Inst Cardiovasc Dis Res, Xuzhou 221002, Peoples R China.	dongyeli@medmail.com.cn; sunh@xzmc.edu.cn	李, 东/GYA-4703-2022; 李, 东野/AAY-6410-2020		President Support Funding of Xuzhou Medical College [09KJZ31]; Social Development Program of Xuzhou [XM08C063]	President Support Funding of Xuzhou Medical College; Social Development Program of Xuzhou	This work was supported by the President Support Funding of Xuzhou Medical College (grant number 09KJZ31) and the Social Development Program of Xuzhou (grant number XM08C063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bopassa JC, 2010, AM J PHYSIOL-HEART C, V298, pH16, DOI 10.1152/ajpheart.00588.2009; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Brouri F, 2004, EUR J PHARMACOL, V485, P227, DOI 10.1016/j.ejphar.2003.11.063; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Dincer UD, 2001, DIABETES, V50, P455, DOI 10.2337/diabetes.50.2.455; Dong HY, 2010, BIOCHEM BIOPH RES CO, V398, P383, DOI 10.1016/j.bbrc.2010.06.076; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Guan Y, 2010, AM J PHYSIOL-HEART C, V298, pH1267, DOI 10.1152/ajpheart.00410.2009; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Hamdani N, 2008, J MUSCLE RES CELL M, V29, P189, DOI 10.1007/s10974-008-9160-y; Hao YL, 2009, J CARDIOVASC PHARM, V54, P3, DOI 10.1097/FJC.0b013e3181a91410; Jessup JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015433; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Liu AY, 2012, J ENDOCRINOL, V212, P61, DOI 10.1530/JOE-11-0181; Murph E, 2007, CARDIOVASC RES, V75, P478, DOI 10.1016/j.cardiores.2007.03.025; O'Dowd BF, 1998, GENOMICS, V47, P310, DOI 10.1006/geno.1998.5095; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Parveen A, 2012, J CARDIOVASC PHARM T, V17, P199, DOI 10.1177/1074248411416816; Patel VH, 2010, INT J MOL MED, V26, P193, DOI 10.3892/ijmm_00000452; Penna C, 2008, J PHYSIOL PHARMACOL, V59, P645; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Roth DM, 1999, CIRCULATION, V99, P3099, DOI 10.1161/01.CIR.99.24.3099; Shizukuda Y, 2002, J MOL CELL CARDIOL, V34, P823, DOI 10.1006/jmcc.2002.2020; Sun JF, 2011, GEN COMP ENDOCR, V172, P518, DOI 10.1016/j.ygcen.2011.04.019; Viguerie N, 2002, J CLIN ENDOCR METAB, V87, P630, DOI 10.1210/jc.87.2.630; Weil BR, 2010, SURGERY, V148, P436, DOI 10.1016/j.surg.2010.03.011; Wu Q, 2008, EXP PHYSIOL, V93, P1034, DOI 10.1113/expphysiol.2007.041939; Xiao RP, 2004, TRENDS PHARMACOL SCI, V25, P358, DOI 10.1016/j.tips.2004.05.007; Xu CY, 2010, J RECEPT SIG TRANSD, V30, P255, DOI 10.3109/10799893.2010.488242; Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013; Zhu WZ, 2005, CIRC RES, V97, P507, DOI 10.1161/01.RES.0000184615.56822.bd	33	46	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48185	10.1371/journal.pone.0048185	http://dx.doi.org/10.1371/journal.pone.0048185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110207	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500048
J	Soppina, V; Herbstman, JF; Skiniotis, G; Verhey, KJ				Soppina, Virupakshi; Herbstman, Jeffrey F.; Skiniotis, Georgios; Verhey, Kristen J.			Luminal Localization of alpha-tubulin K40 Acetylation by Cryo-EM Analysis of Fab-Labeled Microtubules	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; HISTONE DEACETYLASE-6; IN-VIVO; DOMAIN; ACETYLTRANSFERASE; BINDING; CILIOGENESIS; STABILITY; TRANSPORT; EXPOSURE	The alpha beta-tubulin subunits of microtubules can undergo a variety of evolutionarily-conserved post-translational modifications (PTMs) that provide functional specialization to subsets of cellular microtubules. Acetylation of alpha-tubulin residue Lysine-40 (K40) has been correlated with increased microtubule stability, intracellular transport, and ciliary assembly, yet a mechanistic understanding of how acetylation influences these events is lacking. Using the anti-acetylated tubulin antibody 6-11B-1 and electron cryo-microscopy, we demonstrate that the K40 acetylation site is located inside the microtubule lumen and thus cannot directly influence events on the microtubule surface, including kinesin-1 binding. Surprisingly, the monoclonal 6-11B-1 antibody recognizes both acetylated and deacetylated microtubules. These results suggest that acetylation induces structural changes in the K40-containing loop that could have important functional consequences on microtubule stability, bending, and subunit interactions. This work has important implications for acetylation and deacetylation reaction mechanisms as well as for interpreting experiments based on 6-11B-1 labeling.	[Soppina, Virupakshi; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Herbstman, Jeffrey F.; Skiniotis, Georgios] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI USA; [Herbstman, Jeffrey F.; Skiniotis, Georgios] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Verhey, KJ (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	kjverhey@umich.edu	Soppina, Virupakshi/GNW-5432-2022	Skiniotis, Georgios/0000-0003-0238-7846	National Institutes of Health NIGMS [GM070862, GM083254]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083254, R01GM070862] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding to KJV provided by National Institutes of Health NIGMS (GM070862 and GM083254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Chang JF, 2009, J CELL SCI, V122, P2274, DOI 10.1242/jcs.048975; CHRETIEN D, 1992, J CELL BIOL, V117, P1031, DOI 10.1083/jcb.117.5.1031; CUEVA JG, 2012, CURR BIOL, V22, P1066, DOI [DOI 10.1016/j.cub.2012.05.012, DOI 10.1016/J.CUB.2012.05.012]; Di Fulvio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028563; Diaz JF, 2003, J BIOL CHEM, V278, P8407, DOI 10.1074/jbc.M211163200; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Downing KH, 1999, CELL STRUCT FUNCT, V24, P269; DRABER P, 1989, J CELL SCI, V92, P519; Draberova E, 2000, EUR J CELL BIOL, V79, P982, DOI 10.1078/0171-9335-00129; Garvalov BK, 2006, J CELL BIOL, V174, P759, DOI 10.1083/jcb.200606074; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; INOUE S, 1981, J CELL BIOL, V91, pS131, DOI 10.1083/jcb.91.3.131s; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LHERNAULT SW, 1983, J CELL BIOL, V97, P258, DOI 10.1083/jcb.97.1.258; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Odde D, 1998, EUR BIOPHYS J BIOPHY, V27, P514, DOI 10.1007/s002490050161; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; SALE WS, 1988, CELL MOTIL CYTOSKEL, V9, P243, DOI 10.1002/cm.970090306; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Walter WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042218; WEBSTER DR, 1989, J CELL SCI, V92, P57; WHITTAKER M, 1995, ULTRAMICROSCOPY, V58, P245, DOI 10.1016/0304-3991(95)00057-8; Yajima H, 2012, J CELL BIOL, V198, P315, DOI 10.1083/jcb.201201161; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	47	69	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48204	10.1371/journal.pone.0048204	http://dx.doi.org/10.1371/journal.pone.0048204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110214	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500051
J	Alba, G; Reyes, ME; Santa-Maria, C; Ramirez, R; Geniz, I; Jimenez, J; Martin-Nieto, J; Pintado, E; Sobrino, F				Alba, Gonzalo; Reyes, Maria Edith; Santa-Maria, Consuelo; Ramirez, Remedios; Geniz, Isabel; Jimenez, Juan; Martin-Nieto, Jose; Pintado, Elizabeth; Sobrino, Francisco			Transcription of Liver X Receptor Is Down-Regulated by 15-Deoxy-Delta(12,14)-Prostaglandin J(2) through Oxidative Stress in Human Neutrophils	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; HEME OXYGENASE-1 EXPRESSION; TUMOR-NECROSIS-FACTOR; PPAR-GAMMA; GENE-EXPRESSION; NUCLEAR RECEPTORS; LIPID-METABOLISM; LXR-ALPHA	Liver X receptors (LXRs) are ligand-activated transcription factors of the nuclear receptor superfamily. They play important roles in controlling cholesterol homeostasis and as regulators of inflammatory gene expression and innate immunity, by blunting the induction of classical pro-inflammatory genes. However, opposite data have also been reported on the consequences of LXR activation by oxysterols, resulting in the specific production of potent pro-inflammatory cytokines and reactive oxygen species (ROS). The effect of the inflammatory state on the expression of LXRs has not been studied in human cells, and constitutes the main aim of the present work. Our data show that when human neutrophils are triggered with synthetic ligands, the synthesis of LXR alpha mRNA became activated together with transcription of the LXR target genes ABCA1, ABCG1 and SREBP1c. An inflammatory mediator, 15-deoxy-Delta(12,14)-prostaglandin J(2) (15dPGJ(2)), hindered T0901317-promoted induction of LXR alpha mRNA expression together with transcription of its target genes in both neutrophils and human macrophages. This down-regulatory effect was dependent on the release of reactive oxygen species elicited by 15dPGJ(2), since it was enhanced by pro-oxidant treatment and reversed by antioxidants, and was also mediated by ERK1/2 activation. Present data also support that the 15dPGJ(2)-induced serine phosphorylation of the LXR alpha molecule is mediated by ERK1/2. These results allow to postulate that down-regulation of LXR cellular levels by pro-inflammatory stimuli might be involved in the development of different vascular diseases, such as atherosclerosis.	[Alba, Gonzalo; Reyes, Maria Edith; Ramirez, Remedios; Jimenez, Juan; Pintado, Elizabeth; Sobrino, Francisco] Univ Seville, Dept Bioquim Med & Biol Mol, Seville, Spain; [Santa-Maria, Consuelo] Univ Seville, Dept Bioquim & Biol Mol, Seville, Spain; [Geniz, Isabel] Serv Andaluz Salud, Dist Sanitario Sevilla Norte, Seville, Spain; [Martin-Nieto, Jose] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain	University of Sevilla; University of Sevilla; Universitat d'Alacant	Sobrino, F (corresponding author), Univ Seville, Dept Bioquim Med & Biol Mol, Seville, Spain.	fsobrino@us.es	Jiménez, Juan/L-1027-2014; Alba Jiménez, Gonzalo/K-9283-2014; MARTÍN-NIETO, JOSÉ/R-5428-2018; Santa-Maria Perez, Consuelo/K-7879-2014	Jiménez, Juan/0000-0002-6909-4696; Alba Jiménez, Gonzalo/0000-0002-6598-2039; MARTÍN-NIETO, JOSÉ/0000-0002-7815-6887; Santa-Maria Perez, Consuelo/0000-0001-9195-2792; Pintado, Elizabeth/0000-0002-5237-5045; Sobrino, Francisco/0000-0002-4503-5739	Ministerio de Educacion y Ciencia [BFU2006-13802]; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, the Consejeria de Salud, Junta de Andalucia [P08-CVI-03550, P06-CTS-01936, CS 0116/200]	Ministerio de Educacion y Ciencia(Spanish Government); Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, the Consejeria de Salud, Junta de Andalucia(Junta de Andalucia)	Funding provided by the Ministerio de Educacion y Ciencia (BFU2006-13802) and the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (P08-CVI-03550) (P06-CTS-01936) Consejeria de Salud, Junta de Andalucia (CS 0116/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba G, 2008, J LEUKOCYTE BIOL, V84, P397, DOI 10.1189/jlb.0108035; Alvarez-Maqueda M, 2004, J BIOL CHEM, V279, P21929, DOI 10.1074/jbc.M400492200; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; BEAULIEU AD, 1992, J BIOL CHEM, V267, P426; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley MN, 2007, J CLIN INVEST, V117, P2337, DOI 10.1172/JCI31909; Calpe-Berdiel L, 2008, J LIPID RES, V49, P1904, DOI 10.1194/jlr.M700470-JLR200; Carballo M, 1999, J BIOL CHEM, V274, P93, DOI 10.1074/jbc.274.1.93; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1493, DOI 10.1152/ajpcell.00016.2006; Chen MY, 2006, FEBS LETT, V580, P4835, DOI 10.1016/j.febslet.2006.07.074; Chen YC, 2005, BBA-MOL CELL RES, V1743, P291, DOI 10.1016/j.bbamcr.2004.10.016; Chen ZY, 2005, MOL PHARMACOL, V68, P1203, DOI 10.1124/mol.105.014944; Costet P, 2000, J BIOL CHEM, V275, P28240; Couturier C, 1999, J BIOL CHEM, V274, P23085, DOI 10.1074/jbc.274.33.23085; Davies John Q, 2005, Methods Mol Biol, V290, P105; El Bekay R, 2002, J LEUKOCYTE BIOL, V71, P255; El Bekay R, 2003, BLOOD, V102, P662, DOI 10.1182/blood-2002-09-2785; Fontaine C, 2007, CIRC RES, V101, P40, DOI 10.1161/CIRCRESAHA.106.135814; Fowler AJ, 2003, J INVEST DERMATOL, V120, P246, DOI 10.1046/j.1523-1747.2003.12033.x; Gilbert C, 2002, J IMMUNOL METHODS, V261, P85, DOI 10.1016/S0022-1759(01)00553-1; Harris SG, 2002, J IMMUNOL, V168, P1372, DOI 10.4049/jimmunol.168.3.1372; Hong HY, 2008, FEBS LETT, V582, P861, DOI 10.1016/j.febslet.2008.02.012; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Imaizumi T, 2003, PROSTAG OTH LIPID M, V71, P293, DOI 10.1016/S1098-8823(03)00051-0; Joffre C, 2007, CURR EYE RES, V32, P271, DOI 10.1080/02713680601187951; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kawahito Y, 2000, J CLIN INVEST, V106, P189, DOI 10.1172/JCI9652; Kim EH, 2006, ANN NY ACAD SCI, V1090, P375, DOI 10.1196/annals.1378.041; Kim EH, 2006, BIOCHEM PHARMACOL, V72, P1516, DOI 10.1016/j.bcp.2006.07.030; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Landis MS, 2002, J BIOL CHEM, V277, P4713, DOI 10.1074/jbc.M108807200; Law RE, 2000, CIRCULATION, V101, P1311, DOI 10.1161/01.CIR.101.11.1311; Lemaire-Ewing S, 2005, CELL BIOL TOXICOL, V21, P97, DOI 10.1007/s10565-005-0141-2; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Lu Y, 2007, FREE RADICAL BIO MED, V43, P1061, DOI 10.1016/j.freeradbiomed.2007.06.021; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; MANSFIELD MA, 1995, ANAL BIOCHEM, V229, P140, DOI 10.1006/abio.1995.1391; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; Mazor R, 2008, ATHEROSCLEROSIS, V197, P937, DOI 10.1016/j.atherosclerosis.2007.08.014; McLeish KR, 1998, J LEUKOCYTE BIOL, V64, P835, DOI 10.1002/jlb.64.6.835; Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328; Mo JY, 2002, J BIOL CHEM, V277, P50788, DOI 10.1074/jbc.M210376200; Monneret G, 2002, J IMMUNOL, V168, P3563, DOI 10.4049/jimmunol.168.7.3563; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Naughton P, 2002, J BIOL CHEM, V277, P40666, DOI 10.1074/jbc.M203863200; Pascual-Garcia M, 2012, ARCH IMMUNOL THER EX; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Puddu GM, 2005, J BIOMED SCI, V12, P839, DOI 10.1007/s11373-005-9024-z; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Rosenblat M, 2002, ATHEROSCLEROSIS, V160, P69, DOI 10.1016/S0021-9150(01)00563-9; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; SANTORO MG, 1994, EXPERIENTIA, V50, P1039, DOI 10.1007/BF01923459; Scher JU, 2009, J INVEST MED, V57, P703, DOI 10.2310/JIM.0b013e31819aaa76; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Smoak K, 2008, J IMMUNOL, V180, P3305, DOI 10.4049/jimmunol.180.5.3305; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Takata Y, 2002, CIRC RES, V91, P427, DOI 10.1161/01.RES.0000031271.20771.4F; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Torra IP, 2008, MOL CELL BIOL, V28, P2626, DOI 10.1128/MCB.01575-07; Valledor AF, 2005, IMMUNOBIOLOGY, V210, P127, DOI 10.1016/j.imbio.2005.05.007; Wang JJ, 2011, PROSTAG OTH LIPID M, V94, P104, DOI 10.1016/j.prostaglandins.2011.01.004; Wang YY, 2006, SHOCK, V25, P141, DOI 10.1097/01.shk.0000191377.78144.d9; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Yasunari K, 2006, CURR PHARM BIOTECHNO, V7, P73, DOI 10.2174/138920106776597612; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771; Zhou XY, 2010, J BIOL CHEM, V285, P6316, DOI 10.1074/jbc.M109.073601	82	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e42195	10.1371/journal.pone.0042195	http://dx.doi.org/10.1371/journal.pone.0042195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115616	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200003
J	Bozzacchi, C; Giusti, MA; Pitzalis, S; Spinelli, D; Di Russo, F				Bozzacchi, Chiara; Giusti, Maria Assunta; Pitzalis, Sabrina; Spinelli, Donatella; Di Russo, Francesco			Similar Cerebral Motor Plans for Real and Virtual Actions	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; FINGER MOVEMENTS; CORTICAL POTENTIALS; PREMOTOR CORTEX; VOLUNTARY; HUMANS; AREAS; ACTIVATION; PARIETAL; DORSAL	A simple movement, such as pressing a button, can acquire different meanings by producing different consequences, such as starting an elevator or switching a TV channel. We evaluated whether the brain activity preceding a simple action is modulated by the expected consequences of the action itself. To further this aim, the motor-related cortical potentials were compared during two key-press actions that were identical from the kinematics point of view but different in both meaning and consequences. In one case (virtual grasp), the key-press started a video clip showing a hand moving toward a cup and grasping it; in the other case, the key-press did not produce any consequence (key-press). A third condition (real grasp) was also compared, in which subjects actually grasped the cup, producing the same action presented in the video clip. Data were collected from fifteen subjects. The results showed that motor preparation for virtual grasp (starting 3 s before the movement onset) was different from that of the key-press and similar to the real grasp preparation-as if subjects had to grasp the cup in person. In particular, both virtual and real grasp presented a posterior parietal negativity preceding activity in motor and pre-motor areas. In summary, this finding supports the hypothesis that motor preparation is affected by the meaning of the action, even when the action is only virtual.	[Bozzacchi, Chiara; Pitzalis, Sabrina; Spinelli, Donatella; Di Russo, Francesco] Univ Rome Foro Italico, Dept Educ Motor Activ & Sport, Rome, Italy; [Giusti, Maria Assunta; Pitzalis, Sabrina; Spinelli, Donatella; Di Russo, Francesco] IRCCS Santa Lucia Fdn, Neuropsychol Ctr, Rome, Italy; [Bozzacchi, Chiara; Giusti, Maria Assunta] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	Foro Italico University of Rome; IRCCS Santa Lucia; Sapienza University Rome	Bozzacchi, C (corresponding author), Univ Rome Foro Italico, Dept Educ Motor Activ & Sport, Rome, Italy.	chiara.bozzacchi@uniroma4.it	Di Russo, Francesco/N-6686-2015; Pitzalis, Sabrina/AAA-9406-2019	Di Russo, Francesco/0000-0002-3127-9433; pitzalis, sabrina/0000-0002-4445-0391; SPINELLI, Donatella/0000-0002-4890-6931	SFAMS Department of the University of Rome Foro Italico [RIC109/2011]	SFAMS Department of the University of Rome Foro Italico	This research was supported by the SFAMS Department of the University of Rome Foro Italico, grant code RIC109/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai O, 2005, CLIN NEUROPHYSIOL, V116, P1213, DOI 10.1016/j.clinph.2005.01.006; Baumeister J, 2010, NEUROSCI LETT, V481, P47, DOI 10.1016/j.neulet.2010.06.051; BENECKE R, 1985, NEUROSCI LETT, V62, P347, DOI 10.1016/0304-3940(85)90573-7; BOCKER KBE, 1994, ELECTROEN CLIN NEURO, V91, P275, DOI 10.1016/0013-4694(94)90191-0; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Davare M, 2010, CURR BIOL, V20, P176, DOI 10.1016/j.cub.2009.11.063; Davare M, 2009, CORTEX, V45, P1050, DOI 10.1016/j.cortex.2009.02.011; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Di Russo F, 2005, MED SCI SPORT EXER, V37, P1586, DOI 10.1249/01.mss.0000177458.71676.0d; Dvorkin AY, 2006, CYBERPSYCHOL BEHAV, V9, P133, DOI 10.1089/cpb.2006.9.133; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Galati G, 2011, EUR J NEUROSCI, V34, P1871, DOI 10.1111/j.1460-9568.2011.07885.x; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hamilton AFD, 2008, CEREB CORTEX, V18, P1160, DOI 10.1093/cercor/bhm150; KAWASHIMA R, 1993, BRAIN RES, V623, P33, DOI 10.1016/0006-8993(93)90006-9; KITAMURA J, 1993, ELECTROEN CLIN NEURO, V86, P176, DOI 10.1016/0013-4694(93)90005-G; KITAMURA JI, 1993, ELECTROEN CLIN NEURO, V86, P252, DOI 10.1016/0013-4694(93)90106-6; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kroliczak G, 2008, J NEUROPHYSIOL, V100, P2627, DOI 10.1152/jn.01376.2007; Kroliczak G, 2007, J NEUROPHYSIOL, V97, P2410, DOI 10.1152/jn.00778.2006; Lang W., 2003, BEREITSCHAFTSPOTENTI, P19; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Liuzzi G, 2010, CEREB CORTEX, V20, P1323, DOI 10.1093/cercor/bhp196; Machado S, 2010, REV NEUROLOGIA, V51, P427; Muller-Putz GR, 2008, IEEE T BIO-MED ENG, V55, P361, DOI 10.1109/TBME.2007.897815; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PLATZ T, 1995, EUR J NEUROSCI, V7, P1536, DOI 10.1111/j.1460-9568.1995.tb01149.x; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P378, DOI 10.1097/00001199-200210000-00002; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V50, P201, DOI 10.1016/0013-4694(80)90147-9; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; SIMONETTA M, 1991, ELECTROEN CLIN NEURO, V81, P129, DOI 10.1016/0168-5597(91)90006-J; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; Viau A, 2004, J NEUROENG REHABIL, V1, P1; Wheaton LA, 2005, CLIN NEUROPHYSIOL, V116, P1201, DOI 10.1016/j.clinph.2005.01.001; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	42	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47783	10.1371/journal.pone.0047783	http://dx.doi.org/10.1371/journal.pone.0047783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112847	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200081
J	Bozzali, M; Mastropasqua, C; Cercignani, M; Giulietti, G; Bonni, S; Caltagirone, C; Koch, G				Bozzali, Marco; Mastropasqua, Chiara; Cercignani, Mara; Giulietti, Giovanni; Bonni, Sonia; Caltagirone, Carlo; Koch, Giacomo			Microstructural Damage of the Posterior Corpus Callosum Contributes to the Clinical Severity of Neglect	PLOS ONE			English	Article							DIFFUSION TENSOR; VISUOSPATIAL ATTENTION; UNILATERAL NEGLECT; LEFT-HEMISPHERE; LOCALIZATION; DEGENERATION; STIMULATION; CONNECTIONS; RECOVERY; MRI	One theory to account for neglect symptoms in patients with right focal damage invokes a release of inhibition of the right parietal cortex over the left parieto-frontal circuits, by disconnection mechanism. This theory is supported by transcranial magnetic stimulation studies showing the existence of asymmetric inhibitory interactions between the left and right posterior parietal cortex, with a right hemispheric advantage. These inhibitory mechanisms are mediated by direct transcallosal projections located in the posterior portions of the corpus callosum. The current study, using diffusion imaging and tract-based spatial statistics (TBSS), aims at assessing, in a data-driven fashion, the contribution of structural disconnection between hemispheres in determining the presence and severity of neglect. Eleven patients with right acute stroke and 11 healthy matched controls underwent MRI at 3T, including diffusion imaging, and T1-weighted volumes. TBSS was modified to account for the presence of the lesion and used to assess the presence and extension of changes in diffusion indices of microscopic white matter integrity in the left hemisphere of patients compared to controls, and to investigate, by correlation analysis, whether this damage might account for the presence and severity of patients' neglect, as assessed by the Behavioural Inattention Test (BIT). None of the patients had any macroscopic abnormality in the left hemisphere; however, 3 cases were discarded due to image artefacts in the MRI data. Conversely, TBSS analysis revealed widespread changes in diffusion indices in most of their left hemisphere tracts, with a predominant involvement of the corpus callosum and its projections on the parietal white matter. A region of association between patients' scores at BIT and brain FA values was found in the posterior part of the corpus callosum. This study strongly supports the hypothesis of a major role of structural disconnection between the right and left parietal cortex in determining 'neglect'.	[Bozzali, Marco; Mastropasqua, Chiara; Cercignani, Mara; Giulietti, Giovanni] Santa Lucia Fdn Ist Ricovero & Cura Carattere Sci, Neuroimaging Lab, Rome, Italy; [Bonni, Sonia; Caltagirone, Carlo; Koch, Giacomo] Ist Ricovero & Cura Carattere Sci, Santa Lucia Fdn, Dept Clin & Behav Neurol, Rome, Italy; [Koch, Giacomo] Univ Roma Tor Vergata, Dept Neurosci, Stroke Unit, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata	Bozzali, M (corresponding author), Santa Lucia Fdn Ist Ricovero & Cura Carattere Sci, Neuroimaging Lab, Rome, Italy.	m.bozzali@hsantalucia.it	Giulietti, Giovanni/D-2771-2009; Caltagirone, Carlo/B-4930-2013; Koch, Giacomo/G-3155-2012; Bozzali, Marco/AAC-1031-2022; Mastropasqua, Chiara/AAA-7415-2019	Bozzali, Marco/0000-0002-0568-2026; KOch, Giacomo/0000-0001-6155-9439; Cercignani, Mara/0000-0002-4550-2456				Andersson J.L.R, 2007, TR07JA2 FMRIB; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Benjamin S, 2011, PSYCHIAT CLIN N AM, V34, P423, DOI 10.1016/j.psc.2011.02.001; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P759, DOI 10.1016/0028-3932(86)90075-8; Bozzali M, 2011, HUM BRAIN MAPP; Bozzali M, 2007, MAGN RESON IMAGING, V25, P969, DOI 10.1016/j.mri.2007.03.017; Busch D, 2010, LATERALITY, V15, P610, DOI 10.1080/13576500903081806; Cassidy TP, 1998, J NEUROL NEUROSUR PS, V64, P555, DOI 10.1136/jnnp.64.4.555; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Driver J, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P589; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Griffin John W., 1995, P375; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Heilman KM, 2000, SEMIN NEUROL, V20, P463, DOI 10.1055/s-2000-13179; Inglese M, 2010, NMR BIOMED, V23, P865, DOI 10.1002/nbm.1515; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Karnath H. O., 2002, COGNITIVE NEURAL BAS; Kinsbourne M, 1977, Adv Neurol, V18, P41; Koch G, 2012, NEUROLOGY, V78, P24, DOI 10.1212/WNL.0b013e31823ed08f; Koch G, NEUROSCIENT IN PRESS; Koch G, 2011, J NEUROSCI, V31, P8967, DOI 10.1523/JNEUROSCI.6567-10.2011; Koch G, 2008, BRAIN, V131, P3147, DOI 10.1093/brain/awn273; Kyriakopoulos M, 2009, CURR OPIN PSYCHIATR, V22, P168, DOI 10.1097/YCO.0b013e328325aa23; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Ridding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169; Serra L, 2010, J ALZHEIMERS DIS, V19, P147, DOI 10.3233/JAD-2010-1223; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Vallar Giuseppe, 2003, Adv Neurol, V93, P293; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98	36	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48079	10.1371/journal.pone.0048079	http://dx.doi.org/10.1371/journal.pone.0048079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110177	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000310310200147
J	Convertino, M; Mangoubi, RS; Linkov, I; Lowry, NC; Desai, M				Convertino, Matteo; Mangoubi, Rami S.; Linkov, Igor; Lowry, Nathan C.; Desai, Mukund			Inferring Species Richness and Turnover by Statistical Multiresolution Texture Analysis of Satellite Imagery	PLOS ONE			English	Article							BETA DIVERSITY; INDEPENDENT ALPHA; VEGETATION; RESOLUTION; CLASSIFICATION; BIODIVERSITY; INDEX; HETEROGENEITY; REFLECTANCE; INFORMATION	Background: The quantification of species-richness and species-turnover is essential to effective monitoring of ecosystems. Wetland ecosystems are particularly in need of such monitoring due to their sensitivity to rainfall, water management and other external factors that affect hydrology, soil, and species patterns. A key challenge for environmental scientists is determining the linkage between natural and human stressors, and the effect of that linkage at the species level in space and time. We propose pixel intensity based Shannon entropy for estimating species-richness, and introduce a method based on statistical wavelet multiresolution texture analysis to quantitatively assess interseasonal and interannual species turnover. Methodology/Principal Findings: We model satellite images of regions of interest as textures. We define a texture in an image as a spatial domain where the variations in pixel intensity across the image are both stochastic and multiscale. To compare two textures quantitatively, we first obtain a multiresolution wavelet decomposition of each. Either an appropriate probability density function (pdf) model for the coefficients at each subband is selected, and its parameters estimated, or, a non-parametric approach using histograms is adopted. We choose the former, where the wavelet coefficients of the multiresolution decomposition at each subband are modeled as samples from the generalized Gaussian pdf. We then obtain the joint pdf for the coefficients for all subbands, assuming independence across subbands; an approximation that simplifies the computational burden significantly without sacrificing the ability to statistically distinguish textures. We measure the difference between two textures' representative pdf's via the Kullback-Leibler divergence (KL). Species turnover, or b diversity, is estimated using both this KL divergence and the difference in Shannon entropy. Additionally, we predict species richness, or a diversity, based on the Shannon entropy of pixel intensity. To test our approach, we specifically use the green band of Landsat images for a water conservation area in the Florida Everglades. We validate our predictions against data of species occurrences for a twenty-eight years long period for both wet and dry seasons. Our method correctly predicts 73% of species richness. For species turnover, the newly proposed KL divergence prediction performance is near 100% accurate. This represents a significant improvement over the more conventional Shannon entropy difference, which provides 85% accuracy. Furthermore, we find that changes in soil and water patterns, as measured by fluctuations of the Shannon entropy for the red and blue bands respectively, are positively correlated with changes in vegetation. The fluctuations are smaller in the wet season when compared to the dry season. Conclusions/Significance: Texture-based statistical multiresolution image analysis is a promising method for quantifying interseasonal differences and, consequently, the degree to which vegetation, soil, and water patterns vary. The proposed automated method for quantifying species richness and turnover can also provide analysis at higher spatial and temporal resolution than is currently obtainable from expensive monitoring campaigns, thus enabling more prompt, more cost effective inference and decision making support regarding anomalous variations in biodiversity. Additionally, a matrix-based visualization of the statistical multiresolution analysis is presented to facilitate both insight and quick recognition of anomalous data.	[Convertino, Matteo; Linkov, Igor] USA, Engn Res & Dev Ctr, Environm Lab, Risk & Decis Sci Team,Corps Engineers, Concord, MA USA; [Convertino, Matteo] Univ Florida, Inst Food & Agr Sci, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Convertino, Matteo] Florida State Univ, Univ Florida, Florida Climate Inst, Gainesville, FL USA; [Mangoubi, Rami S.; Lowry, Nathan C.; Desai, Mukund] Charles Stark Draper Lab Inc, Algorithms & Software, Cambridge, MA USA; [Linkov, Igor] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); ERDC - Risk Modeling; State University System of Florida; University of Florida; State University System of Florida; Florida State University; University of Florida; The Charles Stark Draper Laboratory, Inc.; Carnegie Mellon University	Convertino, M (corresponding author), USA, Engn Res & Dev Ctr, Environm Lab, Risk & Decis Sci Team,Corps Engineers, Concord, MA USA.	mconvertino@ufl.edu; mangoubi@draper.com	Convertino, Matteo/ABD-5828-2021; Linkov, Igor/AAH-5981-2019; Convertino, Matteo/J-1365-2016	Linkov, Igor/0000-0002-0823-8107; Convertino, Matteo/0000-0001-7003-7587				Adler PB, 2007, OIKOS, V116, P221, DOI [10.1111/j.2006.0030-1299.15327.x, 10.1111/j.0030-1299.2007.15327.x]; Ajithkumar TT, 2008, J ENVIRON BIOL, V29, P785; Gallardo-Cruz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030506; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Azaele S, 2012, ECOLOGICAL IN PRESS; Baselga A, 2010, ECOLOGY, V91, P1974, DOI 10.1890/09-0320.1; Bellis LM, 2008, ECOL APPL, V18, P1956, DOI 10.1890/07-0243.1; Belluco E, 2006, REMOTE SENS ENVIRON, V105, P54, DOI 10.1016/j.rse.2006.06.006; Bernhardt C, 2009, ECOLOGICAL APPL, V19; Brandt L, 1998, TECHNICAL REPORT; Bubier JL, 1997, J GEOPHYS RES, P102; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Childers D, 2006, LIMNOL OCEANOGR, V51; Childers D, 2003, J ENV QUAL, P32; Cho HJ, 2007, INT J REMOTE SENS, V28, P1455, DOI 10.1080/01431160600962772; Cohen M, 2007, TECHNICAL REPORT; Cohen MJ, 2011, CRIT REV ENV SCI TEC, V41, P395, DOI 10.1080/10643389.2010.531224; Connolly J, 2011, ECOLOGY, V92, P1385, DOI 10.1890/10-2270.1; Convertino M, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR007799; Daehler CC, 2003, ANN REV ECOLOGICAL E, P34; Do MN, 2002, IEEE T IMAGE PROCESS, V11, P146, DOI 10.1109/83.982822; Engler O., 2009, INTRO TEXTURE ANAL M, V2nd; Erb TM, 2011, STEM CELLS DEV, V20, P1601, DOI 10.1089/scd.2010.0281; Ferretti M, 2003, SCI TOTAL ENVIRON, V310, P171, DOI 10.1016/S0048-9697(02)00637-X; GBIF, 2012, TECHNICAL REPORT; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; GLOVIS, 2011, TECHNICAL REPORT; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Jeffreys C, 2004, TECHNICAL REPORT; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2010, ECOLOGY, V91, P1969, DOI 10.1890/09-0368.1; Jurasinski G, 2009, OECOLOGIA, V159, P15, DOI 10.1007/s00442-008-1190-z; Key T, 2001, REMOTE SENS ENVIRON, V75, P100, DOI 10.1016/S0034-4257(00)00159-0; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lagerwall G, 2012, ECOLOGICAL IN PRESS; Latifi H, 2012, REMOTE SENS ENVIRON, V121, P10, DOI 10.1016/j.rse.2012.01.015; Lhermitte S, 2011, REMOTE SENS ENVIRON, V115, P3129, DOI 10.1016/j.rse.2011.06.020; Lowry N, 2010, I S BIOMED IMAGING, P141, DOI 10.1109/ISBI.2010.5490395; Ludovisi A, 2006, ECOL MODEL, V192, P299, DOI 10.1016/j.ecolmodel.2005.05.022; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Mangoubi R, 2008, APPL IM PATT REC WOR, V0, P1; Mangoubi R, 2008, I S BIOMED IMAGING, P380, DOI 10.1109/ISBI.2008.4541012; Mangoubi R, 2007, I S BIOMED IMAGING, P284, DOI 10.1109/ISBI.2007.356844; Marcon E, 2012, OIKOS, V121, P516, DOI 10.1111/j.1600-0706.2011.19267.x; McGlinn D, 2010, PLANT ECOL, P1; McGlinn D, 2012, ECOLOGY; McVoy C., 2011, LANDSCAPE HYDROLOGY; Miao SL, 2009, AQUAT BOT, V90, P157, DOI 10.1016/j.aquabot.2008.08.006; Mitsch W., 2000, WETLANDS, V3rd; Muneepeerakul R, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006153; Nagendra H, 2008, BIODIVERS CONSERV, V17, P3431, DOI 10.1007/s10531-008-9479-0; Nagendra H, 2010, REMOTE SENS-BASEL, V2, P478, DOI 10.3390/rs2020478; Ozesmi SL, 2002, WETLANDS ECOLOGY MAN, V10; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Poveda G, 2004, REMOTE SENS ENVIRON, V93, P391, DOI 10.1016/j.rse.2004.08.001; Prigent C, 2001, GEOPHYS RES LETT, V28, P4631, DOI 10.1029/2001GL013263; Redfield G, 2000, EVERGLADES CONSOLIDA; Ricotta C, 2006, ECOL MODEL, V197, P59, DOI 10.1016/j.ecolmodel.2006.03.001; Rocchini D, 2007, APPL VEG SCI, V10, P325, DOI 10.1111/j.1654-109X.2007.tb00431.x; Rocchini D, 2004, ACTA OECOL, V26, P117, DOI 10.1016/j.actao.2004.03.008; Rocchini D, 2007, REMOTE SENS ENVIRON, V111, P423, DOI 10.1016/j.rse.2007.03.018; Rocchini D, 2012, INT J REMOTE SENS, V33, P4458, DOI 10.1080/01431161.2011.648286; Rocchini D, 2010, ECOL INFORM, V5, P318, DOI 10.1016/j.ecoinf.2010.06.001; Rocchini D, 2010, J ENVIRON MONITOR, V12, P825, DOI 10.1039/b921835a; Rocchini D, 2009, SENSORS-BASEL, V9, P303, DOI 10.3390/s90100303; Rose P, 1979, TECHNICAL REPORT; Rundquist D.C., 2001, REMOTE SENS REV, V20, P207, DOI DOI 10.1080/02757250109532435; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; Southworth J, 2004, AGR ECOSYST ENVIRON, V101, P185, DOI 10.1016/j.agee.2003.09.011; St-Louis V, 2009, ECOGRAPHY, V32, P468, DOI 10.1111/j.1600-0587.2008.05512.x; Sun Y, 2011, ISPRS J PHOTOGRAMMET; Thenkabail PS, 2004, REMOTE SENS ENVIRON, V91, P354, DOI 10.1016/j.rse.2004.03.013; Tilley D, 2004, TECHNICAL REPORT; Todd MJ, 2012, ECOHYDROLOGY, V5, P326, DOI 10.1002/eco.223; Todd MJ, 2010, ADV WATER RESOUR, V33, P1279, DOI 10.1016/j.advwatres.2010.04.003; Tomppo EO, 2009, REMOTE SENS ENVIRON, V113, P500, DOI 10.1016/j.rse.2008.05.021; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009; U.S. Geological Survey, 2003, PREL ASS VAL LANDS 7; USACE, 2012, TECHNICAL REPORT; USGS, 2011, TECHNICAL REPORT; Van de Wouwer G, 1999, IEEE T IMAGE PROCESS, V8, P592, DOI 10.1109/83.753747; Veech JA, 2010, ECOLOGY, V91, P1964, DOI 10.1890/08-1727.1; Viedma O, 2012, REMOTE SENS ENVIRON, V119, P208, DOI 10.1016/j.rse.2011.12.024; Wang C, 2007, REMOTE SENS ENVIRON, V107, P559, DOI 10.1016/j.rse.2006.10.007; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Whittaker RH, 1960, ECOLOGICAL MONOGRAPH, P30; Wilsey BJ, 2010, ECOLOGY, V91, P1984, DOI 10.1890/09-0351.1; Wulder MA, 2004, BIOSCIENCE, V54, P511, DOI 10.1641/0006-3568(2004)054[0511:HSRRSD]2.0.CO;2; Yesson C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001124; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673	92	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e46616	10.1371/journal.pone.0046616	http://dx.doi.org/10.1371/journal.pone.0046616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115629	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200016
J	He, LS; Xu, Y; Matsumura, K; Zhang, Y; Zhang, G; Qi, SH; Qian, PY				He, Li-Sheng; Xu, Ying; Matsumura, Kiyotaka; Zhang, Yu; Zhang, Gen; Qi, Shu-Hua; Qian, Pei-Yuan			Evidence for the Involvement of p38 MAPK Activation in Barnacle Larval Settlement	PLOS ONE			English	Article							PROTEIN COMPLEX SIPC; BALANUS-AMPHITRITE; CYPRIS LARVA; KINASE; BALANOIDES; ATTACHMENT	The barnacle Balanus (= Amphibalanus) amphitrite is a major marine fouling animal. Understanding the molecular mechanism of larval settlement in this species is critical for anti-fouling research. In this study, we cloned one isoform of p38 MAPK (Bar-p38 MAPK) from this species, which shares the significant characteristic of containing a TGY motif with other species such as yeast, Drosophila and humans. The activation of p38 MAPK was detected by an antibody that recognizes the conserved dual phosphorylation sites of TGY. The results showed that phospho-p38 MAPK (pp38 MAPK) was more highly expressed at the cyprid stage, particularly in aged cyprids, in comparison to other stages, including the nauplius and juvenile stages. Immunostaining showed that Bar-p38 MAPK and pp38 MAPK were mainly located at the cyprid antennules, and especially the third and fourth segments, which are responsible for substratum exploration during settlement. The expression and localization patterns of Bar-p38 MAPK suggest its involvement in larval settlement. This postulation was also supported by the larval settlement bioassay with the p38 MAPK inhibitor SB203580. Behavioral analysis by live imaging revealed that the larvae were still capable of exploring the surface of the substratum after SB203580 treatment. This shows that the effect of p38 MAPK on larval settlement might be by regulating the secretion of permanent proteinaceous substances. Furthermore, the level of pp38 MAPK dramatically decreased after full settlement, suggesting that Bar-p38 MAPK maybe plays a role in larval settlement rather than metamorphosis. Finally, we found that Bar-p38 MAPK was highly activated when larvae confronted extracts of adult barnacle containing settlement cues, whereas larvae pre-treated with SB203580 failed to respond to the crude adult extracts.	[He, Li-Sheng; Xu, Ying; Matsumura, Kiyotaka; Zhang, Yu; Zhang, Gen; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, KAUST Global Collaborat Res Program, Div Life Sci, Kowloon, Hong Kong Sar, Peoples R China; [Qi, Shu-Hua] Chinese Acad Sci, S China Sea Inst Oceanog, Guangzhou, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, KAUST Global Collaborat Res Program, Div Life Sci, Kowloon, Hong Kong Sar, Peoples R China.	boqianpy@ust.hk	Xu, Ying/E-2072-2018; Zhang, Yu/K-4912-2012; Zhang/L-6428-2017; Matz, Mikhail/K-4392-2017	Xu, Ying/0000-0003-4658-3283; Zhang/0000-0001-8619-3285; Matz, Mikhail/0000-0001-5453-9819; Qian, Pei-Yuan/0000-0003-4074-9078	King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Research Grants Council of the Hong Kong Special Administrative Region [N-HKUST602/09, AoE/P-04/04-II]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This work was supported by an award from the King Abdullah University of Science and Technology (SA-C0040/UK-C0016) and grants (N-HKUST602/09 and AoE/P-04/04-II) from the Research Grants Council of the Hong Kong Special Administrative Region to PY Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred N, 2009, FUNCTIONAL SURFACES IN BIOLOGY: ADHESION RELATED PHENOMENA, VOL 2, P43, DOI 10.1007/978-1-4020-6695-5_3; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; CLARE AS, 1995, J EXP BIOL, V198, P655; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; Dreanno C, 2006, BIOL LETTERS, V2, P423, DOI 10.1098/rsbl.2006.0503; Dreanno C, 2006, P ROY SOC B-BIOL SCI, V273, P2721, DOI 10.1098/rspb.2006.3649; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; He LS, 2011, CELL MOL LIFE SCI, V68, P1633, DOI 10.1007/s00018-010-0562-9; Kato-Yoshinaga Y, 2000, COMP BIOCHEM PHYS A, V125, P511, DOI 10.1016/S1095-6433(00)00179-3; Kultz D, 1998, J MOL EVOL, V46, P571, DOI 10.1007/PL00006338; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; Matsumura K, 1998, J EXP ZOOL, V280, P213, DOI 10.1002/(SICI)1097-010X(19980215)280:3<213::AID-JEZ2>3.0.CO;2-Q; Matsumura K, 1998, P ROY SOC B-BIOL SCI, V265, P1825, DOI 10.1098/rspb.1998.0508; Matsumura K, 1998, J EXP ZOOL, V281, P12, DOI 10.1002/(SICI)1097-010X(19980501)281:1<12::AID-JEZ3>3.3.CO;2-L; Nasrolahi Ali, 2007, Pakistan Journal of Biological Sciences, V10, P2231, DOI 10.3923/pjbs.2007.2231.2236; NOTT JA, 1969, PHILOS T ROY SOC B, V256, P115, DOI 10.1098/rstb.1969.0038; Phang IY, 2006, BIOFOULING, V22, P245, DOI 10.1080/08927010600857686; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Satuito CG, 1996, MAR BIOL, V127, P125, DOI 10.1007/BF00993652; Satuito CG, 1997, HYDROBIOLOGIA, V358, P275, DOI 10.1023/A:1003109625166; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; WALKER G, 1971, MAR BIOL, V9, P205, DOI 10.1007/BF00351380; Wang H, 2010, J EXP ZOOL PART B, V314B, P390, DOI 10.1002/jez.b.21344; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Zhang Y, 2010, J PROTEOME RES, V9, P3146, DOI 10.1021/pr1000384	29	28	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47195	10.1371/journal.pone.0047195	http://dx.doi.org/10.1371/journal.pone.0047195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115639	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200029
J	Lipworth, L; Mumma, MT; Cavanaugh, KL; Edwards, TL; Ikizler, TA; Tarone, RE; McLaughlin, JK; Blot, WJ				Lipworth, Loren; Mumma, Michael T.; Cavanaugh, Kerri L.; Edwards, Todd L.; Ikizler, T. Alp; Tarone, Robert E.; McLaughlin, Joseph K.; Blot, William J.			Incidence and Predictors of End Stage Renal Disease among Low-Income Blacks and Whites	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; CHRONIC KIDNEY-DISEASE; 3RD NATIONAL-HEALTH; GLOMERULAR-FILTRATION-RATE; AFRICAN-AMERICANS; RACIAL DISPARITIES; SERUM CREATININE; HIGH PREVALENCE; US POPULATION; RISK	We evaluated whether black race is associated with higher incidence of End Stage Renal Disease (ESRD) among a cohort of blacks and whites of similar, generally low socioeconomic status, and whether risk factor patterns differ among blacks and whites and explain the poorly understood racial disparity in ESRD. Incident diagnoses of ESRD among 79,943 black and white participants in the Southern Community Cohort Study (SCCS) were ascertained by linkage with the United States Renal Data System (USRDS) from 2002 through 2009. Person-years of follow up were calculated from date of entry into the SCCS until date of ESRD diagnosis, date of death, or September 1, 2009, whichever occurred first. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CI) for incident ESRD among black and white participants in relation to baseline characteristics. After 329,003 person-years of follow-up, 687 incident cases of ESRD were identified in the cohort. The age-adjusted ESRD incidence rate was 273 (per 100,000) among blacks, 3.5-fold higher than the rate of 78 among whites. Risk factors for ESRD included male sex (HR = 1.6; 95% CI 1.4-1.9), low income (HR = 1.5; 95% CI 1.2-1.8 for income below vs. above $15,000), smoking (HR = 1.2; 95% CI 1.02-1.4) and histories of diabetes (HRs increasing to 9.4 (95% CI 7.4-11.9) among those with >= 20 years diabetes duration) and hypertension (HR = 2.9; 95% CI 2.3-3.7). Patterns and magnitudes of association were virtually identical among blacks and whites. After adjustment for these risk factors, blacks continued to have a higher risk for ESRD (HR = 2.4; 95% CI = 1.9-3.0) relative to whites. The black-white disparity in risk of ESRD was attenuated but not eliminated after control for known risk factors in a closely socioeconomically matched cohort. Further research characterizing biomedical factors, including CKD progression, in ESRD occurrence in these two racial groups is needed.	[Lipworth, Loren; Edwards, Todd L.; Tarone, Robert E.; McLaughlin, Joseph K.; Blot, William J.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN 37235 USA; [Lipworth, Loren; Edwards, Todd L.; Tarone, Robert E.; McLaughlin, Joseph K.; Blot, William J.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Mumma, Michael T.; Tarone, Robert E.; McLaughlin, Joseph K.; Blot, William J.] Int Epidemiol Inst, Rockville, MD USA; [Cavanaugh, Kerri L.; Ikizler, T. Alp] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Lipworth, L (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN 37235 USA.	loren.lipworth@vanderbilt.edu	Edwards, Todd/B-9750-2012	Ikizler, Talat/0000-0002-5717-4218	National Cancer Institute (NCI) [R01 CA92447]; American Recovery and Reinvestment Act [3R01 CA029447-08S1]; American Society of Nephrology;  [DK080952]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092986, K23DK080952] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Recovery and Reinvestment Act; American Society of Nephrology; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Southern Community Cohort Study (SCCS) is funded by grant R01 CA92447 from the National Cancer Institute (NCI), including American Recovery and Reinvestment Act funding (3R01 CA029447-08S1). Dr. Cavanaugh is funded by DK080952 and an American Society of Nephrology Carl W. Gottschalk Research Scholar Grant. Data on end stage renal disease diagnoses were provided by the United States Renal Data System (USRDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAMAH ES, 1990, J LAB CLIN MED, V116, P327; Alves TP, 2010, J AM SOC NEPHROL, V21, P1361, DOI 10.1681/ASN.2009060654; Bash LD, 2010, AM J KIDNEY DIS, V55, P31, DOI 10.1053/j.ajkd.2009.09.006; Burton C, 1996, AM J KIDNEY DIS, V27, P765, DOI 10.1016/S0272-6386(96)90512-0; Choi AI, 2009, AM J MED, V122, P672, DOI 10.1016/j.amjmed.2008.11.021; Clase CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013291.78621.26; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Eggers PW, 2010, CLIN J AM SOC NEPHRO, V5, P1908, DOI 10.2215/CJN.08170910; Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; GOLDSCHMID MG, 1995, DIABETES CARE, V18, P955, DOI 10.2337/diacare.18.7.955; Hall YN, 2010, CLIN J AM SOC NEPHRO, V5, P828, DOI 10.2215/CJN.09011209; Hargreaves MK, 2006, MULTICULTURAL MED HL, P485; Hebert Lee A., 1997, Hypertension (Dallas), V30, P428; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Jones CA, 1998, AM J KIDNEY DIS, V32, P992, DOI 10.1016/S0272-6386(98)70074-5; Kanji Z, 2011, J AM SOC NEPHROL, V22, P2091, DOI 10.1681/ASN.2010121234; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Klein JB, 2010, J NATL MED ASSOC, V102, P108, DOI 10.1016/S0027-9684(15)30498-3; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Martins D, 2002, AM J MED SCI, V323, P65, DOI 10.1097/00000441-200202000-00002; MCCLELLAN W, 1988, AM J KIDNEY DIS, V12, P285, DOI 10.1016/S0272-6386(88)80221-X; McClellan W, 2006, J AM SOC NEPHROL, V17, P1710, DOI 10.1681/ASN.2005111200; McClellan WM, 2011, J AM SOC NEPHROL, V22, P1721, DOI 10.1681/ASN.2010101085; McClellan WM, 2010, AM J NEPHROL, V32, P38, DOI 10.1159/000313883; Pollak MR, 2012, CURR OPIN NEPHROL HY, V21, P179, DOI 10.1097/MNH.0b013e32835012ab; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Thaler LM, 1998, DIABETES CARE, V21, P1576, DOI 10.2337/diacare.21.9.1576; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; WALKER WG, 1992, JAMA-J AM MED ASSOC, V268, P3085, DOI 10.1001/jama.268.21.3085; Xue JL, 2007, J AM SOC NEPHROL, V18, P1299, DOI 10.1681/ASN.2006050524	33	68	68	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48407	10.1371/journal.pone.0048407	http://dx.doi.org/10.1371/journal.pone.0048407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110237	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200168
J	Tsai, JP; Liou, JH; Kao, WT; Wang, SC; Lian, JD; Chang, HR				Tsai, Jen-Pi; Liou, Jia-Hung; Kao, Wei-Tse; Wang, Shao-Chung; Lian, Jong-Da; Chang, Horng-Rong			Increased Expression of Intranuclear Matrix Metalloproteinase 9 in Atrophic Renal Tubules Is Associated with Renal Fibrosis	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE ACTIVITY; CONVERTING ENZYME-INHIBITION; DAMAGE; ROLES	Background: Reduced turnover of extracellular matrix has a role in renal fibrosis. Matrix metalloproteinases (MMPs) is associated with many glomerular diseases, but the histological association of MMPs and human renal fibrosis is unclear. Methods: This is a retrospective study. Institutional Review Board approval was obtained for the review of patients' medical records, data analysis and pathological specimens staining with waiver of informed consents. Specimens of forty-six patients were examined by immunohistochemical stain of MMP-9 in nephrectomized kidneys, and the association of renal expression of MMP-9 and renal fibrosis was determined. MMP-9 expression in individual renal components and fibrosis was graded as high or low based on MMP-9 staining and fibrotic scores. Results: Patients with high interstitial fibrosis scores (IFS) and glomerular fibrosis scores (GFS) had significantly higher serum creatinine, lower estimated glomerular filtration rate (eGFR), and were more likely to have chronic kidney disease (CKD) and urothelial cell carcinoma. Univariate analysis showed that IFS and GFS were negatively associated with normal and atrophic tubular cytoplasmic MMP-9 expression and IFS was positively correlated with atrophic tubular nuclear MMP-9 expression. Multivariate stepwise regression indicated that MMP-9 expression in atrophic tubular nuclei (r = 0.4, p = 0.002) was an independent predictor of IFS, and that MMP-9 expression in normal tubular cytoplasm (r = -0.465, p<0.001) was an independent predictor of GFS. Conclusions: Interstitial fibrosis correlated with MMP-9 expression in the atrophic tubular nuclei. Our results indicate that renal fibrosis is associated with a decline of MMP-9 expression in the cytoplasm of normal tubular cells and increased expression of MMP-9 in the nuclei of tubular atrophic renal tubules.	[Tsai, Jen-Pi; Liou, Jia-Hung; Kao, Wei-Tse; Wang, Shao-Chung; Chang, Horng-Rong] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tsai, Jen-Pi] Buddhist Dalin Tzu Chi Gen Hosp, Dept Nephrol, Chiayi, Taiwan; [Liou, Jia-Hung] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Liou, Jia-Hung] Jen Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Wang, Shao-Chung] Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan; [Lian, Jong-Da; Chang, Horng-Rong] Chung Shan Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung, Taiwan	Chung Shan Medical University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Chang, HR (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	chr@csmu.edu.tw						Bauvois B, 2007, NEPHROL DIAL TRANSPL, V22, P1115, DOI 10.1093/ndt/gfl743; Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515; Bolbrinker J, 2006, J PHARMACOL EXP THER, V316, P8, DOI 10.1124/jpet.105.093112; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Chang HR, 2006, CLIN CHIM ACTA, V366, P243, DOI 10.1016/j.cca.2005.10.007; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Kawata N, 2007, UROLOGY, V69, P1049, DOI 10.1016/j.urology.2007.02.044; Kunugi S, 2011, LAB INVEST, V91, P170, DOI 10.1038/labinvest.2010.174; Legallicier B, 2001, J AM SOC NEPHROL, V12, P2358, DOI 10.1681/ASN.V12112358; Lelongt B, 2001, CURR OPIN NEPHROL HY, V10, P7, DOI 10.1097/00041552-200101000-00002; Lenz O, 2000, J AM SOC NEPHROL, V11, P574, DOI 10.1681/ASN.V113574; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lods N, 2003, J AM SOC NEPHROL, V14, P2861, DOI 10.1097/01.ASN.0000092789.67966.5C; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; Maric C, 2004, J AM SOC NEPHROL, V15, P1546, DOI 10.1097/01.ASN.0000128219.65330.EA; McLennan SV, 2002, DIABETOLOGIA, V45, P268, DOI 10.1007/s00125-001-0730-4; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Reis LO, 2010, WORLD J UROL, V28, P499, DOI 10.1007/s00345-010-0545-3; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Tsai YY, 2005, MOL VIS, V11, P71; Urushihara M, 2002, NEPHROL DIAL TRANSPL, V17, P1189, DOI 10.1093/ndt/17.7.1189; Wang XH, 2010, AM J PHYSIOL-RENAL, V299, pF973, DOI 10.1152/ajprenal.00216.2010; Yang Y, 2010, J NEUROCHEM, V112, P134, DOI 10.1111/j.1471-4159.2009.06433.x; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	26	22	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48164	10.1371/journal.pone.0048164	http://dx.doi.org/10.1371/journal.pone.0048164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110201	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200155
J	Wright, E; Schofield, PT; Seed, P; Molokhia, M				Wright, Ellen; Schofield, Peter T.; Seed, Paul; Molokhia, Mariam			Bisphosphonates and Risk of Upper Gastrointestinal Cancer - A Case Control Study Using the General Practice Research Database (GPRD)	PLOS ONE			English	Article							ESOPHAGEAL CANCER; ORAL BISPHOSPHONATES; WOMEN; DRUGS; UK	Background: Concerns have been raised as to the safety of bisphosphonates; in particular a possible link between bisphosphonate use and upper gastrointestinal (GI) cancer. Two published studies using different study populations but drawn from earlier versions of the same national UK database, reached differing conclusions: one finding no evidence for an increase in the risk of gastric or oesophageal cancer in bisphosphonate users and one finding a small but significantly increased risk of oesophageal cancer linked to duration of bisphosphonate use. Methodology/Principal Findings: Design-A case control study comparing bisphosphonate prescribing in cases of upper GI cancer from 1995 to 2007 using UK primary care electronic health records (GPRD). Main Outcome Measure-Relative Risk (approximated to Odds Ratio for rare events) for oesophageal and gastric cancer development in bisphosphonate users compared to non-users. The odds of being a case of oesophageal cancer, adjusted for smoking status, were significantly increased in women who had had one or more bisphosphonate prescriptions, odds ratio 1.54 (95% CI 1.27-1.88) compared to non-users. There was no significant effect on gastric cancer in women, odds ratio adjusted for smoking status, 1.06 (95% CI 0.83-1.37) and also no apparent risk in men for either oesophageal or gastric cancer, odds ratio adjusted for smoking status 0.78 (95% CI 0.56-1.09) and 0.87 (95% CI 0.55-1.36) respectively. Conclusions/Significance: Our results support a small but significant increased risk of oesophageal cancer in women prescribed bisphosphonates and is based on the largest number of exposed cases to date in the UK.	[Wright, Ellen; Schofield, Peter T.; Seed, Paul; Molokhia, Mariam] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	University of London; King's College London	Wright, E (corresponding author), Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England.	ellen.wright@kcl.ac.uk	Wright, Ellen/AAT-4573-2021; Schofield, Peter/B-7821-2011; Seed, Paul T/C-4435-2008	Schofield, Peter/0000-0003-1201-527X; Seed, Paul T/0000-0001-7904-7933	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London; Medical Research Council	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The GPRD dataset for this study was obtained under the collaborative research licence funded by the Medical Research Council and the study was approved by the Independent Scientific Advisory Committee of the GPRD (protocol number 09_093R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2011, J BONE MINER RES; Abrahamsen B, 2009, NEW ENGL J MED, V360, P1789, DOI 10.1056/NEJMc096026; Altman D, 1991, PRACTICAL SYST MED R; Cardwell CR, 2010, JAMA-J AM MED ASSOC, V304, P657, DOI 10.1001/jama.2010.1098; Chen Y-M, 2011, ALENDRONATE RISK ESO; Colina RE, 1997, AM J GASTROENTEROL, V92, P704; Dixon WG, 2011, NAT REV RHEUMATOL, V7, P369, DOI 10.1038/nrrheum.2011.60; GPRD, 2010, DAT; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Haber SL, 2012, ANN PHARMACOTHER, V46, P419, DOI 10.1345/aph.1Q482; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Ho YF, 2012, CANCER EPIDEM BIOMAR, V21, P993, DOI 10.1158/1055-9965.EPI-12-0259; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Nguyen DM, 2010, DIGEST DIS SCI, V55, P3404, DOI 10.1007/s10620-010-1198-1; Parfitt JR, 2007, HUM PATHOL, V38, P527, DOI 10.1016/j.humpath.2007.01.014; Siris ES, 2009, NEW ENGL J MED, V360, P1791; Solomon DH, 2009, NEW ENGL J MED, V360, P1789; Thomson ABR, 2002, J RHEUMATOL, V29, P1965; Vestergaard P, 2011, CALCIFIED TISSUE INT, V89, P434, DOI 10.1007/s00223-011-9539-4; Vinogradova Y, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000548; Walker AM, 2011, PHARMACOEPIDEM DR S, V20, P1159, DOI 10.1002/pds.2249; Watson J, 2007, EUR J CLIN PHARMACOL, V63, P843, DOI 10.1007/s00228-007-0320-6; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738; Wysowski DK, 2010, BMJ, V341; Zhang J, 2011, CURR RHEUMATOL REP, V13, P273, DOI 10.1007/s11926-011-0168-8	25	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47616	10.1371/journal.pone.0047616	http://dx.doi.org/10.1371/journal.pone.0047616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112825	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200058
J	Zhang, Q; Ding, DR; Zeng, SX; Ye, QZ; Lu, H				Zhang, Qi; Ding, Derong; Zeng, Shelya X.; Ye, Qi-Zhuang; Lu, Hua			Structure and Activity Analysis of Inauhzin Analogs as Novel Antitumor Compounds That Induce p53 and Inhibit Cell Growth	PLOS ONE			English	Article							TUMOR-GROWTH; ACTIVATION; MUTATIONS	Identifying effective small molecules that specifically target the p53 pathway in cancer has been an exciting, though challenging, approach for the development of anti-cancer therapy. We recently identified Inauhzin (INZ) as a novel p53 activator, selectively and efficiently suppressing tumor growth without displaying genotoxicity and with little toxicity to normal cells. In order to reveal the structural features essential for anti-cancer activity of this small molecule, we have synthesized a panel of INZ analogs and evaluated their ability to induce cellular p53 and to inhibit cell growth in cell-based assays. This study as described here leads to the discovery of INZ analog 37 that displays much better potency than INZ in both of p53 activation and cell growth inhibition in several human cancer cell lines including H460 and HCT116(+/+) cells. This INZ analog exhibited much less effect on p53-null H1299 cells and HCT116(-/-) cells, and importantly no toxicity on normal human p53-containing WI-38 cells. Hence, our results not only unveil key chemical features for INZ activity, but also identify the newly synthesized INZ analog 37 as a better small molecule for further development of anti-cancer therapy.	[Zhang, Qi; Ding, Derong; Zeng, Shelya X.; Ye, Qi-Zhuang; Lu, Hua] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Zhang, Qi; Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Zhang, Qi; Zeng, Shelya X.; Lu, Hua] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Lu, Hua] Simon Canc Ctr, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Tulane University; Tulane University	Ye, QZ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	yeq@iupui.edu; hlu2@tulane.edu			National Institutes of Health-National Cancer Institute [CA127724, CA095441, CA172468, CA129828]; National Institute of Health [AI065898]; NATIONAL CANCER INSTITUTE [R01CA127724, R01CA095441, R01CA129828, R01CA172468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065898, R01AI065898] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	H.L. was supported by National Institutes of Health-National Cancer Institute grants CA127724, CA095441, CA172468, and CA129828. Q.-Z.Y. was supported by National Institute of Health grant AI065898.	Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kgokong JL, 2005, BIOORGAN MED CHEM, V13, P2935, DOI 10.1016/j.bmc.2005.02.017; Krizhanovsky V., 2009, NATURE, p[53, 53]; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Vang T, 2011, J MED CHEM, V54, P562, DOI 10.1021/jm101004d; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang YW, 2012, CANCER BIOL THER, V13, P915, DOI 10.4161/cbt.20844	15	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e46294	10.1371/journal.pone.0046294	http://dx.doi.org/10.1371/journal.pone.0046294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115626	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200013
J	Margadant, C; van den Bout, I; van Boxtel, AL; Thijssen, VL; Sonnenberg, A				Margadant, Coert; van den Bout, Iman; van Boxtel, Antonius L.; Thijssen, Victor L.; Sonnenberg, Arnoud			Epigenetic Regulation of Galectin-3 Expression by beta 1 Integrins Promotes Cell Adhesion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; DNA METHYLATION; BREAST-CARCINOMA; BINDING-PROTEIN; GENE-EXPRESSION; INTEGRINS; FIBRONECTIN; BETA-1; REEPITHILIALIZATION; ALPHA-5-BETA-1	Introduction of the integrin beta 1- but not the beta 3-subunit in GE11 cells induces an epithelial-to-mesenchymal-transition (EMT)-like phenomenon that is characterized by the loss of cell-cell contacts, cell scattering, increased cell migration and RhoA activity, and fibronectin fibrillogenesis. Because galactosebinding lectins (galectins) have been implicated in these phenomena, we investigated whether galectins are involved in the beta-induced phenotype. We examined 9 galectins and, intriguingly, found that the expression of galectin-3 (Gal-3) is specifically induced by beta 1 but not by beta 3. Using beta 1-beta 3 chimeric integrins, we show that the induction of Gal-3 expression requires the hypervariable region in the extracellular domain of beta 1, but not its cytoplasmic tail. Furthermore, Gal-3 expression does not depend on RhoA signaling, serum factors, or any of the major signal transduction pathways involving protein kinase C (PKC), p38 mitogen-activated protein kinase (p38MAPK), extracellular signal-regulated kinase-1/-2 (ERK-1/2), phosphatidylinositol3- OH kinase (PI3-K), or Src kinases. Instead, Gal-3 expression is controlled in an epigenetic manner. Whereas DNA methylation of the Lgals3 promoter maintains Gal-3 silencing in GE11 cells, expression of beta 1 causes its demethylation, leading to transcriptional activation of the Lgals3 gene. In turn, Gal-3 expression enhances beta 1 integrin-mediated cell adhesion to fibronectin (FN) and laminin (LN), as well as cell migration. Gal-3 also promotes beta 1-mediated cell adhesion to LN and Collagen-1 (Col)-1 in cells that endogenously express Gal-3 and beta 1 integrins. In conclusion, we identify a functional feedback-loop between beta 1 integrins and Gal-3 that involves the epigenetic induction of Gal-3 expression during integrin-induced EMT and cell scattering.	[Margadant, Coert; van den Bout, Iman; Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [van Boxtel, Antonius L.] Vrije Univ Amsterdam, Inst Environm Studies IVM, NL-1081 HV Amsterdam, Netherlands; [Thijssen, Victor L.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, NL-1081 HV Amsterdam, Netherlands; [Thijssen, Victor L.] Vrije Univ Amsterdam Med Ctr, Dept Radiat Oncol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van den Bout, I (corresponding author), Paterson Inst Canc Res, Inositide Lab, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	ivbout@picr.man.ac.uk; a.sonnenberg@nki.nl	Thijssen, Victor LJL/B-2792-2009	Thijssen, Victor LJL/0000-0002-6146-1842; van den Bout, Iman/0000-0001-6333-1470	Dutch Cancer Society [NKI 2001-2488]; Netherlands Organization for Scientific Research [864.09.005]	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Dutch Cancer Society (NKI 2001-2488) and in part by the Netherlands Organization for Scientific Research (864.09.005, to A.L.v.B.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Benvenuto G, 1996, MOL CELL BIOL, V16, P2736; CAMPBELL ID, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a004994; Cao ZY, 2002, J BIOL CHEM, V277, P42299, DOI 10.1074/jbc.M200981200; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; Chiariotti L, 2002, GLYCOCONJUGATE J, V19, P441, DOI 10.1023/B:GLYC.0000014073.23096.3a; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Friedrichs J, 2007, J BIOL CHEM, V282, P29375, DOI 10.1074/jbc.M701867200; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Hughes RC, 2001, BIOCHIMIE, V83, P667; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kuwabara I, 1996, J IMMUNOL, V156, P3939; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Matarrese P, 2000, INT J CANCER, V85, P545, DOI 10.1002/(SICI)1097-0215(20000215)85:4<545::AID-IJC17>3.0.CO;2-N; Miao H, 2002, J CELL SCI, V115, P2199; Moiseeva EP, 2003, BIOCHEM BIOPH RES CO, V310, P1010, DOI 10.1016/j.bbrc.2003.09.112; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; Pacienza N, 2008, FASEB J, V22, P1113, DOI 10.1096/fj.07-9524com; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Rao SP, 2007, J IMMUNOL, V179, P7800, DOI 10.4049/jimmunol.179.11.7800; Rozhon W, 2008, ANAL BIOCHEM, V375, P354, DOI 10.1016/j.ab.2008.01.001; Ruebel KH, 2005, CANCER RES, V65, P1136, DOI 10.1158/0008-5472.CAN-04-3578; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Thijssen VLJL, 2004, EXP CELL RES, V299, P286, DOI 10.1016/j.yexcr.2004.06.014; Warfield PR, 1997, INVAS METAST, V17, P101; WOO HJ, 1990, J BIOL CHEM, V265, P7097	48	38	40	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44684	44693		10.1074/jbc.M112.426445	http://dx.doi.org/10.1074/jbc.M112.426445			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23118221	Green Published, hybrid			2022-12-25	WOS:000312938600064
J	Jin, Y; Tong, DY; Chen, JN; Feng, ZY; Yang, JY; Shao, CK; Li, JP				Jin, Yi; Tong, Da-yue; Chen, Jian-ning; Feng, Zhi-ying; Yang, Jian-yong; Shao, Chun-kui; Li, Jia-ping			Overexpression of Osteopontin, alpha v beta 3 and Pim-1 Associated with Prognostically Important Clinicopathologic Variables in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							BREAST-CANCER; INTEGRIN ALPHA-V-BETA-3; PROTOONCOGENE PIM-1; EXPRESSION; ALPHA(V)BETA(3); MIGRATION; TRANSCRIPTION; METASTASIS; ACTIVATION; CARCINOMA	In this study, we examined the expression of osteopontin (OPN), alpha v beta 3 and Pim-1 in non-small cell lung cancer (NSCLC) and investigated the potential clinical implications of their expression patterns in NSCLC. Immunohistochemical assays were used to examine the protein expression of OPN, alpha v beta 3 and Pim-1 in 208 NSCLC samples and their adjacent normal lung tissue specimens. Statistical analyses were performed to evaluate the relationships between OPN, alpha v beta 3 and Pim-1 expression patterns, and their association with the clinical-pathological parameters of NSCLC patients. In NSCLC tissues, the positive rates of OPN, alpha v beta 3 and Pim-1 expression were 67.8% (141/208), 76.0% (158/208) and 58.7% (122/208), respectively. However, in the adjacent normal lung tissues, the positive rates of OPN, alpha v beta 3 and Pim-1 were 20.2% (42/208), 24.0% (50/208) and 14.9% (31/208), respectively. The differences in the positive expression rates of OPN, alpha v beta 3 and Pim-1 between NSCLCs and the adjacent normal lung tissues were all significant (P<0.01). Additionally, the positive expression of OPN, alpha v beta 3 and Pim-1 in NSCLCs was associated with an increase in pathological grade, lymph node metastasis and advanced clinical stage (all P<0.01). Furthermore, associations between the expression of OPN and alpha v beta 3, OPN and Pim-1, and alpha v beta 3 and Pim-1 were also observed in our NSCLC cohort (all P<0.01). The OPN, alpha v beta 3 and Pim-1 proteins are frequently overexpressed in NSCLC and are associated with some clinicopathologic variables that are of known prognostic importance in NSCLC, suggesting that they may play an important role in the development and/or progression of NSCLC.	[Jin, Yi; Chen, Jian-ning; Feng, Zhi-ying; Shao, Chun-kui] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Da-yue] Sun Yat Sen Univ, ZhongShan Med Sch, Dept Forens Med, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Jian-yong; Li, Jia-ping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Shao, CK (corresponding author), Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	chunkuishao2011@163.com; jpli3s@126.com						Angelucci A, 2004, PROSTATE, V59, P157, DOI 10.1002/pros.20008; Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Bao LH, 2007, J BIOMED SCI, V14, P373, DOI 10.1007/s11373-006-9143-1; Beer AJ, 2008, J NUCL MED, V49, P255, DOI 10.2967/jnumed.107.045526; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Chiang WF, 2006, INT J ORAL MAX SURG, V35, P740, DOI 10.1016/j.ijom.2006.01.027; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; Cui R, 2007, LUNG CANCER, V57, P302, DOI 10.1016/j.lungcan.2007.03.019; Fong YC, 2009, LUNG CANCER, V64, P263, DOI 10.1016/j.lungcan.2008.09.003; Guo SJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-161; He HC, 2009, MED ONCOL, V26, P303, DOI 10.1007/s12032-008-9120-9; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hsu AR, 2006, MOL IMAGING BIOL, V8, P315, DOI 10.1007/s11307-006-0059-y; Hu Z, 2005, CLIN CANCER RES, V11, P4646, DOI 10.1158/1078-0432.CCR-04-2013; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim Dae Sik, 2008, Cancer Res Treat, V40, P190, DOI 10.4143/crt.2008.40.4.190; Krishnan N, 2003, ENDOCRINE, V20, P123, DOI 10.1385/ENDO:20:1-2:123; Li P, 2011, INT J MOL MED, V27, P679, DOI 10.3892/ijmm.2011.628; Lossner D, 2009, J CELL PHYSIOL, V220, P367, DOI 10.1002/jcp.21774; Macri A, 2009, TUMORI J, V95, P48; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Rodrigues LR, 2007, CANCER EPIDEM BIOMAR, V16, P1087, DOI 10.1158/1055-9965.EPI-06-1008; SENGER DR, 1979, CELL, V16, P885, DOI 10.1016/0092-8674(79)90103-X; Trvris WD, 2004, WHO CLASSIFICATION T; Verbisck NV, 2009, CANCER RES, V69, P5546, DOI 10.1158/0008-5472.CAN-08-2976; Wang Z, 2001, J Vet Sci, V2, P167; Warnecke-Eberz U, 2009, ANTICANCER RES, V29, P4451; Zhang J, 2001, CANCER LETT, V171, P215, DOI 10.1016/S0304-3835(01)00607-3; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zhao XQ, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-98	30	23	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48575	10.1371/journal.pone.0048575	http://dx.doi.org/10.1371/journal.pone.0048575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119061	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500172
J	Kim, AS; Poisson, SN; Easton, JD; Johnston, SC				Kim, Anthony S.; Poisson, Sharon N.; Easton, J. Donald; Johnston, S. Claiborne			A Cross-Sectional Study of Individuals Seeking Information on Transient Ischemic Attack and Stroke Symptoms Online: A Target for Intervention?	PLOS ONE			English	Article							HEALTH INFORMATION; MINOR STROKE; MEDICAL ATTENTION; POPULATION; RISK; INTERNET; EMERGENCY; ACCESS; DELAY; TIA	Background: Individuals with TIA/stroke symptoms often do not seek urgent medical attention. We assessed the feasibility of identifying individuals searching for information on TIA/stroke symptoms online as a target for future interventions to encourage urgent evaluation and we evaluated the performance of a self-reported risk score to identify subjects with true TIA or stroke. Methodology/Principal Findings: We placed online advertisements to target English-speaking adults in the United States searching for TIA/stroke-related keywords. After completing an online questionnaire, participants were telephoned by a vascular neurologist to assess the likelihood of TIA/stroke. We used logistic regression and the c-statistic to assess associations and model discrimination respectively. Over 122 days, 251 (1%) of 25,292 website visitors completed the online questionnaire and 175 were reached by telephone (mean age 58.5 years; 63% women) for follow-up. Of these participants, 37 (21%) had symptoms within 24 hours, 60 (34%) had not had a medical evaluation yet, and 68 (39%) had TIA/stroke. Applying a modified ABCD(2) score yielded a c-statistic of 0.66, but 2 of 12 with a zero score had a TIA/stroke. Those with new symptoms were more likely to have TIA/stroke (OR 4.90, 95% CI 2.56-9.09). Conclusions/Significance: Individuals with TIA/stroke that are seeking real-time information on symptoms online can be readily identified, in some cases before they have sought formal medical evaluation. Although a simple self-reported risk score was unable to identify a low-risk population in this selected group, this population may still present an attractive target for future interventions designed to encourage urgent medical evaluation.	[Kim, Anthony S.; Poisson, Sharon N.; Easton, J. Donald; Johnston, S. Claiborne] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Johnston, S. Claiborne] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kim, AS (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	akim@ucsf.edu		Poisson, Sharon/0000-0002-7162-4043	National Stroke Association through Boehringer Ingelheim Pharmaceuticals, Inc.	National Stroke Association through Boehringer Ingelheim Pharmaceuticals, Inc.	This study was sponsored by the National Stroke Association through a grant from Boehringer Ingelheim Pharmaceuticals, Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chandratheva A, 2010, STROKE, V41, P1108, DOI 10.1161/STROKEAHA.109.576611; Choi N, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1753; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Ferro JM, 1996, STROKE, V27, P2225, DOI 10.1161/01.STR.27.12.2225; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Giles MF, 2006, STROKE, V37, P1254, DOI 10.1161/01.STR.0000217388.57851.62; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2003, NEUROLOGY, V60, P1429, DOI 10.1212/01.WNL.0000063309.41867.0F; Johnston SC, 2003, NEUROLOGY, V60, P280; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Jones WJ, 2001, STROKE, V32, P2232, DOI 10.1161/hs1001.096191; Josephson SA, 2008, STROKE, V39, P3096, DOI 10.1161/STROKEAHA.108.514562; Lasserson DS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1569; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Lustria MLA, 2011, HEALTH INFORM J, V17, P224, DOI 10.1177/1460458211414843; Maestroni A, 2008, EMERG MED J, V25, P340, DOI 10.1136/emj.2007.048389; Mandelzweig L, 2006, STROKE, V37, P1248, DOI 10.1161/01.STR.0000217200.61167.39; Palomeras E, 2008, EUR J NEUROL, V15, P329, DOI 10.1111/j.1468-1331.2008.02082.x; Quinn TJ, 2009, STROKE, V40, P749, DOI 10.1161/STROKEAHA.108.530444; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Sprigg N, 2009, J NEUROL NEUROSUR PS, V80, P871, DOI 10.1136/jnnp.2008.167924; Walcott BP, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1124; Wasserman IM, 2005, SOC SCI QUART, V86, P252, DOI 10.1111/j.0038-4941.2005.00301.x; Zach L, 2012, HEALTH INFO LIBR J, V29, P61, DOI 10.1111/j.1471-1842.2011.00971.x	26	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47997	10.1371/journal.pone.0047997	http://dx.doi.org/10.1371/journal.pone.0047997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118919	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500055
J	Falone, S; D'Alessandro, A; Mirabilio, A; Cacchio, M; Di Ilio, C; Di Loreto, S; Amicarelli, F				Falone, Stefano; D'Alessandro, Antonella; Mirabilio, Alessandro; Cacchio, Marisa; Di Ilio, Carmine; Di Loreto, Silvia; Amicarelli, Fernanda			Late-Onset Running Biphasically Improves Redox Balance, Energy- and Methylglyoxal-Related Status, as well as SIRT1 Expression in Mouse Hippocampus	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; OXIDATIVE STRESS; CALORIC RESTRICTION; COGNITIVE DECLINE; SKELETAL-MUSCLE; FREE-RADICALS; UP-REGULATION; EXERCISE; AGE; PROTEIN	Despite the active research in this field, molecular mechanisms underlying exercise-induced beneficial effects on brain physiology and functions are still matter of debate, especially with regard to biological processes activated by regular exercise affecting the onset and progression of hippocampal aging in individuals unfamiliar with habitual physical activity. Since such responses seem to be mediated by changes in antioxidative, antiglycative and metabolic status, a possible exercise-induced coordinated response involving redox, methylglyoxal- and sirtuin-related molecular networks may be hypothesized. In this study, hippocampi of CD1 mice undergoing the transition from mature to middle age were analyzed for redox-related profile, oxidative and methylglyoxal-dependent damage patterns, energy metabolism, sirtuin1 and glyoxalase1 expression after a 2- or 4-mo treadmill running program. Our findings suggested that the 4-mo regular running lowered the chance of dicarbonyl and oxidative stress, activated mitochondrial catabolism and preserved sirtuin1-related neuroprotection. Surprisingly, the same cellular pathways were negatively affected by the first 2 months of exercise, thus showing an interesting biphasic response. In conclusion, the duration of exercise caused a profound shift in the response to regular running within the rodent hippocampus in a time-dependent fashion. This research revealed important details of the interaction between exercise and mammal hippocampus during the transition from mature to middle age, and this might help to develop non-pharmacological approaches aimed at retarding brain senescence, even in individuals unfamiliar with habitual exercise.	[Falone, Stefano; D'Alessandro, Antonella; Mirabilio, Alessandro; Amicarelli, Fernanda] Univ Aquila, Dept Basic & Appl Biol, I-67100 Laquila, AQ, Italy; [Cacchio, Marisa] Univ G DAnnunzio, Dept Basic & Appl Med Sci, Chieti, CH, Italy; [Di Ilio, Carmine] Univ G DAnnunzio, Dept Biomed Sci, Chieti, CH, Italy; [Di Loreto, Silvia] Natl Res Council CNR, Inst Translat Pharmacol IFT, Laquila, AQ, Italy	University of L'Aquila; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Amicarelli, F (corresponding author), Univ Aquila, Dept Basic & Appl Biol, I-67100 Laquila, AQ, Italy.	fernanda.amicarelli@univaq.it	Di Loreto, Silvia/AAK-3406-2021; Di Loreto, Silvia/R-1849-2018; Falone, Stefano/D-8692-2017	Falone, Stefano/0000-0002-5978-0545; Amicarelli, Fernanda/0000-0003-4528-4660	Foundation of the Cassa di Risparmio dell'Aquila (CARISPAQ)	Foundation of the Cassa di Risparmio dell'Aquila (CARISPAQ)	This work was funded by the Foundation of the Cassa di Risparmio dell'Aquila (CARISPAQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; Amicarelli F, 1998, CARCINOGENESIS, V19, P519, DOI 10.1093/carcin/19.3.519; Amicarelli F, 2001, INT J BIOCHEM CELL B, V33, P1129, DOI 10.1016/S1357-2725(01)00010-3; Amicarelli F, 1997, MECH AGEING DEV, V97, P215, DOI 10.1016/S0047-6374(97)00061-4; Amicarelli F, 1998, CHEM-BIOL INTERACT, V114, P177, DOI 10.1016/S0009-2797(98)00048-9; Amicarelli F, 1999, BBA-MOL BASIS DIS, V1453, P105, DOI 10.1016/S0925-4439(98)00088-X; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; Bayod S, 2012, EXP GERONTOL, V47, P925, DOI 10.1016/j.exger.2012.08.004; Bayod S, 2011, J APPL PHYSIOL, V111, P1380, DOI 10.1152/japplphysiol.00425.2011; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Bergmeyer HU, 1974, METHOD ENZYMAT AN, P451; BLOMQUIST KB, 1987, PERCEPT MOTOR SKILL, V65, P175, DOI 10.2466/pms.1987.65.1.175; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Denu JM, 2007, CELL, V129, P453, DOI 10.1016/j.cell.2007.04.023; Di Loreto S, 2004, BRAIN RES, V1006, P157, DOI 10.1016/j.brainres.2004.01.066; Di Loreto S, 2008, INT J BIOCHEM CELL B, V40, P245, DOI 10.1016/j.biocel.2007.07.019; Falone S, 2010, PHYSIOL RES, V59, P953, DOI 10.33549/physiolres.931884; Falone S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031401; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Fouquet C, 2011, NEUROBIOL AGING, V32, P1881, DOI 10.1016/j.neurobiolaging.2009.11.001; Frazzini V, 2006, BIOGERONTOLOGY, V7, P307, DOI 10.1007/s10522-006-9045-7; Fulle S, 2005, EXP GERONTOL, V40, P189, DOI 10.1016/j.exger.2004.11.006; Griffin EW, 2011, PHYSIOL BEHAV, V104, P934, DOI 10.1016/j.physbeh.2011.06.005; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; Hipkiss AR, 2008, BIOGERONTOLOGY, V9, P49, DOI 10.1007/s10522-007-9110-x; Hipkiss AR, 2006, MECH AGEING DEV, V127, P8, DOI 10.1016/j.mad.2005.09.006; JACKSON MJ, 1987, P NUTR SOC, V46, P77, DOI 10.1079/PNS19870010; Ji L L, 1995, Exerc Sport Sci Rev, V23, P135; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; Kong XX, 2009, BIOCHEMISTRY-MOSCOW+, V74, P703, DOI 10.1134/S0006297909070013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane RM, 2005, J LIPID RES, V46, P949, DOI 10.1194/jlr.M400486-JLR200; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Liu JK, 2000, J APPL PHYSIOL, V89, P21; Liu YF, 2008, NEUROBIOL LEARN MEM, V90, P81, DOI 10.1016/j.nlm.2008.02.005; Luth HJ, 2005, CEREB CORTEX, V15, P211, DOI 10.1093/cercor/bhh123; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Marton O, 2010, BIOGERONTOLOGY, V11, P679, DOI 10.1007/s10522-010-9279-2; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Muscari A, 2010, INT J GERIATR PSYCH, V25, P1055, DOI 10.1002/gps.2462; PHILLIPS SA, 1993, BIOCHEM PHARMACOL, V46, P805, DOI 10.1016/0006-2952(93)90488-I; Pietrelli A, 2012, NEUROSCIENCE, V202, P252, DOI 10.1016/j.neuroscience.2011.11.054; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; Radak Z, 2001, EXERC IMMUNOL REV, V7, P90; Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029; Radak Z, 2007, APPL PHYSIOL NUTR ME, V32, P942, DOI 10.1139/H07-081; Radak Z, 2006, NEUROCHEM INT, V49, P387, DOI 10.1016/j.neuint.2006.02.004; Rolland Y, 2010, CLIN GERIATR MED, V26, P75, DOI 10.1016/j.cger.2009.11.002; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Skapare E, 2011, CELL BIOCHEM FUNCT, V29, P171, DOI 10.1002/cbf.1723; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; SOMANI SM, 1995, PHARMACOL BIOCHEM BE, V51, P627, DOI 10.1016/0091-3057(94)00427-K; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; Tatone C, 2008, HUM REPROD UPDATE, V14, P131, DOI 10.1093/humupd/dmm048; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Vina J, 2000, IUBMB LIFE, V50, P271, DOI 10.1080/15216540051080994; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Williamson J, 2010, ARCH INTERN MED, V170, P124, DOI 10.1001/archinternmed.2009.491; Yagi K, 1998, Methods Mol Biol, V108, P101	67	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48334	10.1371/journal.pone.0048334	http://dx.doi.org/10.1371/journal.pone.0048334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110231	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500061
J	Castilla, MA; Diaz-Martin, J; Sarrio, D; Romero-Perez, L; Lopez-Garcia, MA; Vieites, B; Biscuola, M; Ramiro-Fuentes, S; Isacke, CM; Palacios, J				Angeles Castilla, Maria; Diaz-Martin, Juan; Sarrio, David; Romero-Perez, Laura; Angeles Lopez-Garcia, Maria; Vieites, Begona; Biscuola, Michele; Ramiro-Fuentes, Susana; Isacke, Clare M.; Palacios, Jose			MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; E-CADHERIN EXPRESSION; GENE-EXPRESSION; METAPLASTIC CARCINOMA; MIR-200 FAMILY; FEEDBACK LOOP; CLAUDIN-LOW; PROGRESSION; SUBTYPES	The epithelial to mesenchymal transition (EMT) contributes to tumor invasion and metastasis in a variety of cancer types. In human breast cancer, gene expression studies have determined that basal-B/claudin-low and metaplastic cancers exhibit EMT-related characteristics, but the molecular mechanisms underlying this observation are unknown. As the family of miR-200 microRNAs has been shown to regulate EMT in normal tissues and cancer, here we evaluated whether the expression of the miR-200 family (miR-200f) and their epigenetic state correlate with EMT features in human breast carcinomas. We analyzed by qRT-PCR the expression of miR-200f members and various EMT-transcriptional inducers in a series of 70 breast cancers comprising an array of phenotypic subtypes: estrogen receptor positive (ER+), HER2 positive (HER2+), and triple negative (TN), including a subset of metaplastic breast carcinomas (MBCs) with sarcomatous (homologous or heterologous) differentiation. No MBCs with squamous differentiation were included. The DNA methylation status of miR-200f loci in tumor samples were inspected using Sequenom MassArray (R) MALDI-TOF platform. We also used two non-tumorigenic breast basal cell lines that spontaneously undergo EMT to study the modulation of miR-200f expression during EMT in vitro. We demonstrate that miR-200f is strongly decreased in MBCs compared with other cancer types. TN and HER2+ breast cancers also exhibited lower miR-200f expression than ER+ tumors. Significantly, the decreased miR-200f expression found in MBCs is accompanied by an increase in the expression levels of EMT-transcriptional inducers, and hypermethylation of the miR-200c-141 locus. Similar to tumor samples, we demonstrated that downregulation of miR-200f and hypermethylation of the miR-200c-141 locus, together with upregulation of EMT-transcriptional inducers also occur in an in vitro cellular model of spontaneous EMT. Thus, the expression and methylation status of miR-200f could be used as hypothetical biomarkers to assess the occurrence of EMT in breast cancer.	[Angeles Castilla, Maria; Diaz-Martin, Juan; Romero-Perez, Laura; Angeles Lopez-Garcia, Maria; Vieites, Begona; Biscuola, Michele; Ramiro-Fuentes, Susana; Palacios, Jose] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Dept Pathol,Inst Biomed Sevilla, Seville, Spain; [Angeles Castilla, Maria; Diaz-Martin, Juan; Romero-Perez, Laura; Angeles Lopez-Garcia, Maria; Vieites, Begona; Biscuola, Michele; Palacios, Jose] RTICC, Madrid, Spain; [Sarrio, David; Isacke, Clare M.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Palacios, Jose] Hosp Univ Ramon Y Cajal, Dept Pathol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Hospital Universitario Ramon y Cajal	Diaz-Martin, J (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Dept Pathol,Inst Biomed Sevilla, Seville, Spain.	jdiaz-ibis@us.es; jose.palacios@salud.madrid.org	Romero-Pérez, Laura/C-8314-2015; Diaz-Martin, Juan/GSI-9230-2022; Diaz-Martin, Juan/F-4765-2015; Castilla, M Angeles/C-9454-2015; SARRIO, DAVID/Y-8903-2019; Palacios, Jose/AAV-3765-2020; Diaz-Martin, Juan/AAU-1685-2021; IBIS, NEUROPEPTIDOS/H-7482-2016	Romero-Pérez, Laura/0000-0003-3196-4382; Diaz-Martin, Juan/0000-0002-3985-6434; Diaz-Martin, Juan/0000-0002-3985-6434; Sarrio, David/0000-0003-4886-8290; Isacke, Clare/0000-0002-9222-3345	Instituto de Salud Carlos III (ISCIII) [PI07/90324, PI080971]; Ministerio de Ciencia e Innovacion (MCINN); European Development Regional Fund, "A way to achieve Europe" EDRF [RD06/0020/0013]; Junta de Andalucia (Consejeria de Salud) [PI-0384/2007, PI0581/2009]; Consejeria de Innovacion (Proyecto de Excelencia) [P07-CVI-03100]; Sandra Ibarra Foundation [2011/088]; ISCIII [PI080971, RD06/0020/0013]; Consejeria de Salud, Junta de Andalucia [PI0581/2009]; EU Marie Curie Intra-European Fellowship [PIEF-GA-2008-221083]; Breakthrough Breast Cancer; PFIS fellowship [F109/00193]; ISCIII-Red de Biobancos [RD09/0076/00085]	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund, "A way to achieve Europe" EDRF; Junta de Andalucia (Consejeria de Salud)(Junta de Andalucia); Consejeria de Innovacion (Proyecto de Excelencia); Sandra Ibarra Foundation; ISCIII(Instituto de Salud Carlos III); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); EU Marie Curie Intra-European Fellowship(European Commission); Breakthrough Breast Cancer; PFIS fellowship; ISCIII-Red de Biobancos	This work was supported by grants from: the Instituto de Salud Carlos III (ISCIII; Grant Nos PI07/90324 and PI080971) and the Ministerio de Ciencia e Innovacion (MCINN), co-financed by the European Development Regional Fund, "A way to achieve Europe" EDRF (Grant No. RD06/0020/0013); the Junta de Andalucia (Consejeria de Salud, Grant No. PI-0384/2007, PI0581/2009); the Consejeria de Innovacion (Proyecto de Excelencia, Grant No. P07-CVI-03100); and Sandra Ibarra Foundation (Grant No. 2011/088) to JP. MAC and JDM are PhD researchers funded by the ISCIII (Grant No. RD06/0020/0013) and the Consejeria de Salud, Junta de Andalucia (PI0581/2009), respectively. DS was funded by an EU Marie Curie Intra-European Fellowship (PIEF-GA-2008-221083) and by Breakthrough Breast Cancer. LRP is a PhD student recipient of a PFIS fellowship (Grant No. F109/00193). MB is a researcher funded by the ISCIII-Red de Biobancos RD09/0076/00085. SR works as a lab technician supported by the ISCIII (PI080971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Davalos V, 2011, ONCOGENE; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Holliday DL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2218; Howe EN, 2012, J MAMMARY GLAND BIOL; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Lien HC, 2004, J PATHOL, V204, P131, DOI 10.1002/path.1624; Liu YN, 2012, ONCOGENE; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Reis JS, 2006, HISTOPATHOLOGY, V49, P10, DOI 10.1111/j.1365-2559.2006.02467.x; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Vrba L, 2011, GENOME RES; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wee EJ, 2012, ONCOGENE; Wiklund ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027840; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Yuan JH, 2011, HEPATOLOGY, V54, P2025, DOI 10.1002/hep.24606; Zhang YH, 2012, MODERN PATHOL, V25, P178, DOI 10.1038/modpathol.2011.167	50	84	85	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47709	10.1371/journal.pone.0047709	http://dx.doi.org/10.1371/journal.pone.0047709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112837	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200071
J	Fraccaroli, A; Franco, CA; Rognoni, E; Neto, F; Rehberg, M; Aszodi, A; Wedlich-Soldner, R; Pohl, U; Gerhardt, H; Montanez, E				Fraccaroli, Alessia; Franco, Claudio A.; Rognoni, Emanuel; Filipa Neto; Rehberg, Markus; Aszodi, Attila; Wedlich-Soeldner, Roland; Pohl, Ulrich; Gerhardt, Holger; Montanez, Eloi			Visualization of Endothelial Actin Cytoskeleton in the Mouse Retina	PLOS ONE			English	Article							F-ACTIN; IN-VIVO; ANGIOGENESIS; VASCULATURE; FILOPODIA; LIFEACT; CELLS; MICE	Angiogenesis requires coordinated changes in cell shape of endothelial cells (ECs), orchestrated by the actin cytoskeleton. The mechanisms that regulate this rearrangement in vivo are poorly understood - largely because of the difficulty to visualize filamentous actin (F-actin) structures with sufficient resolution. Here, we use transgenic mice expressing Lifeact-EGFP to visualize F-actin in ECs. We show that in the retina, Lifeact-EGFP expression is largely restricted to ECs allowing detailed visualization of F-actin in ECs in situ. Lifeact-EGFP labels actin associated with cell-cell junctions, apical and basal membranes and highlights actin-based structures such as filopodia and stress fiber-like cytoplasmic bundles. We also show that in the skin and the skeletal muscle, Lifeact-EGFP is highly expressed in vascular mural cells (vMCs), enabling vMC imaging. In summary, our results indicate that the Lifeact-EGFP transgenic mouse in combination with the postnatal retinal angiogenic model constitutes an excellent system for vascular cell biology research. Our approach is ideally suited to address structural and mechanistic details of angiogenic processes, such as endothelial tip cell migration and fusion, EC polarization or lumen formation.	[Fraccaroli, Alessia; Rehberg, Markus; Pohl, Ulrich; Montanez, Eloi] Univ Munich, Walter Brendel Ctr Expt Med & Munich Heart Allian, Munich, Germany; [Franco, Claudio A.; Filipa Neto; Gerhardt, Holger] Lincolns Inn Fields Labs, London Res Inst, Vasc Biol Lab, Canc Res UK, London, England; [Rognoni, Emanuel; Wedlich-Soeldner, Roland] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Aszodi, Attila] Univ Munich, Dept Surg, Munich, Germany	Munich Heart Alliance; University of Munich; Cancer Research UK; Max Planck Society; University of Munich	Montanez, E (corresponding author), Univ Munich, Walter Brendel Ctr Expt Med & Munich Heart Allian, Munich, Germany.	Eloi.Montanez@med.uni-muenchen.de	Franco, Claudio A/B-1060-2013; Rognoni, Emanuel/M-3024-2019; Gerhardt, Holger/G-4610-2011; Montanez, Eloi/Y-6723-2019; Franco, Claudio A/D-8117-2015; Gerhardt, Holger/G-4610-2011	Franco, Claudio A/0000-0002-2861-3883; Rognoni, Emanuel/0000-0001-6050-2860; Gerhardt, Holger/0000-0002-3030-0384; Montanez, Eloi/0000-0003-4059-5056; Franco, Claudio A/0000-0002-2861-3883; Gerhardt, Holger/0000-0001-9228-7472; Rehberg, Markus/0000-0001-7314-6332	Friedrich-Baur-Stiftung; DFG [MO2562/1-1]; Marie Curie FP7 fellowship; Cancer Research UK; Lister Institute of Preventive Medicine; Leducq Transatlantic Network ARTEMIS	Friedrich-Baur-Stiftung; DFG(German Research Foundation (DFG)); Marie Curie FP7 fellowship; Cancer Research UK(Cancer Research UK); Lister Institute of Preventive Medicine; Leducq Transatlantic Network ARTEMIS(Leducq Foundation)	AF, MR, UP and EM are supported by the Bioimaging Network of the Ludwig-Maximilians University Munich (LMU innovative), EM is supported by the Friedrich-Baur-Stiftung and the DFG (MO2562/1-1), CAF is supported by Marie Curie FP7 fellowship, HG is supported by Cancer Research UK, the Lister Institute of Preventive Medicine, and the Leducq Transatlantic Network ARTEMIS.	Bayless KJ, 2011, J VASC RES, V48, P369, DOI 10.1159/000324751; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Iruela-Arispe ML, 2011, DEV CELL, V20, P412, DOI 10.1016/j.devcel.2011.03.020; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Khandoga AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004693; Lee CY, 2011, PHYSIOLOGY, V26, P326, DOI 10.1152/physiol.00018.2011; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rehberg M, 2010, NANO LETT, V10, P3656, DOI 10.1021/nl102100m; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Stenzel D, 2011, EMBO REP, V12, P1135, DOI 10.1038/embor.2011.194; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799	20	27	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47488	10.1371/journal.pone.0047488	http://dx.doi.org/10.1371/journal.pone.0047488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115648	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000310310200043
J	Mencalha, AL; Binato, R; Ferreira, GM; Du Rocher, B; Abdelhay, E				Mencalha, Andre L.; Binato, Renata; Ferreira, Gerson M.; Du Rocher, Barbara; Abdelhay, Eliana			Forkhead Box M1 (FoxM1) Gene Is a New STAT3 Transcriptional Factor Target and Is Essential for Proliferation, Survival and DNA Repair of K562 Cell Line	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; TRANSACTIVATING ACTIVITY; SONIC HEDGEHOG; EXPRESSION; PROGRESSION; CONTRIBUTES; INHIBITION; RESISTANCE; PROGRAM; ARREST	The forkhead box (Fox) M1 gene belongs to a superfamily of evolutionarily conserved transcriptional regulators that are involved in a wide range of biological processes, and its deregulation has been implicated in cancer survival, proliferation and chemotherapy resistance. However, the role of FoxM1, the signaling involved in its activation and its role in leukemia are poorly known. Here, we demonstrate by gene promoter analysis, Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assays that FoxM1 is a new target of the STAT3 transcriptional activator. Additionally, FoxM1 is transcriptionally dependent on STAT3 signaling activation. Furthermore, we verified that FoxM1 is crucial for K562 cell proliferation, cell cycle checkpoints and viability and could be related to chemotherapeutic resistance. By microarray analysis, we determined the signaling pathways related to FoxM1 expression and its role in DNA repair using K562 cells. Our results revealed new signaling involved in FoxM1 expression and its role in leukemic cells that elucidate cellular mechanisms associated with the development of leukemia and disease progression.	[Mencalha, Andre L.; Binato, Renata; Ferreira, Gerson M.; Du Rocher, Barbara; Abdelhay, Eliana] Inst Nacl Canc, Div Labs CEMO, Lab Celulas Tronco, Rio De Janeiro, Brazil	National Cancer Institute (Inca)	Mencalha, AL (corresponding author), Inst Nacl Canc, Div Labs CEMO, Lab Celulas Tronco, Rio De Janeiro, Brazil.	amencalha@inca.gov.br	Mencalha, Andre/AAC-6700-2019; Mencalha, A/F-6677-2012; Mencalha, Andre Luiz/Y-2522-2019; Du Rocher D'Aguiar Silva, Bárbara/A-1805-2014; Ferreira, Gerson Moura/B-4698-2017	Ferreira, Gerson Moura/0000-0002-3467-2580; Mencalha, Andre Luiz/0000-0003-3229-8094; Du-Rocher, Barbara/0000-0002-1020-8038	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Ministerio da Saude, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Saude, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Ministerio da Saude, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barre B, 2005, J BIOL CHEM, V280, P15673, DOI 10.1074/jbc.M413203200; Bau DT, 2006, CANCER LETT, V240, P1, DOI 10.1016/j.canlet.2005.08.003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bewry NN, 2008, MOL CANCER THER, V7, P3169, DOI 10.1158/1535-7163.MCT-08-0314; Bicknell Katrina A., 2004, V296, P247; Binato R, 2009, MOL MED REP, V2, P657, DOI 10.3892/mmr_00000153; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209; Cilloni D, 2012, CLIN CANC R IN PRESS; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; Douard R, 2006, SURGERY, V139, P665, DOI 10.1016/j.surg.2005.10.012; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laurendeau I, 2010, MOL MED, V16, P262, DOI 10.2119/molmed.2010.00005; Le Lay J, 2010, PHYSIOL REV, V90, P1, DOI 10.1152/physrev.00018.2009; Leber B, 2011, CURR ONCOL, V18, pE185; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long B, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-8; Ma RYM, 2010, METHODS MOL BIOL, V647, P113, DOI 10.1007/978-1-60761-738-9_6; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Masuda M, 2010, CURR CANCER DRUG TAR, V10, P117, DOI 10.2174/156800910790980197; Mencalha AL, 2010, CANCER CHEMOTH PHARM, V65, P1039, DOI 10.1007/s00280-009-1109-3; Nakamura S, 2010, CARCINOGENESIS, V31, P2012, DOI 10.1093/carcin/bgq185; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Priller M, 2011, CLIN CANCER RES, V17, P6791, DOI 10.1158/1078-0432.CCR-11-1214; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Skorski T, 2008, LEUKEMIA LYMPHOMA, V49, P610, DOI 10.1080/03093640701859089; Teh MT, 2002, CANCER RES, V62, P4773; Teh MT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-45; Turner SD, 2002, MOL CELL BIOL, V22, P4011, DOI 10.1128/MCB.22.12.4011-4019.2002; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang M, 2011, ONCOTARGET, V2, P1218; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Yang DK, 2009, HUM PATHOL, V40, P464, DOI 10.1016/j.humpath.2008.10.001; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036	45	52	54	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48160	10.1371/journal.pone.0048160	http://dx.doi.org/10.1371/journal.pone.0048160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110199	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200154
J	Sonne, S; Shekhawat, PS; Matern, D; Ganapathy, V; Ignatowicz, L				Sonne, Srinivas; Shekhawat, Prem S.; Matern, Dietrich; Ganapathy, Vadivel; Ignatowicz, Leszek			Carnitine Deficiency in OCTN2(-/-) Newborn Mice Leads to a Severe Gut and Immune Phenotype with Widespread Atrophy, Apoptosis and a Pro-Inflammatory Response	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; DISTAL ULCERATIVE-COLITIS; ACID OXIDATION DISORDERS; TANDEM MASS-SPECTROMETRY; NECROTIZING ENTEROCOLITIS; CROHNS-DISEASE; TRANSPORTER OCTN2; NEURODEVELOPMENTAL OUTCOMES; FUNCTIONAL VARIANTS; TOPICAL IRRIGATION	We have investigated the gross, microscopic and molecular effects of carnitine deficiency in the neonatal gut using a mouse model with a loss-of-function mutation in the OCTN2 (SLC22A5) carnitine transporter. The tissue carnitine content of neonatal homozygous (OCTN2(-/-)) mouse small intestine was markedly reduced; the intestine displayed signs of stunted villous growth, early signs of inflammation, lymphocytic and macrophage infiltration and villous structure breakdown. Mitochondrial beta-oxidation was active throughout the GI tract in wild type newborn mice as seen by expression of 6 key enzymes involved in b-oxidation of fatty acids and genes for these 6 enzymes were up-regulated in OCTN2(-/-) mice. There was increased apoptosis in gut samples from OCTN2(-/-) mice. OCTN2(-/-) mice developed a severe immune phenotype, where the thymus, spleen and lymph nodes became atrophied secondary to increased apoptosis. Carnitine deficiency led to increased expression of CD45-B220(+) lymphocytes with increased production of basal and anti-CD3-stimulated pro-inflammatory cytokines in immune cells. Real-time PCR array analysis in OCTN2(-/-) mouse gut epithelium demonstrated down-regulation of TGF-beta/BMP pathway genes. We conclude that carnitine plays a major role in neonatal OCTN2(-/-) mouse gut development and differentiation, and that severe carnitine deficiency leads to increased apoptosis of enterocytes, villous atrophy, inflammation and gut injury.	[Sonne, Srinivas; Shekhawat, Prem S.] Georgia Hlth Sci Univ, Dept Pediat, Med Coll Georgia, Augusta, GA USA; [Sonne, Srinivas; Shekhawat, Prem S.; Ganapathy, Vadivel] Georgia Hlth Sci Univ, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA USA; [Matern, Dietrich] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Matern, Dietrich] Mayo Clin, Coll Med, Dept Med Genet, Rochester, MN USA; [Matern, Dietrich] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA; [Ignatowicz, Leszek] Georgia Hlth Sci Univ, Ctr Biotechnol & Genom Med, Med Coll Georgia, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Mayo Clinic; Mayo Clinic; Mayo Clinic; University System of Georgia; Augusta University	Shekhawat, PS (corresponding author), Georgia Hlth Sci Univ, Dept Pediat, Med Coll Georgia, Augusta, GA USA.	shekhawatp@ecu.edu	Shekhawat, Prem/I-9933-2019	Shekhawat, Prem/0000-0002-6080-4321; Sonne, Srinivas/0000-0002-3274-8473	National Institutes of Health grant [HD 048867]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD048867] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by National Institutes of Health grant HD 048867 to PSS, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisu M, 2002, BIOL NEONATE, V81, P260, DOI 10.1159/000056757; Babusukumar U, 2006, AM J GASTROENTEROL, V101, P1354, DOI 10.1111/j.1572-0241.2006.00564.x; Barbara PD, 2005, DEV DYNAM, V234, P312, DOI 10.1002/dvdy.20554; Batts LE, 2006, DEV DYNAM, V235, P1563, DOI 10.1002/dvdy.20741; Bene J, 2006, WORLD J GASTROENTERO, V12, P5550, DOI 10.3748/wjg.v12.i34.5550; Bisquera JA, 2002, PEDIATRICS, V109, P423, DOI 10.1542/peds.109.3.423; Boles RG, 1998, J PEDIATR-US, V132, P924, DOI 10.1016/S0022-3476(98)70385-3; Cederbaum SD, 2002, MOL GENET METAB, V77, P195, DOI 10.1016/S1096-7192(02)00169-5; Chace DH, 2003, PEDIATR RES, V53, P823, DOI 10.1203/01.PDR.0000059220.39578.3D; Chace DH, 2001, CLIN CHEM, V47, P1166; Crill CM, 2006, JPEN-PARENTER ENTER, V30, P421, DOI 10.1177/0148607106030005421; Ferrara F, 2005, DRUG EXP CLIN RES, V31, P109; Ferraris A, 2006, INFLAMM BOWEL DIS, V12, P355, DOI 10.1097/01.MIB.0000217338.23065.58; Fisher SA, 2006, HUM MUTAT, V27, P778, DOI 10.1002/humu.20358; Fortin G, 2009, CLIN EXP IMMUNOL, V156, P161, DOI 10.1111/j.1365-2249.2009.03879.x; Gasbarrini G, 2003, HEPATO-GASTROENTEROL, V50, P1385; Gazouli M, 2005, WORLD J GASTROENTERO, V11, P7525, DOI 10.3748/wjg.v11.i47.7525; Giancaterini A, 2001, AM J GASTROENTEROL, V96, P2275, DOI 10.1016/S0002-9270(01)02551-5; JOHNSON JA, 1992, GASTROENTEROLOGY, V103, P1709, DOI 10.1016/0016-5085(92)91215-P; JOHNSON JA, 1993, DIS COLON RECTUM, V36, P518, DOI 10.1007/BF02050022; Kabaroglu C, 2005, PEDIATR INT, V47, P10, DOI 10.1111/j.1442-200x.2005.01999.x; Koizumi A, 1999, HUM MOL GENET, V8, P2247, DOI 10.1093/hmg/8.12.2247; Lahjouji K, 2002, MOL GENET METAB, V76, P76, DOI 10.1016/S1096-7192(02)00017-3; LARSSON LE, 1990, ACTA ANAESTH SCAND, V34, P501, DOI 10.1111/j.1399-6576.1990.tb03132.x; Laviano A, 2011, CANCER INVEST, V29, P696, DOI 10.3109/07357907.2011.626476; Maheshwari A, 2011, GASTROENTEROLOGY, V140, P242, DOI 10.1053/j.gastro.2010.09.043; Meyburg J, 2002, PEDIATR RES, V52, P720, DOI [10.1203/00006450-200211000-00018, 10.1203/01.PDR.0000032157.26265.0C]; Meyburg J, 2001, PEDIATR RES, V49, P125, DOI 10.1203/00006450-200101000-00024; Mikhailova TL, 2011, ALIMENT PHARM THER, V34, P1088, DOI 10.1111/j.1365-2036.2011.04844.x; Neu J, 2005, ACTA PAEDIATR, V94, P100, DOI 10.1080/08035320510043637; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Newman B, 2005, GASTROENTEROLOGY, V128, P260, DOI 10.1053/j.gastro.2004.11.056; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Ohtsuka Y, 2000, CURR OPIN GASTROEN, V16, P541, DOI 10.1097/00001574-200011000-00014; Patole S, 2005, J MATERN-FETAL NEO M, V17, P69, DOI 10.1080/14767050400028832; Patole S, 2007, EARLY HUM DEV, V83, P635, DOI 10.1016/j.earlhumdev.2007.07.007; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Penn D, 1997, PEDIATR RES, V42, P114, DOI 10.1203/00006450-199707000-00018; Penn D, 1998, SHOCK, V10, P377, DOI 10.1097/00024382-199811000-00012; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rees CM, 2007, ARCH DIS CHILD-FETAL, V92, pF193, DOI 10.1136/adc.2006.099929; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Rinaldo Piero, 1998, Current Opinion in Pediatrics, V10, P615; SACHAN DS, 1989, AM J PERINAT, V6, P14, DOI 10.1055/s-2007-999535; Sakuraba H, 2007, BIOCHEM BIOPH RES CO, V359, P406, DOI 10.1016/j.bbrc.2007.05.117; SCHMIDTSOMMERFELD E, 1988, EUR J PEDIATR, V147, P356, DOI 10.1007/BF00496410; Schulzke SM, 2007, ARCH PEDIAT ADOL MED, V161, P583, DOI 10.1001/archpedi.161.6.583; Scriver CR, 2001, METABOLIC MOL BASES; Shekhawat P, 2003, AM J PHYSIOL-ENDOC M, V284, pE1098, DOI 10.1152/ajpendo.00481.2002; Shekhawat PS, 2007, MOL GENET METAB, V92, P315, DOI 10.1016/j.ymgme.2007.08.002; SHENAI JP, 1983, PEDIATR RES, V17, P579, DOI 10.1203/00006450-198307000-00012; SHENAI JP, 1984, PEDIATR RES, V18, P679, DOI 10.1203/00006450-198407000-00024; Sisk PM, 2007, J PERINATOL, V27, P428, DOI 10.1038/sj.jp.7211758; Soraisham AS, 2006, J PAEDIATR CHILD H, V42, P499, DOI 10.1111/j.1440-1754.2006.00910.x; Spiekerkoetter U, 2003, J INHERIT METAB DIS, V26, P613, DOI 10.1023/A:1025968502527; Stevens RD, 2000, CLIN CHEM, V46, P727; Thangasamy T, 2009, BIOGERONTOLOGY, V10, P163, DOI 10.1007/s10522-008-9159-1; Wang J, 2011, HUM GENET, V129, P597, DOI 10.1007/s00439-011-0952-6; Wang YH, 2000, HUM MUTAT, V15, P238, DOI 10.1002/(SICI)1098-1004(200003)15:3<238::AID-HUMU4>3.0.CO;2-3; Wang YH, 1999, P NATL ACAD SCI USA, V96, P2356, DOI 10.1073/pnas.96.5.2356; Wilcken B, 2001, J PEDIATR-US, V138, P581, DOI 10.1067/mpd.2001.111813; Yuan Yong, 2011, J Clin Med Res, V3, P78, DOI 10.4021/jocmr540w	62	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47729	10.1371/journal.pone.0047729	http://dx.doi.org/10.1371/journal.pone.0047729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112839	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200073
J	Fallica, B; Maffei, JS; Villa, S; Makin, G; Zaman, M				Fallica, Brian; Maffei, Joseph S.; Villa, Shaun; Makin, Guy; Zaman, Muhammad			Alteration of Cellular Behavior and Response to PI3K Pathway Inhibition by Culture in 3D Collagen Gels	PLOS ONE			English	Article							IN-VITRO; EXTRACELLULAR-MATRIX; BREAST-CANCER; GENE-EXPRESSION; TUMOR INVASION; CELLS; CHEMORESISTANCE; PROGNOSIS; ADHESION; KINASE	Most investigations into cancer cell drug response are performed with cells cultured on flat (2D) tissue culture plastic. Emerging research has shown that the presence of a three-dimensional (3D) extracellular matrix (ECM) is critical for normal cell behavior including migration, adhesion, signaling, proliferation and apoptosis. In this study we investigate differences between cancer cell signaling in 2D culture and a 3D ECM, employing real-time, live cell tracking to directly observe U2OS human osteosarcoma and MCF7 human breast cancer cells embedded in type 1 collagen gels. The activation of the important PI3K signaling pathway under these different growth conditions is studied, and the response to inhibition of both PI3K and mTOR with PI103 investigated. Cells grown in 3D gels show reduced proliferation and migration as well as reduced PI3K pathway activation when compared to cells grown in 2D. Our results quantitatively demonstrate that a collagen ECM can protect U2OS cells from PI103. Overall, our data suggests that 3D gels may provide a better medium for investigation of anti-cancer drugs than 2D monolayers, therefore allowing better understanding of cellular response and behavior in native like environments.	[Fallica, Brian; Maffei, Joseph S.; Zaman, Muhammad] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Villa, Shaun; Makin, Guy] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England; [Villa, Shaun; Makin, Guy] Univ Manchester, Sch Canc & Enabling Sci, Manchester Canc Res Ctr, Manchester, Lancs, England; [Villa, Shaun; Makin, Guy] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Makin, Guy] Royal Manchester Childrens Hosp, Dept Paediat Oncol, Manchester M27 1HA, Lancs, England	Boston University; Paterson Institute for Cancer Research; University of Manchester; University of Manchester; University of Manchester; Royal Manchester Children's Hospital	Zaman, M (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	zaman@bu.edu		Makin, Guy/0000-0003-3513-3957	Research Councils UK through the Science Bridge collaboration by Manchester: Integrating Medicine and Innovative Technology (MIMIT) [EP/G041733/1]; Center for Integration of Medicine and Innovative Technology (CIMIT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/G041733/1] Funding Source: researchfish; EPSRC [EP/G041733/1] Funding Source: UKRI	Research Councils UK through the Science Bridge collaboration by Manchester: Integrating Medicine and Innovative Technology (MIMIT); Center for Integration of Medicine and Innovative Technology (CIMIT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Research Councils UK [grant number EP/G041733/1] through the Science Bridge collaboration supported by Manchester: Integrating Medicine and Innovative Technology (MIMIT) and the Center for Integration of Medicine and Innovative Technology (CIMIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Baker EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020355; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z; Bates RC, 2001, CANCER RES, V61, P5275; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Brown LM, 2006, MOL PHARMACOL, V69, P411, DOI 10.1124/mol.105.015743; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; de Vicente JC, 2007, J ORAL PATHOL MED, V36, P415, DOI 10.1111/j.1600-0714.2007.00546.x; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Dempsey JM, 2010, MTORC1 MEDIATED CO B, V28, P1; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fallica B, 2011, INTEGR BIOL-UK, V3, P529, DOI 10.1039/c0ib00142b; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; FUJIMOTO D, 1978, J BIOCHEM-TOKYO, V83, P863, DOI 10.1093/oxfordjournals.jbchem.a131983; Gatti L, 2005, METH MOLEC MED, V111, P127; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harjanto D, 2010, ORGANIC BIOMOLECULAR, V8; Hishikawa Y, 1997, ONCOLOGY, V54, P342; Kubica N, 2010, CANCER DRUG DISCOV D, P1, DOI 10.1007/978-1-60327-271-1_1; Leeman MF, 2002, J CLIN PATHOL, V55, P758, DOI 10.1136/jcp.55.10.758; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; MILLER BE, 1985, CANCER RES, V45, P4200; National Cancer Institute, 2011, SEER CANC STAT REV 1; Netti PA, 2000, CANCER RES, V60, P2497; Niforou Katerina N., 2008, Cancer Genomics & Proteomics, V5, P63; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park S, 2008, LEUKEMIA, V22, P1698, DOI 10.1038/leu.2008.144; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polak P, 2006, DEV CELL, V11, P433, DOI 10.1016/j.devcel.2006.09.005; Ranuncolo SM, 2003, INT J CANCER, V106, P745, DOI 10.1002/ijc.11288; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Sotiriou C, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr433; Tornoczky T, 2003, J CLIN PATHOL, V56, P363, DOI 10.1136/jcp.56.5.363; USAJ M, 2010, BIOLOGY, V236, P107, DOI DOI 10.1007/S00232-010-9272-3; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Yakes FM, 2002, CANCER RES, V62, P4132; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	56	61	61	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e48024	10.1371/journal.pone.0048024	http://dx.doi.org/10.1371/journal.pone.0048024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110163	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193600044
J	Li, XM; Polacino, P; Garcia-Navarro, R; Hu, SL; Tsuji, M				Li, Xiangming; Polacino, Patricia; Garcia-Navarro, Raquel; Hu, Shiu-Lok; Tsuji, Moriya			Peripheral Blood Invariant Natural Killer T Cells of Pig-Tailed Macaques	PLOS ONE			English	Article							ALPHA-GALACTOSYLCERAMIDE; NKT CELLS; IN-VIVO; DENDRITIC CELLS; PROTECTS MICE; ACTIVATION; PREVENTS; CD4(+); MODEL; IDENTIFICATION	In humans, invariant natural killer T (iNKT) cells represent a small but significant population of peripheral blood mononuclear cells (PBMCs) with a high degree of variability. In this study, pursuant to our goal of identifying an appropriate non-human primate model suitable for pre-clinical glycolipid testing, we evaluated the percentage and function of iNKT cells in the peripheral blood of pig-tailed macaques. First, using a human CD1d-tetramer loaded with alpha-GalCer (alpha-GalCer-CD1d- Tet), we found that alpha-GalCer-CD1d-Tet(+)CD3(+) iNKT cells make up 0.13% to 0.4% of pig-tailed macaque PBMCs, which are comparable to the percentage of iNKT cells found in human PBMCs. Second, we observed that a large proportion of V alpha 24(+)CD3(+) cells are alpha-GalCer-CD1d-Tet(+)CD3(+) iNKT cells, which primarily consist of either the CD4(+) or CD8(+) subpopulation. Third, we found that pig-tailed macaque iNKT cells produce IFN-gamma in response to alpha-GalCer, as shown by ELISpot assay and intracellular cytokine staining (ICCS), as well as TNF-alpha, as shown by ICCS, indicating that these iNKT cells are fully functional. Interestingly, the majority of pig-tailed macaque iNKT cells that secrete IFN-gamma are CD8(+) iNKT cells. Based on these findings, we conclude that the pig-tailed macaques exhibit potential as a non-human animal model for the pre-clinical testing of iNKT-stimulating glycolipids.	[Li, Xiangming; Garcia-Navarro, Raquel; Tsuji, Moriya] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, HIV & Malaria Vaccine Program, New York, NY 10021 USA; [Polacino, Patricia; Hu, Shiu-Lok] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Hu, Shiu-Lok] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	Rockefeller University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tsuji, M (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, HIV & Malaria Vaccine Program, 1230 York Ave, New York, NY 10021 USA.	mtsuji@adarc.org		Tsuji, Moriya/0000-0001-8587-277X	National Institutes of Health [AI070258]; Irene Diamond Foundation; WaNPRC [P51 RR000166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070258, R56AI070258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene Diamond Foundation; WaNPRC; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from National Institutes of Health AI070258 (M.T.), the Irene Diamond Foundation, and P51 RR000166 (WaNPRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Carnaud C, 1999, J IMMUNOL, V163, P4647; Chackerian A, 2002, INFECT IMMUN, V70, P6302, DOI 10.1128/IAI.70.11.6302-6309.2002; Clements JE, 2008, J NEUROVIROL, V14, P309, DOI 10.1080/13550280802132832; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Eberl G, 2000, J IMMUNOL, V165, P4305, DOI 10.4049/jimmunol.165.8.4305; Eberl G, 2000, EUR J IMMUNOL, V30, P985, DOI 10.1002/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E; Fernandez CS, 2009, J VIROL, V83, P1617, DOI 10.1128/JVI.02138-08; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gansert JL, 2003, J IMMUNOL, V170, P3154, DOI 10.4049/jimmunol.170.6.3154; Gansuvd B, 2003, J IMMUNOL, V171, P2904, DOI 10.4049/jimmunol.171.6.2904; Gansuvd B, 2008, J MED PRIMATOL, V37, P1, DOI 10.1111/j.1600-0684.2007.00222.x; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Gonzalez-Aseguinolaza G, 2000, P NATL ACAD SCI USA, V97, P8461, DOI 10.1073/pnas.97.15.8461; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Henning T, 2011, J MED PRIMATOL, V40, P214, DOI 10.1111/j.1600-0684.2011.00488.x; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kashiwase K, 2003, IMMUNOGENETICS, V54, P776, DOI 10.1007/s00251-002-0527-8; Kawakami K, 2001, INFECT IMMUN, V69, P213, DOI 10.1128/IAI.69.1.213-220.2001; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kitamura H, 2000, CELL IMMUNOL, V199, P37, DOI 10.1006/cimm.1999.1602; Klatt NR, 2012, J VIROL, V86, P1203, DOI 10.1128/JVI.06033-11; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Lucas M, 2003, J VIROL, V77, P2251, DOI 10.1128/JVI.77.3.2251-2257.2003; Motsinger A, 2003, J VIROL, V77, P8153, DOI 10.1128/JVI.77.14.8153-8158.2003; Nicol AJ, 2011, CLIN CANCER RES, V17, P5140, DOI 10.1158/1078-0432.CCR-10-3105; O'Reilly V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028648; Rout N, 2010, J MED PRIMATOL, V39, P224, DOI 10.1111/j.1600-0684.2010.00431.x; Rout N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009787; Sanderson JP, 2012, EUR J IMMUNOL, V42, P248, DOI 10.1002/eji.201141956; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Taniguchi M, 2000, SEMIN IMMUNOL, V12, P543, DOI 10.1006/smim.2000.0270; Thippeshappa R, 2011, J VIROL, V85, P3767, DOI 10.1128/JVI.02438-10; Vasan S, 2007, INT IMMUNOL, V19, P943, DOI 10.1093/intimm/dxm055	42	1	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e48166	10.1371/journal.pone.0048166	http://dx.doi.org/10.1371/journal.pone.0048166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110202	gold, Green Published, Green Submitted			2022-12-25	WOS:000310193600050
J	Madhuprakash, J; Tanneeru, K; Purushotham, P; Guruprasad, L; Podile, AR				Madhuprakash, Jogi; Tanneeru, Karunakar; Purushotham, Pallinti; Guruprasad, Lalitha; Podile, Appa Rao			Transglycosylation by Chitinase D from Serratia proteamaculans Improved through Altered Substrate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY 18 CHITINASES; BINDING CLEFT; RESIDUES; CHITOOLIGOSACCHARIDES; LIGNIFICATION; MUTAGENESIS; ACTIVATION; ELICITOR; MUTATION; SITE	We describe the improvement of transglycosylation (TG) by chitinase D from Serratia proteamaculans (SpChiD). The SpChiD produced a smaller quantity of TG products for up to 90 min with 2 mM chitotetraose as the substrate and subsequently produced only hydrolytic products. Of the five residues targeted at the catalytic center, E159D resulted in substantial loss of both hydrolytic and TG activities. Y160A resulted in a product profile similar to SpChiD and a rapid turnover of substrate with slightly increased TG activity. The rest of the three mutants, M226A, Y228A, and R284A, displayed improved TG and decreased hydrolytic ability. Four of the five amino acid substitutions, F64W, F125A, G119S, and S116G, at the catalytic groove increased TG activity, whereas W120A completely lost the TG activity with a concomitant increase in hydrolysis. Mutation of Trp-247 at the solvent-accessible region significantly reduced the hydrolytic activity with increased TG activity. The mutants M226A, Y228A, F125A, S116G, F64W, G119S, R284A, and W247A accumulated approximately double the concentration of TG products like chitopentaose and chitohexaose, compared with SpChiD. The double mutant E159D/F64W regained the activity with accumulation of 6.0% chitopentaose at 6 h, similar to SpChiD at 30 min. Loss of chitobiase activity was unique to Y228A. Substitution of amino acids at the catalytic center and/or groove substantially improved the TG activity of SpChiD, both in terms of the quantity of TG products produced and the extended duration of TG activity.	[Madhuprakash, Jogi; Purushotham, Pallinti; Podile, Appa Rao] Univ Hyderabad, Dept Plant Sci, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India; [Tanneeru, Karunakar; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Podile, AR (corresponding author), Univ Hyderabad, Dept Plant Sci, Sch Life Sci, Hyderabad 500046, Andhra Pradesh, India.	arpsl@uohyd.ernet.in	Jogi, Madhuprakash/AAU-9958-2021; Tanneeru, Karunakar/C-8946-2016; Tanneeru, Karunakar/C-8200-2019; Podile, Appa Rao/W-5077-2018	Tanneeru, PhD, FICS, Dr. Karunakar/0000-0002-9250-6476; Podile, Appa Rao/0000-0003-3208-765X; Pallinti, Purushotham Naidu/0000-0002-5565-1762	University Grants Commission in the form of Centre for Advanced Studies in Life Sciences and Department Biotechnology, Government of India; Centre for Research and Education in Biology and Biotechnology to the School of Life Sciences; Department of Science and Technology-Funds for Infrastructure in Science and Technology Level II; University Grants Commission-Centre for Advanced Studies in Chemistry; International Research and Training Group-Molecular and Cellular Glycosciences, Deutsche Forschungsgemeinschaft (Germany); University Grants Commission, India	University Grants Commission in the form of Centre for Advanced Studies in Life Sciences and Department Biotechnology, Government of India; Centre for Research and Education in Biology and Biotechnology to the School of Life Sciences; Department of Science and Technology-Funds for Infrastructure in Science and Technology Level II; University Grants Commission-Centre for Advanced Studies in Chemistry; International Research and Training Group-Molecular and Cellular Glycosciences, Deutsche Forschungsgemeinschaft (Germany); University Grants Commission, India(University Grants Commission, India)	We thank the Department of Science and Technology, Government of India, Funds for Infrastructure in Science and Technology, Level II support to the Department of Plant Sciences. We gratefully acknowledge the support from University Grants Commission in the form of Centre for Advanced Studies in Life Sciences, and Department Biotechnology, Government of India, Centre for Research and Education in Biology and Biotechnology to the School of Life Sciences. We also thank the support given under Department of Science and Technology-Funds for Infrastructure in Science and Technology Level II and University Grants Commission-Centre for Advanced Studies in Chemistry to the School of Chemistry, and University Grants Commission-supported University with Potential for Excellence (Phase II) to the University of Hyderabad for the infrastructural support. We thank Prof. B. M. Moerschbacher and Dr. Nour Eddine El Gueddari for suggestions during revision of the manuscript.; Supported in part by International Research and Training Group-Molecular and Cellular Glycosciences, Deutsche Forschungsgemeinschaft (Germany), and University Grants Commission, India.	Aronson NN, 2006, BIOSCI BIOTECH BIOCH, V70, P243, DOI 10.1271/bbb.70.243; BARBER MS, 1989, PHYSIOL MOL PLANT P, V34, P3, DOI 10.1016/0885-5765(89)90012-X; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Cabrera JC, 2006, PHYSIOL PLANTARUM, V127, P44, DOI 10.1111/j.1399-3054.2006.00677.x; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; FUKAMIZO T, 1989, AGR BIOL CHEM TOKYO, V53, P2641, DOI 10.1080/00021369.1989.10869717; GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804; GOTTHARDT U, 1992, J PLANT PHYSIOL, V139, P659, DOI 10.1016/S0176-1617(11)81707-4; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; KENDRA DF, 1984, EXP MYCOL, V8, P276, DOI 10.1016/0147-5975(84)90013-6; Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012; Krokeide IM, 2007, ANAL BIOCHEM, V363, P128, DOI 10.1016/j.ab.2006.12.044; Li CS, 2008, BIOORGAN MED CHEM, V16, P8366, DOI 10.1016/j.bmc.2008.08.042; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Lu Y, 2009, GLYCOCONJUGATE J, V26, P525, DOI 10.1007/s10719-008-9203-z; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Makino A, 2006, BIOMACROMOLECULES, V7, P950, DOI 10.1021/bm050895d; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; MOERSCHBACHER B, 1986, Z NATURFORSCH C, V41, P830; Neeraja C, 2010, BIORESOURCE TECHNOL, V101, P3635, DOI 10.1016/j.biortech.2009.12.118; Norberg AL, 2011, FEBS LETT, V585, P2339, DOI 10.1016/j.febslet.2011.06.002; Purushotham P, 2012, J BACTERIOL, V194, P4260, DOI 10.1128/JB.06473-11; Purushotham P, 2012, BIORESOURCE TECHNOL, V112, P261, DOI 10.1016/j.biortech.2012.02.062; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Sakai K., 1990, DENPUN KAGAKU, V37, P79; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sashidhar B, 2010, J MOL MICROB BIOTECH, V18, P109, DOI 10.1159/000293819; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Taira T, 2010, BBA-PROTEINS PROTEOM, V1804, P668, DOI 10.1016/j.bbapap.2009.10.015; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Vander P, 1998, PLANT PHYSIOL, V118, P1353, DOI 10.1104/pp.118.4.1353; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zakariassen H, 2010, CARBOHYD POLYM, V81, P14, DOI 10.1016/j.carbpol.2010.01.048	41	38	38	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44619	44627		10.1074/jbc.M112.400879	http://dx.doi.org/10.1074/jbc.M112.400879			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23115231	hybrid, Green Published			2022-12-25	WOS:000312938600058
J	Huang, JY; Zhao, XB; Weng, XY; Wang, L; Xie, WB				Huang, Jianyan; Zhao, Xiaobo; Weng, Xiaoyu; Wang, Lei; Xie, Weibo			The Rice B-Box Zinc Finger Gene Family: Genomic Identification, Characterization, Expression Profiling and Diurnal Analysis	PLOS ONE			English	Article							CONSTANS-LIKE GENE; IN-SILICO ANALYSIS; ARABIDOPSIS; TRANSCRIPTION; PROTEIN; LIGHT; DATABASE; ANNOTATION; REGULATOR; EVOLUTION	Background: The B-box (BBX) -containing proteins are a class of zinc finger proteins that contain one or two B-box domains and play important roles in plant growth and development. The Arabidopsis BBX gene family has recently been re-identified and renamed. However, there has not been a genome-wide survey of the rice BBX (OsBBX) gene family until now. Methodology/Principal Findings: In this study, we identified 30 rice BBX genes through a comprehensive bioinformatics analysis. Each gene was assigned a uniform nomenclature. We described the chromosome localizations, gene structures, protein domains, phylogenetic relationship, whole life-cycle expression profile and diurnal expression patterns of the OsBBX family members. Based on the phylogeny and domain constitution, the OsBBX gene family was classified into five subfamilies. The gene duplication analysis revealed that only chromosomal segmental duplication contributed to the expansion of the OsBBX gene family. The expression profile of the OsBBX genes was analyzed by Affymetrix GeneChip microarrays throughout the entire life-cycle of rice cultivar Zhenshan 97 (ZS97). In addition, microarray analysis was performed to obtain the expression patterns of these genes under light/dark conditions and after three phytohormone treatments. This analysis revealed that the expression patterns of the OsBBX genes could be classified into eight groups. Eight genes were regulated under the light/dark treatments, and eleven genes showed differential expression under at least one phytohormone treatment. Moreover, we verified the diurnal expression of the OsBBX genes using the data obtained from the Diurnal Project and qPCR analysis, and the results indicated that many of these genes had a diurnal expression pattern. Conclusions/Significance: The combination of the genome-wide identification and the expression and diurnal analysis of the OsBBX gene family should facilitate additional functional studies of the OsBBX genes.	[Huang, Jianyan; Zhao, Xiaobo; Weng, Xiaoyu; Wang, Lei; Xie, Weibo] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Huang, Jianyan; Zhao, Xiaobo; Weng, Xiaoyu; Wang, Lei; Xie, Weibo] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Zhao, XB (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	zxb018@webmail.hzau.edu.cn	Zhao, Xiaobo/AAR-3217-2021; Xie, Weibo/B-3771-2008; Weng, Xiaoyu/J-4899-2019; Xie, Weibo/AAI-2412-2021; Zhao, Xiaobo/K-4182-2012; Zhao, Xiaobo/AAZ-5503-2021	Zhao, Xiaobo/0000-0002-6012-0261; Xie, Weibo/0000-0002-2768-3572; Xie, Weibo/0000-0002-2768-3572; weng, xiaoyu/0000-0002-3831-7551	National 863 Project [2012AA100103]; National Natural Science Foundation of China [30921091]; National 863 Project [2012AA100103]; National Natural Science Foundation of China [30921091]	National 863 Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National 863 Project (2012AA100103) and the National Natural Science Foundation of China (30921091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Casal JJ, 2004, TRENDS PLANT SCI, V9, P309, DOI 10.1016/j.tplants.2004.04.007; Chang CSJ, 2008, PLANT J, V54, P205, DOI 10.1111/j.1365-313X.2008.03401.x; Chang CSJ, 2011, PLANT PHYSIOL, V156, P228, DOI 10.1104/pp.111.175042; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; Datta S, 2008, PLANT CELL, V20, P2324, DOI 10.1105/tpc.108.061747; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Gao G, 2006, BIOINFORMATICS, V22, P1286, DOI 10.1093/bioinformatics/btl107; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; Gray J, 2009, PLANT PHYSIOL, V149, P4, DOI 10.1104/pp.108.128504; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hassidim M, 2009, PLANTA, V230, P481, DOI 10.1007/s00425-009-0958-7; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Holtan HE, 2011, PLANT PHYSIOL, V156, P2109, DOI 10.1104/pp.111.177139; Indorf M, 2007, PLANT J, V51, P563, DOI 10.1111/j.1365-313X.2007.03162.x; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kim SK, 2008, PLANTA, V228, P355, DOI 10.1007/s00425-008-0742-0; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kumagai T, 2008, BIOSCI BIOTECH BIOCH, V72, P1539, DOI 10.1271/bbb.80041; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Lee YS, 2010, PLANT J, V63, P18, DOI 10.1111/j.1365-313X.2010.04226.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mochida K, 2011, DNA RES, V18, P321, DOI 10.1093/dnares/dsr019; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x; Vij S, 2006, BIOESSAYS, V28, P421, DOI 10.1002/bies.20399; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang QM, 2011, PLANTA, V233, P13, DOI 10.1007/s00425-010-1274-y; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yilmaz A, 2009, PLANT PHYSIOL, V149, P171, DOI 10.1104/pp.108.128579; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhao XB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-92	57	88	106	7	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48242	10.1371/journal.pone.0048242	http://dx.doi.org/10.1371/journal.pone.0048242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118960	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500085
J	Lv, K; Zhang, YY; Zhang, MY; Zhong, M; Suo, QF				Lv, Kun; Zhang, Yingying; Zhang, Mengying; Zhong, Min; Suo, Qifeng			Galectin-9 Ameliorates Con A-Induced Hepatitis by Inducing CD4(+)CD25(low/int) Effector T-Cell Apoptosis and Increasing Regulatory T Cell Number	PLOS ONE			English	Article							INTERFERON-GAMMA; PROTECTS MICE; LIVER-INJURY; FAS LIGAND; ACTIVATION; ROLES; TIM-3	Background: T cell-mediated liver damage is a key event in the pathogenesis of many chronic human liver diseases, such as liver transplant rejection, primary biliary cirrhosis, and sclerosing cholangitis. We and other groups have previously reported that galectin-9, one of the beta-galactoside binding animal lectins, might be potentially useful in the treatment of T cell-mediated diseases. To evaluate the direct effect of galectin-9 on hepatitis induced by concanavalin A (Con A) administration in mice and to clarify the mechanisms involved, we administered galectin-9 into mice, and evaluated its therapeutic effect on Con A-induced hepatitis. Methodology/Principal Findings: Galectin-9 was administrated i.v. to Balb/c mice 30 min before Con A injection. Compared with no treatment, galectin-9 pretreatment significantly reduced serum ALT and AST levels and improved liver histopathology, suggesting an ameliorated hepatitis. This therapeutic effect was not only attributable to a blunted Th1 immune response, but also to an increased number in regulatory T cells, as reflected in a significantly increased apoptosis of CD4+CD25(low/int) effector T cells and in reduced proinflammatory cytokine levels. Conclusion/Significance: Our findings constitute the first preclinical data indicating that interfering with TIM-3/galectin-9 signaling in vivo could ameliorate Con A-induced hepatitis. This strategy may represent a new therapeutic approach in treating human diseases involving T cell activation.	[Lv, Kun; Zhang, Mengying; Zhong, Min; Suo, Qifeng] Wannan Med Coll, Yijishan Hosp, Cent Lab, Wuhu, Peoples R China; [Zhang, Yingying] Wannan Med Coll, Yijishan Hosp, Lab Medcine, Wuhu, Peoples R China	Wannan Medical College; Wannan Medical College	Lv, K (corresponding author), Wannan Med Coll, Yijishan Hosp, Cent Lab, Wuhu, Peoples R China.	lvkun315@126.com			Natural Science Foundation of the Anhui Higher Education Institutions of China [KJ2011B191, KJ2011B198]; Foundation of Introducing Talents of Yijishan Hospital [YJRC2009003]	Natural Science Foundation of the Anhui Higher Education Institutions of China; Foundation of Introducing Talents of Yijishan Hospital	This work was funded by Natural Science Foundation of the Anhui Higher Education Institutions of China (KJ2011B191, KJ2011B198) and The Foundation of Introducing Talents of Yijishan Hospital (YJRC2009003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird L, 2010, NAT REV IMMUNOL, V10, P289, DOI 10.1038/nri2777; Boenisch O, 2010, J IMMUNOL, V185, P5806, DOI 10.4049/jimmunol.0903435; Dardalhon V, 2010, J IMMUNOL, V185, P1383, DOI 10.4049/jimmunol.0903275; Fukushima A, 2008, INT ARCH ALLERGY IMM, V146, P36, DOI 10.1159/000112501; GANTNER F, 1995, HEPATOLOGY, V21, P190, DOI 10.1002/hep.1840210131; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Kern M, 2010, GASTROENTEROLOGY, V138, P336, DOI 10.1053/j.gastro.2009.08.057; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Lv K, 2011, CLIN IMMUNOL, V140, P92, DOI 10.1016/j.clim.2011.03.017; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; MORITA M, 1995, HEPATOLOGY, V21, P1585, DOI 10.1016/0270-9139(95)90463-8; Nagata T, 2008, J IMMUNOL, V181, P7473, DOI 10.4049/jimmunol.181.11.7473; Nakaya M, 2009, J IMMUNOL, V183, P7047, DOI 10.4049/jimmunol.0900547; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Rodriguez I, 1996, J EXP MED, V184, P2067, DOI 10.1084/jem.184.5.2067; Saita N, 2002, INT ARCH ALLERGY IMM, V128, P42, DOI 10.1159/000058002; Sehrawat S, 2009, J IMMUNOL, V182, P3191, DOI 10.4049/jimmunol.0803673; Seino KI, 1997, GASTROENTEROLOGY, V113, P1315, DOI 10.1053/gast.1997.v113.pm9322527; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; SHINAGAWA T, 1991, J PATHOL, V165, P247, DOI 10.1002/path.1711650309; Tagawa Y, 1997, J IMMUNOL, V159, P1418; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Trautwein C, 1998, GASTROENTEROLOGY, V114, P1035, DOI 10.1016/S0016-5085(98)70324-5; Tsuboi Y, 2007, CLIN IMMUNOL, V124, P221, DOI 10.1016/j.clim.2007.04.015; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wang H, 2010, HEPATOLOGY, V51, P1354, DOI 10.1002/hep.23430; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	31	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48379	10.1371/journal.pone.0048379	http://dx.doi.org/10.1371/journal.pone.0048379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118999	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500119
J	Mata, M; Sarrion, I; Armengot, M; Carda, C; Martinez, I; Melero, JA; Cortijo, J				Mata, Manuel; Sarrion, Irene; Armengot, Miguel; Carda, Carmen; Martinez, Isidoro; Melero, Jose A.; Cortijo, Julio			Respiratory Syncytial Virus Inhibits Ciliagenesis in Differentiated Normal Human Bronchial Epithelial Cells: Effectiveness of N-Acetylcysteine	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; INFLUENZA-VIRUS; G GLYCOPROTEIN; ANTIGENIC STRUCTURE; IMMUNE-RESPONSES; EXPRESSION; IL-13; INFLAMMATION; EOSINOPHILIA; GENERATION	Persistent respiratory syncytial virus (RSV) infections have been associated with the exacerbation of chronic inflammatory diseases, including chronic obstructive pulmonary disease (COPD). This virus infects the respiratory epithelium, leading to chronic inflammation, and induces the release of mucins and the loss of cilia activity, two factors that determine mucus clearance and the increase in sputum volume. These alterations involve reactive oxygen species-dependent mechanisms. The antioxidant N-acetylcysteine (NAC) has proven useful in the management of COPD, reducing symptoms, exacerbations, and accelerated lung function decline. NAC inhibits RSV infection and mucin release in human A549 cells. The main objective of this study was to analyze the effects of NAC in modulating ciliary activity, ciliagenesis, and metaplasia in primary normal human bronchial epithelial cell (NHBEC) cultures infected with RSV. Our results indicated that RSV induced ultrastructural abnormalities in axonemal basal bodies and decreased the expression of beta-tubulin as well as two genes involved in ciliagenesis, FOXJ1 and DNAI2. These alterations led to a decrease in ciliary activity. Furthermore, RSV induced metaplastic changes to the epithelium and increased the number of goblet cells and the expression of MUC5AC and GOB5. NAC restored the normal functions of the epithelium, inhibiting ICAM1 expression, subsequent RSV infection through mechanisms involving nuclear receptor factor 2, and the expression of heme oxygenase 1, which correlated with the restoration of the antioxidant capacity, the intracellular H2O2 levels and glutathione content of NHBECs. The results presented in this study support the therapeutic use of NAC for the management of chronic respiratory diseases, including COPD.	[Mata, Manuel; Sarrion, Irene; Cortijo, Julio] Univ Gen Hosp Valencia, Res Fdn, Valencia, Spain; [Mata, Manuel; Martinez, Isidoro; Melero, Jose A.; Cortijo, Julio] Ctr Invest Biomed Red CIBER Enfermedades Resp, Valencia, Spain; [Martinez, Isidoro] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Interacc Virus Celula, Madrid, Spain; [Melero, Jose A.] Inst Salud Carlos III, Unidad Biol Viral, Ctr Nacl Microbiol, Madrid, Spain; [Armengot, Miguel; Carda, Carmen; Cortijo, Julio] Univ Valencia, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of Valencia	Mata, M (corresponding author), Univ Gen Hosp Valencia, Res Fdn, Valencia, Spain.	mata_manroi@gva.es	Armengot, Miguel/E-4664-2016; SARRION, IRENE/L-6608-2017; Morcillo, Esteban/I-1552-2015; Roig, Manuel Mata/G-4338-2015; Batalla, Carmen Carda/E-9885-2017; Martínez, Isidoro/J-3032-2012	Armengot, Miguel/0000-0001-8258-6292; Morcillo, Esteban/0000-0003-4373-9457; Roig, Manuel Mata/0000-0002-1506-7983; Batalla, Carmen Carda/0000-0002-5130-136X; Martínez, Isidoro/0000-0002-9949-9264; SARRION SOS, IRENE/0000-0002-0565-7082	Ministry of Science and Innovation [SAF2005-00669/SAF2008-03113, PI10/02294, CIBERES (CB06/06/0027)]; Health Institute 'Carlos III' of the Spanish government; regional government (Generalitat Valenciana) [GV2007/287, AP073/10]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Health Institute 'Carlos III' of the Spanish government; regional government (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF))	This work was supported by grants SAF2005-00669/SAF2008-03113 (JC), PI10/02294 (MM), and CIBERES (CB06/06/0027) from the Ministry of Science and Innovation and the Health Institute 'Carlos III' of the Spanish government as well as research grants from regional government (GV2007/287 and AP073/10, Generalitat Valenciana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1990, J CLIN INVEST, V85, P739, DOI 10.1172/JCI114499; Allahverdian S, 2008, AM J RESP CELL MOL, V38, P153, DOI 10.1165/rcmb.2007-0173OC; Armengot M, 2010, AM J RHINOL ALLERGY, V24, P175, DOI 10.2500/ajra.2010.24.3448; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Behera AK, 2001, BIOCHEM BIOPH RES CO, V280, P188, DOI 10.1006/bbrc.2000.4093; Carpenter LR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-5; Cho HY, 2009, AM J RESP CRIT CARE, V179, P138, DOI 10.1164/rccm.200804-535OC; COLLINS PL, 2001, FIELDS VIROLOGY, P1443; Cortijo J, 2010, CHEM-BIOL INTERACT, V183, P25, DOI 10.1016/j.cbi.2009.09.011; Cotgreave I A, 1997, Adv Pharmacol, V38, P205; Dekhuijzen P N R, 2006, Int J Chron Obstruct Pulmon Dis, V1, P99, DOI 10.2147/copd.2006.1.2.99; Di Rosa F, 1998, IMMUNOL REV, V164, P17; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; FISHAUT M, 1978, J INFECT DIS, V138, P644, DOI 10.1093/infdis/138.5.644; Gangl K, 2009, ALLERGY, V64, P398, DOI 10.1111/j.1398-9995.2008.01861.x; GARCIABARRENO B, 1989, J VIROL, V63, P925; Geiler J, 2010, BIOCHEM PHARMACOL, V79, P413, DOI 10.1016/j.bcp.2009.08.025; Gillissen A, 1998, RESP MED, V92, P609, DOI 10.1016/S0954-6111(98)90506-6; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Herranz C, 2011, VIROLOGY, V410, P56, DOI 10.1016/j.virol.2010.10.035; Hirschner W, 2007, J NEUROCHEM, V101, P274, DOI 10.1111/j.1471-4159.04500.x; JACOBY DB, 1994, FREE RADICAL BIO MED, V16, P821, DOI 10.1016/0891-5849(94)90198-8; Johnson TR, 2003, J IMMUNOL, V170, P2037, DOI 10.4049/jimmunol.170.4.2037; Johnson TR, 1999, J VIROL, V73, P8485, DOI 10.1128/JVI.73.10.8485-8495.1999; Kinane DF, 2006, GENES IMMUN, V7, P190, DOI 10.1038/sj.gene.6364282; KINNULA VL, 1992, AM J PHYSIOL, V262, pL708, DOI 10.1152/ajplung.1992.262.6.L708; Krishnan S, 2004, VIRAL IMMUNOL, V17, P220, DOI 10.1089/0882824041310612; Leverence JT, 2011, CHEM-BIOL INTERACT, V189, P72, DOI 10.1016/j.cbi.2010.09.026; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Lukacs NW, 2006, AM J PATHOL, V169, P977, DOI 10.2353/ajpath.2006.051055; Makogoba MW, 1998, EUR J IMMUNOL, V18, P637; Mallia P, 2006, CHEST, V130, P1203, DOI 10.1378/chest.130.4.1203; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; Martinez I, 2007, J GEN VIROL, V88, P570, DOI 10.1099/vir.0.82187-0; Martinez I, 2009, VIROLOGY, V388, P31, DOI 10.1016/j.virol.2009.03.008; Mata M, 2005, THORAX, V60, P144, DOI 10.1136/thx.2004.025692; Mata M, 2011, BIOCHEM PHARMACOL, V82, P548, DOI 10.1016/j.bcp.2011.05.014; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MBIGUINO A, 1991, J VIROL METHODS, V31, P161, DOI 10.1016/0166-0934(91)90154-R; Moore ML, 2006, PHARMACOL THERAPEUT, V112, P405, DOI 10.1016/j.pharmthera.2006.04.008; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Okada SF, 2011, AM J RESP CELL MOL, V45, P253, DOI 10.1165/rcmb.2010-0253OC; Philippou S, 2000, VIRCHOWS ARCH, V436, P617, DOI 10.1007/s004280000197; Stey C, 2000, EUR RESPIR J, V16, P253, DOI 10.1034/j.1399-3003.2000.16b12.x; Takeyama K, 2001, AM J RESP CRIT CARE, V163, P511, DOI 10.1164/ajrccm.163.2.2001038; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Tristram DA, 1998, ARCH OTOLARYNGOL, V124, P777, DOI 10.1001/archotol.124.7.777; VIGNOLA AM, 1993, AM REV RESPIR DIS, V148, P689, DOI 10.1164/ajrccm/148.3.689; Wedzicha Jadwiga A, 2004, Proc Am Thorac Soc, V1, P115, DOI 10.1513/pats.2306030; Wilkinson TMA, 2006, AM J RESP CRIT CARE, V173, P871, DOI 10.1164/rccm.200509-1489OC; Zeng RH, 2011, CYTOKINE, V53, P1, DOI 10.1016/j.cyto.2010.09.011	51	46	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48037	10.1371/journal.pone.0048037	http://dx.doi.org/10.1371/journal.pone.0048037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118923	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500058
J	Mozdzer, TJ; Megonigal, JP				Mozdzer, Thomas J.; Megonigal, J. Patrick			Jack-and-Master Trait Responses to Elevated CO2 and N: A Comparison of Native and Introduced Phragmites australis	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; COMMON REED; CRYPTIC INVASION; ATMOSPHERIC CO2; CARBON-DIOXIDE; NITROGEN; MARSH; ENRICHMENT; PATTERNS; GROWTH	Global change is predicted to promote plant invasions world-wide, reducing biodiversity and ecosystem function. Phenotypic plasticity may influence the ability of introduced plant species to invade and dominate extant communities. However, interpreting differences in plasticity can be confounded by phylogenetic differences in morphology and physiology. Here we present a novel case investigating the role of fitness trait values and phenotypic plasticity to global change factors between conspecific lineages of Phragmites australis. We hypothesized that due to observed differences in the competitive success of North American-native and Eurasian-introduced P. australis genotypes, Eurasian-introduced P. australis would exhibit greater fitness in response to global change factors. Plasticity and plant performance to ambient and predicted levels of carbon dioxide and nitrogen pollution were investigated to understand how invasion pressure may change in North America under a realistic global change scenario. We found that the introduced Eurasian genotype expressed greater mean trait values in nearly every ecophysiological trait measured - aboveground and belowground - to elevated CO2 and nitrogen, outperforming the native North American conspecific by a factor of two to three under every global change scenario. This response is consistent with "jack and master" phenotypic plasticity. We suggest that differences in plant nitrogen productivity, specific leaf area, belowground biomass allocation, and inherently higher relative growth rate are the plant traits that may enhance invasion of Eurasian Phragmites in North America. Given the high degree of genotypic variability within this species, and our limited number of genotypes, our results must be interpreted cautiously. Our study is the first to demonstrate the potential importance of jack-and-master phenotypic plasticity in plant invasions when facing imminent global change conditions. We suggest that jack-and-master invasive genotypes and/or species similar to introduced P. australis will have an increased ecological fitness, facilitating their invasion in both stressful and resource rich environments.	[Mozdzer, Thomas J.; Megonigal, J. Patrick] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	Smithsonian Institution; Smithsonian Environmental Research Center	Mozdzer, TJ (corresponding author), Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA.	tmozdzer@brynmawr.edu	Mozdzer, Thomas/A-3599-2014	Mozdzer, Thomas/0000-0002-1053-0967; Megonigal, Patrick/0000-0002-2018-7883	Smithsonian Institution Fellowship	Smithsonian Institution Fellowship(Smithsonian InstitutionSmithsonian National Museum of Natural History)	Funding to TJM came from a Smithsonian Institution Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Bradshaw AD, 1965, EVOLUTIONARY SIGNIFI; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Clevering OA, 2001, AQUAT BOT, V69, P89, DOI 10.1016/S0304-3770(01)00132-2; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gianoli E, 2012, BIOL J LINN SOC, V105, P1, DOI 10.1111/j.1095-8312.2011.01793.x; Godoy O, 2011, FUNCT ECOL, V25, P1248, DOI 10.1111/j.1365-2435.2011.01886.x; Gonzalez AL, 2010, OIKOS, V119, P779, DOI 10.1111/j.1600-0706.2009.18549.x; Hansen DL, 2007, AQUAT BOT, V86, P269, DOI 10.1016/j.aquabot.2006.11.005; Harvey PH, 1996, J ANIM ECOL, V65, P255, DOI 10.2307/5872; Holdredge C, 2010, OIKOS, V119, P1776, DOI 10.1111/j.1600-0706.2010.18647.x; Holm LG., 1977, WORLDS WORST WEEDS D; Hopkinson CS, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P991, DOI 10.1016/B978-0-12-372522-6.00022-0; Kim SY, 2008, HYDROBIOLOGIA, V605, P123, DOI 10.1007/s10750-008-9325-0; King RS, 2007, ESTUAR COAST, V30, P469, DOI 10.1007/BF02819393; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lambert AM, 2007, ENVIRON ENTOMOL, V36, P451, DOI 10.1603/0046-225X(2007)36[451:SONANC]2.0.CO;2; Lambert AM, 2007, AQUAT BOT, V86, P163, DOI 10.1016/j.aquabot.2006.09.017; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Li JH, 2010, GLOBAL CHANGE BIOL, V16, P234, DOI 10.1111/j.1365-2486.2009.01941.x; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Manea A, 2010, OECOLOGIA, P1; McCormick MK, 2010, J ECOL, V98, P1369, DOI 10.1111/j.1365-2745.2010.01712.x; Meyerson LA, 2010, BIOL INVASIONS, V12, P103, DOI 10.1007/s10530-009-9434-3; Mozdzer TJ, 2010, ESTUAR COAST, V33, P784, DOI 10.1007/s12237-009-9254-9; Mozdzer TJ, 2010, J ECOL, V98, P451, DOI 10.1111/j.1365-2745.2009.01625.x; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Niering WA., 1977, OUR DYNAMIC TIDAL MA; ORSON RA, 1987, ESTUARIES, V10, P20, DOI 10.2307/1352021; Otfinowski R, 2008, PLANT ECOL, V199, P235, DOI 10.1007/s11258-008-9428-8; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rogers HH, 2008, J ENVIRON QUAL, V37, P395, DOI 10.2134/jeq2007.0155; ROGERS HH, 1994, ENVIRON POLLUT, V83, P155, DOI 10.1016/0269-7491(94)90034-5; Rooth J. E., 2000, Wetlands Ecology and Management, V8, P173, DOI 10.1023/A:1008444502859; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Saltonstall K, 2007, AQUAT BOT, V86, P331, DOI 10.1016/j.aquabot.2006.12.003; Saltonstall Kristin, 2004, SIDA Contributions to Botany, V21, P683; Song LY, 2009, ACTA OECOL, V35, P128, DOI 10.1016/j.actao.2008.09.002; THOMAS RB, 1991, PLANT PHYSIOL, V96, P627, DOI 10.1104/pp.96.2.627; TISSUE DT, 1987, ECOLOGY, V68, P401, DOI 10.2307/1939271; Tulbure MT, 2007, COMP ECOLOGY NATIVE; VALIELA I, 1974, ECOLOGY HALOPHYTES, P547, DOI DOI 10.1016/B978-0-12-586450-3.50025-1; Vasquez EA, 2005, MAR ECOL PROG SER, V298, P1, DOI 10.3354/meps298001; White DA, 2004, SOUTHEAST NAT, V3, P531, DOI 10.1656/1528-7092(2004)003[0531:CDIPAF]2.0.CO;2; Wolf AA, 2007, GLOBAL CHANGE BIOL, V13, P2036, DOI 10.1111/j.1365-2486.2007.01407.x	56	69	70	2	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e42794	10.1371/journal.pone.0042794	http://dx.doi.org/10.1371/journal.pone.0042794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118844	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500001
J	Drew, JA; Barber, PH				Drew, Joshua A.; Barber, Paul H.			Comparative Phylogeography in Fijian Coral Reef Fishes: A Multi-Taxa Approach towards Marine Reserve Design	PLOS ONE			English	Article							GENETIC-STRUCTURE; POPULATION-GENETICS; MITOCHONDRIAL-DNA; PELAGIC LARVAE; CONSERVATION; UMBRELLA; POMACENTRIDAE; CONNECTIVITY; MIGRATION; ENDEMISM	Delineating barriers to connectivity is important in marine reserve design as they describe the strength and number of connections among a reserve's constituent parts, and ultimately help characterize the resilience of the system to perturbations at each node. Here we demonstrate the utility of multi-taxa phylogeography in the design of a system of marine protected areas within Fiji. Gathering mtDNA control region data from five species of coral reef fish in five genera and two families, we find a range of population structure patterns, from those experiencing little (Chrysiptera talboti, Halichoeres hortulanus, and Pomacentrus maafu), to moderate (Amphiprion barberi, Phi(st) = 0.14 and Amblyglyphidodon orbicularis Phi(st) = 0.05) barriers to dispersal. Furthermore estimates of gene flow over ecological time scales suggest species-specific, asymmetric migration among the regions within Fiji. The diversity among species-specific results underscores the limitations of generalizing from single-taxon studies, including the inability to differentiate between a species-specific result and a replication of concordant phylogeographic patterns, and suggests that greater taxonomic coverage results in greater resolution of community dynamics within Fiji. Our results indicate that the Fijian reefs should not be managed as a single unit, and that closely related species can express dramatically different levels of population connectivity.	[Drew, Joshua A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Barber, Paul H.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Columbia University; University of California System; University of California Los Angeles	Drew, JA (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	jd2977@columbia.edu		Drew, Joshua/0000-0001-9072-0885	Ecosystem Based Management Grant from the Wildlife Conservation Society; Ocean Sciences Division-Biological Oceanography at the National Science Foundation (NSF [OCE-0349177]; NSF [DBI-0805458]; Gordon and Betty Moore Foundation; MacArthur Foundation	Ecosystem Based Management Grant from the Wildlife Conservation Society; Ocean Sciences Division-Biological Oceanography at the National Science Foundation (NSF; NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); MacArthur Foundation	This work was funded by an Ecosystem Based Management Grant from the Wildlife Conservation Society, the Ocean Sciences Division-Biological Oceanography at the National Science Foundation (NSF) to P. Barber (OCE-0349177), and an NSF postdoctoral fellowship in bioinformatics to J. Drew (DBI-0805458). This work is a contribution of the Marine Management Area Science Program of Conservation International, funded by the Gordon and Betty Moore Foundation. Additional resources provided by John D. and Catherine T. MacArthur Foundation support of the Encyclopedia of Life. Computational resources were provided by the Josephine Bay Paul center at the Marine Biological Laboratory, Woods Hole, MA with support from J. Wernergreen. The Institute for Comparative Genomics at the American Museum of Natural History aided in DNA sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Gerald R., 2002, Aqua (Miradolo Terme), V5, P139; Allen Gerald R., 2012, Aqua, V18, P171; Allen Gerald R., 2008, Aqua (Miradolo Terme), V14, P105; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Anderson TW, 2007, MAR ECOL PROG SER, V350, P109, DOI 10.3354/meps07135; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Avise JC, 2008, P NATL ACAD SCI USA, V105, P11564, DOI 10.1073/pnas.0801924105; Barber PH, 2006, EVOLUTION, V60, P1825; Barber PH, 2002, MOL ECOL, V11, P659, DOI 10.1046/j.1365-294X.2002.01468.x; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Beerli Peter, 2009, V17, P42; Bernardi G, 2004, MAR BIOL, V145, P803, DOI 10.1007/s00227-004-1355-1; Bernardi G, 2001, MAR BIOL, V138, P457, DOI 10.1007/s002270000484; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Burke L., 2011, REEFS RISK REVISITED; Burton RS, 2009, BIOSCIENCE, V59, P831, DOI 10.1525/bio.2009.59.10.5; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Chabanet P, 2005, CORAL REEFS, V24, P138, DOI 10.1007/s00338-004-0425-7; Craig MT, 2010, J BIOGEOGR, V37, P2125, DOI 10.1111/j.1365-2699.2010.02358.x; Dawson MN, 2012, MOL ECOL, V21, P987, DOI 10.1111/j.1365-294X.2011.05417.x; DiBattista JD, 2011, J MAR BIOL, DOI DOI 10.1155/2011/839134; Domingues VS, 2006, MOL PHYLOGENET EVOL, V40, P139, DOI 10.1016/j.ympev.2006.02.009; Drew J, 2008, CONSERV BIOL, V22, P965, DOI 10.1111/j.1523-1739.2008.01011.x; Drew J, 2009, MOL PHYLOGENET EVOL, V53, P335, DOI 10.1016/j.ympev.2009.04.014; Eble JA, 2010, J MARINE BIOL; Eble JA, 2011, MAR ECOL PROG SER, V428, P245, DOI 10.3354/meps09083; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fleishman E, 2001, ECOL APPL, V11, P1489, DOI 10.1890/1051-0761(2001)011[1489:EVOAMF]2.0.CO;2; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Hellberg ME, 2002, B MAR SCI, V70, P273; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jupiter S.D., 2011, J MARINE BIOL, P1, DOI [10.1155/2011/940765, DOI 10.1155/2011/940765]; Karl SA, 2012, MOL ECOLOGY IN PRESS; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Knutsen H, 2003, MOL ECOL, V12, P385, DOI 10.1046/j.1365-294X.2003.01750.x; Kool JT, 2010, ECOGRAPHY, V33, P597, DOI 10.1111/j.1600-0587.2009.06012.x; Kulbicki M, 2005, AQUAT CONSERV, V15, pS127, DOI 10.1002/aqc.692; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; LEE WJ, 1995, J MOL EVOL, V41, P54; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mills M, 2012, CONSERVATIO IN PRESS; Nabholz B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-54; Nelson JS, 2000, MAR BIOL, V137, P727, DOI 10.1007/s002270000379; Norse Elliott A., 2005, P302; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Palumbi SR, 2003, ECOL APPL, V13, pS146; Planes S, 2002, EVOLUTION, V56, P378; Ray GC, 1999, AQUAT CONSERV, V9, P607; Rivera MAJ, 2004, BIOL J LINN SOC, V81, P449, DOI 10.1111/j.1095-8312.2003.00304.x; Roberts CM, 2000, B MAR SCI, V66, P581; Rocha LA, 2007, CORAL REEFS, V26, P501, DOI 10.1007/s00338-007-0261-7; Roff JC, 2000, AQUAT CONSERV, V10, P209, DOI 10.1002/1099-0755(200005/06)10:3<209::AID-AQC408>3.0.CO;2-J; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Sadovy Y, 2003, REV FISH BIOL FISHER, V13, P327, DOI 10.1023/B:RFBF.0000033122.90679.97; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Seddon PJ, 2008, ORYX, V42, P240, DOI 10.1017/S003060530806119X; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; Taylor MS, 2005, EVOLUTION, V59, P374; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thacker CE, 2004, CORAL REEFS, V23, P357, DOI 10.1007/s00338-004-0391-0; Thorne JH, 2006, NAT AREA J, V26, P137, DOI 10.3375/0885-8608(2006)26[137:ACDFTC]2.0.CO;2; Timm J, 2008, MOL PHYLOGENET EVOL, V49, P268, DOI 10.1016/j.ympev.2008.04.024; Toonen RJ, 2011, J MAR BIOL, V2011, DOI DOI 10.1155/2011/460173; Treml EA, 2012, CONSERVATIO IN PRESS; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; White JW, 2010, MAR ECOL PROG SER, V398, P49, DOI 10.3354/meps08327; Zacharias MA, 2001, AQUAT CONSERV, V11, P59, DOI 10.1002/aqc.429	81	33	35	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e47710	10.1371/journal.pone.0047710	http://dx.doi.org/10.1371/journal.pone.0047710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118892	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705600015
J	Barbarroja, N; Lopez-Pedrera, C; Garrido-Sanchez, L; Mayas, MD; Oliva-Olivera, W; Bernal-Lopez, MR; El Bekay, R; Tinahones, FJ				Barbarroja, Nuria; Lopez-Pedrera, Chary; Garrido-Sanchez, Lourdes; Dolores Mayas, Maria; Oliva-Olivera, Wilfredo; Rosa Bernal-Lopez, Maria; El Bekay, Rajaa; Jose Tinahones, Francisco			Progression from High Insulin Resistance to Type 2 Diabetes Does Not Entail Additional Visceral Adipose Tissue Inflammation	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; NECROSIS-FACTOR-ALPHA; BETA-CELL FUNCTION; RECEPTOR SUBSTRATE-1; MACROPHAGE INFILTRATION; ISLET INFLAMMATION; GENE-EXPRESSION; IRS PROTEINS; PHOSPHORYLATION; OBESITY	Obesity is associated with a low-grade chronic inflammation state. As a consequence, adipose tissue expresses pro-inflammatory cytokines that propagate inflammatory responses systemically elsewhere, promoting whole-body insulin resistance and consequential islet beta-cell exhaustation. Thus, insulin resistance is considered the early stage of type 2 diabetes. However, there is evidence of obese individuals that never develop diabetes indicating that the mechanisms governing the association between the increase of inflammatory factors and type 2 diabetes are much more complex and deserve further investigation. We studied for the first time the differences in insulin signalling and inflammatory pathways in blood and visceral adipose tissue (VAT) of 20 lean healthy donors and 40 equal morbidly obese (MO) patients classified in high insulin resistance (high IR) degree and diabetes state. We studied the changes in proinflammatory markers and lipid content from serum; macrophage infiltration, mRNA expression of inflammatory cytokines and transcription factors, activation of kinases involved in inflammation and expression of insulin signalling molecules in VAT. VAT comparison of these experimental groups revealed that type 2 diabetic-MO subjects exhibit the same pro-inflammatory profile than the high IR-MO patients, characterized by elevated levels of IL-1 beta, IL-6, TNF alpha, JNK1/2, ERK1/2, STAT3 and NF kappa B. Our work rules out the assumption that the inflammation should be increased in obese people with type 2 diabetes compared to high IR obese. These findings indicate that some mechanisms, other than systemic and VAT inflammation must be involved in the development of type 2 diabetes in obesity.	[Barbarroja, Nuria; Oliva-Olivera, Wilfredo; Rosa Bernal-Lopez, Maria; El Bekay, Rajaa; Jose Tinahones, Francisco] Hosp Virgen Victoria, Fdn IMABIS, Serv Endocrinol & Nutr, Malaga, Spain; [Barbarroja, Nuria; Oliva-Olivera, Wilfredo; Rosa Bernal-Lopez, Maria; El Bekay, Rajaa; Jose Tinahones, Francisco] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Madrid, Spain; [Lopez-Pedrera, Chary] Hosp Reina Sofia IMIBIC, Unidad Invest, Cordoba, Spain; [Garrido-Sanchez, Lourdes] Univ Rovira & Virgili, IISPV, Hosp Univ Tarragona Joan 23, CIBERDEM, Tarragona, Spain; [Dolores Mayas, Maria] Univ Jaen, Area Fisiol, Jaen, Spain	FIMABIS; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universidad de Jaen	Barbarroja, N (corresponding author), Hosp Virgen Victoria, Fdn IMABIS, Serv Endocrinol & Nutr, Malaga, Spain.	nuria.barbarroja.exts@juntadeandalucia.es	El Bekay, RAJAA/AGN-6069-2022; Barbarroja, Nuria/AAO-6534-2021; Bekay, Rajaa El/AAZ-3959-2020; Lopez-Pedrera, Chary/M-4603-2015; Tinahones, Francisco José/AAB-2882-2020	El Bekay, RAJAA/0000-0003-3332-3431; Lopez-Pedrera, Chary/0000-0003-2067-4603; Tinahones, Francisco J/0000-0001-6871-4403; Oliva Olivera, Wilfredo/0000-0003-3473-7898; Barbarroja, Nuria/0000-0002-0962-6072	Junta de Andalucia [P08-CTS-04369]; Fondo de Investigacion Sanitaria, Spain [PS09/00997]; "Sara Borrell" postdoctoral contract from the "Instituto de Salud Carlos III", Spain; "Juan de la Cierva" postdoctoral contract [JCI-2009-04086]	Junta de Andalucia(Junta de Andalucia); Fondo de Investigacion Sanitaria, Spain; "Sara Borrell" postdoctoral contract from the "Instituto de Salud Carlos III", Spain; "Juan de la Cierva" postdoctoral contract	This work was supported by the Junta de Andalucia, (grant number P08-CTS-04369) and the Fondo de Investigacion Sanitaria (grant number PS09/00997), Spain. NB was supported by a "Sara Borrell" postdoctoral contract from the "Instituto de Salud Carlos III", Spain. LGS was supported by a "Juan de la Cierva (JCI-2009-04086)" postdoctoral contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bal Y, 2010, BRATISL MED J, V111, P200; Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bendinelli P, 2000, MOL CELL ENDOCRINOL, V168, P11, DOI 10.1016/S0303-7207(00)00313-0; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Carlsen H, 2009, GENES NUTR, V4, P215, DOI 10.1007/s12263-009-0133-6; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Ehses Jan A., 2009, Archives of Physiology and Biochemistry, V115, P240, DOI 10.1080/13813450903025879; Engelman JA, 2000, MOL ENDOCRINOL, V14, P1557, DOI 10.1210/me.14.10.1557; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gastaldelli A, 2002, J CLIN ENDOCR METAB, V87, P5098, DOI 10.1210/jc.2002-020696; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Knopp Robert H, 2006, Curr Cardiol Rep, V8, P452, DOI 10.1007/s11886-006-0104-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKenney RL, 2011, SURG CLIN N AM, V91, P1139, DOI 10.1016/j.suc.2011.08.007; Misra A, 2003, NUTRITION, V19, P457, DOI 10.1016/S0899-9007(02)01003-1; Morris DL, 2011, CURR OPIN CLIN NUTR, V14, P341, DOI 10.1097/MCO.0b013e328347970b; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samaras K, 2010, OBESITY, V18, P884, DOI 10.1038/oby.2009.443; Serrano-Marco L, 2011, DIABETES, V60, P1990, DOI 10.2337/db10-0704; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Sun HY, 2011, MOL CELL BIOCHEM, V347, P183, DOI 10.1007/s11010-010-0627-y; Tanabe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018146; Tordjman J, 2009, J HEPATOL, V51, P354, DOI 10.1016/j.jhep.2009.02.031; Ugi S, 2010, OBESITY, V18, P1277, DOI 10.1038/oby.2009.442; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Youngren JF, 2007, CELL MOL LIFE SCI, V64, P873, DOI 10.1007/s00018-007-6359-9; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8; Zlotnik A, 2011, BIOL REPROD, V84, P581, DOI 10.1095/biolreprod.110.088120	42	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48155	10.1371/journal.pone.0048155	http://dx.doi.org/10.1371/journal.pone.0048155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110196	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200153
J	Miller, AM; Purves, D; McConnachie, A; Asquith, DL; Batty, GD; Burns, H; Cavanagh, J; Ford, I; McLean, JS; Packard, CJ; Shiels, PG; Turner, H; Velupillai, YN; Deans, KA; Welsh, P; McInnes, IB; Sattar, N				Miller, Ashley M.; Purves, David; McConnachie, Alex; Asquith, Darren L.; Batty, G. David; Burns, Harry; Cavanagh, Jonathan; Ford, Ian; McLean, Jennifer S.; Packard, Chris J.; Shiels, Paul G.; Turner, Helen; Velupillai, Yoga N.; Deans, Kevin A.; Welsh, Paul; McInnes, Iain B.; Sattar, Naveed			Soluble ST2 Associates with Diabetes but Not Established Cardiovascular Risk Factors: A New Inflammatory Pathway of Relevance to Diabetes?	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; FATTY LIVER-DISEASE; FAMILY-MEMBER ST2; INTERLEUKIN-1 RECEPTOR; GLUCOSE CONCENTRATION; INSULIN-RESISTANCE; HEART-FAILURE; TYPE-2; PROTEIN; IL-33	Preliminary data mostly from animal models suggest the sST2/IL-33 pathway may have causal relevance for vascular disease and diabetes and thus point to a potential novel inflammatory link to cardiometabolic disease. However, the characterisation of sST2 levels in terms of metabolic or vascular risk in man is completely lacking. We sought to address this gap via a comprehensive analysis of risk factor and vascular correlates of sST2 in a cross-sectional study (pSoBid). We measured sST2 in plasma in 639 subjects and comprehensively related it to cardiovascular and diabetes risk factors and imaged atherosclerosis measures. Circulating sST2 levels increased with age, were lower in women and in highest earners. After adjusting for age and gender, sST2 levels associated strongly with markers of diabetes, including triglycerides [effect estimate (EE) per 1 standard deviation increase in sST2: 1.05 [95% CI 1.01,1.10]), liver function (alanine aminotransaminase [ALT] and c-glutamyl transferase [GGT]: EE 1.05 [1.01,1.09] and 1.13 [1.07,1.19] respectively), glucose (1.02 [1.00,1.03]) and sICAM-1 (1.05 [1.02,1.07]). However, sST2 levels were not related to smoking, cholesterol, blood pressure, or atheroma (carotid intima media thickness, plaque presence). These results suggest that sST2 levels, in individuals largely without vascular disease, are related principally to markers associated with diabetes and ectopic fat and add support for a role of sST2 in diabetes. Further mechanistic studies determining how sST2 is linked to diabetes pathways may offer new insights into the inflammatory paradigm for type 2 diabetes.	[Miller, Ashley M.; Welsh, Paul; Sattar, Naveed] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Purves, David; McConnachie, Alex; Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Asquith, Darren L.; McInnes, Iain B.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England; [Burns, Harry] Scottish Govt, Edinburgh, Midlothian, Scotland; [Cavanagh, Jonathan] Coll Med Vet & Life Sci, Inst Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [McLean, Jennifer S.] Ctr Populat Hlth, Glasgow, Lanark, Scotland; [Packard, Chris J.] Univ Glasgow, Western Infirm, Glasgow Clin Res Facil, Glasgow G11 6NT, Lanark, Scotland; [Shiels, Paul G.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow, Lanark, Scotland; [Turner, Helen; Deans, Kevin A.] Aberdeen Royal Infirm, Dept Clin Biochem, Aberdeen, Scotland; [Velupillai, Yoga N.] Univ Limerick, GEMS, Limerick, Ireland	University of Glasgow; University of Glasgow; University of Glasgow; University of London; University College London; University of Glasgow; University of Glasgow; University of Glasgow; University of Aberdeen; University of Limerick	Miller, AM (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	Ashley.Miller@glasgow.ac.uk	Batty, GD/Y-4401-2018; Welsh, Paul/H-5249-2019; Ford, Ian/ABE-6145-2020	Batty, GD/0000-0003-1822-5753; Welsh, Paul/0000-0002-7970-3643; Shiels, Paul/0000-0002-7577-9843; McInnes, Iain/0000-0002-6462-4280	Medical Research Council UK; Wellcome Trust; British Heart Foundation; Glasgow Royal Infirmary Research Endowment Fund and NHS Grampian Endowments; Glasgow Centre for Population Health; Scottish Government; British Heart Foundation [FS/08/035/25309] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Glasgow Royal Infirmary Research Endowment Fund and NHS Grampian Endowments; Glasgow Centre for Population Health; Scottish Government; British Heart Foundation(British Heart Foundation)	AM Miller is a British Heart Foundation Intermediate Basic Science Research Fellow [FS/08/035/25309]. GD Batty is a Wellcome Trust Fellow. The authors received financial support from the Medical Research Council UK, the Wellcome Trust, the British Heart Foundation, Glasgow Royal Infirmary Research Endowment Fund and NHS Grampian Endowments. The Glasgow Centre for Population Health also supported this work, which is a partnership between NHS Greater Glasgow and Clyde, Glasgow City Council and the University of Glasgow, supported by the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartunek J, 2008, J AM COLL CARDIOL, V52, P2166, DOI 10.1016/j.jacc.2008.09.027; Batty GD, 2004, CANCER CAUSE CONTROL, V15, P873, DOI 10.1007/s10552-004-1050-z; Deans KA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4170; Dhillon OS, 2011, AM HEART J, V161, P1163, DOI 10.1016/j.ahj.2011.03.025; Dieplinger B, 2011, CLIN CHEM LAB MED, V49, P1515, DOI 10.1515/CCLM.2011.239; Fernandez-Real JM, 2012, DIABETOLOGIA, V55, P273, DOI 10.1007/s00125-011-2387-y; Fousteris E, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-101; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Januzzi JL, 2007, J AM COLL CARDIOL, V50, P607, DOI 10.1016/j.jacc.2007.05.014; Kohli P, 2012, CLIN CHEM, V58, P257, DOI 10.1373/clinchem.2011.173369; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kuhn E, 2009, CLIN CHEM, V55, P1108, DOI 10.1373/clinchem.2009.123935; Logue J, 2011, DIABETOLOGIA, V54, P3003, DOI 10.1007/s00125-011-2313-3; Mildner M, 2010, CARDIOVASC RES, V87, P769, DOI 10.1093/cvr/cvq104; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Sattar N, 2009, DIABETOLOGIA, V52, P235, DOI 10.1007/s00125-008-1217-3; Sattar N, 2007, DIABETES, V56, P984, DOI 10.2337/db06-1256; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Song YQ, 2007, DIABETES, V56, P1898, DOI 10.2337/db07-0250; Suskin N, 2000, EUR HEART J, V21, P1368, DOI 10.1053/euhj.1999.2043; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Velupillai YN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-126; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913; Wannamethee SG, 2012, ARTERIOSCLER THROMB; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Zdravkovic N, 2009, MOL IMMUNOL, V47, P28, DOI 10.1016/j.molimm.2008.12.023	35	52	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47830	10.1371/journal.pone.0047830	http://dx.doi.org/10.1371/journal.pone.0047830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112853	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000310310200088
J	Sakurai, H; Sakaguchi, Y; Shoji, E; Nishino, T; Maki, I; Sakai, H; Hanaoka, K; Kakizuka, A; Sehara-Fujisawa, A				Sakurai, Hidetoshi; Sakaguchi, Yasuko; Shoji, Emi; Nishino, Tokiko; Maki, Izumi; Sakai, Hiroshi; Hanaoka, Kazunori; Kakizuka, Akira; Sehara-Fujisawa, Atsuko			In Vitro Modeling of Paraxial Mesodermal Progenitors Derived from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; PDGF RECEPTOR-ALPHA; DIVERGING POINT; SKELETAL-MUSCLE; PRECURSOR CELLS; MOUSE; GENE; EXPRESSION; GENERATION; DIFFERENTIATION	Induced pluripotent stem (iPS) cells are generated from adult somatic cells by transduction of defined factors. Given their unlimited proliferation and differentiation potential, iPS cells represent promising sources for cell therapy and tools for research and drug discovery. However, systems for the directional differentiation of iPS cells toward paraxial mesodermal lineages have not been reported. In the present study, we established a protocol for the differentiation of mouse iPS cells into paraxial mesodermal lineages in serum-free culture. The protocol was dependent on Activin signaling in addition to BMP and Wnt signaling which were previously shown to be effective for mouse ES cell differentiation. Independently of the cell origin, the number of transgenes, or the type of vectors used to generate iPS cells, the use of serum-free monolayer culture stimulated with a combination of BMP4, Activin A, and LiCl enabled preferential promotion of mouse iPS cells to a PDGFR-alpha(+)/Flk-1(-) population, which represents a paraxial mesodermal lineage. The mouse iPS cell-derived paraxial mesodermal cells exhibited differentiation potential into osteogenic, chondrogenic, and myogenic cells both in vitro and in vivo and contributed to muscle regeneration. Moreover, purification of the PDGFR-alpha(+)/KDR- population after differentiation allowed enrichment of human iPS cell populations with paraxial mesodermal characteristics. The resultant PDGFR-alpha(+)/KDR- population derived from human iPS cells specifically exhibited osteogenic, chondrogenic, and myogenic differentiation potential in vitro, implying generation of paraxial mesodermal progenitors similar to mouse iPS cell-derived progenitors. These findings highlight the potential of protocols based on the serum-free, stepwise induction and purification of paraxial mesodermal cell lineages for use in stem cell therapies to treat diseased bone, cartilage, and muscle.	[Sakurai, Hidetoshi; Sakaguchi, Yasuko; Shoji, Emi; Sakai, Hiroshi; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto, Japan; [Sakurai, Hidetoshi; Nishino, Tokiko; Maki, Izumi] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Clin Applicat, Kyoto, Japan; [Sakaguchi, Yasuko; Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies, Lab Funct Biol, Kyoto, Japan; [Hanaoka, Kazunori] Kitasato Univ, Sch Sci, Dept Biosci, Kanagawa, Japan	Kyoto University; Kyoto University; Kyoto University; Kitasato University	Sakurai, H (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto, Japan.	hsakurai@cira.kyoto-u.ac.jp	Hiroshi, SAKAI/B-1450-2016	Hiroshi, SAKAI/0000-0001-9456-0911; Shoji, Emi/0000-0003-2576-5491	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (the Leading Project for the Realization of Regenerative Medicine), Scientific Research from the JSPS [22790284]; Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare; Leading Project of MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (the Leading Project for the Realization of Regenerative Medicine), Scientific Research from the JSPS; Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare; Leading Project of MEXT	This work was funded in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (the Leading Project for the Realization of Regenerative Medicine), Scientific Research Grant No. 22790284 from the JSPS, and in part by a Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare. A.S. is a member of the Global COE Program (Center for Frontier Medicine, Field of Regenerative Medicine). This research is also supported in by a grant from the Leading Project of MEXT (www.mext.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Hart AH, 2002, DEVELOPMENT, V129, P3597; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; JONES CM, 1995, DEVELOPMENT, V121, P3651; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kudoh H, 2005, BIOCHEM BIOPH RES CO, V328, P507, DOI 10.1016/j.bbrc.2004.12.191; Labastie MC, 1998, BLOOD, V92, P3624, DOI 10.1182/blood.V92.10.3624.422k17_3624_3635; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muraglia A, 2003, J CELL SCI, V116, P2949, DOI 10.1242/jcs.00527; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; OTT MO, 1991, DEVELOPMENT, V111, P1097; Reshef R, 1998, GENE DEV, V12, P290, DOI 10.1101/gad.12.3.290; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Sakurai H, 2008, STEM CELLS; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Sakurai H, 2009, STEM CELL RES, V3, P157, DOI 10.1016/j.scr.2009.08.002; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang Y, 2010, STEM CELL RES, V4, P223, DOI 10.1016/j.scr.2010.03.002; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	47	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47078	10.1371/journal.pone.0047078	http://dx.doi.org/10.1371/journal.pone.0047078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115636	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200025
J	Smith, KE; Wilkie, SE; Tebbs-Warner, JT; Jarvis, BJ; Gallasch, L; Stocker, M; Hunt, DM				Smith, Katie E.; Wilkie, Susan E.; Tebbs-Warner, Joseph T.; Jarvis, Bradley J.; Gallasch, Linn; Stocker, Martin; Hunt, David M.			Functional Analysis of Missense Mutations in Kv8.2 Causing Cone Dystrophy with Supernormal Rod Electroretinogram	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL SUBUNIT; K+ CHANNEL; ALPHA-SUBUNITS; N-TERMINUS; KV2.1; DOMAIN; GENE; SHAB; TETRAMERIZATION	Mutations in KCNV2 have been proposed as the molecular basis for cone dystrophy with supernormal rod electroretinogram. KCNV2 codes for the modulatory voltage-gated potassium channel alpha-subunit, Kv8.2, which is incapable of forming functional channels on its own. Functional heteromeric channels are however formed with Kv2.1 in heterologous expression systems, with both alpha-subunit genes expressed in rod and cone photoreceptors. Of the 30 mutations identified in the KCNV2 gene, we have selected three missense mutations localized in the potassium channel pore and two missense mutations localized in the tetramerization domain for analysis. We characterized the differences between homomeric Kv2.1 and heteromeric Kv2.1/Kv8.2 channels and investigated the influence of the selected mutations on the function of heteromeric channels. We found that two pore mutations (W467G and G478R) led to the formation of nonconducting heteromeric Kv2.1/Kv8.2 channels, whereas the mutations localized in the tetramerization domain prevented heteromer generation and resulted in the formation of homomeric Kv2.1 channels only. Consequently, our study suggests the existence of two distinct molecular mechanisms involved in the disease pathology.	[Smith, Katie E.; Tebbs-Warner, Joseph T.; Jarvis, Bradley J.; Gallasch, Linn; Stocker, Martin] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Smith, Katie E.; Wilkie, Susan E.; Hunt, David M.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Hunt, David M.] Univ Western Australia, Sch Anim Biol, Oceans Inst, Perth, WA 6009, Australia; [Hunt, David M.] Univ Western Australia, Lions Eye Inst, Perth, WA 6009, Australia	University of London; University College London; University of London; University College London; University of Western Australia; Lions Eye Institute; University of Western Australia	Stocker, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England.	M.Stocker@ucl.ac.uk; david.hunt@uwa.edu.au	Stocker, Martin/C-1844-2008; Smith, Katie Elizabeth/GXH-2114-2022; Hunt, David M/K-6024-2012	Hunt, David M/0000-0002-9264-3948; Smith, Katie E./0000-0002-6302-0274	United Kingdom Biotechnology and Biological Sciences Research Council [BB/E023142/1]; Australian National Health and Medical Research Council [AP102740]; Biotechnology and Biological Sciences Research Council [BB/D526961/1]; BBSRC [BB/E023142/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E023142/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by United Kingdom Biotechnology and Biological Sciences Research Council Grant BB/E023142/1 (to D. M. H. and M. S.) and Australian National Health and Medical Research Council Grant AP102740 (to D. M. H.).; Supported by Biotechnology and Biological Sciences Research Council Doctoral Training Grant Studentship BB/D526961/1.	BEECH DJ, 1989, NEURON, V3, P573, DOI 10.1016/0896-6273(89)90267-5; Ben Salah S, 2008, AM J OPHTHALMOL, V145, P1099, DOI 10.1016/j.ajo.2008.02.004; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bocksteins E, 2012, PHYSIOLOGY, V27, P73, DOI 10.1152/physiol.00023.2011; Bocksteins E, 2009, J BIOL CHEM, V284, P31625, DOI 10.1074/jbc.M109.039479; Castellano A, 1997, J NEUROSCI, V17, P4652; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chiara MD, 1999, J NEUROSCI, V19, P6865, DOI 10.1523/JNEUROSCI.19-16-06865.1999; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; Czirjak G, 2007, J NEUROPHYSIOL, V98, P1213, DOI 10.1152/jn.00493.2007; Demontis GC, 1999, J PHYSIOL-LONDON, V515, P813, DOI 10.1111/j.1469-7793.1999.813ab.x; Es-Salah-Lamoureux Z, 2011, BIOPHYS J, V101, P662, DOI 10.1016/j.bpj.2011.06.028; Frings S, 1998, J GEN PHYSIOL, V111, P583, DOI 10.1085/jgp.111.4.583; GOURAS P, 1983, ARCH OPHTHALMOL-CHIC, V101, P718, DOI 10.1001/archopht.1983.01040010718003; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hugnot JP, 1996, EMBO J, V15, P3322, DOI 10.1002/j.1460-2075.1996.tb00697.x; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kerschensteiner D, 1999, BIOPHYS J, V77, P248, DOI 10.1016/S0006-3495(99)76886-4; Khan AO, 2012, BRIT J OPHTHALMOL, V96, P422, DOI 10.1136/bjophthalmol-2011-300271; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Kullmann DM, 2010, ANNU REV NEUROSCI, V33, P151, DOI 10.1146/annurev-neuro-060909-153122; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Schnitzler MMY, 2009, J BIOL CHEM, V284, P4695, DOI 10.1074/jbc.M808786200; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Park Kang-Sik, 2007, Channels (Austin), V1, P59; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Patel AJ, 1999, ANN NY ACAD SCI, V868, P438, DOI 10.1111/j.1749-6632.1999.tb11309.x; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Robson AG, 2010, RETINA-J RET VIT DIS, V30, P51, DOI 10.1097/IAE.0b013e3181bfe24e; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Sergouniotis PI, 2012, BRIT J OPHTHALMOL, V96, P213, DOI 10.1136/bjo.2011.203638; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Stocker M, 1999, J NEUROCHEM, V72, P1725, DOI 10.1046/j.1471-4159.1999.721725.x; Thiagalingam S, 2007, OPHTHALMIC GENET, V28, P135, DOI 10.1080/13816810701503681; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WERBLIN FS, 1979, J PHYSIOL-LONDON, V294, P613, DOI 10.1113/jphysiol.1979.sp012949; Wissinger B, 2008, INVEST OPHTH VIS SCI, V49, P751, DOI 10.1167/iovs.07-0471; Wissinger B, 2011, HUM MUTAT, V32, P1398, DOI 10.1002/humu.21580; Wu HM, 2006, AM J HUM GENET, V79, P574, DOI 10.1086/507568; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P337	57	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43972	43983		10.1074/jbc.M112.388033	http://dx.doi.org/10.1074/jbc.M112.388033			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115240	Green Published, hybrid			2022-12-25	WOS:000312940800072
J	Atabakhsh, E; Schild-Poulter, C				Atabakhsh, Elnaz; Schild-Poulter, Caroline			RanBPM Is an Inhibitor of ERK Signaling	PLOS ONE			English	Article							PROTEIN-KINASE CASCADE; E3 UBIQUITIN LIGASE; BINDING-PROTEIN; MALIGNANT-TRANSFORMATION; INTERACTING PROTEIN; CELL-MIGRATION; DNA-DAMAGE; PATHWAY; RAF-1; ACTIVATION	Ran-binding protein M (RanBPM) is a nucleocytoplasmic protein of yet unknown function. We have previously shown that RanBPM inhibits expression of the anti-apoptotic factor Bcl-2 and promotes apoptosis induced by DNA damage. Here we show that the effects of RanBPM on Bcl-2 expression occur through a regulation of the ERK signaling pathway. Transient and stable down-regulation of RanBPM stimulated ERK phosphorylation, leading to Bcl-2 up-regulation, while re-expression of RanBPM reversed these effects. RanBPM was found to inhibit MEK and ERK activation induced by ectopic expression of active RasV12. Activation of ERK by active c-Raf was also prevented by RanBPM. Expression of RanBPM correlated with a marked decrease in the protein levels of ectopically expressed active c-Raf and also affected the expression of endogenous c-Raf. RanBPM formed a complex with both active c-Raf, consisting of the C-terminal kinase domain, and endogenous c-Raf in mammalian cells. In addition, RanBPM was found to decrease the binding of Hsp90 to c-Raf. Finally, we show that loss of RanBPM expression confers increased cell proliferation and cell migration properties to HEK293 cells. Altogether, these findings establish RanBPM as a novel inhibitor of the ERK pathway through an interaction with the c-Raf complex and a regulation of c-Raf stability, and provide evidence that RanBPM loss of expression results in constitutive activation of the ERK pathway and promotes cellular events leading to cellular transformation and tumorigenesis.	[Schild-Poulter, Caroline] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada; Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Schild-Poulter, C (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, London, ON, Canada.	cschild-poulter@robarts.ca	Schild-Poulter, Caroline/K-4476-2013		Robarts Research Institute; Canadian Institutes for Health Research (CIHR) [MOP-114958, IC1-102946]; QEIIGSST	Robarts Research Institute; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); QEIIGSST	This work was supported by funds from the Robarts Research Institute, a generous donation from Mrs. Marilynne Fuller and by operating grants [MOP-114958 and IC1-102946] from the Canadian Institutes for Health Research (CIHR) to CSP. EA was supported by a QEIIGSST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabakhsh E, 2009, MOL CANCER RES, V7, P1962, DOI 10.1158/1541-7786.MCR-09-0098; Bai D, 2003, BIOCHEM BIOPH RES CO, V309, P552, DOI 10.1016/j.bbrc.2003.08.033; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; Johnson SE, 2006, BIOCHEM BIOPH RES CO, V340, P409, DOI 10.1016/j.bbrc.2005.12.023; Jonsen MD, 2009, MOL ENDOCRINOL, V23, P1371, DOI 10.1210/me.2008-0137; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kavsan VM, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-23; Kerkhoff E, 1998, ONCOGENE, V17, P1457, DOI 10.1038/sj.onc.1202185; Kramer S, 2005, ONCOGENE, V24, P938, DOI 10.1038/sj.onc.1208257; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lakshmana MK, 2010, FASEB J, V24, P119, DOI 10.1096/fj.09-136457; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mikolajczyk M, 2003, BIOCHEM BIOPH RES CO, V310, P14, DOI 10.1016/j.bbrc.2003.08.116; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Pardo OE, 2002, J BIOL CHEM, V277, P12040, DOI 10.1074/jbc.M109006200; Poirier MB, 2006, J MOL ENDOCRINOL, V36, P313, DOI 10.1677/jme.1.01891; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Puverel S, 2011, DEVELOPMENT, V138, P2511, DOI 10.1242/dev.062505; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schild-Poulter C, 2007, ONCOGENE, V26, P3980, DOI 10.1038/sj.onc.1210165; Schild-Poulter C, 2003, CANCER RES, V63, P7197; Schulte TW, 1996, MOL CELL BIOL, V16, P5839; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Suresh B, 2010, J BIOL CHEM, V285, P35340, DOI 10.1074/jbc.M110.156836; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Wang Y, 2002, BIOCHEM BIOPH RES CO, V297, P148, DOI 10.1016/S0006-291X(02)02020-X; Waters C, 2004, SEMIN CELL DEV BIOL, V15, P309, DOI 10.1016/j.semcdb.2003.12.020; Xiang XQ, 2002, J BIOL CHEM, V277, P44996, DOI 10.1074/jbc.M203953200; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yin YX, 2010, J NEUROCHEM, V114, P110, DOI 10.1111/j.1471-4159.2010.06745.x; Yuan Y, 2006, NEUROSCI LETT, V407, P26, DOI 10.1016/j.neulet.2006.06.059; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47803	10.1371/journal.pone.0047803	http://dx.doi.org/10.1371/journal.pone.0047803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118896	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500036
J	Barbiero, C; Lonciari, I; Montico, M; Monasta, L; Penge, R; Vio, C; Tressoldi, PE; Ferluga, V; Bigoni, A; Tullio, A; Carrozzi, M; Ronfani, L				Barbiero, Chiara; Lonciari, Isabella; Montico, Marcella; Monasta, Lorenzo; Penge, Roberta; Vio, Claudio; Tressoldi, Patrizio Emanuele; Ferluga, Valentina; Bigoni, Anna; Tullio, Alessia; Carrozzi, Marco; Ronfani, Luca		CENDi Natl Comm Epidemiology Dysle; Epidemiology Dyslexia Friuli Venez	The Submerged Dyslexia Iceberg: How Many School Children Are Not Diagnosed? Results from an Italian Study	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; ADOLESCENTS; DISORDER; DEFICIT	Background: Although dyslexia is one of the most common neurobehavioral disorders affecting children, prevalence is uncertain and available data are scanty and dated. The objective of this study is to evaluate the prevalence of dyslexia in an unselected school population using clearly defined and rigorous diagnostic criteria and methods. Methods: Cross sectional study. We selected a random cluster sample of 94 fourth grade elementary school classes of Friuli Venezia Giulia, a Region of North Eastern Italy. We carried out three consecutive levels of screening: the first two at school and the last at the Neuropsychiatry Unit of a third level Mother and Child Hospital. The main outcome measure was the prevalence of dyslexia, defined as the number of children positive to the third level of screening divided by the total number of children enrolled. Results: We recruited 1774 children aged 8-10 years, of which 1528 received parents' consent to participate. After applying exclusion criteria, 1357 pupils constituted the final working sample. The prevalence of dyslexia in the enrolled population ranged from 3.1% (95% CI 2.2-4.1%) to 3.2% (95% CI 2.4-4.3%) depending on different criteria adopted. In two out of three children with dyslexia the disorder had not been previously diagnosed. Conclusions: This study shows that dyslexia is largely underestimated in Italy and underlines the need for reliable information on prevalence, in order to better allocate resources both to Health Services and Schools.	[Barbiero, Chiara; Montico, Marcella; Monasta, Lorenzo; Ferluga, Valentina; Bigoni, Anna; Tullio, Alessia; Ronfani, Luca] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Epidemiol & Biostat Unit, Trieste, Italy; [Barbiero, Chiara; Lonciari, Isabella; Carrozzi, Marco] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Child Neurol & Psychiat Ward, Trieste, Italy; [Penge, Roberta] UOC NPI B La Sapienza Univ, Child Neuropsychiat Dept, Rome, Italy; [Vio, Claudio] Hosp San Dona di Piave, Child Neuropsychiat Unit, San Dona Di Piave, Italy; [Tressoldi, Patrizio Emanuele] Univ Padua, Dept Psychol, Padua, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; ULSS 4 Veneto Orientale; Ospedale di San Dona di Piave; University of Padua	Ronfani, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Epidemiol & Biostat Unit, Trieste, Italy.	ronfani@burlo.trieste.it	barbiero, chiara/B-5340-2013; Montico, Marcella/B-5290-2013; Tressoldi, Patrizio E./A-5566-2009; Monasta, Lorenzo/B-1388-2012; Ronfani, Luca/B-6668-2013	Montico, Marcella/0000-0003-0377-8232; Tressoldi, Patrizio E./0000-0002-6404-0058; Monasta, Lorenzo/0000-0001-7774-548X; Ronfani, Luca/0000-0001-5710-3914; Carrozzi, Marco/0000-0001-6282-4417; PENGE, Roberta/0000-0003-4648-4031; Barbiero, Chiara/0000-0003-2589-3717	Friuli Venezia Giulia Regional Health Service (Agenzia Regionale della Sanita) [42]; Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste (Epidemiologia dei Disturbi Specifici dell'Apprendimento in una popolazione scolastica non selezionata) [63/07]	Friuli Venezia Giulia Regional Health Service (Agenzia Regionale della Sanita); Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste (Epidemiologia dei Disturbi Specifici dell'Apprendimento in una popolazione scolastica non selezionata)	The study was funded by the Friuli Venezia Giulia Regional Health Service (Agenzia Regionale della Sanita, resolution no 42, April 4, 2008) through a grant to the Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste and by internal research funds of the same Institute (Research project 63/07 Epidemiologia dei Disturbi Specifici dell'Apprendimento in una popolazione scolastica non selezionata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Angelelli P, 2010, CORTEX, V46, P1299, DOI 10.1016/j.cortex.2010.06.015; Baldini G, 1958, INFANZIA ANORMALE, V26, P167; BERGER M, 1975, BRIT J PSYCHIAT, V126, P510, DOI 10.1192/bjp.126.6.510; Bisiacchi P, 1978, FORMAZIONE CAMBIAMEN, V1, P3; Bracken B. A., 2003, TMA TEST VALUTAZIONE; Cappa C, 2012, DISLESSIA, V1; Cassini A., 1984, ETA EVOLUTIVA, V18, P66; Consensus Conference, 2007, DIST EV SPEC APPR; Cornoldi C., 2010, DISLESSIA, V7, P89; Cornoldi C., 2004, PROVE LETTURA MT SCU; Coscarella C, 2001, PSICHIATRIA INFANZIA, V68, P7; Daniel SS, 2006, J LEARN DISABIL-US, V39, P507, DOI 10.1177/00222194060390060301; Demonet JF, 2004, LANCET, V363, P1451, DOI 10.1016/S0140-6736(04)16106-0; Faglioni P., 1967, INFANZIA ANORMALE, V81, P628; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Gruppo di lavoro regionale sui D.S.A, 2011, AL CON DIST SPEC APP; Harter S., 1985, SELF PERCEPTION PROF; Herrmann JA, 2006, DYSLEXIA, V12, P195, DOI 10.1002/dys.324; Interagency Commission on Learning Disabilities, 1987, LEARN DIS REP US C; Istituto Superiore di Sanita, 2011, CONS C DIST SPEC APP; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; Le Jan G, 2007, P ANN INT IEEE EMBS, P3781, DOI 10.1109/IEMBS.2007.4353155; Levi G., 1982, NEUROPSICHIATRIA INF, V250, P439; LINDGREN SD, 1985, CHILD DEV, V56, P1404, DOI 10.1111/j.1467-8624.1985.tb00206.x; Lucangeli D, 2006, ABCA TEST ABILITA CA; Masala C., 1998, PSICHIATRIA INFANZIA, V65, P648; Mugnaini D, 2009, WORLD J PEDIATR, V5, P255, DOI 10.1007/s12519-009-0049-7; Orsini A., 2006, WISC 3 CONTRIBUTO TA; Orsolini M, 2006, LANG COGNITIVE PROC, V21, P576, DOI 10.1080/01690960500139355; PARCC, 2011, DSA DOC INT; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Peterson RL, 2012, LANCET, V379, P1997, DOI 10.1016/S0140-6736(12)60198-6; Raven JC, 2006, CPM COLOURED PROGR M; Roberto M., 2005, DISLESSIA, V2, P135; Sartori G., 2007, DDE 2 BATTERIA VALUT, V2nd ed.; Sava D, 1981, GIORNALE ITALIANO PS, V8, P405; Seymour PHK, 2003, BRIT J PSYCHOL, V94, P143, DOI 10.1348/000712603321661859; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; SHAYWITZ SE, 1994, TOP LANG DISORD, V14, P1, DOI 10.1097/00011363-199408000-00003; Tressoldi P. E., 2000, BATTERIA VALUTAZIONE; Tressoldi P. E., 1996, DIAGNOSI DISTURBI AP; Wechsler D., 2006, SCALA INTELLIGENZA W, VThird; WHITAKER S, 2004, BRIT J LEARNING DISA, V32, P139, DOI DOI 10.1111/J.1468-3156.2004.00264.X; *WHO, 1993, INT CLASS DIS, V10; Willcutt EG, 2000, J CHILD PSYCHOL PSYC, V41, P1039, DOI 10.1017/S0021963099006368	46	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48082	10.1371/journal.pone.0048082	http://dx.doi.org/10.1371/journal.pone.0048082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WJ	23118930	Green Submitted, gold, Green Published			2022-12-25	WOS:000310600500064
J	Deng, W; Tsao, SW; Guan, XY; Cheung, ALM				Deng, Wen; Tsao, Sai Wah; Guan, Xin-Yuan; Cheung, Annie L. M.			Pericentromeric Regions Are Refractory To Prompt Repair after Replication Stress-Induced Breakage in HPV16 E6E7-Expressing Epithelial Cells	PLOS ONE			English	Article							FRAGILE SITES; CHROMOSOMAL INSTABILITY; GENOMIC INSTABILITY; HUMAN FIBROBLASTS; TYPE-16 E6; TELOMERES; CANCER; HETEROCHROMATIN; IDENTIFICATION; ABNORMALITIES	Chromosomal instability is the major form of genomic instability in cancer cells. Amongst various forms of chromosomal instability, pericentromeric or centromeric instability remains particularly poorly understood. In the present study, we found that pericentromeric instability, evidenced by dynamic formation of pericentromeric or centromeric rearrangements, breaks, deletions or iso-chromosomes, was a general phenomenon in human cells immortalized by expression of human papillomavirus type 16 E6 and E7 (HPV16 E6E7). In particular, for the first time, we surprisingly found a dramatic increase in the proportion of pericentromeric chromosomal aberrations relative to total aberrations in HPV16 E6E7-expressing cells 72 h after release from aphidicolin (APH)-induced replication stress, with pericentromeric chromosomal aberrations becoming the predominant type of structural aberrations (similar to 70% of total aberrations). In contrast, pericentromeric aberrations accounted for only about 20% of total aberrations in cells at the end of APH treatment. This increase in relative proportion of pericentromeric aberrations after release from APH treatment revealed that pericentromeric breaks induced by replication stress are refractory to prompt repair in HPV16 E6E7-expressing epithelial cells. Telomerase-immortalized epithelial cells without HPV16 E6E7 expression did not exhibit such preferential pericentromeric instability after release from APH treatment. Cancer development is often associated with replication stress. Since HPV16 E6 and E7 inactivate p53 and Rb, and p53 and Rb pathway defects are common in cancer, our finding that pericentromeric regions are refractory to prompt repair after replication stress-induced breakage in HPV16 E6E7-expressing cells may shed light on mechanism of general pericentromeric instability in cancer.	[Deng, Wen; Tsao, Sai Wah; Cheung, Annie L. M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Cheung, ALM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	lmcheung@hkucc.hku.hk	Deng, Wen/M-5208-2019; /C-4230-2009; /A-3639-2009	/0000-0003-3217-1456; /0000-0003-1874-9805	University of Hong Kong [201007176014]	University of Hong Kong(University of Hong Kong)	This study was supported by a grant from The University of Hong Kong, Project No. 201007176014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Beheshti B, 2000, MOL DIAGN, V5, P23, DOI 10.2165/00066982-200005010-00008; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chen B, 2009, CELL CYCLE, V8, P1775, DOI 10.4161/cc.8.11.8724; Cheung PY, 2010, CANCER LETT, V293, P41, DOI 10.1016/j.canlet.2009.12.015; Deng W, 2004, ONCOGENE, V23, P9090, DOI 10.1038/sj.onc.1208119; Deng W, 2003, CYTOM PART A, V51A, P46, DOI 10.1002/cyto.a.10004; Deng W, 2011, ONCOGENE, V30, P1281, DOI 10.1038/onc.2010.508; Deng W, 2008, CANCER RES, V68, P7200, DOI 10.1158/0008-5472.CAN-07-6569; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Duensing S, 2002, CANCER RES, V62, P7075; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Gagos S, 2008, CANCER RES, V68, P8146, DOI 10.1158/0008-5472.CAN-08-0945; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermsen MAJA, 1996, GENE CHROMOSOME CANC, V15, P1; ISCN, 1995, INT SYSTEM HUMAN CYT, V7055; Jin YS, 2000, CHROMOSOMA, V109, P476, DOI 10.1007/s004120000107; JIN YS, 1995, CANCER RES, V55, P3204; JOHANSSON M, 1995, CANCER GENET CYTOGEN, V81, P46, DOI 10.1016/0165-4608(94)00207-X; Kaufmann WK, 1997, CELL GROWTH DIFFER, V8, P1105; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Leach TJ, 2000, MOL CELL BIOL, V20, P6308, DOI 10.1128/MCB.20.17.6308-6316.2000; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Padilla-Nash HM, 2001, GENE CHROMOSOME CANC, V30, P349, DOI 10.1002/gcc.1101; PANDIS N, 1992, GENE CHROMOSOME CANC, V5, P235, DOI 10.1002/gcc.2870050310; Perrod S, 2003, CELL MOL LIFE SCI, V60, P2303, DOI 10.1007/s00018-003-3246-x; Plug-DeMaggio AW, 2004, ONCOGENE, V23, P3561, DOI 10.1038/sj.onc.1207388; RAU D, 1991, ANTICANCER RES, V11, P1477; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P721, DOI 10.1136/jcp.55.10.721; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Wong N, 2000, HEPATOLOGY, V32, P1060, DOI 10.1053/jhep.2000.19349; ZHU D, 1995, CANCER GENET CYTOGEN, V80, P63, DOI 10.1016/0165-4608(94)00128-X; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48576	10.1371/journal.pone.0048576	http://dx.doi.org/10.1371/journal.pone.0048576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119062	gold, Green Published			2022-12-25	WOS:000310600500173
J	Deracinois, B; Duban-Deweer, S; Pottiez, G; Cecchelli, R; Karamanos, Y; Flahaut, C				Deracinois, Barbara; Duban-Deweer, Sophie; Pottiez, Gwenael; Cecchelli, Romeo; Karamanos, Yannis; Flahaut, Christophe			TNAP and EHD1 Are Over-Expressed in Bovine Brain Capillary Endothelial Cells after the Re-Induction of Blood-Brain Barrier Properties	PLOS ONE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; LASER CAPTURE MICRODISSECTION; RAT-BRAIN; MASS-SPECTROMETRY; MICROVASCULAR ENDOTHELIUM; PROTEIN EXPRESSION; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; GENE-EXPRESSION; CEREBRAL-CORTEX	Although the physiological properties of the blood-brain barrier (BBB) are relatively well known, the phenotype of the component brain capillary endothelial cells (BCECs) has yet to be described in detail. Likewise, the molecular mechanisms that govern the establishment and maintenance of the BBB are largely unknown. Proteomics can be used to assess quantitative changes in protein levels and identify proteins involved in the molecular pathways responsible for cellular differentiation. Using the well-established in vitro BBB model developed in our laboratory, we performed a differential nano-LC MALDI-TOF/TOF-MS study of Triton X-100-soluble protein species from bovine BCECs displaying either limited BBB functions or BBB functions re-induced by glial cells. Due to the heterogeneity of the crude extract, we increased identification yields by applying a repeatable, reproducible fractionation process based on the proteins' relative hydrophobicity. We present proteomic and biochemical evidence to show that tissue non-specific alkaline phosphatase (TNAP) and Eps15 homology domain-containing protein 1(EDH1) are over-expressed by bovine BCECs after the re-induction of BBB properties. We discuss the impact of these findings on current knowledge of endothelial and BBB permeability.	[Deracinois, Barbara; Duban-Deweer, Sophie; Pottiez, Gwenael; Cecchelli, Romeo; Karamanos, Yannis; Flahaut, Christophe] Univ Lille Nord France, Lille, France; [Deracinois, Barbara; Duban-Deweer, Sophie; Pottiez, Gwenael; Cecchelli, Romeo; Karamanos, Yannis; Flahaut, Christophe] Univ Artois, LBHE, Lens, France; [Deracinois, Barbara; Duban-Deweer, Sophie; Pottiez, Gwenael; Cecchelli, Romeo; Karamanos, Yannis; Flahaut, Christophe] IMPRT IFR114, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite d'Artois	Flahaut, C (corresponding author), Univ Lille Nord France, Lille, France.	christophe.flahaut@univ-artois.fr	Deracinois, Barbara/AAB-5265-2021; FLAHAUT, Christophe/AAF-5742-2019; Karamanos, Yannis/AAE-9379-2020	FLAHAUT, Christophe/0000-0002-2603-962X; Karamanos, Yannis/0000-0002-2411-6636	Ministere de la Recherche et de l'Enseignement Superieur; European Regional Development Fund; Fonds d'Industrialisation des Bassins Miniers (FIBM); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Universite d'Artois	Ministere de la Recherche et de l'Enseignement Superieur; European Regional Development Fund(European Commission); Fonds d'Industrialisation des Bassins Miniers (FIBM); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Universite d'Artois	This research was funded by the Ministere de la Recherche et de l'Enseignement Superieur. The mass spectrometry facilities used for this study were funded by the European Regional Development Fund, the Fonds d'Industrialisation des Bassins Miniers (FIBM), the Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche and the Universite d'Artois. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ADAMS SE, 1985, J CELL PHYSIOL, V124, P120, DOI 10.1002/jcp.1041240119; Agarwal N, 2010, J NEUROCHEM, V112, P625, DOI 10.1111/j.1471-4159.2009.06481.x; Anstrom JA, 2002, J NEUROPATH EXP NEUR, V61, P76, DOI 10.1093/jnen/61.1.76; BALASUBRAMANIAM S, 2010, J INHERIT METAB DIS; Banks WA, 2010, BBA-MOL BASIS DIS, V1802, P881, DOI 10.1016/j.bbadis.2009.10.011; BECK DW, 1986, BRAIN RES, V381, P131, DOI 10.1016/0006-8993(86)90700-6; BELL MA, 1985, BRAIN RES, V335, P139, DOI 10.1016/0006-8993(85)90284-7; BEUCKMANN C, 1995, EUR J BIOCHEM, V229, P641, DOI 10.1111/j.1432-1033.1995.tb20508.x; BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97; Brun-Heath I, 2011, CELL TISSUE RES, V343, P521, DOI 10.1007/s00441-010-1111-4; Calabria AR, 2008, J CEREBR BLOOD F MET, V28, P135, DOI 10.1038/sj.jcbfm.9600518; Calabria AR, 2006, DRUG DISCOV TODAY, V11, P792, DOI 10.1016/j.drudis.2006.07.006; Calhau C, 2002, N-S ARCH PHARMACOL, V365, P349, DOI 10.1007/s00210-002-0542-1; Calhau C, 2002, J CELL BIOCHEM, V84, P389, DOI 10.1002/jcb.10027; Calhau C, 1999, CLIN BIOCHEM, V32, P153, DOI 10.1016/S0009-9120(98)00094-0; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cayrol R, 2011, METHODS MOL BIOL, V686, P275, DOI 10.1007/978-1-60761-938-3_13; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; CHAN JRA, 1986, J BIOL CHEM, V261, P7635; Culot M, 2008, TOXICOL IN VITRO, V22, P799, DOI 10.1016/j.tiv.2007.12.016; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; DERMIETZEL R, 1991, INT REV CYTOL, V127, P57; di Salvo ML, 2011, BBA-PROTEINS PROTEOM, V1814, P1597, DOI 10.1016/j.bbapap.2010.12.006; Diaz-Hernandez M, 2010, J BIOL CHEM, V285, P32539, DOI 10.1074/jbc.M110.145003; Diez-Zaera M, 2011, MOL BIOL CELL, V22, P1014, DOI 10.1091/mbc.E10-09-0740; EHRLICH YH, 1986, NATURE, V320, P67, DOI 10.1038/320067a0; Enerson BE, 2006, J CEREBR BLOOD F MET, V26, P959, DOI 10.1038/sj.jcbfm.9600249; Ermonval M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006497; FEDDE KN, 1993, J CELL BIOCHEM, V53, P43, DOI 10.1002/jcb.240530106; Fichtman B, 2008, CELL MOL BIOL LETT, V13, P632, DOI 10.2478/s11658-008-0027-4; Fonta C, 2005, J COMP NEUROL, V486, P179, DOI 10.1002/cne.20524; Fonta C, 2004, CEREB CORTEX, V14, P595, DOI 10.1093/cercor/bhh021; Gosselet F, 2009, BRAIN RES, V1249, P34, DOI 10.1016/j.brainres.2008.10.036; Grammas P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001918; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Haqqani AS, 2005, FASEB J, V19, P1809, DOI 10.1096/fj.05-3793com; Haseloff Reiner F, 2003, Methods Mol Med, V89, P465; Haseloff RF, 2006, PROTEOMICS, V6, P1803, DOI 10.1002/pmic.200500182; Hawkins BT, 2008, CURR TOP DEV BIOL, V80, P277, DOI 10.1016/S0070-2153(07)80007-X; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Kaunitz JD, 2008, J CELL BIOCHEM, V105, P655, DOI 10.1002/jcb.21885; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Langer D, 2008, CELL TISSUE RES, V334, P199, DOI 10.1007/s00441-008-0681-x; LECHARDEUR D, 1995, EXP CELL RES, V220, P161, DOI 10.1006/excr.1995.1302; Li JY, 2001, J CEREBR BLOOD F MET, V21, P61, DOI 10.1097/00004647-200101000-00008; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Lu L, 2007, PHYSIOL RES, V56, P159, DOI 10.33549/physiolres.930919; Lu QZ, 2008, ELECTROPHORESIS, V29, P2689, DOI 10.1002/elps.200700936; MABRY CC, 1970, J PEDIATR-US, V77, P74, DOI 10.1016/S0022-3476(70)80047-6; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Madsen SJ, 2010, J BIOPHOTONICS, V3, P356, DOI 10.1002/jbio.200900095; Martel F, 1999, PHARMACOL RES, V40, P275, DOI 10.1006/phrs.1999.0506; MATSUURA S, 1990, BIOCHEM BIOPH RES CO, V168, P993, DOI 10.1016/0006-291X(90)91127-E; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; MERESSE S, 1989, J NEUROCHEM, V53, P1363, DOI 10.1111/j.1471-4159.1989.tb08526.x; MEUNIER MT, 1978, ARCH ANAT MICROSC MO, V67, P81; MEYER J, 1990, BRAIN RES, V514, P305, DOI 10.1016/0006-8993(90)91425-G; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Montana V, 2006, GLIA, V54, P700, DOI 10.1002/glia.20367; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; MULKINS MA, 1987, J CELL PHYSIOL, V133, P539, DOI 10.1002/jcp.1041330315; Nag S, 2011, METHODS MOL BIOL, V686, P3, DOI 10.1007/978-1-60761-938-3_1; Nakazato H, 1997, LIFE SCI, V61, P2065, DOI 10.1016/S0024-3205(97)00865-5; Narisawa S, 2001, J PATHOL, V193, P125, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH722&gt;3.0.CO;2-Y; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Naslavsky N, 2007, BIOCHEM BIOPH RES CO, V357, P792, DOI 10.1016/j.bbrc.2007.04.022; Ngarmukos C, 2001, BRAIN RES, V900, P1, DOI 10.1016/S0006-8993(01)02184-9; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Palmer AM, 2010, NEUROBIOL DIS, V37, P3, DOI 10.1016/j.nbd.2009.07.029; Patel MM, 2009, CNS DRUGS, V23, P35, DOI 10.2165/0023210-200923010-00003; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; PLESNER L, 1995, INT REV CYTOL, V158, P141; Pont F, 2010, PROTEOMICS, V10, P1091, DOI 10.1002/pmic.200900667; Pottiez G, 2011, J PROTEOMICS, V75, P628, DOI 10.1016/j.jprot.2011.09.002; Pottiez G, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-57; Pottiez G, 2009, PROTEOMICS, V9, P1207, DOI 10.1002/pmic.200800503; PRON'KO P S, 1975, Voprosy Pitaniya, P48; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shusta Eric V, 2005, NeuroRx, V2, P151, DOI 10.1007/BF03206651; Shusta EV, 2002, J CEREBR BLOOD F MET, V22, P245, DOI 10.1097/00004647-200203000-00001; Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6; TAYLOR EM, 1991, J NEUROCHEM, V57, P1584, DOI 10.1111/j.1471-4159.1991.tb06355.x; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; VANBELLE H, 1976, CLIN CHEM, V22, P972; Vardy ERLC, 2012, NEURODEGENER DIS, V9, P31, DOI 10.1159/000329722; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Wilkins MR, 2006, PROTEOMICS, V6, P4, DOI 10.1002/pmic.200500856; Yamaguchi A, 1997, J BIOL CHEM, V272, P31230, DOI 10.1074/jbc.272.50.31230; Yarlagadda Atmaram, 2007, Psychiatry (Edgmont), V4, P58; ZHOU H, 1994, J BIOL CHEM, V269, P22433; ZOELLNER HFA, 1989, J HISTOCHEM CYTOCHEM, V37, P1893, DOI 10.1177/37.12.2584695	110	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48428	10.1371/journal.pone.0048428	http://dx.doi.org/10.1371/journal.pone.0048428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119012	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500132
J	Faber, LG; Maurits, NM; Lorist, MM				Faber, Leon G.; Maurits, Natasha M.; Lorist, Monicque M.			Mental Fatigue Affects Visual Selective Attention	PLOS ONE			English	Article							RECURRENT NETWORK ARCHITECTURE; FIGURE-GROUND SEGREGATION; SPATIAL ATTENTION; MACAQUE MONKEY; CORTICAL AREAS; CORTEX; STRIATE; MODEL; MODULATION; SPOTLIGHT	Mental fatigue is a form of fatigue, induced by continuous task performance. Mentally fatigued people often report having a hard time keeping their attention focussed and being easily distracted. In this study, we examined the relation between mental fatigue, as induced by time on task, and attention-related changes in event-related potentials (ERPs). EEG, reaction times and response accuracies were obtained from 17 healthy volunteers during two hours of task performance on an adapted Eriksen flanker task. In this task, the size of targets and flankers was manipulated to discern neuronal processes that are related to processing of relevant information from processes related to the processing of irrelevant information. The ERP data showed that effects induced by target size manipulation were not affected by time on task, while an initial effect of flanker size manipulation decreased gradually with increasing time on task. We conclude that attention was affected by mental fatigue, in the form of a decrease in the ability to suppress irrelevant information. In behavioural results, this was reflected by a tendency of participants to increasingly base their response decision on irrelevant information, resulting in decreased response accuracies.	[Faber, Leon G.; Lorist, Monicque M.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Faber, Leon G.; Maurits, Natasha M.; Lorist, Monicque M.] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Faber, LG (corresponding author), Univ Groningen, Dept Expt Psychol, Groningen, Netherlands.	l.g.faber@rug.nl		Lorist, Monicque M./0000-0002-7361-093X; Maurits, Natasha/0000-0001-6231-7044	Faculty of Behavioural and Social Sciences of the University of Groningen	Faculty of Behavioural and Social Sciences of the University of Groningen	The study was funded by the Faculty of Behavioural and Social Sciences of the University of Groningen (http://www.rug.nl/gmw/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aine CJ, 1996, CEREB CORTEX, V6, P354, DOI 10.1093/cercor/6.3.354; Bartlett FC, 1943, PROC R SOC SER B-BIO, V131, P247, DOI 10.1098/rspb.1943.0006; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; EASON RG, 1981, B PSYCHONOMIC SOC, V18, P203; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Harter M. R., 1984, VARIETIES ATTENTION, P293; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hillyard SA, 1987, CURRENT TRENDS E S40, P138; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Jehee JFM, 2007, VISION RES, V47, P1153, DOI 10.1016/j.visres.2006.12.018; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lorist M. M., 2011, COGNITIVE FATIGUE, P105, DOI [10.1037/12343-005, DOI 10.1037/12343-005]; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez A, 2001, VISION RES, V41, P1437, DOI 10.1016/S0042-6989(00)00267-4; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; Meijman TF, 1997, INT J IND ERGONOM, V20, P31, DOI 10.1016/S0169-8141(96)00029-7; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ridderinkhof KR, 1997, ADV PSYCHOL, V118, P119; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; van der Linden D., COGNITIVE FATIGUE MU, P149, DOI [10.1037/12343-007, DOI 10.1037/12343-007]; van der Linden D, 2006, PSYCHOL RES-PSYCH FO, V70, P395, DOI 10.1007/s00426-005-0228-7; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Zijlstra F, 1985, CONSTRUCTION SUBJECT	43	124	128	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48073	10.1371/journal.pone.0048073	http://dx.doi.org/10.1371/journal.pone.0048073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WJ	23118927	Green Published, gold			2022-12-25	WOS:000310600500061
J	Lee, JG; Wu, R				Lee, Jasmine G.; Wu, Reen			Combination Erlotinib-Cisplatin and Atg3-Mediated Autophagy in Erlotinib Resistant Lung Cancer	PLOS ONE			English	Article							STRAND BREAK REPAIR; CELL-DEATH; CHEMOTHERAPY RESISTANCE; GEFITINIB RESISTANCE; ACQUIRED-RESISTANCE; EPITHELIAL-CELLS; UP-REGULATION; EGF RECEPTOR; GROWTH; PATHWAY	Tyrosine kinase inhibitors such as erlotinib are commonly used as a therapeutic agent against cancer due to its relatively low side-effect profile and, at times, greater efficacy. However, erlotinib resistance (ER) in non-small cell lung cancer is being recognized as a major problem. Therefore, understanding the mechanism behind ER and developing effective regimens are needed. Autophagy's role in cancer has been controversial and remains unclear. In this study, we examined the effectiveness of low dose erlotinib-cisplatin combination in erlotinib resistant lung adenocarcinoma (ERPC9) cells and the role of autophagy in ER. ERPC9 cells were established from erlotinib sensitive PC9 cells. Appropriate treatments were done over two days and cell survival was quantified with Alamar Blue assay. LC3II and regulatory proteins of autophagy were measured by western blot. Small interfering RNA (siRNA) was utilized to inhibit translation of the protein of interest. In ERPC9 cells, combination treatment induced synergistic cell death and a significant decrease in autophagy. At baseline, ERPC9 cells had a significantly higher LC3II and lower p-mTOR levels compared to PC9 cells. The addition of rapamycin increased resistance and 3-methyladenine sensitized ERPC9 cells, indicating autophagy may be acting as a protective mechanism. Further examination revealed that ERPC9 cells harbored high baseline Atg3 levels. The high basal Atg3 was targeted and significantly lowered with combination treatment. siRNA transfection of Atg3 resulted in the reversal of ER; 42.0% more cells died in erlotinib-alone treatment with transfection compared to non-transfected ERPC9 cells. We reveal a novel role for Atg3 in the promotion of ER as the inhibition of Atg3 translation was able to result in the re-sensitization of ERPC9 cells to erlotinib-alone treatment. Also, we demonstrate that combination erlotinib-cisplatin is an effective treatment against erlotinib resistant cancer by targeting (down-regulating) Atg3 mediated autophagy and induction of apoptotic cell death.	[Lee, Jasmine G.; Wu, Reen] Univ Calif Davis, Div Resp Med, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis	Lee, JG (corresponding author), Univ Calif Davis, Div Resp Med, Dept Internal Med, Davis, CA 95616 USA.	jgelee@ucdavis.edu			National Institutes of Health (NIH) [T32 HL07013, HL077902, HL096373]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077902, T32HL007013, R01HL096373] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Jasmine G. Lee was funded in part by National Institutes of Health (NIH) T32 HL07013. This project was funded in part by NIH grants HL077902 and HL096373. The authors report no financial conflict of interest concerning the study including materials or methods used or the findings specified in this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Barabas K, 2008, VET COMP ONCOL, V6, P1, DOI 10.1111/j.1476-5829.2007.00142.x; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bouker KB, 2004, CANCER RES, V64, P4030, DOI 10.1158/0008-5472.CAN-03-3602; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Diep CH, 2011, CLIN CANCER RES, V17, P2744, DOI 10.1158/1078-0432.CCR-10-2214; Elkind NB, 2005, CANCER RES, V65, P1770, DOI 10.1158/0008-5472.CAN-04-3303; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; ENNIS BW, 1991, CANCER INVEST, V9, P553, DOI 10.3109/07357909109018953; Eskelinen EL, 2011, CURR OPIN PHARMACOL, DOI [10.1016/j.poph.2011.03.009, DOI 10.1016/J.POPH.2011.03.009]; Gamez-Pozo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007731; Gossage L, 2007, CANCER TREAT REV, V33, P565, DOI 10.1016/j.ctrv.2007.07.001; Habib AA, 2003, MOL CANCER RES, V1, P219; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hou HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035665; Hsieh YC, 2009, TRENDS MOL MED, V15, P129, DOI 10.1016/j.molmed.2009.01.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kelsey CR, 2006, CANCER J, V12, P283, DOI 10.1097/00130404-200607000-00006; Kim HP, 2008, MOL CANCER THER, V7, P607, DOI 10.1158/1535-7163.MCT-07-2068; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kosaka T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/165214; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lin CI, 2009, SURGERY, V146, P1208, DOI 10.1016/j.surg.2009.09.019; Ling YH, 2011, CLIN CANCER RES, V17, P5353, DOI 10.1158/1078-0432.CCR-10-1948; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; MIYASHITA T, 1993, BLOOD, V81, P151; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Mumenthaler SM, 2011, MOL PHARMACEUT, V8, P2069, DOI 10.1021/mp200270v; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Okabe T, 2009, CLIN CANCER RES, V15, P907, DOI 10.1158/1078-0432.CCR-08-2251; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Oxnard GR, 2011, CLIN CANCER RES, V17, P5530, DOI 10.1158/1078-0432.CCR-10-2571; Pore MM, 2013, CANCER LETT, V332, P359, DOI 10.1016/j.canlet.2010.09.012; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Samaddar JS, 2008, MOL CANCER THER, V7, P2977, DOI 10.1158/1535-7163.MCT-08-0447; Sartorius UA, 2002, INT J CANCER, V97, P584, DOI 10.1002/ijc.10096; Shanker M, 2010, LUNG CANCER-TARGETS, V1, P23; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shimizu S, 2012, INT J CANCER, V131, P548, DOI 10.1002/ijc.26374; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Siu LL, 2007, J CLIN ONCOL, V25, P2178, DOI 10.1200/JCO.2006.07.6547; Skarda J, 2008, CANC THER, V6, P377; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Steins MB, 2010, ONKOLOGIE, V33, P704, DOI 10.1159/000322214; Tsang RY, 2009, DRUG SAFETY, V32, P1109, DOI 10.2165/11316640-000000000-00000; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Viola G, 2012, BIOCHEM PHARMACOL, V83, P16, DOI 10.1016/j.bcp.2011.09.017; Wu R, 1997, EUR RESPIR J, V10, P2398, DOI 10.1183/09031936.97.10102398; WU R, 1990, AM J RESP CELL MOL, V3, P467, DOI 10.1165/ajrcmb/3.5.467; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020	68	32	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48532	10.1371/journal.pone.0048532	http://dx.doi.org/10.1371/journal.pone.0048532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119048	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500161
J	Rana, AK; Singh, A; Gurcha, SS; Cox, LR; Bhatt, A; Besra, GS				Rana, Amrita K.; Singh, Albel; Gurcha, Sudagar S.; Cox, Liam R.; Bhatt, Apoorva; Besra, Gurdyal S.			Ppm1-Encoded Polyprenyl Monophosphomannose Synthase Activity Is Essential for Lipoglycan Synthesis and Survival in Mycobacteria	PLOS ONE			English	Article							CORYNEBACTERIUM-GLUTAMICUM; LIPOARABINOMANNAN BIOSYNTHESIS; STRUCTURAL-CHARACTERIZATION; IDENTIFICATION; ARABINOGALACTAN; TUBERCULOSIS; LIPOMANNAN; GENE; RECOGNITION; CHELONAE	The biosynthesis of mycobacterial mannose-containing lipoglycans, such as lipomannan (LM) and the immunomodulator lipoarabinomanan (LAM), is carried out by the GT-C superfamily of glycosyltransferases that require polyprenylphosphate-based mannose (PPM) as a sugar donor. The essentiality of lipoglycan synthesis for growth makes the glycosyltransferase that synthesizes PPM, a potential drug target in Mycobacterium tuberculosis, the causative agent of tuberculosis. In M. tuberculosis, PPM has been shown to be synthesized by Ppm1 in enzymatic assays. However, genetic evidence for its essentiality and in vivo role in LM/LAM and PPM biosynthesis is lacking. In this study, we demonstrate that MSMEG3859, a Mycobacterium smegmatis gene encoding the homologue of the catalytic domain of M. tuberculosis Ppm1, is essential for survival. Depletion of MSMEG3859 in a conditional mutant of M. smegmatis resulted in the loss of higher order phosphatidyl-myo-inositol mannosides (PIMs) and lipomannan. We were also able to demonstrate that two other M. tuberculosis genes encoding glycosyltransferases that either had been shown to possess PPM synthase activity (Rv3779), or were involved in synthesizing similar polyprenol-linked donors (ppgS), were unable to compensate for the loss of MSMEG3859 in the conditional mutant.	[Rana, Amrita K.; Cox, Liam R.] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England; [Rana, Amrita K.; Singh, Albel; Gurcha, Sudagar S.; Bhatt, Apoorva; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Cox, LR (corresponding author), Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England.	l.r.cox@bham.ac.uk; a.bhatt@bham.ac.uk; g.besra@bham.ac.uk	Cox, Liam/AAG-9351-2020	Cox, Liam/0000-0001-7018-3904; Besra, Gurdyal/0000-0002-5605-0395	Wellcome Trust; Royal Society Wolfson Research Merit Award; Medical Research Council (UK); University of Birmingham; MRC [G0901690, G0600105] Funding Source: UKRI; Medical Research Council [G0600105, G0901690] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Birmingham; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	G.S.B. acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick, funding from the Wellcome Trust and a Royal Society Wolfson Research Merit Award. A. B. and G. S. B. also acknowledge grant support from the Medical Research Council (UK). A. R. is funded by a PhD studentship from the University of Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelmelk BJ, 2008, CELL MICROBIOL, V10, P930, DOI 10.1111/j.1462-5822.2007.01097.x; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Baulard AR, 2003, J BIOL CHEM, V278, P2242, DOI 10.1074/jbc.M207922200; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Bhatt A, 2005, J BACTERIOL, V187, P7596, DOI 10.1128/JB.187.22.7596-7606.2005; Birch HL, 2008, MOL MICROBIOL, V69, P1191, DOI 10.1111/j.1365-2958.2008.06354.x; Birch HL, 2010, P NATL ACAD SCI USA, V107, P2634, DOI 10.1073/pnas.0915082107; CHATTERJEE D, 1993, GLYCOBIOLOGY, V3, P497, DOI 10.1093/glycob/3.5.497; Dinadayala P, 2006, J BIOL CHEM, V281, P20027, DOI 10.1074/jbc.M603395200; Dobson G., 1985, CHEM METHODS BACTERI, P237; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Gibson KJC, 2003, J BIOL CHEM, V278, P40842, DOI 10.1074/jbc.M307988200; Guerardel Y, 2002, J BIOL CHEM, V277, P30635, DOI 10.1074/jbc.M204398200; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2010, J BIOL CHEM, V285, P33577, DOI 10.1074/jbc.R110.168328; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Jankute M, 2012, FUTURE MICROBIOL, V7, P129, DOI [10.2217/fmb.11.123, 10.2217/FMB.11.123]; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Ludwiczak P, 2001, ANAL CHEM, V73, P2323, DOI 10.1021/ac001368h; Mahon RN, 2009, INFECT IMMUN, V77, P4574, DOI 10.1128/IAI.00222-09; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2008, ANTON LEEUW INT J G, V94, P277, DOI 10.1007/s10482-008-9243-1; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mishra AK, 2011, MOL MICROBIOL, V80, P1241, DOI 10.1111/j.1365-2958.2011.07640.x; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Scherman H, 2009, J BACTERIOL, V191, P6769, DOI 10.1128/JB.00431-09; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Skovierova H, 2010, J BIOL CHEM, V285, P41348, DOI 10.1074/jbc.M110.188110; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Vignal C, 2003, J IMMUNOL, V171, P2014, DOI 10.4049/jimmunol.171.4.2014; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; World Health Organization, WHO MULT EXT DRUG RE; World Health Organization, 2010, WHO REP 2010 GLOB TU; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	38	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48211	10.1371/journal.pone.0048211	http://dx.doi.org/10.1371/journal.pone.0048211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118955	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500083
J	Rosana, ARR; Chamot, D; Owttrim, GW				Rosana, Albert Remus R.; Chamot, Danuta; Owttrim, George W.			Autoregulation of RNA Helicase Expression in Response to Temperature Stress in Synechocystis sp PCC 6803	PLOS ONE			English	Article							COLD-SHOCK PROTEIN; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; GENE-EXPRESSION; ABIOTIC STRESS; STABILITY; FAMILY; DEGRADOSOME; PROTEOLYSIS; ADAPTATION	RNA helicases are ubiquitous enzymes whose modification of RNA secondary structure is known to regulate RNA function. The pathways controlling RNA helicase expression, however, have not been well characterized. Expression of the cyanobacterial RNA helicase, crhR, is regulated in response to environmental signals that alter the redox poise of the electron transport chain, including light and temperature. Here we analyze crhR expression in response to alteration of abiotic conditions in wild type and a crhR mutant, providing evidence that CrhR autoregulates its own expression through a combination of transcriptional and post-transcriptional mechanisms. Temperature regulates crhR expression through alteration of both transcript and protein half-life which are significantly extended at low temperature (20 degrees C). CrhR-dependent mechanisms regulate both the transient accumulation of crhR transcript at 20 degrees C and stability of the CrhR protein at all temperatures. CrhR-independent mechanisms regulate temperature sensing and induction of crhR transcript accumulation at 20 degrees C and the temperature regulation of crhR transcript stability, suggesting CrhR is not directly associated with crhR mRNA turnover. Many of the processes are CrhR- and temperature-dependent and occur in the absence of a correlation between crhR transcript and protein abundance. The data provide important insights into not only how RNA helicase gene expression is regulated but also the role that rearrangement of RNA secondary structure performs in the molecular response to temperature stress. We propose that the crhR-regulatory pathway exhibits characteristics similar to the heat shock response rather than a cold stress-specific mechanism.	[Rosana, Albert Remus R.; Chamot, Danuta; Owttrim, George W.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Owttrim, GW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	gowttrim@ualberta.ca	Rosana, Albert Remus/AAL-3288-2020; Owttrim, George/L-4605-2013; Rosana, Albert Remus R/R-5602-2016	Rosana, Albert Remus/0000-0001-7847-7763; Rosana, Albert Remus R/0000-0001-7847-7763; Owttrim, George/0000-0002-4709-2091	Natural Sciences and Engineering Research Council of Canada (NSERC) [171319]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grant number 171319 from the Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca/index_eng.asp) to GWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PS, 1999, J BACTERIOL, V181, P7028, DOI 10.1128/JB.181.22.7028-7033.1999; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Bowers HA, 2006, RNA, V12, P903, DOI 10.1261/rna.2323406; Chamot D, 2000, J BACTERIOL, V182, P1251, DOI 10.1128/JB.182.5.1251-1256.2000; Chamot D, 2005, J BIOL CHEM, V280, P2036, DOI 10.1074/jbc.M409700200; Chamot D, 1999, J BACTERIOL, V181, P1728, DOI 10.1128/JB.181.6.1728-1732.1999; Charollais J, 2004, NUCLEIC ACIDS RES, V32, P2751, DOI 10.1093/nar/gkh603; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; El-Fahmawi B, 2003, MOL MICROBIOL, V50, P1439, DOI 10.1046/j.1365-2958.2003.03783.x; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Giuliodori AM, 2007, ANN NY ACAD SCI, V1113, P95, DOI 10.1196/annals.1391.008; Goldenberg D, 1996, MOL MICROBIOL, V19, P241, DOI 10.1046/j.1365-2958.1996.363898.x; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Hunger K, 2006, J BACTERIOL, V188, P240, DOI 10.1128/JB.188.1.240-248.2006; Iost I, 2006, NUCLEIC ACIDS RES, V34, P4189, DOI 10.1093/nar/gkl500; Khemici V, 2004, MOL MICROBIOL, V54, P1422, DOI 10.1111/j.1365-2958.2004.04361.x; Kim JS, 2008, PLANT CELL PHYSIOL, V49, P1563, DOI 10.1093/pcp/pcn125; Kujat SL, 2000, PLANT PHYSIOL, V124, P703, DOI 10.1104/pp.124.2.703; Lim J, 2000, J MOL BIOL, V297, P553, DOI 10.1006/jmbi.2000.3585; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Lopez-Maury L, 2002, MOL MICROBIOL, V43, P247, DOI 10.1046/j.1365-2958.2002.02741.x; Meyer AS, 2011, CURR OPIN MICROBIOL, V14, P194, DOI 10.1016/j.mib.2011.02.001; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Nickel M, 2004, MOL GENET GENOMICS, V272, P98, DOI 10.1007/s00438-004-1038-0; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Owttrim GW, 2012, METHOD ENZYMOL, V511, P385, DOI 10.1016/B978-0-12-396546-2.00018-8; Pandiani F, 2011, APPL ENVIRON MICROB, V77, P5604, DOI 10.1128/AEM.02974-10; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Purusharth RI, 2005, J BIOL CHEM, V280, P14572, DOI 10.1074/jbc.M413507200; Regonesi ME, 2006, BIOCHIMIE, V88, P151, DOI 10.1016/j.biochi.2005.07.012; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rosana ARR, 2012, PLANT CELL PHYSIOL, V53, P646, DOI 10.1093/pcp/pcs020; SATO N, 1995, NUCLEIC ACIDS RES, V23, P2161; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shenhar Y, 2009, ENVIRON MICROBIOL, V11, P2989, DOI 10.1111/j.1462-2920.2009.01993.x; Shimura Y, 2012, PLANT CELL PHYSIOL, V53, P1255, DOI 10.1093/pcp/pcs068; Vinnemeier J, 1999, ARCH MICROBIOL, V172, P377, DOI 10.1007/s002030050774; Yu E, 2000, NUCLEIC ACIDS RES, V28, P3926, DOI 10.1093/nar/28.20.3926	43	20	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48683	10.1371/journal.pone.0048683	http://dx.doi.org/10.1371/journal.pone.0048683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119089	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500197
J	Suarez, LM; Cid, E; Gal, B; Inostroza, M; Brotons-Mas, JR; Gomez-Dominguez, D; de la Prida, LM; Solis, JM				Suarez, Luz M.; Cid, Elena; Gal, Beatriz; Inostroza, Marion; Brotons-Mas, Jorge R.; Gomez-Dominguez, Daniel; Menendez de la Prida, Liset; Solis, Jose M.			Systemic Injection of Kainic Acid Differently Affects LTP Magnitude Depending on its Epileptogenic Efficiency	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TEMPORAL-LOBE EPILEPSY; SYNAPTIC PLASTICITY; KAINATE RECEPTORS; RAT HIPPOCAMPUS; EPILEPTIFORM ACTIVITY; NEUROTROPHIC FACTOR; GAMMA OSCILLATIONS; WATER MAZE; CELL-DEATH	Seizures have profound impact on synaptic function and plasticity. While kainic acid is a popular method to induce seizures and to potentially affect synaptic plasticity, it can also produce physiological-like oscillations and trigger some forms of long-term potentiation (LTP). Here, we examine whether induction of LTP is altered in hippocampal slices prepared from rats with different sensitivity to develop status epilepticus (SE) by systemic injection of kainic acid. Rats were treated with multiple low doses of kainic acid (5 mg/kg; i.p.) to develop SE in a majority of animals (72-85% rats). A group of rats were resistant to develop SE (15-28%) after several accumulated doses. Animals were subsequently tested using chronic recordings and object recognition tasks before brain slices were prepared for histological studies and to examine basic features of hippocampal synaptic function and plasticity, including input/output curves, paired-pulse facilitation and theta-burst induced LTP. Consistent with previous reports in kindling and pilocapine models, LTP was reduced in rats that developed SE after kainic acid injection. These animals exhibited signs of hippocampal sclerosis and developed spontaneous seizures. In contrast, resistant rats did not become epileptic and had no signs of cell loss and mossy fiber sprouting. In slices from resistant rats, theta-burst stimulation induced LTP of higher magnitude when compared with control and epileptic rats. Variations on LTP magnitude correlate with animals' performance in a hippocampal-dependent spatial memory task. Our results suggest dissociable long-term effects of treatment with kainic acid on synaptic function and plasticity depending on its epileptogenic efficiency.	[Suarez, Luz M.; Cid, Elena; Gal, Beatriz; Inostroza, Marion; Brotons-Mas, Jorge R.; Gomez-Dominguez, Daniel; Menendez de la Prida, Liset] Inst Cajal CSIC, Madrid, Spain; [Suarez, Luz M.; Solis, Jose M.] IRYCIS, Hosp Univ Ramon y Cajal, Madrid, Spain; [Gal, Beatriz] Univ Europea Madrid, Madrid, Spain; [Inostroza, Marion] Univ Chile, Santiago, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Hospital Universitario Ramon y Cajal; European University of Madrid; Universidad de Chile	de la Prida, LM (corresponding author), Inst Cajal CSIC, Madrid, Spain.	lmprida@cajal.csic.es; jose.m.solis@hrc.es	Suarez, Luz/H-8817-2015; de la Prida, Liset M/O-1342-2013; Gal, Beatriz/J-3530-2018; Inostroza, Marion/R-9394-2018; Cid, Elena/N-5072-2014	Suarez, Luz/0000-0003-1276-2259; de la Prida, Liset M/0000-0002-0160-6472; Gal, Beatriz/0000-0001-5189-1147; Solis, Jose M./0000-0001-6478-0489; Inostroza, Marion/0000-0003-3483-1905; Cid, Elena/0000-0003-4852-595X	European Commission [201600]; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BFU2009-07989, PIU081067]; European Social Fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Social Fund(European Social Fund (ESF))	This work was supported by grants from the European Commission under FP7 (MemStick Grant Agreement No 201600) to LMP and from the Spanish Ministerio de Ciencia e Innovacion (MICINN) BFU2009-07989 and PIU081067 to LMP and JMS, respectively. EC is a JAE-Doc fellow from the CSIC JAE Program co-funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg MH, 2004, J PHYSIOL-LONDON, V554, P439, DOI 10.1113/jphysiol.2003.052662; ANWYL R, 1987, BRAIN RES, V435, P377, DOI 10.1016/0006-8993(87)91629-5; Arida RM, 2005, EPILEPSIA, V46, P189, DOI 10.1111/j.1528-1167.2005.01065.x; Barr DS, 1997, EPILEPSY RES, V27, P111, DOI 10.1016/S0920-1211(97)01027-9; Behr J, 2001, J NEUROPHYSIOL, V85, P2195, DOI 10.1152/jn.2001.85.5.2195; BENARI Y, 1990, TRENDS NEUROSCI, V13, P312, DOI 10.1016/0166-2236(90)90135-W; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; CAIN DP, 1993, HIPPOCAMPUS, V3, P153, DOI 10.1002/hipo.450030208; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Danzer SC, 2004, HIPPOCAMPUS, V14, P345, DOI 10.1002/hipo.10190; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P65, DOI 10.1113/jphysiol.2004.077388; Galani R, 1998, BEHAV BRAIN RES, V96, P1, DOI 10.1016/S0166-4328(97)00197-6; Gilbert TH, 1996, BEHAV BRAIN RES, V82, P57, DOI 10.1016/S0166-4328(97)81108-4; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Inostroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022372; Jinde S, 2009, EUR J NEUROSCI, V30, P1036, DOI 10.1111/j.1460-9568.2009.06896.x; Khalilov I, 2002, J NEUROPHYSIOL, V88, P523, DOI 10.1152/jn.2002.88.1.523; Leung LS, 2003, NEUROREPORT, V14, P211, DOI 10.1097/00001756-200302100-00010; Lodato S, 2011, J NEUROSCI, V31, P4650, DOI 10.1523/JNEUROSCI.6580-10.2011; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Meldrum BS, 2002, PROG BRAIN RES, V135, P3; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Paddock S, 2007, AM J PSYCHIAT, V164, P1181, DOI 10.1176/appi.ajp.2007.06111790; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Qiu SF, 2009, TOXICOL SCI, V111, P140, DOI 10.1093/toxsci/kfp141; Queiroz CMT, 2007, EUR J NEUROSCI, V25, P3071, DOI 10.1111/j.1460-9568.2007.05573.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Racine RJ, 1999, EPILEPSY RES, V35, P183, DOI 10.1016/S0920-1211(99)00013-3; Reibel S, 2000, NEUROSCIENCE, V100, P777, DOI 10.1016/S0306-4522(00)00351-1; Sarkisian MR, 1997, EPILEPSIA, V38, P1157, DOI 10.1111/j.1528-1157.1997.tb01211.x; Schubert M, 2005, LEARN MEMORY, V12, P520, DOI 10.1101/lm.4205; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Tanaka K, 2010, EPILEPSY RES, V88, P151, DOI 10.1016/j.eplepsyres.2009.10.012; Tandon P, 1999, NEUROSCIENCE, V91, P293, DOI 10.1016/S0306-4522(98)00609-5; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wu K, 2003, NEUROSCIENCE, V116, P599, DOI 10.1016/S0306-4522(02)00567-5; Xu B, 2004, EUR J NEUROSCI, V20, P403, DOI 10.1111/j.1460-9568.2004.03489.x; Zhang Y, 2010, EPILEPSY BEHAV, V17, P448, DOI 10.1016/j.yebeh.2010.02.008; Zhou JL, 2007, EUR J NEUROSCI, V25, P3667, DOI 10.1111/j.1460-9568.2007.05598.x	42	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48128	10.1371/journal.pone.0048128	http://dx.doi.org/10.1371/journal.pone.0048128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118939	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500070
J	Tsui, NBY; Jiang, PY; Chow, KCK; Su, XX; Leung, TY; Sun, H; Chan, KCA; Chiu, RWK; Lo, YMD				Tsui, Nancy B. Y.; Jiang, Peiyong; Chow, Katherine C. K.; Su, Xiaoxi; Leung, Tak Y.; Sun, Hao; Chan, K. C. Allen; Chiu, Rossa W. K.; Lo, Y. M. Dennis			High Resolution Size Analysis of Fetal DNA in the Urine of Pregnant Women by Paired-End Massively Parallel Sequencing	PLOS ONE			English	Article							CELL-FREE DNA; MATERNAL PLASMA; PRENATAL-DIAGNOSIS; TRANSPLANT RECIPIENTS; RENAL-TRANSPLANTATION; CANCER; ANEUPLOIDY; CLEARANCE; REJECTION; MARKER	Background: Fetal DNA in maternal urine, if present, would be a valuable source of fetal genetic material for noninvasive prenatal diagnosis. However, the existence of fetal DNA in maternal urine has remained controversial. The issue is due to the lack of appropriate technology to robustly detect the potentially highly degraded fetal DNA in maternal urine. Methodology: We have used massively parallel paired-end sequencing to investigate cell-free DNA molecules in maternal urine. Catheterized urine samples were collected from seven pregnant women during the third trimester of pregnancies. We detected fetal DNA by identifying sequenced reads that contained fetal-specific alleles of the single nucleotide polymorphisms. The sizes of individual urinary DNA fragments were deduced from the alignment positions of the paired reads. We measured the fractional fetal DNA concentration as well as the size distributions of fetal and maternal DNA in maternal urine. Principal Findings: Cell-free fetal DNA was detected in five of the seven maternal urine samples, with the fractional fetal DNA concentrations ranged from 1.92% to 4.73%. Fetal DNA became undetectable in maternal urine after delivery. The total urinary cell-free DNA molecules were less intact when compared with plasma DNA. Urinary fetal DNA fragments were very short, and the most dominant fetal sequences were between 29 bp and 45 bp in length. Conclusions: With the use of massively parallel sequencing, we have confirmed the existence of transrenal fetal DNA in maternal urine, and have shown that urinary fetal DNA was heavily degraded.	[Tsui, Nancy B. Y.; Jiang, Peiyong; Chow, Katherine C. K.; Su, Xiaoxi; Sun, Hao; Chan, K. C. Allen; Chiu, Rossa W. K.; Lo, Y. M. Dennis] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Ctr Res Circulating Fetal Nucl Acids, Shatin, Hong Kong, Peoples R China; [Leung, Tak Y.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Obstet & Gynaecol, Ctr Res Circulating Fetal Nucl Acids, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Tsui, NBY (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Ctr Res Circulating Fetal Nucl Acids, Shatin, Hong Kong, Peoples R China.	nancytsui@cuhk.edu.hk	Sun, Hao/T-5576-2019; Chan, K.C. Allen/M-2930-2013; JIANG, Peiyong/AAZ-9898-2020; Lo, Yuk Ming Dennis/D-4468-2011; sun, hao/GRS-7732-2022; Sun, Hao/J-9964-2013	Sun, Hao/0000-0002-5547-9501; Chan, K.C. Allen/0000-0003-1780-1691; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Sun, Hao/0000-0002-5547-9501; Jiang, Peiyong/0000-0003-4523-3476	University Grants Committee of the Government of the Hong Kong Special Administration Region, China [AoE/M-04/06]; Sequenom	University Grants Committee of the Government of the Hong Kong Special Administration Region, China; Sequenom	The study was supported by the University Grants Committee of the Government of the Hong Kong Special Administration Region, China, under the Areas of Excellence Scheme (AoE/M-04/06). YMDL was supported by an Endowed Chair from the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KCAC, RWKC and YMDL have filed the United States patent applications 20090029377 "Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing", 20110105353 "Fetal genomic analysis from a maternal biological sample", and 20110276277 "Size-based genomic analysis". RWKC and YMDL have received research support from, are consultants to, and hold equities in Sequenom. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Al-Yatama MK, 2001, PRENATAL DIAG, V21, P399, DOI 10.1002/pd.69; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Botezatu I, 2000, CLIN CHEM, V46, P1078; Cairns P, 2007, NAT REV CANCER, V7, P531, DOI 10.1038/nrc2170; Chan KCA, 2008, CLIN CANCER RES, V14, P4809, DOI 10.1158/1078-0432.CCR-08-1112; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Cherepanova A, 2007, J IMMUNOL METHODS, V325, P96, DOI 10.1016/j.jim.2007.06.004; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2012, ANNU REV GENOM HUM G, V13, P1011; Foran DR, 2006, J FORENSIC SCI, V51, P766, DOI 10.1111/j.1556-4029.2006.00176.x; Moreira VG, 2009, CLIN CHEM, V55, P1958, DOI 10.1373/clinchem.2009.129072; Hung ECW, 2009, CLIN CHEM, V55, P715, DOI 10.1373/clinchem.2008.113530; Illanes S, 2006, PRENATAL DIAG, V26, P1216, DOI 10.1002/pd.1591; Koide K, 2005, PRENATAL DIAG, V25, P604, DOI 10.1002/pd.1213; Kotnik V, 2003, CROAT MED J, V44, P707; Lau TW, 2002, CLIN CHEM, V48, P2141; Li Y, 2005, CLIN CHEM, V51, P1903, DOI 10.1373/clinchem.2005.055038; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lodde M, 2008, CURR OPIN UROL, V18, P499, DOI 10.1097/MOU.0b013e32830b86d1; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Majer S, 2007, PRENATAL DIAG, V27, P1219, DOI 10.1002/pd.1875; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Shekhtman EM, 2009, CLIN CHEM, V55, P723, DOI 10.1373/clinchem.2008.113050; Su YH, 2004, J MOL DIAGN, V6, P101, DOI 10.1016/S1525-1578(10)60497-7; Tryggvason K, 2005, PHYSIOLOGY, V20, P96, DOI 10.1152/physiol.00045.2004; Umansky SR, 2006, EXPERT REV MOL DIAGN, V6, P153, DOI 10.1586/14737159.6.2.153; Ying L, 2003, J SOC GYNECOL INVEST, V10, P503, DOI 10.1016/S1071-5576(03)00155-2; Zhang J, 1999, CLIN CHEM, V45, P1741; Zheng YWL, 2012, CLIN CHEM, V58, P549, DOI 10.1373/clinchem.2011.169318; Zhong XY, 2001, ANN NY ACAD SCI, V945, P250	32	65	73	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48319	10.1371/journal.pone.0048319	http://dx.doi.org/10.1371/journal.pone.0048319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118982	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500102
J	Xu, T; Qin, R; Zhou, JX; Yan, Y; Lu, YC; Zhang, XP; Fu, D; Lv, ZW; Li, WQ; Xia, CY; Hu, GH; Ding, XH; Chen, JX				Xu, Tao; Qin, Rong; Zhou, Jinxu; Yan, Yong; Lu, Yicheng; Zhang, Xiaoping; Fu, Da; Lv, Zhongwei; Li, Weiqing; Xia, Chunyan; Hu, Guohan; Ding, Xuehua; Chen, Juxiang			High Bone Sialoprotein (BSP) Expression Correlates with Increased Tumor Grade and Predicts a Poorer Prognosis of High-Grade Glioma Patients	PLOS ONE			English	Article							LINKED GLYCOPROTEINS SIBLINGS; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; CELL; GLIOBLASTOMA; METASTASIS; OUTCOMES; MARKERS; GROWTH	Objectives: To investigate the expression and prognostic value of bone sialoprotein (BSP) in glioma patients. Methods: We determined the expression of BSP using real-time RT-PCR and immunohistochemistry in tissue microarrays containing 15 normal brain and 270 glioma samples. Cumulative survival was calculated by the Kaplan-Meier method and analyzed by the log-rank test. Univariate and multivariate analyses were performed by the stepwise forward Cox regression model. Results: Both BSP mRNA and protein levels were significantly elevated in high-grade glioma tissues compared with those of normal brain and low-grade glioma tissues, and BSP expression positively correlated with tumor grade (P < 0.001). Univariate and multivariate analysis showed high BSP expression was an independent prognostic factor for a shorter progression-free survival (PFS) and overall survival (OS) in both grade III and grade IV glioma patients [hazard ratio (HR) = 2.549 and 3.154 for grade III glioma, and HR = 1.637 and 1.574 for grade IV glioma, respectively]. Patients with low BSP expression had a significantly longer median OS and PFS than those with high BSP expression. Small extent of resection and lineage of astrocyte served as independent risk factors of both shorter PFS and OS in grade III glioma patients; GBM patients without O-6-methylguanine (O-6-meG) DNA methyltransferase (MGMT) methylation and Karnofsky performance score (KPS) less than 70 points were related to poor prognosis. Lack of radiotherapy related to shorter OS but not affect PFS in both grade III and grade IV glioma patients. Conclusion: High BSP expression occurs in a significant subset of high-grade glioma patients and predicts a poorer outcome. The study identifies a potentially useful molecular marker for the categorization and targeted therapy of gliomas.	[Xu, Tao; Qin, Rong; Zhou, Jinxu; Yan, Yong; Lu, Yicheng; Hu, Guohan; Ding, Xuehua; Chen, Juxiang] Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai, Peoples R China; [Li, Weiqing; Xia, Chunyan] Second Mil Med Univ, Changzheng Hosp, Dept Pathol, Shanghai, Peoples R China; [Zhang, Xiaoping; Fu, Da; Lv, Zhongwei] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nucl Med, Shanghai 200092, Peoples R China; [Zhang, Xiaoping; Fu, Da; Lv, Zhongwei] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Inst Hlth Sci,Sch Med, Shanghai 200030, Peoples R China	Naval Medical University; Naval Medical University; Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Chen, JX (corresponding author), Second Mil Med Univ, Changzheng Hosp, Shanghai Inst Neurosurg, Dept Neurosurg, Shanghai, Peoples R China.	juxiangchen.cz@gmail.com	Fu, Da/F-1763-2013	Ding, Xuehua/0000-0002-7117-0328	National "863" High Technique Project [2007AA02Z483]; National Natural Science Foundation [81101907, 30973076]; Program for academic leaders in health sciences [XBR2011030]; "Shu Guang" project in Shanghai [11SG37]	National "863" High Technique Project(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for academic leaders in health sciences; "Shu Guang" project in Shanghai	This work was supported by National "863" High Technique Project (2007AA02Z483), National Natural Science Foundation (No. 81101907, 30973076), Program for academic leaders in health sciences (No. XBR2011030) and "Shu Guang" project (No.11SG37) in Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnholtz-Sloan JS, 2008, J NEUROSURG, V108, P642, DOI 10.3171/JNS/2008/108/4/0642; Bellahcene A, 2000, CIRC RES, V86, P885, DOI 10.1161/01.RES.86.8.885; BELLAHCENE A, 1994, CANCER RES, V54, P2823; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Diel IJ, 1999, CLIN CANCER RES, V5, P3914; Fedarko NS, 2004, FASEB J, V18, P734, DOI 10.1096/fj.03-0966fje; Fisher LW, 2004, CLIN CANCER RES, V10, P8501, DOI 10.1158/1078-0432.CCR-04-1072; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Jung K, 2004, INT J CANCER, V111, P783, DOI 10.1002/ijc.20314; Kayed H, 2007, CANCER LETT, V245, P171, DOI 10.1016/j.canlet.2006.01.002; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Mukerji N, 2008, J NEURO-ONCOL, V86, P329, DOI 10.1007/s11060-007-9476-2; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Papotti M, 2006, J CLIN ONCOL, V24, P4818, DOI 10.1200/JCO.2006.06.1952; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Riminucci M, 2003, CALCIFIED TISSUE INT, V73, P281, DOI 10.1007/s00223-002-2134-y; Schomas DA, 2009, NEURO-ONCOLOGY, V11, P437, DOI 10.1215/15228517-2008-102; Tu QS, 2009, J CELL PHYSIOL, V218, P135, DOI 10.1002/jcp.21576; Valabrega G, 2003, BRIT J CANCER, V88, P396, DOI 10.1038/sj.bjc.6600735; van den Bent MJ, 2007, NEUROL CLIN, V25, P1089, DOI 10.1016/j.ncl.2007.07.013; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Waltregny D, 1998, J NATL CANCER I, V90, P1000, DOI 10.1093/jnci/90.13.1000; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yang GH, 2008, ONCOLOGIST, V13, P1155, DOI 10.1634/theoncologist.2008-0081; Zhang JH, 2004, ANTICANCER RES, V24, P1361	27	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48415	10.1371/journal.pone.0048415	http://dx.doi.org/10.1371/journal.pone.0048415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119009	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500129
J	Yeh, YT; Hur, SS; Chang, J; Wang, KC; Chiu, JJ; Li, YS; Chien, S				Yeh, Yi-Ting; Hur, Sung Sik; Chang, Joann; Wang, Kuei-Chun; Chiu, Jeng-Jiann; Li, Yi-Shuan; Chien, Shu			Matrix Stiffness Regulates Endothelial Cell Proliferation through Septin 9	PLOS ONE			English	Article							SUBSTRATE STIFFNESS; CYTOSKELETAL TENSION; ARTERIAL STIFFNESS; MAMMALIAN SEPTIN; SMOOTH-MUSCLE; RPTP-ALPHA; RHO-KINASE; INTEGRINS; ADHESION; RIGIDITY	Endothelial proliferation, which is an important process in vascular homeostasis, can be regulated by the extracellular microenvironment. In this study we demonstrated that proliferation of endothelial cells (ECs) was enhanced on hydrogels with high stiffness (HSG, 21.5 kPa) in comparison to those with low stiffness (LSG, 1.72 kPa). ECs on HSG showed markedly prominent stress fibers and a higher RhoA activity than ECs on LSG. Blockade of RhoA attenuated stress fiber formation and proliferation of ECs on HSG, but had little effect on ECs on LSG; enhancement of RhoA had opposite effects. The phosphorylations of Src and Vav2, which are positive RhoA upstream effectors, were higher in ECs on HSG. The inhibition of Src/Vav2 attenuated the HSG-mediated RhoA activation and EC proliferation but exhibited nominal effects on ECs on LSG. Septin 9 (SEPT9), the negative upstream effector for RhoA, was significantly higher in ECs on LSG. The inhibition of SEPT9 increased RhoA activation, Src/Vav2 phosphorylations, and EC proliferation on LSG, but showed minor effects on ECs on HSG. We further demonstrated that the inactivation of integrin alpha(v)beta(3) caused an increase of SEPT9 expression in ECs on HSG to attenuate Src/Vav2 phosphorylations and inhibit RhoA-dependent EC proliferation. These results demonstrate that the SEPT9/Src/Vav2/RhoA pathway constitutes an important molecular mechanism for the mechanical regulation of EC proliferation.	[Yeh, Yi-Ting; Hur, Sung Sik; Chang, Joann; Wang, Kuei-Chun; Li, Yi-Shuan; Chien, Shu] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Yeh, Yi-Ting; Hur, Sung Sik; Chang, Joann; Wang, Kuei-Chun; Li, Yi-Shuan; Chien, Shu] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA; [Yeh, Yi-Ting; Chiu, Jeng-Jiann] Natl Hlth Res Inst, Div Med Engn Res, Zhunan, Taiwan; [Yeh, Yi-Ting] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Yeh, Yi-Ting] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	University of California System; University of California San Diego; University of California System; University of California San Diego; National Health Research Institutes - Taiwan; National Tsing Hua University; National Tsing Hua University	Chien, S (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	shuchien@ucsd.edu	Chiu, Jeng-Jiann/E-3980-2010; Wang, Kuei-Chun/N-3089-2017; Wang, Kuei-Chun (Mark)/N-3419-2017		National Institutes of Health [HL104402, HL106579, NSC-101-2325-B-400-009, NSC-100-2321-B-400-001, NSC-99-2911-I-009-101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108735, R01HL106579, R21HL104402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Research Grants HL104402 and HL106579 (S. C.), NSC-101-2325-B-400-009 and NSC-100-2321-B-400-001 (J.-J.C.), and NSC-99-2911-I-009-101 to UST-UCSD International Center of Excellence in Advanced Bioengineering (to S. C. and J.-J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Atabek ME, 2006, DIABETES RES CLIN PR, V74, P33, DOI 10.1016/j.diabres.2006.03.004; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ghosh K, 2008, P NATL ACAD SCI USA, V105, P11305, DOI 10.1073/pnas.0800835105; Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170; Gilden J, 2010, CYTOSKELETON, V67, P477, DOI 10.1002/cm.20461; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Kalikin LM, 2000, GENOMICS, V63, P165, DOI 10.1006/geno.1999.6077; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; LEE RT, 1992, ARTERIOSCLER THROMB, V12, P1, DOI 10.1161/01.ATV.12.1.1; Liao DP, 1999, HYPERTENSION, V34, P201, DOI 10.1161/01.HYP.34.2.201; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miao H, 2002, J CELL SCI, V115, P2199; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Peng XL, 2012, J BIOMECH, V45, P116, DOI 10.1016/j.jbiomech.2011.09.013; Peterson EA, 2010, CLIN GENET, V77, P511, DOI 10.1111/j.1399-0004.2010.01392.x; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; VERNON RB, 1992, LAB INVEST, V66, P536; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Wallace CS, 2007, AM J PHYSIOL-HEART C, V293, pH1978, DOI 10.1152/ajpheart.00618.2007; Wallace CS, 2010, AM J PHYSIOL-HEART C, V299, pH338, DOI 10.1152/ajpheart.01029.2009; Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7; Wei WC, 2008, AM J PHYSIOL-CELL PH, V295, pC1579, DOI 10.1152/ajpcell.00223.2008; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	52	88	89	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e46889	10.1371/journal.pone.0046889	http://dx.doi.org/10.1371/journal.pone.0046889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118862	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500011
J	Argyros, O; Wong, SP; Gowers, K; Harbottle, RP				Argyros, Orestis; Wong, Suet Ping; Gowers, Kate; Harbottle, Richard Paul			Genetic Modification of Cancer Cells Using Non-Viral, Episomal S/MAR Vectors for In Vivo Tumour Modelling	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; HEPATOCELLULAR-CARCINOMA; MAMMALIAN REPLICON; PLASMID DNA; EXPRESSION; DELIVERY; METHYLATION; THERAPY; REPLICATION; ORIGIN	The development of genetically marked animal tumour xenografts is an area of ongoing research to enable easier and more reliable testing of cancer therapies. Genetically marked tumour models have a number of advantages over conventional tumour models, including the easy longitudinal monitoring of therapies and the reduced number of animals needed for trials. Several different methods have been used in previous studies to mark tumours genetically, however all have limitations, such as genotoxicity and other artifacts related to the usage of integrating viral vectors. Recently, we have generated an episomally maintained plasmid DNA (pDNA) expression system based on Scaffold/Matrix Attachment Region (S/MAR), which permits long-term luciferase transgene expression in the mouse liver. Here we describe a further usage of this pDNA vector with the human Ubiquitin C promoter to create stably transfected human hepatoma (Huh7) and human Pancreatic Carcinoma (MIA-PaCa2) cell lines, which were delivered into "immune deficient" mice and monitored longitudinally over time using a bioluminometer. Both cell lines revealed sustained episomal long-term luciferase expression and formation of a tumour showing the pathological characteristics of hepatocellular carcinoma (HCC) and pancreatic carcinoma (PaCa), respectively. This is the first demonstration that a pDNA vector can confer sustained episomal luciferase transgene expression in various mouse tumour models and can thus be readily utilised to follow tumour formation without interfering with the cellular genome.	[Argyros, Orestis; Wong, Suet Ping; Gowers, Kate; Harbottle, Richard Paul] Univ London Imperial Coll Sci Technol & Med, Gene Therapy Res Grp, Sect Mol Med, Natl Heart & Lung Inst, London, England	Imperial College London	Harbottle, RP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Gene Therapy Res Grp, Sect Mol Med, Natl Heart & Lung Inst, London, England.	r.harbottle@imperial.ac.uk		Harbottle, Richard/0000-0002-3332-8024	Myrovlytis Trust	Myrovlytis Trust	This research was funded by the Myrovlytis Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AboodyGuterman KS, 1997, NEUROREPORT, V8, P3801, DOI 10.1097/00001756-199712010-00029; Argyros O, 2008, GENE THER, V15, P1593, DOI 10.1038/gt.2008.113; Argyros O, 2011, EXPERT OPIN BIOL TH, V11, P1177, DOI 10.1517/14712598.2011.582035; Argyros O, 2011, J MOL MED, V89, P515, DOI 10.1007/s00109-010-0713-3; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Dikmen ZG, 2008, J CELL BIOCHEM, V104, P985, DOI 10.1002/jcb.21681; Dinca EB, 2007, J NEUROSURG, V107, P610, DOI 10.3171/JNS-07/09/0610; Edinger Matthias, 1999, Neoplasia (New York), V1, P303, DOI 10.1038/sj.neo.7900048; Herweijer H, 2001, J GENE MED, V3, P280, DOI 10.1002/jgm.178; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hong K, 2001, BIOMOL ENG, V18, P185, DOI 10.1016/S1389-0344(01)00100-9; Jackson DA, 2006, MOL THER, V14, P613, DOI 10.1016/j.ymthe.2006.03.026; Jenke ACW, 2004, P NATL ACAD SCI USA, V101, P11322, DOI 10.1073/pnas.0401355101; Jenke ACW, 2004, MOL BIOL REP, V31, P85, DOI 10.1023/B:MOLE.0000031363.35839.46; Jenke BHC, 2002, EMBO REP, V3, P349, DOI 10.1093/embo-reports/kvf070; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Kerbel RS, 1998, CANCER METAST REV, V17, P301, DOI 10.1023/A:1006152915959; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Lufino MMP, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm570; Papapetrou EP, 2006, GENE THER, V13, P40, DOI 10.1038/sj.gt.3302593; Piechaczek C, 1999, NUCLEIC ACIDS RES, V27, P426, DOI 10.1093/nar/27.2.426; Schaarschmidt D, 2004, EMBO J, V23, P191, DOI 10.1038/sj.emboj.7600029; Stehle IM, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-33; Stell A, 2007, INT J BIOCHEM CELL B, V39, P1288, DOI 10.1016/j.biocel.2007.02.019; Wang Y, 2007, BIOTECHNOL LETT, V29, P1665, DOI 10.1007/s10529-007-9452-0; Wetterwald A, 2002, AM J PATHOLOGY; Wilber A, 2005, HUM GENE THER, V16, P1325, DOI 10.1089/hum.2005.16.1325; Wong SP, 2011, GENE THER, V18, P82, DOI 10.1038/gt.2010.116; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206; Zeamari S, 2004, BRIT J CANCER, V90, P1259, DOI 10.1038/sj.bjc.6601637	31	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47920	10.1371/journal.pone.0047920	http://dx.doi.org/10.1371/journal.pone.0047920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110132	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500028
J	Tang, YY; George, A; Taylor, T; Hildreth, JEK				Tang, Yuyang; George, Alvin; Taylor, Thyneice; Hildreth, James E. K.			Cholesterol Depletion Inactivates XMRV and Leads to Viral Envelope Protein Release from Virions: Evidence for Role of Cholesterol in XMRV Infection	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; LIPID RAFTS; HIV PATHOGENESIS; PALMITOYLATION; TYPE-1; ENTRY; RETROVIRUS; GAG; MICRODOMAINS	Membrane cholesterol plays an important role in replication of HIV-1 and other retroviruses. Here, we report that the gammaretrovirus XMRV requires cholesterol and lipid rafts for infection and replication. We demonstrate that treatment of XMRV with a low concentration (10 mM) of 2-hydroxypropyl-beta-cyclodextrin (2OHp beta CD) partially depleted virion-associated cholesterol resulting in complete inactivation of the virus. This effect could not be reversed by adding cholesterol back to treated virions. Further analysis revealed that following cholesterol depletion, virus-associated Env protein was significantly reduced while the virions remained intact and retained core proteins. Increasing concentrations of 2OHpbCD (>= 20 mM) resulted in loss of the majority of virion-associated cholesterol, causing disruption of membrane integrity and loss of internal Gag proteins and viral RNA. Depletion of cholesterol from XMRV-infected cells significantly reduced virus release, suggesting that cholesterol and intact lipid rafts are required for the budding process of XMRV. These results suggest that unlike glycoproteins of other retroviruses, the association of XMRV glycoprotein with virions is highly dependent on cholesterol and lipid rafts.	[Tang, Yuyang; George, Alvin; Hildreth, James E. K.] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; [Taylor, Thyneice] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	University of California System; University of California Davis; Vanderbilt University	Hildreth, JEK (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA.	jekhildreth@ucdavis.edu	Taylor-Bowden, Thyneice/ABC-3891-2020; Tang, Yuyang/AAX-5681-2020		National Institutes of Health ARRA grant [P30 AI054999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999] Funding Source: NIH RePORTER	National Institutes of Health ARRA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an National Institutes of Health ARRA grant (supplement to P30 AI054999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Beer C, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-21; Beer C, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-36; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Cingoz O, 2012, J VIROL, V86, P328, DOI 10.1128/JVI.06022-11; Datta SAK, 2011, J VIROL, V85, P12733, DOI 10.1128/JVI.05889-11; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Grek Martyna, 2007, Postepy Biochem, V53, P334; Hadravova R, 2012, J VIROL, V86, P1297, DOI 10.1128/JVI.05564-11; HENSEL J, 1995, EUR J BIOCHEM, V232, P373, DOI 10.1111/j.1432-1033.1995.373zz.x; Karpas A, 2004, BIOL REV, V79, P911, DOI 10.1017/S1464793104006505; Li M, 2002, J VIROL, V76, P11845, DOI 10.1128/JVI.76.23.11845-11852.2002; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Lu XB, 2000, VIROLOGY, V276, P251, DOI 10.1006/viro.2000.0555; Menendez-Arias L, 2011, REV MED VIROL, V21, P3, DOI 10.1002/rmv.673; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nitta T, 2010, P NATL ACAD SCI USA, V107, P1190, DOI 10.1073/pnas.0908660107; Olsen KEP, 1999, J VIROL, V73, P8975, DOI 10.1128/JVI.73.11.8975-8981.1999; Ono A, 2005, ADV VIRUS RES, V64, P311, DOI 10.1016/S0065-3527(05)64010-9; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Pickl WF, 2001, J VIROL, V75, P7175, DOI 10.1128/JVI.75.15.7175-7183.2001; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Yang CL, 1996, VIROLOGY, V221, P87, DOI 10.1006/viro.1996.0355	37	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48013	10.1371/journal.pone.0048013	http://dx.doi.org/10.1371/journal.pone.0048013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110160	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500030
J	Borg, CMA; Bruno, E; Kiorboe, T				Borg, Christian Marc Andersen; Bruno, Eleonora; Kiorboe, Thomas			The Kinematics of Swimming and Relocation Jumps in Copepod Nauplii	PLOS ONE			English	Article							PLANKTONIC COPEPODS; BEHAVIOR; ESCAPE; MOTION; MICROZOOPLANKTON; SELECTIVITY; MECHANISMS; CIRRIPEDIA; LOCOMOTION; EFFICIENCY	Copepod nauplii move in a world dominated by viscosity. Their swimming-by-jumping propulsion mode, with alternating power and recovery strokes of three pairs of cephalic appendages, is fundamentally different from the way other microplankters move. Protozoans move using cilia or flagella, and copepodites are equipped with highly specialized swimming legs. In some species the nauplius may also propel itself more slowly through the water by beating and rotating the appendages in a different, more complex pattern. We use high-speed video to describe jumping and swimming in nauplii of three species of pelagic copepods: Temora longicornis, Oithona davisae and Acartia tonsa. The kinematics of jumping is similar between the three species. Jumps result in a very erratic translation with no phase of passive coasting and the nauplii move backwards during recovery strokes. This is due to poorly synchronized recovery strokes and a low beat frequency relative to the coasting time scale. For the same reason, the propulsion efficiency of the nauplii is low. Given the universality of the nauplius body plan, it is surprising that they seem to be inefficient when jumping, which is different from the very efficient larger copepodites. A slow-swimming mode is only displayed by T. longicornis. In this mode, beating of the appendages results in the creation of a strong feeding current that is about 10 times faster than the average translation speed of the nauplius. The nauplius is thus essentially hovering when feeding, which results in a higher feeding efficiency than that of a nauplius cruising through the water.	[Borg, Christian Marc Andersen; Bruno, Eleonora; Kiorboe, Thomas] Tech Univ Denmark, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark	Technical University of Denmark	Borg, CMA (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Ctr Ocean Life, Charlottenlund, Denmark.	manbo@aqua.dtu.dk	Kiørboe, Thomas/ABI-4733-2020	Kiørboe, Thomas/0000-0002-3265-336X	Swedish Research Council Formas; Danish Council for Independent Research; Villum Fonden [00007178] Funding Source: researchfish	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum Fonden(Villum Fonden)	This research was supported by the Swedish Research Council Formas through a postdoctoral grant to CMAB, and by a grant from the Danish Council for Independent Research to TK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJORNBERG T. K. S., 1986, SYLLOGEUS, V58, P51; Burdick DS, 2007, LIMNOL OCEANOGR, V52, P2373, DOI 10.4319/lo.2007.52.6.2373; BUSKEY EJ, 1993, B MAR SCI, V53, P29; Buskey EJ, 2002, MAR ECOL PROG SER, V235, P135, DOI 10.3354/meps235135; BUSKEY EJ, 1994, HYDROBIOLOGIA, V293, P447; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Christensen-Dalsgaard KK, 2003, AQUAT MICROB ECOL, V33, P77, DOI 10.3354/ame033077; Crenshaw HC, 1996, AM ZOOL, V36, P608; CRENSHAW HC, 1993, B MATH BIOL, V55, P197, DOI 10.1007/BF02460302; CRISP D. J., 1962, CRUSTACEANA, V3, P207, DOI 10.1163/156854062X00436; DODGE JD, 1987, BIOL DINOFLAGELLATES, P92; Dusenbery DB, 2009, LIVING MICROSCALE UN; FANTA E S, 1972, Crustaceana (Leiden), V23, P165, DOI 10.1163/156854072X00345; FENCHEL T, 1988, MAR ECOL PROG SER, V48, P1, DOI 10.3354/meps048001; Fenchel T., 1986, Progress in Protistology, V1, P65; Fenchel T, 2001, PROTIST, V152, P329, DOI 10.1078/1434-4610-00071; Fryer G., 1986, SYLLOGEUS, V58, P150; GAINES G, 1985, J PROTOZOOL, V32, P290; GAULD D. T., 1859, PROC ZOOL SOC LONDON, V132, P31; Gerritsen J., 1978, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V20, P2531; Goldstein S.F., 1992, P99; Guasto JS, 2012, ANNU REV FLUID MECH, V44, P373, DOI 10.1146/annurev-fluid-120710-101156; Guasto JS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168102; Hamel A, 2011, P NATL ACAD SCI USA, V108, P7290, DOI 10.1073/pnas.1016687108; Henriksen CI, 2007, MAR ECOL PROG SER, V331, P119, DOI 10.3354/meps331119; HO J, 1990, J CRUSTACEAN BIOL, V10, P528, DOI 10.2307/1548343; Ho SH, 1994, HYDROBIOLOGIA, V292/293, P32; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Huys R, 1991, COPEPOD EVOLUTION; HYAMS JS, 1978, J CELL SCI, V33, P235; Jiang HS, 2011, J R SOC INTERFACE, V8, P1090, DOI 10.1098/rsif.2010.0481; Jiang HS, 2011, J EXP BIOL, V214, P476, DOI 10.1242/jeb.049288; Jiang HS, 2004, MAR ECOL PROG SER, V278, P225, DOI 10.3354/meps278225; Jiang HS, 2002, J PLANKTON RES, V24, P191, DOI 10.1093/plankt/24.3.191; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Kiorboe T, 2011, J PLANKTON RES, V33, P677, DOI 10.1093/plankt/fbq159; Kiorboe T, 2010, P ROY SOC B-BIOL SCI, V277, P3229, DOI 10.1098/rspb.2010.0629; Kiorboe T, 2010, J R SOC INTERFACE, V7, P1591, DOI 10.1098/rsif.2010.0176; Kiorboe T, 2009, P NATL ACAD SCI USA, V106, P12394, DOI 10.1073/pnas.0903350106; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Lenz PH, 2004, J MARINE SYST, V49, P133, DOI 10.1016/j.jmarsys.2003.05.006; Lowndes A. G., 1935, P ZOOL SOC LOND, V3, P687, DOI [10.1111/j.1096-3642.1935.tb01688.x, DOI 10.1111/J.1096-3642.1935.TB01688.X]; MOYSE J, 1984, ZOOL J LINN SOC-LOND, V80, P323, DOI 10.1111/j.1096-3642.1984.tb01981.x; PAFFENHOFER GA, 1989, MAR ECOL PROG SER, V57, P129, DOI 10.3354/meps057129; Paffenhofer GA, 1996, J PLANKTON RES, V18, P1699, DOI 10.1093/plankt/18.9.1699; Ross PM, 2003, J CRUSTACEAN BIOL, V23, P328, DOI 10.1651/0278-0372(2003)023[0328:AKFTIO]2.0.CO;2; STORCH OTTO, 1928, ZOOL JAHRB ABT ALLGEM ZOOL U PHYSIOL, V45, P385; Strickler J.R., 1975, P599; Svetlichnyy L. S., 1987, Oceanology, V27, P497; Titelman J, 2003, MAR ECOL PROG SER, V247, P123, DOI 10.3354/meps247123; Titelman J, 2003, MAR ECOL PROG SER, V247, P137, DOI 10.3354/meps247137; Titelman J, 2001, MAR ECOL PROG SER, V213, P203, DOI 10.3354/meps213203; van Duren LA, 2003, J EXP BIOL, V206, P269, DOI 10.1242/jeb.00079; VANDUREN LA, 1995, MAR ECOL PROG SER, V126, P153, DOI 10.3354/meps126153; VLYMEN WJ, 1970, LIMNOL OCEANOGR, V15, P348, DOI 10.4319/lo.1970.15.3.0348; Walker G, 2004, J MAR BIOL ASSOC UK, V84, P737, DOI 10.1017/S002531540400983Xh; WILLIAMS TA, 1994, AM ZOOL, V34, P562	57	25	25	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47486	10.1371/journal.pone.0047486	http://dx.doi.org/10.1371/journal.pone.0047486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115647	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200042
J	He, CW; Qu, XY; Wan, JB; Rong, R; Huang, LL; Cai, C; Zhou, KY; Gu, Y; Qian, SY; Kang, JX				He, Chengwei; Qu, Xiying; Wan, Jianbo; Rong, Rong; Huang, Lili; Cai, Chun; Zhou, Keyuan; Gu, Yan; Qian, Steven Y.; Kang, Jing X.			Inhibiting Delta-6 Desaturase Activity Suppresses Tumor Growth in Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; PROSTATE-CANCER; TRANSGENIC MICE; CHRONIC DISEASES; LIPID MEDIATORS; GENE-EXPRESSION; FAT-1 MICE; IN-VIVO; ANGIOGENESIS; ACTIVATION	Recent studies have shown that a tumor-supportive microenvironment is characterized by high levels of pro-inflammatory and pro-angiogenic eicosanoids derived from omega-6 (n-6) arachidonic acid (AA). Although the metabolic pathways (COX, LOX, and P450) that generate these n-6 AA eicosanoids have been targeted, the role of endogenous AA production in tumorigenesis remains unexplored. Delta-6 desaturase (D6D) is the rate-limiting enzyme responsible for the synthesis of n-6 AA and increased D6D activity can lead to enhanced n-6 AA production. Here, we show that D6D activity is upregulated during melanoma and lung tumor growth and that suppressing D6D activity, either by RNAi knockdown or a specific D6D inhibitor, dramatically reduces tumor growth. Accordingly, the content of AA and AA-derived tumor-promoting metabolites is significantly decreased. Angiogenesis and inflammatory status are also reduced. These results identify D6D as a key factor for tumor growth and as a potential target for cancer therapy and prevention.	[He, Chengwei; Qu, Xiying; Wan, Jianbo; Rong, Rong; Huang, Lili; Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Lab Lipid Med & Technol, Boston, MA 02114 USA; [He, Chengwei; Qu, Xiying; Wan, Jianbo; Rong, Rong; Huang, Lili; Kang, Jing X.] Harvard Univ, Sch Med, Boston, MA USA; [Cai, Chun; Zhou, Keyuan; Kang, Jing X.] Guangdong Med Coll, Lab Genet Nutr & Hlth, Zhanjiang, Guangdong, Peoples R China; [Gu, Yan; Qian, Steven Y.] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA; [He, Chengwei] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med UM, Taipa, Macao Sar, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Guangdong Medical University; North Dakota State University Fargo; University of Macau	Kang, JX (corresponding author), Massachusetts Gen Hosp, Dept Med, Lab Lipid Med & Technol, Boston, MA 02114 USA.	jxkang@partners.org	Wan, Jian-Bo/D-8368-2014	Wan, Jian-Bo/0000-0002-6750-2617; He, Chengwei/0000-0003-4701-2984	National Institutes of Health [CA113605]; NATIONAL CANCER INSTITUTE [R01CA113605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant CA113605 to JXK. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT MED, V17, P231, DOI 10.1038/nm0311-231; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Cheranov SY, 2009, BLOOD, V113, P6023, DOI 10.1182/blood-2008-10-183210; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Gravitz L, 2011, NATURE, V471, pS5, DOI 10.1038/471S5a; Griffitts J, 2010, BBA-MOL CELL BIOL L, V1801, P1133, DOI 10.1016/j.bbalip.2010.06.008; Hansen-Petrik MB, 2002, CANCER LETT, V175, P157, DOI 10.1016/S0304-3835(01)00715-7; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Ito Y, 1996, INT J CANCER, V67, P148, DOI 10.1002/(SICI)1097-0215(19960703)67:1<148::AID-IJC24>3.3.CO;2-6; Jain S, 2008, CANCER RES, V68, P7750, DOI 10.1158/0008-5472.CAN-07-6689; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; Kang JX, 2011, WORLD REV NUTR DIET, V102, P22, DOI 10.1159/000327787; Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kundumani-Sridharan V, 2010, BLOOD, V115, P2105, DOI 10.1182/blood-2009-09-241802; LEAF A, 1987, AM J CLIN NUTR, V45, P1048, DOI 10.1093/ajcn/45.5.1048; Lim K, 2009, MOL CANCER THER, V8, P3046, DOI 10.1158/1535-7163.MCT-09-0551; Lu Y, 2008, MOL CANCER THER, V7, P3203, DOI 10.1158/1535-7163.MCT-08-0494; Mazhar D, 2006, BRIT J CANCER, V94, P346, DOI 10.1038/sj.bjc.6602942; Nakamura MT, 2003, PROSTAG LEUKOTR ESS, V68, P145, DOI 10.1016/S0952-3278(02)00264-8; Nie DT, 2006, J BIOL CHEM, V281, P18601, DOI 10.1074/jbc.M601887200; Noonan DM, 2008, CANCER METAST REV, V27, P31, DOI 10.1007/s10555-007-9108-5; Nowak J, 2007, CARCINOGENESIS, V28, P1991, DOI 10.1093/carcin/bgm166; Obukowicz MG, 1998, J PHARMACOL EXP THER, V287, P157; Polyak K, 2011, NAT MED, V17, P283, DOI 10.1038/nm0311-283; Prensner JR, 2011, NAT MED, V17, P291, DOI 10.1038/nm0311-291; Ruegg C, 2006, J LEUKOCYTE BIOL, V80, P682, DOI 10.1189/jlb.0606394; Sala A, 1999, J BIOL CHEM, V274, P28264, DOI 10.1074/jbc.274.40.28264; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Spencer L, 2009, EUR J CANCER, V45, P2077, DOI 10.1016/j.ejca.2009.04.026; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Swinnen JV, 2000, ONCOGENE, V19, P5173, DOI 10.1038/sj.onc.1203889; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Weylandt KH, 2011, CARCINOGENESIS, V32, P897, DOI 10.1093/carcin/bgr049; Weylandt KH, 2005, LANCET, V366, P618, DOI 10.1016/S0140-6736(05)67119-X; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Zhang BL, 2005, CANCER RES, V65, P7283, DOI 10.1158/0008-5472.CAN-05-0633; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	48	42	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47567	10.1371/journal.pone.0047567	http://dx.doi.org/10.1371/journal.pone.0047567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112819	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200052
J	Hegde, GV; de la Cruz, C; Eastham-Anderson, J; Zheng, YY; Sweet-Cordero, EA; Jackson, EL				Hegde, Ganapati V.; de la Cruz, Cecile; Eastham-Anderson, Jeffrey; Zheng, Yanyan; Sweet-Cordero, E. Alejandro; Jackson, Erica L.			Residual Tumor Cells That Drive Disease Relapse after Chemotherapy Do Not Have Enhanced Tumor Initiating Capacity	PLOS ONE			English	Article							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; LUNG-CANCER; IDENTIFICATION; RESISTANCE; CD133; SENSITIVITY; PROGRESSION; EXPRESSION; INDUCTION	Although chemotherapy is used to treat most advanced solid tumors, recurrent disease is still the major cause of cancer-related mortality. Cancer stem cells (CSCs) have been the focus of intense research in recent years because they provide a possible explanation for disease relapse. However, the precise role of CSCs in recurrent disease remains poorly understood and surprisingly little attention has been focused on studying the cells responsible for re-initiating tumor growth within the original host after chemotherapy treatment. We utilized both xenograft and genetically engineered mouse models of non-small cell lung cancer (NSCLC) to characterize the residual tumor cells that survive chemotherapy treatment and go on to cause tumor regrowth, which we refer to as tumor re-initiating cells (TRICs). We set out to determine whether TRICs display characteristics of CSCs, and whether assays used to define CSCs also provide an accurate readout of a cell's ability to cause tumor recurrence. We did not find consistent enrichment of CSC marker positive cells or enhanced tumor initiating potential in TRICs. However, TRICs from all models do appear to be in EMT, a state that has been linked to chemoresistance in numerous types of cancer. Thus, the standard CSC assays may not accurately reflect a cell's ability to drive disease recurrence.	[Hegde, Ganapati V.; de la Cruz, Cecile; Jackson, Erica L.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA USA; [Eastham-Anderson, Jeffrey] Genentech Inc, Dept Pathol, San Francisco, CA USA; [Zheng, Yanyan; Sweet-Cordero, E. Alejandro] Stanford Univ, Dept Pediat, Sch Med, Canc Biol Program, Stanford, CA 94305 USA	Roche Holding; Genentech; Roche Holding; Genentech; Stanford University	Jackson, EL (corresponding author), Genentech Inc, Dept Discovery Oncol, San Francisco, CA USA.	ericaj@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	Genentech, Inc. funded this research. The study was funded by Genentech, Inc. through the employment (at the time of the study) of Ganapati V. Hegde, Cecile de la Cruz, Jeffrey Eastham-Anderson and Erica L. Jackson. These authors contributed to all aspects of the study.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Argast GM, 2011, CLIN EXP METASTAS, V28, P593, DOI 10.1007/s10585-011-9394-8; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Costello RT, 2000, CANCER RES, V60, P4403; Cui F, 2011, ONCOL REP, V25, P701, DOI 10.3892/or.2010.1115; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Harvey I, 2005, LUNG CANC PRINCIPLES; Howlader N NA, 2011, SEER CANC STAT REV; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janikova M, 2010, BIOMED PAP, V154, P321, DOI 10.5507/bp.2010.048; Kajiyama H, 2007, INT J ONCOL, V31, P277; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li SG, 2007, J CELL MOL MED, V11, P1251, DOI 10.1111/j.1582-4934.2007.00108.x; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Pietras A, 2011, ADV CANCER RES, V112, P255, DOI 10.1016/B978-0-12-387688-1.00009-0; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Singh SK, 2003, CANCER RES, V63, P5821; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Wang D, 2004, ONCOGENE, V23, P1668, DOI 10.1038/sj.onc.1207282; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wiwanitkit V, 2010, EUR J CARDIO-THORAC, V37, P988, DOI 10.1016/j.ejcts.2009.10.027; Yan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024397; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Zhang HJ, 2011, MOL CELL BIOCHEM, V355, P309, DOI 10.1007/s11010-011-0869-3	43	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e45647	10.1371/journal.pone.0045647	http://dx.doi.org/10.1371/journal.pone.0045647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115623	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200010
J	Hester, SE; Lui, MH; Nicholson, T; Nowacki, D; Harvill, ET				Hester, Sara E.; Lui, Minghsun; Nicholson, Tracy; Nowacki, Daryl; Harvill, Eric T.			Identification of a CO2 Responsive Regulon in Bordetella	PLOS ONE			English	Article							ADENYLATE-CYCLASE TOXIN; BVG-INTERMEDIATE PHASE; VIRULENCE GENE-EXPRESSION; III SECRETION SYSTEM; TRANSCRIPTIONAL CONTROL; TRACHEAL COLONIZATION; SIGNAL-TRANSDUCTION; RNA-POLYMERASE; PERTUSSIS; BRONCHISEPTICA	Sensing the environment allows pathogenic bacteria to coordinately regulate gene expression to maximize survival within or outside of a host. Here we show that Bordetella species regulate virulence factor expression in response to carbon dioxide levels that mimic in vivo conditions within the respiratory tract. We found strains of Bordetella bronchiseptica that did not produce adenylate cyclase toxin (ACT) when grown in liquid or solid media with ambient air aeration, but produced ACT and additional antigens when grown in air supplemented to 5% CO2. Transcriptome analysis and quantitative real time-PCR analysis revealed that strain 761, as well as strain RB50, increased transcription of genes encoding ACT, filamentous hemagglutinin (FHA), pertactin, fimbriae and the type III secretion system in 5% CO2 conditions, relative to ambient air. Furthermore, transcription of cyaA and fhaB in response to 5% CO2 was increased even in the absence of BvgS. In vitro analysis also revealed increases in cytotoxicity and adherence when strains were grown in 5% CO2. The human pathogens B. pertussis and B. parapertussis also increased transcription of several virulence factors when grown in 5% CO2, indicating that this response is conserved among the classical bordetellae. Together, our data indicate that Bordetella species can sense and respond to physiologically relevant changes in CO2 concentrations by regulating virulence factors important for colonization, persistence and evasion of the host immune response.	[Hester, Sara E.; Nowacki, Daryl; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Hester, Sara E.; Nowacki, Daryl] Penn State Univ, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA; [Lui, Minghsun] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Nicholson, Tracy] USDA, Natl Anim Dis Ctr, ARS, Ames, IA 50010 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Agriculture (USDA)	Harvill, ET (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	harvill@psu.edu		Harvill, Eric/0000-0001-8893-2133	National Institutes of Health grant [GM083113]; Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2010-65110-20488]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083113] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM083113 (to ETH) and by the Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2010-65110-20488 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUCHER PE, 1995, J BACTERIOL, V177, P6486, DOI 10.1128/jb.177.22.6486-6491.1995; Boucher PE, 2003, MOL CELL, V11, P163, DOI 10.1016/S1097-2765(03)00007-8; Buboltz AM, 2008, J BACTERIOL, V190, P5502, DOI 10.1128/JB.00226-08; Buboltz AM, 2009, INFECT IMMUN, V77, P3969, DOI 10.1128/IAI.01362-08; Buboltz AM, 2009, INFECT IMMUN, V77, P3249, DOI 10.1128/IAI.01448-08; CAPARON MG, 1992, J BACTERIOL, V174, P5693, DOI 10.1128/JB.174.17.5693-5701.1992; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Cotter PA, 1998, INFECT IMMUN, V66, P5921, DOI 10.1128/IAI.66.12.5921-5929.1998; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Fouet A, 1996, INFECT IMMUN, V64, P4928, DOI 10.1128/IAI.64.12.4928-4932.1996; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Harvill ET, 1999, INFECT IMMUN, V67, P6109, DOI 10.1128/IAI.67.11.6109-6118.1999; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; Heininger U, 2002, INFECT IMMUN, V70, P3777, DOI 10.1128/IAI.70.7.3777-3784.2002; HEININGER U, 1994, PEDIATR INFECT DIS J, V13, P306, DOI 10.1097/00006454-199404000-00011; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Karimova G, 1996, MOL MICROBIOL, V20, P489, DOI 10.1046/j.1365-2958.1996.5231057.x; KHELEF N, 1992, MICROB PATHOGENESIS, V12, P227, DOI 10.1016/0882-4010(92)90057-U; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mann P, 2007, INFECT IMMUN, V75, P3665, DOI 10.1128/IAI.01648-06; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mattoo S, 2000, INFECT IMMUN, V68, P2024, DOI 10.1128/IAI.68.4.2024-2033.2000; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Merkel TJ, 1998, J BACTERIOL, V180, P1682, DOI 10.1128/JB.180.7.1682-1690.1998; Merkel TJ, 2003, J BACTERIOL, V185, P6902, DOI 10.1128/JB.185.23.6902-6912.2003; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Nicholson TL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-220; Nicholson TL, 2009, INFECT IMMUN, V77, P4221, DOI 10.1128/IAI.00136-09; OKADA N, 1993, MOL MICROBIOL, V7, P893, DOI 10.1111/j.1365-2958.1993.tb01180.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIRARD JC, 1994, J BACTERIOL, V176, P5188, DOI 10.1128/jb.176.16.5188-5192.1994; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Staveley CM, 2003, J VET DIAGN INVEST, V15, P570, DOI 10.1177/104063870301500610; Steffen P, 1996, EMBO J, V15, P102, DOI 10.1002/j.1460-2075.1996.tb00338.x; Sterne M, 1937, J VET SCI ANIM IND, V8, P271; STIBITZ S, 1991, J BACTERIOL, V173, P4288, DOI 10.1128/JB.173.14.4288-4296.1991; Stockbauer KE, 2001, MOL MICROBIOL, V39, P65, DOI 10.1046/j.1365-2958.2001.02191.x; Torres VJ, 2007, CELL HOST MICROBE, V1, P109, DOI 10.1016/j.chom.2007.03.001; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; Vergara-Irigaray N, 2005, INFECT IMMUN, V73, P748, DOI 10.1128/IAI.73.2.748-760.2005; Weingart CL, 2000, INFECT IMMUN, V68, P1735, DOI 10.1128/IAI.68.3.1735-1739.2000; WEISS AA, 1989, INFECT IMMUN, V57, P3757, DOI 10.1128/IAI.57.12.3757-3764.1989; Williams CL, 2005, MOL MICROBIOL, V56, P175, DOI 10.1111/j.1365-2958.2004.04526.x; Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x	54	18	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47635	10.1371/journal.pone.0047635	http://dx.doi.org/10.1371/journal.pone.0047635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112828	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200061
J	Li, CQ; Shang, DS; Wang, Y; Li, J; Han, JW; Wang, SY; Yao, QL; Wang, YY; Zhang, YP; Zhang, CL; Xu, YJ; Jiang, W; Li, X				Li, Chunquan; Shang, Desi; Wang, Yan; Li, Jing; Han, Junwei; Wang, Shuyuan; Yao, Qianlan; Wang, Yingying; Zhang, Yunpeng; Zhang, Chunlong; Xu, Yanjun; Jiang, Wei; Li, Xia			Characterizing the Network of Drugs and Their Affected Metabolic Subpathways	PLOS ONE			English	Article							FOLATE METABOLISM; CLINDAMYCIN; BIOLOGY; TARGET; GENES; PHARMACOGENETICS; IDENTIFICATION; TRYPTOPHAN; DISCOVERY; ETODOLAC	A fundamental issue in biology and medicine is illustration of the overall drug impact which is always the consequence of changes in local regions of metabolic pathways (subpathways). To gain insights into the global relationship between drugs and their affected metabolic subpathways, we constructed a drug-metabolic subpathway network (DRSN). This network included 3925 significant drug-metabolic subpathway associations representing drug dual effects. Through analyses based on network biology, we found that if drugs were linked to the same subpathways in the DRSN, they tended to share the same indications and side effects. Furthermore, if drugs shared more subpathways, they tended to share more side effects. We then calculated the association score by integrating drug-affected subpathways and disease-related subpathways to quantify the extent of the associations between each drug class and disease class. The results showed some close drugdisease associations such as sex hormone drugs and cancer suggesting drug dual effects. Surprisingly, most drugs displayed close associations with their side effects rather than their indications. To further investigate the mechanism of drug dual effects, we classified all the subpathways in the DRSN into therapeutic and non-therapeutic subpathways representing drug therapeutic effects and side effects. Compared to drug side effects, the therapeutic effects tended to work through tissuespecific genes and these genes tend to be expressed in the adrenal gland, liver and kidney; while drug side effects always occurred in the liver, bone marrow and trachea. Taken together, the DRSN could provide great insights into understanding the global relationship between drugs and metabolic subpathways.	[Li, Chunquan; Shang, Desi; Wang, Yan; Li, Jing; Han, Junwei; Wang, Shuyuan; Yao, Qianlan; Wang, Yingying; Zhang, Yunpeng; Zhang, Chunlong; Xu, Yanjun; Jiang, Wei; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	lixia@hrbmu.edu.cn	Li, Chunquan/AAI-1072-2020; li, xia/HHZ-7468-2022; Wang, Yingying/ABF-4496-2021; shang, desi/GOJ-9200-2022; Han, Junwei/T-9849-2018	Li, Chunquan/0000-0002-4700-5496; Han, Junwei/0000-0002-3276-0819; qianlan, yao/0000-0003-0737-4147	National Natural Science Foundation of China grant [61170154, 61073136]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307120027, 20102307110022]	National Natural Science Foundation of China grant(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported in part by the National Natural Science Foundation of China grant nos. 61170154 and 61073136) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (grant nos. 20102307120027 and 20102307110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam G, 2002, BIPOLAR DISORD, V4, P15, DOI 10.1034/j.1399-5618.4.s1.2.x; ANTUNES LM, 2011, ANTIMICROB AGENTS CH; Aygun C, 2007, WORLD J GASTROENTERO, V13, P5408, DOI 10.3748/wjg.v13.i40.5408; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BENGTSSON U, 1975, ACTA MED SCAND, V198, P223; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Braun P, 2008, P NATL ACAD SCI USA, V105, P9849, DOI 10.1073/pnas.0805644105; Burkard TR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001001; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chen CT, 2008, PROSTAG LEUKOTR ESS, V79, P85, DOI 10.1016/j.plefa.2008.09.003; Chen XJ, 2011, BIOINFORMATICS, V27, P649, DOI 10.1093/bioinformatics/btq714; Coersmeier C, 1986, Agents Actions Suppl, V19, P137; Cuppoletti J, 2000, CLIN EXP PHARMACOL P, V27, P896, DOI 10.1046/j.1440-1681.2000.03357.x; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; de Groot MCH, 2007, BRIT J CLIN PHARMACO, V64, P542, DOI 10.1111/j.1365-2125.2007.02908.x; Dong ZG, 1999, ANTICANCER RES, V19, P3743; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Ervens J, 2004, J CRANIO MAXILL SURG, V32, P330, DOI 10.1016/j.jcms.2004.05.007; Extier A, 2009, NEUROCHEM INT, V55, P295, DOI 10.1016/j.neuint.2009.03.009; Fliri AF, 2005, NAT CHEM BIOL, V1, P389, DOI 10.1038/nchembio747; Fliri AF, 2007, CHEMMEDCHEM, V2, P1774, DOI 10.1002/cmdc.200700153; Folkerd EJ, 2010, J CLIN ONCOL, V28, P4038, DOI 10.1200/JCO.2009.27.4290; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guarner PT, 2011, CURR TOP MED CHEM; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hardisty JF, 2005, TOXICOL PATHOL, V33, P35, DOI 10.1080/01926230590522077; Hatzimanikatis V, 2004, CURR OPIN STRUC BIOL, V14, P300, DOI 10.1016/j.sbi.2004.04.004; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2009, NATURE, V462, P167, DOI 10.1038/462167a; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Hugues FC, 2000, ANN MED INTERNE, V151, P10; INOUE K, 1994, PROSTAG LEUKOTR ESS, V51, P451, DOI 10.1016/0952-3278(94)90064-7; Kamaraj S, 2010, EUR J PHARMACOL, V649, P320, DOI 10.1016/j.ejphar.2010.09.017; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Khan MM, 2003, J NEUROCHEM, V86, P1089, DOI 10.1046/j.1471-4159.2003.01866.x; Kim P, 2002, CLIN EXP OPHTHALMOL, V30, P147, DOI 10.1046/j.1442-6404.2002.00502.x; Krejsa CM, 2003, CURR OPIN DRUG DISC, V6, P470; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee SI, 2008, J ANESTH, V22, P385, DOI 10.1007/s00540-008-0646-y; Lehavi A, 2011, MINERVA ANESTESIOL; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li X, 2012, BRIEF BIOINFORM, V13, P175, DOI 10.1093/bib/bbr043; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021131; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Lowe JA, 2010, CURR OPIN DRUG DISC, V13, P524; Miller AL, 2005, ALTERN MED REV, V10, P5; Nacher Jose C., 2008, BMC Pharmacology, V8, P5, DOI 10.1186/1471-2210-8-5; Nacher JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030028; Oprea TI, 2011, MOL INFORM, V30, P100, DOI 10.1002/minf.201100023; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Qiao WJ, 2011, ASIAN PAC J CANCER P, V12, P99; Ren YP, 2011, J CLIN LAB ANAL, V25, P246, DOI 10.1002/jcla.20467; Robien K, 2005, PHARMACOGENOMICS, V6, P673, DOI 10.2217/14622416.6.7.673; Rossi, 2006, AUSTR MED HDB; Russo S, 2003, PSYCHOSOM MED, V65, P665, DOI 10.1097/01.PSY.0000078188.74020.CC; Sanchez-Mejia RO, 2010, BBA-MOL CELL BIOL L, V1801, P784, DOI 10.1016/j.bbalip.2010.05.013; Sauer K, 2010, NAT REV IMMUNOL, V10, P257, DOI 10.1038/nri2745; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; Shigeta K, 2002, BIOSCI BIOTECH BIOCH, V66, P2491, DOI 10.1271/bbb.66.2491; Sridhar Padmavati, 2008, Pac Symp Biocomput, P291; Sudheer Kumar M, 2004, Indian J Exp Biol, V42, P179; Swiader MJ, 2005, PHARMACOL REP, V57, P531; SZABO S, 1989, TOXICOL PATHOL, V17, P317, DOI 10.1177/019262338901700208; Takarabe Masataka, 2008, Genome Inform, V20, P252; Tamada Yoshinori, 2005, Genome Inform, V16, P182; Tas C, 2007, DRUG DELIV, V14, P453, DOI 10.1080/10717540701603746; Ulrich CM, 2002, PHARMACOGENOMICS, V3, P299, DOI 10.1517/14622416.3.3.299; Wacker MJ, 2009, J PHARMACOL EXP THER, V331, P917, DOI 10.1124/jpet.109.157677; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yao LX, 2008, GENOME RES, V18, P206, DOI 10.1101/gr.6888208; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yuthavong Y, 2006, FUTURE MICROBIOL, V1, P113, DOI 10.2217/17460913.1.1.113	81	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47326	10.1371/journal.pone.0047326	http://dx.doi.org/10.1371/journal.pone.0047326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112813	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200035
J	Trigilio, J; Antoine, TE; Paulowicz, I; Mishra, YK; Adelung, R; Shukla, D				Trigilio, James; Antoine, Thessicar E.; Paulowicz, Ingo; Mishra, Yogendra K.; Adelung, Rainer; Shukla, Deepak			Tin Oxide Nanowires Suppress Herpes Simplex Virus-1 Entry and Cell-to-Cell Membrane Fusion	PLOS ONE			English	Article							3-O-SULFATED HEPARAN-SULFATE; TYPE-1; NANOPARTICLES; PERFORMANCE; INHIBITION; INFECTION; SPREAD	The advent of nanotechnology has ushered in the use of modified nanoparticles as potential antiviral agents against diseases such as herpes simplex virus 1 and 2 (HSV-1) (HSV-2), human immunodeficiency virus (HIV), monkeypox virus, and hepatitis B virus. Here we describe the application of tin oxide (SnO2) nanowires as an effective treatment against HSV-1 infection. SnO2 nanowires work as a carrier of negatively charged structures that compete with HSV-1 attachment to cell bound heparan sulfate (HS), therefore inhibiting entry and subsequent cell-to-cell spread. This promising new approach can be developed into a novel form of broad-spectrum antiviral therapy especially since HS has been shown to serve as a cellular co-receptor for a number of other viruses as well, including the respiratory syncytial virus, adeno-associated virus type 2, and human papilloma virus.	[Trigilio, James; Antoine, Thessicar E.; Shukla, Deepak] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA; [Antoine, Thessicar E.; Shukla, Deepak] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Paulowicz, Ingo; Mishra, Yogendra K.; Adelung, Rainer] Univ Kiel, Dept Engn, Inst Mat Sci, Kiel, Germany	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Kiel	Shukla, D (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	dshukla@uic.edu	Mishra, Yogendra Kumar/G-6241-2010; Adelung, Rainer/AAU-1027-2021	Mishra, Yogendra Kumar/0000-0002-8786-9379; Adelung, Rainer/0000-0002-2617-678X; Shukla, Deepak/0000-0002-3039-6953	National Institutes of Health [RO1 AI057860, AI081869]; AvH foundation; DFG [SFB-855 A5]; Heisenberg Professorship; inflammation at interfaces cluster; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057860, K02AI081869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AvH foundation(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG)); Heisenberg Professorship(German Research Foundation (DFG)); inflammation at interfaces cluster; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants RO1 AI057860 and AI081869 to D. Shukla. YKM acknowledges a grant from AvH foundation, RA gratefully acknowledges the funds from DFG from SFB-855 A5, and a Heisenberg Professorship, and support from the inflammation at interfaces cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelung R., 2011, Germany Patent, Patent No. [DE 2011/000282, 2011000282, DE2011/000282]; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Baram-Pinto D, 2010, SMALL, V6, P1044, DOI 10.1002/smll.200902384; Baram-Pinto D, 2009, BIOCONJUGATE CHEM, V20, P1497, DOI 10.1021/bc900215b; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Cocchi F, 2000, J VIROL, V74, P3909, DOI 10.1128/JVI.74.8.3909-3917.2000; Desai P, 1998, J VIROL, V72, P7563, DOI 10.1128/JVI.72.9.7563-7568.1998; Gurlo A, 2011, NANOSCALE, V3, P154, DOI 10.1039/c0nr00560f; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Karasneh GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-481; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Novak N, 2005, CLIN EXP IMMUNOL, V142, P405, DOI 10.1111/j.1365-2249.2005.02927.x; O'Donnell CD, 2009, J BIOL CHEM, V284, P29654, DOI 10.1074/jbc.M109.037960; Roller RJ, 1997, J VIROL, V71, P5805, DOI 10.1128/JVI.71.8.5805-5813.1997; Salameh Sarah, 2012, Open Virol J, V6, P1, DOI 10.2174/1874357901206010001; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Tiwari V, 2005, J VIROL, V79, P13173, DOI 10.1128/JVI.79.20.13173-13179.2005; Tiwari V, 2004, J GEN VIROL, V85, P805, DOI 10.1099/vir.0.19641-0; Tiwari V, 2012, GLYCOBIOLOGY; Tiwari V, 2009, BIOCHEM BIOPH RES CO, V390, P382, DOI 10.1016/j.bbrc.2009.08.174; van Lint AL, 2007, VIROLOGY, V368, P227, DOI 10.1016/j.virol.2007.08.030; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Zhe R, 2008, ARCH VIROL, V153, P1401, DOI 10.1007/s00705-008-0110-1	25	34	34	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48147	10.1371/journal.pone.0048147	http://dx.doi.org/10.1371/journal.pone.0048147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110193	gold, Green Published			2022-12-25	WOS:000310310200152
J	Yue, Q; Liu, MQ; Nie, XJ; Wu, QZ; Li, J; Zhang, W; Huang, XQ; Gong, QY				Yue, Qiang; Liu, Mengqi; Nie, Xiaojing; Wu, Qizhu; Li, Jun; Zhang, Wei; Huang, Xiaoqi; Gong, Qiyong			Quantitative 3.0T MR Spectroscopy Reveals Decreased Creatine Concentration in the Dorsolateral Prefrontal Cortex of Patients with Social Anxiety Disorder	PLOS ONE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; METABOLITE RELAXATION-TIMES; CEREBRAL-BLOOD-FLOW; HUMAN BRAIN; TISSUE WATER; AMYGDALA; PHOBIA; GLUTAMATE; SPECTRA; TESLA	Background: The brain biochemical changes of social anxiety have not been clarified although there have been a limited number of MR spectroscopic studies which utilized metabolite/creatine ratios. Present study aimed to explore the alteration of absolute metabolite concentration in social anxiety disorder using quantitative MR spectroscopy. Materials and Methods: With a 3.0T MR scanner, single voxel MR spectroscopy (stimulated echo acquisition mode, TR/TE/TM = 2000/20/16 ms) was performed in the left dorsolateral prefrontal cortex and related regions of nine medication-free patients with social anxiety disorder and nine controls. Absolute metabolite concentration was calculated using tissue water as the internal reference and corrected for the partial volume of cerebrospinal fluid. Results: In the left dorsolateral prefrontal cortex, the N-acetyl aspartate/creatine ratio of patients was significantly higher than that of controls, and this was due to the decrease of creatine concentration instead of the increase of N-acetyl aspartate concentration. Furthermore, the creatine concentration of the left dorsolateral prefrontal cortex was negatively correlated with the scores of Liebowitz social anxiety scale. Conclusions: The alteration of creatine level in the left dorsolateral prefrontal cortex suggests abnormal energy metabolism and correlates with symptom severity in social anxiety disorder. And metabolite concentration is preferable to metabolite/creatine ratio for the investigation of individual, absolute metabolite changes in this region of social anxiety disorder.	[Nie, Xiaojing; Zhang, Wei] Sichuan Univ, W China Hosp, Dept Psychiat, Chengdu 610064, Peoples R China; [Yue, Qiang; Liu, Mengqi; Wu, Qizhu; Huang, Xiaoqi; Gong, Qiyong] Sichuan Univ, W China Hosp, Dept Radiol, HMRRC, Chengdu 610064, Peoples R China; [Li, Jun] Sichuan Univ, W China Hosp, Dept Geriatr, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Zhang, W (corresponding author), Sichuan Univ, W China Hosp, Dept Psychiat, Chengdu 610064, Peoples R China.	weizhang27@163.com; qiyonggong@hmrrc.org.cn	Gong, Qiyong/W-3052-2019; Huang, Xiaoqi/O-7904-2017	Gong, Qiyong/0000-0002-5912-4871; Huang, Xiaoqi/0000-0001-8686-5010; Liu, Mengqi/0000-0003-3768-2562	CMB Distinguished Professorship Award [F510000/G16916411]; National Natural Science Foundation [81030027, 30900363, 81227002, 81220108013]; National Key Technologies R&D Program of China [2012BAI01B03]	CMB Distinguished Professorship Award; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program)	Dr. Qiyong Gong acknowledges the support from his CMB Distinguished Professorship Award (Award No. F510000/G16916411) administered by the Institute of International Education, USA. The authors would also like to thank Ms Hehan Tang and Mr Chunchao Xia for their assistances in data acquisition.; This study was supported by the National Natural Science Foundation (Grant Nos. 81030027, 30900363, 81227002, 81220108013) and National Key Technologies R&D Program of China (Program No. 2012BAI01B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGER JR, 1990, RADIOLOGY, V177, P633, DOI 10.1148/radiology.177.3.2243962; Amir N, 2005, BIOL PSYCHIAT, V57, P975, DOI 10.1016/j.biopsych.2005.01.044; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; BARKER PB, 1993, NMR BIOMED, V6, P89, DOI 10.1002/nbm.1940060114; Brewer GJ, 2000, J NEUROCHEM, V74, P1968, DOI 10.1046/j.1471-4159.2000.0741968.x; Brooks JCW, 2001, CEREB CORTEX, V11, P598, DOI 10.1093/cercor/11.7.598; Caetano SC, 2005, NEUROSCI LETT, V384, P321, DOI 10.1016/j.neulet.2005.04.099; Castillo M, 1996, AM J NEURORADIOL, V17, P1; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P107, DOI 10.1016/0730-725X(93)90418-D; CHRISTIANSEN P, 1994, MAGN RESON IMAGING, V12, P1237, DOI 10.1016/0730-725X(94)90088-9; Coplan JD, 2006, PSYCHIAT RES-NEUROIM, V147, P27, DOI 10.1016/j.pscychresns.2005.12.011; DAVIDSON JRT, 1993, J CLIN PSYCHIAT, V54, P19; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Frey BN, 2007, BIPOLAR DISORD, V9, P119, DOI 10.1111/j.1399-5618.2007.00454.x; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gemar MC, 2007, DEPRESS ANXIETY, V24, P597, DOI 10.1002/da.20242; Grachev ID, 2000, MOL PSYCHIATR, V5, P482, DOI 10.1038/sj.mp.4000778; Grams AE, 2011, ACAD RADIOL, V18, P584, DOI 10.1016/j.acra.2010.12.010; Grossman RI, 2012, NMR BIOMED; Guyer AE, 2008, ARCH GEN PSYCHIAT, V65, P1303, DOI 10.1001/archpsyc.65.11.1303; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Hazlett EA, 2012, BIOL PSYCHIAT; Helms G, 1999, MAGN RESON IMAGING, V17, P1211, DOI 10.1016/S0730-725X(99)00058-2; Hoerst M, 2010, BIOL PSYCHIAT, V67, P399, DOI 10.1016/j.biopsych.2009.09.030; Isobe T, 2002, MAGN RESON IMAGING, V20, P343, DOI 10.1016/S0730-725X(02)00500-3; Kanowski M, 2004, MAGNET RESON MED, V51, P904, DOI 10.1002/mrm.20063; Lee S, 2005, J AFFECT DISORDERS, V88, P183, DOI 10.1016/j.jad.2005.05.018; Li Y, 2008, J MAGN RESON IMAGING, V28, P342, DOI 10.1002/jmri.21453; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; Mader I, 2001, BRAIN, V124, P953, DOI 10.1093/brain/124.5.953; MINER CM, 1995, BIOL PSYCHIAT, V38, P696, DOI 10.1016/0006-3223(95)00287-1; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Nelson EE, 2007, BIPOLAR DISORD, V9, P810, DOI 10.1111/j.1399-5618.2007.00419.x; New AS, 2009, BIOL PSYCHIAT, V66, P1107, DOI 10.1016/j.biopsych.2009.07.015; Penet MF, 2011, CANCER RES, V71, P6948, DOI 10.1158/0008-5472.CAN-11-1095; Phan KL, 2005, NEUROREPORT, V16, P183, DOI 10.1097/00001756-200502080-00024; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Pollack MH, 2008, PROG NEURO-PSYCHOPH, V32, P739, DOI 10.1016/j.pnpbp.2007.11.023; Preedy VR, 2009, COMPREHENSIVE HANDBOOK OF IODINE: NUTRITIONAL, BIOCHEMICAL, PATHOLOGICAL AND THERAPEUTIC ASPECTS, P1; Schaller B, 2007, STATE OF THE ART IMA; Schubert F, 2004, NEUROIMAGE, V21, P1762, DOI 10.1016/j.neuroimage.2003.11.014; Tillfors M, 2002, BIOL PSYCHIAT, V52, P1113, DOI 10.1016/S0006-3223(02)01396-3; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; Tupler LA, 1997, BIOL PSYCHIAT, V42, P419, DOI 10.1016/S0006-3223(96)00501-X; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Xiao Rong, 2006, Sichuan Da Xue Xue Bao Yi Xue Ban, V37, P636; Yue QA, 2009, NEURORADIOLOGY, V51, P61, DOI 10.1007/s00234-008-0461-z	50	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e48105	10.1371/journal.pone.0048105	http://dx.doi.org/10.1371/journal.pone.0048105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110183	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600047
J	Bellini, A; Girard, PM; Lambert, S; Tessier, L; Sage, E; Francesconi, S				Bellini, Angela; Girard, Pierre-Marie; Lambert, Sarah; Tessier, Ludovic; Sage, Evelyne; Francesconi, Stefania			Stress Activated Protein Kinase Pathway Modulates Homologous Recombination in Fission Yeast	PLOS ONE			English	Article							ATF1 TRANSCRIPTION FACTOR; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; DNA-DAMAGE; ENVIRONMENTAL-STRESS; UVA RADIATION; TEMPLATE EXCHANGE; TOPOISOMERASE-I; GENETIC-CONTROL; SPC1 KINASE	Rad52 is a key player in homologous recombination (HR), a DNA repair pathway that is dedicated to double strand breaks repair and recovery of perturbed replication forks. Here we show that fission yeast Rad52 homologue is phosphorylated when S phase cells are exposed to ROS inducers such as ultraviolet A radiation or hydrogen peroxide, but not to ultraviolet C or camptothecin. Phosphorylation does not depend on kinases Chk1, Rad3, Tel1 or Cdc2, but depends on a functional stress activated protein kinase (SAPK) pathway and can be partially prevented by anti-oxidant treatment. Indeed, cells lacking Sty1, the major fission yeast MAP kinase of the SAPK pathway, do not display Rad52 phosphorylation and have UVA induced Rad52 foci that persist longer if compared to wild type cells. In addition, spontaneous intrachromosomal HR is diminished in cells lacking Sty1 and, more precisely, gene conversion is affected. Moreover, HR induced by site-specific arrest of replication forks is twice less efficient in cells that do not express Sty1. Importantly, impairing HR by deletion of the gene encoding the recombinase Rhp51 leads to Sty1 dependent Rad52 phosphorylation. Thus, SAPK pathway impinges on early step of HR through phosphorylation of Rad52 in cells challenged by oxidative stress or lacking Rhp51 and is required to promote spontaneous gene conversion and recovery from blocked replication forks.	[Bellini, Angela; Girard, Pierre-Marie; Lambert, Sarah; Tessier, Ludovic; Sage, Evelyne; Francesconi, Stefania] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Bellini, Angela; Girard, Pierre-Marie; Lambert, Sarah; Tessier, Ludovic; Sage, Evelyne; Francesconi, Stefania] Ctr Univ Orsay, CNRS UMR 3348, F-91405 Orsay, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Francesconi, S (corresponding author), Inst Curie, Ctr Rech, F-91405 Orsay, France.	stefania.francesconi@curie.fr	Francesconi, Stefania/J-7910-2016; lambert, sarah/K-7750-2017	girard, pierre-marie/0000-0001-9703-4407; francesconi, stefania/0000-0002-9665-349X; lambert, sarah/0000-0002-1403-3204	Centre National de la Recherche Scientifique; Curie Institute; Association pour la Recherche sur le Cancer	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Curie Institute; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by "Centre National de la Recherche Scientifique" and Curie Institute. A. Bellini was supported by PhD fellowships from Curie Institute and "Association pour la Recherche sur le Cancer". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autier P, 2011, CURR OPIN ONCOL, V23, P189, DOI 10.1097/CCO.0b013e3283436e5d; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Dardalhon D, 2008, CELL CYCLE, V7, P611, DOI 10.4161/cc.7.5.5400; Day AM, 2010, J BIOL CHEM, V285, P7505, DOI 10.1074/jbc.M109.040840; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Doe CL, 2004, NUCLEIC ACIDS RES, V32, P5570, DOI 10.1093/nar/gkh853; Dunand-Sauthier I, 2005, EUKARYOT CELL, V4, P1785, DOI 10.1128/EC.4.11.1785-1793.2005; Francesconi S, 2002, GENES CELLS, V7, P663, DOI 10.1046/j.1365-2443.2002.00552.x; Gao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005533; Gella A, 2009, CELL ADHES MIGR, V3, P88, DOI 10.4161/cam.3.1.7402; Girard PM, 2008, DNA REPAIR, V7, P1500, DOI 10.1016/j.dnarep.2008.05.004; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hartmuth S, 2009, J CELL SCI, V122, P1737, DOI 10.1242/jcs.049387; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; KAUFMANN WK, 1981, J MOL BIOL, V149, P171, DOI 10.1016/0022-2836(81)90297-7; Kozmin S, 2005, P NATL ACAD SCI USA, V102, P13538, DOI 10.1073/pnas.0504497102; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Krutmann J, 2000, J DERMATOL SCI, V23, pS22, DOI 10.1016/S0923-1811(99)00077-8; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Mikhailov A, 2005, CELL CYCLE, V4, P57, DOI 10.4161/cc.4.1.1357; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nemoto N, 2010, J MOL BIOL, V404, P183, DOI 10.1016/j.jmb.2010.09.016; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; Osman F, 2000, CURR GENET, V38, P113, DOI 10.1007/s002940000145; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Sage E, 2012, PHOTOCH PHOTOBIO SCI, V11, P74, DOI 10.1039/c1pp05219e; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; Sanso M, 2011, MOL MICROBIOL, V82, P542, DOI 10.1111/j.1365-2958.2011.07851.x; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Surendran S, 2010, NEUROL SCI, V31, P531, DOI 10.1007/s10072-010-0245-1; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Taricani L, 2007, J BIOL CHEM, V282, P8793, DOI 10.1074/jbc.M609282200; Taricani L, 2006, MOL BIOL CELL, V17, P3456, DOI 10.1091/mbc.E06-01-0056; Thorpe PH, 2011, J CELL BIOL, V194, P665, DOI 10.1083/jcb.201108095; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Van Dyck E, 2001, EMBO REP, V2, P905, DOI 10.1093/embo-reports/kve201; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Zhang J, 2012, PHOTOCH PHOTOBIO SCI, V11, P54, DOI 10.1039/c1pp05133d; Zhou X, 2010, J BIOL CHEM, V285, P32818, DOI 10.1074/jbc.M110.135764; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	58	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47987	10.1371/journal.pone.0047987	http://dx.doi.org/10.1371/journal.pone.0047987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118915	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500051
J	Blanca, J; Canizares, J; Cordero, L; Pascual, L; Diez, MJ; Nuez, F				Blanca, Jose; Canizares, Joaquin; Cordero, Laura; Pascual, Laura; Jose Diez, Maria; Nuez, Fernando			Variation Revealed by SNP Genotyping and Morphology Provides Insight into the Origin of the Tomato	PLOS ONE			English	Article							L. SECTION LYCOPERSICON; GENETIC-VARIATION; PHYLOGENETIC-RELATIONSHIPS; POPULATION-STRUCTURE; SOLANUM-PIMPINELLIFOLIUM; GENUS LYCOPERSICON; MILL. WETTST.; NUCLEAR GENE; DIVERSITY; ESCULENTUM	Tomato, Solanum lycopersicum, is divided into two widely distributed varieties: the cultivated S. lycopersicum var. lycopersicum, and the weedy S. lycopersicum var. cerasiforme. Solanum pimpinellifolium is the most closely related wild species of tomato. The roles of S. pimpinellifolium and S. l. cerasiforme during the domestication of tomato are still under debate. Some authors consider S. l. cerasiforme to be the ancestor, whereas others think that S. l. cerasiforme is an admixture of S. pimpinellifolium and the cultivated S. l. lycopersicum. It is also not clear whether the domestication occurred in the Andean region or in Mesoamerica. We characterized 272 accessions (63 S. pimpinellifolium, 106 S. l. cerasiforme, 95 S. l. lycopersicum and 8 derived from hybridization processes) were morphologically and genetically using the SolCap platform (7,414 SNPs). The two species were distinguished in a PCA analysis and displayed a rich geographic structure. Solanum lycopersicum var. cerasiforme and S. l. lycopersicum were also differentiated in the PCA and Structure analyses, which supports maintaining them as different varieties. Solanum pimpinellifolium and the Andean S. l. cerasiforme were more diverse than the non-Andean S. lycopersicum. Solanum lycopersicum var. cerasiforme was morphologically and molecularly intermediate between S. pimpinellifolium and tomato. Solanum lycopersicum var. cerasiforme, with the exception of several Ecuadorian and Mexican accessions, is composed of the products of admixture processes according to the Structure analysis. The non-admixtured S. l. cerasiforme might be similar to the ancestral cultivars from which the cultivated tomato originated, and presents remarkable morphological diversity, including fruits of up to 6 cm in diameter. The data obtained would fit a model in which a pre-domestication took place in the Andean region, with the domestication being completed in Mesoamerica. Subsequently, the Spaniards took plants from Mesoamerica to Spain and from there they were exported to the rest of the world.	[Blanca, Jose; Canizares, Joaquin; Cordero, Laura; Pascual, Laura; Jose Diez, Maria; Nuez, Fernando] Univ Politecn Valencia, Inst Conservat & Improvement Agr Biodivers, E-46071 Valencia, Spain	Universitat Politecnica de Valencia	Canizares, J (corresponding author), Univ Politecn Valencia, Inst Conservat & Improvement Agr Biodivers, E-46071 Valencia, Spain.	jcanizares@upv.es	Canizares, Joaquin/X-9702-2019; Pascual, Laura/AAB-5630-2019; pascual, laura/AAA-8817-2019; Canizares, Joaquin/M-3255-2014; Blanca, Jose M/H-6695-2015	Canizares, Joaquin/0000-0001-9002-5516; Pascual, Laura/0000-0002-3728-3652; pascual, laura/0000-0002-3728-3652; Canizares, Joaquin/0000-0001-9002-5516; Blanca, Jose M/0000-0002-5884-8624; Diez, Maria Jose/0000-0002-1422-2144				Belkhir K, 1996, 5171 CNRS UMR U MONT; BRUCHER H, 1969, BER DEUT BOT GES, V82, P621; Brucher H, 1989, USEFUL PLANTS NEOTRO, VX; Caicedo AL, 2004, MOL ECOL, V13, P1871, DOI 10.1111/j.1365-294X.2004.02191.x; Diez M, 1995, EL CULTIVO TOMATE, P93; Dondarini R, 2010, POMODORO; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Esquinas_ Alcazar J, 1995, CULTIVO TOMATE; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Hamilton JP, 2012, PLANT GENOME, V5; International Plant Genetic Resources Institute (IPGRI), 1996, DESCR TOM LYC SPP; JENKINS J. A., 1948, ECON BOT, V2, P379, DOI 10.1007/BF02859492; Long Janet, 1995, ESTUDIOS CULTURA NAH, V59, P239; Luckwill LC, 1943, GENUS LYCOPERSICON H; MANTEL N, 1967, CANCER RES, V27, P209; Marshall JA, 2001, THEOR APPL GENET, V103, P1216, DOI 10.1007/s001220100671; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; MCCLEAN PE, 1986, GENETICS, V112, P649; MILLER JC, 1990, THEOR APPL GENET, V80, P437, DOI 10.1007/BF00226743; Nesbitt TC, 2002, GENETICS, V162, P365; Noli E, 1999, SEED SCI TECHNOL, V27, P1; PALMER JD, 1982, P NATL ACAD SCI-BIOL, V79, P5006, DOI 10.1073/pnas.79.16.5006; Park YH, 2004, GENOME, V47, P510, DOI [10.1139/g04-004, 10.1139/G04-004]; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Peralta IE, 2001, AM J BOT, V88, P1888, DOI 10.2307/3558365; Peralta IE, 2007, GENETIC IMPROVEMENT, V2; Peralta IE, 2008, TAXONOMY WILD TOMATO, P151; Ranc N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-130; Rick C M, 1973, Basic Life Sci, V2, P255; Rick C. M., 1976, Evolution of crop plants., P268; RICK C M, 1986, Hortscience, V21, P1087; RICK CHARLES M., 1958, ECON BOT, V12, P346, DOI 10.1007/BF02860023; RICK CM, 1974, P NATL ACAD SCI USA, V71, P835, DOI 10.1073/pnas.71.3.835; RICK CM, 1978, PLANT SYST EVOL, V129, P31, DOI 10.1007/BF00988982; RICK CM, 1977, PLANT SYST EVOL, V127, P139, DOI 10.1007/BF00984147; RICK CM, 1990, ECON BOT, V44, P69, DOI 10.1007/BF02860476; RICK CM, 1975, B TORREY BOT CLUB, V102, P376, DOI 10.2307/2484764; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Romesburg HC, 2004, CLUSTER ANAL RES, VXII; Sauer J. D., 1993, HIST GEOGRAPHY CROP; Sifres A, 2007, GENET RESOUR CROP EV, V54, P359, DOI 10.1007/s10722-005-5725-4; Sim SC, 2012, PLOS ONE; Spooner DM, 2005, TAXON, V54, P43, DOI 10.2307/25065301; Tam SM, 2005, THEOR APPL GENET, V110, P819, DOI 10.1007/s00122-004-1837-z; Teppner H, 1993, AMERIKA ENTDECKUNG K, P189; Valdez Francisco, 2005, CR PALEVOL, V4, P369; Villand J, 1998, CROP SCI, V38, P1339, DOI 10.2135/cropsci1998.0011183X003800050032x; WARNOCK SJ, 1991, HORTSCIENCE, V26, P466, DOI 10.21273/HORTSCI.26.5.466; WILLIAMS CE, 1993, GENOME, V36, P619, DOI 10.1139/g93-083; Zuriaga E, 2009, GENET RESOUR CROP EV, V56, P663, DOI 10.1007/s10722-008-9392-0; Zuriaga E, 2009, GENET RESOUR CROP EV, V56, P39, DOI 10.1007/s10722-008-9340-z	53	108	111	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48198	10.1371/journal.pone.0048198	http://dx.doi.org/10.1371/journal.pone.0048198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118951	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500080
J	Hubert, J; Nesvorna, M; Sagova-Mareckova, M; Kopecky, J				Hubert, Jan; Nesvorna, Marta; Sagova-Mareckova, Marketa; Kopecky, Jan			Shift of Bacterial Community in Synanthropic Mite Tyrophagus putrescentiae Induced by Fusarium Fungal Diet	PLOS ONE			English	Article							ALLERGENIC CHARACTERIZATION; SCHRANK ACARI; ECOLOGY; LYSOZYME; GROWTH; CHITIN	Background: Tyrophagus putrescentiae (Acari: Astigmata) and Fusarium sp. co-occur in poorly managed grain. In a laboratory experiment, mite grazing resulted in significant reduction of fungal mycelium on cultivation plates. The destruction of mycelium appeared to be a result of an interaction between the mites, fungi and associated bacteria. Methodology and Principal Findings: A laboratory experiment was performed to simulate a situation of grain multiinfested by mites and Fusarium fungi. Changes of mite-associated bacterial community in T. putrescentiae were described in 3 habitats: (i) T. putrescentiae mites from a rearing diet prior to their transfer to fungal diet; (ii) fungal mycelium before mite introduction; (iii) mites after 7 day diet of each Fusarium avenaceum, F. culmorum, F. poae and F. verticillioides. Bacterial communities were characterized by 16 S rRNA gene sequencing. In total, 157 nearly full-length 16 S rRNA gene sequences from 9 samples representing selected habitats were analyzed. In the mites, the shift from rearing to fungal diet caused changes in mite associated bacterial community. A diverse bacterial community was associated with mites feeding on F. avenaceum, while feeding on the other three Fusarium spp. led to selection of a community dominated by Bacillaceae. Conclusions/Significance: The work demonstrated changes of bacterial community associated with T. putrescentiae after shift to fungal diets suggesting selection for Bacillaceae species known as chitinase producers, which might participate in the fungal mycelium hydrolysis.	[Sagova-Mareckova, Marketa; Kopecky, Jan] Crop Res Inst, Lab Diagnost & Epidemiol Microorganisms, Prague, Czech Republic; [Hubert, Jan; Nesvorna, Marta] Crop Res Inst, Dept Pest Control Stored Prod & Food Safety, Prague, Czech Republic	Czech Crop Research Institute (CRI); Czech Crop Research Institute (CRI)	Kopecky, J (corresponding author), Crop Res Inst, Lab Diagnost & Epidemiol Microorganisms, Prague, Czech Republic.	jkopecky@vurv.cz	Nesvorná, Marta/ABA-4351-2020; Mareckova, Marketa/D-9898-2017; Hubert, Jan/K-5489-2012; Mareckova, Marketa/AAD-7361-2021; Kopecky, Jan/C-7400-2013	Nesvorná, Marta/0000-0003-0572-4131; Mareckova, Marketa/0000-0002-0331-8570; Hubert, Jan/0000-0003-0740-166X; Mareckova, Marketa/0000-0002-0331-8570; Kopecky, Jan/0000-0002-3437-257X	Czech Science Foundation [GA525/09/1872]	Czech Science Foundation(Grant Agency of the Czech Republic)	The study was supported by Czech Science Foundation, grant No. GA525/09/1872 (http://www.gacr.cz). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian LG, 1997, ANN ALLERG ASTHMA IM, V79, P525, DOI 10.1016/S1081-1206(10)63060-8; ARMITAGE D M, 1986, Experimental and Applied Acarology, V2, P111, DOI 10.1007/BF01213755; Athanassiou CG, 2001, PHYTOPARASITICA, V29, P379, DOI 10.1007/BF02981856; Barbieri E, 2001, ENVIRON MICROBIOL, V3, P151, DOI 10.1046/j.1462-2920.2001.00172.x; CHILDS M, 1981, COMP BIOCHEM PHYS B, V70, P615, DOI 10.1016/0305-0491(81)90305-9; Colloff M., 2009, DUST MITES; De Boer W, 1998, SOIL BIOL BIOCHEM, V30, P193, DOI 10.1016/S0038-0717(97)00100-4; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Duek L, 2001, MYCOSES, V44, P390, DOI 10.1046/j.1439-0507.2001.00684.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erban T, 2008, EXP APPL ACAROL, V44, P199, DOI 10.1007/s10493-008-9138-x; Essghaier B, 2009, J APPL MICROBIOL, V106, P833, DOI 10.1111/j.1365-2672.2008.04053.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hubert J, 2004, J ECON ENTOMOL, V97, P2144, DOI 10.1603/0022-0493-97.6.2144; Hubert J, 2004, PEDOBIOLOGIA, V48, P205, DOI 10.1016/j.pedobi.2003.12.005; Hubert J, 2012, MICROB ECOL, V63, P919, DOI 10.1007/s00248-011-9969-6; Jeong KY, 2007, PROTEIN PEPTIDE LETT, V14, P431; Jow H, 2002, MOL BIOL EVOL, V19, P1591, DOI 10.1093/oxfordjournals.molbev.a004221; Magan N, 2003, EUR J PLANT PATHOL, V109, P723, DOI 10.1023/A:1026082425177; MITCHELL R, 1963, CAN J MICROBIOL, V9, P169, DOI 10.1139/m63-023; Nesvorna M, 2012, J STORED PROD RES, V48, P37, DOI 10.1016/j.jspr.2011.08.006; OConnor B.M., 1979, P273; OCONNOR BM, 1982, ANNU REV ENTOMOL, V27, P385, DOI 10.1146/annurev.en.27.010182.002125; Pleban S, 1997, LETT APPL MICROBIOL, V25, P284, DOI 10.1046/j.1472-765X.1997.00224.x; Samson RA, 1996, INTRODUCTION TO FOOD; Santo Domingo JW, 1998, MOL ECOL, V7, P761, DOI 10.1046/j.1365-294x.1998.00390.x; SINHA RN, 1979, ANN TECHNOL AGR, V28, P191; SMRZ J, 1989, Acta Universitatis Carolinae-Biologica, V33, P81; SMRZ J, 1991, J APPL ENTOMOL, V111, P206, DOI 10.1111/j.1439-0418.1991.tb00312.x; Smrz J, 2003, EXP APPL ACAROL, V31, P105, DOI 10.1023/B:APPA.0000005111.05959.d6; SMRZ J, 1987, J APPL ENTOMOL, V104, P329, DOI 10.1111/j.1439-0418.1987.tb00533.x; Smrz J, 2010, SYMBIOSIS, V52, P33, DOI 10.1007/s13199-010-0099-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trachuk LA, 1996, CAN J MICROBIOL, V42, P307, DOI 10.1139/m96-046; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WATANABE T, 1990, J BACTERIOL, V172, P4017, DOI 10.1128/jb.172.7.4017-4022.1990	37	18	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48429	10.1371/journal.pone.0048429	http://dx.doi.org/10.1371/journal.pone.0048429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119013	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500133
J	Lopez-Perez, M; Villasis, E; Machado, RLD; Povoa, MM; Vinetz, JM; Blair, S; Gamboa, D; Lustigman, S				Lopez-Perez, Mary; Villasis, Elizabeth; Machado, Ricardo L. D.; Povoa, Marinete M.; Vinetz, Joseph M.; Blair, Silvia; Gamboa, Dionicia; Lustigman, Sara			Plasmodium falciparum Field Isolates from South America Use an Atypical Red Blood Cell Invasion Pathway Associated with Invasion Ligand Polymorphisms	PLOS ONE			English	Article							ERYTHROCYTE-BINDING LIGAND; YOELII ADHESIVE PROTEINS; RECEPTOR SPECIFICITY; MEROZOITE PROTEINS; MALARIA PARASITES; GENETIC DIVERSITY; GLYCOPHORIN-A; EBL-1 GENE; VIVAX; EXPRESSION	Studies of Plasmodium falciparum invasion pathways in field isolates have been limited. Red blood cell (RBC) invasion is a complex process involving two invasion protein families; Erythrocyte Binding-Like (EBL) and the Reticulocyte Binding-Like (PfRh) proteins, which are polymorphic and not fully characterized in field isolates. To determine the various P. falciparum invasion pathways used by parasite isolates from South America, we studied the invasion phenotypes in three regions: Colombia, Peru and Brazil. Additionally, polymorphisms in three members of the EBL (EBA-181, EBA-175 and EBL-1) and five members of the PfRh (PfRh1, PfRh2a, PfRh2b, PfRh4, PfRh5) families were determined. We found that most P. falciparum field isolates from Colombia and Peru invade RBCs through an atypical invasion pathway phenotypically characterized as resistant to all enzyme treatments (NrTrCr). Moreover, the invasion pathways and the ligand polymorphisms differed substantially among the Colombian and Brazilian isolates while the Peruvian isolates represent an amalgam of those present in the Colombian and Brazilian field isolates. The NrTrCr invasion profile was associated with the presence of the PfRh2a pepC variant, the PfRh5 variant 1 and EBA-181 RVNKN variant. The ebl and Pfrh expression levels in a field isolate displaying the NrTrCr profile also pointed to PfRh2a, PfRh5 and EBA-181 as being possibly the major players in this invasion pathway. Notably, our studies demonstrate the uniqueness of the Peruvian P. falciparum field isolates in terms of their invasion profiles and ligand polymorphisms, and present a unique opportunity for studying the ability of P. falciparum parasites to expand their invasion repertoire after being reintroduced to human populations. The present study is directly relevant to asexual blood stage vaccine design focused on invasion pathway proteins, suggesting that regional invasion variants and global geographical variation are likely to preclude a simple one size fits all type of vaccine.	[Lopez-Perez, Mary; Lustigman, Sara] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Villasis, Elizabeth; Vinetz, Joseph M.; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Malaria Lab, Lima, Peru; [Machado, Ricardo L. D.] Med Sch Sao Jose do Rio Preto, Dept Dermatol Parasit & Infect Dis, Ctr Microorganism Invest, Sao Jose Do Rio Preto, SP, Brazil; [Povoa, Marinete M.] Inst Evandro Chagas, Secao Parasitol, Belem, Para, Brazil; [Vinetz, Joseph M.] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [Blair, Silvia] Univ Antioquia, Sede Invest Univ, Malaria Grp, Medellin, Colombia; [Vinetz, Joseph M.; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Dept Ciencias Celulares & Mol, Lima, Peru	New York Blood Center; Universidad Peruana Cayetano Heredia; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Instituto Evandro Chagas; University of California System; University of California San Diego; Universidad de Antioquia; Universidad Peruana Cayetano Heredia	Lustigman, S (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.	slustigman@nybloodcenter.org	Lopez-Perez, Mary/E-5059-2016; Machado, Ricardo Luiz Dantas Dantas/P-1288-2014; Povoa, Marinete Marins/C-7039-2017; Gamboa, Dionicia/CAF-2097-2022; Machado, Ricardo/GXM-8198-2022	Lopez-Perez, Mary/0000-0002-9876-0248; Machado, Ricardo Luiz Dantas Dantas/0000-0002-8955-3204; Povoa, Marinete Marins/0000-0003-3517-2227; Gamboa, Dionicia/0000-0002-1420-7729; Blair Trujillo, silvia/0000-0002-9030-6585; Vinetz, Joseph/0000-0001-8344-2004; VILLASIS, ELIZABETH/0000-0002-6824-2239	National Institutes of Health [R03TW007349]; ICEMR-Amazonia [U19AI089681]; Universidad de Antioquia; New York Blood Center; FOGARTY INTERNATIONAL CENTER [R03TW007349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089681, K24AI068903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ICEMR-Amazonia; Universidad de Antioquia; New York Blood Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported in part by the New York Blood Center and the National Institutes of Health grant R03TW007349. This work was also financed in part by ICEMR-Amazonia U19AI089681 (NIH-USA). Intramural funding from the Universidad de Antioquia supported the collection of the samples in Colombia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahouidi AD, 2010, INFECT GENET EVOL, V10, P200, DOI 10.1016/j.meegid.2009.11.008; Arevalo-Herrera M, 2012, ACTA TROP, V121, P303, DOI 10.1016/j.actatropica.2011.06.008; Baum J, 2003, GENETICS, V163, P1327; Baum J, 2003, INFECT IMMUN, V71, P1856, DOI 10.1128/IAI.71.4.1856-1863.2003; Baum J, 2005, PLOS PATHOG, V1, P299, DOI 10.1371/journal.ppat.0010037; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Bei AK, 2007, MOL BIOCHEM PARASIT, V153, P66, DOI 10.1016/j.molbiopara.2007.01.007; Bei AK, 2012, INT J PARASITOL, V42, P575, DOI 10.1016/j.ijpara.2012.03.006; BHASIN VK, 1984, AM J TROP MED HYG, V33, P534, DOI 10.4269/ajtmh.1984.33.534; Blair PL, 2002, NUCLEIC ACIDS RES, V30, P2224, DOI 10.1093/nar/30.10.2224; BURKOT TR, 1984, T ROY SOC TROP MED H, V78, P339, DOI 10.1016/0035-9203(84)90114-7; Chung WY, 2008, PARASITOL RES, V102, P259, DOI 10.1007/s00436-007-0756-8; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Deans AM, 2007, INFECT IMMUN, V75, P3014, DOI 10.1128/IAI.00249-07; DeSimone TM, 2009, MOL MICROBIOL, V72, P578, DOI 10.1111/j.1365-2958.2009.06667.x; Dharia NV, 2010, GENOME RES, V20, P1534, DOI 10.1101/gr.105163.110; DLUZEWSKI AR, 1984, T ROY SOC TROP MED H, V78, P622, DOI 10.1016/0035-9203(84)90221-9; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Drummond PB, 2005, MOL BIOCHEM PARASIT, V140, P241, DOI 10.1016/j.molbiopara.2005.01.003; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; FAJFARWHETSTONE CJ, 1987, AM J TROP MED HYG, V36, P221, DOI 10.4269/ajtmh.1987.36.221; Ford L, 2007, AM J TROP MED HYG, V77, P977, DOI 10.4269/ajtmh.2007.77.977; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Githui EK, 2010, INFECT GENET EVOL, V10, P834, DOI 10.1016/j.meegid.2009.10.005; Gomez-Escobar N, 2010, J INFECT DIS, V201, P444, DOI 10.1086/649902; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Guinet F, 1996, J CELL BIOL, V135, P269, DOI 10.1083/jcb.135.1.269; Gunalan K, 2011, INFECT IMMUN, V79, P3421, DOI 10.1128/IAI.00201-11; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Jennings CV, 2007, INFECT IMMUN, V75, P3531, DOI 10.1128/IAI.00122-07; Jolliffe, 2002, PRINCIPAL COMPONENT; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lantos PM, 2009, PARASITOLOGY, V136, P1, DOI 10.1017/S0031182008005167; Li X, 2012, MOL BIOCH PARASITOL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lobo CA, 2006, MOL BIOCHEM PARASIT, V149, P246, DOI 10.1016/j.molbiopara.2006.05.011; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Mayer DCG, 2004, P NATL ACAD SCI USA, V101, P2518, DOI 10.1073/pnas.0307318101; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Nery S, 2006, MOL BIOCHEM PARASIT, V149, P208, DOI 10.1016/j.molbiopara.2006.05.014; Ocarnpo M, 2004, PARASITOL INT, V53, P77, DOI 10.1016/j.parint.2003.11.004; ODUOLA AMJ, 1988, EXP PARASITOL, V67, P354, DOI 10.1016/0014-4894(88)90082-3; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Ord RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030251; ORLANDI PA, 1990, MOL BIOCHEM PARASIT, V40, P285, DOI 10.1016/0166-6851(90)90050-V; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Rodriguez JCP, 2011, MEM I OSWALDO CRUZ, V106, P114, DOI 10.1590/S0074-02762011000900015; Peterson DS, 2000, MOL BIOCHEM PARASIT, V105, P105, DOI 10.1016/S0166-6851(99)00173-5; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Roberts DR, 1997, EMERG INFECT DIS, V3, P295, DOI 10.3201/eid0303.970305; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Schoeler GB, 2003, J AM MOSQUITO CONTR, V19, P286; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Tarazona-Santos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016123; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Taylor HM, 2001, INFECT IMMUN, V69, P3635, DOI 10.1128/IAI.69.6.3635-3645.2001; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yalcindag E, 2012, P NATL ACAD SCI USA, V109, P511, DOI 10.1073/pnas.1119058109	81	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47913	10.1371/journal.pone.0047913	http://dx.doi.org/10.1371/journal.pone.0047913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118907	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500045
J	Mock, KE; Callahan, CM; Islam-Faridi, MN; Shaw, JD; Rai, HS; Sanderson, SC; Rowe, CA; Ryel, RJ; Madritch, MD; Gardner, RS; Wolf, PG				Mock, Karen E.; Callahan, Colin M.; Islam-Faridi, M. Nurul; Shaw, John D.; Rai, Hardeep S.; Sanderson, Stewart C.; Rowe, Carol A.; Ryel, Ronald J.; Madritch, Michael D.; Gardner, Richard S.; Wolf, Paul G.			Widespread Triploidy in Western North American Aspen (Populus tremuloides)	PLOS ONE			English	Article							GENETIC DIVERSITY; CLONE SIZE; POLYPLOIDY; DYNAMICS; PATTERNS; DIEBACK; CLIMATE; POPLAR; GROWTH; VULNERABILITY	We document high rates of triploidy in aspen (Populus tremuloides) across the western USA (up to 69% of genets), and ask whether the incidence of triploidy across the species range corresponds with latitude, glacial history (as has been documented in other species), climate, or regional variance in clone size. Using a combination of microsatellite genotyping, flow cytometry, and cytology, we demonstrate that triploidy is highest in unglaciated, drought-prone regions of North America, where the largest clone sizes have been reported for this species. While we cannot completely rule out a low incidence of undetected aneuploidy, tetraploidy or duplicated loci, our evidence suggests that these phenomena are unlikely to be significant contributors to our observed patterns. We suggest that the distribution of triploid aspen is due to a positive synergy between triploidy and ecological factors driving clonality. Although triploids are expected to have low fertility, they are hypothesized to be an evolutionary link to sexual tetraploidy. Thus, interactions between clonality and polyploidy may be a broadly important component of geographic speciation patterns in perennial plants. Further, cytotypes are expected to show physiological and structural differences which may influence susceptibility to ecological factors such as drought, and we suggest that cytotype may be a significant and previously overlooked factor in recent patterns of high aspen mortality in the southwestern portion of the species range. Finally, triploidy should be carefully considered as a source of variance in genomic and ecological studies of aspen, particularly in western U.S. landscapes.	[Mock, Karen E.; Callahan, Colin M.; Rai, Hardeep S.; Rowe, Carol A.; Ryel, Ronald J.; Gardner, Richard S.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Islam-Faridi, M. Nurul] Texas A&M Univ, USDA, US Forest Serv, So Inst Forest Genet,Forest Tree Mol Cytogenet La, College Stn, TX USA; [Shaw, John D.] US Forest Serv, USDA, Rocky Mt Res Stn, Ogden, UT USA; [Sanderson, Stewart C.] US Forest Serv, USDA, Rocky Mt Res Stn, Shrub Sci Lab, Provo, UT USA; [Madritch, Michael D.] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA; [Wolf, Paul G.] Utah State Univ, Dept Biol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; University of North Carolina; Appalachian State University; Utah System of Higher Education; Utah State University	Mock, KE (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	karen.mock@usu.edu	Mock, Karen E/C-1418-2011; Wolf, Paul/F-7664-2010	Mock, Karen E/0000-0002-8357-4434; Wolf, Paul/0000-0002-4317-6976	United States Department of Agriculture (USDA) Forest Inventory and Analysis Program; NASA Biodiversity Program; USDA National Research Initiative; USDA Natural Resource Conservation Service; Utah Agricultural Experiment Station; Utah State University (USU) Cedar Mountain Initiative; USU ADVANCE program	United States Department of Agriculture (USDA) Forest Inventory and Analysis Program; NASA Biodiversity Program(National Aeronautics & Space Administration (NASA)); USDA National Research Initiative(United States Department of Agriculture (USDA)); USDA Natural Resource Conservation Service; Utah Agricultural Experiment Station; Utah State University (USU) Cedar Mountain Initiative; USU ADVANCE program	The authors thank the United States Department of Agriculture (USDA) Forest Inventory and Analysis Program, NASA Biodiversity Program, USDA National Research Initiative, USDA Natural Resource Conservation Service, Utah Agricultural Experiment Station, Utah State University (USU) Cedar Mountain Initiative, and USU ADVANCE program, and for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; Allario T, 2011, J EXP BOT, V62, P2507, DOI 10.1093/jxb/erq467; Ally D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000454; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Arango-Velez A, 2011, PHYSIOL PLANTARUM, V143, P154, DOI 10.1111/j.1399-3054.2011.01489.x; Awad H, 2010, PHYSIOL PLANTARUM, V139, P280, DOI 10.1111/j.1399-3054.2010.01367.x; Baker FS, 1925, USDA TECHNICAL B; BARNES BV, 1966, ECOLOGY, V47, P439, DOI 10.2307/1932983; Besnard G, 2009, CR BIOL, V332, P1115, DOI 10.1016/j.crvi.2009.09.014; BIERZYCHUDEK P, 1985, EXPERIENTIA, V41, P1255, DOI 10.1007/BF01952068; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; CALLAGHAN TV, 1988, PLANT POPULATION ECO, P111; Callahan CM, 2012, CONTINENTAL SCALE CH; CHELIAK WM, 1982, CAN J GENET CYTOL, V24, P611, DOI 10.1139/g82-065; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cook R.E., 1985, POPULATION BIOL EVOL, P259; De Woody J, 2009, FOREST ECOL MANAG, V258, P687, DOI 10.1016/j.foreco.2009.05.006; DeByle N.V., 1985, USDA FOREST SERVICE; DeWoody J, 2008, WEST N AM NATURALIST, V68, P493, DOI 10.3398/1527-0904-68.4.493; Dzialuk A, 2007, ANN BOT-LONDON, V99, P959, DOI 10.1093/aob/mcm043; ECKERT CG, 1993, AM J BOT, V80, P1175, DOI 10.2307/2445546; Ehlers J, 2011, QUATERNARY GLACIAT 2; EINSPAHR D. W., 1963, SILVAE GENET, V12, P51; Einspahr DW, 1977, WO25 USDA FOR SERV; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; ERIKSSON O, 1993, TRENDS ECOL EVOL, V8, P313, DOI 10.1016/0169-5347(93)90237-J; EVERY A D, 1971, Madrono, V21, P138; Felber F, 1997, BIOL J LINN SOC, V60, P95, DOI 10.1006/bijl.1996.0090; Frey BR, 2004, CAN J FOREST RES, V34, P1379, DOI 10.1139/X04-062; Garcia D, 2003, J VEG SCI, V14, P921, DOI 10.1111/j.1654-1103.2003.tb02227.x; GRANT MC, 1992, NATURE, V360, P216, DOI 10.1038/360216a0; GRANT V, 1952, CHROMOSOMA, V5, P372; GUSTAFSSON A, 1948, HEREDITAS, V34, P1; HARLAN JR, 1975, BOT REV, V41, P361, DOI 10.1007/BF02860830; Harper JL, 1978, STRUCTURE FUNCTIONIN, P27; Hegarty M, 2007, CURR BIOL, V17, pR927, DOI 10.1016/j.cub.2007.08.060; Heilborn O, 1934, HEREDITAS, V19, P233; Hodgson JG, 2010, ANN BOT-LONDON, V105, P573, DOI 10.1093/aob/mcq011; Hogg EH, 2008, CAN J FOREST RES, V38, P1373, DOI 10.1139/X08-001; Hogg EH, 2002, CAN J FOREST RES, V32, P823, DOI [10.1139/x01-152, 10.1139/X01-152]; Jewell David C., 1994, P484; Jump AS, 2003, NEW PHYTOL, V160, P349, DOI 10.1046/j.1469-8137.2003.00873.x; KEMPERMAN JA, 1976, CAN J BOT, V54, P2603, DOI 10.1139/b76-280; Kroon H.D., 1997, ECOLOGY EVOLUTION CL; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Li WL, 1996, AM J BOT, V83, P15, DOI 10.2307/2445949; Little EL, 1971, USDA MISCELLANEOUS P, V1; Lynch AJJ, 1998, AUST J BOT, V46, P25, DOI 10.1071/BT96120; Martin SL, 2009, J ECOL, V97, P913, DOI 10.1111/j.1365-2745.2009.01543.x; McArthur ED, 1999, AM J BOT, V86, P1754, DOI 10.2307/2656673; McDonough W.T., 1979, INT234 USDA FOR SERV; McIntyre PJ, 2012, AM J BOT, V99, P655, DOI 10.3732/ajb.1100466; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Mock KE, 2008, MOL ECOL, V17, P4827, DOI 10.1111/j.1365-294X.2008.03963.x; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Perala DA., 1990, USDA AGR HDB, V654, P555; Rahman MH, 2000, GENOME, V43, P293, DOI 10.1139/gen-43-2-293; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Rehfeldt GE, 2009, FOREST ECOL MANAG, V258, P2353, DOI 10.1016/j.foreco.2009.06.005; Schier G. A., 1978, USDA Forest Service General Technical Report, Intermountain Forest and Range Experiment Station; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Smulders MJM, 2001, MOL ECOL NOTES, V1, P188, DOI 10.1046/j.1471-8278.2001.00071.x; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Stebbins GL, 1940, AM NAT, V74, P54, DOI 10.1086/280872; STEBBINS GL, 1984, BOT HELV, V94, P1; Stebbins GL, 1938, AM J BOT, V25, P189, DOI 10.2307/2436589; Sterck L, 2005, NEW PHYTOL, V167, P165, DOI 10.1111/j.1469-8137.2005.01378.x; Sudworth GB, 1934, USDA TECHNICAL B; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van Buijtenen JP, 1957, P SOC AM FORESTERS, P62; VASEK FC, 1980, AM J BOT, V67, P246, DOI 10.2307/2442649; Worrall JJ, 2008, FOREST ECOL MANAG, V255, P686, DOI 10.1016/j.foreco.2007.09.071; Worrall JJ, 2010, FOREST ECOL MANAG, V260, P638, DOI 10.1016/j.foreco.2010.05.020; Young AG, 2002, BIOL CONSERV, V106, P71, DOI 10.1016/S0006-3207(01)00230-0	77	49	49	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48406	10.1371/journal.pone.0048406	http://dx.doi.org/10.1371/journal.pone.0048406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119006	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500126
J	Rosenbusch, KE; Bakker, D; Kuijper, EJ; Smits, WK				Rosenbusch, Katharina E.; Bakker, Dennis; Kuijper, Ed J.; Smits, Wiep Klaas			C. difficile 630 Delta erm Spo0A Regulates Sporulation, but Does Not Contribute to Toxin Production, by Direct High-Affinity Binding to Target DNA	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SPO0A; IN-VITRO TRANSCRIPTION; CLOSTRIDIUM-DIFFICILE; BACILLUS-SUBTILIS; ADP-RIBOSYLTRANSFERASE; ENDOSPORE FORMATION; RNA-POLYMERASE; BINARY TOXIN; SIGMA-FACTOR; SPOOA	Clostridium difficile is a Gram positive, anaerobic bacterium that can form highly resistant endospores. The bacterium is the causative agent of C. difficile infection (CDI), for which the symptoms can range from a mild diarrhea to potentially fatal pseudomembranous colitis and toxic megacolon. Endospore formation in Firmicutes, including C. difficile, is governed by the key regulator for sporulation, Spo0A. In Bacillus subtilis, this transcription factor is also directly or indirectly involved in various other cellular processes. Here, we report that C. difficile Spo0A shows a high degree of similarity to the well characterized B. subtilis protein and recognizes a similar binding sequence. We find that the laboratory strain C. difficile 630 Delta erm contains an 18bp-duplication near the DNA-binding domain compared to its ancestral strain 630. In vitro binding assays using purified C-terminal DNA binding domain of the C. difficile Spo0A protein demonstrate direct binding to DNA upstream of spo0A and sigH, early sporulation genes and several other putative targets. In vitro binding assays suggest that the gene encoding the major clostridial toxin TcdB may be a direct target of Spo0A, but supernatant derived from a spo0A negative strain was no less toxic towards Vero cells than that obtained from a wild type strain, in contrast to previous reports. These results identify for the first time direct (putative) targets of the Spo0A protein in C. difficile and make a positive effect of Spo0A on production of the large clostridial toxins unlikely.	[Rosenbusch, Katharina E.; Bakker, Dennis; Kuijper, Ed J.; Smits, Wiep Klaas] Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Smits, WK (corresponding author), Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands.	w.k.smits@lumc.nl	Smits, Wiep Klaas/A-8366-2008; Kuijper, ed/AAB-7853-2022	Smits, Wiep Klaas/0000-0002-7409-2847; Kuijper, ed/0000-0001-5726-2405; Rosenbusch, Katharina Elke/0000-0001-9498-3543	Veni fellowship from the Netherlands Organization for Scientific Research (NWO-ZonMW); Gisela Thier Fellowship from the Leiden University Medical Center	Veni fellowship from the Netherlands Organization for Scientific Research (NWO-ZonMW); Gisela Thier Fellowship from the Leiden University Medical Center	This work was supported by a Veni fellowship from the Netherlands Organization for Scientific Research (NWO-ZonMW) and a Gisela Thier Fellowship from the Leiden University Medical Center to WKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AGAISSE H, 1994, J BACTERIOL, V176, P4734, DOI 10.1128/JB.176.15.4734-4741.1994; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bakker D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043247; BALDUS JM, 1995, MOL MICROBIOL, V17, P281, DOI 10.1111/j.1365-2958.1995.mmi_17020281.x; BALDUS JM, 1994, J BACTERIOL, V176, P296, DOI 10.1128/JB.176.2.296-306.1994; BAUM JA, 1995, MOL MICROBIOL, V18, P1, DOI 10.1111/j.1365-2958.1995.mmi_18010001.x; BIRD TH, 1993, MOL MICROBIOL, V9, P741, DOI 10.1111/j.1365-2958.1993.tb01734.x; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Carter GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002317; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Castilla-Llorente V, 2006, EMBO J, V25, P3890, DOI 10.1038/sj.emboj.7601266; Chen HJ, 2010, FEMS MICROBIOL LETT, V304, P74, DOI [10.1111/j.1574-6968.2010.01888.x, 10.1111/j.1574-6968.2009.01888.x]; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; DUNCAN CL, 1972, J BACTERIOL, V110, P378, DOI 10.1128/JB.110.1.378-391.1972; Dupuy B, 2008, J MED MICROBIOL, V57, P685, DOI 10.1099/jmm.0.47775-0; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; FERRARI FA, 1985, P NATL ACAD SCI USA, V82, P2647, DOI 10.1073/pnas.82.9.2647; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Fujita M, 2005, GENE DEV, V19, P2236, DOI 10.1101/gad.1335705; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Fujita M, 1998, J BIOCHEM-TOKYO, V124, P98, DOI 10.1093/oxfordjournals.jbchem.a022103; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; GRIMSLEY JK, 1994, J BIOL CHEM, V269, P16977; HAHN J, 1995, J BACTERIOL, V177, P3601, DOI 10.1128/jb.177.12.3601-3605.1995; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Harris LM, 2002, J BACTERIOL, V184, P3586, DOI 10.1128/JB.184.13.3586-3597.2002; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, METHODS MOL BIOL, V646, P165, DOI 10.1007/978-1-60327-365-7_11; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lewis RJ, 2000, MOL MICROBIOL, V38, P198, DOI 10.1046/j.1365-2958.2000.02134.x; Lewis RJ, 2002, J MOL BIOL, V316, P235, DOI 10.1006/jmbi.2001.5331; Liu JJ, 2003, NUCLEIC ACIDS RES, V31, P6891, DOI 10.1093/nar/gkg879; Lucking G, 2009, MICROBIOL-SGM, V155, P922, DOI 10.1099/mic.0.024125-0; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Muchova K, 2004, MOL MICROBIOL, V53, P829, DOI 10.1111/j.1365-2958.2004.04171.x; Olling A, 2012, MICROB PATHOGENESIS, V52, P92, DOI 10.1016/j.micpath.2011.10.009; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Paredes-Sabja D, 2011, MICROB PATHOGENESIS, V51, P384, DOI 10.1016/j.micpath.2011.05.006; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Poncet S, 1997, MICROBIOL-UK, V143, P2743, DOI 10.1099/00221287-143-8-2743; PREDICH M, 1992, J BACTERIOL, V174, P2771, DOI 10.1128/JB.174.9.2771-2778.1992; Ravagnani A, 2000, MOL MICROBIOL, V37, P1172, DOI 10.1046/j.1365-2958.2000.02071.x; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; SATOLA S, 1991, P NATL ACAD SCI USA, V88, P4533, DOI 10.1073/pnas.88.10.4533; Saujet L, 2011, J BACTERIOL, V193, P3186, DOI 10.1128/JB.00272-11; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Steiner E, 2011, MOL MICROBIOL, V80, P641, DOI 10.1111/j.1365-2958.2011.07608.x; STRAUCH M, 1990, P NATL ACAD SCI USA, V87, P1801, DOI 10.1073/pnas.87.5.1801; STRAUCH MA, 1992, BIOCHIMIE, V74, P619, DOI 10.1016/0300-9084(92)90133-Y; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; Tan KS, 2001, J MED MICROBIOL, V50, P613, DOI 10.1099/0022-1317-50-7-613; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Vedantam G, 2012, GUT MICROBES, V3; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; WEIR J, 1991, J BACTERIOL, V173, P521, DOI 10.1128/jb.173.2.521-529.1991; YORK K, 1992, J BACTERIOL, V174, P2648, DOI 10.1128/jb.174.8.2648-2658.1992; Zhao H, 2002, STRUCTURE, V10, P1041, DOI 10.1016/S0969-2126(02)00803-1; Zhao YL, 1998, J BACTERIOL, V180, P136, DOI 10.1128/JB.180.1.136-142.1998	66	49	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48608	10.1371/journal.pone.0048608	http://dx.doi.org/10.1371/journal.pone.0048608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119071	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500180
J	Saeger, J; Hytonen, VP; Klotzsch, E; Vogel, V				Saeger, John; Hytonen, Vesa P.; Klotzsch, Enrico; Vogel, Viola			GFP's Mechanical Intermediate States	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; MOLECULAR-DYNAMICS SIMULATIONS; LIFETIME IMAGING MICROSCOPY; UNFOLDING PATHWAYS; FORCE-FIELD; CELL; ELASTICITY; FIBRILS; DOMAINS; BINDING	Green fluorescent protein (GFP) mutants have become the most widely used fluorescence markers in the life sciences, and although they are becoming increasingly popular as mechanical force or strain probes, there is little direct information on how their fluorescence changes when mechanically stretched. Here we derive high-resolution structural models of the mechanical intermediate states of stretched GFP using steered molecular dynamics (SMD) simulations. These structures were used to produce mutants of EGFP and EYFP that mimic GFP's different mechanical intermediates. A spectroscopic analysis revealed that a population of EGFP molecules with a missing N-terminal a-helix was significantly dimmed, while the fluorescence lifetime characteristic of the anionic chromophore state remained unaffected. This suggests a mechanism how N-terminal deletions can switch the protonation state of the chromophore, and how the fluorescence of GFP molecules in response to mechanical disturbance might be turned off.	[Saeger, John; Hytonen, Vesa P.; Klotzsch, Enrico; Vogel, Viola] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Zurich, Switzerland; [Hytonen, Vesa P.] Tampere Univ Hosp, Tampere, Finland; [Hytonen, Vesa P.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Tampere University; Tampere University Hospital; Tampere University	Vogel, V (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Appl Mechanobiol, Zurich, Switzerland.	viola.vogel@hest.ethz.ch	Hytonen, Vesa P./E-8855-2013; Klotzsch, Enrico/J-8831-2012; Vogel, Viola/O-8025-2015	Hytonen, Vesa P./0000-0002-9357-1480; Klotzsch, Enrico/0000-0002-7577-9042; Vogel, Viola/0000-0003-2898-7671	Swiss National Supercomputer Centre; ETH Zurich; Commission of the European Communities; ERC [233157]; Acadamy of Finland	Swiss National Supercomputer Centre; ETH Zurich(ETH Zurich); Commission of the European Communities(European Commission); ERC(European Research Council (ERC)European Commission); Acadamy of Finland	This work was supported by Swiss National Supercomputer Centre (Computational Resources) (http://www.cscs.ch/), ETH Zurich (http://www.ethz.ch/index_EN), Commission of the European Communities, ERC Advanced Grant Number 233157 (http://ec.europa.eu/index_en.htm), and The Acadamy of Finland (http://www.aka.fi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Lail NI, 2006, MATRIX BIOL, V25, P175, DOI 10.1016/j.matbio.2005.10.007; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Barstow B, 2008, P NATL ACAD SCI USA, V105, P13362, DOI 10.1073/pnas.0802252105; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; BEAVEN GH, 1952, ADV PROTEIN CHEM, V7, P319, DOI 10.1016/S0065-3233(08)60022-4; Brown AEX, 2009, CURR BIOL, V19, pR781, DOI 10.1016/j.cub.2009.06.054; Caraglio M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021918; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Cheng SM, 2010, BIOPHYS J, V99, P3863, DOI 10.1016/j.bpj.2010.10.011; Craig D, 2004, STRUCTURE, V12, P21, DOI 10.1016/j.str.2003.11.024; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dittrich M, 2005, J PHYS CHEM B, V109, P13006, DOI 10.1021/jp050943o; Dopf J, 1996, GENE, V173, P39, DOI 10.1016/0378-1119(95)00692-3; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Duncan RR, 2004, J MICROSC-OXFORD, V215, P1, DOI 10.1111/j.0022-2720.2004.01343.x; Eyal E, 2008, BIOPHYS J, V94, P3424, DOI 10.1529/biophysj.107.120733; Farres J, 2005, BIOCHEMISTRY-US, V44, P4125, DOI 10.1021/bi047389d; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Freddolino PL, 2010, NAT PHYS, V6, P751, DOI 10.1038/NPHYS1713; Freddolino PL, 2009, BIOPHYS J, V97, P2338, DOI 10.1016/j.bpj.2009.08.012; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Heilemann M, 2002, ANAL CHEM, V74, P3511, DOI 10.1021/ac025576g; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Hsin J, 2011, ANNU REV BIOPHYS, V40, P187, DOI 10.1146/annurev-biophys-072110-125325; Huang YM, 2009, BIOCHEMISTRY-US, V48, P929, DOI 10.1021/bi802027g; Hyeon C, 2006, STRUCTURE, V14, P1633, DOI 10.1016/j.str.2006.09.002; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung K, 2005, B KOREAN CHEM SOC, V26, P413; Kufer SK, 2008, SCIENCE, V319, P594, DOI 10.1126/science.1151424; Kufer SK, 2005, EUR BIOPHYS J BIOPHY, V35, P72, DOI 10.1007/s00249-005-0010-1; LAKOWICZ JR, 1992, ANAL BIOCHEM, V202, P316, DOI 10.1016/0003-2697(92)90112-K; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; Lee EH, 2010, BIOPHYS J, V98, P1085, DOI 10.1016/j.bpj.2009.12.4192; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; Lee W, 2012, J BIOL CHEM, V287, P19115, DOI 10.1074/jbc.M112.365569; Lemmon CA, 2011, J BIOL CHEM, V286, P26375, DOI 10.1074/jbc.M111.240028; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meng F, 2008, FEBS J, V275, P3072, DOI 10.1111/j.1742-4658.2008.06461.x; Meng FJ, 2011, J CELL SCI, V124, P261, DOI 10.1242/jcs.071928; Mickler M, 2007, P NATL ACAD SCI USA, V104, P20268, DOI 10.1073/pnas.0705458104; Nelson MT, 1996, INT J SUPERCOMPUT AP, V10, P251, DOI 10.1177/109434209601000401; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Reuter N, 2002, J PHYS CHEM B, V106, P6310, DOI 10.1021/jp014476w; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Ruijgrok PV, 2010, OPT EXPRESS, V18, P6360, DOI 10.1364/OE.18.006360; Schmidt C, 2010, LAB CHIP, V10, P2195, DOI 10.1039/c005241h; Schwartz MA, 2009, SCIENCE, V323, P588, DOI 10.1126/science.1169414; Sharma D, 2008, BIOPHYS J, V95, P3935, DOI 10.1529/biophysj.108.134072; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	69	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e46962	10.1371/journal.pone.0046962	http://dx.doi.org/10.1371/journal.pone.0046962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118864	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500013
J	Yashunsky, V; Marciano, T; Lirtsman, V; Golosovsky, M; Davidov, D; Aroeti, B				Yashunsky, Victor; Marciano, Tal; Lirtsman, Vladislav; Golosovsky, Michael; Davidov, Dan; Aroeti, Benjamin			Real-Time Sensing of Cell Morphology by Infrared Waveguide Spectroscopy	PLOS ONE			English	Article							SPECTRAL EMISSIVITY; MORPHOGENESIS; ACTIN; SKIN	We demonstrate that a live epithelial cell monolayer can act as a planar waveguide. Our infrared reflectivity measurements show that highly differentiated simple epithelial cells, which maintain tight intercellular connectivity, support efficient waveguiding of the infrared light in the spectral region of 1.4-2.5 mu m and 3.5-4 mu m. The wavelength and the magnitude of the waveguide mode resonances disclose quantitative dynamic information on cell height and cell-cell connectivity. To demonstrate this we show two experiments. In the first one we trace in real-time the kinetics of the disruption of cell-cell contacts induced by calcium depletion. In the second one we show that cell treatment with the PI3-kinase inhibitor LY294002 results in a progressive decrease in cell height without affecting intercellular connectivity. Our data suggest that infrared waveguide spectroscopy can be used as a novel bio-sensing approach for studying the morphology of epithelial cell sheets in real-time, label-free manner and with high spatial-temporal resolution.	[Yashunsky, Victor; Marciano, Tal; Lirtsman, Vladislav; Golosovsky, Michael; Davidov, Dan] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Aroeti, Benjamin] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Dev Biol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Yashunsky, V (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	victor.yashunsky@mail.huji.ac.il	Yashunsky, Victor/M-9523-2017; Yashunsky, Victor/P-1456-2019; Golosovsky, Michael/L-8303-2013	Yashunsky, Victor/0000-0003-3175-3390; Yashunsky, Victor/0000-0003-3175-3390; 	NOFAR of the Israel Ministry of Industry and Trade; Lady Davis Fellowship Foundation	NOFAR of the Israel Ministry of Industry and Trade; Lady Davis Fellowship Foundation	This work was supported by the NOFAR grant of the Israel Ministry of Industry and Trade. V.L. acknowledges support from the Lady Davis Fellowship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Castillo AM, 1998, J MUSCLE RES CELL M, V19, P557, DOI 10.1023/A:1005316711538; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; FOLBERTH W, 1984, INFRARED PHYS, V24, P353, DOI 10.1016/0020-0891(84)90092-7; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gather MC, 2011, NAT PHOTONICS, V5, P406, DOI [10.1038/nphoton.2011.99, 10.1038/NPHOTON.2011.99]; Gilon M, 2008, DIFFERENTIATION, V76, P518, DOI 10.1111/j.1432-0436.2007.00246.x; HALL DB, 1973, J APPL PHYS, V44, P2271, DOI 10.1063/1.1662549; HOH JH, 1994, J CELL SCI, V107, P1105; Jeanes A, 2009, J MOL HISTOL, V40, P395, DOI 10.1007/s10735-010-9253-y; Jones BF, 1998, IEEE T MED IMAGING, V17, P1019, DOI 10.1109/42.746635; Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569; Levayer R, 2012, TRENDS CELL BIOL, V22, P61, DOI 10.1016/j.tcb.2011.10.001; Muller DJ, 2011, CURR BIOL, V21, pR212, DOI 10.1016/j.cub.2011.01.046; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; RAETHER H, 1988, SPRINGER TRAC MOD PH, V111, P1; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sason H, 2009, MOL BIOL CELL, V20, P544, DOI 10.1091/mbc.E08-05-0516; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Singer AJ, 2000, ACAD EMERG MED, V7, P1, DOI 10.1111/j.1553-2712.2000.tb01881.x; STEKETEE J, 1973, PHYS MED BIOL, V18, P686, DOI 10.1088/0031-9155/18/5/307; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Trepat X, 2011, TRENDS CELL BIOL; Ulrich R., 1973, APPL PHYS, V1, P55; Wang CC, 2012, WIRES SYST BIOL MED, V4, P51, DOI 10.1002/wsbm.159; Windt DL, 1998, COMPUT PHYS, V12, P360, DOI 10.1063/1.168689; Wolf E, 2000, PRINCIPLES OPTICS EL; Yashunsky V, 2010, AIP CONF PROC, V1281, P1617, DOI 10.1063/1.3498133; Yashunsky V, 2012, SPIE C P, V8234; Yashunsky V, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.8.081409; Yashunsky V, 2010, BIOPHYS J, V99, P4028, DOI 10.1016/j.bpj.2010.10.017; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639; Zilbershtein A, 2012, VIB SPECTROSC, V61, P43, DOI 10.1016/j.vibspec.2012.01.019	37	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48454	10.1371/journal.pone.0048454	http://dx.doi.org/10.1371/journal.pone.0048454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119025	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500143
J	Jenssen, R; Kloft, M; Zien, A; Sonnenburg, S; Muller, KR				Jenssen, Robert; Kloft, Marius; Zien, Alexander; Sonnenburg, Soeren; Mueller, Klaus-Robert			A Scatter-Based Prototype Framework and Multi-Class Extension of Support Vector Machines	PLOS ONE			English	Article							CLASSIFICATION; ALGORITHM	We provide a novel interpretation of the dual of support vector machines (SVMs) in terms of scatter with respect to class prototypes and their mean. As a key contribution, we extend this framework to multiple classes, providing a new joint Scatter SVM algorithm, at the level of its binary counterpart in the number of optimization variables. This enables us to implement computationally efficient solvers based on sequential minimal and chunking optimization. As a further contribution, the primal problem formulation is developed in terms of regularized risk minimization and the hinge loss, revealing the score function to be used in the actual classification of test patterns. We investigate Scatter SVM properties related to generalization ability, computational efficiency, sparsity and sensitivity maps, and report promising results.	[Jenssen, Robert] Univ Tromso, Dept Phys & Technol, Tromso, Norway; [Kloft, Marius; Mueller, Klaus-Robert] Berlin Inst Technol, Machine Learning Lab, Berlin, Germany; [Zien, Alexander] Mol Hlth GmbH, Heidelberg, Germany; [Sonnenburg, Soeren] TomTom Res, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	UiT The Arctic University of Tromso; Technical University of Berlin; Korea University	Jenssen, R (corresponding author), Univ Tromso, Dept Phys & Technol, Tromso, Norway.	robert.jenssen@uit.no	Muller, Klaus R/C-3196-2013; Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685	Research Council of Norway [171125/V30]; German Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 01-IS07007A]; FP7-ICT Programme of the European Community, under the PASCAL2 Network of Excellence [ICT-216886]; German Science Foundation [DFG MU 987/6-1, RA 1894/1-1]; World Class University Program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology [R31-10008]; German Research Foundation (DFG) [RA 1894/1-1, MU 987/6-1]; German Academic Exchange Service (DAAD)	Research Council of Norway(Research Council of Norway); German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); FP7-ICT Programme of the European Community, under the PASCAL2 Network of Excellence; German Science Foundation(German Research Foundation (DFG)); World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was financed in part by the Research Council of Norway, grant 171125/V30, by the German Bundesministerium fur Bildung und Forschung (BMBF) grant FKZ 01-IS07007A, and by the FP7-ICT Programme of the European Community, under the PASCAL2 Network of Excellence, ICT-216886. This work was also supported by the German Science Foundation (DFG MU 987/6-1, RA 1894/1-1) and by the World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology, under Grant R31-10008. Soren Sonnenburg acknowledges financial support by the German Research Foundation (DFG) under the grant MU 987/6-1 and RA 1894/1-1; Marius Kloft acknowledges a research scholarship by the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengio S., 2010, ADV NEURAL INFORM PR; Bennett K.P., 2000, ICML, P57; Bordes A, 2005, LECT NOTES ARTIF INT, V3720, P505, DOI 10.1007/11564096_48; BOTTOU L, 1994, INT C PATT RECOG, P77, DOI 10.1109/ICPR.1994.576879; Bredensteiner EJ, 1999, COMPUT OPTIM APPL, V12, P53, DOI 10.1023/A:1008663629662; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1965, IEEE TRANS ELECTRON, VEC14, P326, DOI 10.1109/PGEC.1965.264137; Crammer K., 2001, J MACHINE LEARNING R, V2, P265; Crisp DJ, 1999, ADV NEURAL INFORM PR, V11, P244; DUDA RO, 2001, PATTERN CLASSIFICATI; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fei-Fei L., 2004, CVPR WORKSH GEN MOD, P178; Gehler P, 2009, P 12 IEEE INT C COMP; Graf ABA, 2009, NEURAL COMPUT, V21, P272, DOI 10.1162/neco.2009.01-07-443; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; HULL JJ, 1994, IEEE T PATTERN ANAL, V16, P550, DOI 10.1109/34.291440; Jenssen R, 2011, P IEEE WORKSH MACH L; Jenssen R., 2009, 0142009 TU BERL; Jenssen R, 2010, IEEE T PATTERN ANAL, V32, P847, DOI 10.1109/TPAMI.2009.100; Joachims T., 1999, MAKING LARGE SCALE S; Keerthi SS, 2000, IEEE T NEURAL NETWOR, V11, P124, DOI 10.1109/72.822516; Kressel UHG, 1999, ADVANCES IN KERNEL METHODS, P255; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee YK, 2004, J AM STAT ASSOC, V99, P67, DOI 10.1198/016214504000000098; Mavroforakis ME, 2006, INT C PATT RECOG, P564; Mavroforakis ME, 2006, IEEE T NEURAL NETWOR, V17, P671, DOI 10.1109/TNN.2006.873281; Nanculef R., 2009, INT J HYBRID INTELL, V6, P69; Platt JC, 1999, ADVANCES IN KERNEL METHODS, P185; Qiao XY, 2010, J AM STAT ASSOC, V105, P401, DOI 10.1198/jasa.2010.tm08487; Rasmussen PM, 2011, NEUROIMAGE, V55, P1120, DOI 10.1016/j.neuroimage.2010.12.035; Rifkin RM, 2007, J MACH LEARN RES, V8, P441; Scholkopf B, 1999, IEEE T NEURAL NETWOR, V10, P1000, DOI 10.1109/72.788641; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Scholkopf B, 2002, LEARNING KERNELS; Silverman BW, 1986, DENSITY ESTIMATION S, DOI 10.1201/9781315140919; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Theodoridis S., 2008, PATTERN RECOGN, V4th ed.; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Weston J., 1999, P 7 EUR S ART NEUR N, P219	43	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e42947	10.1371/journal.pone.0042947	http://dx.doi.org/10.1371/journal.pone.0042947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118845	gold, Green Submitted, Green Published			2022-12-25	WOS:000310705600001
J	Pettengill, MA; Lam, VW; Ollawa, I; Marques-da-Silva, C; Ojcius, DM				Pettengill, Matthew A.; Lam, Verissa W.; Ollawa, Ikechukwu; Marques-da-Silva, Camila; Ojcius, David M.			Ivermectin Inhibits Growth of Chlamydia trachomatis in Epithelial Cells	PLOS ONE			English	Article							POTENT ANTHELMINTIC AGENTS; AVERMECTINS; FAMILY; RECEPTORS; EFFICACY; PLASMA	Ivermectin is currently approved for treatment of both clinical and veterinary infections by nematodes, including Onchocerca cervicalis in horses and Onchocerca volvulus in humans. However, ivermectin has never been shown to be effective against bacterial pathogens. Here we show that ivermectin also inhibits infection of epithelial cells by the bacterial pathogen, Chlamydia trachomatis, at doses that could be envisioned clinically for sexually-transmitted or ocular infections by Chlamydia.	[Pettengill, Matthew A.; Lam, Verissa W.; Ollawa, Ikechukwu; Marques-da-Silva, Camila; Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA 95344 USA; [Pettengill, Matthew A.] Harvard Univ, Childrens Hosp, Sch Med, Boston, MA 02115 USA; [Marques-da-Silva, Camila] Univ Fed Rio de Janeiro, Biophys Inst Carlos Chagas Filho, Rio De Janeiro, Brazil	University of California System; University of California Merced; Harvard University; Boston Children's Hospital; Harvard Medical School; Universidade Federal do Rio de Janeiro	Ojcius, DM (corresponding author), Univ Calif Merced, Hlth Sci Res Inst, Merced, CA 95344 USA.	dojcius@ucmerced.edu	Marques-da-Silva, Camila/B-9284-2014; Ojcius, David/ABE-6557-2020	Pettengill, Matthew/0000-0002-4579-0187; Ojcius, David/0000-0003-1461-4495; Silva, Camila/0000-0003-1132-1793	National Institutes of Health [R01 DE019444]; University of California Presidential Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Presidential Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Work in the authors' laboratory is supported by National Institutes of Health grant R01 DE019444 and a University of California Presidential Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Baraka OZ, 1996, EUR J CLIN PHARMACOL, V50, P407, DOI 10.1007/s002280050131; Bavoil PM, 2000, MICROBIOL-UK, V146, P2723, DOI 10.1099/00221287-146-11-2723; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; CHABALA JC, 1980, J MED CHEM, V23, P1134, DOI 10.1021/jm00184a014; Chosidow O, 2010, NEW ENGL J MED, V362, P896, DOI 10.1056/NEJMoa0905471; Currie BJ, 2010, NEW ENGL J MED, V362, P717, DOI 10.1056/NEJMct0910329; EGERTON JR, 1979, ANTIMICROB AGENTS CH, V15, P372, DOI 10.1128/AAC.15.3.372; Fields KA, 2006, CHLAMYDIA GENOMICS P, P219; Gokbulut C, 2010, VET PARASITOL, V170, P120, DOI 10.1016/j.vetpar.2010.01.041; MILLER TW, 1979, ANTIMICROB AGENTS CH, V15, P368, DOI 10.1128/AAC.15.3.368; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Omura S, 2004, NAT REV MICROBIOL, V2, P984, DOI 10.1038/nrmicro1048; Pettengill MA, 2012, INFECT IMMU IN PRESS; Pettengill MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008299; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x	18	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48456	10.1371/journal.pone.0048456	http://dx.doi.org/10.1371/journal.pone.0048456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23119027	Green Published, gold, Green Submitted			2022-12-25	WOS:000310705600044
J	Sydow, K; Schmitz, C; von Leitner, EC; von Leitner, R; Klinke, A; Atzler, D; Krebs, C; Wieboldt, H; Ehmke, H; Schwedhelm, E; Meinertz, T; Blankenberg, S; Boger, RH; Magnus, T; Baldus, S; Wenzel, U				Sydow, Karsten; Schmitz, Christine; von Leitner, Eike-Christin; von Leitner, Robin; Klinke, Anna; Atzler, Dorothee; Krebs, Christian; Wieboldt, Hartwig; Ehmke, Heimo; Schwedhelm, Edzard; Meinertz, Thomas; Blankenberg, Stefan; Boeger, Rainer H.; Magnus, Tim; Baldus, Stephan; Wenzel, Ulrich			Dimethylarginine Dimethylaminohydrolase1 Is an Organ-Specific Mediator of End Organ Damage in a Murine Model of Hypertension	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CHRONIC KIDNEY-DISEASE; ASYMMETRIC DIMETHYLARGININE; NITRIC-OXIDE; ANGIOTENSIN-II; L-ARGININE; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; MICE; PROGRESSION	Background: The endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) is an independent predictor of cardiovascular and overall mortality. Moreover, elevated ADMA plasma concentrations are associated with the extent of hypertension. However, data from small-sized clinical trials and experimental approaches using murine transgenic models have revealed conflicting results regarding the impact of ADMA and its metabolizing enzyme dimethylarginine dimethylaminohydrolase (DDAH) in the pathogenesis of hypertension. Methodology/Principal Findings: Therefore, we investigated the role of ADMA and DDAH1 in hypertension-induced end organ damage using the uninephrectomized, deoxycorticosterone actetate salt, and angiotensin II-induced hypertension model in human DDAH1 (hDDAH1) overexpressing and wild-type (WT) mice. ADMA plasma concentrations differed significantly between hDDAH1 and WT mice at baseline, but did not significantly change during the induction of hypertension. hDDAH1 overexpression did not protect against hypertension-induced cardiac fibrosis and hypertrophy. In addition, the hypertension-induced impairment of the endothelium-dependent vasorelaxation of aortic segments ex vivo was not significantly attenuated by hDDAH1 overexpression. However, hDDAH1 mice displayed an attenuated hypertensive inflammatory response in renal tissue, resulting in less hypertensive renal injury. Conclusion/Significance: Our data reveal that hDDAH1 organ-specifically modulates the inflammatory response in this murine model of hypertension. The lack of protection in cardiac and aortic tissues may be due to DDAH1 tissue selectivity and/or the extent of hypertension by the used combined model. However, our study underlines the potency of hDDAH1 overexpression in modulating inflammatory processes as a crucial step in the pathogenesis of hypertension, which needs further experimental and clinical investigation.	[Sydow, Karsten; Schmitz, Christine; von Leitner, Eike-Christin; Klinke, Anna; Wieboldt, Hartwig; Meinertz, Thomas; Blankenberg, Stefan; Baldus, Stephan] Univ Hamburg, Ctr Heart, Univ Hosp Hamburg Eppendorf, Dept Intervent Cardiol, Hamburg, Germany; [von Leitner, Robin; Krebs, Christian] Univ Hosp Hamburg Eppendorf, Dept Nephrol, Hamburg, Germany; [Atzler, Dorothee; Schwedhelm, Edzard; Boeger, Rainer H.] Univ Hosp Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Ehmke, Heimo] Univ Hosp Hamburg Eppendorf, Inst Cellular & Integrat Physiol, Hamburg, Germany; [Magnus, Tim] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Sydow, K (corresponding author), Univ Hamburg, Ctr Heart, Univ Hosp Hamburg Eppendorf, Dept Intervent Cardiol, Hamburg, Germany.	sydow@uke.uni-hamburg.de	Krebs, Christian F/HII-9867-2022	Krebs, Christian F/0000-0003-2739-5578; Atzler, Dorothee/0000-0002-6551-1544	Fachbereich Medizin der Universitat Hamburg [Forschungsforderungsfond F-167-1]	Fachbereich Medizin der Universitat Hamburg	This work was supported by a research grant provided by the Fachbereich Medizin der Universitat Hamburg (Forschungsforderungsfond F-167-1) to Dr. Sydow. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Boger RH, 2009, PHARMACOL RES, V60, P481, DOI 10.1016/j.phrs.2009.07.001; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Brilla CG, 2000, HERZ, V25, P299, DOI 10.1007/s000590050024; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Daiber A, 2005, MOL PHARMACOL, V68, P579, DOI 10.1124/mol.105.011585; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Deschepper CF, 2002, HYPERTENSION, V39, P332, DOI 10.1161/hy0202.102787; Fliser D, 2005, J AM SOC NEPHROL, V16, P2456, DOI 10.1681/ASN.2005020179; Fujimi-Hayashida A, 2011, AM J NEPHROL, V33, P1, DOI 10.1159/000322367; HARRISON DG, 1994, BASIC RES CARDIOL, V89, P87; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; Ishola DA, 2006, NEPHROL DIAL TRANSPL, V21, P591, DOI 10.1093/ndt/gfi303; Jacobi J, 2008, AM J PHYSIOL-HEART C, V294, pH1058, DOI 10.1152/ajpheart.01103.2007; Kielstein JT, 2011, AM J PHYSIOL-RENAL, V301, pF1042, DOI 10.1152/ajprenal.00640.2010; Kielstein JT, 2011, NEPHROL DIAL TRANSPL, V26, P324, DOI 10.1093/ndt/gfq395; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Kirchhoff F, 2008, KIDNEY INT, V73, P643, DOI 10.1038/sj.ki.5002689; Konishi H, 2007, J AM COLL CARDIOL, V49, P1099, DOI 10.1016/j.jacc.2006.10.068; Krebs C, 2007, KIDNEY INT, V72, P725, DOI 10.1038/sj.ki.5002408; Krebs C, 2012, AM J HYPERTENS, V25, P479, DOI 10.1038/ajh.2011.243; Kren S, 1999, KIDNEY INT, V56, P333, DOI 10.1046/j.1523-1755.1999.00527.x; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Leypoldt F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007337; Liao TD, 2008, HYPERTENSION, V52, P256, DOI 10.1161/HYPERTENSIONAHA.108.112706; Martens CR, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/267257; Matsumoto Y, 2007, J AM SOC NEPHROL, V18, P1525, DOI 10.1681/ASN.2006070696; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; MUNZEL T, 1995, P NATL ACAD SCI USA, V92, P5244, DOI 10.1073/pnas.92.11.5244; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Perticone F, 2005, J AM COLL CARDIOL, V46, P518, DOI 10.1016/j.jacc.2005.04.040; Raij L, 1998, HYPERTENSION, V31, P189, DOI 10.1161/01.HYP.31.1.189; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; Sasser JM, 2010, AM J PHYSIOL-REG I, V298, pR740, DOI 10.1152/ajpregu.90875.2008; Schnabel R, 2005, CIRC RES, V97, P53, DOI 10.1161/01.RES.0000181286.44222.61; Schwedhelm E, 2007, J CHROMATOGR B, V851, P211, DOI 10.1016/j.jchromb.2006.11.052; Schwedhelm E, 2009, PHARMACOL RES, V60, P494, DOI 10.1016/j.phrs.2009.08.001; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Surdacki A, 1999, J CARDIOVASC PHARM, V33, P652, DOI 10.1097/00005344-199904000-00020; Sydow K, 2008, ARTERIOSCL THROM VAS, V28, P692, DOI 10.1161/ATVBAHA.108.162073; Tanaka M, 2005, CIRCULATION, V112, P1549, DOI 10.1161/CIRCULATIONAHA.105.537670; Tojo A, 1997, KIDNEY INT, V52, P1593, DOI 10.1038/ki.1997.490; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Wesseling S, 2005, AM J PHYSIOL-RENAL, V288, pF1191, DOI 10.1152/ajprenal.00322.2004; Zhou MS, 2003, HYPERTENSION, V42, P945, DOI 10.1161/01.HYP.0000094220.06020.C8; Zhou XY, 2007, MED CHEM, V3, P61, DOI 10.2174/157340607779317634; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	51	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48150	10.1371/journal.pone.0048150	http://dx.doi.org/10.1371/journal.pone.0048150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110194	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500041
J	Ong, HL; Jang, SI; Ambudkar, IS				Ong, Hwei Ling; Jang, Shyh-Ing; Ambudkar, Indu Suresh			Distinct Contributions of Orai1 and TRPC1 to Agonist-Induced [Ca2+](i) Signals Determine Specificity of Ca2+-Dependent Gene Expression	PLOS ONE			English	Article							ACTIVATES CRAC CHANNELS; OPERATED CA2+ ENTRY; CALCIUM OSCILLATIONS; STIM1 GATES; STORE; INFLUX; ELEMENTARY; MECHANISMS; SENSOR; PORE	Regulation of critical cellular functions, including Ca2+-dependent gene expression, is determined by the temporal and spatial aspects of agonist-induced Ca2+ signals. Stimulation of cells with physiological concentrations of agonists trigger increases [Ca2+](i) due to intracellular Ca2+ release and Ca2+ influx. While Orai1-STIM1 channels account for agonist-stimulated [Ca2+](i) increase as well as activation of NFAT in cells such as lymphocytes, RBL and mast cells, both Orai1-STIM1 and TRPC1-STIM1 channels contribute to [Ca2+](i) increases in human submandibular gland (HSG) cells. However, only Orai1-mediated Ca2+ entry regulates the activation of NFAT in HSG cells. Since both TRPC1 and Orai1 are activated following internal Ca2+ store depletion in these cells, it is not clear how the cells decode individual Ca2+ signals generated by the two channels for the regulation of specific cellular functions. Here we have examined the contributions of Orai1 and TRPC1 to carbachol (CCh)-induced [Ca2+](i) signals and activation of NFAT in single cells. We report that Orai1-mediated Ca2+ entry generates [Ca2+](i) oscillations at different [CCh], ranging from very low to high. In contrast, TRPC1-mediated Ca2+ entry generates sustained [Ca2+](i) elevation at high [CCh] and contributes to frequency of [Ca2+](i) oscillations at lower [agonist]. More importantly, the two channels are coupled to activation of distinct Ca2+ dependent gene expression pathways, consistent with the different patterns of [Ca2+](i) signals mediated by them. Nuclear translocation of NFAT and NFAT-dependent gene expression display "all-or-none" activation that is exclusively driven by local [Ca2+](i) generated by Orai1, independent of global [Ca2+](i) changes or TRPC1-mediated Ca2+ entry. In contrast, Ca2+ entry via TRPC1 primarily regulates NF kappa B-mediated gene expression. Together, these findings reveal that Orai1 and TRPC1 mediate distinct local and global Ca2+ signals following agonist stimulation of cells, which determine the functional specificity of the channels in activating different Ca2+-dependent gene expression pathways.	[Ong, Hwei Ling; Jang, Shyh-Ing; Ambudkar, Indu Suresh] Natl Inst Dent & Craniofacial Res, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ambudkar, IS (corresponding author), Natl Inst Dent & Craniofacial Res, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	indu.ambudkar@nih.gov		Ong, Hwei Ling/0000-0002-7551-6883	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Di Capite J, 2009, FASEB J, V23, P894, DOI 10.1096/fj.08-118935; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hong JH, 2011, TRAFFIC, V12, P232, DOI 10.1111/j.1600-0854.2010.01138.x; Jones BF, 2008, HEPATOLOGY, V48, P1273, DOI 10.1002/hep.22461; Kar P, 2012, P NATL ACAD SCI USA, V109, P6969, DOI 10.1073/pnas.1201204109; Kar P, 2012, CURR BIOL, V22, P242, DOI 10.1016/j.cub.2011.12.025; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma X, 2011, CELL CALCIUM, V50, P502, DOI 10.1016/j.ceca.2011.08.006; MARTIN SC, 1994, FEBS LETT, V352, P32, DOI 10.1016/0014-5793(94)00913-9; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Putney James W Jr, 2004, Sci STKE, V2004, ppe37, DOI 10.1126/stke.2432004pe37; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Scharenberg AM, 2007, NAT REV IMMUNOL, V7, P778, DOI 10.1038/nri2172; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	42	36	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47146	10.1371/journal.pone.0047146	http://dx.doi.org/10.1371/journal.pone.0047146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115638	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200027
J	Pern, F; Bogdanova, N; Schurmann, P; Lin, M; Ay, A; Langer, F; Hillemanns, P; Christiansen, H; Park-Simon, TW; Dork, T				Pern, Franziska; Bogdanova, Natalia; Schuermann, Peter; Lin, Min; Ay, Aysun; Laenger, Florian; Hillemanns, Peter; Christiansen, Hans; Park-Simon, Tjoung-Won; Doerk, Thilo			Mutation Analysis of BRCA1, BRCA2, PALB2 and BRD7 in a Hospital-Based Series of German Patients with Triple-Negative Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; POLY(ADP-RIBOSE) POLYMERASE; POPULATION; PREVALENCE; PHENOTYPE; P53; CARRIERS; GENES	Triple-negative breast cancer (TNBC) is an aggressive form of breast carcinoma with a poor prognosis. Recent evidence suggests that some patients with TNBC harbour germ-line mutations in DNA repair genes which may render their tumours susceptible to novel therapies such as treatment with PARP inhibitors. In the present study, we have investigated a hospital-based series of 40 German patients with TNBC for the presence of germ-line mutations in BRCA1, BRCA2, PALB2, and BRD7 genes. Microfluidic array PCR and next-generation sequencing was used for BRCA1 and BRCA2 analysis while conventional high-resolution melting and Sanger sequencing was applied to study the coding regions of PALB2 and BRD7, respectively. Truncating mutations in BRCA1 were found in six patients, and truncating mutations in BRCA2 and PALB2 were detected in one patient each, whereas no truncating mutation was identified in BRD7. One patient was a double heterozygote for the PALB2 mutation, c.758insT, and a BRCA1 mutation, c.927delA. Our results confirm in a hospital-based setting that a substantial proportion of German TNBC patients (17.5%) harbour germ-line mutations in genes involved in homology-directed DNA repair, with a preponderance of BRCA1 mutations. Triple-negative breast cancer should be considered as an additional criterion for future genetic counselling and diagnostic sequencing.	[Pern, Franziska; Bogdanova, Natalia; Schuermann, Peter; Ay, Aysun; Hillemanns, Peter; Park-Simon, Tjoung-Won; Doerk, Thilo] Hannover Med Sch, Clin Obstet & Gynaecol, D-3000 Hannover, Germany; [Bogdanova, Natalia; Christiansen, Hans] Hannover Med Sch, Clin Radiat Oncol, D-3000 Hannover, Germany; [Lin, Min] Fluidigm Corp, San Francisco, CA USA; [Laenger, Florian] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Dork, T (corresponding author), Hannover Med Sch, Clin Obstet & Gynaecol, D-3000 Hannover, Germany.	doerk.thilo@mh-hannover.de	Dörk, Thilo/J-8620-2012; Bogdanova, Natalia V./Y-2205-2019	Dörk, Thilo/0000-0002-9458-0282; Laenger, Florian/0000-0003-1191-4855				Armes JE, 1999, CANCER RES, V59, P2011; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Backe J, 1999, GYNECOL ONCOL, V72, P402, DOI 10.1006/gyno.1998.5270; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Bayraktar S, 2011, BREAST CANCER RES TR, V130, P145, DOI 10.1007/s10549-011-1711-z; Bogdanova N, 2011, BREAST CANCER RES TR, V126, P545, DOI 10.1007/s10549-010-1290-4; Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Comen E, 2011, BREAST CANCER RES TR, V129, P185, DOI 10.1007/s10549-011-1433-2; Comen EA, 2010, CANCER J, V16, P48, DOI 10.1097/PPO.0b013e3181cf01eb; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Evans DG, 2011, J MED GENET, V48, P520, DOI 10.1136/jmedgenet-2011-100006; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fostira F, 2012, BREAST CANC RES TREA; Foulkes WD, 2004, CLIN CANCER RES, V10, P2029, DOI 10.1158/1078-0432.CCR-03-1061; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Harte MT, 2010, CANCER RES, V70, P2538, DOI 10.1158/0008-5472.CAN-09-2089; Hartman AR, 2012, CANCER-AM CANCER SOC, V118, P2787, DOI 10.1002/cncr.26576; Heidemann S, 2012, BREAST CANC RES TREA; Heikkinen T, 2009, CLIN CANCER RES, V15, P3214, DOI 10.1158/1078-0432.CCR-08-3128; Hellebrand H, 2011, HUM MUTAT, V32, pE2176, DOI 10.1002/humu.21478; Hollants S, 2012, CLIN CHEM, V58, P717, DOI 10.1373/clinchem.2011.173963; Jaspers JE, 2009, BBA-REV CANCER, V1796, P266, DOI 10.1016/j.bbcan.2009.07.001; Kwon JS, 2010, J CLIN ONCOL, V28, P4214, DOI 10.1200/JCO.2010.28.0719; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lavie O, 2011, ANN ONCOL, V22, P964, DOI 10.1093/annonc/mdq460; Meyer P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038361; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Penkert J, 2012, FAM CANC IN PRESS; Phipps AI, 2011, BREAST CANCER RES TR, V126, P671, DOI 10.1007/s10549-010-1148-9; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Robertson L, 2012, BRIT J CANCER, V106, P1234, DOI 10.1038/bjc.2012.31; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Stevens KN, 2012, CANCER RES, V72, P1795, DOI 10.1158/0008-5472.CAN-11-3364; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Young SR, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-86	44	40	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47993	10.1371/journal.pone.0047993	http://dx.doi.org/10.1371/journal.pone.0047993			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110154	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200130
J	Shabani, F; Kumar, L; Taylor, S				Shabani, Farzin; Kumar, Lalit; Taylor, Subhashni			Climate Change Impacts on the Future Distribution of Date Palms: A Modeling Exercise Using CLIMEX	PLOS ONE			English	Article								Climate is changing and, as a consequence, some areas that are climatically suitable for date palm (Phoenix dactylifera L.) cultivation at the present time will become unsuitable in the future. In contrast, some areas that are unsuitable under the current climate will become suitable in the future. Consequently, countries that are dependent on date fruit export will experience economic decline, while other countries' economies could improve. Knowledge of the likely potential distribution of this economically important crop under current and future climate scenarios will be useful in planning better strategies to manage such issues. This study used CLIMEX to estimate potential date palm distribution under current and future climate models by using one emission scenario (A2) with two different global climate models (GCMs), CSIRO-Mk3.0 (CS) and MIROC-H (MR). The results indicate that in North Africa, many areas with a suitable climate for this species are projected to become climatically unsuitable by 2100. In North and South America, locations such as south-eastern Bolivia and northern Venezuela will become climatically more suitable. By 2070, Saudi Arabia, Iraq and western Iran are projected to have a reduction in climate suitability. The results indicate that cold and dry stresses will play an important role in date palm distribution in the future. These results can inform strategic planning by government and agricultural organizations by identifying new areas in which to cultivate this economically important crop in the future and those areas that will need greater attention due to becoming marginal regions for continued date palm cultivation.	[Shabani, Farzin; Kumar, Lalit; Taylor, Subhashni] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of New England	Shabani, F (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	Fshabani@une.edu.au	Kumar, Lalit/A-6397-2011; Taylor, Subhashni/Q-6338-2018; shabani, Farzin/P-1033-2019	Kumar, Lalit/0000-0002-9205-756X; Taylor, Subhashni/0000-0002-1624-0901; shabani, Farzin/0000-0002-5100-8921	university of New England	university of New England	The university of New England have financially supported the Work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS IH, 1991, MYCOL RES, V95, P509, DOI 10.1016/S0953-7562(09)80857-5; Ahmed MVOM, 2011, SCI HORTIC-AMSTERDAM, V127, P367, DOI 10.1016/j.scienta.2010.11.011; Al-Senaidy AM, 2011, SAUDI J BIOL SCI, V18, P293, DOI 10.1016/j.sjbs.2011.04.005; Andrewartha H.G., 1954, DISTRIBUTION ABUNDAN, P782; [Anonymous], 2003, CLIM CHANG HUM HEAL; AUDA H, 1979, RADIAT PHYS CHEM, V14, P775, DOI 10.1016/0146-5724(79)90113-4; Bokhary H A, 2010, Saudi J Biol Sci, V17, P327, DOI 10.1016/j.sjbs.2010.06.005; Burt J, 2005, GROWING DATE PALMS W; Chakraborty S, 1998, AUSTRALAS PLANT PATH, V27, P15, DOI 10.1071/AP98001; Chiew FHS, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P3907; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Elhoumaizi M., 2001, GENETIC RESOURCES CR, V49, P483; Elshibli S., 2009, DATE PALM PHOENIX DA; Eshraghi P, 2005, AFR J BIOTECHNOL, V4, P1309; Gordon HB, 2002, CSIRO MK3 CLIMATE SY; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hasan S., 2006, INT J AGRIC BIOL, V8, P1; HEAKAL MS, 1989, GEODERMA, V44, P261, DOI 10.1016/0016-7061(89)90035-9; Hennessy K., 2007, GLOBAL CLIMATE CHANG; Intergovernmental Panel on Climate Change, 2012, SPEC REP EM SCEN SPE; Jain SM, 2011, DATE PALM BIOTECHNOLOGY, P271, DOI 10.1007/978-94-007-1318-5_14; Jain S. M., 2011, Emirates Journal of Food and Agriculture, V23, P110; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos DJ, 2007, J APPL ECOL, V44, P853, DOI 10.1111/j.1365-2664.2007.01331.x; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Mahmoudi H., 2008, J ORGANIC SYSTEMS, V3, P30; Markhand G., 2000, FRUIT CHARACTERIZATI; Marques J, 2011, PLANT PHYSIOL BIOCH, V49, P388, DOI 10.1016/j.plaphy.2011.02.008; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Saadi I, 2006, PLANT PATHOL, V55, P572, DOI 10.1111/j.1365-3059.2006.01409.x; Shayesteh N., 2010, Julius-Kuhn-Archiv, P151; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; SUPPIAH R, 2007, 4 IPCC, V56, P131; Sutherst R, 1999, IMPACTS GLOBAL CHANG; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst RW, 2005, ENVIRON ENTOMOL, V34, P317, DOI 10.1603/0046-225X-34.2.317; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; Sutherst RW, 2001, INT J PARASITOL, V31, P933, DOI 10.1016/S0020-7519(01)00203-X; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Tengberg M., 2011, J ARID ENVIRON, V5, P1; Woodcock I, 2010, DATE PALM PLANTATION, V16, P26; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152; Zaid A, 2012, DATE PALM CULTIVATIO	47	70	71	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48021	10.1371/journal.pone.0048021	http://dx.doi.org/10.1371/journal.pone.0048021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110162	gold, Green Published, Green Accepted			2022-12-25	WOS:000310310200138
J	Wang, L; Bastiaansen, M; Yang, YF; Hagoort, P				Wang, Lin; Bastiaansen, Marcel; Yang, Yufang; Hagoort, Peter			Information Structure Influences Depth of Syntactic Processing: Event-Related Potential Evidence for the Chomsky Illusion	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; LINGUISTIC FOCUS; MEMORY; ATTENTION; CONTEXT; P600	Information structure facilitates communication between interlocutors by highlighting relevant information. It has previously been shown that information structure modulates the depth of semantic processing. Here we used event-related potentials to investigate whether information structure can modulate the depth of syntactic processing. In question-answer pairs, subtle (number agreement) or salient (phrase structure) syntactic violations were placed either in focus or out of focus through information structure marking. P600 effects to these violations reflect the depth of syntactic processing. For subtle violations, a P600 effect was observed in the focus condition, but not in the non-focus condition. For salient violations, comparable P600 effects were found in both conditions. These results indicate that information structure can modulate the depth of syntactic processing, but that this effect depends on the salience of the information. When subtle violations are not in focus, they are processed less elaborately. We label this phenomenon the Chomsky illusion.	[Wang, Lin; Bastiaansen, Marcel; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Wang, Lin; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Wang, Lin; Bastiaansen, Marcel; Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Chinese Academy of Sciences; Institute of Psychology, CAS; Radboud University Nijmegen	Hagoort, P (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	peter.hagoort@mpi.nl	Hagoort, Peter/B-7417-2012	Bastiaansen, Marcel/0000-0003-2865-7859	Chinese Academy of Sciences (CAS)-Royal Netherlands Academy of Arts and Sciences (KNAW)	Chinese Academy of Sciences (CAS)-Royal Netherlands Academy of Arts and Sciences (KNAW)	This work was supported by the Chinese Academy of Sciences (CAS)-Royal Netherlands Academy of Arts and Sciences (KNAW) Joint PhD Training Program (http://www.knaw.nl/Pages/DEF/27/259.bGFuZz1FTkc.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch S, 1997, MEM COGNITION, V25, P653, DOI 10.3758/BF03211306; Bornkessel-Schlesewsky I, 2008, BRAIN RES REV, V59, P55, DOI 10.1016/j.brainresrev.2008.05.003; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; CUTLER A, 1979, COGNITION, V7, P49, DOI 10.1016/0010-0277(79)90010-6; Delong KA, 2011, PSYCHOPHYSIOLOGY, V48, P1203, DOI 10.1111/j.1469-8986.2011.01199.x; ERICKSON TD, 1981, J VERB LEARN VERB BE, V20, P540, DOI 10.1016/S0022-5371(81)90165-1; Federmeier KD, 2007, BRAIN RES, V1146, P75, DOI 10.1016/j.brainres.2006.06.101; Ferreira F, 2003, COGNITIVE PSYCHOL, V47, P164, DOI 10.1016/S0010-0285(03)00005-7; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Ferreira F, 2007, LANG LINGUIST COMPAS, V1, P71, DOI 10.1111/j.1749-818x.2007.00007.x; Frisch S, 2002, COGNITION, V85, pB83, DOI 10.1016/S0010-0277(02)00126-9; Gimenes M, 2009, EUR J COGN PSYCHOL, V21, P980, DOI 10.1080/09541440802469523; Gimenes M, 2009, LANG COGNITIVE PROC, V24, P440, DOI 10.1080/01690960802193670; Gunter TC, 1999, PSYCHOPHYSIOLOGY, V36, P126, DOI 10.1017/S004857729997155X; Hagiwara H, 2007, J COGNITIVE NEUROSCI, V19, P175, DOI 10.1162/jocn.2007.19.2.175; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Jackendoff R., 2002, FDN LANGUAGE BRAIN M; Jasinskaja E, 2004, INTERDISCIPLINARY ST, V1, P151; Kolk HHJ, 2003, BRAIN LANG, V85, P1, DOI 10.1016/S0093-934X(02)00548-5; Kruijff-Korbayova Ivana, 2003, J LOGIC LANG INFORM, V12, P249, DOI DOI 10.1023/A:1024160025821; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Li XQ, 2008, J COGNITIVE NEUROSCI, V20, P906, DOI 10.1162/jocn.2008.20512; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Sanford AJ, 2002, MIND LANG, V17, P188, DOI 10.1111/1468-0017.00195; Sanford AJ, 2002, TRENDS COGN SCI, V6, P382, DOI 10.1016/S1364-6613(02)01958-7; Sanford AJ, 2006, DISCOURSE PROCESS, V42, P99, DOI 10.1207/s15326950dp4202_1; van Berkum JJA, 1999, J MEM LANG, V41, P147, DOI 10.1006/jmla.1999.2641; Wang L, 2011, NEUROPSYCHOLOGIA, V49, P813, DOI 10.1016/j.neuropsychologia.2010.12.035; Wang L, 2009, BRAIN RES, V1282, P50, DOI 10.1016/j.brainres.2009.05.069; Ward P, 2007, MEM COGNITION, V35, P73, DOI 10.3758/BF03195944	37	22	26	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47917	10.1371/journal.pone.0047917	http://dx.doi.org/10.1371/journal.pone.0047917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026VC	23110131	Green Published, Green Submitted, gold			2022-12-25	WOS:000310310200108
J	Contasti, AL; Tissier, EJ; Johnstone, JF; McLoughlin, PD				Contasti, Adrienne L.; Tissier, Emily J.; Johnstone, Jill F.; McLoughlin, Philip D.			Explaining Spatial Heterogeneity in Population Dynamics and Genetics from Spatial Variation in Resources for a Large Herbivore	PLOS ONE			English	Article							SABLE ISLAND; F-STATISTICS; DIVERSITY; MOORLAND; MOUNTAIN; DENSITY; WATER	Fine-scale spatial variation in genetic relatedness and inbreeding occur across continuous distributions of several populations of vertebrates; however, the basis of observed variation is often left untested. Here we test the hypothesis that prior observations of spatial patterns in genetics for an island population of feral horses (Sable Island, Canada) were the result of spatial variation in population dynamics, itself based in spatial heterogeneity in underlying habitat quality. In order to assess how genetic and population structuring related to habitat, we used hierarchical cluster analysis of water sources and an indicator analysis of the availability of important forage species to identify a longitudinal gradient in habitat quality along the length of Sable Island. We quantify a west-east gradient in access to fresh water and availability of two important food species to horses: sandwort, Honckenya peploides, and beach pea, Lathyrus japonicas. Accordingly, the population clusters into three groups that occupy different island segments (west, central, and east) that vary markedly in their local dynamics. Density, body condition, and survival and reproduction of adult females were highest in the west, followed by central and east areas. These results mirror a previous analysis of genetics, which showed that inbreeding levels are highest in the west (with outbreeding in the east), and that there are significant differences in fixation indices among groups of horses along the length of Sable Island. Our results suggest that inbreeding depression is not an important limiting factor to the horse population. We conclude that where habitat gradients exist, we can anticipate fine-scale heterogeneity in population dynamics and hence genetics.	[Contasti, Adrienne L.; Tissier, Emily J.; Johnstone, Jill F.; McLoughlin, Philip D.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	McLoughlin, PD (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	philip.mcloughlin@usask.ca	Johnstone, Jill F./C-9204-2009	Johnstone, Jill F./0000-0001-6131-9339	Natural Sciences and Engineering Research Council (Canada); Canada Foundation for Innovation; University of Saskatchewan	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); University of Saskatchewan	Funding was provided by the Natural Sciences and Engineering Research Council (Canada), the Canada Foundation for Innovation, and the University of Saskatchewan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CIRCULATION, DOI DOI 10.1161/01.CIR.0000033824.02722.F7; Berger J., 1986, WILD HORSES GREAT BA; Brazeau DA, 2011, AQUAT BIOL, V12, P55, DOI 10.3354/ab00313; Cameron EZ, 2007, BIOL LETTERS, V3, P395, DOI 10.1098/rsbl.2007.0089; Castellan NJ, 1988, NONPARAMETRIC STAT B; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Catling P. M., 1984, Proceedings of the Nova Scotian Institute of Science, V34, P181; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Chesser RK, 1998, J MAMMAL, V79, P713, DOI 10.2307/1383082; CHESSER RK, 1991, GENETICS, V127, P437; Christie B, 1995, HORSES SABLE ISLAND; CLUTTONBROCK TH, 1989, NATURE, V337, P70, DOI 10.1038/337070a0; Coltman DW, 2003, MOL ECOL, V12, P733, DOI 10.1046/j.1365-294X.2003.01762.x; Contasti AL, 2011, THESIS U SASKATCHEWA; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Cullingham CI, 2011, EVOL APPL, V4, P116, DOI 10.1111/j.1752-4571.2010.00142.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edwards MA, 2008, URSUS, V19, P91, DOI 10.2192/1537-6176-19.2.91; Environment Canada, 2011, NAT CLIM DAT INF ARC; Fitze PS, 2011, AM NAT, V178, P256, DOI 10.1086/660826; Fortin D, 2008, ISR J ECOL EVOL, V54, P311, DOI 10.1560/IJEE.54.3-4.311; Freedman B, 2011, CAN FIELD NAT, V125, P200, DOI 10.22621/cfn.v125i3.1222; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GADAGKAR R, 1983, ANIM BEHAV, V31, P26, DOI 10.1016/S0003-3472(83)80170-5; Kenkel NC, 2006, CAN J PLANT SCI, V86, P663, DOI 10.4141/P05-164; Lucas ZL, 2009, CAN J ZOOL, V87, P310, DOI 10.1139/Z09-019; Mauritzen M, 2002, J APPL ECOL, V39, P79, DOI 10.1046/j.1365-2664.2002.00690.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Monard AM, 1996, BEHAVIOUR, V133, P1095, DOI 10.1163/156853996X00611; Morris W. F., 2002, QUANTITATIVE CONSERV; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Plante Y, 2007, J HERED, V98, P594, DOI 10.1093/jhered/esm064; Prystupa JM, 2012, ANIMAL, V6, P19, DOI 10.1017/S1751731111001212; Prystupa JM, 2012, J HERED, V103, P380, DOI 10.1093/jhered/ess003; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; R Development Core Team, 2011, R LANG ENV STAT COMP; Ritter RC, 1995, AFR J ECOL, V33, P395, DOI 10.1111/j.1365-2028.1995.tb01048.x; Roberts D.W., 2010, LABDSV ORDINATION MU; RUBENSTEIN DI, 1981, EQUINE VET J, V13, P27, DOI 10.1111/j.2042-3306.1981.tb03443.x; Stalter R, 2006, J TORREY BOT SOC, V133, P362, DOI 10.3159/1095-5674(2006)133[362:THAEFO]2.0.CO;2; Stopher KV, 2012, EVOLUTION, V66, P2411, DOI 10.1111/j.1558-5646.2012.01620.x; THOULESS CR, 1986, ANIM BEHAV, V34, P1166, DOI 10.1016/S0003-3472(86)80176-2; Tissier EJ, 2011, THESIS U SASKATCHEWA; Van Sickle John, 1997, Journal of Agricultural Biological and Environmental Statistics, V2, P370; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Veran S, 2009, ECOL LETT, V12, P129, DOI 10.1111/j.1461-0248.2008.01268.x; Virgl JA, 2000, CAN J ZOOL, V78, P1483, DOI 10.1139/cjz-78-8-1483; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Welsh DA, 1975, THESIS DALHOUSIE U; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	52	23	23	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47858	10.1371/journal.pone.0047858	http://dx.doi.org/10.1371/journal.pone.0047858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118900	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500040
J	Kim, JW; Kim, ST; Turner, AR; Young, T; Smith, S; Liu, WN; Lindberg, J; Egevad, L; Gronberg, H; Isaacs, WB; Xu, JF				Kim, Jin W.; Kim, Seong-Tae; Turner, Aubrey R.; Young, Tracey; Smith, Shelly; Liu, Wennuan; Lindberg, Johan; Egevad, Lars; Gronberg, Henrik; Isaacs, William B.; Xu, Jianfeng			Identification of New Differentially Methylated Genes That Have Potential Functional Consequences in Prostate Cancer	PLOS ONE			English	Article							INTRAGENIC DNA METHYLATION; ALDEHYDE OXIDASE; CPG ISLANDS; GENOME; HYPERMETHYLATION; COACTIVATORS; QUANTITATION; MICROARRAY; PATTERNS; REVEALS	Many differentially methylated genes have been identified in prostate cancer (PCa), primarily using candidate gene-based assays. Recently, several global DNA methylation profiles have been reported in PCa, however, each of these has weaknesses in terms of ability to observe global DNA methylation alterations in PCa. We hypothesize that there remains unidentified aberrant DNA methylation in PCa, which may be identified using higher resolution assay methods. We used the newly developed Illumina HumanMethylation450 BeadChip in PCa (n = 19) and adjacent normal tissues (n = 4) and combined these with gene expression data for identifying new DNA methylation that may have functional consequences in PCa development and progression. We also confirmed our methylation results in an independent data set. Two aberrant DNA methylation genes were validated among an additional 56 PCa samples and 55 adjacent normal tissues. A total 28,735 CpG sites showed significant differences in DNA methylation (FDR adjusted P<0.05), defined as a mean methylation difference of at least 20% between PCa and normal samples. Furthermore, a total of 122 genes had more than one differentially methylated CpG site in their promoter region and a gene expression pattern that was inverse to the direction of change in DNA methylation (e. g. decreased expression with increased methylation, and vice-versa). Aberrant DNA methylation of two genes, AOX1 and SPON2, were confirmed via bisulfate sequencing, with most of the respective CpG sites showing significant differences between tumor samples and normal tissues. The AOX1 promoter region showed hypermethylation in 92.6% of 54 tested PCa samples in contrast to only three out of 53 tested normal tissues. This study used a new BeadChip combined with gene expression data in PCa to identify novel differentially methylated CpG sites located within genes. The newly identified differentially methylated genes may be used as biomarkers for PCa diagnosis.	[Kim, Jin W.; Kim, Seong-Tae; Turner, Aubrey R.; Young, Tracey; Smith, Shelly; Liu, Wennuan; Xu, Jianfeng] Wake Forest Univ, Ctr Canc Genom, Winston Salem, NC 27109 USA; [Kim, Jin W.; Kim, Seong-Tae; Turner, Aubrey R.; Young, Tracey; Smith, Shelly; Liu, Wennuan; Xu, Jianfeng] Wake Forest Univ, Ctr Genom & Personalized Med Res, Winston Salem, NC 27109 USA; [Kim, Jin W.] Wake Forest Univ, Dept Canc Biol, Winston Salem, NC 27109 USA; [Lindberg, Johan; Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Egevad, Lars] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Isaacs, William B.] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA	Wake Forest University; Wake Forest University; Wake Forest University; Karolinska Institutet; Karolinska Institutet; Johns Hopkins University; Johns Hopkins Medicine	Xu, JF (corresponding author), Wake Forest Univ, Ctr Canc Genom, Winston Salem, NC 27109 USA.	jxu@wfubmc.edu	Kim, Seong-Tae/E-4474-2017	Kim, Seong-Tae/0000-0001-7436-1405; Egevad, Lars/0000-0001-8531-222X; Lindberg, Johan/0000-0003-3610-6774	National Institutes of Health [CA106523, CA95052, CA105055, CA135008, CA133066]; Department of Defense [PC051264]; NATIONAL CANCER INSTITUTE [R01CA105055, R01CA095052, R01CA106523, R01CA135008, R01CA133066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grants CA106523, CA95052, and CA105055 (to JX); CA135008 (to WL and WBI); CA133066 (to WL and JWK) and the Department of Defense grant PC051264 (to JX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; BOVA GS, 1993, CANCER RES, V53, P3869; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Friedlander TW, 2012, CANCER RES, V72, P616, DOI 10.1158/0008-5472.CAN-11-2079; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Jeronimo C, 2001, J NATL CANCER I, V93, P1747, DOI 10.1093/jnci/93.22.1747; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JW, 2009, INT J CANCER, V124, P734, DOI 10.1002/ijc.23972; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Kim SJ, 2011, CANCER LETT, V302, P47, DOI 10.1016/j.canlet.2010.12.010; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Kron K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004830; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mahapatra S, 2012, CLIN CANCER RES, V18, P2882, DOI 10.1158/1078-0432.CCR-11-2090; Malumbres M, 1999, ONCOGENE, V18, P385, DOI 10.1038/sj.onc.1202299; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Oster B, 2011, INT J CANCER, V129, P2855, DOI 10.1002/ijc.25951; Parry R, 2005, CANCER RES, V65, P8397, DOI 10.1158/0008-5472.CAN-05-1203; Pryde DC, 2010, J MED CHEM, V53, P8441, DOI 10.1021/jm100888d; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; SHAW S, 1990, BIOCHEM J, V268, P579, DOI 10.1042/bj2680579; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Shiota M, 2010, MOL ENDOCRINOL, V24, P114, DOI 10.1210/me.2009-0302; Sigruener A, 2007, HORM METAB RES, V39, P781, DOI 10.1055/s-2007-992129; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Vasiljevic N, 2011, DIS MARKERS, V30, P151, DOI 10.3233/DMA-2011-0790; Wirtenberger M, 2006, CARCINOGENESIS, V27, P2201, DOI 10.1093/carcin/bgl067; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006	55	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48455	10.1371/journal.pone.0048455	http://dx.doi.org/10.1371/journal.pone.0048455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119026	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500144
J	Ku, T; Choi, C				Ku, Taeyun; Choi, Chulhee			Noninvasive Optical Measurement of Cerebral Blood Flow in Mice Using Molecular Dynamics Analysis of Indocyanine Green	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; LASER-DOPPLER FLOWMETRY; ACUTE ISCHEMIC-STROKE; IN-VIVO; COMPUTED-TOMOGRAPHY; BOLUS-TRACKING; HUMAN BRAIN; DYE BOLUS; PERFUSION; FLUORESCENCE	In preclinical studies of ischemic brain disorders, it is crucial to measure cerebral blood flow (CBF); however, this requires radiological techniques with heavy instrumentation or invasive procedures. Here, we propose a noninvasive and easy-to-use optical imaging technique for measuring CBF in experimental small animals. Mice were injected with indocyanine green (ICG) via tail-vein catheterization. Time-series near-infrared fluorescence signals excited by 760 nm light-emitting diodes were imaged overhead by a charge-coupled device coupled with an 830 nm bandpass-filter. We calculated four CBF parameters including arrival time, rising time and mean transit time of a bolus and blood flow index based on time and intensity information of ICG fluorescence dynamics. CBF maps were generated using the parameters to estimate the status of CBF, and they dominantly represented intracerebral blood flows in mice even in the presence of an intact skull and scalp. We demonstrated that this noninvasive optical imaging technique successfully detected reduced local CBF during middle cerebral artery occlusion. We further showed that the proposed method is sufficiently sensitive to detect the differences between CBF status in mice anesthetized with either isoflurane or ketamine-xylazine, and monitor the dynamic changes in CBF after reperfusion during transient middle cerebral artery occlusion. The near-infrared optical imaging of ICG fluorescence combined with a time-series analysis of the molecular dynamics can be a useful noninvasive tool for preclinical studies of brain ischemia.	[Ku, Taeyun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Choi, Chulhee] Korea Adv Inst Sci & Technol, KI BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Choi, C (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea.	cchoi@kaist.ac.kr	Choi, Chulhee/C-1642-2011; Ku, Taeyun/T-7080-2019	Choi, Chulhee/0000-0001-5542-9136; Ku, Taeyun/0000-0001-9447-7579	Brain Research Center [2011K000286]; Ministry of Education, Science and Technology, the Republic of Korea	Brain Research Center; Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a grant (2011K000286) from the Brain Research Center of the 21st Century Frontier Research Program, funded by the Ministry of Education, Science and Technology, the Republic of Korea (to C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXEL L, 1980, RADIOLOGY, V137, P679, DOI 10.1148/radiology.137.3.7003648; CARSON ER, 1979, NEW ENGL J MED, V300, P1078, DOI 10.1056/NEJM197905103001904; De Visscher G, 2002, COMP BIOCHEM PHYS A, V132, P87, DOI 10.1016/S1095-6433(01)00533-5; Desmettre T, 2000, SURV OPHTHALMOL, V45, P15, DOI 10.1016/S0039-6257(00)00123-5; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; FUKUDA O, 1995, NEUROSURGERY, V36, P358, DOI 10.1227/00006123-199502000-00016; GOBBEL GT, 1991, STROKE, V22, P768, DOI 10.1161/01.STR.22.6.768; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Hillman EMC, 2011, PHILOS T R SOC A, V369, P4620, DOI 10.1098/rsta.2011.0264; Hoffmann C, 2010, TRANSPL P, V42, P1526, DOI 10.1016/j.transproceed.2010.01.069; HONGO K, 1995, NEUROL RES, V17, P89, DOI 10.1080/01616412.1995.11740293; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Jia YL, 2011, J BIOPHOTONICS, V4, P57, DOI 10.1002/jbio.201000001; KANAYA N, 1995, BRIT J ANAESTH, V74, P164, DOI 10.1093/bja/74.2.164; Kang Y, 2010, INT J CARDIOL, V145, pE99, DOI 10.1016/j.ijcard.2008.12.166; Kang Y, 2010, MICROVASC RES, V80, P552, DOI 10.1016/j.mvr.2010.07.004; Kang Y, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004651, 10.1371/journal.pone.0004275]; Kehl F, 2002, ANESTHESIOLOGY, V97, P1528, DOI 10.1097/00000542-200212000-00027; Keller E, 2003, NEUROIMAGE, V20, P828, DOI 10.1016/S1053-8119(03)00315-X; Kohl-Bareis M, 2002, J BIOMED OPT, V7, P464, DOI 10.1117/1.1482719; Kosior JC, 2010, J MAGN RESON IMAGING, V31, P753, DOI 10.1002/jmri.22052; Kuebler WM, 1998, J CEREBR BLOOD F MET, V18, P445, DOI 10.1097/00004647-199804000-00013; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Liebert A, 2006, NEUROIMAGE, V31, P600, DOI 10.1016/j.neuroimage.2005.12.046; Liebert A, 2005, NEUROIMAGE, V24, P426, DOI 10.1016/j.neuroimage.2004.08.046; Liu X, 2010, OPT EXPRESS, V18, P6300, DOI 10.1364/OE.18.006300; MCCORMICK PW, 1992, J NEUROSURG, V76, P315, DOI 10.3171/jns.1992.76.2.0315; Mizushima Y, 2003, SURG TODAY, V33, P101, DOI 10.1007/s005950300021; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Regillo C D, 1999, Curr Opin Ophthalmol, V10, P189, DOI 10.1097/00055735-199906000-00007; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Steinbrink J, 2008, NEURODEGENER DIS, V5, P296, DOI 10.1159/000135614; Steinkellner O, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505009; Terborg C, 2004, J NEUROL NEUROSUR PS, V75, P38; Terborg C, 2009, EUR NEUROL, V62, P338, DOI 10.1159/000239794; THOMPSON HK, 1964, CIRC RES, V14, P502, DOI 10.1161/01.RES.14.6.502; Thompson JS, 2002, COMPARATIVE MED, V52, P63; Toriumi H, 2009, STROKE, V40, P3378, DOI 10.1161/STROKEAHA.109.558577; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Woitzik J, 2006, STROKE, V37, P1549, DOI 10.1161/01.STR.0000221671.94521.51; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165	44	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48383	10.1371/journal.pone.0048383	http://dx.doi.org/10.1371/journal.pone.0048383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119000	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500120
J	Li, B; Chen, SB; Zeng, SQ; Luo, QM; Li, PC				Li, Bing; Chen, Shangbin; Zeng, Shaoqun; Luo, Qingming; Li, Pengcheng			Modeling the Contributions of Ca2+ Flows to Spontaneous Ca2+ Oscillations and Cortical Spreading Depression-Triggered Ca2+ Waves in Astrocyte Networks	PLOS ONE			English	Article							INTRACELLULAR CALCIUM OSCILLATIONS; IN-SITU; NEURONAL-ACTIVITY; EXTRACELLULAR POTASSIUM; QUANTITATIVE MODEL; MATHEMATICAL-MODEL; CLINICAL-RELEVANCE; MOUSE NEOCORTEX; GLIAL-CELLS; PROPAGATION	Astrocytes participate in brain functions through Ca2+ signals, including Ca2+ waves and Ca2+ oscillations. Currently the mechanisms of Ca2+ signals in astrocytes are not fully clear. Here, we present a computational model to specify the relative contributions of different Ca2+ flows between the extracellular space, the cytoplasm and the endoplasmic reticulum of astrocytes to the generation of spontaneous Ca2+ oscillations (CASs) and cortical spreading depression (CSD)-triggered Ca2+ waves (CSDCWs) in a one-dimensional astrocyte network. This model shows that CASs depend primarily on Ca2+ released from internal stores of astrocytes, and CSDCWs depend mainly on voltage-gated Ca2+ influx. It predicts that voltage-gated Ca2+ influx is able to generate Ca2+ waves during the process of CSD even after depleting internal Ca2+ stores. Furthermore, the model investigates the interactions between CASs and CSDCWs and shows that the pass of CSDCWs suppresses CASs, whereas CASs do not prevent the generation of CSDCWs. This work quantitatively analyzes the generation of astrocytic Ca2+ signals and indicates different mechanisms underlying CSDCWs and non-CSDCWs. Research on the different types of Ca2+ signals might help to understand the ways by which astrocytes participate in information processing in brain functions.	[Li, Bing; Chen, Shangbin; Zeng, Shaoqun; Luo, Qingming; Li, Pengcheng] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Li, Bing; Chen, Shangbin; Zeng, Shaoqun; Luo, Qingming; Li, Pengcheng] Huazhong Univ Sci & Technol, Dept Biomed Engn, Minist Educ, Key Lab Biomed Photon, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, PC (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China.	pengchengli@mail.hust.edu.cn		Li, Bing/0000-0001-8949-733X; Luo, Qingming/0000-0002-6725-9311	Science Fund for Creative Research Group of China [61121004]; National High Technology Research and Development Program of China [2012AA011602]; Program for New Century Excellent Talents in University [NCET-08-0213]; National Natural Science Foundation of China [30970964, 30800339]	Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Science Fund for Creative Research Group of China (Grant No. 61121004), the National High Technology Research and Development Program of China (Grant No. 2012AA011602), the Program for New Century Excellent Talents in University (Grant No. NCET-08-0213), and the National Natural Science Foundation of China (Grant Nos. 30970964, 30800339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado F, 2002, J NEUROSCI, V22, P9430; Akopian G, 1996, GLIA, V17, P181; ATRI A, 1993, BIOPHYS J, V65, P1727, DOI 10.1016/S0006-3495(93)81191-3; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bennett MR, 2008, BIOPHYS J, V95, P5648, DOI 10.1529/biophysj.108.137190; Bennett MR, 2005, BIOPHYS J, V89, P2235, DOI 10.1529/biophysj.105.062968; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Carmignoto G, 1998, J NEUROSCI, V18, P4637; Chapuisat G, 2008, PROG BIOPHYS MOL BIO, V97, P4, DOI 10.1016/j.pbiomolbio.2007.10.004; Charles A, 1998, GLIA, V24, P39, DOI 10.1002/(SICI)1098-1136(199809)24:1<39::AID-GLIA5>3.0.CO;2-W; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; Codazzi F, 2001, CURR BIOL, V11, P1089, DOI 10.1016/S0960-9822(01)00326-8; D'ascenzo M, 2004, GLIA, V45, P354, DOI 10.1002/glia.10336; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; De Pitta M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.030903; Despa SI, 1996, BIOSYSTEMS, V39, P233, DOI 10.1016/0303-2647(96)01619-X; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Ding H, 2008, COMPUTATION VISUALIZ; Dode L, 2001, J BIOL CHEM, V276, P3911, DOI 10.1074/jbc.M007719200; Dronne MA, 2006, J THEOR BIOL, V240, P599, DOI 10.1016/j.jtbi.2005.10.023; Edwards JR, 2010, J THEOR BIOL, V263, P45, DOI 10.1016/j.jtbi.2009.12.002; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Fam SR, 2000, J NEUROSCI, V20, P2800; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Gallagher CJ, 2003, J NEUROSCI, V23, P6728; Goldberg M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000909; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Haas B, 2006, CEREB CORTEX, V16, P237, DOI 10.1093/cercor/bhi101; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Hisatsune C, 2005, J BIOL CHEM, V280, P11723, DOI 10.1074/jbc.M409535200; Hofer T, 2002, J NEUROSCI, V22, P4850, DOI 10.1523/JNEUROSCI.22-12-04850.2002; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kawamura M, 2011, CELL CALCIUM, V49, P249, DOI 10.1016/j.ceca.2011.02.009; Kuga N, 2011, J NEUROSCI, V31, P2607, DOI 10.1523/JNEUROSCI.5319-10.2011; Landeira-Fernandez AM, 2004, AM J PHYSIOL-REG I, V286, pR398, DOI 10.1152/ajpregu.00392.2003; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lavrentovich M, 2008, J THEOR BIOL, V251, P553, DOI 10.1016/j.jtbi.2007.12.011; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Manning TJ, 1997, GLIA, V21, P332; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; Navarrete M, 2012, CEREB CORTEX; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; NEWMAN EA, 1986, SCIENCE, V233, P453, DOI 10.1126/science.3726539; Nimmerjahn A, 2009, J PHYSIOL-LONDON, V587, P1639, DOI 10.1113/jphysiol.2008.167171; OBRENOVITCH TP, 1995, J NEUROPHYSIOL, V73, P2107, DOI 10.1152/jn.1995.73.5.2107; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Parri HR, 2003, NEUROSCIENCE, V120, P979, DOI 10.1016/S0306-4522(03)00379-8; Pasti L, 1997, J NEUROSCI, V17, P7817; Peters O, 2003, J NEUROSCI, V23, P9888; REGGIA JA, 1994, J AM MED INFORM ASSN, P873; Saheki Y, 2005, BRAIN RES, V1055, P196, DOI 10.1016/j.brainres.2005.06.056; Sasaki T, 2011, CEREB CORTEX, V21, P1889, DOI 10.1093/cercor/bhq256; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Schipke CG, 2008, CELL CALCIUM, V43, P285, DOI 10.1016/j.ceca.2007.06.002; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Simard M, 2003, J NEUROSCI, V23, P9254; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; Sneyd J, 2004, P NATL ACAD SCI USA, V101, P1392, DOI 10.1073/pnas.0303472101; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stamatakis M, 2006, J THEOR BIOL, V241, P649, DOI 10.1016/j.jtbi.2006.01.002; Syyong HT, 2009, BRIT J PHARMACOL, V156, P587, DOI 10.1111/j.1476-5381.2008.00063.x; Takata N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002525; Tashiro A, 2002, J NEUROBIOL, V50, P45, DOI 10.1002/neu.10019; Temburni MK, 2001, P NATL ACAD SCI USA, V98, P3631; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Ullah G, 2006, CELL CALCIUM, V39, P197, DOI 10.1016/j.ceca.2005.10.009; Verkhratsky A, 2000, BRAIN RES REV, V32, P380, DOI 10.1016/S0165-0173(99)00093-4; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Zeng SA, 2009, BIOPHYS J, V97, P2429, DOI 10.1016/j.bpj.2009.08.030; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	77	6	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48534	10.1371/journal.pone.0048534	http://dx.doi.org/10.1371/journal.pone.0048534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119049	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500162
J	Soyiri, IN; Reidpath, DD				Soyiri, Ireneous N.; Reidpath, Daniel D.			Humans as Animal Sentinels for Forecasting Asthma Events: Helping Health Services Become More Responsive	PLOS ONE			English	Article							AIR-POLLUTION; CONSULTATIONS; ASSOCIATION	The concept of forecasting asthma using humans as animal sentinels is uncommon. This study explores the plausibility of predicting future asthma daily admissions using retrospective data in London (2005-2006). Negative binomial regressions were used in modeling; allowing the non-contiguous autoregressive components. Selected lags were based on partial autocorrelation function (PACF) plot with a maximum lag of 7 days. The model was contrasted with naive historical and seasonal models. All models were cross validated. Mean daily asthma admission in 2005 was 27.9 and in 2006 it was 28.9. The lags 1, 2, 3, 6 and 7 were independently associated with daily asthma admissions based on their PACF plots. The lag model prediction of peak admissions were often slightly out of synchronization with the actual data, but the days of greater admissions were better matched than the days of lower admissions. A further investigation across various populations is necessary.	[Soyiri, Ireneous N.; Reidpath, Daniel D.] Monash Univ, SEACO, Bandar Sunway, Selangor, Malaysia; [Soyiri, Ireneous N.] Univ Ghana, Sch Publ Hlth, Accra, Ghana	Monash University; Monash University Sunway; University of Ghana	Soyiri, IN (corresponding author), Monash Univ, SEACO, Bandar Sunway, Selangor, Malaysia.	soyiriin@yahoo.com	Soyiri, Ireneous N./H-4594-2011; Soyiri, Ireneous/AAE-7617-2019	Soyiri, Ireneous N./0000-0003-4697-5156; Soyiri, Ireneous/0000-0003-4697-5156; Reidpath, Daniel/0000-0002-8796-0420				ALT JE, 2000, POLITICAL ANAL, V0009; [Anonymous], 2012, NAT MED, V18, P631, DOI 10.1038/nm.2777; [Anonymous], 2008, BRIEF OVERVIEW COUNT; Barnett AG, 2009, ANALYSING SEASONAL H, V168, P139; Bibi H, 2002, CHEST, V122, P1627, DOI 10.1378/chest.122.5.1627; Craigmile PF, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-28; de Graaff MB, 2012, HEALTH RISK SOC, V14, P129, DOI 10.1080/13698575.2012.661040; Eisner MD, 2012, CHEST, V141, P58, DOI 10.1378/chest.11-0020; Erbas B, 2005, INT J ENVIRON HEAL R, V15, P437, DOI 10.1080/09603120500289192; Hajat S, 2001, AM J EPIDEMIOL, V153, P704, DOI 10.1093/aje/153.7.704; Hajat S, 1999, THORAX, V54, P597, DOI 10.1136/thx.54.7.597; Henning Kelly J, 2004, MMWR Suppl, V53, P5; HES, 2008, HES USER GUIDE; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Holgate ST, 1995, ASTHMA AND OUTDOOR A; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Hyndman RJ, 2006, INT J FORECASTING, V22, P679, DOI 10.1016/j.ijforecast.2006.03.001; Johnstone JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00102.1; Koehler AB, 2012, INT J FORECASTING, V28, P477, DOI 10.1016/j.ijforecast.2011.05.001; Kyriakis CS, 2011, ZOONOSES PUBLIC HLTH, V58, P93, DOI 10.1111/j.1863-2378.2009.01301.x; Long JS, 2001, STATA J, V1, P51, DOI 10.1177/1536867X0100100103; Mitchell SM, 2000, WORKING PAPERS; Nitatpattana N, 2011, VECTOR-BORNE ZOONOT, V11, P391, DOI 10.1089/vbz.2010.0035; OBRIEN DJ, 1993, ENVIRON HEALTH PERSP, V99, P351, DOI 10.2307/3431509; Peng RD, 2008, USE R, P1; Pollick M, 2012, WISEGEEK ARTICLES; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reidpath DD, 2000, STAT MED, V19, P1295, DOI 10.1002/(SICI)1097-0258(20000530)19:10<1295::AID-SIM493>3.0.CO;2-Z; Rodrigo GJ, 2004, CHEST, V125, P1081, DOI 10.1378/chest.125.3.1081; Singh JP, 2012, INT J WIREL INF NETW, V19, P38, DOI 10.1007/s10776-011-0163-z; Soyiri IN, 2012, INT J GEN MED, V5, P381, DOI 10.2147/IJGM.S31079; Soyiri IN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027184; Stata SE, 2009, RELEASE 11; Tikka J, 2005, LECT NOTES COMPUT SC, V3512, P1002; Unkel S, 2012, J R STAT SOC A STAT, V175, P49, DOI 10.1111/j.1467-985X.2011.00714.x; Zhang GQ, 1998, INT J FORECASTING, V14, P35, DOI 10.1016/S0169-2070(97)00044-7; Zorn C, 1998, WORKING PAPERS	38	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47823	10.1371/journal.pone.0047823	http://dx.doi.org/10.1371/journal.pone.0047823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	030WJ	23118897	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500037
J	Wang, HE; Shapiro, NI; Griffin, R; Safford, MM; Judd, S; Howard, G				Wang, Henry E.; Shapiro, Nathan I.; Griffin, Russell; Safford, Monika M.; Judd, Suzanne; Howard, George			Chronic Medical Conditions and Risk of Sepsis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES; MYOCARDIAL-INFARCTION; RACIAL-DIFFERENCES; GLYCEMIC CONTROL; MORTALITY; INFLAMMATION; PNEUMONIA; INFECTION; STROKE	Background: We sought to determine the associations between baseline chronic medical conditions and future risk of sepsis. Methods: Longitudinal cohort study using the 30,239 community-dwelling participants of the REGARDS cohort. We determined associations between baseline chronic medical conditions and incident sepsis episodes, defined as hospitalization for an infection with the presence of infection plus two or more systemic inflammatory response syndrome criteria. Results: Over the mean observation time of 4.6 years (February 5, 2003 through October 14, 2011), there were 975 incident cases of sepsis. Incident sepsis episodes were associated with older age (p<0.001), white race (HR 1.39; 95% CI: 1.22-1.59), lower education (p<0.001) and income (p<0.001), tobacco use (p<0.001), and alcohol use (p = 0.02). Incident sepsis episodes were associated with baseline chronic lung disease (adjusted HR 2.43; 95% CI: 2.05-2.86), peripheral artery disease (2.16; 1.58-2.95), chronic kidney disease (1.99; 1.73-2.29), myocardial infarction 1.79 (1.49-2.15), diabetes 1.78 (1.53-2.07), stroke 1.67 (1.34-2.07), deep vein thrombosis 1.63 (1.29-2.06), coronary artery disease 1.61 (1.38-1.87), hypertension 1.49 (1.29-1.74), atrial fibrillation 1.48 (1.21-1.81) and dyslipidemia 1.16 (1.01-1.34). Sepsis risk increased with the number of chronic medical conditions (p<0.001). Conclusions: Individuals with chronic medical conditions are at increased risk of future sepsis events.	[Wang, Henry E.] Univ Alabama Birmingham, Sch Med, Dept Emergency Med, Birmingham, AL 35294 USA; [Shapiro, Nathan I.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Griffin, Russell] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Safford, Monika M.] Univ Alabama Birmingham, Sch Med, Dept Med, Div Prevent Med, Birmingham, AL USA; [Judd, Suzanne; Howard, George] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Harvard University; Beth Israel Deaconess Medical Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, HE (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Emergency Med, Birmingham, AL 35294 USA.	hwang@uabmc.edu	Shapiro, Nathan/F-1718-2016	Griffin, Russell/0000-0002-5004-7996; Howard, George/0000-0002-3068-5720	National Institute for Nursing Research [R01-NR012726]; National Center for Research Resources [UL1-RR025777]; Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services [U01 NS041588]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012726] Funding Source: NIH RePORTER	National Institute for Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by R01-NR012726 from the National Institute for Nursing Research, UL1-RR025777 from the National Center for Research Resources, as well as by grants from the Center for Clinical and Translational Science and the Lister Hill Center for Health Policy of the University of Alabama at Birmingham. The parent study was supported by cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives from these organizations did not have any role in the design and conduct of the study, the collection, management, analysis, and interpretation of the data, or the preparation or approval of the manuscript.	Aird WC, 2007, CURR DRUG TARGETS, V8, P501, DOI 10.2174/138945007780362782; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Bertoni AG, 2001, DIABETES CARE, V24, P1044, DOI 10.2337/diacare.24.6.1044; Brooks-Worrell B, 2012, CLIN EXP IMMUNOL, V167, P40, DOI 10.1111/j.1365-2249.2011.04501.x; Cave MC, 2008, NUTR CLIN PRACT, V23, P16, DOI 10.1177/011542650802300116; Centre for Disease Control Prevention, 1999, MMWR-MORBID MORTAL W, V48, P241, DOI DOI 10.1001/JAMA.281.16.1481; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P763, DOI 10.1097/01.CCM.0000256726.80998.BF; Esper AM, 2006, CRIT CARE MED, V34, P2576, DOI 10.1097/01.CCM.0000239114.50519.0E; Goldstein LB, 2001, CIRCULATION, V103, P163; Gotch FA, 2010, KIDNEY INT, V78, P343, DOI 10.1038/ki.2010.157; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kornum JB, 2008, DIABETES CARE, V31, P1541, DOI 10.2337/dc08-0138; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; Mayr FB, 2010, JAMA-J AM MED ASSOC, V303, P2495, DOI 10.1001/jama.2010.851; Memis D, 2007, J CLIN ANESTH, V19, P186, DOI 10.1016/j.jclinane.2006.10.008; Murray SB, 2006, ACAD EMERG MED, V13, P530, DOI 10.1197/j.aem.2005.11.084; National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rosner SA, 2005, HUM GENET, V118, P287, DOI 10.1007/s00439-005-0052-6; Salman Salam, 2008, J Intensive Care Med, V23, P178, DOI 10.1177/0885066608315838; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Skyler JS, 2009, CIRCULATION, V119, P351, DOI 10.1161/CIRCULATIONAHA.108.191305; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Tousoulis D, 2011, CURR PHARM DESIGN, V17, P4087, DOI 10.2174/138161211798764762; TRAN DD, 1990, CRIT CARE MED, V18, P474, DOI 10.1097/00003246-199005000-00002; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615; Wang HE, 2007, CRIT CARE MED, V35, P1928, DOI 10.1097/01.CCM.0000277043.85378.C1; Wang HE, 2011, AM J NEPHROL, V34, P330, DOI 10.1159/000330673; Wang HE, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-9; Yang Y, 2009, J CRIT CARE; Yende S, 2007, J AM GERIATR SOC, V55, P518, DOI 10.1111/j.1532-5415.2007.01100.x; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	41	194	202	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48307	10.1371/journal.pone.0048307	http://dx.doi.org/10.1371/journal.pone.0048307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118977	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500097
J	Bricchi, I; Bertea, CM; Occhipinti, A; Paponov, IA; Maffei, ME				Bricchi, Irene; Bertea, Cinzia M.; Occhipinti, Andrea; Paponov, Ivan A.; Maffei, Massimo E.			Dynamics of Membrane Potential Variation and Gene Expression Induced by Spodoptera littoralis, Myzus persicae, and Pseudomonas syringae in Arabidopsis	PLOS ONE			English	Article							INTRACELLULAR CALCIUM VARIATIONS; SYSTEMIC ACQUIRED-RESISTANCE; HEAT-SHOCK PROTEINS; PV. TOMATO DC3000; LIMA-BEAN LEAVES; DEFENSE RESPONSES; TRANSCRIPTION FACTOR; SALICYLIC-ACID; PLANT-DEFENSE; OXIDATIVE STRESS	Background: Biotic stress induced by various herbivores and pathogens invokes plant responses involving different defense mechanisms. However, we do not know whether different biotic stresses share a common response or which signaling pathways are involved in responses to different biotic stresses. We investigated the common and specific responses of Arabidopsis thaliana to three biotic stress agents: Spodoptera littoralis, Myzus persicae, and the pathogen Pseudomonas syringae. Methodology/Principal Findings: We used electrophysiology to determine the plasma membrane potential (V-m) and we performed a gene microarray transcriptome analysis on Arabidopsis upon either herbivory or bacterial infection. V-m depolarization was induced by insect attack; however, the response was much more rapid to S. littoralis (30 min -2 h) than to M. persicae (4-6 h). M. persicae differentially regulated almost 10-fold more genes than by S. littoralis with an opposite regulation. M. persicae modulated genes involved in flavonoid, fatty acid, hormone, drug transport and chitin metabolism. S. littoralis regulated responses to heat, transcription and ion transport. The latest V-m depolarization (16 h) was found for P. syringae. The pathogen regulated responses to salicylate, jasmonate and to microorganisms. Despite this late response, the number of genes differentially regulated by P. syringae was closer to those regulated by S. littoralis than by M. persicae. Conclusions/Significance: Arabidopsis plasma membranes respond with a V-m depolarization at times depending on the nature of biotic attack which allow setting a time point for comparative genome-wide analysis. A clear relationship between V-m depolarization and gene expression was found. At V-m depolarization timing, M. persicae regulates a wider array of Arabidopsis genes with a clear and distinct regulation than S. littoralis. An almost completely opposite regulation was observed between the aphid and the pathogen, with the former suppressing and the latter activating Arabidopsis defense responses.	[Bricchi, Irene; Bertea, Cinzia M.; Occhipinti, Andrea; Maffei, Massimo E.] Univ Turin, Dept Life Sci & Syst Biol, Plant Physiol Unit, Innovat Ctr, Turin, Italy; [Paponov, Ivan A.] Univ Freiburg, Fac Biol, Inst Biol Mol Plant Physiol 2, D-79106 Freiburg, Germany	University of Turin; University of Freiburg	Maffei, ME (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Plant Physiol Unit, Innovat Ctr, Turin, Italy.	massimo.maffei@unito.it	Occhipinti, Andrea/E-4607-2017; Maffei, Massimo E/K-9593-2015; Paponov, Ivan A./H-9680-2016; Bertea, Cinzia Margherita/AAH-6434-2019	Occhipinti, Andrea/0000-0003-2723-6374; Maffei, Massimo E/0000-0001-6814-2353; Paponov, Ivan A./0000-0002-2138-0722; Bertea, Cinzia Margherita/0000-0003-2919-0445	Doctorate School of Pharmaceutical and Biomolecular Sciences of the University of Turin, Italy	Doctorate School of Pharmaceutical and Biomolecular Sciences of the University of Turin, Italy	This work was partly funded by the Doctorate School of Pharmaceutical and Biomolecular Sciences of the University of Turin, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alba JM, 2011, J PLANT INTERACT, V6, P221, DOI 10.1080/17429145.2010.551670; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2015, SPRINGERPLUS, DOI DOI 10.1186/s40064-015-1263-5; Anstead J, 2010, ENTOMOL EXP APPL, V134, P170, DOI 10.1111/j.1570-7458.2009.00945.x; Appelhagen I, 2011, GENE, V484, P62, DOI 10.1016/j.gene.2011.05.031; Arimura GI, 2011, INT J MOL SCI, V12, P3723, DOI 10.3390/ijms12063723; Arimura G, 2010, BIOCHEM BIOPH RES CO, V400, P455, DOI 10.1016/j.bbrc.2010.08.134; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Attaran E, 2009, PLANT CELL, V21, P954, DOI 10.1105/tpc.108.063164; Avila CA, 2012, PLANT PHYSIOL, V158, P2028, DOI 10.1104/pp.111.191262; Baxter CEL, 2007, PLANT J, V52, P105, DOI 10.1111/j.1365-313X.2007.03222.x; Bidart-Bouzat MG, 2011, OECOLOGIA, V167, P677, DOI 10.1007/s00442-011-2015-z; Bodenhausen N, 2007, MOL PLANT MICROBE IN, V20, P1406, DOI 10.1094/MPMI-20-11-1406; Boursiac Y, 2007, J BIOENERG BIOMEMBR, V39, P409, DOI 10.1007/s10863-007-9104-z; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bricchi I, 2012, PLANT J IN PRESS; Bricchi I, 2010, PLANTA, V232, P719, DOI 10.1007/s00425-010-1203-0; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Cao J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-465; Chen KG, 2003, PLANT MOL BIOL, V53, P61, DOI 10.1023/B:PLAN.0000009265.72567.58; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Cho HT, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P262; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Chujo T, 2009, BIOSCI BIOTECH BIOCH, V73, P1901, DOI 10.1271/bbb.90262; Couldridge C, 2007, B ENTOMOL RES, V97, P523, DOI 10.1017/S0007485307005160; Czernic P, 1999, PLANT J, V18, P321, DOI 10.1046/j.1365-313X.1999.00447.x; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; de Roman M, 2011, J ECOL, V99, P36, DOI 10.1111/j.1365-2745.2010.01752.x; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; de Vos M, 2007, BIOESSAYS, V29, P871, DOI 10.1002/bies.20624; de Vos M, 2010, P NATL ACAD SCI USA, V107, P14673, DOI 10.1073/pnas.1001539107; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; De-La-Pena C, 2012, MOL PLANT PATHOL, V13, P388, DOI 10.1111/j.1364-3703.2011.00757.x; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; Downes BP, 1998, PLANT MOL BIOL, V37, P437, DOI 10.1023/A:1005920732211; Erb M, 2011, J ECOL, V99, P7, DOI 10.1111/j.1365-2745.2010.01757.x; Farinas B, 2011, PLANT J, V66, P318, DOI 10.1111/j.1365-313X.2011.04484.x; Fluhr R, 2001, PLANT PHYSIOL, V127, P1367, DOI 10.1104/pp.010763; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Gfeller A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3109cm3; Gimenez-Ibanez S, 2010, MICROBES INFECT, V12, P428, DOI 10.1016/j.micinf.2010.03.002; Giordanengo P, 2010, CR BIOL, V333, P516, DOI 10.1016/j.crvi.2010.03.007; Gotz M, 2010, PROTOPLASMA, V243, P95, DOI 10.1007/s00709-009-0064-5; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Gonzali S, 2006, J PLANT RES, V119, P115, DOI 10.1007/s10265-005-0251-1; Guerrieri E, 2008, J PLANT INTERACT, V3, P223, DOI 10.1080/17429140802567173; Hauser M, 2001, MOL MEMBR BIOL, V18, P105, DOI 10.1080/713816114; He ZH, 1998, PLANT J, V14, P55, DOI 10.1046/j.1365-313X.1998.00092.x; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Holtan HE, 2011, PLANT PHYSIOL, V156, P2109, DOI 10.1104/pp.111.177139; Hossain MA, 2011, PLANT PHYSIOL, V156, P430, DOI 10.1104/pp.111.172254; Hu YR, 2012, PLANT SCI, V185, P288, DOI 10.1016/j.plantsci.2011.12.003; Ishikawa K, 2010, PLANT PHYSIOL, V152, P2000, DOI 10.1104/pp.110.153569; Jagadeeswaran G, 2007, PLANT J, V51, P234, DOI 10.1111/j.1365-313X.2007.03130.x; Jan AT, 2011, J PLANT INTERACT, V6, P195, DOI 10.1080/17429145.2010.541944; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Jelenska J, 2010, P NATL ACAD SCI USA, V107, P13177, DOI 10.1073/pnas.0910943107; Kai K, 2011, PLANT BIOTECHNOL-NAR, V28, P379, DOI 10.5511/plantbiotechnology.11.0704b; Kim YK, 2007, PLANT CELL REP, V26, P1179, DOI 10.1007/s00299-007-0340-9; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Krinke O, 2009, PLANT PHYSIOL, V150, P424, DOI 10.1104/pp.108.133595; Kubigsteltig I, 1999, PLANTA, V208, P463, DOI 10.1007/s004250050583; Kuhlmann F, 2010, PLANT BIOLOGY, V12, P676, DOI 10.1111/j.1438-8677.2009.00257.x; Kusnierczyk A, 2007, J EXP BOT, V58, P2537, DOI 10.1093/jxb/erm043; Lattanzio V, 2000, J AGR FOOD CHEM, V48, P5316, DOI 10.1021/jf000229y; Lee JY, 2011, PLANT CELL, V23, P3353, DOI 10.1105/tpc.111.087742; Libault M, 2007, MOL PLANT MICROBE IN, V20, P900, DOI 10.1094/MPMI-20-8-0900; Lin PC, 2011, PLANT J, V65, P253, DOI 10.1111/j.1365-313X.2010.04419.x; Louis J, 2010, PLANT J, V64, P800, DOI 10.1111/j.1365-313X.2010.04378.x; Lu BB, 2011, J BIOSCIENCES, V36, P123, DOI 10.1007/s12038-011-9016-2; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Maffei M, 2004, PLANT PHYSIOL, V134, P1752, DOI 10.1104/pp.103.034165; Maffei ME, 2007, PHYTOCHEMISTRY, V68, P2946, DOI 10.1016/j.phytochem.2007.07.016; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; Mithofer A, 2009, ANNU PLANT REV, V34, P261, DOI 10.1111/b.9781405175326.2009.00009.x; Mithoefer Axel, 2009, V479, P79, DOI 10.1007/978-1-59745-289-2_5; Mohanta TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032822; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Morita M, 2009, P NATL ACAD SCI USA, V106, P2447, DOI 10.1073/pnas.0812512106; Paponov IA, 2008, MOL PLANT, V1, P321, DOI 10.1093/mp/ssm021; Park HJ, 2011, PLANT PATHOLOGY J, V27, P170, DOI 10.5423/PPJ.2011.27.2.170; Pavlova EL, 2009, RUSS J PLANT PHYSL+, V56, P68, DOI 10.1134/S1021443709010105; Perez-Amador MA, 2002, PLANT PHYSIOL, V130, P1454, DOI 10.1104/pp.009951; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pike SM, 2005, PLANT PHYSIOL, V138, P1009, DOI 10.1104/pp.104.047142; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; POWELL G, 1995, EUR J PLANT PATHOL, V101, P411, DOI 10.1007/BF01874855; Qiu YJ, 2012, PLANT J, V69, P489, DOI 10.1111/j.1365-313X.2011.04807.x; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Rawat R, 2009, P NATL ACAD SCI USA, V106, P16883, DOI 10.1073/pnas.0813035106; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rietz S, 2011, NEW PHYTOL, V191, P107, DOI 10.1111/j.1469-8137.2011.03675.x; Rikhvanov EG, 2007, PLANT J, V52, P763, DOI 10.1111/j.1365-313X.2007.03275.x; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rousseaux MC, 2004, OECOLOGIA, V138, P505, DOI 10.1007/s00442-003-1471-5; Roxrud I, 2007, PLANT CELL PHYSIOL, V48, P471, DOI 10.1093/pcp/pcm016; Rozen S, 2000, Methods Mol Biol, V132, P365; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Sharova EI, 2007, RUSS J PLANT PHYSL+, V54, P713, DOI 10.1134/S1021443707060015; Singh AK, 2011, MOL PLANT MICROBE IN, V24, P506, DOI 10.1094/MPMI-09-10-0201; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Son GH, 2012, MOL PLANT MICROBE IN, V25, P48, DOI 10.1094/MPMI-06-11-0165; Song J, 2004, BIOL PLANTARUM, V48, P361, DOI 10.1023/B:BIOP.0000041087.17353.d8; Stacey G, 2002, TRENDS PLANT SCI, V7, P257, DOI 10.1016/S1360-1385(02)02249-5; Stracke R, 2009, PLANTA, V229, P427, DOI 10.1007/s00425-008-0841-y; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsutsui T, 2009, J PLANT RES, V122, P633, DOI 10.1007/s10265-009-0252-6; van Damme M, 2008, PLANT J, V54, P785, DOI 10.1111/j.1365-313X.2008.03427.x; Wan Jinrong, 2002, Funct Integr Genomics, V2, P259, DOI 10.1007/s10142-002-0080-4; Wan JR, 2004, MOL PLANT PATHOL, V5, P125, DOI [10.1111/j.1364-3703.2004.00215.x, 10.1111/J.1364-3703.2004.00215.X]; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wildermuth MC, 2002, NATURE, V417, P571, DOI 10.1038/417571a; Woldemariam MG, 2011, J PLANT INTERACT, V6, P113, DOI 10.1080/17429145.2010.544779; Wrzaczek M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-95; Zebelo SA, 2012, ARTHROPOD-PLANT INTE, V6, P543, DOI 10.1007/s11829-012-9200-9; Zhang JH, 2010, PLANT MOL BIOL REP, V28, P324, DOI 10.1007/s11105-009-0156-6; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106; Zhang SC, 2011, J PLANT PHYSIOL, V168, P2093, DOI 10.1016/j.jplph.2011.06.010	130	36	38	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e46673	10.1371/journal.pone.0046673	http://dx.doi.org/10.1371/journal.pone.0046673			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118859	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705600008
J	Filhol, O; Ciais, D; Lajaunie, C; Charbonnier, P; Foveau, N; Vert, JP; Vandenbrouck, Y				Filhol, Odile; Ciais, Delphine; Lajaunie, Christian; Charbonnier, Peggy; Foveau, Nicolas; Vert, Jean-Philippe; Vandenbrouck, Yves			DSIR: Assessing the Design of Highly Potent siRNA by Testing a Set of Cancer-Relevant Target Genes	PLOS ONE			English	Article							SMALL INTERFERING RNAS; PROTEIN-KINASE CK2; SYSTEMATIC ANALYSIS; MAMMALIAN-CELLS; EFFICACY PREDICTION; SPECIFICITY; INHIBITION; EXPRESSION; GENOME; DETERMINANTS	Chemically synthesized small interfering RNA (siRNA) is a widespread molecular tool used to knock down genes in mammalian cells. However, designing potent siRNA remains challenging. Among tools predicting siRNA efficacy, very few have been validated on endogenous targets in realistic experimental conditions. We previously described a tool to assist efficient siRNA design (DSIR, Designer of siRNA), which focuses on intrinsic features of the siRNA sequence. Here, we evaluated DSIR's performance by systematically investigating the potency of the siRNA it designs to target ten cancer-related genes. mRNA knockdown was measured by quantitative RT-PCR in cell-based assays, revealing that over 60% of siRNA sequences designed by DSIR silenced their target genes by at least 70%. Silencing efficacy was sustained even when low siRNA concentrations were used. This systematic analysis revealed in particular that, for a subset of genes, the efficiency of siRNA constructs significantly increases when the sequence is located closer to the 5'-end of the target gene coding sequence, suggesting the distance to the 5'-end as a new feature for siRNA potency prediction. A new version of DSIR incorporating these new findings, as well as the list of validated siRNA against the tested cancer genes, has been made available on the web (http://biodev.extra.cea.fr/DSIR).	[Filhol, Odile; Ciais, Delphine] CEA, DSV, IRTSV, Lab Biol Canc & Infect, Grenoble, France; [Filhol, Odile; Ciais, Delphine] INSERM, U1036, Grenoble, France; [Filhol, Odile; Ciais, Delphine; Charbonnier, Peggy; Foveau, Nicolas; Vandenbrouck, Yves] Univ Grenoble 1, Grenoble, France; [Lajaunie, Christian; Vert, Jean-Philippe] Mines ParisTech, Ctr Computat Biol, Fontainebleau, France; [Lajaunie, Christian; Vert, Jean-Philippe] Inst Curie, Paris, France; [Lajaunie, Christian; Vert, Jean-Philippe] INSERM, U900, Paris, France; [Charbonnier, Peggy; Foveau, Nicolas; Vandenbrouck, Yves] CEA, DSV, IRTSV, Lab Biol Grande Echelle, Grenoble, France; [Charbonnier, Peggy; Foveau, Nicolas; Vandenbrouck, Yves] INSERM, U1038, Grenoble, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Filhol, O (corresponding author), CEA, DSV, IRTSV, Lab Biol Canc & Infect, Grenoble, France.	odile.filhol-cochet@cea.fr; yves.vandenbrouck@cea.fr	Ciais, Delphine/O-9435-2016; Filhol-Cochet, Odile/I-3962-2016; VANDENBROUCK, Yves/Q-2675-2017	VANDENBROUCK, Yves/0000-0002-1292-373X; Filhol, Odile/0000-0003-1964-7958; Vert, Jean-Philippe/0000-0001-9510-8441; Ciais, Delphine/0000-0002-1649-897X	Ligue Nationale Contre le Cancer	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work is part of the national program called "Cartes d'Identite des Tumeurs'' program (CIT) funded and developed by the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Anderson EM, 2008, RNA, V14, P853, DOI 10.1261/rna.704708; Baeza-Yates R, 1989, NEW APPROACH TEXT SE, P168; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chang IY, 2005, BIOCHEM BIOPH RES CO, V327, P225, DOI 10.1016/j.bbrc.2004.12.008; Chen HY, 2007, J NEURO-ONCOL, V82, P257, DOI 10.1007/s11060-006-9290-2; Dahlgren C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn190; Deshiere, 2012, ONCOGENE IN PRESS; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Gu S, 2005, RNA, V11, P38, DOI 10.1261/rna.7158605; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Hu XY, 2004, NUCLEIC ACIDS RES, V32, P4609, DOI 10.1093/nar/gkh790; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Huppi K, 2005, MOL CELL, V17, P1, DOI 10.1016/j.molcel.2004.12.017; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Klingelhoefer JW, 2009, BIOINFORMATICS, V25, P1594, DOI 10.1093/bioinformatics/btp284; Kruger U, 2007, OLIGONUCLEOTIDES, V17, P237, DOI 10.1089/oli.2006.0065; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Li W, 2007, CELL MOL LIFE SCI, V64, P1785, DOI 10.1007/s00018-007-7057-3; Liu Q, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-181; Matthias P, 2008, CELL CYCLE, V7, P7, DOI 10.4161/cc.7.1.5186; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Metzen Eric, 2007, Biochem J, V408, pe5; Mysara M, 2012, J BIOMED INFORM, V45, P528, DOI 10.1016/j.jbi.2012.02.005; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Overhoff M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh168; Overhoff M, 2005, J MOL BIOL, V348, P871, DOI 10.1016/j.jmb.2005.03.012; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rossi JJ, 2005, NAT BIOTECHNOL, V23, P682, DOI 10.1038/nbt0605-682; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Saetrom P, 2004, BIOCHEM BIOPH RES CO, V321, P247, DOI 10.1016/j.bbrc.2004.06.116; Schaack B, 2004, SMALL INTERFERING RN; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Westerhout EM, 2007, NUCLEIC ACIDS RES, V35, P4322, DOI 10.1093/nar/gkm437; Zhang J, 2007, MOL CARCINOGEN, V46, P665, DOI 10.1002/mc.20330	56	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48057	10.1371/journal.pone.0048057	http://dx.doi.org/10.1371/journal.pone.0048057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118925	Green Published, Green Submitted, gold			2022-12-25	WOS:000310705600023
J	Sato, C; Turkoz, M; Dearborn, JT; Wozniak, DF; Kopan, R; Hass, MR				Sato, Chihiro; Turkoz, Mustafa; Dearborn, Joshua T.; Wozniak, David F.; Kopan, Raphael; Hass, Matthew R.			Loss of RBPj in Postnatal Excitatory Neurons Does Not Cause Neurodegeneration or Memory Impairments in Aged Mice	PLOS ONE			English	Article							NEURAL STEM-CELLS; LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; GAMMA-SECRETASE; HIDRADENITIS SUPPURATIVA; TUMOR-SUPPRESSOR; ACNE INVERSA; J PROMOTES; NOTCH; DROSOPHILA	Previous studies suggest that loss of gamma-secretase activity in postnatal mouse brains causes age-dependent memory impairment and neurodegeneration. Due to the diverse array of gamma-secretase substrates, it remains to be demonstrated whether loss of cleavage of any specific substrate(s) is responsible for these defects. The bulk of the phenotypes observed in mammals deficient for gamma-secretase or exposed to gamma-secretase inhibitors are caused by the loss of Notch receptor proteolysis. Accordingly, inhibition of Notch signaling is the main cause for untoward effects for gamma-secretase inhibitors as therapeutics for Alzheimer's disease. Therefore, we wished to determine if loss of canonical Notch signaling is responsible for the age-dependent neurodegeneration observed upon gamma-secrectase deficiency in the mouse brain. We generated postnatal forebrain-specific RBPj conditional knockout (cKO) mice using the CamKII-Cre driver and examined behavior and brain pathology in 12-18 month old animals. Since all four mammalian Notch receptor homologues signal via this DNA binding protein, these mice lack canonical Notch signaling. We found that loss of RBPj in mature excitatory neurons was well tolerated, with no evidence for neurodegeneration or of learning and memory impairment in mice aged up to 18 months. The only phenotypic deficit we observed in the RBPj-deficient mice was a subtle abnormality in olfactory preferences, particularly in females. We conclude that the loss of canonical Notch signaling through the four receptors is not responsible for age-dependent neurodegeneration or learning and memory deficits seen in gamma-secretase deficient mice.	[Sato, Chihiro; Turkoz, Mustafa; Kopan, Raphael; Hass, Matthew R.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA; [Dearborn, Joshua T.; Wozniak, David F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Hass, MR (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA.	mhass@wustl.edu	Naganawa, Shinji/I-1572-2012; Kopan, Raphael/AAF-1357-2022; Kopan, Raphael/AFG-3275-2022	Naganawa, Shinji/0000-0002-0214-613X; Dearborn, Joshua/0000-0003-0335-1087; Sato, Chihiro/0000-0002-7639-8727; Kopan, Raphael/0000-0002-0350-2730	NRSA training grant [F32GM083604-03]; NIH Neuroscience Blueprint Interdisciplinary Center Core Grant [P30 NS057105]; JSPS;  [RO1 GM54479]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083604, R01GM055479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	NRSA training grant; NIH Neuroscience Blueprint Interdisciplinary Center Core Grant; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by RO1 GM54479 awarded to (RK), NRSA training grant F32GM083604-03 (MRH), NIH Neuroscience Blueprint Interdisciplinary Center Core Grant P30 NS057105 to Washington University (DFW) and JSPS Postdoctoral Fellowship for Research Abroad (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Cau E, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-36; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Endo K, 2012, NAT NEUROSCI, V15, P224, DOI 10.1038/nn.2998; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Fujimoto M, 2009, DEV BIOL, V332, P339, DOI 10.1016/j.ydbio.2009.06.001; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kato H, 1997, DEVELOPMENT, V124, P4133; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Komine O, 2011, DEV BIOL, V354, P44, DOI 10.1016/j.ydbio.2011.03.020; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lapins J, 2001, ARCH DERMATOL, V137, P730; Li CR, 2011, BRIT J DERMATOL, V165, P415, DOI 10.1111/j.1365-2133.2011.10372.x; Li T, 2007, J BIOL CHEM, V282, P32264, DOI 10.1074/jbc.M703649200; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Lieber T, 2011, NEURON, V69, P468, DOI 10.1016/j.neuron.2010.12.015; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Pink AE, 2011, J INVEST DERMATOL, V131, P1568, DOI 10.1038/jid.2011.42; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Presente A, 2002, GENESIS, V34, P165, DOI 10.1002/gene.10149; Presente A, 2001, NEUROREPORT, V12, P3321, DOI 10.1097/00001756-200110290-00035; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Sato C, 2011, CURR ALZHEIMER RES; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Song QX, 2009, J NEUROGENET, V23, P405, DOI 10.3109/01677060903096133; Stratman JL, 2003, TRANSGENIC RES, V12, P521, DOI 10.1023/A:1024225408961; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006; Zheng J, 2012, J BIOL CHEM, V287, P20356, DOI 10.1074/jbc.M112.349738; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	52	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48180	10.1371/journal.pone.0048180	http://dx.doi.org/10.1371/journal.pone.0048180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110206	gold, Green Submitted, Green Published			2022-12-25	WOS:000310262500047
J	Diorio, C; Tomlinson, D; Boydell, KM; Regier, DA; Ethier, MC; Alli, A; Alexander, S; Gassas, A; Taylor, J; Kellow, C; Mills, D; Sung, L				Diorio, Caroline; Tomlinson, Deborah; Boydell, Katherine M.; Regier, Dean A.; Ethier, Marie-Chantal; Alli, Amanda; Alexander, Sarah; Gassas, Adam; Taylor, Jonathan; Kellow, Charis; Mills, Denise; Sung, Lillian			Attitudes toward Infection Prophylaxis in Pediatric Oncology: A Qualitative Approach	PLOS ONE			English	Article							ANTIFUNGAL PROPHYLAXIS; MORTALITY	Background: The risks and benefits of infection prophylaxis are uncertain in children with cancer and thus, preferences should be considered in decision making. The purpose of this report was to describe the attitudes of parents, children and healthcare professionals to infection prophylaxis in pediatric oncology. Methods: The study was completed in three phases: 1) An initial qualitative pilot to identify the main attributes influencing the decision to use infection prophylaxis, which were then incorporated into a discrete choice experiment; 2) A think aloud during the discrete choice experiment in which preferences for infection prophylaxis were elicited quantitatively; and 3) In-depth follow up interviews. Interviews were recorded verbatim and analyzed using an iterative, thematic analysis. Final themes were selected using a consensus approach. Results: A total of 35 parents, 22 children and 28 healthcare professionals participated. All three groups suggested that the most important factor influencing their decision making was the effect of prophylaxis on reducing the chance of death. Themes of importance to the three groups included antimicrobial resistance, side effects of medications, the financial impact of outpatient prophylaxis and the route and schedule of administration. Conclusion: Effect of prophylaxis on risk of death was a key factor in decision making. Other identified factors were antimicrobial resistance, side effects of medication, financial impact and administration details. Better understanding of factors driving decision making for infection prophylaxis will help facilitate future implementation of prophylactic regiments.	[Diorio, Caroline; Tomlinson, Deborah; Ethier, Marie-Chantal; Alli, Amanda; Taylor, Jonathan; Kellow, Charis; Sung, Lillian] Hosp Sick Children, Program Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Boydell, Katherine M.; Mills, Denise] Hosp Sick Children, Community Hlth Syst Resource Grp, Toronto, ON M5G 1X8, Canada; [Alexander, Sarah; Gassas, Adam; Sung, Lillian] Hosp Sick Children, Dept Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Regier, Dean A.] British Columbia Canc Agcy, Canadian Ctr Appl Res Canc Control, Vancouver, BC V5Z 4E6, Canada; [Ethier, Marie-Chantal] McMaster Univ, Program Hlth Res Methodol, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); British Columbia Cancer Agency; McMaster University	Sung, L (corresponding author), Hosp Sick Children, Program Child Hlth Evaluat Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	lillian.sung@sickkids.ca	Boydell, Katherine/J-6419-2014; Boydell, Katherine/AAR-2918-2021	Boydell, Katherine/0000-0002-1464-8532; Boydell, Katherine/0000-0002-1464-8532; Regier, Dean/0000-0001-8876-0511; Diorio, Caroline/0000-0002-8005-3836	New Investigator Award from the Canadian Institutes of Health Research [87719]; Pediatric Oncology Group of Ontario Research Unit	New Investigator Award from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pediatric Oncology Group of Ontario Research Unit	LS is supported by a New Investigator Award from the Canadian Institutes of Health Research (Grant no. 87719). This research is supported by the Pediatric Oncology Group of Ontario Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 2012, PEDIATR BLOOD CANCER, V59, P16, DOI 10.1002/pbc.23416; Braun V., 2006, MAY, V3, P77, DOI 10.1191/1478088706qp063oa; Dvorak CC, 2012, PEDIATR BLOOD CANCER, V59, P21, DOI 10.1002/pbc.23415; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Lehrnbecher T, 2009, BRIT J HAEMATOL, V147, P125, DOI 10.1111/j.1365-2141.2009.07844.x; McCracken G, 1989, LONG INTERVIEW; Robenshtok E, 2007, J CLIN ONCOL, V25, P5471, DOI 10.1200/JCO.2007.12.3851; Ryan M, 2009, HEALTH ECON, V18, P321, DOI 10.1002/hec.1369; Sung LL, 2007, BLOOD, V110, P3532, DOI 10.1182/blood-2007-05-091942; Tuckett Anthony G, 2005, Contemp Nurse, V19, P75	11	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47815	10.1371/journal.pone.0047815	http://dx.doi.org/10.1371/journal.pone.0047815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112849	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200084
J	Garland, P; Broom, LJ; Quraishe, S; Dalton, PD; Skipp, P; Newman, TA; Perry, VH				Garland, Patrick; Broom, Lucy J.; Quraishe, Shmma; Dalton, Paul D.; Skipp, Paul; Newman, Tracey A.; Perry, V. Hugh			Soluble Axoplasm Enriched from Injured CNS Axons Reveals the Early Modulation of the Actin Cytoskeleton	PLOS ONE			English	Article							SPINAL-CORD-INJURY; RAT PERIPHERAL-NERVE; WALLERIAN DEGENERATION; OPTIC-NERVE; CELL-DEATH; NEURONS; TRANSPORT; REGENERATION; HIPPOCAMPAL; RETROGRADE	Axon injury and degeneration is a common consequence of diverse neurological conditions including multiple sclerosis, traumatic brain injury and spinal cord injury. The molecular events underlying axon degeneration are poorly understood. We have developed a novel method to enrich for axoplasm from rodent optic nerve and characterised the early events in Wallerian degeneration using an unbiased proteomics screen. Our detergent-free method draws axoplasm into a dehydrated hydrogel of the polymer poly(2-hydroxyethyl methacrylate), which is then recovered using centrifugation. This technique is able to recover axonal proteins and significantly deplete glial contamination as confirmed by immunoblotting. We have used iTRAQ to compare axoplasm-enriched samples from naive vs injured optic nerves, which has revealed a pronounced modulation of proteins associated with the actin cytoskeleton. To confirm the modulation of the actin cytoskeleton in injured axons we focused on the RhoA pathway. Western blotting revealed an augmentation of RhoA and phosphorylated cofilin in axoplasm-enriched samples from injured optic nerve. To investigate the localisation of these components of the RhoA pathway in injured axons we transected axons of primary hippocampal neurons in vitro. We observed an early modulation of filamentous actin with a concomitant redistribution of phosphorylated cofilin in injured axons. At later time-points, RhoA is found to accumulate in axonal swellings and also colocalises with filamentous actin. The actin cytoskeleton is a known sensor of cell viability across multiple eukaryotes, and our results suggest a similar role for the actin cytoskeleton following axon injury. In agreement with other reports, our data also highlights the role of the RhoA pathway in axon degeneration. These findings highlight a previously unexplored area of axon biology, which may open novel avenues to prevent axon degeneration. Our method for isolating CNS axoplasm also represents a new tool to study axon biology.	[Garland, Patrick; Broom, Lucy J.; Perry, V. Hugh] Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England; [Dalton, Paul D.] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China	University of Southampton; Shanghai Jiao Tong University	Garland, P (corresponding author), Univ Southampton, Southampton Gen Hosp, Ctr Biol Sci, Southampton, Hants, England.	pg1p07@soton.ac.uk	Perry, V. Hugh/Y-2935-2019; Dalton, Paul/AAO-9805-2021; Newman, Tracey A/I-8884-2012	Dalton, Paul/0000-0001-9602-4151; Newman, Tracey A/0000-0002-3727-9258; Garland, Patrick/0000-0002-7679-6426	(EU) NeuroproMiSe [LSHM-CT-2005-018637]; Multiple Sclerosis Society (United Kingdom); Kerkut Trust (United Kingdom)	(EU) NeuroproMiSe; Multiple Sclerosis Society (United Kingdom); Kerkut Trust (United Kingdom)	(EU) NeuroproMiSe: LSHM-CT-2005-018637. Multiple Sclerosis Society (United Kingdom). Kerkut Trust (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin D, 2010, J NEUROTRAUM, V27, P349; Arundell M, 2011, LAB CHIP, V11, P3001, DOI 10.1039/c1lc20120d; Beirowski B, 2010, J NEUROPATH EXP NEUR, V69, P455, DOI 10.1097/NEN.0b013e3181da84db; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Hejcl A, 2008, PHYSIOL RES, V57, pS121, DOI 10.33549/physiolres.931606; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Larsen AK, 2008, BIOCHEM J, V411, P657, DOI 10.1042/BJ20070522; LAWSON LJ, 1994, J NEUROCYTOL, V23, P729, DOI 10.1007/BF01268086; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; MARQUIS JK, 1974, J NEUROCHEM, V23, P1085, DOI 10.1111/j.1471-4159.1974.tb10763.x; Masiero L, 1999, J CELL SCI, V112, P3205; Michaelevski I, 2010, MOL CELL PROTEOMICS, V9, P976, DOI 10.1074/mcp.M900369-MCP200; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Morley SC, 2003, J CELL BIOCHEM, V88, P1066, DOI 10.1002/jcb.10449; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Perlson E, 2004, MOL CELL PROTEOMICS, V3, P510, DOI 10.1074/mcp.M400004-MCP200; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rishal I, 2010, DEV NEUROBIOL, V70, P126, DOI 10.1002/dneu.20755; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; SCHLAEPFER WW, 1979, BRAIN RES, V168, P299, DOI 10.1016/0006-8993(79)90171-9; SCHLAEPFER WW, 1974, BRAIN RES, V78, P71, DOI 10.1016/0006-8993(74)90354-0; SCHMIED R, 1993, J NEUROSCI, V13, P4064; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Thomas SG, 2006, J CELL BIOL, V174, P221, DOI 10.1083/jcb.200604011; VERONESI B, 1988, EXP NEUROL, V101, P176, DOI 10.1016/0014-4886(88)90002-7; Waller A, 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yamagishi S, 2005, J BIOL CHEM, V280, P20384, DOI 10.1074/jbc.M501945200	39	19	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47552	10.1371/journal.pone.0047552	http://dx.doi.org/10.1371/journal.pone.0047552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115653	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000310310200049
J	Ogura, M; Kakuda, T; Takarada, T; Nakamichi, N; Fukumori, R; Kim, YH; Hinoi, E; Yoneda, Y				Ogura, Masato; Kakuda, Takami; Takarada, Takeshi; Nakamichi, Noritaka; Fukumori, Ryo; Kim, Yeong-Hun; Hinoi, Eiichi; Yoneda, Yukio			Promotion of Both Proliferation and Neuronal Differentiation in Pluripotent P19 Cells with Stable Overexpression of the Glutamine Transporter slc38a1	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; RAT NEOCORTICAL ASTROCYTES; EMBRYONAL CARCINOMA-CELLS; CENTRAL-NERVOUS-SYSTEM; GAMMA-GLUTAMYLETHYLAMIDE; STEM-CELLS; THEANINE; BRAIN; EXPRESSION; NEUROGENESIS	Background: We previously demonstrated the functional expression in newborn rat neocortical astrocytes of glutamine transporter (GlnT = slc38a1) believed to predominate in neurons over astroglia in the brain. In order to evaluate the possible role of this transporter in neurogenesis, we attempted to establish stable transfectants of GlnT in mouse embryonal carcinoma P19 cells endowed to proliferate for self-renewal and differentiate into progeny cells such as neurons and astroglia, in addition to in vitro pharmacological profiling of the green tea ingredient theanine, which is shown to be a potent inhibitor of glutamine transport mediated by GlnT in cultured neurons and astroglia. Methodology/Principal Findings: The full-length coding region of rat GlnT was inserted into a vector for gene transfection along with selection by G418, followed by culture with all-trans retinoic acid under floating conditions and subsequent dispersion for spontaneous differentiation under adherent conditions. Stable overexpression of GlnT led to marked increases in the size of round spheres formed during the culture for 4 days and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2Htetrazolium bromide reduction, with concomitant promotion of subsequent differentiation into cells immunoreactive for a neuronal marker protein. In these stable GlnT transfectants before differentiation, drastic upregulation was seen for mRNA expression of several proneural genes with a basic helix-loop-helix domain such as NeuroD1. Although a drastic increase was seen in NeuroD1 promoter activity in stable GlnT transfectants, theanine doubled NeuroD1 promoter activity in stable transfectants of empty vector (EV), without affecting the promoter activity already elevated in GlnT transfectants. Similarly, theanine promoted cellular proliferation and neuronal differentiation in stable EV transfectants, but failed to further stimulate the acceleration of both proliferation and neuronal differentiation found in stable GlnT transfectants. Conclusions/Significance: GlnT would promote both proliferation and neuronal differentiation through a mechanism relevant to the upregulation of particular proneural genes in undifferentiated P19 cells.	[Ogura, Masato; Takarada, Takeshi; Nakamichi, Noritaka; Fukumori, Ryo; Kim, Yeong-Hun; Hinoi, Eiichi; Yoneda, Yukio] Kanazawa Univ, Grad Sch, Mol Pharmacol Lab, Kanazawa, Ishikawa, Japan; [Kakuda, Takami] Itoen Ltd, R&D Div, Makinohara City, Japan	Kanazawa University	Yoneda, Y (corresponding author), Kanazawa Univ, Grad Sch, Mol Pharmacol Lab, Kanazawa, Ishikawa, Japan.	yyoneda@p.kanazawa-u.ac.jp	Nakamichi, Noritaka/D-8403-2015; Ogura, Masato/AAK-1619-2020; Nakamichi, Noritaka/AAB-7388-2020; Yoneda, Yukio/ABI-1864-2020	Nakamichi, Noritaka/0000-0002-0283-3546; Yoneda, Yukio/0000-0002-4624-177X; Ogura, Masato/0000-0001-9557-5023; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22500330, 24650196]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research to T.T. (No. 22500330) and Y.Y. (No. 24650196) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers A, 2001, PFLUG ARCH EUR J PHY, V443, P92, DOI 10.1007/s004240100663; BALCAR VJ, 1975, J NEUROCHEM, V24, P875, DOI 10.1111/j.1471-4159.1975.tb03650.x; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; Broer A, 1999, J NEUROCHEM, V73, P2184; Broer S, 2002, PFLUG ARCH EUR J PHY, V444, P457, DOI 10.1007/s00424-002-0840-y; Casarosa S, 1999, DEVELOPMENT, V126, P525; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995, DOI 10.1152/ajprenal.2001.281.6.F995; Deitmer JW, 2003, J NEUROCHEM, V87, P127, DOI 10.1046/j.1471-4159.2003.01981.x; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dolinska M, 2004, NEUROCHEM INT, V44, P75, DOI 10.1016/S0197-0186(03)00123-2; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Fukui M, 2011, J PHARMACOL SCI, V115, P45, DOI 10.1254/jphs.10254FP; Fukumori R, 2010, J PHARMACOL SCI, V112, P273, DOI 10.1254/jphs.09294FP; Fumarola C, 2005, J CELL PHYSIOL, V204, P155, DOI 10.1002/jcp.20272; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Hatanaka T, 2001, FEBS LETT, V505, P317, DOI 10.1016/S0014-5793(01)02848-4; Heckel T, 2003, NEUROCHEM INT, V43, P289, DOI 10.1016/S0197-0186(03)00014-7; Hinoi E, 2006, J BIOL CHEM, V281, P18015, DOI 10.1074/jbc.M600603200; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kakuda T, 2000, BIOSCI BIOTECH BIOCH, V64, P287, DOI 10.1271/bbb.64.287; Kakuda T, 2002, BIOSCI BIOTECH BIOCH, V66, P2683, DOI 10.1271/bbb.66.2683; Kakuda T, 2000, NEUROSCI LETT, V289, P189, DOI 10.1016/S0304-3940(00)01286-6; Kakuda T, 2008, J NEUROSCI RES, V86, P1846, DOI 10.1002/jnr.21637; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; MUMMERY CL, 1985, DEV BIOL, V109, P402, DOI 10.1016/0012-1606(85)90466-X; Nagaraja TN, 1996, J NEUROCHEM, V66, P1665; Nakajo T, 2005, BIOCHEM BIOPH RES CO, V326, P174, DOI 10.1016/j.bbrc.2004.11.015; Nakamura Y, 2009, J PHARMACOL SCI, V109, P413, DOI 10.1254/jphs.08315FP; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Ogura M, 2007, J CELL PHYSIOL, V212, P375, DOI 10.1002/jcp.21031; Ogura M, 2006, J NEUROSCI RES, V83, P1447, DOI 10.1002/jnr.20855; Ogura M, 2011, NEUROCHEM INT, V58, P504, DOI 10.1016/j.neuint.2011.01.007; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; SCHOUSBOE A, 1979, J NEUROCHEM, V32, P943, DOI 10.1111/j.1471-4159.1979.tb04579.x; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takarada T, 2009, J NEUROCHEM, V110, P1457, DOI 10.1111/j.1471-4159.2009.06225.x; Takarada T, 2009, NEUROSCI LETT, V451, P99, DOI 10.1016/j.neulet.2008.12.037; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tsuge H, 2003, BBA-GEN SUBJECTS, V1620, P47, DOI 10.1016/S0304-4165(02)00504-4; Uno K, 2011, J PHARMACOL SCI, V115, P309, DOI 10.1254/jphs.10310FP; UtsunomiyaTate N, 1996, J BIOL CHEM, V271, P14883, DOI 10.1074/jbc.271.25.14883; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; YOKOGOSHI H, 1995, BIOSCI BIOTECH BIOCH, V59, P615, DOI 10.1271/bbb.59.615; Yoneyama M, 2007, J NEUROCHEM, V100, P1667, DOI 10.1111/j.1471-4159.2006.04322.x	54	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48270	10.1371/journal.pone.0048270	http://dx.doi.org/10.1371/journal.pone.0048270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110224	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200164
J	Wang, T; Liang, ZA; Sandford, AJ; Xiong, XY; Yang, YY; Ji, YL; He, JQ				Wang, Ting; Liang, Zong-An; Sandford, Andrew J.; Xiong, Xing-Yu; Yang, Yin-Yin; Ji, Yu-Lin; He, Jian-Qing			Selection of Suitable Housekeeping Genes for Real-Time Quantitative PCR in CD4+ Lymphocytes from Asthmatics with or without Depression	PLOS ONE			English	Article							QUALITY-OF-LIFE; CD4(+) T-CELLS; MODEL; CYCLOPHILIN; DISORDERS; INFLAMMATION; RECRUITMENT; DISEASE; PHASE; LUNG	Objective: No optimal housekeeping genes (HKGs) have been identified for CD4(+) T cells from non-depressive asthmatic and depressive asthmatic adults for normalizing quantitative real-time PCR (qPCR) assays. The aim of present study was to select appropriate HKGs for gene expression analysis in purified CD4(+) T cells from these asthmatics. Methods: Three groups of subjects (Non-depressive asthmatic, NDA, n = 10, Depressive asthmatic, DA, n = 11, and Healthy control, HC, n = 10 respectively) were studied. qPCR for 9 potential HKGs, namely RNA, 28S ribosomal 1 (RN28S1), ribosomal protein, large, P0 (RPLP0), actin, beta (ACTB), cyclophilin A (PPIA), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), phosphoglycerate kinase 1 (PGK1), beta-2-microglobulin (B2M), glucuronidase, beta (GUSB) and ribosomal protein L13a (RPL13A), was performed. Then the data were analyzed with three different applications namely BestKeeper, geNorm, and NormFinder. Results: The analysis of gene expression data identified B2M and RPLP0 as the most stable reference genes and showed that the level of PPIA was significantly different among subjects of three groups when the two best HKGs identified were applied. Post-hoc analysis by Student-Newman-Keuls correction shows that depressive asthmatics and non-depressive asthmatics exhibited lower expression level of PPIA than healthy controls (p<0.05). Conclusions: B2M and RPLP0 were identified as the most optimal HKGs in gene expression studies involving human blood CD4(+) T cells derived from normal, depressive asthmatics and non-depressive asthmatics. The suitability of using the PPIA gene as the HKG for such studies was questioned due to its low expression in asthmatics.	[Wang, Ting; Liang, Zong-An; Xiong, Xing-Yu; Yang, Yin-Yin; Ji, Yu-Lin; He, Jian-Qing] Sichuan Univ, W China Hosp, Dept Resp Med, Chengdu 610064, Sichuan Provinc, Peoples R China; [Sandford, Andrew J.] Univ British Columbia, St Pauls Hosp, Inst Heart Lung Hlth, UBC James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada	Sichuan University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Ji, YL (corresponding author), Sichuan Univ, W China Hosp, Dept Resp Med, Chengdu 610064, Sichuan Provinc, Peoples R China.	jiyulin@263.net; jianqing.he@hli.ubc.ca	He, Jian-Qing/AAA-6269-2021	He, Jian-Qing/0000-0002-0966-1302	National Natural Science Foundation of China [31071008, 81171320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants No. 31071008, 81171320 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; Balsley MA, 2010, J IMMUNOL, V185, P7663, DOI 10.4049/jimmunol.1001707; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; CORRIGAN CJ, 1988, LANCET, V1, P1129; Damsker JM, 2007, J LEUKOCYTE BIOL, V82, P613, DOI 10.1189/jlb.0506317; Fonceca AM, 2012, THORAX, V67, P42, DOI 10.1136/thoraxjnl-2011-200131; GONZALEZ MC, 1987, AM REV RESPIR DIS, V136, P600, DOI 10.1164/ajrccm/136.3.600; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Humbles AA, 1997, J EXP MED, V186, P601, DOI 10.1084/jem.186.4.601; Irwin MR, 2007, BRAIN BEHAV IMMUN, V21, P374, DOI 10.1016/j.bbi.2007.01.010; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Lavoie KL, 2006, CHEST, V130, P1039, DOI 10.1378/chest.130.4.1039; Mane Viraj P, 2008, J Biomol Tech, V19, P342; Miller AH, 2010, BRAIN BEHAV IMMUN, V24, P1, DOI 10.1016/j.bbi.2009.09.009; Oosthuizen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020527; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Robinson DS, 2010, J ALLERGY CLIN IMMUN, V126, P1081, DOI 10.1016/j.jaci.2010.06.025; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Scott KM, 2007, GEN HOSP PSYCHIAT, V29, P123, DOI 10.1016/j.genhosppsych.2006.12.006; Stemmy EJ, 2011, AM J RESP CELL MOL, V45, P991, DOI 10.1165/rcmb.2011-0007OC; Van den Toorn LM, 2001, AM J RESP CRIT CARE, V164, P2107, DOI 10.1164/ajrccm.164.11.2006165; Van Lieshout RJ, 2009, PSYCHOSOM MED, V71, P187, DOI 10.1097/PSY.0b013e3181907012; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	28	34	35	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48367	10.1371/journal.pone.0048367	http://dx.doi.org/10.1371/journal.pone.0048367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110234	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200167
J	Gawecka, JE; Young-Robbins, SS; Sulzmaier, FJ; Caliva, MJ; Heikkila, MM; Matter, ML; Ramos, JW				Gawecka, Joanna E.; Young-Robbins, Shirley S.; Sulzmaier, Florian J.; Caliva, Maisel J.; Heikkilae, Minna M.; Matter, Michelle L.; Ramos, Joe W.			RSK2 Protein Suppresses Integrin Activation and Fibronectin Matrix Assembly and Promotes Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; TYROSINE PHOSPHORYLATION; CYTOPLASMIC DOMAIN; FILAMIN BINDING; MEK/ERK PATHWAY; TALIN BINDING; MAP KINASE; CANCER; RAS; PEA-15	Modulation of integrin activation is important in many cellular functions including adhesion, migration, and assembly of the extracellular matrix. RSK2 functions downstream of Ras/Raf and promotes tumor cell motility and metastasis. We therefore investigated whether RSK2 affects integrin function. We report that RSK2 mediates Ras/Raf inactivation of integrins. As a result, we find that RSK2 impairs cell adhesion and integrin-mediated matrix assembly and promotes cell motility. Active RSK2 appears to affect integrins by reducing actin stress fibers and disrupting focal adhesions. Moreover, RSK2 co-localizes with the integrin activator talin and is present at integrin cytoplasmic tails. It is thereby in a position to modulate integrin activation and integrin-mediated migration. Activation of RSK2 promotes filamin phosphorylation and binding to integrins. We also find that RSK2 is activated in response to integrin ligation to fibronectin. Thus, RSK2 could participate in a feedback loop controlling integrin function. These results reveal RSK2 as a key regulator of integrin activity and provide a novel mechanism by which it may promote cell migration and cancer metastasis.	[Gawecka, Joanna E.; Young-Robbins, Shirley S.; Sulzmaier, Florian J.; Caliva, Maisel J.; Heikkilae, Minna M.; Ramos, Joe W.] Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Canc Biol Program, Honolulu, HI 96813 USA; [Matter, Michelle L.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Sulzmaier, Florian J.; Ramos, Joe W.] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Ramos, JW (corresponding author), Univ Hawaii Manoa, Univ Hawaii Canc Ctr, Canc Biol Program, 651 Ilalo St, Honolulu, HI 96813 USA.	jramos@cc.hawaii.edu	Matter, Michelle/GSN-9703-2022; Ramos, Joe/G-4074-2010	Ramos, Joe/0000-0002-9708-2115; Matter, Michelle/0000-0002-5988-9663	National Institutes of Health [R01-CA093849, R01-GM088266]; Robert C. Perry Fund of the Hawai'i Community Foundation [20061496]; Department of Defense [05245002]; National Center for Research Resources [P20-RR016453]; NATIONAL CANCER INSTITUTE [R01CA093849] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert C. Perry Fund of the Hawai'i Community Foundation; Department of Defense(United States Department of Defense); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA093849 and R01-GM088266 (to J. W. R.). This work was also supported by Grant 20061496 from the Robert C. Perry Fund of the Hawai'i Community Foundation (to J. W. R.) and Department of Defense Grant 05245002 (to J. W. R.).; Supported by National Center for Research Resources Grant P20-RR016453.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; BECKERLE MC, 1989, J CELL BIOL, V109, P3333, DOI 10.1083/jcb.109.6.3333; Belkin AM, 1997, J CELL BIOL, V139, P1583, DOI 10.1083/jcb.139.6.1583; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; BERTAGNOLLI ME, 1993, J CELL SCI, V106, P1189; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Chou FL, 2003, J BIOL CHEM, V278, P52587, DOI 10.1074/jbc.M309322200; Clark DE, 2005, CANCER RES, V65, P3108; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Glading A, 2007, CANCER RES, V67, P1536, DOI 10.1158/0008-5472.CAN-06-1378; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jockusch BM, 1995, ANNU REV CELL DEV BI, V11, P379, DOI 10.1146/annurev.cellbio.11.1.379; Kang S, 2008, J BIOL CHEM, V283, P4652, DOI 10.1074/jbc.M709673200; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; Kato-Stankiewicz J, 2002, P NATL ACAD SCI USA, V99, P14398, DOI 10.1073/pnas.222222699; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; Lara R, 2011, ONCOGENE, V30, P3513, DOI 10.1038/onc.2011.61; Liu SC, 2000, J CELL SCI, V113, P3563; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Ohta Y, 1996, J BIOL CHEM, V271, P11858, DOI 10.1074/jbc.271.20.11858; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Pearson G, 2000, J BIOL CHEM, V275, P37303, DOI 10.1074/jbc.C000570200; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Ramos JW, 1998, J BIOL CHEM, V273, P33897, DOI 10.1074/jbc.273.51.33897; Renault-Mihara F, 2006, MOL BIOL CELL, V17, P5141, DOI 10.1091/mbc.E05-11-1072; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; SMITH DB, 1993, NUCLEIC ACIDS RES, V21, P359, DOI 10.1093/nar/21.2.359; Smith DB, 2001, CURRENT PROTOCOLS MO, V28; Smith JA, 2005, CANCER RES, V65, P1027; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	56	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43424	43437		10.1074/jbc.M112.423046	http://dx.doi.org/10.1074/jbc.M112.423046			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23118220	Green Published, hybrid			2022-12-25	WOS:000312940800024
J	Noh, EH; Hwang, HS; Hwang, HS; Min, B; Im, E; Chung, KC				Noh, Eun Hye; Hwang, Hee Sook; Hwang, Hee Sun; Min, Boram; Im, Eunju; Chung, Kwang Chul			Covalent NEDD8 Conjugation Increases RCAN1 Protein Stability and Potentiates Its Inhibitory Action on Calcineurin	PLOS ONE			English	Article							SYNDROME CRITICAL REGION; UBIQUITIN-LIKE PROTEIN; KAPPA-B-ALPHA; DOWN-SYNDROME; PROTEASOMAL DEGRADATION; INTERACTING PROTEIN-1; OXIDATIVE STRESS; LIGASE; DSCR1; PHOSPHORYLATION	Similar to ubiquitin, regulatory roles for NEDD8 (neural precursor cell-expressed developmentally down-regulated 8) are being clarified during cell growth, signal transduction, immune response, and development. However, NEDD8 targets and their functional alterations are not well known. Regulator of calcineurin 1 (RCAN1/DSCR1P1) is located near the Down syndrome critical region on the distal part of chromosome 21, and its gene product is an endogenous inhibitor of calcineurin signaling. RCAN1 is modified by ubiquitin and consequently undergoes proteasomal degradation. Here we report that NEDD8 is conjugated to RCAN1 (RCAN1-1S) via three lysine residues, K96, K104, and K107. Neddylation enhances RCAN1 protein stability without affecting its cellular location. In addition, we found that neddylation significantly inhibits proteasomal degradation of RCAN1, which may underlie the ability of NEDD8 to enhance RCAN1 stability. Furthermore, neddylation increases RCAN1 binding to calcineurin, which potentiates its inhibitory activity toward downstream NFAT signaling. The present study provides a new regulatory mechanism of RCAN1 function and highlights an important role for diverse RCAN1-involved cellular physiology.	[Noh, Eun Hye; Hwang, Hee Sook; Hwang, Hee Sun; Min, Boram; Im, Eunju; Chung, Kwang Chul] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea	Yonsei University	Chung, KC (corresponding author), Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	rchnds, rchnds/D-7595-2016; Im, Eunju/Y-2601-2018	Im, Eunju/0000-0002-7839-8878	Korea Healthcare Technology RD Project [A092004, A111653]; Ministry for Health, Welfare & Family Affairs, Republic of Korea; Brain Research Center of the 21st Century Frontier Research Program Technology [2009K-001251]; National Research Foundation of Korea (NRF) [2010-0018916]; Basic Science Research Program through NRF [2012-0000810]; Ministry of Education, Science and Technology (MEST), Republic of Korea	Korea Healthcare Technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Brain Research Center of the 21st Century Frontier Research Program Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Basic Science Research Program through NRF(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants from the Korea Healthcare Technology R&D Project (A092004 and A111653 to K. C. C.) funded by the Ministry for Health, Welfare & Family Affairs, Republic of Korea. This work was also partially supported by grants from the Brain Research Center of the 21st Century Frontier Research Program Technology (2009K-001251 to K. C. C.), the National Research Foundation of Korea (NRF; 2010-0018916 to K. C. C.), and the Basic Science Research Program through NRF (2012-0000810 to K. C. C.) funded by the Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Antoine K, 2005, MOL CELL BIOCHEM, V271, P215, DOI 10.1007/s11010-005-6417-2; Asada S, 2008, INT J MOL MED, V22, P95; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cho YJ, 2005, ARCH BIOCHEM BIOPHYS, V439, P121, DOI 10.1016/j.abb.2005.05.002; Danciu TE, 2012, J BIOL CHEM IN PRESS; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Ho CW, 2011, J BIOL CHEM, V286, P21826, DOI 10.1074/jbc.M111.234914; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kim SS, 2010, GENES GENOM, V32, P578, DOI 10.1007/s13258-010-0109-3; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kishi T, 2007, P NATL ACAD SCI USA, V104, P17418, DOI 10.1073/pnas.0704951104; Kuazi AD, 2003, J PATHOL, V199, P259, DOI 10.1002/path.1283; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Lee JY, 2009, BBA-GEN SUBJECTS, V1790, P1673, DOI 10.1016/j.bbagen.2009.08.005; Lee JW, 2012, BIOCHEM BIOPH RES CO, V420, P404, DOI 10.1016/j.bbrc.2012.03.007; Lee J, 2008, J BIOL CHEM, V283, P3392, DOI 10.1074/jbc.M706707200; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Ma H, 2004, J NEUROCHEM, V88, P1485, DOI 10.1046/j.1471-4159.2003.02294.x; Mori F, 2005, NEUROPATH APPL NEURO, V31, P53, DOI 10.1111/j.1365-2990.2004.00603.x; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Oh Y, 2012, J BIOL CHEM IN PRESS; Oved S, 2006, J BIOL CHEM, V281, P21640, DOI 10.1074/jbc.M513034200; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Porta S, 2007, HUM MOL GENET, V16, P1039, DOI 10.1093/hmg/ddm049; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryu JH, 2011, J BIOL CHEM, V286, P6963, DOI 10.1074/jbc.M110.188706; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Seo SR, 2008, FEBS LETT, V582, P1889, DOI 10.1016/j.febslet.2008.04.059; Skaar JR, 2007, CANCER RES, V67, P2006, DOI 10.1158/0008-5472.CAN-06-3241; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Watson IR, 2006, NEOPLASIA, V8, P655, DOI 10.1593/neo.06439; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yueh A, 2006, J VIROL, V80, P342, DOI 10.1128/JVI.80.1.342-352.2006	52	15	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48315	10.1371/journal.pone.0048315	http://dx.doi.org/10.1371/journal.pone.0048315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118980	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500100
J	Perdiguero, B; Gomez, CE; Najera, JL; Sorzano, COS; Delaloye, J; Gonzalez-Sanz, R; Jimenez, V; Roger, T; Calandra, T; Pantaleo, G; Esteban, M				Perdiguero, Beatriz; Elena Gomez, Carmen; Luis Najera, Jose; Sorzano, Carlos Oscar S.; Delaloye, Julie; Gonzalez-Sanz, Ruben; Jimenez, Victoria; Roger, Thierry; Calandra, Thierry; Pantaleo, Giuseppe; Esteban, Mariano			Deletion of the Viral Anti-Apoptotic Gene F1L in the HIV/AIDS Vaccine Candidate MVA-C Enhances Immune Responses against HIV-1 Antigens	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN DENDRITIC CELLS; CROSS-PRESENTATION; MEMORY RESPONSES; PHASE-1 SAFETY; DNA VACCINE; PROTEIN F1L; ANKARA; IMMUNOGENICITY	Vaccinia virus (VACV) encodes an anti-apoptotic Bcl-2-like protein F1 that acts as an inhibitor of caspase-9 and of the Bak/Bax checkpoint but the role of this gene in immune responses is not known. Because dendritic cells that have phagocytosed apoptotic infected cells cross-present viral antigens to cytotoxic T cells inducing an antigen-specific immunity, we hypothesized that deletion of the viral anti-apoptotic F1L gene might have a profound effect on the capacity of poxvirus vectors to activate specific immune responses to virus-expressed recombinant antigens. This has been tested in a mouse model with an F1L deletion mutant of the HIV/AIDS vaccine candidate MVA-C that expresses Env and Gag-Pol-Nef antigens (MVA-C-Delta F1L). The viral gene F1L is not required for virus replication in cultured cells and its deletion in MVA-C induces extensive apoptosis and expression of immunomodulatory genes in infected cells. Analysis of the immune responses induced in BALB/c mice after DNA prime/MVA boost revealed that, in comparison with parental MVA-C, the mutant MVA-C-Delta F1L improves the magnitude of the HIV-1-specific CD8 T cell adaptive immune responses and impacts on the CD8 T cell memory phase by enhancing the magnitude of the response, reducing the contraction phase and changing the memory differentiation pattern. These findings reveal the immunomodulatory role of F1L and that the loss of this gene is a valid strategy for the optimization of MVA as vaccine vector.	[Perdiguero, Beatriz; Elena Gomez, Carmen; Luis Najera, Jose; Gonzalez-Sanz, Ruben; Jimenez, Victoria; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry] CHU Vaudois, Dept Med, Infect Dis Serv, CH-1011 Lausanne, Switzerland; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry] Univ Lausanne, Lausanne, Switzerland; [Pantaleo, Giuseppe] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Esteban, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	S. Sorzano, Carlos Oscar/ABE-4884-2021; Esteban, Mariano/ABG-5375-2020; Perdiguero, Beatriz/K-6587-2017; González, Rubén/N-7936-2019; Pantaleo, Giuseppe/K-6163-2016; NAJERA, Jose Luis/W-8177-2019; Calandra, Thierry/D-9017-2015; gonzalez, ruben/O-5088-2014; Roger, Thierry/G-2007-2012; Sorzano, Carlos Oscar S S./F-2639-2016; Gomez, Carmen Elena/K-1940-2014	S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Esteban, Mariano/0000-0003-0846-2827; Perdiguero, Beatriz/0000-0001-6276-7766; Calandra, Thierry/0000-0003-3051-1285; Roger, Thierry/0000-0002-9358-0109; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; Najera, jose Luis/0000-0001-7798-3330	Ministry of Science and Innovation of Spain [SAF2008-02036]; Foundation FIPSE; PTVDC/CAVD program; Bill and Melinda Gates Foundation	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation FIPSE; PTVDC/CAVD program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This investigation was supported by grants from the Ministry of Science and Innovation of Spain (SAF2008-02036), Foundation FIPSE and PTVDC/CAVD program with support from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud S, 2010, CLIN VACCINE IMMUNOL, V17, P1124, DOI 10.1128/CVI.00008-10; Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Campbell S, 2010, J BIOL CHEM, V285, P4695, DOI 10.1074/jbc.M109.053769; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Chahroudi A, 2005, J VIROL, V79, P10397, DOI 10.1128/JVI.79.16.10397-10407.2005; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Climent N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019644; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Coulibaly S, 2005, VIROLOGY, V341, P91, DOI 10.1016/j.virol.2005.06.043; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Didierlaurent A, 2004, VACCINE, V22, P3395, DOI 10.1016/j.vaccine.2004.02.025; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Gomez CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035485; Gomez CE, 2012, J VIROL, V86, P5026, DOI 10.1128/JVI.06684-11; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; Ferrer PE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002083; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Flechsig C, 2011, CYTOTHERAPY, V13, P739, DOI 10.3109/14653249.2010.549123; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Gomez CE, 2001, VACCINE, V20, P961, DOI 10.1016/S0264-410X(01)00389-9; Greiner S, 2006, CLIN EXP IMMUNOL, V146, P344, DOI 10.1111/j.1365-2249.2006.03177.x; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kastenmuller W, 2006, VIROLOGY, V350, P276, DOI 10.1016/j.virol.2006.02.039; Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Lanzavecchia A, 2004, NAT IMMUNOL, V5, P1201, DOI 10.1038/ni1204-1201; Larsson M, 2001, EUR J IMMUNOL, V31, P3432, DOI 10.1002/1521-4141(200112)31:12<3432::AID-IMMU3432>3.0.CO;2-R; Lehmann MH, 2009, J VIROL, V83, P2540, DOI 10.1128/JVI.01884-08; Liu L, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-15; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Motta I, 2001, J IMMUNOL, V167, P1795, DOI 10.4049/jimmunol.167.3.1795; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Pantaleo G, 2010, CURR OPIN HIV AIDS, V5, P391, DOI 10.1097/COH.0b013e32833d1e87; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; Postigo A, 2012, J VIROL, V86, P203, DOI 10.1128/JVI.05817-11; Postigo A, 2009, MICROBES INFECT, V11, P1071, DOI 10.1016/j.micinf.2009.08.012; Quakkelaar ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016819; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Robinson HL, 2007, AIDS RES HUM RETROV, V23, P1555, DOI 10.1089/aid.2007.0165; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Shisler JL, 2001, SEMIN IMMUNOL, V13, P67, DOI 10.1006/smim.2000.0297; Sigal LJ, 2000, J EXP MED, V192, P1143, DOI 10.1084/jem.192.8.1143; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; Stewart TL, 2005, J VIROL, V79, P1084, DOI 10.1128/JVI.79.2.1084-1098.2005; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; Sutter Gerd, 2003, Current Drug Targets - Infectious Disorders, V3, P263, DOI 10.2174/1568005033481123; Taylor JM, 2006, VIROLOGY, V344, P139, DOI 10.1016/j.virol.2005.09.032; Taylor JM, 2006, J BIOL CHEM, V281, P39728, DOI 10.1074/jbc.M607465200; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; Wasilenko ST, 2003, P NATL ACAD SCI USA, V100, P14345, DOI 10.1073/pnas.2235583100; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; Wyatt LS, 2009, J VIROL, V83, P7176, DOI 10.1128/JVI.00687-09; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu E, 2011, J BIOL CHEM, V286, P30748, DOI 10.1074/jbc.M111.280149; Zhai DY, 2010, J BIOL CHEM, V285, P5569, DOI 10.1074/jbc.M109.078113; Zhang ZN, 2005, ANN NY ACAD SCI, V1056, P69, DOI 10.1196/annals.1352.005; Zhao XQ, 2002, J VIROL, V76, P3007, DOI 10.1128/JVI.76.6.3007-3014.2002	89	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48524	10.1371/journal.pone.0048524	http://dx.doi.org/10.1371/journal.pone.0048524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119046	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500159
J	Poteet, E; Winters, A; Yan, LJ; Shufelt, K; Green, KN; Simpkins, JW; Wen, Y; Yang, SH				Poteet, Ethan; Winters, Ali; Yan, Liang-Jun; Shufelt, Kyle; Green, Kayla N.; Simpkins, James W.; Wen, Yi; Yang, Shao-Hua			Neuroprotective Actions of Methylene Blue and Its Derivatives	PLOS ONE			English	Article							OXIDATIVE STRESS; LIVER MITOCHONDRIA; OXYGEN-CONSUMPTION; ALZHEIMERS-DISEASE; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; VITAMIN-C; CELL-LINE; INJURY; MEMORY	Methylene blue (MB), the first lead chemical structure of phenothiazine and other derivatives, is commonly used in diagnostic procedures and as a treatment for methemoglobinemia. We have previously demonstrated that MB could function as an alternative mitochondrial electron transfer carrier, enhance cellular oxygen consumption, and provide protection in vitro and in rodent models of Parkinson's disease and stroke. In the present study, we investigated the structure-activity relationships of MB in vitro using MB and six structurally related compounds. MB reduces mitochondrial superoxide production via alternative electron transfer that bypasses mitochondrial complexes I-III. MB mitigates reactive free radical production and provides neuroprotection in HT-22 cells against glutamate, IAA and rotenone toxicity. Distinctly, MB provides no protection against direct oxidative stress induced by glucose oxidase. Substitution of a side chain at MB's 10-nitrogen rendered a 1000-fold reduction of the protective potency against glutamate neurototoxicity. Compounds without side chains at positions 3 and 7, chlorophenothiazine and phenothiazine, have distinct redox potentials compared to MB and are incapable of enhancing mitochondrial electron transfer, while obtaining direct antioxidant actions against glutamate, IAA, and rotenone insults. Chlorophenothiazine exhibited direct antioxidant actions in mitochondria lysate assay compared to MB, which required reduction by NADH and mitochondria. MB increased complex IV expression and activity, while 2-chlorphenothiazine had no effect. Our study indicated that MB could attenuate superoxide production by functioning as an alternative mitochondrial electron transfer carrier and as a regenerable anti-oxidant in mitochondria.	[Poteet, Ethan; Winters, Ali; Yan, Liang-Jun; Simpkins, James W.; Wen, Yi; Yang, Shao-Hua] Univ N Texas, Hlth Sci Ctr Ft Worth, Inst Alzheimers Dis & Aging Res, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Shufelt, Kyle; Green, Kayla N.] Texas Christian Univ, Dept Chem, Ft Worth, TX 76129 USA	University of North Texas System; University of North Texas Health Science Center; Texas Christian University	Yang, SH (corresponding author), Univ N Texas, Hlth Sci Ctr Ft Worth, Inst Alzheimers Dis & Aging Res, Dept Pharmacol & Neurosci, Ft Worth, TX USA.	shaohua.yang@unthsc.edu	Yang, Shaohua/D-1738-2013; Green, Kayla N./P-3481-2014	Green, Kayla N./0000-0001-8816-7646; Yan, Liang-Jun/0000-0002-5815-5430	National Institutes of Health [R01NS054687, R01NS054651]; ECP [T32 AG020494]; Robert A. Welch Foundation [P-1760]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054687, R01NS054651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ECP; Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partly supported by National Institutes of Health grants R01NS054687 (SY), R01NS054651 (SY), and ECP is a predoctoral trainee supported by T32 AG020494. The Robert A. Welch Foundation to KG (P-1760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Atamna H, 2010, J ALZHEIMERS DIS, V20, pS439, DOI 10.3233/JAD-2010-100414; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Barron E S, 1930, J Exp Med, V52, P447, DOI 10.1084/jem.52.3.447; Barron ESG, 1930, J GEN PHYSIOL, V13, P483, DOI 10.1085/jgp.13.4.483; Bergen DC, 2008, ARCH NEUROL-CHICAGO, V65, P154, DOI DOI 10.1001/ARCHNEUROL.2007.19; BERNHEIM MARY L. C., 1959, PROC SOC EXPTL BIOL AND MED, V102, P660; Biaglow JE, 1998, INT J RADIAT ONCOL, V42, P769, DOI 10.1016/S0360-3016(98)00313-7; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; Callaway NL, 2004, PHARMACOL BIOCHEM BE, V77, P175, DOI 10.1016/j.pbb.2003.10.007; Clifton Jack 2nd, 2003, Am J Ther, V10, P289; Dickens F, 1933, BIOCHEM J, V27, P1141, DOI 10.1042/bj0271141; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P259, DOI 10.1016/0005-2728(71)90093-4; Dykens JA, 2002, MITOCHONDRION, V1, P461, DOI 10.1016/S1567-7249(02)00011-9; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Galzigna L, 1996, FREE RADICAL BIO MED, V20, P807, DOI 10.1016/0891-5849(95)02213-9; GILLE JJP, 1992, MUTAT RES, V275, P405, DOI 10.1016/0921-8734(92)90043-O; Gonzalez-Lima F, 2004, LEARN MEMORY, V11, P633, DOI 10.1101/lm.82404; Hajieva P, 2009, J NEUROCHEM, V110, P118, DOI 10.1111/j.1471-4159.2009.06114.x; Kamat CD, 2008, J ALZHEIMERS DIS, V15, P473; KEILIN D, 1952, BIOCHEM J, V50, P331, DOI 10.1042/bj0500331; Kwok Edmund S H, 2006, J Intensive Care Med, V21, P359, DOI 10.1177/0885066606290671; Lapchak PA, 2007, NEUROSCIENCE, V150, P585, DOI 10.1016/j.neuroscience.2007.09.033; Laurin D, 2002, JAMA-J AM MED ASSOC, V288, P2266, DOI 10.1001/jama.288.18.2266; May JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1390, DOI 10.1152/ajpcell.00512.2003; Michaelis L, 1936, J BIOL CHEM, V113, P717; Mocko JB, 2010, NEUROBIOL DIS, V40, P120, DOI 10.1016/j.nbd.2010.03.019; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Muratsubaki H, 2008, CELL BIOCHEM FUNCT, V26, P275, DOI 10.1002/cbf.1429; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; Panee J, 2007, INT J BIOL SCI, V3, P335; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Rego AC, 1999, NEUROCHEM RES, V24, P351, DOI 10.1023/A:1020977331372; Riha PD, 2005, EUR J PHARMACOL, V511, P151, DOI 10.1016/j.ejphar.2005.02.001; Rojas JC, 2009, NEUROSCIENCE, V163, P877, DOI 10.1016/j.neuroscience.2009.07.012; Rojas JC, 2009, NEUROTOX RES, V15, P260, DOI 10.1007/s12640-009-9027-z; ROLLER SD, 1984, J CHEM TECH BIOT B, V34, P3; Sanchez-Moreno C, 2004, STROKE, V35, P163, DOI 10.1161/01.STR.0000105391.62306.2E; Schirmer RH, 2003, REDOX REP, V8, P272, DOI 10.1179/135100003225002899; Sigalov E, 2000, J MOL NEUROSCI, V15, P147, DOI 10.1385/JMN:15:3:147; SIMON RH, 1981, J BIOL CHEM, V256, P7181; Visarius TM, 1997, FEBS LETT, V412, P157, DOI 10.1016/S0014-5793(97)00767-9; WEINSTEIN J, 1964, J BIOL CHEM, V239, P3031; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yan LJ, 2009, ANAL BIOCHEM, V389, P143, DOI 10.1016/j.ab.2009.03.043	50	106	110	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48279	10.1371/journal.pone.0048279	http://dx.doi.org/10.1371/journal.pone.0048279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118969	Green Submitted, gold, Green Published			2022-12-25	WOS:000310600500088
J	Sanchez-Ponce, D; DeFelipe, J; Garrido, JJ; Munoz, A				Sanchez-Ponce, Diana; DeFelipe, Javier; Jose Garrido, Juan; Munoz, Alberto			Developmental Expression of Kv Potassium Channels at the Axon Initial Segment of Cultured Hippocampal Neurons	PLOS ONE			English	Article							ACTION-POTENTIAL INITIATION; KV2.1 K+ CHANNEL; GATED ION CHANNELS; KAPPA-B-ALPHA; DELAYED RECTIFIER; SODIUM-CHANNELS; KCNQ CHANNELS; ANKYRIN-G; MOLECULAR RELATIONSHIPS; INTERNATIONAL-UNION	Axonal outgrowth and the formation of the axon initial segment (AIS) are early events in the acquisition of neuronal polarity. The AIS is characterized by a high concentration of voltage-dependent sodium and potassium channels. However, the specific ion channel subunits present and their precise localization in this axonal subdomain vary both during development and among the types of neurons, probably determining their firing characteristics in response to stimulation. Here, we characterize the developmental expression of different subfamilies of voltage-gated potassium channels in the AISs of cultured mouse hippocampal neurons, including subunits Kv1.2, Kv2.2 and Kv7.2. In contrast to the early appearance of voltage-gated sodium channels and the Kv7.2 subunit at the AIS, Kv1.2 and Kv2.2 subunits were tethered at the AIS only after 10 days in vitro. Interestingly, we observed different patterns of Kv1.2 and Kv2.2 subunit expression, with each confined to distinct neuronal populations. The accumulation of Kv1.2 and Kv2.2 subunits at the AIS was dependent on ankyrin G tethering, it was not affected by disruption of the actin cytoskeleton and it was resistant to detergent extraction, as described previously for other AIS proteins. This distribution of potassium channels in the AIS further emphasizes the heterogeneity of this structure in different neuronal populations, as proposed previously, and suggests corresponding differences in action potential regulation.	[Sanchez-Ponce, Diana; Jose Garrido, Juan] CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, Madrid, Spain; [Sanchez-Ponce, Diana; DeFelipe, Javier; Munoz, Alberto] CSIC, Inst Cajal, Dept Funct & Syst Neurobiol, Madrid, Spain; [Sanchez-Ponce, Diana; DeFelipe, Javier; Munoz, Alberto] Univ Politecn Madrid, Lab Cajal Circuitos Cort, Ctr Tecnol Biomed, Madrid, Spain; [Sanchez-Ponce, Diana; Munoz, Alberto] Univ Complutense, Dept Cell Biol, E-28040 Madrid, Spain; [DeFelipe, Javier; Jose Garrido, Juan] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Complutense University of Madrid; CIBERNED	Garrido, JJ (corresponding author), CSIC, Inst Cajal, Dept Mol Cellular & Dev Neurobiol, Madrid, Spain.	jjgarrido@cajal.csic.es; amunozc@bio.ucm.es	Muñoz, Alberto/D-4225-2014; DEFELIPE, JAVIER/D-1195-2014; Garrido, Juan Jose/E-6782-2012	Muñoz, Alberto/0000-0003-4607-3398; DEFELIPE, JAVIER/0000-0001-5484-0660; Garrido, Juan Jose/0000-0002-4499-4487	Ministerio de Ciencia e Innovacion [SAF 2010-18218, SAF 2009-12249-C02-02, SAF 2009-09394]; Cajal Blue Brain Project; Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED); FPU fellowship from the Ministerio de Educacion (Spain)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Cajal Blue Brain Project; Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED); FPU fellowship from the Ministerio de Educacion (Spain)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (SAF 2010-18218 to A. M., SAF 2009-12249-C02-02 to J.J.G. and SAF 2009-09394 to J.D.), the Cajal Blue Brain Project and the Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED). D. S. is supported by an FPU fellowship from the Ministerio de Educacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bocksteins E, 2009, AM J PHYSIOL-CELL PH, V296, pC1271, DOI 10.1152/ajpcell.00088.2009; Boiko T, 2003, J NEUROSCI, V23, P2306; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Buffington SA, 2012, MOL CELL NEUROSCI, V50, P1, DOI 10.1016/j.mcn.2012.03.003; Burkarth N, 2007, MOL CELL NEUROSCI, V36, P59, DOI 10.1016/j.mcn.2007.06.001; CHANDY KG, 1991, NATURE, V352, P26, DOI 10.1038/352026b0; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Clark BD, 2009, NEUROSCIENTIST, V15, P651, DOI 10.1177/1073858409341973; Colbert CM, 1999, J NEUROSCI, V19, P8163; Cooper EC, 2011, SEMIN CELL DEV BIOL, V22, P185, DOI 10.1016/j.semcdb.2010.10.001; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; Duflocq A, 2008, MOL CELL NEUROSCI, V39, P180, DOI 10.1016/j.mcn.2008.06.008; Duflocq A, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-66; Eunson LH, 2000, ANN NEUROL, V48, P647; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Glasscock E, 2010, J NEUROSCI, V30, P5167, DOI 10.1523/JNEUROSCI.5591-09.2010; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2006, J NEUROCHEM, V98, P1345, DOI 10.1111/j.1471-4159.2006.04001.x; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Heusser K, 2005, CURR OPIN NEUROBIOL, V15, P364, DOI 10.1016/j.conb.2005.04.001; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; HWANG PM, 1993, J NEUROSCI, V13, P1569; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jensen CS, 2011, MOL CELL NEUROSCI, V48, P288, DOI 10.1016/j.mcn.2011.05.007; Jentsch TJ, 2000, EPILEPSIA, V41, P1068, DOI 10.1111/j.1528-1157.2000.tb00302.x; Johnston J, 2008, J PHYSIOL-LONDON, V586, P3493, DOI 10.1113/jphysiol.2008.153734; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Kang J, 2000, J NEUROPHYSIOL, V83, P70, DOI 10.1152/jn.2000.83.1.70; Kaufmann WA, 2010, NEUROSCIENCE, V169, P974, DOI 10.1016/j.neuroscience.2010.05.070; Kaufmann WA, 2009, J COMP NEUROL, V515, P215, DOI 10.1002/cne.22066; Kihira Y, 2010, J BIOL CHEM, V285, P15048, DOI 10.1074/jbc.M109.074260; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Klinger F, 2011, NEUROIMAGE, V58, P761, DOI 10.1016/j.neuroimage.2011.07.003; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Li Y, 2006, NEUROSCIENTIST, V12, P199, DOI 10.1177/1073858406287717; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Manganas LN, 2001, J BIOL CHEM, V276, P49427, DOI 10.1074/jbc.M109325200; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2010, NEUROSCIENTIST, V16, P51, DOI 10.1177/1073858409341085; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Ogawa Y, 2010, J NEUROSCI, V30, P1038, DOI 10.1523/JNEUROSCI.4661-09.2010; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Paspalas CD, 2004, J NEUROSCI, V24, P5292, DOI 10.1523/JNEUROSCI.0195-04.2004; Rasband MN, 2010, NEUROSCI LETT, V486, P101, DOI 10.1016/j.neulet.2010.08.081; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rasmussen HB, 2007, J CELL SCI, V120, P953, DOI 10.1242/jcs.03396; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Sanchez-Ponce D, 2011, CEREB CORTEX; Sanchez-Ponce D, 2011, MOL CELL NEURO UNPUB; Sanchez-Ponce D, 2008, MOL CELL NEUROSCI, V37, P832, DOI 10.1016/j.mcn.2008.01.010; Sanchez-Ponce D, 2011, MOL CELL NEUROSCI, V46, P222, DOI 10.1016/j.mcn.2010.09.005; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Surmeier DJ, 2004, NAT NEUROSCI, V7, P691, DOI 10.1038/nn0704-691; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Tapia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012908; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Van Wart A, 2006, NEUROSCI LETT, V403, P315, DOI 10.1016/j.neulet.2006.05.019; Vervaeke K, 2006, J PHYSIOL-LONDON, V576, P235, DOI 10.1113/jphysiol.2006.111336; Weigel AV, 2011, P NATL ACAD SCI USA, V108, P6438, DOI 10.1073/pnas.1016325108; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008; Yu YG, 2010, J NEUROSCI, V30, P11858, DOI 10.1523/JNEUROSCI.2651-10.2010; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	101	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48557	10.1371/journal.pone.0048557	http://dx.doi.org/10.1371/journal.pone.0048557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119056	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000310600500169
J	Wikman, H; Sielaff-Frimpong, B; Kropidlowski, J; Witzel, I; Milde-Langosch, K; Sauter, G; Westphal, M; Lamszus, K; Pantel, K				Wikman, Harriet; Sielaff-Frimpong, Bettina; Kropidlowski, Jolanthe; Witzel, Isabell; Milde-Langosch, Karin; Sauter, Guido; Westphal, Manfred; Lamszus, Katrin; Pantel, Klaus			Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; LUNG CANCERS; TUMOR; CHROMOSOME-11; INACTIVATION; SURVIVAL; SUBTYPES; HSRBC; HETEROZYGOSITY	The occurrence of brain metastases among breast cancer patients is currently rising with approximately 20-25% incidence rates, underlining the importance of the identification of new therapeutic and prognostic markers. We have previously screened for new markers for brain metastasis by array CGH. We found that loss of 11p15 is common among these patients. In this study, we investigated the clinical significance of loss of 11p15 in primary breast cancer (BC) and breast cancer brain metastases (BCBM). 11p15 aberration patterns were assessed by allelic imbalance (AI) analysis in primary BC (n = 78), BCBM (n = 21) and metastases from other distant sites (n = 6) using six different markers. AI at 11p15 was significantly associated with BCBM (p = 0.002). Interestingly, a subgroup of primary BC with a later relapse to the brain had almost equally high AI rates as the BCBM cases. In primary BC, AI was statistically significantly associated with high grade, negative hormone receptor status, and triple-negative (TNBC) tumors. Gene expression profiling identified PRKCDBP in the 11p15 region to be significantly downregulated in both BCBM and primary BC with brain relapse compared to primary tumors without relapse or bone metastasis (fdr < 0.05). qRT-PCR confirmed these results and methylation was shown to be a common way to silence this gene. In conclusion, we found loss at 11p15 to be a marker for TNBC primary tumors and BCBM and PRKCDBP to be a potential target gene in this locus.	[Wikman, Harriet; Sielaff-Frimpong, Bettina; Kropidlowski, Jolanthe; Pantel, Klaus] Univ Med Ctr Hamburg Eppendorf, Inst Tumor Biol, Hamburg, Germany; [Witzel, Isabell; Milde-Langosch, Karin] Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, Hamburg, Germany; [Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Westphal, Manfred; Lamszus, Katrin] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wikman, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Tumor Biol, Hamburg, Germany.	hwikman@uke.de		Wikman, Harriet/0000-0001-6862-0888	Deutschen Forschungsgemeinschaft (DFG) [PA 341/15-2]; European Union (EU; DISMAL-project)	Deutschen Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union (EU; DISMAL-project)	The work was funded by the Deutschen Forschungsgemeinschaft (DFG; PA 341/15-2) and the European Union (EU; DISMAL-project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bepler G, 2002, J CLIN ONCOL, V20, P1353, DOI 10.1200/JCO.20.5.1353; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Caren H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-66; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chunder N, 2004, DIAGN MOL PATHOL, V13, P172, DOI 10.1097/01.pas.0000124337.49401.0b; Dellas A, 2002, CLIN CANCER RES, V8, P1210; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Fanale D., 2011, ONCOGENE; Fornari D, 2006, CANCER GENET CYTOGEN, V167, P15, DOI 10.1016/j.cancergencyto.2005.10.015; Gaedcke J, 2007, MODERN PATHOL, V20, P864, DOI 10.1038/modpathol.3800830; Hampl M, 1999, INVAS METAST, V18, P81, DOI 10.1159/000024501; Han W, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-92; Hannemann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026362; Karnik P, 1998, HUM MOL GENET, V7, P895, DOI 10.1093/hmg/7.5.895; Lee JH, 2008, INT J CANCER, V122, P1573, DOI 10.1002/ijc.23166; Lee JH, 2011, CLIN CANCER RES, V17, P7551, DOI 10.1158/1078-0432.CCR-11-1026; Leong SPL, 2006, CANCER METAST REV, V25, P221, DOI 10.1007/s10555-006-8502-8; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Nishizaki T, 1997, GENE CHROMOSOME CANC, V19, P267, DOI 10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V; Nordgard SH, 2008, GENE CHROMOSOME CANC, V47, P680, DOI 10.1002/gcc.20569; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Petersen I, 2000, BRAIN PATHOL, V10, P395; Regitnig P, 2002, J PATHOL, V198, P190, DOI 10.1002/path.1193; Rigaud G, 2001, CANCER RES, V61, P285; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; TAKITA K, 1992, CANCER RES, V52, P3914; Tong SY, 2010, ACTA OBSTET GYN SCAN, V89, P629, DOI 10.3109/00016341003678443; Wang CJ, 2009, GENE CHROMOSOME CANC, V48, P1091, DOI 10.1002/gcc.20711; Wikman H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3150; WINQVIST R, 1995, CANCER RES, V55, P2660; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188; Xu XL, 2001, CANCER RES, V61, P7943; Zochbauer-Muller S, 2005, ONCOGENE, V24, P6249, DOI 10.1038/sj.onc.1208775	34	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47537	10.1371/journal.pone.0047537	http://dx.doi.org/10.1371/journal.pone.0047537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118876	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500021
J	Shen, W; Chen, M; Wei, G; Li, Y				Shen, Wei; Chen, Ming; Wei, Guo; Li, Yan			MicroRNA Prediction Using a Fixed-Order Markov Model Based on the Secondary Structure Pattern	PLOS ONE			English	Article							PRECURSOR MICRORNAS; CLASSIFICATION; IDENTIFICATION; MIRNAS; BIOGENESIS; SEQUENCES; GENOMICS; FEATURES; MIRBASE; TARGETS	Predicting miRNAs is an arduous task, due to the diversity of the precursors and complexity of enzyme processes. Although several prediction approaches have reached impressive performances, few of them could achieve a full-function recognition of mature miRNA directly from the candidate hairpins across species. Therefore, researchers continue to seek a more powerful model close to biological recognition to miRNA structure. In this report, we describe a novel miRNA prediction algorithm, known as FOMmiR, using a fixed-order Markov model based on the secondary structural pattern. For a training dataset containing 809 human pre-miRNAs and 6441 human pseudo-miRNA hairpins, the model's parameters were defined and evaluated. The results showed that FOMmiR reached 91% accuracy on the human dataset through 5-fold cross-validation. Moreover, for the independent test datasets, the FOMmiR presented an outstanding prediction in human and other species including vertebrates, Drosophila, worms and viruses, even plants, in contrast to the well-known algorithms and models. Especially, the FOMmiR was not only able to distinguish the miRNA precursors from the hairpins, but also locate the position and strand of the mature miRNA. Therefore, this study provides a new generation of miRNA prediction algorithm, which successfully realizes a full-function recognition of the mature miRNAs directly from the hairpin sequences. And it presents a new understanding of the biological recognition based on the strongest signal's location detected by FOMmiR, which might be closely associated with the enzyme cleavage mechanism during the miRNA maturation.	[Shen, Wei; Chen, Ming; Wei, Guo; Li, Yan] Third Mil Med Univ, Southwest Hosp, Med Res Ctr, Chongqing, Peoples R China; [Li, Yan] Chongqing Key Lab Dis Prote, Bioinformat Lab, Chongqing, Peoples R China	Army Medical University	Li, Y (corresponding author), Third Mil Med Univ, Southwest Hosp, Med Res Ctr, Chongqing, Peoples R China.	liyan.com@gmail.com	Shen, Wei/AFL-4859-2022; Li, Yan/O-7342-2016	Shen, Wei/0000-0002-8099-8258; Li, Yan/0000-0002-2091-7313	Foundation of Innovative Scientific Research of the Third Military Medical University [2007XG53]	Foundation of Innovative Scientific Research of the Third Military Medical University	This project was supported by the Foundation of Innovative Scientific Research of the Third Military Medical University (2007XG53). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Begleiter R, 2004, J ARTIF INTELL RES, V22, P385, DOI 10.1613/jair.1491; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Dezulian T, 2006, BIOINFORMATICS, V22, P359, DOI 10.1093/bioinformatics/bti802; Faller M, 2008, BBA-GENE REGUL MECH, V1779, P663, DOI 10.1016/j.bbagrm.2008.08.005; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kadri S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S35; Loong SNK, 2007, RNA, V13, P170, DOI 10.1261/rna.223807; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Ng KLS, 2007, BIOINFORMATICS, V23, P1321, DOI 10.1093/bioinformatics/btm026; Shmilovici A, 2007, COMPUTATION STAT, V22, P49, DOI 10.1007/s00180-007-0021-8; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Tyagi S, 2008, BIOCHEM BIOPH RES CO, V372, P831, DOI 10.1016/j.bbrc.2008.05.134; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu YP, 2008, BIOINFORMATICS, V24, pI50, DOI 10.1093/bioinformatics/btn175; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7	28	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48236	10.1371/journal.pone.0048236	http://dx.doi.org/10.1371/journal.pone.0048236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118959	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705600032
J	Socolovschi, C; Pages, F; Ndiath, MO; Ratmanov, P; Raoult, D				Socolovschi, Cristina; Pages, Frederic; Ndiath, Mamadou O.; Ratmanov, Pavel; Raoult, Didier			Rickettsia Species in African Anopheles Mosquitoes	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; GENUS RICKETTSIA; FELIS INFECTION; BARTONELLA-SPP.; FLEAS; IDENTIFICATION; TRANSMISSION; EVOLUTION; FEVER; MICROORGANISMS	Background: There is higher rate of R. felis infection among febrile patients than in healthy people in Sub-Saharan Africa, predominantly in the rainy season. Mosquitoes possess a high vectorial capacity and, because of their abundance and aggressiveness, likely play a role in rickettsial epidemiology. Methodology/Principal Findings: Quantitative and traditional PCR assays specific for Rickettsia genes detected rickettsial DNA in 13 of 848 (1.5%) Anopheles mosquitoes collected from Cote d'Ivoire, Gabon, and Senegal. R. felis was detected in one An. gambiae molecular form S mosquito collected from Kahin, Cote d'Ivoire (1/77, 1.3%). Additionally, a new Rickettsia genotype was detected in five An. gambiae molecular form S mosquitoes collected from Cote d'Ivoire (5/77, 6.5%) and one mosquito from Libreville, Gabon (1/88, 1.1%), as well as six An. melas (6/67, 9%) mosquitoes collected from Port Gentil, Gabon. A sequence analysis of the gltA, ompB, ompA and sca4 genes indicated that this new Rickettsia sp. is closely related to R. felis. No rickettsial DNA was detected from An. funestus, An. arabiensis, or An. gambiae molecular form M mosquitoes. Additionally, a BLAST analysis of the gltA sequence from the new Rickettsia sp. resulted in a 99.71% sequence similarity to a species (JQ674485) previously detected in a blood sample of a Senegalese patient with a fever from the Bandafassi village, Kedougou region. Conclusion: R. felis was detected for the first time in An. gambiae molecular form S, which represents the major African malaria vector. The discovery of R. felis, as well as a new Rickettsia species, in mosquitoes raises new issues with respect to African rickettsial epidemiology that need to be investigated, such as bacterial isolation, the degree of the vectorial capacity of mosquitoes, the animal reservoirs, and human pathogenicity.	[Socolovschi, Cristina; Ratmanov, Pavel; Raoult, Didier] Aix Marseille Univ, URMITE, CNRS 7278, Inserm 1095,UM63,IRD 198, Marseille, France; [Ndiath, Mamadou O.] IRD, Lab Paludol, UMR URMITE 198, Dakar, Senegal	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	Raoult, D (corresponding author), Aix Marseille Univ, URMITE, CNRS 7278, Inserm 1095,UM63,IRD 198, Marseille, France.	Didier.Raoult@univmed.fr	Ratmanov, Pavel E/A-9301-2016; RAOULT, Didier/A-8434-2008; Ratmanov, Pavel/K-8952-2019	Ratmanov, Pavel E/0000-0002-6292-8758; RAOULT, Didier/0000-0002-0633-5974; Ratmanov, Pavel/0000-0002-6292-8758				Berrelha J, 2009, CLIN MICROBIOL INFEC, V15, P251, DOI 10.1111/j.1469-0691.2008.02273.x; Bitam I, 2006, AM J TROP MED HYG, V74, P532, DOI 10.4269/ajtmh.2006.74.532; Boudebouch N, 2011, ANN TROP MED PARASIT, V105, P493, DOI 10.1179/1364859411Y.0000000038; Bouyer DH, 2001, INT J SYST EVOL MICR, V51, P339, DOI 10.1099/00207713-51-2-339; Caspi-Fluger A, 2012, P ROY SOC B-BIOL SCI, V279, P1791, DOI 10.1098/rspb.2011.2095; Cutler SJ, 2006, ANN NY ACAD SCI, V1078, P373, DOI 10.1196/annals.1374.074; de Almeida F, 2011, INFECT GENET EVOL, V11, P2138, DOI 10.1016/j.meegid.2011.08.022; Duh D, 2010, INT J SYST EVOL MICR, V60, P977, DOI 10.1099/ijs.0.011049-0; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5456, DOI 10.1128/JCM.41.12.5456-5465.2003; Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gillies M, 1987, ANOPHELINAE AFRICA S; Girod R, 2006, J MED ENTOMOL, V43, P1082, DOI 10.1603/0022-2585(2006)43[1082:MTAIRO]2.0.CO;2; Hertig M, 1924, J MED RES, V44, P329; Hii SF, 2011, VECTOR-BORNE ZOONOT, V11, P1007, DOI 10.1089/vbz.2010.0270; Hii SF, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-198; Jiang J, 2012, DETECTION UNIQ UNPUB; Khaldi M, 2012, COMP IMMUNOL MICROB, V35, P117, DOI 10.1016/j.cimid.2011.11.007; Loftis AD, 2006, AM J TROP MED HYG, V75, P41, DOI 10.4269/ajtmh.2006.75.41; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Maina AN, 2012, EMERG INFECT DIS, V18, P328, DOI 10.3201/eid1802.111372; Mediannikov O, 2012, COMP IMMUNOL MICROB, V35, P145, DOI 10.1016/j.cimid.2011.12.011; Mediannikov O, 2012, LANCET INF DIS UNPUB; Mediannikov O, 2012, EMERG INFECT DIS, V18, P1385, DOI 10.3201/eid1808.111243; Merhej V, 2011, BIOL REV, V86, P379, DOI 10.1111/j.1469-185X.2010.00151.x; Mokrani K, 2012, TICKS TICK IN PRESS; Mourou JR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-321; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Orlandi-Pradines E, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-171; Oteo JA, 2006, J CLIN MICROBIOL, V44, P2669, DOI 10.1128/JCM.00366-06; Pages F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-178; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Parola P, 2003, ANN NY ACAD SCI, V990, P173, DOI 10.1111/j.1749-6632.2003.tb07359.x; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Reif KE, 2009, J MED ENTOMOL, V46, P723, DOI 10.1603/033.046.0402; Reif KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002805; Richards AL, 2010, EMERG INFECT DIS, V16, P1081, DOI 10.3201/eid1607.091885; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rolain JM, 2005, EMERG INFECT DIS, V11, P1742, DOI 10.3201/eid1111.050861; Roucher C, 2012, VECTOR-BORNE ZOONOT, V12, P360, DOI 10.1089/vbz.2011.0734; Roux V, 1997, INT J SYST BACTERIOL, V47, P252, DOI 10.1099/00207713-47-2-252; ROUX V, 1995, RES MICROBIOL, V146, P385, DOI 10.1016/0923-2508(96)80284-1; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Sackal C, 2008, EMERG INFECT DIS, V14, P1972, DOI 10.3201/eid1412.080610; SCHRIEFER ME, 1994, J MED ENTOMOL, V31, P681, DOI 10.1093/jmedent/31.5.681; Sekeyova Z, 2001, INT J SYST EVOL MICR, V51, P1353, DOI 10.1099/00207713-51-4-1353; Service M. W., 1993, P120; Socolovschi C, 2012, EMERG INFEC IN PRESS; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1140, DOI 10.3201/eid1607.100070; Sunish IP, 2011, TROP BIOMED, V28, P569; Thepparit C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016396; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; YEN JH, 1975, ANN NY ACAD SCI, V266, P152, DOI 10.1111/j.1749-6632.1975.tb35096.x; Znazen A, 2006, EMERG INFECT DIS, V12, P138, DOI 10.3201/eid1201.050876	57	47	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48254	10.1371/journal.pone.0048254	http://dx.doi.org/10.1371/journal.pone.0048254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118963	gold, Green Published, Green Submitted			2022-12-25	WOS:000310705600035
J	Dellal, SS; Hume, RI				Dellal, Shlomo S.; Hume, Richard I.			Covalent Modification of Mutant Rat P2X2 Receptors with a Thiol-Reactive Fluorophore Allows Channel Activation by Zinc or Acidic pH without ATP	PLOS ONE			English	Article							HUMAN P2X(1) RECEPTORS; GATED ION CHANNELS; EXTRACELLULAR PH; BINDING-SITE; MOLECULAR-MECHANISM; SMALL-INTESTINE; AMINO-ACIDS; RESIDUES; SUBUNITS; MODULATION	Rat P2X2 receptors open at an undetectably low rate in the absence of ATP. Furthermore, two allosteric modulators, zinc and acidic pH, cannot by themselves open these channels. We describe here the properties of a mutant receptor, K69C, before and after treatment with the thiol-reactive fluorophore Alexa Fluor 546 C-S-maleimide (AM546). Xenopus oocytes expressing unmodified K69C were not activated under basal conditions nor by 1,000 mM ATP. AM546 treatment caused a small increase in the inward holding current which persisted on washout and control experiments demonstrated this current was due to ATP independent opening of the channels. Following AM546 treatment, zinc (100 mM) or acidic external solution (pH 6.5) elicited inward currents when applied without any exogenous ATP. In the double mutant K69C/H319K, zinc elicited much larger inward currents, while acidic pH generated outward currents. Suramin, which is an antagonist of wild type receptors, behaved as an agonist at AM546-treated K69C receptors. Several other cysteine-reactive fluorophores tested on K69C did not cause these changes. These modified receptors show promise as a tool for studying the mechanisms of P2X receptor activation.	[Dellal, Shlomo S.; Hume, Richard I.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Dellal, Shlomo S.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of Michigan System; University of Michigan; University of California System; University of California Los Angeles	Hume, RI (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	rhume@umich.edu	, Richard/AAI-5000-2020	Hume, Richard/0000-0001-9807-112X	PHS grant [NS039196]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039196] Funding Source: NIH RePORTER	PHS grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by PHS grant NS039196 to RIH (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian XC, 2003, J PHYSIOL-LONDON, V551, P309, DOI 10.1113/jphysiol.2003.044172; Brown SG, 2002, J PHARMACOL EXP THER, V300, P673, DOI 10.1124/jpet.300.2.673; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; EVANS RJ, 2008, EUR BIOPHYS J; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fischer W, 2007, EUR J PHARMACOL, V576, P7, DOI 10.1016/j.ejphar.2007.07.068; Fujiwara Y, 2004, J PHYSIOL-LONDON, V558, P31, DOI 10.1113/jphysiol.2004.064568; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Kanjhan R, 1999, J COMP NEUROL, V407, P11; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; King BF, 1996, BRIT J PHARMACOL, V117, P1371, DOI 10.1111/j.1476-5381.1996.tb15293.x; King BF, 1997, BRIT J PHARMACOL, V121, P1445, DOI 10.1038/sj.bjp.0701286; King BF, 2000, J NEUROSCI, V20, P4871; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Mio K, 2005, BIOCHEM BIOPH RES CO, V337, P998, DOI 10.1016/j.bbrc.2005.09.141; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nakazawa K, 1997, J NEUROPHYSIOL, V78, P884, DOI 10.1152/jn.1997.78.2.884; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Punthambaker S, 2012, J BIOL CHEM, V287, P22099, DOI 10.1074/jbc.M112.369157; Ren JH, 2003, J PHYSIOL-LONDON, V552, P809, DOI 10.1113/jphysiol.2003.047944; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Rong WF, 2003, J NEUROSCI, V23, P11315; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Tittle RK, 2007, J BIOL CHEM, V282, P19526, DOI 10.1074/jbc.M701604200; Wildman SS, 1998, BRIT J PHARMACOL, V123, P1214, DOI 10.1038/sj.bjp.0701717; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x; Zhou Z, 1998, J PHYSIOL-LONDON, V507, P353, DOI 10.1111/j.1469-7793.1998.353bt.x	37	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47147	10.1371/journal.pone.0047147	http://dx.doi.org/10.1371/journal.pone.0047147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112811	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200028
J	Liu, J; Ma, KL; Gao, M; Wang, CX; Ni, J; Zhang, Y; Zhang, XL; Liu, H; Wang, YL; Liu, BC				Liu, Jing; Ma, Kun Ling; Gao, Min; Wang, Chang Xian; Ni, Jie; Zhang, Yang; Zhang, Xiao Liang; Liu, Hong; Wang, Yan Li; Liu, Bi Cheng			Inflammation Disrupts the LDL Receptor Pathway and Accelerates the Progression of Vascular Calcification in ESRD Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SMOOTH-MUSCLE-CELLS; CARDIOVASCULAR-DISEASE; HEMODIALYSIS-PATIENTS; MEDIA CALCIFICATION; RENAL-DISEASE; MORTALITY; MECHANISMS; IMPACT	Background: Chronic inflammation plays a crucial role in the progression of vascular calcification (VC). This study was designed to investigate whether the low-density lipoprotein receptor (LDLr) pathway is involved in the progression of VC in patients with end-stage renal disease (ESRD) during inflammation. Methods and Results: Twenty-eight ESRD patients were divided into control and inflamed groups according to plasma C-reactive protein (CRP) level. Surgically removed tissues from the radial arteries of patients receiving arteriovenostomy were used in the experiments. The expression of tumour necrosis factor-alpha (TNF-alpha) and monocyte chemotactic protein-1 (MCP-1) of the radial artery were increased in the inflamed group. Hematoxylin-eosin and alizarin red S staining revealed parallel increases in foam cell formation and calcium deposit formation in continuous cross-sections of radial arteries in the inflamed group compared to the control, which were closely correlated with increased LDLr, sterol regulatory element binding protein-2 (SREBP-2), bone morphogenetic proteins-2 (BMP-2), and collagen I protein expression, as shown by immunohistochemical and immunofluorescent staining. Confocal microscopy confirmed that inflammation enhanced the translocation of the SREBP cleavage-activating protein (SCAP)/SREBP-2 complex from the endoplasmic reticulum to the Golgi, thereby activating LDLr gene transcription. Inflammation increased alkaline phosphatase protein expression and reduced alpha-smooth muscle actin protein expression, contributing to the conversion of the vascular smooth muscle cells in calcified vessels from the fibroblastic to the osteogenic phenotype; osteogenic cells are the main cellular components involved in VC. Further analysis showed that the inflammation-induced disruption of the LDLr pathway was significantly associated with enhanced BMP-2 and collagen I expression. Conclusions: Inflammation accelerated the progression of VC in ESRD patients by disrupting the LDLr pathway, which may represent a novel mechanism involved in the progression of both VC and atherosclerosis.	[Liu, Jing; Ma, Kun Ling; Gao, Min; Ni, Jie; Zhang, Yang; Zhang, Xiao Liang; Liu, Hong; Wang, Yan Li; Liu, Bi Cheng] Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Wang, Chang Xian] Southeast Univ, Sch Med, Zhong Da Hosp, Dept Infect Management, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Ma, KL (corresponding author), Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China.	mmkkll@hotmail.com			Natural Science Foundation of Jiangsu Province [BK2009279]; National Natural Science Foundation of China [81170792, 81070571]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Jiangsu Province (BK2009279) and the National Natural Science Foundation of China (Grants 81170792 and 81070571). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi T, 1995, NEPHROL DIAL TRANSPL, V10, P2244, DOI 10.1093/ndt/10.12.2244; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Geng YF, 2011, J BIOL CHEM, V286, P33701, DOI 10.1074/jbc.M111.269639; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; London GM, 2003, J AM SOC NEPHROL, V14, pS305, DOI 10.1097/01.ASN.0000081664.65772.EB; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Ma KL, 2007, AM J PHYSIOL-HEART C, V292, pH2721, DOI 10.1152/ajpheart.01174.2006; Moe SM, 2005, BLOOD PURIFICAT, V23, P64, DOI 10.1159/000082013; Ruan XZ, 2006, ARTERIOSCL THROM VAS, V26, P1150, DOI 10.1161/01.ATV.0000217957.93135.c2; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Silverstein DM, 2009, PEDIATR NEPHROL, V24, P1445, DOI 10.1007/s00467-008-1046-0; Thalmaier D, 2006, ALIMENT PHARM THERAP, V24, P1105, DOI 10.1111/j.1365-2036.2006.03093.x; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	19	21	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47217	10.1371/journal.pone.0047217	http://dx.doi.org/10.1371/journal.pone.0047217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115640	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200030
J	Mondal, P; Tatem, AJ				Mondal, Pinki; Tatem, Andrew J.			Uncertainties in Measuring Populations Potentially Impacted by Sea Level Rise and Coastal Flooding	PLOS ONE			English	Article							CLIMATE-CHANGE; MAPS	A better understanding of the impact of global climate change requires information on the locations and characteristics of populations affected. For instance, with global sea level predicted to rise and coastal flooding set to become more frequent and intense, high-resolution spatial population datasets are increasingly being used to estimate the size of vulnerable coastal populations. Many previous studies have undertaken this by quantifying the size of populations residing in low elevation coastal zones using one of two global spatial population datasets available - LandScan and the Global Rural Urban Mapping Project (GRUMP). This has been undertaken without consideration of the effects of this choice, which are a function of the quality of input datasets and differences in methods used to construct each spatial population dataset. Here we calculate estimated low elevation coastal zone resident population sizes from LandScan and GRUMP using previously adopted approaches, and quantify the absolute and relative differences achieved through switching datasets. Our findings suggest that the choice of one particular dataset over another can translate to a difference of more than 7.5 million vulnerable people for countries with extensive coastal populations, such as Indonesia and Japan. Our findings also show variations in estimates of proportions of national populations at risk range from,0.1% to 45% differences when switching between datasets, with large differences predominantly for countries where coarse and outdated input data were used in the construction of the spatial population datasets. The results highlight the need for the construction of spatial population datasets built on accurate, contemporary and detailed census data for use in climate change impact studies and the importance of acknowledging uncertainties inherent in existing spatial population datasets when estimating the demographic impacts of climate change.	[Mondal, Pinki; Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Mondal, P (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA.	pm2658@columbia.edu	Mondal, Pinki/AFU-2382-2022	Mondal, Pinki/0000-0002-7323-6335; Tatem, Andrew/0000-0002-7270-941X	Bill & Melinda Gates Foundation [49446, OPP1032350]; RAPIDD program of the Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); RAPIDD program of the Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	AJT is supported by grants from the Bill & Melinda Gates Foundation (#49446 and #OPP1032350) and also acknowledges funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, TRANSFORMING POPULAT; Balk D, 2005, FOOD POLICY, V30, P584, DOI 10.1016/j.foodpol.2005.10.007; Balk D., 2009, POPULATION DYNAMICS, P80; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Brooker S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000779; Butler D., 2011, NATURE, V474, P36; de Sherbinin A, 2007, ENVIRON URBAN, V19, P39, DOI 10.1177/0956247807076725; Doocy Shannon, 2007, Am J Public Health, V97 Suppl 1, pS146; Ericson JP, 2006, GLOBAL PLANET CHANGE, V50, P63, DOI 10.1016/j.gloplacha.2005.07.004; Guzman J.M., 2009, POPULATION DYNAMICS; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hirabayashi Y., 2009, HYDROLOGIC RES LETT, V3, P6, DOI [10.3178/hrl.3.6, DOI 10.3178/HRL.3.6]; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Lam NSN, 2009, J COASTAL RES, P1522; Lichter M, 2011, J COASTAL RES, V27, P757, DOI 10.2112/JCOASTRES-D-10-00072.1; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Linard C, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-7; McDonald RI, 2011, P NATL ACAD SCI USA, V108, P6312, DOI 10.1073/pnas.1011615108; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Nicholls RJ, 2005, RES UNIT SUSTAINABIL; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Parry M. L., 2007, CLIMATE CHANGE 2007; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Rowley R. J., 2007, EOS T AM GEOPHYS UN, V88, P105, DOI DOI 10.1029/2007EO090001; Salvatore M., 2005, MAPPING GLOBAL URBAN; Tatem AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-8; Tatem AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-4; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Tatem AJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-218; UN Population Division, 2010, WORLD POP PROSP 2010; Vafeidis A, 2011, ANAL LAND AREA POPUL	33	46	48	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48191	10.1371/journal.pone.0048191	http://dx.doi.org/10.1371/journal.pone.0048191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026VC	23110208	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200156
J	Saluste, G; Albarran, MI; Alvarez, RM; Rabal, O; Ortega, MA; Blanco, C; Kurz, G; Salgado, A; Pevarello, P; Bischoff, JR; Pastor, J; Oyarzabal, J				Saluste, Gustavo; Albarran, Maria I.; Alvarez, Rosa M.; Rabal, Obdulia; Angel Ortega, Miguel; Blanco, Carmen; Kurz, Guido; Salgado, Antonio; Pevarello, Paolo; Bischoff, James R.; Pastor, Joaquin; Oyarzabal, Julen			Fragment-Hopping-Based Discovery of a Novel Chemical Series of Proto-Oncogene PIM-1 Kinase Inhibitors	PLOS ONE			English	Article							PUTATIVE ONCOGENE PIM-1; SERINE/THREONINE KINASES; MOLECULAR SHAPE; PROTEIN; LYMPHOMAGENESIS; OVEREXPRESSION; PERFORMANCE; THERAPY; GROWTH; CANCER	A new chemical series, triazolo[4,5-b] pyridines, has been identified as an inhibitor of PIM-1 by a chemotype hopping strategy based on a chemically feasible fragment database. In this case, structure-based virtual screening and in silico chemogenomics provide added value to the previously reported strategy of prioritizing among proposed novel scaffolds. Pairwise comparison between compound 3, recently discontinued from Phase I clinical trials, and molecule 8, bearing the selected novel scaffold, shows that the primary activities are similar (IC50 in the 20 to 150 nM range). At the same time, some ADME properties (for example, an increase of more than 45% in metabolic stability in human liver microsomes) and the off-target selectivity (for example, an increase of more than 2 log units in IC50 vs. FLT3) are improved, and the intellectual property (IP) position is enhanced. The discovery of a reliable starting point that fulfills critical criteria for a plausible medicinal chemistry project is demonstrated in this prospective study.	[Saluste, Gustavo; Albarran, Maria I.; Alvarez, Rosa M.; Rabal, Obdulia; Angel Ortega, Miguel; Blanco, Carmen; Kurz, Guido; Salgado, Antonio; Pevarello, Paolo; Bischoff, James R.; Pastor, Joaquin; Oyarzabal, Julen] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Program, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Oyarzabal, J (corresponding author), Ctr Appl Med Res CIMA, Pamplona, Spain.	julenoyarzabal@unav.es	Albarrán, M Isabel M.I.Albarrán/F-3898-2016; Rabal, Obdulia/D-3076-2017; Oyarzabal, Julen/K-7393-2017; Fernandez, Joaquin Pastor/I-4567-2015; Salgado, Antonio/AAL-4417-2021	Albarrán, M Isabel M.I.Albarrán/0000-0003-0750-3869; Rabal, Obdulia/0000-0002-3224-0987; Oyarzabal, Julen/0000-0003-1941-7255; Fernandez, Joaquin Pastor/0000-0003-0553-8021; Salgado, Antonio/0000-0001-9964-0048	Spanish Ministerio de Ciencia e Innovacion	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	The authors gratefully acknowledge support from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActivityBase Environment, ACTIVITYBASE ENV; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; AMSON R, 1989, P NATL ACAD SCI USA, V86, P8857, DOI 10.1073/pnas.86.22.8857; [Anonymous], MOL OP ENV MOE; [Anonymous], PIP PIL; [Anonymous], OPENEYE SCI SOFTW; Bearss D, 2008, Patent, Patent No. [WO2008058126 A2, 2008058126, WO2008058126A2]; Blanco-Aparicio C, 2011, CANCER LETT, V300, P145, DOI 10.1016/j.canlet.2010.09.016; Bostrom J, 2001, J COMPUT AID MOL DES, V15, P1137, DOI 10.1023/A:1015930826903; Bostrom J, 2003, J MOL GRAPH MODEL, V21, P449, DOI 10.1016/S1093-3263(02)00204-8; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; Chen J, 2009, AM J PATHOL, V175, P400, DOI 10.2353/ajpath.2009.080972; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; CUYPERS HT, 1984, CELL, V37, P141; Eidogen-Sertanty Inc. website, KIN KNOWL KKB; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Gu JJ, 2009, ONCOGENE, V28, P4261, DOI 10.1038/onc.2009.276; HOOVER D, 1991, J BIOL CHEM, V266, P14018; Hsi ED, 2008, LEUKEMIA LYMPHOMA, V49, P2081, DOI 10.1080/10428190802419640; Jennings A, 2007, J CHEM INF MODEL, V47, P1829, DOI 10.1021/ci600549q; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kirchmair J, 2006, J CHEM INF MODEL, V46, P1848, DOI 10.1021/ci060084g; Ledeboer M, 2004, Patent, Patent No. [WO2004058749 A1, 2004058749]; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mumenthaler SM, 2009, MOL CANCER THER, V8, P2882, DOI 10.1158/1535-7163.MCT-09-0293; Nicholls A, 2005, J COMPUT AID MOL DES, V19, P661, DOI 10.1007/s10822-005-9019-x; Oyarzabal J, 2009, J MED CHEM, V52, P2076, DOI 10.1021/jm8016199; Pastor Fernandez J, 2011, Patent, Patent No. [WO2011101644 A1, 2011101644]; Pastor J, 2012, BIOORG MED CHEM LETT, V22, P1591, DOI 10.1016/j.bmcl.2011.12.130; Pierce AC, 2008, J MED CHEM, V51, P1972, DOI 10.1021/jm701248t; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; RIVALLE C, 1981, TETRAHEDRON, V37, P2097, DOI 10.1016/S0040-4020(01)97964-5; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; SELTEN G, 1985, EMBO J, V4, P1793, DOI 10.1002/j.1460-2075.1985.tb03852.x; Urbano-Cuadrado M, 2011, COMB CHEM HIGH T SCR, V14, P429, DOI 10.2174/138620711795767848; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang Z, 2001, J Vet Sci, V2, P167; Warnecke-Eberz U, 2009, ANTICANCER RES, V29, P4451; Willert M, 2010, BASIC RES CARDIOL, V105, P267, DOI 10.1007/s00395-009-0055-x; Xu Y, 2005, J SURG ONCOL, V92, P326, DOI 10.1002/jso.20325	45	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e45964	10.1371/journal.pone.0045964	http://dx.doi.org/10.1371/journal.pone.0045964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115625	gold, Green Published, Green Submitted			2022-12-25	WOS:000310310200012
J	Schnell, E; Bensen, AL; Washburn, EK; Westbrook, GL				Schnell, Eric; Bensen, AeSoon L.; Washburn, Eric K.; Westbrook, Gary L.			Neuroligin-1 Overexpression in Newborn Granule Cells In Vivo	PLOS ONE			English	Article							NEWLY GENERATED NEURONS; TRAUMATIC BRAIN-INJURY; INHIBITORY SYNAPSE FORMATION; DENTATE GYRUS; PARKINSONS-DISEASE; EXCITATORY SYNAPSES; ADULT HIPPOCAMPUS; ADHESION MOLECULE; NEUROGENESIS; PLASTICITY	Adult-born dentate granule cells integrate into the hippocampal network, extend neurites and form synapses in otherwise mature tissue. Excitatory and inhibitory inputs innervate these new granule cells in a stereotyped, temporally segregated manner, which presents a unique opportunity to study synapse development in the adult brain. To examine the role of neuroligins as synapse-inducing molecules in vivo, we infected dividing neural precursors in adult mice with a retroviral construct that increased neuroligin-1 levels during granule cell differentiation. By 21 days post-mitosis, exogenous neuroligin-1 was expressed at the tips of dendritic spines and increased the number of dendritic spines. Neuroligin-1-overexpressing cells showed a selective increase in functional excitatory synapses and connection multiplicity by single afferent fibers, as well as an increase in the synaptic AMPA/NMDA receptor ratio. In contrast to its synapse-inducing ability in vitro, neuroligin-1 overexpression did not induce precocious synapse formation in adult-born neurons. However, the dendrites of neuroligin-1-overexpressing cells did have more thin protrusions during an early period of dendritic outgrowth, suggesting enhanced filopodium formation or stabilization. Our results indicate that neuroligin-1 expression selectively increases the degree, but not the onset, of excitatory synapse formation in adult-born neurons.	[Schnell, Eric] Portland VA Med Ctr, Portland, OR USA; [Schnell, Eric] OHSU Dept Anesthesiol & Perioperat Med, Portland, OR USA; [Bensen, AeSoon L.; Washburn, Eric K.; Westbrook, Gary L.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University	Schnell, E (corresponding author), Portland VA Med Ctr, Portland, OR USA.	schneler@ohsu.edu		Schnell, Eric/0000-0002-5623-5015	Oregon Medical Research Foundation; Department of Veteran's Affairs Career Development Award; National Institute of Mental Health [R01MH46613]; NIH [P30 NS06180]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	Oregon Medical Research Foundation; Department of Veteran's Affairs Career Development Award; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Oregon Medical Research Foundation (ES), a Department of Veteran's Affairs Career Development Award (ES), the National Institute of Mental Health (R01MH46613; GLW), and the Jungers Center Light Microscopy Image Core that is supported in part by NIH P30 NS06180. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstikaitis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016998; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Chen SX, 2010, NEURON, V67, P967, DOI 10.1016/j.neuron.2010.08.016; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Eichler SA, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.002.2008; El-Hussein AE, 2000, SCIENCE, V290, P1364; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gorecki DC, 1999, MOL CELL NEUROSCI, V13, P218, DOI 10.1006/mcne.1999.0740; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hagell P, 2005, BRAIN RES BULL, V68, P4, DOI 10.1016/j.brainresbull.2004.10.013; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jung SY, 2010, P NATL ACAD SCI USA, V107, P4710, DOI 10.1073/pnas.1001084107; Kernie SG, 2009, NEUROBIOL DIS; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Kumamoto N, 2012, NAT NEUROSCI, V15, P399, DOI 10.1038/nn.3042; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Liu JL, 1998, J NEUROSCI, V18, P7768; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; Sahay A, 2007, PROG BRAIN RES, V163, P697, DOI 10.1016/S0079-6123(07)63038-6; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shi P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1518; Shipman SL, 2011, NAT NEUROSCI, V14, P718, DOI 10.1038/nn.2825; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Soler-Llavina GJ, 2011, P NATL ACAD SCI USA, V108, P16502, DOI 10.1073/pnas.1114028108; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stan A, 2010, P NATL ACAD SCI USA, V107, P11116, DOI 10.1073/pnas.0914233107; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Zhao CS, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01632.x; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	79	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e48045	10.1371/journal.pone.0048045	http://dx.doi.org/10.1371/journal.pone.0048045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110172	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193400031
J	Traore, KA; Rouamba, H; Nebie, Y; Sanou, M; Traore, AS; Barro, N; Roques, P				Traore, Kuan Abdoulaye; Rouamba, Hortense; Nebie, Yacouba; Sanou, Mahamadou; Traore, Alfred S.; Barro, Nicolas; Roques, Pierre			Seroprevalence of Fecal-Oral Transmitted Hepatitis A and E Virus Antibodies in Burkina Faso	PLOS ONE			English	Article							PREGNANT-WOMEN; BLOOD-DONORS; HIGHLY PREVALENT; VIRAL-HEPATITIS; YOUNG-CHILDREN; INFECTION; EPIDEMIOLOGY; POPULATION; OUTBREAK; STRAINS	Hepatitis A virus (HAV) and hepatitis E virus (HEV) infections occur chiefly as a result of unhygienic conditions. The purpose of this study was to assess the seroprevalence of antibodies to both viruses in central Burkina Faso in the absence of a recorded hepatitis epidemic. Serum samples from 178 blood donors (131 males and 47 females) and from 189 pregnant women were collected from November 2010 to March 2012, at blood banks and medical centers in Burkina Faso. An immunochromatography test was used to screen for Anti-HAV IgM and IgG in a subgroup of 91 blood donors and 100 pregnant women. The seroprevalence of anti-HAV IgG was 14.3% [CI95, 7.1-21.4%] for all blood donors and 23% [CI95, 14.8-31.2%] for pregnant women. Anti-HEV IgG were detected using the ELISA kits Dia.pro and Wantai and were found in 19.1% [CI95, 13.3-24.9%] of the blood donors and 11.6% [CI95, 7.1-16.2%] of the pregnant women. The seroprevalences of anti-HAV and anti-HEV IgGs did not differ significantly between men and women blood donors. Anti-HAV IgM was detected in 3.3% of the blood donors and in 2% of the pregnant women. These findings for asymptomatic individuals indicate that the HAV and HEV circulate at low but significant levels. This is the first evaluation of the acute hepatitis virus burden in Burkina Faso and the underlying epidemiologic status of the population.	[Traore, Kuan Abdoulaye; Traore, Alfred S.; Barro, Nicolas] Univ Ouagadougou, CRSBAN, Ouagadougou, Burkina Faso; [Rouamba, Hortense] Ctr Natl Transfus Sanguine, Ouagadougou, Burkina Faso; [Nebie, Yacouba; Sanou, Mahamadou] Ctr Med Samandin, Ouagadougou, Burkina Faso; [Roques, Pierre] CEA, Inst Emerging Dis & Innovat Therapies, Div Immuno Virol, Fontenay Aux Roses, France; [Roques, Pierre] Univ Paris 11, Unite Mixte Rech E1, Orsay, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Barro, N (corresponding author), Univ Ouagadougou, CRSBAN, Ouagadougou, Burkina Faso.	nicolas_barro@univ-ouaga.bf; pierre.roques@cea.fr	Roques, Pierre/M-2212-2013	Roques, Pierre/0000-0003-1825-1054	Burkina Faso	Burkina Faso	TKA is recipient of a thesis grant from Burkina Faso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Traore Kuan Abdoulaye is PhD student co-mentored by University Paris XI and University of Ouagadougou. This work was supported the Laboratory of Foodborne Pathogen Epidemiology and Surveillance of CRSBAN, University of Ouagadougou, Burkina Faso. We are also grateful to the nurses and staff of the National Center of Blood Transfusion and the Samadin Medical Center and to all the blood donors and pregnant women who participated in the study. We thank Alex Edelman and Associates for English revision.	Adjei AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-108; ARANKALLE VA, 1995, J INFECT DIS, V171, P447, DOI 10.1093/infdis/171.2.447; Atabek ME, 2004, HEALTH POLICY, V67, P265, DOI 10.1016/S0168-8510(03)00123-4; Aubry P, 1997, AM J TROP MED HYG, V57, P272, DOI 10.4269/ajtmh.1997.57.272; Balayan MS, 1997, J VIRAL HEPATITIS, V4, P155, DOI 10.1046/j.1365-2893.1997.00145.x; Barro N, 2005, PRINCIPAUX AGENTS PE; Barro N., 2008, HYGIENE ITS ROLE HLT, P129; Barzaga NG, 2000, VACCINE, V18, pS61, DOI 10.1016/S0264-410X(99)00467-3; Ben HM, 1998, TUN MED, V76, P129; BILE K, 1994, AM J TROP MED HYG, V51, P466, DOI 10.4269/ajtmh.1994.51.466; Bonkoungou IJO, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-94; Bouquet J, 2011, EMERG INFECT DIS, V17, P2018, DOI 10.3201/eid1711.110616; Buisson Y, 1995, Med Trop (Mars), V55, P305; Buisson Y, 1994, MED TROP, V54, p9S; Buisson Y, 1996, SELECTION MED SCI, P95; Caron M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-158; Castera L, 2001, GASTROEN CLIN BIOL, V25, P521; Cevrioglu AS, 2004, J OBSTET GYNAECOL RE, V30, P48, DOI 10.1111/j.1341-8076.2004.00155.x; Costa-Mattioli M, 2003, J GEN VIROL, V84, P3191, DOI 10.1099/vir.0.19532-0; *CTR DIS CONTR PRE, 1996, MMWR-MORBID MORTAL W, V45, P1; Dalekos GN, 1998, TRANSFUSION, V38, P589, DOI 10.1046/j.1537-2995.1998.38698326339.x; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Denis F, 2003, GASTROEN CLIN BIOL, V27, P727; Di Bartolo I, 2012, EMERG INFECT DIS, V18, P1282, DOI 10.3201/eid1808.111783; Dubois F, 1991, BEH; Emerson S. U, 2004, VIRUS TAXONOMY, V1st, P851; Fix AD, 2002, AM J TROP MED HYG, V66, P628, DOI 10.4269/ajtmh.2002.66.628; Guthmann JP, 2006, CLIN INFECT DIS, V42, P1685, DOI 10.1086/504321; Hannachi N, 2011, Pathol Biol (Paris), V59, pe115, DOI 10.1016/j.patbio.2009.06.004; Izopet J, 2012, EMERG INFECT DIS, V18, P1274, DOI 10.3201/eid1808.120057; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kaufmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021150; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Law B, 1997, J PAEDIAT CHILD H S1, V33, pS58; Lee A, 1999, PUBLIC HEALTH, V113, P185, DOI 10.1016/S0033-3506(99)00151-1; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Mansuy JM, 2008, J MED VIROL, V80, P289, DOI 10.1002/jmv.21056; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Mateos ML, 1999, VOX SANG, V76, P78; Nicand E., 1999, VIRUS HEPATITE E VIR, P125; Nicand E, 2008, PATHOL BIOL PARIS, V57, P203; Pavio N, 2010, VET RES, V41, DOI 10.1051/vetres/2010018; Peron Jean-Marie, 2006, Gastroenterol Clin Biol, V30, P757, DOI 10.1016/S0399-8320(06)73310-3; Poda SH, 2010, SEROPREVALENCE VIRUS; Raj VS, 2012, EMERG INFECT DIS, V18, P1369, DOI 10.3201/eid1808.111659; Rezig D, 2008, PATHOL BIOL, V56, P148, DOI 10.1016/j.patbio.2007.09.026; ROBERTSON BH, 1992, J GEN VIROL, V73, P1365, DOI 10.1099/0022-1317-73-6-1365; Roque-Afonso AM, 2006, IMMUNO-ANAL BIOL SPE, V21, P202; Rouger P, 2006, PRATIQUE NOUVELLE TR; Sacy RG, 2005, AM J TROP MED HYG, V73, P453, DOI 10.4269/ajtmh.2005.73.453; Severo CA, 1997, EUR J EPIDEMIOL, V13, P139, DOI 10.1023/A:1007336609638; Simpore J, 2009, Pak J Biol Sci, V12, P258, DOI 10.3923/pjbs.2009.258.263; Smith PF, 1997, EPIDEMIOL INFECT, V118, P243, DOI 10.1017/S0950268897007462; Sohn YM, 2000, YONSEI MED J, V41, P34, DOI 10.3349/ymj.2000.41.1.34; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P95, DOI 10.1016/j.trstmh.2004.12.005; Taremi M., 2008, Eastern Mediterranean Health Journal, V14, P157; Tucker TJ, 1996, J MED VIROL, V50, P117, DOI 10.1002/(SICI)1096-9071(199610)50:2&lt;117::AID-JMV3&gt;3.0.CO;2-D; van Cuyck H, 2005, J VIROL, V79, P9306, DOI 10.1128/JVI.79.14.9306-9314.2005; Victor JC, 2006, EPIDEMIOL INFECT, V134, P492, DOI 10.1017/S0950268805005194; W.H.O/EB126, 2009, HEP VIR; Wu JC, 1998, HEPATOLOGY, V27, P1415, DOI 10.1002/hep.510270532	64	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e48125	10.1371/journal.pone.0048125	http://dx.doi.org/10.1371/journal.pone.0048125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110187	gold, Green Submitted, Green Published			2022-12-25	WOS:000310193400032
J	Rodriguez, S; Huynh-Do, U				Rodriguez, Stephane; Huynh-Do, Uyen			Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor	FASEB JOURNAL			English	Article						PTEN protein phosphatase; PTEN dephosphorylation; c-Cbl; NHERF1	TUMOR-SUPPRESSOR GENE; CELL-MIGRATION; TYROSINE KINASE; UP-REGULATION; C-CBL; EXPRESSION; PTEN; PROTEIN; PHOSPHORYLATION; ACTIVATION	Deregulation of receptor tyrosine kinases (RTKs) is linked to a broad range of cancers, stressing the necessity of studying their regulatory pathways. We and others demonstrated previously that c-Cbl is necessary for the lysosomal degradation of erythropoietin-producing hepatocellular B1 (EphB1) carcinoma and epidermal growth factor receptor (EGFR) RTKs. Moreover, the tumor suppressor phosphatase and tensin homolog (PTEN) was shown to modulate c-Cbl-dependent EGFR degradation. We therefore investigated the involvement of PTEN in EphB1 signaling and degradation. We used PTEN mutants, PTEN, and NHERF1 small interfering RNA in CHO-EphB1 and SW480 cells endogenously expressing EphB1 to delineate EphB1-PTEN interactions. PTEN was constitutively associated with c-Cbl, protecting it from degradation. EphB1 stimulation triggered similar to 50% serine-threonine PTEN dephosphorylation and PTEN-Cbl complex disruption, a process requiring PTEN protein phosphatase activity. Both proteins independently translocated to EphB1, with PTEN in association with the scaffold protein NHERF1. Biologically, PTEN lipid phosphatase activity impairs EphB1-dependent cell adhesion and chemotaxis. This study demonstrates for the first time in mammalian cells that the Eph receptor and PTEN associate and influence their signaling. Moreover, it contributes to the emerging concept that PTEN regulates expression of RTKs through modulation of their degradation. Finally, it reveals a new role for PTEN protein phosphatase activity involved in this process.-Rodriguez, S., Huynh-Do, U. Phosphatase and tensin homolog regulates stability and activity of EphB1 receptor. FASEB J. 27, 632-644 (2013). www.fasebj.org	[Huynh-Do, Uyen] Univ Bern, Sch Med, Div Nephrol & Hypertens, Inselspital, CH-3010 Bern, Switzerland; [Huynh-Do, Uyen] Univ Bern, Sch Med, Dept Clin Res, Inselspital, CH-3010 Bern, Switzerland	University of Bern; University of Bern	Huynh-Do, U (corresponding author), Univ Bern, Sch Med, Div Nephrol & Hypertens, Inselspital, KiKli G4 E212, CH-3010 Bern, Switzerland.	uyen.huynh-do@insel.ch			Swiss National Science Foundation [3100A0-1183691]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Dr. D. Stroka (Clinic of Visceral Surgery and Medicine, University of Bern, Bern, Switzerland) and Professors B. M. Frey and F. J. Frey (Division of Nephrology and Hypertension, Inselspital, University of Bern) for continuous support and fruitful discussion and are very grateful to Dr. Kenneth Yamada (U. S. National Institutes of Health, National Institute of Dental Research, Bethesda, MD, USA) and Dr. Nick R. Leslie (College of Life Sciences, University of Dundee, Dundee, UK), who provided PTEN mutants. This work was supported by grant 3100A0-1183691 from the Swiss National Science Foundation to U. H. The authors declare no conflicts of interest.	Abounader R, 2004, ONCOGENE, V23, P9173, DOI 10.1038/sj.onc.1208146; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Berardi AC, 2008, ANTICANCER RES, V28, P763; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Brisbin S, 2009, DEV CELL, V17, P459, DOI 10.1016/j.devcel.2009.08.009; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Chi JH, 2008, J NEUROSURG, V108, P299, DOI 10.3171/JNS/2008/108/2/0299; Claperon A, 2012, ONCOGENE, V31, P1376, DOI 10.1038/onc.2011.334; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Easty DJ, 1999, INT J CANCER, V84, P494, DOI 10.1002/(SICI)1097-0215(19991022)84:5<494::AID-IJC8>3.3.CO;2-F; Fasen K, 2008, TRAFFIC, V9, P251, DOI 10.1111/j.1600-0854.2007.00679.x; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hu YL, 2007, ARCH BIOCHEM BIOPHYS, V467, P1, DOI 10.1016/j.abb.2007.07.027; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Mahimainathan L, 2004, J BIOL CHEM, V279, P15258, DOI 10.1074/jbc.M314328200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nakamura R, 2005, CANCER SCI, V96, P42, DOI 10.1111/j.1349-7006.2005.00007.x; Onnockx S, 2008, J CELL PHYSIOL, V214, P260, DOI 10.1002/jcp.21193; Panner A, 2009, CANCER RES, V69, P7911, DOI 10.1158/0008-5472.CAN-09-1287; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Sheng Z, 2008, PATHOBIOLOGY, V75, P274, DOI 10.1159/000151707; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Stephen LJ, 2007, DEV BIOL, V302, P66, DOI 10.1016/j.ydbio.2006.08.058; Stephenson S A, 2001, BMC Mol Biol, V2, P15, DOI 10.1186/1471-2199-2-15; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Truitt L, 2010, CANCER RES, V70, P1141, DOI 10.1158/0008-5472.CAN-09-1710; Uyen HD, 2002, J CELL SCI, V115, P3073; Vandenbroere I, 2003, BIOCHEM BIOPH RES CO, V300, P494, DOI 10.1016/S0006-291X(02)02894-2; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Vihanto MM, 2006, J CELL SCI, V119, P2299, DOI 10.1242/jcs.02946; Vindis C, 2004, J BIOL CHEM, V279, P27965, DOI 10.1074/jbc.M401295200; Vindis C, 2003, J CELL BIOL, V162, P661, DOI 10.1083/jcb.200302073; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Wang JD, 2007, ONCOLOGY-BASEL, V73, P238, DOI 10.1159/000127421; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yang NY, 2006, J BIOL CHEM, V281, P32574, DOI 10.1074/jbc.M604338200; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004	50	5	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					632	644		10.1096/fj.12-215582	http://dx.doi.org/10.1096/fj.12-215582			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23118026				2022-12-25	WOS:000314358000022
J	Belaguli, NS; Zhang, M; Brunicardi, FC; Berger, DH				Belaguli, Narasimhaswamy S.; Zhang, Mao; Brunicardi, F. Charles; Berger, David H.			Forkhead Box Protein A2 (FOXA2) Protein Stability and Activity Are Regulated by Sumoylation	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; TRANSCRIPTIONAL ACTIVATION; PDX-1 GENE; INSULIN-SECRETION; HEPATOCYTE; DOMAINS; EXPRESSION; BINDING; SUMO; METABOLISM	The forkhead box protein A2 (FOXA2) is an important regulator of glucose and lipid metabolism and organismal energy balance. Little is known about how FOXA2 protein expression and activity are regulated by post-translational modifications. We have identified that FOXA2 is post-translationally modified by covalent attachment of a small ubiquitin related modifier-1 (SUMO-1) and mapped the sumoylation site to the amino acid lysine 6 (K6). Preventing sumoylation by mutating the SUMO acceptor K6 to arginine resulted in downregulation of FOXA2 protein but not RNA expression in INS-1E insulinoma cells. K6R mutation also downregulated FOXA2 protein levels in HepG2 hepatocellular carcinoma cells, HCT116 colon cancer cells and LNCaP and DU145 prostate cancer cells. Further, interfering with FOXA2 sumoylation through siRNA mediated knockdown of UBC9, an essential SUMO E2 conjugase, resulted in downregulation of FOXA2 protein levels. Stability of sumoylation deficient FOXA2K6R mutant protein was restored when SUMO-1 was fused in-frame. FOXA2 sumoylation and FOXA2 protein levels were increased by PIAS1 SUMO ligase but not a SUMO ligase activity deficient PIAS1 mutant. Although expressed at lower levels, sumoylation deficient FOXA2K6R mutant protein was detectable in the nucleus indicating that FOXA2 nuclear localization is independent of sumoylation. Sumoylation increased the transcriptional activity of FOXA2 on Pdx-1 area I enhancer. Together, our results show that sumoylation regulates FOXA2 protein expression and activity.	[Belaguli, Narasimhaswamy S.; Berger, David H.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Belaguli, Narasimhaswamy S.; Berger, David H.] Baylor Coll Med, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Zhang, Mao] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy Ctr, Houston, TX 77030 USA; [Brunicardi, F. Charles] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Belaguli, NS (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	elaguli@bcm.edu			Veterans Affairs Merit Review grant; American Diabetes Association	Veterans Affairs Merit Review grant(US Department of Veterans Affairs); American Diabetes Association(American Diabetes Association)	This work was supported in part by Veterans Affairs Merit Review grant and American Diabetes Association research award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baroukh N, 2007, J BIOL CHEM, V282, P19575, DOI 10.1074/jbc.M611841200; Belaguli NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035717; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Cox B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011996; Danciu TE, 2012, J BIOL CHEM, V287, P18318, DOI 10.1074/jbc.M112.339424; de Cristofaro T, 2009, J MOL ENDOCRINOL, V42, P35, DOI 10.1677/JME-08-0100; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kaestner KH, 2010, PHYSIOL REV, V90, P1; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee CS, 2002, DIABETES, V51, P2546, DOI 10.2337/diabetes.51.8.2546; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Marongiu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009477; Marshak S, 2000, MOL CELL BIOL, V20, P7583, DOI 10.1128/MCB.20.20.7583-7590.2000; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; Potter AS, 2012, J CELL BIOCHEM, V113, P110, DOI 10.1002/jcb.23333; QIAN XB, 1995, NUCLEIC ACIDS RES, V23, P1184, DOI 10.1093/nar/23.7.1184; Rausa FM, 2004, J BIOL CHEM, V279, P43070, DOI 10.1074/jbc.M407472200; Rausa FM, 2003, MOL CELL BIOL, V23, P437, DOI 10.1128/MCB.23.2.437-449.2003; Sarkar A, 2011, FASEB J, V25, P2592, DOI 10.1096/fj.10-173757; Silva JP, 2009, NATURE, V462, P646, DOI 10.1038/nature08589; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	48	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48019	10.1371/journal.pone.0048019	http://dx.doi.org/10.1371/journal.pone.0048019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118920	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500056
J	Chen, SCC; Huang, YF; Wang, JD				Chen, Solomon Chih Cheng; Huang, Ya Fang; Wang, Jung Der			Hyperferritinemia and Hyperuricemia May Be Associated with Liver Function Abnormality in Obese Adolescents	PLOS ONE			English	Article							HFE GENE-MUTATIONS; C VIRUS-INFECTION; FATTY LIVER; IRON DEPLETION; HEPATITIS-C; METABOLIC SYNDROME; OXIDATIVE STRESS; URIC-ACID; ALANINE AMINOTRANSFERASE; INSULIN-RESISTANCE	Background: The iron status in human body and its association with liver function in adolescents was rarely studied. The objective was to investigate the association among the levels of serum ferritin, uric acid and alanine aminotransferase (ALT) in adolescents. Methods and Results: A total of 2090 adolescents negative for hepatitis B surface antigen from one junior high school (786, 12-13 years), three senior high schools (973, 15-16 years) and one college (331, 18-19 years) participated in this survey. Anthropometric and biochemical measurements, including complete blood count, ALT, serum ferritin and uric acid were performed. An ALT>42 U/L was defined as elevated, a ferritin level >200 mu g/L was defined as hyperferritinemia. A uric acid level>460 mu mol/L in males and >340 mu mol/L in females was defined as hyperuricemia. The chi-squared test, linear regression and multivariate logistic regression were used for the data analysis. Elevated ALT levels were detected in 76 (3.6%) students and were more prevalent in males than females (6.4% vs. 2.0%, p<0.001). The univariate analysis found gender, age group, body mass index, ferritin level, uric acid level and white blood cell count all to be significantly associated with elevated ALT. Linear regression showed a positive correlation among log(ferritin), uric acid level and ALT level. Elevated ALT occurred more frequently at ferritin level >100 mu g/L. The logistic regression analysis found that body mass index, hyperferritinemia and hyperuricemia were significant factors associated with the ALT elevation, but gender, age, and white blood cell count were not. Conclusions: Hyperferritinemia and hyperuricemia are two independently significant factors associated with ALT elevation among obese adolescents. More studies are needed to corroborate any hypothesis related to these phenomena.	[Chen, Solomon Chih Cheng] Chia Yi Christian Hosp, Dept Pediat, Chiayi, Taiwan; [Chen, Solomon Chih Cheng] Taipei Med Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Huang, Ya Fang] Pingtung Christian Hosp, Dept Clin Lab, Pingtung City, Taiwan; [Wang, Jung Der] Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med & Hosp, Tainan 70101, Taiwan	Taipei Medical University; National Cheng Kung University	Chen, SCC (corresponding author), Chia Yi Christian Hosp, Dept Pediat, Chiayi, Taiwan.	solomon.ccc@gmail.com		Chen, Solomon/0000-0003-0031-6147	National Science Council, Taiwan [NSC99-2314-B-475-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by a grant (NSC99-2314-B-475-001) from the National Science Council, Taiwan (http://web1.nsc.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2006, LIVER INT, V26, P298, DOI 10.1111/j.1478-3231.2005.01238.x; Aigner E, 2010, EUR J CLIN INVEST, V40, P155, DOI 10.1111/j.1365-2362.2009.02238.x; Albano E, 2005, ALIMENT PHARM THER, V22, P71, DOI 10.1111/j.1365-2036.2005.02601.x; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Britton RS, 2002, INT J HEMATOL, V76, P219, DOI 10.1007/BF02982791; Carlo C, 2003, HEPATO-GASTROENTEROL, V50, P1467; Centers for Disease Control and Prevention, 2012, HEM IR STOR DIS DIAG; CHANG MH, 1993, J MED VIROL, V40, P322, DOI 10.1002/jmv.1890400411; Chen SCC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013269; Cheng HL, 2012, OBES REV, V13, P150, DOI 10.1111/j.1467-789X.2011.00938.x; DePalma RG, 2010, J VASC SURG, V51, P1498, DOI 10.1016/j.jvs.2009.12.068; Facchini FS, 2002, GASTROENTEROLOGY, V122, P931, DOI 10.1053/gast.2002.32403; Fernandez-Real JM, 2002, DIABETES CARE, V25, P2249, DOI 10.2337/diacare.25.12.2249; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Ghaziani T, 2007, HEPATOL RES, V37, P172, DOI 10.1111/j.1872-034X.2007.00026.x; Ghio AJ, 2005, FREE RADICAL RES, V39, P337, DOI 10.1080/10715760400026088; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; HSU HC, 1990, AM J HEMATOL, V34, P287, DOI 10.1002/ajh.2830340410; Iron Disorders Institute, 2012, IR TESTS; Johnson S, 1999, MED HYPOTHESES, V53, P407, DOI 10.1054/mehy.1999.0925; Kang YH, 2008, ENDOCR J, V55, P1093, DOI 10.1507/endocrj.K08E-077; Kladchareon Nusont, 2004, Journal of the Medical Association of Thailand, V87, pS29; Knovich MA, 2009, BLOOD REV, V23, P95, DOI 10.1016/j.blre.2008.08.001; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Le Page L, 2005, REV MED INTERNE, V26, P368, DOI 10.1016/j.revmed.2005.01.005; LEE SD, 1991, HEPATOLOGY, V13, P830, DOI 10.1016/0270-9139(91)90249-U; LOCKITCH G, 1988, CLIN CHEM, V34, P1622; Mah YH, 2005, LIVER INT, V25, P214, DOI 10.1111/j.1478-3231.2005.01055.x; Manousou P, 2011, LIVER INT, V31, P730, DOI 10.1111/j.1478-3231.2011.02488.x; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; McLaren CE, 2003, AM J MED SCI, V325, P53, DOI 10.1097/00000441-200302000-00001; Petta S, 2008, AM J GASTROENTEROL, V103, P1136, DOI 10.1111/j.1572-0241.2008.01813.x; Riquelme A, 2004, DIGEST DIS SCI, V49, P1012, DOI 10.1023/B:DDAS.0000034564.68307.39; Romagnuolo J, 2005, SCAND J GASTROENTERO, V40, P1365, DOI 10.1080/00365520500287400; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Stevens D, 2000, ARCH DIS CHILD, V82, P269; Teehan Geoffrey S, 2004, Hemodial Int, V8, P226, DOI 10.1111/j.1492-7535.2004.01100.x; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Valenti L, 2003, GASTROENTEROLOGY, V124, P866, DOI 10.1053/gast.2003.50130; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x	43	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48645	10.1371/journal.pone.0048645	http://dx.doi.org/10.1371/journal.pone.0048645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119080	Green Published, gold			2022-12-25	WOS:000310600500188
J	Danko, MJ; Kozlowski, J				Danko, Maciej Jan; Kozlowski, Jan			Mutation Accumulation May Only Be a Minor Force in Shaping Life-History Traits, Even when Reproduction Is Sexual	PLOS ONE			English	Article							EVOLUTION; SENESCENCE; MODEL	In a previous theoretical study we investigated whether adaptive or non-adaptive processes are more important in the evolution of senescence. We built a model that combined both processes and found that mutation accumulation is important only at those ages where mortality has a negligible impact on fitness. This model, however, was limited to haploid organisms. Here we extend our model by introducing diploidy and sexual reproduction. We assume that only recessive (mutated) homozygotes experience detrimental effects. Our results corroborate our previous conclusions, confirming that life histories are largely determined by adaptive processes. We also found that the equilibrium frequencies of mutated alleles are at higher values than in haploid model, because mutations in heterozygotes are hidden for directional selection. Nevertheless, the equilibrium frequencies of recessive homozygotes that make mutations visible to selection are very similar to the equilibrium frequencies of these alleles in our haploid model. Diploidy and sexual reproduction with recombination slows down approaching selection-mutation balance.	[Danko, Maciej Jan] Max Planck Inst Demog Res, Rostock, Germany; [Kozlowski, Jan] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Max Planck Society; Jagiellonian University	Danko, MJ (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	danko@demogr.mpg.de	Dańko, Maciej J./W-3099-2019; Kozlowski, Jan/K-5549-2012	Dańko, Maciej J./0000-0002-7924-9022; Kozlowski, Jan/0000-0002-7084-2030	Max Planck Institute for Demographic Research; Jagiellonian University [DS/WBiNoZ/INoS/757/10]	Max Planck Institute for Demographic Research; Jagiellonian University	MJD is funded by the Max Planck Institute for Demographic Research (URL: www.demogr.mpg.de), and JK is funded by Jagiellonian University grant DS/WBiNoZ/INoS/757/10 (URL: eko.uj.edu.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Danko MJ, 2012, PLOS ONE, V7; FELSENSTEIN J, 1974, GENETICS, V78, P737; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Medawar P., 1952, UNSOLVED PROBLEM BIO; Moorad JA, 2008, GENETICS, V179, P2061, DOI 10.1534/genetics.108.088526; Moorad JA, 2009, P ROY SOC B-BIOL SCI, V276, P2271, DOI 10.1098/rspb.2009.0183; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; PENNA TJP, 1995, J STAT PHYS, V78, P1629, DOI 10.1007/BF02180147; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Snoke MS, 2003, HEREDITY, V91, P546, DOI 10.1038/sj.hdy.6800353; Stauffer D, 2007, BIOINFORM BIOL INSIG, V1, P91; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	16	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48302	10.1371/journal.pone.0048302	http://dx.doi.org/10.1371/journal.pone.0048302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118976	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500096
J	Liu, HT; Liang, YJ; Wang, LL; Tian, LT; Song, RP; Han, TW; Pan, SH; Liu, LX				Liu, Haitao; Liang, Yingjian; Wang, Luoluo; Tian, Lantian; Song, Ruipeng; Han, Tianwen; Pan, Shangha; Liu, Lianxin			In Vivo and In Vitro Suppression of Hepatocellular Carcinoma by EF24, a Curcumin Analog	PLOS ONE			English	Article							CANCER-CELLS; GENE-EXPRESSION; GROWTH; ANGIOGENESIS; INHIBITION; APOPTOSIS; MITOCHONDRIA; ANTICANCER; RECEPTOR; PHYTOCHEMICALS	The synthetic compound 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24) is a potent analog of curcumin that exhibits enhanced biological activity and bioavailability without increasing toxicity. EF24 exerts antitumor activity by arresting the cell cycle and inducing apoptosis, suppressing many types of cancer cells in vitro. The antiproliferative and antiangiogenic properties of EF24 provide theoretical support for its development and application to liver cancers. We investigated the in vitro and in vivo activities of EF24 on liver cancer to better understand its therapeutic effects and mechanisms. EF24 induced significant apoptosis and G2/M-phase cell cycle arrest in mouse liver cancer cell lines, Hepa1-6 and H22. The expression levels of G2/M cell cycle regulating factors, cyclin B1 and Cdc2, were significantly decreased, pp53, p53, and p21 were significantly increased in EF24-treated cells. In addition, EF24 treatment significantly reduced Bcl-2 concomitant with an increase in Bax, enhanced the release of cytochrome c from the mitochondria into the cytosol, resulting in an upregulation of cleaved-caspase-3, which promoted poly (ADP-ribose) polymerase cleavage. EF24-treated cells also displayed decreases in phosphorylated Akt, phosphorylated extracellular signal-regulated kinase and vascular endothelial growth factor. Our in vitro protein expression data were confirmed in vivo using a subcutaneous hepatocellular carcinoma (HCC) tumor model. This mouse HCC model confirmed that total body weight was unchanged following EF24 treatment, although tumor weight was significantly decreased. Using an orthotopic HCC model, EF24 significantly reduced the liver/body weight ratio and relative tumor areas compared to the control group. In situ detection of apoptotic cells and quantification of Ki-67, a biomarker of cell proliferation, all indicated significant tumor suppression with EF24 treatment. These results suggest that EF24 exhibits anti-tumor activity on liver cancer cells via mitochondria-dependent apoptosis and inducing cell cycle arrest coupled with antiangiogenesis. The demonstrated activities of EF24 support its further evaluation as a treatment for human liver cancers.	[Liu, Haitao; Liang, Yingjian; Wang, Luoluo; Tian, Lantian; Song, Ruipeng; Han, Tianwen; Liu, Lianxin] Harbin Med Univ, Affiliated Hosp 1, Dept Hepat Surg, Key Lab Hepatosplen Surg,Minist Educ, Harbin, Heilongjiang Pr, Peoples R China; [Pan, Shangha] Harbin Med Univ, Affiliated Hosp 1, Res Ctr, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Liu, LX (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Hepat Surg, Key Lab Hepatosplen Surg,Minist Educ, Harbin, Heilongjiang Pr, Peoples R China.	liulianxin@medmail.com.cn	Liu, LianXin/D-6712-2013; Liu, Haitao/AAY-3944-2021	Liu, Haitao/0000-0002-3757-779X	Program for Innovative Research Team (in Science and Technology) in Higher Educational Institutions of Heilongjiang Province [2009td06]	Program for Innovative Research Team (in Science and Technology) in Higher Educational Institutions of Heilongjiang Province	This study was supported by Program for Innovative Research Team (in Science and Technology) in Higher Educational Institutions of Heilongjiang Province (2009td06); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BK, 2005, ANTI-CANCER DRUG, V16, P263, DOI 10.1097/00001813-200503000-00005; Adams BK, 2004, BIOORGAN MED CHEM, V12, P3871, DOI 10.1016/j.bmc.2004.05.006; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Bae MK, 2006, ONCOL REP, V15, P1557; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Buhrow SA, 2005, AACR M 2005, V2005, p[2005, 984]; Chen A, 2006, ONCOGENE, V25, P278, DOI [10.1038/sj.onc.1209019, 10.1038/sj.onc.1209573]; Choi H, 2006, MOL PHARMACOL, V70, P1664, DOI 10.1124/mol.106.025817; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; de Groot RP, 1998, CELL SIGNAL, V10, P619, DOI 10.1016/S0898-6568(98)00023-0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ferenci P, 2010, J CLIN GASTROENTEROL, V44, P239, DOI 10.1097/MCG.0b013e3181d46ef2; Je YJ, 2009, LANCET ONCOL, V10, P967, DOI 10.1016/S1470-2045(09)70222-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Kern MA, 2006, CANCER RES, V66, P7059, DOI 10.1158/0008-5472.CAN-06-0325; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kris-Etherton Penny M., 2002, American Journal of Medicine, V113, p71S; Krystal GW, 2002, MOL CANCER THER, V1, P913; Labbozzetta M, 2006, ANN NY ACAD SCI, V1089, P268, DOI 10.1196/annals.1386.014; Liang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023908; Liu FJ, 2008, CANCER SCI, V99, P2055, DOI 10.1111/j.1349-7006.2008.00905.x; Liu XH, 2000, J UROLOGY, V164, P820, DOI 10.1016/S0022-5347(05)67321-1; Liu XS, 2006, MOL CANCER THER, V5, P494, DOI 10.1158/1535-7163.MCT-05-0049; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lu SC, 2010, HEPATOLOGY, V51, P734, DOI 10.1002/hep.23497; Malemud CJ, 2007, CURR OPIN PHARMACOL, V7, P339, DOI 10.1016/j.coph.2006.11.012; Mayo LD, 2002, J BIOL CHEM, V277, P5484, DOI 10.1074/jbc.M108302200; Moiseeva EP, 2009, CANCER PREV RES, V2, P611, DOI 10.1158/1940-6207.CAPR-08-0102; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Naithani R, 2008, CURR MED CHEM, V15, P1044, DOI 10.2174/092986708784221403; NAKASHIMA T, 1983, CANCER, V51, P863, DOI 10.1002/1097-0142(19830301)51:5<863::AID-CNCR2820510520>3.0.CO;2-D; Rennefahrt U, 2005, CANCER LETT, V217, P1, DOI 10.1016/j.canlet.2004.08.003; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Selvendiran K, 2007, J BIOL CHEM, V282, P28609, DOI 10.1074/jbc.M703796200; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Shoji M, 2008, J DRUG TARGET, V16, P185, DOI [10.1080/10611860801890093, 10.1080/10611860801890093 ]; Subramaniam D, 2008, CANCER RES, V68, P1962, DOI 10.1158/0008-5472.CAN-07-6011; Thomas SL, 2008, CELL CYCLE, V7, P2409, DOI 10.4161/cc.6410; Thomas SL, 2010, BIOCHEM PHARMACOL, V80, P1309, DOI 10.1016/j.bcp.2010.06.048; Thoppil RJ, 2011, WORLD J HEPATOL, V3, P228, DOI 10.4254/wjh.v3.i9.228; United States National Institutes of Health National Cancer Institute (nci), 2010, CANC TRENDS PROGR RE; Wang JZ, 2011, J HEPATOL, V55, P359, DOI 10.1016/j.jhep.2010.10.043; Wang XD, 2001, GENE DEV, V15, P2922; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Zhou YJ, 2007, LAB INVEST, V87, P488, DOI 10.1038/labinvest.3700532	53	40	41	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48075	10.1371/journal.pone.0048075	http://dx.doi.org/10.1371/journal.pone.0048075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118928	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500062
J	Ortiz-Masia, D; Diez, I; Calatayud, S; Hernandez, C; Cosin-Roger, J; Hinojosa, J; Esplugues, JV; Barrachina, MD				Ortiz-Masia, Dolores; Diez, Irene; Calatayud, Sara; Hernandez, Carlos; Cosin-Roger, Jesus; Hinojosa, Joaquin; Esplugues, Juan V.; Barrachina, Maria D.			Induction of CD36 and Thrombospondin-1 in Macrophages by Hypoxia-Inducible Factor 1 and Its Relevance in the Inflammatory Process	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; BOWEL-DISEASE; FACTOR-I; EXPRESSION; CELLS; GAMMA; PHAGOCYTOSIS; RECOGNITION; HIF-1-ALPHA; RECEPTOR	Inflammation is part of a complex biological response of vascular tissue to pathogens or damaged cells. First inflammatory cells attempt to remove the injurious stimuli and this is followed by a healing process mediated principally by phagocytosis of senescent cells. Hypoxia and p38-MAPK are associated with inflammation, and hypoxia inducible factor 1 (HIF-1) has been detected in inflamed tissues. We aimed to analyse the role of p38-MAPK and HIF-1 in the transcriptional regulation of CD36, a class B scavenger receptor, and its ligand thrombospondin (TSP-1) in macrophages and to evaluate the involvement of this pathway in phagocytosis of apoptotic neutrophils. We have also assessed HIF-1 alpha, p38-MAPK and CD36 immunostaining in the mucosa of patients with inflammatory bowel disease. Results show that hypoxia increases neutrophil phagocytosis by macrophages and induces the expression of CD36 and TSP-1. Addition of a p38-MAPK inhibitor significantly reduced the increase in CD36 and TSP-1 expression provoked by hypoxia and decreased HIF-1 alpha stabilization in macrophages. Transient transfection of macrophages with a miHIF-1 alpha-targeting vector blocked the increase in mRNA expression of CD36 and TSP-1 during hypoxia and reduced phagocytosis, thus highlighting a role for the transcriptional activity of HIF-1. CD36 and TSP-1 were necessary for the phagocytosis of neutrophils induced by hypoxic macrophages, since functional blockade of these proteins undermined this process. Immunohistochemical studies revealed CD36, HIF-1 alpha and p38-MAPK expression in the mucosa of patients with inflammatory bowel disease. A positive and significant correlation between HIF-1 alpha and CD36 expression and CD36 and p38-MAPK expression was observed in cells of the lamina propria of the damaged mucosa. Our results demonstrate a HIF-1-dependent up-regulation of CD36 and TSP-1 that mediates the increased phagocytosis of neutrophils by macrophages during hypoxia. Moreover, they suggest that CD36 expression in the damaged mucosa of patients with inflammatory bowel disease depends on p38-MAPK and HIF-1 activity.	[Ortiz-Masia, Dolores; Diez, Irene; Calatayud, Sara; Cosin-Roger, Jesus; Esplugues, Juan V.; Barrachina, Maria D.] Univ Valencia, Fac Med, Dept Farmacol & CIBERehd, Valencia, Spain; [Hernandez, Carlos; Esplugues, Juan V.] Hosp Dr Peset, FISABIO, Valencia, Spain; [Hinojosa, Joaquin] Hosp Manises, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia	Barrachina, MD (corresponding author), Univ Valencia, Fac Med, Dept Farmacol & CIBERehd, Valencia, Spain.	dolores.barrachina@uv.es	Barrachina, Maria/ABB-9683-2021; Esplugues, Juan/ABC-1488-2021; SAEZ, CARLOS HERNANDEZ/M-3029-2014; Calatayud, Sara/ABB-9665-2021; ORTIZ-MASIA, MARIA DOLORES/M-1413-2017	SAEZ, CARLOS HERNANDEZ/0000-0001-8536-429X; Calatayud, Sara/0000-0001-9675-2423; ORTIZ-MASIA, MARIA DOLORES/0000-0002-7924-9962; Esplugues Mota, Juan Vicente/0000-0001-8205-021X; Cosin roger, Jesus/0000-0002-2468-4908; Barrachina, Maria Dolores/0000-0002-4332-2929	Ministerio de Educacion y Cultura, Spain [SAF2010-20231]; Ministerio de Sanidad y Consumo, Spain [CIBERehd CD06/04/0071]; Conselleria de Educacion, Generalitat Valenciana, Spain [PROMETEO/2010/060]	Ministerio de Educacion y Cultura, Spain(Spanish Government); Ministerio de Sanidad y Consumo, Spain(Spanish Government); Conselleria de Educacion, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	This project was funded by SAF2010-20231 (Ministerio de Educacion y Cultura), CIBERehd CD06/04/0071 (Ministerio de Sanidad y Consumo), and PROMETEO/2010/060 (Conselleria de Educacion, Generalitat Valenciana), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Iborra B, 2009, J IMMUNOL, V182, P3155, DOI 10.4049/jimmunol.0801710; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Anand RJ, 2007, J LEUKOCYTE BIOL, V82, P1257, DOI 10.1189/jlb.0307195; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Bird DA, 1999, P NATL ACAD SCI USA, V96, P6347, DOI 10.1073/pnas.96.11.6347; Brandt E, 2000, CLIN EXP IMMUNOL, V122, P180, DOI 10.1046/j.1365-2249.2000.01364.x; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; De Pablo C, 2010, AIDS, V24, P1259, DOI 10.1097/QAD.0b013e32833a2b02; Diez I, 2010, BR J PHARM; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng YJ, 2011, J DIGEST DIS, V12, P327, DOI 10.1111/j.1751-2980.2011.00525.x; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Giatromanolaki A, 2003, J CLIN PATHOL, V56, P209, DOI 10.1136/jcp.56.3.209; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; HASS R, 1989, EUR J CELL BIOL, V48, P282; Hernandez C, 2009, BRIT J PHARMACOL, V156, P262, DOI 10.1111/j.1476-5381.2008.00044.x; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kong TQ, 2004, P NATL ACAD SCI USA, V101, P10440, DOI 10.1073/pnas.0401339101; Li X, 2007, NEPHROL DIAL TRANSPL, V22, P1041, DOI 10.1093/ndt/gfl766; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mortimer HJ, 2007, PULM PHARMACOL THER, V20, P718, DOI 10.1016/j.pupt.2006.08.007; Mwaikambo BR, 2009, J BIOL CHEM, V284, P26695, DOI 10.1074/jbc.M109.033480; Nikolaus S, 1998, GUT, V42, P470, DOI 10.1136/gut.42.4.470; Oda T, 2006, AM J PHYSIOL-CELL PH, V291, pC104, DOI 10.1152/ajpcell.00614.2005; Okuda T, 2005, WORLD J GASTROENTERO, V11, P1535; Olagnier D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002254; Ortiz-Masia D, 2010, FASEB J, V24, P136, DOI 10.1096/fj.09-137489; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Walmsley SR, 2005, TRENDS IMMUNOL, V26, P434, DOI 10.1016/j.it.2005.06.007; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Yamamoto-Furusho JK, 2011, INFLAMM BOWEL DIS, V17, P680, DOI 10.1002/ibd.21322	38	40	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48535	10.1371/journal.pone.0048535	http://dx.doi.org/10.1371/journal.pone.0048535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119050	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500163
J	Sardinha, LB; Santos, DA; Silva, AM; Coelho-e-Silva, MJ; Raimundo, AM; Moreira, H; Santos, R; Vale, S; Baptista, F; Mota, J				Sardinha, Luis B.; Santos, Diana A.; Silva, Analiza M.; Coelho-e-Silva, Manuel J.; Raimundo, Armando M.; Moreira, Helena; Santos, Rute; Vale, Susana; Baptista, Fatima; Mota, Jorge			Prevalence of Overweight, Obesity, and Abdominal Obesity in a Representative Sample of Portuguese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; CARE COSTS; TRENDS; HEALTH; INEQUALITIES; MORTALITY	This study determined the prevalence of overweight, obesity, and abdominal obesity in the Portuguese adults and examined the relationship between above mentioned prevalences and educational level. Body mass, stature, and waist circumference were measured in a representative sample of the Portuguese population aged 18-103 years (n = 9,447; 18-64 years: n = 6,908; >= 65 years: n = 2,539). Overweight and obesity corresponded to a body mass index ranging between 25-29.9 kg/m(2) and >= 30 kg/m(2), respectively. Abdominal obesity was assessed as > 102 cm for males and > 88 cm for females. After adjusting for educational level, the combined prevalences of overweight and obesity were 66.6% in males and 57.9% in females (18-64 years). Respective values in older adults (>= 65 years) were 70.4% for males and 74.7% for females. About 19.3% of adult males and 37.9% of adult females presented abdominal obesity. Correspondent values in older adults were 32.1%, for males, and 69.7%, for females. In adults, low educational level was related to an increased risk for overweight (OR = 2.54; 95% CI: 2.08-3.09), obesity (OR = 2.76; 95% CI: 2.20-3.45), and abdominal obesity (OR = 5.48; 95% CI: 4.60-6.52). This reinforces the importance of adjusting public health strategies for educational level.	[Sardinha, Luis B.; Santos, Diana A.; Silva, Analiza M.; Baptista, Fatima] Univ Tecn Lisboa, Fac Human Kinet, Interdisciplinary Ctr Study Human Performance, Exercise & Hlth Lab, Cruz Quebrada, Portugal; [Coelho-e-Silva, Manuel J.] Univ Coimbra, Fac Sport Sci & Phys Educ, Coimbra, Portugal; [Raimundo, Armando M.] Univ Evora, Dept Sport & Hlth, Res Ctr Sports Hlth Sci & Human Dev, Evora, Portugal; [Moreira, Helena] Univ Tras Os Montes & Alto Douro, Dept Sport Sci Exercise & Hlth, Vila Real, Portugal; [Santos, Rute; Vale, Susana; Mota, Jorge] Univ Porto, Fac Sports, Res Ctr Phys Act Hlth & Leisure, P-4100 Oporto, Portugal; [Santos, Rute] Maia Inst Higher Educ, Maia, Portugal	Universidade de Lisboa; Universidade de Coimbra; University of Evora; University of Tras-os-Montes & Alto Douro; Universidade do Porto; Instituto Universitario da Maia (ISMAI)	Sardinha, LB (corresponding author), Univ Tecn Lisboa, Fac Human Kinet, Interdisciplinary Ctr Study Human Performance, Exercise & Hlth Lab, Cruz Quebrada, Portugal.	lsardinha@fmh.utl.pt	De+Mendonça+Raimundo, Armando/AAK-4627-2020; Sardinha, Luís Bettencourt/F-2641-2013; Sardinha, Luís B./ABG-5389-2020; Vale, Susana/L-8367-2013; Silva, Manuel Coelho E/O-2604-2019; Santos, Vanessa/AAP-4130-2020; Silva, Analiza M/C-9858-2010; Baptista, Fátima/N-4043-2013; mota, jorge/B-2980-2013; Coelho-e-Silva, Manuel J/V-1645-2017; Santos, Diana A/H-9086-2013; Moreira, Maria H. R./K-2996-2013; Santos, Rute/A-6401-2012	De+Mendonça+Raimundo, Armando/0000-0001-9753-8381; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Sardinha, Luís B./0000-0002-6230-6027; Silva, Manuel Coelho E/0000-0003-4512-7331; Silva, Analiza M/0000-0002-8984-8600; Baptista, Fátima/0000-0002-0214-5401; mota, jorge/0000-0001-7571-9181; Coelho-e-Silva, Manuel J/0000-0003-4512-7331; Santos, Diana A/0000-0003-0429-3093; Moreira, Maria H. R./0000-0002-5481-0688; Santos, Rute/0000-0002-7604-5753; Vale, Susana/0000-0002-1703-9361	Portuguese Foundation for Science and Technology [SFRH/BD/46503/2008]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	Diana A. Santos received a PhD fellowship from the Portuguese Foundation for Science and Technology (SFRH/BD/46503/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, CLIN GUID ID EV TREA; Bentley TGK, 2011, QUAL LIFE RES, V20, P665, DOI 10.1007/s11136-011-9878-7; Bes-Rastrollo M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-213; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Cameron AJ, 2012, INT J EPIDEMIOL, V41, P484, DOI 10.1093/ije/dyr198; Carreno-Luengo H., 2012, PUBLIC HEALTH NUTR, P1; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Czernichow S, 2011, OBES REV, V12, P680, DOI 10.1111/j.1467-789X.2011.00879.x; do Carmo I, 2008, OBES REV, V9, P11, DOI 10.1111/j.1467-789X.2007.00422.x; Doak CM, 2012, OBES REV, V13, P174, DOI 10.1111/j.1467-789X.2011.00943.x; FFMS, 2008, PORDATA BAS DAD PORT; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Gomes A, 2010, OBES REV, V11, P627, DOI 10.1111/j.1467-789X.2010.00739.x; Grimble RF, 2010, P NUTR SOC, V69, P511, DOI 10.1017/S0029665110001709; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Marques-Vidal P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-772; McKee M, 2011, J EPIDEMIOL COMMUN H, V65, P391, DOI 10.1136/jech.2010.129999; Moriarty JP, 2012, J OCCUP ENVIRON MED, V54, P286, DOI 10.1097/JOM.0b013e318246f1f4; National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Perez M, 2012, OBESITY, V20, P879, DOI 10.1038/oby.2011.89; Ricciuto L, 2006, EUR J CLIN NUTR, V60, P778, DOI 10.1038/sj.ejcn.1602382; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Health Organization, 1995, PHYS STAT US INT ANT; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yu Y, 2012, OBESITY, V20, P904, DOI 10.1038/oby.2011.307	33	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47883	10.1371/journal.pone.0047883	http://dx.doi.org/10.1371/journal.pone.0047883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118905	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500043
J	Skottrup, PD; Sorensen, G; Ksiazek, M; Potempa, J; Riise, E				Skottrup, Peter Durand; Sorensen, Grete; Ksiazek, Miroslaw; Potempa, Jan; Riise, Erik			A Phage Display Selected 7-mer Peptide Inhibitor of the Tannerella forsythia Metalloprotease-Like Enzyme Karilysin Can Be Truncated to Ser-Trp-Phe-Pro	PLOS ONE			English	Article							GINGIPAINS; EXPRESSION; AFFINITY; CLONING; CELLS; RGPB	Tannerella forsythia is a gram-negative bacteria, which is strongly associated with the development of periodontal disease. Karilysin is a newly identified metalloprotease-like enzyme, that is secreted from T. forsythia. Karilysin modulates the host immune response and is therefore considered a likely drug target. In this study peptides were selected towards the catalytic domain from Karilysin (Kly18) by phage display. The peptides were linear with low micromolar binding affinities. The two best binders (peptide14 and peptide15), shared the consensus sequence XWFPXXXGGG. A peptide15 fusion with Maltose Binding protein (MBP) was produced with peptide15 fused to the N-terminus of MBP. The peptide15-MBP was expressed in E. coli and the purified fusion-protein was used to verify Kly18 specific binding. Chemically synthesised peptide15 (SWFPLRSGGG) could inhibit the enzymatic activity of both Kly18 and intact Karilysin (Kly48). Furthermore, peptide15 could slow down the autoprocessing of intact Kly48 to Kly18. The WFP motif was important for inhibition and a truncation study further demonstrated that the N-terminal serine was also essential for Kly18 inhibition. The SWFP peptide had a Ki value in the low micromolar range, which was similar to the intact peptide15. In conclusion SWFP is the first reported inhibitor of Karilysin and can be used as a valuable tool in structure-function studies of Karilysin.	[Skottrup, Peter Durand; Sorensen, Grete; Riise, Erik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Biomol Interact Grp, Copenhagen, Denmark; [Ksiazek, Miroslaw; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Oral Hlth & Syst Dis Res Grp, Louisville, KY 40292 USA	University of Copenhagen; Jagiellonian University; University of Louisville	Skottrup, PD (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Biomol Interact Grp, Copenhagen, Denmark.	pds@farma.ku.dk	Potempa, Jan/AAA-6850-2021; Skottrup, Peter/R-5744-2016	Skottrup, Peter/0000-0002-8867-3845; Potempa, Jan/0000-0002-3600-7461	Lundbeck Foundation [R54-A5291]; National Institutes of Health, United States of America [DE 09761]; National Science Center, Krakow, Poland [2011/01/B/NZ6/00268]; European Community [FP7-HEALTH-2010-261460]; Foundation for Polish Science [TEAM] [DPS/424-329/10]; Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University (FBBB-UJ) [K/DSC/000361]; European Union [POIG.02.01.00-12-064/08]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center, Krakow, Poland(National Science Centre, Poland); European Community(European Commission); Foundation for Polish Science [TEAM](European Commission); Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University (FBBB-UJ); European Union(European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Lundbeck Foundation [grant number R54-A5291 to PDS]; the National Institutes of Health [Grant number DE 09761, United States of America to JP); National Science Center [2011/01/B/NZ6/00268, Krakow, Poland to JP]; the European Community [FP7-HEALTH-2010-261460 "Gums&Joints" to JP]; the Foundation for Polish Science [TEAM project DPS/424-329/10 to JP]; the Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University (FBB&B-UJ) [project no. K/DSC/000361 to MK); and structural funds from the European Union [POIG.02.01.00-12-064/08 to FBB&B-UJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behle JH, 2006, INT DENT J, V56, P256; Byrne DP, 2010, BIOCHEM J, V425, P257, DOI 10.1042/BJ20090343; Carlisle MD, 2009, J INNATE IMMUN, V1, P118, DOI 10.1159/000181015; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; Cronan CA, 2006, ORAL MICROBIOL IMMUN, V21, P212, DOI 10.1111/j.1399-302X.2006.00277.x; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Fitzpatrick RE, 2009, J INNATE IMMUN, V1, P109, DOI 10.1159/000181145; Grenier D, 2002, J PERIODONTOL, V73, P79, DOI 10.1902/jop.2002.73.1.79; GRENIER D, 1995, MICROBIOL-UK, V141, P921, DOI 10.1099/13500872-141-4-921; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Ishihara K, 2010, BIOL CHEM, V391, P1047, DOI 10.1515/BC.2010.113; Jani M, 2005, BIOCHIMIE, V87, P385, DOI 10.1016/j.biochi.2004.09.008; Johansen LK, 1995, PROTEIN ENG, V8, P1063, DOI 10.1093/protein/8.10.1063; Jordan RCK, 2004, PERIODONTOL 2000, V34, P217, DOI 10.1046/j.0906-6713.2002.003433.x; Jusko M, 2012, J IMMUNOLOG IN PRESS, V188; Karim AY, 2010, BIOL CHEM, V391, P105, DOI 10.1515/BC.2010.009; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; Koziel J, 2010, J INNATE IMMUN, V2, P288, DOI 10.1159/000281881; Krauser JA, 2002, BIOL CHEM, V383, P1193, DOI 10.1515/BC.2002.131; Matsushita K, 2006, J PERIODONTAL RES, V41, P171, DOI 10.1111/j.1600-0765.2005.00854.x; Monteiro AC, 2009, J IMMUNOL, V183, P3700, DOI 10.4049/jimmunol.0900895; Nixon Andrew E., 2002, Current Pharmaceutical Biotechnology, V3, P1; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pan WJ, 2003, J BIOL CHEM, V278, P27820, DOI 10.1074/jbc.M304436200; Persson GR, 2006, INT DENT J, V56, P240; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; RATH S, 1988, J IMMUNOL METHODS, V106, P245, DOI 10.1016/0022-1759(88)90204-9; Saito T, 1997, INFECT IMMUN, V65, P4888, DOI 10.1128/IAI.65.11.4888-4891.1997; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Skottrup PD, 2011, ANAL BIOCHEM, V415, P158, DOI 10.1016/j.ab.2011.04.015; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552	36	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48537	10.1371/journal.pone.0048537	http://dx.doi.org/10.1371/journal.pone.0048537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119051	Green Published, gold			2022-12-25	WOS:000310600500164
J	Tanifum, EA; Dasgupta, I; Srivastava, M; Bhavane, RC; Sun, L; Berridge, J; Pourgarzham, H; Kamath, R; Espinosa, G; Cook, SC; Eriksen, JL; Annapragada, A				Tanifum, Eric A.; Dasgupta, Indrani; Srivastava, Mayank; Bhavane, Rohan C.; Sun, Li; Berridge, John; Pourgarzham, Hoda; Kamath, Rashmi; Espinosa, Gabriela; Cook, Stephen C.; Eriksen, Jason L.; Annapragada, Ananth			Intravenous Delivery of Targeted Liposomes to Amyloid-beta Pathology in APP/PSEN1 Transgenic Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; STEREOSELECTIVE-SYNTHESIS; NEUROVASCULAR MECHANISMS; INTERSTITIAL FLUID; CONTRAST AGENT; MOUSE MODEL; HUMAN BRAIN; PLAQUES; ANGIOPATHY	Extracellular amyloid-beta (A beta) plaques and intracellular neurofibrillary tangles constitute the major neuropathological hallmarks of Alzheimer's disease (AD). It is now apparent that parenchymal A beta plaque deposition precedes behavioral signs of disease by several years. The development of agents that can target these plaques may be useful as diagnostic or therapeutic tools. In this study, we synthesized an A beta-targeted lipid conjugate, incorporated it in stealth liposomal nanoparticles and tested their ability to bind amyloid plaque deposits in an AD mouse model. The results show that the particles maintain binding profiles to synthetic A beta aggregates comparable to the free ligand, and selectively bind A beta plaque deposits in brain tissue sections of an AD mouse model (APP/PSEN1 transgenic mice) with high efficiency. When administered intravenously, these long circulating nanoparticles appear to cross the blood-brain barrier and bind to A beta plaque deposits, labeling parenchymal amyloid deposits and vascular amyloid characteristic of cerebral amyloid angiopathy.	[Tanifum, Eric A.; Dasgupta, Indrani; Srivastava, Mayank; Bhavane, Rohan C.; Eriksen, Jason L.; Annapragada, Ananth] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77225 USA; [Tanifum, Eric A.; Srivastava, Mayank; Bhavane, Rohan C.; Kamath, Rashmi; Espinosa, Gabriela; Annapragada, Ananth] Texas Childrens Hosp, Houston, TX 77030 USA; [Sun, Li; Berridge, John; Pourgarzham, Hoda] Univ Houston, Dept Pharmacol & Pharmaceut Sci, Houston, TX USA; [Annapragada, Ananth] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Cook, Stephen C.] Fieldstone Partners, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Houston System; University of Houston; Baylor College of Medicine	Eriksen, JL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77225 USA.	jeriksen@central.uh.edu; avannapr@texaschildrens.org	Annapragada, Ananth/GOK-1576-2022; Eriksen, Jason/A-8054-2008	Eriksen, Jason/0000-0003-1549-4165; Annapragada, Ananth/0000-0002-3156-9617	Cure Alzheimer's fund; Alliance for Nanohealth; National Institutes of Health [1R15AG039008-01]; Alzheimer's Association [NIRG-08-92033]; NCI Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R15AG039008] Funding Source: NIH RePORTER	Cure Alzheimer's fund; Alliance for Nanohealth; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported with funds from the Cure Alzheimer's fund (A. A. and J.L.E.), the Alliance for Nanohealth (A. A. and J.L.E.), the National Institutes of Health (J.E., 1R15AG039008-01) and the Alzheimer's Association (J.L.E., NIRG-08-92033). NMR work at the MD Anderson Cancer Center was supported by NCI Cancer Center support grant CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Alzheimer's Disease International, 2010, WORLD ALZH REP 2009; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Amatsubo T, 2009, NEUROSCI RES, V63, P76, DOI 10.1016/j.neures.2008.10.006; Armstrong RA, 1999, NEUROSCI LETT, V261, P97, DOI 10.1016/S0304-3940(99)00009-9; Ball KK, 2010, J CEREBR BLOOD F MET, V30, P162, DOI 10.1038/jcbfm.2009.206; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Benarroch E, 2007, NEUROLOGY, V69, P306, DOI 10.1212/01.wnl.0000267407.79757.75; Biron KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023789; Blakemore PR, 1998, SYNLETT, P26; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Bussiere T, 2004, AM J PATHOL, V165, P987, DOI 10.1016/S0002-9440(10)63360-3; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Drzezga A, 2008, EUR J NUCL MED MOL I, V35, pS4, DOI 10.1007/s00259-007-0697-6; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghaghada KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007628; Gobbi M, 2010, BIOMATERIALS, V31, P6519, DOI 10.1016/j.biomaterials.2010.04.044; Hatanaka Y, 1994, Bioorg Med Chem, V2, P1367, DOI 10.1016/S0968-0896(00)82088-X; Herzig MC, 2006, BRAIN PATHOL, V16, P40, DOI 10.1111/j.1750-3639.2006.tb00560.x; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Lockhart A, 2006, DRUG DISCOV TODAY, V11, P1093, DOI 10.1016/j.drudis.2006.10.008; Lucignani G, 2009, EUR J NUCL MED MOL I, V36, P1009, DOI 10.1007/s00259-009-1124-y; MAEDA H, 1991, ADV DRUG DELIVER REV, V6, P181, DOI 10.1016/0169-409X(91)90040-J; Mathis CA, 2004, CURR PHARM DESIGN, V10, P1469, DOI 10.2174/1381612043384772; Meyer EP, 2008, P NATL ACAD SCI USA, V105, P3587, DOI 10.1073/pnas.0709788105; MIYAURA N, 1979, J CHEM SOC CHEM COMM, P866, DOI 10.1039/c39790000866; Mourtas S, 2011, BIOMATERIALS, V32, P1635, DOI 10.1016/j.biomaterials.2010.10.027; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; Nicoll JAR, 2004, NEUROBIOL AGING, V25, P589, DOI 10.1016/j.neurobiolaging.2004.02.003; Paris D, 2003, NEUROL RES, V25, P642, DOI 10.1179/016164103101201940; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Schlapbach A, 2008, BIOORG MED CHEM LETT, V18, P6142, DOI 10.1016/j.bmcl.2008.10.039; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; TAKAI K, 1986, J AM CHEM SOC, V108, P7408, DOI 10.1021/ja00283a046; Tarawneh R, 2010, NEUROPHARMACOLOGY, V59, P310, DOI 10.1016/j.neuropharm.2010.04.006; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Wang JL, 2005, CURR TOP MED CHEM, V5, P1053, DOI 10.2174/156802605774297056; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Weller RO, 2008, BRAIN PATHOL, V18, P253, DOI 10.1111/j.1750-3639.2008.00133.x; Weller RO, 2009, ACTA NEUROPATHOL, V117, P1, DOI 10.1007/s00401-008-0457-0; Zhang W, 2005, J MED CHEM, V48, P5980, DOI 10.1021/jm050166g; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	56	48	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48515	10.1371/journal.pone.0048515	http://dx.doi.org/10.1371/journal.pone.0048515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119043	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500156
J	Cloyd, KL; El-Hamamsy, I; Boonrungsiman, S; Hedegaard, M; Gentleman, E; Sarathchandra, P; Colazzo, F; Gentleman, MM; Yacoub, MH; Chester, AH; Stevens, MM				Cloyd, Kristy L.; El-Hamamsy, Ismail; Boonrungsiman, Suwimon; Hedegaard, Martin; Gentleman, Eileen; Sarathchandra, Padmini; Colazzo, Francesca; Gentleman, Molly M.; Yacoub, Magdi H.; Chester, Adrian H.; Stevens, Molly M.			Characterization of Porcine Aortic Valvular Interstitial Cell 'Calcified' Nodules	PLOS ONE			English	Article							VALVE DISEASE; ELECTRON-MICROSCOPY; HEART-VALVES; CALCIFICATION; STENOSIS; BONE; IDENTIFICATION; PATHOBIOLOGY; PATHOGENESIS; PROGRESSION	Valve interstitial cells populate aortic valve cusps and have been implicated in aortic valve calcification. Here we investigate a common in vitro model for aortic valve calcification by characterizing nodule formation in porcine aortic valve interstitial cells (PAVICs) cultured in osteogenic (OST) medium supplemented with transforming growth factor beta 1 (TGF-beta 1). Using a combination of materials science and biological techniques, we investigate the relevance of PAVICs nodules in modeling the mineralised material produced in calcified aortic valve disease. PAVICs were grown in OST medium supplemented with TGF-beta 1 (OST+TGF-beta 1) or basal (CTL) medium for up to 21 days. Murine calvarial osteoblasts (MOBs) were grown in OST medium for 28 days as a known mineralizing model for comparison. PAVICs grown in OST+TGF-beta 1 produced nodular structures staining positive for calcium content; however, micro-Raman spectroscopy allowed live, noninvasive imaging that showed an absence of mineralized material, which was readily identified in nodules formed by MOBs and has been identified in human valves. Gene expression analysis, immunostaining, and transmission electron microscopy imaging revealed that PAVICs grown in OST+TGF-beta 1 medium produced abundant extracellular matrix via the upregulation of the gene for Type I Collagen. PAVICs, nevertheless, did not appear to further transdifferentiate to osteoblasts. Our results demonstrate that 'calcified' nodules formed from PAVICs grown in OST+TGF-beta 1 medium do not mineralize after 21 days in culture, but rather they express a myofibroblast-like phenotype and produce a collagen-rich extracellular matrix. This study clarifies further the role of PAVICs as a model of calcification of the human aortic valve.	[Cloyd, Kristy L.; Boonrungsiman, Suwimon; Hedegaard, Martin; Gentleman, Eileen; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England; [Cloyd, Kristy L.; Boonrungsiman, Suwimon; Hedegaard, Martin; Gentleman, Eileen; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London, England; [Cloyd, Kristy L.; Boonrungsiman, Suwimon; Hedegaard, Martin; Gentleman, Eileen; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Sarathchandra, Padmini; Colazzo, Francesca; Yacoub, Magdi H.; Chester, Adrian H.] Imperial Coll London, Harefield Heart Sci Ctr, Harefield, Middx, England; [El-Hamamsy, Ismail] Montreal Heart Inst, Div Cardiac Surg, Montreal, PQ H1T 1C8, Canada; [Gentleman, Molly M.] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Universite de Montreal; Texas A&M University System; Texas A&M University College Station	Stevens, MM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.	m.stevens@imperial.ac.uk	Hedegaard, Martin A.B. A B/X-9953-2018	Hedegaard, Martin A.B. A B/0000-0003-2972-0899; COLAZZO, FRANCESCA/0000-0002-5782-1606; Gentleman, Eileen/0000-0003-0447-5137; Boonrungsiman, Suwimon/0000-0002-9550-939X	British Heart Foundation; Rosetrees Trust	British Heart Foundation(British Heart Foundation); Rosetrees Trust(Rosetrees Trust)	This work was supported by the British Heart Foundation and the Rosetrees Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; Barragan-Adjemian C, 2006, CALCIFIED TISSUE INT, V79, P340, DOI 10.1007/s00223-006-0107-2; Boonrungsiman S, 2012, P NATL ACAD SCI; Cawley PJ, 2009, ANN MED, V41, P100, DOI 10.1080/07853890802331394; Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237; Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750; Cheng WT, 2005, MICROSC RES TECHNIQ, V68, P75, DOI 10.1002/jemt.20229; Chester AH, 2011, ASWAN HEART CTR SCI, V2011, P4, DOI [10.5339/ahcsps.2011.4, DOI 10.5339/AHCSPS.2011.4]; Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026; Delogne C, 2007, J MICROSC-OXFORD, V228, P62, DOI 10.1111/j.1365-2818.2007.01824.x; Dorfmuller P, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/685926; Durbin AD, 2002, CARDIOVASC PATHOL, V11, P69, DOI 10.1016/S1054-8807(01)00109-0; El-Hamamsy I, 2010, LANCET, V376, P524, DOI 10.1016/S0140-6736(10)60828-8; Elmariah Sammy, 2010, Curr Cardiol Rep, V12, P125, DOI 10.1007/s11886-010-0089-6; FILIP DA, 1986, CIRC RES, V59, P310, DOI 10.1161/01.RES.59.3.310; Frederick JS, CARDIOVASCULAR PATHO, V14, P189; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211; GELADI P, 1985, APPL SPECTROSC, V39, P491, DOI 10.1366/0003702854248656; Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/NMAT2505, 10.1038/nmat2505]; Gruber HE, 2009, BIOTECH HISTOCHEM, V84, P283, DOI 10.3109/10520290902984266; Hancewicz TM, 1995, SPECTROCHIM ACTA A, V51, P2193, DOI 10.1016/0584-8539(95)01500-5; Hodge AJ, 1963, ASPECT PROTEIN STRUC; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1; Kennedy JA, 2009, EUR J PHARMACOL, V602, P28, DOI 10.1016/j.ejphar.2008.11.029; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Mikroulis D, 2002, J MATER SCI-MATER M, V13, P885, DOI 10.1023/A:1016556514203; Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Monzack EL, 2011, J HEART VALVE DIS, V20, P449; Monzack EL, 2009, ARTERIOSCL THROM VAS, V29, P246, DOI 10.1161/ATVBAHA.108.179218; Mulholland DL, 1996, CAN J CARDIOL, V12, P231; Norgaard L, 2000, APPL SPECTROSC, V54, P413, DOI 10.1366/0003702001949500; O'Brien KD, 2006, ARTERIOSCL THROM VAS, V26, P1721, DOI 10.1161/01.ATV.0000227513.13697.ac; Osman L, 2006, CIRCULATION, V114, pI547, DOI 10.1161/CIRCULATIONAHA.105.001115; Rajamannan NM, 2009, ARTERIOSCL THROM VAS, V29, P162, DOI 10.1161/ATVBAHA.107.156752; Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69; Rocha R, 2007, PHOTOMED LASER SURG, V25, P287, DOI 10.1089/pho.2007.2100; Rodriguez KJ, 2009, J BIOMED MATER RES A, V90A, P1043, DOI 10.1002/jbm.a.32187; SAPPINO AP, 1990, LAB INVEST, V63, P144; Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911; Starborg T, 2008, METHODS, V45, P53, DOI 10.1016/j.ymeth.2008.01.004; Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; Weska RF, 2010, ARTIF ORGANS, V34, P311, DOI 10.1111/j.1525-1594.2009.00858.x; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; Yacoub MH, 1999, ANN THORAC SURG, V68, pS37, DOI 10.1016/S0003-4975(99)00745-6; Yacoub N, 2005, NAT CLIN PRACT CARD, V2, P60, DOI 10.1038/ncpcardio0112; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394	50	40	41	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48154	10.1371/journal.pone.0048154	http://dx.doi.org/10.1371/journal.pone.0048154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110195	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500042
J	Qu, XJ; Liu, TQ; Song, KD; Li, XQ; Ge, D				Qu, Xinjian; Liu, Tianqing; Song, Kedong; Li, Xiangqin; Ge, Dan			Induced Pluripotent Stem Cells Generated from Human Adipose-Derived Stem Cells Using a Non-Viral Polycistronic Plasmid in Feeder-Free Conditions	PLOS ONE			English	Article							IPS CELLS; DIFFERENTIATION; DERIVATION	Induced pluripotent stem cells (iPSCs) can be generated from somatic cells by ectopic expression of defined transcription factors (TFs). However, the optimal cell type and the easy reprogramming approaches that minimize genetic aberrations of parent cells must be considered before generating the iPSCs. This paper reports a method to generate iPSCs from adult human adipose-derived stem cells (hADSCs) without the use of a feeder layer, by ectopic expression of the defined transcription factors OCT4, SOX2, KLF4 and C-MYC using a polycistronic plasmid. The results, based on the expression of pluripotent marker, demonstrated that the iPSCs have the characteristics similar to those of embryonic stem cells (ESCs). The iPSCs differentiated into three embryonic germ layers both in vitro by embryoid body generation and in vivo by teratoma formation after being injected into immunodeficient mice. More importantly, the plasmid DNA does not integrate into the genome of human iPSCs as revealed by Southern blotting experiments. Karyotypic analysis also demonstrated that the reprogramming of hADSCs by the defined factors did not induce chromosomal abnormalities. Therefore, this technology provides a platform for studying the biology of iPSCs without viral vectors, and can hopefully overcome immune rejection and ethical concerns, which are the two important barriers of ESC applications.	[Qu, Xinjian; Liu, Tianqing; Song, Kedong; Li, Xiangqin; Ge, Dan] Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology	Liu, TQ (corresponding author), Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, Dalian, Liaoning, Peoples R China.	liutq@dlut.edu.cn			National Natural Science Foundation of China [31170945]; Fundamental Research Funds for the Central Universities of China [DUT11SM04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31170945) and the Fundamental Research Funds for the Central Universities of China (NO. DUT11SM04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Baker M, 2010, NAT METHODS, V7, P17, DOI 10.1038/NMETH.F.281; Carey B, 2008, P NATL ACAD SCI USA, V106, P162; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gonzalez-Cruz RD, 2012, P NATL ACAD SCI USA, V109, pE1523, DOI 10.1073/pnas.1120349109; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; Hughes B, 2008, NAT REV DRUG DISCOV, V7, P645, DOI 10.1038/nrd2645; Iwamuro M, 2010, CELL TRANSPLANT, V19, P841, DOI 10.3727/096368910X508960; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Nelson T, 2009, CIRCULATION, V120, pS747; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Peitz M, 2009, ACTA NEUROPATHOL, V118, P456; Sakurada K, 2009, VOX SANG, V97, P21; Scholer HR, 2009, HUM GENE THER, V20, P1375; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Schwanke K, 2009, HUM GENE THER, V20, P1526; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Sun N, 2010, CELL CYCLE, V9, P880, DOI 10.4161/cc.9.5.10827; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yamasaki S, 2011, IN VITRO CELL DEV-AN, V47, pS45; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zarzeczny A, 2009, CELL, V139, P1032, DOI 10.1016/j.cell.2009.11.039; Zhang ZC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024608, 10.1371/journal.pone.0028817]; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhu YX, 2009, MOL CELL BIOCHEM, V324, P117, DOI 10.1007/s11010-008-9990-3	30	25	30	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48161	10.1371/journal.pone.0048161	http://dx.doi.org/10.1371/journal.pone.0048161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110200	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500044
J	Sadler, NC; Angel, TE; Lewis, MP; Pederson, LM; Chauvigne-Hines, LM; Wiedner, SD; Zink, EM; Smith, RD; Wright, AT				Sadler, Natalie C.; Angel, Thomas E.; Lewis, Michael P.; Pederson, LeeAnna M.; Chauvigne-Hines, Lacie M.; Wiedner, Susan D.; Zink, Erika M.; Smith, Richard D.; Wright, Aaron T.			Activity-Based Protein Profiling Reveals Mitochondrial Oxidative Enzyme Impairment and Restoration in Diet-Induced Obese Mice	PLOS ONE			English	Article							HIGH-FAT-DIET; MUSCLE INSULIN-RESISTANCE; HUMAN SKELETAL-MUSCLE; ACID OXIDATION; DYSFUNCTION; PHOSPHORYLATION; METABOLISM; EXERCISE; GENES; RATS	High-fat diet (HFD) induced obesity and concomitant development of insulin resistance (IR) and type 2 diabetes mellitus have been linked to mitochondrial dysfunction. However, it is not clear whether mitochondrial dysfunction is a direct effect of a HFD, or if mitochondrial function is reduced with increased HFD duration. We hypothesized that the function of mitochondrial oxidative and lipid metabolism functions in skeletal muscle mitochondria for HFD mice are similar, or elevated, relative to standard diet (SD) mice; thereby, IR is neither cause nor consequence of mitochondrial dysfunction. We applied a chemical probe approach to identify functionally reactive ATPases and nucleotide-binding proteins in mitochondria isolated from skeletal muscle of C57Bl/6J mice fed HFD or SD chow for 2-, 8-, or 16-weeks; feeding time points known to induce IR. A total of 293 probe-labeled proteins were identified by mass spectrometry-based proteomics, of which 54 differed in abundance between HFD and SD mice. We found proteins associated with the TCA cycle, oxidative phosphorylation (OXPHOS), and lipid metabolism were altered in function when comparing SD to HFD fed mice at 2- weeks, however by 16-weeks HFD mice had TCA cycle, beta-oxidation, and respiratory chain function at levels similar to or higher than SD mice.	[Sadler, Natalie C.; Angel, Thomas E.; Lewis, Michael P.; Pederson, LeeAnna M.; Chauvigne-Hines, Lacie M.; Wiedner, Susan D.; Zink, Erika M.; Smith, Richard D.; Wright, Aaron T.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Wright, AT (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	aaron.wright@pnnl.gov	Smith, Richard D/J-3664-2012; Zink, Erika/E-2135-2014	Smith, Richard D/0000-0002-2381-2349; Zink, Erika/0000-0003-0754-9816; Wright, Aaron/0000-0002-3172-5253	Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL), a multiprogram national laboratory; Battelle for the U.S. Department of Energy [DE-AC05-76RL01830]; National Institutes of Health (NIH) National Center for Research Resources [5P41RR018522]; National Institute of General Medical Sciences from the NIH [8 P41 GM103493-10]; U.S. Department of Energy Office of Biological and Environmental Research (DOE-BER); PNNL Linus Pauling Distinguished Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER	Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL), a multiprogram national laboratory; Battelle for the U.S. Department of Energy(United States Department of Energy (DOE)); National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the NIH; U.S. Department of Energy Office of Biological and Environmental Research (DOE-BER)(United States Department of Energy (DOE)); PNNL Linus Pauling Distinguished Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Laboratory Directed Research and Development Program at Pacific Northwest National Laboratory (PNNL), a multiprogram national laboratory operated by Battelle for the U.S. Department of Energy under Contract DE-AC05-76RL01830. This work used instrumentation and capabilities developed under support from the National Institutes of Health (NIH) National Center for Research Resources (Grant 5P41RR018522) and the National Institute of General Medical Sciences (8 P41 GM103493-10) from the NIH, and the U.S. Department of Energy Office of Biological and Environmental Research (DOE-BER). Work was performed in the Environmental Molecular Sciences Laboratory, a DOE-BER national scientific user facility at PNNL. SDW is grateful for the support of the PNNL Linus Pauling Distinguished Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756; Dumas JF, 2009, DIABETES METAB, V35, P159, DOI 10.1016/j.diabet.2009.02.002; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Hegarty BD, 2003, ACTA PHYSIOL SCAND, V178, P373, DOI 10.1046/j.1365-201X.2003.01162.x; Hegarty BD, 2002, DIABETES, V51, P1477, DOI 10.2337/diabetes.51.5.1477; Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210; Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200; Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Jeukendrup AE, 2002, ANN NY ACAD SCI, V967, P217; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kraegen EW, 2008, P NATL ACAD SCI USA, V105, P7627, DOI 10.1073/pnas.0803901105; Li N, 2012, CURR OPIN CHEM BIOL, V16, P227, DOI 10.1016/j.cbpa.2012.01.008; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MILLER WC, 1984, J APPL PHYSIOL, V56, P78, DOI 10.1152/jappl.1984.56.1.78; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; NEMETH PM, 1992, AM J PHYSIOL, V262, pC282, DOI 10.1152/ajpcell.1992.262.2.C282; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qiu HB, 2007, ANAL CHEM, V79, P5547, DOI 10.1021/ac0622375; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; van den Broek NMA, 2010, FASEB J, V24, P1354, DOI 10.1096/fj.09-143842; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	45	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47996	10.1371/journal.pone.0047996	http://dx.doi.org/10.1371/journal.pone.0047996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110155	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200131
J	Thurston, SF; Kulacz, WA; Shaikh, S; Lee, JM; Copeland, JW				Thurston, Susan F.; Kulacz, Wojciech A.; Shaikh, Sahir; Lee, Jonathan M.; Copeland, John W.			The Ability to Induce Microtubule Acetylation Is a General Feature of Formin Proteins	PLOS ONE			English	Article							DIAPHANOUS-RELATED FORMIN; POLARITY PROTEINS; MAMMALIAN FORMIN; FIBER FORMATION; ACTIN-FILAMENT; MOUSE OOCYTES; FH2 DOMAIN; F-ACTIN; CANCER; FHOD1	Cytoplasmic microtubules exist as distinct dynamic and stable populations within the cell. Stable microtubules direct and maintain cell polarity and it is thought that their stabilization is dependent on coordinative organization between the microtubule network and the actin cytoskeleton. A growing body of work suggests that some members of the formin family of actin remodeling proteins also regulate microtubule organization and stability. For example, we showed previously that expression of the novel formin INF1 is sufficient to induce microtubule stabilization and tubulin acetylation, but not tubulin detyrosination. An important issue with respect to the relationship between formins and microtubules is the determination of which formin domains mediate microtubule stabilization. INF1 has a distinct microtubule-binding domain at its C-terminus and the endogenous INF1 protein is associated with the microtubule network. Surprisingly, the INF1 microtubule-binding domain is not essential for INF1-induced microtubule acetylation. We show here that expression of the isolated FH1 + FH2 functional unit of INF1 is sufficient to induce microtubule acetylation independent of the INF1 microtubule-binding domain. It is not yet clear whether or not microtubule stabilization is a general property of all mammalian formins; therefore we expressed constitutively active derivatives of thirteen of the fifteen mammalian formin proteins in HeLa and NIH3T3 cells and measured their effects on stress fiber formation, MT organization and MT acetylation. We found that expression of the FH1 + FH2 unit of the majority of mammalian formins is sufficient to induce microtubule acetylation. Our results suggest that the regulation of microtubule acetylation is likely a general formin activity and that the FH2 should be thought of as a dual-function domain capable of regulating both actin and microtubule networks.	[Thurston, Susan F.; Kulacz, Wojciech A.; Copeland, John W.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Shaikh, Sahir; Lee, Jonathan M.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Copeland, JW (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada.	John.copeland@uottawa.ca			Heart and Stroke Foundation of Canada [T6317]; Natural Sciences and Engineering Research Council of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grant T6317 from the Heart and Stroke Foundation of Canada awarded to John Copeland. http://www.hsf.ca/research/en/home. Work in Jonathan Lee's laboratory is supported by an Natural Sciences and Engineering Research Council of Canada Discovery Grant. http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Cheng LN, 2011, DEV CELL, V20, P342, DOI 10.1016/j.devcel.2011.01.008; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Copeland SJ, 2007, J BIOL CHEM, V282, P30120, DOI 10.1074/jbc.M703834200; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Eng CH, 2006, MOL BIOL CELL, V17, P5004, DOI 10.1091/mbc.E05-10-0914; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gasteier JE, 2005, EXP CELL RES, V306, P192, DOI 10.1016/j.yexcr.2005.02.006; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Katoh M, 2004, INT J MOL MED, V13, P929; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Nakaya MA, 2004, GENE EXPR PATTERNS, V5, P97, DOI 10.1016/j.modgep.2004.06.001; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinones GB, 2011, MOL BIOL CELL, V22, P1045, DOI 10.1091/mbc.E10-06-0519; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Schulte A, 2008, STRUCTURE, V16, P1313, DOI 10.1016/j.str.2008.06.008; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Wen YD, 2004, KENYON REV, V26, P1; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Young KG, 2008, MOL BIOL CELL, V19, P5168, DOI 10.1091/mbc.E08-05-0469; Zhou F, 2006, EXP CELL RES, V312, P1119, DOI 10.1016/j.yexcr.2005.12.035	45	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48041	10.1371/journal.pone.0048041	http://dx.doi.org/10.1371/journal.pone.0048041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110170	Green Submitted, Green Published, gold			2022-12-25	WOS:000310310200143
J	Ji, XM; Hou, ZG; Wang, T; Jin, KX; Fan, JJ; Luo, C; Chen, MJ; Han, RH; Ni, CH				Ji, Xiaoming; Hou, Zhiguo; Wang, Ting; Jin, Kexin; Fan, Jingjing; Luo, Chen; Chen, Minjuan; Han, Ruhui; Ni, Chunhui			Polymorphisms in Inflammasome Genes and Risk of Coal Workers' Pneumoconiosis in a Chinese Population	PLOS ONE			English	Article							NOD-LIKE PROTEINS; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; ASSOCIATION; FIBROSIS; DISEASE; INTERLEUKIN-1-BETA; EXPRESSION; SILICOSIS; SEVERITY	Background: Coal workers' pneumoconiosis (CWP), resulting from the inhalation of silica-containing coal mine dust, is characterized by fibrosing nodular lesions that eventually develop into progressive pulmonary fibrosis. Recently, it has been hypothesized that inflammasomes could have a crucial role in the host response to silica and recent studies show that the inflammasome contributes to inflammation and pulmonary fibrosis. NLRP3, CARD8 are components of the NLRP3 inflammasome, which triggers caspase 1-mediated IL-1 beta and IL-18 release. In the present study, we investigated whether common single nucleotide polymorphisms (SNPs) in inflammasome genes are associated with CWP. Methods: We performed an association study analyzing 3 NLRP3, 1 CARD8, 1 IL-1 beta, 2 IL-18 SNPs in a case-control study of 697 CWP and 694 controls. Genotyping was carried out by the TaqMan method. Results: The NLRP3 rs1539019 TT genotype was associated with a significantly increased risk of CWP (adjusted odds ratio (OR) = 1.39, 95% confidence interval (CI) = 1.07-1.81), compared with the GG/GT genotype, in particular among smokers (adjusted OR = 1.67, 95% CI = 1.15-2.42). In addition, the polymorphism was significantly associated with risk of CWP patients with stage I. Conclusions: This is the first report showing an association between the NLRP3 rs1539019 polymorphism and CWP, and suggests that this polymorphism may confer increased risk for the development of the disease. Further studies are warranted to confirm our findings.	[Ji, Xiaoming; Hou, Zhiguo; Wang, Ting; Jin, Kexin; Fan, Jingjing; Luo, Chen; Chen, Minjuan; Han, Ruhui; Ni, Chunhui] Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Ni, CH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Occupat Med & Environm Hlth, Nanjing, Jiangsu, Peoples R China.	chni@njmu.edu.cn	wang, tingting/AAK-2640-2020	Jin, Kexin/0000-0001-8439-5916	National Natural Science Foundation of China [81072282, 81273044]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was partly supported by the National Natural Science Foundation of China (81072282 and 81273044) and the project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ates I, 2008, AM J IND MED, V51, P741, DOI 10.1002/ajim.20632; Ates I, 2011, EXP TOXICOL PATHOL, V63, P175, DOI 10.1016/j.etp.2009.11.006; Biswas R, 2011, PULM MED, V2011, DOI 10.1155/2011/105707; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Castranova V, 2000, ENVIRON HEALTH PERSP, V108, P675, DOI 10.2307/3454404; Chang KC, 2001, INT J TUBERC LUNG D, V5, P177; Cisneros-Lira J, 2003, AM J PHYSIOL-LUNG C, V285, pL949, DOI 10.1152/ajplung.00074.2003; Cohen RAC, 2010, OCCUP ENVIRON MED, V67, P649, DOI 10.1136/oem.2009.050096; Cummings JRF, 2010, TISSUE ANTIGENS, V76, P48, DOI 10.1111/j.1399-0039.2010.01470.x; Davidson CJ, 2003, J THROMB HAEMOST, V1, P1487, DOI 10.1046/j.1538-7836.2003.00334.x; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Freedman ML, 2004, HUM MOL GENET, V13, P2431, DOI 10.1093/hmg/ddh270; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Fujimura N, 2000, Curr Opin Pulm Med, V6, P140, DOI 10.1097/00063198-200003000-00010; Gonzalez-Benitez JF, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/614345; Harrison P, 2008, RHEUMATOLOGY, V47, P1768, DOI 10.1093/rheumatology/ken374; Hessel PA, 2003, SCAND J WORK ENV HEA, V29, P329, DOI 10.5271/sjweh.739; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kastbom A, 2010, ANN RHEUM DIS, V69, P723, DOI 10.1136/ard.2008.106989; Lee JM, 2008, RESP MED, V102, P1311, DOI 10.1016/j.rmed.2008.03.026; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Mason DR, 2012, J INNATE IMMUN, V4, P16, DOI 10.1159/000334247; Mazurek J. M., 2009, Morbidity and Mortality Weekly Report, V58, P1412; McCunney RJ, 2009, J OCCUP ENVIRON MED, V51, P462, DOI 10.1097/JOM.0b013e3181a01ada; Nadif R, 2006, EUR RESPIR J, V28, P1100, DOI 10.1183/09031936.00031506; Nakamura Y, 2009, J EXP MED, V206, P1037, DOI 10.1084/jem.20082179; NG TP, 1991, THORAX, V46, P229, DOI 10.1136/thx.46.4.229; Ni CH, 2009, J TOXICOL ENV HEAL A, V72, P712, DOI 10.1080/15287390902841102; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Omi T, 2006, EUR J HUM GENET, V14, P1295, DOI 10.1038/sj.ejhg.5201698; Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Roberts RL, 2010, GENES IMMUN, V11, P351, DOI 10.1038/gene.2010.11; Sano M, 2005, AM J HYPERTENS, V18, P403, DOI 10.1016/j.amjhyper.2004.10.016; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Serlin DM, 2006, J CELL BIOCHEM, V97, P519, DOI 10.1002/jcb.20661; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Wang M, J HUM GENET, V55, P13; Wang ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022624; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Xu JF, 2012, AM J RESP CRIT CARE; Yang CS, 2012, INT NEUROUROL J, V16, P2, DOI 10.5213/inj.2012.16.1.2; Zhai RH, 2002, J OCCUP ENVIRON MED, V44, P372, DOI 10.1097/00043764-200204000-00019; Zhang AQ, 2011, CRIT CARE, V15, DOI 10.1186/cc10564	54	35	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47949	10.1371/journal.pone.0047949	http://dx.doi.org/10.1371/journal.pone.0047949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110140	gold, Green Submitted, Green Published			2022-12-25	WOS:000310193400027
J	Lu, CS; Truong, LN; Aslanian, A; Shi, LDZ; Li, YJ; Hwang, PYH; Koh, KH; Hunter, T; Yates, JR; Berns, MW; Wu, XH				Lu, Chi-Sheng; Truong, Lan N.; Aslanian, Aaron; Shi, Linda Z.; Li, Yongjiang; Hwang, Patty Yi-Hwa; Koh, Kwi Hye; Hunter, Tony; Yates, John R., III; Berns, Michael W.; Wu, Xiaohua			The RING Finger Protein RNF8 Ubiquitinates Nbs1 to Promote DNA Double-strand Break Repair by Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE CHECKPOINT; DAMAGE RESPONSE; ATM ACTIVATION; MRE11-RAD50-NBS1 COMPLEX; POLYUBIQUITIN CHAINS; CHROMATIN RETENTION; GENOMIC STABILITY; MRE11 COMPLEX; HISTONE H2AX; MRN COMPLEX	Ubiquitination plays an important role in the DNA damage response. We identified a novel interaction of the E3 ubiquitin ligase RNF8 with Nbs1, a key regulator of DNA double-strand break (DSB) repair. We found that Nbs1 is ubiquitinated both before and after DNA damage and is a direct ubiquitination substrate of RNF8. We also identified key residues on Nbs1 that are ubiquitinated by RNF8. By using laser microirradiation and live-cell imaging, we observed that RNF8 and its ubiquitination activity are important for promoting optimal binding of Nbs1 to DSB-containing chromatin. We also demonstrated that RNF8-mediated ubiquitination of Nbs1 contributes to the efficient and stable binding of Nbs1 to DSBs and is important for HR-mediated DSB repair. Taken together, these studies suggest that Nbs1 is one important target of RNF8 to regulate DNA DSB repair.	[Lu, Chi-Sheng; Truong, Lan N.; Li, Yongjiang; Hwang, Patty Yi-Hwa; Koh, Kwi Hye; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Aslanian, Aaron; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Aslanian, Aaron; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; University of California System; University of California San Diego	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu		Berns, Michael/0000-0002-9640-2885	National Institutes of Health [CA102361, GM080677, CA140972, CA102361-07S1, CA80100, P41 RR011823]; Beckman Laser Institute Inc. Foundation; NATIONAL CANCER INSTITUTE [R01CA080100, R01CA102361, R01CA140972] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677, P41GM103533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Laser Institute Inc. Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102361, GM080677, CA140972, and CA102361-07S1 (to X. W.); CA80100 (to T. H.); and P41 RR011823 (to J. R. Y.). This work was also supported by the Beckman Laser Institute Inc. Foundation (to M. W. B.).	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Al-Hakim A, 2010, DNA REPAIR, V9, P1229, DOI 10.1016/j.dnarep.2010.09.011; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Dinkelmann M, 2009, NAT STRUCT MOL BIOL, V16, P808, DOI 10.1038/nsmb.1639; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ito K, 2001, EUR J BIOCHEM, V268, P2725, DOI 10.1046/j.1432-1327.2001.02169.x; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lok GTM, 2012, NUCLEIC ACIDS RES, V40, P196, DOI 10.1093/nar/gkr655; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Nussenzweig A, 2007, CELL, V131, P223, DOI 10.1016/j.cell.2007.10.005; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Wu J, 2012, MOL CELL, V46, P351, DOI 10.1016/j.molcel.2012.02.018; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949	61	40	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43984	43994		10.1074/jbc.M112.421545	http://dx.doi.org/10.1074/jbc.M112.421545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23115235	Green Published, hybrid			2022-12-25	WOS:000312940800073
J	Becker, CG; Rodriguez, D; Longo, AV; Talaba, AL; Zamudio, KR				Becker, C. Guilherme; Rodriguez, David; Longo, Ana V.; Talaba, Amanda L.; Zamudio, Kelly R.			Disease Risk in Temperate Amphibian Populations Is Higher at Closed-Canopy Sites	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS INFECTION; HABITAT FRAGMENTATION; ENVIRONMENTAL-CHANGE; CHYTRID PATHOGEN; EMERGING DISEASE; CLIMATE; CHYTRIDIOMYCOSIS; WIDESPREAD; DYNAMICS; BIODIVERSITY	Habitat loss and chytridiomycosis (a disease caused by the chytrid fungus Batrachochytrium dendrobatidis - Bd) are major drivers of amphibian declines worldwide. Habitat loss regulates host-pathogen interactions by altering biotic and abiotic factors directly linked to both host and pathogen fitness. Therefore, studies investigating the links between natural vegetation and chytridiomycosis require integrative approaches to control for the multitude of possible interactions of biological and environmental variables in spatial epidemiology. In this study, we quantified Bd infection dynamics across a gradient of natural vegetation and microclimates, looking for causal associations between vegetation cover, multiple microclimatic variables, and pathogen prevalence and infection intensity. To minimize the effects of host diversity in our analyses, we sampled amphibian populations in the Adirondack Mountains of New York State, a region with relatively high single-host dominance. We sampled permanent ponds for anurans, focusing on populations of the habitat generalist frog Lithobates clamitans, and recorded various biotic and abiotic factors that potentially affect host-pathogen interactions: natural vegetation, canopy density, water temperature, and host population and community attributes. We screened for important explanatory variables of Bd infections and used path analyses to statistically test for the strength of cascading effects linking vegetation cover, microclimate, and Bd parameters. We found that canopy density, natural vegetation, and daily average water temperature were the best predictors of Bd. High canopy density resulted in lower water temperature, which in turn predicted higher Bd prevalence and infection intensity. Our results confirm that microclimatic shifts arising from changes in natural vegetation play an important role in Bd spatial epidemiology, with areas of closed canopy favoring Bd. Given increasing rates of anthropogenic habitat modification and the resulting declines in temperate and tropical frogs, understanding how vegetation cover and disease interact is critical for predicting Bd spread and developing appropriate management tools for wild populations.	[Becker, C. Guilherme; Rodriguez, David; Longo, Ana V.; Talaba, Amanda L.; Zamudio, Kelly R.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA	Cornell University	Becker, CG (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	cgb58@cornell.edu	Longo, Ana/L-2129-2015; Becker, C. Guilherme/B-9887-2014; Zamudio, Kelly/R-3533-2016; Longo, Ana V./AAH-1522-2020	Longo, Ana/0000-0002-5112-1246; Zamudio, Kelly/0000-0001-5107-6206; Longo, Ana V./0000-0002-5112-1246	Kieckhefer Adirondack Fellowship; Capes/Fulbright [2157-08]; Department of Ecology and Evolutionary Biology at Cornell University	Kieckhefer Adirondack Fellowship; Capes/Fulbright(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Department of Ecology and Evolutionary Biology at Cornell University	The authors' work was funded by grants from Kieckhefer Adirondack Fellowship, Capes/Fulbright (# 2157-08), and the Department of Ecology and Evolutionary Biology at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LW, 2004, P ROY SOC B-BIOL SCI, V271, P1293, DOI 10.1098/rspb.2004.2720; Arens P, 2007, LANDSCAPE ECOL, V22, P1489, DOI 10.1007/s10980-007-9132-4; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brem FMR, 2008, DIS AQUAT ORGAN, V81, P189, DOI 10.3354/dao01960; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Carey C, 2005, INTEGR COMP BIOL, V45, P4, DOI 10.1093/icb/45.1.4; CAREY C, 1993, SCIENCE, V259, P390, DOI 10.1126/science.259.5093.390-b; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Costa MH, 2000, J CLIMATE, V13, P18, DOI [10.1175/1520-0442(2000)013<0018:CEODAD>2.0.CO;2, 10.1175/1520-0442(2000)013&lt;0018:CEODAD&gt;2.0.CO;2]; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Daskin JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026215; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Gibbs JP, 1998, LANDSCAPE ECOL, V13, P263, DOI 10.1023/A:1008056424692; Hecnar SJ, 1997, CONSERV BIOL, V11, P670, DOI 10.1046/j.1523-1739.1997.96096.x; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; IUCN Conservation International & NatureServe, 2012, GLOB AMPH ASS; KAPOS V, 1989, J TROP ECOL, V5, P173, DOI 10.1017/S0266467400003448; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Knapp RA, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00028.1; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079; Meentemeyer RK, 2008, ECOL APPL, V18, P159, DOI 10.1890/07-0232.1; Murphy PJ, 2011, DIS AQUAT ORGAN, V95, P31, DOI 10.3354/dao02336; Navas Carlos A., 2007, PHYLLOMEDUSA, V6, P83; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Puschendorf Robert, 2005, Herpetological Review, V36, P53; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Raffel TR, 2010, ECOHEALTH, V7, P526, DOI 10.1007/s10393-010-0358-2; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Regosin JV, 2003, J HERPETOL, V37, P390, DOI 10.1670/0022-1511(2003)037[0390:THUAWD]2.0.CO;2; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Ryan JM, 2008, ADIRONDACK WILDLIFE; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Searle CL, 2011, P NATL ACAD SCI USA, V108, P16322, DOI 10.1073/pnas.1108490108; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Systat, 2007, SYSTAT WIND VERS 11; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	64	60	61	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48205	10.1371/journal.pone.0048205	http://dx.doi.org/10.1371/journal.pone.0048205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118953	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500081
J	Bird, SC				Bird, Steven C.			Towards Improvements in the Estimation of the Coalescent: Implications for the Most Effective Use of Y Chromosome Short Tandem Repeat Mutation Rates	PLOS ONE			English	Article							STEPWISE MUTATION; LOCI; MICROSATELLITES; POPULATION; MODEL	Over the past two decades, many short tandem repeat (STR) microsatellite loci on the human Y chromosome have been identified together with mutation rate estimates for the individual loci. These have been used to estimate the coalescent age, or the time to the most recent common ancestor (TMRCA) expressed in generations, in conjunction with the average square difference measure (ASD), an unbiased point estimator of TMRCA based upon the average within-locus allele variance between haplotypes. The ASD estimator, in turn, depends on accurate mutation rate estimates to be able to produce good approximations of the coalescent age of a sample. Here, a comparison is made between three published sets of per locus mutation rate estimates as they are applied to the calculation of the coalescent age for real and simulated population samples. A novel evaluation method is developed for estimating the degree of conformity of any Y chromosome STR locus of interest to the strict stepwise mutation model and specific recommendations are made regarding the suitability of thirty-two commonly used Y-STR loci for the purpose of estimating the coalescent. The use of the geometric mean for averaging ASD and (mu) over cap across loci is shown to improve the consistency of the resulting estimates, with decreased sensitivity to outliers and to the number of STR loci compared or the particular set of mutation rates selected.	Texas State Univ, Dept Biol, San Marcos, TX 78666 USA	Texas State University System; Texas State University San Marcos	Bird, SC (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	sb1611@txstate.edu						Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Behar DM, 2003, AM J HUM GENET, V73, P768, DOI 10.1086/378506; Burgarella C, 2011, EUR J HUM GENET, V19, P70, DOI 10.1038/ejhg.2010.154; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Calabrese PP, 2001, GENETICS, V159, P839; CARTWRIGHT DI, 1978, P AM MATH SOC, V71, P36, DOI 10.2307/2042211; de Knijff P, 2000, AM J HUM GENET, V67, P1055; Goedbloed M, 2009, INT J LEGAL MED, V123, P471, DOI 10.1007/s00414-009-0342-y; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gusmao L, 2003, INT J LEGAL MED, V117, P287, DOI 10.1007/s00414-003-0388-1; Hudson R, 1991, OXFORD SURVEYS EVOLU, V7, P1; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kimmel M, 1996, THEOR POPUL BIOL, V50, P345, DOI 10.1006/tpbi.1996.0035; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; MALLOWS C, 1991, AM STAT, V45, P257; Mills L. S., 2007, CONSERVATION WILDLIF; Nachman MW, 2000, GENETICS, V156, P297; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Patel JK, 1996, HDB NORMAL DISTRIBUT; SCHWERTMAN NC, 1990, AM STAT, V44, P38, DOI 10.2307/2684955; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; SLATKIN M, 1995, GENETICS, V139, P457; Stumpf MPH, 2001, SCIENCE, V291, P1738, DOI 10.1126/science.291.5509.1738; Sun JX, 2009, MOL BIOL EVOL, V26, P1017, DOI 10.1093/molbev/msp025; Uchida Y, 2008, J INEQUAL PURE APPL, V9; Vermeulen M, 2009, FORENSIC SCI INT-GEN, V3, P205, DOI 10.1016/j.fsigen.2009.01.009; Walsh B, 2001, GENETICS, V158, P897; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	32	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48638	10.1371/journal.pone.0048638	http://dx.doi.org/10.1371/journal.pone.0048638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119076	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500184
J	Daboul, A; Schwahn, C; Schaffner, G; Soehnel, S; Samietz, S; Aljaghsi, A; Habes, M; Hegenscheid, K; Puls, R; Klinke, T; Biffar, R				Daboul, Amro; Schwahn, Christian; Schaffner, Grit; Soehnel, Silvia; Samietz, Stefanie; Aljaghsi, Ahmad; Habes, Mohammad; Hegenscheid, Katrin; Puls, Ralf; Klinke, Thomas; Biffar, Reiner			Reproducibility of Frankfort Horizontal Plane on 3D Multi-Planar Reconstructed MR Images	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; LANDMARK IDENTIFICATION; INTRACLASS CORRELATIONS; COMPUTED-TOMOGRAPHY; ANATOMIC LANDMARKS; ORIENTATION; RELIABILITY; THICKNESS; ACCURACY; MUSCLES	Objective: The purpose of this study was to determine the accuracy and reliability of Frankfort horizontal plane identification using displays of multi-planar reconstructed MRI images, and propose it as a sufficiently stable and standardized reference plane for craniofacial structures. Materials and Methods: MRI images of 43 subjects were obtained from the longitudinal population based cohort study SHIP-2 using a T1-weighted 3D sequence. Five examiners independently identified the three landmarks that form FH plane. Intra-examiner reproducibility and inter-examiner reliability, correlation coefficients (ICC), coefficient of variability and Bland-Altman plots were obtained for all landmarks coordinates to assess reproducibility. Intra-examiner reproducibility and inter-examiner reliability in terms of location and plane angulation were also assessed. Results: Intra-and inter-examiner reliabilities for X, Y and Z coordinates of all three landmarks were excellent with ICC values ranging from 0.914 to 0.998. Differences among examiners were more in X and Z than in Y dimensions. The Bland-Altman analysis demonstrated excellent intra-as well as inter-examiner agreement between examiners in all coordinates for all landmarks. Intra-examiner reproducibility and inter-examiner reliability of the three landmarks in terms of distance showed mean differences between 1.3 to 2.9 mm, Mean differences in plane angulation were between 1.0 degrees to 1.5 degrees among examiners. Conclusion: This study revealed excellent intra-examiner reproducibility and inter-examiner reliability of Frankfort Horizontal plane through 3D landmark identification in MRI. Sufficiently stable landmark-based reference plane could be used for different treatments and studies.	[Daboul, Amro; Schwahn, Christian; Schaffner, Grit; Soehnel, Silvia; Samietz, Stefanie; Aljaghsi, Ahmad; Klinke, Thomas; Biffar, Reiner] Ernst Moritz Arndt Univ Greifswald, Polyclin Prosthodont & Biomat, Greifswald, Germany; [Habes, Mohammad] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, Greifswald, Germany; [Hegenscheid, Katrin; Puls, Ralf] Ernst Moritz Arndt Univ Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Daboul, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Polyclin Prosthodont & Biomat, Greifswald, Germany.	daboulamro@gmail.com	Habes, Mohamad/M-2865-2016	Habes, Mohamad/0000-0001-9447-5805; Al Jaghsi, Ahmad/0000-0002-7888-1149	Siemens Healthcare (Siemens, Erlangen, Germany); Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	Siemens Healthcare (Siemens, Erlangen, Germany); Federal State of Mecklenburg-West Pomerania; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	The present work has been supported by a joint grant from Siemens Healthcare (Siemens, Erlangen, Germany) and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of Siemens AG. SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs and the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PVM, 2008, J CRANIOFAC SURG, V19, P211, DOI 10.1097/scs.0b013e31814fb80e; Berco M, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2008.08.021; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; Boom HPW, 2008, ARCH ORAL BIOL, V53, P273, DOI 10.1016/j.archoralbio.2007.08.013; Cotton F, 2005, SURG RADIOL ANAT, V27, P64, DOI 10.1007/s00276-004-0283-6; Damstra J, 2012, CLIN ORAL INVEST, V16, P285, DOI 10.1007/s00784-011-0512-4; de Oliveira AEF, 2009, ORAL SURG ORAL MED O, V107, P256, DOI 10.1016/j.tripleo.2008.05.039; Farrugia ME, 2007, CLIN RADIOL, V62, P1078, DOI 10.1016/j.crad.2007.05.003; FERRARIO VF, 1994, AM J ORTHOD DENTOFAC, V106, P257, DOI 10.1016/S0889-5406(94)70045-1; Gokalp H, 2001, EUR J ORTHODONT, V23, P579, DOI 10.1093/ejo/23.5.579; Goto TK, 2006, J DENT RES, V85, P552, DOI 10.1177/154405910608500614; Goto TK, 2007, ORAL SURG ORAL MED O, V103, P550, DOI 10.1016/j.tripleo.2006.03.011; Goto TK, 2005, J DENT RES, V84, P570, DOI 10.1177/154405910508400616; Gravely J F, 1974, Br J Orthod, V1, P95; Gray CF, 1998, BRIT DENT J, V184, P603, DOI 10.1038/sj.bdj.4809707; Guler N, 2003, DENTOMAXILLOFAC RAD, V32, P304, DOI 10.1259/dmfr/24534480; Halazonetis DJ, 2002, AM J ORTHOD DENTOFAC, V121, P364, DOI 10.1067/mod.2002.121663; Hassan B, 2009, EUR J ORTHODONT, V31, P129, DOI 10.1093/ejo/cjn088; Hatipoglu HG, 2008, FORENSIC SCI INT, V182, P46, DOI 10.1016/j.forsciint.2008.09.014; Hegenscheid K, 2009, ROFO-FORTSCHR RONTG, V181, P748, DOI 10.1055/s-0028-1109510; Hirohi T, 2010, J PLAST RECONSTR AES, V63, P1251, DOI 10.1016/j.bjps.2009.07.025; HOUSTON WJB, 1986, EUR J ORTHODONT, V8, P149, DOI 10.1093/ejo/8.3.149; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Kollmann J., 1883, ARCH ANTHR, V15, P1; Kragskov J, 1997, CLEFT PALATE-CRAN J, V34, P111, DOI 10.1597/1545-1569(1997)034<0111:COTROC>2.3.CO;2; Lagravere MO, 2011, ORAL SURG ORAL MED O, V111, P771, DOI 10.1016/j.tripleo.2011.02.017; Lagravere MO, 2010, AM J ORTHOD DENTOFAC, V137, P598, DOI 10.1016/j.ajodo.2008.07.018; LAM EWN, 1991, ARCH ORAL BIOL, V36, P845, DOI 10.1016/0003-9969(91)90034-R; Lou L, 2007, ORAL SURG ORAL MED O, V104, P402, DOI 10.1016/j.tripleo.2006.07.015; Ludlow JB, 2009, AM J ORTHOD DENTOFAC, V136, DOI [10.1016/j.ajodo.2009.04.009, 10.1016/j.ajodo.2008.12.018]; LUNDSTROM A, 1995, AM J ORTHOD DENTOFAC, V107, P537, DOI 10.1016/S0889-5406(95)70121-4; MATTESON SR, 1989, J ORAL MAXIL SURG, V47, P1053, DOI 10.1016/0278-2391(89)90180-8; MCWILLIAM JS, 1978, ANGLE ORTHOD, V48, P49; Muramatsu A, 2008, ANGLE ORTHOD, V78, P396, DOI 10.2319/040207-166.1; Olszewski R, 2010, J CRANIO MAXILL SURG, V38, P214, DOI 10.1016/j.jcms.2009.05.005; Pancherz H, 1996, EUR J ORTHODONT, V18, P367; RICKETTS RM, 1976, AM J ORTHOD DENTOFAC, V69, P648, DOI 10.1016/0002-9416(76)90147-0; Sahni D, 2008, FORENSIC SCI INT, V176, P137, DOI 10.1016/j.forsciint.2007.07.012; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Szklo M, 2007, EPIDEMIOLOGY BASICS, P297; Trpkova B, 1997, AM J ORTHOD DENTOFAC, V112, P165, DOI 10.1016/S0889-5406(97)70242-7; TYNDALL DA, 1992, J ORAL MAXIL SURG, V50, P1164, DOI 10.1016/0278-2391(92)90147-R; vanEijden TMGJ, 1997, ANAT REC, V248, P464; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P112, DOI 10.1597/1545-1569(1992)029<0112:CSMBOC>2.3.CO;2; You KH, 2010, AM J ORTHOD DENTOFAC, V138, DOI 10.1016/j.ajodo.2010.06.008	47	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48281	10.1371/journal.pone.0048281	http://dx.doi.org/10.1371/journal.pone.0048281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118970	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500089
J	Lee, JJ; Gonzalez-Izquierdo, A; Gilbert, R				Lee, Joseph Jonathan; Gonzalez-Izquierdo, Arturo; Gilbert, Ruth			Risk of Maltreatment-Related Injury: A Cross-Sectional Study of Children under Five Years Old Admitted to Hospital with a Head or Neck Injury or Fracture	PLOS ONE			English	Article							ABUSE; DATABASE; INFANTS	Objectives: To determine the predictive value and sensitivity of demographic features and injuries (indicators) for maltreatment-related codes in hospital discharge records of children admitted with a head or neck injury or fracture. Methods: Study design: Population-based, cross sectional study. Setting: NHS hospitals in England. Subjects: Children under five years old admitted acutely to hospital with head or neck injury or fracture. Data source: Hospital Episodes Statistics, 1997 to 2009. Main outcome measure: Maltreatment-related injury admissions, defined by ICD10 codes, were used to calculate for each indicator (demographic feature and/or type of injury): i) the predictive value (proportion of injury admissions that were maltreatment-related); ii) sensitivity (proportion of all maltreatment-related injury admissions with the indicator). Results: Of 260,294 childhood admissions for fracture or head or neck injury, 3.2% (8,337) were maltreatment-related. With increasing age of the child, the predictive value for maltreatment-related injury declined but sensitivity increased. Half of the maltreatment-related admissions occurred in children older than one year, and 63% occurred in children with head injuries without fractures or intracranial injury. Conclusions: Highly predictive injuries accounted for very few maltreatment-related admissions. Protocols that focus on high-risk injuries may miss the majority of maltreated children.	[Lee, Joseph Jonathan; Gonzalez-Izquierdo, Arturo; Gilbert, Ruth] UCL, Inst Child Hlth, London, England	University of London; University College London	Gilbert, R (corresponding author), UCL, Inst Child Hlth, London, England.	r.gilbert@ucl.ac.uk		Gonzalez-Izquierdo, Arturo/0000-0002-0984-5830; Lee, Joseph/0000-0002-4033-0915; Gilbert, Ruth/0000-0001-9347-2709	Department of Health (Clinical Strategies and Clinical Audit Division); Policy Research Programme; Department of Health; MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546B, G0400546] Funding Source: researchfish; National Institute for Health Research [ACF-2009-18-034] Funding Source: researchfish	Department of Health (Clinical Strategies and Clinical Audit Division); Policy Research Programme; Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AGI was supported by funding from the Department of Health (http://www.dh.gov.uk/en/index.htm) Clinical Strategies and Clinical Audit Division) and the Policy Research Programme through funding to the Policy Research Unit in the Health of Children, Young People and Families. This is an independent report commissioned and funded by the Department of Health. The views expressed are not necessarily those of the Department. There was no other external funding of this project.	Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Coffey C, 2005, J PEDIATR SURG, V40, P120, DOI 10.1016/j.jpedsurg.2004.09.003; Gilbert R, 2012, LANCET, V379, P758, DOI 10.1016/S0140-6736(11)61087-8; Gilbert R, 2009, LANCET, V373, P167, DOI 10.1016/S0140-6736(08)61707-9; Gonzalez-Izquierdo A, 2010, ARCH DIS CHILD, V95, P918, DOI 10.1136/adc.2009.180216; Hooft B, 2012, PEDIATRICS IN PRESS; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Kemp AM, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1518; Leventhal JM, 2010, PEDIATRICS, V126, pE104, DOI 10.1542/peds.2009-1076; Louwers ECFM, 2011, ARCH DIS CHILD, V96, P422, DOI 10.1136/adc.2010.202358; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; McKenzie K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-8; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Saperia J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2689; Schnitzer PG, 2011, CHILD ABUSE NEGLECT, V35, P3, DOI 10.1016/j.chiabu.2010.06.008; Scott D, 2009, CHILD ABUSE NEGLECT, V33, P791, DOI 10.1016/j.chiabu.2009.08.005; Strait T, 1995, PEDIATRICS, V96, P667; Woodman J, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12330	20	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e46522	10.1371/journal.pone.0046522	http://dx.doi.org/10.1371/journal.pone.0046522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118853	Green Published, gold			2022-12-25	WOS:000310600500006
J	Maiolino, G; Pedon, L; Cesari, M; Frigo, AC; Wolfert, RL; Barisa, M; Pagliani, L; Rossitto, G; Seccia, TM; Zanchetta, M; Rossi, GP				Maiolino, Giuseppe; Pedon, Luigi; Cesari, Maurizio; Frigo, Anna Chiara; Wolfert, Robert L.; Barisa, Marlena; Pagliani, Leopoldo; Rossitto, Giacomo; Seccia, Teresa Maria; Zanchetta, Mario; Rossi, Gian Paolo			Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; LOW-DENSITY LIPOPROTEINS; OXIDE SYNTHASE GENOTYPE; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; HEART-DISEASE; FACTOR ACETYLHYDROLASE; ENDOTHELIAL-CELLS; PROPENSITY-SCORE; ATHEROGENIC LIPOPROTEINS	Objective: Lipoprotein-associated phospholipase A2 (Lp-PLA2) is deemed to play a role in atherosclerosis and plaque destabilization as demonstrated in animal models and in prospective clinical studies. However, most of the literature is either focused on high-risk, apparently healthy patients, or is based on cross sectional studies. Therefore, we tested the hypothesis that serum Lp-PLA2 mass and activity are useful for predicting cardiovascular (CV) events over the coronary atherosclerotic burden and conventional risk factors in high-risk coronary artery disease patients. Methods and Results: In a prospective cohort study of 712 Caucasian patients, who underwent coronary angiography and measurement of both Lp-PLA2 mass and activity at baseline, we determined incident CV events at follow-up after splitting the patients into a high and a low Lp-PLA2 mass and activity groups based on ROC analysis and Youden index. Kaplan-Meier and propensity score matching analysis were used to compare CV event-free survival between groups. Follow-up data were obtained in 75% of the cohort after a median of 7.2 years (range 1-12.7 years) during which 129 (25.5%) CV events were observed. The high Lp-PLA2 activity patients showed worse CV event-free survival (66.7% vs. 79.5%, p = 0.023) and acute coronary syndrome-free survival (75.4% vs. 85.6%, p = 0.04) than those in low Lp-PLA2 group. Conclusions: A high Lp-PLA2 activity implies a worse CV prognosis at long term follow up in high-risk Caucasian patients referred for coronary angiography.	[Maiolino, Giuseppe; Cesari, Maurizio; Barisa, Marlena; Pagliani, Leopoldo; Rossitto, Giacomo; Seccia, Teresa Maria; Rossi, Gian Paolo] Univ Padua, Dept Med, Padua, Italy; [Pedon, Luigi; Zanchetta, Mario] Osped Cittadella, Div Cardiol, Cittadella, Italy; [Frigo, Anna Chiara] Univ Padua, Dept Environm Med & Publ Hlth, Padua, Italy; [Wolfert, Robert L.] DiaDexus, San Francisco, CA USA	University of Padua; ULSS 6 Euganea; Ospedale di Cittadella; University of Padua	Maiolino, G (corresponding author), Univ Padua, Dept Med, Padua, Italy.	gianpaolo.rossi@unipd.it	Seccia, T./G-5342-2012; Rossitto, Giacomo/AAC-6914-2022	Seccia, T./0000-0002-3639-4086; Rossitto, Giacomo/0000-0001-9023-0835; maiolino, giuseppe/0000-0001-6050-1155; ROSSI, GIAN PAOLO/0000-0002-7963-0931	Italian Cabinet of University and Scientific Research (MURST) [9906193152_001/06]; Regione Veneto [863/01/98]; Unindustria of Treviso; F.O.R.I.C.A.; GSK	Italian Cabinet of University and Scientific Research (MURST)(Ministry of Education, Universities and Research (MIUR)); Regione Veneto(Regione Veneto); Unindustria of Treviso; F.O.R.I.C.A.(Keygene N.V.); GSK(GlaxoSmithKline)	This study was supported by grants of the Italian Cabinet of University and Scientific Research (MURST) to ACP (9906193152_001/06) and by unrestricted research grants from Regione Veneto(863/01/98), Unindustria of Treviso, F.O.R.I.C.A., and GSK to G. P. Rossi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; Anderson JL, 2008, AM J CARDIOL, V101, p23F, DOI 10.1016/j.amjcard.2008.04.015; [Anonymous], 2006, SURVIVAL ANAL TECHNI; Asano K, 1999, BIOCHEM BIOPH RES CO, V261, P511, DOI 10.1006/bbrc.1999.1066; Atik B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011026; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Blake GJ, 2001, J AM COLL CARDIOL, V38, P1302, DOI 10.1016/S0735-1097(01)01554-6; Brilakis ES, 2005, EUR HEART J, V26, P137, DOI 10.1093/eurheartj/ehi010; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Califf RM, 1996, J AM COLL CARDIOL, V27, P1007, DOI 10.1016/0735-1097(96)87733-3; Cesari M, 2006, J INTERN MED, V260, P474, DOI 10.1111/j.1365-2796.2006.01714.x; Cesari M, 2003, J CARDIOVASC PHARM, V42, P484, DOI 10.1097/00005344-200310000-00005; Cook NR, 2012, CLIN CHEM, V58, P1352, DOI 10.1373/clinchem.2012.188870; Epps KC, 2011, J INTERN MED, V269, P94, DOI 10.1111/j.1365-2796.2010.02297.x; Gaubatz JW, 2007, J LIPID RES, V48, P348, DOI 10.1194/jlr.M600249-JLR200; Gazi I, 2005, CLIN CHEM, V51, P2264, DOI 10.1373/clinchem.2005.058404; Gerber Y, 2006, ARTERIOSCL THROM VAS, V26, P2517, DOI 10.1161/01.ATV.0000240406.89440.0c; Hakkinen T, 1999, ARTERIOSCL THROM VAS, V19, P2909, DOI 10.1161/01.ATV.19.12.2909; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; Hochman JS, 2011, CIRCULATION, V124, P2320, DOI 10.1161/CIRCULATIONAHA.111.041749; Inoue N, 2001, ATHEROSCLEROSIS, V155, P45, DOI 10.1016/S0021-9150(00)00530-X; Kizer JR, 2012, DIABETES CARE, V35, P840, DOI 10.2337/dc11-1639; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P1586, DOI 10.1161/01.ATV.0000222983.73369.c8; Koh JS, 2012, AM J CARDIOL, V109, P461, DOI 10.1016/j.amjcard.2011.09.039; Kohno M, 1998, CIRCULATION, V98, P353, DOI 10.1161/01.CIR.98.4.353; Kolodgie FD, 2006, ARTERIOSCL THROM VAS, V26, P2523, DOI 10.1161/01.ATV.0000244681.72738.bc; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; May HT, 2006, AM HEART J, V152, P997, DOI 10.1016/j.ahj.2006.01.011; O'Donoghue M, 2006, CIRCULATION, V113, P1745, DOI 10.1161/CIRCULATIONAHA.105.612630; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Rana JS, 2011, EUR HEART J, V32, P336, DOI 10.1093/eurheartj/ehp010; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rossi GP, 2006, J AM COLL CARDIOL, V48, P1166, DOI 10.1016/j.jacc.2006.05.046; Rossi GP, 2003, CIRCULATION, V108, P2467, DOI 10.1161/01.CIR.0000097122.19430.48; Rossi GP, 2003, J AM COLL CARDIOL, V41, P930, DOI 10.1016/S0735-1097(02)03012-7; Sabatine MS, 2007, ARTERIOSCL THROM VAS, V27, P2463, DOI 10.1161/ATVBAHA.107.151670; Safaya R, 2005, J SURG RES, V126, P182, DOI 10.1016/j.jss.2005.01.015; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215; Tabachnick B. G., 2001, USING MULTIVARIATE S; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Velez-Carrasco W, 2008, J NUTR BIOCHEM, V19, P362, DOI 10.1016/j.jnutbio.2007.05.005; White H, 2010, AM HEART J, V160, P655, DOI 10.1016/j.ahj.2010.07.006; Winkler K, 2007, CLIN CHEM, V53, P1440, DOI 10.1373/clinchem.2007.086298	52	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48171	10.1371/journal.pone.0048171	http://dx.doi.org/10.1371/journal.pone.0048171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118945	gold, Green Published, Green Submitted			2022-12-25	WOS:000310600500076
J	Reed, C; Katz, JM; Hancock, K; Balish, A; Fry, AM				Reed, Carrie; Katz, Jacqueline M.; Hancock, Kathy; Balish, Amanda; Fry, Alicia M.		H1N1 Serosurvey Working Grp	Prevalence of Seropositivity to Pandemic Influenza A/H1N1 Virus in the United States following the 2009 Pandemic	PLOS ONE			English	Article							A H1N1 VIRUS; HOUSEHOLD TRANSMISSION; INFECTION; VACCINE; CHALLENGE; ANTIBODY; DISEASE; ENGLAND; HUMANS; BURDEN	Background: 2009 pandemic influenza A/H1N1 (A(H1N1)pdm09) was first detected in the United States in April 2009 and resulted in a global pandemic. We conducted a serologic survey to estimate the cumulative incidence of A(H1N1) pdm09 through the end of 2009 when pandemic activity had waned in the United States. Methods: We conducted a pair of cross sectional serologic surveys before and after the spring/fall waves of the pandemic for evidence of seropositivity (titer >= 40) using the hemagglutination inhibition (HI) assay. We tested a baseline sample of 1,142 serum specimens from the 2007-2008 National Health and Nutrition Examination Survey (NHANES), and 2,759 serum specimens submitted for routine screening to clinical diagnostic laboratories from ten representative sites. Results: The age-adjusted prevalence of seropositivity to A(H1N1) pdm09 by year-end 2009 was 36.9% (95%CI: 31.7-42.2%). After adjusting for baseline cross-reactive antibody, pandemic vaccination coverage and the sensitivity/specificity of the HI assay, we estimate that 20.2% (95%CI: 10.1-28.3%) of the population was infected with A(H1N1) pdm09 by December 2009, including 53.3% (95%CI: 39.0-67.1%) of children aged 5-17 years. Conclusions: By December 2009, approximately one-fifth of the US population, or 61.9 million persons, may have been infected with A(H1N1) pdm09, including around half of school-aged children.	[Reed, Carrie; Katz, Jacqueline M.; Hancock, Kathy; Balish, Amanda; Fry, Alicia M.; H1N1 Serosurvey Working Grp] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Reed, C (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	creed1@cdc.gov; agf1@cdc.gov						Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; CDC, 2009, INFL SEAS; Centers for Disease Control and Prevention, CDC EST 2009 H1N1 IN; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Cox CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029301; Dawood FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009880; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Ikonen N, 2010, EURO SURVEILL, V15; Jackson ML, 2011, CLIN INFECT DIS, V53, P455, DOI 10.1093/cid/cir437; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Kelly H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021828; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; NCHS (National Center for Health Statistics), 2010, CONT NHANES WEB TUT; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Skowronski DM, 2010, CAN MED ASSOC J, V182, P1851, DOI 10.1503/cmaj.100910; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; World Health Organization, MAN LAB DIAGN VIR SU; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	36	42	42	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48187	10.1371/journal.pone.0048187	http://dx.doi.org/10.1371/journal.pone.0048187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118949	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500078
J	Shen, J; Wang, WZ; Wu, JD; Feng, B; Chen, W; Wang, M; Tang, JC; Wang, FQ; Cheng, F; Pu, LY; Tang, QY; Wang, XH; Li, XC				Shen, Jian; Wang, Weizhi; Wu, Jindao; Feng, Bing; Chen, Wen; Wang, Meng; Tang, Jincao; Wang, Fuqiang; Cheng, Feng; Pu, Liyong; Tang, Qiyun; Wang, Xuehao; Li, Xiangcheng			Comparative Proteomic Profiling of Human Bile Reveals SSP411 as a Novel Biomarker of Cholangiocarcinoma	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; RISK-FACTORS; INTRAHEPATIC CHOLANGIOCARCINOMA; PHOSPHOGLYCERATE MUTASE; PANCREATIC-CANCER; OVARIAN-CANCER; PROTEIN; EXPRESSION; IDENTIFICATION; EPIDEMIOLOGY	Background: Cholangiocarcinoma (CC) is an intractable cancer, arising from biliary epithelial cells, which has a poor prognosis and is increasing in incidence. Early diagnosis of CC is essential as surgical resection remains the only effective therapy. The purpose of this study was to identify improved biomarkers to facilitate early diagnosis and prognostication in CC. Methods: A comparative expression profile of human bile samples from patients with cholangitis and CC was constructed using a classic 2D/MS/MS strategy and the expression of selected proteins was confirmed by Western blotting. Immunohistochemistry was performed to determine the expression levels of selected candidate biomarkers in CC and matched normal tissues. Finally, spermatogenesis associated 20 (SSP411; also named SPATA20) was quantified in serum samples using an ELISA. Results: We identified 97 differentially expressed protein spots, corresponding to 49 different genes, of which 38 were upregulated in bile from CC patients. Western blotting confirmed that phosphoglycerate mutase 1 (brain) (PGAM-1), protein disulfide isomerase family A, member 3 (PDIA3), heat shock 60 kDa protein 1 (chaperonin) (HSPD1) and SSP411 were significantly upregulated in individual bile samples from CC patients. Immunohistochemistry demonstrated these proteins were also overexpressed in CC, relative to normal tissues. SSP411 displayed value as a potential serum diagnostic biomarker for CC, with a sensitivity of 90.0% and specificity of 83.3% at a cutoff value of 0.63. Conclusions: We successfully constructed a proteomic profile of CC bile proteins, providing a valuable pool novel of candidate biomarkers. SSP411 has potential as a biomarker for the diagnosis of CC.	[Shen, Jian; Wang, Weizhi; Wu, Jindao; Feng, Bing; Wang, Meng; Tang, Jincao; Cheng, Feng; Pu, Liyong; Wang, Xuehao; Li, Xiangcheng] Nanjing Med Univ, Affiliated Hosp 1, Key Lab Living Donor Liver Transplantat, Minist Publ Hlth,Dept Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; [Shen, Jian] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Chen, Wen] Nanjing Med Univ, Nanjing Hosp 1, Dept Thorac & Cardiovasc Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Fuqiang] Nanjing Med Univ, Lab Reprod Med, Dept Histol & Embryol, Nanjing, Jiangsu, Peoples R China; [Tang, Qiyun] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wu, JD (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Key Lab Living Donor Liver Transplantat, Minist Publ Hlth,Dept Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China.	wujindao@njmu.edu.cn; drxcli@njmu.edu.cn	li, xiang/GWM-6319-2022	Wang, Fuqiang/0000-0002-7777-3541	Department of Public Health of Jiangsu Province [RC2007056]; National Natural Science Foundation of China [81170415]	Department of Public Health of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from the Department of Public Health of Jiangsu Province (RC2007056) and the National Natural Science Foundation of China (81170415). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston AT, 2005, J BIOL CHEM, V280, P18302, DOI 10.1074/jbc.M501675200; Blechacz BRA, 2008, CLIN LIVER DIS, V12, P131, DOI 10.1016/j.cld.2007.11.003; Burak K, 2004, AM J GASTROENTEROL, V99, P523, DOI 10.1111/j.1572-0241.2004.04067.x; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Chen B, 2007, HEPATOB PANCREAT DIS, V6, P402; Cicchillitti L, 2010, INT J ONCOL, V37, P445, DOI 10.3892/ijo_00000693; Claessen MMH, 2009, J HEPATOL, V50, P158, DOI 10.1016/j.jhep.2008.08.013; de Atauri P, 2005, BBA-MOL BASIS DIS, V1740, P403, DOI 10.1016/j.bbadis.2004.11.023; Dos Santos A, 2010, MOL CELL PROTEOMICS, V9, P1991, DOI 10.1074/mcp.M110.000026; Ehmann M, 2007, PANCREAS, V34, P205, DOI 10.1097/01.mpa.0000250128.57026.b2; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; Farid SG, 2011, PROTEOMICS, V11, P2134, DOI 10.1002/pmic.201000653; Farina A, 2011, J PROTEOME RES, V10, P2047, DOI 10.1021/pr200011b; Farina A, 2009, EXPERT REV PROTEOMIC, V6, P285, DOI 10.1586/EPR.09.12; Farina A, 2009, J PROTEOME RES, V8, P159, DOI 10.1021/pr8004925; Gatto M, 2010, DIGEST LIVER DIS, V42, P253, DOI 10.1016/j.dld.2009.12.008; Glaessgen A, 2008, APMIS, V116, P888, DOI 10.1111/j.1600-0463.2008.01051.x; Halton JM, 1998, CANCER, V83, P379, DOI 10.1002/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P; Hirano S, 2010, J HEPATO-BIL-PAN SCI, V17, P455, DOI 10.1007/s00534-009-0208-1; Huang XY, 2008, J PROTEOME RES, V7, P3435, DOI 10.1021/pr800179h; Khan SA, 2008, HPB, V10, P77, DOI 10.1080/13651820801992641; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Koopmann J, 2004, CANCER-AM CANCER SOC, V101, P1609, DOI 10.1002/cncr.20469; Korita PV, 2010, ANTICANCER RES, V30, P2279; Kozak KR, 2005, PROTEOMICS, V5, P4589, DOI 10.1002/pmic.200500093; Kristiansen TZ, 2004, MOL CELL PROTEOMICS, V3, P715, DOI 10.1074/mcp.M400015-MCP200; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; Lee SG, 2010, J HEPATO-BIL-PAN SCI, V17, P476, DOI 10.1007/s00534-009-0204-5; Nehls O, 2004, SEMIN LIVER DIS, V24, P139, DOI 10.1055/s-2004-828891; Nguyen K, 2008, WORLD J GASTROENTERO, V14, P2995, DOI 10.3748/wjg.14.2995; Okuda K, 2002, J GASTROEN HEPATOL, V17, P1049, DOI 10.1046/j.1440-1746.2002.02781.x; Poomphakwaen K, 2009, ASIAN PAC J CANCER P, V10, P251; Ren FL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-81; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Shi HJ, 2004, J ANDROL, V25, P479; Srinivas PR, 2001, CLIN CHEM, V47, P1901; Srisomsap C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/437143; Takaishi S, 2007, CANCER SCI, V98, P284, DOI 10.1111/j.1349-7006.2007.00392.x; Turano C, 2011, CELL MOL BIOL LETT, V16, P539, DOI 10.2478/s11658-011-0022-z; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Wang X, 2009, EUR J CANCER CARE, V18, P625, DOI 10.1111/j.1365-2354.2008.00965.x; Welzel TM, 2007, INT J CANCER, V120, P638, DOI 10.1002/ijc.22283; Welzel TM, 2007, CLIN GASTROENTEROL H, V5, P1221, DOI 10.1016/j.cgh.2007.05.020; Wu JD, 2010, J HEPATOL, V53, P73, DOI 10.1016/j.jhep.2010.01.032; Zhou H, 2005, RAPID COMMUN MASS SP, V19, P3569, DOI [10.1002/rcm.2207, 10.1007/rcm.2207]	46	53	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e47476	10.1371/journal.pone.0047476	http://dx.doi.org/10.1371/journal.pone.0047476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118872	Green Published, Green Submitted, gold			2022-12-25	WOS:000310600500018
J	Zeng, XH; Karnon, J; Wang, SY; Wu, B; Wan, XM; Peng, LB				Zeng, Xiaohui; Karnon, Jonathan; Wang, Siying; Wu, Bin; Wan, Xiaomin; Peng, Liubao			The Cost of Treating Advanced Non-Small Cell Lung Cancer: Estimates from the Chinese Experience	PLOS ONE			English	Article							HEALTH-CARE COSTS; 1ST-LINE TREATMENT; OPEN-LABEL; PHASE-III; CHEMOTHERAPY; GEFITINIB; CISPLATIN; THERAPY; PHARMACOECONOMICS; MULTICENTER	Background: Because of the potentially significant economic burden of healthcare costs associated with many diseases, it is critical that regulatory and medical insurance organisations collect and utilise data on the cost-effectiveness of care provision to make rational policy decisions. However, little is known about healthcare costs in China. Methodology/Principal Findings: Based on health expenditure data for 253 cases of advanced non-small cell lung cancer (NSCLC) registered at the Second Xiangya Hospital of Central South University in China between 2006 and 2010, the cost of care provision was analysed. The monthly and aggregate annual medical costs were estimated for patients who were in either a progression-free state (PFS) or a disease-progression state (DPS). Monthly healthcare costs accumulated during the terminal 3 months were collected separately. The mean cost of treatment for PFS and DPS patients over one year was approximately US$11,566 and $14,519, respectively. The monthly costs for all patients were higher initially than in the subsequent months (PFS: $2,490; DPS: $2,503). For PFS patients, healthcare expenditures stabilised after the 7th month, with a mean monthly medical expenditure of $82.49. For DPS patients, expenditures stabilised after the 9th month, and the mean expenditure during the 9th month was $307.9. Medical care costs in the three successive months prior to death were $3,754, $5,829 and $7,372, respectively. Conclusions/Significance: The economic evaluation of health care technologies is becoming ever more important in China, especially in disease areas for which new and expensive therapies are being introduced on a regular basis. This is first paper to present empirically estimated China-specific costs associated with the treatment of NSCLC. The cost estimates are presented in a format that is specifically intended to inform cost-effectiveness analyses of treatments for NSCLC, and hence, contribute to the more efficient allocation of limited healthcare resources in China.	[Zeng, Xiaohui; Wang, Siying; Wan, Xiaomin; Peng, Liubao] Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China; [Zeng, Xiaohui; Wang, Siying; Wan, Xiaomin; Peng, Liubao] Cent South Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China; [Karnon, Jonathan] Univ Adelaide, Dept Publ Hlth, Adelaide, SA, Australia; [Wu, Bin] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Pharm, Shanghai, Peoples R China	Central South University; Central South University; University of Adelaide; Shanghai Jiao Tong University	Peng, LB (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China.	pengliubao@126.com	Wan, Xiaomin/GPX-4388-2022	/0000-0001-5315-8141; Karnon, Jonathan/0000-0003-3220-2099	National Natural Science Foundation of China [81173028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National Natural Science Foundation of China (No.81173028). URL: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PUBLICITY MED PRICES; Carlson JJ, 2009, VALUE HEALTH, V12, P20, DOI 10.1111/j.1524-4733.2008.00415.x; Chouaid C, 2004, BRIT J CANCER, V90, P397, DOI 10.1038/sj.bjc.6601547; Chouaid C, 2007, CURR MED RES OPIN, V23, P1509, DOI 10.1185/030079907X199718; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gattani SG, 2009, ASIAN J PHARM CLIN R, V2, P15; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Grieve R, 2001, STROKE, V32, P1684, DOI 10.1161/01.STR.32.7.1684; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karnon J, 2007, BRIT J CANCER, V97, P479, DOI 10.1038/sj.bjc.6603887; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Kutikova L, 2005, LUNG CANCER, V50, P143, DOI 10.1016/j.lungcan.2005.06.005; Landi L, 2011, NAT REV CLIN ONCOL, V8, P571, DOI 10.1038/nrclinonc.2011.135; Li HaiTao, 2009, Pharmaceutical Medicine, V23, P279; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Navaratnam S, 2010, LUNG CANCER, V70, P110, DOI 10.1016/j.lungcan.2010.01.012; NCCN, 2011, NONSM CELL LUNG CANC; Paz-Ares L, 2012, LANCET ONCOL, V13, P247, DOI 10.1016/S1470-2045(12)70063-3; Pompen M, 2009, LUNG CANCER, V64, P110, DOI 10.1016/j.lungcan.2008.07.009; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Stahl JE, 2008, PHARMACOECONOMICS, V26, P131, DOI 10.2165/00019053-200826020-00004; Sun Y, 2005, J CLIN ONCOL S, V23; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang Jinwan, 2005, Zhongguo Fei Ai Za Zhi, V8, P283, DOI 10.3779/j.issn.1009-3419.2005.04.07; Woodward RM, 2007, CANCER-AM CANCER SOC, V110, P2511, DOI 10.1002/cncr.23058; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032530; Wu B, 2011, CLIN THER, V33, P1446, DOI 10.1016/j.clinthera.2011.09.016; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	36	33	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48323	10.1371/journal.pone.0048323	http://dx.doi.org/10.1371/journal.pone.0048323			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118985	Green Published, gold			2022-12-25	WOS:000310600500105
J	Tan, JY; Pan, RG; Qiao, L; Zou, XF; Pan, ZS				Tan, Jinying; Pan, Ruangang; Qiao, Lei; Zou, Xiufen; Pan, Zishu			Modeling and Dynamical Analysis of Virus-Triggered Innate Immune Signaling Pathways	PLOS ONE			English	Article							INTERFERON-BETA; INFLUENZA-VIRUS; I INTERFERONS; SYSTEMS BIOLOGY; DELAY MODEL; RECOGNITION; INDUCTION; PROTEIN; CELLS; ACTIVATION	The investigation of the dynamics and regulation of virus-triggered innate immune signaling pathways at a system level will enable comprehensive analysis of the complex interactions that maintain the delicate balance between resistance to infection and viral disease. In this study, we developed a delayed mathematical model to describe the virus-induced interferon (IFN) signaling process by considering several key players in the innate immune response. Using dynamic analysis and numerical simulation, we evaluated the following predictions regarding the antiviral responses: (1) When the replication ratio of virus is less than 1, the infectious virus will be eliminated by the immune system's defenses regardless of how the time delays are changed. (2) The IFN positive feedback regulation enhances the stability of the innate immune response and causes the immune system to present the bistability phenomenon. (3) The appropriate duration of viral replication and IFN feedback processes stabilizes the innate immune response. The predictions from the model were confirmed by monitoring the virus titer and IFN expression in infected cells. The results suggest that the balance between viral replication and IFN-induced feedback regulation coordinates the dynamical behavior of virus-triggered signaling and antiviral responses. This work will help clarify the mechanisms of the virus-induced innate immune response at a system level and provide instruction for further biological experiments.	[Tan, Jinying; Zou, Xiufen] Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China; [Tan, Jinying] Huazhong Agr Univ, Coll Sci, Wuhan, Peoples R China; [Pan, Ruangang; Qiao, Lei; Pan, Zishu] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Huazhong Agricultural University; Wuhan University	Zou, XF (corresponding author), Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China.	xfzou@whu.edu.cn; zspan@whu.edu.cn			National Basic Research Program of China (973 Program) [2010CB911803]; Major Research Plan of the National Natural Science Foundation of China [91230118]; National Natural Science Foundation of China [61173060]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (No. 2010CB911803), the Major Research Plan of the National Natural Science Foundation of China (No. 91230118) and the National Natural Science Foundation of China (No. 61173060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNHEITER H, 1980, VIROLOGY, V103, P11, DOI 10.1016/0042-6822(80)90122-1; BARRY RD, 1979, BRIT MED BULL, V35, P39, DOI 10.1093/oxfordjournals.bmb.a071540; Bazhan SI, 1999, J THEOR BIOL, V198, P375, DOI 10.1006/jtbi.1999.0921; Beirer Stephan, 2006, Genome Inform, V17, P152; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Cirit Murat, 2011, Commun Integr Biol, V4, P353, DOI 10.4161/cib.4.3.15149; Dorf R.C., 2001, MODERN CONTROL SYSTE; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Grigorov B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024135; Hale J., 1977, THEORY FUNCTIONAL DI; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hassard B., 1981, THEORY APPL HOPF BIF; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Janzen C, 2000, J VIROL, V74, P8202, DOI 10.1128/JVI.74.17.8202-8206.2000; Johnson DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037337; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kuri T, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-50; Lei JZ, 2009, NONLINEARITY, V22, P2845, DOI 10.1088/0951-7715/22/12/003; Luo XL, 2009, CAN J MICROBIOL, V55, P698, DOI [10.1139/W09-013, 10.1139/w09-013]; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mier-y-Teran-Romero L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000726; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Nikolov S, 2007, J MECH MED BIOL, V7, P297, DOI 10.1142/S0219519407002315; Qiao L, 2010, BIOPHYS J, V98, P505, DOI 10.1016/j.bpj.2009.10.049; RONNI T, 1993, J IMMUNOL, V150, P1715; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sevim V, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000842; Shapira SD, 2011, CURR OPIN IMMUNOL, V23, P71, DOI 10.1016/j.coi.2010.10.022; Smieja J, 2008, BIOINFORMATICS, V24, P2363, DOI 10.1093/bioinformatics/btn400; Soebiyanto RP, 2007, BIOSYSTEMS, V90, P830, DOI 10.1016/j.biosystems.2007.05.005; Stewart W, 1979, INTERFERON SYSTEM; Vitale G, 2009, AM J PHYSIOL-ENDOC M, V296, pE559, DOI 10.1152/ajpendo.90770.2008; VONWUSSOW P, 1990, EUR J IMMUNOL, V20, P2015, DOI 10.1002/eji.1830200920; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamada S, 2003, FEBS LETT, V534, P190, DOI 10.1016/S0014-5793(02)03842-5; Zak DE, 2009, IMMUNOL REV, V227, P264, DOI 10.1111/j.1600-065X.2008.00721.x; Zou XF, 2010, J THEOR BIOL, V265, P691, DOI 10.1016/j.jtbi.2010.05.001	45	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2012	7	10							e48114	10.1371/journal.pone.0048114	http://dx.doi.org/10.1371/journal.pone.0048114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HJ	23118935	Green Submitted, Green Published, gold			2022-12-25	WOS:000310705600024
J	Li, WC; Yeh, HJ; Shankarling, GS; Ji, Z; Tian, B; MacDonald, CC				Li, Wencheng; Yeh, Hsiang-Jui; Shankarling, Ganesh S.; Ji, Zhe; Tian, Bin; MacDonald, Clinton C.			The tau CstF-64 Polyadenylation Protein Controls Genome Expression in Testis	PLOS ONE			English	Article							PRE-MESSENGER-RNA; 3' UNTRANSLATED REGIONS; ALTERNATIVE POLYADENYLATION; FACTOR CSTF-64; MICE LACKING; CLEAVAGE; MOUSE; CELLS; GENE; EVOLUTION	The tau CstF-64 polyadenylation protein (gene symbol Cstf2t) is a testis-expressed orthologue of CstF-64. Mice in which Cstf2t was knocked out had a phenotype that was only detected in meiotic and postmeiotic male germ cells, giving us the opportunity to examine CstF-64 function in an isolated developmental system. We performed massively parallel clonally amplified sequencing of cDNAs from testes of wild type and Cstf2t(-/-) mice. These results revealed that loss of tau CstF-64 resulted in large-scale changes in patterns of genome expression. We determined that there was a significant overrepresentation of RNAs from introns and intergenic regions in testes of Cstf2t(-/-) mice, and a concomitant use of more distal polyadenylation sites. We observed this effect particularly in intronless small genes, many of which are expressed retroposons that likely co-evolved with tau CstF-64. Finally, we observed overexpression of long interspersed nuclear element (LINE) sequences in Cstf2t(-/-) testes. These results suggest that tau CstF-64 plays a role in 3' end determination and transcription termination for a large range of germ cell-expressed genes.	[Yeh, Hsiang-Jui; Shankarling, Ganesh S.; MacDonald, Clinton C.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Li, Wencheng; Ji, Zhe; Tian, Bin] UMDNJ New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	MacDonald, CC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	clint.macdonald@ttuhsc.edu	Ji, Zhe/U-8320-2018	Ji, Zhe/0000-0002-1809-8099; Tian, Bin/0000-0001-8903-8256; MacDonald, Clinton/0000-0003-3209-1982	National Institutes of Health [HD037109, GM084089]; South Plains Foundation; TTUHSC School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Plains Foundation; TTUHSC School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (HD037109), the South Plains Foundation, and the TTUHSC School of Medicine to C.C.M., and NIH (GM084089) to B.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Cevher MA, 2010, WIRES RNA, V1, P193, DOI 10.1002/wrna.20; Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54; Darmon SK, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/876893; Dass B, 2002, GENOMICS, V80, P509, DOI 10.1006/geno.2002.6862; Dass B, 2001, J BIOL CHEM, V276, P8044, DOI 10.1074/jbc.M009091200; Dass B, 2007, P NATL ACAD SCI USA, V104, P20374, DOI 10.1073/pnas.0707589104; Deka P, 2005, J MOL BIOL, V347, P719, DOI 10.1016/j.jmb.2005.01.046; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Grzybowska EA, 2012, BIOCHEM BIOPH RES CO, V424, P1, DOI 10.1016/j.bbrc.2012.06.092; Heard E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002675; Hockert KJ, 2011, J REPROD IMMUNOL, V89, P26, DOI 10.1016/j.jri.2011.01.018; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Liu DL, 2007, NUCLEIC ACIDS RES, V35, P234, DOI 10.1093/nar/gkl919; MacDonald CC, 2010, WIRES RNA, V1, P494, DOI 10.1002/wrna.29; Martin G, 2012, CELL REPORTS, V1; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Milcarek C, 2011, J BIOL CHEM, V286, P33795, DOI 10.1074/jbc.M111.272096; Park NJ, 2004, MOL CELL BIOL, V24, P4092, DOI 10.1128/MCB.24.10.4092-4103.2004; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Ruepp MD, 2011, MOL BIOL CELL, V22, P91, DOI 10.1091/mbc.E10-06-0543; Salisbury J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-55; Sartini BL, 2008, BIOL REPROD, V78, P472, DOI 10.1095/biolreprod.107.064774; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Smit A, 2010, REPEATMASKER OPEN 1; Stirling PC, 2012, GENE DEV, V26, P163, DOI 10.1101/gad.179721.111; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tardif S, 2010, BIOL REPROD, V83, P464, DOI 10.1095/biolreprod.109.083238; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; Vemuganti SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-285; Wallace AM, 2004, BIOL REPROD, V70, P1080, DOI 10.1095/biolreprod.103.022947; Wallace AM, 1999, P NATL ACAD SCI USA, V96, P6763, DOI 10.1073/pnas.96.12.6763; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Yan W, 2009, EPIGENETICS-US, V4, P452, DOI 10.4161/epi.4.7.9923; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48373	10.1371/journal.pone.0048373	http://dx.doi.org/10.1371/journal.pone.0048373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110235	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500064
J	Huang, JJ; Pan, C; Hu, HG; Zheng, S; Ding, L				Huang, Jianjin; Pan, Chi; Hu, Hanguang; Zheng, Shu; Ding, Ling			Osteopontin-Enhanced Hepatic Metastasis of Colorectal Cancer Cells	PLOS ONE			English	Article							PLASMA OSTEOPONTIN; TUMOR PROGRESSION; GAP-JUNCTIONS; BONE; SURVIVAL; EXPRESSION; TARGETS; MARKER	Liver metastasis is a major cause of mortality from colorectal cancer (CRC). However, mechanisms underlying this process are largely unknown. Osteopontin (OPN) is a secreted phosphorylated glycoprotein that is involved in tumor migration and metastasis. The role of OPN in cancer is currently unclear. In this study, OPN mRNA was examined in tissues from CRC, adjacent normal mucosa, and liver metastatic lesions using quantitative real-time PCR analysis. The protein expression of OPN and its receptors (integrin alpha v and CD44 v6) was detected by using an immunohistochemical (IHC) method. The role of OPN in liver metastasis was studied in established colon cancer Colo-205 and SW-480 cell lines transfected with sense- or antisense-OPN eukaryotic expression plasmids by flow cytometry and cell adhesion assay. Florescence redistribution after photobleaching (FRAP) was used to study gap functional intercellular communication (GJIC) among OPN-transfected cells. It was found that OPN was highly expressed in metastatic hepatic lesions from CRC compared to primary CRC tissue and adjacent normal mucosa. The expression of OPN mRNA in tumor tissues was significantly related with the CRC stages. OPN expression was also detected in normal hepatocytes surrounding CRC metastatic lesions. Two known receptors of OPN, integrin alpha v and CD44v6 proteins, were strongly expressed in hepatocytes from normal liver. CRC cells with forced OPN expression exhibited increased heterotypic adhesion with endothelial cells and weakened intercellular communication. OPN plays a significant role in CRC metastasis to liver through interaction with its receptors in hepatocytes, decreased homotypic adhesion, and enhanced heterotypic adhesion.	[Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Jianjin; Pan, Chi; Hu, Hanguang; Ding, Ling] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ding, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China.	zhengshu@zju.edu.cn; lingding@zju.edu.cn	Pan, Chi/GRR-6330-2022		Natural Science Foundation of China [81102012]; Zhejiang qianjiang talents project [2011R10029]; Zhejiang medicine scientific research fund projects [2010ZB073]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang qianjiang talents project; Zhejiang medicine scientific research fund projects	This work was supported by a Natural Science Foundation of China (81102012; http://www.nsfc.gov.cn/), Zhejiang qianjiang talents project (2011R10029; http://kjt.zj.gov.cn/), and Zhejiang medicine scientific research fund projects (2010ZB073; http://www.zjtcm.gov.cn/) to LD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2002, J NATL CANCER I, V94, P513; Agrawal D, 2003, CR BIOL, V326, P1041, DOI 10.1016/j.crvi.2003.09.007; Carruba G, 2002, ANN NY ACAD SCI, V963, P156; Cui Bo-Kang, 2006, Ai Zheng, V25, P876; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Hayashi C, 2007, J CELL BIOCHEM, V101, P979, DOI 10.1002/jcb.21298; Hotte SJ, 2002, CANCER-AM CANCER SOC, V95, P506, DOI 10.1002/cncr.10709; Hu Zhi, 2007, Zhonghua Zhongliu Zazhi, V29, P591; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; LIOTTA LA, 1992, SCI AM, V266, P54, DOI 10.1038/scientificamerican0292-54; MOERTEL CG, 1993, JAMA-J AM MED ASSOC, V270, P943, DOI 10.1001/jama.270.8.943; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Ramankulov A, 2007, PROSTATE, V67, P330, DOI 10.1002/pros.20540; Rangel J, 2008, CANCER-AM CANCER SOC, V112, P144, DOI 10.1002/cncr.23147; Rodrigues LR, 2007, CANCER EPIDEM BIOMAR, V16, P1087, DOI 10.1158/1055-9965.EPI-06-1008; Ruers T, 2002, EUR J CANCER, V38, P1023, DOI 10.1016/S0959-8049(02)00059-X; Salameh A, 2005, BBA-BIOMEMBRANES, V1719, P36, DOI 10.1016/j.bbamem.2005.09.007; Siegel RL, 2008, J NATL MED ASSOC, V100, P1441, DOI 10.1016/S0027-9684(15)31544-3; Trosko JE, 2002, CURR DRUG TARGETS, V3, P465, DOI 10.2174/1389450023347371; Wai PY, 2005, CARCINOGENESIS, V26, P741, DOI 10.1093/carcin/bgi027; Yeatman TJ, 2003, CLIN EXP METASTAS, V20, P85, DOI 10.1023/A:1022502805474; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709	22	32	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47901	10.1371/journal.pone.0047901	http://dx.doi.org/10.1371/journal.pone.0047901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112867	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200103
J	Jha, AN; Singh, VK; Kumari, N; Singh, A; Antony, J; van Tong, H; Singh, S; Pati, SS; Patra, PK; Singh, R; Toan, NL; Song, LH; Assaf, A; Messias-Reason, IJT; Velavan, TP; Singh, L; Thangaraj, K				Jha, Aditya Nath; Singh, Vipin Kumar; Kumari, Namrata; Singh, Ashish; Antony, Justin; van Tong, Hoang; Singh, Sakshi; Pati, Sudhanshu S.; Patra, Pradeep K.; Singh, Rajender; Toan, Nguyen L.; Song, Le H.; Assaf, Amal; Messias-Reason, Iara J. T.; Velavan, Thirumalaisamy P.; Singh, Lalji; Thangaraj, Kumarasamy			IL-4 Haplotype-590T,-34T and Intron-3 VNTR R2 Is Associated with Reduced Malaria Risk among Ancestral Indian Tribal Populations	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TUMOR-NECROSIS-FACTOR; IGE ANTIMALARIAL ANTIBODIES; STAGE RENAL-DISEASE; T-CELL RESPONSES; CEREBRAL MALARIA; LIVER STAGES; GENE POLYMORPHISM; IL4 POLYMORPHISM; PROMOTER	Background: Interleukin 4 (IL-4) is an anti-inflammatory cytokine, which regulates balance between T(H)1 and T(H)2 immune response, immunoglobulin class switching and humoral immunity. Polymorphisms in this gene have been reported to affect the risk of infectious and autoimmune diseases. Methods: We have analyzed three regulatory IL-4 polymorphisms; -590C > T, -34C > T and 70 bp intron-3 VNTR, in 4216 individuals; including: (1) 430 ethnically matched case-control groups (173 severe malaria, 101 mild malaria and 156 asymptomatic); (2) 3452 individuals from 76 linguistically and geographically distinct endogamous populations of India, and (3) 334 individuals with different ancestry from outside India (84 Brazilian, 104 Syrian, and 146 Vietnamese). Results: The -590T, -34T and intron-3 VNTR R2 alleles were found to be associated with reduced malaria risk (P < 0.001 for 590C > T and -34C > T, and P = 0.003 for VNTR). These three alleles were in strong LD (r(2)> 0.75) and the TTR2 (-590T, -34T and intron-3 VNTR R2) haplotype appeared to be a susceptibility factor for malaria (P = 0.009, OR = 0.552, 95% CI = 0.356-0.854). Allele and genotype frequencies differ significantly between caste, nomadic, tribe and ancestral tribal populations (ATP). The distribution of protective haplotype TTR2 was found to be significant (chi(2)(3) = 182.95, p-value < 0.001), which is highest in ATP (40.5%); intermediate in tribes (33%); and lowest in caste (17.8%) and nomadic (21.6%). Conclusions: Our study suggests that the IL-4 polymorphisms regulate host susceptibility to malaria and disease progression. TTR2 haplotype, which gives protection against malaria, is high among ATPs. Since they inhabited in isolation and mainly practice hunter-gatherer lifestyles and exposed to various parasites, IL-4 TTR2 haplotype might be under positive selection.	[Jha, Aditya Nath; Singh, Vipin Kumar; Kumari, Namrata; Singh, Ashish; Singh, Sakshi; Singh, Lalji; Thangaraj, Kumarasamy] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Antony, Justin; van Tong, Hoang; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Pati, Sudhanshu S.] Ispat Gen Hosp, Rourkela, Orissa, India; [Patra, Pradeep K.] Pt Jawaharlal Nehru Mem Med Coll, Raipur, Madhya Pradesh, India; [Singh, Rajender] CSIR, Cent Drug Res Inst, Lucknow, Uttar Pradesh, India; [Toan, Nguyen L.] Vietnam Mil Med Univ, Dept Pathophysiol, Hanoi, Vietnam; [Song, Le H.] Tran Hung Dao Hosp, Hanoi, Vietnam; [Assaf, Amal] Univ Damascus, Dept Lab Med, Damascus, Syria; [Messias-Reason, Iara J. T.] Univ Fed Parana, Hosp Clienicas, Lab Imunopatol Mol, BR-80060000 Curitiba, Parana, Brazil; [Singh, Lalji] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Eberhard Karls University of Tubingen; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Universidade Federal do Parana; Banaras Hindu University (BHU)	Thangaraj, K (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	thangs@ccmb.res.in	Velavan, Thirumalaisamy P/C-1223-2010; van Tong, Hoang/E-9448-2011; ANTONY, JUSTIN S/F-3994-2010; Singh, Rajender/ABE-3512-2020; Kumari, Namrata/I-8521-2019	Velavan, Thirumalaisamy P/0000-0002-9809-9883; van Tong, Hoang/0000-0002-7170-8810; Kumari, Namrata/0000-0002-3670-4961; Jose de Messias Reason, Iara/0000-0002-5573-260X; Thangaraj, Kumarasamy/0000-0002-0075-0106; Jha, Aditya Nath/0000-0002-2824-7131; Singh, Ashish/0000-0001-8076-0816	Council of Scientific and Industrial Research, New Delhi [OLP0011]; UK-India Education and Research Initiative [RG-4772]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); UK-India Education and Research Initiative	This work was supported by the Council of Scientific and Industrial Research, New Delhi(www.csir.res.in) [Senior research fellowship to ANJ, Bhatanagar Fellowship OLP0011 to LS] and UK-India Education and Research Initiative (www.ukieri.org) RG-4772 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairwa M, 2012, HUMAN VACCINES IMMUN, P8; BANCHEREAU J, 1994, J LIPID MEDIAT CELL, V9, P43; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beasley TM, 1995, J EXP EDUC, V64, P79, DOI 10.1080/00220973.1995.9943797; Buchs N, 2000, RHEUMATOLOGY, V39, P1126, DOI 10.1093/rheumatology/39.10.1126; Burke TF, 2000, BIOCHEM BIOPH RES CO, V270, P1016, DOI 10.1006/bbrc.2000.2508; Cabantous S, 2009, J INFECT DIS, V200, P1530, DOI 10.1086/644600; Carvalho LH, 2002, NAT MED, V8, P166, DOI 10.1038/nm0202-166; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Driss A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-271; Eid NA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-119; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farouk SE, 2005, MICROBES INFECT, V7, P110, DOI 10.1016/j.micinf.2004.09.012; FELL AH, 1994, PARASITE IMMUNOL, V16, P579, DOI 10.1111/j.1365-3024.1994.tb00313.x; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Gyan BA, 2004, CLIN EXP IMMUNOL, V138, P145, DOI 10.1111/j.1365-2249.2004.02590.x; Hill AVS, 1999, P ASSOC AM PHYSICIAN, V111, P272, DOI 10.1046/j.1525-1381.1999.99234.x; Huber JP, 2010, J IMMUNOL, V185, P813, DOI 10.4049/jimmunol.1000469; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P1984, DOI 10.1210/jc.85.5.1984; Kantarci OH, 2003, J NEUROIMMUNOL, V137, P134, DOI 10.1016/S0165-5728(03)00046-8; Luoni G, 2001, GENES IMMUN, V2, P411, DOI 10.1038/sj.gene.6363797; MARSH DG, 1995, CLIN EXP ALLERGY, V25, P79, DOI 10.1111/j.1365-2222.1995.tb00429.x; McGuire W, 1999, J INFECT DIS, V179, P287, DOI 10.1086/314533; Mittal RD, 2007, IMMUNOGENETICS, V59, P159, DOI 10.1007/s00251-006-0182-6; Morrell CN, 2011, INFECT IMMUN, V79, P1750, DOI 10.1128/IAI.00810-10; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakashima H, 2002, GENES IMMUN, V3, P107, DOI 10.1038/sj.gene.6363830; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; PERLMANN H, 1994, CLIN EXP IMMUNOL, V97, P284, DOI 10.1111/j.1365-2249.1994.tb06082.x; Perlmann P, 1999, IMMUNOL LETT, V65, P29, DOI 10.1016/S0165-2478(98)00120-5; Perlmann P, 2000, AM J TROP MED HYG, V62, P373, DOI 10.4269/ajtmh.2000.62.373; Perlmann P, 1997, INFECT IMMUN, V65, P116, DOI 10.1128/IAI.65.1.116-121.1997; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rockman MV, 2003, CURR BIOL, V13, P2118, DOI 10.1016/j.cub.2003.11.025; Rosenwasser LJ, 1997, AM J RESP CRIT CARE, V156, pS152, DOI 10.1164/ajrccm.156.4.12tac-14; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Tangteerawatana P, 2007, ACTA TROP, V101, P258, DOI 10.1016/j.actatropica.2007.02.008; Thangaraj K, 2002, J ANDROL, V23, P815; Vafa M, 2007, MICROBES INFECT, V9, P1043, DOI 10.1016/j.micinf.2007.04.011; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Vasudevan R, 2011, GENET MOL RES, V10, P943, DOI 10.4238/vol10-2gmr1066; Verra F, 2004, ACTA TROP, V90, P205, DOI 10.1016/j.actatropica.2003.11.014; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416	49	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e48136	10.1371/journal.pone.0048136	http://dx.doi.org/10.1371/journal.pone.0048136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110190	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200150
J	Massad, TJ; Dyer, LA; Vega, CG				Massad, Tara Joy; Dyer, Lee A.; Vega, Gerardo C.			Costs of Defense and a Test of the Carbon-Nutrient Balance and Growth-Differentiation Balance Hypotheses for Two Co-Occurring Classes of Plant Defense	PLOS ONE			English	Article							RESOURCE AVAILABILITY; INDUCED RESISTANCE; DECIDUOUS TREES; FITNESS COSTS; YOUNG LEAVES; ALLOCATION; RESPONSES; LIGHT; HERBIVORY; NITROGEN	One of the goals of chemical ecology is to assess costs of plant defenses. Intraspecific trade-offs between growth and defense are traditionally viewed in the context of the carbon-nutrient balance hypothesis (CNBH) and the growth-differentiation balance hypothesis (GDBH). Broadly, these hypotheses suggest that growth is limited by deficiencies in carbon or nitrogen while rates of photosynthesis remain unchanged, and the subsequent reduced growth results in the more abundant resource being invested in increased defense (mass-balance based allocation). The GDBH further predicts trade-offs in growth and defense should only be observed when resources are abundant. Most support for these hypotheses comes from work with phenolics. We examined trade-offs related to production of two classes of defenses, saponins (triterpenoids) and flavans (phenolics), in Pentaclethra macroloba (Fabaceae), an abundant tree in Costa Rican wet forests. We quantified physiological costs of plant defenses by measuring photosynthetic parameters (which are often assumed to be stable) in addition to biomass. Pentaclethra macroloba were grown in full sunlight or shade under three levels of nitrogen alone or with conspecific neighbors that could potentially alter nutrient availability via competition or facilitation. Biomass and photosynthesis were not affected by nitrogen or competition for seedlings in full sunlight, but they responded positively to nitrogen in shade-grown plants. The trade-off predicted by the GDBH between growth and metabolite production was only present between flavans and biomass in sun-grown plants (abundant resource conditions). Support was also only partial for the CNBH as flavans declined with nitrogen but saponins increased. This suggests saponin production should be considered in terms of detailed biosynthetic pathway models while phenolic production fits mass-balance based allocation models (such as the CNBH). Contrary to expectations based on the two defense hypotheses, trade-offs were found between defenses and photosynthesis, indicating that studies of plant defenses should include direct measures of physiological responses.	[Dyer, Lee A.; Vega, Gerardo C.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Massad, Tara Joy] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Tulane University	Massad, TJ (corresponding author), Univ Chicago, Program Global Environm, Chicago, IL 60637 USA.	tmassad77@gmail.com	Massad, Tara Joy/AAS-6548-2021; Massad, Tara J/E-1587-2013	Massad, Tara Joy/0000-0002-7669-3312; 	Environmental Protection Agency STAR Fellowship; National Science Foundation grant [CHE 0849369]; Organization for Tropical Studies	Environmental Protection Agency STAR Fellowship(United States Environmental Protection Agency); National Science Foundation grant(National Science Foundation (NSF)); Organization for Tropical Studies	This work was funded by an Environmental Protection Agency STAR Fellowship; support was also provided by the National Science Foundation grant, CHE 0849369, and the Organization for Tropical Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Agrell J, 2004, J CHEM ECOL, V30, P2309, DOI 10.1023/B:JOEC.0000048791.74017.93; Agrell J, 2000, OIKOS, V88, P259, DOI 10.1034/j.1600-0706.2000.880204.x; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; BALDWIN IT, 1990, ECOLOGY, V71, P252, DOI 10.2307/1940264; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Boege K, 2004, PLANT ECOL, V175, P59, DOI 10.1023/B:VEGE.0000048092.82296.9a; BROWN DG, 1988, OECOLOGIA, V76, P467, DOI 10.1007/BF00377044; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Burns AE, 2002, OECOLOGIA, V133, P288, DOI 10.1007/s00442-002-1055-9; CATES RG, 1975, ECOLOGY, V56, P410, DOI 10.2307/1934971; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Coley PD, 2005, ECOLOGY, V86, P2633, DOI 10.1890/04-1283; Coley PD, 2002, OECOLOGIA, V133, P62, DOI 10.1007/s00442-002-1005-6; Cornelissen TG, 2001, AUSTRAL ECOL, V26, P246, DOI 10.1046/j.1442-9993.2001.01109.x; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Delaney KJ, 2009, AM MIDL NAT, V162, P224, DOI 10.1674/0003-0031-162.2.224; Donaldson JR, 2006, NEW PHYTOL, V169, P561, DOI 10.1111/j.1469-8137.2005.01613.x; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Fincher R, 2007, THESIS TULANE U; Folgarait PJ, 1996, ENTOMOL EXP APPL, V80, P521, DOI 10.1007/BF00343477; FOX LR, 1981, AM ZOOL, V21, P853; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Gershenzon J., 1994, INSECT PLANT INTERAC, V5, P73; Glynn C, 2003, OIKOS, V101, P385, DOI 10.1034/j.1600-0706.2003.12089.x; Gould F, 1988, VARIABLE PLANTS HERB, P13; Hale BK, 2005, J CHEM ECOL, V31, P2601, DOI 10.1007/s10886-005-7616-8; Hamback PA, 2003, OIKOS, V101, P26, DOI 10.1034/j.1600-0706.2003.12568.x; Hamilton JG, 2001, ECOL LETT, V4, P86, DOI 10.1046/j.1461-0248.2001.00192.x; Haukioja E, 1998, CHEMOECOLOGY, V8, P133, DOI 10.1007/s000490050018; Heidel AJ, 2004, PLANT CELL ENVIRON, V27, P1362, DOI 10.1111/j.1365-3040.2004.01228.x; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Hemming JDC, 1999, J CHEM ECOL, V25, P1687, DOI 10.1023/A:1020805420160; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Honkanen T, 1999, FUNCT ECOL, V13, P126, DOI 10.1046/j.1365-2435.1999.00296.x; IASON GR, 1993, J ECOL, V81, P75, DOI 10.2307/2261225; Jaakola L, 2004, PLANTA, V218, P721, DOI 10.1007/s00425-003-1161-x; Jones CG, 1999, OIKOS, V86, P27, DOI 10.2307/3546567; Koricheva J, 1998, OIKOS, V83, P212, DOI 10.2307/3546833; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Kurokawa H, 2004, OECOLOGIA, V140, P261, DOI 10.1007/s00442-004-1566-7; Kursar TA, 2009, P NATL ACAD SCI USA, V106, P18073, DOI 10.1073/pnas.0904786106; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; LERDAU M, 1995, ECOLOGY, V76, P2640, DOI 10.2307/2265834; Lerdau M, 2002, OIKOS, V98, P534, DOI 10.1034/j.1600-0706.2002.980318.x; LEVIN DA, 1976, ANNU REV ECOL SYST, V7, P121, DOI 10.1146/annurev.es.07.110176.001005; Liang Y, 2008, PLANT BIOLOGY, V10, P415, DOI 10.1111/j.1438-8677.2008.00064.x; LINDROTH RL, 1993, ECOLOGY, V74, P763, DOI 10.2307/1940804; Lokvam J, 2005, J CHEM ECOL, V31, P2563, DOI 10.1007/s10886-005-7614-x; Lou YG, 2004, PLANT PHYSIOL, V135, P496, DOI 10.1104/pp.104.040360; Massad T, 2009, THESIS TULANE U; Massad TJ, 2011, ARTHROPOD-PLANT INTE, V5, P125, DOI 10.1007/s11829-011-9121-z; Massey FP, 2005, J TROP ECOL, V21, P195, DOI 10.1017/S0266467404002111; McDonald EP, 1999, OECOLOGIA, V119, P389, DOI 10.1007/PL00008822; MOLE S, 1988, J CHEM ECOL, V14, P1, DOI 10.1007/BF01022527; MUZIKA RM, 1992, TREES-STRUCT FUNCT, V6, P241, DOI 10.1007/BF00224343; NICHOLSORIANS CM, 1991, ECOLOGY, V72, P1609, DOI 10.2307/1940961; Osier TL, 2006, OECOLOGIA, V148, P293, DOI 10.1007/s00442-006-0373-8; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; ROTH SK, 1994, OECOLOGIA, V98, P133, DOI 10.1007/BF00341464; Ruuhola T, 2003, J CHEM ECOL, V29, P1565, DOI 10.1023/A:1024266612585; SAGE RF, 1987, PLANT PHYSIOL, V85, P355, DOI 10.1104/pp.85.2.355; SAGERS CL, 1995, ECOLOGY, V76, P1835, DOI 10.2307/1940715; Schmidtke A, 2010, OECOLOGIA, V164, P665, DOI 10.1007/s00442-010-1688-z; Shipley B., 2000, CAUSE CORRELATIONS B; SMEDEGAARDPETERSEN V, 1981, PHYTOPATHOLOGY, V71, P396, DOI 10.1094/Phyto-71-396; Stamp N, 2004, OIKOS, V107, P439, DOI 10.1111/j.0030-1299.2004.12039.x; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; WALTER CA, 1989, OECOLOGIA, V80, P27, DOI 10.1007/BF00789927; Zangerl AR, 1997, OECOLOGIA, V109, P433, DOI 10.1007/s004420050103	71	72	77	1	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47554	10.1371/journal.pone.0047554	http://dx.doi.org/10.1371/journal.pone.0047554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23115654	Green Published, gold, Green Submitted			2022-12-25	WOS:000310310200050
J	Luo, M; Weng, YG; Tang, J; Hu, M; Liu, Q; Jiang, FB; Yang, DD; Liu, C; Zhan, XQ; Song, PP; Bai, HL; Li, BL; Shi, Q				Luo, Min; Weng, Yaguang; Tang, Jian; Hu, Min; Liu, Qiang; Jiang, Fengbing; Yang, Dandan; Liu, Chen; Zhan, Xiaoqin; Song, Peipei; Bai, Huili; Li, Baolin; Shi, Qiong			MicroRNA-450a-3p Represses Cell Proliferation and Regulates Embryo Development by Regulating Bub1 Expression in Mouse	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CHROMOSOME SEGREGATION; MITOTIC CHECKPOINT; HUMAN CANCER; MICRORNAS; MECHANISM; GENES; DIFFERENTIATION; ASSOCIATION; INHIBITION	Bub1 is a critical component of the spindle assembly checkpoint (SAC) and closely linked to cell proliferation and differentiation. We previously found that spontaneous abortion embryos contained a low level of Bub1 protein but normal mRNA level, while the knockdown of Bub1 leads to abnormal numerical chromosomes in embryonic cells. Here, we investigated the mechanism through which governs the post-transcriptional regulation of Bub1 protein expression level. We first conducted bioinformatics analysis and identified eight putative miRNAs that may target Bub1. Luciferase reporter assay confirmed that miR-450a-3p can directly regulate Bub1 by binding to the 3'-untranslated region of Bub1 mRNA. We found that the overexpression of miR-450a-3p in mouse embryonic fibroblast (MEF) cells down-regulated Bub1 protein level, repressed cell proliferation, increased apoptosis and restricted most cells in G1 phase of the cell cycle. Furthermore, when the fertilized eggs were microinjected with miR-450a-3p mimics, the cleavage of zygotes was effectively suppressed. Our results strongly suggest that an abnormally decreased Bub1 level regulated by miRNAs may be implicated in the pathogenesis of spontaneous miscarriage. Therefore, the blockade of miR-450a-3p may be explored as a novel therapeutic strategy for preventing spontaneous miscarriages.	[Luo, Min; Weng, Yaguang; Hu, Min; Liu, Qiang; Jiang, Fengbing; Yang, Dandan; Liu, Chen; Zhan, Xiaoqin; Song, Peipei; Bai, Huili; Li, Baolin; Shi, Qiong] Chongqing Med Univ, Key Lab Clin Lab Diagnost, Educ Minist China, Chongqing, Peoples R China; [Luo, Min; Weng, Yaguang; Hu, Min; Liu, Qiang; Jiang, Fengbing; Yang, Dandan; Liu, Chen; Zhan, Xiaoqin; Song, Peipei; Bai, Huili; Li, Baolin; Shi, Qiong] Chongqing Med Univ, Sch Clin Diagnost & Lab Med, Chongqing, Peoples R China; [Tang, Jian] Chongqing Med Univ, Affiliated Chengdu Women & Childrens Cent Hosp, Chengdu, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Shi, Q (corresponding author), Chongqing Med Univ, Key Lab Clin Lab Diagnost, Educ Minist China, Chongqing, Peoples R China.	anniesq8718@yahoo.com.cn	Liu, Qiang/HHZ-3181-2022; YANG, Dan/HHD-2733-2022		National Natural Science Foundation of China [30872770, NSFC30872770, 30371485, NSFC 30371485]; Chongqing Science and Technology Commission (CSTC) [2011BB5131]; Ministry of Education Foundation of China [20060631012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science and Technology Commission (CSTC)(Natural Science Foundation Project of CQ CSTC); Ministry of Education Foundation of China(Ministry of Education, China)	This work was supported by grant 30872770 from the National Natural Science Foundation of China (NSFC30872770) Foundation, by Chongqing Science and Technology Commission (CSTC,2011BB5131), by the Ministry of Education Foundation of China (20060631012), and by grant 30371485 from the National Natural Science Foundation of China (NSFC 30371485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Doak SH, 2004, MUTAT RES-FUND MOL M, V547, P133, DOI 10.1016/j.mrfmmm.2003.12.009; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Gao FM, 2009, CANCER BIOL THER, V8, P627, DOI 10.4161/cbt.8.7.7928; Gjoerup OV, 2007, P NATL ACAD SCI USA, V104, P8334, DOI 10.1073/pnas.0703164104; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hernando E, 2001, INT J CANCER, V95, P223, DOI 10.1002/1097-0215(20010720)95:4<223::AID-IJC1038>3.0.CO;2-L; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li SSL, 2006, STEM CELLS DEV, V15, P532, DOI 10.1089/scd.2006.15.532; Masuda A, 2002, ONCOGENE, V21, P6884, DOI 10.1038/sj.onc.1205566; Meraldi P, 2005, EMBO J, V24, P1621, DOI 10.1038/sj.emboj.7600641; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Niikura Y, 2007, J CELL BIOL, V178, P283, DOI 10.1083/jcb.200702134; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Perera D, 2007, DEV CELL, V13, P566, DOI 10.1016/j.devcel.2007.08.008; Shi QO, 2011, MOL HUM REPROD, V17, P14, DOI 10.1093/molehr/gaq065; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Steuerwald N, 2001, MOL HUM REPROD, V7, P49, DOI 10.1093/molehr/7.1.49; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Tilston Valerie, 2009, BMC Res Notes, V2, P190, DOI 10.1186/1756-0500-2-190; Wells D, 2005, HUM REPROD, V20, P1339, DOI 10.1093/humrep/deh778; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105	32	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47914	10.1371/journal.pone.0047914	http://dx.doi.org/10.1371/journal.pone.0047914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110129	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400025
J	Lanaspa, MA; Sanchez-Lozada, LG; Cicerchi, C; Li, NX; Roncal-Jimenez, CA; Ishimoto, T; Le, M; Garcia, GE; Thomas, JB; Rivard, CJ; Andres-Hernando, A; Hunter, B; Schreiner, G; Rodriguez-Iturbe, B; Sautin, YY; Johnson, RJ				Lanaspa, Miguel A.; Sanchez-Lozada, Laura G.; Cicerchi, Christina; Li, Nanxing; Roncal-Jimenez, Carlos A.; Ishimoto, Takuji; Le, Myphuong; Garcia, Gabriela E.; Thomas, Jeffrey B.; Rivard, Christopher J.; Andres-Hernando, Ana; Hunter, Brandi; Schreiner, George; Rodriguez-Iturbe, Bernardo; Sautin, Yuri Y.; Johnson, Richard J.			Uric Acid Stimulates Fructokinase and Accelerates Fructose Metabolism in the Development of Fatty Liver	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIETARY FRUCTOSE; HYPERINSULINEMIC MEN; RISK-FACTORS; DISEASE; GLUCOSE; EXPRESSION; RAT; HOMEOSTASIS; STEATOHEPATITIS	Excessive dietary fructose intake may have an important role in the current epidemics of fatty liver, obesity and diabetes as its intake parallels the development of these syndromes and because it can induce features of metabolic syndrome. The effects of fructose to induce fatty liver, hypertriglyceridemia and insulin resistance, however, vary dramatically among individuals. The first step in fructose metabolism is mediated by fructokinase (KHK), which phosphorylates fructose to fructose-1-phosphate; intracellular uric acid is also generated as a consequence of the transient ATP depletion that occurs during this reaction. Here we show in human hepatocytes that uric acid up-regulates KHK expression thus leading to the amplification of the lipogenic effects of fructose. Inhibition of uric acid production markedly blocked fructose-induced triglyceride accumulation in hepatocytes in vitro and in vivo. The mechanism whereby uric acid stimulates KHK expression involves the activation of the transcription factor ChREBP, which, in turn, results in the transcriptional activation of KHK by binding to a specific sequence within its promoter. Since subjects sensitive to fructose often develop phenotypes associated with hyperuricemia, uric acid may be an underlying factor in sensitizing hepatocytes to fructose metabolism during the development of fatty liver.	[Lanaspa, Miguel A.; Sanchez-Lozada, Laura G.; Cicerchi, Christina; Li, Nanxing; Roncal-Jimenez, Carlos A.; Ishimoto, Takuji; Le, Myphuong; Garcia, Gabriela E.; Thomas, Jeffrey B.; Rivard, Christopher J.; Andres-Hernando, Ana; Hunter, Brandi; Johnson, Richard J.] Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO 80045 USA; [Sanchez-Lozada, Laura G.] INC Ignacio Chavez, Lab Renal Physiopathol, Mexico City, DF, Mexico; [Sanchez-Lozada, Laura G.] INC Ignacio Chavez, Dept Nephrol, Mexico City, DF, Mexico; [Schreiner, George] Cardero Therapeut Inc, Menlo Pk, CA USA; [Rodriguez-Iturbe, Bernardo] Inst Venezolano Invest Cient Zuli, Maracaibo, Venezuela; [Rodriguez-Iturbe, Bernardo] Hosp Univ & Univ Zulia, Maracaibo, Venezuela; [Sautin, Yuri Y.] Univ Florida, Dept Med, Div Nephrol Hypertens & Transplantat, Gainesville, FL USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of Florida	Lanaspa, MA (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO 80045 USA.	miguel.lanaspagarcia@ucdenver.edu	Sanchez-Lozada, Laura/AAS-2104-2021; Ishimoto, Takuji/M-4873-2014; Lanaspa, Miguel/AAO-4971-2020	Ishimoto, Takuji/0000-0002-9861-5331; Andres-Hernando, Ana/0000-0002-0676-0188; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617; Sautin, Yuri/0000-0003-3618-5134	University of Colorado [HL-68607, RC4 DK090859-01]; CONACyT, Mexico [081054]; National Institutes of Health; Amway; Cardero; Danone; Questcor; Sugar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090859] Funding Source: NIH RePORTER	University of Colorado; CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amway; Cardero; Danone(Danone Nutricia); Questcor; Sugar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grants HL-68607 and RC4 DK090859-01, and startup funds from the University of Colorado (to RJJ) and by grant 081054 from CONACyT, Mexico (to LGSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: MAL, TI, and RJJ are listed as inventors on a patent application from the University of Colorado related to developing isoform-specific fructokinase inhibitors in the treatment of disorders associated with obesity and insulin resistance. Patent international number PCT/US11/46938 filed on August 8, 2011. TI and RJJ are listed as inventors on several patent applications related to lowering uric acid as a means to prevent or treat metabolic syndrome, as follows: US Patent No. 6,352,975 B1, Issued March 5, 2002 (Application No. 09/392,932, filed 09/09/1999) "Methods of Treating Hypertension and Compositions for Use Therein." US Patent No 6,677,300. Issued Jan 13, 2004. (Application No. 09/392, 931, filed 09/09/99) "Treatment of Microvascular Angiopathies." US Patent No. 7,030,083 B2 Issued April 18, 2006 (Application No. 10/418,529, Filed 4/16/2003) Issued Nov 10, 2005 "Treatment of eclampsia and preeclampsia." US Patent No 7,799,794 B2, Issued Sep 21, 2010, (Application 09/892,505; Filed Jun 28, 2001 Treatment for Cardiovascular Disease. RJJ also has a patent with the University of Washington and Merck for the use of allopurinol to treat hypertension. RJJ also discloses that he has consulted for Ardea, Astellas, Danone and Novartis, that he is on the scientific board of Amway, and that he has received grants from the National Institutes of Health and from Amway, Cardero, Danone, Questcor and the Sugar Foundation. GS is employed by a commercial company (Cardero Therapeutics). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; BODE JC, 1973, EUR J CLIN INVEST, V3, P436, DOI 10.1111/j.1365-2362.1973.tb02211.x; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; BURANT CF, 1994, AM J PHYSIOL, V267, pG71, DOI 10.1152/ajpgi.1994.267.1.G71; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Couchepin C, 2008, DIABETES CARE, V31, P1254, DOI 10.2337/dc07-2001; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Ferreira VSG, 2010, ARQ BRAS ENDOCRINOL, V54, P362, DOI 10.1590/S0004-27302010000400004; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; HALLFRISCH J, 1983, AM J CLIN NUTR, V37, P740, DOI 10.1093/ajcn/37.5.740; HALLFRISCH J, 1986, J AM COLL NUTR, V5, P61; HALLFRISCH J, 1983, J NUTR, V113, P1819, DOI 10.1093/jn/113.9.1819; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Johnson Richard J, 2010, Trans Am Clin Climatol Assoc, V121, P295; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Johnson RJ, 2010, T AM CLIN CLIMAT ASS, V121, P305; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Koo HY, 2008, BBA-MOL BASIS DIS, V1782, P341, DOI 10.1016/j.bbadis.2008.02.007; Koo HY, 2009, BIOCHEM BIOPH RES CO, V390, P285, DOI 10.1016/j.bbrc.2009.09.109; KORIEH A, 1991, ARCH INT PHYSIOL BIO, V99, P455; Kuo CF, 2010, SCAND J RHEUMATOL, V39, P466, DOI 10.3109/03009741003742797; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Lee K, 2009, DIABETES METAB, V35, P447, DOI 10.1016/j.diabet.2009.04.011; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Van den Berghe G, 1986, Prog Biochem Pharmacol, V21, P1; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Xu CF, 2010, HEPATOLOGY, V52, P1865, DOI 10.1002/hep.23798; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Yamada T, 2010, ACTA GASTRO-ENT BELG, V73, P12; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	45	181	192	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47948	10.1371/journal.pone.0047948	http://dx.doi.org/10.1371/journal.pone.0047948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112875	gold, Green Submitted, Green Published			2022-12-25	WOS:000310310200116
J	Rau, TF; Lu, Q; Sharma, S; Sun, XT; Leary, G; Beckman, ML; Hou, YL; Wainwright, MS; Kavanaugh, M; Poulsen, DJ; Black, SM				Rau, Thomas F.; Lu, Qing; Sharma, Shruti; Sun, Xutong; Leary, Gregory; Beckman, Matthew L.; Hou, Yali; Wainwright, Mark S.; Kavanaugh, Michael; Poulsen, David J.; Black, Stephen M.			Oxygen Glucose Deprivation in Rat Hippocampal Slice Cultures Results in Alterations in Carnitine Homeostasis and Mitochondrial Dysfunction	PLOS ONE			English	Article							ACETYL-L-CARNITINE; OLD RATS; PULMONARY-HYPERTENSION; OXIDATIVE STRESS; ENERGY DEPLETION; NEURONAL DEATH; BRAIN-INJURY; LIPOIC ACID; ISCHEMIA; DECAY	Mitochondrial dysfunction characterized by depolarization of mitochondrial membranes and the initiation of mitochondrial-mediated apoptosis are pathological responses to hypoxia-ischemia (HI) in the neonatal brain. Carnitine metabolism directly supports mitochondrial metabolism by shuttling long chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Our previous studies have shown that HI disrupts carnitine homeostasis in neonatal rats and that L-carnitine can be neuroprotective. Thus, this study was undertaken to elucidate the molecular mechanisms by which HI alters carnitine metabolism and to begin to elucidate the mechanism underlying the neuroprotective effect of L-carnitine (LCAR) supplementation. Utilizing neonatal rat hippocampal slice cultures we found that oxygen glucose deprivation (OGD) decreased the levels of free carnitines (FC) and increased the acylcarnitine (AC): FC ratio. These changes in carnitine homeostasis correlated with decreases in the protein levels of carnitine palmitoyl transferase (CPT) 1 and 2. LCAR supplementation prevented the decrease in CPT1 and CPT2, enhanced both FC and the AC: FC ratio and increased slice culture metabolic viability, the mitochondrial membrane potential prior to OGD and prevented the subsequent loss of neurons during later stages of reperfusion through a reduction in apoptotic cell death. Finally, we found that LCAR supplementation preserved the structural integrity and synaptic transmission within the hippocampus after OGD. Thus, we conclude that LCAR supplementation preserves the key enzymes responsible for maintaining carnitine homeostasis and preserves both cell viability and synaptic transmission after OGD.	[Rau, Thomas F.; Leary, Gregory; Beckman, Matthew L.; Kavanaugh, Michael; Poulsen, David J.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Lu, Qing; Sharma, Shruti; Sun, Xutong; Hou, Yali; Black, Stephen M.] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Wainwright, Mark S.] Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA	University of Montana System; University of Montana; University System of Georgia; Augusta University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Rau, TF (corresponding author), Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.	david.poulsen@umontana.edu; sblack@georgiahealth.edu		Sharma, Shruti/0000-0001-8200-108X; Verma, Vipin/0000-0002-3296-5494	United States National Institutes of Health [HD039110, HL60190, HL67841, HL084739, HD057406]; Fondation LeDucq; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039110, R21HD057406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067841, R01HL084739, R01HL060190] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation LeDucq(Leducq Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by grants HD039110 (SMB), HL60190 (SMB), HL67841 (SMB), HL084739 (SMB), and HD057406 (SMB) all from the United States National Institutes of Health and by a grant from the Fondation LeDucq (SMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2006, CLIN EXP PHARMACOL P, V33, P725, DOI 10.1111/j.1440-1681.2006.04425.x; Ambalavanan N, 2006, PEDIATRICS, V118, P2084, DOI 10.1542/peds.2006-1591; Ames BN, 1998, TOXICOL LETT, V103, P5, DOI 10.1016/S0378-4274(98)00282-3; Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073; Ames BN, 2004, ARCH BIOCHEM BIOPHYS, V423, P227, DOI 10.1016/j.abb.2003.11.002; Ames BN, 2003, J NUTR, V133, p1544S, DOI 10.1093/jn/133.5.1544S; Bayes R, 2001, EARLY HUM DEV, V65, pS103, DOI 10.1016/S0378-3782(01)00212-2; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Brennan LA, 2003, CIRC RES, V92, P683, DOI 10.1161/01.RES.0000063424.28903.BB; Budd SL, 1998, PHARMACOL THERAPEUT, V80, P203, DOI 10.1016/S0163-7258(98)00029-1; Burda J, 2009, CELL MOL NEUROBIOL, V29, P821, DOI 10.1007/s10571-009-9363-9; Cam H, 2005, J TROP PEDIATRICS, V51, P106, DOI 10.1093/tropej/fmh089; Cronberg T, 2004, STROKE, V35, P753, DOI 10.1161/01.STR.0000117576.09512.32; Domorakova I, 2009, CELL MOL NEUROBIOL, V29, P837, DOI 10.1007/s10571-009-9365-7; Dutta A, 2009, INT J BIOMETEOROL, V53, P397, DOI 10.1007/s00484-009-0224-5; Grobe AC, 2006, AM J PHYSIOL-LUNG C, V290, pL1069, DOI 10.1152/ajplung.00408.2005; Hagen TM, 2002, P NATL ACAD SCI USA, V99, P7184; Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562; HOSHIDA S, 1993, AM J PHYSIOL, V264, pH33, DOI 10.1152/ajpheart.1993.264.1.H33; Hoshida S, 2002, CARDIOVASC RES, V55, P495, DOI 10.1016/S0008-6363(02)00337-1; HOSHIDA S, 1993, HEART VESSELS, V8, P115, DOI 10.1007/BF01744795; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Hwang YC, 2002, CORONARY ARTERY DIS, V13, P313, DOI 10.1097/00019501-200209000-00002; Kim JH, 2007, NEUROSCI LETT, V411, P56, DOI 10.1016/j.neulet.2006.10.004; Kim JH, 2006, NEUROSCI LETT, V400, P1, DOI 10.1016/j.neulet.2006.01.035; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Long JG, 2009, NEUROCHEM RES, V34, P755, DOI 10.1007/s11064-008-9850-2; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McLean C, 2004, SEMIN PERINATOL, V28, P425, DOI 10.1053/j.semperi.2004.10.005; Nabetani M, 1997, BRAIN RES, V769, P158, DOI 10.1016/S0006-8993(97)00819-6; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; Northington FJ, 2005, BRAIN RES REV, V50, P244, DOI 10.1016/j.brainresrev.2005.07.003; Pogatsa G, 2001, CORONARY ARTERY DIS, V12, pS29; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Singh N, 2012, CELL MOL NEUROBIOL; SOMJEN GG, 1993, RES P ARNMD, V71, P51; Stubbs M, 2010, ADV ENZYME REGUL, V50, P44, DOI 10.1016/j.advenzreg.2009.10.027; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; VALLEE L, 1994, EUR J PEDIATR, V153, P598, DOI 10.1007/BF02190669; Wainwright MS, 2003, PEDIATR RES, V54, P688, DOI 10.1203/01.PDR.0000085036.07561.9C; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	45	70	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e40881	10.1371/journal.pone.0040881	http://dx.doi.org/10.1371/journal.pone.0040881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	23112863	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700001
J	Santos, ARC; Corredor, RG; Obeso, BA; Trakhtenberg, EF; Wang, Y; Ponmattam, J; Dvoriantchikova, G; Ivanov, D; Shestopalov, VI; Goldberg, JL; Fini, ME; Bajenaru, ML				Santos, Andrea Rachelle C.; Corredor, Raul G.; Obeso, Betty Albo; Trakhtenberg, Ephraim F.; Wang, Ying; Ponmattam, Jamie; Dvoriantchikova, Galina; Ivanov, Dmitry; Shestopalov, Valery I.; Goldberg, Jeffrey L.; Fini, Mary Elizabeth; Bajenaru, Michaela Livia			beta 1 Integrin-Focal Adhesion Kinase (FAK) Signaling Modulates Retinal Ganglion Cell (RGC) Survival	PLOS ONE			English	Article							NEURITE OUTGROWTH; EXTRACELLULAR-MATRIX; AXONAL REGENERATION; LINKED KINASE; UP-REGULATION; BRAIN-INJURY; OPTIC-NERVE; IN-VITRO; ISCHEMIA; PATHWAY	Extracellular matrix (ECM) integrity in the central nervous system (CNS) is essential for neuronal homeostasis. Signals from the ECM are transmitted to neurons through integrins, a family of cell surface receptors that mediate cell attachment to ECM. We have previously established a causal link between the activation of the matrix metalloproteinase-9 (MMP-9), degradation of laminin in the ECM of retinal ganglion cells (RGCs), and RGC death in a mouse model of retinal ischemia-reperfusion injury (RIRI). Here we investigated the role of laminin-integrin signaling in RGC survival in vitro, and after ischemia in vivo. In purified primary rat RGCs, stimulation of the beta 1 integrin receptor with laminin, or agonist antibodies enhanced RGC survival in correlation with activation of beta 1 integrin's major downstream regulator, focal adhesion kinase (FAK). Furthermore, beta 1 integrin binding and FAK activation were required for RGCs' survival response to laminin. Finally, in vivo after RIRI, we observed an up-regulation of MMP-9, proteolytic degradation of laminin, decreased RGC expression of beta 1 integrin, FAK and Akt dephosphorylation, and reduced expression of the pro-survival molecule bcl-xL in the period preceding RGC apoptosis. RGC death was prevented, in the context of laminin degradation, by maintaining beta 1 integrin activation with agonist antibodies. Thus, disruption of homeostatic RGC-laminin interaction and signaling leads to cell death after retinal ischemia, and maintaining integrin activation may be a therapeutic approach to neuroprotection.	[Santos, Andrea Rachelle C.; Corredor, Raul G.; Obeso, Betty Albo; Trakhtenberg, Ephraim F.; Wang, Ying; Ponmattam, Jamie; Dvoriantchikova, Galina; Ivanov, Dmitry; Shestopalov, Valery I.; Goldberg, Jeffrey L.; Fini, Mary Elizabeth; Bajenaru, Michaela Livia] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Trakhtenberg, Ephraim F.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Neurosci Program, Miami, FL 33136 USA; [Fini, Mary Elizabeth] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Southern California	Bajenaru, ML (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	lbajenaru@med.miami.edu	Santos, Ana M./AAB-6302-2019; López-Sánchez, Noelia/F-5533-2010; Frade, Jose M/E-7913-2013; Martín-Oliva, David/L-8472-2014; de la Villa, Pedro/G-2322-2016; Shestopalov, Valery/AAE-9838-2020; Cuadros, Miguel A/L-3954-2014	Santos, Ana M./0000-0002-9540-2226; Frade, Jose M/0000-0001-7067-2505; Martín-Oliva, David/0000-0002-8095-5442; de la Villa, Pedro/0000-0001-9856-6616; Cuadros, Miguel A/0000-0003-4259-1649; Goldberg, Jeffrey/0000-0002-1390-7360; Shestopalov, Valery/0000-0002-1568-6637; Lopez-Sanchez, Noelia/0000-0003-3095-3438; Ivanov, Dmitry/0000-0002-5573-4402	American Heart Association (AHA) [09SDG2280555, 0735014B, 11PRE7310069]; National Institutes of Health (NIH) [EY12651]; NIH [EY020913, NS061348, R21EY020613, EY017991, T32 NS007492, 5 P30-EY014801-08]; Glaucoma Foundation (TGF); Research to Prevent Blindness (RPB)	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Foundation (TGF); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	The authors acknowledge support from American Heart Association (http://www.heart.org/HEARTORG/) Scientist Development Grant (AHA SDG) 09SDG2280555 to M.L.B.; National Institutes of Health (http://www.nih.gov/) (NIH) grant EY12651, Walter G. Ross Distinguished Chair in Ophthalmic Research to M.E.F.; NIH grant EY020913, NS061348, and Walter G. Ross Distinguished Chair in Ophthalmic Research to J.L.G; NIH grant R21EY020613, American Heart Association (AHA) 0735014B to D.I.; NIH grant EY017991, The Glaucoma Foundation (http://www.glaucomafoundation.org/) (TGF) grant, Research to Prevent Blindness (https://www.rpbusa.org/rpb/)(RPB) Career Development Award to V.I.S.; NIH grant T32 NS007492, American Heart Association (AHA) 11PRE7310069 to E.F.T. Bascom Palmer is also supported by NIH core center grant 5 P30-EY014801-08, and an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AE, 1998, PHARMACOL REV, V50, P197; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahi M, 2001, NEUROREPORT, V12, P3003, DOI 10.1097/00001756-200109170-00050; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Bozzi M, 2009, MATRIX BIOL, V28, P179, DOI 10.1016/j.matbio.2009.03.003; BREM RB, 1994, INVEST OPHTH VIS SCI, V35, P3466; Brocco MA, 1999, DEV BRAIN RES, V118, P23, DOI 10.1016/S0165-3806(99)00120-0; BUCHI ER, 1991, OPHTHALMOLOGICA, V203, P138; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Clegg DO, 2003, FRONT BIOSCI-LANDMRK, V8, pD723, DOI 10.2741/1020; COHEN S, 1987, IN VITRO CELL DEV B, V23, P239; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; DECURTIS I, 1993, DEVELOPMENT, V118, P377; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; Dreixler JC, 2009, EXP EYE RES, V88, P512, DOI 10.1016/j.exer.2008.11.013; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gardiner NJ, 2005, MOL CELL NEUROSCI, V28, P229, DOI 10.1016/j.mcn.2004.08.017; Gary DS, 2003, J NEUROCHEM, V84, P878, DOI 10.1046/j.1471-4159.2003.01579.x; Gary DS, 2001, J NEUROCHEM, V76, P1485, DOI 10.1046/j.1471-4159.2001.00173.x; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Grimpe B, 2002, J NEUROSCI, V22, P3144, DOI 10.1523/JNEUROSCI.22-08-03144.2002; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Halfter W, 2000, DEV BIOL, V220, P111, DOI 10.1006/dbio.2000.9649; Hu Y, 2010, INVEST OPHTH VIS SCI, V51, P1747, DOI 10.1167/iovs.09-4450; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Ivins JK, 2004, J NEUROSCI, V24, P1212, DOI 10.1523/JNEUROSCI.4689-03.2004; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Ju WK, 2003, EXP EYE RES, V77, P137, DOI 10.1016/S0014-4835(03)00128-3; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kaneda K, 1999, BRAIN RES, V815, P11, DOI 10.1016/S0006-8993(98)01074-9; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Kunzevitzky NJ, 2010, INVEST OPHTH VIS SCI, V51, P3800, DOI 10.1167/iovs.09-4540; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P967; Lemons ML, 2006, EXP NEUROL, V202, P324, DOI 10.1016/j.expneurol.2006.06.008; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Libby R T, 2000, Results Probl Cell Differ, V31, P115; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Limb GA, 2002, AM J PATHOL, V160, P1847, DOI 10.1016/S0002-9440(10)61131-5; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Molina A, 2005, J AM SOC NEPHROL, V16, P374, DOI 10.1681/ASN.2004070528; Morissette N, 1995, J NEUROSCI, V15, P8067; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; NEUGEBAUER KM, 1991, NATURE, V350, P68, DOI 10.1038/350068a0; Otsuka K, 1997, J Nihon Univ Sch Dent, V39, P182; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Plantman S, 2005, NEUROREPORT, V16, P709, DOI 10.1097/00001756-200505120-00011; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; Savitz SI, 2006, BRAIN RES, V1118, P168, DOI 10.1016/j.brainres.2006.05.060; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Tagami Y, 2009, JPN J OPHTHALMOL, V53, P257, DOI 10.1007/s10384-009-0657-8; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Tonges L, 2011, J NEUROCHEM, V117, P892, DOI 10.1111/j.1471-4159.2011.07257.x; Vachon P. H., 2011, J SIGNAL TRANSDUCT, V2011; WEAVER CD, 1995, J NEUROSCI, V15, P5275; Yu WM, 2005, J NEUROSCI, V25, P4463, DOI 10.1523/JNEUROSCI.5032-04.2005; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang Y, 2005, INVEST OPHTH VIS SCI, V46, P2133, DOI 10.1167/iovs.04-1235; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	89	53	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48332	10.1371/journal.pone.0048332	http://dx.doi.org/10.1371/journal.pone.0048332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	22558402	gold, Green Submitted, Green Published			2022-12-25	WOS:000310600500108
J	Zheng, DH; Limmon, GV; Yin, L; Leung, NHN; Yu, H; Chow, VTK; Chen, JZ				Zheng, Dahai; Limmon, Gino V.; Yin, Lu; Leung, Nicola H. N.; Yu, Hanry; Chow, Vincent T. K.; Chen, Jianzhu			Regeneration of Alveolar Type I and II Cells from Scgb1a1-Expressing Cells following Severe Pulmonary Damage Induced by Bleomycin and Influenza	PLOS ONE			English	Article							LUNG STEM-CELLS; MOUSE LUNG; PROGENITOR CELLS; MAINTENANCE; EPITHELIUM; REPAIR; AIRWAY; TOXICITY; CANCER; MICE	The lung comprises an extensive surface of epithelia constantly exposed to environmental insults. Maintaining the integrity of the alveolar epithelia is critical for lung function and gaseous exchange. However, following severe pulmonary damage, what progenitor cells give rise to alveolar type I and II cells during the regeneration of alveolar epithelia has not been fully determined. In this study, we have investigated this issue by using transgenic mice in which Scgb1a1-expressing cells and their progeny can be genetically labeled with EGFP. We show that following severe alveolar damage induced either by bleomycin or by infection with influenza virus, the majority of the newly generated alveolar type II cells in the damaged parenchyma were labeled with EGFP. A large proportion of EGFP-expressing type I cells were also observed among the type II cells. These findings strongly suggest that Scgb1a1-expressing cells, most likely Clara cells, are a major cell type that gives rise to alveolar type I and II cells during the regeneration of alveolar epithelia in response to severe pulmonary damage in mice.	[Chow, Vincent T. K.] Natl Univ Singapore, Sch Med, Dept Microbiol, Human Genome Lab, Singapore 117548, Singapore; [Zheng, Dahai; Limmon, Gino V.; Yin, Lu; Leung, Nicola H. N.; Chen, Jianzhu] Singapore Massachusetts Inst Technol Alliance Res, Interdisciplinary Res Grp Infect Dis, Singapore, Singapore; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA USA; [Yu, Hanry] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Yu, Hanry] Natl Univ Singapore, Dept Physiol & Mechanobiol, Singapore 117548, Singapore	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore	Chow, VTK (corresponding author), Natl Univ Singapore, Sch Med, Dept Microbiol, Human Genome Lab, Singapore 117548, Singapore.	vincent_chow@nuhs.edu.sg; jchen@mit.edu	Yu, Hanry/L-6050-2019; Limmon, Gino/X-5913-2019; Yu, Hanry/C-7375-2011; Yu, Hanry/C-1031-2013	Yu, Hanry/0000-0002-0339-3685; Limmon, Gino/0000-0003-3030-7022; Yu, Hanry/0000-0002-0339-3685; Chow, Vincent/0000-0003-2634-6213; Zheng, Dawei/0000-0002-7545-167X; Yin, Lu/0000-0002-3651-8608	National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's Infectious Disease-IRG research programme	National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's Infectious Disease-IRG research programme	This research was supported by the National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's Infectious Disease-IRG research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1976, ENVIRON HEALTH PERSP, V16, P119, DOI 10.2307/3428592; [Anonymous], 2011, NAT MED, V17, P788; ASO Y, 1976, LAB INVEST, V35, P558; Azambuja E, 2005, PULM PHARMACOL THER, V18, P363, DOI 10.1016/j.pupt.2005.01.007; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Liu XM, 2006, METHOD ENZYMOL, V419, P285, DOI 10.1016/S0076-6879(06)19012-6; McQualter JL, 2012, STEM CELLS, V30, P811, DOI 10.1002/stem.1055; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2010, INT J BIOCHEM CELL B, V42, P1, DOI 10.1016/j.biocel.2009.09.002; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Schraufnagel Dean E, 2010, Pathophysiology, V17, P337, DOI 10.1016/j.pathophys.2009.10.008; Siniscalco Dario, 2008, Ther Adv Respir Dis, V2, P173, DOI 10.1177/1753465808092340; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Teisanu RM, 2009, STEM CELLS, V27, P612, DOI 10.1634/stemcells.2008-0838; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; WOOLFENDEN JM, 1979, CANCER, V43, P1652, DOI 10.1002/1097-0142(197905)43:5<1652::AID-CNCR2820430514>3.0.CO;2-I	26	134	139	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48451	10.1371/journal.pone.0048451	http://dx.doi.org/10.1371/journal.pone.0048451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119022	Green Published, gold, Green Submitted			2022-12-25	WOS:000310600500140
J	Xu, J; Ji, PF; Zhao, ZX; Zhang, Y; Feng, JX; Wang, J; Li, JT; Zhang, XF; Zhao, L; Liu, GZ; Xu, P; Sun, XW				Xu, Jian; Ji, Peifeng; Zhao, Zixia; Zhang, Yan; Feng, Jianxin; Wang, Jian; Li, Jiongtang; Zhang, Xiaofeng; Zhao, Lan; Liu, Guangzan; Xu, Peng; Sun, Xiaowen			Genome-Wide SNP Discovery from Transcriptome of Four Common Carp Strains	PLOS ONE			English	Article							ASSOCIATION MAPPING POPULATION; CYPRINUS-CARPIO; LINKAGE MAP; MARKERS; MICROSATELLITE; GENERATION; CATFISH; CONSTRUCTION; SEQUENCES; LOCI	Background: Single nucleotide polymorphisms (SNPs) have been used as genetic marker for genome-wide association studies in many species. Gene-associated SNPs could offer sufficient coverage in trait related research and further more could themselves be causative SNPs for traits. Common carp (Cyprinus carpio) is one of the most important aquaculture species in the world accounting for nearly 14% of freshwater aquaculture production. There are various strains of common carp with different economic traits, however, the genetic mechanism underlying the different traits have not been elucidated yet. In this project, we identified a large number of gene-associated SNPs from four strains of common carp using next-generation sequencing. Results: Transcriptome sequencing of four strains of common carp (mirror carp, purse red carp, Xingguo red carp, Yellow River carp) was performed with Solexa HiSeq2000 platform. De novo assembled transcriptome was used as reference for alignments, and SNP calling was done through BWA and SAMtools. A total of 712,042 Intra-strain SNPs were discovered in four strains, of which 483,276 SNPs for mirror carp, 486,629 SNPs for purse red carp, 478,028 SNPs for Xingguo red carp and 488,281 SNPs for Yellow River carp were discovered, respectively. Besides, 53,893 inter-SNPs were identified. Strain-specific SNPs of four strains were 53,938, 53,866, 48,701, 40,131 in mirror carp, purse red carp, Xingguo red carp and Yellow River carp, respectively. GO and KEGG pathway analysis were done to reveal strain-specific genes affected by strain-specific non-synonymous SNPs. Validation of selected SNPs revealed that 48% percent of SNPs (12 of 25) were tested to be true SNPs. Conclusions: Transcriptome analysis of common carp using RNA-Seq is a cost-effective way of generating numerous reads for SNP discovery. After validation of identified SNPs, these data will provide a solid base for SNP array designing and genome-wide association studies.	[Xu, Jian; Ji, Peifeng; Zhao, Zixia; Zhang, Yan; Wang, Jian; Li, Jiongtang; Zhao, Lan; Xu, Peng; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Zhang, Xiaofeng; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang Fisheries Res Inst, Harbin, Peoples R China; [Feng, Jianxin] Henan Acad Fishery Sci, Zhengzhou, Henan, Peoples R China; [Liu, Guangzan] Natl Fish Hatchery Xingguo Red Carp, Xingguo, Jiangxi, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS	Xu, P (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China.	xupeng@cafs.ac.cn; sunxw2002@163.com	Wang, Jian/M-4594-2018; Zhao, Zi-Xia/AAM-8065-2021; Xu, Jian/H-5349-2019; Sun, Xiaowen/F-1516-2014; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078	National Department Public Benefit Research Foundation [200903045]; National High-tech R&D Program of China [2009AA10Z105, 2011AA100401]; China Ministry of Agriculture "948" Program [2010-Z11]; National Natural Science Foundation [31101893]	National Department Public Benefit Research Foundation; National High-tech R&D Program of China(National High Technology Research and Development Program of China); China Ministry of Agriculture "948" Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from National Department Public Benefit Research Foundation (200903045), National High-tech R&D Program of China (2009AA10Z105 and 2011AA100401), China Ministry of Agriculture "948" Program (2010-Z11) and National Natural Science Foundation (31101893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Feugang JM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-176; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kongchum P, 2010, FISH SHELLFISH IMMUN, V29, P356, DOI 10.1016/j.fsi.2010.04.013; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Mao Rui-Xin, 2009, Yichuan, V31, P407, DOI 10.3724/SP.J.1005.2009.00407; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Sun X., 2012, PLANT ANIMAL GENOME; Sun X, 2004, AQUACULTURE, V238, P8; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Vera M, 2011, AQUACULTURE, V313, P31, DOI 10.1016/j.aquaculture.2011.01.038; Wan Y, 2011, MOL BIOL REPORTS; Wang D, 2007, AQUACULTURE, V271, P558, DOI 10.1016/j.aquaculture.2007.06.001; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Wood SH, 2009, IMMUNOGENETICS, V61, P765, DOI 10.1007/s00251-009-0402-y; Xu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021057; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zhang Ya-Qin, 2011, Medical Mycology, V49, P435, DOI 10.3109/13693786.2010.540723; Zhang Y, 2008, J GENET GENOMICS, V35, P97, DOI 10.1016/S1673-8527(08)60015-6; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3; Zheng Xian-Hu, 2011, Yichuan, V33, P1366, DOI 10.3724/SP.J.1005.2011.01366; Zhou Jianfeng, 2004, Genetika, V40, P1389	41	104	115	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48140	10.1371/journal.pone.0048140	http://dx.doi.org/10.1371/journal.pone.0048140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	22383953	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500040
J	Kim, M; Yoon, S; Lee, S; Ha, SA; Kim, HK; Kim, JW; Chung, J				Kim, Minsoo; Yoon, Soomin; Lee, Sukmook; Ha, Seon Ah; Kim, Hyun Kee; Kim, Jin Woo; Chung, Junho			Gremlin-1 Induces BMP-Independent Tumor Cell Proliferation, Migration, and Invasion	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; ANTAGONIST GREMLIN-1; DRM/GREMLIN; CANCER; EXPRESSION; CARCINOMA; DAN	Gremlin-1, a bone morphogenetic protein (BMP) antagonist, is overexpressed in various cancerous tissues but its role in carcinogenesis has not been established. Here, we report that gremlin-1 binds various cancer cell lines and this interaction is inhibited by our newly developed gremlin-1 antibody, GRE1. Gremlin-1 binding to cancer cells was unaffected by the presence of BMP-2, BMP-4, and BMP-7. In addition, the binding was independent of vascular endothelial growth factor receptor-2 (VEGFR2) expression on the cell surface. Addition of gremlin-1 to A549 cells induced a fibroblast-like morphology and decreased E-cadherin expression. In a scratch wound healing assay, A549 cells incubated with gremlin-1 or transfected with gremlin-1 showed increased migration, which was inhibited in the presence of the GRE1 antibody. Gremlin-1 transfected A549 cells also exhibited increased invasiveness as well as an increased growth rate. These effects were also inhibited by the addition of the GRE1 antibody. In conclusion, this study demonstrates that gremlin-1 directly interacts with cancer cells in a BMP- and VEGFR2-independent manner and can induce cell migration, invasion, and proliferation.	[Kim, Minsoo; Yoon, Soomin; Chung, Junho] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Kim, Minsoo] Seoul Natl Univ, Coll Med, Dept Canc Biol, Seoul, South Korea; [Kim, Minsoo; Chung, Junho] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Sukmook] Scripps Korea Antibody Inst, Chuncheon Si, Gangwon Do, South Korea; [Ha, Seon Ah; Kim, Jin Woo] Catholic Univ Korea, Coll Med, Mol Genet Lab, Seoul, South Korea; [Kim, Hyun Kee; Kim, Jin Woo] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Catholic University of Korea	Kim, M (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.	jjhchung@snu.ac.kr	Chung, Junho/J-2792-2012		Korea Biotech R&D Group of Next-generation growth engine project of the Ministry of Education, Science and Technology, Republic of Korea [2011K000737]	Korea Biotech R&D Group of Next-generation growth engine project of the Ministry of Education, Science and Technology, Republic of Korea	This research was supported by a grant (2011K000737) from Korea Biotech R&D Group of Next-generation growth engine project of the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobinac D, 2005, CROAT MED J, V46, P389; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chung L, 2004, FASEB J, V18, pA345, DOI 10.1096/fj.03-0586fje; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Kim K, 2007, BIOCHEM BIOPH RES CO, V354, P115, DOI 10.1016/j.bbrc.2006.12.164; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Lappin DWP, 2000, CURR OPIN NEPHROL HY, V9, P469, DOI 10.1097/00041552-200009000-00002; Lee MS, 2008, HYBRIDOMA, V27, P18, DOI 10.1089/hyb.2007.0532; Li XL, 2009, CANCER CHEMOTH PHARM, V64, P1097, DOI 10.1007/s00280-009-0966-0; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Merino R, 1999, DEVELOPMENT, V126, P5515; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Park S, 2010, CLIN CHIM ACTA, V411, P1238, DOI 10.1016/j.cca.2010.04.027; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Sha GH, 2009, FERTIL STERIL, V91, P350, DOI 10.1016/j.fertnstert.2007.12.007; Shi W, 2001, AM J PHYSIOL-LUNG C, V280, pL1030, DOI 10.1152/ajplung.2001.280.5.L1030; Singh A, 2010, CYTOKINE GROWTH F R, V21, P299, DOI 10.1016/j.cytogfr.2010.06.003; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Stanley E, 1998, MECH DEVELOP, V77, P173, DOI 10.1016/S0925-4773(98)00139-7; Sun JP, 2006, J BIOL CHEM, V281, P29349, DOI 10.1074/jbc.M603833200; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Topol LZ, 2000, CYTOGENET CELL GENET, V89, P79, DOI 10.1159/000015568; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801	27	102	114	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35100	10.1371/journal.pone.0035100	http://dx.doi.org/10.1371/journal.pone.0035100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	23118971	gold, Green Submitted, Green Published			2022-12-25	WOS:000305341600118
J	Zhang, RL; Chopp, M; Roberts, C; Wei, M; Wang, XL; Liu, XS; Lu, M; Zhang, ZG				Zhang, Rui Lan; Chopp, Michael; Roberts, Cynthia; Wei, Min; Wang, Xinli; Liu, Xianshuang; Lu, Mei; Zhang, Zheng Gang			Sildenafil Enhances Neurogenesis and Oligodendrogenesis in Ischemic Brain of Middle-Aged Mouse	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SUBVENTRICULAR ZONE; PROGENITOR CELLS; FUNCTIONAL RECOVERY; EMBOLIC STROKE; WHITE-MATTER; OLIGODENDROCYTES; DIFFERENTIATION; ANGIOGENESIS; RATS	Adult neural stem cells give rise to neurons, oligodendrocytes and astrocytes. Aging reduces neural stem cells. Using an inducible nestin-CreER(T2)/R26R-yellow fluorescent protein (YFP) mouse, we investigated the effect of Sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, on nestin lineage neural stem cells and their progeny in the ischemic brain of the middle-aged mouse. We showed that focal cerebral ischemia induced nestin lineage neural stem cells in the subventricular zone (SVZ) of the lateral ventricles and nestin expressing NeuN positive neurons and adenomatous polyposis coli (APC) positive mature oligodendrocytes in the ischemic striatum and corpus callosum in the aged mouse. Treatment of the ischemic middle-aged mouse with Sildenafil increased nestin expressing neural stem cells, mature neurons, and oligodendrocytes by 33, 75, and 30%, respectively, in the ischemic brain. These data indicate that Sildenafil amplifies nestin expressing neural stem cells and their neuronal and oligodendrocyte progeny in the ischemic brain of the middle-aged mouse.	[Zhang, Rui Lan; Chopp, Michael; Roberts, Cynthia; Wei, Min; Wang, Xinli; Liu, Xianshuang; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University; Henry Ford Health System; Henry Ford Hospital	Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		National Institute of Neurological Disorders and Stroke [PO1 NS23392, RO1 AG037506, RO1 NS75156]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023392, R01NS075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	PO1 NS23392, RO1 AG037506, RO1 NS75156 (National Institute of Neurological Disorders and Stroke Grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Basak O, 2012, J NEUROSCI, V32, P5654, DOI 10.1523/JNEUROSCI.0455-12.2012; Bouab M, 2011, NEUROSCIENCE, V173, P135, DOI 10.1016/j.neuroscience.2010.11.032; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; CARROLL WM, 1990, BRAIN, V113, P953, DOI 10.1093/brain/113.4.953; Chalimoniuk M, 1998, MOL CHEM NEUROPATHOL, V35, P77, DOI 10.1007/BF02815117; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dewar D, 1999, EUR J PHARMACOL, V375, P41, DOI 10.1016/S0014-2999(99)00280-0; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Doetsch F, 1997, J NEUROSCI, V17, P5046; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Ness JK, 2005, GLIA, V50, P321, DOI 10.1002/glia.20206; Olariu A, 2007, J COMP NEUROL, V501, P659, DOI 10.1002/cne.21268; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; SHEN S, 2008, NAT NEUROSCI; Shen SM, 2008, NEUROBIOL AGING, V29, P452, DOI 10.1016/j.neurobiolaging.2006.10.026; Shruster A, 2010, APOPTOSIS, V15, P1415, DOI 10.1007/s10495-010-0491-y; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang L, 2006, BRAIN RES; Zhang L.N., 2010, IEEE T MAGN, V2010, P5, DOI DOI 10.1371/J0URNAL.P0NE.0011016; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2006, J NEUROSCI RES, V83, P1213, DOI 10.1002/jnr.20813; Zhang RL, 2011, J CEREBR BLOOD F MET, V31, P614, DOI 10.1038/jcbfm.2010.134; Zhang ZG, 1998, BRAIN RES, V784, P210, DOI 10.1016/S0006-8993(97)01317-6; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	45	68	70	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48141	10.1371/journal.pone.0048141	http://dx.doi.org/10.1371/journal.pone.0048141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118941	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500072
J	Santos, AM; Lopez-Sanchez, N; Martin-Oliva, D; de la Villa, P; Cuadros, MA; Frade, JM				Santos, Ana M.; Lopez-Sanchez, Noelia; Martin-Oliva, David; de la Villa, Pedro; Cuadros, Miguel A.; Frade, Jose M.			Sortilin Participates in Light-dependent Photoreceptor Degeneration in Vivo	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CELL-DEATH; NEUROTROPHIC FACTOR; NEURONAL APOPTOSIS; RECEPTOR SORTILIN; INHIBITORY FACTOR; PRONGF; P75; EXPRESSION; P75(NTR)	Both proNGF and the neurotrophin receptor p75 (p75(NTR)) are known to regulate photoreceptor cell death caused by exposure of albino mice to intense illumination. ProNGF-induced apoptosis requires the participation of sortilin as a necessary p75(NTR) co-receptor, suggesting that sortilin may participate in the photoreceptor degeneration triggered by intense lighting. We report here that light-exposed albino mice showed sortilin, p75(NTR), and proNGF expression in the outer nuclear layer, the retinal layer where photoreceptor cell bodies are located. In addition, cone progenitor-derived 661W cells subjected to intense illumination expressed sortilin and p75(NTR) and released proNGF into the culture medium. Pharmacological blockade of sortilin with either neurotensin or the "pro'' domain of proNGF (pro-peptide) favored the survival of 661W cells subjected to intense light. In vivo, the pro-peptide attenuated retinal cell death in light-exposed albino mice. We propose that an auto/paracrine proapoptotic mechanism based on the interaction of proNGF with the receptor complex p75(NTR)/sortilin participates in intense light-dependent photoreceptor cell death. We therefore propose sortilin as a putative target for intervention in hereditary retinal dystrophies.	[Santos, Ana M.; Martin-Oliva, David; Cuadros, Miguel A.] Univ Granada, Dept Cell Biol, Granada, Spain; [Lopez-Sanchez, Noelia; Frade, Jose M.] IC CSIC, Inst Cajal, Madrid, Spain; [de la Villa, Pedro] Univ Alcala De Henares, Dept Physiol, Sch Med, Madrid, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad de Alcala	Santos, AM (corresponding author), Univ Granada, Dept Cell Biol, Granada, Spain.	frade@cajal.csic.es	Santos, Ana M./AAB-6302-2019; López-Sánchez, Noelia/F-5533-2010; Frade, Jose M/E-7913-2013; Martín-Oliva, David/L-8472-2014; de la Villa, Pedro/G-2322-2016; Shestopalov, Valery/AAE-9838-2020; Cuadros, Miguel A/L-3954-2014	Santos, Ana M./0000-0002-9540-2226; Frade, Jose M/0000-0001-7067-2505; Martín-Oliva, David/0000-0002-8095-5442; de la Villa, Pedro/0000-0001-9856-6616; Cuadros, Miguel A/0000-0003-4259-1649; Goldberg, Jeffrey/0000-0002-1390-7360; Shestopalov, Valery/0000-0002-1568-6637; Lopez-Sanchez, Noelia/0000-0003-3095-3438; Ivanov, Dmitry/0000-0002-5573-4402	Ministerio de Ciencia e Innovacion [BFU2009-07671, BFU2007-61659]; Fundacion Lucha contra la Ceguera [FUNDALUCE-2008]; Junta de Andalucia [P07-CVI-03008]; University of Granada (GREIB)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Lucha contra la Ceguera; Junta de Andalucia(Junta de Andalucia); University of Granada (GREIB)	This study was supported by grants from the "Ministerio de Ciencia e Innovacion'' (BFU2009-07671) and from "Fundacion Lucha contra la Ceguera'' (FUNDALUCE-2008) to JMF, as well as from "Ministerio de Ciencia e Innovacion'' (BFU2007-61659), from "Junta de Andalucia'' (P07-CVI-03008), and from "University of Granada'' (2011 GREIB incentive) to MAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi R, 2008, EUR J NEUROSCI, V27, P2103, DOI 10.1111/j.1460-9568.2008.06152.x; Al-Shawi R, 2007, ANN NY ACAD SCI, V1119, P208, DOI 10.1196/annals.1404.024; ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; Andersen OS, 2010, J BIOL CHEM, V285, P12210, DOI 10.1074/jbc.M109.062364; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Chen LW, 2008, CNS NEUROL DISORD-DR, V7, P512, DOI 10.2174/187152708787122923; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; deKozak Y, 1997, OCUL IMMUNOL INFLAMM, V5, P85, DOI 10.3109/09273949709085056; Dicou E, 2004, J NEUROSCI RES, V78, P92, DOI 10.1002/jnr.20231; Dimaras H, 2006, MOL CARCINOGEN, V45, P333, DOI 10.1002/mc.20179; Dobrowsky RT, 2000, J NEUROSCI RES, V61, P237, DOI 10.1002/1097-4547(20000801)61:3<237::AID-JNR1>3.0.CO;2-M; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Frade JM, 1996, NATURE, V383, P166; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kanan Y, 2010, ADV EXP MED BIOL, V664, P3, DOI 10.1007/978-1-4419-1399-9_1; KORSCHING S, 1987, METHOD ENZYMOL, V147, P167; Larsen JV, 2010, MOL CELL BIOL, V30, P4175, DOI 10.1128/MCB.00274-10; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nakamura K, 2007, CELL DEATH DIFFER, V14, P1552, DOI 10.1038/sj.cdd.4402173; NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Provenzano MJ, 2008, LARYNGOSCOPE, V118, P87, DOI 10.1097/MLG.0b013e31814b8d9f; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rogue RS, 1999, BRAIN RES, V836, P110, DOI 10.1016/S0006-8993(99)01625-X; Rohrer B, 2003, EXP EYE RES, V76, P125, DOI 10.1016/S0014-4835(02)00258-0; Santos AM, 2010, J COMP NEUROL, V518, P477, DOI 10.1002/cne.22227; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Sheedlo HJ, 2002, MOL BRAIN RES, V103, P71, DOI 10.1016/S0169-328X(02)00185-7; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; Srinivasan B, 2004, J BIOL CHEM, V279, P41839, DOI 10.1074/jbc.M402872200; Srinivasan B, 2007, MOL CELL NEUROSCI, V36, P449, DOI 10.1016/j.mcn.2007.08.005; Stoica G, 2008, BRAIN RES, V1208, P204, DOI 10.1016/j.brainres.2008.02.085; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tauris J, 2011, EUR J NEUROSCI, V33, P622, DOI 10.1111/j.1460-9568.2010.07556.x; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Wei Y, 2007, NEUROSCI LETT, V429, P169, DOI 10.1016/j.neulet.2007.10.012; Xu FF, 2009, NEUROSCI LETT, V454, P81, DOI 10.1016/j.neulet.2009.02.036; YAMATO S, 1984, STAIN TECHNOL, V59, P113, DOI 10.3109/10520298409113840; Yang LP, 2007, MOL VIS, V13, P2048; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Yu DY, 2006, INVEST OPHTH VIS SCI, V47, P1109, DOI 10.1167/iovs.05-1118	59	53	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36243	10.1371/journal.pone.0036243	http://dx.doi.org/10.1371/journal.pone.0036243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558402	Green Published, Green Submitted, gold			2022-12-25	WOS:000305336000169
J	Fu, SM; Xu, J; Li, XB; Xie, YF; Qiu, YF; Du, XY; Yu, S; Bai, YX; Chen, YF; Wang, TK; Wang, ZJ; Yu, YQ; Peng, GN; Huang, KH; Huang, LY; Wang, YF; Chen, ZL				Fu, Simei; Xu, Jie; Li, Xianbo; Xie, Yongfei; Qiu, Yefeng; Du, Xinying; Yu, Shuang; Bai, Yaoxia; Chen, Yanfen; Wang, Tongkun; Wang, Zhoujia; Yu, Yaqing; Peng, Guangneng; Huang, Kehe; Huang, Liuyu; Wang, Yufei; Chen, Zeliang			Immunization of Mice with Recombinant Protein CobB or AsnC Confers Protection against Brucella abortus Infection	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; IMMUNE-RESPONSES; GAMMA-INTERFERON; MELITENSIS 16M; BALB/C MICE; LIVE; VACCINATION; IDENTIFICATION; MACROPHAGES; PERSISTENCE	Due to drawbacks of live attenuated vaccines, much more attention has been focused on screening of Brucella protective antigens as subunit vaccine candidates. Brucella is a facultative intracellular bacterium and cell mediated immunity plays essential roles for protection against Brucella infection. Identification of Brucella antigens that present T-cell epitopes to the host could enable development of such vaccines. In this study, 45 proven or putative pathogenesis-associated factors of Brucella were selected according to currently available data. After expressed and purified, 35 proteins were qualified for analysis of their abilities to stimulate T-cell responses in vitro. Then, an in vitro gamma interferon (IFN-gamma) assay was used to identify potential T-cell antigens from B. abortus. In total, 7 individual proteins that stimulated strong IFN-gamma responses in splenocytes from mice immunized with B. abortus live vaccine S19 were identified. The protective efficiencies of these 7 recombinant proteins were further evaluated. Mice given BAB1_1316 (CobB) or BAB1_1688 (AsnC) plus adjuvant could provide protection against virulent B. abortus infection, similarly with the known protective antigen Cu-Zn SOD and the license vaccine S19. In addition, CobB and AsnC could induce strong antibodies responses in BALB/c mice. Altogether, the present study showed that CobB or AsnC protein could be useful antigen candidates for the development of subunit vaccines against brucellosis with adequate immunogenicity and protection efficacy.	[Fu, Simei; Xu, Jie; Li, Xianbo; Xie, Yongfei; Du, Xinying; Yu, Shuang; Bai, Yaoxia; Chen, Yanfen; Wang, Tongkun; Wang, Zhoujia; Huang, Liuyu; Wang, Yufei; Chen, Zeliang] Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China; [Fu, Simei; Xu, Jie; Chen, Yanfen; Yu, Yaqing] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis,Sch Publ Hlth, Changchun 130023, Peoples R China; [Qiu, Yefeng] Acad Mil Med Sci, Ctr Expt Anim, Beijing, Peoples R China; [Xie, Yongfei; Huang, Kehe] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Li, Xianbo; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Yaan, Peoples R China	Academy of Military Medical Sciences - China; Jilin University; Academy of Military Medical Sciences - China; Nanjing Agricultural University; Sichuan Agricultural University	Fu, SM (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China.	yufeiwang21@yahoo.com; zeliangchen@yahoo.com	Wang, Jian/M-4594-2018; Zhao, Zi-Xia/AAM-8065-2021; Xu, Jian/H-5349-2019; Sun, Xiaowen/F-1516-2014; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078	National Key Program for Infectious Diseases of China [2008ZX10004-015]; National Basic Research Program of China [2009CB522602]; National Natural Science Foundation of China [30901071, 31000041, 81071320]	National Key Program for Infectious Diseases of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Key Program for Infectious Diseases of China (2008ZX10004-015), National Basic Research Program of China (Grant No. 2009CB522602), and the National Natural Science Foundation of China (30901071, 31000041, 81071320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mariri A, 2010, VACCINE, V28, P1766, DOI 10.1016/j.vaccine.2009.12.012; Altindis E, 2009, VACCINE, V27, P542, DOI 10.1016/j.vaccine.2008.11.020; Andrews E, 2006, MICROBIOL IMMUNOL, V50, P389, DOI 10.1111/j.1348-0421.2006.tb03805.x; Arenas GN, 2000, INFECT IMMUN, V68, P4255, DOI 10.1128/IAI.68.7.4255-4263.2000; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cassataro J, 2007, VACCINE, V25, P4437, DOI 10.1016/j.vaccine.2007.03.028; Chen ZJ, 2004, PROTEOMICS, V4, P3203, DOI 10.1002/pmic.200300844; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Covert BA, 2001, PROTEOMICS, V1, P574; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; den Hartigh AB, 2008, J BACTERIOL, V190, P4427, DOI 10.1128/JB.00406-08; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Edmonds MD, 2002, VET MICROBIOL, V88, P205, DOI 10.1016/S0378-1135(02)00110-4; Eze MO, 2000, INFECT IMMUN, V68, P257, DOI 10.1128/IAI.68.1.257-263.2000; Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gomes MS, 1998, IMMUNOLOGY, V95, P165; Grillo MJ, 2009, VACCINE, V27, P187, DOI 10.1016/j.vaccine.2008.10.065; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; He YQ, 2002, INFECT IMMUN, V70, P2535, DOI 10.1128/IAI.70.5.2535-2543.2002; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; Kaushik P, 2010, VET RES COMMUN, V34, P119, DOI 10.1007/s11259-009-9337-x; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003; Li B, 2005, INFECT IMMUN, V73, P3734, DOI 10.1128/IAI.73.6.3734-3739.2005; Li B, 2009, INFECT IMMUN, V77, P4356, DOI 10.1128/IAI.00242-09; Mallick AI, 2007, VACCINE, V25, P3692, DOI 10.1016/j.vaccine.2007.01.066; Mallick AI, 2007, VACCINE, V25, P7873, DOI 10.1016/j.vaccine.2007.09.008; Marchesini MI, 2004, MICROB PATHOGENESIS, V37, P95, DOI 10.1016/j.micpath.2004.06.001; Masignani V, 2002, EXPERT OPIN BIOL TH, V2, P895, DOI 10.1517/14712598.2.8.895; Mora M, 2003, DRUG DISCOV TODAY, V8, P459, DOI 10.1016/S1359-6446(03)02689-8; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Velikovsky CA, 2002, INFECT IMMUN, V70, P2507, DOI 10.1128/IAI.70.5.2507-2511.2002; Wang Y, 2011, VET MICROBIOLOGY; Yang YL, 2011, FEMS IMMUNOL MED MIC, V61, P159, DOI 10.1111/j.1574-695X.2010.00758.x; ZHAN YF, 1993, INFECT IMMUN, V61, P4899, DOI 10.1128/IAI.61.11.4899-4901.1993	40	104	115	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e29552	10.1371/journal.pone.0029552	http://dx.doi.org/10.1371/journal.pone.0029552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383953	Green Submitted, Green Published, gold			2022-12-25	WOS:000302916800002
J	Liu, Y; Niu, WQ; Wu, ZJ; Su, XX; Chen, QJ; Lu, L; Jin, W				Liu, Yan; Niu, Wenquan; Wu, Zhijun; Su, Xiuxiu; Chen, Qiujin; Lu, Lin; Jin, Wei			Variants in Exon 11 of MEF2A Gene and Coronary Artery Disease: Evidence from a Case-Control Study, Systematic Review, and Meta-Analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MEF2A; CAG REPEAT POLYMORPHISM; GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; SEQUENCE VARIANTS; HEART-DISEASE; MUTATIONS; SUSCEPTIBILITY; COMMON; RISK	Background: Coronary artery disease (CAD) is the most common heart disease worldwide. Association of CAD with variants in the myocyte enhancer factor 2A (MEF2A) gene, the first identified CAD-causing gene, has attracted special attention but the results are controversial. We aimed to evaluate this genetic association via a case-control study and meta-analysis. Methodology/Principal Findings: We performed a case-control association study to investigate the relationship between variations in exon 11 of MEF2A gene and CAD in 1045 sporadic patients and 1008 controls enrolled angiographically among southern Chinese population, and then the data from this study were compared and discussed in a systematic review and meta-analysis with all available published studies on MEF2A gene and CAD. In total, eight variants were identified (21-bp deletion, CAG repeats, CCG repeats, a CCA deletion and four SNPs). No significant link was observed between the common (CAG)(n) polymorphism and CAD, whereas the rare 21-bp deletion was detected only in five affected individuals. The meta-analysis of (CAG) n polymorphism and CAD risk, including nine studies with 3801 CAD patients and 4020 controls, also provided no convincing evidence for the genetic association, even upon stratification by race (mainly Whites and Chinese). However, the 21-bp deletion was regarded as a potentially logical, albeit undetermined, candidate for CAD in the following systematic review. Conclusions/Significance: Our findings failed to demonstrate a correlation between (CAG) n polymorphism with CAD, however, we concluded that the rare 21-bp deletion might have a more compelling effect on CAD than the common (CAG) n polymorphism, and MEF2A genetic variant might be a rare but specific cause of CAD/MI.	[Liu, Yan; Wu, Zhijun; Su, Xiuxiu; Chen, Qiujin; Lu, Lin; Jin, Wei] Shanghai Jiao Tong Univ, Dept Cardiol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Liu, Y (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	jinwei_ivy@126.com	wu, zhi/GXH-3041-2022	Jin, Wei/0000-0002-2905-2109	National Natural Science Foundation of China [81070177]; Shanghai Science and Technology Development Funds, China [08411963500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Funds, China	This work was supported by the National Natural Science Foundation of China (Grant Number: 81070177) and Shanghai Science and Technology Development Funds, China (08411963500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, J CLIN INVEST, V115, P831, DOI 10.1172/JCI200524715; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Dai DP, 2010, EUR J CLIN INVEST, V40, P669, DOI 10.1111/j.1365-2362.2010.02307.x; Dai DP, 2006, CHIN J GERIATR HEART, V8, P671; Damani SB, 2011, JACC-CARDIOVASC INTE, V4, P473, DOI 10.1016/j.jcin.2010.12.016; Dan QH, 2008, J DIAGN CONCEPTS PRA, V7, P404; De La Vega FM, 2011, BIOCOMPUT-PAC SYM, P74; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EINARSON TR, 1985, AM J HOSP PHARM, V42, P1957, DOI 10.1093/ajhp/42.9.1957; Elhawari S, 2010, ATHEROSCLEROSIS, V209, P152, DOI 10.1016/j.atherosclerosis.2009.09.005; Evans D, 2011, EXPERT REV CARDIOVAS, V9, P637, DOI [10.1586/ERC.11.53, 10.1586/erc.11.53]; Gonzalez P, 2006, J MED GENET, V43, P167, DOI 10.1136/jmg.2005.035071; Guella I, 2009, CIRC-CARDIOVASC GENE, V2, P165, DOI 10.1161/CIRCGENETICS.108.819326; Gulec S, 2008, CLIN APPL THROMB-HEM, V14, P465, DOI 10.1177/1076029607306403; Han YL, 2007, CLIN CHEM LAB MED, V45, P987, DOI 10.1515/CCLM.2007.159; Hartiala J, 2011, HUM GENET, V129, P617, DOI 10.1007/s00439-011-0963-3; He MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004851; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Horan PG, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-65; Hsu LA, 2010, CLIN APPL THROMB-HEM, V16, P301, DOI 10.1177/1076029608330476; Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71; Kajimoto K, 2005, CIRC J, V69, P1192, DOI 10.1253/circj.69.1192; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li Jing, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P265; Lida A, 2003, J HUM GENET, V48, P476, DOI 10.1007/s10038-003-0054-y; Lieb W, 2008, CIRCULATION, V117, P185, DOI 10.1161/CIRCULATIONAHA.107.728485; Lusis AJ, 2003, TRENDS CARDIOVAS MED, V13, P309, DOI 10.1016/j.tcm.2003.08.001; Maiolino G, 2012, EUR J CARDI IN PRESS; Ozaki K, 2005, CELL MOL LIFE SCI, V62, P1804, DOI 10.1007/s00018-005-5098-z; Panagiotou OA, 2010, AM J EPIDEMIOL, V172, P869, DOI 10.1093/aje/kwq234; Patel RS, 2011, HEART, V97, P1463, DOI 10.1136/hrt.2010.219675; Polychronakos C, 2008, CURR ATHEROSCLER REP, V10, P194, DOI 10.1007/s11883-008-0031-1; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Scheuner MT, 2003, GENET MED, V5, P269, DOI 10.1097/01.GIM.0000079364.98247.26; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Tsantes AE, 2007, INT J CARDIOL, V118, P189, DOI 10.1016/j.ijcard.2006.06.047; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2005, J CLIN INVEST, V115, P1399, DOI 10.1172/JCI25475; Weng L, 2005, J CLIN INVEST, V115, P1016, DOI 10.1172/JCI24186; White AJ, 2007, CARDIOVASC RES, V75, P813, DOI 10.1016/j.cardiores.2007.05.003; Wu D, 2008, CHINESE J CARDIAC PA, V22, P144; Yamada Yoshiji, 2008, Genomic Med, V2, P7, DOI 10.1007/s11568-008-9025-x; Yuan Hong, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P453	48	126	132	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31406	10.1371/journal.pone.0031406	http://dx.doi.org/10.1371/journal.pone.0031406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	23118931	Green Published, gold, Green Submitted			2022-12-25	WOS:000302873700054
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	23110176	Green Submitted, Green Published, gold			2022-12-25	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110176	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Development Core Team, 2009, R FDN STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	23110176	gold, Green Submitted, Green Published			2022-12-25	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200040
